(function(){const w=document.createElement("link").relList;if(w&&w.supports&&w.supports("modulepreload"))return;for(const H of document.querySelectorAll('link[rel="modulepreload"]'))u(H);new MutationObserver(H=>{for(const C of H)if(C.type==="childList")for(const L of C.addedNodes)L.tagName==="LINK"&&L.rel==="modulepreload"&&u(L)}).observe(document,{childList:!0,subtree:!0});function b(H){const C={};return H.integrity&&(C.integrity=H.integrity),H.referrerPolicy&&(C.referrerPolicy=H.referrerPolicy),H.crossOrigin==="use-credentials"?C.credentials="include":H.crossOrigin==="anonymous"?C.credentials="omit":C.credentials="same-origin",C}function u(H){if(H.ep)return;H.ep=!0;const C=b(H);fetch(H.href,C)}})();var kd={exports:{}},On={};var Lg;function Cp(){if(Lg)return On;Lg=1;var v=Symbol.for("react.transitional.element"),w=Symbol.for("react.fragment");function b(u,H,C){var L=null;if(C!==void 0&&(L=""+C),H.key!==void 0&&(L=""+H.key),"key"in H){C={};for(var x in H)x!=="key"&&(C[x]=H[x])}else C=H;return H=C.ref,{$$typeof:v,type:u,key:L,ref:H!==void 0?H:null,props:C}}return On.Fragment=w,On.jsx=b,On.jsxs=b,On}var Ug;function wp(){return Ug||(Ug=1,kd.exports=Cp()),kd.exports}var r=wp(),vd={exports:{}},q={};var Vg;function Dp(){if(Vg)return q;Vg=1;var v=Symbol.for("react.transitional.element"),w=Symbol.for("react.portal"),b=Symbol.for("react.fragment"),u=Symbol.for("react.strict_mode"),H=Symbol.for("react.profiler"),C=Symbol.for("react.consumer"),L=Symbol.for("react.context"),x=Symbol.for("react.forward_ref"),D=Symbol.for("react.suspense"),y=Symbol.for("react.memo"),O=Symbol.for("react.lazy"),E=Symbol.for("react.activity"),J=Symbol.iterator;function ze(m){return m===null||typeof m!="object"?null:(m=J&&m[J]||m["@@iterator"],typeof m=="function"?m:null)}var Be={isMounted:function(){return!1},enqueueForceUpdate:function(){},enqueueReplaceState:function(){},enqueueSetState:function(){}},Ce=Object.assign,Ti={};function Ge(m,S,M){this.props=m,this.context=S,this.refs=Ti,this.updater=M||Be}Ge.prototype.isReactComponent={},Ge.prototype.setState=function(m,S){if(typeof m!="object"&&typeof m!="function"&&m!=null)throw Error("takes an object of state variables to update or a function which returns an object of state variables.");this.updater.enqueueSetState(this,m,S,"setState")},Ge.prototype.forceUpdate=function(m){this.updater.enqueueForceUpdate(this,m,"forceUpdate")};function Ke(){}Ke.prototype=Ge.prototype;function j(m,S,M){this.props=m,this.context=S,this.refs=Ti,this.updater=M||Be}var ae=j.prototype=new Ke;ae.constructor=j,Ce(ae,Ge.prototype),ae.isPureReactComponent=!0;var we=Array.isArray;function Ae(){}var X={H:null,A:null,T:null,S:null},_e=Object.prototype.hasOwnProperty;function Ei(m,S,M){var U=M.ref;return{$$typeof:v,type:m,key:S,ref:U!==void 0?U:null,props:M}}function Xa(m,S){return Ei(m.type,S,m.props)}function Oi(m){return typeof m=="object"&&m!==null&&m.$$typeof===v}function Xe(m){var S={"=":"=0",":":"=2"};return"$"+m.replace(/[=:]/g,function(M){return S[M]})}var Da=/\/+/g;function Li(m,S){return typeof m=="object"&&m!==null&&m.key!=null?Xe(""+m.key):S.toString(36)}function Si(m){switch(m.status){case"fulfilled":return m.value;case"rejected":throw m.reason;default:switch(typeof m.status=="string"?m.then(Ae,Ae):(m.status="pending",m.then(function(S){m.status==="pending"&&(m.status="fulfilled",m.value=S)},function(S){m.status==="pending"&&(m.status="rejected",m.reason=S)})),m.status){case"fulfilled":return m.value;case"rejected":throw m.reason}}throw m}function N(m,S,M,U,F){var Z=typeof m;(Z==="undefined"||Z==="boolean")&&(m=null);var re=!1;if(m===null)re=!0;else switch(Z){case"bigint":case"string":case"number":re=!0;break;case"object":switch(m.$$typeof){case v:case w:re=!0;break;case O:return re=m._init,N(re(m._payload),S,M,U,F)}}if(re)return F=F(m),re=U===""?"."+Li(m,0):U,we(F)?(M="",re!=null&&(M=re.replace(Da,"$&/")+"/"),N(F,S,M,"",function(Ut){return Ut})):F!=null&&(Oi(F)&&(F=Xa(F,M+(F.key==null||m&&m.key===F.key?"":(""+F.key).replace(Da,"$&/")+"/")+re)),S.push(F)),1;re=0;var Fe=U===""?".":U+":";if(we(m))for(var Ne=0;Ne<m.length;Ne++)U=m[Ne],Z=Fe+Li(U,Ne),re+=N(U,S,M,Z,F);else if(Ne=ze(m),typeof Ne=="function")for(m=Ne.call(m),Ne=0;!(U=m.next()).done;)U=U.value,Z=Fe+Li(U,Ne++),re+=N(U,S,M,Z,F);else if(Z==="object"){if(typeof m.then=="function")return N(Si(m),S,M,U,F);throw S=String(m),Error("Objects are not valid as a React child (found: "+(S==="[object Object]"?"object with keys {"+Object.keys(m).join(", ")+"}":S)+"). If you meant to render a collection of children, use an array instead.")}return re}function R(m,S,M){if(m==null)return m;var U=[],F=0;return N(m,U,"","",function(Z){return S.call(M,Z,F++)}),U}function G(m){if(m._status===-1){var S=m._result;S=S(),S.then(function(M){(m._status===0||m._status===-1)&&(m._status=1,m._result=M)},function(M){(m._status===0||m._status===-1)&&(m._status=2,m._result=M)}),m._status===-1&&(m._status=0,m._result=S)}if(m._status===1)return m._result.default;throw m._result}var ce=typeof reportError=="function"?reportError:function(m){if(typeof window=="object"&&typeof window.ErrorEvent=="function"){var S=new window.ErrorEvent("error",{bubbles:!0,cancelable:!0,message:typeof m=="object"&&m!==null&&typeof m.message=="string"?String(m.message):String(m),error:m});if(!window.dispatchEvent(S))return}else if(typeof process=="object"&&typeof process.emit=="function"){process.emit("uncaughtException",m);return}console.error(m)},he={map:R,forEach:function(m,S,M){R(m,function(){S.apply(this,arguments)},M)},count:function(m){var S=0;return R(m,function(){S++}),S},toArray:function(m){return R(m,function(S){return S})||[]},only:function(m){if(!Oi(m))throw Error("React.Children.only expected to receive a single React element child.");return m}};return q.Activity=E,q.Children=he,q.Component=Ge,q.Fragment=b,q.Profiler=H,q.PureComponent=j,q.StrictMode=u,q.Suspense=D,q.__CLIENT_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE=X,q.__COMPILER_RUNTIME={__proto__:null,c:function(m){return X.H.useMemoCache(m)}},q.cache=function(m){return function(){return m.apply(null,arguments)}},q.cacheSignal=function(){return null},q.cloneElement=function(m,S,M){if(m==null)throw Error("The argument must be a React element, but you passed "+m+".");var U=Ce({},m.props),F=m.key;if(S!=null)for(Z in S.key!==void 0&&(F=""+S.key),S)!_e.call(S,Z)||Z==="key"||Z==="__self"||Z==="__source"||Z==="ref"&&S.ref===void 0||(U[Z]=S[Z]);var Z=arguments.length-2;if(Z===1)U.children=M;else if(1<Z){for(var re=Array(Z),Fe=0;Fe<Z;Fe++)re[Fe]=arguments[Fe+2];U.children=re}return Ei(m.type,F,U)},q.createContext=function(m){return m={$$typeof:L,_currentValue:m,_currentValue2:m,_threadCount:0,Provider:null,Consumer:null},m.Provider=m,m.Consumer={$$typeof:C,_context:m},m},q.createElement=function(m,S,M){var U,F={},Z=null;if(S!=null)for(U in S.key!==void 0&&(Z=""+S.key),S)_e.call(S,U)&&U!=="key"&&U!=="__self"&&U!=="__source"&&(F[U]=S[U]);var re=arguments.length-2;if(re===1)F.children=M;else if(1<re){for(var Fe=Array(re),Ne=0;Ne<re;Ne++)Fe[Ne]=arguments[Ne+2];F.children=Fe}if(m&&m.defaultProps)for(U in re=m.defaultProps,re)F[U]===void 0&&(F[U]=re[U]);return Ei(m,Z,F)},q.createRef=function(){return{current:null}},q.forwardRef=function(m){return{$$typeof:x,render:m}},q.isValidElement=Oi,q.lazy=function(m){return{$$typeof:O,_payload:{_status:-1,_result:m},_init:G}},q.memo=function(m,S){return{$$typeof:y,type:m,compare:S===void 0?null:S}},q.startTransition=function(m){var S=X.T,M={};X.T=M;try{var U=m(),F=X.S;F!==null&&F(M,U),typeof U=="object"&&U!==null&&typeof U.then=="function"&&U.then(Ae,ce)}catch(Z){ce(Z)}finally{S!==null&&M.types!==null&&(S.types=M.types),X.T=S}},q.unstable_useCacheRefresh=function(){return X.H.useCacheRefresh()},q.use=function(m){return X.H.use(m)},q.useActionState=function(m,S,M){return X.H.useActionState(m,S,M)},q.useCallback=function(m,S){return X.H.useCallback(m,S)},q.useContext=function(m){return X.H.useContext(m)},q.useDebugValue=function(){},q.useDeferredValue=function(m,S){return X.H.useDeferredValue(m,S)},q.useEffect=function(m,S){return X.H.useEffect(m,S)},q.useEffectEvent=function(m){return X.H.useEffectEvent(m)},q.useId=function(){return X.H.useId()},q.useImperativeHandle=function(m,S,M){return X.H.useImperativeHandle(m,S,M)},q.useInsertionEffect=function(m,S){return X.H.useInsertionEffect(m,S)},q.useLayoutEffect=function(m,S){return X.H.useLayoutEffect(m,S)},q.useMemo=function(m,S){return X.H.useMemo(m,S)},q.useOptimistic=function(m,S){return X.H.useOptimistic(m,S)},q.useReducer=function(m,S,M){return X.H.useReducer(m,S,M)},q.useRef=function(m){return X.H.useRef(m)},q.useState=function(m){return X.H.useState(m)},q.useSyncExternalStore=function(m,S,M){return X.H.useSyncExternalStore(m,S,M)},q.useTransition=function(){return X.H.useTransition()},q.version="19.2.0",q}var jg;function Md(){return jg||(jg=1,vd.exports=Dp()),vd.exports}var _=Md(),Nd={exports:{}},Rn={},Id={exports:{}},Td={};var zg;function xp(){return zg||(zg=1,(function(v){function w(N,R){var G=N.length;N.push(R);e:for(;0<G;){var ce=G-1>>>1,he=N[ce];if(0<H(he,R))N[ce]=R,N[G]=he,G=ce;else break e}}function b(N){return N.length===0?null:N[0]}function u(N){if(N.length===0)return null;var R=N[0],G=N.pop();if(G!==R){N[0]=G;e:for(var ce=0,he=N.length,m=he>>>1;ce<m;){var S=2*(ce+1)-1,M=N[S],U=S+1,F=N[U];if(0>H(M,G))U<he&&0>H(F,M)?(N[ce]=F,N[U]=G,ce=U):(N[ce]=M,N[S]=G,ce=S);else if(U<he&&0>H(F,G))N[ce]=F,N[U]=G,ce=U;else break e}}return R}function H(N,R){var G=N.sortIndex-R.sortIndex;return G!==0?G:N.id-R.id}if(v.unstable_now=void 0,typeof performance=="object"&&typeof performance.now=="function"){var C=performance;v.unstable_now=function(){return C.now()}}else{var L=Date,x=L.now();v.unstable_now=function(){return L.now()-x}}var D=[],y=[],O=1,E=null,J=3,ze=!1,Be=!1,Ce=!1,Ti=!1,Ge=typeof setTimeout=="function"?setTimeout:null,Ke=typeof clearTimeout=="function"?clearTimeout:null,j=typeof setImmediate<"u"?setImmediate:null;function ae(N){for(var R=b(y);R!==null;){if(R.callback===null)u(y);else if(R.startTime<=N)u(y),R.sortIndex=R.expirationTime,w(D,R);else break;R=b(y)}}function we(N){if(Ce=!1,ae(N),!Be)if(b(D)!==null)Be=!0,Ae||(Ae=!0,Xe());else{var R=b(y);R!==null&&Si(we,R.startTime-N)}}var Ae=!1,X=-1,_e=5,Ei=-1;function Xa(){return Ti?!0:!(v.unstable_now()-Ei<_e)}function Oi(){if(Ti=!1,Ae){var N=v.unstable_now();Ei=N;var R=!0;try{e:{Be=!1,Ce&&(Ce=!1,Ke(X),X=-1),ze=!0;var G=J;try{i:{for(ae(N),E=b(D);E!==null&&!(E.expirationTime>N&&Xa());){var ce=E.callback;if(typeof ce=="function"){E.callback=null,J=E.priorityLevel;var he=ce(E.expirationTime<=N);if(N=v.unstable_now(),typeof he=="function"){E.callback=he,ae(N),R=!0;break i}E===b(D)&&u(D),ae(N)}else u(D);E=b(D)}if(E!==null)R=!0;else{var m=b(y);m!==null&&Si(we,m.startTime-N),R=!1}}break e}finally{E=null,J=G,ze=!1}R=void 0}}finally{R?Xe():Ae=!1}}}var Xe;if(typeof j=="function")Xe=function(){j(Oi)};else if(typeof MessageChannel<"u"){var Da=new MessageChannel,Li=Da.port2;Da.port1.onmessage=Oi,Xe=function(){Li.postMessage(null)}}else Xe=function(){Ge(Oi,0)};function Si(N,R){X=Ge(function(){N(v.unstable_now())},R)}v.unstable_IdlePriority=5,v.unstable_ImmediatePriority=1,v.unstable_LowPriority=4,v.unstable_NormalPriority=3,v.unstable_Profiling=null,v.unstable_UserBlockingPriority=2,v.unstable_cancelCallback=function(N){N.callback=null},v.unstable_forceFrameRate=function(N){0>N||125<N?console.error("forceFrameRate takes a positive int between 0 and 125, forcing frame rates higher than 125 fps is not supported"):_e=0<N?Math.floor(1e3/N):5},v.unstable_getCurrentPriorityLevel=function(){return J},v.unstable_next=function(N){switch(J){case 1:case 2:case 3:var R=3;break;default:R=J}var G=J;J=R;try{return N()}finally{J=G}},v.unstable_requestPaint=function(){Ti=!0},v.unstable_runWithPriority=function(N,R){switch(N){case 1:case 2:case 3:case 4:case 5:break;default:N=3}var G=J;J=N;try{return R()}finally{J=G}},v.unstable_scheduleCallback=function(N,R,G){var ce=v.unstable_now();switch(typeof G=="object"&&G!==null?(G=G.delay,G=typeof G=="number"&&0<G?ce+G:ce):G=ce,N){case 1:var he=-1;break;case 2:he=250;break;case 5:he=1073741823;break;case 4:he=1e4;break;default:he=5e3}return he=G+he,N={id:O++,callback:R,priorityLevel:N,startTime:G,expirationTime:he,sortIndex:-1},G>ce?(N.sortIndex=G,w(y,N),b(D)===null&&N===b(y)&&(Ce?(Ke(X),X=-1):Ce=!0,Si(we,G-ce))):(N.sortIndex=he,w(D,N),Be||ze||(Be=!0,Ae||(Ae=!0,Xe()))),N},v.unstable_shouldYield=Xa,v.unstable_wrapCallback=function(N){var R=J;return function(){var G=J;J=R;try{return N.apply(this,arguments)}finally{J=G}}}})(Td)),Td}var Bg;function Ep(){return Bg||(Bg=1,Id.exports=xp()),Id.exports}var Sd={exports:{}},qe={};var Gg;function Op(){if(Gg)return qe;Gg=1;var v=Md();function w(D){var y="https://react.dev/errors/"+D;if(1<arguments.length){y+="?args[]="+encodeURIComponent(arguments[1]);for(var O=2;O<arguments.length;O++)y+="&args[]="+encodeURIComponent(arguments[O])}return"Minified React error #"+D+"; visit "+y+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}function b(){}var u={d:{f:b,r:function(){throw Error(w(522))},D:b,C:b,L:b,m:b,X:b,S:b,M:b},p:0,findDOMNode:null},H=Symbol.for("react.portal");function C(D,y,O){var E=3<arguments.length&&arguments[3]!==void 0?arguments[3]:null;return{$$typeof:H,key:E==null?null:""+E,children:D,containerInfo:y,implementation:O}}var L=v.__CLIENT_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE;function x(D,y){if(D==="font")return"";if(typeof y=="string")return y==="use-credentials"?y:""}return qe.__DOM_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE=u,qe.createPortal=function(D,y){var O=2<arguments.length&&arguments[2]!==void 0?arguments[2]:null;if(!y||y.nodeType!==1&&y.nodeType!==9&&y.nodeType!==11)throw Error(w(299));return C(D,y,null,O)},qe.flushSync=function(D){var y=L.T,O=u.p;try{if(L.T=null,u.p=2,D)return D()}finally{L.T=y,u.p=O,u.d.f()}},qe.preconnect=function(D,y){typeof D=="string"&&(y?(y=y.crossOrigin,y=typeof y=="string"?y==="use-credentials"?y:"":void 0):y=null,u.d.C(D,y))},qe.prefetchDNS=function(D){typeof D=="string"&&u.d.D(D)},qe.preinit=function(D,y){if(typeof D=="string"&&y&&typeof y.as=="string"){var O=y.as,E=x(O,y.crossOrigin),J=typeof y.integrity=="string"?y.integrity:void 0,ze=typeof y.fetchPriority=="string"?y.fetchPriority:void 0;O==="style"?u.d.S(D,typeof y.precedence=="string"?y.precedence:void 0,{crossOrigin:E,integrity:J,fetchPriority:ze}):O==="script"&&u.d.X(D,{crossOrigin:E,integrity:J,fetchPriority:ze,nonce:typeof y.nonce=="string"?y.nonce:void 0})}},qe.preinitModule=function(D,y){if(typeof D=="string")if(typeof y=="object"&&y!==null){if(y.as==null||y.as==="script"){var O=x(y.as,y.crossOrigin);u.d.M(D,{crossOrigin:O,integrity:typeof y.integrity=="string"?y.integrity:void 0,nonce:typeof y.nonce=="string"?y.nonce:void 0})}}else y==null&&u.d.M(D)},qe.preload=function(D,y){if(typeof D=="string"&&typeof y=="object"&&y!==null&&typeof y.as=="string"){var O=y.as,E=x(O,y.crossOrigin);u.d.L(D,O,{crossOrigin:E,integrity:typeof y.integrity=="string"?y.integrity:void 0,nonce:typeof y.nonce=="string"?y.nonce:void 0,type:typeof y.type=="string"?y.type:void 0,fetchPriority:typeof y.fetchPriority=="string"?y.fetchPriority:void 0,referrerPolicy:typeof y.referrerPolicy=="string"?y.referrerPolicy:void 0,imageSrcSet:typeof y.imageSrcSet=="string"?y.imageSrcSet:void 0,imageSizes:typeof y.imageSizes=="string"?y.imageSizes:void 0,media:typeof y.media=="string"?y.media:void 0})}},qe.preloadModule=function(D,y){if(typeof D=="string")if(y){var O=x(y.as,y.crossOrigin);u.d.m(D,{as:typeof y.as=="string"&&y.as!=="script"?y.as:void 0,crossOrigin:O,integrity:typeof y.integrity=="string"?y.integrity:void 0})}else u.d.m(D)},qe.requestFormReset=function(D){u.d.r(D)},qe.unstable_batchedUpdates=function(D,y){return D(y)},qe.useFormState=function(D,y,O){return L.H.useFormState(D,y,O)},qe.useFormStatus=function(){return L.H.useHostTransitionStatus()},qe.version="19.2.0",qe}var qg;function Rp(){if(qg)return Sd.exports;qg=1;function v(){if(!(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__>"u"||typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE!="function"))try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(v)}catch(w){console.error(w)}}return v(),Sd.exports=Op(),Sd.exports}var Fg;function Mp(){if(Fg)return Rn;Fg=1;var v=Ep(),w=Md(),b=Rp();function u(e){var i="https://react.dev/errors/"+e;if(1<arguments.length){i+="?args[]="+encodeURIComponent(arguments[1]);for(var a=2;a<arguments.length;a++)i+="&args[]="+encodeURIComponent(arguments[a])}return"Minified React error #"+e+"; visit "+i+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}function H(e){return!(!e||e.nodeType!==1&&e.nodeType!==9&&e.nodeType!==11)}function C(e){var i=e,a=e;if(e.alternate)for(;i.return;)i=i.return;else{e=i;do i=e,(i.flags&4098)!==0&&(a=i.return),e=i.return;while(e)}return i.tag===3?a:null}function L(e){if(e.tag===13){var i=e.memoizedState;if(i===null&&(e=e.alternate,e!==null&&(i=e.memoizedState)),i!==null)return i.dehydrated}return null}function x(e){if(e.tag===31){var i=e.memoizedState;if(i===null&&(e=e.alternate,e!==null&&(i=e.memoizedState)),i!==null)return i.dehydrated}return null}function D(e){if(C(e)!==e)throw Error(u(188))}function y(e){var i=e.alternate;if(!i){if(i=C(e),i===null)throw Error(u(188));return i!==e?null:e}for(var a=e,t=i;;){var n=a.return;if(n===null)break;var o=n.alternate;if(o===null){if(t=n.return,t!==null){a=t;continue}break}if(n.child===o.child){for(o=n.child;o;){if(o===a)return D(n),e;if(o===t)return D(n),i;o=o.sibling}throw Error(u(188))}if(a.return!==t.return)a=n,t=o;else{for(var s=!1,d=n.child;d;){if(d===a){s=!0,a=n,t=o;break}if(d===t){s=!0,t=n,a=o;break}d=d.sibling}if(!s){for(d=o.child;d;){if(d===a){s=!0,a=o,t=n;break}if(d===t){s=!0,t=o,a=n;break}d=d.sibling}if(!s)throw Error(u(189))}}if(a.alternate!==t)throw Error(u(190))}if(a.tag!==3)throw Error(u(188));return a.stateNode.current===a?e:i}function O(e){var i=e.tag;if(i===5||i===26||i===27||i===6)return e;for(e=e.child;e!==null;){if(i=O(e),i!==null)return i;e=e.sibling}return null}var E=Object.assign,J=Symbol.for("react.element"),ze=Symbol.for("react.transitional.element"),Be=Symbol.for("react.portal"),Ce=Symbol.for("react.fragment"),Ti=Symbol.for("react.strict_mode"),Ge=Symbol.for("react.profiler"),Ke=Symbol.for("react.consumer"),j=Symbol.for("react.context"),ae=Symbol.for("react.forward_ref"),we=Symbol.for("react.suspense"),Ae=Symbol.for("react.suspense_list"),X=Symbol.for("react.memo"),_e=Symbol.for("react.lazy"),Ei=Symbol.for("react.activity"),Xa=Symbol.for("react.memo_cache_sentinel"),Oi=Symbol.iterator;function Xe(e){return e===null||typeof e!="object"?null:(e=Oi&&e[Oi]||e["@@iterator"],typeof e=="function"?e:null)}var Da=Symbol.for("react.client.reference");function Li(e){if(e==null)return null;if(typeof e=="function")return e.$$typeof===Da?null:e.displayName||e.name||null;if(typeof e=="string")return e;switch(e){case Ce:return"Fragment";case Ge:return"Profiler";case Ti:return"StrictMode";case we:return"Suspense";case Ae:return"SuspenseList";case Ei:return"Activity"}if(typeof e=="object")switch(e.$$typeof){case Be:return"Portal";case j:return e.displayName||"Context";case Ke:return(e._context.displayName||"Context")+".Consumer";case ae:var i=e.render;return e=e.displayName,e||(e=i.displayName||i.name||"",e=e!==""?"ForwardRef("+e+")":"ForwardRef"),e;case X:return i=e.displayName||null,i!==null?i:Li(e.type)||"Memo";case _e:i=e._payload,e=e._init;try{return Li(e(i))}catch{}}return null}var Si=Array.isArray,N=w.__CLIENT_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE,R=b.__DOM_INTERNALS_DO_NOT_USE_OR_WARN_USERS_THEY_CANNOT_UPGRADE,G={pending:!1,data:null,method:null,action:null},ce=[],he=-1;function m(e){return{current:e}}function S(e){0>he||(e.current=ce[he],ce[he]=null,he--)}function M(e,i){he++,ce[he]=e.current,e.current=i}var U=m(null),F=m(null),Z=m(null),re=m(null);function Fe(e,i){switch(M(Z,i),M(F,e),M(U,null),i.nodeType){case 9:case 11:e=(e=i.documentElement)&&(e=e.namespaceURI)?og(e):0;break;default:if(e=i.tagName,i=i.namespaceURI)i=og(i),e=rg(i,e);else switch(e){case"svg":e=1;break;case"math":e=2;break;default:e=0}}S(U),M(U,e)}function Ne(){S(U),S(F),S(Z)}function Ut(e){e.memoizedState!==null&&M(re,e);var i=U.current,a=rg(i,e.type);i!==a&&(M(F,e),M(U,a))}function Hn(e){F.current===e&&(S(U),S(F)),re.current===e&&(S(re),wn._currentValue=G)}var ar,Pd;function xa(e){if(ar===void 0)try{throw Error()}catch(a){var i=a.stack.trim().match(/\n( *(at )?)/);ar=i&&i[1]||"",Pd=-1<a.stack.indexOf(`
    at`)?" (<anonymous>)":-1<a.stack.indexOf("@")?"@unknown:0:0":""}return`
`+ar+e+Pd}var tr=!1;function nr(e,i){if(!e||tr)return"";tr=!0;var a=Error.prepareStackTrace;Error.prepareStackTrace=void 0;try{var t={DetermineComponentFrameRoot:function(){try{if(i){var T=function(){throw Error()};if(Object.defineProperty(T.prototype,"props",{set:function(){throw Error()}}),typeof Reflect=="object"&&Reflect.construct){try{Reflect.construct(T,[])}catch(A){var f=A}Reflect.construct(e,[],T)}else{try{T.call()}catch(A){f=A}e.call(T.prototype)}}else{try{throw Error()}catch(A){f=A}(T=e())&&typeof T.catch=="function"&&T.catch(function(){})}}catch(A){if(A&&f&&typeof A.stack=="string")return[A.stack,f.stack]}return[null,null]}};t.DetermineComponentFrameRoot.displayName="DetermineComponentFrameRoot";var n=Object.getOwnPropertyDescriptor(t.DetermineComponentFrameRoot,"name");n&&n.configurable&&Object.defineProperty(t.DetermineComponentFrameRoot,"name",{value:"DetermineComponentFrameRoot"});var o=t.DetermineComponentFrameRoot(),s=o[0],d=o[1];if(s&&d){var l=s.split(`
`),p=d.split(`
`);for(n=t=0;t<l.length&&!l[t].includes("DetermineComponentFrameRoot");)t++;for(;n<p.length&&!p[n].includes("DetermineComponentFrameRoot");)n++;if(t===l.length||n===p.length)for(t=l.length-1,n=p.length-1;1<=t&&0<=n&&l[t]!==p[n];)n--;for(;1<=t&&0<=n;t--,n--)if(l[t]!==p[n]){if(t!==1||n!==1)do if(t--,n--,0>n||l[t]!==p[n]){var k=`
`+l[t].replace(" at new "," at ");return e.displayName&&k.includes("<anonymous>")&&(k=k.replace("<anonymous>",e.displayName)),k}while(1<=t&&0<=n);break}}}finally{tr=!1,Error.prepareStackTrace=a}return(a=e?e.displayName||e.name:"")?xa(a):""}function tu(e,i){switch(e.tag){case 26:case 27:case 5:return xa(e.type);case 16:return xa("Lazy");case 13:return e.child!==i&&i!==null?xa("Suspense Fallback"):xa("Suspense");case 19:return xa("SuspenseList");case 0:case 15:return nr(e.type,!1);case 11:return nr(e.type.render,!1);case 1:return nr(e.type,!0);case 31:return xa("Activity");default:return""}}function Ld(e){try{var i="",a=null;do i+=tu(e,a),a=e,e=e.return;while(e);return i}catch(t){return`
Error generating stack: `+t.message+`
`+t.stack}}var or=Object.prototype.hasOwnProperty,rr=v.unstable_scheduleCallback,sr=v.unstable_cancelCallback,nu=v.unstable_shouldYield,ou=v.unstable_requestPaint,ai=v.unstable_now,ru=v.unstable_getCurrentPriorityLevel,Ud=v.unstable_ImmediatePriority,Vd=v.unstable_UserBlockingPriority,Pn=v.unstable_NormalPriority,su=v.unstable_LowPriority,jd=v.unstable_IdlePriority,du=v.log,lu=v.unstable_setDisableYieldValue,Vt=null,ti=null;function ia(e){if(typeof du=="function"&&lu(e),ti&&typeof ti.setStrictMode=="function")try{ti.setStrictMode(Vt,e)}catch{}}var ni=Math.clz32?Math.clz32:gu,cu=Math.log,mu=Math.LN2;function gu(e){return e>>>=0,e===0?32:31-(cu(e)/mu|0)|0}var Ln=256,Un=262144,Vn=4194304;function Ea(e){var i=e&42;if(i!==0)return i;switch(e&-e){case 1:return 1;case 2:return 2;case 4:return 4;case 8:return 8;case 16:return 16;case 32:return 32;case 64:return 64;case 128:return 128;case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:return e&261888;case 262144:case 524288:case 1048576:case 2097152:return e&3932160;case 4194304:case 8388608:case 16777216:case 33554432:return e&62914560;case 67108864:return 67108864;case 134217728:return 134217728;case 268435456:return 268435456;case 536870912:return 536870912;case 1073741824:return 0;default:return e}}function jn(e,i,a){var t=e.pendingLanes;if(t===0)return 0;var n=0,o=e.suspendedLanes,s=e.pingedLanes;e=e.warmLanes;var d=t&134217727;return d!==0?(t=d&~o,t!==0?n=Ea(t):(s&=d,s!==0?n=Ea(s):a||(a=d&~e,a!==0&&(n=Ea(a))))):(d=t&~o,d!==0?n=Ea(d):s!==0?n=Ea(s):a||(a=t&~e,a!==0&&(n=Ea(a)))),n===0?0:i!==0&&i!==n&&(i&o)===0&&(o=n&-n,a=i&-i,o>=a||o===32&&(a&4194048)!==0)?i:n}function jt(e,i){return(e.pendingLanes&~(e.suspendedLanes&~e.pingedLanes)&i)===0}function uu(e,i){switch(e){case 1:case 2:case 4:case 8:case 64:return i+250;case 16:case 32:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return i+5e3;case 4194304:case 8388608:case 16777216:case 33554432:return-1;case 67108864:case 134217728:case 268435456:case 536870912:case 1073741824:return-1;default:return-1}}function zd(){var e=Vn;return Vn<<=1,(Vn&62914560)===0&&(Vn=4194304),e}function dr(e){for(var i=[],a=0;31>a;a++)i.push(e);return i}function zt(e,i){e.pendingLanes|=i,i!==268435456&&(e.suspendedLanes=0,e.pingedLanes=0,e.warmLanes=0)}function hu(e,i,a,t,n,o){var s=e.pendingLanes;e.pendingLanes=a,e.suspendedLanes=0,e.pingedLanes=0,e.warmLanes=0,e.expiredLanes&=a,e.entangledLanes&=a,e.errorRecoveryDisabledLanes&=a,e.shellSuspendCounter=0;var d=e.entanglements,l=e.expirationTimes,p=e.hiddenUpdates;for(a=s&~a;0<a;){var k=31-ni(a),T=1<<k;d[k]=0,l[k]=-1;var f=p[k];if(f!==null)for(p[k]=null,k=0;k<f.length;k++){var A=f[k];A!==null&&(A.lane&=-536870913)}a&=~T}t!==0&&Bd(e,t,0),o!==0&&n===0&&e.tag!==0&&(e.suspendedLanes|=o&~(s&~i))}function Bd(e,i,a){e.pendingLanes|=i,e.suspendedLanes&=~i;var t=31-ni(i);e.entangledLanes|=i,e.entanglements[t]=e.entanglements[t]|1073741824|a&261930}function Gd(e,i){var a=e.entangledLanes|=i;for(e=e.entanglements;a;){var t=31-ni(a),n=1<<t;n&i|e[t]&i&&(e[t]|=i),a&=~n}}function qd(e,i){var a=i&-i;return a=(a&42)!==0?1:lr(a),(a&(e.suspendedLanes|i))!==0?0:a}function lr(e){switch(e){case 2:e=1;break;case 8:e=4;break;case 32:e=16;break;case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:case 4194304:case 8388608:case 16777216:case 33554432:e=128;break;case 268435456:e=134217728;break;default:e=0}return e}function cr(e){return e&=-e,2<e?8<e?(e&134217727)!==0?32:268435456:8:2}function Fd(){var e=R.p;return e!==0?e:(e=window.event,e===void 0?32:xg(e.type))}function Yd(e,i){var a=R.p;try{return R.p=e,i()}finally{R.p=a}}var aa=Math.random().toString(36).slice(2),Pe="__reactFiber$"+aa,Ze="__reactProps$"+aa,Za="__reactContainer$"+aa,mr="__reactEvents$"+aa,pu="__reactListeners$"+aa,fu="__reactHandles$"+aa,Kd="__reactResources$"+aa,Bt="__reactMarker$"+aa;function gr(e){delete e[Pe],delete e[Ze],delete e[mr],delete e[pu],delete e[fu]}function Qa(e){var i=e[Pe];if(i)return i;for(var a=e.parentNode;a;){if(i=a[Za]||a[Pe]){if(a=i.alternate,i.child!==null||a!==null&&a.child!==null)for(e=ug(e);e!==null;){if(a=e[Pe])return a;e=ug(e)}return i}e=a,a=e.parentNode}return null}function Wa(e){if(e=e[Pe]||e[Za]){var i=e.tag;if(i===5||i===6||i===13||i===31||i===26||i===27||i===3)return e}return null}function Gt(e){var i=e.tag;if(i===5||i===26||i===27||i===6)return e.stateNode;throw Error(u(33))}function Ja(e){var i=e[Kd];return i||(i=e[Kd]={hoistableStyles:new Map,hoistableScripts:new Map}),i}function Me(e){e[Bt]=!0}var _d=new Set,Xd={};function Oa(e,i){$a(e,i),$a(e+"Capture",i)}function $a(e,i){for(Xd[e]=i,e=0;e<i.length;e++)_d.add(i[e])}var yu=RegExp("^[:A-Z_a-z\\u00C0-\\u00D6\\u00D8-\\u00F6\\u00F8-\\u02FF\\u0370-\\u037D\\u037F-\\u1FFF\\u200C-\\u200D\\u2070-\\u218F\\u2C00-\\u2FEF\\u3001-\\uD7FF\\uF900-\\uFDCF\\uFDF0-\\uFFFD][:A-Z_a-z\\u00C0-\\u00D6\\u00D8-\\u00F6\\u00F8-\\u02FF\\u0370-\\u037D\\u037F-\\u1FFF\\u200C-\\u200D\\u2070-\\u218F\\u2C00-\\u2FEF\\u3001-\\uD7FF\\uF900-\\uFDCF\\uFDF0-\\uFFFD\\-.0-9\\u00B7\\u0300-\\u036F\\u203F-\\u2040]*$"),Zd={},Qd={};function bu(e){return or.call(Qd,e)?!0:or.call(Zd,e)?!1:yu.test(e)?Qd[e]=!0:(Zd[e]=!0,!1)}function zn(e,i,a){if(bu(i))if(a===null)e.removeAttribute(i);else{switch(typeof a){case"undefined":case"function":case"symbol":e.removeAttribute(i);return;case"boolean":var t=i.toLowerCase().slice(0,5);if(t!=="data-"&&t!=="aria-"){e.removeAttribute(i);return}}e.setAttribute(i,""+a)}}function Bn(e,i,a){if(a===null)e.removeAttribute(i);else{switch(typeof a){case"undefined":case"function":case"symbol":case"boolean":e.removeAttribute(i);return}e.setAttribute(i,""+a)}}function Ui(e,i,a,t){if(t===null)e.removeAttribute(a);else{switch(typeof t){case"undefined":case"function":case"symbol":case"boolean":e.removeAttribute(a);return}e.setAttributeNS(i,a,""+t)}}function ui(e){switch(typeof e){case"bigint":case"boolean":case"number":case"string":case"undefined":return e;case"object":return e;default:return""}}function Wd(e){var i=e.type;return(e=e.nodeName)&&e.toLowerCase()==="input"&&(i==="checkbox"||i==="radio")}function Au(e,i,a){var t=Object.getOwnPropertyDescriptor(e.constructor.prototype,i);if(!e.hasOwnProperty(i)&&typeof t<"u"&&typeof t.get=="function"&&typeof t.set=="function"){var n=t.get,o=t.set;return Object.defineProperty(e,i,{configurable:!0,get:function(){return n.call(this)},set:function(s){a=""+s,o.call(this,s)}}),Object.defineProperty(e,i,{enumerable:t.enumerable}),{getValue:function(){return a},setValue:function(s){a=""+s},stopTracking:function(){e._valueTracker=null,delete e[i]}}}}function ur(e){if(!e._valueTracker){var i=Wd(e)?"checked":"value";e._valueTracker=Au(e,i,""+e[i])}}function Jd(e){if(!e)return!1;var i=e._valueTracker;if(!i)return!0;var a=i.getValue(),t="";return e&&(t=Wd(e)?e.checked?"true":"false":e.value),e=t,e!==a?(i.setValue(e),!0):!1}function Gn(e){if(e=e||(typeof document<"u"?document:void 0),typeof e>"u")return null;try{return e.activeElement||e.body}catch{return e.body}}var ku=/[\n"\\]/g;function hi(e){return e.replace(ku,function(i){return"\\"+i.charCodeAt(0).toString(16)+" "})}function hr(e,i,a,t,n,o,s,d){e.name="",s!=null&&typeof s!="function"&&typeof s!="symbol"&&typeof s!="boolean"?e.type=s:e.removeAttribute("type"),i!=null?s==="number"?(i===0&&e.value===""||e.value!=i)&&(e.value=""+ui(i)):e.value!==""+ui(i)&&(e.value=""+ui(i)):s!=="submit"&&s!=="reset"||e.removeAttribute("value"),i!=null?pr(e,s,ui(i)):a!=null?pr(e,s,ui(a)):t!=null&&e.removeAttribute("value"),n==null&&o!=null&&(e.defaultChecked=!!o),n!=null&&(e.checked=n&&typeof n!="function"&&typeof n!="symbol"),d!=null&&typeof d!="function"&&typeof d!="symbol"&&typeof d!="boolean"?e.name=""+ui(d):e.removeAttribute("name")}function $d(e,i,a,t,n,o,s,d){if(o!=null&&typeof o!="function"&&typeof o!="symbol"&&typeof o!="boolean"&&(e.type=o),i!=null||a!=null){if(!(o!=="submit"&&o!=="reset"||i!=null)){ur(e);return}a=a!=null?""+ui(a):"",i=i!=null?""+ui(i):a,d||i===e.value||(e.value=i),e.defaultValue=i}t=t??n,t=typeof t!="function"&&typeof t!="symbol"&&!!t,e.checked=d?e.checked:!!t,e.defaultChecked=!!t,s!=null&&typeof s!="function"&&typeof s!="symbol"&&typeof s!="boolean"&&(e.name=s),ur(e)}function pr(e,i,a){i==="number"&&Gn(e.ownerDocument)===e||e.defaultValue===""+a||(e.defaultValue=""+a)}function et(e,i,a,t){if(e=e.options,i){i={};for(var n=0;n<a.length;n++)i["$"+a[n]]=!0;for(a=0;a<e.length;a++)n=i.hasOwnProperty("$"+e[a].value),e[a].selected!==n&&(e[a].selected=n),n&&t&&(e[a].defaultSelected=!0)}else{for(a=""+ui(a),i=null,n=0;n<e.length;n++){if(e[n].value===a){e[n].selected=!0,t&&(e[n].defaultSelected=!0);return}i!==null||e[n].disabled||(i=e[n])}i!==null&&(i.selected=!0)}}function el(e,i,a){if(i!=null&&(i=""+ui(i),i!==e.value&&(e.value=i),a==null)){e.defaultValue!==i&&(e.defaultValue=i);return}e.defaultValue=a!=null?""+ui(a):""}function il(e,i,a,t){if(i==null){if(t!=null){if(a!=null)throw Error(u(92));if(Si(t)){if(1<t.length)throw Error(u(93));t=t[0]}a=t}a==null&&(a=""),i=a}a=ui(i),e.defaultValue=a,t=e.textContent,t===a&&t!==""&&t!==null&&(e.value=t),ur(e)}function it(e,i){if(i){var a=e.firstChild;if(a&&a===e.lastChild&&a.nodeType===3){a.nodeValue=i;return}}e.textContent=i}var vu=new Set("animationIterationCount aspectRatio borderImageOutset borderImageSlice borderImageWidth boxFlex boxFlexGroup boxOrdinalGroup columnCount columns flex flexGrow flexPositive flexShrink flexNegative flexOrder gridArea gridRow gridRowEnd gridRowSpan gridRowStart gridColumn gridColumnEnd gridColumnSpan gridColumnStart fontWeight lineClamp lineHeight opacity order orphans scale tabSize widows zIndex zoom fillOpacity floodOpacity stopOpacity strokeDasharray strokeDashoffset strokeMiterlimit strokeOpacity strokeWidth MozAnimationIterationCount MozBoxFlex MozBoxFlexGroup MozLineClamp msAnimationIterationCount msFlex msZoom msFlexGrow msFlexNegative msFlexOrder msFlexPositive msFlexShrink msGridColumn msGridColumnSpan msGridRow msGridRowSpan WebkitAnimationIterationCount WebkitBoxFlex WebKitBoxFlexGroup WebkitBoxOrdinalGroup WebkitColumnCount WebkitColumns WebkitFlex WebkitFlexGrow WebkitFlexPositive WebkitFlexShrink WebkitLineClamp".split(" "));function al(e,i,a){var t=i.indexOf("--")===0;a==null||typeof a=="boolean"||a===""?t?e.setProperty(i,""):i==="float"?e.cssFloat="":e[i]="":t?e.setProperty(i,a):typeof a!="number"||a===0||vu.has(i)?i==="float"?e.cssFloat=a:e[i]=(""+a).trim():e[i]=a+"px"}function tl(e,i,a){if(i!=null&&typeof i!="object")throw Error(u(62));if(e=e.style,a!=null){for(var t in a)!a.hasOwnProperty(t)||i!=null&&i.hasOwnProperty(t)||(t.indexOf("--")===0?e.setProperty(t,""):t==="float"?e.cssFloat="":e[t]="");for(var n in i)t=i[n],i.hasOwnProperty(n)&&a[n]!==t&&al(e,n,t)}else for(var o in i)i.hasOwnProperty(o)&&al(e,o,i[o])}function fr(e){if(e.indexOf("-")===-1)return!1;switch(e){case"annotation-xml":case"color-profile":case"font-face":case"font-face-src":case"font-face-uri":case"font-face-format":case"font-face-name":case"missing-glyph":return!1;default:return!0}}var Nu=new Map([["acceptCharset","accept-charset"],["htmlFor","for"],["httpEquiv","http-equiv"],["crossOrigin","crossorigin"],["accentHeight","accent-height"],["alignmentBaseline","alignment-baseline"],["arabicForm","arabic-form"],["baselineShift","baseline-shift"],["capHeight","cap-height"],["clipPath","clip-path"],["clipRule","clip-rule"],["colorInterpolation","color-interpolation"],["colorInterpolationFilters","color-interpolation-filters"],["colorProfile","color-profile"],["colorRendering","color-rendering"],["dominantBaseline","dominant-baseline"],["enableBackground","enable-background"],["fillOpacity","fill-opacity"],["fillRule","fill-rule"],["floodColor","flood-color"],["floodOpacity","flood-opacity"],["fontFamily","font-family"],["fontSize","font-size"],["fontSizeAdjust","font-size-adjust"],["fontStretch","font-stretch"],["fontStyle","font-style"],["fontVariant","font-variant"],["fontWeight","font-weight"],["glyphName","glyph-name"],["glyphOrientationHorizontal","glyph-orientation-horizontal"],["glyphOrientationVertical","glyph-orientation-vertical"],["horizAdvX","horiz-adv-x"],["horizOriginX","horiz-origin-x"],["imageRendering","image-rendering"],["letterSpacing","letter-spacing"],["lightingColor","lighting-color"],["markerEnd","marker-end"],["markerMid","marker-mid"],["markerStart","marker-start"],["overlinePosition","overline-position"],["overlineThickness","overline-thickness"],["paintOrder","paint-order"],["panose-1","panose-1"],["pointerEvents","pointer-events"],["renderingIntent","rendering-intent"],["shapeRendering","shape-rendering"],["stopColor","stop-color"],["stopOpacity","stop-opacity"],["strikethroughPosition","strikethrough-position"],["strikethroughThickness","strikethrough-thickness"],["strokeDasharray","stroke-dasharray"],["strokeDashoffset","stroke-dashoffset"],["strokeLinecap","stroke-linecap"],["strokeLinejoin","stroke-linejoin"],["strokeMiterlimit","stroke-miterlimit"],["strokeOpacity","stroke-opacity"],["strokeWidth","stroke-width"],["textAnchor","text-anchor"],["textDecoration","text-decoration"],["textRendering","text-rendering"],["transformOrigin","transform-origin"],["underlinePosition","underline-position"],["underlineThickness","underline-thickness"],["unicodeBidi","unicode-bidi"],["unicodeRange","unicode-range"],["unitsPerEm","units-per-em"],["vAlphabetic","v-alphabetic"],["vHanging","v-hanging"],["vIdeographic","v-ideographic"],["vMathematical","v-mathematical"],["vectorEffect","vector-effect"],["vertAdvY","vert-adv-y"],["vertOriginX","vert-origin-x"],["vertOriginY","vert-origin-y"],["wordSpacing","word-spacing"],["writingMode","writing-mode"],["xmlnsXlink","xmlns:xlink"],["xHeight","x-height"]]),Iu=/^[\u0000-\u001F ]*j[\r\n\t]*a[\r\n\t]*v[\r\n\t]*a[\r\n\t]*s[\r\n\t]*c[\r\n\t]*r[\r\n\t]*i[\r\n\t]*p[\r\n\t]*t[\r\n\t]*:/i;function qn(e){return Iu.test(""+e)?"javascript:throw new Error('React has blocked a javascript: URL as a security precaution.')":e}function Vi(){}var yr=null;function br(e){return e=e.target||e.srcElement||window,e.correspondingUseElement&&(e=e.correspondingUseElement),e.nodeType===3?e.parentNode:e}var at=null,tt=null;function nl(e){var i=Wa(e);if(i&&(e=i.stateNode)){var a=e[Ze]||null;e:switch(e=i.stateNode,i.type){case"input":if(hr(e,a.value,a.defaultValue,a.defaultValue,a.checked,a.defaultChecked,a.type,a.name),i=a.name,a.type==="radio"&&i!=null){for(a=e;a.parentNode;)a=a.parentNode;for(a=a.querySelectorAll('input[name="'+hi(""+i)+'"][type="radio"]'),i=0;i<a.length;i++){var t=a[i];if(t!==e&&t.form===e.form){var n=t[Ze]||null;if(!n)throw Error(u(90));hr(t,n.value,n.defaultValue,n.defaultValue,n.checked,n.defaultChecked,n.type,n.name)}}for(i=0;i<a.length;i++)t=a[i],t.form===e.form&&Jd(t)}break e;case"textarea":el(e,a.value,a.defaultValue);break e;case"select":i=a.value,i!=null&&et(e,!!a.multiple,i,!1)}}}var Ar=!1;function ol(e,i,a){if(Ar)return e(i,a);Ar=!0;try{var t=e(i);return t}finally{if(Ar=!1,(at!==null||tt!==null)&&(Oo(),at&&(i=at,e=tt,tt=at=null,nl(i),e)))for(i=0;i<e.length;i++)nl(e[i])}}function qt(e,i){var a=e.stateNode;if(a===null)return null;var t=a[Ze]||null;if(t===null)return null;a=t[i];e:switch(i){case"onClick":case"onClickCapture":case"onDoubleClick":case"onDoubleClickCapture":case"onMouseDown":case"onMouseDownCapture":case"onMouseMove":case"onMouseMoveCapture":case"onMouseUp":case"onMouseUpCapture":case"onMouseEnter":(t=!t.disabled)||(e=e.type,t=!(e==="button"||e==="input"||e==="select"||e==="textarea")),e=!t;break e;default:e=!1}if(e)return null;if(a&&typeof a!="function")throw Error(u(231,i,typeof a));return a}var ji=!(typeof window>"u"||typeof window.document>"u"||typeof window.document.createElement>"u"),kr=!1;if(ji)try{var Ft={};Object.defineProperty(Ft,"passive",{get:function(){kr=!0}}),window.addEventListener("test",Ft,Ft),window.removeEventListener("test",Ft,Ft)}catch{kr=!1}var ta=null,vr=null,Fn=null;function rl(){if(Fn)return Fn;var e,i=vr,a=i.length,t,n="value"in ta?ta.value:ta.textContent,o=n.length;for(e=0;e<a&&i[e]===n[e];e++);var s=a-e;for(t=1;t<=s&&i[a-t]===n[o-t];t++);return Fn=n.slice(e,1<t?1-t:void 0)}function Yn(e){var i=e.keyCode;return"charCode"in e?(e=e.charCode,e===0&&i===13&&(e=13)):e=i,e===10&&(e=13),32<=e||e===13?e:0}function Kn(){return!0}function sl(){return!1}function Qe(e){function i(a,t,n,o,s){this._reactName=a,this._targetInst=n,this.type=t,this.nativeEvent=o,this.target=s,this.currentTarget=null;for(var d in e)e.hasOwnProperty(d)&&(a=e[d],this[d]=a?a(o):o[d]);return this.isDefaultPrevented=(o.defaultPrevented!=null?o.defaultPrevented:o.returnValue===!1)?Kn:sl,this.isPropagationStopped=sl,this}return E(i.prototype,{preventDefault:function(){this.defaultPrevented=!0;var a=this.nativeEvent;a&&(a.preventDefault?a.preventDefault():typeof a.returnValue!="unknown"&&(a.returnValue=!1),this.isDefaultPrevented=Kn)},stopPropagation:function(){var a=this.nativeEvent;a&&(a.stopPropagation?a.stopPropagation():typeof a.cancelBubble!="unknown"&&(a.cancelBubble=!0),this.isPropagationStopped=Kn)},persist:function(){},isPersistent:Kn}),i}var Ra={eventPhase:0,bubbles:0,cancelable:0,timeStamp:function(e){return e.timeStamp||Date.now()},defaultPrevented:0,isTrusted:0},_n=Qe(Ra),Yt=E({},Ra,{view:0,detail:0}),Tu=Qe(Yt),Nr,Ir,Kt,Xn=E({},Yt,{screenX:0,screenY:0,clientX:0,clientY:0,pageX:0,pageY:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,getModifierState:Sr,button:0,buttons:0,relatedTarget:function(e){return e.relatedTarget===void 0?e.fromElement===e.srcElement?e.toElement:e.fromElement:e.relatedTarget},movementX:function(e){return"movementX"in e?e.movementX:(e!==Kt&&(Kt&&e.type==="mousemove"?(Nr=e.screenX-Kt.screenX,Ir=e.screenY-Kt.screenY):Ir=Nr=0,Kt=e),Nr)},movementY:function(e){return"movementY"in e?e.movementY:Ir}}),dl=Qe(Xn),Su=E({},Xn,{dataTransfer:0}),Cu=Qe(Su),wu=E({},Yt,{relatedTarget:0}),Tr=Qe(wu),Du=E({},Ra,{animationName:0,elapsedTime:0,pseudoElement:0}),xu=Qe(Du),Eu=E({},Ra,{clipboardData:function(e){return"clipboardData"in e?e.clipboardData:window.clipboardData}}),Ou=Qe(Eu),Ru=E({},Ra,{data:0}),ll=Qe(Ru),Mu={Esc:"Escape",Spacebar:" ",Left:"ArrowLeft",Up:"ArrowUp",Right:"ArrowRight",Down:"ArrowDown",Del:"Delete",Win:"OS",Menu:"ContextMenu",Apps:"ContextMenu",Scroll:"ScrollLock",MozPrintableKey:"Unidentified"},Hu={8:"Backspace",9:"Tab",12:"Clear",13:"Enter",16:"Shift",17:"Control",18:"Alt",19:"Pause",20:"CapsLock",27:"Escape",32:" ",33:"PageUp",34:"PageDown",35:"End",36:"Home",37:"ArrowLeft",38:"ArrowUp",39:"ArrowRight",40:"ArrowDown",45:"Insert",46:"Delete",112:"F1",113:"F2",114:"F3",115:"F4",116:"F5",117:"F6",118:"F7",119:"F8",120:"F9",121:"F10",122:"F11",123:"F12",144:"NumLock",145:"ScrollLock",224:"Meta"},Pu={Alt:"altKey",Control:"ctrlKey",Meta:"metaKey",Shift:"shiftKey"};function Lu(e){var i=this.nativeEvent;return i.getModifierState?i.getModifierState(e):(e=Pu[e])?!!i[e]:!1}function Sr(){return Lu}var Uu=E({},Yt,{key:function(e){if(e.key){var i=Mu[e.key]||e.key;if(i!=="Unidentified")return i}return e.type==="keypress"?(e=Yn(e),e===13?"Enter":String.fromCharCode(e)):e.type==="keydown"||e.type==="keyup"?Hu[e.keyCode]||"Unidentified":""},code:0,location:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,repeat:0,locale:0,getModifierState:Sr,charCode:function(e){return e.type==="keypress"?Yn(e):0},keyCode:function(e){return e.type==="keydown"||e.type==="keyup"?e.keyCode:0},which:function(e){return e.type==="keypress"?Yn(e):e.type==="keydown"||e.type==="keyup"?e.keyCode:0}}),Vu=Qe(Uu),ju=E({},Xn,{pointerId:0,width:0,height:0,pressure:0,tangentialPressure:0,tiltX:0,tiltY:0,twist:0,pointerType:0,isPrimary:0}),cl=Qe(ju),zu=E({},Yt,{touches:0,targetTouches:0,changedTouches:0,altKey:0,metaKey:0,ctrlKey:0,shiftKey:0,getModifierState:Sr}),Bu=Qe(zu),Gu=E({},Ra,{propertyName:0,elapsedTime:0,pseudoElement:0}),qu=Qe(Gu),Fu=E({},Xn,{deltaX:function(e){return"deltaX"in e?e.deltaX:"wheelDeltaX"in e?-e.wheelDeltaX:0},deltaY:function(e){return"deltaY"in e?e.deltaY:"wheelDeltaY"in e?-e.wheelDeltaY:"wheelDelta"in e?-e.wheelDelta:0},deltaZ:0,deltaMode:0}),Yu=Qe(Fu),Ku=E({},Ra,{newState:0,oldState:0}),_u=Qe(Ku),Xu=[9,13,27,32],Cr=ji&&"CompositionEvent"in window,_t=null;ji&&"documentMode"in document&&(_t=document.documentMode);var Zu=ji&&"TextEvent"in window&&!_t,ml=ji&&(!Cr||_t&&8<_t&&11>=_t),gl=" ",ul=!1;function hl(e,i){switch(e){case"keyup":return Xu.indexOf(i.keyCode)!==-1;case"keydown":return i.keyCode!==229;case"keypress":case"mousedown":case"focusout":return!0;default:return!1}}function pl(e){return e=e.detail,typeof e=="object"&&"data"in e?e.data:null}var nt=!1;function Qu(e,i){switch(e){case"compositionend":return pl(i);case"keypress":return i.which!==32?null:(ul=!0,gl);case"textInput":return e=i.data,e===gl&&ul?null:e;default:return null}}function Wu(e,i){if(nt)return e==="compositionend"||!Cr&&hl(e,i)?(e=rl(),Fn=vr=ta=null,nt=!1,e):null;switch(e){case"paste":return null;case"keypress":if(!(i.ctrlKey||i.altKey||i.metaKey)||i.ctrlKey&&i.altKey){if(i.char&&1<i.char.length)return i.char;if(i.which)return String.fromCharCode(i.which)}return null;case"compositionend":return ml&&i.locale!=="ko"?null:i.data;default:return null}}var Ju={color:!0,date:!0,datetime:!0,"datetime-local":!0,email:!0,month:!0,number:!0,password:!0,range:!0,search:!0,tel:!0,text:!0,time:!0,url:!0,week:!0};function fl(e){var i=e&&e.nodeName&&e.nodeName.toLowerCase();return i==="input"?!!Ju[e.type]:i==="textarea"}function yl(e,i,a,t){at?tt?tt.push(t):tt=[t]:at=t,i=Vo(i,"onChange"),0<i.length&&(a=new _n("onChange","change",null,a,t),e.push({event:a,listeners:i}))}var Xt=null,Zt=null;function $u(e){$m(e,0)}function Zn(e){var i=Gt(e);if(Jd(i))return e}function bl(e,i){if(e==="change")return i}var Al=!1;if(ji){var wr;if(ji){var Dr="oninput"in document;if(!Dr){var kl=document.createElement("div");kl.setAttribute("oninput","return;"),Dr=typeof kl.oninput=="function"}wr=Dr}else wr=!1;Al=wr&&(!document.documentMode||9<document.documentMode)}function vl(){Xt&&(Xt.detachEvent("onpropertychange",Nl),Zt=Xt=null)}function Nl(e){if(e.propertyName==="value"&&Zn(Zt)){var i=[];yl(i,Zt,e,br(e)),ol($u,i)}}function eh(e,i,a){e==="focusin"?(vl(),Xt=i,Zt=a,Xt.attachEvent("onpropertychange",Nl)):e==="focusout"&&vl()}function ih(e){if(e==="selectionchange"||e==="keyup"||e==="keydown")return Zn(Zt)}function ah(e,i){if(e==="click")return Zn(i)}function th(e,i){if(e==="input"||e==="change")return Zn(i)}function nh(e,i){return e===i&&(e!==0||1/e===1/i)||e!==e&&i!==i}var oi=typeof Object.is=="function"?Object.is:nh;function Qt(e,i){if(oi(e,i))return!0;if(typeof e!="object"||e===null||typeof i!="object"||i===null)return!1;var a=Object.keys(e),t=Object.keys(i);if(a.length!==t.length)return!1;for(t=0;t<a.length;t++){var n=a[t];if(!or.call(i,n)||!oi(e[n],i[n]))return!1}return!0}function Il(e){for(;e&&e.firstChild;)e=e.firstChild;return e}function Tl(e,i){var a=Il(e);e=0;for(var t;a;){if(a.nodeType===3){if(t=e+a.textContent.length,e<=i&&t>=i)return{node:a,offset:i-e};e=t}e:{for(;a;){if(a.nextSibling){a=a.nextSibling;break e}a=a.parentNode}a=void 0}a=Il(a)}}function Sl(e,i){return e&&i?e===i?!0:e&&e.nodeType===3?!1:i&&i.nodeType===3?Sl(e,i.parentNode):"contains"in e?e.contains(i):e.compareDocumentPosition?!!(e.compareDocumentPosition(i)&16):!1:!1}function Cl(e){e=e!=null&&e.ownerDocument!=null&&e.ownerDocument.defaultView!=null?e.ownerDocument.defaultView:window;for(var i=Gn(e.document);i instanceof e.HTMLIFrameElement;){try{var a=typeof i.contentWindow.location.href=="string"}catch{a=!1}if(a)e=i.contentWindow;else break;i=Gn(e.document)}return i}function xr(e){var i=e&&e.nodeName&&e.nodeName.toLowerCase();return i&&(i==="input"&&(e.type==="text"||e.type==="search"||e.type==="tel"||e.type==="url"||e.type==="password")||i==="textarea"||e.contentEditable==="true")}var oh=ji&&"documentMode"in document&&11>=document.documentMode,ot=null,Er=null,Wt=null,Or=!1;function wl(e,i,a){var t=a.window===a?a.document:a.nodeType===9?a:a.ownerDocument;Or||ot==null||ot!==Gn(t)||(t=ot,"selectionStart"in t&&xr(t)?t={start:t.selectionStart,end:t.selectionEnd}:(t=(t.ownerDocument&&t.ownerDocument.defaultView||window).getSelection(),t={anchorNode:t.anchorNode,anchorOffset:t.anchorOffset,focusNode:t.focusNode,focusOffset:t.focusOffset}),Wt&&Qt(Wt,t)||(Wt=t,t=Vo(Er,"onSelect"),0<t.length&&(i=new _n("onSelect","select",null,i,a),e.push({event:i,listeners:t}),i.target=ot)))}function Ma(e,i){var a={};return a[e.toLowerCase()]=i.toLowerCase(),a["Webkit"+e]="webkit"+i,a["Moz"+e]="moz"+i,a}var rt={animationend:Ma("Animation","AnimationEnd"),animationiteration:Ma("Animation","AnimationIteration"),animationstart:Ma("Animation","AnimationStart"),transitionrun:Ma("Transition","TransitionRun"),transitionstart:Ma("Transition","TransitionStart"),transitioncancel:Ma("Transition","TransitionCancel"),transitionend:Ma("Transition","TransitionEnd")},Rr={},Dl={};ji&&(Dl=document.createElement("div").style,"AnimationEvent"in window||(delete rt.animationend.animation,delete rt.animationiteration.animation,delete rt.animationstart.animation),"TransitionEvent"in window||delete rt.transitionend.transition);function Ha(e){if(Rr[e])return Rr[e];if(!rt[e])return e;var i=rt[e],a;for(a in i)if(i.hasOwnProperty(a)&&a in Dl)return Rr[e]=i[a];return e}var xl=Ha("animationend"),El=Ha("animationiteration"),Ol=Ha("animationstart"),rh=Ha("transitionrun"),sh=Ha("transitionstart"),dh=Ha("transitioncancel"),Rl=Ha("transitionend"),Ml=new Map,Mr="abort auxClick beforeToggle cancel canPlay canPlayThrough click close contextMenu copy cut drag dragEnd dragEnter dragExit dragLeave dragOver dragStart drop durationChange emptied encrypted ended error gotPointerCapture input invalid keyDown keyPress keyUp load loadedData loadedMetadata loadStart lostPointerCapture mouseDown mouseMove mouseOut mouseOver mouseUp paste pause play playing pointerCancel pointerDown pointerMove pointerOut pointerOver pointerUp progress rateChange reset resize seeked seeking stalled submit suspend timeUpdate touchCancel touchEnd touchStart volumeChange scroll toggle touchMove waiting wheel".split(" ");Mr.push("scrollEnd");function Ci(e,i){Ml.set(e,i),Oa(i,[e])}var Qn=typeof reportError=="function"?reportError:function(e){if(typeof window=="object"&&typeof window.ErrorEvent=="function"){var i=new window.ErrorEvent("error",{bubbles:!0,cancelable:!0,message:typeof e=="object"&&e!==null&&typeof e.message=="string"?String(e.message):String(e),error:e});if(!window.dispatchEvent(i))return}else if(typeof process=="object"&&typeof process.emit=="function"){process.emit("uncaughtException",e);return}console.error(e)},pi=[],st=0,Hr=0;function Wn(){for(var e=st,i=Hr=st=0;i<e;){var a=pi[i];pi[i++]=null;var t=pi[i];pi[i++]=null;var n=pi[i];pi[i++]=null;var o=pi[i];if(pi[i++]=null,t!==null&&n!==null){var s=t.pending;s===null?n.next=n:(n.next=s.next,s.next=n),t.pending=n}o!==0&&Hl(a,n,o)}}function Jn(e,i,a,t){pi[st++]=e,pi[st++]=i,pi[st++]=a,pi[st++]=t,Hr|=t,e.lanes|=t,e=e.alternate,e!==null&&(e.lanes|=t)}function Pr(e,i,a,t){return Jn(e,i,a,t),$n(e)}function Pa(e,i){return Jn(e,null,null,i),$n(e)}function Hl(e,i,a){e.lanes|=a;var t=e.alternate;t!==null&&(t.lanes|=a);for(var n=!1,o=e.return;o!==null;)o.childLanes|=a,t=o.alternate,t!==null&&(t.childLanes|=a),o.tag===22&&(e=o.stateNode,e===null||e._visibility&1||(n=!0)),e=o,o=o.return;return e.tag===3?(o=e.stateNode,n&&i!==null&&(n=31-ni(a),e=o.hiddenUpdates,t=e[n],t===null?e[n]=[i]:t.push(i),i.lane=a|536870912),o):null}function $n(e){if(50<kn)throw kn=0,Fs=null,Error(u(185));for(var i=e.return;i!==null;)e=i,i=e.return;return e.tag===3?e.stateNode:null}var dt={};function lh(e,i,a,t){this.tag=e,this.key=a,this.sibling=this.child=this.return=this.stateNode=this.type=this.elementType=null,this.index=0,this.refCleanup=this.ref=null,this.pendingProps=i,this.dependencies=this.memoizedState=this.updateQueue=this.memoizedProps=null,this.mode=t,this.subtreeFlags=this.flags=0,this.deletions=null,this.childLanes=this.lanes=0,this.alternate=null}function ri(e,i,a,t){return new lh(e,i,a,t)}function Lr(e){return e=e.prototype,!(!e||!e.isReactComponent)}function zi(e,i){var a=e.alternate;return a===null?(a=ri(e.tag,i,e.key,e.mode),a.elementType=e.elementType,a.type=e.type,a.stateNode=e.stateNode,a.alternate=e,e.alternate=a):(a.pendingProps=i,a.type=e.type,a.flags=0,a.subtreeFlags=0,a.deletions=null),a.flags=e.flags&65011712,a.childLanes=e.childLanes,a.lanes=e.lanes,a.child=e.child,a.memoizedProps=e.memoizedProps,a.memoizedState=e.memoizedState,a.updateQueue=e.updateQueue,i=e.dependencies,a.dependencies=i===null?null:{lanes:i.lanes,firstContext:i.firstContext},a.sibling=e.sibling,a.index=e.index,a.ref=e.ref,a.refCleanup=e.refCleanup,a}function Pl(e,i){e.flags&=65011714;var a=e.alternate;return a===null?(e.childLanes=0,e.lanes=i,e.child=null,e.subtreeFlags=0,e.memoizedProps=null,e.memoizedState=null,e.updateQueue=null,e.dependencies=null,e.stateNode=null):(e.childLanes=a.childLanes,e.lanes=a.lanes,e.child=a.child,e.subtreeFlags=0,e.deletions=null,e.memoizedProps=a.memoizedProps,e.memoizedState=a.memoizedState,e.updateQueue=a.updateQueue,e.type=a.type,i=a.dependencies,e.dependencies=i===null?null:{lanes:i.lanes,firstContext:i.firstContext}),e}function eo(e,i,a,t,n,o){var s=0;if(t=e,typeof e=="function")Lr(e)&&(s=1);else if(typeof e=="string")s=hp(e,a,U.current)?26:e==="html"||e==="head"||e==="body"?27:5;else e:switch(e){case Ei:return e=ri(31,a,i,n),e.elementType=Ei,e.lanes=o,e;case Ce:return La(a.children,n,o,i);case Ti:s=8,n|=24;break;case Ge:return e=ri(12,a,i,n|2),e.elementType=Ge,e.lanes=o,e;case we:return e=ri(13,a,i,n),e.elementType=we,e.lanes=o,e;case Ae:return e=ri(19,a,i,n),e.elementType=Ae,e.lanes=o,e;default:if(typeof e=="object"&&e!==null)switch(e.$$typeof){case j:s=10;break e;case Ke:s=9;break e;case ae:s=11;break e;case X:s=14;break e;case _e:s=16,t=null;break e}s=29,a=Error(u(130,e===null?"null":typeof e,"")),t=null}return i=ri(s,a,i,n),i.elementType=e,i.type=t,i.lanes=o,i}function La(e,i,a,t){return e=ri(7,e,t,i),e.lanes=a,e}function Ur(e,i,a){return e=ri(6,e,null,i),e.lanes=a,e}function Ll(e){var i=ri(18,null,null,0);return i.stateNode=e,i}function Vr(e,i,a){return i=ri(4,e.children!==null?e.children:[],e.key,i),i.lanes=a,i.stateNode={containerInfo:e.containerInfo,pendingChildren:null,implementation:e.implementation},i}var Ul=new WeakMap;function fi(e,i){if(typeof e=="object"&&e!==null){var a=Ul.get(e);return a!==void 0?a:(i={value:e,source:i,stack:Ld(i)},Ul.set(e,i),i)}return{value:e,source:i,stack:Ld(i)}}var lt=[],ct=0,io=null,Jt=0,yi=[],bi=0,na=null,Ri=1,Mi="";function Bi(e,i){lt[ct++]=Jt,lt[ct++]=io,io=e,Jt=i}function Vl(e,i,a){yi[bi++]=Ri,yi[bi++]=Mi,yi[bi++]=na,na=e;var t=Ri;e=Mi;var n=32-ni(t)-1;t&=~(1<<n),a+=1;var o=32-ni(i)+n;if(30<o){var s=n-n%5;o=(t&(1<<s)-1).toString(32),t>>=s,n-=s,Ri=1<<32-ni(i)+n|a<<n|t,Mi=o+e}else Ri=1<<o|a<<n|t,Mi=e}function jr(e){e.return!==null&&(Bi(e,1),Vl(e,1,0))}function zr(e){for(;e===io;)io=lt[--ct],lt[ct]=null,Jt=lt[--ct],lt[ct]=null;for(;e===na;)na=yi[--bi],yi[bi]=null,Mi=yi[--bi],yi[bi]=null,Ri=yi[--bi],yi[bi]=null}function jl(e,i){yi[bi++]=Ri,yi[bi++]=Mi,yi[bi++]=na,Ri=i.id,Mi=i.overflow,na=e}var Le=null,fe=null,ie=!1,oa=null,Ai=!1,Br=Error(u(519));function ra(e){var i=Error(u(418,1<arguments.length&&arguments[1]!==void 0&&arguments[1]?"text":"HTML",""));throw $t(fi(i,e)),Br}function zl(e){var i=e.stateNode,a=e.type,t=e.memoizedProps;switch(i[Pe]=e,i[Ze]=t,a){case"dialog":W("cancel",i),W("close",i);break;case"iframe":case"object":case"embed":W("load",i);break;case"video":case"audio":for(a=0;a<Nn.length;a++)W(Nn[a],i);break;case"source":W("error",i);break;case"img":case"image":case"link":W("error",i),W("load",i);break;case"details":W("toggle",i);break;case"input":W("invalid",i),$d(i,t.value,t.defaultValue,t.checked,t.defaultChecked,t.type,t.name,!0);break;case"select":W("invalid",i);break;case"textarea":W("invalid",i),il(i,t.value,t.defaultValue,t.children)}a=t.children,typeof a!="string"&&typeof a!="number"&&typeof a!="bigint"||i.textContent===""+a||t.suppressHydrationWarning===!0||tg(i.textContent,a)?(t.popover!=null&&(W("beforetoggle",i),W("toggle",i)),t.onScroll!=null&&W("scroll",i),t.onScrollEnd!=null&&W("scrollend",i),t.onClick!=null&&(i.onclick=Vi),i=!0):i=!1,i||ra(e,!0)}function Bl(e){for(Le=e.return;Le;)switch(Le.tag){case 5:case 31:case 13:Ai=!1;return;case 27:case 3:Ai=!0;return;default:Le=Le.return}}function mt(e){if(e!==Le)return!1;if(!ie)return Bl(e),ie=!0,!1;var i=e.tag,a;if((a=i!==3&&i!==27)&&((a=i===5)&&(a=e.type,a=!(a!=="form"&&a!=="button")||od(e.type,e.memoizedProps)),a=!a),a&&fe&&ra(e),Bl(e),i===13){if(e=e.memoizedState,e=e!==null?e.dehydrated:null,!e)throw Error(u(317));fe=gg(e)}else if(i===31){if(e=e.memoizedState,e=e!==null?e.dehydrated:null,!e)throw Error(u(317));fe=gg(e)}else i===27?(i=fe,ka(e.type)?(e=cd,cd=null,fe=e):fe=i):fe=Le?vi(e.stateNode.nextSibling):null;return!0}function Ua(){fe=Le=null,ie=!1}function Gr(){var e=oa;return e!==null&&(ei===null?ei=e:ei.push.apply(ei,e),oa=null),e}function $t(e){oa===null?oa=[e]:oa.push(e)}var qr=m(null),Va=null,Gi=null;function sa(e,i,a){M(qr,i._currentValue),i._currentValue=a}function qi(e){e._currentValue=qr.current,S(qr)}function Fr(e,i,a){for(;e!==null;){var t=e.alternate;if((e.childLanes&i)!==i?(e.childLanes|=i,t!==null&&(t.childLanes|=i)):t!==null&&(t.childLanes&i)!==i&&(t.childLanes|=i),e===a)break;e=e.return}}function Yr(e,i,a,t){var n=e.child;for(n!==null&&(n.return=e);n!==null;){var o=n.dependencies;if(o!==null){var s=n.child;o=o.firstContext;e:for(;o!==null;){var d=o;o=n;for(var l=0;l<i.length;l++)if(d.context===i[l]){o.lanes|=a,d=o.alternate,d!==null&&(d.lanes|=a),Fr(o.return,a,e),t||(s=null);break e}o=d.next}}else if(n.tag===18){if(s=n.return,s===null)throw Error(u(341));s.lanes|=a,o=s.alternate,o!==null&&(o.lanes|=a),Fr(s,a,e),s=null}else s=n.child;if(s!==null)s.return=n;else for(s=n;s!==null;){if(s===e){s=null;break}if(n=s.sibling,n!==null){n.return=s.return,s=n;break}s=s.return}n=s}}function gt(e,i,a,t){e=null;for(var n=i,o=!1;n!==null;){if(!o){if((n.flags&524288)!==0)o=!0;else if((n.flags&262144)!==0)break}if(n.tag===10){var s=n.alternate;if(s===null)throw Error(u(387));if(s=s.memoizedProps,s!==null){var d=n.type;oi(n.pendingProps.value,s.value)||(e!==null?e.push(d):e=[d])}}else if(n===re.current){if(s=n.alternate,s===null)throw Error(u(387));s.memoizedState.memoizedState!==n.memoizedState.memoizedState&&(e!==null?e.push(wn):e=[wn])}n=n.return}e!==null&&Yr(i,e,a,t),i.flags|=262144}function ao(e){for(e=e.firstContext;e!==null;){if(!oi(e.context._currentValue,e.memoizedValue))return!0;e=e.next}return!1}function ja(e){Va=e,Gi=null,e=e.dependencies,e!==null&&(e.firstContext=null)}function Ue(e){return Gl(Va,e)}function to(e,i){return Va===null&&ja(e),Gl(e,i)}function Gl(e,i){var a=i._currentValue;if(i={context:i,memoizedValue:a,next:null},Gi===null){if(e===null)throw Error(u(308));Gi=i,e.dependencies={lanes:0,firstContext:i},e.flags|=524288}else Gi=Gi.next=i;return a}var ch=typeof AbortController<"u"?AbortController:function(){var e=[],i=this.signal={aborted:!1,addEventListener:function(a,t){e.push(t)}};this.abort=function(){i.aborted=!0,e.forEach(function(a){return a()})}},mh=v.unstable_scheduleCallback,gh=v.unstable_NormalPriority,De={$$typeof:j,Consumer:null,Provider:null,_currentValue:null,_currentValue2:null,_threadCount:0};function Kr(){return{controller:new ch,data:new Map,refCount:0}}function en(e){e.refCount--,e.refCount===0&&mh(gh,function(){e.controller.abort()})}var an=null,_r=0,ut=0,ht=null;function uh(e,i){if(an===null){var a=an=[];_r=0,ut=Qs(),ht={status:"pending",value:void 0,then:function(t){a.push(t)}}}return _r++,i.then(ql,ql),i}function ql(){if(--_r===0&&an!==null){ht!==null&&(ht.status="fulfilled");var e=an;an=null,ut=0,ht=null;for(var i=0;i<e.length;i++)(0,e[i])()}}function hh(e,i){var a=[],t={status:"pending",value:null,reason:null,then:function(n){a.push(n)}};return e.then(function(){t.status="fulfilled",t.value=i;for(var n=0;n<a.length;n++)(0,a[n])(i)},function(n){for(t.status="rejected",t.reason=n,n=0;n<a.length;n++)(0,a[n])(void 0)}),t}var Fl=N.S;N.S=function(e,i){wm=ai(),typeof i=="object"&&i!==null&&typeof i.then=="function"&&uh(e,i),Fl!==null&&Fl(e,i)};var za=m(null);function Xr(){var e=za.current;return e!==null?e:pe.pooledCache}function no(e,i){i===null?M(za,za.current):M(za,i.pool)}function Yl(){var e=Xr();return e===null?null:{parent:De._currentValue,pool:e}}var pt=Error(u(460)),Zr=Error(u(474)),oo=Error(u(542)),ro={then:function(){}};function Kl(e){return e=e.status,e==="fulfilled"||e==="rejected"}function _l(e,i,a){switch(a=e[a],a===void 0?e.push(i):a!==i&&(i.then(Vi,Vi),i=a),i.status){case"fulfilled":return i.value;case"rejected":throw e=i.reason,Zl(e),e;default:if(typeof i.status=="string")i.then(Vi,Vi);else{if(e=pe,e!==null&&100<e.shellSuspendCounter)throw Error(u(482));e=i,e.status="pending",e.then(function(t){if(i.status==="pending"){var n=i;n.status="fulfilled",n.value=t}},function(t){if(i.status==="pending"){var n=i;n.status="rejected",n.reason=t}})}switch(i.status){case"fulfilled":return i.value;case"rejected":throw e=i.reason,Zl(e),e}throw Ga=i,pt}}function Ba(e){try{var i=e._init;return i(e._payload)}catch(a){throw a!==null&&typeof a=="object"&&typeof a.then=="function"?(Ga=a,pt):a}}var Ga=null;function Xl(){if(Ga===null)throw Error(u(459));var e=Ga;return Ga=null,e}function Zl(e){if(e===pt||e===oo)throw Error(u(483))}var ft=null,tn=0;function so(e){var i=tn;return tn+=1,ft===null&&(ft=[]),_l(ft,e,i)}function nn(e,i){i=i.props.ref,e.ref=i!==void 0?i:null}function lo(e,i){throw i.$$typeof===J?Error(u(525)):(e=Object.prototype.toString.call(i),Error(u(31,e==="[object Object]"?"object with keys {"+Object.keys(i).join(", ")+"}":e)))}function Ql(e){function i(g,c){if(e){var h=g.deletions;h===null?(g.deletions=[c],g.flags|=16):h.push(c)}}function a(g,c){if(!e)return null;for(;c!==null;)i(g,c),c=c.sibling;return null}function t(g){for(var c=new Map;g!==null;)g.key!==null?c.set(g.key,g):c.set(g.index,g),g=g.sibling;return c}function n(g,c){return g=zi(g,c),g.index=0,g.sibling=null,g}function o(g,c,h){return g.index=h,e?(h=g.alternate,h!==null?(h=h.index,h<c?(g.flags|=67108866,c):h):(g.flags|=67108866,c)):(g.flags|=1048576,c)}function s(g){return e&&g.alternate===null&&(g.flags|=67108866),g}function d(g,c,h,I){return c===null||c.tag!==6?(c=Ur(h,g.mode,I),c.return=g,c):(c=n(c,h),c.return=g,c)}function l(g,c,h,I){var z=h.type;return z===Ce?k(g,c,h.props.children,I,h.key):c!==null&&(c.elementType===z||typeof z=="object"&&z!==null&&z.$$typeof===_e&&Ba(z)===c.type)?(c=n(c,h.props),nn(c,h),c.return=g,c):(c=eo(h.type,h.key,h.props,null,g.mode,I),nn(c,h),c.return=g,c)}function p(g,c,h,I){return c===null||c.tag!==4||c.stateNode.containerInfo!==h.containerInfo||c.stateNode.implementation!==h.implementation?(c=Vr(h,g.mode,I),c.return=g,c):(c=n(c,h.children||[]),c.return=g,c)}function k(g,c,h,I,z){return c===null||c.tag!==7?(c=La(h,g.mode,I,z),c.return=g,c):(c=n(c,h),c.return=g,c)}function T(g,c,h){if(typeof c=="string"&&c!==""||typeof c=="number"||typeof c=="bigint")return c=Ur(""+c,g.mode,h),c.return=g,c;if(typeof c=="object"&&c!==null){switch(c.$$typeof){case ze:return h=eo(c.type,c.key,c.props,null,g.mode,h),nn(h,c),h.return=g,h;case Be:return c=Vr(c,g.mode,h),c.return=g,c;case _e:return c=Ba(c),T(g,c,h)}if(Si(c)||Xe(c))return c=La(c,g.mode,h,null),c.return=g,c;if(typeof c.then=="function")return T(g,so(c),h);if(c.$$typeof===j)return T(g,to(g,c),h);lo(g,c)}return null}function f(g,c,h,I){var z=c!==null?c.key:null;if(typeof h=="string"&&h!==""||typeof h=="number"||typeof h=="bigint")return z!==null?null:d(g,c,""+h,I);if(typeof h=="object"&&h!==null){switch(h.$$typeof){case ze:return h.key===z?l(g,c,h,I):null;case Be:return h.key===z?p(g,c,h,I):null;case _e:return h=Ba(h),f(g,c,h,I)}if(Si(h)||Xe(h))return z!==null?null:k(g,c,h,I,null);if(typeof h.then=="function")return f(g,c,so(h),I);if(h.$$typeof===j)return f(g,c,to(g,h),I);lo(g,h)}return null}function A(g,c,h,I,z){if(typeof I=="string"&&I!==""||typeof I=="number"||typeof I=="bigint")return g=g.get(h)||null,d(c,g,""+I,z);if(typeof I=="object"&&I!==null){switch(I.$$typeof){case ze:return g=g.get(I.key===null?h:I.key)||null,l(c,g,I,z);case Be:return g=g.get(I.key===null?h:I.key)||null,p(c,g,I,z);case _e:return I=Ba(I),A(g,c,h,I,z)}if(Si(I)||Xe(I))return g=g.get(h)||null,k(c,g,I,z,null);if(typeof I.then=="function")return A(g,c,h,so(I),z);if(I.$$typeof===j)return A(g,c,h,to(c,I),z);lo(c,I)}return null}function P(g,c,h,I){for(var z=null,te=null,V=c,K=c=0,ee=null;V!==null&&K<h.length;K++){V.index>K?(ee=V,V=null):ee=V.sibling;var ne=f(g,V,h[K],I);if(ne===null){V===null&&(V=ee);break}e&&V&&ne.alternate===null&&i(g,V),c=o(ne,c,K),te===null?z=ne:te.sibling=ne,te=ne,V=ee}if(K===h.length)return a(g,V),ie&&Bi(g,K),z;if(V===null){for(;K<h.length;K++)V=T(g,h[K],I),V!==null&&(c=o(V,c,K),te===null?z=V:te.sibling=V,te=V);return ie&&Bi(g,K),z}for(V=t(V);K<h.length;K++)ee=A(V,g,K,h[K],I),ee!==null&&(e&&ee.alternate!==null&&V.delete(ee.key===null?K:ee.key),c=o(ee,c,K),te===null?z=ee:te.sibling=ee,te=ee);return e&&V.forEach(function(Sa){return i(g,Sa)}),ie&&Bi(g,K),z}function B(g,c,h,I){if(h==null)throw Error(u(151));for(var z=null,te=null,V=c,K=c=0,ee=null,ne=h.next();V!==null&&!ne.done;K++,ne=h.next()){V.index>K?(ee=V,V=null):ee=V.sibling;var Sa=f(g,V,ne.value,I);if(Sa===null){V===null&&(V=ee);break}e&&V&&Sa.alternate===null&&i(g,V),c=o(Sa,c,K),te===null?z=Sa:te.sibling=Sa,te=Sa,V=ee}if(ne.done)return a(g,V),ie&&Bi(g,K),z;if(V===null){for(;!ne.done;K++,ne=h.next())ne=T(g,ne.value,I),ne!==null&&(c=o(ne,c,K),te===null?z=ne:te.sibling=ne,te=ne);return ie&&Bi(g,K),z}for(V=t(V);!ne.done;K++,ne=h.next())ne=A(V,g,K,ne.value,I),ne!==null&&(e&&ne.alternate!==null&&V.delete(ne.key===null?K:ne.key),c=o(ne,c,K),te===null?z=ne:te.sibling=ne,te=ne);return e&&V.forEach(function(Sp){return i(g,Sp)}),ie&&Bi(g,K),z}function ue(g,c,h,I){if(typeof h=="object"&&h!==null&&h.type===Ce&&h.key===null&&(h=h.props.children),typeof h=="object"&&h!==null){switch(h.$$typeof){case ze:e:{for(var z=h.key;c!==null;){if(c.key===z){if(z=h.type,z===Ce){if(c.tag===7){a(g,c.sibling),I=n(c,h.props.children),I.return=g,g=I;break e}}else if(c.elementType===z||typeof z=="object"&&z!==null&&z.$$typeof===_e&&Ba(z)===c.type){a(g,c.sibling),I=n(c,h.props),nn(I,h),I.return=g,g=I;break e}a(g,c);break}else i(g,c);c=c.sibling}h.type===Ce?(I=La(h.props.children,g.mode,I,h.key),I.return=g,g=I):(I=eo(h.type,h.key,h.props,null,g.mode,I),nn(I,h),I.return=g,g=I)}return s(g);case Be:e:{for(z=h.key;c!==null;){if(c.key===z)if(c.tag===4&&c.stateNode.containerInfo===h.containerInfo&&c.stateNode.implementation===h.implementation){a(g,c.sibling),I=n(c,h.children||[]),I.return=g,g=I;break e}else{a(g,c);break}else i(g,c);c=c.sibling}I=Vr(h,g.mode,I),I.return=g,g=I}return s(g);case _e:return h=Ba(h),ue(g,c,h,I)}if(Si(h))return P(g,c,h,I);if(Xe(h)){if(z=Xe(h),typeof z!="function")throw Error(u(150));return h=z.call(h),B(g,c,h,I)}if(typeof h.then=="function")return ue(g,c,so(h),I);if(h.$$typeof===j)return ue(g,c,to(g,h),I);lo(g,h)}return typeof h=="string"&&h!==""||typeof h=="number"||typeof h=="bigint"?(h=""+h,c!==null&&c.tag===6?(a(g,c.sibling),I=n(c,h),I.return=g,g=I):(a(g,c),I=Ur(h,g.mode,I),I.return=g,g=I),s(g)):a(g,c)}return function(g,c,h,I){try{tn=0;var z=ue(g,c,h,I);return ft=null,z}catch(V){if(V===pt||V===oo)throw V;var te=ri(29,V,null,g.mode);return te.lanes=I,te.return=g,te}finally{}}}var qa=Ql(!0),Wl=Ql(!1),da=!1;function Qr(e){e.updateQueue={baseState:e.memoizedState,firstBaseUpdate:null,lastBaseUpdate:null,shared:{pending:null,lanes:0,hiddenCallbacks:null},callbacks:null}}function Wr(e,i){e=e.updateQueue,i.updateQueue===e&&(i.updateQueue={baseState:e.baseState,firstBaseUpdate:e.firstBaseUpdate,lastBaseUpdate:e.lastBaseUpdate,shared:e.shared,callbacks:null})}function la(e){return{lane:e,tag:0,payload:null,callback:null,next:null}}function ca(e,i,a){var t=e.updateQueue;if(t===null)return null;if(t=t.shared,(oe&2)!==0){var n=t.pending;return n===null?i.next=i:(i.next=n.next,n.next=i),t.pending=i,i=$n(e),Hl(e,null,a),i}return Jn(e,t,i,a),$n(e)}function on(e,i,a){if(i=i.updateQueue,i!==null&&(i=i.shared,(a&4194048)!==0)){var t=i.lanes;t&=e.pendingLanes,a|=t,i.lanes=a,Gd(e,a)}}function Jr(e,i){var a=e.updateQueue,t=e.alternate;if(t!==null&&(t=t.updateQueue,a===t)){var n=null,o=null;if(a=a.firstBaseUpdate,a!==null){do{var s={lane:a.lane,tag:a.tag,payload:a.payload,callback:null,next:null};o===null?n=o=s:o=o.next=s,a=a.next}while(a!==null);o===null?n=o=i:o=o.next=i}else n=o=i;a={baseState:t.baseState,firstBaseUpdate:n,lastBaseUpdate:o,shared:t.shared,callbacks:t.callbacks},e.updateQueue=a;return}e=a.lastBaseUpdate,e===null?a.firstBaseUpdate=i:e.next=i,a.lastBaseUpdate=i}var $r=!1;function rn(){if($r){var e=ht;if(e!==null)throw e}}function sn(e,i,a,t){$r=!1;var n=e.updateQueue;da=!1;var o=n.firstBaseUpdate,s=n.lastBaseUpdate,d=n.shared.pending;if(d!==null){n.shared.pending=null;var l=d,p=l.next;l.next=null,s===null?o=p:s.next=p,s=l;var k=e.alternate;k!==null&&(k=k.updateQueue,d=k.lastBaseUpdate,d!==s&&(d===null?k.firstBaseUpdate=p:d.next=p,k.lastBaseUpdate=l))}if(o!==null){var T=n.baseState;s=0,k=p=l=null,d=o;do{var f=d.lane&-536870913,A=f!==d.lane;if(A?($&f)===f:(t&f)===f){f!==0&&f===ut&&($r=!0),k!==null&&(k=k.next={lane:0,tag:d.tag,payload:d.payload,callback:null,next:null});e:{var P=e,B=d;f=i;var ue=a;switch(B.tag){case 1:if(P=B.payload,typeof P=="function"){T=P.call(ue,T,f);break e}T=P;break e;case 3:P.flags=P.flags&-65537|128;case 0:if(P=B.payload,f=typeof P=="function"?P.call(ue,T,f):P,f==null)break e;T=E({},T,f);break e;case 2:da=!0}}f=d.callback,f!==null&&(e.flags|=64,A&&(e.flags|=8192),A=n.callbacks,A===null?n.callbacks=[f]:A.push(f))}else A={lane:f,tag:d.tag,payload:d.payload,callback:d.callback,next:null},k===null?(p=k=A,l=T):k=k.next=A,s|=f;if(d=d.next,d===null){if(d=n.shared.pending,d===null)break;A=d,d=A.next,A.next=null,n.lastBaseUpdate=A,n.shared.pending=null}}while(!0);k===null&&(l=T),n.baseState=l,n.firstBaseUpdate=p,n.lastBaseUpdate=k,o===null&&(n.shared.lanes=0),pa|=s,e.lanes=s,e.memoizedState=T}}function Jl(e,i){if(typeof e!="function")throw Error(u(191,e));e.call(i)}function $l(e,i){var a=e.callbacks;if(a!==null)for(e.callbacks=null,e=0;e<a.length;e++)Jl(a[e],i)}var yt=m(null),co=m(0);function ec(e,i){e=Ji,M(co,e),M(yt,i),Ji=e|i.baseLanes}function es(){M(co,Ji),M(yt,yt.current)}function is(){Ji=co.current,S(yt),S(co)}var si=m(null),ki=null;function ma(e){var i=e.alternate;M(Ie,Ie.current&1),M(si,e),ki===null&&(i===null||yt.current!==null||i.memoizedState!==null)&&(ki=e)}function as(e){M(Ie,Ie.current),M(si,e),ki===null&&(ki=e)}function ic(e){e.tag===22?(M(Ie,Ie.current),M(si,e),ki===null&&(ki=e)):ga()}function ga(){M(Ie,Ie.current),M(si,si.current)}function di(e){S(si),ki===e&&(ki=null),S(Ie)}var Ie=m(0);function mo(e){for(var i=e;i!==null;){if(i.tag===13){var a=i.memoizedState;if(a!==null&&(a=a.dehydrated,a===null||dd(a)||ld(a)))return i}else if(i.tag===19&&(i.memoizedProps.revealOrder==="forwards"||i.memoizedProps.revealOrder==="backwards"||i.memoizedProps.revealOrder==="unstable_legacy-backwards"||i.memoizedProps.revealOrder==="together")){if((i.flags&128)!==0)return i}else if(i.child!==null){i.child.return=i,i=i.child;continue}if(i===e)break;for(;i.sibling===null;){if(i.return===null||i.return===e)return null;i=i.return}i.sibling.return=i.return,i=i.sibling}return null}var Fi=0,Y=null,me=null,xe=null,go=!1,bt=!1,Fa=!1,uo=0,dn=0,At=null,ph=0;function ke(){throw Error(u(321))}function ts(e,i){if(i===null)return!1;for(var a=0;a<i.length&&a<e.length;a++)if(!oi(e[a],i[a]))return!1;return!0}function ns(e,i,a,t,n,o){return Fi=o,Y=i,i.memoizedState=null,i.updateQueue=null,i.lanes=0,N.H=e===null||e.memoizedState===null?Vc:As,Fa=!1,o=a(t,n),Fa=!1,bt&&(o=tc(i,a,t,n)),ac(e),o}function ac(e){N.H=mn;var i=me!==null&&me.next!==null;if(Fi=0,xe=me=Y=null,go=!1,dn=0,At=null,i)throw Error(u(300));e===null||Ee||(e=e.dependencies,e!==null&&ao(e)&&(Ee=!0))}function tc(e,i,a,t){Y=e;var n=0;do{if(bt&&(At=null),dn=0,bt=!1,25<=n)throw Error(u(301));if(n+=1,xe=me=null,e.updateQueue!=null){var o=e.updateQueue;o.lastEffect=null,o.events=null,o.stores=null,o.memoCache!=null&&(o.memoCache.index=0)}N.H=jc,o=i(a,t)}while(bt);return o}function fh(){var e=N.H,i=e.useState()[0];return i=typeof i.then=="function"?ln(i):i,e=e.useState()[0],(me!==null?me.memoizedState:null)!==e&&(Y.flags|=1024),i}function os(){var e=uo!==0;return uo=0,e}function rs(e,i,a){i.updateQueue=e.updateQueue,i.flags&=-2053,e.lanes&=~a}function ss(e){if(go){for(e=e.memoizedState;e!==null;){var i=e.queue;i!==null&&(i.pending=null),e=e.next}go=!1}Fi=0,xe=me=Y=null,bt=!1,dn=uo=0,At=null}function Ye(){var e={memoizedState:null,baseState:null,baseQueue:null,queue:null,next:null};return xe===null?Y.memoizedState=xe=e:xe=xe.next=e,xe}function Te(){if(me===null){var e=Y.alternate;e=e!==null?e.memoizedState:null}else e=me.next;var i=xe===null?Y.memoizedState:xe.next;if(i!==null)xe=i,me=e;else{if(e===null)throw Y.alternate===null?Error(u(467)):Error(u(310));me=e,e={memoizedState:me.memoizedState,baseState:me.baseState,baseQueue:me.baseQueue,queue:me.queue,next:null},xe===null?Y.memoizedState=xe=e:xe=xe.next=e}return xe}function ho(){return{lastEffect:null,events:null,stores:null,memoCache:null}}function ln(e){var i=dn;return dn+=1,At===null&&(At=[]),e=_l(At,e,i),i=Y,(xe===null?i.memoizedState:xe.next)===null&&(i=i.alternate,N.H=i===null||i.memoizedState===null?Vc:As),e}function po(e){if(e!==null&&typeof e=="object"){if(typeof e.then=="function")return ln(e);if(e.$$typeof===j)return Ue(e)}throw Error(u(438,String(e)))}function ds(e){var i=null,a=Y.updateQueue;if(a!==null&&(i=a.memoCache),i==null){var t=Y.alternate;t!==null&&(t=t.updateQueue,t!==null&&(t=t.memoCache,t!=null&&(i={data:t.data.map(function(n){return n.slice()}),index:0})))}if(i==null&&(i={data:[],index:0}),a===null&&(a=ho(),Y.updateQueue=a),a.memoCache=i,a=i.data[i.index],a===void 0)for(a=i.data[i.index]=Array(e),t=0;t<e;t++)a[t]=Xa;return i.index++,a}function Yi(e,i){return typeof i=="function"?i(e):i}function fo(e){var i=Te();return ls(i,me,e)}function ls(e,i,a){var t=e.queue;if(t===null)throw Error(u(311));t.lastRenderedReducer=a;var n=e.baseQueue,o=t.pending;if(o!==null){if(n!==null){var s=n.next;n.next=o.next,o.next=s}i.baseQueue=n=o,t.pending=null}if(o=e.baseState,n===null)e.memoizedState=o;else{i=n.next;var d=s=null,l=null,p=i,k=!1;do{var T=p.lane&-536870913;if(T!==p.lane?($&T)===T:(Fi&T)===T){var f=p.revertLane;if(f===0)l!==null&&(l=l.next={lane:0,revertLane:0,gesture:null,action:p.action,hasEagerState:p.hasEagerState,eagerState:p.eagerState,next:null}),T===ut&&(k=!0);else if((Fi&f)===f){p=p.next,f===ut&&(k=!0);continue}else T={lane:0,revertLane:p.revertLane,gesture:null,action:p.action,hasEagerState:p.hasEagerState,eagerState:p.eagerState,next:null},l===null?(d=l=T,s=o):l=l.next=T,Y.lanes|=f,pa|=f;T=p.action,Fa&&a(o,T),o=p.hasEagerState?p.eagerState:a(o,T)}else f={lane:T,revertLane:p.revertLane,gesture:p.gesture,action:p.action,hasEagerState:p.hasEagerState,eagerState:p.eagerState,next:null},l===null?(d=l=f,s=o):l=l.next=f,Y.lanes|=T,pa|=T;p=p.next}while(p!==null&&p!==i);if(l===null?s=o:l.next=d,!oi(o,e.memoizedState)&&(Ee=!0,k&&(a=ht,a!==null)))throw a;e.memoizedState=o,e.baseState=s,e.baseQueue=l,t.lastRenderedState=o}return n===null&&(t.lanes=0),[e.memoizedState,t.dispatch]}function cs(e){var i=Te(),a=i.queue;if(a===null)throw Error(u(311));a.lastRenderedReducer=e;var t=a.dispatch,n=a.pending,o=i.memoizedState;if(n!==null){a.pending=null;var s=n=n.next;do o=e(o,s.action),s=s.next;while(s!==n);oi(o,i.memoizedState)||(Ee=!0),i.memoizedState=o,i.baseQueue===null&&(i.baseState=o),a.lastRenderedState=o}return[o,t]}function nc(e,i,a){var t=Y,n=Te(),o=ie;if(o){if(a===void 0)throw Error(u(407));a=a()}else a=i();var s=!oi((me||n).memoizedState,a);if(s&&(n.memoizedState=a,Ee=!0),n=n.queue,us(sc.bind(null,t,n,e),[e]),n.getSnapshot!==i||s||xe!==null&&xe.memoizedState.tag&1){if(t.flags|=2048,kt(9,{destroy:void 0},rc.bind(null,t,n,a,i),null),pe===null)throw Error(u(349));o||(Fi&127)!==0||oc(t,i,a)}return a}function oc(e,i,a){e.flags|=16384,e={getSnapshot:i,value:a},i=Y.updateQueue,i===null?(i=ho(),Y.updateQueue=i,i.stores=[e]):(a=i.stores,a===null?i.stores=[e]:a.push(e))}function rc(e,i,a,t){i.value=a,i.getSnapshot=t,dc(i)&&lc(e)}function sc(e,i,a){return a(function(){dc(i)&&lc(e)})}function dc(e){var i=e.getSnapshot;e=e.value;try{var a=i();return!oi(e,a)}catch{return!0}}function lc(e){var i=Pa(e,2);i!==null&&ii(i,e,2)}function ms(e){var i=Ye();if(typeof e=="function"){var a=e;if(e=a(),Fa){ia(!0);try{a()}finally{ia(!1)}}}return i.memoizedState=i.baseState=e,i.queue={pending:null,lanes:0,dispatch:null,lastRenderedReducer:Yi,lastRenderedState:e},i}function cc(e,i,a,t){return e.baseState=a,ls(e,me,typeof t=="function"?t:Yi)}function yh(e,i,a,t,n){if(Ao(e))throw Error(u(485));if(e=i.action,e!==null){var o={payload:n,action:e,next:null,isTransition:!0,status:"pending",value:null,reason:null,listeners:[],then:function(s){o.listeners.push(s)}};N.T!==null?a(!0):o.isTransition=!1,t(o),a=i.pending,a===null?(o.next=i.pending=o,mc(i,o)):(o.next=a.next,i.pending=a.next=o)}}function mc(e,i){var a=i.action,t=i.payload,n=e.state;if(i.isTransition){var o=N.T,s={};N.T=s;try{var d=a(n,t),l=N.S;l!==null&&l(s,d),gc(e,i,d)}catch(p){gs(e,i,p)}finally{o!==null&&s.types!==null&&(o.types=s.types),N.T=o}}else try{o=a(n,t),gc(e,i,o)}catch(p){gs(e,i,p)}}function gc(e,i,a){a!==null&&typeof a=="object"&&typeof a.then=="function"?a.then(function(t){uc(e,i,t)},function(t){return gs(e,i,t)}):uc(e,i,a)}function uc(e,i,a){i.status="fulfilled",i.value=a,hc(i),e.state=a,i=e.pending,i!==null&&(a=i.next,a===i?e.pending=null:(a=a.next,i.next=a,mc(e,a)))}function gs(e,i,a){var t=e.pending;if(e.pending=null,t!==null){t=t.next;do i.status="rejected",i.reason=a,hc(i),i=i.next;while(i!==t)}e.action=null}function hc(e){e=e.listeners;for(var i=0;i<e.length;i++)(0,e[i])()}function pc(e,i){return i}function fc(e,i){if(ie){var a=pe.formState;if(a!==null){e:{var t=Y;if(ie){if(fe){i:{for(var n=fe,o=Ai;n.nodeType!==8;){if(!o){n=null;break i}if(n=vi(n.nextSibling),n===null){n=null;break i}}o=n.data,n=o==="F!"||o==="F"?n:null}if(n){fe=vi(n.nextSibling),t=n.data==="F!";break e}}ra(t)}t=!1}t&&(i=a[0])}}return a=Ye(),a.memoizedState=a.baseState=i,t={pending:null,lanes:0,dispatch:null,lastRenderedReducer:pc,lastRenderedState:i},a.queue=t,a=Pc.bind(null,Y,t),t.dispatch=a,t=ms(!1),o=bs.bind(null,Y,!1,t.queue),t=Ye(),n={state:i,dispatch:null,action:e,pending:null},t.queue=n,a=yh.bind(null,Y,n,o,a),n.dispatch=a,t.memoizedState=e,[i,a,!1]}function yc(e){var i=Te();return bc(i,me,e)}function bc(e,i,a){if(i=ls(e,i,pc)[0],e=fo(Yi)[0],typeof i=="object"&&i!==null&&typeof i.then=="function")try{var t=ln(i)}catch(s){throw s===pt?oo:s}else t=i;i=Te();var n=i.queue,o=n.dispatch;return a!==i.memoizedState&&(Y.flags|=2048,kt(9,{destroy:void 0},bh.bind(null,n,a),null)),[t,o,e]}function bh(e,i){e.action=i}function Ac(e){var i=Te(),a=me;if(a!==null)return bc(i,a,e);Te(),i=i.memoizedState,a=Te();var t=a.queue.dispatch;return a.memoizedState=e,[i,t,!1]}function kt(e,i,a,t){return e={tag:e,create:a,deps:t,inst:i,next:null},i=Y.updateQueue,i===null&&(i=ho(),Y.updateQueue=i),a=i.lastEffect,a===null?i.lastEffect=e.next=e:(t=a.next,a.next=e,e.next=t,i.lastEffect=e),e}function kc(){return Te().memoizedState}function yo(e,i,a,t){var n=Ye();Y.flags|=e,n.memoizedState=kt(1|i,{destroy:void 0},a,t===void 0?null:t)}function bo(e,i,a,t){var n=Te();t=t===void 0?null:t;var o=n.memoizedState.inst;me!==null&&t!==null&&ts(t,me.memoizedState.deps)?n.memoizedState=kt(i,o,a,t):(Y.flags|=e,n.memoizedState=kt(1|i,o,a,t))}function vc(e,i){yo(8390656,8,e,i)}function us(e,i){bo(2048,8,e,i)}function Ah(e){Y.flags|=4;var i=Y.updateQueue;if(i===null)i=ho(),Y.updateQueue=i,i.events=[e];else{var a=i.events;a===null?i.events=[e]:a.push(e)}}function Nc(e){var i=Te().memoizedState;return Ah({ref:i,nextImpl:e}),function(){if((oe&2)!==0)throw Error(u(440));return i.impl.apply(void 0,arguments)}}function Ic(e,i){return bo(4,2,e,i)}function Tc(e,i){return bo(4,4,e,i)}function Sc(e,i){if(typeof i=="function"){e=e();var a=i(e);return function(){typeof a=="function"?a():i(null)}}if(i!=null)return e=e(),i.current=e,function(){i.current=null}}function Cc(e,i,a){a=a!=null?a.concat([e]):null,bo(4,4,Sc.bind(null,i,e),a)}function hs(){}function wc(e,i){var a=Te();i=i===void 0?null:i;var t=a.memoizedState;return i!==null&&ts(i,t[1])?t[0]:(a.memoizedState=[e,i],e)}function Dc(e,i){var a=Te();i=i===void 0?null:i;var t=a.memoizedState;if(i!==null&&ts(i,t[1]))return t[0];if(t=e(),Fa){ia(!0);try{e()}finally{ia(!1)}}return a.memoizedState=[t,i],t}function ps(e,i,a){return a===void 0||(Fi&1073741824)!==0&&($&261930)===0?e.memoizedState=i:(e.memoizedState=a,e=xm(),Y.lanes|=e,pa|=e,a)}function xc(e,i,a,t){return oi(a,i)?a:yt.current!==null?(e=ps(e,a,t),oi(e,i)||(Ee=!0),e):(Fi&42)===0||(Fi&1073741824)!==0&&($&261930)===0?(Ee=!0,e.memoizedState=a):(e=xm(),Y.lanes|=e,pa|=e,i)}function Ec(e,i,a,t,n){var o=R.p;R.p=o!==0&&8>o?o:8;var s=N.T,d={};N.T=d,bs(e,!1,i,a);try{var l=n(),p=N.S;if(p!==null&&p(d,l),l!==null&&typeof l=="object"&&typeof l.then=="function"){var k=hh(l,t);cn(e,i,k,mi(e))}else cn(e,i,t,mi(e))}catch(T){cn(e,i,{then:function(){},status:"rejected",reason:T},mi())}finally{R.p=o,s!==null&&d.types!==null&&(s.types=d.types),N.T=s}}function kh(){}function fs(e,i,a,t){if(e.tag!==5)throw Error(u(476));var n=Oc(e).queue;Ec(e,n,i,G,a===null?kh:function(){return Rc(e),a(t)})}function Oc(e){var i=e.memoizedState;if(i!==null)return i;i={memoizedState:G,baseState:G,baseQueue:null,queue:{pending:null,lanes:0,dispatch:null,lastRenderedReducer:Yi,lastRenderedState:G},next:null};var a={};return i.next={memoizedState:a,baseState:a,baseQueue:null,queue:{pending:null,lanes:0,dispatch:null,lastRenderedReducer:Yi,lastRenderedState:a},next:null},e.memoizedState=i,e=e.alternate,e!==null&&(e.memoizedState=i),i}function Rc(e){var i=Oc(e);i.next===null&&(i=e.alternate.memoizedState),cn(e,i.next.queue,{},mi())}function ys(){return Ue(wn)}function Mc(){return Te().memoizedState}function Hc(){return Te().memoizedState}function vh(e){for(var i=e.return;i!==null;){switch(i.tag){case 24:case 3:var a=mi();e=la(a);var t=ca(i,e,a);t!==null&&(ii(t,i,a),on(t,i,a)),i={cache:Kr()},e.payload=i;return}i=i.return}}function Nh(e,i,a){var t=mi();a={lane:t,revertLane:0,gesture:null,action:a,hasEagerState:!1,eagerState:null,next:null},Ao(e)?Lc(i,a):(a=Pr(e,i,a,t),a!==null&&(ii(a,e,t),Uc(a,i,t)))}function Pc(e,i,a){var t=mi();cn(e,i,a,t)}function cn(e,i,a,t){var n={lane:t,revertLane:0,gesture:null,action:a,hasEagerState:!1,eagerState:null,next:null};if(Ao(e))Lc(i,n);else{var o=e.alternate;if(e.lanes===0&&(o===null||o.lanes===0)&&(o=i.lastRenderedReducer,o!==null))try{var s=i.lastRenderedState,d=o(s,a);if(n.hasEagerState=!0,n.eagerState=d,oi(d,s))return Jn(e,i,n,0),pe===null&&Wn(),!1}catch{}finally{}if(a=Pr(e,i,n,t),a!==null)return ii(a,e,t),Uc(a,i,t),!0}return!1}function bs(e,i,a,t){if(t={lane:2,revertLane:Qs(),gesture:null,action:t,hasEagerState:!1,eagerState:null,next:null},Ao(e)){if(i)throw Error(u(479))}else i=Pr(e,a,t,2),i!==null&&ii(i,e,2)}function Ao(e){var i=e.alternate;return e===Y||i!==null&&i===Y}function Lc(e,i){bt=go=!0;var a=e.pending;a===null?i.next=i:(i.next=a.next,a.next=i),e.pending=i}function Uc(e,i,a){if((a&4194048)!==0){var t=i.lanes;t&=e.pendingLanes,a|=t,i.lanes=a,Gd(e,a)}}var mn={readContext:Ue,use:po,useCallback:ke,useContext:ke,useEffect:ke,useImperativeHandle:ke,useLayoutEffect:ke,useInsertionEffect:ke,useMemo:ke,useReducer:ke,useRef:ke,useState:ke,useDebugValue:ke,useDeferredValue:ke,useTransition:ke,useSyncExternalStore:ke,useId:ke,useHostTransitionStatus:ke,useFormState:ke,useActionState:ke,useOptimistic:ke,useMemoCache:ke,useCacheRefresh:ke};mn.useEffectEvent=ke;var Vc={readContext:Ue,use:po,useCallback:function(e,i){return Ye().memoizedState=[e,i===void 0?null:i],e},useContext:Ue,useEffect:vc,useImperativeHandle:function(e,i,a){a=a!=null?a.concat([e]):null,yo(4194308,4,Sc.bind(null,i,e),a)},useLayoutEffect:function(e,i){return yo(4194308,4,e,i)},useInsertionEffect:function(e,i){yo(4,2,e,i)},useMemo:function(e,i){var a=Ye();i=i===void 0?null:i;var t=e();if(Fa){ia(!0);try{e()}finally{ia(!1)}}return a.memoizedState=[t,i],t},useReducer:function(e,i,a){var t=Ye();if(a!==void 0){var n=a(i);if(Fa){ia(!0);try{a(i)}finally{ia(!1)}}}else n=i;return t.memoizedState=t.baseState=n,e={pending:null,lanes:0,dispatch:null,lastRenderedReducer:e,lastRenderedState:n},t.queue=e,e=e.dispatch=Nh.bind(null,Y,e),[t.memoizedState,e]},useRef:function(e){var i=Ye();return e={current:e},i.memoizedState=e},useState:function(e){e=ms(e);var i=e.queue,a=Pc.bind(null,Y,i);return i.dispatch=a,[e.memoizedState,a]},useDebugValue:hs,useDeferredValue:function(e,i){var a=Ye();return ps(a,e,i)},useTransition:function(){var e=ms(!1);return e=Ec.bind(null,Y,e.queue,!0,!1),Ye().memoizedState=e,[!1,e]},useSyncExternalStore:function(e,i,a){var t=Y,n=Ye();if(ie){if(a===void 0)throw Error(u(407));a=a()}else{if(a=i(),pe===null)throw Error(u(349));($&127)!==0||oc(t,i,a)}n.memoizedState=a;var o={value:a,getSnapshot:i};return n.queue=o,vc(sc.bind(null,t,o,e),[e]),t.flags|=2048,kt(9,{destroy:void 0},rc.bind(null,t,o,a,i),null),a},useId:function(){var e=Ye(),i=pe.identifierPrefix;if(ie){var a=Mi,t=Ri;a=(t&~(1<<32-ni(t)-1)).toString(32)+a,i="_"+i+"R_"+a,a=uo++,0<a&&(i+="H"+a.toString(32)),i+="_"}else a=ph++,i="_"+i+"r_"+a.toString(32)+"_";return e.memoizedState=i},useHostTransitionStatus:ys,useFormState:fc,useActionState:fc,useOptimistic:function(e){var i=Ye();i.memoizedState=i.baseState=e;var a={pending:null,lanes:0,dispatch:null,lastRenderedReducer:null,lastRenderedState:null};return i.queue=a,i=bs.bind(null,Y,!0,a),a.dispatch=i,[e,i]},useMemoCache:ds,useCacheRefresh:function(){return Ye().memoizedState=vh.bind(null,Y)},useEffectEvent:function(e){var i=Ye(),a={impl:e};return i.memoizedState=a,function(){if((oe&2)!==0)throw Error(u(440));return a.impl.apply(void 0,arguments)}}},As={readContext:Ue,use:po,useCallback:wc,useContext:Ue,useEffect:us,useImperativeHandle:Cc,useInsertionEffect:Ic,useLayoutEffect:Tc,useMemo:Dc,useReducer:fo,useRef:kc,useState:function(){return fo(Yi)},useDebugValue:hs,useDeferredValue:function(e,i){var a=Te();return xc(a,me.memoizedState,e,i)},useTransition:function(){var e=fo(Yi)[0],i=Te().memoizedState;return[typeof e=="boolean"?e:ln(e),i]},useSyncExternalStore:nc,useId:Mc,useHostTransitionStatus:ys,useFormState:yc,useActionState:yc,useOptimistic:function(e,i){var a=Te();return cc(a,me,e,i)},useMemoCache:ds,useCacheRefresh:Hc};As.useEffectEvent=Nc;var jc={readContext:Ue,use:po,useCallback:wc,useContext:Ue,useEffect:us,useImperativeHandle:Cc,useInsertionEffect:Ic,useLayoutEffect:Tc,useMemo:Dc,useReducer:cs,useRef:kc,useState:function(){return cs(Yi)},useDebugValue:hs,useDeferredValue:function(e,i){var a=Te();return me===null?ps(a,e,i):xc(a,me.memoizedState,e,i)},useTransition:function(){var e=cs(Yi)[0],i=Te().memoizedState;return[typeof e=="boolean"?e:ln(e),i]},useSyncExternalStore:nc,useId:Mc,useHostTransitionStatus:ys,useFormState:Ac,useActionState:Ac,useOptimistic:function(e,i){var a=Te();return me!==null?cc(a,me,e,i):(a.baseState=e,[e,a.queue.dispatch])},useMemoCache:ds,useCacheRefresh:Hc};jc.useEffectEvent=Nc;function ks(e,i,a,t){i=e.memoizedState,a=a(t,i),a=a==null?i:E({},i,a),e.memoizedState=a,e.lanes===0&&(e.updateQueue.baseState=a)}var vs={enqueueSetState:function(e,i,a){e=e._reactInternals;var t=mi(),n=la(t);n.payload=i,a!=null&&(n.callback=a),i=ca(e,n,t),i!==null&&(ii(i,e,t),on(i,e,t))},enqueueReplaceState:function(e,i,a){e=e._reactInternals;var t=mi(),n=la(t);n.tag=1,n.payload=i,a!=null&&(n.callback=a),i=ca(e,n,t),i!==null&&(ii(i,e,t),on(i,e,t))},enqueueForceUpdate:function(e,i){e=e._reactInternals;var a=mi(),t=la(a);t.tag=2,i!=null&&(t.callback=i),i=ca(e,t,a),i!==null&&(ii(i,e,a),on(i,e,a))}};function zc(e,i,a,t,n,o,s){return e=e.stateNode,typeof e.shouldComponentUpdate=="function"?e.shouldComponentUpdate(t,o,s):i.prototype&&i.prototype.isPureReactComponent?!Qt(a,t)||!Qt(n,o):!0}function Bc(e,i,a,t){e=i.state,typeof i.componentWillReceiveProps=="function"&&i.componentWillReceiveProps(a,t),typeof i.UNSAFE_componentWillReceiveProps=="function"&&i.UNSAFE_componentWillReceiveProps(a,t),i.state!==e&&vs.enqueueReplaceState(i,i.state,null)}function Ya(e,i){var a=i;if("ref"in i){a={};for(var t in i)t!=="ref"&&(a[t]=i[t])}if(e=e.defaultProps){a===i&&(a=E({},a));for(var n in e)a[n]===void 0&&(a[n]=e[n])}return a}function Gc(e){Qn(e)}function qc(e){console.error(e)}function Fc(e){Qn(e)}function ko(e,i){try{var a=e.onUncaughtError;a(i.value,{componentStack:i.stack})}catch(t){setTimeout(function(){throw t})}}function Yc(e,i,a){try{var t=e.onCaughtError;t(a.value,{componentStack:a.stack,errorBoundary:i.tag===1?i.stateNode:null})}catch(n){setTimeout(function(){throw n})}}function Ns(e,i,a){return a=la(a),a.tag=3,a.payload={element:null},a.callback=function(){ko(e,i)},a}function Kc(e){return e=la(e),e.tag=3,e}function _c(e,i,a,t){var n=a.type.getDerivedStateFromError;if(typeof n=="function"){var o=t.value;e.payload=function(){return n(o)},e.callback=function(){Yc(i,a,t)}}var s=a.stateNode;s!==null&&typeof s.componentDidCatch=="function"&&(e.callback=function(){Yc(i,a,t),typeof n!="function"&&(fa===null?fa=new Set([this]):fa.add(this));var d=t.stack;this.componentDidCatch(t.value,{componentStack:d!==null?d:""})})}function Ih(e,i,a,t,n){if(a.flags|=32768,t!==null&&typeof t=="object"&&typeof t.then=="function"){if(i=a.alternate,i!==null&&gt(i,a,n,!0),a=si.current,a!==null){switch(a.tag){case 31:case 13:return ki===null?Ro():a.alternate===null&&ve===0&&(ve=3),a.flags&=-257,a.flags|=65536,a.lanes=n,t===ro?a.flags|=16384:(i=a.updateQueue,i===null?a.updateQueue=new Set([t]):i.add(t),_s(e,t,n)),!1;case 22:return a.flags|=65536,t===ro?a.flags|=16384:(i=a.updateQueue,i===null?(i={transitions:null,markerInstances:null,retryQueue:new Set([t])},a.updateQueue=i):(a=i.retryQueue,a===null?i.retryQueue=new Set([t]):a.add(t)),_s(e,t,n)),!1}throw Error(u(435,a.tag))}return _s(e,t,n),Ro(),!1}if(ie)return i=si.current,i!==null?((i.flags&65536)===0&&(i.flags|=256),i.flags|=65536,i.lanes=n,t!==Br&&(e=Error(u(422),{cause:t}),$t(fi(e,a)))):(t!==Br&&(i=Error(u(423),{cause:t}),$t(fi(i,a))),e=e.current.alternate,e.flags|=65536,n&=-n,e.lanes|=n,t=fi(t,a),n=Ns(e.stateNode,t,n),Jr(e,n),ve!==4&&(ve=2)),!1;var o=Error(u(520),{cause:t});if(o=fi(o,a),An===null?An=[o]:An.push(o),ve!==4&&(ve=2),i===null)return!0;t=fi(t,a),a=i;do{switch(a.tag){case 3:return a.flags|=65536,e=n&-n,a.lanes|=e,e=Ns(a.stateNode,t,e),Jr(a,e),!1;case 1:if(i=a.type,o=a.stateNode,(a.flags&128)===0&&(typeof i.getDerivedStateFromError=="function"||o!==null&&typeof o.componentDidCatch=="function"&&(fa===null||!fa.has(o))))return a.flags|=65536,n&=-n,a.lanes|=n,n=Kc(n),_c(n,e,a,t),Jr(a,n),!1}a=a.return}while(a!==null);return!1}var Is=Error(u(461)),Ee=!1;function Ve(e,i,a,t){i.child=e===null?Wl(i,null,a,t):qa(i,e.child,a,t)}function Xc(e,i,a,t,n){a=a.render;var o=i.ref;if("ref"in t){var s={};for(var d in t)d!=="ref"&&(s[d]=t[d])}else s=t;return ja(i),t=ns(e,i,a,s,o,n),d=os(),e!==null&&!Ee?(rs(e,i,n),Ki(e,i,n)):(ie&&d&&jr(i),i.flags|=1,Ve(e,i,t,n),i.child)}function Zc(e,i,a,t,n){if(e===null){var o=a.type;return typeof o=="function"&&!Lr(o)&&o.defaultProps===void 0&&a.compare===null?(i.tag=15,i.type=o,Qc(e,i,o,t,n)):(e=eo(a.type,null,t,i,i.mode,n),e.ref=i.ref,e.return=i,i.child=e)}if(o=e.child,!Os(e,n)){var s=o.memoizedProps;if(a=a.compare,a=a!==null?a:Qt,a(s,t)&&e.ref===i.ref)return Ki(e,i,n)}return i.flags|=1,e=zi(o,t),e.ref=i.ref,e.return=i,i.child=e}function Qc(e,i,a,t,n){if(e!==null){var o=e.memoizedProps;if(Qt(o,t)&&e.ref===i.ref)if(Ee=!1,i.pendingProps=t=o,Os(e,n))(e.flags&131072)!==0&&(Ee=!0);else return i.lanes=e.lanes,Ki(e,i,n)}return Ts(e,i,a,t,n)}function Wc(e,i,a,t){var n=t.children,o=e!==null?e.memoizedState:null;if(e===null&&i.stateNode===null&&(i.stateNode={_visibility:1,_pendingMarkers:null,_retryCache:null,_transitions:null}),t.mode==="hidden"){if((i.flags&128)!==0){if(o=o!==null?o.baseLanes|a:a,e!==null){for(t=i.child=e.child,n=0;t!==null;)n=n|t.lanes|t.childLanes,t=t.sibling;t=n&~o}else t=0,i.child=null;return Jc(e,i,o,a,t)}if((a&536870912)!==0)i.memoizedState={baseLanes:0,cachePool:null},e!==null&&no(i,o!==null?o.cachePool:null),o!==null?ec(i,o):es(),ic(i);else return t=i.lanes=536870912,Jc(e,i,o!==null?o.baseLanes|a:a,a,t)}else o!==null?(no(i,o.cachePool),ec(i,o),ga(),i.memoizedState=null):(e!==null&&no(i,null),es(),ga());return Ve(e,i,n,a),i.child}function gn(e,i){return e!==null&&e.tag===22||i.stateNode!==null||(i.stateNode={_visibility:1,_pendingMarkers:null,_retryCache:null,_transitions:null}),i.sibling}function Jc(e,i,a,t,n){var o=Xr();return o=o===null?null:{parent:De._currentValue,pool:o},i.memoizedState={baseLanes:a,cachePool:o},e!==null&&no(i,null),es(),ic(i),e!==null&&gt(e,i,t,!0),i.childLanes=n,null}function vo(e,i){return i=Io({mode:i.mode,children:i.children},e.mode),i.ref=e.ref,e.child=i,i.return=e,i}function $c(e,i,a){return qa(i,e.child,null,a),e=vo(i,i.pendingProps),e.flags|=2,di(i),i.memoizedState=null,e}function Th(e,i,a){var t=i.pendingProps,n=(i.flags&128)!==0;if(i.flags&=-129,e===null){if(ie){if(t.mode==="hidden")return e=vo(i,t),i.lanes=536870912,gn(null,e);if(as(i),(e=fe)?(e=mg(e,Ai),e=e!==null&&e.data==="&"?e:null,e!==null&&(i.memoizedState={dehydrated:e,treeContext:na!==null?{id:Ri,overflow:Mi}:null,retryLane:536870912,hydrationErrors:null},a=Ll(e),a.return=i,i.child=a,Le=i,fe=null)):e=null,e===null)throw ra(i);return i.lanes=536870912,null}return vo(i,t)}var o=e.memoizedState;if(o!==null){var s=o.dehydrated;if(as(i),n)if(i.flags&256)i.flags&=-257,i=$c(e,i,a);else if(i.memoizedState!==null)i.child=e.child,i.flags|=128,i=null;else throw Error(u(558));else if(Ee||gt(e,i,a,!1),n=(a&e.childLanes)!==0,Ee||n){if(t=pe,t!==null&&(s=qd(t,a),s!==0&&s!==o.retryLane))throw o.retryLane=s,Pa(e,s),ii(t,e,s),Is;Ro(),i=$c(e,i,a)}else e=o.treeContext,fe=vi(s.nextSibling),Le=i,ie=!0,oa=null,Ai=!1,e!==null&&jl(i,e),i=vo(i,t),i.flags|=4096;return i}return e=zi(e.child,{mode:t.mode,children:t.children}),e.ref=i.ref,i.child=e,e.return=i,e}function No(e,i){var a=i.ref;if(a===null)e!==null&&e.ref!==null&&(i.flags|=4194816);else{if(typeof a!="function"&&typeof a!="object")throw Error(u(284));(e===null||e.ref!==a)&&(i.flags|=4194816)}}function Ts(e,i,a,t,n){return ja(i),a=ns(e,i,a,t,void 0,n),t=os(),e!==null&&!Ee?(rs(e,i,n),Ki(e,i,n)):(ie&&t&&jr(i),i.flags|=1,Ve(e,i,a,n),i.child)}function em(e,i,a,t,n,o){return ja(i),i.updateQueue=null,a=tc(i,t,a,n),ac(e),t=os(),e!==null&&!Ee?(rs(e,i,o),Ki(e,i,o)):(ie&&t&&jr(i),i.flags|=1,Ve(e,i,a,o),i.child)}function im(e,i,a,t,n){if(ja(i),i.stateNode===null){var o=dt,s=a.contextType;typeof s=="object"&&s!==null&&(o=Ue(s)),o=new a(t,o),i.memoizedState=o.state!==null&&o.state!==void 0?o.state:null,o.updater=vs,i.stateNode=o,o._reactInternals=i,o=i.stateNode,o.props=t,o.state=i.memoizedState,o.refs={},Qr(i),s=a.contextType,o.context=typeof s=="object"&&s!==null?Ue(s):dt,o.state=i.memoizedState,s=a.getDerivedStateFromProps,typeof s=="function"&&(ks(i,a,s,t),o.state=i.memoizedState),typeof a.getDerivedStateFromProps=="function"||typeof o.getSnapshotBeforeUpdate=="function"||typeof o.UNSAFE_componentWillMount!="function"&&typeof o.componentWillMount!="function"||(s=o.state,typeof o.componentWillMount=="function"&&o.componentWillMount(),typeof o.UNSAFE_componentWillMount=="function"&&o.UNSAFE_componentWillMount(),s!==o.state&&vs.enqueueReplaceState(o,o.state,null),sn(i,t,o,n),rn(),o.state=i.memoizedState),typeof o.componentDidMount=="function"&&(i.flags|=4194308),t=!0}else if(e===null){o=i.stateNode;var d=i.memoizedProps,l=Ya(a,d);o.props=l;var p=o.context,k=a.contextType;s=dt,typeof k=="object"&&k!==null&&(s=Ue(k));var T=a.getDerivedStateFromProps;k=typeof T=="function"||typeof o.getSnapshotBeforeUpdate=="function",d=i.pendingProps!==d,k||typeof o.UNSAFE_componentWillReceiveProps!="function"&&typeof o.componentWillReceiveProps!="function"||(d||p!==s)&&Bc(i,o,t,s),da=!1;var f=i.memoizedState;o.state=f,sn(i,t,o,n),rn(),p=i.memoizedState,d||f!==p||da?(typeof T=="function"&&(ks(i,a,T,t),p=i.memoizedState),(l=da||zc(i,a,l,t,f,p,s))?(k||typeof o.UNSAFE_componentWillMount!="function"&&typeof o.componentWillMount!="function"||(typeof o.componentWillMount=="function"&&o.componentWillMount(),typeof o.UNSAFE_componentWillMount=="function"&&o.UNSAFE_componentWillMount()),typeof o.componentDidMount=="function"&&(i.flags|=4194308)):(typeof o.componentDidMount=="function"&&(i.flags|=4194308),i.memoizedProps=t,i.memoizedState=p),o.props=t,o.state=p,o.context=s,t=l):(typeof o.componentDidMount=="function"&&(i.flags|=4194308),t=!1)}else{o=i.stateNode,Wr(e,i),s=i.memoizedProps,k=Ya(a,s),o.props=k,T=i.pendingProps,f=o.context,p=a.contextType,l=dt,typeof p=="object"&&p!==null&&(l=Ue(p)),d=a.getDerivedStateFromProps,(p=typeof d=="function"||typeof o.getSnapshotBeforeUpdate=="function")||typeof o.UNSAFE_componentWillReceiveProps!="function"&&typeof o.componentWillReceiveProps!="function"||(s!==T||f!==l)&&Bc(i,o,t,l),da=!1,f=i.memoizedState,o.state=f,sn(i,t,o,n),rn();var A=i.memoizedState;s!==T||f!==A||da||e!==null&&e.dependencies!==null&&ao(e.dependencies)?(typeof d=="function"&&(ks(i,a,d,t),A=i.memoizedState),(k=da||zc(i,a,k,t,f,A,l)||e!==null&&e.dependencies!==null&&ao(e.dependencies))?(p||typeof o.UNSAFE_componentWillUpdate!="function"&&typeof o.componentWillUpdate!="function"||(typeof o.componentWillUpdate=="function"&&o.componentWillUpdate(t,A,l),typeof o.UNSAFE_componentWillUpdate=="function"&&o.UNSAFE_componentWillUpdate(t,A,l)),typeof o.componentDidUpdate=="function"&&(i.flags|=4),typeof o.getSnapshotBeforeUpdate=="function"&&(i.flags|=1024)):(typeof o.componentDidUpdate!="function"||s===e.memoizedProps&&f===e.memoizedState||(i.flags|=4),typeof o.getSnapshotBeforeUpdate!="function"||s===e.memoizedProps&&f===e.memoizedState||(i.flags|=1024),i.memoizedProps=t,i.memoizedState=A),o.props=t,o.state=A,o.context=l,t=k):(typeof o.componentDidUpdate!="function"||s===e.memoizedProps&&f===e.memoizedState||(i.flags|=4),typeof o.getSnapshotBeforeUpdate!="function"||s===e.memoizedProps&&f===e.memoizedState||(i.flags|=1024),t=!1)}return o=t,No(e,i),t=(i.flags&128)!==0,o||t?(o=i.stateNode,a=t&&typeof a.getDerivedStateFromError!="function"?null:o.render(),i.flags|=1,e!==null&&t?(i.child=qa(i,e.child,null,n),i.child=qa(i,null,a,n)):Ve(e,i,a,n),i.memoizedState=o.state,e=i.child):e=Ki(e,i,n),e}function am(e,i,a,t){return Ua(),i.flags|=256,Ve(e,i,a,t),i.child}var Ss={dehydrated:null,treeContext:null,retryLane:0,hydrationErrors:null};function Cs(e){return{baseLanes:e,cachePool:Yl()}}function ws(e,i,a){return e=e!==null?e.childLanes&~a:0,i&&(e|=ci),e}function tm(e,i,a){var t=i.pendingProps,n=!1,o=(i.flags&128)!==0,s;if((s=o)||(s=e!==null&&e.memoizedState===null?!1:(Ie.current&2)!==0),s&&(n=!0,i.flags&=-129),s=(i.flags&32)!==0,i.flags&=-33,e===null){if(ie){if(n?ma(i):ga(),(e=fe)?(e=mg(e,Ai),e=e!==null&&e.data!=="&"?e:null,e!==null&&(i.memoizedState={dehydrated:e,treeContext:na!==null?{id:Ri,overflow:Mi}:null,retryLane:536870912,hydrationErrors:null},a=Ll(e),a.return=i,i.child=a,Le=i,fe=null)):e=null,e===null)throw ra(i);return ld(e)?i.lanes=32:i.lanes=536870912,null}var d=t.children;return t=t.fallback,n?(ga(),n=i.mode,d=Io({mode:"hidden",children:d},n),t=La(t,n,a,null),d.return=i,t.return=i,d.sibling=t,i.child=d,t=i.child,t.memoizedState=Cs(a),t.childLanes=ws(e,s,a),i.memoizedState=Ss,gn(null,t)):(ma(i),Ds(i,d))}var l=e.memoizedState;if(l!==null&&(d=l.dehydrated,d!==null)){if(o)i.flags&256?(ma(i),i.flags&=-257,i=xs(e,i,a)):i.memoizedState!==null?(ga(),i.child=e.child,i.flags|=128,i=null):(ga(),d=t.fallback,n=i.mode,t=Io({mode:"visible",children:t.children},n),d=La(d,n,a,null),d.flags|=2,t.return=i,d.return=i,t.sibling=d,i.child=t,qa(i,e.child,null,a),t=i.child,t.memoizedState=Cs(a),t.childLanes=ws(e,s,a),i.memoizedState=Ss,i=gn(null,t));else if(ma(i),ld(d)){if(s=d.nextSibling&&d.nextSibling.dataset,s)var p=s.dgst;s=p,t=Error(u(419)),t.stack="",t.digest=s,$t({value:t,source:null,stack:null}),i=xs(e,i,a)}else if(Ee||gt(e,i,a,!1),s=(a&e.childLanes)!==0,Ee||s){if(s=pe,s!==null&&(t=qd(s,a),t!==0&&t!==l.retryLane))throw l.retryLane=t,Pa(e,t),ii(s,e,t),Is;dd(d)||Ro(),i=xs(e,i,a)}else dd(d)?(i.flags|=192,i.child=e.child,i=null):(e=l.treeContext,fe=vi(d.nextSibling),Le=i,ie=!0,oa=null,Ai=!1,e!==null&&jl(i,e),i=Ds(i,t.children),i.flags|=4096);return i}return n?(ga(),d=t.fallback,n=i.mode,l=e.child,p=l.sibling,t=zi(l,{mode:"hidden",children:t.children}),t.subtreeFlags=l.subtreeFlags&65011712,p!==null?d=zi(p,d):(d=La(d,n,a,null),d.flags|=2),d.return=i,t.return=i,t.sibling=d,i.child=t,gn(null,t),t=i.child,d=e.child.memoizedState,d===null?d=Cs(a):(n=d.cachePool,n!==null?(l=De._currentValue,n=n.parent!==l?{parent:l,pool:l}:n):n=Yl(),d={baseLanes:d.baseLanes|a,cachePool:n}),t.memoizedState=d,t.childLanes=ws(e,s,a),i.memoizedState=Ss,gn(e.child,t)):(ma(i),a=e.child,e=a.sibling,a=zi(a,{mode:"visible",children:t.children}),a.return=i,a.sibling=null,e!==null&&(s=i.deletions,s===null?(i.deletions=[e],i.flags|=16):s.push(e)),i.child=a,i.memoizedState=null,a)}function Ds(e,i){return i=Io({mode:"visible",children:i},e.mode),i.return=e,e.child=i}function Io(e,i){return e=ri(22,e,null,i),e.lanes=0,e}function xs(e,i,a){return qa(i,e.child,null,a),e=Ds(i,i.pendingProps.children),e.flags|=2,i.memoizedState=null,e}function nm(e,i,a){e.lanes|=i;var t=e.alternate;t!==null&&(t.lanes|=i),Fr(e.return,i,a)}function Es(e,i,a,t,n,o){var s=e.memoizedState;s===null?e.memoizedState={isBackwards:i,rendering:null,renderingStartTime:0,last:t,tail:a,tailMode:n,treeForkCount:o}:(s.isBackwards=i,s.rendering=null,s.renderingStartTime=0,s.last=t,s.tail=a,s.tailMode=n,s.treeForkCount=o)}function om(e,i,a){var t=i.pendingProps,n=t.revealOrder,o=t.tail;t=t.children;var s=Ie.current,d=(s&2)!==0;if(d?(s=s&1|2,i.flags|=128):s&=1,M(Ie,s),Ve(e,i,t,a),t=ie?Jt:0,!d&&e!==null&&(e.flags&128)!==0)e:for(e=i.child;e!==null;){if(e.tag===13)e.memoizedState!==null&&nm(e,a,i);else if(e.tag===19)nm(e,a,i);else if(e.child!==null){e.child.return=e,e=e.child;continue}if(e===i)break e;for(;e.sibling===null;){if(e.return===null||e.return===i)break e;e=e.return}e.sibling.return=e.return,e=e.sibling}switch(n){case"forwards":for(a=i.child,n=null;a!==null;)e=a.alternate,e!==null&&mo(e)===null&&(n=a),a=a.sibling;a=n,a===null?(n=i.child,i.child=null):(n=a.sibling,a.sibling=null),Es(i,!1,n,a,o,t);break;case"backwards":case"unstable_legacy-backwards":for(a=null,n=i.child,i.child=null;n!==null;){if(e=n.alternate,e!==null&&mo(e)===null){i.child=n;break}e=n.sibling,n.sibling=a,a=n,n=e}Es(i,!0,a,null,o,t);break;case"together":Es(i,!1,null,null,void 0,t);break;default:i.memoizedState=null}return i.child}function Ki(e,i,a){if(e!==null&&(i.dependencies=e.dependencies),pa|=i.lanes,(a&i.childLanes)===0)if(e!==null){if(gt(e,i,a,!1),(a&i.childLanes)===0)return null}else return null;if(e!==null&&i.child!==e.child)throw Error(u(153));if(i.child!==null){for(e=i.child,a=zi(e,e.pendingProps),i.child=a,a.return=i;e.sibling!==null;)e=e.sibling,a=a.sibling=zi(e,e.pendingProps),a.return=i;a.sibling=null}return i.child}function Os(e,i){return(e.lanes&i)!==0?!0:(e=e.dependencies,!!(e!==null&&ao(e)))}function Sh(e,i,a){switch(i.tag){case 3:Fe(i,i.stateNode.containerInfo),sa(i,De,e.memoizedState.cache),Ua();break;case 27:case 5:Ut(i);break;case 4:Fe(i,i.stateNode.containerInfo);break;case 10:sa(i,i.type,i.memoizedProps.value);break;case 31:if(i.memoizedState!==null)return i.flags|=128,as(i),null;break;case 13:var t=i.memoizedState;if(t!==null)return t.dehydrated!==null?(ma(i),i.flags|=128,null):(a&i.child.childLanes)!==0?tm(e,i,a):(ma(i),e=Ki(e,i,a),e!==null?e.sibling:null);ma(i);break;case 19:var n=(e.flags&128)!==0;if(t=(a&i.childLanes)!==0,t||(gt(e,i,a,!1),t=(a&i.childLanes)!==0),n){if(t)return om(e,i,a);i.flags|=128}if(n=i.memoizedState,n!==null&&(n.rendering=null,n.tail=null,n.lastEffect=null),M(Ie,Ie.current),t)break;return null;case 22:return i.lanes=0,Wc(e,i,a,i.pendingProps);case 24:sa(i,De,e.memoizedState.cache)}return Ki(e,i,a)}function rm(e,i,a){if(e!==null)if(e.memoizedProps!==i.pendingProps)Ee=!0;else{if(!Os(e,a)&&(i.flags&128)===0)return Ee=!1,Sh(e,i,a);Ee=(e.flags&131072)!==0}else Ee=!1,ie&&(i.flags&1048576)!==0&&Vl(i,Jt,i.index);switch(i.lanes=0,i.tag){case 16:e:{var t=i.pendingProps;if(e=Ba(i.elementType),i.type=e,typeof e=="function")Lr(e)?(t=Ya(e,t),i.tag=1,i=im(null,i,e,t,a)):(i.tag=0,i=Ts(null,i,e,t,a));else{if(e!=null){var n=e.$$typeof;if(n===ae){i.tag=11,i=Xc(null,i,e,t,a);break e}else if(n===X){i.tag=14,i=Zc(null,i,e,t,a);break e}}throw i=Li(e)||e,Error(u(306,i,""))}}return i;case 0:return Ts(e,i,i.type,i.pendingProps,a);case 1:return t=i.type,n=Ya(t,i.pendingProps),im(e,i,t,n,a);case 3:e:{if(Fe(i,i.stateNode.containerInfo),e===null)throw Error(u(387));t=i.pendingProps;var o=i.memoizedState;n=o.element,Wr(e,i),sn(i,t,null,a);var s=i.memoizedState;if(t=s.cache,sa(i,De,t),t!==o.cache&&Yr(i,[De],a,!0),rn(),t=s.element,o.isDehydrated)if(o={element:t,isDehydrated:!1,cache:s.cache},i.updateQueue.baseState=o,i.memoizedState=o,i.flags&256){i=am(e,i,t,a);break e}else if(t!==n){n=fi(Error(u(424)),i),$t(n),i=am(e,i,t,a);break e}else{switch(e=i.stateNode.containerInfo,e.nodeType){case 9:e=e.body;break;default:e=e.nodeName==="HTML"?e.ownerDocument.body:e}for(fe=vi(e.firstChild),Le=i,ie=!0,oa=null,Ai=!0,a=Wl(i,null,t,a),i.child=a;a;)a.flags=a.flags&-3|4096,a=a.sibling}else{if(Ua(),t===n){i=Ki(e,i,a);break e}Ve(e,i,t,a)}i=i.child}return i;case 26:return No(e,i),e===null?(a=yg(i.type,null,i.pendingProps,null))?i.memoizedState=a:ie||(a=i.type,e=i.pendingProps,t=jo(Z.current).createElement(a),t[Pe]=i,t[Ze]=e,je(t,a,e),Me(t),i.stateNode=t):i.memoizedState=yg(i.type,e.memoizedProps,i.pendingProps,e.memoizedState),null;case 27:return Ut(i),e===null&&ie&&(t=i.stateNode=hg(i.type,i.pendingProps,Z.current),Le=i,Ai=!0,n=fe,ka(i.type)?(cd=n,fe=vi(t.firstChild)):fe=n),Ve(e,i,i.pendingProps.children,a),No(e,i),e===null&&(i.flags|=4194304),i.child;case 5:return e===null&&ie&&((n=t=fe)&&(t=ip(t,i.type,i.pendingProps,Ai),t!==null?(i.stateNode=t,Le=i,fe=vi(t.firstChild),Ai=!1,n=!0):n=!1),n||ra(i)),Ut(i),n=i.type,o=i.pendingProps,s=e!==null?e.memoizedProps:null,t=o.children,od(n,o)?t=null:s!==null&&od(n,s)&&(i.flags|=32),i.memoizedState!==null&&(n=ns(e,i,fh,null,null,a),wn._currentValue=n),No(e,i),Ve(e,i,t,a),i.child;case 6:return e===null&&ie&&((e=a=fe)&&(a=ap(a,i.pendingProps,Ai),a!==null?(i.stateNode=a,Le=i,fe=null,e=!0):e=!1),e||ra(i)),null;case 13:return tm(e,i,a);case 4:return Fe(i,i.stateNode.containerInfo),t=i.pendingProps,e===null?i.child=qa(i,null,t,a):Ve(e,i,t,a),i.child;case 11:return Xc(e,i,i.type,i.pendingProps,a);case 7:return Ve(e,i,i.pendingProps,a),i.child;case 8:return Ve(e,i,i.pendingProps.children,a),i.child;case 12:return Ve(e,i,i.pendingProps.children,a),i.child;case 10:return t=i.pendingProps,sa(i,i.type,t.value),Ve(e,i,t.children,a),i.child;case 9:return n=i.type._context,t=i.pendingProps.children,ja(i),n=Ue(n),t=t(n),i.flags|=1,Ve(e,i,t,a),i.child;case 14:return Zc(e,i,i.type,i.pendingProps,a);case 15:return Qc(e,i,i.type,i.pendingProps,a);case 19:return om(e,i,a);case 31:return Th(e,i,a);case 22:return Wc(e,i,a,i.pendingProps);case 24:return ja(i),t=Ue(De),e===null?(n=Xr(),n===null&&(n=pe,o=Kr(),n.pooledCache=o,o.refCount++,o!==null&&(n.pooledCacheLanes|=a),n=o),i.memoizedState={parent:t,cache:n},Qr(i),sa(i,De,n)):((e.lanes&a)!==0&&(Wr(e,i),sn(i,null,null,a),rn()),n=e.memoizedState,o=i.memoizedState,n.parent!==t?(n={parent:t,cache:t},i.memoizedState=n,i.lanes===0&&(i.memoizedState=i.updateQueue.baseState=n),sa(i,De,t)):(t=o.cache,sa(i,De,t),t!==n.cache&&Yr(i,[De],a,!0))),Ve(e,i,i.pendingProps.children,a),i.child;case 29:throw i.pendingProps}throw Error(u(156,i.tag))}function _i(e){e.flags|=4}function Rs(e,i,a,t,n){if((i=(e.mode&32)!==0)&&(i=!1),i){if(e.flags|=16777216,(n&335544128)===n)if(e.stateNode.complete)e.flags|=8192;else if(Mm())e.flags|=8192;else throw Ga=ro,Zr}else e.flags&=-16777217}function sm(e,i){if(i.type!=="stylesheet"||(i.state.loading&4)!==0)e.flags&=-16777217;else if(e.flags|=16777216,!Ng(i))if(Mm())e.flags|=8192;else throw Ga=ro,Zr}function To(e,i){i!==null&&(e.flags|=4),e.flags&16384&&(i=e.tag!==22?zd():536870912,e.lanes|=i,Tt|=i)}function un(e,i){if(!ie)switch(e.tailMode){case"hidden":i=e.tail;for(var a=null;i!==null;)i.alternate!==null&&(a=i),i=i.sibling;a===null?e.tail=null:a.sibling=null;break;case"collapsed":a=e.tail;for(var t=null;a!==null;)a.alternate!==null&&(t=a),a=a.sibling;t===null?i||e.tail===null?e.tail=null:e.tail.sibling=null:t.sibling=null}}function ye(e){var i=e.alternate!==null&&e.alternate.child===e.child,a=0,t=0;if(i)for(var n=e.child;n!==null;)a|=n.lanes|n.childLanes,t|=n.subtreeFlags&65011712,t|=n.flags&65011712,n.return=e,n=n.sibling;else for(n=e.child;n!==null;)a|=n.lanes|n.childLanes,t|=n.subtreeFlags,t|=n.flags,n.return=e,n=n.sibling;return e.subtreeFlags|=t,e.childLanes=a,i}function Ch(e,i,a){var t=i.pendingProps;switch(zr(i),i.tag){case 16:case 15:case 0:case 11:case 7:case 8:case 12:case 9:case 14:return ye(i),null;case 1:return ye(i),null;case 3:return a=i.stateNode,t=null,e!==null&&(t=e.memoizedState.cache),i.memoizedState.cache!==t&&(i.flags|=2048),qi(De),Ne(),a.pendingContext&&(a.context=a.pendingContext,a.pendingContext=null),(e===null||e.child===null)&&(mt(i)?_i(i):e===null||e.memoizedState.isDehydrated&&(i.flags&256)===0||(i.flags|=1024,Gr())),ye(i),null;case 26:var n=i.type,o=i.memoizedState;return e===null?(_i(i),o!==null?(ye(i),sm(i,o)):(ye(i),Rs(i,n,null,t,a))):o?o!==e.memoizedState?(_i(i),ye(i),sm(i,o)):(ye(i),i.flags&=-16777217):(e=e.memoizedProps,e!==t&&_i(i),ye(i),Rs(i,n,e,t,a)),null;case 27:if(Hn(i),a=Z.current,n=i.type,e!==null&&i.stateNode!=null)e.memoizedProps!==t&&_i(i);else{if(!t){if(i.stateNode===null)throw Error(u(166));return ye(i),null}e=U.current,mt(i)?zl(i):(e=hg(n,t,a),i.stateNode=e,_i(i))}return ye(i),null;case 5:if(Hn(i),n=i.type,e!==null&&i.stateNode!=null)e.memoizedProps!==t&&_i(i);else{if(!t){if(i.stateNode===null)throw Error(u(166));return ye(i),null}if(o=U.current,mt(i))zl(i);else{var s=jo(Z.current);switch(o){case 1:o=s.createElementNS("http://www.w3.org/2000/svg",n);break;case 2:o=s.createElementNS("http://www.w3.org/1998/Math/MathML",n);break;default:switch(n){case"svg":o=s.createElementNS("http://www.w3.org/2000/svg",n);break;case"math":o=s.createElementNS("http://www.w3.org/1998/Math/MathML",n);break;case"script":o=s.createElement("div"),o.innerHTML="<script><\/script>",o=o.removeChild(o.firstChild);break;case"select":o=typeof t.is=="string"?s.createElement("select",{is:t.is}):s.createElement("select"),t.multiple?o.multiple=!0:t.size&&(o.size=t.size);break;default:o=typeof t.is=="string"?s.createElement(n,{is:t.is}):s.createElement(n)}}o[Pe]=i,o[Ze]=t;e:for(s=i.child;s!==null;){if(s.tag===5||s.tag===6)o.appendChild(s.stateNode);else if(s.tag!==4&&s.tag!==27&&s.child!==null){s.child.return=s,s=s.child;continue}if(s===i)break e;for(;s.sibling===null;){if(s.return===null||s.return===i)break e;s=s.return}s.sibling.return=s.return,s=s.sibling}i.stateNode=o;e:switch(je(o,n,t),n){case"button":case"input":case"select":case"textarea":t=!!t.autoFocus;break e;case"img":t=!0;break e;default:t=!1}t&&_i(i)}}return ye(i),Rs(i,i.type,e===null?null:e.memoizedProps,i.pendingProps,a),null;case 6:if(e&&i.stateNode!=null)e.memoizedProps!==t&&_i(i);else{if(typeof t!="string"&&i.stateNode===null)throw Error(u(166));if(e=Z.current,mt(i)){if(e=i.stateNode,a=i.memoizedProps,t=null,n=Le,n!==null)switch(n.tag){case 27:case 5:t=n.memoizedProps}e[Pe]=i,e=!!(e.nodeValue===a||t!==null&&t.suppressHydrationWarning===!0||tg(e.nodeValue,a)),e||ra(i,!0)}else e=jo(e).createTextNode(t),e[Pe]=i,i.stateNode=e}return ye(i),null;case 31:if(a=i.memoizedState,e===null||e.memoizedState!==null){if(t=mt(i),a!==null){if(e===null){if(!t)throw Error(u(318));if(e=i.memoizedState,e=e!==null?e.dehydrated:null,!e)throw Error(u(557));e[Pe]=i}else Ua(),(i.flags&128)===0&&(i.memoizedState=null),i.flags|=4;ye(i),e=!1}else a=Gr(),e!==null&&e.memoizedState!==null&&(e.memoizedState.hydrationErrors=a),e=!0;if(!e)return i.flags&256?(di(i),i):(di(i),null);if((i.flags&128)!==0)throw Error(u(558))}return ye(i),null;case 13:if(t=i.memoizedState,e===null||e.memoizedState!==null&&e.memoizedState.dehydrated!==null){if(n=mt(i),t!==null&&t.dehydrated!==null){if(e===null){if(!n)throw Error(u(318));if(n=i.memoizedState,n=n!==null?n.dehydrated:null,!n)throw Error(u(317));n[Pe]=i}else Ua(),(i.flags&128)===0&&(i.memoizedState=null),i.flags|=4;ye(i),n=!1}else n=Gr(),e!==null&&e.memoizedState!==null&&(e.memoizedState.hydrationErrors=n),n=!0;if(!n)return i.flags&256?(di(i),i):(di(i),null)}return di(i),(i.flags&128)!==0?(i.lanes=a,i):(a=t!==null,e=e!==null&&e.memoizedState!==null,a&&(t=i.child,n=null,t.alternate!==null&&t.alternate.memoizedState!==null&&t.alternate.memoizedState.cachePool!==null&&(n=t.alternate.memoizedState.cachePool.pool),o=null,t.memoizedState!==null&&t.memoizedState.cachePool!==null&&(o=t.memoizedState.cachePool.pool),o!==n&&(t.flags|=2048)),a!==e&&a&&(i.child.flags|=8192),To(i,i.updateQueue),ye(i),null);case 4:return Ne(),e===null&&ed(i.stateNode.containerInfo),ye(i),null;case 10:return qi(i.type),ye(i),null;case 19:if(S(Ie),t=i.memoizedState,t===null)return ye(i),null;if(n=(i.flags&128)!==0,o=t.rendering,o===null)if(n)un(t,!1);else{if(ve!==0||e!==null&&(e.flags&128)!==0)for(e=i.child;e!==null;){if(o=mo(e),o!==null){for(i.flags|=128,un(t,!1),e=o.updateQueue,i.updateQueue=e,To(i,e),i.subtreeFlags=0,e=a,a=i.child;a!==null;)Pl(a,e),a=a.sibling;return M(Ie,Ie.current&1|2),ie&&Bi(i,t.treeForkCount),i.child}e=e.sibling}t.tail!==null&&ai()>xo&&(i.flags|=128,n=!0,un(t,!1),i.lanes=4194304)}else{if(!n)if(e=mo(o),e!==null){if(i.flags|=128,n=!0,e=e.updateQueue,i.updateQueue=e,To(i,e),un(t,!0),t.tail===null&&t.tailMode==="hidden"&&!o.alternate&&!ie)return ye(i),null}else 2*ai()-t.renderingStartTime>xo&&a!==536870912&&(i.flags|=128,n=!0,un(t,!1),i.lanes=4194304);t.isBackwards?(o.sibling=i.child,i.child=o):(e=t.last,e!==null?e.sibling=o:i.child=o,t.last=o)}return t.tail!==null?(e=t.tail,t.rendering=e,t.tail=e.sibling,t.renderingStartTime=ai(),e.sibling=null,a=Ie.current,M(Ie,n?a&1|2:a&1),ie&&Bi(i,t.treeForkCount),e):(ye(i),null);case 22:case 23:return di(i),is(),t=i.memoizedState!==null,e!==null?e.memoizedState!==null!==t&&(i.flags|=8192):t&&(i.flags|=8192),t?(a&536870912)!==0&&(i.flags&128)===0&&(ye(i),i.subtreeFlags&6&&(i.flags|=8192)):ye(i),a=i.updateQueue,a!==null&&To(i,a.retryQueue),a=null,e!==null&&e.memoizedState!==null&&e.memoizedState.cachePool!==null&&(a=e.memoizedState.cachePool.pool),t=null,i.memoizedState!==null&&i.memoizedState.cachePool!==null&&(t=i.memoizedState.cachePool.pool),t!==a&&(i.flags|=2048),e!==null&&S(za),null;case 24:return a=null,e!==null&&(a=e.memoizedState.cache),i.memoizedState.cache!==a&&(i.flags|=2048),qi(De),ye(i),null;case 25:return null;case 30:return null}throw Error(u(156,i.tag))}function wh(e,i){switch(zr(i),i.tag){case 1:return e=i.flags,e&65536?(i.flags=e&-65537|128,i):null;case 3:return qi(De),Ne(),e=i.flags,(e&65536)!==0&&(e&128)===0?(i.flags=e&-65537|128,i):null;case 26:case 27:case 5:return Hn(i),null;case 31:if(i.memoizedState!==null){if(di(i),i.alternate===null)throw Error(u(340));Ua()}return e=i.flags,e&65536?(i.flags=e&-65537|128,i):null;case 13:if(di(i),e=i.memoizedState,e!==null&&e.dehydrated!==null){if(i.alternate===null)throw Error(u(340));Ua()}return e=i.flags,e&65536?(i.flags=e&-65537|128,i):null;case 19:return S(Ie),null;case 4:return Ne(),null;case 10:return qi(i.type),null;case 22:case 23:return di(i),is(),e!==null&&S(za),e=i.flags,e&65536?(i.flags=e&-65537|128,i):null;case 24:return qi(De),null;case 25:return null;default:return null}}function dm(e,i){switch(zr(i),i.tag){case 3:qi(De),Ne();break;case 26:case 27:case 5:Hn(i);break;case 4:Ne();break;case 31:i.memoizedState!==null&&di(i);break;case 13:di(i);break;case 19:S(Ie);break;case 10:qi(i.type);break;case 22:case 23:di(i),is(),e!==null&&S(za);break;case 24:qi(De)}}function hn(e,i){try{var a=i.updateQueue,t=a!==null?a.lastEffect:null;if(t!==null){var n=t.next;a=n;do{if((a.tag&e)===e){t=void 0;var o=a.create,s=a.inst;t=o(),s.destroy=t}a=a.next}while(a!==n)}}catch(d){de(i,i.return,d)}}function ua(e,i,a){try{var t=i.updateQueue,n=t!==null?t.lastEffect:null;if(n!==null){var o=n.next;t=o;do{if((t.tag&e)===e){var s=t.inst,d=s.destroy;if(d!==void 0){s.destroy=void 0,n=i;var l=a,p=d;try{p()}catch(k){de(n,l,k)}}}t=t.next}while(t!==o)}}catch(k){de(i,i.return,k)}}function lm(e){var i=e.updateQueue;if(i!==null){var a=e.stateNode;try{$l(i,a)}catch(t){de(e,e.return,t)}}}function cm(e,i,a){a.props=Ya(e.type,e.memoizedProps),a.state=e.memoizedState;try{a.componentWillUnmount()}catch(t){de(e,i,t)}}function pn(e,i){try{var a=e.ref;if(a!==null){switch(e.tag){case 26:case 27:case 5:var t=e.stateNode;break;case 30:t=e.stateNode;break;default:t=e.stateNode}typeof a=="function"?e.refCleanup=a(t):a.current=t}}catch(n){de(e,i,n)}}function Hi(e,i){var a=e.ref,t=e.refCleanup;if(a!==null)if(typeof t=="function")try{t()}catch(n){de(e,i,n)}finally{e.refCleanup=null,e=e.alternate,e!=null&&(e.refCleanup=null)}else if(typeof a=="function")try{a(null)}catch(n){de(e,i,n)}else a.current=null}function mm(e){var i=e.type,a=e.memoizedProps,t=e.stateNode;try{e:switch(i){case"button":case"input":case"select":case"textarea":a.autoFocus&&t.focus();break e;case"img":a.src?t.src=a.src:a.srcSet&&(t.srcset=a.srcSet)}}catch(n){de(e,e.return,n)}}function Ms(e,i,a){try{var t=e.stateNode;Zh(t,e.type,a,i),t[Ze]=i}catch(n){de(e,e.return,n)}}function gm(e){return e.tag===5||e.tag===3||e.tag===26||e.tag===27&&ka(e.type)||e.tag===4}function Hs(e){e:for(;;){for(;e.sibling===null;){if(e.return===null||gm(e.return))return null;e=e.return}for(e.sibling.return=e.return,e=e.sibling;e.tag!==5&&e.tag!==6&&e.tag!==18;){if(e.tag===27&&ka(e.type)||e.flags&2||e.child===null||e.tag===4)continue e;e.child.return=e,e=e.child}if(!(e.flags&2))return e.stateNode}}function Ps(e,i,a){var t=e.tag;if(t===5||t===6)e=e.stateNode,i?(a.nodeType===9?a.body:a.nodeName==="HTML"?a.ownerDocument.body:a).insertBefore(e,i):(i=a.nodeType===9?a.body:a.nodeName==="HTML"?a.ownerDocument.body:a,i.appendChild(e),a=a._reactRootContainer,a!=null||i.onclick!==null||(i.onclick=Vi));else if(t!==4&&(t===27&&ka(e.type)&&(a=e.stateNode,i=null),e=e.child,e!==null))for(Ps(e,i,a),e=e.sibling;e!==null;)Ps(e,i,a),e=e.sibling}function So(e,i,a){var t=e.tag;if(t===5||t===6)e=e.stateNode,i?a.insertBefore(e,i):a.appendChild(e);else if(t!==4&&(t===27&&ka(e.type)&&(a=e.stateNode),e=e.child,e!==null))for(So(e,i,a),e=e.sibling;e!==null;)So(e,i,a),e=e.sibling}function um(e){var i=e.stateNode,a=e.memoizedProps;try{for(var t=e.type,n=i.attributes;n.length;)i.removeAttributeNode(n[0]);je(i,t,a),i[Pe]=e,i[Ze]=a}catch(o){de(e,e.return,o)}}var Xi=!1,Oe=!1,Ls=!1,hm=typeof WeakSet=="function"?WeakSet:Set,He=null;function Dh(e,i){if(e=e.containerInfo,td=Ko,e=Cl(e),xr(e)){if("selectionStart"in e)var a={start:e.selectionStart,end:e.selectionEnd};else e:{a=(a=e.ownerDocument)&&a.defaultView||window;var t=a.getSelection&&a.getSelection();if(t&&t.rangeCount!==0){a=t.anchorNode;var n=t.anchorOffset,o=t.focusNode;t=t.focusOffset;try{a.nodeType,o.nodeType}catch{a=null;break e}var s=0,d=-1,l=-1,p=0,k=0,T=e,f=null;i:for(;;){for(var A;T!==a||n!==0&&T.nodeType!==3||(d=s+n),T!==o||t!==0&&T.nodeType!==3||(l=s+t),T.nodeType===3&&(s+=T.nodeValue.length),(A=T.firstChild)!==null;)f=T,T=A;for(;;){if(T===e)break i;if(f===a&&++p===n&&(d=s),f===o&&++k===t&&(l=s),(A=T.nextSibling)!==null)break;T=f,f=T.parentNode}T=A}a=d===-1||l===-1?null:{start:d,end:l}}else a=null}a=a||{start:0,end:0}}else a=null;for(nd={focusedElem:e,selectionRange:a},Ko=!1,He=i;He!==null;)if(i=He,e=i.child,(i.subtreeFlags&1028)!==0&&e!==null)e.return=i,He=e;else for(;He!==null;){switch(i=He,o=i.alternate,e=i.flags,i.tag){case 0:if((e&4)!==0&&(e=i.updateQueue,e=e!==null?e.events:null,e!==null))for(a=0;a<e.length;a++)n=e[a],n.ref.impl=n.nextImpl;break;case 11:case 15:break;case 1:if((e&1024)!==0&&o!==null){e=void 0,a=i,n=o.memoizedProps,o=o.memoizedState,t=a.stateNode;try{var P=Ya(a.type,n);e=t.getSnapshotBeforeUpdate(P,o),t.__reactInternalSnapshotBeforeUpdate=e}catch(B){de(a,a.return,B)}}break;case 3:if((e&1024)!==0){if(e=i.stateNode.containerInfo,a=e.nodeType,a===9)sd(e);else if(a===1)switch(e.nodeName){case"HEAD":case"HTML":case"BODY":sd(e);break;default:e.textContent=""}}break;case 5:case 26:case 27:case 6:case 4:case 17:break;default:if((e&1024)!==0)throw Error(u(163))}if(e=i.sibling,e!==null){e.return=i.return,He=e;break}He=i.return}}function pm(e,i,a){var t=a.flags;switch(a.tag){case 0:case 11:case 15:Qi(e,a),t&4&&hn(5,a);break;case 1:if(Qi(e,a),t&4)if(e=a.stateNode,i===null)try{e.componentDidMount()}catch(s){de(a,a.return,s)}else{var n=Ya(a.type,i.memoizedProps);i=i.memoizedState;try{e.componentDidUpdate(n,i,e.__reactInternalSnapshotBeforeUpdate)}catch(s){de(a,a.return,s)}}t&64&&lm(a),t&512&&pn(a,a.return);break;case 3:if(Qi(e,a),t&64&&(e=a.updateQueue,e!==null)){if(i=null,a.child!==null)switch(a.child.tag){case 27:case 5:i=a.child.stateNode;break;case 1:i=a.child.stateNode}try{$l(e,i)}catch(s){de(a,a.return,s)}}break;case 27:i===null&&t&4&&um(a);case 26:case 5:Qi(e,a),i===null&&t&4&&mm(a),t&512&&pn(a,a.return);break;case 12:Qi(e,a);break;case 31:Qi(e,a),t&4&&bm(e,a);break;case 13:Qi(e,a),t&4&&Am(e,a),t&64&&(e=a.memoizedState,e!==null&&(e=e.dehydrated,e!==null&&(a=Uh.bind(null,a),tp(e,a))));break;case 22:if(t=a.memoizedState!==null||Xi,!t){i=i!==null&&i.memoizedState!==null||Oe,n=Xi;var o=Oe;Xi=t,(Oe=i)&&!o?Wi(e,a,(a.subtreeFlags&8772)!==0):Qi(e,a),Xi=n,Oe=o}break;case 30:break;default:Qi(e,a)}}function fm(e){var i=e.alternate;i!==null&&(e.alternate=null,fm(i)),e.child=null,e.deletions=null,e.sibling=null,e.tag===5&&(i=e.stateNode,i!==null&&gr(i)),e.stateNode=null,e.return=null,e.dependencies=null,e.memoizedProps=null,e.memoizedState=null,e.pendingProps=null,e.stateNode=null,e.updateQueue=null}var be=null,We=!1;function Zi(e,i,a){for(a=a.child;a!==null;)ym(e,i,a),a=a.sibling}function ym(e,i,a){if(ti&&typeof ti.onCommitFiberUnmount=="function")try{ti.onCommitFiberUnmount(Vt,a)}catch{}switch(a.tag){case 26:Oe||Hi(a,i),Zi(e,i,a),a.memoizedState?a.memoizedState.count--:a.stateNode&&(a=a.stateNode,a.parentNode.removeChild(a));break;case 27:Oe||Hi(a,i);var t=be,n=We;ka(a.type)&&(be=a.stateNode,We=!1),Zi(e,i,a),Tn(a.stateNode),be=t,We=n;break;case 5:Oe||Hi(a,i);case 6:if(t=be,n=We,be=null,Zi(e,i,a),be=t,We=n,be!==null)if(We)try{(be.nodeType===9?be.body:be.nodeName==="HTML"?be.ownerDocument.body:be).removeChild(a.stateNode)}catch(o){de(a,i,o)}else try{be.removeChild(a.stateNode)}catch(o){de(a,i,o)}break;case 18:be!==null&&(We?(e=be,lg(e.nodeType===9?e.body:e.nodeName==="HTML"?e.ownerDocument.body:e,a.stateNode),Rt(e)):lg(be,a.stateNode));break;case 4:t=be,n=We,be=a.stateNode.containerInfo,We=!0,Zi(e,i,a),be=t,We=n;break;case 0:case 11:case 14:case 15:ua(2,a,i),Oe||ua(4,a,i),Zi(e,i,a);break;case 1:Oe||(Hi(a,i),t=a.stateNode,typeof t.componentWillUnmount=="function"&&cm(a,i,t)),Zi(e,i,a);break;case 21:Zi(e,i,a);break;case 22:Oe=(t=Oe)||a.memoizedState!==null,Zi(e,i,a),Oe=t;break;default:Zi(e,i,a)}}function bm(e,i){if(i.memoizedState===null&&(e=i.alternate,e!==null&&(e=e.memoizedState,e!==null))){e=e.dehydrated;try{Rt(e)}catch(a){de(i,i.return,a)}}}function Am(e,i){if(i.memoizedState===null&&(e=i.alternate,e!==null&&(e=e.memoizedState,e!==null&&(e=e.dehydrated,e!==null))))try{Rt(e)}catch(a){de(i,i.return,a)}}function xh(e){switch(e.tag){case 31:case 13:case 19:var i=e.stateNode;return i===null&&(i=e.stateNode=new hm),i;case 22:return e=e.stateNode,i=e._retryCache,i===null&&(i=e._retryCache=new hm),i;default:throw Error(u(435,e.tag))}}function Co(e,i){var a=xh(e);i.forEach(function(t){if(!a.has(t)){a.add(t);var n=Vh.bind(null,e,t);t.then(n,n)}})}function Je(e,i){var a=i.deletions;if(a!==null)for(var t=0;t<a.length;t++){var n=a[t],o=e,s=i,d=s;e:for(;d!==null;){switch(d.tag){case 27:if(ka(d.type)){be=d.stateNode,We=!1;break e}break;case 5:be=d.stateNode,We=!1;break e;case 3:case 4:be=d.stateNode.containerInfo,We=!0;break e}d=d.return}if(be===null)throw Error(u(160));ym(o,s,n),be=null,We=!1,o=n.alternate,o!==null&&(o.return=null),n.return=null}if(i.subtreeFlags&13886)for(i=i.child;i!==null;)km(i,e),i=i.sibling}var wi=null;function km(e,i){var a=e.alternate,t=e.flags;switch(e.tag){case 0:case 11:case 14:case 15:Je(i,e),$e(e),t&4&&(ua(3,e,e.return),hn(3,e),ua(5,e,e.return));break;case 1:Je(i,e),$e(e),t&512&&(Oe||a===null||Hi(a,a.return)),t&64&&Xi&&(e=e.updateQueue,e!==null&&(t=e.callbacks,t!==null&&(a=e.shared.hiddenCallbacks,e.shared.hiddenCallbacks=a===null?t:a.concat(t))));break;case 26:var n=wi;if(Je(i,e),$e(e),t&512&&(Oe||a===null||Hi(a,a.return)),t&4){var o=a!==null?a.memoizedState:null;if(t=e.memoizedState,a===null)if(t===null)if(e.stateNode===null){e:{t=e.type,a=e.memoizedProps,n=n.ownerDocument||n;i:switch(t){case"title":o=n.getElementsByTagName("title")[0],(!o||o[Bt]||o[Pe]||o.namespaceURI==="http://www.w3.org/2000/svg"||o.hasAttribute("itemprop"))&&(o=n.createElement(t),n.head.insertBefore(o,n.querySelector("head > title"))),je(o,t,a),o[Pe]=e,Me(o),t=o;break e;case"link":var s=kg("link","href",n).get(t+(a.href||""));if(s){for(var d=0;d<s.length;d++)if(o=s[d],o.getAttribute("href")===(a.href==null||a.href===""?null:a.href)&&o.getAttribute("rel")===(a.rel==null?null:a.rel)&&o.getAttribute("title")===(a.title==null?null:a.title)&&o.getAttribute("crossorigin")===(a.crossOrigin==null?null:a.crossOrigin)){s.splice(d,1);break i}}o=n.createElement(t),je(o,t,a),n.head.appendChild(o);break;case"meta":if(s=kg("meta","content",n).get(t+(a.content||""))){for(d=0;d<s.length;d++)if(o=s[d],o.getAttribute("content")===(a.content==null?null:""+a.content)&&o.getAttribute("name")===(a.name==null?null:a.name)&&o.getAttribute("property")===(a.property==null?null:a.property)&&o.getAttribute("http-equiv")===(a.httpEquiv==null?null:a.httpEquiv)&&o.getAttribute("charset")===(a.charSet==null?null:a.charSet)){s.splice(d,1);break i}}o=n.createElement(t),je(o,t,a),n.head.appendChild(o);break;default:throw Error(u(468,t))}o[Pe]=e,Me(o),t=o}e.stateNode=t}else vg(n,e.type,e.stateNode);else e.stateNode=Ag(n,t,e.memoizedProps);else o!==t?(o===null?a.stateNode!==null&&(a=a.stateNode,a.parentNode.removeChild(a)):o.count--,t===null?vg(n,e.type,e.stateNode):Ag(n,t,e.memoizedProps)):t===null&&e.stateNode!==null&&Ms(e,e.memoizedProps,a.memoizedProps)}break;case 27:Je(i,e),$e(e),t&512&&(Oe||a===null||Hi(a,a.return)),a!==null&&t&4&&Ms(e,e.memoizedProps,a.memoizedProps);break;case 5:if(Je(i,e),$e(e),t&512&&(Oe||a===null||Hi(a,a.return)),e.flags&32){n=e.stateNode;try{it(n,"")}catch(P){de(e,e.return,P)}}t&4&&e.stateNode!=null&&(n=e.memoizedProps,Ms(e,n,a!==null?a.memoizedProps:n)),t&1024&&(Ls=!0);break;case 6:if(Je(i,e),$e(e),t&4){if(e.stateNode===null)throw Error(u(162));t=e.memoizedProps,a=e.stateNode;try{a.nodeValue=t}catch(P){de(e,e.return,P)}}break;case 3:if(Go=null,n=wi,wi=zo(i.containerInfo),Je(i,e),wi=n,$e(e),t&4&&a!==null&&a.memoizedState.isDehydrated)try{Rt(i.containerInfo)}catch(P){de(e,e.return,P)}Ls&&(Ls=!1,vm(e));break;case 4:t=wi,wi=zo(e.stateNode.containerInfo),Je(i,e),$e(e),wi=t;break;case 12:Je(i,e),$e(e);break;case 31:Je(i,e),$e(e),t&4&&(t=e.updateQueue,t!==null&&(e.updateQueue=null,Co(e,t)));break;case 13:Je(i,e),$e(e),e.child.flags&8192&&e.memoizedState!==null!=(a!==null&&a.memoizedState!==null)&&(Do=ai()),t&4&&(t=e.updateQueue,t!==null&&(e.updateQueue=null,Co(e,t)));break;case 22:n=e.memoizedState!==null;var l=a!==null&&a.memoizedState!==null,p=Xi,k=Oe;if(Xi=p||n,Oe=k||l,Je(i,e),Oe=k,Xi=p,$e(e),t&8192)e:for(i=e.stateNode,i._visibility=n?i._visibility&-2:i._visibility|1,n&&(a===null||l||Xi||Oe||Ka(e)),a=null,i=e;;){if(i.tag===5||i.tag===26){if(a===null){l=a=i;try{if(o=l.stateNode,n)s=o.style,typeof s.setProperty=="function"?s.setProperty("display","none","important"):s.display="none";else{d=l.stateNode;var T=l.memoizedProps.style,f=T!=null&&T.hasOwnProperty("display")?T.display:null;d.style.display=f==null||typeof f=="boolean"?"":(""+f).trim()}}catch(P){de(l,l.return,P)}}}else if(i.tag===6){if(a===null){l=i;try{l.stateNode.nodeValue=n?"":l.memoizedProps}catch(P){de(l,l.return,P)}}}else if(i.tag===18){if(a===null){l=i;try{var A=l.stateNode;n?cg(A,!0):cg(l.stateNode,!1)}catch(P){de(l,l.return,P)}}}else if((i.tag!==22&&i.tag!==23||i.memoizedState===null||i===e)&&i.child!==null){i.child.return=i,i=i.child;continue}if(i===e)break e;for(;i.sibling===null;){if(i.return===null||i.return===e)break e;a===i&&(a=null),i=i.return}a===i&&(a=null),i.sibling.return=i.return,i=i.sibling}t&4&&(t=e.updateQueue,t!==null&&(a=t.retryQueue,a!==null&&(t.retryQueue=null,Co(e,a))));break;case 19:Je(i,e),$e(e),t&4&&(t=e.updateQueue,t!==null&&(e.updateQueue=null,Co(e,t)));break;case 30:break;case 21:break;default:Je(i,e),$e(e)}}function $e(e){var i=e.flags;if(i&2){try{for(var a,t=e.return;t!==null;){if(gm(t)){a=t;break}t=t.return}if(a==null)throw Error(u(160));switch(a.tag){case 27:var n=a.stateNode,o=Hs(e);So(e,o,n);break;case 5:var s=a.stateNode;a.flags&32&&(it(s,""),a.flags&=-33);var d=Hs(e);So(e,d,s);break;case 3:case 4:var l=a.stateNode.containerInfo,p=Hs(e);Ps(e,p,l);break;default:throw Error(u(161))}}catch(k){de(e,e.return,k)}e.flags&=-3}i&4096&&(e.flags&=-4097)}function vm(e){if(e.subtreeFlags&1024)for(e=e.child;e!==null;){var i=e;vm(i),i.tag===5&&i.flags&1024&&i.stateNode.reset(),e=e.sibling}}function Qi(e,i){if(i.subtreeFlags&8772)for(i=i.child;i!==null;)pm(e,i.alternate,i),i=i.sibling}function Ka(e){for(e=e.child;e!==null;){var i=e;switch(i.tag){case 0:case 11:case 14:case 15:ua(4,i,i.return),Ka(i);break;case 1:Hi(i,i.return);var a=i.stateNode;typeof a.componentWillUnmount=="function"&&cm(i,i.return,a),Ka(i);break;case 27:Tn(i.stateNode);case 26:case 5:Hi(i,i.return),Ka(i);break;case 22:i.memoizedState===null&&Ka(i);break;case 30:Ka(i);break;default:Ka(i)}e=e.sibling}}function Wi(e,i,a){for(a=a&&(i.subtreeFlags&8772)!==0,i=i.child;i!==null;){var t=i.alternate,n=e,o=i,s=o.flags;switch(o.tag){case 0:case 11:case 15:Wi(n,o,a),hn(4,o);break;case 1:if(Wi(n,o,a),t=o,n=t.stateNode,typeof n.componentDidMount=="function")try{n.componentDidMount()}catch(p){de(t,t.return,p)}if(t=o,n=t.updateQueue,n!==null){var d=t.stateNode;try{var l=n.shared.hiddenCallbacks;if(l!==null)for(n.shared.hiddenCallbacks=null,n=0;n<l.length;n++)Jl(l[n],d)}catch(p){de(t,t.return,p)}}a&&s&64&&lm(o),pn(o,o.return);break;case 27:um(o);case 26:case 5:Wi(n,o,a),a&&t===null&&s&4&&mm(o),pn(o,o.return);break;case 12:Wi(n,o,a);break;case 31:Wi(n,o,a),a&&s&4&&bm(n,o);break;case 13:Wi(n,o,a),a&&s&4&&Am(n,o);break;case 22:o.memoizedState===null&&Wi(n,o,a),pn(o,o.return);break;case 30:break;default:Wi(n,o,a)}i=i.sibling}}function Us(e,i){var a=null;e!==null&&e.memoizedState!==null&&e.memoizedState.cachePool!==null&&(a=e.memoizedState.cachePool.pool),e=null,i.memoizedState!==null&&i.memoizedState.cachePool!==null&&(e=i.memoizedState.cachePool.pool),e!==a&&(e!=null&&e.refCount++,a!=null&&en(a))}function Vs(e,i){e=null,i.alternate!==null&&(e=i.alternate.memoizedState.cache),i=i.memoizedState.cache,i!==e&&(i.refCount++,e!=null&&en(e))}function Di(e,i,a,t){if(i.subtreeFlags&10256)for(i=i.child;i!==null;)Nm(e,i,a,t),i=i.sibling}function Nm(e,i,a,t){var n=i.flags;switch(i.tag){case 0:case 11:case 15:Di(e,i,a,t),n&2048&&hn(9,i);break;case 1:Di(e,i,a,t);break;case 3:Di(e,i,a,t),n&2048&&(e=null,i.alternate!==null&&(e=i.alternate.memoizedState.cache),i=i.memoizedState.cache,i!==e&&(i.refCount++,e!=null&&en(e)));break;case 12:if(n&2048){Di(e,i,a,t),e=i.stateNode;try{var o=i.memoizedProps,s=o.id,d=o.onPostCommit;typeof d=="function"&&d(s,i.alternate===null?"mount":"update",e.passiveEffectDuration,-0)}catch(l){de(i,i.return,l)}}else Di(e,i,a,t);break;case 31:Di(e,i,a,t);break;case 13:Di(e,i,a,t);break;case 23:break;case 22:o=i.stateNode,s=i.alternate,i.memoizedState!==null?o._visibility&2?Di(e,i,a,t):fn(e,i):o._visibility&2?Di(e,i,a,t):(o._visibility|=2,vt(e,i,a,t,(i.subtreeFlags&10256)!==0||!1)),n&2048&&Us(s,i);break;case 24:Di(e,i,a,t),n&2048&&Vs(i.alternate,i);break;default:Di(e,i,a,t)}}function vt(e,i,a,t,n){for(n=n&&((i.subtreeFlags&10256)!==0||!1),i=i.child;i!==null;){var o=e,s=i,d=a,l=t,p=s.flags;switch(s.tag){case 0:case 11:case 15:vt(o,s,d,l,n),hn(8,s);break;case 23:break;case 22:var k=s.stateNode;s.memoizedState!==null?k._visibility&2?vt(o,s,d,l,n):fn(o,s):(k._visibility|=2,vt(o,s,d,l,n)),n&&p&2048&&Us(s.alternate,s);break;case 24:vt(o,s,d,l,n),n&&p&2048&&Vs(s.alternate,s);break;default:vt(o,s,d,l,n)}i=i.sibling}}function fn(e,i){if(i.subtreeFlags&10256)for(i=i.child;i!==null;){var a=e,t=i,n=t.flags;switch(t.tag){case 22:fn(a,t),n&2048&&Us(t.alternate,t);break;case 24:fn(a,t),n&2048&&Vs(t.alternate,t);break;default:fn(a,t)}i=i.sibling}}var yn=8192;function Nt(e,i,a){if(e.subtreeFlags&yn)for(e=e.child;e!==null;)Im(e,i,a),e=e.sibling}function Im(e,i,a){switch(e.tag){case 26:Nt(e,i,a),e.flags&yn&&e.memoizedState!==null&&pp(a,wi,e.memoizedState,e.memoizedProps);break;case 5:Nt(e,i,a);break;case 3:case 4:var t=wi;wi=zo(e.stateNode.containerInfo),Nt(e,i,a),wi=t;break;case 22:e.memoizedState===null&&(t=e.alternate,t!==null&&t.memoizedState!==null?(t=yn,yn=16777216,Nt(e,i,a),yn=t):Nt(e,i,a));break;default:Nt(e,i,a)}}function Tm(e){var i=e.alternate;if(i!==null&&(e=i.child,e!==null)){i.child=null;do i=e.sibling,e.sibling=null,e=i;while(e!==null)}}function bn(e){var i=e.deletions;if((e.flags&16)!==0){if(i!==null)for(var a=0;a<i.length;a++){var t=i[a];He=t,Cm(t,e)}Tm(e)}if(e.subtreeFlags&10256)for(e=e.child;e!==null;)Sm(e),e=e.sibling}function Sm(e){switch(e.tag){case 0:case 11:case 15:bn(e),e.flags&2048&&ua(9,e,e.return);break;case 3:bn(e);break;case 12:bn(e);break;case 22:var i=e.stateNode;e.memoizedState!==null&&i._visibility&2&&(e.return===null||e.return.tag!==13)?(i._visibility&=-3,wo(e)):bn(e);break;default:bn(e)}}function wo(e){var i=e.deletions;if((e.flags&16)!==0){if(i!==null)for(var a=0;a<i.length;a++){var t=i[a];He=t,Cm(t,e)}Tm(e)}for(e=e.child;e!==null;){switch(i=e,i.tag){case 0:case 11:case 15:ua(8,i,i.return),wo(i);break;case 22:a=i.stateNode,a._visibility&2&&(a._visibility&=-3,wo(i));break;default:wo(i)}e=e.sibling}}function Cm(e,i){for(;He!==null;){var a=He;switch(a.tag){case 0:case 11:case 15:ua(8,a,i);break;case 23:case 22:if(a.memoizedState!==null&&a.memoizedState.cachePool!==null){var t=a.memoizedState.cachePool.pool;t!=null&&t.refCount++}break;case 24:en(a.memoizedState.cache)}if(t=a.child,t!==null)t.return=a,He=t;else e:for(a=e;He!==null;){t=He;var n=t.sibling,o=t.return;if(fm(t),t===a){He=null;break e}if(n!==null){n.return=o,He=n;break e}He=o}}}var Eh={getCacheForType:function(e){var i=Ue(De),a=i.data.get(e);return a===void 0&&(a=e(),i.data.set(e,a)),a},cacheSignal:function(){return Ue(De).controller.signal}},Oh=typeof WeakMap=="function"?WeakMap:Map,oe=0,pe=null,Q=null,$=0,se=0,li=null,ha=!1,It=!1,js=!1,Ji=0,ve=0,pa=0,_a=0,zs=0,ci=0,Tt=0,An=null,ei=null,Bs=!1,Do=0,wm=0,xo=1/0,Eo=null,fa=null,Re=0,ya=null,St=null,$i=0,Gs=0,qs=null,Dm=null,kn=0,Fs=null;function mi(){return(oe&2)!==0&&$!==0?$&-$:N.T!==null?Qs():Fd()}function xm(){if(ci===0)if(($&536870912)===0||ie){var e=Un;Un<<=1,(Un&3932160)===0&&(Un=262144),ci=e}else ci=536870912;return e=si.current,e!==null&&(e.flags|=32),ci}function ii(e,i,a){(e===pe&&(se===2||se===9)||e.cancelPendingCommit!==null)&&(Ct(e,0),ba(e,$,ci,!1)),zt(e,a),((oe&2)===0||e!==pe)&&(e===pe&&((oe&2)===0&&(_a|=a),ve===4&&ba(e,$,ci,!1)),Pi(e))}function Em(e,i,a){if((oe&6)!==0)throw Error(u(327));var t=!a&&(i&127)===0&&(i&e.expiredLanes)===0||jt(e,i),n=t?Hh(e,i):Ks(e,i,!0),o=t;do{if(n===0){It&&!t&&ba(e,i,0,!1);break}else{if(a=e.current.alternate,o&&!Rh(a)){n=Ks(e,i,!1),o=!1;continue}if(n===2){if(o=i,e.errorRecoveryDisabledLanes&o)var s=0;else s=e.pendingLanes&-536870913,s=s!==0?s:s&536870912?536870912:0;if(s!==0){i=s;e:{var d=e;n=An;var l=d.current.memoizedState.isDehydrated;if(l&&(Ct(d,s).flags|=256),s=Ks(d,s,!1),s!==2){if(js&&!l){d.errorRecoveryDisabledLanes|=o,_a|=o,n=4;break e}o=ei,ei=n,o!==null&&(ei===null?ei=o:ei.push.apply(ei,o))}n=s}if(o=!1,n!==2)continue}}if(n===1){Ct(e,0),ba(e,i,0,!0);break}e:{switch(t=e,o=n,o){case 0:case 1:throw Error(u(345));case 4:if((i&4194048)!==i)break;case 6:ba(t,i,ci,!ha);break e;case 2:ei=null;break;case 3:case 5:break;default:throw Error(u(329))}if((i&62914560)===i&&(n=Do+300-ai(),10<n)){if(ba(t,i,ci,!ha),jn(t,0,!0)!==0)break e;$i=i,t.timeoutHandle=sg(Om.bind(null,t,a,ei,Eo,Bs,i,ci,_a,Tt,ha,o,"Throttled",-0,0),n);break e}Om(t,a,ei,Eo,Bs,i,ci,_a,Tt,ha,o,null,-0,0)}}break}while(!0);Pi(e)}function Om(e,i,a,t,n,o,s,d,l,p,k,T,f,A){if(e.timeoutHandle=-1,T=i.subtreeFlags,T&8192||(T&16785408)===16785408){T={stylesheets:null,count:0,imgCount:0,imgBytes:0,suspenseyImages:[],waitingForImages:!0,waitingForViewTransition:!1,unsuspend:Vi},Im(i,o,T);var P=(o&62914560)===o?Do-ai():(o&4194048)===o?wm-ai():0;if(P=fp(T,P),P!==null){$i=o,e.cancelPendingCommit=P(jm.bind(null,e,i,o,a,t,n,s,d,l,k,T,null,f,A)),ba(e,o,s,!p);return}}jm(e,i,o,a,t,n,s,d,l)}function Rh(e){for(var i=e;;){var a=i.tag;if((a===0||a===11||a===15)&&i.flags&16384&&(a=i.updateQueue,a!==null&&(a=a.stores,a!==null)))for(var t=0;t<a.length;t++){var n=a[t],o=n.getSnapshot;n=n.value;try{if(!oi(o(),n))return!1}catch{return!1}}if(a=i.child,i.subtreeFlags&16384&&a!==null)a.return=i,i=a;else{if(i===e)break;for(;i.sibling===null;){if(i.return===null||i.return===e)return!0;i=i.return}i.sibling.return=i.return,i=i.sibling}}return!0}function ba(e,i,a,t){i&=~zs,i&=~_a,e.suspendedLanes|=i,e.pingedLanes&=~i,t&&(e.warmLanes|=i),t=e.expirationTimes;for(var n=i;0<n;){var o=31-ni(n),s=1<<o;t[o]=-1,n&=~s}a!==0&&Bd(e,a,i)}function Oo(){return(oe&6)===0?(vn(0),!1):!0}function Ys(){if(Q!==null){if(se===0)var e=Q.return;else e=Q,Gi=Va=null,ss(e),ft=null,tn=0,e=Q;for(;e!==null;)dm(e.alternate,e),e=e.return;Q=null}}function Ct(e,i){var a=e.timeoutHandle;a!==-1&&(e.timeoutHandle=-1,Jh(a)),a=e.cancelPendingCommit,a!==null&&(e.cancelPendingCommit=null,a()),$i=0,Ys(),pe=e,Q=a=zi(e.current,null),$=i,se=0,li=null,ha=!1,It=jt(e,i),js=!1,Tt=ci=zs=_a=pa=ve=0,ei=An=null,Bs=!1,(i&8)!==0&&(i|=i&32);var t=e.entangledLanes;if(t!==0)for(e=e.entanglements,t&=i;0<t;){var n=31-ni(t),o=1<<n;i|=e[n],t&=~o}return Ji=i,Wn(),a}function Rm(e,i){Y=null,N.H=mn,i===pt||i===oo?(i=Xl(),se=3):i===Zr?(i=Xl(),se=4):se=i===Is?8:i!==null&&typeof i=="object"&&typeof i.then=="function"?6:1,li=i,Q===null&&(ve=1,ko(e,fi(i,e.current)))}function Mm(){var e=si.current;return e===null?!0:($&4194048)===$?ki===null:($&62914560)===$||($&536870912)!==0?e===ki:!1}function Hm(){var e=N.H;return N.H=mn,e===null?mn:e}function Pm(){var e=N.A;return N.A=Eh,e}function Ro(){ve=4,ha||($&4194048)!==$&&si.current!==null||(It=!0),(pa&134217727)===0&&(_a&134217727)===0||pe===null||ba(pe,$,ci,!1)}function Ks(e,i,a){var t=oe;oe|=2;var n=Hm(),o=Pm();(pe!==e||$!==i)&&(Eo=null,Ct(e,i)),i=!1;var s=ve;e:do try{if(se!==0&&Q!==null){var d=Q,l=li;switch(se){case 8:Ys(),s=6;break e;case 3:case 2:case 9:case 6:si.current===null&&(i=!0);var p=se;if(se=0,li=null,wt(e,d,l,p),a&&It){s=0;break e}break;default:p=se,se=0,li=null,wt(e,d,l,p)}}Mh(),s=ve;break}catch(k){Rm(e,k)}while(!0);return i&&e.shellSuspendCounter++,Gi=Va=null,oe=t,N.H=n,N.A=o,Q===null&&(pe=null,$=0,Wn()),s}function Mh(){for(;Q!==null;)Lm(Q)}function Hh(e,i){var a=oe;oe|=2;var t=Hm(),n=Pm();pe!==e||$!==i?(Eo=null,xo=ai()+500,Ct(e,i)):It=jt(e,i);e:do try{if(se!==0&&Q!==null){i=Q;var o=li;i:switch(se){case 1:se=0,li=null,wt(e,i,o,1);break;case 2:case 9:if(Kl(o)){se=0,li=null,Um(i);break}i=function(){se!==2&&se!==9||pe!==e||(se=7),Pi(e)},o.then(i,i);break e;case 3:se=7;break e;case 4:se=5;break e;case 7:Kl(o)?(se=0,li=null,Um(i)):(se=0,li=null,wt(e,i,o,7));break;case 5:var s=null;switch(Q.tag){case 26:s=Q.memoizedState;case 5:case 27:var d=Q;if(s?Ng(s):d.stateNode.complete){se=0,li=null;var l=d.sibling;if(l!==null)Q=l;else{var p=d.return;p!==null?(Q=p,Mo(p)):Q=null}break i}}se=0,li=null,wt(e,i,o,5);break;case 6:se=0,li=null,wt(e,i,o,6);break;case 8:Ys(),ve=6;break e;default:throw Error(u(462))}}Ph();break}catch(k){Rm(e,k)}while(!0);return Gi=Va=null,N.H=t,N.A=n,oe=a,Q!==null?0:(pe=null,$=0,Wn(),ve)}function Ph(){for(;Q!==null&&!nu();)Lm(Q)}function Lm(e){var i=rm(e.alternate,e,Ji);e.memoizedProps=e.pendingProps,i===null?Mo(e):Q=i}function Um(e){var i=e,a=i.alternate;switch(i.tag){case 15:case 0:i=em(a,i,i.pendingProps,i.type,void 0,$);break;case 11:i=em(a,i,i.pendingProps,i.type.render,i.ref,$);break;case 5:ss(i);default:dm(a,i),i=Q=Pl(i,Ji),i=rm(a,i,Ji)}e.memoizedProps=e.pendingProps,i===null?Mo(e):Q=i}function wt(e,i,a,t){Gi=Va=null,ss(i),ft=null,tn=0;var n=i.return;try{if(Ih(e,n,i,a,$)){ve=1,ko(e,fi(a,e.current)),Q=null;return}}catch(o){if(n!==null)throw Q=n,o;ve=1,ko(e,fi(a,e.current)),Q=null;return}i.flags&32768?(ie||t===1?e=!0:It||($&536870912)!==0?e=!1:(ha=e=!0,(t===2||t===9||t===3||t===6)&&(t=si.current,t!==null&&t.tag===13&&(t.flags|=16384))),Vm(i,e)):Mo(i)}function Mo(e){var i=e;do{if((i.flags&32768)!==0){Vm(i,ha);return}e=i.return;var a=Ch(i.alternate,i,Ji);if(a!==null){Q=a;return}if(i=i.sibling,i!==null){Q=i;return}Q=i=e}while(i!==null);ve===0&&(ve=5)}function Vm(e,i){do{var a=wh(e.alternate,e);if(a!==null){a.flags&=32767,Q=a;return}if(a=e.return,a!==null&&(a.flags|=32768,a.subtreeFlags=0,a.deletions=null),!i&&(e=e.sibling,e!==null)){Q=e;return}Q=e=a}while(e!==null);ve=6,Q=null}function jm(e,i,a,t,n,o,s,d,l){e.cancelPendingCommit=null;do Ho();while(Re!==0);if((oe&6)!==0)throw Error(u(327));if(i!==null){if(i===e.current)throw Error(u(177));if(o=i.lanes|i.childLanes,o|=Hr,hu(e,a,o,s,d,l),e===pe&&(Q=pe=null,$=0),St=i,ya=e,$i=a,Gs=o,qs=n,Dm=t,(i.subtreeFlags&10256)!==0||(i.flags&10256)!==0?(e.callbackNode=null,e.callbackPriority=0,jh(Pn,function(){return Fm(),null})):(e.callbackNode=null,e.callbackPriority=0),t=(i.flags&13878)!==0,(i.subtreeFlags&13878)!==0||t){t=N.T,N.T=null,n=R.p,R.p=2,s=oe,oe|=4;try{Dh(e,i,a)}finally{oe=s,R.p=n,N.T=t}}Re=1,zm(),Bm(),Gm()}}function zm(){if(Re===1){Re=0;var e=ya,i=St,a=(i.flags&13878)!==0;if((i.subtreeFlags&13878)!==0||a){a=N.T,N.T=null;var t=R.p;R.p=2;var n=oe;oe|=4;try{km(i,e);var o=nd,s=Cl(e.containerInfo),d=o.focusedElem,l=o.selectionRange;if(s!==d&&d&&d.ownerDocument&&Sl(d.ownerDocument.documentElement,d)){if(l!==null&&xr(d)){var p=l.start,k=l.end;if(k===void 0&&(k=p),"selectionStart"in d)d.selectionStart=p,d.selectionEnd=Math.min(k,d.value.length);else{var T=d.ownerDocument||document,f=T&&T.defaultView||window;if(f.getSelection){var A=f.getSelection(),P=d.textContent.length,B=Math.min(l.start,P),ue=l.end===void 0?B:Math.min(l.end,P);!A.extend&&B>ue&&(s=ue,ue=B,B=s);var g=Tl(d,B),c=Tl(d,ue);if(g&&c&&(A.rangeCount!==1||A.anchorNode!==g.node||A.anchorOffset!==g.offset||A.focusNode!==c.node||A.focusOffset!==c.offset)){var h=T.createRange();h.setStart(g.node,g.offset),A.removeAllRanges(),B>ue?(A.addRange(h),A.extend(c.node,c.offset)):(h.setEnd(c.node,c.offset),A.addRange(h))}}}}for(T=[],A=d;A=A.parentNode;)A.nodeType===1&&T.push({element:A,left:A.scrollLeft,top:A.scrollTop});for(typeof d.focus=="function"&&d.focus(),d=0;d<T.length;d++){var I=T[d];I.element.scrollLeft=I.left,I.element.scrollTop=I.top}}Ko=!!td,nd=td=null}finally{oe=n,R.p=t,N.T=a}}e.current=i,Re=2}}function Bm(){if(Re===2){Re=0;var e=ya,i=St,a=(i.flags&8772)!==0;if((i.subtreeFlags&8772)!==0||a){a=N.T,N.T=null;var t=R.p;R.p=2;var n=oe;oe|=4;try{pm(e,i.alternate,i)}finally{oe=n,R.p=t,N.T=a}}Re=3}}function Gm(){if(Re===4||Re===3){Re=0,ou();var e=ya,i=St,a=$i,t=Dm;(i.subtreeFlags&10256)!==0||(i.flags&10256)!==0?Re=5:(Re=0,St=ya=null,qm(e,e.pendingLanes));var n=e.pendingLanes;if(n===0&&(fa=null),cr(a),i=i.stateNode,ti&&typeof ti.onCommitFiberRoot=="function")try{ti.onCommitFiberRoot(Vt,i,void 0,(i.current.flags&128)===128)}catch{}if(t!==null){i=N.T,n=R.p,R.p=2,N.T=null;try{for(var o=e.onRecoverableError,s=0;s<t.length;s++){var d=t[s];o(d.value,{componentStack:d.stack})}}finally{N.T=i,R.p=n}}($i&3)!==0&&Ho(),Pi(e),n=e.pendingLanes,(a&261930)!==0&&(n&42)!==0?e===Fs?kn++:(kn=0,Fs=e):kn=0,vn(0)}}function qm(e,i){(e.pooledCacheLanes&=i)===0&&(i=e.pooledCache,i!=null&&(e.pooledCache=null,en(i)))}function Ho(){return zm(),Bm(),Gm(),Fm()}function Fm(){if(Re!==5)return!1;var e=ya,i=Gs;Gs=0;var a=cr($i),t=N.T,n=R.p;try{R.p=32>a?32:a,N.T=null,a=qs,qs=null;var o=ya,s=$i;if(Re=0,St=ya=null,$i=0,(oe&6)!==0)throw Error(u(331));var d=oe;if(oe|=4,Sm(o.current),Nm(o,o.current,s,a),oe=d,vn(0,!1),ti&&typeof ti.onPostCommitFiberRoot=="function")try{ti.onPostCommitFiberRoot(Vt,o)}catch{}return!0}finally{R.p=n,N.T=t,qm(e,i)}}function Ym(e,i,a){i=fi(a,i),i=Ns(e.stateNode,i,2),e=ca(e,i,2),e!==null&&(zt(e,2),Pi(e))}function de(e,i,a){if(e.tag===3)Ym(e,e,a);else for(;i!==null;){if(i.tag===3){Ym(i,e,a);break}else if(i.tag===1){var t=i.stateNode;if(typeof i.type.getDerivedStateFromError=="function"||typeof t.componentDidCatch=="function"&&(fa===null||!fa.has(t))){e=fi(a,e),a=Kc(2),t=ca(i,a,2),t!==null&&(_c(a,t,i,e),zt(t,2),Pi(t));break}}i=i.return}}function _s(e,i,a){var t=e.pingCache;if(t===null){t=e.pingCache=new Oh;var n=new Set;t.set(i,n)}else n=t.get(i),n===void 0&&(n=new Set,t.set(i,n));n.has(a)||(js=!0,n.add(a),e=Lh.bind(null,e,i,a),i.then(e,e))}function Lh(e,i,a){var t=e.pingCache;t!==null&&t.delete(i),e.pingedLanes|=e.suspendedLanes&a,e.warmLanes&=~a,pe===e&&($&a)===a&&(ve===4||ve===3&&($&62914560)===$&&300>ai()-Do?(oe&2)===0&&Ct(e,0):zs|=a,Tt===$&&(Tt=0)),Pi(e)}function Km(e,i){i===0&&(i=zd()),e=Pa(e,i),e!==null&&(zt(e,i),Pi(e))}function Uh(e){var i=e.memoizedState,a=0;i!==null&&(a=i.retryLane),Km(e,a)}function Vh(e,i){var a=0;switch(e.tag){case 31:case 13:var t=e.stateNode,n=e.memoizedState;n!==null&&(a=n.retryLane);break;case 19:t=e.stateNode;break;case 22:t=e.stateNode._retryCache;break;default:throw Error(u(314))}t!==null&&t.delete(i),Km(e,a)}function jh(e,i){return rr(e,i)}var Po=null,Dt=null,Xs=!1,Lo=!1,Zs=!1,Aa=0;function Pi(e){e!==Dt&&e.next===null&&(Dt===null?Po=Dt=e:Dt=Dt.next=e),Lo=!0,Xs||(Xs=!0,Bh())}function vn(e,i){if(!Zs&&Lo){Zs=!0;do for(var a=!1,t=Po;t!==null;){if(e!==0){var n=t.pendingLanes;if(n===0)var o=0;else{var s=t.suspendedLanes,d=t.pingedLanes;o=(1<<31-ni(42|e)+1)-1,o&=n&~(s&~d),o=o&201326741?o&201326741|1:o?o|2:0}o!==0&&(a=!0,Qm(t,o))}else o=$,o=jn(t,t===pe?o:0,t.cancelPendingCommit!==null||t.timeoutHandle!==-1),(o&3)===0||jt(t,o)||(a=!0,Qm(t,o));t=t.next}while(a);Zs=!1}}function zh(){_m()}function _m(){Lo=Xs=!1;var e=0;Aa!==0&&Wh()&&(e=Aa);for(var i=ai(),a=null,t=Po;t!==null;){var n=t.next,o=Xm(t,i);o===0?(t.next=null,a===null?Po=n:a.next=n,n===null&&(Dt=a)):(a=t,(e!==0||(o&3)!==0)&&(Lo=!0)),t=n}Re!==0&&Re!==5||vn(e),Aa!==0&&(Aa=0)}function Xm(e,i){for(var a=e.suspendedLanes,t=e.pingedLanes,n=e.expirationTimes,o=e.pendingLanes&-62914561;0<o;){var s=31-ni(o),d=1<<s,l=n[s];l===-1?((d&a)===0||(d&t)!==0)&&(n[s]=uu(d,i)):l<=i&&(e.expiredLanes|=d),o&=~d}if(i=pe,a=$,a=jn(e,e===i?a:0,e.cancelPendingCommit!==null||e.timeoutHandle!==-1),t=e.callbackNode,a===0||e===i&&(se===2||se===9)||e.cancelPendingCommit!==null)return t!==null&&t!==null&&sr(t),e.callbackNode=null,e.callbackPriority=0;if((a&3)===0||jt(e,a)){if(i=a&-a,i===e.callbackPriority)return i;switch(t!==null&&sr(t),cr(a)){case 2:case 8:a=Vd;break;case 32:a=Pn;break;case 268435456:a=jd;break;default:a=Pn}return t=Zm.bind(null,e),a=rr(a,t),e.callbackPriority=i,e.callbackNode=a,i}return t!==null&&t!==null&&sr(t),e.callbackPriority=2,e.callbackNode=null,2}function Zm(e,i){if(Re!==0&&Re!==5)return e.callbackNode=null,e.callbackPriority=0,null;var a=e.callbackNode;if(Ho()&&e.callbackNode!==a)return null;var t=$;return t=jn(e,e===pe?t:0,e.cancelPendingCommit!==null||e.timeoutHandle!==-1),t===0?null:(Em(e,t,i),Xm(e,ai()),e.callbackNode!=null&&e.callbackNode===a?Zm.bind(null,e):null)}function Qm(e,i){if(Ho())return null;Em(e,i,!0)}function Bh(){$h(function(){(oe&6)!==0?rr(Ud,zh):_m()})}function Qs(){if(Aa===0){var e=ut;e===0&&(e=Ln,Ln<<=1,(Ln&261888)===0&&(Ln=256)),Aa=e}return Aa}function Wm(e){return e==null||typeof e=="symbol"||typeof e=="boolean"?null:typeof e=="function"?e:qn(""+e)}function Jm(e,i){var a=i.ownerDocument.createElement("input");return a.name=i.name,a.value=i.value,e.id&&a.setAttribute("form",e.id),i.parentNode.insertBefore(a,i),e=new FormData(e),a.parentNode.removeChild(a),e}function Gh(e,i,a,t,n){if(i==="submit"&&a&&a.stateNode===n){var o=Wm((n[Ze]||null).action),s=t.submitter;s&&(i=(i=s[Ze]||null)?Wm(i.formAction):s.getAttribute("formAction"),i!==null&&(o=i,s=null));var d=new _n("action","action",null,t,n);e.push({event:d,listeners:[{instance:null,listener:function(){if(t.defaultPrevented){if(Aa!==0){var l=s?Jm(n,s):new FormData(n);fs(a,{pending:!0,data:l,method:n.method,action:o},null,l)}}else typeof o=="function"&&(d.preventDefault(),l=s?Jm(n,s):new FormData(n),fs(a,{pending:!0,data:l,method:n.method,action:o},o,l))},currentTarget:n}]})}}for(var Ws=0;Ws<Mr.length;Ws++){var Js=Mr[Ws],qh=Js.toLowerCase(),Fh=Js[0].toUpperCase()+Js.slice(1);Ci(qh,"on"+Fh)}Ci(xl,"onAnimationEnd"),Ci(El,"onAnimationIteration"),Ci(Ol,"onAnimationStart"),Ci("dblclick","onDoubleClick"),Ci("focusin","onFocus"),Ci("focusout","onBlur"),Ci(rh,"onTransitionRun"),Ci(sh,"onTransitionStart"),Ci(dh,"onTransitionCancel"),Ci(Rl,"onTransitionEnd"),$a("onMouseEnter",["mouseout","mouseover"]),$a("onMouseLeave",["mouseout","mouseover"]),$a("onPointerEnter",["pointerout","pointerover"]),$a("onPointerLeave",["pointerout","pointerover"]),Oa("onChange","change click focusin focusout input keydown keyup selectionchange".split(" ")),Oa("onSelect","focusout contextmenu dragend focusin keydown keyup mousedown mouseup selectionchange".split(" ")),Oa("onBeforeInput",["compositionend","keypress","textInput","paste"]),Oa("onCompositionEnd","compositionend focusout keydown keypress keyup mousedown".split(" ")),Oa("onCompositionStart","compositionstart focusout keydown keypress keyup mousedown".split(" ")),Oa("onCompositionUpdate","compositionupdate focusout keydown keypress keyup mousedown".split(" "));var Nn="abort canplay canplaythrough durationchange emptied encrypted ended error loadeddata loadedmetadata loadstart pause play playing progress ratechange resize seeked seeking stalled suspend timeupdate volumechange waiting".split(" "),Yh=new Set("beforetoggle cancel close invalid load scroll scrollend toggle".split(" ").concat(Nn));function $m(e,i){i=(i&4)!==0;for(var a=0;a<e.length;a++){var t=e[a],n=t.event;t=t.listeners;e:{var o=void 0;if(i)for(var s=t.length-1;0<=s;s--){var d=t[s],l=d.instance,p=d.currentTarget;if(d=d.listener,l!==o&&n.isPropagationStopped())break e;o=d,n.currentTarget=p;try{o(n)}catch(k){Qn(k)}n.currentTarget=null,o=l}else for(s=0;s<t.length;s++){if(d=t[s],l=d.instance,p=d.currentTarget,d=d.listener,l!==o&&n.isPropagationStopped())break e;o=d,n.currentTarget=p;try{o(n)}catch(k){Qn(k)}n.currentTarget=null,o=l}}}}function W(e,i){var a=i[mr];a===void 0&&(a=i[mr]=new Set);var t=e+"__bubble";a.has(t)||(eg(i,e,2,!1),a.add(t))}function $s(e,i,a){var t=0;i&&(t|=4),eg(a,e,t,i)}var Uo="_reactListening"+Math.random().toString(36).slice(2);function ed(e){if(!e[Uo]){e[Uo]=!0,_d.forEach(function(a){a!=="selectionchange"&&(Yh.has(a)||$s(a,!1,e),$s(a,!0,e))});var i=e.nodeType===9?e:e.ownerDocument;i===null||i[Uo]||(i[Uo]=!0,$s("selectionchange",!1,i))}}function eg(e,i,a,t){switch(xg(i)){case 2:var n=Ap;break;case 8:n=kp;break;default:n=pd}a=n.bind(null,i,a,e),n=void 0,!kr||i!=="touchstart"&&i!=="touchmove"&&i!=="wheel"||(n=!0),t?n!==void 0?e.addEventListener(i,a,{capture:!0,passive:n}):e.addEventListener(i,a,!0):n!==void 0?e.addEventListener(i,a,{passive:n}):e.addEventListener(i,a,!1)}function id(e,i,a,t,n){var o=t;if((i&1)===0&&(i&2)===0&&t!==null)e:for(;;){if(t===null)return;var s=t.tag;if(s===3||s===4){var d=t.stateNode.containerInfo;if(d===n)break;if(s===4)for(s=t.return;s!==null;){var l=s.tag;if((l===3||l===4)&&s.stateNode.containerInfo===n)return;s=s.return}for(;d!==null;){if(s=Qa(d),s===null)return;if(l=s.tag,l===5||l===6||l===26||l===27){t=o=s;continue e}d=d.parentNode}}t=t.return}ol(function(){var p=o,k=br(a),T=[];e:{var f=Ml.get(e);if(f!==void 0){var A=_n,P=e;switch(e){case"keypress":if(Yn(a)===0)break e;case"keydown":case"keyup":A=Vu;break;case"focusin":P="focus",A=Tr;break;case"focusout":P="blur",A=Tr;break;case"beforeblur":case"afterblur":A=Tr;break;case"click":if(a.button===2)break e;case"auxclick":case"dblclick":case"mousedown":case"mousemove":case"mouseup":case"mouseout":case"mouseover":case"contextmenu":A=dl;break;case"drag":case"dragend":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"dragstart":case"drop":A=Cu;break;case"touchcancel":case"touchend":case"touchmove":case"touchstart":A=Bu;break;case xl:case El:case Ol:A=xu;break;case Rl:A=qu;break;case"scroll":case"scrollend":A=Tu;break;case"wheel":A=Yu;break;case"copy":case"cut":case"paste":A=Ou;break;case"gotpointercapture":case"lostpointercapture":case"pointercancel":case"pointerdown":case"pointermove":case"pointerout":case"pointerover":case"pointerup":A=cl;break;case"toggle":case"beforetoggle":A=_u}var B=(i&4)!==0,ue=!B&&(e==="scroll"||e==="scrollend"),g=B?f!==null?f+"Capture":null:f;B=[];for(var c=p,h;c!==null;){var I=c;if(h=I.stateNode,I=I.tag,I!==5&&I!==26&&I!==27||h===null||g===null||(I=qt(c,g),I!=null&&B.push(In(c,I,h))),ue)break;c=c.return}0<B.length&&(f=new A(f,P,null,a,k),T.push({event:f,listeners:B}))}}if((i&7)===0){e:{if(f=e==="mouseover"||e==="pointerover",A=e==="mouseout"||e==="pointerout",f&&a!==yr&&(P=a.relatedTarget||a.fromElement)&&(Qa(P)||P[Za]))break e;if((A||f)&&(f=k.window===k?k:(f=k.ownerDocument)?f.defaultView||f.parentWindow:window,A?(P=a.relatedTarget||a.toElement,A=p,P=P?Qa(P):null,P!==null&&(ue=C(P),B=P.tag,P!==ue||B!==5&&B!==27&&B!==6)&&(P=null)):(A=null,P=p),A!==P)){if(B=dl,I="onMouseLeave",g="onMouseEnter",c="mouse",(e==="pointerout"||e==="pointerover")&&(B=cl,I="onPointerLeave",g="onPointerEnter",c="pointer"),ue=A==null?f:Gt(A),h=P==null?f:Gt(P),f=new B(I,c+"leave",A,a,k),f.target=ue,f.relatedTarget=h,I=null,Qa(k)===p&&(B=new B(g,c+"enter",P,a,k),B.target=h,B.relatedTarget=ue,I=B),ue=I,A&&P)i:{for(B=Kh,g=A,c=P,h=0,I=g;I;I=B(I))h++;I=0;for(var z=c;z;z=B(z))I++;for(;0<h-I;)g=B(g),h--;for(;0<I-h;)c=B(c),I--;for(;h--;){if(g===c||c!==null&&g===c.alternate){B=g;break i}g=B(g),c=B(c)}B=null}else B=null;A!==null&&ig(T,f,A,B,!1),P!==null&&ue!==null&&ig(T,ue,P,B,!0)}}e:{if(f=p?Gt(p):window,A=f.nodeName&&f.nodeName.toLowerCase(),A==="select"||A==="input"&&f.type==="file")var te=bl;else if(fl(f))if(Al)te=th;else{te=ih;var V=eh}else A=f.nodeName,!A||A.toLowerCase()!=="input"||f.type!=="checkbox"&&f.type!=="radio"?p&&fr(p.elementType)&&(te=bl):te=ah;if(te&&(te=te(e,p))){yl(T,te,a,k);break e}V&&V(e,f,p),e==="focusout"&&p&&f.type==="number"&&p.memoizedProps.value!=null&&pr(f,"number",f.value)}switch(V=p?Gt(p):window,e){case"focusin":(fl(V)||V.contentEditable==="true")&&(ot=V,Er=p,Wt=null);break;case"focusout":Wt=Er=ot=null;break;case"mousedown":Or=!0;break;case"contextmenu":case"mouseup":case"dragend":Or=!1,wl(T,a,k);break;case"selectionchange":if(oh)break;case"keydown":case"keyup":wl(T,a,k)}var K;if(Cr)e:{switch(e){case"compositionstart":var ee="onCompositionStart";break e;case"compositionend":ee="onCompositionEnd";break e;case"compositionupdate":ee="onCompositionUpdate";break e}ee=void 0}else nt?hl(e,a)&&(ee="onCompositionEnd"):e==="keydown"&&a.keyCode===229&&(ee="onCompositionStart");ee&&(ml&&a.locale!=="ko"&&(nt||ee!=="onCompositionStart"?ee==="onCompositionEnd"&&nt&&(K=rl()):(ta=k,vr="value"in ta?ta.value:ta.textContent,nt=!0)),V=Vo(p,ee),0<V.length&&(ee=new ll(ee,e,null,a,k),T.push({event:ee,listeners:V}),K?ee.data=K:(K=pl(a),K!==null&&(ee.data=K)))),(K=Zu?Qu(e,a):Wu(e,a))&&(ee=Vo(p,"onBeforeInput"),0<ee.length&&(V=new ll("onBeforeInput","beforeinput",null,a,k),T.push({event:V,listeners:ee}),V.data=K)),Gh(T,e,p,a,k)}$m(T,i)})}function In(e,i,a){return{instance:e,listener:i,currentTarget:a}}function Vo(e,i){for(var a=i+"Capture",t=[];e!==null;){var n=e,o=n.stateNode;if(n=n.tag,n!==5&&n!==26&&n!==27||o===null||(n=qt(e,a),n!=null&&t.unshift(In(e,n,o)),n=qt(e,i),n!=null&&t.push(In(e,n,o))),e.tag===3)return t;e=e.return}return[]}function Kh(e){if(e===null)return null;do e=e.return;while(e&&e.tag!==5&&e.tag!==27);return e||null}function ig(e,i,a,t,n){for(var o=i._reactName,s=[];a!==null&&a!==t;){var d=a,l=d.alternate,p=d.stateNode;if(d=d.tag,l!==null&&l===t)break;d!==5&&d!==26&&d!==27||p===null||(l=p,n?(p=qt(a,o),p!=null&&s.unshift(In(a,p,l))):n||(p=qt(a,o),p!=null&&s.push(In(a,p,l)))),a=a.return}s.length!==0&&e.push({event:i,listeners:s})}var _h=/\r\n?/g,Xh=/\u0000|\uFFFD/g;function ag(e){return(typeof e=="string"?e:""+e).replace(_h,`
`).replace(Xh,"")}function tg(e,i){return i=ag(i),ag(e)===i}function ge(e,i,a,t,n,o){switch(a){case"children":typeof t=="string"?i==="body"||i==="textarea"&&t===""||it(e,t):(typeof t=="number"||typeof t=="bigint")&&i!=="body"&&it(e,""+t);break;case"className":Bn(e,"class",t);break;case"tabIndex":Bn(e,"tabindex",t);break;case"dir":case"role":case"viewBox":case"width":case"height":Bn(e,a,t);break;case"style":tl(e,t,o);break;case"data":if(i!=="object"){Bn(e,"data",t);break}case"src":case"href":if(t===""&&(i!=="a"||a!=="href")){e.removeAttribute(a);break}if(t==null||typeof t=="function"||typeof t=="symbol"||typeof t=="boolean"){e.removeAttribute(a);break}t=qn(""+t),e.setAttribute(a,t);break;case"action":case"formAction":if(typeof t=="function"){e.setAttribute(a,"javascript:throw new Error('A React form was unexpectedly submitted. If you called form.submit() manually, consider using form.requestSubmit() instead. If you\\'re trying to use event.stopPropagation() in a submit event handler, consider also calling event.preventDefault().')");break}else typeof o=="function"&&(a==="formAction"?(i!=="input"&&ge(e,i,"name",n.name,n,null),ge(e,i,"formEncType",n.formEncType,n,null),ge(e,i,"formMethod",n.formMethod,n,null),ge(e,i,"formTarget",n.formTarget,n,null)):(ge(e,i,"encType",n.encType,n,null),ge(e,i,"method",n.method,n,null),ge(e,i,"target",n.target,n,null)));if(t==null||typeof t=="symbol"||typeof t=="boolean"){e.removeAttribute(a);break}t=qn(""+t),e.setAttribute(a,t);break;case"onClick":t!=null&&(e.onclick=Vi);break;case"onScroll":t!=null&&W("scroll",e);break;case"onScrollEnd":t!=null&&W("scrollend",e);break;case"dangerouslySetInnerHTML":if(t!=null){if(typeof t!="object"||!("__html"in t))throw Error(u(61));if(a=t.__html,a!=null){if(n.children!=null)throw Error(u(60));e.innerHTML=a}}break;case"multiple":e.multiple=t&&typeof t!="function"&&typeof t!="symbol";break;case"muted":e.muted=t&&typeof t!="function"&&typeof t!="symbol";break;case"suppressContentEditableWarning":case"suppressHydrationWarning":case"defaultValue":case"defaultChecked":case"innerHTML":case"ref":break;case"autoFocus":break;case"xlinkHref":if(t==null||typeof t=="function"||typeof t=="boolean"||typeof t=="symbol"){e.removeAttribute("xlink:href");break}a=qn(""+t),e.setAttributeNS("http://www.w3.org/1999/xlink","xlink:href",a);break;case"contentEditable":case"spellCheck":case"draggable":case"value":case"autoReverse":case"externalResourcesRequired":case"focusable":case"preserveAlpha":t!=null&&typeof t!="function"&&typeof t!="symbol"?e.setAttribute(a,""+t):e.removeAttribute(a);break;case"inert":case"allowFullScreen":case"async":case"autoPlay":case"controls":case"default":case"defer":case"disabled":case"disablePictureInPicture":case"disableRemotePlayback":case"formNoValidate":case"hidden":case"loop":case"noModule":case"noValidate":case"open":case"playsInline":case"readOnly":case"required":case"reversed":case"scoped":case"seamless":case"itemScope":t&&typeof t!="function"&&typeof t!="symbol"?e.setAttribute(a,""):e.removeAttribute(a);break;case"capture":case"download":t===!0?e.setAttribute(a,""):t!==!1&&t!=null&&typeof t!="function"&&typeof t!="symbol"?e.setAttribute(a,t):e.removeAttribute(a);break;case"cols":case"rows":case"size":case"span":t!=null&&typeof t!="function"&&typeof t!="symbol"&&!isNaN(t)&&1<=t?e.setAttribute(a,t):e.removeAttribute(a);break;case"rowSpan":case"start":t==null||typeof t=="function"||typeof t=="symbol"||isNaN(t)?e.removeAttribute(a):e.setAttribute(a,t);break;case"popover":W("beforetoggle",e),W("toggle",e),zn(e,"popover",t);break;case"xlinkActuate":Ui(e,"http://www.w3.org/1999/xlink","xlink:actuate",t);break;case"xlinkArcrole":Ui(e,"http://www.w3.org/1999/xlink","xlink:arcrole",t);break;case"xlinkRole":Ui(e,"http://www.w3.org/1999/xlink","xlink:role",t);break;case"xlinkShow":Ui(e,"http://www.w3.org/1999/xlink","xlink:show",t);break;case"xlinkTitle":Ui(e,"http://www.w3.org/1999/xlink","xlink:title",t);break;case"xlinkType":Ui(e,"http://www.w3.org/1999/xlink","xlink:type",t);break;case"xmlBase":Ui(e,"http://www.w3.org/XML/1998/namespace","xml:base",t);break;case"xmlLang":Ui(e,"http://www.w3.org/XML/1998/namespace","xml:lang",t);break;case"xmlSpace":Ui(e,"http://www.w3.org/XML/1998/namespace","xml:space",t);break;case"is":zn(e,"is",t);break;case"innerText":case"textContent":break;default:(!(2<a.length)||a[0]!=="o"&&a[0]!=="O"||a[1]!=="n"&&a[1]!=="N")&&(a=Nu.get(a)||a,zn(e,a,t))}}function ad(e,i,a,t,n,o){switch(a){case"style":tl(e,t,o);break;case"dangerouslySetInnerHTML":if(t!=null){if(typeof t!="object"||!("__html"in t))throw Error(u(61));if(a=t.__html,a!=null){if(n.children!=null)throw Error(u(60));e.innerHTML=a}}break;case"children":typeof t=="string"?it(e,t):(typeof t=="number"||typeof t=="bigint")&&it(e,""+t);break;case"onScroll":t!=null&&W("scroll",e);break;case"onScrollEnd":t!=null&&W("scrollend",e);break;case"onClick":t!=null&&(e.onclick=Vi);break;case"suppressContentEditableWarning":case"suppressHydrationWarning":case"innerHTML":case"ref":break;case"innerText":case"textContent":break;default:if(!Xd.hasOwnProperty(a))e:{if(a[0]==="o"&&a[1]==="n"&&(n=a.endsWith("Capture"),i=a.slice(2,n?a.length-7:void 0),o=e[Ze]||null,o=o!=null?o[a]:null,typeof o=="function"&&e.removeEventListener(i,o,n),typeof t=="function")){typeof o!="function"&&o!==null&&(a in e?e[a]=null:e.hasAttribute(a)&&e.removeAttribute(a)),e.addEventListener(i,t,n);break e}a in e?e[a]=t:t===!0?e.setAttribute(a,""):zn(e,a,t)}}}function je(e,i,a){switch(i){case"div":case"span":case"svg":case"path":case"a":case"g":case"p":case"li":break;case"img":W("error",e),W("load",e);var t=!1,n=!1,o;for(o in a)if(a.hasOwnProperty(o)){var s=a[o];if(s!=null)switch(o){case"src":t=!0;break;case"srcSet":n=!0;break;case"children":case"dangerouslySetInnerHTML":throw Error(u(137,i));default:ge(e,i,o,s,a,null)}}n&&ge(e,i,"srcSet",a.srcSet,a,null),t&&ge(e,i,"src",a.src,a,null);return;case"input":W("invalid",e);var d=o=s=n=null,l=null,p=null;for(t in a)if(a.hasOwnProperty(t)){var k=a[t];if(k!=null)switch(t){case"name":n=k;break;case"type":s=k;break;case"checked":l=k;break;case"defaultChecked":p=k;break;case"value":o=k;break;case"defaultValue":d=k;break;case"children":case"dangerouslySetInnerHTML":if(k!=null)throw Error(u(137,i));break;default:ge(e,i,t,k,a,null)}}$d(e,o,d,l,p,s,n,!1);return;case"select":W("invalid",e),t=s=o=null;for(n in a)if(a.hasOwnProperty(n)&&(d=a[n],d!=null))switch(n){case"value":o=d;break;case"defaultValue":s=d;break;case"multiple":t=d;default:ge(e,i,n,d,a,null)}i=o,a=s,e.multiple=!!t,i!=null?et(e,!!t,i,!1):a!=null&&et(e,!!t,a,!0);return;case"textarea":W("invalid",e),o=n=t=null;for(s in a)if(a.hasOwnProperty(s)&&(d=a[s],d!=null))switch(s){case"value":t=d;break;case"defaultValue":n=d;break;case"children":o=d;break;case"dangerouslySetInnerHTML":if(d!=null)throw Error(u(91));break;default:ge(e,i,s,d,a,null)}il(e,t,n,o);return;case"option":for(l in a)if(a.hasOwnProperty(l)&&(t=a[l],t!=null))switch(l){case"selected":e.selected=t&&typeof t!="function"&&typeof t!="symbol";break;default:ge(e,i,l,t,a,null)}return;case"dialog":W("beforetoggle",e),W("toggle",e),W("cancel",e),W("close",e);break;case"iframe":case"object":W("load",e);break;case"video":case"audio":for(t=0;t<Nn.length;t++)W(Nn[t],e);break;case"image":W("error",e),W("load",e);break;case"details":W("toggle",e);break;case"embed":case"source":case"link":W("error",e),W("load",e);case"area":case"base":case"br":case"col":case"hr":case"keygen":case"meta":case"param":case"track":case"wbr":case"menuitem":for(p in a)if(a.hasOwnProperty(p)&&(t=a[p],t!=null))switch(p){case"children":case"dangerouslySetInnerHTML":throw Error(u(137,i));default:ge(e,i,p,t,a,null)}return;default:if(fr(i)){for(k in a)a.hasOwnProperty(k)&&(t=a[k],t!==void 0&&ad(e,i,k,t,a,void 0));return}}for(d in a)a.hasOwnProperty(d)&&(t=a[d],t!=null&&ge(e,i,d,t,a,null))}function Zh(e,i,a,t){switch(i){case"div":case"span":case"svg":case"path":case"a":case"g":case"p":case"li":break;case"input":var n=null,o=null,s=null,d=null,l=null,p=null,k=null;for(A in a){var T=a[A];if(a.hasOwnProperty(A)&&T!=null)switch(A){case"checked":break;case"value":break;case"defaultValue":l=T;default:t.hasOwnProperty(A)||ge(e,i,A,null,t,T)}}for(var f in t){var A=t[f];if(T=a[f],t.hasOwnProperty(f)&&(A!=null||T!=null))switch(f){case"type":o=A;break;case"name":n=A;break;case"checked":p=A;break;case"defaultChecked":k=A;break;case"value":s=A;break;case"defaultValue":d=A;break;case"children":case"dangerouslySetInnerHTML":if(A!=null)throw Error(u(137,i));break;default:A!==T&&ge(e,i,f,A,t,T)}}hr(e,s,d,l,p,k,o,n);return;case"select":A=s=d=f=null;for(o in a)if(l=a[o],a.hasOwnProperty(o)&&l!=null)switch(o){case"value":break;case"multiple":A=l;default:t.hasOwnProperty(o)||ge(e,i,o,null,t,l)}for(n in t)if(o=t[n],l=a[n],t.hasOwnProperty(n)&&(o!=null||l!=null))switch(n){case"value":f=o;break;case"defaultValue":d=o;break;case"multiple":s=o;default:o!==l&&ge(e,i,n,o,t,l)}i=d,a=s,t=A,f!=null?et(e,!!a,f,!1):!!t!=!!a&&(i!=null?et(e,!!a,i,!0):et(e,!!a,a?[]:"",!1));return;case"textarea":A=f=null;for(d in a)if(n=a[d],a.hasOwnProperty(d)&&n!=null&&!t.hasOwnProperty(d))switch(d){case"value":break;case"children":break;default:ge(e,i,d,null,t,n)}for(s in t)if(n=t[s],o=a[s],t.hasOwnProperty(s)&&(n!=null||o!=null))switch(s){case"value":f=n;break;case"defaultValue":A=n;break;case"children":break;case"dangerouslySetInnerHTML":if(n!=null)throw Error(u(91));break;default:n!==o&&ge(e,i,s,n,t,o)}el(e,f,A);return;case"option":for(var P in a)if(f=a[P],a.hasOwnProperty(P)&&f!=null&&!t.hasOwnProperty(P))switch(P){case"selected":e.selected=!1;break;default:ge(e,i,P,null,t,f)}for(l in t)if(f=t[l],A=a[l],t.hasOwnProperty(l)&&f!==A&&(f!=null||A!=null))switch(l){case"selected":e.selected=f&&typeof f!="function"&&typeof f!="symbol";break;default:ge(e,i,l,f,t,A)}return;case"img":case"link":case"area":case"base":case"br":case"col":case"embed":case"hr":case"keygen":case"meta":case"param":case"source":case"track":case"wbr":case"menuitem":for(var B in a)f=a[B],a.hasOwnProperty(B)&&f!=null&&!t.hasOwnProperty(B)&&ge(e,i,B,null,t,f);for(p in t)if(f=t[p],A=a[p],t.hasOwnProperty(p)&&f!==A&&(f!=null||A!=null))switch(p){case"children":case"dangerouslySetInnerHTML":if(f!=null)throw Error(u(137,i));break;default:ge(e,i,p,f,t,A)}return;default:if(fr(i)){for(var ue in a)f=a[ue],a.hasOwnProperty(ue)&&f!==void 0&&!t.hasOwnProperty(ue)&&ad(e,i,ue,void 0,t,f);for(k in t)f=t[k],A=a[k],!t.hasOwnProperty(k)||f===A||f===void 0&&A===void 0||ad(e,i,k,f,t,A);return}}for(var g in a)f=a[g],a.hasOwnProperty(g)&&f!=null&&!t.hasOwnProperty(g)&&ge(e,i,g,null,t,f);for(T in t)f=t[T],A=a[T],!t.hasOwnProperty(T)||f===A||f==null&&A==null||ge(e,i,T,f,t,A)}function ng(e){switch(e){case"css":case"script":case"font":case"img":case"image":case"input":case"link":return!0;default:return!1}}function Qh(){if(typeof performance.getEntriesByType=="function"){for(var e=0,i=0,a=performance.getEntriesByType("resource"),t=0;t<a.length;t++){var n=a[t],o=n.transferSize,s=n.initiatorType,d=n.duration;if(o&&d&&ng(s)){for(s=0,d=n.responseEnd,t+=1;t<a.length;t++){var l=a[t],p=l.startTime;if(p>d)break;var k=l.transferSize,T=l.initiatorType;k&&ng(T)&&(l=l.responseEnd,s+=k*(l<d?1:(d-p)/(l-p)))}if(--t,i+=8*(o+s)/(n.duration/1e3),e++,10<e)break}}if(0<e)return i/e/1e6}return navigator.connection&&(e=navigator.connection.downlink,typeof e=="number")?e:5}var td=null,nd=null;function jo(e){return e.nodeType===9?e:e.ownerDocument}function og(e){switch(e){case"http://www.w3.org/2000/svg":return 1;case"http://www.w3.org/1998/Math/MathML":return 2;default:return 0}}function rg(e,i){if(e===0)switch(i){case"svg":return 1;case"math":return 2;default:return 0}return e===1&&i==="foreignObject"?0:e}function od(e,i){return e==="textarea"||e==="noscript"||typeof i.children=="string"||typeof i.children=="number"||typeof i.children=="bigint"||typeof i.dangerouslySetInnerHTML=="object"&&i.dangerouslySetInnerHTML!==null&&i.dangerouslySetInnerHTML.__html!=null}var rd=null;function Wh(){var e=window.event;return e&&e.type==="popstate"?e===rd?!1:(rd=e,!0):(rd=null,!1)}var sg=typeof setTimeout=="function"?setTimeout:void 0,Jh=typeof clearTimeout=="function"?clearTimeout:void 0,dg=typeof Promise=="function"?Promise:void 0,$h=typeof queueMicrotask=="function"?queueMicrotask:typeof dg<"u"?function(e){return dg.resolve(null).then(e).catch(ep)}:sg;function ep(e){setTimeout(function(){throw e})}function ka(e){return e==="head"}function lg(e,i){var a=i,t=0;do{var n=a.nextSibling;if(e.removeChild(a),n&&n.nodeType===8)if(a=n.data,a==="/$"||a==="/&"){if(t===0){e.removeChild(n),Rt(i);return}t--}else if(a==="$"||a==="$?"||a==="$~"||a==="$!"||a==="&")t++;else if(a==="html")Tn(e.ownerDocument.documentElement);else if(a==="head"){a=e.ownerDocument.head,Tn(a);for(var o=a.firstChild;o;){var s=o.nextSibling,d=o.nodeName;o[Bt]||d==="SCRIPT"||d==="STYLE"||d==="LINK"&&o.rel.toLowerCase()==="stylesheet"||a.removeChild(o),o=s}}else a==="body"&&Tn(e.ownerDocument.body);a=n}while(a);Rt(i)}function cg(e,i){var a=e;e=0;do{var t=a.nextSibling;if(a.nodeType===1?i?(a._stashedDisplay=a.style.display,a.style.display="none"):(a.style.display=a._stashedDisplay||"",a.getAttribute("style")===""&&a.removeAttribute("style")):a.nodeType===3&&(i?(a._stashedText=a.nodeValue,a.nodeValue=""):a.nodeValue=a._stashedText||""),t&&t.nodeType===8)if(a=t.data,a==="/$"){if(e===0)break;e--}else a!=="$"&&a!=="$?"&&a!=="$~"&&a!=="$!"||e++;a=t}while(a)}function sd(e){var i=e.firstChild;for(i&&i.nodeType===10&&(i=i.nextSibling);i;){var a=i;switch(i=i.nextSibling,a.nodeName){case"HTML":case"HEAD":case"BODY":sd(a),gr(a);continue;case"SCRIPT":case"STYLE":continue;case"LINK":if(a.rel.toLowerCase()==="stylesheet")continue}e.removeChild(a)}}function ip(e,i,a,t){for(;e.nodeType===1;){var n=a;if(e.nodeName.toLowerCase()!==i.toLowerCase()){if(!t&&(e.nodeName!=="INPUT"||e.type!=="hidden"))break}else if(t){if(!e[Bt])switch(i){case"meta":if(!e.hasAttribute("itemprop"))break;return e;case"link":if(o=e.getAttribute("rel"),o==="stylesheet"&&e.hasAttribute("data-precedence"))break;if(o!==n.rel||e.getAttribute("href")!==(n.href==null||n.href===""?null:n.href)||e.getAttribute("crossorigin")!==(n.crossOrigin==null?null:n.crossOrigin)||e.getAttribute("title")!==(n.title==null?null:n.title))break;return e;case"style":if(e.hasAttribute("data-precedence"))break;return e;case"script":if(o=e.getAttribute("src"),(o!==(n.src==null?null:n.src)||e.getAttribute("type")!==(n.type==null?null:n.type)||e.getAttribute("crossorigin")!==(n.crossOrigin==null?null:n.crossOrigin))&&o&&e.hasAttribute("async")&&!e.hasAttribute("itemprop"))break;return e;default:return e}}else if(i==="input"&&e.type==="hidden"){var o=n.name==null?null:""+n.name;if(n.type==="hidden"&&e.getAttribute("name")===o)return e}else return e;if(e=vi(e.nextSibling),e===null)break}return null}function ap(e,i,a){if(i==="")return null;for(;e.nodeType!==3;)if((e.nodeType!==1||e.nodeName!=="INPUT"||e.type!=="hidden")&&!a||(e=vi(e.nextSibling),e===null))return null;return e}function mg(e,i){for(;e.nodeType!==8;)if((e.nodeType!==1||e.nodeName!=="INPUT"||e.type!=="hidden")&&!i||(e=vi(e.nextSibling),e===null))return null;return e}function dd(e){return e.data==="$?"||e.data==="$~"}function ld(e){return e.data==="$!"||e.data==="$?"&&e.ownerDocument.readyState!=="loading"}function tp(e,i){var a=e.ownerDocument;if(e.data==="$~")e._reactRetry=i;else if(e.data!=="$?"||a.readyState!=="loading")i();else{var t=function(){i(),a.removeEventListener("DOMContentLoaded",t)};a.addEventListener("DOMContentLoaded",t),e._reactRetry=t}}function vi(e){for(;e!=null;e=e.nextSibling){var i=e.nodeType;if(i===1||i===3)break;if(i===8){if(i=e.data,i==="$"||i==="$!"||i==="$?"||i==="$~"||i==="&"||i==="F!"||i==="F")break;if(i==="/$"||i==="/&")return null}}return e}var cd=null;function gg(e){e=e.nextSibling;for(var i=0;e;){if(e.nodeType===8){var a=e.data;if(a==="/$"||a==="/&"){if(i===0)return vi(e.nextSibling);i--}else a!=="$"&&a!=="$!"&&a!=="$?"&&a!=="$~"&&a!=="&"||i++}e=e.nextSibling}return null}function ug(e){e=e.previousSibling;for(var i=0;e;){if(e.nodeType===8){var a=e.data;if(a==="$"||a==="$!"||a==="$?"||a==="$~"||a==="&"){if(i===0)return e;i--}else a!=="/$"&&a!=="/&"||i++}e=e.previousSibling}return null}function hg(e,i,a){switch(i=jo(a),e){case"html":if(e=i.documentElement,!e)throw Error(u(452));return e;case"head":if(e=i.head,!e)throw Error(u(453));return e;case"body":if(e=i.body,!e)throw Error(u(454));return e;default:throw Error(u(451))}}function Tn(e){for(var i=e.attributes;i.length;)e.removeAttributeNode(i[0]);gr(e)}var Ni=new Map,pg=new Set;function zo(e){return typeof e.getRootNode=="function"?e.getRootNode():e.nodeType===9?e:e.ownerDocument}var ea=R.d;R.d={f:np,r:op,D:rp,C:sp,L:dp,m:lp,X:mp,S:cp,M:gp};function np(){var e=ea.f(),i=Oo();return e||i}function op(e){var i=Wa(e);i!==null&&i.tag===5&&i.type==="form"?Rc(i):ea.r(e)}var xt=typeof document>"u"?null:document;function fg(e,i,a){var t=xt;if(t&&typeof i=="string"&&i){var n=hi(i);n='link[rel="'+e+'"][href="'+n+'"]',typeof a=="string"&&(n+='[crossorigin="'+a+'"]'),pg.has(n)||(pg.add(n),e={rel:e,crossOrigin:a,href:i},t.querySelector(n)===null&&(i=t.createElement("link"),je(i,"link",e),Me(i),t.head.appendChild(i)))}}function rp(e){ea.D(e),fg("dns-prefetch",e,null)}function sp(e,i){ea.C(e,i),fg("preconnect",e,i)}function dp(e,i,a){ea.L(e,i,a);var t=xt;if(t&&e&&i){var n='link[rel="preload"][as="'+hi(i)+'"]';i==="image"&&a&&a.imageSrcSet?(n+='[imagesrcset="'+hi(a.imageSrcSet)+'"]',typeof a.imageSizes=="string"&&(n+='[imagesizes="'+hi(a.imageSizes)+'"]')):n+='[href="'+hi(e)+'"]';var o=n;switch(i){case"style":o=Et(e);break;case"script":o=Ot(e)}Ni.has(o)||(e=E({rel:"preload",href:i==="image"&&a&&a.imageSrcSet?void 0:e,as:i},a),Ni.set(o,e),t.querySelector(n)!==null||i==="style"&&t.querySelector(Sn(o))||i==="script"&&t.querySelector(Cn(o))||(i=t.createElement("link"),je(i,"link",e),Me(i),t.head.appendChild(i)))}}function lp(e,i){ea.m(e,i);var a=xt;if(a&&e){var t=i&&typeof i.as=="string"?i.as:"script",n='link[rel="modulepreload"][as="'+hi(t)+'"][href="'+hi(e)+'"]',o=n;switch(t){case"audioworklet":case"paintworklet":case"serviceworker":case"sharedworker":case"worker":case"script":o=Ot(e)}if(!Ni.has(o)&&(e=E({rel:"modulepreload",href:e},i),Ni.set(o,e),a.querySelector(n)===null)){switch(t){case"audioworklet":case"paintworklet":case"serviceworker":case"sharedworker":case"worker":case"script":if(a.querySelector(Cn(o)))return}t=a.createElement("link"),je(t,"link",e),Me(t),a.head.appendChild(t)}}}function cp(e,i,a){ea.S(e,i,a);var t=xt;if(t&&e){var n=Ja(t).hoistableStyles,o=Et(e);i=i||"default";var s=n.get(o);if(!s){var d={loading:0,preload:null};if(s=t.querySelector(Sn(o)))d.loading=5;else{e=E({rel:"stylesheet",href:e,"data-precedence":i},a),(a=Ni.get(o))&&md(e,a);var l=s=t.createElement("link");Me(l),je(l,"link",e),l._p=new Promise(function(p,k){l.onload=p,l.onerror=k}),l.addEventListener("load",function(){d.loading|=1}),l.addEventListener("error",function(){d.loading|=2}),d.loading|=4,Bo(s,i,t)}s={type:"stylesheet",instance:s,count:1,state:d},n.set(o,s)}}}function mp(e,i){ea.X(e,i);var a=xt;if(a&&e){var t=Ja(a).hoistableScripts,n=Ot(e),o=t.get(n);o||(o=a.querySelector(Cn(n)),o||(e=E({src:e,async:!0},i),(i=Ni.get(n))&&gd(e,i),o=a.createElement("script"),Me(o),je(o,"link",e),a.head.appendChild(o)),o={type:"script",instance:o,count:1,state:null},t.set(n,o))}}function gp(e,i){ea.M(e,i);var a=xt;if(a&&e){var t=Ja(a).hoistableScripts,n=Ot(e),o=t.get(n);o||(o=a.querySelector(Cn(n)),o||(e=E({src:e,async:!0,type:"module"},i),(i=Ni.get(n))&&gd(e,i),o=a.createElement("script"),Me(o),je(o,"link",e),a.head.appendChild(o)),o={type:"script",instance:o,count:1,state:null},t.set(n,o))}}function yg(e,i,a,t){var n=(n=Z.current)?zo(n):null;if(!n)throw Error(u(446));switch(e){case"meta":case"title":return null;case"style":return typeof a.precedence=="string"&&typeof a.href=="string"?(i=Et(a.href),a=Ja(n).hoistableStyles,t=a.get(i),t||(t={type:"style",instance:null,count:0,state:null},a.set(i,t)),t):{type:"void",instance:null,count:0,state:null};case"link":if(a.rel==="stylesheet"&&typeof a.href=="string"&&typeof a.precedence=="string"){e=Et(a.href);var o=Ja(n).hoistableStyles,s=o.get(e);if(s||(n=n.ownerDocument||n,s={type:"stylesheet",instance:null,count:0,state:{loading:0,preload:null}},o.set(e,s),(o=n.querySelector(Sn(e)))&&!o._p&&(s.instance=o,s.state.loading=5),Ni.has(e)||(a={rel:"preload",as:"style",href:a.href,crossOrigin:a.crossOrigin,integrity:a.integrity,media:a.media,hrefLang:a.hrefLang,referrerPolicy:a.referrerPolicy},Ni.set(e,a),o||up(n,e,a,s.state))),i&&t===null)throw Error(u(528,""));return s}if(i&&t!==null)throw Error(u(529,""));return null;case"script":return i=a.async,a=a.src,typeof a=="string"&&i&&typeof i!="function"&&typeof i!="symbol"?(i=Ot(a),a=Ja(n).hoistableScripts,t=a.get(i),t||(t={type:"script",instance:null,count:0,state:null},a.set(i,t)),t):{type:"void",instance:null,count:0,state:null};default:throw Error(u(444,e))}}function Et(e){return'href="'+hi(e)+'"'}function Sn(e){return'link[rel="stylesheet"]['+e+"]"}function bg(e){return E({},e,{"data-precedence":e.precedence,precedence:null})}function up(e,i,a,t){e.querySelector('link[rel="preload"][as="style"]['+i+"]")?t.loading=1:(i=e.createElement("link"),t.preload=i,i.addEventListener("load",function(){return t.loading|=1}),i.addEventListener("error",function(){return t.loading|=2}),je(i,"link",a),Me(i),e.head.appendChild(i))}function Ot(e){return'[src="'+hi(e)+'"]'}function Cn(e){return"script[async]"+e}function Ag(e,i,a){if(i.count++,i.instance===null)switch(i.type){case"style":var t=e.querySelector('style[data-href~="'+hi(a.href)+'"]');if(t)return i.instance=t,Me(t),t;var n=E({},a,{"data-href":a.href,"data-precedence":a.precedence,href:null,precedence:null});return t=(e.ownerDocument||e).createElement("style"),Me(t),je(t,"style",n),Bo(t,a.precedence,e),i.instance=t;case"stylesheet":n=Et(a.href);var o=e.querySelector(Sn(n));if(o)return i.state.loading|=4,i.instance=o,Me(o),o;t=bg(a),(n=Ni.get(n))&&md(t,n),o=(e.ownerDocument||e).createElement("link"),Me(o);var s=o;return s._p=new Promise(function(d,l){s.onload=d,s.onerror=l}),je(o,"link",t),i.state.loading|=4,Bo(o,a.precedence,e),i.instance=o;case"script":return o=Ot(a.src),(n=e.querySelector(Cn(o)))?(i.instance=n,Me(n),n):(t=a,(n=Ni.get(o))&&(t=E({},a),gd(t,n)),e=e.ownerDocument||e,n=e.createElement("script"),Me(n),je(n,"link",t),e.head.appendChild(n),i.instance=n);case"void":return null;default:throw Error(u(443,i.type))}else i.type==="stylesheet"&&(i.state.loading&4)===0&&(t=i.instance,i.state.loading|=4,Bo(t,a.precedence,e));return i.instance}function Bo(e,i,a){for(var t=a.querySelectorAll('link[rel="stylesheet"][data-precedence],style[data-precedence]'),n=t.length?t[t.length-1]:null,o=n,s=0;s<t.length;s++){var d=t[s];if(d.dataset.precedence===i)o=d;else if(o!==n)break}o?o.parentNode.insertBefore(e,o.nextSibling):(i=a.nodeType===9?a.head:a,i.insertBefore(e,i.firstChild))}function md(e,i){e.crossOrigin==null&&(e.crossOrigin=i.crossOrigin),e.referrerPolicy==null&&(e.referrerPolicy=i.referrerPolicy),e.title==null&&(e.title=i.title)}function gd(e,i){e.crossOrigin==null&&(e.crossOrigin=i.crossOrigin),e.referrerPolicy==null&&(e.referrerPolicy=i.referrerPolicy),e.integrity==null&&(e.integrity=i.integrity)}var Go=null;function kg(e,i,a){if(Go===null){var t=new Map,n=Go=new Map;n.set(a,t)}else n=Go,t=n.get(a),t||(t=new Map,n.set(a,t));if(t.has(e))return t;for(t.set(e,null),a=a.getElementsByTagName(e),n=0;n<a.length;n++){var o=a[n];if(!(o[Bt]||o[Pe]||e==="link"&&o.getAttribute("rel")==="stylesheet")&&o.namespaceURI!=="http://www.w3.org/2000/svg"){var s=o.getAttribute(i)||"";s=e+s;var d=t.get(s);d?d.push(o):t.set(s,[o])}}return t}function vg(e,i,a){e=e.ownerDocument||e,e.head.insertBefore(a,i==="title"?e.querySelector("head > title"):null)}function hp(e,i,a){if(a===1||i.itemProp!=null)return!1;switch(e){case"meta":case"title":return!0;case"style":if(typeof i.precedence!="string"||typeof i.href!="string"||i.href==="")break;return!0;case"link":if(typeof i.rel!="string"||typeof i.href!="string"||i.href===""||i.onLoad||i.onError)break;switch(i.rel){case"stylesheet":return e=i.disabled,typeof i.precedence=="string"&&e==null;default:return!0}case"script":if(i.async&&typeof i.async!="function"&&typeof i.async!="symbol"&&!i.onLoad&&!i.onError&&i.src&&typeof i.src=="string")return!0}return!1}function Ng(e){return!(e.type==="stylesheet"&&(e.state.loading&3)===0)}function pp(e,i,a,t){if(a.type==="stylesheet"&&(typeof t.media!="string"||matchMedia(t.media).matches!==!1)&&(a.state.loading&4)===0){if(a.instance===null){var n=Et(t.href),o=i.querySelector(Sn(n));if(o){i=o._p,i!==null&&typeof i=="object"&&typeof i.then=="function"&&(e.count++,e=qo.bind(e),i.then(e,e)),a.state.loading|=4,a.instance=o,Me(o);return}o=i.ownerDocument||i,t=bg(t),(n=Ni.get(n))&&md(t,n),o=o.createElement("link"),Me(o);var s=o;s._p=new Promise(function(d,l){s.onload=d,s.onerror=l}),je(o,"link",t),a.instance=o}e.stylesheets===null&&(e.stylesheets=new Map),e.stylesheets.set(a,i),(i=a.state.preload)&&(a.state.loading&3)===0&&(e.count++,a=qo.bind(e),i.addEventListener("load",a),i.addEventListener("error",a))}}var ud=0;function fp(e,i){return e.stylesheets&&e.count===0&&Yo(e,e.stylesheets),0<e.count||0<e.imgCount?function(a){var t=setTimeout(function(){if(e.stylesheets&&Yo(e,e.stylesheets),e.unsuspend){var o=e.unsuspend;e.unsuspend=null,o()}},6e4+i);0<e.imgBytes&&ud===0&&(ud=62500*Qh());var n=setTimeout(function(){if(e.waitingForImages=!1,e.count===0&&(e.stylesheets&&Yo(e,e.stylesheets),e.unsuspend)){var o=e.unsuspend;e.unsuspend=null,o()}},(e.imgBytes>ud?50:800)+i);return e.unsuspend=a,function(){e.unsuspend=null,clearTimeout(t),clearTimeout(n)}}:null}function qo(){if(this.count--,this.count===0&&(this.imgCount===0||!this.waitingForImages)){if(this.stylesheets)Yo(this,this.stylesheets);else if(this.unsuspend){var e=this.unsuspend;this.unsuspend=null,e()}}}var Fo=null;function Yo(e,i){e.stylesheets=null,e.unsuspend!==null&&(e.count++,Fo=new Map,i.forEach(yp,e),Fo=null,qo.call(e))}function yp(e,i){if(!(i.state.loading&4)){var a=Fo.get(e);if(a)var t=a.get(null);else{a=new Map,Fo.set(e,a);for(var n=e.querySelectorAll("link[data-precedence],style[data-precedence]"),o=0;o<n.length;o++){var s=n[o];(s.nodeName==="LINK"||s.getAttribute("media")!=="not all")&&(a.set(s.dataset.precedence,s),t=s)}t&&a.set(null,t)}n=i.instance,s=n.getAttribute("data-precedence"),o=a.get(s)||t,o===t&&a.set(null,n),a.set(s,n),this.count++,t=qo.bind(this),n.addEventListener("load",t),n.addEventListener("error",t),o?o.parentNode.insertBefore(n,o.nextSibling):(e=e.nodeType===9?e.head:e,e.insertBefore(n,e.firstChild)),i.state.loading|=4}}var wn={$$typeof:j,Provider:null,Consumer:null,_currentValue:G,_currentValue2:G,_threadCount:0};function bp(e,i,a,t,n,o,s,d,l){this.tag=1,this.containerInfo=e,this.pingCache=this.current=this.pendingChildren=null,this.timeoutHandle=-1,this.callbackNode=this.next=this.pendingContext=this.context=this.cancelPendingCommit=null,this.callbackPriority=0,this.expirationTimes=dr(-1),this.entangledLanes=this.shellSuspendCounter=this.errorRecoveryDisabledLanes=this.expiredLanes=this.warmLanes=this.pingedLanes=this.suspendedLanes=this.pendingLanes=0,this.entanglements=dr(0),this.hiddenUpdates=dr(null),this.identifierPrefix=t,this.onUncaughtError=n,this.onCaughtError=o,this.onRecoverableError=s,this.pooledCache=null,this.pooledCacheLanes=0,this.formState=l,this.incompleteTransitions=new Map}function Ig(e,i,a,t,n,o,s,d,l,p,k,T){return e=new bp(e,i,a,s,l,p,k,T,d),i=1,o===!0&&(i|=24),o=ri(3,null,null,i),e.current=o,o.stateNode=e,i=Kr(),i.refCount++,e.pooledCache=i,i.refCount++,o.memoizedState={element:t,isDehydrated:a,cache:i},Qr(o),e}function Tg(e){return e?(e=dt,e):dt}function Sg(e,i,a,t,n,o){n=Tg(n),t.context===null?t.context=n:t.pendingContext=n,t=la(i),t.payload={element:a},o=o===void 0?null:o,o!==null&&(t.callback=o),a=ca(e,t,i),a!==null&&(ii(a,e,i),on(a,e,i))}function Cg(e,i){if(e=e.memoizedState,e!==null&&e.dehydrated!==null){var a=e.retryLane;e.retryLane=a!==0&&a<i?a:i}}function hd(e,i){Cg(e,i),(e=e.alternate)&&Cg(e,i)}function wg(e){if(e.tag===13||e.tag===31){var i=Pa(e,67108864);i!==null&&ii(i,e,67108864),hd(e,67108864)}}function Dg(e){if(e.tag===13||e.tag===31){var i=mi();i=lr(i);var a=Pa(e,i);a!==null&&ii(a,e,i),hd(e,i)}}var Ko=!0;function Ap(e,i,a,t){var n=N.T;N.T=null;var o=R.p;try{R.p=2,pd(e,i,a,t)}finally{R.p=o,N.T=n}}function kp(e,i,a,t){var n=N.T;N.T=null;var o=R.p;try{R.p=8,pd(e,i,a,t)}finally{R.p=o,N.T=n}}function pd(e,i,a,t){if(Ko){var n=fd(t);if(n===null)id(e,i,t,_o,a),Eg(e,t);else if(Np(n,e,i,a,t))t.stopPropagation();else if(Eg(e,t),i&4&&-1<vp.indexOf(e)){for(;n!==null;){var o=Wa(n);if(o!==null)switch(o.tag){case 3:if(o=o.stateNode,o.current.memoizedState.isDehydrated){var s=Ea(o.pendingLanes);if(s!==0){var d=o;for(d.pendingLanes|=2,d.entangledLanes|=2;s;){var l=1<<31-ni(s);d.entanglements[1]|=l,s&=~l}Pi(o),(oe&6)===0&&(xo=ai()+500,vn(0))}}break;case 31:case 13:d=Pa(o,2),d!==null&&ii(d,o,2),Oo(),hd(o,2)}if(o=fd(t),o===null&&id(e,i,t,_o,a),o===n)break;n=o}n!==null&&t.stopPropagation()}else id(e,i,t,null,a)}}function fd(e){return e=br(e),yd(e)}var _o=null;function yd(e){if(_o=null,e=Qa(e),e!==null){var i=C(e);if(i===null)e=null;else{var a=i.tag;if(a===13){if(e=L(i),e!==null)return e;e=null}else if(a===31){if(e=x(i),e!==null)return e;e=null}else if(a===3){if(i.stateNode.current.memoizedState.isDehydrated)return i.tag===3?i.stateNode.containerInfo:null;e=null}else i!==e&&(e=null)}}return _o=e,null}function xg(e){switch(e){case"beforetoggle":case"cancel":case"click":case"close":case"contextmenu":case"copy":case"cut":case"auxclick":case"dblclick":case"dragend":case"dragstart":case"drop":case"focusin":case"focusout":case"input":case"invalid":case"keydown":case"keypress":case"keyup":case"mousedown":case"mouseup":case"paste":case"pause":case"play":case"pointercancel":case"pointerdown":case"pointerup":case"ratechange":case"reset":case"resize":case"seeked":case"submit":case"toggle":case"touchcancel":case"touchend":case"touchstart":case"volumechange":case"change":case"selectionchange":case"textInput":case"compositionstart":case"compositionend":case"compositionupdate":case"beforeblur":case"afterblur":case"beforeinput":case"blur":case"fullscreenchange":case"focus":case"hashchange":case"popstate":case"select":case"selectstart":return 2;case"drag":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"mousemove":case"mouseout":case"mouseover":case"pointermove":case"pointerout":case"pointerover":case"scroll":case"touchmove":case"wheel":case"mouseenter":case"mouseleave":case"pointerenter":case"pointerleave":return 8;case"message":switch(ru()){case Ud:return 2;case Vd:return 8;case Pn:case su:return 32;case jd:return 268435456;default:return 32}default:return 32}}var bd=!1,va=null,Na=null,Ia=null,Dn=new Map,xn=new Map,Ta=[],vp="mousedown mouseup touchcancel touchend touchstart auxclick dblclick pointercancel pointerdown pointerup dragend dragstart drop compositionend compositionstart keydown keypress keyup input textInput copy cut paste click change contextmenu reset".split(" ");function Eg(e,i){switch(e){case"focusin":case"focusout":va=null;break;case"dragenter":case"dragleave":Na=null;break;case"mouseover":case"mouseout":Ia=null;break;case"pointerover":case"pointerout":Dn.delete(i.pointerId);break;case"gotpointercapture":case"lostpointercapture":xn.delete(i.pointerId)}}function En(e,i,a,t,n,o){return e===null||e.nativeEvent!==o?(e={blockedOn:i,domEventName:a,eventSystemFlags:t,nativeEvent:o,targetContainers:[n]},i!==null&&(i=Wa(i),i!==null&&wg(i)),e):(e.eventSystemFlags|=t,i=e.targetContainers,n!==null&&i.indexOf(n)===-1&&i.push(n),e)}function Np(e,i,a,t,n){switch(i){case"focusin":return va=En(va,e,i,a,t,n),!0;case"dragenter":return Na=En(Na,e,i,a,t,n),!0;case"mouseover":return Ia=En(Ia,e,i,a,t,n),!0;case"pointerover":var o=n.pointerId;return Dn.set(o,En(Dn.get(o)||null,e,i,a,t,n)),!0;case"gotpointercapture":return o=n.pointerId,xn.set(o,En(xn.get(o)||null,e,i,a,t,n)),!0}return!1}function Og(e){var i=Qa(e.target);if(i!==null){var a=C(i);if(a!==null){if(i=a.tag,i===13){if(i=L(a),i!==null){e.blockedOn=i,Yd(e.priority,function(){Dg(a)});return}}else if(i===31){if(i=x(a),i!==null){e.blockedOn=i,Yd(e.priority,function(){Dg(a)});return}}else if(i===3&&a.stateNode.current.memoizedState.isDehydrated){e.blockedOn=a.tag===3?a.stateNode.containerInfo:null;return}}}e.blockedOn=null}function Xo(e){if(e.blockedOn!==null)return!1;for(var i=e.targetContainers;0<i.length;){var a=fd(e.nativeEvent);if(a===null){a=e.nativeEvent;var t=new a.constructor(a.type,a);yr=t,a.target.dispatchEvent(t),yr=null}else return i=Wa(a),i!==null&&wg(i),e.blockedOn=a,!1;i.shift()}return!0}function Rg(e,i,a){Xo(e)&&a.delete(i)}function Ip(){bd=!1,va!==null&&Xo(va)&&(va=null),Na!==null&&Xo(Na)&&(Na=null),Ia!==null&&Xo(Ia)&&(Ia=null),Dn.forEach(Rg),xn.forEach(Rg)}function Zo(e,i){e.blockedOn===i&&(e.blockedOn=null,bd||(bd=!0,v.unstable_scheduleCallback(v.unstable_NormalPriority,Ip)))}var Qo=null;function Mg(e){Qo!==e&&(Qo=e,v.unstable_scheduleCallback(v.unstable_NormalPriority,function(){Qo===e&&(Qo=null);for(var i=0;i<e.length;i+=3){var a=e[i],t=e[i+1],n=e[i+2];if(typeof t!="function"){if(yd(t||a)===null)continue;break}var o=Wa(a);o!==null&&(e.splice(i,3),i-=3,fs(o,{pending:!0,data:n,method:a.method,action:t},t,n))}}))}function Rt(e){function i(l){return Zo(l,e)}va!==null&&Zo(va,e),Na!==null&&Zo(Na,e),Ia!==null&&Zo(Ia,e),Dn.forEach(i),xn.forEach(i);for(var a=0;a<Ta.length;a++){var t=Ta[a];t.blockedOn===e&&(t.blockedOn=null)}for(;0<Ta.length&&(a=Ta[0],a.blockedOn===null);)Og(a),a.blockedOn===null&&Ta.shift();if(a=(e.ownerDocument||e).$$reactFormReplay,a!=null)for(t=0;t<a.length;t+=3){var n=a[t],o=a[t+1],s=n[Ze]||null;if(typeof o=="function")s||Mg(a);else if(s){var d=null;if(o&&o.hasAttribute("formAction")){if(n=o,s=o[Ze]||null)d=s.formAction;else if(yd(n)!==null)continue}else d=s.action;typeof d=="function"?a[t+1]=d:(a.splice(t,3),t-=3),Mg(a)}}}function Hg(){function e(o){o.canIntercept&&o.info==="react-transition"&&o.intercept({handler:function(){return new Promise(function(s){return n=s})},focusReset:"manual",scroll:"manual"})}function i(){n!==null&&(n(),n=null),t||setTimeout(a,20)}function a(){if(!t&&!navigation.transition){var o=navigation.currentEntry;o&&o.url!=null&&navigation.navigate(o.url,{state:o.getState(),info:"react-transition",history:"replace"})}}if(typeof navigation=="object"){var t=!1,n=null;return navigation.addEventListener("navigate",e),navigation.addEventListener("navigatesuccess",i),navigation.addEventListener("navigateerror",i),setTimeout(a,100),function(){t=!0,navigation.removeEventListener("navigate",e),navigation.removeEventListener("navigatesuccess",i),navigation.removeEventListener("navigateerror",i),n!==null&&(n(),n=null)}}}function Ad(e){this._internalRoot=e}Wo.prototype.render=Ad.prototype.render=function(e){var i=this._internalRoot;if(i===null)throw Error(u(409));var a=i.current,t=mi();Sg(a,t,e,i,null,null)},Wo.prototype.unmount=Ad.prototype.unmount=function(){var e=this._internalRoot;if(e!==null){this._internalRoot=null;var i=e.containerInfo;Sg(e.current,2,null,e,null,null),Oo(),i[Za]=null}};function Wo(e){this._internalRoot=e}Wo.prototype.unstable_scheduleHydration=function(e){if(e){var i=Fd();e={blockedOn:null,target:e,priority:i};for(var a=0;a<Ta.length&&i!==0&&i<Ta[a].priority;a++);Ta.splice(a,0,e),a===0&&Og(e)}};var Pg=w.version;if(Pg!=="19.2.0")throw Error(u(527,Pg,"19.2.0"));R.findDOMNode=function(e){var i=e._reactInternals;if(i===void 0)throw typeof e.render=="function"?Error(u(188)):(e=Object.keys(e).join(","),Error(u(268,e)));return e=y(i),e=e!==null?O(e):null,e=e===null?null:e.stateNode,e};var Tp={bundleType:0,version:"19.2.0",rendererPackageName:"react-dom",currentDispatcherRef:N,reconcilerVersion:"19.2.0"};if(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__<"u"){var Jo=__REACT_DEVTOOLS_GLOBAL_HOOK__;if(!Jo.isDisabled&&Jo.supportsFiber)try{Vt=Jo.inject(Tp),ti=Jo}catch{}}return Rn.createRoot=function(e,i){if(!H(e))throw Error(u(299));var a=!1,t="",n=Gc,o=qc,s=Fc;return i!=null&&(i.unstable_strictMode===!0&&(a=!0),i.identifierPrefix!==void 0&&(t=i.identifierPrefix),i.onUncaughtError!==void 0&&(n=i.onUncaughtError),i.onCaughtError!==void 0&&(o=i.onCaughtError),i.onRecoverableError!==void 0&&(s=i.onRecoverableError)),i=Ig(e,1,!1,null,null,a,t,null,n,o,s,Hg),e[Za]=i.current,ed(e),new Ad(i)},Rn.hydrateRoot=function(e,i,a){if(!H(e))throw Error(u(299));var t=!1,n="",o=Gc,s=qc,d=Fc,l=null;return a!=null&&(a.unstable_strictMode===!0&&(t=!0),a.identifierPrefix!==void 0&&(n=a.identifierPrefix),a.onUncaughtError!==void 0&&(o=a.onUncaughtError),a.onCaughtError!==void 0&&(s=a.onCaughtError),a.onRecoverableError!==void 0&&(d=a.onRecoverableError),a.formState!==void 0&&(l=a.formState)),i=Ig(e,1,!0,i,a??null,t,n,l,o,s,d,Hg),i.context=Tg(null),a=i.current,t=mi(),t=lr(t),n=la(t),n.callback=null,ca(a,n,t),a=t,i.current.lanes=a,zt(i,a),Pi(i),e[Za]=i.current,ed(e),new Wo(i)},Rn.version="19.2.0",Rn}var Yg;function Hp(){if(Yg)return Nd.exports;Yg=1;function v(){if(!(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__>"u"||typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE!="function"))try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(v)}catch(w){console.error(w)}}return v(),Nd.exports=Mp(),Nd.exports}var Pp=Hp();const Lp=v=>v.replace(/([a-z0-9])([A-Z])/g,"$1-$2").toLowerCase(),Up=v=>v.replace(/^([A-Z])|[\s-_]+(\w)/g,(w,b,u)=>u?u.toUpperCase():b.toLowerCase()),Kg=v=>{const w=Up(v);return w.charAt(0).toUpperCase()+w.slice(1)},Jg=(...v)=>v.filter((w,b,u)=>!!w&&w.trim()!==""&&u.indexOf(w)===b).join(" ").trim(),Vp=v=>{for(const w in v)if(w.startsWith("aria-")||w==="role"||w==="title")return!0};var jp={xmlns:"http://www.w3.org/2000/svg",width:24,height:24,viewBox:"0 0 24 24",fill:"none",stroke:"currentColor",strokeWidth:2,strokeLinecap:"round",strokeLinejoin:"round"};const zp=_.forwardRef(({color:v="currentColor",size:w=24,strokeWidth:b=2,absoluteStrokeWidth:u,className:H="",children:C,iconNode:L,...x},D)=>_.createElement("svg",{ref:D,...jp,width:w,height:w,stroke:v,strokeWidth:u?Number(b)*24/Number(w):b,className:Jg("lucide",H),...!C&&!Vp(x)&&{"aria-hidden":"true"},...x},[...L.map(([y,O])=>_.createElement(y,O)),...Array.isArray(C)?C:[C]]));const Se=(v,w)=>{const b=_.forwardRef(({className:u,...H},C)=>_.createElement(zp,{ref:C,iconNode:w,className:Jg(`lucide-${Lp(Kg(v))}`,`lucide-${v}`,u),...H}));return b.displayName=Kg(v),b};const Bp=[["path",{d:"M22 12h-2.48a2 2 0 0 0-1.93 1.46l-2.35 8.36a.25.25 0 0 1-.48 0L9.24 2.18a.25.25 0 0 0-.48 0l-2.35 8.36A2 2 0 0 1 4.49 12H2",key:"169zse"}]],Ca=Se("activity",Bp);const Gp=[["path",{d:"M10 16c.5.3 1.2.5 2 .5s1.5-.2 2-.5",key:"1u7htd"}],["path",{d:"M15 12h.01",key:"1k8ypt"}],["path",{d:"M19.38 6.813A9 9 0 0 1 20.8 10.2a2 2 0 0 1 0 3.6 9 9 0 0 1-17.6 0 2 2 0 0 1 0-3.6A9 9 0 0 1 12 3c2 0 3.5 1.1 3.5 2.5s-.9 2.5-2 2.5c-.8 0-1.5-.4-1.5-1",key:"11xh7x"}],["path",{d:"M9 12h.01",key:"157uk2"}]],Pt=Se("baby",Gp);const qp=[["path",{d:"M4.5 3h15",key:"c7n0jr"}],["path",{d:"M6 3v16a2 2 0 0 0 2 2h8a2 2 0 0 0 2-2V3",key:"m1uhx7"}],["path",{d:"M6 14h12",key:"4cwo0f"}]],Rd=Se("beaker",qp);const Fp=[["path",{d:"m9 18 6-6-6-6",key:"mthhwq"}]],Lt=Se("chevron-right",Fp);const Yp=[["path",{d:"M12 6v6l4 2",key:"mmk7yg"}],["circle",{cx:"12",cy:"12",r:"10",key:"1mglay"}]],Hd=Se("clock",Yp);const Kp=[["line",{x1:"12",x2:"12",y1:"2",y2:"22",key:"7eqyqh"}],["path",{d:"M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6",key:"1b0p4s"}]],_p=Se("dollar-sign",Kp);const Xp=[["path",{d:"M7 16.3c2.2 0 4-1.83 4-4.05 0-1.16-.57-2.26-1.71-3.19S7.29 6.75 7 5.3c-.29 1.45-1.14 2.84-2.29 3.76S3 11.1 3 12.25c0 2.22 1.8 4.05 4 4.05z",key:"1ptgy4"}],["path",{d:"M12.56 6.6A10.97 10.97 0 0 0 14 3.02c.5 2.5 2 4.9 4 6.5s3 3.5 3 5.5a6.98 6.98 0 0 1-11.91 4.97",key:"1sl1rz"}]],Cd=Se("droplets",Xp);const Zp=[["path",{d:"M15 3h6v6",key:"1q9fwt"}],["path",{d:"M10 14 21 3",key:"gplh6r"}],["path",{d:"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6",key:"a6xqqp"}]],wd=Se("external-link",Zp);const Qp=[["path",{d:"M6 22a2 2 0 0 1-2-2V4a2 2 0 0 1 2-2h8a2.4 2.4 0 0 1 1.704.706l3.588 3.588A2.4 2.4 0 0 1 20 8v12a2 2 0 0 1-2 2z",key:"1oefj6"}],["path",{d:"M14 2v5a1 1 0 0 0 1 1h5",key:"wfsgrz"}],["path",{d:"M10 9H8",key:"b1mrlr"}],["path",{d:"M16 13H8",key:"t4e002"}],["path",{d:"M16 17H8",key:"z1uh3a"}]],Mt=Se("file-text",Qp);const Wp=[["path",{d:"M2 9.5a5.5 5.5 0 0 1 9.591-3.676.56.56 0 0 0 .818 0A5.49 5.49 0 0 1 22 9.5c0 2.29-1.5 4-3 5.5l-5.492 5.313a2 2 0 0 1-3 .019L5 15c-1.5-1.5-3-3.2-3-5.5",key:"mvr1a0"}]],Dd=Se("heart",Wp);const Jp=[["circle",{cx:"12",cy:"12",r:"10",key:"1mglay"}],["path",{d:"M12 16v-4",key:"1dtifu"}],["path",{d:"M12 8h.01",key:"e9boi3"}]],$g=Se("info",Jp);const $p=[["path",{d:"M22 17a2 2 0 0 1-2 2H6.828a2 2 0 0 0-1.414.586l-2.202 2.202A.71.71 0 0 1 2 21.286V5a2 2 0 0 1 2-2h16a2 2 0 0 1 2 2z",key:"18887p"}]],er=Se("message-square",$p);const ef=[["path",{d:"m10.5 20.5 10-10a4.95 4.95 0 1 0-7-7l-10 10a4.95 4.95 0 1 0 7 7Z",key:"wa1lgi"}],["path",{d:"m8.5 8.5 7 7",key:"rvfmvr"}]],_g=Se("pill",ef);const af=[["path",{d:"m21 21-4.34-4.34",key:"14j7rj"}],["circle",{cx:"11",cy:"11",r:"8",key:"4ej97u"}]],gi=Se("search",af);const tf=[["path",{d:"M20 13c0 5-3.5 7.5-7.66 8.95a1 1 0 0 1-.67-.01C7.5 20.5 4 18 4 13V6a1 1 0 0 1 1-1c2 0 4.5-1.2 6.24-2.72a1.17 1.17 0 0 1 1.52 0C14.51 3.81 17 5 19 5a1 1 0 0 1 1 1z",key:"oel41y"}],["path",{d:"M12 8v4",key:"1got3b"}],["path",{d:"M12 16h.01",key:"1drbdi"}]],nf=Se("shield-alert",tf);const of=[["path",{d:"M20 13c0 5-3.5 7.5-7.66 8.95a1 1 0 0 1-.67-.01C7.5 20.5 4 18 4 13V6a1 1 0 0 1 1-1c2 0 4.5-1.2 6.24-2.72a1.17 1.17 0 0 1 1.52 0C14.51 3.81 17 5 19 5a1 1 0 0 1 1 1z",key:"oel41y"}]],eu=Se("shield",of);const rf=[["path",{d:"M11 2v2",key:"1539x4"}],["path",{d:"M5 2v2",key:"1yf1q8"}],["path",{d:"M5 3H4a2 2 0 0 0-2 2v4a6 6 0 0 0 12 0V5a2 2 0 0 0-2-2h-1",key:"rb5t3r"}],["path",{d:"M8 15a6 6 0 0 0 12 0v-3",key:"x18d4x"}],["circle",{cx:"20",cy:"10",r:"2",key:"ts1r5v"}]],ir=Se("stethoscope",rf);const sf=[["path",{d:"m18 2 4 4",key:"22kx64"}],["path",{d:"m17 7 3-3",key:"1w1zoj"}],["path",{d:"M19 9 8.7 19.3c-1 1-2.5 1-3.4 0l-.6-.6c-1-1-1-2.5 0-3.4L15 5",key:"1exhtz"}],["path",{d:"m9 11 4 4",key:"rovt3i"}],["path",{d:"m5 19-3 3",key:"59f2uf"}],["path",{d:"m14 4 6 6",key:"yqp9t2"}]],Ht=Se("syringe",sf);const df=[["path",{d:"m21.73 18-8-14a2 2 0 0 0-3.48 0l-8 14A2 2 0 0 0 4 21h16a2 2 0 0 0 1.73-3",key:"wmoenq"}],["path",{d:"M12 9v4",key:"juzpu7"}],["path",{d:"M12 17h.01",key:"p32p05"}]],wa=Se("triangle-alert",df);const lf=[["path",{d:"m16 11 2 2 4-4",key:"9rsbq5"}],["path",{d:"M16 21v-2a4 4 0 0 0-4-4H6a4 4 0 0 0-4 4v2",key:"1yyitq"}],["circle",{cx:"9",cy:"7",r:"4",key:"nufk8"}]],iu=Se("user-check",lf);const cf=[["path",{d:"M18 6 6 18",key:"1bl5f8"}],["path",{d:"m6 6 12 12",key:"d8bk6v"}]],au=Se("x",cf),mf=JSON.parse(`[{"id":"drug-5","genericName":"Dexlansoprazole 30 mg, 60mg Delayed Release Capsule","brandName":"Dexilant","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Capsule"],"indications":"i) Treatment of erosive esophagitis (EE)\\nii) Maintenance of healed erosive esophagitis (EE)\\niii) Symptomatic treatment of non-erosive gastroesophageal reflux disease. \\nRestrictions: \\nAs a second-line therapy for: \\ni) Patients with refractory EE\\nii) Geriatrics\\niii) Patients with polypharmacy.","dosing":"i) Treatment of EE  60 mg once daily for 8 weeks\\nii) Maintenance of healed EE  30 mg once daily for 6 months\\niii) Symptomatic non-erosive gastroesophageal reflux disease  30 mg once daily for 4 weeks.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"1.49","prescriberCat":"A*"},{"id":"drug-6","genericName":"Esomeprazole 40 mg Injection","brandName":"Nexium","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Injection"],"indications":"i) Acute erosive/ ulcerative oesophagitis","dosing":"i) 20- 40 mg once daily for 2-5 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, \\nPembedahan)","price":"24.60","prescriberCat":"A*"},{"id":"drug-8","genericName":"Esomeprazole 40 mg Tablet","brandName":"Emanera","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Tablet"],"indications":"i) Gastro-oesophageal reflux disease","dosing":"i) 20mg daily for 4-8 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, \\nPembedahan)","price":"0.48","prescriberCat":"A"},{"id":"drug-10","genericName":"Itopride HCl 50 mg Tablet","brandName":"Progit","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Tablet"],"indications":"Treatment of gastrointestinal symptoms of functional, non-ulcer dyspepsia (chronic gastritis)\\n i.e sensation of bloating, early satiety, upper abdominal pain or discomfort, anorexia, heartburn, nausea and vomiting","dosing":"50 mg 3 times daily before meal","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"0.52","prescriberCat":"A*"},{"id":"drug-11","genericName":"Magnesium Trisilicate Mixture(200ml)","brandName":"Hovid","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Mixture(200ml)"],"indications":"Heartburn, dyspepsia","dosing":"10-20 ml 3-4 times daily before meals","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"KIV (Dept: Product discont due to chloroform)","price":"1.87","prescriberCat":"C"},{"id":"drug-12","genericName":"Magnesium Trisilicate Tablet","brandName":"Idaman Pharma MMT Compound","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Tablet"],"indications":"Heartburn, dyspepsia","dosing":"ADULT  :  1-2 tablet to be chewed up to 6 times a day \\nbefore meals.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.15","prescriberCat":"C"},{"id":"drug-14","genericName":"Mebeverine HCl 135 mg Tablet","brandName":"Dusphatalin","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Tablet"],"indications":"i) Irritable bowel syndrome\\nii) Treatment of gastro-intestinal spasm secondary to organic diseases.","dosing":"135 mg 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, \\nPembedahan)","price":"0.85","prescriberCat":"B"},{"id":"drug-15","genericName":"Omeprazole 20 mg Capsule","brandName":"Ometac 20","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Capsule"],"indications":"i)Reflux oesophagitis","dosing":"i)20 - 80 mg 1 - 2 times daily up to 8 - 12 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, \\nPerubatan, \\nPediatrik)","price":"0.51","prescriberCat":"A/KK"},{"id":"drug-20","genericName":"Pantoprazole 40 mg Injection","brandName":"Vaxcel","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Injection"],"indications":"Bleeding peptic ulcer and acute stress \\nulceration","dosing":"40 mg twice daily until oral administration can be resumed. \\nCHILD not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.71","prescriberCat":"A/KK"},{"id":"drug-21","genericName":"Pantoprazole 40 mg Tablet","brandName":"Vencid","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Tablet"],"indications":"i) Helicobacter pylori eradication","dosing":"i) 40 mg twice daily in combination with any of the 2 antibiotics\\n(Clarithromycin 500 mg twice daily, Amoxicillin 1 g twice daily or Metronidazole 400 mg twice daily) for 1-2 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.19","prescriberCat":"A/KK"},{"id":"drug-26","genericName":"Ranitidine 150 mg Tablet","brandName":"Ranitidine","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Tablet"],"indications":"i) Benign gastric and duodenal ulcer","dosing":"i) 150 mg twice daily (at morning and night) or 300 mg on night for 4-8 weeks. \\nMaintenance: 150-300 mg on night","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.18","prescriberCat":"B"},{"id":"drug-30","genericName":"Ranitidine 50 mg/2 ml Injection","brandName":"Rantac","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["Injection"],"indications":"i) Benign gastric/ duodenal ulceration, reflux oesophagitis, \\nZollinger Ellison Syndrome","dosing":"i) ADULT: Slow IV injection of 50 mg diluted to 20 ml and given over at least 2 minutes. \\nMay be repeated every 6-8 hours or IV infusion at rate of 25 mg/hour for 2 hours, may be repeated at 6-8 hours intervals or IM. \\nCHILD: 1 mg/kg/dose 6-8 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.67","prescriberCat":"B"},{"id":"drug-32","genericName":"Sodium Alginate 1000mg/10ml & Potassium Bicarbonate 200mg/10ml Suspension (150ml)","brandName":"Gaviscon Advance","category":"1.0 ALIMENTARY SYSTEM\\n1.1 ANTACIDS, GASTRIC ULCER REMEDIES","forms":["(150ml)"],"indications":"Treatment of symptoms of gastro-oesophageal reflux eg. acid regurgitation, heartburn,\\nindigestion due to the reflux of stomach contents not responding to conventional antacids or as an addition to PPI when PPI alone fails to control the symptoms","dosing":"Adult, elderly & children 12 year: 5-10 mL.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, \\nPembedahan)","price":"15.40","prescriberCat":"A*"},{"id":"drug-35","genericName":"Diphenoxylate HCL 2.5mg with Atropine Sulphate 0.025mg Tablet","brandName":"Pharmaniaga Diphenoxylate","category":"1.0 ALIMENTARY SYSTEM\\n1.2 ANTIDIARRHOEALS","forms":["Tablet"],"indications":"Symptomatic treatment of acute and \\nchronic diarrhoea","dosing":"ADULT: 2 tablets 4 times daily, later reduced when diarrhoea is controlled.\\nMaintenance: 2 tablets once daily as needed (Max: 8 tablets daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.10","prescriberCat":"B"},{"id":"drug-36","genericName":"Loperamide 2 mg Capsule","brandName":"Lomide","category":"1.0 ALIMENTARY SYSTEM\\n1.2 ANTIDIARRHOEALS","forms":["Capsule"],"indications":"i. Adjunct to rehydration in:\\na. acute diarrhea in adult; and\\nb. chronic diarrhea in adult\\n\\nii. In patients with an ileostomy, it can be used to reduce the number and volume of stools and to harden their consistency","dosing":"6  8 mg per day up to max. of 16mg per day\\n\\nDosing is individualised and according to product insert / protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"0.07","prescriberCat":"B"},{"id":"drug-40","genericName":"Diosmin 450 mg and Hesperidin 50 mg Tablet","brandName":"Hemo Rid","category":"1.0 ALIMENTARY SYSTEM\\n1.3 ANTIHAEMORRHOIDAL","forms":["Tablet"],"indications":"i) Haemorrhoids","dosing":"Acute attack: 6 tablets daily for the first 4 days,\\nthen 4 tablets daily in 2 divided doses for 3 days and 2 tablets thereafter.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.33","prescriberCat":"B"},{"id":"drug-43","genericName":"Zinc Oxide 300 mg, Balsam Peru 50 mg & Benzyl Benzoate 33 mg Suppository","brandName":"Anucare","category":"1.0 ALIMENTARY SYSTEM\\n1.3 ANTIHAEMORRHOIDAL","forms":["Suppository"],"indications":"For relief of pruritus, burning and soreness in patients \\nwith haemorrhoids and perianal conditions","dosing":"Insert 1 suppository night and morning after bowel movements; \\ndo not use for longer than 7 days OR please refer to the product insert.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.87","prescriberCat":"C"},{"id":"drug-46","genericName":"Atropine Sulphate 1mg/ml Injection","brandName":"Pharmaniaga Atropine Sulphate","category":"1.0 ALIMENTARY SYSTEM\\n1.4 ANTISPASMODICS","forms":["Injection"],"indications":"i) Reduce vagal inhibition,salivary\\n and bronchiol secretion in anaesthesia","dosing":"i) Adult: 300-600 mcg IM/SC 30-60 minutes before anaesthesia. \\nAlternatively, 300-600 mcg IV immediately before induction of anaesthesia.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.46","prescriberCat":"B"},{"id":"drug-53","genericName":"Domperidone 10 mg Tablet","brandName":"Molax-M","category":"1.0 ALIMENTARY SYSTEM\\n1.4 ANTISPASMODICS","forms":["Tablet"],"indications":"Nausea, vomiting, dyspepsia, \\ngastro-esophageal reflux","dosing":"Chronic dyspepsia ADULT 10 mg 3 times daily.\\nAcute and subacute conditions (particularly nausea and vomiting)\\nADULT :  20 mg 3-4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-55","genericName":"Domperidone 1mg/ml suspension (60ml)","brandName":"Motidom","category":"1.0 ALIMENTARY SYSTEM\\n1.4 ANTISPASMODICS","forms":["(60ml)"],"indications":"Nausea, vomiting, dyspepsia, \\ngastro-esophageal reflux","dosing":"Adults and adolescents  12 years of age and weighing  35kg & children < 12 years of age and weighing  35kg: 10ml three to four times per day. Maximum dose: 40mg/day. Adults and adolescents ( 12 years of age) weighing < 35kg: 0.25mg/kg three to four times per day. Maximum dose: 35mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.84","prescriberCat":"B"},{"id":"drug-56","genericName":"Hyoscine N-Butylbromide 20 mg/ml Injection","brandName":"Copan","category":"1.0 ALIMENTARY SYSTEM\\n1.4 ANTISPASMODICS","forms":["Injection"],"indications":"Gastrointestinal tract and genito-urinary tract spasm, dyskinesia of the biliary system","dosing":"20 mg IM/IV repeated after 30 min if needed. \\nMax: 100 mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.82","prescriberCat":"B"},{"id":"drug-57","genericName":"Hyoscine N-Butylbromide 10 mg Tablet","brandName":"Spasmoliv","category":"1.0 ALIMENTARY SYSTEM\\n1.4 ANTISPASMODICS","forms":["Tablet"],"indications":"Gastrointestinal tract and genito-urinary tract spasm, dyskinesia of the biliary system.","dosing":"ADULT 10-20mg, 3-4 times a day. \\nCHILD 6-12 years old: 10mg 3 times a day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.19","prescriberCat":"B"},{"id":"drug-60","genericName":"Bisacodyl 5 mg Tablet","brandName":"Laxodyl","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["Tablet"],"indications":"i) Constipation","dosing":"i) ADULT and CHILD over 10 years : 5-10 mg. To be taken at night for effect on the following morning","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.07","prescriberCat":"C"},{"id":"drug-64","genericName":"Bisacodyl 10mg Suppository","brandName":"YSP","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["Suppository"],"indications":"i) Constipation","dosing":"i) ADULT and CHILD over 10 years: 10 mg insert rectally","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.45","prescriberCat":"C"},{"id":"drug-68","genericName":"Glycerin 25% and Sodium Chloride 15% Enema","brandName":"Royce","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["Enema"],"indications":"Constipation","dosing":"1 enema as required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.00","prescriberCat":"C+"},{"id":"drug-69","genericName":"Lactulose 3.35 g/5 ml Liquid","brandName":"Unilac","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["Liquid"],"indications":"i) Constipation","dosing":"i) ADULT : 15 ml twice daily adjusted to patient's need.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.70","prescriberCat":"C+"},{"id":"drug-73","genericName":"Liquid Paraffin 5kg","brandName":"-","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["5kg"],"indications":"Constipation","dosing":"ADULT :  10-30 ml daily at night but should not \\nbe taken immediately before going to bed. \\nCHILD : not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"69.00","prescriberCat":"C"},{"id":"drug-74","genericName":"Macrogol 64g, Anhydrous Sodium Sulfate 5.7g, Sodium Bicarbonate 1.68g, NaCl 1.46g & KCl 0.75g","brandName":"Fortrans","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["0.75g"],"indications":"Bowel cleansing prior to colonoscopy, radiological examination or colonic surgery. \\nSuitable for patients with heart failure or renal failure","dosing":"1 sachet dissolved in 1 L of water. 2-3 L of oral solution are required. \\nWhen morning surgery is planned, the oral solution is given in the late afternoon the day prior. \\nIf surgery is scheduled in afternoon, the oral solution should be given on the same day for ingestion to be completed three hours before surgery","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"13.13","prescriberCat":"A"},{"id":"drug-75","genericName":"Sodium Biphosphate 16%, Sodium Phosphate 6% Rectal Solution","brandName":"Fleet enema","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["Solution"],"indications":"Bowel cleansing before colonic surgery, \\ncolonoscopy or radiological examination to ensure the bowel is free of solid contents. It is not to be used for treatment of constipation","dosing":"ADULT 133 ml (1 bottle) administered rectally. CHILD more than 2 years half the adult dose (66.6ml)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"9.54","prescriberCat":"A"},{"id":"drug-76","genericName":"Monobasic Sodium Phosphate 48%, Dibasic Sodium Phosphate 18%","brandName":"Fleet Phospho - Soda","category":"1.0 ALIMENTARY SYSTEM\\n1.5 LAXATIVES, PURGATIVES (CATHARTICS)","forms":["18%"],"indications":"Bowel cleansing prior to colonoscopy, \\nradiological examination or bowel surgery","dosing":"45 ml diluted with half a glass (120 ml) of water, followed by one full glass (240 ml) of water to be taken depending on the time of the procedure.\\n-  For morning procedure, 45 ml dilute with half glass of water should be taken at 7 am and the second 45 ml at 7 pm on the day before the procedure. \\n-  For afternoon procedure, the first dose should be taken at 7 pm on the day before and the second dose at 7 am on the day of the procedure. \\n-  Solid food must not be taken during the preparation period; clear fluids or water can be taken liberally. \\n-  Not recommended for use in children","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"11.16","prescriberCat":"A"},{"id":"drug-79","genericName":"Benzydamine HCl 0.15% Solution","brandName":"Difflam","category":"1.0 ALIMENTARY SYSTEM\\n1.6 MOUTH AND THROAT PREPARATION","forms":["Solution"],"indications":"For relief of painful condition of the oral \\ncavity","dosing":"Used as a 30 seconds gargle or rinse, undiluted. \\nADULT : 15 ml. \\nCHILD less 12 years :  5-15 ml. \\nUninterrupted treatment should not be more than 7 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.95","prescriberCat":"B"},{"id":"drug-80","genericName":"Choline Salicylate 8.7%, Cetylkonium Chloride 0.01% Dental Gel","brandName":"Oracue","category":"1.0 ALIMENTARY SYSTEM\\n1.6 MOUTH AND THROAT PREPARATION","forms":["Gel"],"indications":"For relief of the pain and discomfort in\\nmouth ulcers and sores, infant teething \\nand denture irritation","dosing":"Apply to area 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.40","prescriberCat":"B"},{"id":"drug-81","genericName":"Glycerin Oral Gel","brandName":"Glycerin","category":"1.0 ALIMENTARY SYSTEM\\n1.6 MOUTH AND THROAT PREPARATION","forms":["Gel"],"indications":"As a lubricant and osmotic dehydrating agent","dosing":"Apply to area when required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"80.34","prescriberCat":"C+"},{"id":"drug-82","genericName":"Thymol Compound Gargle","brandName":"Thymol","category":"1.0 ALIMENTARY SYSTEM\\n1.6 MOUTH AND THROAT PREPARATION","forms":["Gargle"],"indications":"For sore throat and minor mouth \\ninflammation","dosing":"To be gargled 3-4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.20","prescriberCat":"C"},{"id":"drug-85","genericName":"Aprepitant 125mg AND 80mg Capsule","brandName":"Emend","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Capsule"],"indications":"In combination with other antiemetic \\nagents for prevention of delayed nausea \\nand vomiting associated with \\ninitial and repeat \\ncourse of highly emetogenic chemotherapy","dosing":"125 mg 1 hour prior to chemotherapy on Day 1. \\nTo be given as part of a 3-day regimen that includes a corticosteroid and a 5-HT3 antagonist","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"222.6","prescriberCat":"A*"},{"id":"drug-87","genericName":"Granisetron HCl 3 mg/3 ml Injection","brandName":"Kytron","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Injection"],"indications":"i) Prevention and treatment of nausea and vomiting associated with chemotherapy and radiotherapy","dosing":"i) ADULT : 1-3 mg as an IV bolus not not less than 30 seconds; maximum 9 mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"3.98","prescriberCat":"A"},{"id":"drug-90","genericName":"Granisetron HCl 1 mg Tablet","brandName":"Kytron","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Tablet"],"indications":"Prevention and treatment of nausea and vomiting associated with chemotherapy and radiotherapy","dosing":"ADULT : 1 mg twice daily or 2 mg once daily with the first dose to be administered \\nwithin 1 hour prior to cytostatic therapy and can be given for up to 1 week following radiotherapy. \\nMaximum 9 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.80","prescriberCat":"A"},{"id":"drug-91","genericName":"Meclozine HCl 25 mg and Pyridoxine 50 mg Tablet","brandName":"Veloxin","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Tablet"],"indications":"Nausea and vomiting in pregnancy","dosing":"Optimum dosing: 1 to 2 tablets OD. Maximum dosing: 4 tablets/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.67","prescriberCat":"B"},{"id":"drug-92","genericName":"Metoclopramide HCl 10 mg/2 ml Injection","brandName":"Malon","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Injection"],"indications":"Use in adults for: i) Prevention of post-operative nausea and vomiting","dosing":"All indications (adult): A single 10mg dose is recommended for the prevention of post-operative nausea and vomiting. \\nThe recommended dose for the symptomatic treatment of nausea and vomiting, including nausea and vomiting induced by migraine attacks and for the prevention of radiotherapy-induced nausea and vomiting is 10mg per dose, 1 to 3 times daily. \\nThe maximum recommended daily dose is 30mg or 0.5mg/kg. Treatment duration when administering by injection should be as short as possible and a switch to administration via oral or rectal route should be instituted as quickly as possible.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.63","prescriberCat":"B"},{"id":"drug-96","genericName":"Metoclopramide HCl 10 mg Tablet","brandName":"Sunward","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Tablet"],"indications":"Use in adults for: i) Prevention of delayed chemotherapy induced nausea and vomiting (CINV)","dosing":"Adult: The recommended single dose is 10mg, repeated up to three times daily. The maximum recommended daily dose is 30mg or 0.5mg/kg body weight. The maximum recommended treatment duration is 5 days. Prevention of delayed CINV (children aged 1-18 years): The recommended dose is 0.1-0.5mg/kg body weight, repeated up to three times daily by oral route. The maximum dose in 24 hours is 0.5mg/kg body weight.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.03","prescriberCat":"B"},{"id":"drug-100","genericName":"Prochlorperazine Maleate 5mg Tablet","brandName":"Prochlor Tablet 5","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Tablet"],"indications":"i) Severe nausea and vomiting","dosing":"Nausea and vomiting Adult: As maleate or mesilate: 20 mg, further doses are given if needed. Recommended buccal dose: As maleate: 3-6 mg bid.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.17","prescriberCat":"B"},{"id":"drug-102","genericName":"Prochlorperazine Mesylate 12.5 mg/ml Injection","brandName":"Lartil","category":"1.0 ALIMENTARY SYSTEM\\n1.7 ANTIEMETICS","forms":["Injection"],"indications":"i) Severe nausea and vomiting","dosing":"Deep IM injection, 12.5 mg repeated if necessary after 6 hours and then followed by an oral dose. Not recommended in children","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.25","prescriberCat":"B"},{"id":"drug-106","genericName":"Glycopyrrolate 200 mcg/ml Injection","brandName":"Pyronium","category":"1.0 ALIMENTARY SYSTEM\\n1.8 ANTICHOLINERGIC / ANESTHETIC PREMEDICATION AGENTS","forms":["Injection"],"indications":"i) To reduce secretions (respiratory tract) \\nfor certain types of surgery","dosing":"i) Pre-op: 4 mcg/kg via IM administration 30-60 mins before procedure. \\nIntraoperative: 0.1 mg via IV administration, repeat at 2-3 min intervals when needed. \\nMax: 400 mcg/dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.34","prescriberCat":"A*"},{"id":"drug-108","genericName":"Glycopyrrolate 1mg tablet","brandName":"Glycorate","category":"1.0 ALIMENTARY SYSTEM\\n1.8 ANTICHOLINERGIC / ANESTHETIC PREMEDICATION AGENTS","forms":["tablet"],"indications":"Excessive airway secretion","dosing":"Child: 3 years Initially, 20 mcg/kg tid. Titrate dose in increments of 20 mcg/kg every 5-7 days according to response. Max: 100 mcg/kg tid not to exceed 1,500-3,000 mcg/dose.\\n\\nHSM Practice: 1mg TDS","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"import permit required for purchase (UKK) (Dept: Pediatrik)","price":"0.67","prescriberCat":"Not in FUKKM"},{"id":"drug-111","genericName":"Aminophylline 25 mg/ml Injection (250mg/10ml)","brandName":"Fresenius Aminophylline","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["(250mg/10ml)"],"indications":"Reversible airways obstruction, acute severe brochospasm","dosing":"Adult: Loading dose: 5 mg/kg (ideal body weight) or 250-500 mg (25 mg/ml) by slow inj or infusion over 20-30 min. \\nMaintenance infusion dose: 0.5 mg/kg/hr. \\nMax rate: 25 mg/min.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.36","prescriberCat":"B"},{"id":"drug-113","genericName":"Beclomethasone Dipropionate (100 mcg/dose, 200 doses MDI )","brandName":"Biosone","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":[")"],"indications":"Prophylaxis of asthma especially if not fully controlled by bronchodilators","dosing":"Adults: The usual maintenance dose is one to two inhalations (200-400 mcg) twice daily.\\nIf needed,the dose can be increased up to 1600 mcg/day divided in two to four doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.3","prescriberCat":"B"},{"id":"drug-115","genericName":"Beclomethasone dipropionate 100mcg and formoterol fumarate dihydrate 6mcg pressurized inhalation solution","brandName":"Foster","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["solution"],"indications":"Prescriber category A/KK:\\ni) Regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2 agonist) is appropriate in:\\na) Patients not adequately controlled with inhaled corticosteroids and \\"as needed\\" inhaled short-acting beta2 agonist, or\\nb) Patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.\\n\\nPrescriber category A*:\\nii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more\\niii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","dosing":"For asthma, the dosage is based on treatment approach:\\ni) Maintenance therapy (taken as regular maintenance treatment with a separate as needed rapid-acting bronchodilator):\\nDose recommendations for adults 18 years and above: One or two inhalations twice daily. The maximum daily dose is 4 inhalations.\\nii) Maintenance and reliever therapy (taken as regular maintenance treatment and as needed in response to asthma symptoms):\\nDose recommendations for adults 18 years and above: The recommended maintenance dose is 1 inhalation twice daily (one inhalation in the morning and one inhalation in the evening). Patients should take 1 additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. The maximum daily dose is 8 inhalations.\\n\\nFor COPD:\\n2 puffs two times a day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"To start by Respi Consultant (visiting) only (Dept: Perubatan)","price":"66.73","prescriberCat":"A*, A/KK"},{"id":"drug-116","genericName":"Benralizumab 30mg/ml injection","brandName":"Fasenra","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["injection"],"indications":"As add-on maintenance treatment in adult patients from 18 years with severe eosinophilic asthma characterised by the following criteria:\\na) At least two exacerbations in the past 12 months on the current standard therapy (high-dose inhaled corticosteroids plus long-acting bronchodilators) and/or need for treatment with systemic corticosteroids.\\nb) Eosinophil count in the blood of 0.3 G/L (corresponding to 300 cells/L)\\n\\nPrescribing restriction:\\nTo be prescribed by Respiratory Physician (Pulmonologist) only","dosing":"30 mg every 4 weeks for the first 3 doses, and then every 8 weeks thereafter administered as subcutaneous injection","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"3713","prescriberCat":"A*"},{"id":"drug-117","genericName":"Budesonide (200 mcg/dose,300 doses MDI )","brandName":"Budesonide Aerosol for inhalation","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":[")"],"indications":"Maintenance treatment of asthma as prophylactic therapy especially if not fully controlled by bronchodilators","dosing":"ADULT:200 - 1600 mcg daily in 2-4 divided doses. Maintenance with twice daily dosing.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"21.46","prescriberCat":"B"},{"id":"drug-122","genericName":"Budesonide 1 mg/2 ml Nebulising Solution","brandName":"Talgan","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Solution"],"indications":"Treatment of asthma in patients where use of a pressurized inhaler or dry\\npowder formulation is unsatisfactory or inappropriate.","dosing":"ADULT : Initially 1 - 2 mg twice daily. CHILD 3 months - 12 years of age : 500 mcg - 1 mg. Maintenance dose : half of the above doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.44","prescriberCat":"B"},{"id":"drug-123","genericName":"Budesonide 160 mcg and Formoterol 4.5 mcg Inhalation Turbuhaler (120 doses, 30 doses)","brandName":"Symbicort Turbuhaler\\n(120 doses)\\n\\nSymbicort Turbuhaler (30 doses)","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses)"],"indications":"Category of prescriber A/KK: \\ni) Regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:\\n- Patients not adequately controlled with inhaled corticosteroids and \\"as needed\\" inhaled short-acting beta2-agonists. or \\n- Patients already adequately controlled on both inhaled corticosteroids and long- acting beta2-agonists.\\nii) As a reliever treatment for mild asthma patients who do not adhere to regular inhaled corticosteroid","dosing":"i) Asthma Maintenance therapy:  \\nAdult 18 yr : 160 mcg to 320 mcg bd. Some patients may require up to a max of 640 mcg bd. \\nAdolescent 12-17 yr :  160 mcg to 320 mcg bd.\\nChildren 6-11 yr :  160 mcg bd.\\n<6 yr Not recommended. \\nMaintenance & relief : Adult and adolescent 12 yr : 320 mcg/day either as 160 mcg bd or 320 mcg od either morning or evening. \\n\\nFor some patients a maintenance dose of 320 mcg bd may be appropriate. Patients should take 160 mcg additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. \\nNot more than 960 mcg should be taken on any single occasion. A total daily dose of more than 1280 mcg is not normally needed, however a total daily dose of up to 1920 mcg could be used for a limited period. Patients using more than 1280 mcg daily should seek medical advice, should be reassessed & their maintenance therapy reconsidered. \\n\\nii) Asthma reliever-only therapy: 160mcg as needed, but no more than 960mcg in a single occasion.\\nChildren <12 yr: Not recommended. \\n\\niii) & iv) COPD: Adult 18 yr : 320 mcg bd.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan (120 & 30 doses)\\n\\nJabatan Pesakit Luar (30 doses))","price":"70.17   20.00","prescriberCat":"A/KK & A*"},{"id":"drug-126","genericName":"Budesonide 320 mcg and Formoterol 9 mcg Inhalation Turbuhaler, 60 doses","brandName":"Symbicort Turbuhaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"i) Category of prescriber A/KK: Regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- - Patients not adequately controlled with inhaled corticosteroids and \\"as needed\\" inhaled short-acting beta2-agonists. or - Patients already adequately controlled on both inhaled corticosteroids and long- acting beta2-agonists. \\n\\nCategory of prescriber A*: ii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more \\niii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","dosing":"Asthma Maintenance therapy Adult 18 yr 160 mcg to 320 mcg bd. Some patients may require up to a max of 640 mcg bd. \\nAdolescent 12-17 yr 160 mcg to 320 mcg bd. \\nChildn 6-11 yr 160 mcg bd, <6 yr Not recommended. \\nMaintenance & relief Adult and adolescent 12 yr 320 mcg/day either as 160 mcg bd or 320 mcg od either morning or evening. For some patients a maintenance dose of 320 mcg bd may be appropriate. Patients should take 160 mcg additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. Not more than 960 mcg should be taken on any single occasion. A total daily dose of more than 1280 mcg is not normally needed, however a total daily dose of up to 1920 mcg could be used for a limited period. Patients using more than 1280 mcg daily should seek medical advice, should be reassessed & their maintenance therapy reconsidered. Children & adolescent <12 yr: Not recommended. COPD: Adult 18 yr 320 mcg bd.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"88.30","prescriberCat":"A/KK"},{"id":"drug-127","genericName":"Fluticasone Propionate 125 mcg/dose Inhalation MDI, 120 doses","brandName":"Flixotide \\nEvohaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"Prophylactic treatment for asthma","dosing":"ADULT and CHILD more than 16 years\\ni) Mild asthma : 100 mcg - 250 mcg twice daily \\nii) Moderate asthma : 250 - 500 mcg twice daily \\niii) Severe asthma : 500 mcg - 1000 mcg twice daily. \\nAlternatively, the starting dose of fluticasone dipropionate may be gauged at half the total daily dose of beclomethasone dipropionate or equivalent administered by inhalation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.50","prescriberCat":"B"},{"id":"drug-128","genericName":"Glycopyrronium 50mcg Inhalation Powder Hard Capsules","brandName":"Seebri","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Capsules"],"indications":"For maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). COPD diagnosis is confirmed by spirometry.","dosing":"One capsule daily. The recommended dose is the inhalation of the content of one capsule once daily using inhaler. It is recommended to be administered, at the same time of the day each day. \\nNo relevant use of glycopyrronium in pediatric population (<18 years) for COPD.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"80.60","prescriberCat":"A/KK"},{"id":"drug-129","genericName":"Indacaterol Maleate 110mcg and Glycopyrronium Bromide 50mcg inhalation powder capsules","brandName":"Ultibro \\nBreezhaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["capsules"],"indications":"As a once-daily maintenance bronchodilator treatment to relieve symptoms and reduce exacerbations in adult patients with chronic obstructive pulmonary disease (COPD).","dosing":"One capsule inhalation daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"80.83","prescriberCat":"A/KK"},{"id":"drug-130","genericName":"Indacaterol Maleate 150 mcg Inhalation Capsule","brandName":"Onbrez","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Capsule"],"indications":"Maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD). \\nPrescribing restriction: Initiation of LABA, LAMA and LABA/LAMA for COPD: \\ni) The diagnosis of COPD should be confirmed by spirometry \\nii) For Pulmonologist: COPD patient must be assessed for suitability for lung volume reduction (surgical or bronchoscopic approach) and lung transplant before they are discharged to Klinik Kesihatan. \\niii) For Family Medicines Specialist: COPD patients must be referred to Pulmonologist for assessment of suitability for lung volume reduction (surgical or bronchoscopic approach) and lung transplant prior initiation of LABA, LAMA and LABA/LAMA in Klinik Kesihatan.","dosing":"Once-daily inhalation of the content of one 150/300 microgram capsule. Maximum dose is 300 microgram once-daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"3.13","prescriberCat":"A/KK"},{"id":"drug-131","genericName":"Ipratropium Bromide 0.025% Nebulising Solution (UDV 500mcg/2ml) and 0.0125% Nebulising Solution (UDV 250mcg/2ml)","brandName":"Ipraneb 500, Ipraneb 250","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["250mcg/2ml)"],"indications":"Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. Used concomitantly with inhaled beta-agonists in the treatment of acute bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and asthma.","dosing":"Maintenance treatment: \\ni) Adult and adolescents over 12 years old: 500mcg per dose, 3 to 4 times daily. \\nii) Children 6 - 12 years old: 250mcg per dose, 3 to 4 times daily. \\niii) Children less than 6 years old: 100 - 250mcg per dose, 3 to 4 times daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.00, 0.79","prescriberCat":"B"},{"id":"drug-133","genericName":"Ipratropium Bromide 20 mcg and Fenoterol 50 mcg/dose Inhalation MDI, 200 doses","brandName":"Berodual","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"Management of symptoms in chronic obstructive airway disorders with reversible bronchospasm such as bronchial asthma and chronic bronchitis with or without emphysema","dosing":"ADULT & CHILD more than 6 years; Acute asthma 2 puffs. Severe cases: if breathing has not noticeably improved after 5 mins, 2 further puffs may be taken. Intermittent and long-term treatment : 1-2 puffs for each administration, up to max 8 puffs/day (average: 1-2 puffs three times daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"16.59","prescriberCat":"B"},{"id":"drug-134","genericName":"Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg per UDV","brandName":"Combineb","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["UDV"],"indications":"Management of reversible bronchospasm associated with obstructive airway diseases","dosing":"Acute attacks : 1 unit dose vial. In severe cases not relieved by 1 unit dose vial, 2 unit dose vials may require, patient should consult a doctor immediately. \\nMaintenance : 1 unit dose vial 3 - 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.62","prescriberCat":"B"},{"id":"drug-135","genericName":"Montelukast Sodium 4 mg Oral Granules","brandName":"4mg Aspira\\n\\n5mg Montelair Hovid\\n\\n10mg Montular","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Granules"],"indications":"Asthmatics, not controlled on high dose inhaled corticosteroids more than 1600 mcg/day and with co-morbid allergic disorders. Chronic treatment of asthma","dosing":"12 months - 5 years: 1 packet of 4mg oral granules daily at bedtime","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"0.72/4mg,   0.20/5mg,  0.18/10mg","prescriberCat":"A*"},{"id":"drug-136","genericName":"Montelukast Sodium 5 mg Tablet","brandName":"Generic","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Tablet"],"indications":"Asthmatics, not controlled on high dose inhaled corticosteroids more than 1600 mcg/day and with co-morbid allergic disorders. Chronic treatment of asthma","dosing":"CHILD 6 - 14 years: One 5 mg chewable tablet daily at bedtime","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"","prescriberCat":"A*"},{"id":"drug-137","genericName":"Montelukast Sodium 10 mg Tablet","brandName":"Generic","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Tablet"],"indications":"Chronic treatment of asthma and relief of symptoms of seasonal allergic rhinitis for children more than 15 years and adults","dosing":"CHILD more than 15 years and ADULT: 10 mg daily at bedtime","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"","prescriberCat":"A/KK"},{"id":"drug-138","genericName":"Salbutamol 100 mcg/dose, 200 doses MDI","brandName":"Biomol","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["MDI"],"indications":"Asthma and other conditions associated with reversible airways obstruction","dosing":"ADULT : 100 - 200 mcg up to 3 - 4 times daily. \\nCHILD : 100 mcg increased to 200 mcg if necessary","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.97","prescriberCat":"B"},{"id":"drug-139","genericName":"(200 mcg/dose, 200 doses Easyhaler)","brandName":"Buventol Easyhaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Easyhaler)"],"indications":"Asthma and other conditions associated with reversible airways obstruction","dosing":"CHILD : 100 - 200 mcg. Maintenance : 100 - 200 mcg 2 - 4 times daily. \\nADULT : 100 - 400 mcg. Maitenance : 100 - 400 mcg 2 - 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"91.50","prescriberCat":"B"},{"id":"drug-140","genericName":"Salbutamol 0.5 % Inhalation Solution","brandName":"Pharmaniaga Salbutamol","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Solution"],"indications":"Indicated for the relief of bronchospasm in patients with reversible\\nobstructive airway disease and acute bronchospasm.","dosing":"2.5 to 5mg (0.5ml  1ml), repeat according to response and tolerability.\\nDosing is individualised and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.10","prescriberCat":"B"},{"id":"drug-141","genericName":"Salbutamol 0.5 mg/ml Injection","brandName":"YSP Salbutamol","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Injection"],"indications":"Asthma and other conditions associated with reversible airways obstruction","dosing":"500 mcg by SC/IM injection 4 hourly or 250 mcg by slow IV. If required, by IV infusion, initially 5 mcg/min adjusted according to response and heart rate, usually in the range 3 - 20 mcg/min","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.83","prescriberCat":"A"},{"id":"drug-142","genericName":"Salbutamol 2 mg/5 ml Syrup","brandName":"KCK Salbutamol","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Syrup"],"indications":"Asthma and other conditions associated with reversible airways obstruction","dosing":"CHILD 2 - 6 years : 1 - 2 mg 3 - 4 times daily, \\n6 - 12 years : 2 mg 3 -4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.03","prescriberCat":"B"},{"id":"drug-143","genericName":"Salmeterol 50 mcg and Fluticasone Propionate 250 mcg Inhalation Accuhaler, 60 doses","brandName":"Seretide Accuhaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"Category of prescriber A/KK:\\ni) Regular treatment of reversible obstructive airways diseases including asthma. \\nCategory of prescriber A*: \\nii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more\\niii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","dosing":"i) ADULT and CHILD more than 12 years : 1 puff twice daily.  \\nii) For COPD: Dose is one inhalation 50/250mcg to 50/500mcg twice daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"77.40","prescriberCat":"A/KK"},{"id":"drug-144","genericName":"Salmeterol 50 mcg and Fluticasone Propionate 500 mcg Inhalation Accuhaler, 60 doses","brandName":"Seretide Accuhaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"Category of prescriber A/KK is only approved for indication (i):\\n i) Regular treatment of reversible obstructive airways diseases including asthma. \\nThe following indication is still under category of prescriber A*: \\nii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more \\niii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","dosing":"i) ADULT and CHILD more than 12 years : 1 puff twice daily.   \\nii) ADULT :  1 puff twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"40.20","prescriberCat":"A/KK"},{"id":"drug-145","genericName":"Salmeterol 25 mcg and Fluticasone Propionate 125 mcg Inhalation MDI, 120 doses","brandName":"Seretide Evohaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"Regular treatment of reversible obstructive airway diseases including asthma.","dosing":"ADULT and CHILD more than 12 years : 1 - 2 puff twice daily.   \\nCHILD over 4 years : 1 puff twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"12.13","prescriberCat":"A*"},{"id":"drug-146","genericName":"Salmeterol 25 mcg and Fluticasone Propionate 50 mcg Inhalation MDI, 120 doses","brandName":"Seretide Evohaler","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["doses"],"indications":"Regular treatment of reversible obstructive airway diseases including asthma in children, where use of lower dose of a combination (bronchodilator and inhaled corticosteroids) is appropriate. Prescribing is limited to pediatric population for the purpose of dose tapering.","dosing":"CHILD more than 12 years : 2 puff twice daily. CHILD over 4 years : 2 puff twice daily No data on use for children aged under 4 years.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan, Pediatrik)","price":"55.20","prescriberCat":"A*"},{"id":"drug-147","genericName":"Terbutaline Sulphate 10 mg/ml Inhalation Solution","brandName":"Terbutaline","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Solution"],"indications":"Asthma and other conditions associated with reversible airways obstruction","dosing":"ADULT : 5 - 10 mg 2 -4 times daily, additional doses may be necessary in severe acute asthma. \\nCHILD up to 3 years : 2 mg, 3 - 6 years : 3 mg, 6 - 8 years : 4 mg, over 8 years : 5 mg ,  2 - 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"28.80","prescriberCat":"B"},{"id":"drug-148","genericName":"Terbutaline Sulphate 0.5 mg/ml Injection","brandName":"Baltic","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Injection"],"indications":"Bronchial asthma, chronic bronchitis, emphysema and other lung diseases where broncoconstriction is a complicating factor","dosing":"SC, IM or slow IV : 250-500 mcg up to 4 times daily. \\nCHILD 2 - 15 years :  10mcg/kg to a maximum of 300 mcg. \\nContinuous IV infusion, as a solution containing 3 - 5 mcg/ml, 1.5 - 5 mcg/minute for 8 - 10 hours; reduce dose for children","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.65","prescriberCat":"B"},{"id":"drug-149","genericName":"Tezepelumab 210 mg Solution for Injection in Pre-Filled Pen/Syringe","brandName":"Tezspire","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Pen/Syringe"],"indications":"As add-on maintenance treatment for severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment","dosing":"SC\\nAdult: 210 mg once every 4 weeks.\\nChild: 12 years Same as adult dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial drugs approval (UKK) required (Dept: Perubatan)","price":"4272.28","prescriberCat":"Not in FUKKM"},{"id":"drug-150","genericName":"Theophylline 125 mg Tablet","brandName":"Pharmaniaga Theophylline","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Tablet"],"indications":"Reversible airways obstruction, acute severe asthma","dosing":"ADULT: 125 mg 3 - 4 times daily after food, increased to 250 mg if required. \\nCHILD: 1 - 15 years : 5 mg/kg/dose (up to 600 mg/ day) every 3 - 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-151","genericName":"Theophylline 250 mg Long Acting Tablet","brandName":"Neulin SR","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Tablet"],"indications":"Reversible airways obstruction and acute severe asthma","dosing":"ADULT: 250 mg 2 times daily. \\nCHILD under 12 years : Up to 10 mg/kg body weight 2 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.16","prescriberCat":"B"},{"id":"drug-152","genericName":"Tiotropium 2.5mcg and Olodaterol 2.5mcg inhalation","brandName":"Spiolto","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["inhalation"],"indications":"As a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD)","dosing":"2 puffs once daily, at the same time of the day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"82.00","prescriberCat":"A/KK"},{"id":"drug-153","genericName":"Umeclidinium 62.5mcg & Vilanterol 25mcg Inhalation","brandName":"Anoro","category":"2.0 RESPIRATORY SYSTEM\\n2.1 ANTIASTHMATIC","forms":["Inhalation"],"indications":"Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).","dosing":"One inhalation daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"89.27","prescriberCat":"A*"},{"id":"drug-156","genericName":"Bromhexine HCl 8 mg Tablet","brandName":"Rexom","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Tablet"],"indications":"Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucous secretion and impaired mucous transport. Prescribing restriction(s): Medical Assistant in health settings without Medical Officer is allowed to prescribe this medicine for adult use only.","dosing":"Adult: 8-16 mg three times daily. \\nChildren: \\nBy body weight: 0.3 mg/kg/day 8 hourly for 7 days, then 0.15 mg/kg/day 8 hourly; or \\nBased on age: 6-12 years : 4 mg three times daily;  2-6 years :  2 mg three times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.02","prescriberCat":"B"},{"id":"drug-157","genericName":"Cetirizine HCl 10 mg Tablet","brandName":"Sunizine","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Tablet"],"indications":"Urticaria, allergic dermatoses (insect bites, atopic eczema), perennial rhinitis, allergic rhinitis","dosing":"ADULT and CHILD over 6 years : 10 mg daily or 5 mg twice daily. \\nChild 2-6 years : 5 mg once daily or 2.5 mg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.05","prescriberCat":"B"},{"id":"drug-158","genericName":"Chlorpheniramine Maleate 10 mg/ml Injection","brandName":"Imach","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Injection"],"indications":"Allergic conditions","dosing":"10 - 20 mg IM or SC, repeated if required. Not to exceed 40 mg in 24 hours. \\n10 - 20 mg over 1 minute by slow IV","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.48","prescriberCat":"B"},{"id":"drug-159","genericName":"Chlorpheniramine Maleate 2 mg/5 ml Syrup","brandName":"Alleryl","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Syrup"],"indications":"Symptomatic treatment of allergic conditions responsive to antihistamine","dosing":"CHILD 2 - 5 years : 1 mg every 4 - 6 hours (maximum 6 mg daily) ;  \\n6 - 12 years : 2 mg every 4 - 6 hours (maximum 12 mg daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.70","prescriberCat":"C"},{"id":"drug-160","genericName":"Chlorpheniramine Maleate 4 mg Tablet","brandName":"Antamin","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Tablet"],"indications":"Symptomatic treatment of allergic conditions responsive to antihistamines","dosing":"ADULT : 4 mg every 4 - 6 hours. Maximum 24 mg daily. \\nCHILD : 2 - 5 years : 1 mg every 4 - 6 hours (maximum 6 mg daily) \\n6 - 12 years : 2 mg every 4 - 6 hours (maximum 12 mg daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.03","prescriberCat":"C"},{"id":"drug-161","genericName":"Diphenhydramine HCl 7 mg/5 ml and Ammonium Chloride 67.5 mg/5 ml Expectorant","brandName":"Uphadyl","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Expectorant"],"indications":"Cough","dosing":"ADULT : 5 - 10 ml 2 - 3 times daily. \\nCHILD : 2.5 - 5 ml 2 - 3 times daily (not to be used in children less than 2 years of age)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.48","prescriberCat":"C"},{"id":"drug-162","genericName":"Diphenhydramine HCl 14 mg/5 ml and Ammonium Chloride 135 mg/5 ml Expectorant","brandName":"Nilco","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Expectorant"],"indications":"Cough","dosing":"ADULT : 5 - 10 ml 2 - 3 times daily. \\nCHILD : 2.5 - 5 ml 2 - 3 times daily (not to be used in children less than 2 years of age)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.36","prescriberCat":"C"},{"id":"drug-163","genericName":"Loratadine 1 mg/1 ml Syrup","brandName":"Rhinitin Syrup","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Syrup"],"indications":"Allergic rhinitis, chronic urticaria and other allergic dermatological disorders","dosing":"ADULT and CHILD over 6 years : 10 mg once daily. \\nCHILD 2 - 6 years : 5 mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.10","prescriberCat":"B"},{"id":"drug-164","genericName":"Loratadine 10 mg Tablet","brandName":"Rhinitin","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Tablet"],"indications":"Allergic rhinitis and allergic dermatoses","dosing":"ADULT and CHILD over 6 years : 10 mg once daily.\\nCHILD 2 - 6 years: 5 mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.14","prescriberCat":"B"},{"id":"drug-165","genericName":"Loratadine 5 mg and Pseudoephedrine Sulphate 120 mg Tablet","brandName":"Carinox","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Tablet"],"indications":"For treatment of allergic rhinitis and allergic dermatoses","dosing":"ADULT and CHILD over 12 years :  1 tablet twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, ENT)","price":"0.96","prescriberCat":"A/KK"},{"id":"drug-166","genericName":"Omalizumab 150mg/ml Solution for Injection in Pre-filled Syringe","brandName":"Xolair","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Syringe"],"indications":"HSM Off-label indication: Chronic Spontaneous / Idiopathic Urticaria","dosing":"ADULT: 300mg S/C every 4 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA\\n\\nSpecial Drugs Approval (UKK) required (Dept: Perubatan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru jika ingin menggunakan peruntukan ubat farmasi)","price":"1164.95","prescriberCat":"Pre-filled Syringe Not in FUKKM"},{"id":"drug-167","genericName":"Promethazine HCl 25 mg/ml Injection","brandName":"Promethazine HCl - Fresenius","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Injection"],"indications":"i) Allergic conditions\\nii) Treatment and prevention of vomiting including:\\n- motion sickness\\n- drug induced nausea\\n- prevention and control of nausea and vomiting associated with\\ncertain types of anaesthesia and surgery","dosing":"i) Allergic Conditions\\nAdult and adolescent dose: 25mg intramuscular or intravenous. May be\\nrepeated within 2 hours if required.\\nChildren 2 years and older: intramuscularly-0.125mg/kg body weight every 4\\nto 6 hours OR 0,5mg/kg bodyweight at bedtime as needed OR 6.25-12.5mg\\nthree times a day as needed OR 25mg at bedtime as needed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.15","prescriberCat":"B"},{"id":"drug-169","genericName":"Triprolidine HCl 1.25 mg and Pseudoephedrine HCl 30 mg per 5 ml Syrup","brandName":"Tridin - P","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Syrup"],"indications":"Decongestion of the upper respiratory tract in common cold, hay fever, allergic and vasomotor rhinitis and sinusitis. Doses to be taken twice daily or three times daily","dosing":"ADULT and CHILD more than 12 year : 10 ml.  \\nCHILD 6 - 12 years : 5 ml \\n2 - 5 years : 2.5 ml","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: To remove from formulary)","price":"2.57","prescriberCat":"B"},{"id":"drug-170","genericName":"Triprolidine HCl 2.5 mg and Pseudoephedrine HCl 60 mg Tablet","brandName":"Decondine","category":"2.0 RESPIRATORY SYSTEM\\n2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS","forms":["Tablet"],"indications":"Decongestion of the upper respiratory tract in common cold, hay fever, allergic and vasomotor rhinitis and aerotitis","dosing":"ADULT :  2.5 mg every 4 - 6 hours; maximum dose 10 mg/day. \\nCHILD (syrup) 6 - 12 years : 1.25 mg every 4 - 6 hours; maximum dose 5 mg/day ; \\n4 - 6 years : 0.938 mg every 4 - 6 hours; maximum dose 3.744 mg/day ; \\n2 - 4 years : 0.625 mg every 4 - 6 hours; maximum dose 2.5 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.14","prescriberCat":"B"},{"id":"drug-173","genericName":"Diltiazem HCl 30 mg Tablet","brandName":"Herbesser","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Treatment of angina pectoris in the following cases: \\ni) inadequate response or intolerance to beta-blockers and Isosorbide Dinitrate \\nii) contraindication to beta-blockers\\niii) coronary artery spasm","dosing":"Initially 30mg tds, may increase to 60mg tds (elderly initially twice daily; increased if necessary to 360 mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.20","prescriberCat":"B"},{"id":"drug-174","genericName":"Glyceryl Trinitrate 0.5 mg Tablet","brandName":"Myonit Insta","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Prophylaxis and treatment of angina and left ventricular failure","dosing":"0.5-1 mg sublingually may be repeated every 5 minutes until relief is obtained. \\nSeek physician if the pain persists after a total of 3 tablets in a 15 minutes period.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"31.05","prescriberCat":"C"},{"id":"drug-175","genericName":"Glyceryl Trinitrate 5mg/ml Injection","brandName":"Gitrinil","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Injection"],"indications":"Prescriber Category A:\\ni) Angina pectoris.\\nii) Congestive heart failure.\\niii) Production of controlled hypotension during surgery.\\n\\nPrescriber Category A/KK:\\niv) Control of hypertensive episodes.","dosing":"Initial:\\n5-25mcg/min\\n\\nDosing is individualised and according to product insert or protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"18.15","prescriberCat":"A, A/KK"},{"id":"drug-176","genericName":"Isosorbide Dinitrate 1 mg/ml Injection","brandName":"Isoket","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Injection"],"indications":"Treatment for angina pectoris and left ventricular failure","dosing":"2-10 mg/hour IV infusion after dilution, higher doses up to 20 mg/hour may be required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"19.23","prescriberCat":"A"},{"id":"drug-177","genericName":"Isosorbide Dinitrate 10 mg Tablet","brandName":"Solbid","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Prophylaxis and treatment for: i) Angina","dosing":"i) 30 - 120 mg daily in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.01","prescriberCat":"B"},{"id":"drug-179","genericName":"Isosorbide-5-Mononitrate \\n60 mg SR Tablet","brandName":"Imdex","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Prophylaxis and treatment of angina\\npectoris","dosing":"60mg once daily, increase to 120 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.32","prescriberCat":"A/KK"},{"id":"drug-180","genericName":"Ranolazine 375mg Prolonged Release Tablet","brandName":"Ranexa","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Indicated in adults as add-on therapy for the symptomatic treatment of\\npatients with stable angina pectoris who are inadequately controlled or intolerant\\nto first-line antianginal therapies (such as beta-blockers and/or calcium\\nantagonists)","dosing":"Initial dose: 375mg BD\\nAfter 2-4 weeks, the dose can titrate up to 500mg BD, according to patient's response, further titrated to a maximum dose of 750mg BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required (Dept: Perubatan)","price":"2.87","prescriberCat":"Not in FUKKM"},{"id":"drug-181","genericName":"Trimetazidine 20 mg Tablet","brandName":"Metazine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Prophylactic treatment of episodes of angina pectoris","dosing":"20 mg 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-182","genericName":"Trimetazidine 35mg MR Tablet","brandName":"Vastarel MR","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.1 ANTIANGINAL DRUGS","forms":["Tablet"],"indications":"Prophylactic treatment of episodes of angina pectoris","dosing":"35 mg twice daily in the morning and evening with meals","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.18","prescriberCat":"B"},{"id":"drug-185","genericName":"Acetylsalicylic Acid 100 mg, Glycine 45 mg Tablet","brandName":"Wincardia","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"Prevention of myocardial infarct, stroke, vascular occlusion and deep vein thrombosis. Transient ischaemic attacks","dosing":"1 tablet daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.07","prescriberCat":"B"},{"id":"drug-186","genericName":"Alteplase 50mg/50ml Powder for Injection","brandName":"Actilyse","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Thrombolytic treatment of acute ischaemic stroke.","dosing":"0.9 mg/kg (maximum of 90 mg) infused over 60 minutes with 10% of the total dose administered as an initial intravenous bolus. Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging technique.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2325.82","prescriberCat":"A*"},{"id":"drug-187","genericName":"Clopidogrel 75 mg Tablet","brandName":"Vitraq","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"Secondary prevention of atherothrombotic events in: \\ni) Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. Prescribing restriction: as second/third line treatment in patients who are sensitive or intolerant to acetylsalicylic acid and/or ticlopidine). \\nii) Adult patients suffering from acute coronary syndrome: \\n Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention. \\n ST segment elevation acute myocardial infarction, in combination with acetylsalicylate acid (ASA) in medically treated patients eligible for thrombolytic therapy.","dosing":"75 mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.24","prescriberCat":"A/KK"},{"id":"drug-188","genericName":"Dabigatran Etexilate 110 mg Capsule","brandName":"Pradaxa","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Capsule"],"indications":"i) Prevention of venous thromboembolic events in patients who have undergone total knee replacement or total hip replacement surgery.","dosing":"i) Following total knee replacement: Initially ADULT 110mg (ELDERLY, 75 mg) within 1- 4 hours after surgery, then 220 mg (ELDERLY, 150 mg) once daily thereafter for 6-10 days. \\nFollowing total hip replacement: Initially ADULT 110 mg (ELDERLY, 75 mg) within 1- 4 hours after surgery, then 220 mg (ELDERLY, 150 mg) once daily thereafter for 28-35 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"3.42","prescriberCat":"A*"},{"id":"drug-192","genericName":"Dabigatran Etexilate150 mg \\nCapsule","brandName":"Generic","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["\\nCapsule"],"indications":"i) Reduction of the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF).","dosing":"i) Recommended daily dose is 300mg taken orally as 150mg hard capsule twice daily. \\nTherapy should be continued lifelong.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"","prescriberCat":""},{"id":"drug-194","genericName":"Edoxaban 60mg Film Coated Tablets","brandName":"Lixiana","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablets"],"indications":"Indicated in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, and age  75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA).","dosing":"The recommended dose is 60 mg edoxaban once daily.\\nTherapy with edoxaban in NVAF patients should be continued long term.\\n\\nThe recommended dose is 30 mg once daily in patients with one or more of the following clinical factors:\\n Moderate or severe renal impairment (creatinine clearance (CrCL) 15 - 50 mL/min)\\n Low body weight  60 kg\\n Concomitant use of the following P-glycoprotein (P-gp) inhibitors: ciclosporin, dronedarone, erythromycin, or ketoconazole.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"6.37","prescriberCat":"A*"},{"id":"drug-195","genericName":"Enoxaparin Sodium 40 mg, 60 mg Injection","brandName":"Clexane","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"KATEGORI PRESKRIBER A*:\\ni. Prophylaxis of venous thromboembolic diseases (DVT and PE) especially in perioperative, high risk surgical cases and medical patients with acute illness at increased risk of VTE\\n\\nii. Treatment of venous thromboembolic diseases (DVT and PE).","dosing":"KATEGORI PRESKRIBER A*\\ni. Moderate risk: 20mg SC 2 hours before surgery then 20mg SC once daily\\nHigh risk: 40mg SC 12 hours before surgery then 40mg SC once daily\\nMedical patients: 40mg once daily\\n\\nii. 1.5mg/kg once daily or 1mg/kg twice daily\\n\\niii. 1 mg/kg every 12 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Obstetrik)","price":"19.00, 23.50","prescriberCat":"A*, A/KK"},{"id":"drug-199","genericName":"Factor VIII 250 IU Injection (Biostate), \\n\\nFactor VIII 250 IU with Von Willebrand factor 500 IUInjection (Biostate)\\n\\nFactor VIII 250 IU with Von Willebrand factor 250 IU Injection  (Alphanate)\\n\\nFactor VIII 250 IU with Von Willebrand factor 500 IU Injection  (Alphanate)","brandName":"Biostate\\n\\nAlphanate 250\\n\\nAlphanate 500","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["(Alphanate)"],"indications":"i)The treatment and prophylaxis of haemorrhage or surgical bleeding in Von Willebrand Disease (VWD) when 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) treatment alone is ineffective or contraindicated.","dosing":"i. Von Willebrand Disease: Spontaneous Bleeding Episodes: Initially, factor VIII 12.5-25 IU/kg and ristocetin cofactor 25-50 IU/kg followed by factor VIII 12.5 IU/kg and ristocetin cofactor 25 IU/kg subsequently every 12-24 hrs. \\nMinor Surgery: Factor VIII 30 IU/kg and ristocetin cofactor 60 IU/kg daily. \\nMajor Surgery: Initially, factor VIII 30-40 IU/kg and ristocetin cofactor 60-80 IU/kg followed by factor VIII 15-30 IU/kg and ristocetin cofactor 30-60 IU/kg subsequently every 12-24 hrs. Prophylaxis: Factor VIII 12.5-20 IU/kg and ristocetin cofactor 25-40 IU/kg 3 times weekly.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Biostate with & without VWF obtained FOC from PDN","price":"0  95.70   191.40","prescriberCat":"A*"},{"id":"drug-201","genericName":"Human Prothrombin Complex, Factor IX,II, X in combination 500 IU/vial injection","brandName":"(prothrombinex-VF)","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["injection"],"indications":"i) Treatment and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors caused by Vit.K antagonists\\n\\nii) Treatment and prophylaxis of bleeding in patients with single/multiple congenital deficiencies of factor IX,II or X","dosing":"25-50 IU/kg\\nNote: INR <4.5 may have sufficient factor VII present to permit efficacy with 3 factor PCC","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"kuota (Dept: Pathologi)","price":"0 (FOC from PDN)","prescriberCat":"A*"},{"id":"drug-202","genericName":"Human Prothrombin Complex, Factor IX,II, VII, X in combination 500 IU/vial injection","brandName":"Octaplex","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["injection"],"indications":"i) Treatment and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors caused by Vit.K antagonists\\n\\nii) Treatment and prophylaxis of bleeding in patients with single/multiple congenital deficiencies of factor IX,II,VII Ior X","dosing":"INR<5, 15IU/kg              \\nINR>5, 30IU/kg                  \\nMax 6 vials per dose (usually 4-5 vials/patient)\\nNote: INR >4.5 do not have meaningful factor VII levels, and thus require 4 factor PCC (Octaplex)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n (80 vials a year) (Dept: Blood Bank)","price":"715.00","prescriberCat":"A*"},{"id":"drug-203","genericName":"Factor IX 500 iu Injection","brandName":"AlphaNine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Prevention and control of bleeding \\nin patients with factor IX deficiency due to haemophilia B","dosing":"Number of factor IX units required =\\nbody weight (kg) x desired factor IX increase (%) x 1.0 IU/kg\\nDosing is individualised and according to product insert/protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pediatrik)","price":"464.00","prescriberCat":"A"},{"id":"drug-204","genericName":"Ferric Subsulphate Solution (Monsel's)","brandName":"Monsel solution","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["(Monsel's)"],"indications":"Cervical cautherisation after cervical biopsy post colposcopy","dosing":"Thickened formulation apply directly to biopsy site to stop bleeding","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase\\n(UKK) (Dept: Obstetrik)","price":"302.80","prescriberCat":"Not in FUKKM"},{"id":"drug-205","genericName":"Fondaparinux Sodium 12.5 mg/ml Injection in Prefilled Syringe (7.5MG/0.6ML)","brandName":"Arixtra","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["(7.5MG/0.6ML)"],"indications":"i)Treatment of acute Deep Vein Thrombosis (DVT)\\nii) Treatment of acute Pulmonary Embolism (PE)","dosing":"The recommended dose to be administered by SC injection once daily is: 5mg for body weight less than 50kg, 7.5mg for body weight 50 to 100kg, 10mg for body weight greater than 100kg. Treatment should be continued for at least 5 days and until adequate oral anticoagulation is established (INR 2 to 3). Concomitant treatment with vitamin K antagonists should be initiated as soon as possible, usually within 72 hours. The usual duration of treatment is 5 to 9 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"restriction: For patient weighing >80kg only (Dept: Perubatan)","price":"50.90","prescriberCat":"A*"},{"id":"drug-206","genericName":"Fondaparinux Sodium 2.5 mg/0.5 ml Injection","brandName":"Arixtra","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Prescribing Category A*:\\ni) Prevention of venous thromboembolic events (VTE) in orthopedic surgery (e.g. hip fracture, major knee or hip replacement surgery), abdominal surgery in patients at risk of thromboembolic complication.","dosing":"i) 2.5 mg once daily given by SC, administered 6 hr following surgical closure provided homeostasis has been established. \\nUsual duration of therapy is 5 to 9 days; for hip fracture patients, an extended course of up to 24 days is recommended.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"22.60","prescriberCat":"A*, A"},{"id":"drug-209","genericName":"Heparin 1000 units/ml, 5000 units/ml Injection","brandName":"Heparinol 1000\\n\\nHeparinol 5000\\n\\nUnihepa 5000","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"i) Prophylaxis and treatment of venous thrombosis and pulmonary embolism.","dosing":"i) By IV injection, loading dose of 5000 units (10,000 units in severe pulmonary embolism) followed by continuous infusion of 15-25 units/kg/hr. By SC injection (for DVT) of 15,000 units every 12 hours (laboratory monitoring on daily basis essential to adjust dose). \\nSmall adult or child, lower loading dose then, 15-25 units/kg/hr by IV infusion, or 250 units/kg every 12 hours by SC injection.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.37   10.79    10.79","prescriberCat":"B"},{"id":"drug-212","genericName":"Heparin Sodium 50 units in Sodium Chloride Injection","brandName":"Heparinol","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"To maintain patency of peripheral venous \\ncatheters","dosing":"Flush with 5 ml (50 units) every 4 hours or as required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.51","prescriberCat":"B"},{"id":"drug-213","genericName":"Rivaroxaban 10 mg Tablet","brandName":"Xarelto","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"i. Prevention of venous thromboembolism in patients undergoing elective hip or knee replacement surgery\\nii. Treatment of deep vein thrombosis (DVT), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute DVT in adults\\niii. Treatment of Pulmonary Embolism (PE), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute PE in adults\\n\\nHSM off label use: \\nTreatment and prevention of thrombosis and coronary aneurysm in peadiatric patient","dosing":"Indication i:\\n10 mg once daily. Initial dose should be taken 6 to 10 hour post-surgery provided that haemostasis has been established. Duration of treatment: Major hip surgery 5 weeks. Major knee surgery 2 weeks\\n\\nIndication ii & iii\\n15mg BD for 21 days, followed by 20mg OD\\nDose reduction to 15mg OD for renal impairment (CrCl 15 to 49 ml/min)\\n\\nHSM Off label: \\n12kg -29.9kg 5mg BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) required for off-label indication (Dept: Pediatrik)","price":"6.74","prescriberCat":"A*"},{"id":"drug-214","genericName":"Rivaroxaban 15 mg, 20 mg Tablet","brandName":"Xarelto","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"i)Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as Congestive heart failure (CHF), hypertension, age  75 yrs, diabetes mellitus, prior stroke or transient ischaemic attack.","dosing":"i)20mg once daily or 15mg once daily \\n(for patients with moderate renal impairment \\n(creatinine clearance 30-49 ml/min))","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"6.8, 6.8","prescriberCat":"A*"},{"id":"drug-217","genericName":"Streptokinase 1,500,000 IU Injection","brandName":"Idaman Streptokinase Karma","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Acute myocardial infarction, acute pulmonary embolism","dosing":"Myocardial infarction: 1,500,000 units over 30 - 60 minutes. \\nPulmonary embolism: 250,000 units by IV infusion over 30 minutes, then 100,000 units every hour for up to 12-72 hours with monitoring of clotting factors","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1055.60","prescriberCat":"A*"},{"id":"drug-218","genericName":"Tenecteplase 10,000 unit (50 mg) Injection","brandName":"Metalyse","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Acute myocardial reinfarction where streptokinase is contraindicated due to previous streptokinase induced antibodies. [antibodies were given more than 5 days and less than 12 months]","dosing":"Less than 60 kg: 30 mg, \\n60 - 69 kg: 35 mg, \\n70 - 79 kg: 40 mg; \\n80 -90 kg: 45 mg, \\n90 kg or above: 50 mg. \\nAdminister single IV bolus over 5-10 seconds","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3548.90","prescriberCat":"A*"},{"id":"drug-219","genericName":"Ticagrelor 90 mg Tablet","brandName":"Brilinta","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"a)Patient who failed clopidogrel readmitted to hospital with recurrent atherothrombotic event while patients are on clopidogrel. \\nb) ACS patients with:\\ni) STEMI - going for invasive (PCI), \\nii) NSTEMI/UA - intermediate to high risk (based on TIMI score). \\niii) Other complicated ACS cases treated either medically or invasively via PCI or CABG (risk of Stent thrombosis, 3VD etc.)","dosing":"Initially, 180mg as single dose followed by 90mg bd with maintenance dose of ASA 75-150 mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Ticagrelor 90 mg Tablet IS\\nNOT KEPT AT OPD pharm. INITIATION ONLY BY CARDIOLOGIST AT HRPB. STOCK FROM KWKK HRPB","price":"2.77","prescriberCat":"A*"},{"id":"drug-220","genericName":"Ticlopidine HCl 250 mg Tablet","brandName":"Dynapharm Ticlopidine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"i) Prevention of thrombotic stroke for patients who are sensitive /intolerant to Acetysalicylic Acid ii) Maintenance of coronary bypass surgery or angioplasty \\niii) Maintenance of patency of access in patients on chronic haemodialysis","dosing":"250 mg twice daily taken with food","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.14","prescriberCat":"A/KK"},{"id":"drug-221","genericName":"Tinzaparin 3500, 4500, 14000 anti-Factor Xa IU Injection","brandName":"Innohep","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"i)Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), not amounting to hemodynamic instability.","dosing":"i)Treatment of DVT and PE, in conjunction with warfarin: \\n175 anti-Factor Xa IU/kg SC once daily for at least 6 days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Obstetrik)","price":"13.61, 18.85, 50.58","prescriberCat":"A*"},{"id":"drug-223","genericName":"Tranexamic Acid 250 mg Capsule","brandName":"Transamin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Capsule"],"indications":"Haemorrhage associated with excessive fibrinolysis","dosing":"ADULT: 1-1.5 g (15-25 mg/kg) 2-4 times daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.37","prescriberCat":"B"},{"id":"drug-225","genericName":"Tranexamic Acid 100 mg/ml Injection","brandName":"Bioindustrial IM","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Haemorrhage associated with excessive fibrinolysis","dosing":"ADULT: Slow IV 0.5-1 g (10 - 15 mg/kg) 3 times daily. \\nContinuous infusion at a rate of 25 - 50 mg/kg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.60","prescriberCat":"B"},{"id":"drug-227","genericName":"Urokinase 60,000 IU Injection","brandName":"Urokinase","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Treatment of thromboembolic disease such as mycocardial infarction, peripheral artery occlusion, pulmonary embolism, retinal artery thrombosis and other ophthalmologic use","dosing":"ADULT: Acute pulmonary embolism: IV loading dose 4400 iu/kg over 10 mins, maintenance 4400 iu/kg/hour for 12 hours. \\nPeripheral vascular occlusion: infuse 2500 iu/ml into clot at a rate of 4000 iu/min for 2 hours. This may be repeated up to 4 times. \\nHyphaema: 5000 IU in 2 ml saline solution is injected and withdrawn repeatedly over the iris. If residual clot remains, leave 0.3ml in the anterior chambers for 24-48 hours to facilitate futher dissolution","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase\\n(UKK)","price":"407.65","prescriberCat":"A"},{"id":"drug-228","genericName":"Vitamin K1 1 mg/ml Injection","brandName":"Kisan","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Vitamin K deficiency in neonates","dosing":"Prophylaxis of vitamin K deficiency bleeding in neonates Child: Neonate: 0.5-1 mg, given as a single dose via IM inj. Alternatively, 2 mg may be given orally, followed by a 2nd dose of 2 mg after 4-7 days. \\nIntravenous Vitamin K deficiency bleeding in neonates Child: Infant: 1 mg by IV/IM/SC inj, further doses may be given if necessary","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.39,","prescriberCat":"C+"},{"id":"drug-229","genericName":"Vitamin K1 10 mg/ml Injection","brandName":"Generic","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Injection"],"indications":"Haemorrhage associated with hypoprothrombinaemia caused by overdose of anticoagulants","dosing":"0.5 - 20 mg by very slow IV at a rate not exceeding 1 mg per minute","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.35","prescriberCat":"B"},{"id":"drug-230","genericName":"Warfarin Sodium 1 mg Tablet","brandName":"Apotex","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"Treatment and prophylaxis of thromboembolic disorders","dosing":"Initially 2 to 5mg per day.\\nMaintenance dose 2-10mg daily according to the INR\\n\\nDosing is individualised based on patients INR and according product insert/protocol/ guideline.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.29","prescriberCat":"B"},{"id":"drug-231","genericName":"Warfarin Sodium 2 mg Tablet","brandName":"Apotex","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.30","prescriberCat":""},{"id":"drug-232","genericName":"Warfarin Sodium 5 mg Tablet","brandName":"Apotex","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.2 ANTICOAGULANTS AND HAEMOSTATICS","forms":["Tablet"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.31","prescriberCat":""},{"id":"drug-235","genericName":"Amlodipine 5 mg, 10 mg Tablet","brandName":"Hovasc","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension","dosing":"5 mg once daily. Max: 10 mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.02, 0.03","prescriberCat":"B"},{"id":"drug-236","genericName":"Amlodipine 10 mg and Valsartan 160 mg Tablet","brandName":"Exforge","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Essential hypertension in patients whose blood pressure is not adequately controlled by monotherapy","dosing":"Doses range from amlodipine besylate 5 mg/valsartan 160 mg to amlodipine besylate 10 mg/valsartan 320 mg ORALLY once daily, with dose titration occurring every 1 to 2 weeks if necessary. \\nMAX :  amlodipine besylate 10 mg/valsartan 320 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.84","prescriberCat":"A/KK"},{"id":"drug-237","genericName":"Atenolol 100 mg Tablet","brandName":"Pharmaniaga Atenolol","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension, angina pectoris, myocardial infarction and arrhythmias","dosing":"Hypertension and arrythmias; 50 - 100 mg daily, \\nAngina; 100 mg daily, \\nMyocardial infarction; individualised","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.17","prescriberCat":"B"},{"id":"drug-238","genericName":"Bisoprolol Fumarate 2.5 mg, 5 mg Tablet","brandName":"Bisocor","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Treatment of stable moderate to severe congestive cardiac failure in addition to ACEI's and diuretics","dosing":"1.25 mg once daily to 5 - 10 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.07, 0.10","prescriberCat":"B"},{"id":"drug-239","genericName":"Captopril 25 mg Tablet","brandName":"APUZIN","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"i) Hypertension","dosing":"i) Initially 12.5 mg twice daily. Maintenance: 25-50 mg 2 - 3 times daily, \\nmay be increased to maximum 450 mg/day in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-243","genericName":"Carvedilol 6.25 mg, 25 mg Tablet","brandName":"Vacodil","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Treatment of stable moderate to severe congestive cardiac failure in addition to ACEI's and diuretics","dosing":"3.125 mg twice daily for 2 weeks, then 6.25 mg twice daily for 2 weeks, then 12.5 mg twice daily for 2 weeks then 25 mg twice daily (titrated up to the highest tolerated level). \\nMax: <85 kg: 25 mg bid; >85 kg: 50 mg bid.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.13, 0.15","prescriberCat":"A/KK"},{"id":"drug-244","genericName":"Clonidine HCL 0.025mg Tablet","brandName":"Sandoz Clonidine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"HSM Off-label indication: Status dystonicus\\n\\nRapid opiod detoxification combination use with naltrexone","dosing":"Status dystonicus: 0.1mcg/kg/dose OD up to 2mcg/kg/dose TDS\\n\\nRapid detoxification in 4-5 days (use with naltrexone): 6 mcg/kg ORALLY divided in 3 doses 6 to 8 hours apart the first day, increasing to 11 mcg/kg divided in 3 doses given day two, tapering to 0.6 mcg/kg the third day. Rapid opioid detoxification for 7 days (use with naltrexone): 0.1 to 0.2 mg every 4 hours as needed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required for off-label indication (Dept: Pediatrik)","price":"1.10","prescriberCat":"A"},{"id":"drug-245","genericName":"Diazoxide 50mg Tablet","brandName":"Eudemine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypoglycemia","dosing":"Adult: Initially, 3-5 mg/kg daily in 2 or 3 divided doses. Maintenance: 3-8 mg/kg daily up to 10-15 mg/kg daily in patients w/ refractory hypoglycaemia or insulinoma.\\nChild: Neonates: Initially, 5 mg/kg bid. Maintenance: 1.5-3 mg/kg bid or tid up to 7 mg/kg tid may be required in some cases. 1 mth Initially, 1.7 mg/kg tid. Maintenance: 1.5-3 mg/kg bid or tid up to 5 mg/kg tid may be required in some cases.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import permit required for purchase (UKK) (Dept: Perubatan)","price":"9.16","prescriberCat":"Not in FUKKM"},{"id":"drug-246","genericName":"Enalapril 5 mg, 20 mg Tablet","brandName":"Pharmaniaga Enalapril\\n\\nInvoril","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"i) Hypertension","dosing":"i) Initially 5 mg daily, (ELDERLY 2.5 mg once daily), usual maintenance dose 10 - 20 mg daily. \\nMaximum: 40 mg/day in 1 - 2 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.18,    0.05","prescriberCat":"B"},{"id":"drug-248","genericName":"Esmolol HCl 10 mg/ml Injection","brandName":"Esocard","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Injection"],"indications":"i) Supraventricular tachycardia\\nii) Intraoperative and postoperative tachycardia and/or hypertension","dosing":"i) & ii) 50-200 mcg/kg/min\\n\\nDosing is invidualised and according to product insert/protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Kecemasan)","price":"117.50","prescriberCat":"A*"},{"id":"drug-249","genericName":"Felodipine 5 mg, 10 mg Tablet","brandName":"Plendil","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension","dosing":"Initiate at 5 mg once daily. Usual dose, 5 - 10 mg once daily in the morning","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.24, 0.28","prescriberCat":"A/KK"},{"id":"drug-250","genericName":"Hydralazine HCl 20 mg Injection","brandName":"Ciron Hydralazine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Injection"],"indications":"Hypertensive crisis in pregnancy","dosing":"i) Slow IV injection, ADULT: 5-10 mg diluted with 10ml sodium chloride 0.9%. May be repeated after 20-30 minutes if necessary. \\nii) IV infusion :  200-300 mcg/minutes. Maintenance dose 50-150 mcg/minutes","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"17.64","prescriberCat":"B"},{"id":"drug-251","genericName":"Labetalol HCl 25 mg/5 ml Injection","brandName":"Pharmaniaga Labetalol","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Injection"],"indications":"Hypertension crisis","dosing":"ADULT: 20mg injected slowly for at least 2 min, followed by 40-80mg dose every 10 min, if necessary upto 300 mg. \\nPatient should remain supine during and 3 hr after the procedure.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"8.60","prescriberCat":"B"},{"id":"drug-252","genericName":"Labetalol HCl 100 mg Tablet","brandName":"Trandate","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension (including in pregnancy)","dosing":"ADULT: 100 mg daily with food, increased at intervals of 14 days to usual dose of 200 mg twice daily, up to 800 mg twice daily (3 - 4 divided doses if higher dose). \\nMax: 2.4 g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.80","prescriberCat":"B"},{"id":"drug-253","genericName":"Losartan Potassium 50 mg, 100 mg Tablet","brandName":"Zylovaa","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Patients intolerant of ACE inhibitors, only in the treatment of i) Hypertensive patient with left ventricular hypertrophy ii) Hypertension in diabetics with proteinuria or nephropathy","dosing":"Hypertension: Usual starting and maintenance dose: 50 mg once daily. Maximum increasing the dose to 100 mg once daily. Patients with intravascular volume-depletion starting dose of 25 mg once daily. \\nRenal protection in Type 2 diabetic patients with proteinuria and hypertension, starting dose: 50 mg once daily, may be increased to 100 mg once daily based on blood pressure response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.03, 0.1","prescriberCat":"B"},{"id":"drug-254","genericName":"Losartan Potassium 50 mg and Hydrochlorothiazide 12.5 mg Tablet","brandName":"Lorista","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension in patients who cannot tolerate ACE inhibitors because of cough, hypertensive patient with left ventricular hypertrophy","dosing":"Fixed dose combination is not indicated for initial therapy. \\ni. Usual starting & maintenance dose: 1 tab of losartan & HCTZ 50/12.5 mg once daily. May be increased to 2 tab of losartan & HCTZ 50/12.5 mg or 1 tab of losartan & HCTZ 100/25mg once daily if blood pressure remain uncontrolled after about 3 weeks of combination therapy with losartan & HCTZ 50/12.5mg. Max: 1 tab of losartan & HCTZ 100/25mg once daily or 2 tab of Losartan & HCTZ 50/12.5 mg once daily. \\nii. Usual starting dose: 50 mg losartan once daily, may be titrated with a combination of losartan 50mg & HCTZ 12.5 mg, maybe substituted with losartan 100mg & HCTZ 12.5mg, followed by losartan 100 mg & HCTZ 25 mg once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.17","prescriberCat":"A/KK"},{"id":"drug-255","genericName":"Minoxidil 5 mg Tablet","brandName":"Hirsutin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Severe hypertension","dosing":"ADULTS and CHILD above 12 years old: \\nInitially 5 mg daily in single or divided doses (elderly 2.5 mg). May increase by 5 - 10 mg daily at intervals of 3 or more days until optimum control is achieved. \\nMaximum 50 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"1.22","prescriberCat":"A*"},{"id":"drug-256","genericName":"Methyldopa 250 mg Tablet","brandName":"Pharmaniaga Methyldopa","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension","dosing":"Adult: 250 mg 2 - 3 times daily, gradually increased at intervals of 2 or more days, maximum; 3 g/day. \\nElderly: initially 125 mg twice daily, increased gradually, maximum; 2 g daily. \\nChild: Initially, 10 mg/kg or 300 mg/m2 daily in 2-4 divided doses; increase as necessary. Max: 65 mg/kg, 2 g/m2 or 3 g daily, whichever is least.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.25","prescriberCat":"B"},{"id":"drug-257","genericName":"Metoprolol Tartrate 100 mg Tablet","brandName":"Betawin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension, angina, myocardial infarction, arrhythmias","dosing":"Hypertension: Initially 100 mg to maximum 400 mg daily, \\nAngina: 50 mg - 100 mg in 2 - 3 times daily. \\nMyocardial infarction: 200 mg daily in divided doses. \\nArrythmias: 50 mg - 300 mg in 2 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.18","prescriberCat":"B"},{"id":"drug-258","genericName":"Nebivolol 5 mg Tablet","brandName":"Nebilet","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Acute Myocardial Infarction","dosing":"2.5mg OM (every morning)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Luar FUKKM (KPK) (Dept: Perubatan)","price":"1.10","prescriberCat":"-"},{"id":"drug-259","genericName":"Nicardipine 10mg/10ml Injection","brandName":"Nicardin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Injection"],"indications":"Treatment of hypertensive crisis","dosing":"i) Adult Dose\\n\\nInitial dose\\nTreatment should start with the continuous administration of nicardipine at a rate of 3-5 mg/h for 15 minutes. Rates can be increased by increments of 0.5 or 1 mg every 15 minutes. The infusion rate should not exceed 15 mg/h.\\n\\nMaintenance dose\\nWhen the target pressure is reached, the dose should be reduced progressively, usually to between 2 and 4 mg/h, to maintain the therapeutic efficacy.\\n\\nii) Paediatric Dose\\nNicardipine should only be used for life-threatening hypertension in paediatric intensive care settings or postoperative contexts.\\n\\nInitial dose:\\nIn case of emergency, a starting dose of 0.5 to 5 mcg/kg/min is recommended.\\n\\nMaintenance dose:\\nThe maintenance dosage of 1 to 4mcg/kg/min is recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"48.05","prescriberCat":"A"},{"id":"drug-260","genericName":"Nifedipine 10 mg Tablet","brandName":"Nudipin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension","dosing":"Initial dose of 10 mg twice daily. Usual range :  10 - 30 mg 3 times daily. Maximum: 120 - 180 mg per day. \\nElderly: Dose reduction may be necessary.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-261","genericName":"Perindopril 4 mg, 8 mg Tablet","brandName":"Provinace, Covinace","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"i) Hypertension","dosing":"Initial: 2mg - 4mg once daily\\nMax. 8mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06,  0.13","prescriberCat":"B"},{"id":"drug-264","genericName":"Perindopril 10 mg and Indapamide 2.5 mg Tablet","brandName":"Coversyl Plus","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"As substitution therapy for treatment of essential hypertension, in patients already controlled with perindopril and indapamide given concurrently at the same dose level.","dosing":"One tablet daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.66","prescriberCat":"A/KK"},{"id":"drug-265","genericName":"Perindopril 4 mg and Indapamide 1.25 mg Tablet","brandName":"Coversyl Plus","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Essential hypertension, for patients whose blood pressure is insufficiently controlled by perindopril alone.","dosing":"One tablet daily, preferably taken in the morning and before a meal.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.36","prescriberCat":"B"},{"id":"drug-266","genericName":"Perindopril Arginine 10mg, Indapamide 2.5mg & Amlodipine 10mg tablet","brandName":"Triplixam","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["tablet"],"indications":"As substitution therapy for treatment of essential hypertension, in patients already controlled with perindopril/indapamide fixed dose combination and amlodipine, taken at the same dose level.","dosing":"1 tablet a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"0.64","prescriberCat":"A/KK"},{"id":"drug-267","genericName":"Prazosin HCl 1 mg, 2 mg Tablet","brandName":"Lopresin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension","dosing":"Initially 0.5 mg 2 - 3 times daily, the initial dose on retiring to bed at night; increased to 1 mg 2 - 3 times daily after 3 - 7 days: further increased if necessary to maximum 20 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.14, 0.18","prescriberCat":"B"},{"id":"drug-268","genericName":"Propranolol HCl 40 mg Tablet","brandName":"Corbeta","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"i) Hypertension","dosing":"i) Initially : 80 mg twice daily increased as required to a usual range of 160 - 320 mg daily. \\nCHILD: Initial doses of 1 mg/kg in divided doses, can be increased to 2 - 4 mg/kg/day in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.01","prescriberCat":"B"},{"id":"drug-275","genericName":"Ramipril 5 mg Tablet","brandName":"Ramtace, Apo - Ramipril","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"i) Hypertension and congestive heart failure","dosing":"i) Hypertension: Initially 2.5 mg once daily, increased at intervals of 1 - 2 weeks to maximum 10 mg once daily; \\nCongestive heart failure:Initially 1.25 mg once daily. Max: 10 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.50","prescriberCat":"A"},{"id":"drug-278","genericName":"Sacubitril/ Valsartan 200 mg tablet\\n\\nSacubitril/ Valsartan 100 mg tablet \\n\\nSacubitril/ Valsartan 50 mg Tablet \\n\\n(Entresto)","brandName":"Entresto: 200mg\\n\\nSavagen: 50mg & 100mg","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["\\n\\n(Entresto)"],"indications":"To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure.\\n\\nPrescribing restriction(s): \\ni. For heart failure patients with reduced ejection fraction\\nii. NYHA class II-IV\\niii. Second line for patients intolerant of or not responding to ACEi or ARB.","dosing":"The recommended starting dose of sacubitril/valsartan is one tablet of 100 mg twice daily.\\nThe dose should be doubled at 2-4 weeks to the target dose of one tablet of 200 mg twice daily, as tolerated by the patient.\\n\\nFor the following patients, initiate with sacubitril/valsartan 50 mg twice daily.\\n- Not currently on ACEI/ ARB\\n- Switching from low dose of ACEI/ ARB\\n- In patients with systolic BP 100 to 110 mmHg.\\n- In patients with moderate renal impairment (eGFR 30-60 ml/min/1.73 m2)\\n- In patients with moderate hepatic impairment (Child-Pugh B classification)\\n\\nFor patients \\"Not currently on ACEI/ ARB\\" and \\"switching from low dose of ACEI/ ARB\\", double the dose every 3-4 weeks to achieve the target dose of 200 mg twice daily as tolerated by the patient.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"200mg: 3.80   100mg: 3.23   50mg: 3.13","prescriberCat":"A*"},{"id":"drug-279","genericName":"Telmisartan 40 mg Tablet","brandName":"Teleact","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension in patients who cannot tolerate ACE inhibitors because of cough","dosing":"40mg - 80mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.20","prescriberCat":"A/KK"},{"id":"drug-280","genericName":"Telmisartan 80 mg Tablet","brandName":"Teleact","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"i)Hypertension in patients who cannot tolerate ACE inhibitors because of cough","dosing":"i) 40mg - 80mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.25","prescriberCat":"A/KK"},{"id":"drug-282","genericName":"Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablet","brandName":"Micardis Plus","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Hypertension in patients who cannot tolerate ACE inhibitors because of cough","dosing":"1 tablet daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.22","prescriberCat":"A/KK"},{"id":"drug-283","genericName":"Valsartan 160 mg Tablet","brandName":"Diovan","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.3 ANTIHYPERTENSIVES","forms":["Tablet"],"indications":"Patients who cannot tolerate ACE inhibitors because of cough, in i) Heart failure ii) Post myocardial infarction","dosing":"i) 40 mg twice daily. Uptitration to 80 mg and 160mg twice daily. Max: 320 mg in divided doses.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.54","prescriberCat":"A/KK"},{"id":"drug-287","genericName":"Adenosine 3 mg/ml Injection","brandName":"Adenorhythm","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Rapid conversion of paroxysmal supraventricular tachycardia to sinus rhythm","dosing":"ADULT: Initially: 3 mg given as a rapid IV bolus (over 2 seconds). Second dose: If the first dose does not result in elimination of the supraventricular tachycardia with in 1 or 2 minutes, 6 mg should be given also as a rapid IV bolus. Third dose: If the second dose does not result in elimination of the supraventicular tachycardia with in 1-2 minutes, 12 mg should be given also as a rapid IV bolus","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"14.36","prescriberCat":"B"},{"id":"drug-288","genericName":"Adrenaline Acid (Epinephrine) Tartrate 1 mg/ml Injection","brandName":"Tacarline","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Cardiopulmonary resuscitation","dosing":"1 mg by intravenous injection repeated every 3-5 minutes according to response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.73","prescriberCat":"B"},{"id":"drug-289","genericName":"Alprostadil 500 mcg/ml Injection","brandName":"Prostin VR","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"For treatment of congenital heart diseases which are ductus arteriosus dependent","dosing":"0.05 - 0.1 mcg/kg/min by continuous IV infusion, then decreased to lowest effective dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1795.00","prescriberCat":"A*"},{"id":"drug-290","genericName":"Amiodarone 150 mg/3 ml Injection","brandName":"Bioindustrial Amiodarone","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Category A*:\\ni) Arrhythmias\\nii) Cardiopulmonary resuscitation of shock-resistant ventricular fibrillation in cardiac arrest\\n\\nCategory A/KK:\\nVentricular arrythmia (ventricular tachycardia and ventricular fibrillation)\\nRestriction:\\nUse only for emergency cases in health clinic with Medical Officers (MO) upon consultation with Family Medicine Specialist (FMS)","dosing":"i) Initial: 5mg/kg over 20-120minutes\\nMaintenance: 10-20mg/kg/24hr\\nMax. dose: 1.2g/24hr.\\n\\nii) Initial: 300mg or 5mg/kg rapid\\nAdditional 150mg if condition persists.\\n\\nDosing is according to product insert / protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"6.10","prescriberCat":"A*, A/KK"},{"id":"drug-291","genericName":"Amiodarone 200 mg Tablet","brandName":"Eurythmic","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Tablet"],"indications":"Arrhythmias","dosing":"200 mg 3 times daily for 1 week, then reduced to 200 mg twice daily for another week. Maintenance dose, usually 200 mg daily or the minimum required to control the arrhythmia","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.79","prescriberCat":"A*"},{"id":"drug-292","genericName":"Digoxin 500 mcg/2 ml Injection","brandName":"Lanoxin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Heart failure with atrial fibrillation, supraventricular arrhythmias (particularly atrial fibrillation)","dosing":"Rapid digitilisation: ADULT & CHILD over 10 years, initially 0.75 - 1.5 mg, followed by 250 mcg 6 hourly until digitilisation is complete","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"13.75","prescriberCat":"A"},{"id":"drug-293","genericName":"Digoxin 0.25 mg Tablet","brandName":"Lanoxin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Tablet"],"indications":"Heart failure , with atrial fibrillation, supraventricular arrhythmias (particularly, atrial fibrillation)","dosing":"Rapid digitalisation: 0.75 -1.5 mg in divided doses over 24 hours; \\nless urgent digitalisation, 250 mcg-500 mcg daily (higher dose may be divided). \\nMaintenance : 62.5mg -500 mcg daily (higher dose may be divided) according to renal function and , in atrial fibrillation, on heart rate response; usual range, 125-250 mcg daily (lower dose may be appropriate in elderly)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.14","prescriberCat":"B"},{"id":"drug-294","genericName":"Dobutamine HCl 250 mg/20 ml Injection","brandName":"Mobitil","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Hypotension and heart failure","dosing":"Initial : 0.5-1 mcg/kg/min by IV, maintenance : 2.5-10mcg/kg/min. \\nFrequently,doses up to 20mcg/kg/min are required for adequate hemodynamic improvement. On rare occasions,infusion rates up to 40mcg/kg/min","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.59","prescriberCat":"A"},{"id":"drug-295","genericName":"Dopamine HCl 40 mg/ml Injection","brandName":"Loxin","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Non-hypovolemic hypotension","dosing":"Initial dose 2-5 mcg/kg/min with incremental changes of 5-10 mcg/kg/min at 10-15 minutes intervals until adequate response is noted. Most patients are maintained at less than 20 mcg/kg/min. If dosage exceeds 50mcg/kg/min, assess renal function frequently","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.48","prescriberCat":"B"},{"id":"drug-296","genericName":"Epinephrine Auto-Injector 0.3 mg Injection","brandName":"Epinephrine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Anaphylactic shock","dosing":"0.3mg PRN","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import permit required for purchase (UKK) (Dept: Perubatan)","price":"318.65","prescriberCat":"Not in FUKKM"},{"id":"drug-297","genericName":"Ephedrine HCl 30 mg/ml Injection","brandName":"Ephedrine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Treatment of bronchial spasm in asthma, adjunct to correct haemodynamic imbalances and treat hypotension in epidural and spinal anaesthesia","dosing":"By IM, SC or IV. Severe, acute bronchospasm : 12.5-25 mg. Further dosage should be determine by patient response. \\nWhen used as a pressor agent : ADULT 25 - 50 mg SC/IM. If necessary, a second IM dose of 50 mg or an IV dose of 25 mg may be given. Direct IV injection, 10 - 25 mg may be given slowly. \\nMaximum parenteral ADULT dose : 150 mg in 24 hours. \\nCHILD : 3 mg/kg or 100 mg/m2 SC or IV daily, in 4 - 6 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.99","prescriberCat":"B"},{"id":"drug-298","genericName":"Ibuprofen 100 mg/5 ml Syrup","brandName":"Ibupen","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Syrup"],"indications":"Pain and inflammation in rheumatic disease","dosing":"Dosage: ADULT : 200 - 400 mg 3 times daily after food, maximum 3.2 g daily. \\nCHILD : 30-50 mg/kg body weight daily in divided doses, maximum 2.4g daily. \\nLowest effective dose for the shortest possible duration.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(KPK) (Dept: Pediatrik)","price":"1.50","prescriberCat":"-"},{"id":"drug-299","genericName":"Isoprenaline HCl 0.2mg/ml Injection","brandName":"ISOLIN","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Complete heart block (third-degree artrioventricular block) not responding to atropine, while waiting for cardiac pacing","dosing":"If given as IM: Initially 0.2 mg (1 ml of 1:5000 solution), followed by 0.02-1 mg depending on clinical response. \\nIf given as SC: 0.2 mg (1 ml of 1:5000 solution), followed by 0.15-0.2 mg depending on clinical response. \\nIf given as IV : 1-2 mg in 500 ml of dextrose 5%, infused at a rate of 0.5-2 ml/min while the patient's EKG is being monitored. The dose should be titrated to produce the desired clinical response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK)","price":"11.29","prescriberCat":"B"},{"id":"drug-300","genericName":"Ivabradine 5 mg, 7.5 mg Tablet","brandName":"Coralan","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Tablet"],"indications":"i) Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate  70 bpm. Ivabradine is indicated: - in adults unable to tolerate or with a contraindication to the use of beta-blockers - or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose. \\nii) Treatment of chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is  75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.","dosing":"Initial dose 5 mg twice daily. May increase dose after 3-4 weeks to 7.5 mg twice daily depending on response. \\nELDERLY : initial dose 2.5 mg twice daily and titrate to a maximum of 7.5 mg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"2.39, 2.39","prescriberCat":"A*"},{"id":"drug-301","genericName":"Lignocaine HCl (Lidocaine) 100 mg/5 ml, 500 mg/5 ml Injection","brandName":"INJECSOL","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Ventricular tachycardia and ventricullar fibrillation. To be diluted before use","dosing":"50-100 mg IV as a bolus, repeated after 5 minutes if necessary. \\nMaintenance : 1-4 mg/min by IV infusion under ECG monitoring","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.50, 1.40","prescriberCat":"B"},{"id":"drug-302","genericName":"Noradrenaline Acid Tartrate (Norepinephrine Bitartrate) 4 mg/4 ml Injection","brandName":"Cardiamed","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Category A:\\ni) For blood pressure control in certain acute hypotensive states (e.g.pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions).\\nii) As an adjunct in the treatment of cardiac arrest and profound hypotension\\n\\nCategory A/KK:\\nSeptic shock and shock where peripheral vascular resistance is low\\nRestrictions\\nUse only for emergency cases in health clinic with Medical Officers (MO) upon consultation with Family Medicine Specialist (FMS)","dosing":"Infuse and titrate to desired pressure response. \\nRange: 0.05 - 0.5 mcg/kg/minute","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.50","prescriberCat":"A, A/KK"},{"id":"drug-303","genericName":"Phenylephrine 10 mg/ml Injection","brandName":"ZYPHRIN","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Treatment of hypotensive episode post \\nspinal anaesthesia","dosing":"Initial dose: 100-180 mcg/min \\nwhen BP stabilized, Maintenance dose: 40-60 mcg/min","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UKK by bulk (Dept: Bius)","price":"6.00","prescriberCat":"Not in FUKKM"},{"id":"drug-304","genericName":"Verapamil HCl 5 mg/2 ml Injection","brandName":"Ratiopharm","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Injection"],"indications":"Supraventricular tachycardia","dosing":"Initially 5-10mg given by slow IV over at least 2 minutes. \\nThe dose can be repeated 10mg 30 minutes after the first dose if the initial response is not adequate.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase (UKK)","price":"10.46","prescriberCat":"A/KK"},{"id":"drug-305","genericName":"Verapamil HCl 40 mg Tablet","brandName":"Akilen 4","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.4 CARDIAC DRUGS","forms":["Tablet"],"indications":"i) Supraventricular tachyarrhythmias (SVT) prophylaxis ii) angina","dosing":"ADULT: 40 - 80 mg 3-4 times daily. In oral long term therapy, max: 480 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.26","prescriberCat":"B"},{"id":"drug-308","genericName":"Betahistine Dihydrochloride 24 mg Tablet","brandName":"Betanor","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["Tablet"],"indications":"i) Meniere's Syndrome as defined by the following core symptoms:\\n- Vertigo (with nausea/vomiting).\\n- Hearing loss (Hardness of hearing).\\n- Tinnitus (ringing in the ears)\\n\\nii) Symptomatic treatment of vestibular vertigo","dosing":"24-48mg in divided doses daily\\n\\nPrescribing Restriction\\n(Hanya terpakai untuk fasiliti kesihatan primer)\\nShort term (max. 2 months) treatment with Betahistine can be initiated by Family Medicine Specialist (FMS) for patients with Menieres syndrome and vestibular vertigo, pending referral/ evaluation by the Otorhinolaryngology team.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan,\\nENT)","price":"0.18","prescriberCat":"A/KK"},{"id":"drug-309","genericName":"Cinnarizine 25 mg Tablet","brandName":"Cinnarizine","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["Tablet"],"indications":"Vestibular disorders","dosing":"Adult: One tablet 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-310","genericName":"Pentoxifylline 400 mg Tablet","brandName":"Trenlin SR","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["Tablet"],"indications":"Peripheral vascular disease","dosing":"400 mg 2 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.89","prescriberCat":"A/KK"},{"id":"drug-311","genericName":"Piracetam 1.2 gm Tablet","brandName":"Nootropil, Ceretam","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["Tablet"],"indications":"Mild cognitive impairment, post concussional head syndrome, head injury disorder, chronic vertigo and myoclonus","dosing":"Initially 7.2 g daily in 2 - 3 divided doses, increased according to response by 4.8 g daily every 3 - 4 days to maximum of 20 g daily. \\nCHILD under 16 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.00, 0.65","prescriberCat":"A*"},{"id":"drug-312","genericName":"Piracetam 20% Solution  (1gm / 5ml)","brandName":"Ceretam","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["5ml)"],"indications":"Children with learning disability, progressive myoclonic epilepsy and hypoxia","dosing":"30 - 160 mg/kg/day orally. To be given 2 times daily or 3 - 4 times daily. Maximum 24 g/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota","price":"34.18","prescriberCat":"A*"},{"id":"drug-313","genericName":"Riluzole 50mg tablet","brandName":"Rilutek","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["tablet"],"indications":"Motor Neuron Disease / Amyotrophic lateral sclerosis","dosing":"50 mg bid. Discontinue if ALT levels increase to 5 times the upper limit of normal (ULN).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required (Dept: Perubatan)","price":"28.86","prescriberCat":"Not in FUKKM"},{"id":"drug-314","genericName":"Sildenafil Citrate 50mg tablet","brandName":"Iqnyde","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.5 VASODILATORS AND CEREBRAL ACTIVATORS","forms":["tablet"],"indications":"Off-label indication: \\ni) Adjunct treatment of pulmonary hypertension of newborn (UKK bulk basis)\\n\\nii) Raynaud's phenomenon (UKK patient basis)","dosing":"i) 0.5 -2 mg/kg QID\\n\\nii) Raynaud's phenomenon: 50mg BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required (Dept: Perubatan)","price":"1.25","prescriberCat":"50mg\\n Not in FUKKM"},{"id":"drug-317","genericName":"Flunarizine HCl 5 mg Capsule","brandName":"Fluden","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.6 VASOCONSTRICTORS AND ANTIMIGRAINE DRUGS","forms":["Capsule"],"indications":"i) Migraine prophylaxis","dosing":"i) ADULT: 5 - 10 mg daily preferably at night. ELDERLY more than 65 years: 5 mg at night. Maintenance 5-day treatment at the same daily dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.51","prescriberCat":"B"},{"id":"drug-319","genericName":"Pizotifen 0.5 mg Tablet","brandName":"Pizogran","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.6 VASOCONSTRICTORS AND ANTIMIGRAINE DRUGS","forms":["Tablet"],"indications":"Prophylactic treatment of vascular headache","dosing":"Starting with 0.5mg daily, the dosage should be progressively increased. The average maintenance dosage is 1.5mg daily in divided doses or as a single dose at night. Max dose: 4.5 mg/day and 3 mg/dose. Child: >2 yr: Up to 1.5 mg daily in divided doses. Max dose: 1 mg/dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.88","prescriberCat":"B"},{"id":"drug-320","genericName":"Sumatriptan 50 mg Tablet","brandName":"Striptan","category":"3.0 CARDIOVASCULAR SYSTEM\\n3.6 VASOCONSTRICTORS AND ANTIMIGRAINE DRUGS","forms":["Tablet"],"indications":"Treatment of acute migraine attacks","dosing":"50 mg per attack and not more than 300 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.33","prescriberCat":"A/KK"},{"id":"drug-323","genericName":"Amiloride HCl 5 mg & Hydrochlorothiazide 50 mg Tablet","brandName":"Moduride","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Tablet"],"indications":"i) Diuretic as an adjunct to the management of oedematous states","dosing":"i) Initially 1 - 2 tab daily adjusted according to response. Max : 4 tabs daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.11","prescriberCat":"B"},{"id":"drug-325","genericName":"Bumetanide 0.5mg/ml Injection","brandName":"Burinex","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Injection"],"indications":"Oedema used in furosemide allergic patient","dosing":"IV injection: 1 - 2 mg repeated after 20 mins. \\nIV infusion: 2 - 5 mg over 30 - 60 mins","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"20.45","prescriberCat":"A*"},{"id":"drug-326","genericName":"Bumetanide 1mg Tablet","brandName":"Burinex","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Tablet"],"indications":"Oedema used in furosemide allergic patient","dosing":"1 mg in the early evening.\\nMax: 10mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"7.98","prescriberCat":"A*"},{"id":"drug-327","genericName":"Eplerenone 50mg tablet","brandName":"Inspra","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["tablet"],"indications":"Reduce risk of CV mortality & morbidity \\nin stable patients w/ left ventricular \\ndysfunction & clinical evidence of heart failure after recent MI.","dosing":"Initially 25 mg once daily & titrate to target dose of 50 mg once daily preferably w/in 4 wk.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special drugs approval (UKK) required (Dept: Perubatan)","price":"4.93","prescriberCat":"Not in FUKKM"},{"id":"drug-328","genericName":"Finerenone 10mg & 20mg Tablet","brandName":"Firialta","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Tablet"],"indications":"To reduce the risk of sustained eGFR decline, end-stage kidney disease,\\ncardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in\\nadult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","dosing":"Recommended target dose is 20 mg once daily\\n\\nMeasure estimated glomerular filtration rate (eGFR) to determine the starting dose:\\n- 20 mg once daily if eGFR  60 mL/min/1.73 m2\\n- 10 mg once daily if eGFR  25 to < 60 mL/min/1.73 m2","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special drugs approval (UKK) required (Dept: Perubatan)","price":"10mg: 5.70  20mg: 6.81","prescriberCat":"Not in FUKKM"},{"id":"drug-329","genericName":"Furosemide 20 mg/2 ml Injection","brandName":"Furosemide","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Injection"],"indications":"Pulmonary oedema","dosing":"Initially 20 -40 mg IM or slow IV (rate not exceeding 4 mg/min). CHILD: 0.5 - 1.5 mg/kg. Max: 20 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.81","prescriberCat":"B"},{"id":"drug-330","genericName":"Furosemide 40 mg Tablet","brandName":"Frusemide","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Tablet"],"indications":"Pulmonary oedema","dosing":"ADULT: Initial 40 - 80 mg on morning if required, can be increased to a max of 1 g/day in certain cases especially in chronic renal failure. CHILD : 1 - 3 mg/kg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.05","prescriberCat":"B"},{"id":"drug-331","genericName":"Furosemide 10mg/ml oral solution","brandName":"Vusimide","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["solution"],"indications":"Pulmonary oedema","dosing":"ADULT: The usual initial oral dose is 40mg once daily, adjusted as necessary according to response. \\nMild cases may respond to 20mg daily or 40mg on alternate days. Some patients may need doses of 80mg or more daily given as one or two doses daily; or intermittently. \\nSevere cases may require gradual titration of the frusemide dosage up to 600mg daily. \\nChildren: The usual dose is 1 to 3mg/kg daily up to a maximum dose of 40mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"69.05","prescriberCat":"B"},{"id":"drug-332","genericName":"Hydrochlorothiazide 25 mg, 50 mg Tablet","brandName":"Apo - hydrochlorothiazide","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Tablet"],"indications":"Diuretic, hypertension","dosing":"ADULT: Diuretics; 25-200 mg daily. Hypertension ; 12.5-25 mg daily. \\nCHILD: Oedema and hypertension; Adjunct; 1 to 2 mg/kg ORALLY daily in single or two divided doses; \\nChildren 2-12 years old MAX dose, not to exceed 100 mg ORALLY daily; \\nInfants less than 6 months old, may require doses up to 3 mg/kg ORALLY daily in two divided doses, \\nInfants up to 2 yrs old: MAX dose, not to exceed 37.5 mg ORALLY daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Only 50mg available","price":"0.13, 0.15","prescriberCat":"B"},{"id":"drug-333","genericName":"Metolazone 5mg tablet","brandName":"Zaroxolyn","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["tablet"],"indications":"i) Oedema associated with heart failure or renal disease\\n\\nii) Hypertension","dosing":"i) Adult: For cases associated with heart failure or renal diseases (e.g. nephrotic syndrome): Slow and incompletely bioavailable formulation: 5-10 mg daily. Doses may be increased to 20 mg daily if necessary. Max: 80 mg daily. Dosage must be individualised according to the severity of condition and patient response.\\n\\nii) Adult: Alone or in combination with other antihypertensives: Slow and incompletely bioavailable formulation: 2.5-5 mg daily; alternatively, initial dose of 1.25 mg daily may be given. Dosage must be individualised and may be adjusted after 3-4 weeks according to response. Maintenance: 5 mg on alternate days. Rapidly absorbed and completely bioavailable formulation: Initially, 0.5 mg once daily, may be increased to 1 mg once daily if necessary.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import permit required for purchase (UKK) (Dept: Perubatan)","price":"1.12","prescriberCat":"5mg Not in FUKKM"},{"id":"drug-334","genericName":"Spironolactone 25 mg Tablet","brandName":"Spiro","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.1 DIURETICS","forms":["Tablet"],"indications":"Oedema and ascites in cirrhosis of the liver, congestive heart failure","dosing":"ADULT: 100 - 200 mg daily in divided doses. Increase to 400 mg if required. \\nCHILD: initially 3 mg/kg daily in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.16","prescriberCat":"B"},{"id":"drug-337","genericName":"Desmopressin Acetate 4 mcg/ml Injection","brandName":"Minirin","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.2 ANTIDIURETICS","forms":["Injection"],"indications":"Diabetes insipidus","dosing":"ADULT : 1 - 4 mcg IV daily. \\nCHILD :0.4 mcg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"50.80","prescriberCat":"A"},{"id":"drug-338","genericName":"Desmopressin 100 mcg/ml Nasal Spray","brandName":"Minirin","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.2 ANTIDIURETICS","forms":["Spray"],"indications":"i) Diabetes Insipidus","dosing":"i) ADULT : 10 - 20 mcg 1-2 times daily. \\nCHILD: 5 - 10mcg 1-2 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"114.84","prescriberCat":"A"},{"id":"drug-340","genericName":"Desmopressin 120mcg Sublingual Tablet","brandName":"Minirin","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.2 ANTIDIURETICS","forms":["Tablet"],"indications":"i)Central diabetes insipidus \\nii)Primary nocturnal enuresis \\niii)Treatment of nocturia associated with nocturnal polyuria in adult","dosing":"i) 60mcg 3 times daily sublingually (daily dose range from 120mcg to 720mcg)\\nii) 120mcg once daily at bedtime, sublingually (maximum dose 240mcg)\\niii) 60mcg once daily at bedtime (dose range from 120mcg to 240mcg)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, pembedahan)","price":"7.05","prescriberCat":"A"},{"id":"drug-341","genericName":"Vasopressin 20 units/ml Injection","brandName":"Hanlim Vasopressin","category":"4.0 DIURETICS AND ANTIDIURETICS\\n4.2 ANTIDIURETICS","forms":["Injection"],"indications":"i) Pituitary diabetes insipidus \\nii) Oesophageal variceal bleeding","dosing":"i) 5 - 20 units SC or IM every 4 hours \\nii) 20 units in 100 - 200 ml 5% dextrose saline over 15 minutes as infusion which may be repeated after at intervals of 1 - 2 hours. Maximum: 4 doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"17.70","prescriberCat":"A"},{"id":"drug-344","genericName":"Prolase Tablet","brandName":"Prozyme","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.1 ANTIINFLAMMATORY ENZYMES","forms":["Tablet"],"indications":"Oedema and inflammation in conjunction with other physical or chemotherapeutic measures","dosing":"2 tablet 4 times daily for the first day, then 1 tablet 4 times daily for at least 5 days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.04","prescriberCat":"B"},{"id":"drug-347","genericName":"Acetylsalicylic Acid 150mg, 300 mg Soluble Tablet","brandName":"Winsiprin\\n150mg\\n\\n300mg","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["Tablet"],"indications":"Initial treatment of cardiovascular disorders such as angina pectoris and myocardial infection and for the prevention of cardiovascular events in patients at risk. Other such uses include the treatment and prevention of cerebrovascular disorders such as stroke.","dosing":"150mg to be taken daily. \\nUse in children under 16 years old is not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Jul 2025: Switching to 150mg after finishing 300mg stock","price":"0.14  0.30","prescriberCat":"C"},{"id":"drug-348","genericName":"Ibuprofen 200 mg Tablet","brandName":"Royce Ibuprofen","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["Tablet"],"indications":"Pain and inflammation in rheumatic disease","dosing":"Dosage: ADULT : 200 - 400 mg 3 times daily after food, maximum 3.2 g daily. \\nCHILD : 30-50 mg/kg body weight daily in divided doses, maximum 2.4g daily. \\nLowest effective dose for the shortest possible duration.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.09","prescriberCat":"B"},{"id":"drug-349","genericName":"Paracetamol 10 mg/ml in 100 mL solution for IV infusion","brandName":"Paracetamol Kabi","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["infusion"],"indications":"Mild to moderate pain and pyrexia","dosing":"Body Weight (BW) = 10kg: 7.5mg/kg, max: 30mg/kg \\nBW >10kg to = 33kg: 15mg/kg, max 60mg/kg not exceeding 2g \\nBW >33kg to = 50kg: 15mg/kg, max 60mg/kg not exceeding 3g \\nBW >50kg (with risk of hepatotoxicity): 1g, max 3g \\nBW >50kg (without risk of hepatotoxicity): 1g, max 4g OR as in the product leaflet","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.44","prescriberCat":"A"},{"id":"drug-350","genericName":"Paracetamol 125 mg, 250 mg Suppository","brandName":"Poro","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["Suppository"],"indications":"Symptomatic relief of fever and post operative pain whom cannot tolerate oral preparations.","dosing":"ADULT & CHILDREN more than 12 years old: 500mg - 1g every 4-6 hours. \\nCHILD 6 - 12 years : 250 - 500 mg; \\n1 - 5 years : 125 - 250 mg; \\n3 - 11 months : 80 mg inserted every 4 - 6 hours if necessary, maximum 4 doses in 24 hours. \\nINFANTS under 3 months should not be given Paracetamol unless advised by doctor; a dose of 10 mg/kg (5 mg/kg if jaundiced) is suitable.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.28,0.36","prescriberCat":"C+,B"},{"id":"drug-351","genericName":"Paracetamol 250 mg/5 ml \\nSyrup","brandName":"Fepril","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["\\nSyrup"],"indications":"Mild to moderate pain and pyrexia","dosing":"CHILD: up to 1 year: 60 - 120 mg. \\n1 - 5 years: 120 - 240 mg. \\n6 - 12 years: 240 - 480 mg per dose. \\nRepeat every 4 - 6 hours when necessary. \\nMaximum of 4 doses in 24 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.48","prescriberCat":"C+"},{"id":"drug-352","genericName":"Paracetamol 500 mg Tablet","brandName":"Uphamol, Paracil","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["Tablet"],"indications":"Mild to moderate pain and pyrexia","dosing":"ADULT: 500 - 1000 mg every 4 - 6 hours, maximum of 4 g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.05","prescriberCat":"C+"},{"id":"drug-353","genericName":"Sucrose 24 % Oral Liquid in 2ml single use amp/vial","brandName":"Phebra","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.2 ANTIPYRETICS & ANALGESICS","forms":["amp/vial"],"indications":"Use as pain relief for painful procedure in neonatal age group (<28 days of life)","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Pediatrik)","price":"6.00","prescriberCat":"Not in FUKKM"},{"id":"drug-356","genericName":"Celecoxib 200 mg Capsule","brandName":"Hovid","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Capsule"],"indications":"i) Osteoarthritis \\nii) Rheumatoid Arthritis \\niii) Acute pain \\niv) Ankylosing Spondylitis","dosing":"i) ADULTS: 200 mg once daily. May increase to 200 mg bid, if necessary. CHILD not recommended \\nii) 100mg twice daily, increased if necessary to 200 mg 2 times daily; CHILD not recommended \\niii) 400mg as a single dose on first day followed by 200mg once daily on subsequent days \\niv) Initial, 200 mg once daily or 100 mg twice daily; if no effect after 6 weeks, may increase to max. 400 mg daily in 1-2 divided doses. If no response following 2 weeks of treatment with 400 mg/day, consider discontinuation and alternative treatment","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.55","prescriberCat":"A"},{"id":"drug-357","genericName":"Diclofenac 1% Emulgel","brandName":"Dicloran","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Emulgel"],"indications":"Post-traumatic inflammation of the tendons,ligaments & joints. Localised forms of soft tissue rheumatism and degenerative rheumatism","dosing":"Apply 3 - 4 times daily and gently rubbed in","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.10","prescriberCat":"A"},{"id":"drug-358","genericName":"Diclofenac Sodium 75 mg/3 ml Injection","brandName":"Dicloran","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Injection"],"indications":"Pain and inflammation in rheumatic disease and of non-rheumatic origin","dosing":"IM 75 mg once daily (2 times daily in severe cases) for not more than 2 days. Max : 150mg/day. \\nNot suitable for children.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.42","prescriberCat":"A/KK"},{"id":"drug-359","genericName":"Diclofenac Sodium 12.5mg,\\n25 mg Suppository","brandName":"Voren","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Suppository"],"indications":"Pain and inflammation in rheumatic disease and juvenile arthritis","dosing":"ADULTS: 75 - 150 mg daily in divided doses. Maximum 150mg/day. \\nCHILD 1-12 years : 12.5- 25 mg daily\\nPAEDS more than 6 months : 1 - 3 mg/kg body weight daily in divided doses. Maximum 3mg/kg/day (Max 150mg/day).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.66","prescriberCat":"A"},{"id":"drug-360","genericName":"Diclofenac Sodium 50 mg Tablet","brandName":"Dicloran","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"Pain and inflammation in rheumatic disease and of non-rheumatic origin","dosing":"ADULTS: Initial dose of 150 mg daily. Mild or long term: 75 - 150 mg daily in 2 to 3 divided doses after food. Maximum : 200mg/day. \\nPAEDS more than 6 months : 1 - 3 mg/kg body weight daily in divided doses. Maximum : 3mg/kg/day (Max 150mg/day).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.03","prescriberCat":"B"},{"id":"drug-361","genericName":"Dihydrocodeine Tartrate 30 mg Tablet","brandName":"P.P. Dihydrocodeine, Dicodine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"For the control of moderate to severe chronic pain","dosing":"ADULT: 30 - 60 mg every 4 - 6 hours. \\nPAED, over 4 yrs: 0.5 - 1 mg/kg body weight every 4-6 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.29","prescriberCat":"B"},{"id":"drug-362","genericName":"Etoricoxib 90 mg Tablet","brandName":"Arcoxia","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"i)Acute and chronic treatment of signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) \\n\\nii)Acute gouty arthritis iii)Acute pain","dosing":"i) OA: 60 mg once daily. RA: 60mg once daily and may be increased to 90mg once daily if needed.Once the patient is stabilized, down-titration to 60mg once daily may be appropriate. \\n\\nii & iii) Acute gouty arthritis and acute pain: 120 mg once daily (Given the exposure to COX-2 inhibitors, doctors are advised to use the lowest effective dose for the shortest possible duration of treatment)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Ortopedik)","price":"1.81","prescriberCat":"A/KK"},{"id":"drug-363","genericName":"Glucosamine Sulfate 500mg Capsule","brandName":"AVM-Artrisa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Capsule"],"indications":"Adjuvant treatment of osteoarthritis","dosing":"1500 mg once daily, as a single dose or in 2-3 divided doses.\\n\\n*For 3-6 months duration only, for patient to self purchase after that  [Pekeliling Pengawalan Penggunaan Glucosamine di fasiliti KKM]","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"PESARA ONLY (Dept: Ortopedik, Rheumatologi)","price":"0.32","prescriberCat":"Not in FUKKM"},{"id":"drug-364","genericName":"Hydroxychloroquine Sulphate 200 mg Tablet","brandName":"Plaquenil , Uniquin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"i) SLE and mixed connective tissue disease for skin, joint and serosa \\n\\nii) Second line therapy for acute rheumatoid arthritis","dosing":"i) Initially 400 mg daily in divided dose. Maintenance : 200 - 400 mg daily \\n\\nii) ADULT : 400 - 600 mg daily. Maintenance: 200 - 400 mg daily. \\nCHILD : up to 6.5 mg/kg daily (maximum 400mg daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.47, 0.43","prescriberCat":"A"},{"id":"drug-365","genericName":"Ketoprofen 2.5% Gel","brandName":"Ketofen gel","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Gel"],"indications":"Local treatment of osteoarticular & muscular painful disorders of rheumatic or\\ntraumatic origin: Contusions, distortions, muscle strains, stiff neck, lumbago.","dosing":"Apply onto affected areas 2-4 times daily up to 10 days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Ortopedik)","price":"0.12","prescriberCat":"A/KK"},{"id":"drug-366","genericName":"Ketoprofen 30 mg Transdermal Plaster","brandName":"Ketotop","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Plaster"],"indications":"Treatment of signs & symptoms of arthritis deformans, periarthritis humero-scapularis, tendinitis, peritendinitis, sore muscle, swelling, pain resulting from trauma (eg. contusion, distorsion, sprain).","dosing":"Apply 1 plaster to the affected area twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Ortopedik)","price":"0.84","prescriberCat":"A"},{"id":"drug-367","genericName":"Ketorolac Tromethamine 30 mg/ml Injection","brandName":"Keto","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Injection"],"indications":"Short term management of moderate to severe postoperative pain","dosing":"ADULT : 60mg as a single dose via IM inj or 30mg as a single IV dose. \\nAlternatively, 30mg every 6 hr via IM or IV admin up to a max of 120mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Bius)","price":"10.99","prescriberCat":"A*"},{"id":"drug-368","genericName":"Leflunomide 10mg, 20 mg Tablet","brandName":"Arava 10\\nArava 20","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"i) Persistent active rheumatoid arthritis \\nii) Active psoriatic arthritis","dosing":"Loading dose: 100 mg once daily for 3 days. \\nMaintenance: 10-20 mg once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota:10mg (Dept: Perubatan\\nRheumatology)","price":"8.67 12.63","prescriberCat":"A*"},{"id":"drug-369","genericName":"Mefenamic Acid 250 mg Capsule","brandName":"Pontacid, Pharmaniaga Mefenamic, Mefa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Capsule"],"indications":"Mild to moderate pain","dosing":"ADULT: 250 - 500 mg 3 times daily after meals. \\nCHILD over 6 months: 6.5 - 25 mg/kg daily 3 - 4 times daily for not longer than 7 days except in juvenile arthritis","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.15","prescriberCat":"B"},{"id":"drug-370","genericName":"Meloxicam 7.5 mg Tablet","brandName":"Aroxicam","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"Only for patients not responding to other NSAIDs in the treatment of i) painful osteoarthritis ii) rheumatoid arthritis","dosing":"i) initially 7.5 mg daily. May be increased to 15 mg daily \\nii) initially 15 mg daily. May be reduced to 7.5 mg daily. Maximum 15 mg daily. \\nChild under 12 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.11","prescriberCat":"A/KK"},{"id":"drug-371","genericName":"Mesalazine MR 500 mg Tablet (Pentasa),\\nMesalazine 500mg Tablet (Salofalk)","brandName":"Pentasa, \\nSalofalk","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["(Salofalk)"],"indications":"Inflammatory bowel disease of ulcerative colitis and Crohn's disease.","dosing":"Active\\nADULT: up to 4g given once daily or in divided doses\\nCHILD: starting with 30-50 mg/kg/day in divided doses. Maximum\\ndose: 75 mg/kg/day in divided doses. Total daily dose 4g/day\\nMaintenance\\nADULT: 1.5g to 2g mesalazine once daily or divided doses\\nCHILD: starting with 30-50 mg/kg/day in divided doses. Maximum\\ndose: 75 mg/kg/day in divided doses. Total daily dose 2g/day\\nDose is according to product insert and dependent on the\\nproduct/brand used.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota: BRAND SALOFALK (Dept: Pembedahan)","price":"1.06 1.42","prescriberCat":"A"},{"id":"drug-372","genericName":"Mesalazine 1g Suppository","brandName":"Pentasa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Suppository"],"indications":"Inflammatory bowel disease of ulcerative colitis and Crohn's disease.","dosing":"Ulcerative colitis: 1 g suppository insert rectally once daily at bedtime. To achieve maximum benefit, it is recommended that the suppository be retained in the rectum for a minimum of 1 to 3 hours or longer. The usual course of therapy, depending upon response, may last from 3 to 6 weeks. CHILD not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"9.76","prescriberCat":"A"},{"id":"drug-373","genericName":"Methyl Salicylate 25% Ointment","brandName":"i-Salic","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Ointment"],"indications":"Relief of minor aches and pains of muscles and joints associated with simple backache, arthritis and rheumatic conditions.","dosing":"To be massage well to the affected area, 3 - 4 times daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.06","prescriberCat":"C+"},{"id":"drug-374","genericName":"Parecoxib Sodium 40mg Injection","brandName":"Dynastat","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Injection"],"indications":"Management of post operative pain in the immediate post operative setting only","dosing":"40 mg followed by 20 or 40 mg every 6 to 12 hours, as required, not exceeding daily dosage of 80 mg. There is limited clinical experience with parecoxib treatment beyond three days. Reduce the initial dose by 50% in elderly less than 50 kg, with a maximum daily dosage of 40 mg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"27.70","prescriberCat":"A*"},{"id":"drug-375","genericName":"Penicillamine 250mg Capsule","brandName":"2. iSALIC Ointment","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Capsule"],"indications":"i) Treatment of severe lead poisoning, it is used as adjunctive treatment following initial treatment with another chelating agent. May also be used as sole therapy in the treatment of asymptomatic patients with moderately elevated blood concentrations \\nii) Wilson's Disease: to aid in elimination of copper ions","dosing":"i) Heavy metal poisoning: 900mg-1800mg daily. Duration of treatment is dictated by the urinary heavy metal excretion. Simultaneous oral vitamin B6 replacement with at least 40mg daily is essential \\nii) Wilson's disease: 0.25g - 1.5g daily on an incremental basis. Maximal daily dose: 2g. Maintenance dose: 0.75g - 1g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"KPK (Dept: Perubatan)","price":"3.15","prescriberCat":"A"},{"id":"drug-376","genericName":"Salicylazosulphapyridine (Sulfasalazine) 500 mg Tablet","brandName":"Salazopyrin \\nEN","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Tablet"],"indications":"i) Treatment of inflammatory bowel disease of ulcerative colitis and Crohn's disease \\nii) Rheumatoid arthritis","dosing":"i) ADULT: acute attack 1-2 g 4 times daily until remission occurs (if necessary corticosteroids may also be given), reducing to a maintenance dose of 500 mg 4 times daily, \\nCHILD over 2 years: acute attack 40-60 mg/kg daily, maintenance dose 20-30 mg/kg daily \\nii) ADULT: initially; 0.5-1 g/day, increase weekly to maintenance dose of 2 g/day in 2 divided doses, maximun 3 g/day. \\nCHILD over 6 years, juvenile rheumatoid arthritis: 30-50 mg/kg/day in 2 divided doses up to a maximum of 2 g/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.43","prescriberCat":"A/KK"},{"id":"drug-377","genericName":"Tramadol HCl 50 mg Capsule","brandName":"Acugesic","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Capsule"],"indications":"Moderate to severe acute or chronic pain (eg. Post-operative pain, chronic cancer pain and analgesia/pain relief for patients with impaired renal function)","dosing":"ADULT: 50mg initially, can take another 50mg after 30 - 60 min if pain not relieved. Max 400 mg daily. \\nCHILD: 1mg/kg/dose repeated every 6 hours (Max: 2mg/kg/dose and 100mg/dose)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"A/KK"},{"id":"drug-378","genericName":"Tramadol HCl 50 mg/ml Injection","brandName":"Acugesic","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS","forms":["Injection"],"indications":"Moderate to severe acute or chronic pain (eg. Post-operative pain, chronic cancer pain and analgesia/pain relief for patients with impaired renal function)","dosing":"ADULT: IV/IM/SC 50 - 100mg. (IV inj over 2-3 min or IV infusion). Initially 100 mg then 50 - 100 mg every 4 - 6 hours. . Max: 400 mg daily. \\nCHILD (1 year and above): 1 - 2mg/kg/dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.00","prescriberCat":"A"},{"id":"drug-381","genericName":"Fentanyl Citrate 50 mcg/ml Injection","brandName":"Talgesil","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Injection"],"indications":"Short duration analgesia during pre-medication induction and maintenance of anaesthesia, and in the immediate post-operative period.","dosing":"Dose should be individualized according to age, body weight, physical status, underlying pathological conditions and type of surgery and anaesthesia. ADULT: Premedication: IM 50 - 100 mcg, 30 - 60 mins prior to surgery. Adjunct to general anaesthesia: Induction IV 50 - 100mcg, repeat 2 - 3 mins intervals until desired effect is achieved. IV/IM 25 - 50mcg in elderly and poor risk patients. Maintenance: IV/IM 25 - 50mcg. Adjunct to regional anaesthesia: IM/slow IV 50 - 100mcg when additinal analgesia is required. Post-operatively (recovery room): IM 50 - 100mcg for pain control, tachypnoea and emergency delirium. May be repeated in 1- 2 hours as needed. CHILD (2 - 12 years): Induction & maintenance: 2 - 3 mcg/kg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.19","prescriberCat":"A"},{"id":"drug-382","genericName":"Fentanyl 25 mcg/ hr Transdermal Patch","brandName":"Fentanyl Hexal","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Patch"],"indications":"Category Prescriber A*:\\ni) As a second line drug in the management of opioid responsive, moderate chronic cancer pain\\n\\nCategory Prescriber A/KK:\\nii) As a second line drug in the management of opioid responsive, severe chronic cancer pain\\nTo be prescribed by Family Medicine Specialists trained in pain management","dosing":"Patients who have not previously received a strong opioid analgesic, initial dose , one 25 mcg/hour patch to be replaced after 72 hours. \\n\\nPatients who have received a strong opioid analgesic, initial dose based on previous 24 hours opioid requirement (oral morphine sulphate 90 mg over 24 hours = one 25 mcg/hour patch). \\n\\nNot recommended in children.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"29.43","prescriberCat":"A*, A/KK"},{"id":"drug-383","genericName":"Morphine HCl 10 mg/5 ml  1L Solution (made from morphine HCL powder BP)","brandName":"Morphine HCL powder BP","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["BP)"],"indications":"For use in management of moderate to severe pain especially that associated with neoplastic disease","dosing":"5-20 mg or more regularly every 4 hours as needed in terminal pain","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical (Dept: Perubatan, Pembedahan)","price":"129.92","prescriberCat":"B"},{"id":"drug-384","genericName":"Morphine Sulphate 10 mg/ml Injection","brandName":"Morpheas Inj","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Injection"],"indications":"For moderate to severe pain especially that associated with neoplastic disease","dosing":"ADULT: 5-20mg SC or IM every 4 hours in terminal pain. \\nCHILD: Up to 1 month: 0.15 mg/kg body weight; \\n1 - 12 months: 0.2 mg/kg body weight; \\n1 - 5 years: 2.5 - 5 mg ; \\n6 - 12 years: 5 - 10 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.95","prescriberCat":"B"},{"id":"drug-385","genericName":"Morphine Sulphate 10 mg Controlled Release Tablet","brandName":"MST Continus","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Tablet"],"indications":"Category Prescriber A/KK:\\ni) Prolonged relief of severe pain associated with neoplastic disease\\nTo be prescribed by Family Medicine Specialists trained in pain management\\n\\nCategory Prescriber A:\\nii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non- pharmacological approach failed\\nInitiated by Pain or Palliative Specialists only","dosing":"10 - 60 mg 12 hourly intervals, depend upon the severity of the pain. \\nChildren (more than 1 year of age) with severe cancer pain: 0.2 - 0.8mg/kg 12 hourly.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.72","prescriberCat":"A, A/KK"},{"id":"drug-386","genericName":"Morphine Sulphate 30 mg Controlled Release Tablet","brandName":"MST Continus","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Tablet"],"indications":"i) Prolonged relief of severe pain associated with neoplastic disease\\n\\nii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non- pharmacological approach failed\\nInitiated by Pain or Palliative Specialists only","dosing":"10 - 60 mg 12 hourly intervals, depend upon the severity of the pain","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"7.21","prescriberCat":"A"},{"id":"drug-387","genericName":"Nalbuphine HCl 10 mg/ml Injection","brandName":"Intapan","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Injection"],"indications":"Perioperative analgesia, for relief of moderate to severe pain","dosing":"10 - 20 mg SC, IM or IV every 3 - 6 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.01","prescriberCat":"B"},{"id":"drug-388","genericName":"Oxycodone HCl 10 mg/ml Injection","brandName":"Oxynorm","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Injection"],"indications":"For the treatment of moderate to severe pain in patients with cancer and post-operative pain. For the treatment of severe pain requiring the use of a strong opioid.\\n\\nPRECAUTIONS\\nGeriatric patients: Caution and proper monitoring is warranted.\\nOpioid related adverse effects may be more prominent in this population therefore should be monitored\\nregularly and addressed if occurred.","dosing":"Adults over 18 years: The following starting doses are recommended. A gradual increase in dose may be required if analgesia is inadequate or if pain severity increases. \\nIV Bolus: Dilute to 1 mg/ml in 0.9% saline, 5% dextrose or water for injections. Administer a bolus dose of 1 to 10 mg slowly over 1-2 minutes. Doses should not be administered more frequently than every 4 hours. \\nIV Infusion: Dilute to 1 mg/ml in 0.9% saline, 5% dextrose or water for injections. A starting dose of 2 mg/hour is recommended. \\nIV PCA: Dilute to 1 mg/ml in 0.9% saline, 5% dextrose or water for injections. \\nBolus doses of 0.03 mg/kg should be administered with a minimum lock-out time of 5 minutes.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"9.51","prescriberCat":"A*\\n\\nConsultant/specialists for specific indications only, including Geriatricians"},{"id":"drug-390","genericName":"Oxycodone HCl 5 mg Immediate Release Capsule","brandName":"Oxynorm","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Capsule"],"indications":"i) Management of moderate to severe chronic cancer pain non-responsive to morphine in accordance with WHO step-wise ladder of chronic pain management \\n\\nii) As a step-down analgesic drug in post-operative procedures iii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non-pharmacological approach failed (Initiated by Pain, Palliative Specialists and geriatricians only)","dosing":"Initially 5 mg every 4 to 6 hours, increased if necessary according to severity of pain, usual max. 400 mg daily, but some patients may require higher doses\\n\\nPRECAUTIONS\\nGeriatric patients: Caution and proper monitoring is\\nwarranted.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.53","prescriberCat":"A*"},{"id":"drug-391","genericName":"Oxycodone HCl 10 mg Prolonged Release Tablet","brandName":"Oxycontin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Tablet"],"indications":"i) Management of moderate to severe chronic cancer pain non-responsive to morphine in accordance with WHO step-wise ladder of chronic pain management.\\n\\nii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non-pharmacological approach failed (Initiated by Pain, Palliative Specialists or Geriatricians only)\\nPRECAUTIONS\\nGeriatric patients: Caution and proper monitoring is\\nwarranted.","dosing":"Adults, elderly and children over 12 years: Usual starting dose for opioid-naive patients or patients presenting with moderate to severe pain uncontrolled by weaker opioids (especially if they are receiving concurrent sedatives, muscle relaxants or other CNS medicines) is 10mg 12 hourly. \\nThe dose should then be carefully titrated with longitudinal patient monitoring, assessing whether the pain is opioid responsive and providing the patient significant pain relief. \\nPatients with renal or hepatic impairment: The recommended adult starting dose should be reduced by 1/3 to 1/2, and each patient should be titrated to adequate pain control according to their clinical situation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.47","prescriberCat":"A*"},{"id":"drug-392","genericName":"Oxycodone HCl 10mg and Naloxone HCl Dihydrate 5 mg Tablet","brandName":"Targin 10/5","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Tablet"],"indications":"The management of moderate to severe chronic pain unresponsive to non-narcotic analgesics. The opioid antagonist naloxone in the fixed combination is added to counteract and/or prevent opioid-induced constipation.\\n\\nPRECAUTIONS\\nGeriatric patients: Caution and proper monitoring is warranted.","dosing":"Adults and paediatric patients from 18 years of age: The usual starting dose for opioid-naive patients or patients presenting with moderate to severe chronic pain uncontrolled by weaker opioids is one tablet 10mg/5mg at 12 hourly intervals, or one tablet 5mg/2.5mg 12-hourly for patients with mild hepatic impairment and patients with renal impairment. The dose should then be cautiously titrated, as frequently as every 1-2 days if necessary, to achieve pain relief.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.80","prescriberCat":"A*\\nConsultant/ specialists for specific indications only, including Geriatricians"},{"id":"drug-393","genericName":"Pethidine HCl 50 mg/ ml, 100 mg/2 ml Injection","brandName":"Pharmaniaga Pethidine HCL\\n\\nDemothine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Injection"],"indications":"For relief of moderate to severe pain (medical and surgical), pre-anaesthetic medication and obstetrical analgesia","dosing":"ADULT: 0.5 - 2 mg/kg SC or IM every 3 - 4 hours if necessary. \\nCHILD: by IM 0.5 - 2 mg/kg. Up to 1 year : 1- 2 mg/kg weight IM, 1 - 5 years : 12.5 - 25 mg IM, 6 - 12 years: 25 - 50 mg IM","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.8  0.93","prescriberCat":"B"},{"id":"drug-394","genericName":"Remifentanil 5 mg Injection","brandName":"Ultiva","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.4 ANALGESICS (NARCOTICS)","forms":["Injection"],"indications":"i) As an analgesic agent for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery. \\nii)Continuation of analgesia into the immediate post-operative period under close supervision, during transition to longer acting analgesia. \\niii)Provision of analgesia and sedation in mechanically ventilated intensive care patients.","dosing":"For IV use only. ADULT: Induction:Bolus infusion: 1g/kg over 30-60 seconds; Continuous infusion: 0.5-1g/kg/min; Maintenance: Continuous infusion: 0.025 to 2 g/kg/min. \\nCHILD (1-12 years of age): Induction: Insufficient data; \\nNeonates: IV infusion 0.4-1.0 mcg/kg/minute depending on the anaesthetic method and adjust according to patient response, supplemental IV inj of 1 mcg/kg dose may be given.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"153.57","prescriberCat":"A*"},{"id":"drug-398","genericName":"Allopurinol 100 mg Tablet","brandName":"Allopurinol\\n100mg\\n\\n300mg","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.5 ANTIGOUT PREPARATIONS","forms":["Tablet"],"indications":"i) Frequent and disabling attacks of gouty arthritis (2 or more flares/year)\\nii) Clinical or radiographic signs of erosive gouty arthritis.\\niii) The presence of tophaceous deposits\\niv) Urate nephropathy\\nv) Urate nephrolithiasis\\nvi) Impending cytotoxic chemotherapy or radiotherapy for lymphoma or\\nleukaemia","dosing":"Initial dose: 50-100 mg daily. \\nMaintenance: 300-900mg daily (depending on renal function).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.07","prescriberCat":"A/KK"},{"id":"drug-399","genericName":"Allopurinol 100mg, 300 mg Tablet","brandName":"Generic","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.5 ANTIGOUT PREPARATIONS","forms":["Tablet"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.07  0.29","prescriberCat":""},{"id":"drug-400","genericName":"Colchicine 0.5 mg Tablet","brandName":"Colchicine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.5 ANTIGOUT PREPARATIONS","forms":["Tablet"],"indications":"i) Acute gout and prophylaxis of recurrent gout. \\n\\nii) Leucocytoclastic Vasculitis either cutaneous or systemic involvement, Behcet's syndrome, Urticarial vasculitis, Systemic sclerosis, Sweet's syndrome and severe recalcitrant aphthous stomatitis","dosing":"i) Initial dose, 1 mg, then 0.5 mg every 2-3 hour until relief of pain is obtained or vomiting or diarrhoea occurs (Maximum : 6 mg). The course should not be repeated within 3 days. Prevention of attacks during initial treatment with allopurinol or uricosuric drugs: 0.5 mg 2-3 times daily. \\n\\nii) 0.5 mg 1-3 times daily depends on disease and severity, up to a maximum of 3 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.09","prescriberCat":"B"},{"id":"drug-401","genericName":"Febuxostat 80 mg Tablet","brandName":"Febuton","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.5 ANTIGOUT PREPARATIONS","forms":["Tablet"],"indications":"Treatment of chronic hyperuricaemia in adult patients, in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).\\nPrescribing restriction(s): \\ni) As second line for patients who are allergic or intolerant to allopurinol, or\\nii) Fail to achieve serum uric acid target despite dose escalation and good compliance to allopurinol","dosing":"The recommended starting dose is 40 mg once daily.\\nThe recommended oral dose is 40 mg or 80 mg once daily.\\nIf serum uric acid is > 6.0 mg/dL (357 mol/L) after 2-4 weeks, 80 mg once daily may be considered.\\n\\nThe 80 mg tablet can be divided into equal halves. In order to provide a 40 mg dose, the tablet should be split just before use. Prescribers should advise patients on how to break the tablets in half and to keep the other half for the next dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.81","prescriberCat":"A/KK"},{"id":"drug-402","genericName":"Probenecid 500 mg Tablet","brandName":"Sunward","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.5 ANTIGOUT PREPARATIONS","forms":["Tablet"],"indications":"Hyperuricemia associated with gout and gouty arthritis \\n(for cases allergic to allopurinol or serum uric acid not controlled by allopurinol alone)","dosing":"500 mg to 1000 mg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"0.35","prescriberCat":"A"},{"id":"drug-405","genericName":"Alprazolam 0.5 mg Tablet","brandName":"Alpraline","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Anxiety disorders","dosing":"0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.45","prescriberCat":"A"},{"id":"drug-406","genericName":"Amisulpride 100 mg, 400 mg Tablet","brandName":"Solian","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Treatment of psychoses, particularly acute or chronic schizophrenia disorders characterized by positive symptoms(e.g. delusion, hallucinations, thought disorders) and/or negative symptoms(e.g. blunted emotions, emotional and social withdrawal) including when the negative symptoms predominate","dosing":"Predominantly negative episodes: 50-300 mg once daily adjusted according to the patient?s response. \\nMixed episodes with positive and negative symptoms: 400-800 mg/day in 2 divided doses adjusted according to the patient?s response. \\nShould be taken on an empty stomach (Preferably taken before meals)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"1.40, 5.22","prescriberCat":"A*"},{"id":"drug-407","genericName":"Aripiprazole 10 mg Tablet","brandName":"Apalife","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Treatment of acute episodes of schizophrenia and for maintenance of clinical improvement during continuation therapy. \\nii) Treatment of acute manic episodes associated with bipolar I disorder","dosing":"Schizophrenia: 10 or 15 mg/day. Maintenance dose: 15 mg/day. \\nBipolar mania: Starting dose: 15 or 30 mg/day. Dose adjustment should occur at intervals of not less than 24 hour","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"1.26","prescriberCat":"A*"},{"id":"drug-408","genericName":"Aripiprazole 400mg Injection","brandName":"Abilify \\nOtsuka","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"Maintenance treatment of schizophrenia & maintenance monotherapy treatment of bipolar I disorder in adult patients.","dosing":"400 mg once mthly as single IM inj (no sooner than 26 days after previous inj).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"680.03","prescriberCat":"A*"},{"id":"drug-409","genericName":"Asenapine  10 mg Sublingual Tablet","brandName":"Saphris","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"For second or third line treatment in adult for: \\ni) Schizophrenia \\nii) Bipolar Disorder\\n - Monotherapy: Acute treatment of manic or mixed episodes associated with Bipolar I disorder. \\n- Adjunctive therapy: As adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with Bipolar I Disorder.","dosing":"i) Schizophrenia: \\n- Acute treatment in adults: Recommended starting and target dose of asenapine is 5mg given twice daily.\\n - Maintenance dose: 5mg twice daily. \\nii) Bipolar Disorder:\\n - Monotherapy: 10mg twice daily. \\nAdjunctive therapy: 5mg twice daily with lithium or valproate. \\nDose can be increased to 10mg twice daily based on clinical response.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"8.85","prescriberCat":"A*"},{"id":"drug-410","genericName":"Brexpiprazole 2mg Tablet","brandName":"Rexulti","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)\\n\\nPrescribing Restriction:\\nTo be prescribed by Psychiatrists only","dosing":"The recommended starting dose as adjunctive treatment is 0.5 mg or 1 mg once daily. Dose titration to 1 mg/day and up to the target dose of 2 mg/day should occur at intervals of up to 1 week based on the patients clinical response and tolerability. Doses up to 3 mg/day have been studied in clinical trials.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"16.17","prescriberCat":"A*"},{"id":"drug-411","genericName":"Chlorpromazine HCl 100 mg Tablet","brandName":"Idaman\\nChlorpromazine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Psychosis mania and agitation","dosing":"ADULT : Initial dose - 25 mg 3 times daily according to response up to 1 g daily. \\nPAEDIATRIC: Up to 5 years: 0.5 mg/kg body weight every 4 - 6 hours (Maximum 40 mg daily). \\nCHILD 6 - 12 years: A third to half adult dose (Maximum 75 mg daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.17","prescriberCat":"B"},{"id":"drug-412","genericName":"Clozapine 25 mg, 100 mg Tablet","brandName":"Clozaril","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Treatment of resistant schizophrenia","dosing":"Initial dose : 12.5 mg ( once or twice ) daily, increase slowly in steps of 25 - 50 mg up to 300 mg daily within 2 - 3 weeks. Maximum : 900 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.41, 0.91","prescriberCat":"A"},{"id":"drug-413","genericName":"Diazepam 10 mg/2 ml Injection","brandName":"Zopam","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"i) Status epilepticus \\n\\nii) Skeletal muscle spasm \\n\\niii) Anxiety disorders","dosing":"i) ADULT: initial dose 10-20mg IV, in the following hours 20mg IM or by intravenous drip infusion as necessary. \\nCHILD 2 to 5 years of age: slow IV 0.2 - 0.5mg every two to five minutes up to a maximum of 5mg. If necessary, dose can be repeated in two to four hours. \\nCHILD 5 years and older: slow IV 1mg every two to five minutes up to a maximum of 10mg. If necessary, dose can be repeated in two to four hours.\\n\\n ii) ADULT: 10mg once or twice IV. \\nCHILD 2 to 5 years of age: IM or IV, 1 to 2mg the dosage being repeated every three to four hours as needed. \\nCHILD 5 years and older: IM or IV, 5 to 10mg, the the dosage being repeated every three to four hours as needed. \\n\\niii) ADULT: 10-20mg three times daily IM or IV until acute symptoms subside.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.52","prescriberCat":"B"},{"id":"drug-414","genericName":"Diazepam 5 mg Tablet","brandName":"Diapo","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Muscle spasm of varied aetiology, including tetanus \\n\\nii) Anxiety disorders","dosing":"i) ADULT: 2-10 mg 3-4 times daily. \\nCHILD 6 months and older: 0.12 - 0.8 mg/kg daily in divided doses, every 6-8 hours \\n\\nii) ADULT : 2 mg 3 times daily, increased in severe anxiety to 15 - 30 mg daily in divided doses. ELDERLY (or delibitated) : half adult dose. \\nCHILD (night terrors) : 1 - 5 mg at bedtime","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.40","prescriberCat":"B"},{"id":"drug-415","genericName":"Flupenthixol Decanoate Depot 20 mg/ml lnjection","brandName":"Fluanxol","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["lnjection"],"indications":"Chronic psychoses","dosing":"By deep IM, initial test dose of 5-20 mg, then after at least 7 days. 20 - 40 mg repeated at intervals of 2 - 4 weeks. Maximum 400 mg weekly. \\n- Usual maintenance dose 50 mg every 4 weeks to 300 mg every 2 weeks. \\n- ELDERLY, initially quarter to half adult dose. \\n - CHILD not recommended. \\n - Deep IM recommended. Not for IV use","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"20.88","prescriberCat":"B"},{"id":"drug-416","genericName":"Fluphenazine Decanoate 25 mg/ml Injection","brandName":"Shrizine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"Long term management of psychotic disorders","dosing":"By deep IM : Test dose 12.5 mg (6.25 mg in ELDERLY), then after 4-7 days 12.5 mg-100 mg repeated at intervals of 14-35 days, adjusted according to response. \\nCHILD not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.92","prescriberCat":"B"},{"id":"drug-417","genericName":"Haloperidol 5 mg/ml Injection","brandName":"MENACE","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"Acute psychoses and mania","dosing":"ADULT: IM or IV , 2 mg - 10 mg then every 4 - 8 hours according to response to total maximum 18 mg daily. Use in child is not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.85","prescriberCat":"B"},{"id":"drug-418","genericName":"Haloperidol 1.5 mg, 5 mg Tablet","brandName":"Haloperidol, HADOL-5","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Schizophrenia and other psychoses","dosing":"Adult:0.5-5 mg bid/tid, may increase up to 100 mg daily in severe or resistant cases. \\nUsual maintenance: 3-10 mg daily.\\nChild: >3 yr: Initially, 25-50 mcg/kg daily in 2 divided doses, increased gradually if necessary. \\nMax: 10 mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.16, 0.14","prescriberCat":"B"},{"id":"drug-419","genericName":"Lithium Carbonate \\n300 mg Tablet","brandName":"Liconate","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Prophylaxis and treatment of acute mania and hypomania episodes \\nii)Prophylaxis of manic depression in bipolar illness or bipolar depression and recurrent depression","dosing":"Dose depends on the preparation used. \\nDoses should be adjusted to produce a serum-lithium concentration of 0.4-1 mmol/l.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.57","prescriberCat":"A"},{"id":"drug-420","genericName":"Lorazepam 1 mg Tablet","brandName":"Tranpam","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Severe anxiety \\nii) Insomnia","dosing":"i) 1 - 4 mg increase to 10 mg daily in divided doses. ELDERLY (or delibitated): half adult dose \\nii) 1 - 2 mg at bedtime Not recommended in children","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.44","prescriberCat":"A/KK"},{"id":"drug-421","genericName":"Methylphenidate HCl 10 mg Tablet","brandName":"Ritalin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Attention deficit hyperactivity disorder (ADHD)","dosing":"CHILD over 6 years, initially 5 mg 1 - 2 times daily, increased if necessary at weekly intervals by 5 - 10 mg daily to maximum of 60 mg daily in divided doses; discontinue if no response after 1 month, also suspend periodically to assess child's condition (usually finally discontinued during or after puberty)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"1.62","prescriberCat":"A"},{"id":"drug-422","genericName":"Methylphenidate HCl 18 mg, 36 mg Extended-release Tablet","brandName":"Concerta","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Attention deficit hyperactivity disorder (ADHD)","dosing":"CHILD over 6 years: Individualize dosage, to be taken once daily in the morning. Dose may be adjusted in increments to a maximum of 54 mg/day, at weekly interval. \\nPatient new to methylphenidate: starting dose 18 mg once daily; adults 18mg or 36mg once daily. \\nPatient currently using methylphenidate: 18 - 36 mg. Maximum 54 mg/day. \\nDiscontinue if no response after 1 month","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"7.45, 11.60","prescriberCat":"A*"},{"id":"drug-423","genericName":"Olanzapine 5 mg, 10 mg Tablet","brandName":"Olenza","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Acute and maintenance treatment of schizophrenia and other psychoses where positive and or negative symptoms are prominent \\nii) Short-term use for acute mania episodes associated with Bipolar 1 disorder","dosing":"i) 5 - 10 mg once daily, increase to 10 mg once daily within 5 - 7 days, adjust by 5 - 10 mg/day at 1 week intervals, maximum 20 mg/day \\nii) 10 - 15 mg once daily, increase by 5 mg/day at intervals of not less than 24 hours. Maintenance : 5 - 20 mg/day; maximum 20 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.21, 0.66","prescriberCat":"B"},{"id":"drug-424","genericName":"Olanzapine 5 mg, 10 mg Disintegrating Tablet","brandName":"Hovid, Jubrexa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Acute and maintenance treatment of schizophrenia and other psychoses where positive and or negative symptoms are prominent \\nii) Short-term use for acute mania episodes associated with Bipolar 1 disorder","dosing":"i) 5 - 10 mg once daily, increase to 10 mg once daily within 5 - 7 days, adjust by 5 - 10 mg/day at 1 week intervals, maximum 20 mg/day \\nii) 10 - 15 mg once daily, increase by 5 mg/day at intervals of not less than 24 hours. Maintenance : 5 - 20 mg/day; maximum 20 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.94, 1.53","prescriberCat":"A*\\n\\nConsultant/ specialists for specific indications only, including Geriatricians"},{"id":"drug-425","genericName":"Paliperidone 6 mg, 9mg Extended Released Tablet","brandName":"Invega","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Second or third line treatment of schizophrenia","dosing":"ADULT : 6 mg once daily in the morning, adjusted if necessary; usual range 3 -12 mg daily. \\nRenal impairment (creatinine clearance between 10-50 mL/min) : 3 mg once daily. \\nAvoid if creatinine clearance less than 10mL/min","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"13.5, 16.2","prescriberCat":"A*"},{"id":"drug-426","genericName":"Paliperidone 100 mg, 150 mg Prolonged Release Injection","brandName":"Invega Sustenna","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"Second or third line treatment of acute and maintenance treatment of schizophrenia in adults","dosing":"Initiation: Deltoid IM 150 mg eq on Day1, followed by deltoid IM 100 mg eq on one week later. Maintenance: Monthly dose of 75 mg eq ( this can be increased or decreased based on individual patient's tolerability and/or efficacy). \\nThese monthly maintenace dose can be administered in either the deltoid or gluteal muscle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"904.51, 919.00","prescriberCat":"A*"},{"id":"drug-427","genericName":"Perphenazine 4 mg Tablet","brandName":"Apo-Perphenazine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Schizophrenia and other psychoses","dosing":"ADULT: Initially 4 mg 3 times daily adjusted according to response, maximum 24 mg daily. \\nELDERLY: 1/4 to 1/2 adult dose. CHILD not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.26","prescriberCat":"B"},{"id":"drug-428","genericName":"Paliperidone 350mg/1.750ml , 525mg/ 2.625ml Prolonged Release for IM Injection","brandName":"Invega Trinza","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"For the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.","dosing":"Apply 3.5 as a dose multiplier to the previous 1-month injection dose, and administer every 3 months","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"2512.90","prescriberCat":"A*"},{"id":"drug-429","genericName":"Quetiapine Fumarate 200mg, 300mg Extended Release Tablet","brandName":"Seroquel XR","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i)Schizophrenia\\nii) Moderate to severe manic episodes in bipolar disorder\\niii) Major depressive episodes in bipolar disorder\\nPrescribing Restriction:\\nConsultant/specialists for specific indications only, including Geriatricians and Neurologists","dosing":"i) & ii) 300 mg once daily on Day 1 then 600 mg on Day 2. Maintenance dose: 400 to 800 mg once daily. Maximum dose: 800 mg daily\\n\\niii) 50 mg on Day 1, 100 mg on Day 2, 200 mg on Day 3 and 300 mg on Day 4. Recommended daily dose is 300 mg. May be titrated up to 600 mg daily. In elderly or hepatic impairment:Start with 50mg/ day, may be increased in increments of 50mg /day to an effective dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"7.70, 11.27","prescriberCat":"A*"},{"id":"drug-430","genericName":"Quetiapine Fumarate 100 mg, 200 mg Immediate Release Tablet","brandName":"Seroquel","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"i) Schizophrenia \\n\\nii) Short term treatment of acute manic episodes associated with bipolar I disorder, either monotherapy or adjunct to lithium or divalproex \\n\\niii) Treatment of depressive episodes associated with bipolar disorder","dosing":"i) Initial titration schedule over 4 days: 25 mg twice daily on Day 1, increase in steps of 25 - 50 mg 2 to 3 times daily on Days 2 and 3 to reach target dose of 300 - 400 mg daily by Day 4, given in 2 - 3 divided doses. \\nInstitute further dose adjustments, if indicated, at intervals of 2 days or more, in steps of 25 - 50 mg twice daily \\n\\nii) 100 mg (Day 1), 200 mg (Day 2), 300 mg (Day 3) & 400 mg (Day 4).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Geriatrik)","price":"1.13, 1.62","prescriberCat":"A*"},{"id":"drug-432","genericName":"Risperidone 1 mg, 2 mg Tablet","brandName":"Rozidal","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Psychoses and schizophrenia","dosing":"ADULT : 2 mg in 1 - 2 divided doses on first day\\n then 4 mg in 1 - 2 divided doses on 2nd day\\n then 6 mg in 1 - 2 divided doses on 3rd day \\n(slower titration appropriate in some patients); usual range 4 - 8 mg daily;\\ndose above 10 mg daily only if benefit outweigh risk (maximum 16 mg daily). \\nElderly (or in hepatic or renal impairment): initially 0.5 mg twice daily increased in steps of 0.5 mg twice daily to 1 - 2 mg twice daily. Not recommended in children under 15 years","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Geriatrik)","price":"0.06, 0.08","prescriberCat":"B"},{"id":"drug-433","genericName":"Sulpiride 200 mg Tablet","brandName":"Negatil","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Acute and chronic schizophrenia, chronic delusional psychoses","dosing":"200-400 mg twice daily; 800 mg daily in predominantly negative symptoms and 2.4 g daily in mainly positive symptoms. \\nElderly, lower initial dose; increased gradually according to response. \\nChild under 14 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.13","prescriberCat":"B"},{"id":"drug-434","genericName":"Trifluoperazine HCI 5 mg Tablet","brandName":"APO-Trifluoperazine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Tablet"],"indications":"Psychotic disorder","dosing":"ADULT: Initially 5 mg twice daily, increase by 5 mg after 1 week, then at 3-day intervals. Maximum 40 mg/day. \\nCHILD up to 12 years: Initially up to 5 mg daily in divided doses adjusted to response, age and body weight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.33","prescriberCat":"B"},{"id":"drug-435","genericName":"Zuclopenthixol 20 mg/ml Drops","brandName":"Clopixol Drops","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Drops"],"indications":"Only for psychoses with insight or compliance","dosing":"Acute Schizophrenia and Other Acute Psychoses; Severe Acute States of Agitation; Mania: Oral treatment: Usually 10-50 mg/day. \\nIn moderate to severe cases initially 20 mg/day increased, if necessary, by 10-20 mg/day every 2-3 days to =75 mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"48.48","prescriberCat":"A*"},{"id":"drug-436","genericName":"Zuclopenthixol Acetate 50 mg/ml Injection","brandName":"Clopixol Accuphase","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"Only for treatment of agitated and violent patients suffering from schizophrenia who are not responding to the available standard drugs","dosing":"Clopixol-Acuphase: Clopixol-Acuphase is administered by IM injection. The dosage range should normally be 50-150 mg (1-3 mL) IM repeated if necessary, preferably with a time interval of 2-3 days. In a few patients, an additional injection may be needed 24-48 hrs following the 1st injection. \\nIn the maintenance therapy, treatment should be continued with oral Clopixol or Clopixol Depot IM after the following guidelines: Change to Oral Clopixol: 2-3 days after the last injection of Clopixol-Acuphase, a patient who has been treated with 100 mg Clopixol-Acuphase, oral treatment should be started at a dosage of about 40 mg daily, possibly in divided dosages. If necessary, the dose can be further increased by 10-20 mg every 2-3 days up to 75 mg or more.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"20.31","prescriberCat":"A*"},{"id":"drug-437","genericName":"Zuclopenthixol Decanoate 200 mg/ml Injection","brandName":"Clopixol Depot","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.6 ANTIPSYCHOTICS","forms":["Injection"],"indications":"Only for treatment of agitated and violent patients suffering from schizophrenia who are not responding to the available standard drugs","dosing":"By deep IM injection test dose 100 mg followed after 7 - 28 days by 100 - 200 mg or more followed by 200 - 400 mg at intervals of 2 - 4 weeks adjusted according to response. Maximum 600 mg weekly. Child not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"23.83","prescriberCat":"B"},{"id":"drug-440","genericName":"Chloral Hydrate 200 mg/5 ml Mixture","brandName":"-","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.7 HYPNOTICS AND SEDATIVES","forms":["Mixture"],"indications":"Preoperative sedation","dosing":"ADULT : 0.5 - 1 g (max 2 g) with plenty of water at bedtime. \\nCHILD : Neonate: 30-50 mg/kg; up to 100 mg/kg may be used with respiratory monitoring. \\n1 mth-12 yr: 30-50 mg/kg (max: 1 g); up to 100 mg/kg (max: 2 g) may be used; \\n12-18 yr: 1-2 g. Doses to be taken 45-60 minutes before procedure. \\nMay be given rectally if oral route is not available.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"B"},{"id":"drug-441","genericName":"Dexmedetomidine HCl 100mcg/ml Injection","brandName":"Hydex","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.7 HYPNOTICS AND SEDATIVES","forms":["Injection"],"indications":"i) Sedation of intubated and mechanically ventilated ICU patients.\\n\\nii) For use only by specialist anaesthetist:\\nFor sedation of non-intubated patients prior to and/or during surgical and other procedures","dosing":"i) Not to be infused for more than 24 hours, 1 mcg/kg over 10 minutes as loading dose. Maintenance dose: 0.2 - 0.7 mcg/kg/hr\\n\\nii) Not to be infused for more than 24 hours, 1 mcg/kg over 10 minutes as loading dose. Maintenance dose: 0.2 - 0.7 mcg/kg/hr","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.81","prescriberCat":"A*"},{"id":"drug-442","genericName":"Melatonin 3 mg Tablet","brandName":"Melatonin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.7 HYPNOTICS AND SEDATIVES","forms":["Tablet"],"indications":"sleep cycle disorder","dosing":"3mg ON (every night)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Pediatrik)","price":"0.60","prescriberCat":"Not in FUKKM"},{"id":"drug-443","genericName":"Midazolam 5 mg/ml, 15 mg/3 ml Injection","brandName":"Domi, Domi","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.7 HYPNOTICS AND SEDATIVES","forms":["Injection"],"indications":"Prescriber Category A:\\ni) Pre-operative sedation, induction of general anaesthesia, premedication and sedation in ICU and sedation for minor procedures\\n\\nPrescriber Category A/KK:\\nii) For induction of intubation and sedation post-intubation","dosing":"Indication (i)\\nUsual sedative range : 2.5 - 7.5 mg (about 70 mcg/kg by IV injection over 30 seconds). \\nPremedication by IM injection : 70 - 100 mcg/kg 30-60 minutes before surgery; ELDERLY: 1 - 1.5 mg/kg.\\nInduction: Induction by slow IV infusion 200 - 300 mcg/kg (ELDERLY 100 - 200 mcg/kg. \\nCHILD over 7 years : 150-200 mcg/kg); Max: 0.35mg/kg. \\nSedation in ICU : 0.03 - 0.2 mg/kg/hour\\n\\nIndication (ii)\\nInduction: Induction by slow IV infusion 200 - 300 mcg/kg (ELDERLY 100 - 200 mcg/kg. \\nCHILD over 7 years 150 - 200 mcg/kg); Max: 0.35mg/kg.\\nSedation: 0.03 - 0.2 mg/kg/hour","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.4, 1.9","prescriberCat":"A, A/KK"},{"id":"drug-444","genericName":"Midazolam 7.5 mg Tablet","brandName":"Dormicum","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.7 HYPNOTICS AND SEDATIVES","forms":["Tablet"],"indications":"Pre and post-operative sedation","dosing":"ADULT: Usually 7.5 - 15 mg at bedtime; or for premedication, 30 - 60 minutes before the procedure. \\nFor ELDERLY, debilitated or impaired liver/kidney function: 7.5 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.20","prescriberCat":"A/KK"},{"id":"drug-445","genericName":"Zolpidem Tartrate 10 mg Tablet","brandName":"Zopim","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.7 HYPNOTICS AND SEDATIVES","forms":["Tablet"],"indications":"For treatment of insomnia","dosing":"10-mg tablet daily. Stilnox should always be taken just before going to bed. \\nIn elderly patients or patients with hepatic insufficiency: Dosage should be halved ie, 5 mg. Dosage must never exceed 10 mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.01","prescriberCat":"A"},{"id":"drug-448","genericName":"Amantadine HCl 100mg Capsule","brandName":"PK-MERZ","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Capsule"],"indications":"Parkinson's disease","dosing":"Initial dose: 100 mg daily and is increased to 100 mg twice daily (not later than 4 p.m.) after a week. \\nElderly over 65 years: less than 100 mg or 100 mg at intervals of more than 1 day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.05","prescriberCat":"B"},{"id":"drug-449","genericName":"Benzhexol 2 mg Tablet","brandName":"Pharmaniaga Benzhexol","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"i) Parkinson's disease \\nii) Drug induced parkinsonism \\niii) Dystonias","dosing":"ADULT: Initially 1 mg daily, increase gradually. \\nMaintenance: 5 - 15 mg daily in 3 - 4 divided doses. (Max 15mg/day)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.04","prescriberCat":"B"},{"id":"drug-450","genericName":"Entacapone 200 mg Tablet","brandName":"Entacapone HTC","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Parkinson's Disease. An adjunct to standard levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson's disease and end of dose motor fluctuations, who cannot be stabilised on those combinations","dosing":"200 mg to be taken with each daily dose of levodopa/dopa-decarboxylase inhibitor. Max 2g daily. May be taken with or without food","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.70","prescriberCat":"A"},{"id":"drug-451","genericName":"Levodopa 100 mg, Benserazide 25 mg HBS capsule","brandName":"Madopar HBS","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["capsule"],"indications":"Parkinson's Disease","dosing":"Initial: 100/25 mg 1-2 times/day, increase every 3-4 days until therapeutic effect, optimal dosage: 400/100 mg to 800/200 mg/day divided into 4-6 doses. \\nDose: 200/50 mg used only when maintenance therapy is reached and not to exceed levodopa 1000-1200 mg/benserazide 250-300 mg per day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"1.05","prescriberCat":"B"},{"id":"drug-452","genericName":"Levodopa 200 mg, Benserazide 50 mg Tablet","brandName":"Madopar-Roche","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Parkinson's Disease","dosing":"Dose: 200/50 mg used only when maintenance therapy is reached and not to exceed levodopa 1000-1200 mg/benserazide 250-300 mg per day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.80","prescriberCat":"B"},{"id":"drug-453","genericName":"Levodopa 100 mg and Carbidopa 25 mg Tablet","brandName":"Apo - levocarb","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Parkinson's disease","dosing":"Patients not receiving Levodopa before, initially 100 - 125 mg 3 - 4 times daily adjusted according to response. Maintenance: 0.75 - 2 g in divided doses. \\nIn patients previously treated with Levodopa the dose should be about 20 - 25% of the dose previously being taken.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.46","prescriberCat":"B"},{"id":"drug-454","genericName":"Levodopa 250 mg and Carbidopa 25 mg Tablet","brandName":"Sinedopa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Parkinson's disease","dosing":"Patients not receiving Levodopa before, initially 100 - 125 mg 3 - 4 times daily adjusted according to response. \\nMaintenance: 0.75 - 2 g in divided doses. In patients previously treated with Levodopa the dose should be about 20 - 25% of the dose previous being taken.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.93","prescriberCat":"B"},{"id":"drug-455","genericName":"Levodopa 150mg, Carbidopa 37.5mg and Entacapone 200mg Tablet\\n\\nLevodopa 100mg, Carbidopa 25mg, Entacapone 200mg","brandName":"Stalevo 150\\nStalevo 100","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["200mg"],"indications":"Idiopathic Parkinson's disease","dosing":"The optimum daily dosage must be determined by careful titration of levodopa in each patient. The daily dose should preferably be optimised using 1 of the 4 available tablet strengths (50/12.5/200mg, 100/25/200mg, 150/37.5/200mg or 200/50/200mg levodopa/carbidopa/entacapone). \\nPatients should be instructed to take only 1 tablet/dose administration. While the experience with total daily dosage >200 mg carbidopa is limited, the maximum recommended daily dose of entacapone is 2000 mg and therefore the maximum dose, for the strengths of 50/12.5/200 mg, 100/25/200 mg and 150/37.5/200 mg, is 10 tablets/day. Ten (10) tablets of the strength 150/37.5/200 mg equals carbidopa 375 mg/day. Therefore, using a maximum recommended daily dose of carbidopa 375 mg, the maximum daily dose of 200/50/200 mg is 7 tablets per day. The maximum total daily levodopa dose administered should not exceed 1500 mg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"3.84 3.80","prescriberCat":"A*"},{"id":"drug-456","genericName":"Memantine HCl 10 mg tablet","brandName":"Marixino","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["tablet"],"indications":"As monotherapy or as adjunctive therapy with cholinesterase inhibitors for the symptomatic treatment of patients with moderate to severe Alzheimer's disease.","dosing":"Adult Initially 5 mg/day on the 1st week, 5mg twice a day on the 2nd week, then 15 mg/day (10mg in the morning and 5mg in the evening) on the 3rd week. From the 4th week on, continue treatment with maintenance dose of 20 mg/day (10mg twice a day). Max: 20 mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Geriatrik)","price":"0.52","prescriberCat":"A*"},{"id":"drug-457","genericName":"Piribedil 50 mg Tablet","brandName":"Triva","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Parkinson disease","dosing":"As monotherapy: 150 - 250 mg as 3 - 5 divided doses daily. \\nAs combination with L-dopa therapy: 50 - 150 mg daily (50 mg per 250 mg of L-dopa)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.79","prescriberCat":"A*"},{"id":"drug-458","genericName":"Pramipexole Dihydrochloride 0.375 mg, 1.5mg ER Tablet","brandName":"Sifrol","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Treatment for signs and symptoms of advanced idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa","dosing":"Dose escalation: 0.375 mg/day on week 1, 0.75 mg/day on week 2, 1.5 mg/day on week 3. Increase by 0.75 mg at weekly intervals if needed up to a max of 4.5 mg/day. \\nPatient on l-dopa: reduce dose. \\nRenal Impairment: CrCl 30-50 mL/min Initially 0.375 mg every other day. \\nMay be increased by 0.375 mg at weekly intervals to max 2.25 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.00, 12.10","prescriberCat":"A*"},{"id":"drug-459","genericName":"Procyclidine HCl 10 mg/2 ml Injection","brandName":"Cyclid","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Injection"],"indications":"i) All forms of Parkinson's disease (idiopathic paralysis agitants), post-encephalitis and arteriosclerosis \\nii) To control troublesome extrapyramidal symptoms induced by neuroleptic drugs including pseudo-parkinsonism, acute dystonic reactions and akathisia","dosing":"i) Initial dose 2.5mg TDS, increasing by 2.5-5mg/day at intervals of 2 or 3 days until the optimum clinical response is achieved. Usual maintenance dose: 15-30mg/day. Max: 60mg/day \\nii) Initial dose 2.5mg TDS, increasing by 2.5mg daily until symptoms are relieved. Usual maintenance dose: 10-30mg/day. IV Emergency: 5-10 mg. IM Emergency: 5-10 mg as a single dose, may repeat after 20 mins if needed. Max: 20 mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"45.00","prescriberCat":"B"},{"id":"drug-460","genericName":"Selegiline HCl 5 mg Tablet","brandName":"Selegos","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.8 ANTIPARKINSON PREPARATION","forms":["Tablet"],"indications":"Only for treatment of late stage Parkinsonism with on and off phenomenon","dosing":"5 mg twice daily at breakfast and lunch. \\nMaximum 10 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.14","prescriberCat":"A*"},{"id":"drug-463","genericName":"Carbamazepine 100 mg/5 ml (2% w/v) Syrup","brandName":"Tegretol","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Syrup"],"indications":"Epilepsy","dosing":"ADULT: Initially, 100-200 mg once or twice daily gradually increased by increments of 100-200 mg every 2 week. Maintenance: 0.8-1.2 g daily in divided doses. \\nCHILD: 10-15 years: 0.6-1 g daily; 5-10 years: 400-600 mg daily; 1-5 years: 200-400 mg daily; less than or equal to 1 year: 100-200 mg daily. \\nAlternatively, 10-20 mg/kg body weight daily in divided doses. Max: Adult: 1.6 g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"50.50","prescriberCat":"A"},{"id":"drug-464","genericName":"Carbamazepine 200 mg Tablet","brandName":"Carzepin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"i) Epilepsy \\nii) Trigeminal neuralgia","dosing":"i) ADULT: 100 - 200 mg 1 - 3 times daily increased gradually to usual dose of 0.8 - 1.2 g daily in divided doses. \\nCHILD: Up to 1 year: 100 - 200 mg daily; 1 - 5 yrs: 200 - 400 mg daily; 5 - 10 years: 400 - 600 mg daily; 10 - 15 years: 0.6 - 1 g daily \\nii) The initial dosage of 200 to 400mg should be slowly raised daily until freedom from pain is achieved (normally at 200mg 3 to 4 times daily). The dosage should then be gradually reduced to the lowest possible maintenance level. In elderly patients, an initial dose of 100mg twice daily is recommended.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.13","prescriberCat":"B"},{"id":"drug-465","genericName":"Carbamazepine CR 400mg","brandName":"Tegretol CR","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["400mg"],"indications":"Epilepsy","dosing":"ADULT: Initial, 200 mg twice daily for the first week, may increase dosage by 200 mg/day at weekly intervals until optimal response is obtained. Maximum 1.6 g/day. \\nCHILD: usual maximum dosage 1000 mg/day in children 12-15 years of age, 1200 mg/day in patients above 15 years of age","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.09","prescriberCat":"A"},{"id":"drug-466","genericName":"Clobazam 10 mg Tablet","brandName":"Frisium","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"As adjunctive therapy in patients with epilepsy not adequately stabilised with their basic medication.","dosing":"The initial dose in adults and adolescents >15 yr should be low (5 to15mg daily), if necessary, increased gradually to a maximum daily dose of about 80mg. Doses of up to 30mg may be taken as a single dose in the evening. \\nThe initial dose in children from 3 to15 yr is normally 5mg. A maintenance dose of 0.3 to 1.0mg/kg body weight daily is usually sufficient.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"0.66","prescriberCat":"A*"},{"id":"drug-467","genericName":"Clonazepam 0.5 mg, 2 mg Tablet","brandName":"Rivotril, Rivopam","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"i) Epilepsy \\nii) Non-epileptic myoclonus","dosing":"i) & ii) ADULT: Initial dose should not exceed 1.5mg/day divided into 3 doses, may be increased in increments of 0.5mg every 3 days until seizures are controlled. Maintenance dose: 3-6mg/day. Maximum: 20mg/day. \\nCHILD up to 10 years: initial dose 0.01-0.03 mg/kg/day in 2-3 divided doses, increased by no more than 0.25-0.5mg every third day, maximum 0.2mg/kg/day. \\nCHILD 10-16 years: initial dose 1-1.5mg/day in 2-3 divided dose, may be increased by 0.25-0.5mg every third day until individual maintenance dose of 3-6mg/day is reached.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.30,  0.26","prescriberCat":"B"},{"id":"drug-468","genericName":"Diazepam 5 mg Rectal Solution Tube","brandName":"Stesolid","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tube"],"indications":"Status epilepticus, skeletal muscle spasm","dosing":"Status epilepticus - ADULT: 0.5 mg/kg repeated after 12 hours if necessary. \\nCHILD (febrile convulsions, prolonged or recurrent): 0.5 mg/kg (maximum 10 mg), repeated if necessary. Not recommended for children below 2 years","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"65.00","prescriberCat":"C"},{"id":"drug-469","genericName":"Gabapentin 300 mg, 600 mg Capsule","brandName":"Neurontin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Capsule"],"indications":"PRESCRIBER CATEGORY A*: Add-on therapy for intractable partial epilepsy, refractory to standard anti-epileptic drugs\\n. \\nPRESCRIBER CATEGORY A/KK: Treatment of various types of neuropathic pain, both peripheral (which includes diabetic neuropathy, post-herpetic neuralgia, trigeminal neuralgia) in adult more than 18 years.","dosing":"ADULT & CHILD > 12 yrs: 900-3600mg/day. \\nTherapy may be initiated by administered 300mg TDS on day 1, or by titrating the dose as: 300mg once on day 1, \\n300mg BD on day 2, \\n300mg TDS on day 3. \\nThereafter, may be increased in 3 equally divided doses up to max 3600mg/day.\\nCHILD 3-12 yr: Initially 10-15 mg/kg/day in 3 divided dose. Effective dose: \\nCHILD 3 to less than 5 yrs: 40mg/kg/day in 3 divided doses, \\nCHILD 5-12 yrs: 25-35mg/kg/day in 3 divided doses \\n\\nii) ADULT: 900mg/day in 3 equally divided doses. Max 3600mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Ortopedik, Perubatan)","price":"0.09, 0.40","prescriberCat":"A*"},{"id":"drug-470","genericName":"Lacosamide 100 mg Tablet","brandName":"Vimpat","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Epilepsy with severe learning disability","dosing":"100mg ON (every night)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"5.32","prescriberCat":"-"},{"id":"drug-471","genericName":"Lamotrigine 5 mg Dispersible Tablet","brandName":"Lamictal","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Management of seizures in children aged 2 - 12 years","dosing":"a) Add-on therapy in patients not taking Valproate: week 1 and 2: 2 mg/kg/day twice daily, week 3 and 4: 5 mg/kg/day twice daily. Maintenance: 5 - 15 mg/kg/day twice daily \\nb) Add-on therapy in patients taking Valproate or other anti-epileptic drugs, \\nweek 1 and 2: 0.2 mg/kg/day as a single dose \\n(children less than 25 kg may take 5 mg on alternate days), \\nweek 3 and 4: 0.5 mg/kg/day as a single dose. \\nMaintenance dose: 1 -5 mg/kg/day once daily or twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"1.26","prescriberCat":"A"},{"id":"drug-472","genericName":"Lamotrigine 25 mg Dispersible Tablet","brandName":"Generic","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Add-on therapy in intractable partial seizures","dosing":"25 mg daily - 50 mg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.59","prescriberCat":"A"},{"id":"drug-473","genericName":"Lamotrigine 100 mg Non-Dispersible tab.","brandName":"Lamotaxyl","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["tab."],"indications":"i) Adjunctive or monotherapy for partial seizures and generalised tonic-clonic seizures not satisfactorily controlled with other antiepileptic drugs \\nii) Prevention of mood episodes in adult 18 years and above with bipolar disorder, predominately by preventing depressive episodes","dosing":"i) Up to 200 mg daily in single or divided dosage \\nii) 25- 200 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"0.20","prescriberCat":"A"},{"id":"drug-474","genericName":"Levetiracetam 100 mg/ml Injection","brandName":"Keppra","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Injection"],"indications":"i) Monotherapy therapy in the treatment of partial onset seizures with or without secondary generalization in patients from age 16 years of age with newly diagnosed epilepsy \\nii) Adjunctive treatment in partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy; juvenile myoclonic epilepsy and idiopathic generalized tonic clonic epilepsy from 12 years of age. To be initiated when conventional IV antiepileptic drugs failed to achieve control, or oral form is temporarily not feasible in seizure emergencies","dosing":"i) ADULTS and ADOLESCENT (from 16 years): Starting dose: 250 mg twice daily, Increase dose to 500 mg twice daily after 2 week. Dose can be further increased by 250 mg twice daily every 2 weeks depending upon the clinical response. Max: 1500 mg twice daily. \\nii) ADULT more than 18 years and ADOLESCENT (12 to 17 years) more than or equal to 50 kg: Initially 500 mg twice daily may be increased up to 1500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2 to 4 weekly. \\nCHILD (4 to 11 years) and ADOLESCENT (12 to 17 years) less than 50 kg : Initially 10 mg/kg twice daily, may be increased up to 30 mg/kg twice daily. \\nDose changes should not exceed increments or decrements of 10 mg/kg twice daily every 2 weeks. CHILD more than or equal to 50 kg: Adult dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan, Pediatrik, Pembedahan)","price":"103.85","prescriberCat":"A*"},{"id":"drug-475","genericName":"Levetiracetam 100 mg/ml\\n Oral Solution","brandName":"Keppra","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Solution"],"indications":"As adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy","dosing":"CHILD: 4-11 years and adolescent (12-17 years) less than 50 kg: Initially 10 mg/kg twice daily, may be increased up to 30 mg/kg twice daily. \\nDose changes should not exceed increments or decrements of 10 mg/kg two times daily twice weekly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"86.65","prescriberCat":"A*"},{"id":"drug-476","genericName":"Levetiracetam 500 mg Tablet","brandName":"Torleva","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"i) Monotherapy therapy in the treatment of partial onset seizures with or without secondary generalization in patients from age 16 years of age with newly diagnosed epilepsy \\nii) Adjunctive treatment in partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy; juvenile myoclonic epilepsy and idiopathic generalized tonic clonic epilepsy from 12 years of age","dosing":"i) Monotherapy ADULTS and ADOLESCENT (from 16 years) : Starting dose: 250 mg twice daily, Increase dose to 500 mg twice daily after 2 week. Dose can be further increased by 250 mg twice daily every 2 week depending upon the clinical response. Max: 1500 mg twice daily. \\nii) ADULT more than 18 years and ADOLESCENT (12-17 years) more than or equal to 50 kg: Initially 500 mg twice daily may be increased up to 1500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2-4 weekly. \\nCHILD (4-11 years) and ADOLESCENT (12-17 years) less than 50 kg : Initially 10 mg/kg twice daily, may be increased up to 30 mg/kg twice daily. Dose changes should not exceed increments or decrements of 10 mg/kg twice daily every 2 weeks. \\nCHILD more than or equal to 50 kg: Adult dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"0.47","prescriberCat":"A*"},{"id":"drug-477","genericName":"Nitrazepam 5 mg Tablet","brandName":"Nitrapam","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Epilepsy (infantile spasms)","dosing":"5 - 10 mg at bedtime. ELDERLY or debilitated 2.5 - 5 mg. \\nCHILD not recommended. Increasing slowly according to response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.62","prescriberCat":"B"},{"id":"drug-478","genericName":"Perampanel 2 mg Film-coated Tablet","brandName":"Fycompa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Refractory Epilepsy","dosing":"2mg ON","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required (Dept: Pediatrik, Perubatan)","price":"3.58","prescriberCat":"Not in FUKKM"},{"id":"drug-479","genericName":"Phenobarbitone Sodium 200 mg/ml Injection","brandName":"Martindale","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Injection"],"indications":"Status Epilepticus","dosing":"ADULT: 10 mg/kg IV at a rate of not faster than 100 mg/minute. Initial maximum dose does not exceeding 1 gm. Daily maintenance :  1 - 4 mg/kg/day. \\nCHILD: 10 - 20 mg/kg/dose loading dose, followed by repeated doses at 10 mg/kg/dose (strictly in ICU setting). Maintenance: 5 - 8 mg/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Registered brand currently not available (UKK)","price":"52.92","prescriberCat":"B"},{"id":"drug-480","genericName":"Phenobarbitone 30 mg Tablet","brandName":"idaman Phenobarbitone","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Epilepsy","dosing":"ADULT: 60 - 180 mg daily on. \\nCHILD: Up to 8 mg/kg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.17","prescriberCat":"B"},{"id":"drug-481","genericName":"Phenytoin Sodium 250 mg/5ml Injection","brandName":"Pharmaniaga\\nPhenytoin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Injection"],"indications":"Status epilepticus","dosing":"i) Status epilepticus: ADULT : 10 - 15 mg/kg by slow IV. Maximum : 50 mg/minute. \\nMaintenance: 100 mg orally/IV every 6 - 8 hours.\\n CHILD : 15 - 20 mg/kg by slow IV. Maximum: 1 - 3 mg/kg/minute \\nii) Neurosurgery :  100 - 200 mg IM approximately at 4 hourly interval","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"15.31","prescriberCat":"B"},{"id":"drug-482","genericName":"Phenytoin Sodium 30 mg, 100 mg Capsule","brandName":"Dilantin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Capsule"],"indications":"Epilepsy","dosing":"ADULT and CHILD more than 6 years: 300-400 mg/day in 3 - 4 divided doses before meals. Maximum: 600 mg/day. \\nCHILD: Initially 5 mg/kg/day in 2 - 3 divided doses. Maintenance: 4 - 8 mg/kg/day. \\nMaximum: 300 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.37, 0.28","prescriberCat":"B"},{"id":"drug-483","genericName":"Pregabalin 75 mg Capsule","brandName":"Prelica","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Capsule"],"indications":"Kategori preskriber A*:\\ni. Fibromyalgia\\nii. Epilepsy\\nRestriction: Consultant/specialists for specific indications only, including Geriatricians\\n\\nKategori preskriber A/KK:\\niii. Neuropathic pain\\nRestriction: In primary care setting, for patients who cannot tolerate gabapentin at high doses.","dosing":"The dose range is 150 to 600 mg per day given in either two or three divided doses.\\n\\nDosing is according to Product Insert","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Ortopedik)","price":"1.08","prescriberCat":"A*, A/KK\\n\\nConsultant/ specialists for specific indications only, including Geriatricians"},{"id":"drug-484","genericName":"Pregabalin 150 mg Capsules","brandName":"Prelica","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Capsules"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.46","prescriberCat":""},{"id":"drug-485","genericName":"Sodium Valproate 400 mg Injection","brandName":"Epilim","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Injection"],"indications":"Status epilepticus","dosing":"ADULT and CHILD above 10 years: 10 to 15 mg/kg/day IV, may increase 5 to 10 mg/kg/week to achieve optimal clinical response \\n(Maximum 60 mg/kg/day or less with a therapeutic range of 50 to 100 mcg/mL)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"85.59","prescriberCat":"B"},{"id":"drug-486","genericName":"Sodium Valproate 200 mg/5 ml Syrup","brandName":"Epilim","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Syrup"],"indications":"Epilepsy","dosing":"ADULT: Initially 600 mg/day; dose may be increased by 200 mg at 3-day intervals to max 2500 mg/day. Usual maintenance dose: 1000-2000 mg/day (20-30 mg/kg/day). \\nCHILD: More than 20 kg: Initially 400 mg/day with spaced increases until control is achieved (usually 20-30 mg/kg/day), dose may be increased to 35 mg/kg/day. \\nLess than 20 kg: 20 mg/kg/day. \\nSevere cases: 50 mg/kg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"55.20","prescriberCat":"B"},{"id":"drug-487","genericName":"Sodium Valproate 200 mg Tablet","brandName":"Epilim","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"i. Epilepsy \\nii. Treatment and prevention of mania associated with bipolar disorders","dosing":"i. Epilepsy: ADULT: Initially 600 mg/day in 2 - 3 divided doses, dose may be increased by 200 mg at 3-day intervals to max 2.5 g/day. \\nUsual maintenance dose: 1-2 g/day (20-30 mg/kg/day). \\nCHILD: More than 20 kg : Initially 400 mg/day with spaced increases until control is achieved (usually 20-30 mg/kg/day), dose may be increased to 35 mg/kg/day. Less than 20 kg : 20 mg/kg/day, in severe cases the dose may be increased provided plasma concentration can be monitored.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.23","prescriberCat":"B"},{"id":"drug-489","genericName":"Topiramate 25 mg, 100 mg Tablet","brandName":"Topamax, Epimate","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"Add-on therapy for intractable partial epilepsy","dosing":"ADULT: Initially 25-50mg nightly for 1 week. Subsequently at wkly or bi-wkly intervals, increase dose by 25-50 to 100mg/day in 2 divided doses. \\nCHILD aged 2 and above: Approx 5-9 mg/kg/day in 2 divided doses. Titrate at 25mg (or less, based on a range of 1-3mg/kg/day) nightly for the 1st week. Subsequently at 1 or 2 wkly intervals, with increments of 1-3 mg/kg/day in 2 divided dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.76,4.08","prescriberCat":"A*"},{"id":"drug-490","genericName":"Valproic Acid & Sodium Valproate (ER) 500mg Tablet","brandName":"Valparin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"i) In the treatment of generalized or partial epilepsy, particularly with the following patterns of seizures:absence, myoclonic, tonic-clonic, atonic-mixed as well as, for partial epilepsy:simple or complex seizures, secondary generalized seizures, specific syndrome (West, Lennox-Gastatut). \\nii) Treatment and prevention of mania associated with bipolar disorders.","dosing":"i) Adults: Dosage should start at 500mg daily increasing by 200mg at three-day intervals until control is achieved. This is generally within the dosage range 1000mg to 2000mg per day. \\nChildren: >20KG: 500mg/day (irrespective of weight) with spaced increases until control is achieved. \\nii) Initial dose of 1000mg/day, to be increase rapidly as possible to achieve lowest therapeutic dose, which produce desired clinical effects. Recommend initial dose is 1000mg & 2000mg daily. Max dose 3000mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"0.62","prescriberCat":"B"},{"id":"drug-491","genericName":"Vigabatrin 500mg Tablet","brandName":"Sabril","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["Tablet"],"indications":"i) early infantile epileptic encephalopathy with infantile spasm\\nii) Epileptic encephalopathy","dosing":"i) 250mg BD (twice daily)\\nii) 500 mg BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"special drugs approval\\n(UKK) (secara pukal) required once a year for infantile spasm (Dept: Pediatrik)","price":"3.35","prescriberCat":"Not in FUKKM"},{"id":"drug-492","genericName":"Zonisamide 100mg tablet","brandName":"Zonergan","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.9 ANTICONVULSANTS","forms":["tablet"],"indications":"As adjunctive therapy in the treatment of partial seizures in adults with epilepsy.\\n\\nOff-label use in HSM: Adjunctive treatment for Parkinson disease","dosing":"For adults, usually 100 to 200mg of zonisomide is to be administered orally 1 to 3 times a day initially. The dose is gradually increased at every one to two weeks up to 200-400mg daily, in 1 to 3 divided dose. The maximum daily dose should not exceed 600mg per day.\\nPrescribing restriction:\\nAs adjunctive therapy in the treatment of partial seizures in adults with epilepsy when 1st line and 2nd line therapy failed.\\n\\nParkinson disease: 100mg OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required for off-label indication (Dept: Perubatan)","price":"1.22","prescriberCat":"A*"},{"id":"drug-495","genericName":"Agomelatine 25mg Tablet","brandName":"Valdoxan","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Major depression","dosing":"The recommended dose is 25mg once daily at bedtime, maybe increased to 50mg once daily at bedtime.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"3.90","prescriberCat":"A*"},{"id":"drug-496","genericName":"Amitriptyline HCl 25 mg Tablet","brandName":"Apo-Amitryptyline","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Depression","dosing":"Initially 25mg 3 times a day. Maintenance: 25-100mg daily in divided doses. \\nHospitalized patient: 100mg/day &gradually increase to 200-300mg/day. \\nADOLESCENT and ELDERLY: initially 20-30mg/day in divided doses w/ gradual increments. \\nCHILD under 16 years are not recommended.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.29","prescriberCat":"B"},{"id":"drug-497","genericName":"Clomipramine HCI 25 mg Tablet","brandName":"Apo-\\nClomipramine","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Depression, obsessive-compulsive disorder.","dosing":"Initially 10 mg daily, increased gradually as necessary to 30 - 150 mg daily in divided doses or as a single dose at bedtime; max 250 mg daily. \\nELDERLY: initially 10 mg daily increased carefully over approximately 10 days to 30 - 75 mg daily\\nChild: 10 yr: Initially, 25 mg daily, increased gradually over 2 wk. Max: 3 mg/kg/day or 100 mg daily, whichever is smaller. \\nGive in divided doses. Once titrated, dose may be given as a single dose at bedtime.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.77","prescriberCat":"A"},{"id":"drug-498","genericName":"Desvenlafaxine Succinate 50 mg Extended Release Tablet","brandName":"Pristiq","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Major depression","dosing":"Recommended dose is 50mg once daily, with or without food.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"4.44","prescriberCat":"A*"},{"id":"drug-499","genericName":"Dothiepin HCl 25 mg, 75 mg Capsule","brandName":"Depropin, Dothep","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Capsule"],"indications":"Depression of any aetiology","dosing":"Initially 75 mg (ELDERLY 50-75 mg) daily in divided doses or single dose at bedtime, increased gradually as necessary to 150 mg daily (ELDERLY 75 mg may be sufficient), up to 225 mg daily in some circumstances. CHILD is not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.37, 1.52","prescriberCat":"A"},{"id":"drug-500","genericName":"Duloxetine 30 mg, 60 mg Capsule","brandName":"Cymbalta, Dulox","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Capsule"],"indications":"Major depression, diabetic peripheral neuropathic pain","dosing":"ADULT: 60 mg once daily up to a maximum dose of 120mg/day (in divided doses) \\nCHILD and ADOLESCENT under 18 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"4.31, 4.31","prescriberCat":"A*"},{"id":"drug-501","genericName":"Escitalopram 10 mg Tablet","brandName":"ESLO","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"i) Major depression \\nii) Treatment of panic disorder with or without agoraphobia","dosing":"i) 10 mg once daily; may be increased to max 20 mg daily. \\nii) Panic disorder with or without agoraphobia :Initially 5 mg for the first week, thereafter increased to 10 mg daily. Max 20 mg daily, \\nELDERLY: initially half the adult dose, lower maintenance dose may be sufficient. \\nCHILD and ADOLESCENT under 18 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Geriatrik)","price":"0.12","prescriberCat":"B"},{"id":"drug-502","genericName":"Fluoxetine HCl 20 mg Capsule","brandName":"Fluovex","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Capsule"],"indications":"i) Depression \\nii) Obsessive-compulsive disorder","dosing":"i) 20 mg once daily increased after 3 weeks if necessary, usual dose 20 - 60 mg (ELDERLY: 20 - 40 mg) once daily. Max : 80 mg once daily (ELDERLY: Max: 60 mg once daily). \\nii) Initially 20 mg once daily increased after 2 weeks if necessary, usual dose 20 - 60 mg (ELDERLY 20 - 40 mg) once daily. Max: 80 mg (ELDERLY max 60 mg) once daily, discontinue if no improvement within 10 weeks. \\nCHILD and ADOLESCENT under 18 years are not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.49","prescriberCat":"A/KK"},{"id":"drug-503","genericName":"Fluvoxamine 50 mg, 100 mg Tablet","brandName":"Luvox","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Depression","dosing":"For depression, initially 50 - 100 mg daily in the evening, increased if necessary to 300 mg daily (over 150 mg in divided doses); usual maintenance dose : 100 mg daily. \\nCHILD and ADOLESCENT under 18 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"0.31,  0.83","prescriberCat":"B"},{"id":"drug-504","genericName":"Mirtazapine 15 mg, 30 mg Orodispersible Tablet","brandName":"Remeron","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Major depression","dosing":"Initially 15 mg daily at bedtime increased according to response up to 45 mg daily as a single dose at bedtime or in 2 divided doses. \\nCHILD and ADOLESCENT under 18 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Geriatrik)","price":"2.35,  4.52","prescriberCat":"A*"},{"id":"drug-505","genericName":"Moclobemide 150 mg Tablet","brandName":"Aurorix","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Treatment of depressive syndrome","dosing":"Initially 300 mg daily in divided doses. Gradually to increase up to 600 mg daily in divided doses depending on response. Usual range 150 - 600 mg daily. Not recommended in children","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"2.40","prescriberCat":"A*"},{"id":"drug-506","genericName":"Sertraline HCI 50 mg Tablet","brandName":"Serlift","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Major depression, obsessive-compulsive disorder (OCD), panic disorder","dosing":"Depression, obsessive-compulsive disorder: 50 mg/day, may increase in steps of 50mg at weekly interval, max:200mg/day. \\nPanic disorder: Initially 25 mg/day. After 1 week, increase dose to 50 mg/day. All dose changes should be made at intervals of more than 1 week, max: 200 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Perubatan, Geriatrik)","price":"0.13","prescriberCat":"B"},{"id":"drug-507","genericName":"Venlafaxine HCl 75 mg Extended Release Capsule","brandName":"EFEXOR","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Capsule"],"indications":"i) Depression \\nii) Generalized anxiety disorder \\niii) Social anxiety disorder (social phobia) \\niv) Panic disorder","dosing":"i), ii) & iii) ADULT: 75 mg once daily. May increase dose by 75 mg/day every 4 days to a maximum dose of 225 mg/day, (severe depression: max: 375mg/day) i\\nv) 37.5 mg/day for the first 4-7 days after which the dose should be increased to 75 mg once daily. CHILD and ADOLESCENT under 18 years not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik)","price":"2.89","prescriberCat":"A*"},{"id":"drug-508","genericName":"Vortioxetine 10 mg Tablet","brandName":"Brintellix","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.10 ANTIDEPRESSANTS","forms":["Tablet"],"indications":"Treatment of major depressive episodes in adults.\\n\\nRestriction:\\nConsultant/specialists for specific indications only, including Geriatricians and Neurologists","dosing":"ADULT\\nInitially 10 mg once daily, may be increased to max: 20 mg once daily or decreased to min: 5 mg once daily.\\n\\nELDERLY\\nInitially 5 mg once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik)","price":"4.60","prescriberCat":"A*"},{"id":"drug-511","genericName":"Atracurium Besylate 25mg/2.5 ml Injection","brandName":"Atracurium - Hameln","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Injection"],"indications":"Muscle relaxant in general anaesthesia, Endotracheal intubation, Aid controlled ventilation.","dosing":"Adult & childn >2 mth: 0.3-0.6 mg/kg IV. \\nEndotracheal intubation dose: 0.5-0.6 mg/kg. \\nSupplementary dose: 0.1-0.2 mg/kg as required. \\nContinuous infusion rates : of 0.3-0.6 mg/kg/hr to maintain neuromuscular block during long surgical procedure.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.52","prescriberCat":"A*"},{"id":"drug-512","genericName":"Baclofen 10 mg Tablet","brandName":"Musafen","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Tablet"],"indications":"Spasticity of the skeletal muscle","dosing":"ADULT: 5 mg 3 times daily. Max: 80 mg daily. \\nCHILD: 0.75 - 2 mg/kg daily \\n(more than 10 years, maximum: 2.5 mg/kg daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.88","prescriberCat":"B"},{"id":"drug-513","genericName":"Cisatracurium Besylate 2 mg/ml Injection","brandName":"Fresenius","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Injection"],"indications":"As an adjunct to general anaesthesia to facilitate endotracheal intubation, to provide skeletal muscle relaxation during surgery and to facilitate mechanical ventilation. Restricted to patients with lung problem such as asthma.","dosing":"Administered as bolus intravenous injection. May be administered as infusion in ICU patients at a rate of 3mcg/kg/min. \\nAdult dose: a) Induction: 0.15mg/kg over 5-10 secs, b) Maintenance: 0.03 mg/kg. \\nChildren 2-12 years: a) Induction: 0.1 mg/kg over 5-10 secs, b) Maintenance: 0.02 mg/kg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"17.70","prescriberCat":"A*"},{"id":"drug-514","genericName":"Clostridium Botulinum Toxin Type A Powder for Injection 100 units","brandName":"Allergan \\nBotox","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["units"],"indications":"i) Focal dystonias\\nii) Hemifacial spasm\\niii) Spasticity including cerebral palsy\\niv) Neurogenic bladder","dosing":"20 - 200 units 3 months once\\n\\nHSM Practice: average 300 units every 4 months","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"1048.50","prescriberCat":"A*"},{"id":"drug-515","genericName":"Eperisone HCl 50 mg Tablet","brandName":"Myonal","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Tablet"],"indications":"Myotonic symptoms associated with cervical syndrome, periarthritis of shoulder and lumbago spastic paralysis","dosing":"50 mg 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.72","prescriberCat":"A"},{"id":"drug-516","genericName":"Orphenadrine Citrate 60mg/2ml Injection","brandName":"Norflex","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Injection"],"indications":"Painful muscle spasm, extrapyramidal side effects associated with antipsychotics","dosing":"Adult: 60mg IM/IV. May be repeated in 12 hours.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase (UKK) (Dept: Psikiatrik)","price":"27.90","prescriberCat":"Not in FUKKM"},{"id":"drug-517","genericName":"Rocuronium Bromide 10 mg/ml Injection","brandName":"Rocuronium Kabi","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Injection"],"indications":"As an adjunct to general anaesthesia to facilitate endotracheal intubation, to provide skeletal muscle relaxation during surgery and to facilitate mechanical ventilation in adults, children and infants from one month of age.","dosing":"Adult: Initially, 600 mcg/kg by inj. Higher doses of 1 mg/kg may be used for intubation during rapid sequence induction of anaesthesia. Maintenance: 150 mcg/kg by inj (may reduce to 75-100 mcg/kg if inhalational anaesthesia is used) or by infusion at a rate of 300-600 mcg/kg/hr. Doses should be based on lean body weight for obese patients weighing >30% above the ideal body weight. \\nChild: Infants and children >1 mth: Initially, 600 mcg/kg by inj. Maintenance: 150 mcg/kg by inj or by infusion at a rate of 300-600 mcg/kg/hr, maintenance doses may be required more frequently than in adult patients. \\nElderly: Reduced maintenance doses: 75-100 mcg/kg. \\nRenal impairment: Initially, 600 mcg/kg by inj. Maintenance: 75-100 mcg/kg. \\nHepatic impairment: or biliary tract disease: Initially, 600 mcg/kg by inj. Maintenance: 75-100 mcg/kg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.47","prescriberCat":"A*"},{"id":"drug-518","genericName":"Suxamethonium Chloride 50 mg/ml lnj","brandName":"Suxamethonium","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["lnj"],"indications":"Muscle relaxant as an adjunct to anaesthesia","dosing":"Intravenous: Muscle relaxant in general anaesthesia \\nAdult: As chloride: single dose of 0.3-1.1 mg/kg injected; supplementary doses of 50-100% of the initial dose may be given at 5-10 min intervals. Max dose (repeated IV injection or continuous infusion): 500 mg/hr \\nChild: As chloride: <1 yr: 2 mg/kg; 1-12 yr: 1 mg/kg. \\nIntramuscular: Muscle relaxant in general anaesthesia \\nAdult: As chloride: 3-4 mg/kg. Max total dose: 150 mg \\nChild: As chloride: <1 yr: Up to 4-5 mg/kg; =1 yr: Up to 4 mg/kg. Max dose: 150 mg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.42","prescriberCat":"B"},{"id":"drug-519","genericName":"Vecuronium Bromide 4 mg/ml Injection","brandName":"Norcuron","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.11 MUSCLE RELAXANTS","forms":["Injection"],"indications":"As an adjunct in anaesthesia to produce skeletal muscle relaxation","dosing":"ADULT & NEONATES > 5 MONTHS Initial: 80-100 mcg/kg as inj. Maintenance: 20-30 mcg/kg, adjust according to response. Alternatively, as continuous infusion at 0.8-1.4 mcg/kg/min after initial IV dose of 40-100 mcg/kg. \\nNEONATE and INFANT up to 4 months: Initially 10 - 20 mcg/kg, then incremental dose to achieve response.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.80","prescriberCat":"A*"},{"id":"drug-522","genericName":"Neostigmine Methylsulphate 2.5 mg/ml Injection","brandName":"Setisin","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.12 CHOLINERGICS","forms":["Injection"],"indications":"i) Myasthenia gravis \\nii) Reversal of non-depolarising neuromuscular blockade","dosing":"i) ADULT: 1 - 2.5 mg at suitable intervals by SC, IM or IV. Usual total daily dose 5 - 20 mg. \\nCHILD: 200 - 500 mcg at suitable intervals throughout the day. \\nNEONATE: 50 - 250 mcg every 4 hours \\nii) By IV injection over 1 minute, 50 - 70 mcg/kg (maximum 5 mg) after or with atropine sulphate 0.6 - 1.2 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.02","prescriberCat":"B"},{"id":"drug-523","genericName":"Pyridostigmine Bromide 60 mg Tablet","brandName":"Mestinon","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.12 CHOLINERGICS","forms":["Tablet"],"indications":"Myasthenia gravis","dosing":"ADULT: 30 - 120 mg at suitable intervals throughout the day, total daily dose 0.3 - 1.2 g. \\nCHILD up to 6 years: Initially 30 mg\\n6 - 12 years: Initially 60mg, usual total daily dose 30-360 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.36","prescriberCat":"B"},{"id":"drug-526","genericName":"Donepezil HCl 5 mg,10 mg Tablet","brandName":"Alzer","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.13 ANTIDEMENTIA","forms":["Tablet"],"indications":"Treatment of mild, moderate and severe dementia in Alzheimer's disease. \\nRestriction:\\nPsychiatrists, Neurologists, Geriatricians, Family Medicine Specialists trained in Mental Health Disorders","dosing":"5 - 10 mg once daily at bedtime. Maximum: 10 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Psikiatrik, Geriatrik)","price":"0.16,  0.26","prescriberCat":"A/KK"},{"id":"drug-527","genericName":"Donepezil Orodispersible 5 mg, 10 mg Tablet","brandName":"Torpezil, Aricept Evess","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.13 ANTIDEMENTIA","forms":["Tablet"],"indications":"Treatment of mild to moderate dementia in Alzheimer's disease, as well as in patients with severe Alzheimer's disease. [psychiatrists and neurologists only]","dosing":"Initiated at 5mg/day (one a day dosing), should be maintained for at least 1 month in order to allow the earliest clinical responses and to allow steady state concentration to be achieved. The maximum recommended daily dose is 10 mg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.93,  5.75","prescriberCat":"A*"},{"id":"drug-528","genericName":"Rivastigmine 3 mg Capsule","brandName":"Rivadem","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.13 ANTIDEMENTIA","forms":["Capsule"],"indications":"For psychiatrists and neurologists only. Mild to moderately severe dementia associated with Alzheimer's or Parkinson's disease","dosing":"Initial dose : 1.5 mg 2 times daily, may increase by 1.5 mg 2 times daily every 2 weeks to maximum of 6 mg 2 times daily. \\nIf treatment is interrupted for several days, should be reinitiated at the lowest daily dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Psikiatrik, Geriatrik)","price":"1.25","prescriberCat":"A*"},{"id":"drug-529","genericName":"Rivastigmine 4.6 mg/24 hr, 9.5 mg/24 hr  Transdermal Patch","brandName":"Rivamensa","category":"5.0 NEUROMUSCULAR SYSTEM\\n5.13 ANTIDEMENTIA","forms":["Patch"],"indications":"Mild to moderately severe dementia associated with Alzheimer's or Parkinson's disease","dosing":"Initial, 4.6 mg/24 hr patch TOPICALLY once daily; after a minimum of 4 weeks and good tolerability, increase the dose to 9.5 mg/24 hr patch once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Psikiatrik, Geriatrik)","price":"6.56","prescriberCat":"A*"},{"id":"drug-532","genericName":"Amikacin 250 mg/2 ml Injection","brandName":"Apalin","category":"6.0 ANTIBIOTICS\\n6.1 AMINOGLYCOSIDES","forms":["Injection"],"indications":"Infections due to susceptible organisms","dosing":"ADULT: (IM or IV): 15 mg/kg/day 8 - 12 hourly for 7 - 10 days. Maximum: 1.5 g/day. \\nCHILD: 15 mg/kg/day 8 - 12 hourly. Maximum: 1.5 g/day. \\nNeonates: Initial loading dose of 10 mg/kg followed by 7.5 mg/kg/day 12 hourly. \\nMaximum 15mg/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.64","prescriberCat":"A"},{"id":"drug-533","genericName":"Gentamicin 7.5 mg Beads","brandName":"Septopal","category":"6.0 ANTIBIOTICS\\n6.1 AMINOGLYCOSIDES","forms":["Beads"],"indications":"Treatment of chronic osteomyelitis of post-traumatic, post-operative or hematogenous origin","dosing":"7.5 - 22.5 mg chains to fill affected cavity","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1253.00","prescriberCat":"A"},{"id":"drug-534","genericName":"Gentamicin Sulphate 80 mg/2 ml Injection","brandName":"Garasent","category":"6.0 ANTIBIOTICS\\n6.1 AMINOGLYCOSIDES","forms":["Injection"],"indications":"Infections due to susceptible organisms","dosing":"ADULT: 3 - 5 mg/kg/day 8 hourly IM or IV. \\nCHILD up to 2 weeks: 3mg/kg every 12 hours; \\n2 weeks - 12 years: 2 mg/kg 8 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.80","prescriberCat":"B"},{"id":"drug-537","genericName":"Cefazolin Sodium 1 g Injection","brandName":"AFT","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Infection caused by cefazolin-sensitive microorganism, infection of the respiratory tract, urogenital tract, skin and soft tissue, bile duct, bones and joint, endocarditis, systemic septic infection, peri-operative/ surgical prophylaxis","dosing":"ADULT: Uncomplicated infections: 500 - 1000 mg 2 - 3 times daily. \\nModerately severe and severe infections: 500 - 1000 mg 3 - 4 times daily. \\nSevere life-threatening infections: 1 - 1.5 g 4 times daily. \\nRarely, dose up to 12 g daily. \\nCHILDREN >1 month: 25-50mg/kg/day in 3-4 divided dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.90","prescriberCat":"A"},{"id":"drug-538","genericName":"Cefepime 1 g Injection","brandName":"Vaxcel","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Febrile neutropenia, septicaemia, lower respiratory tract infection, urinary tract infection, skin and skin structure infections, gynaecologic and intra-abdominal infections","dosing":"ADULT: 1 - 2 g twice daily for most infections. \\nFor severe infections including febrile neutropenia: 2 g 3 times daily. \\nCHILD:2 mth - 16 yr:  40 kg: 50 mg/kg every 8-12 hr for 7-10 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.20","prescriberCat":"A*"},{"id":"drug-539","genericName":"Cefoperazone Sodium 1 g Injection","brandName":"Cefobid , Bicafar","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Infections due to gram-negative bacteria","dosing":"ADULT: 1 - 2 g twice daily IM or IV. By IV, adult dose may be doubled. Maximum: 16 g daily in divided doses. \\nCHILD & INFANT: 50 - 200 mg/kg/day in 2 - 4 divided doses. \\nNEONATE less than 8 days: 50 - 200 mg/kg/day 12 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.48","prescriberCat":"A"},{"id":"drug-540","genericName":"Cefoperazone Sodium 500 mg & Sulbactam Sodium 500 mg Injection","brandName":"CEFOBACTAM","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"i) Treatment of infections due to multi-drug resistance pathogens producing B-lactamase \\nii) Treatment of infections caused by Acinetobacter species","dosing":"ADULT: 1 - 2 g twice daily. In severe or refractory infections the daily dosage of sulbactam/cefoperazone may be increased up to 8g (4g cefopreazone activity) \\nCHILD: 40 - 80 mg/kg/day in 2 to 4 equally divided doses; in serious or refractory infections, may increase to 160mg/kg/d in 2 - 4 equally divided doses.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.52","prescriberCat":"A"},{"id":"drug-541","genericName":"Cefotaxime 0.5 g, 1 g Injection","brandName":"Rekaxime","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Infections due to gram-negative bacteria","dosing":"ADULT: 1 g 12 hourly (up to 12 g/day in severe cases). \\nCHILD: 50 - 180 mg/kg/day in 4 - 6 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.66, 8.47","prescriberCat":"A"},{"id":"drug-542","genericName":"Ceftazidime 2 g Injection","brandName":"Fortum, Cefatum","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Severe gram negative bacterial infections","dosing":"ADULT: 1 g 8 hourly or 2 g 12 hourly. In severe infections: 2 g 8 hourly. CHILD: 25 - 150 mg/kg/day in 2 - 3 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.06","prescriberCat":"A"},{"id":"drug-543","genericName":"Ceftazidime 2g & Avibactam 0.5g Injection","brandName":"Zavicefta","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"i. Complicated intra-abdominal infection, in combination with metronidazole;\\nii. Complicated urinary tract infection, including pyelonephritis;\\niii. Hospital-acquired pneumonia, including ventilator-associated pneumonia.\\n\\nPrescribing Restrictions:\\ni. To be restricted to carbapenem-resistant Enterobacteriaceae (CRE) as an alternative to polymyxin.\\nii. Treatment initiated after proven susceptibility to ceftazidime/avibactam via C&S testing.\\niii. To be prescribed by Infectious Disease Specialist only","dosing":"Ceftazidime 2g / Avibactam 0.5g vial three times daily by intravenous infusion over 2 hours in patients 18 years or older for 5 to 14 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"215.50","prescriberCat":"A"},{"id":"drug-544","genericName":"Ceftriaxone 1g Injection","brandName":"UNOCEF","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Infections caused by susceptible organisms","dosing":"ADULT: 1 - 2 g once daily. Severe infection: 4 g daily at 12 hour intervals. \\nINFANT & CHILD, 3 weeks - 12 years: 20 - 80 mg/kg body weight daily. \\nCHILD with body weight 50 kg or more: adult dose. \\nNEONATE up to 2 weeks: 20 - 50 mg/kg body weight daily, not to exceed 50 mg/kg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.90","prescriberCat":"A"},{"id":"drug-545","genericName":"Cefuroxime Axetil \\n125 mg/5 ml Suspension","brandName":"Zinnat","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Suspension"],"indications":"Infections caused by susceptible organisms","dosing":"30 mg/kg/day in 2 divided doses, up to 500 mg daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"15.19","prescriberCat":"A"},{"id":"drug-546","genericName":"Cefuroxime Axetil 125 mg Tablet","brandName":"Auroxetil","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Tablet"],"indications":"Upper and lower respiratory tract, genito-urinary tract, skin & soft tissue and urinary tract infections (UTI)","dosing":"ADULT:\\nMost infections: 250 mg twice daily\\nSevere infections: 500mg twice daily\\n\\nCHILD:\\nMost infections: 125mg twice daily or 30 mg/kg/day in 2 divided doses, up to 500 mg daily\\nSevere infections: 250mg twice daily\\n\\nDosing is individualised and according to package insert","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.50","prescriberCat":"A/KK"},{"id":"drug-547","genericName":"Cefuroxime Sodium 750 mg Injection","brandName":"Anikef","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Injection"],"indications":"Infections caused by susceptible organisms, surgical prophylaxis","dosing":"ADULT: 750 mg every 6 - 8 hours as IM or IV. Severe infections: 1.5 g every 6 - 8 hours as IV. \\nCHILD: 30 - 100 mg/kg/day in 3 - 4 divided doses or 2-3 divided doses in neonates. \\nSurgical prophylaxis: 1.5 g IV","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.42","prescriberCat":"A"},{"id":"drug-548","genericName":"Cephalexin Monohydrate 250 mg Capsule","brandName":"Cephalexin","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Capsule"],"indications":"i) Respiratory tract infection, urinary tract infection \\nii) Complicated, recurrent or chronic infections, bronchitis \\niii) Pneumonia","dosing":"i) 250 mg 6 hourly \\nii) 250 - 500 mg 6 hourly \\niii) 1 - 1.5 g 3 times daily or 4 times daily. Maximum: 6 g/day \\nChild: 25-100 mg/kg daily in divided doses. Max: 4 g daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.19","prescriberCat":"B"},{"id":"drug-549","genericName":"Cephalexin Monohydrate 125 mg/5 ml Syrup","brandName":"Dynalexin","category":"6.0 ANTIBIOTICS\\n6.2 CEPHALOSPORINS","forms":["Syrup"],"indications":"Respiratory tract infections, ear, nose and throat infections, urinary tract infections, obstetric and gynaecologic infections","dosing":"CHILD: 25 - 100 mg/kg/day every 6 hourly. Maximum: 4 g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.07","prescriberCat":"B"},{"id":"drug-552","genericName":"Azithromycin 200 mg/5 ml Granules","brandName":"Binozyt, Imexa","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Granules"],"indications":"PRESCRIBER CATEGORY A*: Treatment of complicated respiratory tract infections. \\nPRESCRIBER CATEGORY A/K: Treatment of pertussis","dosing":"CHILD: 36 - 45 kg: 400 mg, \\n26 - 35 kg: 300mg, \\n15 - 25 kg: 200 mg,\\n less than 15 kg: 10 mg/kg. \\nTo be taken daily for 3 days or to be taken as a single dose on day 1, then half the daily dose on days 2 - 5","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"6.80, 15.7","prescriberCat":"A*"},{"id":"drug-553","genericName":"Azithromycin 500 mg Injection","brandName":"Vaxcel","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Injection"],"indications":"Only for treatment of severe atypical pneumonia","dosing":"500 mg IV as a single daily dose for a minimum of two days followed by 500 mg oral dose as a single daily dose to complete a 7 - 10 days course","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"18.24","prescriberCat":"A*"},{"id":"drug-554","genericName":"Azithromycin 250 mg Tablet","brandName":"Ziomycin","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Tablet"],"indications":"Category of prescriber A/KK is only approved for indications: \\n(i) Adult treatment of uncomplicated genital infections due to Chlamydia trichomatis or susceptible Neisseria gonorrhoea. \\n(ii) Treatment of pertussis \\nThe following indications are still under the category of prescriber A*: \\n(iii) Treatment of complicated respiratory tract infections; \\n(iv) Prophylaxis against Mycobacterium avium complex in patients with advanced HIV.","dosing":"i) 1 g as a single dose; \\nii) 500mg in a single dose on day 1 then 250mg per day on days 2-5 \\niii) 500 mg daily for 3 days\\niv) 1 g weekly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.48","prescriberCat":"A*"},{"id":"drug-555","genericName":"Clarithromycin 250 mg Tablet","brandName":"Claritrox - 250","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Tablet"],"indications":"Only for i) treatment of complicated respiratory tract infection not responding to standard macrolides \\nii) eradication of Helicobacter pylori infection","dosing":"i) 250 - 500 mg twice daily. Up to 6 - 14 days \\nii) 500 mg twice daily with omeprazole & amoxicillin. Up to 2 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pembedahan, Endoskopi)","price":"0.67","prescriberCat":"A*"},{"id":"drug-556","genericName":"Clindamycin HCl 300 mg Capsule","brandName":"Tidact","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Capsule"],"indications":"i) Skin and soft tissue infections, bone& joint infections \\nii) Cerebral toxoplasmosis \\niii) Children less than 8 years old:Treatment and prophylaxis of malaria in combination with quinine, as an alternative to doxycline","dosing":"i) ADULT: 150 - 300 mg every 6 hours; up to 450 mg every 6 hours in severe infections; Max: 1.8g/day \\nCHILD: 3 - 6 mg/kg every 6 hours. Children weighing <10 kg should receive at least 37.5 mg every 8 hr. \\nii) 600 mg 6 hourly for 6 weeks \\niii) 10mg/kg twice a day, in combination with quinine. The combination to be given for 7 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, pembedahan, ortopedik)","price":"0.78","prescriberCat":"A*"},{"id":"drug-557","genericName":"Clindamycin Phosphate 150mg/ml Injection","brandName":"Tidact","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Injection"],"indications":"i) Skin and soft tissue infections, bone & joint infections\\nii) Cerebral toxoplasmosis","dosing":"i) ADULT: 0.6 - 2.7 g daily (in 2 - 4 divided doses); up to 4.8 g daily; CHILD over 1 month, 20 - 40 mg/kg/day or 350 mg/m2/day in 3 - 4 divided doses\\nii) 1200 mg every 6 hours for 3 weeks followed by 300 mg orally every 6 hours for another 3 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"15.96","prescriberCat":"A*"},{"id":"drug-558","genericName":"Erythromycin Ethylsuccinate 200 mg/5 ml Suspension","brandName":"Ericin, Ettrocin","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Suspension"],"indications":"Treatment of susceptible bacterial infections","dosing":"Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases. \\n2-8 yr: 1 g daily in divided doses; \\n<2 yr: 500 mg daily in divided doses.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.96","prescriberCat":"B"},{"id":"drug-559","genericName":"Erythromycin Ethylsuccinate 400 mg Tablet","brandName":"Axcel","category":"6.0 ANTIBIOTICS\\n6.3 MACROLIDES","forms":["Tablet"],"indications":"Treatment of susceptible bacterial infections","dosing":"Adult: 400 mg 6 hrly or 800 mg 12 hrly. Max: 4 g/day. \\nChildn : 30-50 mg/kg in divided doses. \\nChildn 2-8 yr: 1 g/day in divided doses in severe cases. \\nInfant & childn 2 yr : 500 mg/day in divided doses.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.38","prescriberCat":"B"},{"id":"drug-562","genericName":"Amoxicillin 250 mg Capsule","brandName":"Betamox","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Capsule"],"indications":"Infections caused by susceptible strains of gram positive and gram negative organisms","dosing":"ADULT: 250 - 500 mg 3 times daily. \\nCHILD: 20 - 40 mg/kg/day in divided doses 8 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.24","prescriberCat":"B"},{"id":"drug-563","genericName":"Amoxicillin Trihydrate 125 mg/5 ml Syrup","brandName":"Dyna","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Syrup"],"indications":"Infections caused by susceptible strains of gram positive and gram negative organisms","dosing":"CHILD less than 10 years: 125 - 250 mg 8 hourly. \\nCHILD less than 20 kg: 20 - 40 mg/kg/day in 3 - 4 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.55","prescriberCat":"B"},{"id":"drug-564","genericName":"Amoxicillin 1 g & Clavulanate 200 mg Injection","brandName":"Clavixin","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"Infections caused by susceptible organisms. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection & osteomyelitis","dosing":"CHILD less than 3 months: 30mg/kg 12 hourly. \\n3 months - 12 years: 30mg/kg 6 - 8 hourly. \\nADULT: 1.2 g by IV or intermittent infusion 6 - 8 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.66","prescriberCat":"A"},{"id":"drug-565","genericName":"Amoxicillin & Clavulanate 228 mg/5 ml Syrup","brandName":"Fleming","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Syrup"],"indications":"Infections caused by susceptible organisms","dosing":"Mild to Moderate infection: 25mg/kg/day (based on Amoxicillin dose) in 2 divided dose. \\nSevere infection: 45mg/kg/day (based on Amoxicillin dose) in 2 divided dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"8.00","prescriberCat":"A/KK"},{"id":"drug-566","genericName":"Amoxicillin 500 mg & Clavulanate 125 mg Tablet","brandName":"CO-AMOXICLAV","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Tablet"],"indications":"Infections due to beta-lactamase producing strain where amoxicillin alone is not appropriate. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection & osteomyelitis","dosing":"ADULT & CHILD more than 12 years: \\nMild to moderate infections: 625 mg twice daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.75","prescriberCat":"A/KK"},{"id":"drug-567","genericName":"Ampicillin Sodium 500 mg Injection","brandName":"Kampibiotic 500","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"Treatment of susceptible bacterial infections (non beta-lactamase-producing organisms); meningitis","dosing":"250 - 500 mg IM/IV every 4 - 6 hours. Maximum: 400 mg/kg/day. \\nMeningitis: 2 g 6 hourly. \\nCHILD: 150 mg/kg/daily IV in divided doses. \\nUsual children dose less than 10 years, half adult dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.03","prescriberCat":"B"},{"id":"drug-568","genericName":"Ampicillin Sodium 1g & Sulbactam Sodium 500mg Injection","brandName":"Amsubac","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"Treatment of susceptible bacterial infections","dosing":"ADULT: 1.5 - 12 g/day in divided doses 6 - 8 hourly. Maximum: 4 g Sulbactam. \\nCHILD: 150-300 mg/kg/day 6 - 8 hourly. Prophylaxis of surgical infections: 1.5 - 3 g at induction of anaesthesia. May be repeated 6 - 8 hourly. \\nNEONATES: First week of life, 75mg/kg/day in divided doses every 12 hour","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.78","prescriberCat":"A"},{"id":"drug-569","genericName":"Ampicillin Sodium & Sulbactam Sodium 375 mg Tablet","brandName":"Unasyn","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Tablet"],"indications":"Treatment of susceptible bacterial infections","dosing":"ADULT: 375-750mg twice daily \\nCHILDREN AND INFANTS: 25-50mg/kg/day in 2 divided doses, \\nif  30kg use an adult dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.84","prescriberCat":"A/KK"},{"id":"drug-570","genericName":"Benzathine Penicillin 2.4 mega units Injection","brandName":"Benzapen","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"i) Treatment of mild to moderately severe infections due to Penicillin G-sensitive organisms \\nii) Treatment of syphillis","dosing":"i) ADULT: 1.2 mega units IM \\nii) For syphillis: 2.4 mega units weekly for 1 - 3 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"8.70","prescriberCat":"B"},{"id":"drug-571","genericName":"Benzylpenicillin 1 mega unit (600 mg)  Injection","brandName":"Bepen","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"i) Infections caused by susceptible organisms \\nii) Infective endocarditis","dosing":"i) Adult: 600mg - 3600mg (1 - 6 mega units) daily, divided into 4 to 6 doses. \\nHigher doses (24 mega units) in divided doses may be given in serious infections such as meningitis. \\nChild 1 month to 12 years old: 100mg/kg/day in 4 divided doses, \\nnot exceeding 4g/day; \\nInfants 1 -4 weeks: 75mg/kg/day in 3 divided doses\\nNewborn Infants: 50mg/kg/day in 2 divided doses \\nii)7.2 to 12g (12 - 20 mega units) maybe given daily in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.25, 4.87","prescriberCat":"B"},{"id":"drug-572","genericName":"Benzylpenicillin 5 mega unit (3 g) Injection","brandName":"Generic","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"i) Infections caused by susceptible organisms \\nii) Infective endocarditis","dosing":"i) ADULT: 600 - 1200 mg IM 4 times daily, increased if necessary in more serious infections. \\nCHILD: 50 - 100 mg/kg body weight daily IV in 2 - 4 divided doses \\nii) ADULT: 7.2 g daily by slow IV infusion in 6 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"","prescriberCat":""},{"id":"drug-573","genericName":"Cloxacillin Sodium 250 mg Capsule","brandName":"Cloxacilla","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Capsule"],"indications":"Treatment of susceptible bacterial infections, notably penicillinase-producing staphylococci","dosing":"ADULT: 250 - 500 mg every 6 hours. \\nChild: 50-100 mg/kg in divided doses every 6 hr.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.37","prescriberCat":"B"},{"id":"drug-574","genericName":"Cloxacillin Sodium 250mg, 500 mg Injection","brandName":"Monoclox 250mg\\nCloxabiotic 500mg","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"Treatment of susceptible bacterial infections, notably penicillinase-producing staphylococci infections","dosing":"ADULT: 250 to 500 mg every 6 hours depending on type and severity of infection. CHILD less than 20 kg: 25 to 50 mg/kg/day in equally divided doses every 6 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.93  1.56","prescriberCat":"B"},{"id":"drug-575","genericName":"Cloxacillin Sodium 125 mg/5 ml Suspension","brandName":"Cloxacilla","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Suspension"],"indications":"Treatment of susceptible bacterial infections, notably penicillinase-producing staphylococci","dosing":"Child: 50-100 mg/kg in divided doses every 6 hr","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.95","prescriberCat":"B"},{"id":"drug-576","genericName":"Phenoxymethyl Penicillin 125 mg/5 ml Syrup","brandName":"Beapen VK","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Syrup"],"indications":"Treatment or prophylaxis of infections caused by susceptible organisms","dosing":"CHILD: Up to 1 year: 62.5 mg 6 hourly; \\n1 - 5 years: 125 mg 6 hourly; \\n6 - 12 years: 250 mg 6 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.00","prescriberCat":"C"},{"id":"drug-577","genericName":"Phenoxymethyl Penicillin 125 mg Tablet","brandName":"Penicillin V","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Tablet"],"indications":"i) Treatment or prophylaxis of infections caused by susceptible organisms \\nii) Prophylactic, rheumatic fever","dosing":"i) ADULT: 500 - 750 mg 6 hourly.\\nCHILD; up to 1 year: 62.5 mg, \\n1 - 5 years: 125 mg, \\n6 - 12 years: 250 mg 6 hourly \\nii) ADULT: 125 - 250 mg twice daily. \\nCHILD: 25 - 50 mg/kg in divided doses every 6 - 8 hours. Maximum: 3 g/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.53","prescriberCat":"C"},{"id":"drug-578","genericName":"Piperacillin 4 g & Tazobactam 500 mg Injection","brandName":"AUROTAZ-P","category":"6.0 ANTIBIOTICS\\n6.4 PENICILLINS","forms":["Injection"],"indications":"Febrile neutropenia, lower respiratory tract infection and severe sepsis","dosing":"Adult and children more than 12 years: 4.5g 6 hourly, \\nfor neutropenia adult and children more than 50kg: 4.5g 6 hourly. \\nChildren less than 50kg: 90mg/kg 6 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"8.50","prescriberCat":"A*"},{"id":"drug-581","genericName":"Doxycycline 100 mg Capsule","brandName":"Pharmaniaga Doxycycline","category":"6.0 ANTIBIOTICS\\n6.5 TETRACYCLINE","forms":["Capsule"],"indications":"Prophylaxis and treatment for infections due to susceptible organisms.","dosing":"Prophylaxis\\n100-200mg daily or weekly\\n\\nTreatment\\n100-300mg daily\\n\\nDosing is individualised based on type of infections and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.25","prescriberCat":"B"},{"id":"drug-584","genericName":"Sulphamethoxazole 400 mg & Trimethoprim 80 mg Injection","brandName":"Bactrim","category":"6.0 ANTIBIOTICS\\n6.6 SULPHONAMIDES","forms":["Injection"],"indications":"i) Severe or complicated infections when oral therapy is not feasible \\nii) Treatment and prophylaxis of pneumocystis carinii pneumonia (PCP) in immunocompromised patients","dosing":"i) ADULT: 960 mg twice daily increased to 1.44 g twice daily in severe infections. CHILD: 36 mg/kg daily in 2 divided doses increased to 54 mg/kg/day in severe infections \\nii) Treatment: ADULT & CHILD over 4 weeks: 120 mg/kg/day PO/IV infusion in 2 - 4 divided doses for 14 days. \\nProphylaxis: ADULT: 960 mg once daily or 960 mg on alternate days (3 times a week) or 960 mg twice daily on alternate days (3 times a week). \\nCHILD 6 weeks - 5 months: 120 mg twice daily on 3 consecutive days or 7 days per week; 6 months - 5 years: 240 mg; 6 - 12 years: 480 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"5.73","prescriberCat":"A"},{"id":"drug-585","genericName":"Sulphamethoxazole 200 mg & Trimethoprim 40 mg/5ml Suspension","brandName":"Dynaprim","category":"6.0 ANTIBIOTICS\\n6.6 SULPHONAMIDES","forms":["Suspension"],"indications":"Infections caused by susceptible pathogens","dosing":"Mild to moderate infections: more than 2months: 8 - 12mg Trimethoprim/kg/day divided every 12hours. \\nSerious Infections: 15-20mg Trimethoprim/kg/day divided every 6hours.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.40","prescriberCat":"B"},{"id":"drug-586","genericName":"Sulphamethoxazole 400 mg & Trimethoprim 80 mg Tablet","brandName":"Co-trimoxazole","category":"6.0 ANTIBIOTICS\\n6.6 SULPHONAMIDES","forms":["Tablet"],"indications":"i) Severe or complicated infections due to susceptible infection \\nii) Treatment and prophylaxis of pneumocystis carinii pneumonia (PCP) in immunocompromised patients","dosing":"i) ADULT: 1 - 3 tablets twice daily \\nii) Treatment: ADULT & CHILD over 4 weeks: 120 mg/kg/day in 2 - 4 divided doses for 14 days. \\nProphylaxis: ADULT: 960 mg once daily or 960 mg on alternate days (3 times a week) or 960 mg twice daily on alternate days (3 times a week). \\nCHILD; 6 weeks - 5 months: 120 mg twice daily on 3 consecutive days or 7 days per week; 6 months - 5 years: 240 mg; 6 - 12 years: 480 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.12","prescriberCat":"B"},{"id":"drug-589","genericName":"Ciprofloxacin 200 mg/100 ml Injection","brandName":"Ciproxol","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"Treatment of infections due to susceptible bacterial strains","dosing":"Suggest to rephrase ADULT: the dosage range is 100mg-400mg twice daily Gonorrhoea: 100mg single dose \\nUpper and Lower Urinary Tract Infection: 100mg BD \\nUpper and Lower Respiratory Tract Infection: 200mg-400mg twice daily \\nCystic Fibrosis with psuedomonal Lower RTI: 400mg BD \\nOthers: 200-400mg BD\\nInhalation Anthrax: 400mg BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.50","prescriberCat":"A"},{"id":"drug-590","genericName":"Ciprofloxacin 250 mg Tablet","brandName":"C-FLOX","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Tablet"],"indications":"Treatment of infections due to susceptible bacterial strains","dosing":"ADULT: 125-750 mg twice daily. \\nAcute gonorrhoea: a single dose of 250 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.13","prescriberCat":"A"},{"id":"drug-591","genericName":"Colistimethate 1 Million IU Injection (Polymyxin E)","brandName":"Colomycin","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["E)"],"indications":"Intravenous administration for the treatment of serious infections caused by Gram negative bacteria, when more commonly used systemic antibacterial agents may be contraindicated or may be ineffective because of bacterial resistance.","dosing":"A minimum of 5 days treatment is generally recommended. \\nFor the treatment of respiratory exacerbations in cystic fibrosis patients, treatment should be continued up to 12 days. \\nChildren and adults (including elderly): Up to 60kg: 50,000 units/kg/day to a maximum of 75,000 units/kg/day. The total daily dose should be divided into three doses given at approximately 8-hour intervals. \\nOver 60kg: 1-2 million units three times a day. The maximum dose is 6 million units in 24 hours.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"38.40","prescriberCat":"A*"},{"id":"drug-593","genericName":"Ertapenem 1 g Injection","brandName":"Invanz","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"i) Patient with confirm ESBL producing gram-negative infection. \\nii) Empiric treatment for severe community acquired pneumonia or other infections when Pseudomonas aeruginosa is not suspected.","dosing":"ADULT: 1 g once daily. \\nCHILD 3 month to 12 years: 15 mg/kg twice daily. \\nNot to exceed 1 g/ day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"113.05","prescriberCat":"A*"},{"id":"drug-594","genericName":"Fusidate, Sodium 250 mg Tablet","brandName":"Fucidin","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Tablet"],"indications":"Treatment of infections caused by susceptible organisms especially Staphylococcal infections including Methicillin Resistant Staphylococcus aureus (MRSA)","dosing":"ADULT: 500 mg 3 times daily, \\nskin and soft tissue infection: 250 - 500 mg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Ortopedik)","price":"0.94","prescriberCat":"A*"},{"id":"drug-595","genericName":"Imipenem 500 mg and Cilastatin 500 mg Injection","brandName":"Imipenem / Cilastin Kabi","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"Severe infections caused by susceptible pathogens especially useful in infections involving ESBL organisms. Not to be used for prophylaxis.","dosing":"Based on type or severity of infection, susceptibility of pathogen(s) and patient condition including body weight and renal function. \\n\\nADULT: 1 - 2 g/day in 3 - 4 divided doses. Maximum: 4 g/day or 50 mg/kg/day. Infusion rate: less than 500 mg dose: over 20 - 30 minutes, more than 500 mg: dose over 40 - 60 minutes. \\nCHILDREN:  40kg body weight should receive adult doses. \\nCHILDREN AND INFANTS: <40kg body weight should receive 15mg/kg at six hour intervals. The total daily dose should not exceed 2g.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"16.24","prescriberCat":"A*"},{"id":"drug-596","genericName":"Levofloxacin 500mg tablet","brandName":"Glevo","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["tablet"],"indications":"Community acquired pneumonia","dosing":"500 mg daily for 7 - 14 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.05","prescriberCat":"A*"},{"id":"drug-597","genericName":"Linezolid 2 mg/ml Injection","brandName":"Zyvox","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"MRSA patient with severe sepsis requiring intensive care and not clinically responding to vancomycin","dosing":"ADULT: 600 mg twice daily for 10 - 14 days. \\nCHILD: 10 mg/kg 3 times daily. \\nPREMATURE NEONATES less than 7 days: 10 mg/kg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"150.00","prescriberCat":"A*"},{"id":"drug-598","genericName":"Linezolid 600 mg Tablet","brandName":"Zyvox","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Tablet"],"indications":"MRSA patient with severe sepsis requiring intensive care and not clinically responding to vancomycin.","dosing":"ADULT: Above 12 years : 600 mg every 12 hours for 10-14 days. \\nCHILD :10 mg/kg 3 times daily. \\nPREMATURE NEONATES less than 7 days: 10 mg/kg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"130.15","prescriberCat":"A*"},{"id":"drug-599","genericName":"Linezolid 600mg tablet","brandName":"Zyvox","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["tablet"],"indications":"MRSA patient with severe sepsis requiring intensive care and not clinically responding to vancomycin.","dosing":"ADULT: Above 12 years 600 mg every 12 hours for 10-14 days. CHILD :10 mg/kg 3 times daily. PREMATURE NEONATES less than 7 days: 10 mg/kg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"28.98","prescriberCat":"A*"},{"id":"drug-600","genericName":"Meropenem 1 g Injection","brandName":"KABI","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"i. Emperical treatment for presume infections in patients (adult and children) with febrile neutropenia, used as monotherapy or in combination with anti-virals or antifungal agent \\nii. Septicaemia \\niii. Serious infections in renal impaired patients","dosing":"ADULT: 0.5g - 1g 8 hourly \\nCHILD: (aged 3 months and over): 10-40mg/kg 8 hourly, \\nif body weight over 50kg, adult dosage should be used","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.80","prescriberCat":"A*"},{"id":"drug-601","genericName":"Metronidazole 500 mg/100 ml Injection","brandName":"Metronol","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"Anaerobic infections","dosing":"ADULT: 500 mg IV infusion 8 hourly. \\nCHILD: 7.5 mg/kg body weight every 8 hours. \\nNeonates: 15mg/kg LD, followed by 7.5mg/kg every 12 hourly. \\n1 month to 18 years: 7.5mg/kg (maximum 500mg) every 8 hours.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.31","prescriberCat":"A"},{"id":"drug-602","genericName":"Metronidazole 200 mg Tablet","brandName":"Metronidazole, Metrogyl","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Tablet"],"indications":"Anaerobic infection","dosing":"Anaerobic bacterial infections \\nAdult: Initially, 800 mg followed by 400 mg 8 hly for about 7 days. \\nOther recommended doses: 500 mg 8 hrly or 7.5 mg/kg 6 hrly (max: 4 g in 24 hr). \\nChild: 7.5 mg/kg 8 hrly. \\nElderly: Use lower end of adult dose recommendations. Do not admin as a single dose. \\nProphylaxis of postoperative anaerobic bacterial infections \\nAdult: 400 mg by mouth 8 hrly in the 24 hr prior to surgery followed postoperatively by IV or rectal admin until oral therapy is possible. Other sources recommend that oral doses be initiated only 2 hr prior to surgery and that number of doses for all admin routes be limited to a total of 4. \\nElderly: Dose reduction may be necessary. \\nTab: Should be taken with food.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.10","prescriberCat":"B"},{"id":"drug-603","genericName":"Ofloxacin 100 mg Tablet","brandName":"Oflicin","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Tablet"],"indications":"i) As second-line treatment of leprosy \\nii) As second-line treatment for tuberculosis and multidrug resistant tuberculosis (MDR-TB) \\niii) Sequential therapy for UTI and pyelonephritis","dosing":"i) 400 mg/day \\nii) 400 mg twice daily \\niii) 200 mg twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, ENT)","price":"0.30","prescriberCat":"A"},{"id":"drug-604","genericName":"Polymyxin B Sulphate 500,000 units Injection","brandName":"Poly-Mxb","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"i. Acute infections caused by susceptible strains of Pseudomonas Aeruginosa.\\n Treatment of infections of the meninges and blood stream, caused by susceptible strains of Pseudomonas Aeruginosa.\\n\\nii. Indicated in serious infections caused by susceptible strains of the following organisms, when less potentially toxic drugs are ineffective or contraindicated:\\n H. influenzae, specifically meningeal infections.\\n Aerobacter aerogenes, specifically bacteremia.\\n Klebsiella pneumoniae, specifically bacteremia.\\n\\nPrescribing Restrictions:\\n Use as targeted therapy. As 2nd line for empirical therapy.\\n To be prescribed by Infectious Disease, General Medicine & ICU specialist only","dosing":"Loading dose: 25,000 units/kg/dose.\\n(Maximum dose: 2,000,000 units / 2MU).\\n\\nMaintenance dose: 15,000 units/kg every 12 hours.\\n(Maximum dose per day: 2,000,000 units / 2MU).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"59.75","prescriberCat":"A*"},{"id":"drug-605","genericName":"Vancomycin HCl 500 mg Injection","brandName":"Celovan","category":"6.0 ANTIBIOTICS\\n6.7 OTHERS","forms":["Injection"],"indications":"Only for the treatment of MRSA and CAPD peritonitis","dosing":"Slow IV infusion, ADULT: 500 mg over at least 60 minutes every 6 hours or 1 g over at least 100 minutes every 12 hours. \\nNEONATE up to 1 week: 15 mg/kg initially, then 10 mg/kg every 12 hours. INFANT 1 - 4 weeks: 15 mg/kg initially then 10 mg/kg every 8 hours. \\nCHILD over 1 month: 10 mg/kg every 6 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.84","prescriberCat":"A*"},{"id":"drug-608","genericName":"Albendazole 200 mg/5 ml Suspension","brandName":"Albendazole","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.1 ANTIHELMINTICS","forms":["Suspension"],"indications":"i) Single or mixed infestations of intestinal parasites \\nii) Strongyloides infection","dosing":"i)Child 12-24months: 200mg as a single dose \\nii) Adult & Child above 2 years: 400mg as a single dose for 3 consecutive days; Child 12 - 24months: 200mg as a single dose for 3 consecutive days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.45","prescriberCat":"C+"},{"id":"drug-609","genericName":"Albendazole 200 mg Tablet","brandName":"Champs D-Worms","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.1 ANTIHELMINTICS","forms":["Tablet"],"indications":"i) Single or mixed infestations of intestinal parasites \\nii) Strongyloides infection","dosing":"i) Child 12-24months: 200mg as a single dose \\nii) Adult & Child above 2 years: 400mg as a single dose for 3 consecutive days; Child 12 - 24months: 200mg as a single dose for 3 consecutive days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.58","prescriberCat":"C+"},{"id":"drug-610","genericName":"Levamisole 50mg Tablet","brandName":"Vitilex","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.1 ANTIHELMINTICS","forms":["Tablet"],"indications":"Steroid -sensitive Idiopathic Nephrotic Syndrome","dosing":"Tablet Levamisole 50mg EOD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase\\n(UKK) (Dept: Pediatrik)","price":"1.49","prescriberCat":"Not in FUKKM"},{"id":"drug-614","genericName":"Diethylcarbamazine Citrate 50 mg Tablet","brandName":"DCMC-100","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.2 ANTIFILARIALS","forms":["Tablet"],"indications":"i) Bancrofti filariasis, onchocerciasis, loasis, creeping eruption \\nii) Ascariasis \\niii) Tropical eosinophilia","dosing":"i) 1 mg/kg on the first day and increased gradually over 3 days to 6 mg/kg daily in divided doses. This dosage is maintained for 21 days. \\nii) 13 mg/kg once daily for 7 days. \\nCHILD : 6 - 10 mg/kg 3 times daily for 7 days \\niii) 6 mg/kg/day in 3 divided doses for 21 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.83","prescriberCat":"B"},{"id":"drug-617","genericName":"Amphotericin B 50 mg Injection","brandName":"Amphotret","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Injection"],"indications":"Systemic fungal infections","dosing":"ADULT: 0.25 mg/kg/day by IV infusion, gradually increase if tolerated to 1 mg/kg/day. \\nMaximum in severe cases: 1.5 mg/kg daily or on alternate days. \\nFor neonates, lower doses are recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"39.21","prescriberCat":"A"},{"id":"drug-618","genericName":"Anidulafungin 100mg Injection","brandName":"Eraxis","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Injection"],"indications":"Treatment of invasive candidiasis, including candidemia in adults when intolerance or resistance to Amphotericin B or Fluconazole","dosing":"Loading dose of 200 mg on day 1, then 100 mg once daily thereafter for at least 14 days after the last positive culture.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"340.50","prescriberCat":"A*"},{"id":"drug-619","genericName":"Caspofungin Acetate 50mg injection","brandName":"CANCIDAS","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["injection"],"indications":"i) Confirmed systemic fungal infection in patients who are refractory or intolerant to other fungal therapies\\n\\nii) For pediatric patient (12 month and older) for the following indications : \\na) Empirical therapy for presumed fungal infections in febrile, neutropenic patients b) Treatment of invasive candidiasis, including candidemia and the following Candida infections ; intra-abdominal abscesses, peritonitis and pleural space infections c) Treatment of esophageal candidiasis d) Treatment of invasive Aspergillosis in patients who are refractory to or intolerant of others therapy (eg : Amphotericin B)","dosing":"70mg over 1 hour, then 50mg per day for 2 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"566.00","prescriberCat":"A*"},{"id":"drug-620","genericName":"Fluconazole 100 mg Capsule","brandName":"Pharmaniaga Fluconazole","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Capsule"],"indications":"i) Oropharyngeal candidiasis, atrophic oral candidiasis associated with dentures, other candidal infections of mucosa \\nii) Tinea pedis, corporis, cruris, versicolor and dermal candidiasis \\niii) Invasive candidal & cryptococcal infections (including meningitis) \\niv) Prevention of relapse of cryptococcal meningitis in AIDS patients after completion of primary therapy \\nv) Prevention of fungal infections in immunocompromised patients considered at risk as a consequence of HIV infections or neutropenia following cytotoxic chemotherapy, radiotherapy or bone marrow transplant","dosing":"i) Oropharyngeal candidiasis: 50 - 100 mg daily for 7 - 14 days (Maximum 14 days) except in severely immunocompromised patients, treatment can be continued for longer periods. \\nAtrophic oral candidiasis associated with dentures: 50 mg daily for 14 days. \\nOther candidal infections of mucosa: 50 - 100 mg daily for 14 - 30 days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.76","prescriberCat":"A"},{"id":"drug-622","genericName":"Fluconazole 2 mg/ml Injection","brandName":"Fluconol","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Injection"],"indications":"i) Oropharyngeal candidiasis, atrophic oral candidiasis associated with dentures, other candidal infections of mucosa ii) Tinea pedis, corporis, cruris, versicolor and dermal candidiasis iii) Invasive candidal& cryptococcal infections (including meningitis) iv) Prevention of relapse of cryptococcal meningitis in AIDS patients after completion of primary therapy v) Prevention of fungal infections in immunocompromised patients considered at risk as a consequence of HIV infections or neutropenia following cytotoxic chemotherapy, radiotherapy or bone marrow transplant","dosing":"i) 50 - 100 mg daily for 7 - 14 days (Maximum 14 days) except in severely immunocompromised patients, treatment can be continued for longer periods. Atrophic oral candidiasis associated with dentures: 50 mg daily for 14 days. Other candidal infections of mucosa: 50 - 100 mg daily for 14 - 30 days. \\nCHILD: 3 - 6 mg/kg on first day then 3 mg/kg daily (every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 - 4 weeks old) \\nii) 50 mg daily for 2 - 4 weeks, maximum 6 weeks \\niii) 400 mg initially then 200 - 400 mg daily for 6 - 8 weeks.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.84","prescriberCat":"A"},{"id":"drug-624","genericName":"Flucytosine 500 mg Tablet","brandName":"Flusine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Tablet"],"indications":"Only for the treatment of fungal meningitis","dosing":"ADULT: 50 - 150 mg/kg/day in 4 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Perubatan)","price":"4.04","prescriberCat":"A*"},{"id":"drug-625","genericName":"Griseofulvin 125 mg Tablet","brandName":"Medofulvin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Tablet"],"indications":"Dermatophyte infections of the skin, scalp, hair and nails, where topical therapy has failed or inappropriate","dosing":"(Ultramicrosize 125 mg = 250 mg Microsize) \\nAdults: 500mg-1000mg daily, taken as a single dose or in divided;\\nChildren: 10mg-20mg/kg daily in divided doses.\\n\\nThe dosing is individualized according to product insert / protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.12","prescriberCat":"B"},{"id":"drug-626","genericName":"Itraconazole 100 mg Capsule","brandName":"Inox","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Capsule"],"indications":"i) Dermatomycosis including pityriasis versicolor \\nii) Oral candidiasis \\niii) Palmar tinea manus and plantar tinea pedis \\niv) Fingernail onychomycosis \\nv) Toenail onychomycosis \\nvi) Vulvovaginal candidiasis","dosing":"i) 200 mg once daily for 7 days \\nii) 100 mg daily for 15 days \\niii) 200 mg twice daily for 7 days \\niv) 200mg twice daily for 1 week per month for 2 months \\nv) 200 mg twice daily for 1 week per month for 3 months \\nvi)200 mg morning and evening for 1 day or 200 mg once daily for 3 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.65","prescriberCat":"A/KK"},{"id":"drug-627","genericName":"Nystatin 100,000 units/ml Suspension","brandName":"Tystatin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Suspension"],"indications":"Prevention and treatment of candidiasis of the skin and mucous membranes, protection against candidas overgrowth during antimicrobial /corticosteroid therapy and as selective decontamination regimens","dosing":"NEWBORN: 50,000-100,000 units daily. \\nCHILD up to 5 years: 100,000 -500,000 units 6 hourly. \\nCHILD up to 6-12 years and ADULT: 500,000-1,000,000 units 3 to 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.82","prescriberCat":"B"},{"id":"drug-628","genericName":"Terbinafine HCl 250 mg Tablet","brandName":"Onchofin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Tablet"],"indications":"Fungal infections especially onchomycosis caused by dermatophytes","dosing":"250 mg once daily for 6 weeks for fingernails: \\n12 weeks for toenails","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.13","prescriberCat":"A/KK"},{"id":"drug-629","genericName":"Voriconazole 200mg Tablet","brandName":"Voritrop","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.3 ANTIFUNGALS (SYSTEMIC)","forms":["Tablet"],"indications":"i) Treatment of immunocompromised patients with progressive, possibly life-threatening infections such as invasive aspergillosis, fluconazole-resistant serious invasive candidiasis, candidiasis of the oesophagus, serious fungal infections caused by Scedosporium species and Fusarium species ii) Prevention of breakthrough fungal infections in febrile high-risk neutropenic patients","dosing":"Adult and Children 12 years and greater and over 40 kg: Loading dose: 400 mg 12 hourly for first 24 hours. Maintenance: 200 - 300 mg 12 hourly. Less than 40 kg: Loading dose: 200 mg 12 hourly for first 24 hours. Maintenance: 100 - 150 mg 12 hourly. Children aged 2years to <12years with normal hepatic and renal function: No loading dose needed; 200mg 12hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"51.77","prescriberCat":"A*"},{"id":"drug-632","genericName":"Bedaquiline 100mg Tablet","brandName":"Sirturo","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"Indicated for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. Consideration should be given to official guidance on the appropriate use of antibacterial agents.\\n\\nPRESCRIBING RESTRICTIONS\\nTo be prescribed by Respiratory Physicians only.","dosing":"Week 1 to 2: 400mg once daily,\\nWeek 3 to 24: 200mg three times per week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.65  658.58","prescriberCat":"A*"},{"id":"drug-633","genericName":"Clofazimine 100 mg Capsule","brandName":"Fazim","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Capsule"],"indications":"i) Previously untreated leprosy patients \\nii) Leprosy patients resistant to sulphones \\niii) Suppression of lepra reactions","dosing":"i) ADULT: 100 mg each other day or 50 mg daily with 100mg Dapsone & 300mg once a month with 600mg rifampicin under supervision. Maximum: 200 mg/day.\\n\\nCHILD: 10-14 yr: 50mg clofazimine on alternate days with 50mg dapsone & 150 mg clofazimine with 450 mg rifampicin once a month.Maximum: 100 mg/day. \\n\\nii) 100 mg daily \\n\\niii) 200-300mg usually effective. Treatment with minimum suppression dose continued for at least 6 months","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.37","prescriberCat":"B"},{"id":"drug-634","genericName":"Cycloserine 250 mg Capsule","brandName":"Coxerin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Capsule"],"indications":"Multi-Drug Resistance Tuberculosis treatment failure. (For respiratory physicians)","dosing":"ADULT: Initial: 250 mg every 12 hours for 14 days, then administer 0.5 - 1 g daily in 2 divided doses for 18 - 24 months (maximum daily dose: 1 g). \\nCHILD: 2-12 yr: 5 mg/kg bid; \\n12-18 yr: 250 mg bid for 2 wk then adjusted to a max dose of 1 g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"7.20","prescriberCat":"A*"},{"id":"drug-635","genericName":"Dapsone 100 mg Tablet","brandName":"Dapsone","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"i)Leprosy \\nii) Dermatitis herpetiformis","dosing":"i) ADULT: 6 - 10 mg/kg weekly/ 1.4mg/kg daily (around 50 - 100 mg daily). \\nCHILD: 1 - 2 mg/kg/day. Maximum: 100 mg/day \\nii) ADULT: 50 - 300 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Perubatan)","price":"0.06","prescriberCat":"B"},{"id":"drug-636","genericName":"Ethambutol HCl 400 mg Tablet","brandName":"ECOX","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"Tuberculosis","dosing":"Adult: 15-25mg/kg daily (max : 1200mg) or 50mg/kg biweekly (max : 2000mg). Children: 15-25mg/kg daily or 50 mg/kg twice weekly.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.46","prescriberCat":"B"},{"id":"drug-637","genericName":"Ethionamide 250 mg Tablet","brandName":"Ethomid","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"As second-line therapy in the treatment of Multi Drug Resistant Tuberculosis only in combination with other efficacious agents and only when therapy with isoniazid, rifampicin, or other first-line agents has failed.","dosing":"ADULT: 15-20mg/kg daily, in divided doses if necessary; maximum dose 1g/day. \\nCHILD: 10-20mg/kg in 2-3 divided doses or 15mg/kg/24hrs as a single daily dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.30","prescriberCat":"A*"},{"id":"drug-638","genericName":"Isoniazid 100 mg Tablet","brandName":"Isoniazid","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"i) Tuberculosis \\nii)Tuberculous meningitis","dosing":"i) & ii) ADULT: 5-8mg/kg daily (Max 300mg) or 15-20mg/kg biweekly (max 1200mg)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.24","prescriberCat":"B"},{"id":"drug-639","genericName":"Kanamycin 1 g Injection","brandName":"Kanamycin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Injection"],"indications":"i) Treatment of gonorrhoea and neonatal meningitis \\n\\nii) Treatment of TB patients who require reserved second line drugs but have no pre-existing renal complications","dosing":"i) ADULT: 1 - 2 g daily IM in 1 - 2 equally divided doses. \\nCHILD: 30 - 50 mg/kg/day in 1 - 2 divided doses \\n\\nii) ADULT: 2 g daily IM in 2 equally divided doses twice a week or 1 g once daily 3 days a week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: perubatan)","price":"6.75","prescriberCat":"A*"},{"id":"drug-640","genericName":"Para Amino Salicylic Acid 1 g Tablet","brandName":"Generic","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"Multi-Drug Resistance Tuberculosis treatment failure. \\n(For respiratory physicians)","dosing":"4 gram BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"KPK (Dept: Perubatan)","price":"1.50","prescriberCat":"-"},{"id":"drug-641","genericName":"Minocycline 100 mg Capsule","brandName":"Minocin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Capsule"],"indications":"i) As second-line treatment for leprosy only\\nii) Treatment of infections due to susceptible strains of the designated organism e.g. Carbapenem-resistant acinetobacter baumannii","dosing":"i) 100 mg daily 6 - 18 months\\nii) Initially, 200 mg followed by 100-200mg every 12 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.14","prescriberCat":"A*"},{"id":"drug-642","genericName":"Pyrazinamide 500 mg Tablet","brandName":"Pyrazinamide","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"Tuberculosis","dosing":"Adult: 20-40mg/kg daily (max 1500mg) or 50mg/kg biweekly (max 2000mg). Children: 20-30mg/kg daily or 30-40mg/kg thrice weekly.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.18","prescriberCat":"B"},{"id":"drug-643","genericName":"Rifampicin 150 mg, 300 mg Capsule","brandName":"Rifampicin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Capsule"],"indications":"i) Tuberculosis\\nii) Leprosy\\niii) Prophylaxis for meningococcal meningitis\\niv)Staphylococcus biofilm related prosthetic joint infection or any biofilm\\nsensitive to rifampicin in combination therapy with another antibiotic","dosing":"i) ADULT: 450 - 600 mg as a single morning dose.\\nCHILD: 10 - 20 mg/kg body weight daily in 1 - 2 doses. Directly observed\\ntherapy (DOT): 10 mg/kg twice weekly or 3 times/week. Maximum: 600 mg\\nii) ADULT: 600 mg/day\\nCHILD: 10mg/kg\\niii) ADULT: 600 mg twice daily for 2 days\\nCHILD: 10mg/kg twice daily for 2 days\\nINFANT: 5mg/kg twice daily for 2 days\\niv) ADULT: 600mg OD\\nCHILD: 10-20mg/kg/day in 1-2 divided doses\\nDosing is individualised and according to product insert/protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.20,  0.33","prescriberCat":"B"},{"id":"drug-644","genericName":"Rifampicin 150 mg, Isoniazid 75 mg, Pyrazinamide 400 mg & Ethambutol HCl 275 mg Tablet","brandName":"FORECOX-TRAC","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Tablet"],"indications":"Treatment of both pulmonary and extrapulmonary tuberculosis, in the intensive treatment phase","dosing":"ADULT: 30 - 37 kg: 2 tablets daily, \\n38 - 54 kg: 3 tablets daily, \\n55 - 70 kg: 4 tablets daily, \\nmore than 70 kg: 5 tablets daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.43","prescriberCat":"B"},{"id":"drug-645","genericName":"Streptomycin Sulphate 1 g Injection","brandName":"Streptin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS","forms":["Injection"],"indications":"Tuberculosis","dosing":"ADULT: 15 mg/kg daily; max: 1 g daily. \\nReduce max daily dose to 500-750 mg in patients >40 yr. \\nAs part of an intermittent therapy: 25-30 mg/kg/day 2-3 times/wk; max: 1.5 g/dose. Not >120 g over the course of treatment should be given unless there are no other treatment options. \\nChild: 20-40 mg/kg (max: 1 g) daily or 25-30 mg/kg (max: 1.5 g) 2-3 times wkly.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.49","prescriberCat":"B"},{"id":"drug-648","genericName":"Artemether 20 mg + Lumefantrine 120 mg Tablet","brandName":"Riamet","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["Tablet"],"indications":"Acute uncomplicated falciparum malaria","dosing":"ADULT and CHILD over 12 years weighing over 35 kg : 4 tablets as a single dose at the time of initial diagnosis, again 4 tablets after 8 hours and then 4 tablets twice daily (morning and evening) on each of the following two days (total course comprises 24 tablets). \\nINFANT and CHILD weighing 5 kg to less than 35 kg : A 6 dose regimen with 1 to 3 tablets per dose, depending on bodyweight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.52","prescriberCat":"B"},{"id":"drug-649","genericName":"Artesunate 60 mg Injection","brandName":"Artesun","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["Injection"],"indications":"Treatment of severe malaria in adults and \\nchildren","dosing":"2.4mg of artesunate/kg body weight, by intravenous (IV) or intramuscular (IM) injection, at 0, 12 and 24 hours,  then once daily until oral treatment can be substituted. \\nFor adults and children with severe malaria or who are unable to tolerate oral medicines, artesunate 2.4 mg/kg body weight IV or IM given on admission (time = 0), then at 12 hrs and 24 hrs, then once a day for 5-7 days is the recommended treatment.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"32.00","prescriberCat":"B"},{"id":"drug-650","genericName":"Chloroquine Phosphate 250 mg Tablet (150 mg Chloroquine base)","brandName":"Chloroquine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["base)"],"indications":"Treatment of malaria - acute attack","dosing":"ADULT: 600 mg base stat, 300 mg 6 - 8 hours later and a further 300 mg on each of 2 following days. \\nCHILD 3 - 4 years : 150 mg base stat, 75 mg 6 hours later, then 75 mg daily for 2 days. \\nCHILD 5 - 8 years : 300 mg stat, 150 mg 6 hours later, then 150 mg daily for 2 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.11","prescriberCat":"C"},{"id":"drug-651","genericName":"Pentamidine Isethionate 300 mg Injection / nebulizing solution","brandName":"Pentacarinat","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["solution"],"indications":"Only for the treatment of pneumonia due to Pneumocytosis carinii\\n\\noff-label indication: PCP Prophylaxis in CD4 count less than 200 via inhalation route","dosing":"4 mg/kg once daily by slow IV infusion for at least 14 days\\n\\nInhalation route for PCP Prophylaxis: 300mg monthly until CD4 count more than 200","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required (UKK) to purchase Pentacarinat brand to use via inhalation route (Dept: Perubatan)","price":"141.78","prescriberCat":"A*"},{"id":"drug-652","genericName":"Primaquine 7.5 mg base Tablet","brandName":"Primaquine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["Tablet"],"indications":"i) Treatment of malaria \\nii) Prophylaxis together with a schizonticide such as chloroquine","dosing":"i) 15 mg daily for 14 days, increased to higher doses or longer course if resistance in P.vivax occurs. \\nii) ADULT: 30 mg once weekly. \\nCHILD: 0.5 mg once weekly\\nChild: 250 mcg/kg daily for 14 days. Should be taken with food. \\nTake with meals to avoid GI discomfort.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.16","prescriberCat":"B"},{"id":"drug-653","genericName":"Pyrimethamine 25mg Tablet","brandName":"Daraprim","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["Tablet"],"indications":"cerebral toxoplasmosis","dosing":"25mg OD (once daily)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase (UKK) (Dept: Perubatan)","price":"2.13","prescriberCat":"Not in FUKKM"},{"id":"drug-654","genericName":"Quinine Dihydrochloride 600 mg/2 ml Injection","brandName":"Malakin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["Injection"],"indications":"Severe and complicated malaria","dosing":"By slow intravenous infusion (over 4 hours). \\nADULT : 20 mg/kg followed by 10 mg/kg every 8 hours. \\nCHILD : 20 mg/kg followed by 10 mg/kg every 12 hours, initial dose should be half in patients who have received quinine, quinidine or mefloquine during the previous 12 or 24 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit \\n(KPK)","price":"19.32","prescriberCat":"B"},{"id":"drug-655","genericName":"Sulfadoxine 500 mg & Pyrimethamine 25 mg Tablet","brandName":"FANSIDAR","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.5 ANTIPROTOZOAL, ANTIMALARIALS","forms":["Tablet"],"indications":"Treatment of Plasmodium falciparum malaria in patients in whom chloroquine resistance is suspected and malaria prophylaxis for travellers to areas where chloroquine-resistant malaria is endemic","dosing":"Chloroquine resistant falciparum malaria acute attack. Adult: (Per tab contains pyrimethamine 25 mg and sulfadoxine 500 mg): 2-3 tabs as a single dose. Do not repeat for at least 7 days. \\nChild: Pyrimethamine 25mg + Sulfadoxine 500mg (Tablet): \\n<2 yr (5-10 kg): 1/2 (half) tab as a single dose; \\n2-5 yr (>10-20 kg): 1 tab as a single dose; \\n5-10 yr (< 20-30 kg): 1 1/2 (one and half) tab as a single dose; \\n10-14 yr (> 30-45 kg): 2 tab as a single dose. Do not repeat for at least 7 days. \\nRenal impairment: Dose reduction may be needed. Severe: contra-indicated.\\nHepatic impairment: Dose reduction may be needed. Severe: contra-indicated.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.23","prescriberCat":"B"},{"id":"drug-658","genericName":"Abacavir 300 mg Tablet","brandName":"ABACAVEX","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"HIV Infection","dosing":"Adult: Combined w/ other antiretrovirals: 300 mg bid or 600 mg once daily.\\nChild: 3 mth 14 to <20 kg: 150 mg bid or 300 mg once daily; 20 kg to <25 kg: 150 mg in the morning and 300 mg in the evening or 450 mg once daily; 25 kg: Same as adult dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.02","prescriberCat":"A*"},{"id":"drug-659","genericName":"Abacavir Sulphate 600 mg & Lamivudine 300 mg Tablet","brandName":"Kivexa","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Antiretroviral combination therapy of HIV infection in adults and adolescents from 12 years of age with the following criteria: i)Patients unsuitable or failed other HAART treatment \\nii)Patients who are at high risk of renal impairment \\niii)Patients with osteoporosis or at high risk of bone loss","dosing":"ADULTS & ADOLESCENT (> 12 years of age): Recommended dose is one tablet once daily. Not to be used in adults or adolescents weigh less than 40kg. \\n\\nCHILDREN : Not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"5.23","prescriberCat":"A*"},{"id":"drug-660","genericName":"Acyclovir 250 mg Injection","brandName":"Vaxcel","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Injection"],"indications":"Treatment and prophylaxis of herpes simplex in immunocompromised, severe initial genital herpes and Varicella -Zoster","dosing":"ADULT: 5 mg/kg by IV infusion 8 hourly for 5 days, doubled to 10mg/kg every 8 hourly in varicella-zoster in the immunocompromised and in simplex encephalitis (usually given for at least 10 days in encephalitis; possibly for 14 - 21 days). NEONATE & INFANT up to 3 months with disseminated herpes simplex: 20mg/kg every 8 hourly for 14 days (21 days in CNS involvement),\\n:varicella-zoster 10-20mg/kg every 8 hourly usually for 7 days. \\nCHILD, 3 months - 12 years: Herpes simplex or Varicella Zoster: 250 mg/m2 8 hourly for 5 days, doubled to 500 mg/m2 8 hourly for varicella-zoster in the immunocompromised and in simplex encephalitis (usually given for 10 days in encephalitis)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.96","prescriberCat":"A*"},{"id":"drug-661","genericName":"Acyclovir 200 mg, 800 mg Tablet","brandName":"Aciclovir, Lovir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"i) Mucocutaneous Herpes Simplex infection in immunocompromised and AIDS patients \\nii) Primary and recurrent Varicella Zoster infection in immunocompromised and AIDS patients \\niii) Severe Kaposi Varicella Eruption (Eczema herpeticum) iv) Severe primary HSV infections (eg. Neonatal herpes, encephalitis, eczema herpeticum, genital herpes, gingival stomatitis, vaginal delivery with maternal vulva herpes) v) Severe and complicated varicella infection (eg. Encephalitis, purpura fulminans) \\nvi) Severe zoster infection in paediatrics (eg. Encephalitis, purpura fulminans, immunocompromised patients and facial, sacral and motor zoster)","dosing":"i) ADULT: initially 400 mg 5 times daily for 7 - 14 days. \\nCHILD less than 2 years: 200 mg 4 times daily, \\nCHILD more than 2 years: 400 mg 4 times daily \\n\\nii), iii) and iv) ADULT: 200 - 400 mg 4 times daily. \\nCHILD: less than 2 years, half adult dose; more than 2 years, adult dose \\n\\nv) ADULT: 800 mg 5 times daily for 7 days \\n\\nvi) ADULT: 20 mg/kg (maximum: 800 mg) four times daily for 5 days, \\nCHILD 6 years: 800 mg four times daily. \\nCHILD less than 2 years; 400mg 4 times daily, more than 2 years; 800mg 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.70, 0.56","prescriberCat":"A/KK"},{"id":"drug-662","genericName":"Didanosine 250 mg Enteric Coated Capsule","brandName":"Didanosine Delayed-Release Capsules","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Capsule"],"indications":"HIV infection, in combination with other antiretrovirals","dosing":"ADULT less than 60 kg: 250 mg once daily; 60 kg or greater: 400 mg once daily. Dose may varies if taken in combination with tenofovir","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pediatrik, Perubatan)","price":"3.73","prescriberCat":"A*"},{"id":"drug-663","genericName":"Atazanavir 300 mg capsule","brandName":"Atazor 300","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["capsule"],"indications":"Treatment of HIV-1 infected, antiretroviral treatment experienced adults, in combination with other antiretroviral medicinal products. \\nRestriction: For Infectious Disease Consultant use, in patients with treatment failure on NNRTI regime.","dosing":"The recommended dose is 300mg once daily taken with ritonavir 100mg once daily and with food. Ritonavir is used as a booster of atazanavir pharmacokinetics. If atazanavir with ritonavir is co- administrated with didanosine, it is recommended that didanosine be taken 2 hours after atazanavir with ritonavir taken with food.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"4.96","prescriberCat":"A*"},{"id":"drug-664","genericName":"Daclatasvir 60mg tablet","brandName":"Dasvir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["tablet"],"indications":"To be used in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults.","dosing":"60 mg once daily, to be taken orally with or without meals.\\n\\nDose recommendation when taking concomitant medicines:\\ni. Strong inhibitors of cytochrome P450 enzyme 3A4 (CYP3A4):\\nReduce dose to 30 mg once daily when co-administered with strong inhibitors of CYP3A4.\\n\\nii. Moderate inducers of CYP3A4:\\nIncrease dose to 90 mg once daily when co-administered with moderate inducers of CYP3A4.\\n\\nDaclatasvir must be administered in combination with other medicinal products for the treatment of hepatitis C infection.\\n\\nDose modification of daclatasvir to manage adverse reactions is not recommended.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.71","prescriberCat":"A*"},{"id":"drug-665","genericName":"Dolutegravir 50 mg Tablet","brandName":"Myltega","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Dolutegravir is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age.\\nRestriction: For patients who are not able to tolerate or failing treatment or resistance to the first line therapy (efavirenz and nevirapine).","dosing":"i) HIV-1 patients without documented or clinically suspected resistance to the integrase class: 50 mg (one tablet), once daily, orally. \\nii) HIV-1 patients with resistance to the integrase class: 50 mg (one tablet), twice daily, orally.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"6.20","prescriberCat":"A/KK"},{"id":"drug-666","genericName":"Dolutegravir 50mg, Lamivudine 300mg, Tenofovir Disoproxil Fumarate 300mg Film-Coated Tablets","brandName":"Teldy","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablets"],"indications":"Indicated for use alone as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing 40 kg or greater","dosing":"One tablet once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"6.17","prescriberCat":"A/KK"},{"id":"drug-667","genericName":"Efavirenz 200 mg Capsule","brandName":"Efamat 200","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Capsule"],"indications":"Combination therapy for HIV infections with a protease inhibitor and or Nucleoside Reverse Transcriptase Inhibitors (NRTIs)","dosing":"ADULT: 600 mg once daily. \\nADOLESCENT & CHILD less than 17 years, \\nmore than 40 kg: 600 mg once daily, \\n32.5 - less than 40 kg: 400 mg once daily, \\n25 - less than 32.5 kg: 350 mg once daily, \\n20 - less than 25 kg: 300 mg once daily, \\n15 - less than 20 kg: 250 mg once daily, \\n13 - less than 15 kg: 200 mg once daily. \\nNo studies in children less than 3 years or less than 13 kg. \\nFormulation unsuitable for children less than 40 kg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.31","prescriberCat":"A/KK"},{"id":"drug-668","genericName":"Efavirenz 600mg Tablet","brandName":"Efamat 600","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.38","prescriberCat":"A/KK"},{"id":"drug-669","genericName":"Entecavir 0.5 mg Tablet","brandName":"Hebecavir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"First line treatment of Chronic Hepatitis B in patients who satisfy the criteria for treatment and require long-term therapy or have a very high baseline viral load","dosing":"0.5-1mg once daily. \\nRenal Dose Adjustment: \\n0.5-1mg every 48hours (30-49ml/min); \\n0.5-1mg every 72hours (10-29ml/min); \\n0.5mg-1mg every 5-7 days (<10ml/min; HD or CAPD).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"2.82","prescriberCat":"A*"},{"id":"drug-670","genericName":"Ganciclovir Sodium 500 mg/10 ml Injection","brandName":"Cymevene","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Injection"],"indications":"Treatment of cytomegalovirus (CMV) disease in immunocompromised patients, prevention of CMV disease during immunosuppressive therapy following organ transplantation","dosing":"Initial: 5 mg/kg infused over 1 hour 12 hourly for 14 - 21 days (CMV retinitis treatment) or 7 - 14 days (CMV disease prevention). \\nLong term maintenance: 6 mg/kg daily for 5 days/week or 5 mg/kg daily for 7 days/week (a min duration of 3 months has been practiced)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"140.50","prescriberCat":"A*"},{"id":"drug-671","genericName":"Lamivudine 10 mg/ml Oral Solution","brandName":"3TC Oral Solution","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Solution"],"indications":"HIV infection in combination with other antiretroviral agents","dosing":"ADULT: 150 mg twice daily or 300 mg once daily. \\nINFANT under 1 month: 2 mg/kg twice daily. \\nCHILD 3 month or over: 4 mg/kg twice daily. Maximum 300 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"231.85","prescriberCat":"A*"},{"id":"drug-672","genericName":"Lamivudine 100 mg Tablet","brandName":"Axcel","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Management of chronic hepatitis B infection associated with evidence of hepatitis B viral replication and active liver inflammation","dosing":"Adult:100 mg once daily. \\nFor patients with concomitant HIV infection: 300 mg once daily or in 2 divided doses.\\nChild: >2 yr: 3 mg/kg once daily. Max: 100 mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.21","prescriberCat":"A*"},{"id":"drug-673","genericName":"Lamivudine 150 mg Tablet","brandName":"Valfix","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"HIV infection in combination with other antiretroviral agents","dosing":"ADULT: 150 mg twice daily or 300 mg once daily. \\nINFANT under 1 month: 2 mg/kg twice daily. \\nCHILD 3 month or over: 4 mg/kg twice daily. Maximum 300 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.22","prescriberCat":"A/KK"},{"id":"drug-674","genericName":"Lopinavir 200 mg and \\nRitonavir 50 mg Tablet","brandName":"Kaletra 200/50","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"As second line protease inhibitor if intolerant to indinavir/ ritonavir \\nas part of HAART regimen","dosing":"Adult: (Therapy-naive patients) 400/100 mg bd or 800/200 \\nmg once daily; (Therapy-experienced patients): 400/100 mg bd. Concomitant therapy (efavirenz, nevirapine, amprenavir, fosamprenavir or nelfinavir) 400/100 mg bd. Children >40 kg or w/ BSA >1.4 m2 as adult dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.90","prescriberCat":"A"},{"id":"drug-675","genericName":"Lopinavir 100 mg and\\nRitonavir 25 mg Tablet","brandName":"Kaletra 100/25","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"As second line protease inhibitor if intolerant to indinavir/ ritonavir as part of HAART regimen.","dosing":"Adult: (Therapy-naive patients) 400/100 mg bd or 800/200 mg once daily; \\n(Therapy-experienced patients): 400/100 mg bd. \\nConcomitant therapy (efavirenz, nevirapine, amprenavir, fosamprenavir or nelfinavir) 400/100 mg bd. \\nChildren >40 kg or w/ BSA >1.4 m2 as adult dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"6.60","prescriberCat":"A"},{"id":"drug-676","genericName":"Nevirapine 200 mg Tablet","brandName":"Herapine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Treatment of HIV-1 infection in combination with other antiretroviral agents","dosing":"Combined with other antiretrovirals: 200 mg once daily for the 1st 14 days; up to 200 mg twice daily if rash does not develop. \\nRe-introduce at a lower dose for the 1st 14 days if treatment is interrupted for >7 days,necessitate reintroduction at a lower dose for the first 14 days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.40","prescriberCat":"A/KK"},{"id":"drug-677","genericName":"Oseltamivir 60mg/5ml oral suspension (100ml)","brandName":"Ranbaxy Fluhart","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["(100ml)"],"indications":"i) For treatment of patients with suspected or confirmed influenza and severe disease (requiring hospitalization or evidence of lower respiratory tract infection). ii) For treatment of patients with suspected or confirmed influenza and with co-morbidity and associated with increased risk of influenza complications. Not to be used as prophylaxis","dosing":"Children  1 year (for 5 days): a) 15 kg: 30mg twice daily b) >15kg to 23kg:45mg twice daily c) >23kg to 40kg: 60mg twice daily Children with body weight more than 40kg who are able to swallow capsule is recommended to be dosed as adults.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"98.60","prescriberCat":"A/KK"},{"id":"drug-678","genericName":"Oseltamivir 75 mg Capsule","brandName":"Osmivir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Capsule"],"indications":"i) For treatment of patients with suspected or confirmed influenza and severe disease (requiring hospitalization or evidence of lower respiratory tract infection). \\nii) For treatment of patients with suspected or confirmed influenza and with co-morbidity and associated with increased risk of influenza complications. Not to be used as prophylaxis.","dosing":"Recommended dose in adults and adolescents = 13 years of age and body weight >40kg is 75mg twice daily for 5 days. \\nDosing adjustment for renal impaired patient, follow manufacturer's recommendations in product insert.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.93","prescriberCat":"A/KK"},{"id":"drug-679","genericName":"Raltegravir 400mg Tablet","brandName":"Isentress","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Raltgeravir combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection in patients who are contraindicated to boosted Protease Inhibitor or who are intolerant to boosted Protease Inhibitor.","dosing":"400mg administered orally, twice daily with or without food, to be given combination with other antiretroviral agent.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nDiscontinue by company, not available (Dept: Perubatan)","price":"7.54","prescriberCat":"A*"},{"id":"drug-680","genericName":"Remdesivir 100mg/20ml Injection","brandName":"Veklury","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Injection"],"indications":"Coronavirus disease 2019 (COVID-19)","dosing":"Adult:In hospitalised patients with severe case: 200 mg as a single dose on day 1, followed by 100 mg once daily starting on day 2. Treatment duration: Patients not requiring mechanical ventilation/extracorporeal membrane oxygenation (ECMO): 5 days; may extend for up to 5 additional days (total of 10 days) in patients who do not demonstrate clinical improvement. Patients requiring invasive mechanical ventilation/ECMO: 10 days. Doses are given via infusion over 30-120 minutes. Dosage recommendation is based on currently available data from clinical studies and may vary among local guidelines or countries.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"966.00","prescriberCat":""},{"id":"drug-682","genericName":"Ribavirin 200 mg Capsule","brandName":"Rebetol","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Capsule"],"indications":"For the treatment of chronic hepatitis C (in combination with interferon alfa-2a/2b)","dosing":"ADULT (more than 18 years old): 50mg/kg/day \\nRecommended: \\nBody weight: = 75kg should receive 1000mg daily as two 200mg capsules in the morning and three 200mg capsules in the evening \\nBody weight: >75kg should receive 1200mg as three 200mg capsules in the morning and three 200mg capsules in the evening \\nGenotype 1,4: 48 weeks Genotype: 24 weeks duration should be individualized in accordance with the baseline characteristics of the disease.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"A*"},{"id":"drug-683","genericName":"Ravidasvir 200mg tablet","brandName":"Ravida","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["tablet"],"indications":"To be used in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults\\n\\nPrescribing restriction:\\nIn non-cirrhotic patients or compensated cirrhosis patients who are treatment nave to NS5A inhibitor","dosing":"200 mg once daily, to be taken orally with or without food.\\nPatients without cirrhosis: Ravidasvir plus sofosbuvir for 12 weeks.\\nPatients with compensated cirrhosis: Ravidasvir plus sofosbuvir for 24 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"15.60","prescriberCat":"A*"},{"id":"drug-684","genericName":"Ritonavir 100mg capsule","brandName":"Norvir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["capsule"],"indications":"Progressive or advanced HIV infection in combination with other antiretroviral agents.\\n\\nCriteria of use: \\na) Clinical AIDS\\nb) CD4 less than 350 cells or\\nc) Viral load more than 10,000 copies/ml","dosing":"ADULT: (Single PI) initially 300 mg twice daily, increase by 100 mg twice daily increments to 600 mg twice daily. (Dual PI) Initially 200mg BD, then increase by 100mg BD & reaching 400mg BD within 2 wk.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"4.92","prescriberCat":"A*"},{"id":"drug-685","genericName":"Sofosbuvir 400mg tablet","brandName":"Sofovir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["tablet"],"indications":"To be used in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults.","dosing":"One 400 mg tablet, taken orally, once daily with food.\\nSofosbuvir should be used in combination with other medicinal products. Monotherapy of sofosbuvir is not recommended.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.45","prescriberCat":"A*"},{"id":"drug-686","genericName":"Tenofovir Disoproxil Fumarate 300 mg Tablet","brandName":"Ricovir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Prescriber Category A*:\\ni. Treatment of HIV-1 infected adults in combination with other antiretroviral agents.\\n\\nii. Use as first line monotherapy for chronic hepatitis B or as a rescue therapy for patients with drug resistance hepatitis B virus (according to resistant profile or treatment guidelines).\\n\\nPrescriber Category A/KK:\\niii. For antenatal patients only with chronic Hepatitis B with HBeAg reactive or HBV DNA more than 200,000 or deranged LFT.\\n\\niv. For adult patients with chronic Hepatitis B (CHB) eAg positive or eAg negative chronic hepatitis. (For non-cirrhotic liver disease only)","dosing":"Indication i, ii & iv:\\n300mg once daily.\\n\\nRenal Dose Adjustment: \\n300mg every 48hours (30-49ml/min); \\n300mg every 72hours (10-29ml/min); \\n300mg every 7 days after dialysis (Hemodialysis)\\n\\nIndication iii:\\n300mg once daily from 28 weeks of gestation and continue till 4 weeks postpartum","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.52","prescriberCat":"A*, A/KK"},{"id":"drug-687","genericName":"Tenofovir Disoproxil Fumarate 300 mg & Emtricitabine 200 mg Tablet","brandName":"Tenvir-EM","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"Treatment of HIV-1 infection in adults in combination with other antiretroviral agents (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors).","dosing":"1 tablet once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.86","prescriberCat":"A/KK"},{"id":"drug-688","genericName":"Valganciclovir 450 mg Tablet","brandName":"Valcyte","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"i) For the prevention of cytomegalovirus (CMV) disease in CMV-negative patients who have received a solid organ transplant from a CMV-positive donor\\n\\nii) Treatment of Cytomegalovirus (CMV) disease (e.g CMV retinitis) in immunocompromised patients","dosing":"i) For adult patients who have received other than kidney transplant, \\nthe recommended dose is 900 mg (two 450 mg tablets) once a day starting within 10 days of transplantation until 100 days post-transplantation. \\nFor adult patients who have received a kidney transplant, the recommended dose is 900 mg (two 450 mg tablets) once a day starting within 10 days of transplantation until 200 days post-transplantation.\\n\\nii) induction adults: 900mg BD x 3 weeks\\n   maintenance adults: 900 mg OD (a min of 3 months has  been practiced)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"84.67","prescriberCat":"A*"},{"id":"drug-689","genericName":"Zidovudine 100 mg Capsule","brandName":"Zidovudine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Capsule"],"indications":"i) Management of patients with asymptomatic and symptomatic (early or advanced) HIV infections with CD4 cell counts less than 500 cu. mm \\nii) Neonatal prophylaxis","dosing":"i) HIV infection \\nAdult: 600 mg daily in divided doses, in combination with other antiretroviral agents. \\nChild: 6 wk - 12 yr: 160 mg/m2 every 8 hr. Max: 200 mg every 8 hr. May be used in combination with other anti-retrovirals. \\nRenal and Hepatic impairment: Dose reduction may be needed. \\n\\nii) Prophylaxis of HIV infection in neonates \\nChild: Neonates: 2 mg/kg every 6 hr for 1st 6 wk of life, starting within 12 hr after birth. \\nRenal and hepatic impairment: Dose adjustment may be needed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.10","prescriberCat":"A/KK"},{"id":"drug-690","genericName":"Zidovudine 1% Injection","brandName":"Retrovir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Injection"],"indications":"To reduce the rate of maternal-foetal transmission of HIV in: \\ni) HIV-positive pregnant women over 14 weeks of gestation \\nii) Their newborn infants","dosing":"i) Prophylaxis of maternal-foetal HIV transmission during labour and delivery.\\nAdult: Loading dose: 2 mg/kg, followed by continuous infusion of 1 mg/kg/hr until umbilical cord is clamped. If caesarean section is planned, start the IV infusion 4 hr before the operation. \\nRenal and Hepatic impairment: Dose reduction may be needed. \\nHIV infection (to be discuss: not in indication) \\nAdult: 1-2 mg/kg every 4 hr, given as 2-4 mg/ml infusion over 1 hr. \\nChild: As continuous infusion: 20 mg/m2/hr. Alternatively, as intermittent infusion: 120 mg/m2 every 6 hr. \\nRenal impairment: Haemodialysis or peritoneal dialysis: 1 mg/kg every 6-8 hr. \\n\\nii) Prophylaxis of HIV infection in neonates Child: Neonates: 1.5 mg/kg every 6 hr. Start treatment within 12 hr after birth and continue for 1st 6 wk of life. Dose to be given via IV infusion over 30 minutes. Renal impairment: Dose adjustment may be needed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"146.50","prescriberCat":"A"},{"id":"drug-691","genericName":"Zidovudine 10 mg/ml Syrup","brandName":"Retrovir","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Syrup"],"indications":"i) Management of patients with asymptomatic and symptomatic (early or advanced) HIV infections with CD4 cell counts less than 500 cu. mm.\\n ii) Neonatal prophylaxis","dosing":"i) HIV infection \\nAdult: 600 mg daily in divided doses, in combination with other antiretroviral agents. \\nChild: 6 wk - 12 yr: 160 mg/m2 every 8 hr. Max: 200 mg every 8 hr. May be used in combination with other anti-retrovirals. \\nRenal and Hepatic impairment: Dose reduction may be needed. \\nii) Prophylaxis of HIV infection in neonates \\nChild: Neonates: 2 mg/kg every 6 hr for 1st 6 wk of life, starting within 12 hr after birth. \\nRenal and hepatic impairment: Dose adjustment may be needed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"94.20","prescriberCat":"A*"},{"id":"drug-692","genericName":"Zidovudine 300 mg & Lamivudine 150 mg Tablet","brandName":"Zovilam","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.6 ANTIVIRALS","forms":["Tablet"],"indications":"HIV infection in combination with at least one other antiretroviral drug","dosing":"ADULT and CHILD over 12 years: 1 tablet twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.57","prescriberCat":"A/KK"},{"id":"drug-695","genericName":"Abiraterone acetate 250mg tablet","brandName":"Arabitro","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["tablet"],"indications":"With prednisone or prednisolone, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. \\n\\nRestriction:\\ni. Those who have progressed on OR failed prior docetaxel\\nchemotherapy\\nii. Those who are contraindicated or unsuitable for\\nchemotherapy","dosing":"1000mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"6.23","prescriberCat":"A*"},{"id":"drug-696","genericName":"All-Trans Retinoic Acid (tretinoin) 10mg\\nCapsule","brandName":"Vesanoid","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["10mg\\nCapsule"],"indications":"Acute promyelocytic leukaemia","dosing":"Induction: 45 mg/m2 daily for 30 - 90 days. \\nMaintenance: 45 mg/m2 daily for 2 weeks every \\n3 months. \\nRenal/or hepatic insufficiency: 25mg/m2 daily for \\n30-90 days. \\n\\nRefer to protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"13.58","prescriberCat":"A*"},{"id":"drug-697","genericName":"Abemaciclib 150mg Film Coated Tablet","brandName":"Yulareb","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Abemaciclib, in combination with endocrine therapy, is indicated for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive early breast cancer at high risk of recurrence.\\n\\nIn pre- or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist.\\n\\nPrescribing restrictions:\\ni. For high-risk stage II and III early breast cancer. High risk defined by clinical and pathological features: either pALN (positive axillary lymph nodes) or 1  3 pALN and at least one of the following criteria: tumour size 5cm or histological grade 3.\\nii. To be prescribed by Oncologist only","dosing":"The recommended dosing is 150mg twice daily, taken orally with or without food for 2 years, or until disease recurrence or unacceptable toxicity occurs","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA (Dept: Pembedahan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"1021.9","prescriberCat":"A*"},{"id":"drug-698","genericName":"Adalimumab 40mg Injection","brandName":"Humira","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Third line treatment of:\\n - Severe rheumatoid arthritis \\n- Psoriatic arthritis \\n- For reducing signs and symptoms in patients with active ankylosing spondylitis, after failure of conventional DMARDs or other biologics.\\n\\nii)Treatment of adults with moderate to severe chronic plaque psoriasis who have not responded to, have contraindication or are unable to tolerate phototherapy and/or systemic therapies including acitretin, methotreaxate and cyclosporine","dosing":"i) Severe rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis\\n : Subcutaneous 40 mg every other week \\n\\nii) Chronic plaque psoriasis\\n : Initial, 80 mg SC, followed by 40 mg SC every other week starting one week after the initial dose\\n\\niii) & iv) Crohn's disease & Ulcerative colitis: 160mg at week 0 (dose can be administered as four injections in one day or as two injections per day for two consecutive days) and 80mg at week 2. After induction treatment, the recommended maintenance dose is 40mg every other week via subcutaneous injection.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"500.00","prescriberCat":"A*"},{"id":"drug-700","genericName":"Afatinib  30mg Film Coated Tablet","brandName":"Giotrif","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"First line monotherapy for the treatment of epidermal growth factor receptor (EGFR) TKI-nave patients with locally advanced or metastatic non-small cell lung cancer with EGFR mutation","dosing":"30-40mg OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"49.00","prescriberCat":"A*"},{"id":"drug-701","genericName":"Anastrozole 1 mg Tablet","brandName":"Aremed","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Hormonal therapy in breast cancer in post-menopausal women if failed /contraindicated with Tamoxifen","dosing":"1 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, Obstetrik)","price":"1.58","prescriberCat":"A*"},{"id":"drug-702","genericName":"Azathioprine 50 mg Tablet","brandName":"Imuran","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"i) Prophylaxis of rejection in organ and tissue transplant\\nii) Auto-immune diseases \\niii) Rheumatoid arthritis","dosing":"i) Adult: 1-5 mg/kg/day. Adjust dose according to clinical response and haematological tolerance. Dose may also be given via IV administration. \\nii) Adult: 1-3 mg/kg/day. Discontinue treatment if there is no improvement after 12 week. \\niii) Adult: Initially, 1 mg/kg/day given in 1-2 divided doses for 6-8 week, may increase by 0.5 mg/kg every 4 week until response or up to 2.5 mg/kg/day. \\nMaintenance: Reduce dose gradually to achieve the lowest effective dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.87","prescriberCat":"A"},{"id":"drug-703","genericName":"Baricitinib 4mg Tablet","brandName":"Olumiant","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"1. Treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. May be\\nused as monotherapy or in combination with methotrexate.\\nRestriction: Severe active rheumatoid arthritis: To be prescribed by Rheumatologist only","dosing":"1. Severe active rheumatoid arthritis: 4mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) not needed for Covid as exemption has been given (Dept: Perubatan)","price":"6.19","prescriberCat":"A*"},{"id":"drug-705","genericName":"Belimumab 120mg Powder for Injection","brandName":"Benlysta","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Reducing disease activity in adult patients w/ active autoantibody +ve SLE receiving standard therapy","dosing":"Adult 10 mg/kg IV infusion over 1 hr on days 0, 14 & 28 & at 4-wk intervals thereafter. Patient w/ allergies Premed w/ oral antihistamine w/ or w/o antipyretic before infusion.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required (Dept: Perubatan)","price":"428.00","prescriberCat":"Not in FUKKM"},{"id":"drug-706","genericName":"Bevacizumab 100mg/4ml","brandName":"Avastin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["100mg/4ml"],"indications":"Bevacizumab, in combination with atezolizumab, is indicated for the treatment of patients with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.\\n\\nNote:\\nCurrently, innovator bevacizumab product ie. Avastin is the only product with DCA approved indication for treatment of hepatocellular carcinoma.\\n\\nPrescribing restriction:\\nOnly for patients with Child-Pugh A","dosing":"The recommended dosage is 15 mg/kg intravenously after administration of atezolizumab intravenously on the same day, every 3 weeks until disease progression or unacceptable toxicity.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA (Dept: Pembedahan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"629.00   62.90 (PaSc)","prescriberCat":"A*"},{"id":"drug-707","genericName":"Bicalutamide 50 mg Tablet","brandName":"Bicalox","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Androgen deprivation therapy in advanced prostate cancer in \\ncombination with luteinising hormone-releasing hormone (LHRH) analogue therapy or surgical castration.","dosing":"50 mg once daily. (morning or evening), with or without food. \\nTake on the same time each day. \\nAdult: When used with gonadorelin analogue: Usual dose: 50 mg once daily. \\nMay be started with or at least 3 days before starting gonadorelin analogue therapy.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"1.78","prescriberCat":"A*"},{"id":"drug-708","genericName":"Capecitabine 150mg, 500 mg Tablet","brandName":"Intacape","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"1) Metastatic breast cancer; \\n2) Treatment of colorectal cancer in adjuvant and metastatic setting; \\n3) advanced oesophagogastric cancer in combination with a platinum-based regimen","dosing":"i. As monotherapy or in combination with docetaxel: 1250 mg/m2 twice daily for 2 weeks followed by a 7-day rest period.\\nii. As monotherapy: 1250 mg/m2 twice daily (morning and evening) for 2 weeks, followed by a 7-day rest period. As combination: 1000 mg/m2 twice daily for 2 weeks followed by a 7-day rest period.\\niii. In combination with a platinum: 1000 mg/m2 twice daily for 14 days followed by a 7 day rest period\\n\\nDosing is individualised and according to product insert/ treatment protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"2.74, 3.43","prescriberCat":"A*"},{"id":"drug-709","genericName":"Carboplatin 450 mg Injection","brandName":"Kemocarb","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"1) Solid tumours; 2) Salvage therapy for lymphoma","dosing":"360 - 400 mg/m2 BSA, by IV infusion over 15 mins to 1 hour on Day 1 every 4 weeks. Alternatively, prescription may be based on Area Under Curve (AUC) calculations. \\nCHILD: 500-600 mg/m2 over 1 hour once every 3 weeks. Salvage regimes in lymphomas - refer to specific protocols. Starting dose in renal impairment, please refer to product insert.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"80.11","prescriberCat":"A*"},{"id":"drug-710","genericName":"Chlorambucil 2 mg Tablet","brandName":"Leukeran","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Low grade lymphoma, chronic lymphocytic leukaemia. Ovarian cancer","dosing":"General : Initial :0.1 -0.2 mg/kg body weight daily for 4 - 8 weeks maintanance : given either by reduced daily dosage or intermittent course of treatment. \\nChronic Lymphocytic Leukaemia: initial : 0.15mg/kg/day untill total leukocyte count has fallen to 10,000peruL, then resumed treatment untill 4 weeks after the end of the first course then continued at a dosage 0.1mg/kg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"5.51","prescriberCat":"A"},{"id":"drug-711","genericName":"Ciclosporin 25 mg, 100 mg Capsule Microemulsion","brandName":"Sandimmun Neoral","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Microemulsion"],"indications":"Only for: \\ni) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids \\nii) Follow-up cases of bone marrow transplant \\niii) Patients with severe rheumatoid arthritis not responding to other second line drugs","dosing":"i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. \\nMaintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation \\niii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months \\niv) ADULT: 5 mg/kg/day in 2 divided doses. \\nCHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.74,  15.00","prescriberCat":"A*"},{"id":"drug-713","genericName":"Ciclosporin 100mg/ml Drink Solution","brandName":"Sandimmun Neoral","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Solution"],"indications":"Only for : i) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids \\nii) Follow-up cases of bone marrow transplant \\niii) Patients with severe Rheumatoid arthritis not responding to other second line drugs \\niv) Patients with idiopathic nephrotic syndrome who are steroid toxic or poor response to cyclophosphamide \\nv) Severe aplastic anaemia, pure red cell aplasia \\nvi) Cases of recalcitrant psoriasis and atopic eczema","dosing":"i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. \\nMaintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation \\niii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months \\niv) ADULT: 5 mg/kg/day in 2 divided doses. \\nCHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day \\nv) 12 mg/kg/day \\nvi) 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan, Pediatrik)","price":"1195.00","prescriberCat":"A*"},{"id":"drug-714","genericName":"Ciclosporin 50 mg/ml Injection","brandName":"Sandimmun","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Post bone marrow transplant \\nii) Solid organ transplant","dosing":"i) 3 - 5 mg/kg/day until tolerate orally \\nii) 2 - 3 mg/kg/day for recipients who are unable to take orally","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"19.14","prescriberCat":"A*"},{"id":"drug-715","genericName":"Cisplatin (Cis-Platinum) 50 mg Injection","brandName":"Platol","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"1) Solid tumours; 2) lymphomas","dosing":"Germ cell tumours: 20 mg/m2 daily for 5 days every 3 weeks for 3 - 4 courses. \\nOvarian tumours: 75 mg/m2 once every 3 weeks as part of combination therapy with paclitaxel or 50-60mg/m2 IV once every 3 weeks as a single agent. \\nBaseline creatinine clearance, pretreatment hydration and forced diuresis are mandatory. CHILD: 100mg/m2 over 6 hours once every 3 weeks. Lymphomas: Refer to protocols CHILD: 100mg/m2 over 6 hours once every 3 weeks. Lymphomas: Refer to protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"28.35","prescriberCat":"A"},{"id":"drug-716","genericName":"Cyclophosphamide 50 mg Tablet","brandName":"Endoxan","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"i) Solid tumours, leukaemia, lymphoma, autoimmune disorders, autoimmune bullous diseases, connective tissue disease, pyoderma gangrenosum \\nii) For severe lupus nephritis (Class III & IV), systemic vasculitis and steroid resistant/dependent nephrotic syndrome \\niii) Systemic lupus erythematosus (SLE), rheumatoid arthritis, polyarteritis nodosa, wegener granulomatosis","dosing":"i) ADULT: 50 - 100 mg/day. Monitor full blood count (FBC), liver function, urine microscopy and renal function. \\nCHILD : up to 1 year: 10 - 20 mg daily, \\n1 - 5 years: 30 - 50 mg daily, \\n6 - 12 years: 50 - 100 mg daily \\nii) 2 mg/kg/day for 3 - 4 months \\niii) 1 - 1.5 mg/kg/day orally in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase (UKK) (Dept: Perubatan)","price":"0.50","prescriberCat":"A"},{"id":"drug-717","genericName":"Cyclophosphamide 1 g Injection","brandName":"Endoxan","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Solid tumours; \\nii) Leukaemia, non-Hodgkin's lymphoma, multiple myeloma; \\niii) Severe lupus nephritis (Class III and IV); \\niv) Other systemic vasculitis; \\nv) Systemic lupus erythematosus, rheumatoid arthritis, polyarteritis nodosa, wegener granulomatosis; \\nvi) Pemphigus vulgaris.","dosing":"i) & ii) ADULT: 600 - 750 mg/m2 IV once every 3 weeks as part of combination regime. CHILD: Dose variable depending on disease and protocol. Range 600 mg/m2 to 2 g/m2 infusion over 1 hour to 6 hours (lower doses can be given as bolus). Care with pre and post-hydration. Mesna to be given with doses more than 1 g/m2. Higher doses are used in haematopoetic stem cell transplant-refer to specific protocols \\niii) 750 mg/m2 BSA monthly for 18 months \\niv) 750 mg/m2 BSA monthly for 6 months. \\nDose can be adjusted up to 1,000 mg/m2 BSA to achieve adequate leucocyte suppression","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"39.24","prescriberCat":"A"},{"id":"drug-719","genericName":"Cytarabine 100 mg Injection","brandName":"Cytarine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Central nervous system lymphoma \\nii) Meningeal leukemia \\niii) Non Hodgkin's Lymphoma \\niv) High dose cytarabine as conditioning to cytoreduce the disease before stem cell transplant for relapsed or refractory leukemia \\nv) As salvage for acute lymphocytic leukemia \\nvi) As salvage for acute myeloid leukemia \\nvii) As palliative chemotherapy in elderly acute myeloid leukemia/ myelodysplastic syndrome","dosing":"Standard doses 100 - 200 mg/m2 daily over 5 - 10 days. \\nHigher doses for intensification/consolidation: 1000 - 3000 mg/m2 daily over 3 - 5 days depending on specific protocols. \\nCHILD: Dose variable depending on disease and protocol. Range from 100 mg/m2 to 3 g/m2 twice daily. May be given as SC, IV bolus or infusion. \\n\\nIntrathecal dose: Less than 1 year: 15 mg, 1 - 2 years: 20 mg, 2 - 3 years: 25 mg, more than 3 years: 30 mg. (ENSURE THAT PREPARATION IS SUITABLE FOR INTRATHECAL USE)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.00","prescriberCat":"A"},{"id":"drug-720","genericName":"Docetaxel 20 mg/0.5 ml, 80 mg /2 ml Injection","brandName":"Daxotel","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"For solid tumours such as: Breast Cancer; Non-small cell lung cancer; Prostate cancer; Gastric adenocarcinoma; Head and neck cancer; Ovarian cancer","dosing":"Breast cancer: Adult: 60-100 mg/m2 by infusion over 1 hr once every 3 wk. In combination w/ doxorubicin or capecitabine or as adjuvant therapy w/ doxorubicin and cyclophosphamide: 75 mg/m2 once every 3 wk. In combination w/ trastuzumab: 100 mg/m2 once every 3 wk; \\n\\nGastric adenocarcinoma, Head and neck cancer, Non-small cell lung cancer, Prostate cancer: Adult: 75 mg/m2 by infusion over 1 hr once every 3 wk. \\nFor gastric adenocarcinoma: Dose is given before cisplatin and fluorouracil. \\nFor head and neck cancer: Given before cisplatin and fluorouracil for 3 cycles followed by chemoradiotherapy or 4 wk followed by radiotherapy alone. \\nFor prostate cancer: May be given w/ oral prednisolone 5 mg bid continuously during treatment.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"23.00, 46.50","prescriberCat":"A*"},{"id":"drug-721","genericName":"Doxorubicin HCl 10 mg, 50 mg Injection","brandName":"Adrim","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Solid tumours, leukaemia, non-Hodgkin's lymphoma \\nii) Leukaemia (ALL induction) \\niii) Multiple myeloma","dosing":"i) 30 - 75 mg/m2 IV as a single dose at 21 day intervals \\nii) 25 - 45 mg/m2 once a week for the first 4 weeks during induction or re-induction phase (refer to specific protocol. Caution: Total cumulative dose of doxorubicin must not exceed 550 mg/m2 due to risk of cardiotoxicity. \\nCHILD: 30 mg/m2/dose over 6 - 24 hours for 1 - 2 days. Need to check cardiac function closely by echocardiography every cumulative dose of 100 mg/m2 to maximum 360 mg/m2 iii) 9 mg/m2 over 24 hours infusion for 4 days at monthly intervals","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.60, 23.20","prescriberCat":"A"},{"id":"drug-722","genericName":"Enzalutamide 40mg Capsule","brandName":"Xtandi","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsule"],"indications":"i) Metastatic castration-resistant prostate cancer\\nii) Non-metastatic castration-resistant prostate cancer\\niii) Hormone sensitive metastatic prostate cancer","dosing":"160mg once daily. \\nIf greater than or equal to grade 3 toxicity or intolerable side effects occurs, withhold treatment for 1 week or until symptoms improve to less than or equal to grade 2 toxicity, then resume to normal dosing or reduce to 80-120 mg once daily if needed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA\\n\\nSpecial Drugs Approval (UKK) required (Dept: Pembedahan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"","prescriberCat":"Not in FUKKM"},{"id":"drug-723","genericName":"Epirubicin 10 mg, 50 mg Injection","brandName":"Anthracin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Solid tumour, Non-Hodgkin's lymphoma, Leukaemia (ALL induction)","dosing":"75 - 90mg/m2 body area injected IV in 3 - 5 min, repeated at 21 day intervals.\\nHigher doses up to 135mg/m2 as single agent and 120mg/m2 as combination (effective in treatment of breast cancer) \\nCHILD: 50 mg/m2 over 6 hours. Schedule depends on protocol.Refer to specific product for dosing information","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"33.00, 73.08","prescriberCat":"A*"},{"id":"drug-724","genericName":"Etanercept 50mg Inj","brandName":"Enbrel","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Inj"],"indications":"i)Moderately to severe rheumatoid arthritis as monotherapy or in combination with methotrexate in patients with inadequate response to methotrexate alone. \\nii)Active polyarticular-course juvenile idiopathic arthritis in children 2-17 years with inadequate response to, or who have proved intolerant of methotrexate. \\niii)Psoriatic arthritis as monotherapy or in combination with methotrexate in patients inadequate response to methotrexate alone. \\niv)Active ankylosing spondylitis in adults \\nv)Moderate to severe plaque psoriasis who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA","dosing":"Adult & geriatric dose: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis; 50 mg SC once-weekly for once-weekly dosing or 25 mg SC twice weekly (individual doses should be separated by 72 to 96 hours) for twice-weekly dosing. \\n\\nPaediatric dose (2 to 17 years): Juvenile idiopathic arthritis; 0.8 mg/kg (max. 25 mg/dose) SC once weekly for once-weekly dosing or 0.4 mg/kg (max. 25 mg/dose) SC twice weekly (individual doses should be separated by 72 to 96 hours) for twice-weekly dosing","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"968.19","prescriberCat":"A*"},{"id":"drug-725","genericName":"Etoposide 100 mg/5 ml Injection","brandName":"Fytosid","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) For treatment of children with solid tumours, juvenile myelomonocytic leukemia (JMML) and Langerhan cell histiocytosis \\nii) Leukaemia, lymphoma \\niii) solid tumour","dosing":"i) CHILD: 60-120 mg/m2/day by IV for 3 - 5 days every 3 - 6 weeks depending on protocols \\nii) Maintenance or palliative chemotherapy for elderly acute myeloid leukemia, consolidation therapy for acute lymphoblastic leukemia, stem cell mobilization (Refer to protocol) \\niii) 100 mg/m2 by IV every other day for 3 doses repeated every 3-4 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"20.45","prescriberCat":"A*"},{"id":"drug-726","genericName":"Everolimus 0.25mg, 0.75mg Tablet","brandName":"0.25\\n\\n0.75","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant in combination with ciclosporin for microemulsion and corticosteroids","dosing":"An initial dose regimen of 0.75 mg b.i.d., which is recommended for the general kidney and heart transplant population. The daily dose of everolimus should always be given orally in two divided doses (b.i.d.).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"7.66  23.12","prescriberCat":"A*"},{"id":"drug-727","genericName":"Exemestane 25 mg Tablet","brandName":"Aromasin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Treatment of post-menopausal women with advanced breast cancer whose disease has progressed following tamoxifen and non-steroidal aromatase inhibitors","dosing":"25mg OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, Obstetrik)","price":"6.33","prescriberCat":"A*"},{"id":"drug-728","genericName":"Fluorouracil 250 mg/5 ml Injection (20ml)","brandName":"Intas Flurac","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["(20ml)"],"indications":"Solid tumours. Ophtalmological indication: trabeculectomy","dosing":"Intravenous Infusion: 15 mg/kg bodyweight (to a maximum of 1 g daily) diluted in 300-500mL of 5% glucose given over a period of 4 hours. 12 mg/kg bodyweight daily for 3 consecutive days. Providing there are no signs of toxic effects, the patient may then be given 6mg/kg I.V. on the 5th, 7th and 9th days. If after the 9th day there is still no sign of toxicity, the patient may be placed on maintenance therapy. \\nMaintenance Therapy: 5 - 10mg/kg bodyweight by I.V. injection once a week.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"19.14","prescriberCat":"A*"},{"id":"drug-729","genericName":"Gefitinib 250mg Tablet","brandName":"Intega","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"i) First line treatment of adult patients with locally advanced or metastatic Non Small Cell Lung Cancer (NSCLC) who have activating mutations of the EGFR TK. \\n\\nii) For second line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have previously failed chemotherapy, and who have activating mutation of epidermal growth factor receptor (EGFR).","dosing":"250mg tablet once a day, taken with or without food\\n\\nPrescribing restriction:\\nIndication (i): - Adenocarcinoma histology - Patient's ECOG Performance Status 0-1 - Must be prescribed by an oncologist or oncology-trained respiratory physician. Indication (ii) - Adenocarcinoma histology - Patient's ECOG Performance Status 0-1 - Must be prescribed by an oncologist or oncology-trained respiratory physician. - Must not have received prior TKI for this condition.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"16.60","prescriberCat":"A*"},{"id":"drug-730","genericName":"Gemcitabine HCl 1 g Injection","brandName":"Citabol","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Solid tumours such as: \\n(i) Non-small cell lung cancer\\n(ii) pancreatic cancer\\n(iii) ovarian cancer \\n(iv) breast cancer","dosing":"i) Alone or with cisplatin: 1000 mg/m2 day 1 & 8 every 3 weeks or 1000 mg/m2 day 1, day 8, day 15 every 4 weeks \\nii) Initially 1000 mg/m2 weekly for 7 weeks followed by 1 week rest. Subsequent cycles 1000 mg/ m2 weekly for 3 weeks followed by 1 week rest \\niii) Gemcitabine 1000 mg/m2 as 30 minutes IV infusion day 1 & 8 of each 21-day cycle followed by carboplatin on day 1 to attain a target AUC of 4 mg/ml/minute \\niv) 1250 mg/m2 on days 1 and 8 of each 21-day cycle with paclitaxel 175 mg/m2 given as a 3-hour infusion before gemcitabine on day 1 of each 21-day cycle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"41.20","prescriberCat":"A*"},{"id":"drug-731","genericName":"Golimumab 100mg/ml solution\\nfor injection","brandName":"Simponi","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["injection"],"indications":"i) Rheumatoid arthritis (RA): \\nIn combination with methotrexate (MTX), is indicated for: \\n- The treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to DMARD therapy including MTX has been inadequate. \\n- The treatment of active, severe and progressive rheumatoid arthritis in adult patients not previously treated with MTX. \\nii) Psoriatic arthritis (PsA): \\nGolimumab alone or in combination with MTX, is indicated for: The treatment of active psoriatic arthritis in adult patients when the response to previous DMARD therapy has been inadequate. \\niii) Ankylosing spondylitis (AS):\\nGolimumab(used alone) is indicated for: The treatment of active ankylosing spondylitis in adult patients when the response to conventional therapy has been inadequate.","dosing":"i) Rheumatoid arthritis 50mg given as a subcutaneous injection once a month, on the same date each month. \\n\\nii)Psoriatic arthritis 50mg given as a subcutaneous injection once a month, on the same date each month. \\n\\niii) Ankylosing spondylitis 50mg given as a subcutaneous injection once a month, on the same date each month.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota","price":"3702.00","prescriberCat":"A*"},{"id":"drug-732","genericName":"Hydroxyurea 500 mg Capsule","brandName":"DHNP Hydroxyurea","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsule"],"indications":"i) Solid tumours \\nii) Chronic myelocytic leukaemia and myeloproliferative disease","dosing":"i) Intermittent therapy: 80 mg/kg orally as a single dose every 3rd day.\\nContinuous therapy: 20 - 30 mg/kg orally as a single dose dly.\\nConcomitant therapy with irradiation: 80 mg/kg orally as a single dose every 3rd day (administration of hydroxyurea should be started at least 7 days before initiation of irradiation and continued during radiotherapy as well).\\n\\nii) Continuous therapy 20 - 30 mg/kg orally as a single dose daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.53","prescriberCat":"A"},{"id":"drug-733","genericName":"Ibrutinib 140mg Capsule","brandName":"Imbruvica","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsule"],"indications":"i) Mantle cell lymphoma","dosing":"i) Adult: In patients with relapsed or refractory cases: 560 mg once daily, continue until disease progression or unacceptable toxicity. If toxicity occurs, withhold doses until recovery to baseline or grade 1. Restart treatment at the starting dose for the 1st occurrence, then reduce by 140 mg after the 2nd occurrence, another reduction of 140 mg may be considered if needed. Discontinue following 2 dose reductions if toxicities persist.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA\\n\\nSpecial Drugs Approval (UKK) required (Dept: Perubatan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"215.53","prescriberCat":"Not in FUKKM"},{"id":"drug-736","genericName":"Infliximab 100mg Injection","brandName":"Remsima","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Rheumatoid arthritis (moderate to severe), in combination with methotrexate \\nii) Ankylosing spondylitis in patients with active disease despite treatment with methotrexate \\niii) Crohn's Disease in patients who have an inadequate response to conventional therapies. \\niv) Fistulizing Crohn's Disease in patients who have an inadequate response to conventional therapies \\nv) Ulcerative Colitis in patients who have an inadequate response to conventional therapies","dosing":"i) Rheumatoid arthritis: ADULT over 18 years old: 3 mg/kg at 0, 2, 6 weeks, then every 8 weeks; May increase to 10 mg/kg or increase dosing frequency to 4 weekly for patients with incomplete response. Discontinue if no response by 12 weeks of initial infusion or after dose adjustment \\nii) Ankylosing spondylitis: ADULT over 18 years: 5 mg/kg IV over 2 hour given at week 0, 2, and 6 then every 6-8 weeks. Discontinue if no response by 6 weeks of initial infusion. \\niii), iv) & v)5 mg/kg given as an intravenous infusion over a 2-hour period followed by additional 5 mg/kg infusion doses at 2 and 6 weeks after the first infusion, then every 8 weeks thereafter","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"700.00","prescriberCat":"A*"},{"id":"drug-737","genericName":"Irinotecan HCl Trihydrate 100 mg/5 ml Injection","brandName":"Irinol","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Metastatic colorectal cancer","dosing":"In combination therapy (for previously untreated patients): 180 mg/m2 once every 2 weeks as an IV infusion over 90 mins followed by infusion with folinic acid and 5-fluorouracil. In monotherapy (for previously treated patients): 350 mg/m2 administered as an intravenous infusion over 90 minutes period once every 3 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"40.00","prescriberCat":"A*"},{"id":"drug-738","genericName":"Ixekizumab 80mg Solution for Injection in Pre-filled Syringe","brandName":"Taltz","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Syringe"],"indications":"Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. Monotherapy or in combination w/ methotrexate for active psoriatic arthritis in adults who have responded inadequately to, or who are intolerant to 1 disease-modifying anti-rheumatic drug therapies.\\nOff-label use: Ankylosing Spondylitis","dosing":"SC Plaque psoriasis Recommended dose: 2 inj at wk 0, then 1 inj at wk 2, 4, 6, 8, 10 & 12. Maintenance dose: 1 inj every 4 wk. Psoriatic arthritis Recommended dose: 2 inj at wk 0, then 1 inj every 4 wk thereafter.\\n\\nAnkylosing Spondylitis: 160mg at week 0, then 80mg starting at week 4 every 4 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Guna peruntukan JPA, perlu mohon ubat baru jika nak guna peruntukan hosp (Dept: Perubatan)","price":"2568.10","prescriberCat":""},{"id":"drug-739","genericName":"L-Asparaginase 10,000 IU Injection","brandName":"Leunase","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Acute lymphoblastic leukemia \\nii) Non-hodgkin's lymphoma","dosing":"i) 5,000 iu/m2 for 10 days during induction, 10,000 iu/m2 also used with high dose methotrexate rescue in consolidation phase of acute lymphoblastic leukemia \\nii) CHILD: 5,000 - 25,000 iu/m2 per dose depending on protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"49.56","prescriberCat":"A*"},{"id":"drug-740","genericName":"Lenvatinib 4mg Hard Capsule","brandName":"Lenvima","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsule"],"indications":"Indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have received no prior systemic therapy","dosing":"The recommended daily dose of lenvatinib is 8 mg (two 4 mg capsules) once daily for patients with a body weight of < 60 kg and 12 mg (three 4 mg capsules) once daily for patients with a body weight of  60 kg.\\n\\nDose adjustments are based only on toxicities observed and not on body weight changes during treatment (Refer package insert for dosage adjustments)\\n\\nTreatment should continue as long as clinical benefit is observed or until unacceptable toxicity occurs.\\n\\nPrescribing restriction: Only for patients with Child-Pugh A","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"85.94","prescriberCat":"A*"},{"id":"drug-741","genericName":"Letrozole 2.5 mg Tablet","brandName":"Letero","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Hormonal therapy in breast cancer in post-menopausal women if failed /contraindicated to Tamoxifen","dosing":"2.5 mg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"0.52","prescriberCat":"A*"},{"id":"drug-742","genericName":"Melphalan 2mg Tablet","brandName":"Alkeran","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"i) Multiple myeloma ii) Neuroblastoma, rhabdomyosarcoma iii) Recurrent neuroblastoma (palliative)","dosing":"i) 8 - 10 mg/m2 for 4 days every 4 weeks ii) 10 - 35 mg/m2 once every month For dose regimes, refer to protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"10.13","prescriberCat":"A"},{"id":"drug-743","genericName":"Mercaptopurine 50mg Tablet","brandName":"Averroes \\nmercaptopurine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"i) Langerhan's cell histocytosis ii) Acute lymphoblastic leukaemia iii) Acute promyelocytic leukaemia APML (maintenance)","dosing":"Leukaemia adults: 2.5mg/kg or 80-00mg/m2 p.o per day, given as a single dose. To be increased at the end of 4 weeks, If necessary, up to 5mg/kg p.o per day. \\n\\nMaintainance dosage are 1.5mg/kg -2.5mg/kg p.o per day\\n\\nChildren age 5 and older: Induction: 2.5mg/kg/day p.o once daily. Maintanance dose: 1.5mg/kg -2.5mg.kg p.o once daily or 70-100mg/m2 p.o once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"4.01","prescriberCat":"A"},{"id":"drug-744","genericName":"Methotrexate 50 mg Injection","brandName":"Zexate","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Solid tumours \\nii) Gestational trophoblastic disease \\niii) Acute leukaemia/lymphomas \\niv) Rheumatoid arthritis, psoriatic arthropathy, severe/erythrodermic psoriasis","dosing":"i) 50 mg/m2 once every 2 - 3 weeks in combination with other drugs \\nii) 50 mg IV Day 1, 3, 5, 9 every 3 weeks. For high risk gestational trophoblastic disease, use 100 mg/m2 as part of EMA-CO regime \\niii) High dose regimes: 500 - 3000 mg/m2 per dose may be used, employing the 500 mg preparations. \\nCHILD: Central nervous system prophylaxis for acute leukaemia 2 gm/m2 over 24 hours with folinic acid rescue, 3 doses for B-cell lineage. 4 doses for T-lineage all every 3 weeks. Relapse acute lymphoblastic leukaemia (ALL): 1 gm/m2 over 36 hours with folinic acid rescue every 3 weeks for 9 doses, maintenance: 50 mg/m2 every 2 weeks.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.44","prescriberCat":"A"},{"id":"drug-746","genericName":"Methotrexate 2.5 mg Tablet","brandName":"PFZ","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"i. Antineoplastic Chemotherapy\\n- Treatment of gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole.\\n- Palliation of acute lymphocytic leukemia\\n- Treatment and prophylaxis of meningeal leukemia.\\n- Palliation of acute lymphoblastic (stem-cell) leukemias in children.\\n- Alone or in combination with other anticancer agents in the management of breast cancer, epidermoid cancers of the head and neck, and lung cancer, particularly squamous cells and small cell types.\\n- Treatment of the advanced stages (III & IV, Peters Staging System) of lymphosarcoma, particularly in those cases in children; and in advanced cases of mycosis fungoides.\\n\\nii. Psoriasis Chemotherapy\\nSymptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation.\\n\\niii. Rheumatoid arthritis","dosing":"Dosing is individualised and according to product insert / protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.53","prescriberCat":"A"},{"id":"drug-748","genericName":"Mitomycin-C 10 mg Injection","brandName":"Mito-10","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Gastrointestinal, lung, breast, cervical cancers \\nii) Bladder tumours \\niii) Opthalmological conditions: conjunctival squamous neoplasia, squamous cell carcinoma of conjunctiva, trabeculectomy chronic lymphocytic leukaemia, chronic myelogenous leukaemia. Gastric, colorectal, lung cancer","dosing":"i) 10 - 20 mg/m2 body surface area (BSA) given as a single dose through a running IV infusion repeated every 6 - 8 weeks. The whole schedule may be repeated depending on the bone marrow \\nii) 10 - 40 mg daily or every other day (intravesical) \\niii) 0.4 mg topically as a single application for opthalmological conditions, duration: 1 to 3 minutes","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"No ready stock, will get stock when there is case","price":"205.15","prescriberCat":"A*"},{"id":"drug-749","genericName":"Mycophenolate Mofetil 250 mg capsule, 500 mg tablet   \\n\\nsee notes for which brand to supply","brandName":"Cellcept 500,\\nMycofit 500 \\nMycofit 250","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["supply"],"indications":"i) Prophylaxis of acute organ rejection in patients receiving allogenic renal, cardiac and hepatic transplant\\n\\nii) Used with steroids for induction and maintenance of severe lupus nephritis\\n\\nOff-label use in HSM: Extra-renal lupus, RA ILD","dosing":"i) Renal transplant rejection: \\nADULT: 1 g twice daily. \\nCHILD (3 months and older): 600 mg/m(2)/dose, twice daily; maximum daily dose, 2 g/10 mL. \\nCardiac transplant rejection: 1.5 g twice daily. \\nHepatic transplant rejection: 1.5 g twice daily \\n\\nii) Induction phase: 2 - 3 g/day for up to 6 months. \\nMaintenance phase: dose gradually tapers to 1 g/day\\n\\nExtra renal lupus & RA ILD: 500mg BD (refer rheumatologist)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Cellcept (for transplant patients & patients intolerant to MYCOFIT);\\nMYCOFIT (for other patients) (Dept: Perubatan\\nRheumatology\\n\\nSpecial Drugs Approval (UKK) NOT REQUIRED as exemption has been given)","price":"4.92 1.42 0.82","prescriberCat":"A*"},{"id":"drug-750","genericName":"Mycophenolate Sodium 180mg, 360mg Tablet","brandName":"Myfortic 180mg\\n\\nMyfortic 360mg","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Prophylaxis of acute transplant rejection in adult patients receiving allogenic renal transplant in combination with ciclosporin and corticosteroids\\n\\nOff-label use in HSM (UKK): Extra-renal lupus, RA ILD","dosing":"720 mg twice daily\\n\\n\\nExtra renal lupus & RA ILD: 500mg BD (refer rheumatologist)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan\\nRheumatology\\n\\nSpecial Drugs Approval (UKK) REQUIRED for off-label indication as there is no exemption given for myfortic)","price":"3.45   6.74","prescriberCat":"A*"},{"id":"drug-751","genericName":"Nintedanib 150mg capsule","brandName":"OFEV","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["capsule"],"indications":"i) For the treatment of Idiopathic Pulmonary Fibrosis (IPF) in adults\\n\\nii) Indicated in adults for the treatment of other chronic fibrosing lung disease (ILDs) with a progressive phenotype\\nRestrictions:\\n FVC at least 40% of predicted value, and\\n DLCO 30% to 89% of predicted value\\n To be prescribed by Consultant Respiratory Physician and Rheumatologist only","dosing":"i) The recommended dose is 150 mg twice daily administered approximately 12 hours apart.\\nThe 100 mg twice daily dose is only recommended to be used in patients who do not tolerate the 150 mg twice daily dose.\\n\\nii) 150mg twice a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA (Dept: Perubatan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"57.15","prescriberCat":"A*"},{"id":"drug-752","genericName":"Osimertinib 80mg Tablet","brandName":"Tagrisso","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"The treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC whose disease has progressed on or after EGFR TKI therapy\\n\\nRestriction: Second-line therapy, in patients who progressed from first-line EGFR TKI therapy.\\nTo be prescribed by oncologists and oncology-trained respiratory physicians","dosing":"80 mg once a day until disease progression or unacceptable toxicity, taken with or without food at the same time each day.\\nIf dose reduction is necessary, then the dose should be reduced to 40 mg taken once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"403.60","prescriberCat":"A*"},{"id":"drug-753","genericName":"Oxaliplatin 50 mg/10 ml Injection","brandName":"FK Oxaplin","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Colorectal cancer","dosing":"85 mg/m2 IV repeated every 2 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"22.50","prescriberCat":"A*"},{"id":"drug-754","genericName":"Paclitaxel 100 mg/16.6 ml Injection","brandName":"FK Intaxel","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Treatment of recurrent breast cancer, after failure of anthracycline-based chemotherapy \\nii) Primary adjuvant therapy in advanced ovarian cancer in combination with cisplatin \\niii) Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in chemonaive patients in combination with platinum compounds","dosing":"i) 175 mg/m2 IV over 3 hours every 3 weeks \\nii) 175 mg/m2 IV over 3 hour followed by cisplatin 75 mg/m2 in every 3 weeks or 135 mg/m2 IV over 24 hours followed by cisplatin 75 mg/m2 every 3 weeks \\niii) 135 mg/m2 IV over 24 hours followed by cisplatin 75 mg/m2 every 3 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"60.84","prescriberCat":"A*"},{"id":"drug-755","genericName":"Peginterferon Alfa-2b 80 mcg Injection","brandName":"Peg-Intron","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Treatment of: i) Chronic Hepatitis C ii) Chronic Hepatitis B","dosing":"i) Combination therapy with Ribavirin: \\nADULT: SC 1.5 mcg/kg/week \\nCHILD and ADOLESCENT (3-17 yr): SC 60 mcg/m2/week for 24-48 weeks \\n\\nMonotherapy: ADULT: SC 1 mcg/kg/week for 24 weeks to 1 year \\n\\nii) SC 1.0 - 1.5 mcg/kg once weekly for 52 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"544.00","prescriberCat":"A*"},{"id":"drug-756","genericName":"Palbociclib 75mg, 100mg, 125mg Tablet","brandName":"Ibrance","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.","dosing":"125 mg capsule taken orally once daily for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days.\\n\\nPalbociclib should be taken with food. For dose modification, refer package insert","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"110.65","prescriberCat":"A*"},{"id":"drug-757","genericName":"Pazopanib Hydrochloride 400 mg Tablet","brandName":"Votrient","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"For treatment of advanced and/or metastatic renal cell carcinoma (RCC)\\n\\nRestriction:\\ni) KPS  70% \\nii) Clear cell histology\\niii) No brain metastasis\\niv) Haemoglobin  9g/dl \\nv) Creatinine 2x the ULN\\nvi) Corrected calcium < 12mg/dl\\nvii) Platelet count of >100x103/uL viii) Neutrophil count >1,500/mm3","dosing":"Recommended dose is 800 mg ORALLY once daily. Should be taken without food (at least one hour before or two hours after meal). The dose should not exceed 800 mg.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"113.30","prescriberCat":"A*"},{"id":"drug-758","genericName":"Pemetrexed Disodium 500mg inj","brandName":"Accord","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["inj"],"indications":"In combination with Cisplatin for the 2nd line treatment of patients with locally advanced or metastatic non small cell lung cancer (NSCLC) other than predominantly squamous cell histology","dosing":"Initial therapy 500 mg/m(2) IV over 10 minutes on day 1, followed 30 minutes later by cisplatin 75 mg/m(2) infused IV over 2 hours; repeat cycle every 21-days. Prior chemotherapy : 500 mg/m(2) IV, as a single-agent, over 10 minutes on day 1 of each 21-day cycle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"400.53","prescriberCat":"A*"},{"id":"drug-759","genericName":"Pertuzumab 420mg/14ml injection","brandName":"Perjeta","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["injection"],"indications":"Pertuzumab in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early-stage breast cancer (node-positive) as part of a complete treatment regimen for early breast cancer.\\n\\nPrescribing Restriction:\\nTo be prescribed by Oncologist only","dosing":"The recommended initial dose of pertuzumab is 840mg administered as a 60-minute intravenous infusion, followed every 3 weeks thereafter by a dose of 420mg administered over a period of 30 to 60 minutes for up to 3 cycles.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan\\n\\nMenggunakan peruntukan ZAKAT/NGO. Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"4998.00","prescriberCat":"A*"},{"id":"drug-760","genericName":"Pirfenidone 267 mg capsule","brandName":"Esbriet","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["capsule"],"indications":"Idiopathic pulmonary fibrosis","dosing":"Adult: Initially, 267 mg tid for 7 days, then increase dose to 534 mg tid for 7 days, then to usual maintenance dose: 801 mg tid. Max: 2403 mg daily. Adjust dosage according to toxicity.\\n\\nPatient concomitantly using strong CYP1A2 inhibitors (e.g. enoxacin, fluvoxamine): 267 mg tid.\\nPatient concomitantly using ciprofloxacin at a dosage of 750 mg bid: 534 mg tid.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA\\n\\nSpecial Drugs Approval (UKK) required (Dept: Perubatan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"15.47","prescriberCat":"Not in FUKKM"},{"id":"drug-761","genericName":"Rituximab 10mg/ml Injection (500mg/50ml)","brandName":"Mabthera","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["(500mg/50ml)"],"indications":"i) Treatment of patients with relapsed or chemo-resistant low grade or follicular B-cell Non-Hodgkin's lymphoma \\nii) Adjunctive therapy with combination chemoagents for aggressive Non-Hodgkin Lymphoma \\niii) Severe active rheumatoid arthritis with inadequate response or intolerance to other disease-modifying anti-rheumatic drugs (DMARDs) including one or more tumour necrosis factor (TNF) inhibitor therapies \\niv) Maintenance in relapsed/ refractory follicular lymphoma after response to induction therapy","dosing":"i) 375 mg/m2 BSA administered as an IV infusion through a dedicated line once weekly for 4 weeks \\nii) Combination with CHOP (cyclophosphamide, doxorubicin, prednisone and vincristine) as 375 mg/m2 BSA on day 1 of each chemotherapy cycle for 8 cycles after IV administration of the glucocorticoid component of CHOP. \\niii) 1000 mg IV infusion followed by a second 1000 mg IV infusion two weeks later \\niv) 375mg/m2 BSA once every 3 months until disease progression or for a maximum period of two years.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) required for off-label indication NOT listed (Dept: Perubatan (haematology, rheumatology, neurology, dermatology,  nephrology))","price":"3402.00","prescriberCat":"A*"},{"id":"drug-764","genericName":"Ribociclib 200mg Tablet","brandName":"Kryxana","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"In combination with: - an aromatase inhibitor for the treatment of postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy.","dosing":"600 mg daily for 21 consecutive days followed by 7 days off treatment. Can be taken with or without food. For dose modification, refer package insert.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"47.59","prescriberCat":"A*"},{"id":"drug-765","genericName":"Ruxolitinib 20mg tablet","brandName":"Jakavi","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["tablet"],"indications":"For the treatment of disease-related splenomegaly or symptoms in adult patients with:\\ni) primary myelofibrosis (also known as chronic idiopathic myelofibrosis); or\\nii) post-polycythemia vera myelofibrosis; or\\niii) post-essential thrombocythemia myelofibrosis.","dosing":"The recommended starting dose:\\ni) Platelet count between 100,000/mm and 200,000/mm: 15 mg twice daily for patients\\nii) Platelet count of >200,000/mm: 20 mg twice daily for patients\\niii) Platelet counts between 50,000/mm and <100,000/mm: Limited information to recommend a starting dose for patients.\\nThe maximum recommended starting dose in these patients is 5 mg twice daily and the patients should be titrated cautiously.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA (Dept: Perubatan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi)","price":"253.57","prescriberCat":"A*"},{"id":"drug-766","genericName":"Secukinumab 150mg/ml solution for injection in a pre-filled pen","brandName":"Fraizeron","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["pen"],"indications":"i) Alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.\\nRestriction: To be prescribed by Rheumatologist only\\n\\nii) Indicated for the treatment of active ankylosing spondylitis (AS) in adults who have responded inadequately to conventional therapy.\\nRestriction: 2nd or 3rd line, after failure of conventional DMARDs or TNF-inhibitors.\\n\\niii) Indicated for the treatment of moderate-to-severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.","dosing":"Indication (i)\\n150 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4.\\nFor patients who are anti-TNF inadequate responders (IR) or patients with concomitant moderate to severe plaque psoriasis;\\n300 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4. Each 300 mg dose is given as two subcutaneous injections of 150 mg.\\n\\nIndication (ii)\\n150 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4. Based on clinical response, the dose can be increased to 300 mg.\\n\\nIndication (iii) \\nAdult: 300 mg by subcutaneous injection with initial dosing at weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at week 4. Each 300 mg dose is given as two subcutaneous injections of 150 mg. For some patients, a dosage of 150 mg may be acceptable.\\nChild (6 years and older): The recommended dose is based on body weight* and administered by subcutaneous injection with initial dosing at Weeks 0, 1, 2, 3, and 4 followed by monthly maintenance dosing (every 4 weeks).\\n*<25kg: 75mg; 25-50kg: 75mg; >/=50kg: 150mg (may be increased to 300mg)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"930.00","prescriberCat":"A*"},{"id":"drug-768","genericName":"Sirolimus 1mg tab","brandName":"Rapamune","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["tab"],"indications":"Prophylaxis of organ rejection in patient receiving renal transplant\\n\\nOff-label indication: Autoimmune Lymphoproliferative Syndrome (ALPS)","dosing":"De novo transplant combination therapy: Low to moderate immunologic risk Loading dose: 6 mg as soon as possible after transplant followed by maintenance: 2 mg once daily. High immunologic risk Loading dose: 15 mg on day 1 post-transplant followed by 5 mg on day 2. Adjust dose based on whole blood conc 10-15 ng/mL by obtaining trough levels on days 5-7. Cyclosporine w/drawal Discontinue use over 4-8 wk, 2-4 mth after transplantation. Adjust dose based on whole blood trough conc 16-24 ng/mL (chromatographic method) for 1st yr, thereafter 12-20 ng/mL.\\n\\nAutoimmune Lymphoproliferative Syndrome (ALPS): 1mg OD to BD depending on TDM levels","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special drugs approval (UKK) required (Dept: Pediatrik)","price":"31.23","prescriberCat":"Not in FUKKM"},{"id":"drug-769","genericName":"Tacrolimus Ointment 0.1 %","brandName":"Protopic","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["%"],"indications":"For short-term and intermittent long-term therapy in the treatment of patients with moderate to severe atopic dermatitis in whom the use of alternative, conventional therapies are deemed inadvisable because of potential risks, or in the treatment of patients who are not adequately responsive to or are intolerant of alternative, conventional therapies","dosing":"Adult  16 years: Apply 0.03% or 0.1% to the affected skin twice daily and rub in gently and completely. \\nChildren  2 years: Apply 0.03% ointment thinly to the affected skin bd and rub in gently and completely. Treatment should be continued for 1 week after clearing of signs & symptoms of atopic dermatitis.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"134.58","prescriberCat":"A*"},{"id":"drug-770","genericName":"Tacrolimus 1mg, 0.5mg capsule","brandName":"Prograf 1mg\\n\\nPrograf 0.5mg","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["capsule"],"indications":"i) Primary immunosuppression in liver and kidney allograft recipients. \\nii) Liver and kidney allograft rejection resistant to conventional immunosuppressive agents. It is recommended to be used concomitantly with adrenal corticosteroids. Because of the risk of anaphylaxis. Injection should be reserved for patients unable to take capsules only.\\n\\nOff-label indication: Lupus nephritis and moderate to severe refractory SLE \\n(For patients non-responsive to conventional treatment)","dosing":"0.1-0.2 mg/kg/day for liver transplantation and at 0.15-0.3 mg/kg/day for kidney transplantation administered as 2 divided doses.\\n\\n\\n\\n\\nLupus nephritis: refer nephrologist. 1mg BD to 2mg BD have been used in this hospital","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) NOT REQUIRED for the mention Off-label indication as exemption has been given (Dept: Perubatan)","price":"7.3  4.01","prescriberCat":"A*"},{"id":"drug-771","genericName":"Tacrolimus 0.5mg, 1mg, 5mg Prolonged-Release Hard Capsules","brandName":"Advagraf \\n0.5mg\\n\\nAdvagraf 1mg\\n\\nAdvagraf 5mg","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsules"],"indications":"i) Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. \\nii) Treatment of kidney or liver allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult.","dosing":"i) Prophylaxis of transplant rejection: a) Kidney Transplant: Tacrolimus PR therapy should commence at dose of 0.20-0.30 mg/kg/day administered once daily in the morning. Administration should commence within 24 hours after completion of surgery. b) Liver Transplant Tacrolimus PR therapy should commence at a dose of 0.10-0.20 mg/kg/day administered once daily in the morning. Administration should commence within 12-18 hours after completion of surgery. ii) Treatment of allograft rejection: For conversion: a) From other immunosuppressants to once daily Tacrolimus PR: Treatment should begin with the initial oral dose recommended in kidney and liver transplantation respectively for prophylaxis of transplant rejection. b) From Tacrolimus to Tacrolimus PR: Allograft transplant patients maintained on twice daily Tacrolimus capsules dosing requiring conversion to once daily Tacrolimus PR should be converted on a 1:1 (mg:mg) total daily dose basis. Tacrolimus PR should be administered in the morning.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"7.26   3.87   29.04","prescriberCat":"A*"},{"id":"drug-772","genericName":"Tamoxifen Citrate 20 mg Tablet","brandName":"Nolvadex-D","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Tablet"],"indications":"Breast cancer","dosing":"20 mg in 1-2 divided doses. Max: 40 mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, Obstetrik)","price":"0.45","prescriberCat":"A"},{"id":"drug-773","genericName":"Tegafur 100 mg & uracil 224 mg Capsule","brandName":"Ufur","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsule"],"indications":"i) Non small cell lung cancer;\\nii) Tegafur Uracil plus folinic acid (leucovorin) combination therapy is indicated for the treatment of colorectal cancer in: a) Metastatic stage; b) Adjuvant setting; c) Concurrent setting.","dosing":"i) 300-600 mg daily in 2-3 divided doses;\\nii) Adjuvant setting - 300mg/m2/day , Day 1-28, rest 7 days; Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles; Concurrent setting - 300mg/m2/day; Leucovorin Calcium 25 mg /day, D8- D36, for 4 weeks; Metastatic stage - 300mg/m2/day , Day 1-28, rest 7 days; Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"3.89","prescriberCat":"A*"},{"id":"drug-774","genericName":"Thalidomide 50 mg Capsule","brandName":"Domide","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Capsule"],"indications":"First line induction therapy in newly diagnosed multiple myeloma, salvage therapy in relapsed multiple myeloma and maintenance therapy in multiple myeloma (contraindicated for pregnant women; pregnancy test for females in reproductive age group before starting treatment should be done).","dosing":"50 mg to 200 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"4.12","prescriberCat":"A*"},{"id":"drug-775","genericName":"Tocilizumab 162 mg Injection\\n in prefilled syringe","brandName":"Actemra","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["syringe"],"indications":"Indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients: \\ni) with inadequate respond or intolerance to conventional disease- modifying antirheumatic drugs (DMARDS) \\nii) who has failed antitumour necrosis factors (antiTNFs) \\niii) where TNF is contraindicated (patients with history of pulmonary tuberculosis [PTB]) It also can be used as monotherapy or with combination with methotrexate (MTX) and/ or other DMARDS.","dosing":"Adult patients: 162mg given once every\\n week as a subcutaneous injection.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"642.57","prescriberCat":"A*"},{"id":"drug-776","genericName":"Tocilizumab 400mg/20ml, 80mg/4ml Injection","brandName":"Actemra 400mg\\n\\nActemra 80mg","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"Indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients: i) with inadequate respond or intolerance to conventional disease- modifying antirheumatic drugs (DMARDS) ii) who has failed antitumour necrosis factors (antiTNFs) iii) where TNF is contraindicated (patients with history of pulmonary tuberculosis [PTB]) It also can be used as monotherapy or with combination with methotrexate (MTX) and/ or other DMARDS.\\n\\nOff-label indication: Treatment of severe covid-19 infection","dosing":"Recommended dose for rheumatoid arthritis of tocilizumab for adult patients is 8mg/kg given once every 4 weeks as a single-drip IV infusion over 1 hour. It should be diluted to 100 ml by a healthcare professional with sterile 0.9% w/v sodium chloride solution over 1 hour. For patients whose body weight is more than 100kg, doses exceeding 800mg per infusion are not recommended\\n\\nTreatment of severe covid-19 infection: 8mg/kg single dose (not to exceed 800mg)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) NOT REQUIRED for the mention Off-label indication as exemption has been given (Dept: Perubatan)","price":"2560.2   512.05","prescriberCat":"A*"},{"id":"drug-777","genericName":"Tofacitinib citrate 5mg film coated tablet","brandName":"Xeljanz","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["tablet"],"indications":"Indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).","dosing":"One tablet twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"51.41","prescriberCat":"A*"},{"id":"drug-778","genericName":"Trastuzumab 440mg Injection","brandName":"Herzuma","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) Used only in adjuvant setting for patients with HER2 over-expressed breast cancer, that is HER2 3+ by immunohistochemistry and over-expressed by FISH (Fluorescence in situ hybridization) and high risk group ii) Restriction: Oncologist only: Treatment of HER2-positive non-metastatic breast cancer in combination with neoadjuvant chemotherapy followed by adjuvant trastuzumab, for locally advanced (including inflammatory) breast cancer or tumours >2cm in diameter.","dosing":"i) Initial loading dose is 4 mg/kg administered as a 90 minutes IV infusion. Subsequent doses is 2 mg/kg administered as 30 minutes IV infusion weekly for 51 weeks ii) Initial loading dose of 8 mg/kg body weight, followed by 6 mg/kg body weight 3 weeks later and then 6 mg/kg repeated at 3-weekly intervals administered as infusions over approximately 90 minutes. If the prior dose was well tolerated, the dose can be administered as a 30-minute infusion.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"812.00","prescriberCat":"A*"},{"id":"drug-779","genericName":"Upadacitinib 15mg tablet","brandName":"Rinvoq","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["tablet"],"indications":"i) Indicated for the treatment of severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy.\\nRestriction:\\na. As fourth line of treatment in patients who have failed / have contraindications / experienced adverse events to:\\n Intensive and optimized topical treatment\\n Phototherapy\\n At least two immunosuppressants\\nb. To be prescribed by Dermatologists only.\\n\\nii) Indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. May be used as monotherapy or in combination with methotrexate.\\nRestriction: To be prescribed by Rheumatologist only\\n\\niii) Indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). Upadacitinib may be used as monotherapy or in combination with methotrexate\\nRestriction: \\na. To be prescribed after failing/ intolerance/ contraindicated to csDMARDs (as per Malaysian Consensus on Biologic Usage) and one biologic DMARDs.\\nb. To be prescribed by Rheumatologist only\\n\\nHSM off label use: \\n1. Refractory Ankylosing Spondylitis\\n2. Ulcerative colitis","dosing":"Indication i -severe atopic dermatitis:\\nAdults: The recommended dose of upadacitinib is 15 mg or 30 mg once daily based on individual patient presentation (Refer to package insert). The lowest effective dose for maintenance should be considered.\\n\\nAdolescents (from 12 to 17 years of age): The recommended dose of upadacitinib is 15 mg once daily for adolescents weighing at least 40 kg.\\n\\nUpadacitinib can be used with or without concomitant topical therapies (Refer package insert)\\n\\nIndication ii & iii - active psoriatic arthritis & moderate to severe active rheumatoid arthritis: 15 mg once daily\\n\\nOff-label use\\nAnkylosing Spondylitis: 15 mg once daily\\nUlcerative colitis: 45mg OD for 8 weeks, then 30mg OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial drugs approval (UKK) required for off- label use (Dept: Perubatan (Rheumatology))","price":"96.43","prescriberCat":""},{"id":"drug-782","genericName":"Ustekinumab 45mg/0.5ml injection","brandName":"Stelara","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["injection"],"indications":"Treatment of moderate to severe plaque psoriasis in adults who failed to, or who have contraindication to, or are intolerant to conventional systemic therapies including ciclosporin, methotrexate and photochemotherapy (PUVA).","dosing":"Body weight less than 100kg: Initial dose of 45 mg SC, followed by 45 mg 4 weeks later, then every 12 weeks thereafter. Body weight more than 100 kg: initial dose 90 mg SC, followed by 90 mg 4 weeks later, & then every 12 weeks thereafter.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"7000.00","prescriberCat":"A*"},{"id":"drug-783","genericName":"Vinorelbine 10mg/mL Injection","brandName":"Vinelbine","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS","forms":["Injection"],"indications":"i) First line treatment in non-small cell lung cancer in combination with cisplatin/ifosfomide\\nii) Metastatic breast cancer","dosing":"i) Single agent: Adult 30mg/m2 IV administered over 6-10 minutes once weekly Combination with cisplatin : 30mg/m2 IV administered over 6-10mintes once weekly combination with cisplatin IV on days and 29 and then every 6 weeks or Vinolrebine administered at a dose of 25mg/m2 IV weekly in combination with cisplatin given every 4 weeks at a dose of 100mg/m2\\n\\nii) 25 - 30 mg/m2 diluted in saline solution, infused over 6 - 10 minutes, administered weekly or vinolrebine maybe given as an 8mg/m2 IV BOLUS followed by 8mg/m2 as a 96-hour intravenous infusion.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan (Onco))","price":"188.00","prescriberCat":"A*"},{"id":"drug-786","genericName":"Filgrastim (G-CSF) 30 MU/ml (300mcg/ml) Injection","brandName":"Neupogen","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.8 OTHER DRUGS RELATED TO  CANCER","forms":["Injection"],"indications":"i) Prevention and treatment of febrile neutropenia due to cancer chemotherapy (except chronic myeloid leukaemia and myelodysplastic syndrome) ii) Haemopoeitic stem cell transplantation (HSCT)/stem cell harvesting","dosing":"i) Adult: SC or IV 5 mcg/kg/day. Initiation: 24 - 72 hours after chemotherapy. \\nDuration: Until a clinically adequate neutrophil recovery is achieved (absolute neutrophil count of at least 1 x 109/L on 2 consecutive days) \\nii) Refer to protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"63.80","prescriberCat":"A*"},{"id":"drug-787","genericName":"Leucovorin Calcium (Calcium Folinate) 50 mg /10ml Injection","brandName":"Pharmaniaga Leucovorin Calcium","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.8 OTHER DRUGS RELATED TO  CANCER","forms":["Injection"],"indications":"(i) Biochemical modulator for 5-Fluorouracil in the treatment of solid tumour;\\n(ii) As rescue for high dose methotrexate;\\n(iii) Megaloblastic anaemias due to deficiency of folic acid","dosing":"i) 200mg/m2 by slow IV injection over a minimum 3 minutes, followed by 5-\\nFluorouracil or 20mg/m2\\nIV followed by 5-Fluorouracil. In both cases,\\ntreatment is repeated daily for 5 days; may repeat at 4-week intervals for 2\\ncourses then 4- to 5-week intervals\\nii) 15 mg (approximately 10mg/m2\\n) every 6 hours for 10 doses, starting 24\\nhours after the beginning of the methotrexate infusion\\niii) Up to 1 mg daily\\nDosing is individualised and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, Perubatan)","price":"4.06","prescriberCat":"A"},{"id":"drug-788","genericName":"Leucovorin Calcium (Calcium Folinate) 15mg Tablet","brandName":"Folina","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.8 OTHER DRUGS RELATED TO  CANCER","forms":["Tablet"],"indications":"i) Treatment of folic acid antagonist overdose; \\nii) Leucovorin (folinic acid) plus tegafur-uracil combination therapy is indicated for the treatment of colorectal cancer in: \\na) Metastatic stage, b) Adjuvant setting, c) Concurrent setting.","dosing":"i) 15 mg every 6 hours for the next 48 - 72 hours; \\nii) Adjuvant setting - Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles; Concurrent setting - Leucovorin Calcium 25 mg /day, D8- D36, for 4 weeks; \\nMetastatic stage - Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.45","prescriberCat":"A"},{"id":"drug-789","genericName":"Mesna 400mg/4ml Injection","brandName":"Uromitexan","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.8 OTHER DRUGS RELATED TO  CANCER","forms":["Injection"],"indications":"For prevention of urotoxic effects of oxazaphosphorines e.g. ifosfamide and cyclophosphamide","dosing":"IV injection at a dosage of 20% of the corresponding oxazaphosphorine dose at the times 0 hour (concurrently with the oxazaphosphorine), 4 hours and 8 hours thereafter. CHILD: Dose given at greater frequency (e.g. 6 times) and a shorter intervals (e.g. 3 hours)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.76","prescriberCat":"A"},{"id":"drug-790","genericName":"Pamidronate Disodium 30 mg Injection","brandName":"Biodronate","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.8 OTHER DRUGS RELATED TO  CANCER","forms":["Injection"],"indications":"Hypercalcaemia of malignancy (tumour -induced hypercalcaemia)","dosing":"Dose depends on the initial serum calcium levels. Doses range from a single infusion of 30 - 90 mg infused over 4 to 6 hours\\n (HSM practice: maximum 60mg for renally impaired patients: < 30ml/min)\\nsee notes for restriction of use in HSM","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota bagi CrCL < 30ml/min sahaja. Jika > 30ml/min, guna Zoledronic acid (Zometa) (Dept: Perubatan)","price":"87.00","prescriberCat":"A*"},{"id":"drug-791","genericName":"Zoledronic Acid 4 mg Injection","brandName":"Oledron","category":"7.0 OTHER CHEMOTHERAPEUTICS\\n7.8 OTHER DRUGS RELATED TO  CANCER","forms":["Injection"],"indications":"i) Treatment of hypercalcaemia of malignancy \\nii) Prevention of skeletal related events (SREs) in patients with multiple myeloma involving multiple bone lesions \\niii) Prevention of skeletal related events (SREs) for metastatic cancers of solid tumours","dosing":"i) & (ii): 4 mg reconstituted and should be given as a 15 minutes IV infusion every 3-4 weeks \\niii) 4mg reconstituted and should be given as a 15- minute IV infusion every 12 weeks (as advised in MaHTAS 2018 Report)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"54.00","prescriberCat":"A*"},{"id":"drug-794","genericName":"Carbetocin 100 mcg/ml Injection","brandName":"Pharmidea","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["Injection"],"indications":"Prevention of uterine atony and postpartum hemorrhage following elective cesarean section under epidural or spinal anaesthesia","dosing":"A single IV dose of 100mcg (1ml) is adminitered by bolus injection, slowly over 1minute, only when delivery of the infant has been completed by caesarean section under epidural or spinal anaesthesia, before or after delivery of the placenta.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"56.93","prescriberCat":"A*"},{"id":"drug-795","genericName":"Carboprost Tromethamine 250 mcg Injection","brandName":"Hemabate","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["Injection"],"indications":"Treatment of refractory postpartum haemorrhage unresponsive to\\nconventional methods of management.","dosing":"Initially 250 mcg deep IM inj. The dose may be repeated at intervals of 15-90\\nmin if necessary. Max total dose: 2000 mcg (8 doses).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"162.20","prescriberCat":"A*"},{"id":"drug-796","genericName":"Dinoprostone (Prostagladine E2) 3 mg Vaginal Tablet","brandName":"Prostin E2","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["Tablet"],"indications":"Induction of labour","dosing":"3 mg vaginal tablet to be inserted high into the posterior formix. A second 3 mg tablet may be inserted after 6-8 hours if labour is not established. Max 6 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"27.22","prescriberCat":"A"},{"id":"drug-797","genericName":"Gemeprost (Prostagladin E1 Synthetic Analogue) 1 mg Pessary","brandName":"Cervagem","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["Pessary"],"indications":"i. Softening and dilatation of the Cervix uteri prior to trans-cervical intrauterine operative procedures in pregnant patients in the first trimester of gestation.\\n\\nii. Therapeutic termination of pregnancy in patients in the second trimester of gestation, in licensed institutions.\\n\\niii. Induction of abortion of second trimester pregnancies complicated by intrauterine foetal death.","dosing":"i. One pessary 3 hours before surgery\\n\\nii & iii. One pessary 3-hourly to a maximum of 5 administrations over 24 hours. A second course may be given after 24 hours from the initial commencement of treatment.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"139.00","prescriberCat":"A"},{"id":"drug-798","genericName":"Misoprostol Tablet 200mcg","brandName":"Tector 200","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["200mcg"],"indications":"Therapeutic termination of pregnancy","dosing":"Refer Gynaecologist for dose. \\n400mcg (per vaginal route) 3-4 hrs before surgery","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: O&G)","price":"2.10","prescriberCat":"Not in FUKKM\\n\\n(To purchase if Gemeprost discontinue by supplier)"},{"id":"drug-799","genericName":"Oxytocin 10 units/ml Injection","brandName":"Udoxan","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["Injection"],"indications":"Induction of labour","dosing":"IV: 0.5 - 1 milliunits/minute; gradually increase dose in increments of 1 - 2 milliunits/minute until desired contraction pattern is established; dose may be decreased after desired frequency of contractions is reached and labor has progressed to 5 - 6 cm dilation","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"1.16","prescriberCat":"B"},{"id":"drug-800","genericName":"Oxytocin 5 units & Ergometrine Maleate 0.5 mg/ml Injection","brandName":"Syntometrine","category":"8.0 GENITOURINARY SYSTEM\\n8.1 DRUG ACTING ON UTERUS","forms":["Injection"],"indications":"i)Prevention and treatment of postpartum haemorrhage associated with\\nuterine atony.\\nii)Active management of third stage of labour","dosing":"i) 1 ml IM, may be repeated after 2 hours. Should not exceed 3 ml within 24 hours \\nii) For routine management of third stage of labour, 1 ml IM following delivery of the anterior shoulder or immediately after delivery of the child","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"3.39","prescriberCat":"C+"},{"id":"drug-803","genericName":"Clotrimazole 500 mg Vaginal Tablet","brandName":"Candid","category":"8.0 GENITOURINARY SYSTEM\\n8.2 TRICHOMONACIDES, VAGINAL PREPARATIONS","forms":["Tablet"],"indications":"Vaginal candidiasis","dosing":"500 mg as a single one-time dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.24","prescriberCat":"B"},{"id":"drug-804","genericName":"Estriol 0.03mg + Lactobacillus acidophillus vaginal tablet","brandName":"Gynoflor","category":"8.0 GENITOURINARY SYSTEM\\n8.2 TRICHOMONACIDES, VAGINAL PREPARATIONS","forms":["tablet"],"indications":"i)Atrophic vaginitis due to estrogen deficiency during menopause and post-menopause, or as co-medication to systemic hormone replacement therapy \\nii)Restoration of the Lactobacillus flora after local and/or systemic treatment with anti-infective agents or chemotherapeutic agents","dosing":"Atrophic vaginitis : 1 vaginal tablet daily for 6-12 days followed by a maintenance dose of 1 vaginal tablet for 1-2 days per week.\\nRestoration therapy: 1-2 vaginal tablet daily for 6-12 days \\nAdministration: The vaginal tablets should be inserted deeply into the vagina in the evenings before bedtime. \\nIn cases of a very dry vagina, vaginal tablet can be moistened with 1 or 2 drops of water before insertion into the vagina. \\nDuring menstruation, treatment should be interrupted and resumed afterwards. \\nShould not use vaginal douches or rinses during treatment","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: O&G)","price":"6.78","prescriberCat":"A/KK"},{"id":"drug-805","genericName":"Policresulen Suppository \\n90mg","brandName":"Albothyl","category":"8.0 GENITOURINARY SYSTEM\\n8.2 TRICHOMONACIDES, VAGINAL PREPARATIONS","forms":["\\n90mg"],"indications":"Local treatment of cervical and vaginal inflammation and tissue damage, eg. discharge due to bacterial, trichomonal and fungal infections, protrusions of endocervical mucosa (erosion), haemostasis following biopsy or excision of uterine polyps","dosing":"1 supp intravag on alternate days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.24","prescriberCat":"A"},{"id":"drug-808","genericName":"Nitrofurantoin 100 mg Tablet","brandName":"Apo-\\nNitrofurantoin","category":"8.0 GENITOURINARY SYSTEM\\n8.3 URINARY ANTISEPTICS, ANTISPASMODICS","forms":["Tablet"],"indications":"Uncomplicated lower urinary tract infections","dosing":"Acute uncomplicated urinary tract infections \\nAdult: 50-100 mg 4 times daily for 7 days. \\nDual-release preparation: 100 mg bid. \\nChild: >3 mth and older children: 3 mg/kg daily in 4 divided doses. \\nProphylaxis of uncomplicated urinary tract infections \\nAdult: 50-100 mg at bedtime. \\nChild: >3 mth and older children: 1 mg/kg once daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.70","prescriberCat":"B"},{"id":"drug-809","genericName":"Oxybutynin Chloride 5 mg Tablet","brandName":"Ditropan","category":"8.0 GENITOURINARY SYSTEM\\n8.3 URINARY ANTISEPTICS, ANTISPASMODICS","forms":["Tablet"],"indications":"For the relief of symptoms of bladder instability associated with \\nvoiding in patients with uninhibited neurogenic or reflex neurogenic bladder (ie urgency, frequency, urinary leakage, urge incontinence, dysuria)","dosing":"ADULT: Initially 5 mg 2 - 3 times daily increased if necessary to maximum 5 mg 4 times daily. \\nELDERLY: Initially 2.5 - 3 mg twice daily, increased to 5 mg twice daily according to response and tolerance. \\nCHILD over 5 years, neurogenic bladder instability: 2.5 - 3 mg twice daily increased to 5 mg twice daily to maximum 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan, Pediatrik)","price":"1.63","prescriberCat":"A*"},{"id":"drug-810","genericName":"Polycitra Syrup","brandName":"-","category":"8.0 GENITOURINARY SYSTEM\\n8.3 URINARY ANTISEPTICS, ANTISPASMODICS","forms":["Syrup"],"indications":"For treatment of calcium and uric acid \\nstones","dosing":"The usual dose of potassium citrate is 30 - 60 mEq/day orally in 3 or 4 doses with meals or within 30 minutes after meals. \\nADULT: 15 ml 3 times daily well diluted with water. \\nCHILD: 5-15 ml 3 times daily, after meals and at bedtime.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-811","genericName":"Potassium Citrate 3 g/10 ml and Citric Acid Mixture 0.5g in 10ml","brandName":"Mist Possit","category":"8.0 GENITOURINARY SYSTEM\\n8.3 URINARY ANTISEPTICS, ANTISPASMODICS","forms":["10ml"],"indications":"For systemic or urinary alkalinization","dosing":"ADULT: 10-20 ml 3 times daily, well diluted with water.\\nCHILD up to 1 year: 2.5 ml 3 times daily; 1 - 5 years: 5 ml 3 times daily; 6 - 12\\nyears: 10 ml 3 times daily. To be taken well diluted with water, after meals and at bedtime","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.22","prescriberCat":"C"},{"id":"drug-812","genericName":"Sodium Bicarbonate, Citric Acid, Sodium Citrate and Tartaric Acid - 4 g per sachet","brandName":"Utix","category":"8.0 GENITOURINARY SYSTEM\\n8.3 URINARY ANTISEPTICS, ANTISPASMODICS","forms":["sachet"],"indications":"For relieving of discomfort in mild urinary tract infection, symptomatic relief of dysuria to enchance the action to certain antibiotics especially some sulphonamides. In gout as urinary alkalinizers to prevent cystallisation of urates","dosing":"4 - 8 g (1- 2 sachets) dissolved in a glass of cold water 4 times daily as prescribed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.60","prescriberCat":"B"},{"id":"drug-813","genericName":"Sodium Citrate 0.3 M Solution 500ml","brandName":"-","category":"8.0 GENITOURINARY SYSTEM\\n8.3 URINARY ANTISEPTICS, ANTISPASMODICS","forms":["500ml"],"indications":"Prophylaxis for aspiration pneumonitis\\n (use as an oral solution)","dosing":"Dose depending on clinical cases. Usually, 30 ml given 10- 60 minutes before anaesthesia prior to elective cesarean surgery is an effective antacid","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"2.00","prescriberCat":"B"},{"id":"drug-816","genericName":"Alfuzosin HCl 10 mg Tablet","brandName":"Ranfuzosin","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Treatment of functional symptoms related with benign prostatic hypertrophy (BPH)","dosing":"10 mg once a day pre bed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, Geriatrik)","price":"0.30","prescriberCat":"A*"},{"id":"drug-817","genericName":"Doxazosin Mesilate 4 mg CR Tablet","brandName":"Kamiren XL","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Benign Prostatic Hyperplasia","dosing":"4 mg once daily to maximum 8mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"0.32","prescriberCat":"A*"},{"id":"drug-818","genericName":"Dutasteride 0.5 mg Capsule","brandName":"Avodart","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Capsule"],"indications":"Benign prostatic hyperplasia in men with an enlarged prostate gland","dosing":"0.5 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"3.44","prescriberCat":"A*"},{"id":"drug-819","genericName":"Dutasteride 0.5 mg & Tamsulosin 0.4 mg Capsule","brandName":"Duodart","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Capsule"],"indications":"Combination therapy for the treatment of moderate to severe symptoms of BPH with: \\ni) Large prostate (>30g) \\nii) Poor risk or not fit for surgery \\niii)Those who are awaiting their turn for surgery","dosing":"One capsule daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"1.39","prescriberCat":"A*"},{"id":"drug-820","genericName":"Finasteride 5 mg Tablet","brandName":"Fincar","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Treatment and control of benign prostatic hyperplasia","dosing":"5 mg a day as a single dose. Clinical responses occur within 12 weeks - 6 months of initiation of therapy. Long-term administration is recommended for maximal response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan, Geriatrik)","price":"0.12","prescriberCat":"A*\\nConsultant/specialists for specific indications only, including Geriatricians"},{"id":"drug-821","genericName":"Propiverine HCl 15 mg Tablet","brandName":"Mictonorm","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Treatment of urinary incontinence, urgency and frequency in neurogenic detrusor overactivity (detrusor hyperreflexia) and in idiopathic detrusor overactivity (overactive bladder)","dosing":"ADULT: 15 mg twice daily to 3 times daily, increase to 4 times daily if required. \\nMax dose: 60 mg daily. \\nCHILD more than 5 years: 0.2 to 0.4 mg/kg per day in 2 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"1.73","prescriberCat":"A*"},{"id":"drug-822","genericName":"Mirabegron 50mg Prolonged Release Tablet","brandName":"Betmiga","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome.\\n\\nPrescribing Restriction:\\nFor patients who are not responsive, intolerant or unsuitable to use other existing agents.","dosing":"50mg once daily.\\n\\nShould be taken once daily, with liquid, swallowed whole and is not to be chewed, divided, or crushed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan)","price":"2.61","prescriberCat":"A*"},{"id":"drug-823","genericName":"Solifenacin Succinate 5 mg Tablet","brandName":"Vesicare","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.","dosing":"5mg od. Dose can be increased to 10mg if necessary.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"2.69","prescriberCat":"A*"},{"id":"drug-824","genericName":"Tamsulosin HCl 400 mcg Extended Release Tablet","brandName":"Harnal Ocas","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"Second line treatment of functional symptoms of benign prostatic hyperplasia (BPH) in patients who do not tolerate first line drugs or when first line drugs are inappropriate or contraindicated","dosing":"400 mcg once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan, Geriatrik)","price":"0.41","prescriberCat":"A*\\nConsultant/specialists for specific indications only, including Geriatricians"},{"id":"drug-825","genericName":"Terazosin HCl 5 mg Tablet","brandName":"Terasin","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Tablet"],"indications":"i) Treatment of Benign Prostatic Hyperplasia. \\nii)Hypertension","dosing":"i)Initially 1 mg at night, increased in a stepwise fashion to 2 mg, 5 mg or 10 mg once daily. \\nii)Initial: 1mg once daily at bedtime, Maintenance: 1-5mg once (morning or evening) or twice daily. Max: 20-40mg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pembedahan)","price":"0.27","prescriberCat":"A/KK"},{"id":"drug-826","genericName":"Tolterodine Tartrate ER 4 mg Capsule","brandName":"Detrusitol SR","category":"8.0 GENITOURINARY SYSTEM\\n8.4 OTHERS","forms":["Capsule"],"indications":"Treatment of overactive bladder with symptoms of urinary, frequency or urge incontinence","dosing":"4 mg once daily. May decrease to 2 mg once daily depending on response and tolerability","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"4.03","prescriberCat":"A*"},{"id":"drug-829","genericName":"Dexamethasone Sodium Phosphate 8 mg/2 ml Injection","brandName":"Penatone","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Injection"],"indications":"i) Prophylaxis and management of nausea and vomiting in cancer chemotherapy, post-operation and palliative care, \\nii) Treatment of adrenocortical function abnormalities, \\niii) Any other treatment requiring corticosteroid therapy.","dosing":"Initially 0.5 - 9 mg IM, IV or infusion daily, depending upon the disease being treated","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.81","prescriberCat":"B"},{"id":"drug-830","genericName":"Dexamethasone 0.5 mg Tablet","brandName":"Dexasone","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Tablet"],"indications":"i) Prophylaxis and management of nausea and vomiting in cancer chemotherapy, post-operation and palliative care, \\nii) Treatment of adrenocortical function abnormalities, \\niii) Any other treatment requiring corticosteroid therapy.","dosing":"0.5mg to 10mg daily is given for oral administration, depending upon the disease being treated. Up to 15 mg daily in severe disease.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"A"},{"id":"drug-831","genericName":"Dexamethasone 4mg tablet","brandName":"Vextasone","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["tablet"],"indications":"i) Prophylaxis and management of nausea and vomiting in cancer chemotherapy, post-operation and palliative care, \\nii) Treatment of adrenocortical function abnormalities, \\niii) Any other treatment requiring corticosteroid therapy.","dosing":"0.5mg to 10mg daily is given for oral administration, depending upon the disease being treated.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.35","prescriberCat":"A"},{"id":"drug-832","genericName":"Fludrocortisone 0.1 mg Tablet","brandName":"Floricot","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Tablet"],"indications":"As an adjunct to glucocorticoids in the management of primary adrenocortical insufficiency in Addison's disease and treatment of salt-losing adrenogenital syndrome","dosing":"Adrenocorticoid insufficiency (chronic): ADULT: 1 tablet daily. \\nSalt-losing adrenogenital syndrome: ADULT: 1 - 2 tablets daily. \\nCHILD and INFANT: 0.5 - 1 tablet daily\\n\\nDosing is individualised and according to product insert / protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Perubatan, Pediatrik)","price":"0.85","prescriberCat":"A"},{"id":"drug-833","genericName":"Hydrocortisone Sodium Succinate 100 mg Injection","brandName":"Zycort","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Injection"],"indications":"Conditions responsive to systemic or local glucocorticoid injection therapy especially in emergencies","dosing":"Initially 100 - 500 mg IV over 30 seconds to more than 10 minutes. Dose may be repeated at intervals of 2, 4 or 6 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.52","prescriberCat":"C"},{"id":"drug-834","genericName":"Hydrocortisone 10 mg Tablet","brandName":"Orion","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Tablet"],"indications":"Glucocorticoid replacement therapy in primary or secondary adrenal \\ninsufficiencies and long term management of congenital adrenal hyperplasia in children","dosing":"ADULT: 20 - 30 mg daily in divided doses. \\nCHILD: 10 - 30 mg daily in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.1","prescriberCat":"B"},{"id":"drug-835","genericName":"Methylprednisolone Sodium Succinate 0.5 g Injection","brandName":"Solu-Medrol","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Injection"],"indications":"Suppression of inflammatory and allergic disorders, cerebral oedema, immunosuppression treatment of haematological and oncological disorders, treatment of shock states and endocrine disorders","dosing":"15 - 30 mg/kg daily. Large doses may be repeated 4 - 6 hourly for up to 48 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"46.55","prescriberCat":"A"},{"id":"drug-836","genericName":"Prednisolone 3mg / 5ml Syrup","brandName":"Rexolone","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Syrup"],"indications":"i) Replacement therapy for primary and secondary adrenocortical insufficiency \\nii) Adrenogenital syndrome \\niii) Other therapy","dosing":"i) 5 - 25 mg daily in divided doses \\nii) 10 - 20 mg/m2 body surface daily in divided doses \\niii) ADULT: 5 - 60 mg daily. CHILD: 0.5 - 2 mg/kg/day in divided doses every 6 - 8 hours or as a single daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.00","prescriberCat":"B"},{"id":"drug-837","genericName":"Prednisolone 5 mg Tablet","brandName":"Nisolon","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Tablet"],"indications":"i) Replacement therapy for primary and secondary adrenocortical insufficiency \\nii) Adrenogenital syndrome \\niii) Other therapy","dosing":"i) 5 - 25 mg daily in divided doses \\nii) 10 - 20 mg/m2 body surface daily in divided doses \\niii) ADULT: 5 - 60 mg daily. CHILD: 0.5 - 2 mg/kg/day in divided doses every 6 - 8 hours or as a single daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.11","prescriberCat":"B"},{"id":"drug-838","genericName":"Prednisolone 1mg Tablet","brandName":"Visolone","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Tablet"],"indications":"Indication is as per Prednisolone 5mg Tablet.\\n\\nHSM: For gradual tapering of steroid dependant rheumatology patients","dosing":"Dosing is as per Prednisolone 5mg Tablet\\n\\nRefer rheumatologist for relevant protocols / tapering schedule","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special drugs approval (UKK) required (by batch basis in HSM) (Dept: Perubatan\\nRheumatology)","price":"0.31","prescriberCat":"Not ln FUKKM"},{"id":"drug-839","genericName":"Triamcinolone Acetonide 10 mg/ml Injection","brandName":"Shincort","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Injection"],"indications":"Inflammation of joints, bursae and tendon sheaths","dosing":"Smaller joints: 2.5 - 5 mg and larger joints: 5 - 15 mg. Treatment should be limited to 1 mg/injection site to prevent cutaneous atrophy","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.11","prescriberCat":"A, A/KK"},{"id":"drug-840","genericName":"Triamcinolone Acetonide  40 mg/ml Injection","brandName":"Sivkort","category":"9.0 HORMONES\\n9.1 CORTICOSTEROIDS","forms":["Injection"],"indications":"Allergies, dermatoses, rheumatoid arthritis and inflammatory opthalmic diseases","dosing":"40-80 mg deep into the gluteal muscle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.73","prescriberCat":"A, A/KK"},{"id":"drug-843","genericName":"Conjugated Oestrogens 0.625 mg/g Cream (14g)","brandName":"Premarin","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["(14g)"],"indications":"Treatment of atrophic vaginitis, dyspareunia and kraurosis vulvae","dosing":"i. Atrophic Vaginitis and Kraurosis Vulvae:\\nInitial dose: Intravaginal 0.5g daily for 21 days and then off for 7 days\\n(cyclical regimen). Dose range: 0.5- 2g daily based on individual response.\\nii. Dyspareunia:\\n0.5g intravaginally twice weekly continuous regimen or in a cyclic regimen of\\n21 days of therapy followed by 7 days off of therapy","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"45.49","prescriberCat":"A"},{"id":"drug-844","genericName":"Conjugated Oestrogens 0.625 mg Tablet","brandName":"Premarin","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i. Prevention and management of osteoporosis associated with estrogen\\ndeficiency.\\nii. Female hypoestrogenism.\\niii. Moderate to severe vasomotor symptoms associated with estrogen\\ndeficiency.\\niv. Atrophic vaginitis and atrophic urethritis.","dosing":"i) 0.3 - 0.625 mg daily\\nii) 0.3- 1.25mg daily for 3weeks, then off for 1 week \\niii) & iv) 0.3mg-1.25mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"1.55","prescriberCat":"A"},{"id":"drug-845","genericName":"Conjugated Oestrogens 0.625 mg & Medroxyprogesterone Acetate 2.5 mg Tablet","brandName":"Premelle 2.5","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"Management of moderate to severe vasomotor symptoms associated with menopause, prevention and management of postmenopausal osteoporosis, atropic vaginitis and atropic urethritis in post menopausal woman with intact uterus","dosing":"1 tablet daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.73","prescriberCat":"A"},{"id":"drug-846","genericName":"Danazol 100mg Capsule","brandName":"Nazol","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Capsule"],"indications":"i) Endometriosis\\nii) Benign breast disorders including gynaecomastia fibrocystic breast disease and pubertal breast hypertrophy\\niii) Menorrhagia\\niv) Prophylaxis of hereditary angioedema","dosing":"i. 400mg daily in 2 to 4 divided doses, starting on the 1st day of the menstrual cycle; daily doses of 800mg are also employed.\\nii. 100mg to 400mg daily in divided dose.\\niii. 200 mg BD iv. 400 mg daily. Reduce to 200 mg daily after 2 months attack free period.\\n\\nGeneral dosing range: 200-800mg daily in 2 or 4 divided doses.\\n\\nDosing is individualised and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik, Perubatan)","price":"1.51","prescriberCat":"A/KK"},{"id":"drug-847","genericName":"Dienogest 2 mg Tablet","brandName":"Visanne","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"Treatment of endometriosis","dosing":"One tablet daily. Treatment can be started on any day of menstrual cycle. Tablets must be taken continously without regard to vaginal bleeding.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Obstetrik)","price":"5.00","prescriberCat":"A/KK"},{"id":"drug-848","genericName":"Dydrogesterone 10 mg Tablet","brandName":"Duphaston","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i) Dysmenorrhoea \\nii) Endometriosis \\niii) Dysfunctional uterine bleeding (to arrest and to prevent bleeding) \\niv) Threatened abortion \\nv) Habitual abortion \\nvi) Post menopausal complaints (hormone replacement therapy in combination with oestrogen)","dosing":"i) 10 mg bd from day 5 - 25 of cycle \\nii) 10 mg bd - tds from day 5 - 25 of the cycle or continuously \\niii) To arrest bleeding :10 mg bd with an oestrogen once daily for 5 - 7 days, \\nTo prevent bleeding : 10 mg bd with an oestrogen once daily from day 11 - 25 of the cycle iv) 40 mg at once, then 10mg 8hrly until symptoms remit \\nv) 10 mg bd until 20th week of pregnancy \\nvi) 10-20 mg daily during last 12-14 days of each cycle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"2.16","prescriberCat":"A/KK"},{"id":"drug-849","genericName":"Estradiol Valerate 1 mg Tablet","brandName":"Progynova","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i. Hormone replacement therapy (HRT) for the treatment of signs and\\nsymptoms of estrogen deficiency due to natural menopause or castration.\\nii. Prevention of postmenopausal osteoporosis.","dosing":"1-2 mg daily continuously. Titrate to the minimum effective dose necessary to\\ncontrol symptoms.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.64","prescriberCat":"A*"},{"id":"drug-850","genericName":"Estradiol 1 mg with Dydrogesterone 5 mg Tablet","brandName":"Femoston Conti","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i) Hormone replacement therapy for the relief of symptoms due to oestrogen\\ndeficiency in women with a uterus\\nii) Prevention of postmenopausal osteoporosis in women with a uterus","dosing":"One tablet is to be taken daily for a 28-day cycle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"1.34","prescriberCat":"A*"},{"id":"drug-851","genericName":"Estradiol 1 mg (14 tablet) & Estradiol 1 mg with Dydrogesterone 10 mg (14 tablet)","brandName":"Femoston 1/10","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["tablet)"],"indications":"Hormone Replacement Therapy for women with disorders due to natural or surgically induced menopause with intact uterus.","dosing":"One tablet daily without pill-free interval, starting with 1 mg of Estradiol for first 14 days, followed by 1mg Estradiol with 10 mg Dydrogestrone daily for the next 14 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"1.37","prescriberCat":"A*"},{"id":"drug-852","genericName":"Estradiol Valerate 2 mg & Norgestrel 500 mcg with Estradiol Valerate 2 mg Tablet","brandName":"Progyluton","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i. Hormone replacement therapy (HRT) for the treatment of signs and\\nsymptoms of estrogen deficiency due to menopause or hypogonadism,\\ncastration or primary ovarian failure in women with an intact uterus.\\nii. Prevention of postmenopausal osteoporosis.\\niii. Control of irregular menstrual cycles.\\niv. Treatment of primary or secondary amenorrhea.","dosing":"One white tablet daily for the first 11 days, followed by one light brown tablet\\ndaily for 10 days then stop for a 7- day tablet-free interval before\\ncommencing next pack.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"1.70","prescriberCat":"B"},{"id":"drug-853","genericName":"Medroxyprogesterone Acetate 5 mg Tablet","brandName":"Ravimed","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i) Secondary amenorrhoea \\nii) Abnormal uterine bleeding due to hormonal imbalance","dosing":"i) 5-10 mg daily for 5-10 days started anytime during cycle \\nii) 5-10 mg daily for 5-10 days on day 16-21 of menstrual cycle. \\nOptimum secretory transformation 10 mg daily for 10 days from day 16 of the cycle","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.33","prescriberCat":"B"},{"id":"drug-854","genericName":"Progesterone 100 mg capsule","brandName":"Utrogestan","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["capsule"],"indications":"Supplementation of the luteal phase.","dosing":"Oral route: On average for progesterone insufficiency, the daily dose of progesterone is 200-300mg per day; one capsule after breakfast and one to two capsules at bedtime. Vaginal route: 4 to 6 capsules (in 2 to 3 divided doses) per day starting from the day of the HCG injection until the 12th week of pregnancy.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Obstetrik)","price":"2.17","prescriberCat":"A*"},{"id":"drug-855","genericName":"Testosterone 250 mg/ml Injection","brandName":"Sustanon","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Injection"],"indications":"i. In male:\\nTestosterone replacement therapy for male hypogonadism, when\\ntestosterone deficiency has been confirmed by clinical features and\\nbiochemical test.\\nii. In female:\\nAdditive therapy in cases of advanced breast cancer in postmenopausal\\nwomen.","dosing":"By IM only. Hypogonadism 250 mg every 2-3 weeks. To maintain an adequate androgenic effect 250 mg every 3-6 weeks. Potency disorders 250 mg every 4 weeks. Male climateric disorders: 250 mg every 3-4 weeks. Repeated 6-8 weeks courses at 2-3 months interval","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota","price":"20.80","prescriberCat":"A*"},{"id":"drug-856","genericName":"Tibolone 2.5 mg Tablet","brandName":"Tiboleen","category":"9.0 HORMONES\\n9.2 SEX HORMONES","forms":["Tablet"],"indications":"i. Treatment of complaints resulting from the natural or surgical menopause &\\nin cases at high risk for breast carcinomas where general hormone\\nreplacement therapy is contraindicated\\nii. Prevention of osteoporosis in postmenopausal women at high risk of future\\nfractures who are intolerant of, or contraindicated for, other medicinal\\nproducts approved for the prevention of osteoporosis.","dosing":"2.5mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan, Obstetrik)","price":"1.60","prescriberCat":"A*"},{"id":"drug-859","genericName":"Bromocriptine Mesilate 2.5 mg Tablet","brandName":"Pharmaniaga\\nBromocriptine","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Tablet"],"indications":"i) Hypogonadism, galactorrhoea, infertility in men and women, cyclical benign\\nbreast and menstrual disorders\\nii) Acromegaly\\niii) Hyperprolactinaemia, prolactinomas\\niv) Parkinson's disease","dosing":"i) Initial dose of 1.25-2.5mg once daily at bedtime. Dose may be increased by 2.5mg/day every 3 to 7 days as tolerated to a total of 5 to 7.5mg daily in divided doses\\nii) 1.25 - 2.5 mg at bedtime for 3 days and may be increased by 1.25 - 2.5 mg every 3 to 7 days up to 30 mg a day in divided doses \\niii) Initial dose of 1.25mg, two or three times a day. Increase dosage gradually over several weeks to 10 - 20mg a day in divided doses. Higher doses may be required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan. Obstetrik)","price":"0.77","prescriberCat":"A/KK"},{"id":"drug-861","genericName":"Cabergoline 0.5 mg Tablet","brandName":"Dostinex","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Tablet"],"indications":"i) Inhibition of physiological lactation soon after parturition\\nii) Suppression of established lactation\\niii) Treatment of hyperprolactinaemic disorders","dosing":"i) 1 mg as a single dose during the first post-partum day\\nii) 0.25 mg every 12 hours for 2 days\\niii) Initial: 0.5 mg/week given in one or two divided weekly doses. May gradually increase dose by 0.5 mg/week no sooner than every 4 weeks until an optimal therapeutic response is achieved. Usual dose range: 0.25 mg to 2\\nmg/week (higher doses >1 mg /week may be divided in as many as 3 to 4 divided doses)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"21.30","prescriberCat":"A*"},{"id":"drug-862","genericName":"Chorionic Gonadotrophin Human (HCG) 5000 IU Injection","brandName":"HuCog","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"i. Ovulation induction in subfertility due to anovulation or impaired follicleripening.\\nii. Preparation of follicles for puncture in controlled ovarian hyperstimulation\\n(for assisted reproductive technologies).\\niii. Luteal phase support.","dosing":"i & ii: 5,000-10,000 IU stat once optimal stimulation of follicular growth is achieved.\\niii: Up to three repeat injections of 1000 to 3000 IU may be given within 9 days following ovulation or embryo transfer (E.g.: on day 3, 6 and 9 after ovulation induction)\\nDosing is individualised and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"33.50","prescriberCat":"A*"},{"id":"drug-863","genericName":"Clomiphene Citrate 50mg Tablet","brandName":"Clomid","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Tablet"],"indications":"Treatment of ovulatory failure in women desiring pregnancy","dosing":"Initial: 50 mg once daily for 5 days.\\nIncrease to 100mg OD for 5 days if there is no response (commence as early as 30 days after the previous course).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.67","prescriberCat":"A"},{"id":"drug-864","genericName":"Cyproterone Acetate 50 mg Tablet","brandName":"Androcur","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Tablet"],"indications":"Carcinoma of prostate","dosing":"i) After orchidectomy, 100 mg once daily or twice daily \\nii) If used together with LHRH agonists, the initial dose is 100 mg twice daily for 5 to 7 days before the start of LHRH agonist, then 100 mg twice daily for 3 to 4 weeks together with the LHRH agonist","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik, pembedahan)","price":"3.89","prescriberCat":"A*"},{"id":"drug-865","genericName":"Danazol 100 mg Capsule","brandName":"Anargil","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Capsule"],"indications":"i)Endometriosis and gynaecomastia \\nii)Menorrhagia \\niii)Prophylaxis of hereditary angioedema","dosing":"i)200 - 800 mg daily for max of 9 months \\nii)200 mg daily for 12 weeks \\nii)400 mg daily. Reduce to 200 mg daily after 2 months attack free period","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik, perubatan)","price":"1.55","prescriberCat":"A/KK"},{"id":"drug-866","genericName":"Goserelin 3.6 mg, 10.8mg Depot Injection","brandName":"Zoladex 3.6\\nZoladex 10.8","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"3.6 mg:Androgen deprivation therapy in prostate cancer, endometriosis,leiomyoma uteri and assisted reproduction,breast cancer in premenopausal and perimenopausal women suitable for hormonal manipulation\\n10.8mg: Androgen deprivation therapy in prostate cancer","dosing":"One 3.6 mg depot injected subcutaneously into the anterior abdominal wall, every 28 days.\\n\\nOne 10.8mg depot injected S/C into the anterior abdominal wall, every 12 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota: 10.8mg (Dept: Pembedahan)","price":"298.9 812.0","prescriberCat":"A"},{"id":"drug-867","genericName":"Lanreotide acetate 120mg prolonged-release solution for injection","brandName":"Somatuline Autogel","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["injection"],"indications":"i) Treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumours (GEPNETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease\\n\\nii) Treatment of the clinical symptoms of neuroendocrine (particularly carcinoid) tumours","dosing":"i) 120 mg administered every 28 days\\nii) 60 mg to 120 mg administered every 28 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"4949.00","prescriberCat":"A*"},{"id":"drug-868","genericName":"Leuprolide Acetate 11.25 mg Injection","brandName":"Lucrin","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"i) Endometriosis \\nii) Hormonal therapy in advanced prostate cancer","dosing":"i) & ii) 11.25mg every 3 months","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Obstetrik , Pembedahan)","price":"953.00","prescriberCat":"A*"},{"id":"drug-869","genericName":"Octreotide 0.1 mg/ml Injection","brandName":"Sandostatin","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"i) Acromegaly treatment in patients in whom surgery or radiotherapy is inappropriate or ineffective- based on level of growth hormone and high IGF-1 and residual pituitary tumor\\nii) Relief of symptoms associated with functional gastro-entero-pancreatic (GEP) endocrine tumors:\\n Carcinoid tumors with features of the carcinoid syndrome.\\n VIPomas, Glucagonomas\\n Gastrinomas/Zollinger-Ellison syndrome\\n Insulinomas\\n GRFomas.\\niii) Prevention of complications following pancreatic surgery\\niv) Emergency management of bleeding gastro-eosophageal varices in patients with cirrhosis","dosing":"i) Initially 0.05-0.1mg SC every 8 or 12 hours. Optimal daily dose is 0.3mg, not to exceed maximum dose of 1.5mg/day.\\nii) Initially 0.05 mg once or twice daily, gradually increase to 0.1-0.2mg 3 times daily. Higher doses may be required in exceptional circumstances.\\niii) 0.1 mg 3 times daily for 7 consecutive days, starting on the day of operation, at least 1 hour before laparotomy\\niv) ADULT: 50mcg bolus, followed by continuous infusion of 25-50mcg/hour for 2-5 days.\\nCHILD: IV 1-5 mcg/kg/hour\\n\\nThe dosing is individualized according to product insert / protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik, Pembedahan)","price":"41.59","prescriberCat":"A"},{"id":"drug-871","genericName":"Somatropin 10mg/1.5 ml Pre-filled Pen","brandName":"Nordiflex","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Pen"],"indications":"To be used in children for: \\ni) Growth failure due to inadequate endogenous growth hormone. \\nii) Growth failure in girls due to gonadal dysgenesis (Turner syndrome). iii) Growth failure in short children born small gestational age (SGA) \\nTo be used in adult for: \\ni) Pronounced growth hormone deficiency (GHD) in known hypothalamic-pituitary disease. \\nii) Childhood onset growth hormone insufficiency.","dosing":"i) 0.7-1 mg/m2/day or 0.025-0.035 mg/kg/day SC/IM. \\nii) 1.4 mg/m2/day or 0.045-0.05 mg/kg/day SC. \\niii) 0.035 mg/kg/day or 1 mg/m2/day SC \\nFor adult: a) Replacement therapy: The dosage must be adjusted to the need of the individual patient. b) Childhood-onset GHD: The recommended dose to restart is 0.2-0.5 mg/day with subsequent dose adjustment on the basis of IGF-I concentration determination. c) Adult-onset GHD: It is recommended to start treatment with a low dose 0.1-0.3 mg/day and to increase the dosage gradually at monthly intervals in order to meet the need of the individual patient. \\nSerum IGF-I can be used as guidance for the dose titration. Women may require higher doses than men, with men showing an increasing IGF-I sensitivity over time. This means that there is a risk that women, especially those on oral oestrogen replacement, are under-treated while men are over-treated. Dose requirements decline with age. Maintenance dosages vary from person to person, but seldom exceed 1.0 mg/day (equal to 3 IU/day).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pediatrik)","price":"462.80","prescriberCat":"A*"},{"id":"drug-872","genericName":"Synthetic ACTH (Tetracosactrin Acetate) 250 mcg/ml Injection","brandName":"Synacthen","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"Diagnostic test to differentiate primary adrenal from secondary (pituitary) adrenocortical insufficiency","dosing":"Diagnostic test for investigation of adrenocortical insufficiency \\nAdult: As plain preparation: Measure plasma cortisol concentration immediately before and exactly 30 min after IM/IV inj of 250 mcg. Post-inj rise in plasma cortisol concentration 200 nmol/l (70 mcg/l) if normal adrenocortical function. \\nAs depot preparation (if inconclusive results with plain preparation): Measure plasma cortisol concentration before and exactly 30 min, 1, 2, 3, 4 and 5 hr after an IM inj of 1 mg tetracosactide acetate depot. Adrenocortical function normal if the post-inj rise in plasma cortisol concentration increases 2-fold in 1st hr, and continues to rise steadily. Expected levels in 1st hr: 600-1,250 nmol/l, increasing slowly up to 1000-1800 nmol/l by 5th hr. \\nChild: IV 250 mcg/1.73 m2 BSA. Intramuscular","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\n Import Permit Required for purchase (UKK) (Dept: Perubatan)","price":"82.00","prescriberCat":"A"},{"id":"drug-873","genericName":"Terlipressin 1 mg Injection","brandName":"Glypressin","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"i. Acute oesophageal variceal bleeding\\n\\nii. Treatment of type 1 hepatorenal syndrome, characterised by spontaneous acute renal insufficiency, in patients suffering from severe cirrhosis with ascites.","dosing":"i) 2 mg IV bolus over 1 minute. Maintenance: 1 - 2 mg IV bolus 4 - 6 hourly until bleeding is controlled, up to 24 - 36 hours. The maximum daily dosage is 120-150 mcg/kg body weight.\\n\\nii) Terlipressin is usually started at a dose of 1 mg of terlipressin acetate every 4-6 hours. The dose can be increased to a maximum of 12 mg daily, or 2 mg every 4-6 hours, if serum creatinine levels has not decreased by at least 25% after 3 days of treatment.\\n\\nAs an alternative to bolus injection, terlipressin can be administered as a continuous intravenous (IV) infusion with a starting dose of 2 mg of terlipressin acetate/24 hours and increased to a maximum of 12 mg of terlipressin acetate/24 hours.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"153.60","prescriberCat":"A*"},{"id":"drug-874","genericName":"Triptorelin 3.75 mg Injection","brandName":"Diphereline","category":"9.0 HORMONES\\n9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS","forms":["Injection"],"indications":"i) Treatment of confirmed central precocious puberty (preterm sexual development) (before 8 years in girls and 10 years in boys)\\n\\nii) Genital and extragenital endometriosis (stage I to stage IV). Treatment should not be administered for more than 6 months. It is not recommended to start a second treatment course with triptorelin or another GnRH analogue.","dosing":"1 intramuscular injection every 4 weeks. \\nThe treatment must be started in the first 5 days of the menstrual cycle. The duration of treatment depends on the initial severity of the endometriosis and the changes observed in the clinical features. In principle, the treatment should be administered for at least 4 months and for at most 6 months. It is not recommended to start a second treatment course with triptorelin or another GnRH analogue.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik, \\npembedahan)","price":"252.75","prescriberCat":"A"},{"id":"drug-877","genericName":"Cyproterone Acetate 2 mg & Ethinyloestradiol 0.035 mg Tablet","brandName":"Cybelle","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Tablet"],"indications":"Androgen dependent diseases in women","dosing":"1 tablet daily for 21 days on the first day of the cycle, followed by 7 tab free days. Starting on day 2 to 5 is allowed, but during the first cycle a barrier method is recommended for the first 7days of tablet taking.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.72","prescriberCat":"A*"},{"id":"drug-878","genericName":"Desogestrel 150 mcg & Ethinyloestradiol 30 mcg Tablet","brandName":"Desolon","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Tablet"],"indications":"Contraception","dosing":"1 tablet daily for 21 days, subsequent courses repeated after 7 day interval (during which withdrawal bleeding occurs)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.11","prescriberCat":"C+"},{"id":"drug-879","genericName":"Ethinylestradiol 20 mcg & Levonorgestrel 100 mcg Tablet","brandName":"Minipil 20","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Tablet"],"indications":"i) Oral Contraceptive.\\nii) Treatment of moderate acne vulgaris not controlled by conventional\\ntherapy (e.g. topical preparations and oral antibiotics) in post-menarchal,\\npremenopausal women more than or 14 years who accept contraception.","dosing":"1 tablet daily for 21 consecutive days, followed by a 7 -day tablet free interval\\nbefore the next pack is started","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.40","prescriberCat":"A/KK"},{"id":"drug-880","genericName":"Etonogestrel 68 mg Implant","brandName":"Implanon NXT","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Implant"],"indications":"Contraception","dosing":"A single implant inserted subdermally and can be\\n left in place for three years. \\nThe implant can be removed at any time but not later than three years after the date of insertion.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"303.48","prescriberCat":"A/KK"},{"id":"drug-881","genericName":"Levonorgestrel 1.5 mg Tablet","brandName":"Escapelle","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Tablet"],"indications":"Emergency contraception within 72 hours of unprotected sexual intercourse for the female victim of sexual violence to prevent unwanted pregnancy","dosing":"1.5 mg as a single dose as soon as possible after coitus [preferably within 12 hours but no later than after 72 hours]","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"250.80","prescriberCat":"A*"},{"id":"drug-882","genericName":"Levonorgestrel 52mg Releasing Intrauterine System","brandName":"Mirena","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["System"],"indications":"i. Contraception.\\nii. Idiopathic menorrhagia.\\niii. Protection from endometrial hyperplasia during oestrogen replacement\\ntherapy","dosing":"One unit intrauterine device to be inserted into the uterine cavity within 7 days of the onset of menstruation or immediately after first trimester abortion. Postpartum insertion should be postponed until 6 weeks after delivery.Can be inserted at any time of amenorrheic woman. One unit IUD is effective for 5 years","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"638.30","prescriberCat":"A*"},{"id":"drug-883","genericName":"Medroxyprogesterone Acetate 150 mg/3 ml Injection","brandName":"Condep","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Injection"],"indications":"Prevention of pregnancy and to provide long term contraception","dosing":"150mg to be administered once every 3 month","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.80","prescriberCat":"B"},{"id":"drug-884","genericName":"Copper 250 mm2\\nIntrauterine\\nDevice","brandName":"-","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["mm2\\nIntrauterine\\nDevice"],"indications":"Intrauterine contraception","dosing":"Intrauterine insertion: 1 unit to be replaced within 5 years from the date of\\ninsertion.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"23.00","prescriberCat":"REGISTERED WITH MDA AS MEDICAL DEVICE"},{"id":"drug-885","genericName":"Norethisterone 0.35 mg Tablet","brandName":"Noriday","category":"9.0 HORMONES\\n9.4 CONTRACEPTIVES","forms":["Tablet"],"indications":"Contraception","dosing":"1 tablet daily starting on the first day of the menstrual bleeding","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.29","prescriberCat":"C+"},{"id":"drug-888","genericName":"Atorvastatin 20 mg, 40 mg Tablet","brandName":"Storvas","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Tablet"],"indications":"Hypercholesterolaemia and coronary heart disease intolerant or \\nnot responsive to other forms of therapy","dosing":"10 mg once daily. Maximum: 80 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.12 ,0.14","prescriberCat":"A/KK"},{"id":"drug-889","genericName":"Cholestyramine Resin 4G","brandName":"Cholestyramine","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["4G"],"indications":"i) Hypercholesterolemia \\nii) Familial hypercholesterolemia - heterozygous \\niii) Generalized atherosclerosis \\niv) Diarrhoea due to bile acid malabsorption v) Pruritus of skin associated with partial biliary obstruction","dosing":"Hypercholesterolemia: Adjunct: initial, 4 g orally 1-2 times \\ndaily, maintenance, 8 to 16 g in divided doses, \\nmax 24 g daily CHILD: 50 - 150 mg/ kg 6 - 8 hourly oral\\n\\nHSM Practice: Adult: initial dose 4g TDS","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nimport permit required for purchase (UKK) (Dept: Perubatan)","price":"2.91","prescriberCat":"A"},{"id":"drug-890","genericName":"Ezetimibe 10 mg Tablet","brandName":"Accord","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Tablet"],"indications":"i) Co-administration with statins for patients who have chronic heart disease or are chronic heart disease equivalent or familial hypercholesterolaemia with target LDL-C not achieved by maximum dose of statins\\nii) Monotherapy in patients with documented biochemical intolerance to statins","dosing":"10 mg once daily. Not recommended for children less than 10 years old","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"0.73","prescriberCat":"A*"},{"id":"drug-891","genericName":"Fenofibrate 145 mg Tablet","brandName":"Lipanthyl","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Tablet"],"indications":"1) As second line therapy after failed gemfibrozil in patients:\\na) Hypercholesterolemia and hypertriglyceridemia alone or combined [type IIa,IIb,III and V dysplipidemias] in patients unresponsive to dietary and other non-pharmacological measures especially when there is evidence of associated risk factors\\nb) Treatment of secondary hyperlipoproteinemias if hyperlipoprotenemia persists despite effective treatment of underlying disease\\nc) Dyslipidemia in Type 2 Diabetes Mellitus\\n\\n2) Diabetic retinopathy - indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy.\\nPrescribing restriction: For mild to moderate non-proliferative diabetic retinopathy only.","dosing":"145mg once daily, with or without food","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.03","prescriberCat":"A/KK"},{"id":"drug-892","genericName":"Gemfibrozil 300 mg Capsule","brandName":"Gemfibrozil","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Capsule"],"indications":"Treatment of hyperlipoprotinaemias \\n(TYPES IIA, IIB, III, IV, V)","dosing":"ADULT: 1200 mg/day in 2 divided doses, 30 minutes before breakfast and dinner. \\nDose range from 0.9-1.5 g daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.21","prescriberCat":"A/KK"},{"id":"drug-893","genericName":"Inclisiran 284mg/1.5ml Solution for Injection in Pre-filled Syringe","brandName":"SYBRAVA","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Syringe"],"indications":"Treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet and maximally tolerated statin therapy","dosing":"284 mg administered as a single subcutaneous injection: initially, again at 3 months, followed by every 6 months.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) (Dept: Perubatan)","price":"4343.00","prescriberCat":"Not in FUKKM"},{"id":"drug-894","genericName":"Pravastatin Sodium 20 mg Tablet","brandName":"Pravatas","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Tablet"],"indications":"Hypercholesterolaemia and coronary heart disease intolerant or \\nnot responsive to other forms of therapy. In health clinics, Pravastatin is restricted to HIV patients on HAART.","dosing":"10 - 20 mg once daily. Maximum: 40 mg daily. In patients concomitantly taking cyclosporine, with or without other immunosuppressive drugs: Initial dose is 10mg/day and titration to higher doses should be performed with caution. Maximum dose 20mg/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.29","prescriberCat":"A/KK"},{"id":"drug-895","genericName":"Rosuvastatin 20 mg Tablet","brandName":"Vasticure","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Tablet"],"indications":"Dyslipidaemia not responsive to atorvastatin 40 mg \\nor equivalent doses of other statins","dosing":"Initially 5-10 mg once daily (5mg in patients with pre-disposing factors to myopathy), \\nincreased if necessary at intervals of at least 4 weeks to 20 mg once daily, increased after further 4 weeks to 40 mg daily ONLY in severe hypercholesterolemia with high cardiovascular risk. Patient of Asian origin, patients on concomitant ciclosporin/fibrate and patients with risk factors for myopathy/rhabdomyolysis (including personal/family history of muscular disorders/toxicity), the maximum dose should be 20 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.31","prescriberCat":"A*"},{"id":"drug-896","genericName":"Simvastatin 10 mg, 40 mg Tablet","brandName":"Simvor","category":"10.0 METABOLISM\\n10.1 HYPERLIPIDAEMIC AGENTS","forms":["Tablet"],"indications":"Hypercholesterolaemia and coronary heart disease intolerant or \\nnot responsive to other forms of therapy","dosing":"10 - 20 mg once daily. Maximum: 80 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.04, 0.10","prescriberCat":"B"},{"id":"drug-899","genericName":"Carbimazole 5 mg Tablet","brandName":"Camazol","category":"10.0 METABOLISM\\n10.2 ANTITHYROID AND THYROID PREPARATIONS","forms":["Tablet"],"indications":"Hyperthyroidism","dosing":"ADULT: Initially, 10-60mg daily in divided doses given 8 hourly. Maintenance: 5 to 20mg daily. \\nCHILDREN > 6 years: Initially 15mg daily in divided doses. \\nCHILDREN 1-6 years: Initially 7.5mg daily in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.04","prescriberCat":"B"},{"id":"drug-900","genericName":"Iodine and Potassium Iodide Solution (Lugol's Solution)","brandName":"-","category":"10.0 METABOLISM\\n10.2 ANTITHYROID AND THYROID PREPARATIONS","forms":["Solution)"],"indications":"i) Pre-operative treatment of thyrotoxicosis \\nii) Thyrotoxicosis crisis \\n\\nHSM Off-label indication (O&G): \\nFor cervical staining during colposcopy procedure,cone biopsy and LLETZ","dosing":"i) 1 ml daily in divided doses \\nii) 5-10 drops (6.25mg per drop) every 6-8 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import permit (UKK)\\nrequired for purchase (Dept: Galenical)","price":"-","prescriberCat":"B"},{"id":"drug-901","genericName":"Levothyroxine Sodium 25 mcg, 100mcg Tablet","brandName":"Euthyrox. Thyrosit","category":"10.0 METABOLISM\\n10.2 ANTITHYROID AND THYROID PREPARATIONS","forms":["Tablet"],"indications":"Hypothyroidism","dosing":"Start at low dose and increase at 2-4 weeks interval. \\nUsual recommended dose for \\ni) Treatment of benign euthyroid goitre: 75-200mcg. \\nii) Prophylaxis of relapse after surgery for euthyroid goitre: 75-200mcg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"0.14, 0.07","prescriberCat":"B"},{"id":"drug-904","genericName":"Levothyroxine 200mcg/ml (1ml) injection","brandName":"Serb Levothyroxine","category":"10.0 METABOLISM\\n10.2 ANTITHYROID AND THYROID PREPARATIONS","forms":["injection"],"indications":"Myxedema crisis","dosing":"Adult: 100mcg-200mcg OD x 5 days (consult with endocrinologist)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import permit (UKK)\\nrequired for purchase (Dept: Perubatan\\n\\n(JKUT 1/23: ONE-OFF PURCHASE. TO KEEP IN HSM UNTIL NEAR EXP AND OFFER OUT))","price":"283.00","prescriberCat":""},{"id":"drug-905","genericName":"Potassium Iodide Mixture 200 mg/15 ml","brandName":"-","category":"10.0 METABOLISM\\n10.2 ANTITHYROID AND THYROID PREPARATIONS","forms":["ml"],"indications":"Pre-operative management of hyperthyroidism and thyrotoxicosis","dosing":"ADULT and CHILD: 50 - 250 mg 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"B"},{"id":"drug-906","genericName":"Propylthiouracil 50 mg Tablet","brandName":"Propyl","category":"10.0 METABOLISM\\n10.2 ANTITHYROID AND THYROID PREPARATIONS","forms":["Tablet"],"indications":"Hyperthyroidism","dosing":"ADULT \\nInitially 300-600mg daily in divided doses, at 8 hourly intervals (can be given up to 600-1,200mg/daily in divided doses).\\nMaintenance 50-200mg daily when the condition is controlled, probably within 1 to 3 months.\\n\\nCHILDREN 6-10 years: 50-150mg daily in divided doses.\\nCHILDREN > 10 years: 150-300mg or 150mg/m2 daily Maintenance 50-100mg daily, according to patient's response. Taken with food.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.12","prescriberCat":"B"},{"id":"drug-909","genericName":"Glucagon (Lyophilised) 1 mg/ml Injection","brandName":"Glucagon","category":"10.0 METABOLISM\\n10.3 HYPERGLYCAEMIC AGENTS","forms":["Injection"],"indications":"Management of hypoglycaemia","dosing":"Adult, children > 20kg: 1mg by SC, IM or IV. \\nChildren < 20kg : 0.5mg. \\nIf patient does not respond within 10 minutes, administer IV glucose. Repeat in 20 minutes if necessary.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"161.24","prescriberCat":"B"},{"id":"drug-912","genericName":"Insulin Aspart 100 IU/ml\\nInjection","brandName":"Novorapid \\nFlexpen","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["IU/ml\\nInjection"],"indications":"Diabetic Type 1 and 2 in patients that still experienced hypoglycaemia with use of human insulin","dosing":"Dose to be individualised. \\nThe average daily insulin requirement is between 0.5 to 1.0 units/kg body weight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan, Pediatrik)","price":"18.76","prescriberCat":"A*"},{"id":"drug-913","genericName":"Insulin Aspart 30% and Protaminated Insulin Aspart 70% 100 U/ml Injection","brandName":"Novomix 30 Flexpen","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Injection"],"indications":"Diabetic type 1 and 2 in patients that still experienced hypoglycaemia with use of human insulin","dosing":"Dose to be individualised. The average daily insulin requirement is between 0.5 to 1.0 units/kg body weight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"23.14","prescriberCat":"A/KK"},{"id":"drug-914","genericName":"Insulin Degludec/ Insulin Aspart 70/30 Solution for Injection in Pre- Filled Pen 100 Units/mL","brandName":"Ryzodeg","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Units/mL"],"indications":"Treatment of Type-2 Diabetes Mellitus in adults\\n\\nPrescribing Restrictions: \\nFor patients who remained uncontrolled OR experienced recurrent hypoglycaemia with multiple daily dosing of human/analogue basal-bolus/premixed insulin.\\n\\n\\nHSM off label use: Type 1 DM in pediatric","dosing":"Treatment initiation: 10 units with meal(s) followed by individual dosage adjustments. Once or twice daily with the main meal(s)\\nTreatment switching: Can be administered alone, in combination with oral antidiabetic medicinal products, and in combination with bolus insulin.\\n Convert unit-to-unit to once or twice daily Insulin Degludec/Insulin Aspart at the same total insulin dose as the patients previous total daily basal or premix insulin dose.\\n Patients switching from basal/bolus insulin therapy will need to convert their dose based on individual needs. In general, patients are initiated on the same number of basal units.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) required for off-label indication (Dept: Pediatrik)","price":"45.58","prescriberCat":"A*\\n\\n Must be prescribed by Endocrinologist"},{"id":"drug-915","genericName":"Insulin Detemir 100 IU/ml Injection","brandName":"Levemir Flexpen","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Injection"],"indications":"i)Type 1 Diabetes patients on basal bolus regimen, whom experience hypoglycemia with conventional insulin, to be used in combination with rapid or short-acting insulin. \\nii)Type 2 Diabetes patients on oral anti-diabetics and basal insulin regimen or basal bolus insulin regimen whom experience hypoglycemia with conventional basal insulin.","dosing":"Individualized dose given via SC once or twice daily. Initiate at a dose of 10IU or 0.1-0.2IU/kg. For twice daily dosing, the evening dose can be administered either with the evening meal, at bedtime, or 12 hours after the morning dose.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan, Pediatrik)","price":"31.47","prescriberCat":"A/KK"},{"id":"drug-916","genericName":"Insulin Glargine 300 IU/3 ml Prefilled Pen for Injection","brandName":"BASALOG ONE","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Injection"],"indications":"i) Diabetes mellitus type I in adults and child over 6 years ii) Diabetes mellitus type II in adult","dosing":"ADULT and CHILD over 6 years: individualised dose given by SC, once daily at the same time every day. Adult patients who are insulin naive may be initiated with 10IU daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan, Pediatrik)","price":"22.60","prescriberCat":"A/KK"},{"id":"drug-917","genericName":"Insulin glargine 300 IU/ml Pre-filled Pen","brandName":"Toujeo","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Pen"],"indications":"Diabetes mellitus type I and II in adults; \\nPrescribing restriction(s): \\ni) Patients on insulin not reaching treatment goals defined as high fasting plasma glucose (FPG  7 mmol/L) and/or HbA1c  6.5% after 6 months of therapy and/or; \\nii) patients with a high risk of hypoglycaemia as determined by the following risk factors: Advancing age; Severe cognitive impairment; Poor health knowledge; Increased A1c; Hypoglycaemia unawareness; Low standing insulin therapy; Renal impairment; Neuropathy. \\nNote: Theu use of this strength can only be prescribed / dispensed to patients in diabetic clinic / registered under DMTAC program","dosing":"Initiation: Patient with type 1 diabetes: Once daily with mealtime insulin and requires individual dose adjustments; Patient with type 2 diabetes: 0.2units/kg followed by individual dose adjustment. Please refer to the product information leaflet for details of dosage information (switching, etc).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"49.90","prescriberCat":"A*"},{"id":"drug-918","genericName":"Insulin Recombinant Neutral Human short-acting 100 IU/ml Injection in 10ml vial / 100IU/ml penfill","brandName":"Actrapid vial\\n\\nActrapid penfill","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["penfill"],"indications":"Diabetes mellitus","dosing":"Dose to be individualised. The average daily insulin requirement is between 0.3-1.0 units/kg body weight/day. Daily insulin requirement may be higher in patients with insulin resistance, and lower in patients with residual, endogenous insulin production.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"16.24  5.6","prescriberCat":"B"},{"id":"drug-919","genericName":"Insulin Recombinant Neutral Human, short-acting 100 IU/ml Penfill and Refill","brandName":"Insugen R","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Refill"],"indications":"Diabetes mellitus","dosing":"Dose to be individualised. The average daily insulin requirement is between 0.3-1.0 units/kg body weight/day. Daily insulin requirement may be higher in patients with insulin resistance, and lower in patients with residual, endogenous insulin production.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.26","prescriberCat":"B"},{"id":"drug-920","genericName":"Insulin Recombinant Synthetic Human, intermediate-acting 100 IU/ml Injection in 10ml vial / 100 IU/ml penfill","brandName":"Insulatard vial\\n\\nInsulatard penfill","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["penfill"],"indications":"Diabetes mellitus","dosing":"Dose to be individualised. The daily insulin requirement is usually between 0.3 and 1.0IU/kg /day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"16.24   5.6","prescriberCat":"B"},{"id":"drug-921","genericName":"Insulin Recombinant Synthetic Human, intermediate acting 100 IU/ml Penfill and Refill","brandName":"Insugen N","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Refill"],"indications":"Insulin dependent diabetes mellitus, non insulin dependent diabetes unresponsive to treatment to diet or oral hypoglycaemics, hyperkalaemia to assure proper utilisation of glucose and reduce glucosuria in non diabetic patients receiving parenteral nutrition","dosing":"Dose to be individualised. The daily insulin requirement is usually between 0.3 and 1.0IU/kg /day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.26","prescriberCat":"B"},{"id":"drug-922","genericName":"Insulin Recombinant Synthetic Human, pre-mixed 100 IU/ml Penfill and Refill","brandName":"Mixtard","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Refill"],"indications":"Insulin dependent diabetes mellitus, non insulin dependent diabetes unresponsive to treatment to diet or oral hypoglycaemics, hyperkalaemia to assure proper utilisation of glucose and reduce glucosuria in non diabetic patients receiving parenteral nutrition","dosing":"Dose to be individualised. The average daily insulin requirement is between 0.5-1.0 units/kg body weight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.60","prescriberCat":"B"},{"id":"drug-923","genericName":"Insulin Recombinant Synthetic Human, pre-mixed 100 IU/ml Penfill and Refill","brandName":"Insugen 30/70","category":"10.0 METABOLISM\\n10.4 INSULINS","forms":["Refill"],"indications":"Insulin dependent diabetes mellitus, non insulin dependent diabetes unresponsive to treatment to diet or oral hypoglycaemics, hyperkalaemia to assure proper utilisation of glucose and reduce glucosuria in non diabetic patients receiving parenteral nutrition","dosing":"Dose to be individualised. The average daily insulin requirement is between 0.5-1.0 units/kg body weight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.28","prescriberCat":"B"},{"id":"drug-926","genericName":"Acarbose 50 mg Tablet","brandName":"Garbose","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Only for treatment of: i) Non insulin dependent diabetes mellitus (NIDDM) when diet therapy is insufficient ii) Non insulin dependent diabetes mellitus (NIDDM) in combination with existing conventional oral therapy where glycaemic control is inadequate restriction: i) As second/third line treatment of diabetes type 2, with HBA1c < 8%. ii) For patient who have postprandial hyperglycemia when treated with combination of available oral anti-diabetic/insulin. iii) The use of acarbose should be reviewed 6 months after initiation and stopped if HBA1c reduction is less than 0.5%.","dosing":"Initially 50 mg daily, increase to 3 times daily up to 100 mg 3 times daily. Maximum dose: 100 mg 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.16","prescriberCat":"A/KK"},{"id":"drug-927","genericName":"Dapagliflozin 10mg Tablet","brandName":"Novugen","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Indication 1:\\nDapagliflozin is indicated for use as an add-on combination therapy in combination with other glucose-lowering medicinal products including insulin, to improve glycemic control in adult patients with type 2 diabetes mellitus when these, together with diet and exercise, do not provide adequate glycaemic control.\\n\\nRestriction: Patients with HbA1c between 6.5%-10.0% while on single / combination anti-diabetic therapy.","dosing":"10mg OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: perubatan)","price":"0.78","prescriberCat":"A/KK"},{"id":"drug-931","genericName":"Empagliflozin 25mg Tablet","brandName":"Jardiance","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Indication 1:\\nIndicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults as: Add-on combination therapy: In combination with other glucoselowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.\\n\\nRestriction: Indication 1: Patients with HbA1c between 6.5%-10.0% while on single / combination anti-diabetic therapy.","dosing":"Starting dose is 10 mg empagliflozin once daily for monotherapy and add-on combination therapy with other glucose-lowering medicinal products including insulin. In patients tolerating empagliflozin 10 mg once daily and need tighter glycaemic control, the dose can be increased to 25 mg once daily. The maximum daily dose is 25 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: perubatan)","price":"1.66","prescriberCat":"A/KK\\n\\nConsultant/specialists for specific indications only, including Geriatricians"},{"id":"drug-934","genericName":"Gliclazide 80 mg Tablet","brandName":"Pharmaniaga Gliclazide","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Diabetes mellitus type 2","dosing":"Initially 40-80mg daily. A single dose should not exceed 160mg and when higher doses are required, a twice daily split dosage is advised and should be divided. Maximum daily dose: 320mg. For elderly, starting dose should be 40mg twice daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.16","prescriberCat":"B"},{"id":"drug-935","genericName":"Gliclazide 30mg, 60 mg Modified Release Tablet","brandName":"Remicron MR\\nOziclide MR","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Diabetes mellitus type 2","dosing":"Initially, 30mg daily at breakfast time, may increase in successive steps to 60, 90 or 120mg daily at 1 month intervals (except in patients whose blood glucose level was not reduced after 2 weeks of treatment). Max daily dose: 120mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.08 0.32","prescriberCat":"B"},{"id":"drug-936","genericName":"Metformin HCl 500 mg Tablet","brandName":"Glucoxit","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Diabetes mellitus","dosing":"Initial: 500mg orally twice daily with food. Maintenance: Titrate in 500mg increments weekly, doses up to 2000 mg daily may be divided into 2 equal doses.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.08","prescriberCat":"B"},{"id":"drug-937","genericName":"Metformin HCl 500 mg Extended Release Tablet","brandName":"Diabetmin","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"Diabetes mellitus who experienced gastrointestinal side effects with normal metformin","dosing":"500 mg once daily. Maximum dose 2000 mg once daily with evening meal","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.08","prescriberCat":"B"},{"id":"drug-938","genericName":"Saxagliptin 5 mg Tablet","brandName":"Onglyza FC","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"FUKKM restriction: As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea. \\n\\ni) As add on therapy in type 2 diabetes patients inadequately controlled on metformin monotherapy and high risk of hypoglycaemia, especially elderly patients with co-morbidities. \\nii) As add on therapy in type 2 diabetes patients inadequately controlled with a sulphonylure and intolerant/contraindicated for metformin therapy","dosing":"2.5-5mg once daily. Patients with CrCl < 50ml/min, and when coadministered with strong CYP450 3A4/5 inhibitors: 2.5mg OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"kuota (Dept: Perubatan)","price":"0.97","prescriberCat":"A/KK"},{"id":"drug-940","genericName":"Vildagliptin 50 mg Tablet","brandName":"Galvus","category":"10.0 METABOLISM\\n10.5 ORAL ANTIDIABETIC AGENTS","forms":["Tablet"],"indications":"FUKKM restriction: As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea. \\ni) As second line therapy in type 2 diabetes patients inadequately controlled on maximal tolerated dose of metformin monotherapy and high risk of hypoglycaemia. \\nii) As second line therapy in type 2 diabetes patients inadequately controlled on maximal tolerated dose of sulphonylurea and intolerant/contraindicated for metformin therapy.","dosing":"ADULT over 18 years: 50mg bd when combine with metformin, 50 mg od when combine with sulphonylurea","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"kuota (Dept: Perubatan)","price":"0.42","prescriberCat":"A/KK"},{"id":"drug-944","genericName":"Chloramphenicol 0.5% Eye Drops","brandName":"Nicol","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Drops"],"indications":"Ophthalmic infections","dosing":"Instil 1 drop of a 0.5% solution every 2 hr. Increase dosage interval upon\\nimprovement.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.75","prescriberCat":"C"},{"id":"drug-945","genericName":"Chloramphenicol 1% Eye Ointment","brandName":"Chlorop","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Ointment"],"indications":"Treatment of ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol susceptible organisms","dosing":"ADULT and CHILD : Apply to the conjunctiva, a thin strip (approximately 1 cm) of ointment every 3 hours or more frequently","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.40","prescriberCat":"C"},{"id":"drug-946","genericName":"Ciprofloxacin HCl 0.3% Ophthalmic Solution","brandName":"Cipmax","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Solution"],"indications":"Treatment of bacterial infections caused by susceptible strains in \\ni) corneal ulcers \\nii) bacterial conjunctivitis","dosing":"i) 2 drops every 15 minutes for the first 6 hours, then 2 drops every 30 minutes for the rest of the first day. Second day : 2 drops every hour. Subsequent days (3rd - 14th day) : 2 drops every 4 hours. Treatment may be continued after 14 days if corneal re-epithelialization has not occured \\nii) 1 - 2 drops every 2 hours into the conjunctival sac while awake for 2 days and 1-2 drops every 4 hours while awake for the next 5 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"3.50","prescriberCat":"A*"},{"id":"drug-947","genericName":"Fusidic Acid 1% Eye Drops","brandName":"Fucithalmic","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Drops"],"indications":"Bacterial eye infections caused by susceptible organisms","dosing":"1 drop in conjunctival sac 12 hourly. To be continued for 2 days after the eye appears normal. On the first day of treatment, may be applied more frequently : 1 drop 4 hourly. Surgical prophylaxis : 1 drop every 12 hours, 24 - 48 hours before operation","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"17.55","prescriberCat":"A"},{"id":"drug-948","genericName":"Gentamicin 0.3% Eye Drops","brandName":"Bactigen","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Drops"],"indications":"Bacterial eye infections caused by susceptible organisms","dosing":"1 drops every 4 hours, in severe infection dosage may be increased up to 1\\ndrops every hour\\nDosing is individualised and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.90","prescriberCat":"A/KK"},{"id":"drug-949","genericName":"Gentamicin 0.3% Eye Ointment","brandName":"Gentamicin","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Ointment"],"indications":"Conjunctivitis, blepharitis, blepharo-conjunctivitis, keratitis, keratoconjunctivitis, episcleritis, dacrocystitis, corneal ulcers, styes and infected eye socket","dosing":"Apply into the conjunctival sac 3 - 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.32","prescriberCat":"A/KK"},{"id":"drug-950","genericName":"Moxifloxacin 0.5% \\nOphthalmic Solution","brandName":"Zanaflox","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Solution"],"indications":"Treatment of conjunctivitis caused by \\nsusceptible organism","dosing":"CHILD more than 1 year and ADULT: 1 drop to affected eye(s) 3 times daily for 7 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"11.11","prescriberCat":"A*"},{"id":"drug-951","genericName":"Natamycin 5% Opthalmic \\nSuspension","brandName":"Natacyn","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["\\nSuspension"],"indications":"Treatment of fungal keratitis","dosing":"1 drop in affected eyes every 1 to 2 hours. reduce to 1 drop 6-8 times daily after 3-4 days.  Duration of treatment: 2-3 weeks. Gradually reduce dose at 4-7 day intervals.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nSpecial Drugs Approval (UKK) (Dept: Oftalmologi)","price":"513.00","prescriberCat":"Not in FUKKM"},{"id":"drug-952","genericName":"Oxytetracycline with Polymyxin B Sulphate Eye Ointment","brandName":"Terramycin","category":"11.0 EYE PREPARATIONS\\n11.1 ANTIINFECTIVES","forms":["Ointment"],"indications":"Treatment of superficial ocular infections involving the conjunctiva and/or\\ncornea due to susceptible microorganisms","dosing":"Apply into the conjunctival sac 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"3.04","prescriberCat":"B"},{"id":"drug-955","genericName":"Dexamethasone 0.1% and Neomycin Sulphate 3500 mcg/g and Polymyxin B 6000 iu/g Sulphate Ophthalmic Suspension","brandName":"Maxitrol","category":"11.0 EYE PREPARATIONS\\n11.2 ANTISEPTICS WITH CORTICOSTEROIDS","forms":["Suspension"],"indications":"Treatment of ocular inflammation when concurrent use of an antimicrobial is judged necessary","dosing":"1 - 2 drops hourly for severe cases and 4 - 6 hourly for mild infection","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.26","prescriberCat":"A"},{"id":"drug-956","genericName":"Dexamethasone 0.1% and Neomycin Sulphate 3500 mcg/g and Polymyxin B 6000 iu/g Eye Ointment","brandName":"Maxitrol","category":"11.0 EYE PREPARATIONS\\n11.2 ANTISEPTICS WITH CORTICOSTEROIDS","forms":["Ointment"],"indications":"Treatment of ocular inflammation when concurrent use of an antimicrobial is judged necessary","dosing":"Apply 1 - 1.5 cm 3 - 4 times daily, may be used adjunctively with drops at bedtime","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"9.40","prescriberCat":"A"},{"id":"drug-959","genericName":"Acyclovir 3% Eye Ointment","brandName":"Acivir","category":"11.0 EYE PREPARATIONS\\n11.3 ANTIVIRALS","forms":["Ointment"],"indications":"Only for the treatment of herpes simplex keratitis","dosing":"Apply 1 cm 5 times daily. Continue for at least 3 days after healing","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase (UKK) (Dept: Oftalmologi)","price":"18.47","prescriberCat":"A*"},{"id":"drug-962","genericName":"Dexamethasone Sodium Phosphate 0.1% Eye Drops","brandName":"Maxidex","category":"11.0 EYE PREPARATIONS\\n11.4 CORTICOSTEROIDS","forms":["Drops"],"indications":"Acute steroid responsive inflammatory and allergic conditions","dosing":"1 - 2 drops 4 - 6 times a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"6.18","prescriberCat":"A"},{"id":"drug-963","genericName":"Fluorometholone 0.1% Ophthalmic Suspension","brandName":"FML-fluorone","category":"11.0 EYE PREPARATIONS\\n11.4 CORTICOSTEROIDS","forms":["Suspension"],"indications":"Treatment of steroid responsive ocular inflammation","dosing":"1-2 drops qds. During the initial 24-48 hr, dose may be increased to 2 drops 2 hrly.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"5.05","prescriberCat":"A*"},{"id":"drug-966","genericName":"Pilocarpine 2% Eye Drops","brandName":"Isopto-Carpine","category":"11.0 EYE PREPARATIONS\\n11.5 MIOTICS","forms":["Drops"],"indications":"Miotics in chronic open-angle glaucoma","dosing":"1 drop 1 - 4 times a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"7.90","prescriberCat":"B"},{"id":"drug-969","genericName":"Atropine Sulphate 1% Eye Drops","brandName":"Isopto-Atropine","category":"11.0 EYE PREPARATIONS\\n11.6 MYDRIATICS","forms":["Drops"],"indications":"Determination of refraction, strabismus, iritis and iridocyclitis, after extra or intracapsular extraction of lens","dosing":"PREOPERATIVE MYDRIASIS : one drop of a 1% solution supplemented with one drop of 2.5 or 10% phenylephrine prior to surgery. \\nANTERIOR UVEITIS or POSTOPERATIVE MYDRIASIS : one drop of a 1% or 2% solution up to 3 times a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"10.12","prescriberCat":"B"},{"id":"drug-970","genericName":"Cyclopentolate 1% Eye Drops","brandName":"Cyclogyl","category":"11.0 EYE PREPARATIONS\\n11.6 MYDRIATICS","forms":["Drops"],"indications":"Mydriasis and cycloplegia","dosing":"ADULT : 1 drop of solution in eye(s); may repeat after 5-10 minutes if needed. CHILD : 1 drop of solution in eye(s); may repeat after 5-10 minutes if needed. Pre-treatment on the day prior to examination is usually not necessary. If desirable, 1 or 2 drops may be instilled the evening prior to examination.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"26.32","prescriberCat":"A"},{"id":"drug-971","genericName":"Cyclopentolate 0.2% with Phenylephrine 1% Eye Drops","brandName":"Cyclomydril","category":"11.0 EYE PREPARATIONS\\n11.6 MYDRIATICS","forms":["Drops"],"indications":"Dilating agent for premature babies","dosing":"1 drop every 5 - 10 minutes; not exceeding three times to produce rapid mydriasis. Observe infants closely for at least 30 minutes","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"13.20","prescriberCat":"A"},{"id":"drug-972","genericName":"Homatropine 2% Eye Drops","brandName":"Aurohom","category":"11.0 EYE PREPARATIONS\\n11.6 MYDRIATICS","forms":["Drops"],"indications":"i) Mydriasis and cycloplegia for refraction ii) Treatment of anterior segment inflammation","dosing":"i) Adult: Instill 1 or 2 drops of 2% solution immediately before the procedure, repeat at 5-10-minute intervals if necessary. Child: Instill 1 drop of 2% soln immediately before the procedure, repeat at 10-min intervals if necessary. \\nii) Adult: Instill 1-2 drops of 2% bd-tds up to every 3-4 hr as needed. Child: 3 mth- 2 yr: instill 1 drop of 0.5% soln once daily or on alternate days. >2 yr: instill 1 drop of 1% or 2% soln bd.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Oftalmologi)","price":"10.00","prescriberCat":"B"},{"id":"drug-973","genericName":"Phenylephrine HCI 2.5% Eye Drops","brandName":"Mydfrin","category":"11.0 EYE PREPARATIONS\\n11.6 MYDRIATICS","forms":["Drops"],"indications":"For pupillary dilation in uveitis, for refraction without cyclopegic. For fundoscopy and other diagnostic procedures","dosing":"Mydriasis and vasoconstriction: 1 drop of 2.5% or 10% solution, repeated in one hour if necessary. Chronic mydriasis: 1 drop of a 2.5% or 10% solution 2 - 3 times a day. Uveitis with posterior synechiae (treatment) or synechiae, posterior (prophylaxis): 1 drop of a 2.5% or 10% solution, repeated in one hour if necessary, not to exceed three times a day. Treatment may be continued the following day, if necessary","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"13.14","prescriberCat":"B"},{"id":"drug-974","genericName":"Tropicamide 1% Eye Drops","brandName":"Mydriacyl","category":"11.0 EYE PREPARATIONS\\n11.6 MYDRIATICS","forms":["Drops"],"indications":"Topical use to produce cycloplegic refraction for diagnostic purposes","dosing":"1 - 2 drops several times a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"27.27","prescriberCat":"A/KK"},{"id":"drug-977","genericName":"Acetazolamide 500 mg Injection","brandName":"Diamox","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Injection"],"indications":"Reduction of intra-ocular pressure in open-angle glaucoma, \\nsecondary glaucoma and peri-operatively in angle-closure glaucoma","dosing":"Adult : 250-1000mg per 24hours, usually in divided doses for amounts over 250mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"202.80","prescriberCat":"B"},{"id":"drug-978","genericName":"Acetazolamide 250 mg Tablet","brandName":"Apo - acetazolamide","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Tablet"],"indications":"Reduction of intraocular pressure in open-angle glaucoma, \\nsecondary glaucoma and peri-operatively in angle-closure glaucoma","dosing":"250mg 1-4 times a day, the dosage being titrated according to patient response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.45","prescriberCat":"B"},{"id":"drug-979","genericName":"Artificial tear/ ophthalmic GEL 0.2% 10g  (Polyacrylic acid/ carbomer)","brandName":"Siccapos","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["carbomer)"],"indications":"Symptomatic relief of severe dry eye \\nconditions and as lens lubricant during ophthalmic diagnostic procedures","dosing":"Instill 1-2 drops in affected eye(s) as needed. Refer to product information leaflet.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Same role as Genteal (Dept: Oftalmologi)","price":"12.58","prescriberCat":""},{"id":"drug-980","genericName":"Betaxolol 0.25% Eye Suspension","brandName":"Betoptic S","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Suspension"],"indications":"Ocular hypertension, Open-angle glaucoma","dosing":"Adult: As 0.25% drops: Instill 1 drop bid.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"25.00","prescriberCat":"A"},{"id":"drug-981","genericName":"Bimatoprost 0.03% Ophthalmic Solution","brandName":"Lumigan","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Solution"],"indications":"Bimatoprost 0.01% ophthalmic solution is indicated for the reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (as monotherapy or as adjunctive therapy to beta blockers). (for 2nd line)","dosing":"One drop in the affected eye(s) once daily, administered in the evening. The dose should not exceed once daily, as more frequent administration may lessen the intraocular pressure lowering effect.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":".39.25","prescriberCat":"A*"},{"id":"drug-982","genericName":"Brimonidine Tartrate 0.15% Ophthalmic","brandName":"Alphagan P","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Ophthalmic"],"indications":"Lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension","dosing":"1 drop in the affected eye(s) 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"41.90","prescriberCat":"A*"},{"id":"drug-983","genericName":"Brinzolamide 1% and Brimonidine tartrate 0.2% ophthalmic suspension","brandName":"Simbrinza","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["suspension"],"indications":"Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction","dosing":"1 drop in the affected eye(s) 2 times daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"44.32","prescriberCat":"A*"},{"id":"drug-984","genericName":"Carbachol 0.01% Intraocular Solution","brandName":"Miostat","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Solution"],"indications":"For intraocular use for miosis during surgery","dosing":"Instill no more than 0.5 ml gently into the anterior chamber","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"33.92","prescriberCat":"A"},{"id":"drug-985","genericName":"Ciclosporin 0.5%, 0.05% Eye Drops","brandName":"-","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Drops"],"indications":"To increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking anti inflammatory drugs or using punctal plugs.","dosing":"0.05%:1 drop twice a day in each eye approximately 12 hours apart.\\n0.5%: refer ophtalmologist .(1 drop OD to QID (severe) to affected eye(s) is the recommended dose using the 1% strength-MIMS Malaysia)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Not commercially available-Please refer CDR unit for aseptic preparation (Dept: Oftalmologi)","price":"(0.5%)32.5 (0.05%)10.0","prescriberCat":"A*"},{"id":"drug-986","genericName":"Dorzolamide HCl 2% Ophthalmic Solution","brandName":"Ocudor","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Solution"],"indications":"All glaucoma patients where beta-blockers are contraindicated and when intraocular pressure is not well controlled by other drugs","dosing":"Monotherapy : 1 drop 3 times daily. Adjunctive therapy with an ophthalmic beta-blocker : 1 drop 2 times daily. When substituting for another ophthalmic antiglaucoma agent with this product, discontinue the other agent after proper dosing on one day and start Trusopt on the next day. If more than 1 topical ophthalmic drug is used, the drugs should be administered at least 10 mins apart","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"10.70","prescriberCat":"A*"},{"id":"drug-987","genericName":"Fluorescein 1 mg Ophthalmic Strip","brandName":"Fluoro Touch","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Strip"],"indications":"Used in diagnostic examinations","dosing":"Moisten tip with tear fluid from lower fornix, sterile water or ophthalmic solution and gently stroke across the conjunctiva","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.29","prescriberCat":"B"},{"id":"drug-988","genericName":"Hypromellose 0.3% Eye Drops/ Artificial Tears/Opthalmic solution","brandName":"Eye Glo Moist","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["solution"],"indications":"Dry eye","dosing":"Adult: As 0.3-2.5% soln/gel: Instill 1-2 drops into affected eye(s) tid or as needed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.05","prescriberCat":"B"},{"id":"drug-989","genericName":"Hypromellose 0.3%, Carbomer 980 Ophthalmic Gel","brandName":"Genteal","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Gel"],"indications":"Symptomatic relief of severe dry eye conditions and as lens lubricant during ophthalmic diagnostic procedures","dosing":"Instill 1-2 drops in affected eye(s) as needed. Refer to product information leaflet.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"18.83","prescriberCat":"B"},{"id":"drug-990","genericName":"Latanoprost 0.005% Eye Drops","brandName":"Xalatan","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Drops"],"indications":"Reduction of elevated intraocular pressure in patients with open-angle glaucoma","dosing":"The recommended dosage is one drop (1.5 g) in the affected eye(s) once daily in the evening. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"4.14","prescriberCat":"A*"},{"id":"drug-991","genericName":"Latanoprost 0.005% +Timolol Maleate 0.5% Eye Drops","brandName":"Xalacom","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Drops"],"indications":"For reduction of Intraocular Pressure (IOP) in patients with Open-angle Glaucoma (OAG) and Ocular Hypertension (OH) who are insufficiently responsive to topical beta-blocker.","dosing":"1 drop in the affected eye(s) once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"26.28","prescriberCat":"A*"},{"id":"drug-992","genericName":"Nepafenec 0.1% Ophthalmic Solution","brandName":"Nevanac","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Solution"],"indications":"Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.","dosing":"One drop 3 times/day beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 60 days of the postoperative period as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"15.67","prescriberCat":"A*"},{"id":"drug-993","genericName":"Olopatadine HCl 0.2% Opthalmic Solution","brandName":"Pataday","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Solution"],"indications":"Temporary prevention of ocular itching due to allergic conjunctivitis","dosing":"One drop in each affected eye once a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"30.24","prescriberCat":"A*"},{"id":"drug-994","genericName":"Prednisolone Acetate 1% Ophthalmic Suspension","brandName":"Pred","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Suspension"],"indications":"For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.","dosing":"1 to 2 drops to be instilled into the conjunctival sac 2 to 4 times daily. During the initial 24 to 48 hours the dosage may be safely increased to 2 drops every hour. Care should be taken not to discontinue therapy prematurely.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"5.59","prescriberCat":"A"},{"id":"drug-995","genericName":"Proparacaine HCI 0.5% Ophthalmic Drops","brandName":"Alcaine","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Drops"],"indications":"Topical anaesthesia in ophthalmic procedures","dosing":"Deep anaesthesia:1 or 2 drops in the (eyes) every 5 to 10 minutes for 3 to 5 doses. For minor surgical procedures: instill 1 to 2 drops every 5 to 10 minutes for 1 to 3 doses. Tonometry and/or tonography procedure: 1 to 2 drops in each eye before procedure.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"11.15","prescriberCat":"B"},{"id":"drug-996","genericName":"Sodium Chloride 0.9% eye drop","brandName":"Normal Saline","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["drop"],"indications":"Irrigation of conjunctival sac","dosing":"1 - 2 drops every 3 - 4 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.87","prescriberCat":"C"},{"id":"drug-997","genericName":"Sodium Hyaluronate 0.1% eye drops (preservative- free)","brandName":"Hylo Comod","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["free)"],"indications":"For lubricating surface of eyes in moderate to severe dry eyes post op","dosing":"refer eye clinic: 1 drop TDS, QID, PRN","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"33.00","prescriberCat":"Bukan ubat (medical device)"},{"id":"drug-998","genericName":"Sodium Cromoglycate 2% Eye Drops","brandName":"Allergo-Comod","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Drops"],"indications":"Prevention and treatment of allergic conjunctivitis including seasonal and perennial allergic conjunctivitis and vernal keratoconjunctivitis","dosing":"1 or 2 drops 4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"14.04","prescriberCat":"A/KK"},{"id":"drug-999","genericName":"Timolol Maleate 0.5% Eye Drops (with preservative)","brandName":"Iotim","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["preservative)"],"indications":"Elevated intraocular pressure, chronic open angle glaucoma","dosing":"1 drop for once daily or 2 times daily depending on manufacturer's recommendation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"4.06","prescriberCat":"A"},{"id":"drug-1000","genericName":"Timolol Maleate 0.5% Eye Drops (without preservative)","brandName":"Timo-comod","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["preservative)"],"indications":"Elevated intraocular pressure, chronic open angle glaucoma","dosing":"1 drop for once daily or 2 times daily depending on manufacturer's recommendation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"20.97","prescriberCat":"A"},{"id":"drug-1001","genericName":"Timolol Maleate 0.5% Ophthalmic Gel Forming Solution","brandName":"TIMOLAST","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Solution"],"indications":"treatment of elevated intraocular pressure in patients withocularhypertension or open-angle glaucoma.","dosing":"1 drop daily in affected eye(s)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"12.97","prescriberCat":"A"},{"id":"drug-1002","genericName":"Travoprost 0.004% & Timolol 0.5% Eye Drops","brandName":"Duotrav","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["Drops"],"indications":"To decrease intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to other topical anti glaucomas","dosing":"1 drop in the affected eye(s) once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"51.26","prescriberCat":"A*"},{"id":"drug-1003","genericName":"White petroleum mineral oil eye ointment 3.5g tube","brandName":"Duratears","category":"11.0 EYE PREPARATIONS\\n11.7 OTHERS","forms":["tube"],"indications":"Ocular lubricant. Prevent corneal abrasions or ocular complications during general anesth.","dosing":"1-1.5 cm ribbon of oint under lower lid.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Oftalmologi)","price":"9.09","prescriberCat":""},{"id":"drug-1006","genericName":"Chloramphenicol 5% w/v Ear Drops","brandName":"Enclor","category":"12.0 EAR AND NOSE\\n12.1 EAR","forms":["Drops"],"indications":"Acute otitis media, otitis externa with perforation","dosing":"Apply 2 - 3 drops into the ear 2 - 3 times daily. Not to be used for long term","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.36","prescriberCat":"C"},{"id":"drug-1007","genericName":"Hydrogen Peroxide 1.5% Ear Drops","brandName":"-","category":"12.0 EAR AND NOSE\\n12.1 EAR","forms":["Drops"],"indications":"To soften impacted ear wax","dosing":"Instill 1 - 2 drops into the ear as required (leave for a few minutess)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"C"},{"id":"drug-1008","genericName":"Ear Wax Softener","brandName":"Generic","category":"12.0 EAR AND NOSE\\n12.1 EAR","forms":["Softener"],"indications":"Occlusion or partial occlusion of the external auditory meatus by soft wax or wax plug","dosing":"Instill 5 drops into the ears. Refer product information leaflet","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"9.85","prescriberCat":"B"},{"id":"drug-1009","genericName":"Ofloxacin 0.3% Otic Solution","brandName":"Effexin","category":"12.0 EAR AND NOSE\\n12.1 EAR","forms":["Solution"],"indications":"i. Acute otitis media with tympanostomy tubes \\nii. Chronic suppurative otitis media with perforated tympanic membranes and \\niii. Otitis externa","dosing":"CHILD: 1 - 12 years: 5 drops twice daily for 10 days. \\nADULT and CHILD over 12 years: 6 - 10 drops twice daily and remain in the ear about 10 minutes","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, ENT)","price":"13.57","prescriberCat":"A/KK"},{"id":"drug-1010","genericName":"Sodium Bicarbonate 5% w/v Ear Drops","brandName":"-","category":"12.0 EAR AND NOSE\\n12.1 EAR","forms":["Drops"],"indications":"To soften the impacted ear wax","dosing":"2-3 drops 3-4 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical (Dept: To remove from formulary after finish stock)","price":"-","prescriberCat":"C"},{"id":"drug-1013","genericName":"Alkaline Nasal Douche","brandName":"-","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["Douche"],"indications":"To remove nasal plug","dosing":"To be diluted with an equal volume of warm water before use","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1014","genericName":"Beclomethasone Dipropionate 50 mcg/dose Nasal Spray (200 doses)","brandName":"Aqua BECLOMET Nasal","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["doses)"],"indications":"the treatment of seasonal allergic rhinitis (hayfever) in patients 6 years of age and over.","dosing":"two sprays into each nostril twice a day. The maximum daily dose is a total of eight sprays.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.74","prescriberCat":"A/KK"},{"id":"drug-1015","genericName":"Calcitonin (Synthetic Salmon) 200 IU Nasal Spray","brandName":"Tendolon","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["Spray"],"indications":"treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause when alternative treatments are not suitable","dosing":"For intranasal use only: one spray (200 International Units) per day, alternating nostrils daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"143.20","prescriberCat":"A*"},{"id":"drug-1016","genericName":"Ephedrine 0.5% w/v Nasal Drops","brandName":"-","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["Drops"],"indications":"relieves nasal congestion in adults and children over 12 years old.","dosing":"Use one or two drops in each nostril as required not more than 4 times a day. Do not use for longer than 7 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"A/KK"},{"id":"drug-1017","genericName":"Fluticasone Furoate 27.5 mcg/dose Nasal Spray","brandName":"Avamys","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["Spray"],"indications":"Treatment of nasal symptoms (rhinorrhea, nasal congestion, nasal itching and sneezing) and ocular symptoms (itching/burning, tearing/watering, and redness of the eye) of seasonal and perennial allergic rhinitis.","dosing":"Adults/Adolescents (12 years) : 1-2 sprays (27.5 mcg/spray) in each nostril once daily. Children (2-11 years) : 1-2 sprays (27.5 mcg/spray) in each nostril once daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pediatrik)","price":"24.51","prescriberCat":"A*"},{"id":"drug-1018","genericName":"Menthol 1% Inhalation","brandName":"-","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["Inhalation"],"indications":"For relief of the symptoms of coughs, colds and blocked noses","dosing":"Inhaled via the mouth and nasal passages.\\n\\nAdults, children over 3 months of age and the elderly:\\n\\nAdd one 5ml spoonful to a pint of hot, but not boiling water.\\n\\nThe dose may be repeated after 4 hours if required.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1019","genericName":"Normal Saline Nasal Drops","brandName":"-","category":"12.0 EAR AND NOSE\\n12.2 NOSE","forms":["Drops"],"indications":"to treat dry or irritated nose passages. to thin fluid in the nose passages.","dosing":"1 to 2 drops in each nostril as required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"-"},{"id":"drug-1022","genericName":"Budesonide 64mcg Nasal Spray (120 doses)","brandName":"Budenase","category":"12.0 EAR AND NOSE\\n12.3 DECONGESTANTS","forms":["doses)"],"indications":"Seasonal allergic, perennial rhinitis and nasal polyposis","dosing":"ADULT and CHILD 6 years and older. \\nRhinitis : 2 spray into each nostril once daily in the morning or 1 spray into each nostril twice daily. \\nNasal polyps : 2 spray twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.50","prescriberCat":"A"},{"id":"drug-1023","genericName":"Mometasone Furoate 50 mcg Aqueous Nasal Spray (140 doses)","brandName":"Elonide","category":"12.0 EAR AND NOSE\\n12.3 DECONGESTANTS","forms":["doses)"],"indications":"Allergic rhinitis. For the treatment of nasal polyps in patients 18 years of age and older.","dosing":"ALLERGIC RHINITIS: ADULT and CHILD, 12 years and above: 100 mcg/day (2 sprays) to each nostril once daily. Maximum 200 mcg (4 sprays) once daily. Reduce to 50 mcg (1 spray) once daily when control achieved. CHILD 3 - 11 years old: 50 mcg (1 spray) to each nostril once daily. \\nTREATMENT OF NASAL POLYPS: Two sprays (50 micrograms/spray) in each nostril twice daily (total daily dose of 400 mcg). Once symptoms are adequately controlled, dose reduction to two sprays in each nostril once daily (total daily dose 200 mcg) is recommended.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: ENT)","price":"7.90","prescriberCat":"A*"},{"id":"drug-1024","genericName":"Oxymetazoline HCl 0.05% (Adult) Nasal Spray","brandName":"Oxynase","category":"12.0 EAR AND NOSE\\n12.3 DECONGESTANTS","forms":["Spray"],"indications":"Acute colds, paranasal sinusitis and otitis media","dosing":"2 - 3 sprays into each nostril twice daily, maximum 6 sprays per nostril/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: ENT)","price":"11.10","prescriberCat":"A"},{"id":"drug-1027","genericName":"Fusidic Acid 2% Cream","brandName":"Disuf","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Cream"],"indications":"Skin infections caused by staphylococci, streptococci, corynebacterium minutissumun and other sodium fusidate-sensitive organisms","dosing":"Apply to affected area 2 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.44","prescriberCat":"A"},{"id":"drug-1028","genericName":"Gentamicin 0.1% Cream","brandName":"Gentacin","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Cream"],"indications":"For localised infections","dosing":"Apply 2 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.10","prescriberCat":"A*"},{"id":"drug-1029","genericName":"Mupirocin 2% Cream","brandName":"Bactroban","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Cream"],"indications":"Skin infection by Staphylococcus aureus (including MRSA), Staphylococcus epidermidis and beta-haemolytic streptococcus","dosing":"Adults and child over 1 year, apply up to 3 times daily for up to 10 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"19.00","prescriberCat":"A"},{"id":"drug-1030","genericName":"Mupirocin 2% Ointment","brandName":"Bactopic","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Ointment"],"indications":"For MRSA infections only","dosing":"ADULT and CHILD: Apply up to three times daily for up to 10 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"8.40","prescriberCat":"A"},{"id":"drug-1031","genericName":"Neomycin 0.5% Cream","brandName":"Rexom","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Cream"],"indications":"Infections of the skin due to susceptible organisms","dosing":"Apply sparingly to affected area up to 3 times daily (For short term use, 1 - 2 weeks)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.36","prescriberCat":"B"},{"id":"drug-1032","genericName":"Silver Sulfadiazine 1% Cream","brandName":"Silfazine","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Cream"],"indications":"Prevention and treatment of infections in severe burns, leg ulcers where infections may prevent healing and for the prophylaxis of infections in skin grafting","dosing":"Burns: Apply 3 mm thick layer twice daily with sterile applicator. \\nLeg ulcer: apply at least 3 times a week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"64.95","prescriberCat":"B"},{"id":"drug-1033","genericName":"Sodium Fusidate 2% Ointment","brandName":"FOBAN","category":"13.0 DERMATOLOGICAL\\n13.1 ANTIINFECTIVES","forms":["Ointment"],"indications":"Skin infections caused by staphylococci, streptococci, corynebacterium minutissumun and other sodium fusidate-sensitive organisms","dosing":"Apply to affected area 2 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"7.18","prescriberCat":"A"},{"id":"drug-1036","genericName":"Fusidic Acid 2% in Betamethasone Valerate 0.1% Cream","brandName":"Disuf-B","category":"13.0 DERMATOLOGICAL\\n13.2 ANTIINFECTIVES WITH CORTICOSTEROIDS","forms":["Cream"],"indications":"Inflammatory dermatosis where bacterial infection is likely to occur eg atopic eczema, discoid eczema, stasis eczema, seborrhoic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus","dosing":"Uncovered lesion- Apply 2 to 3 times daily. Covered lesions- Less frequent applications may be adequate","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.95","prescriberCat":"A/KK"},{"id":"drug-1039","genericName":"Betamethasone 17-Valerate 0.1% Cream","brandName":"Betaval","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Cream"],"indications":"Potent topical corticosteroid indicated for adults, elderly and child over 1 year for relief of inflammatory and pruritic manifestation of steroid responsive dermatoses.","dosing":"Apply sparingly to affected area 2 times daily then reduced to once daily when improvement occurs","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.45","prescriberCat":"A/KK"},{"id":"drug-1040","genericName":"Betamethasone 17-Valerate\\n 0.1% Ointment","brandName":"Xorsoint","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Ointment"],"indications":"Potent topical corticosteroid indicated for adults, elderly and child over 1 year for relief of inflammatory and pruritic manifestation of steroid responsive dermatoses.","dosing":"Apply sparingly to affected area 2 times daily then reduced to once daily when improvement occurs","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.64","prescriberCat":"A/KK"},{"id":"drug-1041","genericName":"Betamethasone 17-Valerate 0.01% (i.e. 1: 10), 0.025% (i.e. 1: 4), 0.05% (i.e. 1: 2) Cream","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Cream"],"indications":"Eczemas, prurigo nodularis, limited psoriasis in appropriate in sites","dosing":"Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1042","genericName":"Betamethasone 17-Valerate 0.01% (i.e. 1: 10), 0.025% (i.e. 1: 4), 0.05% (i.e. 1: 2) Ointment","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Ointment"],"indications":"Eczema, prurigo nodularis, limited psoriasis in appropriate in sites","dosing":"Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1043","genericName":"Clobetasol Propionate 0.05% Cream","brandName":"Dermosol","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Cream"],"indications":"Short term treatment only of more resistant dermatoses eg. psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus and other conditions which do not respond satisfactorily to less potent steroids","dosing":"Apply sparingly once or twice daily, changing to lower potency therapy as soon as condition is controlled. For mild to moderate use maximum for 2 weeks. For moderate to severe maximum duration 4 consecutive weeks. Max: 50 g/week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.00","prescriberCat":"A"},{"id":"drug-1044","genericName":"Clobetasol Propionate 0.05% Ointment","brandName":"Cloderm","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Ointment"],"indications":"Short term treatment only of more resistant dermatoses eg. psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus and other conditions which do not respond satisfactorily to less potent steroids","dosing":"Apply sparingly once or twice daily, changing to lower potency therapy as soon as condition is controlled. For mild to moderate use maximum for 2 weeks. For moderate to severe maximum duration 4 consecutive weeks. Max:50 g/week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"2.64","prescriberCat":"A"},{"id":"drug-1045","genericName":"Clobetasone Butyrate 0.05% Cream","brandName":"U-Closone","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Cream"],"indications":"Eczema and dermatitis of all types","dosing":"Apply up to four times daily until condition improves, then reduce frequency","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"4.40","prescriberCat":"A/KK"},{"id":"drug-1046","genericName":"Clobetasone Butyrate 0.05% Ointment","brandName":"U-Closone","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Ointment"],"indications":"Eczema and dermatitis of all types","dosing":"Apply up to four times daily until condition improves, then reduce frequency","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.35","prescriberCat":"A"},{"id":"drug-1047","genericName":"Hydrocortisone 1% Cream","brandName":"Np Hydrocortisone","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Cream"],"indications":"Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses","dosing":"Apply sparingly to affected area 2 - 3 times daily until condition improve, then reduce frequency","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"46.40","prescriberCat":"B"},{"id":"drug-1048","genericName":"Hydrocortisone 1% Ointment","brandName":"H - cort","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Ointment"],"indications":"Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses","dosing":"Apply sparingly to affected area 2 - 3 times daily until condition improve, then reduce frequency","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.57","prescriberCat":"B"},{"id":"drug-1049","genericName":"Mometasone Furoate 0.1% Cream","brandName":"Elosone","category":"13.0 DERMATOLOGICAL\\n13.3 TOPICAL CORTICOSTEROIDS","forms":["Cream"],"indications":"For the relief of the inflammatory and pruritic manifestations of the corticosteroid responsive dermatoses","dosing":"Apply thin layer to the affected skin areas once daily until the lesion heals or for a duration of 3 weeks whichever is sooner.Massage gently and thoroughly until the medication disappears.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.04","prescriberCat":"A*"},{"id":"drug-1052","genericName":"Cetrimide 1% Lotion","brandName":"Xortim","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Lotion"],"indications":"As shampoo and cleansing agent","dosing":"Apply to affected area","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.75","prescriberCat":"C+"},{"id":"drug-1053","genericName":"Calamine with 2% Precipitated Sulphur Lotion","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Lotion"],"indications":"Acne vulgaris","dosing":"Apply to the skin as required and allow to dry, 1 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1054","genericName":"Salicylic acid, Sulphur and Liquid Coal Tar Ointment (Cocois Co. Ointment)","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Ointment)"],"indications":"Scalp psoriasis and severe seborrhoeic dermatitis","dosing":"Rub a small amount into the scalp gently","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1055","genericName":"Ketoconazole 2% Shampoo","brandName":"Ketazone","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Shampoo"],"indications":"Resistant dandruff only","dosing":"Apply twice weekly for 2 - 4 weeks. Prophylaxis: Once every 1 - 2 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"7.88","prescriberCat":"A/KK"},{"id":"drug-1056","genericName":"Coal Tar Solution 1% w/w, Salicylic Acid 2% w/w Shampoo","brandName":"Sebitar","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Shampoo"],"indications":"Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis","dosing":"Apply to the affected areas or as in product leaflet","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"29.92","prescriberCat":"A/KK"},{"id":"drug-1057","genericName":"Selenium Sulphide 2.5% Shampoo","brandName":"Selfide","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Shampoo"],"indications":"Dandruff, seborrheic dermatitis of scalp","dosing":"Dandruff: apply 5-10 mL topically twice weekly for 2 weeks, then 1-4 times per month, as needed, leave on for 2-3 min, then rinse thoroughly. Seborrheic dermatitis of scalp: apply 5-10 mL topically twice weekly for 2 weeks, then 1-4 times per month, as needed, leave on for 2-3 min, then rinse thoroughly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"19.50","prescriberCat":"A/KK"},{"id":"drug-1058","genericName":"Benzoyl Peroxide 5% Gel","brandName":"Benzac AC","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Gel"],"indications":"Mild to moderate acne vulgaris","dosing":"Apply 1-2 times daily preferably after washing with soap and water","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"7.60","prescriberCat":"B"},{"id":"drug-1059","genericName":"Sulphur 2% & Salicylic Acid 2% Cream","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Cream"],"indications":"Acne vulgaris and seborrhoeic dermatitis","dosing":"When used in scalp disorders, a small amount of cream should be rubbed gently into the roots of the hair. When used in skin disorders, the cream should be applied sparingly to the affected area. Apply once daily or until noticeable improvement, then once or twice a week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1060","genericName":"Tretinoin 0.05% Cream","brandName":"Retin-A","category":"13.0 DERMATOLOGICAL\\n13.4 ACNE AND DANDRUFF PREPARATIONS","forms":["Cream"],"indications":"Acne vulgaris and recalcitrant cases of acne (comedonal type)","dosing":"Apply thinly to the affected area once daily or twice daily. Avoid exposure to sunlight. Duration of treatment: 8 - 12 weeks is required before any noticeable response","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"5.30","prescriberCat":"A/KK"},{"id":"drug-1063","genericName":"Acriflavine 0.1% Lotion","brandName":"NW Acriflavine","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["Lotion"],"indications":"Infected skin, lesions, cuts, abrasions, wounds and burns.","dosing":"Apply undiluted three times daily to the affected part .","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.46","prescriberCat":"C+"},{"id":"drug-1064","genericName":"Alcohol 70% Solution","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["Solution"],"indications":"Use as antiseptic and disinfectant","dosing":"Apply to the skin undiluted or when needed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C+"},{"id":"drug-1065","genericName":"Chlorhexidine Gluconate 2% in Alcohol 70% solution","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["solution"],"indications":"Use as disinfectant in central venous catheter care bundle","dosing":"Skin Preparation:Use Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70% and allow to dry. Catheter acces:Apply to catheter ports or hubs prior to accessing the line for administering fluids or injections","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"C"},{"id":"drug-1066","genericName":"Chlorhexidine 2% in alcohol 70% solution (500ml)","brandName":"Steriprep","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["(500ml)"],"indications":"Use as disinfectant in central venous catheter care bundle","dosing":"Skin Preparation:Use Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70% and allow to dry. Catheter acces:Apply to catheter ports or hubs prior to accessing the line for administering fluids or injections","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.70","prescriberCat":"C"},{"id":"drug-1067","genericName":"Chlorhexidine Gluconate 0.2% w/v Hand Disinfectant 1L","brandName":"Alsoft","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["1L"],"indications":"Alcohol-based disinfectant for hand hygiene and surgical disinfection","dosing":"The solution is to be rubbed into the skin and keep the skin moistened for 30 secs (hand disinfectant) or 3 minutes (surgical hand disinfectant)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Unit Kawalan Infeksi)","price":"42.00","prescriberCat":""},{"id":"drug-1068","genericName":"Chlorhexidine Gluconate 0.2% Mouthwash","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["Mouthwash"],"indications":"As a gargle","dosing":"Rinse mouth with 10 ml for about 1 minute twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1069","genericName":"Chlorhexidine Gluconate 5% Solution (1L)","brandName":"Chlorhexida 5","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["(1L)"],"indications":"i) Preoperative skin disinfection \\nii) Wounds or burns \\niii) Emergency disinfection of instruments","dosing":"i) & iii) 1 : 10 in 70 % Alcohol \\nii) 1 : 100","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"46.40","prescriberCat":"C+"},{"id":"drug-1070","genericName":"Chlorinated Lime Solution 2.5% & Buffered Sodium Acetate Solution 0.68%","brandName":"Eusol I, Eusol II","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["0.68%"],"indications":"Wound or ulcer","dosing":"Apply to affected areas undiluted as a cleansing agent","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"21.20","prescriberCat":"C"},{"id":"drug-1071","genericName":"Hydrogen Peroxide 20 volume Solution","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["Solution"],"indications":"Skin disinfection, particularly cleansing and deodorising wounds and ulcers","dosing":"Hydrogen Peroxide 6% (=approx. 20 vol) shall be dispensed. \\nFor cleansing wounds: 1.5% to 6% solution apply 2-3 times daily or when nescessary. As a mouthwash: rinse the mouth for 2-3 minutes with 15ml of hydrogen peroxide 6% diluted in half a tumblerful of warm water 2-3 times daily. \\nDisinfecting cleaned equipment: immersion for 30 minutes in 6% solution. As ear drop for removal of wax: hydrogen peroxide 6% diluted with 3 parts of water preferably just before use","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1072","genericName":"Peracetic Acid < 7% and Hydrogen Peroxide < 5% (5L)","brandName":"Endopa","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["(5L)"],"indications":"High level disinfectant or sterilant for heat labile endoscopes","dosing":"Immersion time based on manufacturer recommendation","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"150.00","prescriberCat":"A"},{"id":"drug-1073","genericName":"Povidone Iodine 10% (equivalent to 1% iodine) Solution (1L/ 500ml)","brandName":"U-Iodine\\n\\nSeptidine\\n\\nBetadine (500ml)","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["500ml)"],"indications":"Skin operation prior to surgery, in cleansing open wounds, as an antiseptic for operative wounds infections","dosing":"To be applied undiluted in pre-operative skin disinfection and general antisepsis.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"28.84  18.80  10.00","prescriberCat":"B"},{"id":"drug-1074","genericName":"Povidone-Iodine 5% w/w antiseptic cream (Betadine) 15gm","brandName":"Betadine","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["15gm"],"indications":"Bacterial and mycotic (fungal) skin infections;Bed sore and leg ulcer; Minor burns, cuts and abrasions;Herpes genitalis.","dosing":"To be applied topically once or twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (KPK) required\\n-TIDAK LULUS- (Dept: wound care)","price":"7.85","prescriberCat":"Not in FUKKM"},{"id":"drug-1075","genericName":"Povidone-Iodine 2.5% w/v spray (Betadine) 55gm","brandName":"Betadine","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["55gm"],"indications":"Treatment and prevention of skin infections in wounds including ulcers, burns, cuts, abrasions and other minor injuries.","dosing":"To be sprayed several times a day (every 3 to 4 hours)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) (secara pukal) required (Dept: wound care)","price":"16.83","prescriberCat":"Not in FUKKM"},{"id":"drug-1076","genericName":"Sodium Dichloroisocyanurate 2.5 g Tablet (100 tabs)","brandName":"DKLOR-TAB","category":"13.0 DERMATOLOGICAL\\n13.5 ANTISEPTICS AND DISINFECTANTS","forms":["tabs)"],"indications":"Low and medium level disinfectant","dosing":"50 - 10,000 ppm av chlorine","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"33.00","prescriberCat":"C"},{"id":"drug-1084","genericName":"Acyclovir 5% Cream 10g","brandName":"Vicide","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["10g"],"indications":"Herpes simplex infections of the skin, including initial and recurrent labial and genital herpes simplex infections","dosing":"Apply every 4 hours for 5 - 10 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.25","prescriberCat":"A*"},{"id":"drug-1085","genericName":"Benzoic Acid 6% + Salicylic Acid 3% Ointment","brandName":"Whitefield's Ointment","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["Ointment"],"indications":"Topical Antifungal & AntiParasite","dosing":"Apply to affected areas two times a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"28.98","prescriberCat":"C"},{"id":"drug-1086","genericName":"Clotrimazole 1% Solution","brandName":"Candid","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["Solution"],"indications":"Cutaneous candidiasis, tinea orporis, tinea cruris, tinea pedis and tinea versicolor","dosing":"Apply gently onto affected and surrounding skin area 2 or 3 times daily continuing for 2-4 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"6.58","prescriberCat":"A"},{"id":"drug-1087","genericName":"Miconazole 2% Cream 15g","brandName":"Mico","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["15g"],"indications":"i) Fungal infections: Tinea pedis, Tinea corporis, Tinea capitis and other dermatophyte infections caused by Trichophyton and Epidermophyton species; \\nii) Antifungal agent that has been in various candida infections including vaginal candidiasis. \\nPrescribing restriction(s): To be used as 2nd line treatment at health facilities without medical officer.","dosing":"Apply sparingly and rub gently onto affected area 1-2 times daily continuing for 14 days after lesions have healed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.12","prescriberCat":"B"},{"id":"drug-1088","genericName":"Nystatin 100,000 units/g Cream","brandName":"Tystatin","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["Cream"],"indications":"Prevention and treatment of cutaneous infections caused by Candida albicans","dosing":"Apply liberally to affected area twice daily or as required. After lesion has disappeared continue treatment for 10 days to prevent relapses. Nail infection: Cut nails as short as possible. Apply cream once daily until growth of new nail has set in","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.42","prescriberCat":"C"},{"id":"drug-1089","genericName":"Salicylic Acid 2 % Lotion \\n(Tinea Lotion)","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["Lotion)"],"indications":"Seborrhoeic dermatitis, scalp, \\npsoriasis and hyperkeratotic skin conditions","dosing":"Apply sparingly to the affected area 2-3 times daily. \\nWash with cleanser 2 - 3 times per day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1090","genericName":"Sodium Thiosulphate 20% Solution","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.7 FUNGISIDE & ANTIVIRAL","forms":["Solution"],"indications":"Fungicides. For the treatment of pityriasis versicolor","dosing":"Apply to all affected parts of the body and face with a brush after a bath once daily or twice daily or 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"C"},{"id":"drug-1093","genericName":"Coal Tar 1%, 2%, 3%, 6%, 9% Ointment (Liquor Picis Carbonis in Ung. Emulsificant)","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.8 KERATOLYTICS","forms":["Emulsificant)"],"indications":"Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis. Used as a mild astringent for the skin, as a soothing and protective application in eczema and as a protective to slight excoriation","dosing":"Apply sparingly to the affected area 1-3 times daily starting with low strength preparations","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1094","genericName":"Coal Tar (LPC) 1% + 2% Salicylic Acid, Coal Tar (LPC) 3% + 2% Salicylic Acid, Coal Tar (LPC) 6% + 3% Salicylic Acid Ointment","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.8 KERATOLYTICS","forms":["Ointment"],"indications":"Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis","dosing":"Apply to the affected areas","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1095","genericName":"Salicylic Acid 2%, 4%, 10% Cream","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.8 KERATOLYTICS","forms":["Cream"],"indications":"Seborrhoeic dermatitis, scalp psoriasis and hyperkeratotic skin conditions","dosing":"Apply sparingly to the affected area 2-3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1096","genericName":"Salicylic Acid 2%, 4%, 10% Ointment","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.8 KERATOLYTICS","forms":["Ointment"],"indications":"Seborrhoeic dermatitis, scalp, psoriasis and hyperkeratotic skin disorders","dosing":"Apply sparingly to the affected area 2-3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1097","genericName":"Salicylic Acid 20% Ointment","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.8 KERATOLYTICS","forms":["Ointment"],"indications":"Plantar warts","dosing":"Apply daily and protect surrounding skin (eg with soft paraffin or specially designed plaster) ,may need to continue up to 3 months","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1098","genericName":"Salicylic Acid 2% in Hydrocortisone 1% Ointment, Cream","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.8 KERATOLYTICS","forms":["Cream"],"indications":"Seborrhoeic capitis","dosing":"Apply sparingly to affected areas 1-2 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"B"},{"id":"drug-1101","genericName":"Aqueous Cream 500g","brandName":"Xorquas","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["500g"],"indications":"Dry skin","dosing":"As a soap or apply to the skin as an emollient cream","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.37","prescriberCat":"C+"},{"id":"drug-1102","genericName":"Calamine Cream 30g","brandName":"Idaman Calamine Cream","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["30g"],"indications":"Soothes and relieves nappy rashes, prickly heat, minor skin irritations, insect bites and sunburn, Pruritic skin conditions.","dosing":"Apply to the affected area as required, 1-3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.80","prescriberCat":"C+"},{"id":"drug-1103","genericName":"Carbamide (Urea) 10 % Cream 20g","brandName":"UO","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["20g"],"indications":"Contact irritant dermatitis, infantile eczemas, acute and chronic allergic eczemas, icthyosis, hyperkeratotic","dosing":"Apply sparingly and rub into affected area 2 - 3 times daily and when required after cleansing skin","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"4.43","prescriberCat":"B"},{"id":"drug-1104","genericName":"Calamine 8%, Zinc Oxide 8% with Menthol 0.035% Lotion 120ml","brandName":"Idaman\\nCalamine Lotion","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["120ml"],"indications":"Soothes and relieves nappy rashes, prickly heat, minor skin irritations, insect bites and sunburn, Pruritic skin conditions.","dosing":"Apply to the skin as required and allow to dry, 1 - 3 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.38","prescriberCat":"C+"},{"id":"drug-1105","genericName":"Emulsificants Ointment 450g","brandName":"Hovid Emulsificant Ointment","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["450g"],"indications":"Xerosis and ichthyosis","dosing":"Use as a soap and emollient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"30.00","prescriberCat":"C"},{"id":"drug-1106","genericName":"Paraffin, Yellow Soft (Vaseline)","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["(Vaseline)"],"indications":"Xerosis and ichthyosis","dosing":"Apply to the affected area","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"17.20","prescriberCat":"C"},{"id":"drug-1107","genericName":"Sunscreen SPF 50+ Lotion 100ml","brandName":"SUNSENSE","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["100ml"],"indications":"To prevent sunburn","dosing":"Apply as required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Skin \\nClinic (Dept: Perubatan)","price":"40.34","prescriberCat":"A"},{"id":"drug-1108","genericName":"Zinc Oxide 555.7mg plus calamine 164.5mg in 3.5g sachet","brandName":"Calmoseptine Ointment","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["sachet"],"indications":"As a skin barrier to prevent wound maceration during dressing","dosing":"apply 2-4 times daily or as required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Buy when needed (Dept: Wound Care)","price":"3.00","prescriberCat":"C"},{"id":"drug-1109","genericName":"Zinc Oxide Cream 500gm","brandName":"Zorbyx","category":"13.0 DERMATOLOGICAL\\n13.9 PIGMENTS AND SKIN PROTECTIVES","forms":["500gm"],"indications":"Skin protective in various skin conditions such as nappy rash, eczema and problem skin","dosing":"Apply 3 times daily or as required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"87.00","prescriberCat":"C+"},{"id":"drug-1112","genericName":"Benzyl Benzoate 12.5% Emulsion","brandName":"Scabitone","category":"13.0 DERMATOLOGICAL\\n13.10 SCABICIDES AND PEDICULOCIDES","forms":["Emulsion"],"indications":"Scabies - for child 2-12 years old","dosing":"After bath, apply over the whole body, neck down and leave on for 24 hours then wash off. Reapply for another 24 hours, the first repeat application should be within 5 days of the initial application, a third application may be required in some cases","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Prepared by diluting Benzyl Benzoate 25% emulsion","price":"3.31","prescriberCat":"C+"},{"id":"drug-1113","genericName":"Benzyl Benzoate 25% Emulsion 120ml","brandName":"Scabitone","category":"13.0 DERMATOLOGICAL\\n13.10 SCABICIDES AND PEDICULOCIDES","forms":["120ml"],"indications":"Scabies for adult and children more than 12 years old.","dosing":"After bath, apply over the whole body, neck down and leave on for 24 hours then wash off. Reapply for another 24 hours, the first repeat application should be within 5 days of the initial application, a third application may be required in some cases.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3.31","prescriberCat":"C+"},{"id":"drug-1114","genericName":"Crotamiton 10 % Cream 15g","brandName":"A-bite","category":"13.0 DERMATOLOGICAL\\n13.10 SCABICIDES AND PEDICULOCIDES","forms":["15g"],"indications":"i) Pruritus\\nii) Scabies \\niii) Insect bite reactions","dosing":"i) and iii) Massage into affected area until the medication is completely absorbed. Repeat as needed. Apply 2 or 3 times daily \\nii) Apply to the whole body from below the chin. 2nd application is applied 24 hr later. May need to use once daily for up to 5 days.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.79","prescriberCat":"B"},{"id":"drug-1115","genericName":"Gamma Benzene Hexachloride 1 % Lotion","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.10 SCABICIDES AND PEDICULOCIDES","forms":["Lotion"],"indications":"For treatment of head lice","dosing":"Leave lotion on hair for exactly 4 minutes. Then wash off of the hair and skin with warm water.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical (Dept: To remove from formulary after finish stock)","price":"-","prescriberCat":"B"},{"id":"drug-1116","genericName":"Permetrin 1% w/v lotion","brandName":"Generic","category":"13.0 DERMATOLOGICAL\\n13.10 SCABICIDES AND PEDICULOCIDES","forms":["lotion"],"indications":"For topical treatment of head lice","dosing":"Apply lotion onto clean towel dried hair ensuring every strand comes in contact with lotion for at least 10 minutes. Rinse completely. Re-apply after 10 days to ensure total recovery","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.21","prescriberCat":"B"},{"id":"drug-1117","genericName":"Permethrin 5% w/v Lotion","brandName":"A-scabs","category":"13.0 DERMATOLOGICAL\\n13.10 SCABICIDES AND PEDICULOCIDES","forms":["Lotion"],"indications":"Treatment of scabies","dosing":"Two applications needed one week apart. Apply thoroughly to all body parts from neck down. Leave overnight for 8 - 14 hours. Washed off. Reapply after one week. Not recommended for children less than 2 months of age.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"9.46","prescriberCat":"A/KK"},{"id":"drug-1120","genericName":"Acitretin 10 mg, 25 mg Capsule","brandName":"Novatretin","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Capsule"],"indications":"i) Severe form of psoriasis including erythrodermic psoriasis and local or generalized pustular psoriasis. \\nii) Severe disorders of keratinization, such as:\\n-congenital ichthyosis -pityriasis rubra pilaris \\n-Darier's disease \\n-other disorders of keratinization which may be resistant to other therapies","dosing":"ADULT: initially 25-30 mg daily for 2-4 weeks, then adjusted according to response, usually within range 25-50 mg daily for further 6-8 weeks (max: 75 mg daily). In disorders of keratinization, maintenance therapy of less than 20mg/day and should not exceed 50mg/day \\nCHILD: 0.5mg/kg daily occasionally up to 1 mg/kg daily to a max. 35 mg daily for limited periods","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.10, 5.57","prescriberCat":"A*"},{"id":"drug-1121","genericName":"Calcipotriol Hydrate 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Ointment (30g)","brandName":"Daivobet","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["(30g)"],"indications":"Resistant plaque psoriasis","dosing":"Apply once daily up to 4 weeks with maximum weekly dose of 100g and maximum treatment area 30% of body surface","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"137.00","prescriberCat":"A*"},{"id":"drug-1122","genericName":"Calcipotriol Hydrate 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Gel (30g)","brandName":"Xamiol","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["(30g)"],"indications":"Topical treatment of scalp and non-scalp plaque psoriasis vulgaris in adults","dosing":"Should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for non-scalp areas. The body surface area treated with calcipotriol containing products should not exceed 30% and maximum dose should not exceed 15g or 100g/ week","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"135.35","prescriberCat":"A*"},{"id":"drug-1123","genericName":"Coal Tar 20% Solution","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Solution"],"indications":"Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis","dosing":"Use 100 ml in a bath","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"1.37","prescriberCat":"B"},{"id":"drug-1124","genericName":"Copper Sulphate Crystal 1kg","brandName":"Cu sulphate crystal","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["1kg"],"indications":"Wounds","dosing":"The tip of the crystal should be moistened by dipping in water and applied carefully to the lesion","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"56.65","prescriberCat":"C"},{"id":"drug-1125","genericName":"Dithranol 0.5%, 1%, 2% Ointment","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Ointment"],"indications":"Short contact treatment for plaque psoriasis and alopecia areata","dosing":"For application to skin or scalp. 0.1-0.5% suitable for overnight treatment. 1-2% for max 1 hour.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"A"},{"id":"drug-1126","genericName":"Dupilumab 300mg Solution for Injection in Pre-filled Syringe","brandName":"Dupixent","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Syringe"],"indications":"(i) Indicated for the treatment of adult patients with severe atopic dermatitis (AD) whose disease is not adequately controlled with systemic immunosuppressants and / or phototherapy or when those therapies are not advisable. Dupilumab can be used with or without topical corticosteroids.\\nRestriction: \\nAs fourth line of treatment in patients who have failed / have contraindications / experienced adverse events to:\\n- Intensive and optimized topical treatment\\n- Phototherapy\\n- At least two immunosuppressants\\n(To be prescribed by Dermatologists only)","dosing":"Indication (i):\\nThe recommended dose is an initial dose of 600 mg (two 300 mg injections), followed by 300 mg given every other week.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"2404.00","prescriberCat":"A*"},{"id":"drug-1128","genericName":"Isotretinoin 10 mg, 20 mg Capsule","brandName":"Acnotin 10\\n\\nAcnotin 20","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Capsule"],"indications":"Only for treatment of \\ni) Severe nodulo-cystic acne \\nii) Acne conglobata \\niii) Acne fulminans \\niv) Severe acne vulgaris failing conventional treatment.","dosing":"0.5-1 mg/kg of body weight per day (in two divided doses) for 15 to 20 weeks; the maximum recommended dose is 2mg/kg of body weight per day. After about 4 weeks, therefore, dosage for the maintenance treatment should be adjusted within the range 0f 0.1-1mg/kg daily to meet individual need. Treatment usually lasts a total of 16 weeks. There should be an interval of at least 8 weeks before re-starting treatment.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"1.40  2.20","prescriberCat":"A*"},{"id":"drug-1129","genericName":"Magnesium Sulphate Paste","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Paste"],"indications":"Inflammatory skin conditions such as boils and carbuncles","dosing":"Apply under dressing","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C"},{"id":"drug-1130","genericName":"Methoxsalen 1% Lotion","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["Lotion"],"indications":"Repigmenting agent in vitiligo in conjuction with controlled doses of UVA or sunlight","dosing":"Apply 0.1% lotion to area to be exposed to the UVA light ( need to dilute the 1% lotion to 0.1% lotion, otherwise the skin will burn)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"import permit required for purchase (KPK)","price":"115.80","prescriberCat":"A"},{"id":"drug-1131","genericName":"Potassium Permanganate Solution 1: 1,000 (0.1%)","brandName":"-","category":"13.0 DERMATOLOGICAL\\n13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)","forms":["(0.1%)"],"indications":"Cleansing and deodorising suppurative eczematous reactions and wounds","dosing":"As soaks or wet dressing 1 - 3 times daily or as required\\nFor soaks/ wet dressing (cuci): 10ml dilute to 100ml water\\nFor baths (mandi): 10ml dilute to 5L water","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"C+"},{"id":"drug-1134","genericName":"Cyanocobalamin 1 mg/ ml Injection","brandName":"Cyanocobalamine","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Injection"],"indications":"i) Prophylaxis of anaemia associated with Vitamin B12 deficiency \\nii) Uncomplicated pernicious anaemia or Vitamin B12 malabsorption","dosing":"i) Prophylaxis of anaemia: 250-1000 mcg IM every month \\nii) Uncomplicated pernicious anaemia or Vitamin B12 malabsorption: Initial 100 mcg daily for 5-10 days followed by 100-200 mcg monthly until complete remission is achieved. Maintenance: up to 1000 mcg monthly. \\nCHILD: 30-50 mcg daily for 2 or more weeks (to a total dose of 1-5mg). OR AS PRESCRIBED.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.81","prescriberCat":"B"},{"id":"drug-1135","genericName":"Cyanocobalamin 50 mcg Tablet","brandName":"Sunward","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Tablet"],"indications":"Vitamin B12 deficiency of dietary origin","dosing":"ADULT: 50-150 mcg daily. CHILD: 50-105 mcg daily in 1-3 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06","prescriberCat":"B"},{"id":"drug-1136","genericName":"Darbepoetin alfa 0.2mcg/0.5ml injection","brandName":"NESP","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["injection"],"indications":"i. Treatment of anaemia associated with chronic renal failure, including patients on dialysis and patients not on dialysis. ii. Anemia with myelodysplastic syndrome\\n\\nrestriction For indication (i): Patients who require higher doses of erythropoietin if it is more cost saving to use a long-acting agent instead of short-acting agents","dosing":"Indication (i): Haemodialysis patients: Initial dose: 20mcg IV once weekly Initial dose for switched ESA-treated patient: 15  60mcg IV once weekly Maintenance dose: 15  60mcg IV once weekly, then 30  120mcg IV biweekly. Peritoneal dialysis patients and patients with chronic kidney disease not on dialysis: Initial dose: 30mcg IV or SC biweekly Initial dose for switched ESA-treated patient: 30  120mcg IV or SC biweekly Maintenance dose: 30  120mcg IV or SC biweekly, then 60  180mcg IV or SC once every four weeks. Indication (ii): Adults: 240mcg administered as a single subcutaneous injection once weekly. The dose should be decreased in view of the degree of anemic symptoms and the patients age.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"47.58","prescriberCat":"A*"},{"id":"drug-1137","genericName":"Erythropoietin Human Recombinant 2000 IU/0.5ml Injection (Epoetin Alfa)","brandName":"Erysaa (contract KKM)","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Alfa)"],"indications":"i) Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases \\nii) Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy","dosing":"i) ADULT by IV injection over 1-5 minutes, initially 50 units/kg 3 times weekly adjusted according to response in step of 25 units/kg 3 times weekly at interval of at least 4 weeks. CHILD initially as for adult. Maintenance: bodyweight under 10 kg usually 75-150 units/kg 3 times weekly, bodyweight 10-30 kg usually 60-150 units/kg 3 times weekly, bodyweight over 30 kg usually 30-100 units/kg 3 times weekly \\n\\nii) ADULT by SC injection (max. 1 ml per injection site), initially 150 units/kg 3 times weekly, increased if appropriate rise in haemoglobin not achieved after 4 weeks to 300 units/kg 3 times weekly. Discontinue if inadequate response after 4 weeks at higher dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota jika pesakit dialisis dari luar HSM / indikasi hematologi\\n\\nErysaa NOT APPROVE for S/C route (Dept: Perubatan)","price":"14.80","prescriberCat":"A*"},{"id":"drug-1138","genericName":"Erythropoietin Human Recombinant 4000 IU/0.4ml Injection (Epoetin Alfa)","brandName":"Binocrit","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Alfa)"],"indications":"i) Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases \\nii) Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy","dosing":"i) ADULT by IV injection over 1-5 minutes, initially 50 units/kg 3 times weekly adjusted according to response in step of 25 units/kg 3 times weekly at interval of at least 4 weeks. CHILD initially as for adult. Maintenance: bodyweight under 10 kg usually 75-150 units/kg 3 times weekly, bodyweight 10-30 kg usually 60-150 units/kg 3 times weekly, bodyweight over 30 kg usually 30-100 units/kg 3 times weekly \\n\\nii) ADULT by SC injection (max. 1 ml per injection site), initially 150 units/kg 3 times weekly, increased if appropriate rise in haemoglobin not achieved after 4 weeks to 300 units/kg 3 times weekly. Discontinue if inadequate response after 4 weeks at higher dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota\\n\\nBinocrit APPROVE for S/C route (Dept: Perubatan)","price":"52.26","prescriberCat":"A*"},{"id":"drug-1139","genericName":"Erythropoietin Human Recombinant 2000 IU/0.3ml, 4000 IU/0.3ml Injection (Epoetin Beta)","brandName":"Recormon 2000\\nRecormon 4000","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Beta)"],"indications":"i) Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases \\nii) Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy","dosing":"i) ADULT by IV injection over 1-5 minutes, initially 50 units/kg 3 times weekly adjusted according to response in step of 25 units/kg 3 times weekly at interval of at least 4 weeks. CHILD initially as for adult. Maintenance, bodyweight under 10 kg usually 75-150 units/kg 3 times weekly, bodyweight 10-30 kg usually 60-150 units/kg 3 times weekly, bodyweight over 30 kg usually 30-100 units/kg 3 times weekly \\nii) ADULT by SC injection (max. 1 ml per injection site), initially 150 units/kg 3 times weekly, increased if appropriate rise in haemoglobin not achieved after 4 weeks to 300 units/kg 3 times weekly. Discontinue if inadequate response after 4 weeks at higher dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"2000 iu: Open Quota for Nephrologist & Haematologist\\n\\n4000iu: Kuota (Dept: Perubatan)","price":"16.25   32.96","prescriberCat":"A"},{"id":"drug-1140","genericName":"Ferric derisomaltose [formerly known as Fe (III) isomaltoside 1000] 100mg/ml (10ml)","brandName":"Monofer","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["(10ml)"],"indications":"Indicated for the treatment of iron deficiency in the following conditions:\\n- when oral iron preparations are ineffective or cannot be used\\n- where there is a clinical need to deliver iron rapidly\\n\\nThe diagnosis must be based on laboratory tests.\\n\\nRestriction: For cases where less number of administration and fewer medical visits or quick achievement of Hb target are imperative / crucial","dosing":"Intravenous bolus injection:\\nUp to 500 mg up to three times a week at an administration rate of up to 250 mg iron/minute.\\n\\nIntravenous drip infusion:\\nUp to 20 mg iron/kg body weight or as weekly infusions until the cumulative iron dose has been administered.\\nIf the cumulative iron dose exceeds 20 mg iron/kg body weight, the dose must be split in two administrations with an interval of at least one week.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Unit Transfusi Darah, Perubatan)","price":"531.00","prescriberCat":"A*"},{"id":"drug-1141","genericName":"Ferrous Fumarate 200 mg Tablet","brandName":"Idaman Iron Tablets","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Tablet"],"indications":"Prevention and treatment of iron-deficiency anaemias","dosing":"Adult: Usual dose range: Up to 600 mg daily. May increase up to 1.2 g daily if necessary. \\nChild: As syrup containing 140 mg(45 mg iron)/5ml. \\nPreterm neonate: 0.6-2.4 ml/kg daily; up to 6 years old: 2.5-5ml twice daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.21","prescriberCat":"C+"},{"id":"drug-1142","genericName":"Ferrous Controlled Release 500 mg, Vitamin B1, B2, B6, B12, Vitamin C 500mg, Niacinamide, Calcium Panthothenate and Folic Acid 800 mcg Tablet","brandName":"Iberet Folic","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Tablet"],"indications":"Anemia due to iron deficiency, megaloblastic anemia where there is an associated deficiency of Vitamin C and Vitamin B-complex particularly in pregnancy. In primary health clinic, the indication is restricted to anemia due to iron deficiency in pregnant women ONLY.","dosing":"One tablet daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Obstetrik)","price":"0.60","prescriberCat":"A/KK"},{"id":"drug-1143","genericName":"Folic Acid 5 mg Tablet","brandName":"Royce Folic Acid","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Tablet"],"indications":"i) For the prevention and treatment of folate deficiency states \\nii) For the prevention of neural tube defect in the foetus","dosing":"i) ADULT initially 10-20mg mg daily for 14 days or until haematopoietic response obtained. Daily maintenance: 2.5 mg-10mg .\\nCHILD up to 1 year:250 mcg/kg daily; 1 to 5 years:2.5mg/day;6-12 years: 5mg/day \\nii) 5 mg daily starting before pregnancy and continued through the first trimester","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.02","prescriberCat":"C+"},{"id":"drug-1144","genericName":"Iron (III) Polymaltose Complex 10mg iron/ml syrup","brandName":"Maltofer","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["syrup"],"indications":"Treatment of latent iron deficiency and iron deficiency anaemia (manifest iron deficiency).\\n\\nRestriction:\\nIn primary care setting, for pediatrics use only","dosing":"Infants (up to 1 year): 2.5-5ml daily (25-50mg iron)\\nChildren (1-12 years old): 5-10ml daily (50-100mg iron)\\nChildren (>12 years), adults: 10-30 ml daily (100-300mg iron)\\nPregnant woman 20-30ml daily (200-300mg iron)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"18.35","prescriberCat":"A/KK"},{"id":"drug-1145","genericName":"Iron Sucrose 100 mg/5 ml Injection","brandName":"Ranofer","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Injection"],"indications":"Treatment of iron deficiency anaemia: \\na) where there is a clinical need for rapid iron supply \\nb) in patients who cannot tolerate oral iron therapy or who are non-compliant \\nc) in active inflammatory bowel disease where oral iron preparations are ineffective","dosing":"Individualised dosage. ADULT and ELDERLY: Cumulative dose is to be administered in single doses of 100 - 200 mg of iron 2 - 3 times weekly depending on Hb level. By IV drip infusion, slow IV injection or directly into the venous limb of the dialyser. Total cumulative dose: 1000 mg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"10.00","prescriberCat":"A/KK"},{"id":"drug-1146","genericName":"Methoxy Polyethylene Glycol-epoetin Beta 100 mcg/0.3 ml, 120 mcg/0.3ml, 150mcg/0.3ml Injection in Prefilled Syringe","brandName":"Mircera 100\\nMircera 120\\nMircera 150","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.1 ANTIANAEMIC DRUGS","forms":["Syringe"],"indications":"Treatment of anaemia associated with chronic renal failure. Prescribing restriction: Patients who require higher doses of erythropoietin if it is more cost saving to use a long-acting agent instead of short-acting agents.","dosing":"Non Erythropoiesis Stimulating Agent (ESA)-treated patients : 0.6 mcg/kg, once every two weeks (IV or SC). When the Hb is >11g/dl, administration can be reduced to once monthly using the dose equal to twice the previous two weekly dose. ESA-treated patients : 120-360 mcg once monthly or 60-180 mcg every two weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"191.10 229.32 286.65","prescriberCat":"A*"},{"id":"drug-1149","genericName":"Essential Phospholipids,\\nNicotinamide,\\nCyanocobalamine, Tocopheryl,\\nPyridoxine, Thiamine,\\nRiboflavine Capsule","brandName":"Livovid","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.2 CHOLAGOGUES, CHOLELITHOLYTICS AND HEPATIC PROTECTORS","forms":["Capsule"],"indications":"Nutritional support in the management of damaged liver (due to chronic liver disease, liver cirrhosis, fatty liver & intoxication by hepatotoxic substances).","dosing":"1-2 capsules 3 times a day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"0.25","prescriberCat":"A/KK"},{"id":"drug-1152","genericName":"Ursodeoxycholic Acid 250 mg Capsule","brandName":"Ursofalk","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.3 DIGESTIVE ENZYMES","forms":["Capsule"],"indications":"Cholestatic liver diseases (eg. primary biliary cholangitis, primary cholangitis\\netc.)","dosing":"10-15 mg/kg daily in 2 to 3 divided doses\\nDosing is individualised based on body weight and according to product\\ninsert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan, Pediatrik)","price":"2.63","prescriberCat":"A"},{"id":"drug-1155","genericName":"Amino Acids 6.53%  Injection 500ml","brandName":"Vaminolact","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["500ml"],"indications":"Source of amino acids in patients needing IV nutrition","dosing":"Dose to be individualised. ADULT usually 500-2000 ml by IV. ADULT usual requirement for amino acid: 1-2 g/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"197.14","prescriberCat":"A"},{"id":"drug-1156","genericName":"Amino Acids N(2)-L-alanyl-L-glutamine 20% Injection 100ml","brandName":"Dipeptivan","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["100ml"],"indications":"indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen in patients with severe catabolic illness-burns, sepsis, trauma, BMT, radiation & chemotherapy, other critical illness.","dosing":"1.5-2 ml/kg body-wt/day equivalent to 0.3-0.4g L-alanyl L-glutamine/kg body-wt.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"166.60","prescriberCat":"A"},{"id":"drug-1157","genericName":"Amino Acids with Glucose with Electrolytes Injection","brandName":"Vamin Glucose","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Injection"],"indications":"Source of amino acids, carbohydrate and electrolytes in patients needing IV nutrition","dosing":"Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day, carbohydrate 4-6 g/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"63.25","prescriberCat":"A"},{"id":"drug-1158","genericName":"Amino Acids, Glucose and Lipid with Electrolytes (Peripheral) 1000 kcal/day","brandName":"Smof Kabiven Peripheral","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["kcal/day"],"indications":"Parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.","dosing":"Adult Individualised dosage. Range: 20-40 mL/kg body wt/day. Max dose: 40 mL/kg body wt/day. Administer by IV infusion into peripheral or central vein over 14-24 hr. Max infusion rate: 3 mL/kg body wt/hr.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"140.14","prescriberCat":"A"},{"id":"drug-1159","genericName":"Amino Acid, Glucose and Lipid Electrolyte Free Injection EF 1000ml, 1100kcal","brandName":"SMOF Kabiven EF 1000ml, 1100kcal","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["1100kcal"],"indications":"Parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.","dosing":"Adult Individualised dosage. Range: 25-30 kcal/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"126.38","prescriberCat":"A"},{"id":"drug-1160","genericName":"Amino Acids, Glucose and Lipid with Electrolytes Injection (Central) 1600 kcal/day","brandName":"Smof Kabiven Central","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["kcal/day"],"indications":"Parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.","dosing":"Adult Individualized dosage. Range: 13-31 mL/kg body wt/day. Max dose: 35 mL/kg body wt/day. Administer via central IV infusion over 14-24 hr. Max infusion rate: 0.25 g/kg body wt/hr for glucose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"180.76","prescriberCat":"A"},{"id":"drug-1161","genericName":"Multivitamin Injection- Cernevit lyophilisate for reconstitution 5ml","brandName":"Cernevit","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["5ml"],"indications":"for adults and children over 11 years of age. When the daily requirements\\nof vitamins are required to be given to the patient by the parenteral route because oral\\nadministration is either contraindicated, impossible or insufficient (eg due to malnutrition,\\ngastrointestinal malabsorption, etc).","dosing":"Adults and children aged 11 years and older: 1 vial per day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pembedahan)","price":"45.00","prescriberCat":"B"},{"id":"drug-1162","genericName":"Dextrose 50% Injection (10 ml amp)","brandName":"Infusol D50","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["amp)"],"indications":"For parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient","dosing":"According to the needs of the patient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.94","prescriberCat":"B"},{"id":"drug-1163","genericName":"Dextrose 5%,10%, 50% Injection 500 ml","brandName":"Infusol D5,  Infusol D10, Infusol D50","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["ml"],"indications":"For parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient","dosing":"According to the needs of the patient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.53, 2.71 8.00","prescriberCat":"B"},{"id":"drug-1164","genericName":"Dextrose Powder 75g","brandName":"Dextrose Monohydrate","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["75g"],"indications":"Use as a diagnostic agent for diabetes","dosing":"75 g stat","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.40","prescriberCat":"B"},{"id":"drug-1165","genericName":"Fat Emulsion 20% for IV Infusion 100ml","brandName":"Smof Lipid 20%","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["100ml"],"indications":"Source of lipid in patients needing IV nutrition","dosing":"Dose to be individualised. ADULT usual lipid requirement 2-3 g/kg/day. INFANT 0.5-1 g/kg/day","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"48.52","prescriberCat":"A"},{"id":"drug-1166","genericName":"Multivitamin Injection - Lipid Soluble Vitamins (Vitamin A, D, E, K)","brandName":"Vitalipid N Infant","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["K)"],"indications":"Vitalipid N Infant is indicated as a supplement in complete intravenous nutrition to meet\\nthe daily requirements of the fat-soluble vitamins A, D2, E and K1  in paediatric patients up to 11 years of age.","dosing":"Must be diluted before use: Infants and children under 11 years.\\nVitalipid N Infant in a dosage of 1 mL per kg bodyweight per day is added to Intralipid\\n10% or 20%. The daily dose must not exceed 10 mL. After mixing by gentle agitation\\nthe emulsion is infused as described for Intralipid.\\nVitalipid N Infant should be added aseptically within one hour of the commencement of\\nthe infusion and should be used within 24 hours.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"34.54","prescriberCat":"B"},{"id":"drug-1167","genericName":"Multivitamin Injection - Lipid Soluble Vitamins (Vitamin A, D, E, K)","brandName":"Vitalipid N Adult","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["K)"],"indications":"Vitalipid N Adult is indicated as a supplement in complete intravenous nutrition to meet\\nthe daily requirements of the fat-soluble vitamins A, D2, E and K1.","dosing":"Must be diluted before use: Adults and children aged 11 years and above.\\nOne ampoule (10 mL) of Vitalipid N Adult is added to 500 mL Intralipid 10% or 20%.\\nAfter mixing by gentle agitation, the emulsion is infused as described for Intralipid","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"34.54","prescriberCat":"B"},{"id":"drug-1168","genericName":"Starter PN Standard","brandName":"-","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Standard"],"indications":"Parenteral nutrition for neonates","dosing":"Dose to be individualized","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Outsource from HRPB (Dept: Pediatrik)","price":"148.70","prescriberCat":"A"},{"id":"drug-1169","genericName":"Preterm PN Normal Sodium","brandName":"Generic","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Sodium"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"144.34","prescriberCat":""},{"id":"drug-1170","genericName":"Preterm PN High Sodium","brandName":"Generic","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Sodium"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"185.61","prescriberCat":""},{"id":"drug-1171","genericName":"Standard Lipid 3.2g in 18ml","brandName":"Generic","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["18ml"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"30.07","prescriberCat":""},{"id":"drug-1172","genericName":"Term PN High Sodium","brandName":"Generic","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Sodium"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"193.51","prescriberCat":""},{"id":"drug-1173","genericName":"Sodium Glycerophosphate 20ml Injection","brandName":"Glycophos","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Injection"],"indications":"Indicated in adult patients and infants as a supplement in intravenous nutrition to meet the requirement of phosphate.","dosing":"Adults: The recommended dosage is individual. The recommended daily dosage of phosphate during intravenous nutrition would normally be 10-20mmol. This can be met by using 10-20ml of sodium glycerophosphate to the infusion solution or to the admixture for which compatibility has been proved. Infants: The recommended dosage is individual. The recommended dose for infants and neonates is 1.0-1.5 mmol/kg bodyweight/day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"14.76","prescriberCat":"A"},{"id":"drug-1174","genericName":"Multivitamin Injection - Water Soluble Vitamins","brandName":"Soluvit N","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["Vitamins"],"indications":"Soluvit N is intended as a supplement in intravenous nutrition in order to meet the daily requirements of\\nthe water-soluble vitamins in adults, children, infants and neonates.","dosing":"Adults and children weighing 10kg or more\\nThe recommended daily dosage is the content of one vial.\\n\\nChildren, infants and neonates weighing less than 10kg\\nChildren weighing less than 10kg should be given 1/10 of the content of one vial per kg body weight per\\nday","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"34.70","prescriberCat":"B"},{"id":"drug-1175","genericName":"Trace Elements and Electrolytes (Adult) Solution 10ml","brandName":"Addaven","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["10ml"],"indications":"Only to be used to cover daily loss of electrolyte and trace elements for patient on parenteral nutrition","dosing":"10 ml added to 500-1000 ml solution, given by IV infusion","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"38.38","prescriberCat":"A*"},{"id":"drug-1176","genericName":"Trace Elements and Electrolytes (Paediatric) Solution 10ml","brandName":"Peditrace","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.4 ENTERAL AND PARENTERAL NUTRITION","forms":["10ml"],"indications":"Only to be used to cover daily loss of electrolyte and trace elements for patient on parenteral nutrition","dosing":"According to the needs of the patient. INFANT and CHILD weighing 15 kg or less: Basal requirements of the included trace elements are covered by 1 ml/kg/day to a maximum dose of 15 ml. CHILD weighing 15 kg or more, a daily dose of 15 ml, should meet basic trace element requirements. However, for patients weighing more than 40 kg the adult preparation trace element should be used","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"38.41","prescriberCat":"A*"},{"id":"drug-1179","genericName":"Alfacalcidol 0.25 mcg Capsule","brandName":"One-alpha","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Capsule"],"indications":"i) Chronic kidney disease mineral bone disorder\\nii) Osteoporosis\\niii) Hypoparathyroidism and pseudohypoparathyroidism\\niv) Rickets and osteomalacia","dosing":"Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily;\\nCHILD under 20kg body weight : 0.05 mcg/kg/day.\\nMaintenance dose : 0.25 mcg to 2 mcg daily\\n\\nDosing is individualised based on serum calcium level and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.22","prescriberCat":"A/KK"},{"id":"drug-1180","genericName":"Alfacalcidol 1 mcg Capsule","brandName":"Alfacip","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Capsule"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.29","prescriberCat":""},{"id":"drug-1181","genericName":"Alfacalcidol 2 mcg/ml Drops (0.1mcg/drop) 20ml","brandName":"One-alpha","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["20ml"],"indications":"i) Neonatal hypocalcemia\\nii) Osteoporosis\\niii) Hypoparathyroidism and pseudohypoparathyroidism\\niv) Rickets and osteomalacia","dosing":"NEONATES : 0.1 mcg/kg/day\\n\\nDosing is individualised based on serum calcium level and according to\\nproduct insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"234.45","prescriberCat":"A*"},{"id":"drug-1182","genericName":"Alfacalcidol 2mcg/ml Injection (1mcg/0.5ml)","brandName":"One-alpha","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["(1mcg/0.5ml)"],"indications":"i) Chronic kidney disease mineral bone disorder\\nii) Osteoporosis\\niii) Hypoparathyroidism and pseudohypoparathyroidism\\niv) Rickets and osteomalacia","dosing":"Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily;\\nCHILD under 20kg body weight : 0.05 mcg/kg/day.\\nMaintenance dose : 0.25 mcg to 2 mcg daily\\n\\nDosing is individualised based on serum calcium level and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"13.45","prescriberCat":"A*"},{"id":"drug-1183","genericName":"Ascorbic Acid 100 mg, 500 mg Tablet","brandName":"Chewette-C\\nDyna","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Vitamin C deficiency","dosing":"ADULT: 100-250 mg once or twice daily \\nCHILD: 100 mg three times daily for one week followed by 100mg daily until symptoms abate.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.06 0.14","prescriberCat":"C+"},{"id":"drug-1184","genericName":"Calcitriol 0.25 mcg Capsule","brandName":"Osteocap","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Capsule"],"indications":"i) Osteoporosis\\nii) Chronic kidney disease-mineral bone disorder\\niii) Hypoparathyroidism and pseudohypoparathyroidism\\niv) Rickets and osteomalacia","dosing":"i) 0.25 mcg 2 times daily\\nii) ADULT and CHILD 3 years and older:\\nInitial dose: 0.25 mcg.\\nIn patients with normal or only slightly reduced serum calcium levels, doses of 0.25 mcg every other day is sufficient. Dosage may be increased if necessary to 0.5 mcg/day. Maintenance dose: 0.5-1mcg daily\\nCHILD less than 3 years: 10 to 15 ng/kg/day\\niii) and iv) 0.25 mcg/day given in the morning","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.26","prescriberCat":"A/KK"},{"id":"drug-1185","genericName":"Calcium Carbonate 500 mg Tablet, 500mg capsule","brandName":"Malaysian Pharmaceutical Calcium Carbonate\\n\\nDuopharma Calsonate","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["capsule"],"indications":"i) Hyperphosphatemia (phosphate binder) in chronic kidney disease patients\\nii) Calcium supplementation","dosing":"i) Total dose of elemental calcium from calcium-based phosphate binder not to exceed 1,500 mg/day.\\nDosing is individualised based on serum phosphate level and according to product insert/protocol\\n\\nii) 500 mg to 4g per day as calcium carbonate in 1-3 divided doses (500mg capsule contains 200mg elemental calcium)\\nDosing is individualised based on serum calcium level and according to product insert/protocol","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.03    0.09","prescriberCat":"B"},{"id":"drug-1186","genericName":"Calcium Gluconate 10% Injection (1 g /10 ml)","brandName":"B Braun","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["ml)"],"indications":"i)Acute hypocalcaemia \\nii)Hypocalcaemic tetany \\niii)Cardiac resuscitation","dosing":"i) 1-2 g (2.25-4.5 mmol). CHILD: 50 mg/kg \\nii) ADULT: 1g (2.2 mmol) by slow IV injection followed by continuous infusion of 4 g (8.8 mmol) daily \\niii) IV or intracardiac injection, 10 ml","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.60","prescriberCat":"B"},{"id":"drug-1187","genericName":"Calcium Lactate 300 mg Tablet","brandName":"Idaman\\nCalcium Lactate","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"For prophylaxis of calcium deficiency and treatment of chronic hypocalcaemia","dosing":"ADULT: 1-5 g daily in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.17","prescriberCat":"C"},{"id":"drug-1188","genericName":"Cholecalciferol 25,000 IU Oral Solution","brandName":"D-Cure","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Solution"],"indications":"Prevention & treatment of vit D deficiency. Adjunctive therapy to osteoporosis in patients w/ vit D deficiency or at risk of vit D insufficiency.","dosing":"Prevention of vit D deficiency Adult 25,000 IU mthly as single dose. Childn 1-18 yr 25,000 IU as single dose every 6 wk, 0-1 yr 25,000 IU as single dose every 8 wk. Treatment of vit D deficiency (<25 ng/mL) Adult 50,000 IU wkly as 2-single dose for 6-8 wk, followed by maintenance therapy: 1,400-2,000 IU daily. Childn 0-18 yr 25,000 IU as single dose once every 2 wk for 6 wk, followed by maintenance therapy: 400-1,000 IU daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special drugs approval (UKK) required (Dept: Perubatan)","price":"7.60","prescriberCat":"Not in FUKKM"},{"id":"drug-1189","genericName":"Cinacalcet Hydrochloride 25mg Tablet","brandName":"Regpara","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Secondary hyperparathyroidism in patients undergoing maintenance dialysis with hypercalcaemia. restriction:For treatment of refractory secondary hyperparathyroidism in patients with end-stage renal disease (including those with calciphylaxis) only in those: i) who have 'very uncontrolled' plasma levels of intact parathyroid hormone (defined as greater than 85pmol/L [800 pg/mL] that are refractory to standard therapy, and an adjusted serum calcium level at upper limit of normal or high, despite appropriate adjustment of phosphate binders including non-calcium based phosphate binders.","dosing":"The starting dose for adults is 25mg once daily to be administered orally. Depending on the serum parathyroid hormone (PTH) and calcium levels, the dose may be adjusted within a range of 25-75mg once daily. If no improvement in PTH, the dose may be increased up to 100 mg once daily. Dose can be increased by 25mg at a time at intervals of at least 3 weeks.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"14.25","prescriberCat":"A*"},{"id":"drug-1191","genericName":"Magnesium Sulphate crystal/powder 1 kg","brandName":"Magnesium Sulphate Crystal BP","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["kg"],"indications":"HSM practice:\\nMagnesium deficiency due to pseudohypoparathyroidism","dosing":"PO: 4 g OD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"22.00","prescriberCat":""},{"id":"drug-1192","genericName":"Magnesium Sulphate 50% Injection","brandName":"Injecsol MgSO4","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Injection"],"indications":"i)Treatment and prophylaxis of acute hypomagnesaemia \\nii) Prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia)","dosing":"i) Mild hypomagnesemia (ADULT): 1gm magnesium sulphate (8mEq) IM every 6 hours for 4 doses. \\nSevere hypomagnesemia (ADULT): 0.25 g/kg IM over 4 hours. Alternative dose of 5g may be given by slow intravenous infusion over 3 hours \\nii) Toxemia of pregnancy: An initial intravenous dose of 4gm of magnesium sulphate is recommended. Followed by an intramuscular dose of 4-5gm into each buttock. This may be followed by a dose of 4-5gm into alternate buttocks every 4 hours as needed. Alternatively, the initial dose IV dose may be followed by an infusion of 1-2gm/hr","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.35","prescriberCat":"C"},{"id":"drug-1193","genericName":"Mecobalamin 500 mcg Tablet","brandName":"Mecovit","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Peripheral neuropathies","dosing":"1 tablet 3 times daily. The dosage should be adjusted according to age of patient and severity of symptoms","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.09","prescriberCat":"B"},{"id":"drug-1194","genericName":"Multivitamin Drops","brandName":"Appeton","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Drops"],"indications":"For prevention and treatment of vitamin deficiencies","dosing":"INFANT less than 1 year: 1 ml daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"19.25","prescriberCat":"B"},{"id":"drug-1195","genericName":"Multivitamin Injection","brandName":"Parentrovite","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Injection"],"indications":"For prevention and treatment of vitamin deficiencies","dosing":"Initially 2 - 4 pairs IV 4 - 8 hourly, reducing to 1 pair IV daily. For less serious cases, 1 pair IV 1 - 2 times daily or based on individual requirements","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"B"},{"id":"drug-1196","genericName":"Oral Rehydration Salts","brandName":"ORS Plus","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Salts"],"indications":"Replacement of fluid and electrolytes loss in diarrhoea","dosing":"Dissolve 1 sachet in 200 or 250mL of water according to product insert.\\nThe amount to give depends on hydration status.\\nADULT: 200-400mL (1 - 2 sachets) for every loose motion/ diarrhoea/ vomiting\\nCHILD (2 yrs & above): 100-200mL (1 sachet) for every loose motion/ diarrhoea/ vomiting. In severe dehydration 100ml/kg for 3-4 hours.\\nINFANT (up to 2 yrs): 1 - 1.5 times their usual feed volume (50-100mL) each diarrhoea/vomiting\\n\\nDose is according to product insert and dependent on the product/ brand used as well as patient comorbidities e.g. heart failure and chronic kidney disease.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.01","prescriberCat":"C"},{"id":"drug-1197","genericName":"Potassium Chloride 1 g/10 ml Injection","brandName":"Injecsol K10","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Injection"],"indications":"For the correction of severe hypokalaemia and when sufficient potassium cannot be taken by mouth","dosing":"By slow IV infusion depending on the deficit or the daily maintenance requirements. 1 g diluted in 500 ml normal saline or glucose and given slowly over 2 - 3 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.67","prescriberCat":"B"},{"id":"drug-1198","genericName":"Potassium Chloride 1g/10 ml Mixture","brandName":"-","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Mixture"],"indications":"Potassium depletion","dosing":"1 g once or twice daily until serum potassium is restored","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"To freshly prepare from powder.\\nReserve for Ryle's tube & Peadiatric pateint only","price":"-","prescriberCat":"C"},{"id":"drug-1199","genericName":"Potassium Chloride 600 mg SR Tablet","brandName":"Protrelease TR","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"For the treatment and specific prevention of hypokalaemia","dosing":"ADULT: 2 - 3 tablets daily. Severe deficiency: 9 - 12 tablets daily or according to the needs of the patient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.03","prescriberCat":"B"},{"id":"drug-1200","genericName":"Potassium Dihydrogen Phosphate Injection","brandName":"DBL KH2PO4 Concentrated","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Injection"],"indications":"For treatment of hypophosphataemia","dosing":"Up to 10mmol phosphate administered over 12 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"16.25","prescriberCat":"A"},{"id":"drug-1201","genericName":"Pre/Post Natal Vitamin & Mineral Tablet","brandName":"Zincofer","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Vitamin and mineral supplement for use during pregnancy and lactation","dosing":"1 tablet daily or based on individual requirements","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.13","prescriberCat":"C+"},{"id":"drug-1202","genericName":"Pyridoxine HCl 10 mg Tablet","brandName":"Malaysian Pharmaceutical Pyridoxine","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"i)Pyridoxine-dependent convulsions in infant \\nii)Sideroblastic anaemia \\niii)B6-deficient anaemia in adult \\niv) Prophylaxis to peripheral neuritis in isoniazid therapy \\nv) Nausea and vomiting of pregnancy and irradiation sickness","dosing":"i) INFANT 4 mg/kg daily for short periods \\nii) 100 - 400 mg daily in divided doses \\niii) ADULT 20 - 50 mg up to 3 times daily \\niv) Prophylaxis 10 mg daily, therapeutic 50 mg 3 times daily \\nv) 20 - 100 mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.07","prescriberCat":"C+"},{"id":"drug-1203","genericName":"Riboflavine 3 mg Tablet","brandName":"Riboflavine","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"For prevention and treatment of riboflavine deficiency","dosing":"CHILD: 2.5-10 mg/day in divided doses. ADULT: 5-30 mg/day in divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.02","prescriberCat":"C"},{"id":"drug-1204","genericName":"Sodium Bicarbonate 8.4% \\n(1 mmol/ml) Injection","brandName":"DB Sodium Bicarbonate","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Injection"],"indications":"For acceleration of excretion in drug intoxication (where excretion of the drug into the urine is accelerated by elevated urine pH) and for acidosis","dosing":"According to the needs of the patient. \\nIn severe shock due to cardiac arrest: 50 ml by IV","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.42","prescriberCat":"B"},{"id":"drug-1205","genericName":"Sodium Bicarbonate Powder 5 g, 2 g, 1.5 g, 1 g, 0.5 g","brandName":"-","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["g"],"indications":"1. For the relief of the symptoms of dyspepsia, heartburn and indigestion.\\n\\n2. As an external lotion for relief of the symptoms of insect bites and sunburn.","dosing":"1. For relief of the symptoms of dyspepsia, heartburn and indigestion:\\n\\nAdults and children over 12 years: one level 5ml spoonful dissolved in warm water, to be taken up to 4 times a day.\\n\\nNot to be taken by children under 12 years old.\\n\\n2. As an external lotion:\\n\\nDissolve one 5ml spoonful in a pint of warm water. Apply with lint or cotton wool.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"-","prescriberCat":"-"},{"id":"drug-1206","genericName":"Sodium Chloride Powder 1 g","brandName":"-","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["g"],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"-","prescriberCat":"-"},{"id":"drug-1207","genericName":"Sodium Dihydrogen Phosphate Powder","brandName":"Generic","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Powder"],"indications":"To treat hypophosphatemia","dosing":"10-20 mmol when required phosphate","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Galenikal","price":"50.40","prescriberCat":"-"},{"id":"drug-1208","genericName":"Sodium Phosphate Monobasic 500 mg (16.1mmol)Effervescent Tablet /\\nPhosphorus 500mg (1.936g sodium acid phosphate) Effervescent Tablet","brandName":"Phosphate- Sandoz","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Phosphate supplement for premature baby with risk of osteopenia","dosing":"Phosphate-Sandoz effervescent tablets should be dissolved in  to  glass of water and taken orally. \\nHypercalcaemia: up to 3 tablets daily (adjustment being made according to requirements).\\nVitamin D-resistant rickets: 2-3 tablets daily\\n\\nPhosphate supplement for premature babies: 1 mmol/kg/day in 1 or 2 divided doses","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Pediatrik)","price":"3.99","prescriberCat":"A"},{"id":"drug-1209","genericName":"Thiamine HCl 100 mg/ml Injection","brandName":"Exeltis Thiamin","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Injection"],"indications":"i) For the prevention or treatment of Vitamin B1 deficiency syndromes including beri-beri and peripheral neuritis associated with pellagra \\nii) Wernicke-Korsakoff Syndrome","dosing":"i) Mild to chronic deficiency: 10-25 mg daily. Severe deficiency: 200- 300 mg daily \\nii) 500 mg every 8 hours for 2 days, followed by 100 mg 2 times daily until patient can take oral dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Perubatan, Pembedahan)","price":"3.20","prescriberCat":"B"},{"id":"drug-1210","genericName":"Thiamine Mononitrate 10 mg Tablet","brandName":"Aneurine","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Prevention and treatment of thiamine deficiency state","dosing":"Mild chronic deficiency: 5mg to 30mg daily\\nSevere deficiency: up to 300mg daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.07","prescriberCat":"C"},{"id":"drug-1211","genericName":"Vitamin B1, B6, B12 Tablet","brandName":"VITBION FORTE","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"For deficiency or raised requirement of Vitamin B1, B6, B12","dosing":"1 - 3 tablets 3 times daily swallowed unchewed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.12","prescriberCat":"B"},{"id":"drug-1212","genericName":"Vitamin B Complex Tablet","brandName":"duobion","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.5 VITAMINS AND MINERAL SUPPLEMENT","forms":["Tablet"],"indications":"Prophylaxis and treatment of vitamin B deficiency","dosing":"1-2 tablets daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.01","prescriberCat":"C+"},{"id":"drug-1215","genericName":"Alendronate Sodium 70 mg Tablet","brandName":"Hovid Alendronate","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.6 DRUGS AFFECTING BONE METABOLISM","forms":["Tablet"],"indications":"Kategori preskriber A*:\\nOsteoporosis (Male)\\n\\nKategori preskriber A/KK:\\nIndicated for the treatment of osteoporosis in high-risk postmenopausal women","dosing":"70 mg once weekly. Swallow the tablet whole with a full glass of plain water only on an empty stomach at least 30 minutes before breakfast (and any other oral medication); stand or sit upright for at least 30 minutes and do not lie down until after eating breakfast","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Ortopedik)","price":"1.13","prescriberCat":"A*, A/KK"},{"id":"drug-1216","genericName":"Alendronate Sodium 70 mg and Cholecalciferol 5600 IU Tablet","brandName":"Fosamax Plus","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.6 DRUGS AFFECTING BONE METABOLISM","forms":["Tablet"],"indications":"Osteoporosis in postmenopausal women with a history of vertebral fracture and whom oestrogen replacement therapy is contraindicated. Review treatment after 2 years and if there is positive response, treatment may be continued up to 5 years and then re-evaluate. Treatment should be stopped if there is no positive response after 5 years. Otherwise, patient needs to be given drug holiday for 1 to 2 years and then continue treatment shall the benefit outweigh the risk.","dosing":"1 tablet once weekly [70mg/5600 IU]. Patient should receive supplemental calcium or vitamin D, if dietary vitamin D inadequate. The tablet should be taken at least half and hour before the first food, beverage, or medication of the day with plain water only. To facilitate delivery to stomach and thus reduce the potential for esophageal irritation, it should only be swallowed upon arising for the day with a full glass of water and patient should not lie down for at least 30 minutes and until after their first food of the day.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Ortopedik)","price":"18.17","prescriberCat":"A*"},{"id":"drug-1217","genericName":"Denosumab in 1.0 mL solution (60 mg/mL) Prefilled syringe (subcutaneous injection)","brandName":"Prolia","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.6 DRUGS AFFECTING BONE METABOLISM","forms":["injection)"],"indications":"Post-Menopausal Osteoporosis.\\n\\nPRESCRIBING RESTRICTIONS\\nTo be used by Orthopaedic Specialist, Rheumatologist, Endocrinologist and Geriatricians","dosing":"A single subcutaneous injection of 60 mg administered once every 6 months. Patients should receive calcium and vitamin D supplements whilst undergoing treatment.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Ortopedik, Perubatan)","price":"650.00","prescriberCat":"A*"},{"id":"drug-1218","genericName":"Ibandronic Acid 150 mg Tablet","brandName":"Bonviva","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.6 DRUGS AFFECTING BONE METABOLISM","forms":["Tablet"],"indications":"Treatment of postmenopausal osteoporosis to reduce the risk of fracture. Review treatment after 2 years and if there is positive response, treatment may be continued up to 5 years and then re-evaluate. Treatment should be stopped if there is no positive response after 5 years. Otherwise, patient needs to be given drug holiday for 1 to 2 years and then continue treatment shall the benefit outweigh the risk.","dosing":"150 mg once monthly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Ortopedik)","price":"86.00","prescriberCat":"A*"},{"id":"drug-1219","genericName":"Teriparatide 20mcg/80mcl Injection in Prefilled-Pen (250mcg/ml)","brandName":"Forteo","category":"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS\\n14.6 DRUGS AFFECTING BONE METABOLISM","forms":["(250mcg/ml)"],"indications":"Osteoporosis in postmenopausal women, Primary or hypogonadal osteoporosis in men, Corticosteroid-induced osteoporosis. In patients at high risk of fracture, or who have failed or are intolerant to other available osteoporosis therapies","dosing":"20 mcg once daily by SC inj in thigh or abdomen. \\nMax duration of treatment: 24 months (a treatment course must not to be repeated over a patient's lifetime).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Ubat PESARA\\n\\nSpecial Drugs Approval (UKK) required (Dept: Ortopedik\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru jika ingin menggunakan peruntukan ubat farmasi)","price":"875.00","prescriberCat":"Not in FUKKM"},{"id":"drug-1222","genericName":"Calcium Chloride Dihydrate, Sodium Chloride, Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate,Potassium Chloride, and Malic Acid Solution","brandName":"Sterofundin ISO","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["Solution"],"indications":"Replacement of extracellular fluid losses in the case of isotonic dehydration, where acidosis is present or imminent.","dosing":"The maximum infusion rate depends on the needs of the patient in fluid replacement and electrolytes, patient's weight, clinical condition, and biological status. Adults, elderly, adolescents:500ml-3L/24hr. Babies, children: 20ml to 100ml/kg/24 hr.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"11.00","prescriberCat":"A"},{"id":"drug-1223","genericName":"Mannitol 10%, 20% Injection 500 ml","brandName":"Infusol M10 Infusol M20","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"Cerebral oedema","dosing":"0.25- 2 g/kg IV of a 15% to 25% solution over 30-60 minutes. Safety and efficacy not established in children under 12 years of age","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.44, 5.37","prescriberCat":"A"},{"id":"drug-1224","genericName":"Sodium Chloride 0.9% Injection 100 ml, 500 ml","brandName":"Infusol NS","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and for restoring/maintaining the concentration of sodium and chloride ions","dosing":"100 - 1000 ml by IV or according to the needs of the patient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.42, 2.42","prescriberCat":"C+"},{"id":"drug-1225","genericName":"Sodium Chloride 3% Injection 500 ml","brandName":"Infusol S3","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"Acute dilutional hyponatraemia","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.80","prescriberCat":"B"},{"id":"drug-1226","genericName":"Sodium Chloride 20% Injection","brandName":"Generic","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["Injection"],"indications":"Addition of sodium electrolyte in parenteral nutrition bags especially in paediatrics or neonates with restricted fluid allowance\\n\\nHSM off label use (Pediatrik):\\nAs hypertonic saline nebulisation for chronic suppurative lung disease","dosing":"refer protocols\\n\\nHSM off label use:\\nTo dilute into 5% NaCl (1ml NaCl 20% + 3ml water for injection) 4 - 12 hourly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special Drugs Approval (UKK) required for off-label indication  (by batch basis in HSM) (Dept: Pediatrik)","price":"0.85","prescriberCat":"B"},{"id":"drug-1227","genericName":"Sodium Chloride 0.9% with Dextrose 5% Injection 500 ml","brandName":"Infusol NSD5","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.80","prescriberCat":"C+"},{"id":"drug-1228","genericName":"Sodium Chloride 0.45% with Dextrose 5% Injection 500 ml","brandName":"Infusol HSD5","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.37","prescriberCat":"B"},{"id":"drug-1229","genericName":"Sodium Chloride 0.45% Injection 500 ml","brandName":"Infusol HS","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and for restoring / maintaining the concentration of sodium and chloride ions","dosing":"100 - 1000 ml by IV or according to the needs of the patient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.42","prescriberCat":"B"},{"id":"drug-1230","genericName":"Sodium Chloride 0.45% with Dextrose 10% Injection 500 ml","brandName":"Infusol HSD10","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.50","prescriberCat":"B"},{"id":"drug-1231","genericName":"Sodium Chloride 0.18% with Dextrose 4.23% Injection 500 ml","brandName":"Infusol QSD1","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"1.87","prescriberCat":"B"},{"id":"drug-1232","genericName":"Sodium Chloride 0.18% with Dextrose 10% Injection 500 ml","brandName":"Infusol QSDIO","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.50","prescriberCat":"B"},{"id":"drug-1233","genericName":"Sodium Citrate 3.8% Solution 500 ml","brandName":"-","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"Sterile solution for irrigation or washout of infected bladder","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"galenical","price":"6.10","prescriberCat":"B"},{"id":"drug-1234","genericName":"Sodium Lactate Compound (Hartmanns Solution/Ringer-lactate]","brandName":"Infusol HM","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["Solution/Ringer-lactate]"],"indications":"Replacement of extracellular losses of fluid and electrolytes, as an alkaliniser agent","dosing":"100-1000 ml by IV or according to the needs of the patient","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"2.21","prescriberCat":"C"},{"id":"drug-1235","genericName":"Water for Injection 10 ml, 500 ml","brandName":"Infusol W","category":"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES","forms":["ml"],"indications":"As a diluent and vehicle for the administration of medications","dosing":"refer protocols","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.31, 2.55","prescriberCat":"C+"},{"id":"drug-1238","genericName":"Barium Sulphate Powder for Suspension 96% w/w","brandName":"E-Z Paque","category":"16.0 RADIOCONTRAST MEDIA","forms":["w/w"],"indications":"For x-ray examination of the alimentary tract: \\ni) Oesophagus \\nii) Stomach and duodenum \\niii) Colon","dosing":"i) Up to 150 ml of a 50% - 200% suspension orally \\nii) Up to 300 ml of a 30% - 200% suspension orally \\niii) Up to 2 litre of a 30% - 200% suspension orally","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK) (Dept: Radiologi)","price":"62.50","prescriberCat":"B"},{"id":"drug-1239","genericName":"Diatrizoate Meglumine and Sodium Amidotrizoate Solution","brandName":"Gastrografin","category":"16.0 RADIOCONTRAST MEDIA","forms":["Solution"],"indications":"i) Contrast medium for the radiological examination of the gastrointestinal tract (primarily in cases in which barium sulphate is contraindicated) \\nii) Computerised tomography in abdominal region \\niii) Treatment of Mecolinium ileus","dosing":"i) ADULT and CHILD more than 10 year, ORALLY: 60 -100 ml RECTALLY, contrast medium should be diluted with 3-4 times its volume of water. \\nORALLY: CHILD less than 10 years,: 15- 30 ml \\nNEWBORN, INFANT contrast medium should be diluted with 3 times its volume of water. \\nRECTALLY: CHILD more than 5 years, contrast medium should be diluted with 4-5 times its volume of water. Younger patients a dilution with 5 times its volume is recommended \\nii) Adult, orally, 25-77 mL in 1000 mL tap water 15-30 minutes prior to imaging","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"63.00","prescriberCat":"A"},{"id":"drug-1240","genericName":"Gadobutrol 1 mmol/ml injection","brandName":"Gadovist","category":"16.0 RADIOCONTRAST MEDIA","forms":["injection"],"indications":"In adults, adolescents and children aged 2 years and older with diagnostic difficulty especially in patients with renal impairment for: i) Contrast enhancement in cranial and spinal magnetic resonance imaging (MRI). ii) Contrast enhanced MRI of liver or kidneys in patients with high suspicion or evidence of having focal lesion to classify these lesions as benign or malignant. iii)Contrast enhancement in Magnetic Resonance Angiography (CE-MRA).","dosing":"A single intravenous injection of 0.1 mmol/kg (equivalent to 0.1 ml/kg body weight). Max: 0.3 mmol/kg (equivalent to 0.3 ml/kg body weight)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"117.60","prescriberCat":"A*"},{"id":"drug-1241","genericName":"Gadoxetic acid disodium 0.25 mmol/ml solution for injection (10ml pre-filled syringe)","brandName":"Primovist","category":"16.0 RADIOCONTRAST MEDIA","forms":["syringe)"],"indications":"For use in adults for the enhancement of magnetic resonance imaging (MRI) of focal liver lesions","dosing":"0.1ml/kg body weight (equivalent to 25 mol per kg body weight). Not recommended for patients younger than 18 years","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"808.50","prescriberCat":"A*"},{"id":"drug-1242","genericName":"Iohexol 300mg iodine/ml  Injection (50ml)","brandName":"Omnipaque","category":"16.0 RADIOCONTRAST MEDIA","forms":["(50ml)"],"indications":"X-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and CT-enhancement. Lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. Arthrography, endoscopic retrograde pancreatography (ERCP), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract","dosing":"Dose will vary depending on the route and procedure\\nRefer to MIMS Gateway Malaysia for more info","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pembedahan, Ortopedik)","price":"30.37","prescriberCat":"A"},{"id":"drug-1245","genericName":"Anti-Hyperammonemic drugs cocktail (mixture of IV Sodium Benzoate 2g in 10ml, IV Sodium Phenylbutyrate 2g in 10ml, IV L-Arginince 5g in 10ml)","brandName":"Generic","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["10ml)"],"indications":"Hyperammonemia due to urea cycle \\ndefects","dosing":"Loading dose: \\ni) IV Sodium Benzoate 250mg/kg\\nii)IV Sodium Phenylbutyrate 250mg/kg\\niii) IV L-Arginine 250mg/kg \\n(mix all 3 in D10% to a total volume of 50mls, infuse over 90 mins)\\n\\nMaintenance dose\\nSame dilution as above but infuse over 24 hours","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"HSM keeps 1 vial each as buffer. Additional stock to be taken from Genetics Pharmacy HKL when required. Purchasing the replacement stock will require application of import permit via special drugs approval request (UKK) (Dept: Paediatrik)","price":"61.7  128.2  68.3","prescriberCat":"-"},{"id":"drug-1246","genericName":"Acetylcysteine 5000 mg/25ml Injection","brandName":"Infusol NAC","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"Antidote for paracetamol poisoning","dosing":"Diluted with dextrose 5% and infused IV. Initial, 150 mg/kg IV in 200 ml over 60 minutes, then 50 mg/kg IV in 500 ml over 4 hours, followed by 100 mg/kg IV in 1000 ml over 16 hours. Total dose: 300mg/kg in 20 hour","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"90.00","prescriberCat":"A*"},{"id":"drug-1247","genericName":"Charcoal, activated granules","brandName":"-","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["granules"],"indications":"Emergency treatment of acute oral poisoning and drug overdose","dosing":"ADULT:Acute poisoning: 50 - 100g in suspension. Severe poisoning: 50 - 100g as an initial dose followed by 20-25g every 4 - 6 hours. CHILDREN: 1g/kg/dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"repacked to 25g","price":"18.54","prescriberCat":"A"},{"id":"drug-1248","genericName":"Calcium Polystyrene Sulphonate Powder 5g/sachet","brandName":"Resin Calcio","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["5g/sachet"],"indications":"Hyperkalemia resulting from acute or chronic renal failure","dosing":"15 - 30g daily in 2-3 divided doses. Each dose should be suspended in 30 - 50ml of water and administered orally","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.81","prescriberCat":"A/KK"},{"id":"drug-1249","genericName":"Deferiprone 500 mg Tablet","brandName":"Ferriprox","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Tablet"],"indications":"Treatment of iron overload in patients with thalassemia major for whom desferrioxamine therapy is contraindicated or inadequate. Add on therapy to desferrioxamine for thalassemia patients with cardiac complication","dosing":"25 mg/kg 3 times a day for total daily dose of 75 mg/kg. Doses greater 100 mg/kg are not recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"3.92","prescriberCat":"A*"},{"id":"drug-1250","genericName":"Desferrioxamine B Methanesulphonate 0.5 g Injection","brandName":"Desferal","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"i) Acute iron poisoning in children \\nii) Investigation and treatment of haemochromatosis \\niii) Diagnosis and treatment of aluminium toxicity in patients with renal failure and dialysis \\niv) Chronic iron toxicity or overload","dosing":"i) 2 g by IM immediately and 5 g by mouth after gastric lavage \\nii) 0.5 - 1.5 g by IM injection daily \\niii) Diagnosis: 5 mg per kg by slow intravenous infusion during the last hour of haemodialysis. Treatment: 5 mg per kg once a week by slow intravenous infusion during the last hour of dialysis \\niv) 30 - 50 mg/kg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"26.50","prescriberCat":"A"},{"id":"drug-1251","genericName":"Deferasirox 90 mg, 180mg, 360 mg Film-Coated Tablets","brandName":"Exjade - FCT 90mg\\n\\nExajde-FCT 360mg\\n\\nIrosix 180mg","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Tablets"],"indications":"Treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and paediatric patients aged 2 years and above.","dosing":" Recommended initial dose is 14mg/kg body weight. \\n An initial dose of 21mg/kg may be considered for patients receiving more than 14ml/kg/month of packed red blood cells, and for whom the objective is reduction of iron overload. \\n An initial dose of 7mg/kg may be considered for patients receiving less than 7ml/kg/month of packed red blood cells, and for whom the objective is reduction of iron overload. \\n For patients already well-managed on treatment with Deferoxamine, a starting dose of Deferasirox film- coated tablets that is numerically one third of the Deferoxamine dose could be considered.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Pediatrik, Perubatan)","price":"3.74   14.83   29.77","prescriberCat":"A*"},{"id":"drug-1252","genericName":"Flumazenil 0.5 mg/5 ml Injection","brandName":"Pharmaniaga\\nFulmazenil","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"i) Diagnosis and/or management of benzodiazepine overdose due to self-poisoning or accidental overdose \\n\\nii) Reversal of sedation following anaesthesia with benzodiazepine","dosing":"i) Initial, 0.2 mg IV over 30 seconds; if desired level of consciousness not obtained after an additional 30 seconds, give dose of 0.3 mg IV over 30 seconds; further doses of 0.5 mg IV over 30 seconds may be given at 1-minutes intervals if needed to maximum total dose of 3 mg; patients with only partial response to 3 mg may require additional slow titration to a total dose of 5 mg; if no response 5 minutes after receiving total dose of 5 mg, overdose is unlikely to be benzodiazepine and further treatment with flumazenil will not help","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.80","prescriberCat":"B"},{"id":"drug-1254","genericName":"Fullers Earth powder 60g","brandName":"Fuller's Earth","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["60g"],"indications":"Adsorbent in pesticide poisoning","dosing":"Adult: 100-150g every 2-4 hours. Child: 1-2g/kg. (100g of Fuller's Earth is mixed with 200ml water. Repeat until Fuller's Earth is seen in stool (normally between 4-6 hours)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"4.15","prescriberCat":"C"},{"id":"drug-1255","genericName":"Idarucizumab 2.5g/50ml inj","brandName":"Praxbind","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["inj"],"indications":"Idarucizumab is a specific reversal agent for dabigatran and is indicated in patients treated with dabigatran when rapid reversal of the anticoagulant effects of dabigatran is required:\\ni. For emergency surgery/urgent procedures\\nii. In life-threatening or uncontrolled bleeding\\n\\nPrescribing Restrictions:\\nTo be prescribed by cardiologist, haematologist, general medicine physician, anaesthesiologist and emergency physician only","dosing":"The recommended dose of Idarucizumab is 5 g (2 x 2.5 g/50 ml) to be administered intravenously, as two consecutive infusions over 5 to 10 minutes each or as a bolus injection.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan\\n\\n(Not kept in HSM, to get stock from HRPB when there is a case and purchase afterwards))","price":"3309.50","prescriberCat":"A*"},{"id":"drug-1256","genericName":"Naloxone HCl 0.4 mg/ml Injection","brandName":"Mapin","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"For the complete/partial reversal of narcotic depression including respiratory depression induced by opioids such as natural and synthetic narcotics. Diagnosis of suspected acute opioids overdosage","dosing":"Initially 0.4 - 2 mg IV repeated at intervals of 2 - 3 minutes according to patient's needs","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.68","prescriberCat":"B"},{"id":"drug-1257","genericName":"Pralidoxime 0.5 g/20 ml Injection","brandName":"Pampara","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"Antidote in the treatment of organophosphorus insecticide poisoning and in the control of overdosage by anticholinergic drugs used in the treatment of myasthenia gravis","dosing":"Adult: Used in combination with atropine. Admin atropine via IM/IV inj and repeat as needed until patient shows signs of atropine toxicity. Maintain atropinisation for at least 48 hr. As soon as the effects of atropine are observed, 1-2 g of pralidoxime (chloride, iodide or mesilate) may be given via IM/IV inj. Repeat dose after 1 hr, then every 8-12 hr, if necessary. In severe poisoning, continuous infusion of 200-500 mg/hr may be given, titrated according to response. Alternatively, pralidoxime chloride may be given at an initial dose of 30 mg/kg via IV infusion over 20 minutes or IV inj over 5 minutes, followed by IV infusion at 8 mg/kg/hr. Max: 12 g/24 hr. \\nChild: As mesilate: 20-60 mg/kg. Renal impairment: Dose adjustment may be required.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"92.13","prescriberCat":"B"},{"id":"drug-1258","genericName":"Protamine Sulphate 50 mg/5 ml Injection","brandName":"Protamine","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"Heparin overdose and following cardiac or arterial surgery or dialysis procedures when required to neutralize the effects of heparin administered during extracorporeal circulation","dosing":"5 ml slow IV injected over 10 minutes. If administered within 15 minutes of heparin dose, 1 mg will neutralise approximately 100 units of heparin. If longer time has elapsed, less protamine is required. Not more than 50 mg should be injected at any one time. The dose is dependent on the amount and type of heparin to be neutralised, its route of administration and the time elapsed since it was last given and blood coagulation studies.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"374.00","prescriberCat":"B"},{"id":"drug-1259","genericName":"Sevelamer 800mg Tablet","brandName":"Renvela","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Tablet"],"indications":"Control of hyperphosphatemia in adult patients receiving haemodialysis and peritoneal dialysis. \\nrestriction: Sevelamer carbonate 800mg tablet should be used in context of multiple therapeutic approach which include calcium supplement, 1, 25-hydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.","dosing":"Starting dose is one or two 800mg tablets three times per day with meals. Adjust by one tablet per meal in two weeks interval as needed to obtain serum phosphorus target (1.13 to 1.78mmol/L).","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota (Dept: Perubatan)","price":"3.16","prescriberCat":"A*"},{"id":"drug-1260","genericName":"Sucroferric Oxyhydroxide 500mg Chewable Tablet","brandName":"Velphoro","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Tablet"],"indications":"Control of hyperphosphataemia in chronic kidney disease, as potent non calcium based phosphate binder","dosing":"For patients requiring haemodialysis or peritoneal dialysis: Initially, 1,500 mg (3 tabs) daily in 3 divided doses with meals. Titrate the dose in increments or decrements of 500 mg daily at intervals of at least 1 week or every 2-4 weeks as needed until acceptable serum phosphorus levels are achieved and with regular monitoring thereafter. \\nUsual maintenance dose: 1,500-2,000 mg (3-4 tabs) daily in divided doses.\\nMax: 3,000 mg (6 tabs) daily.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"UBAT PESARA\\n\\nSpecial Drugs Approval (UKK) required (Dept: Perubatan\\n\\nMenggunakan peruntukan PESARA Mohon hantar borang ubat baru jika ingin menggunakan peruntukan ubat farmasi)","price":"6.48","prescriberCat":"Not in FUKKM"},{"id":"drug-1261","genericName":"Sugammadex 100 mg/ml Injection","brandName":"Bridion","category":"17.0 ANTIDOTES AND DETOXIFYING AGENTS","forms":["Injection"],"indications":"Indicated for reversal of neuromuscular blockade induced by \\nrocuronium and vecuronium in selective patient group: obese, elderly, underlying cardiovascular disease. For pediatric population, sugammadex is recommended for routine reversal","dosing":"2 mg/kg sugammadex is recommended, if spontaneous recovery has occurred up to at least the reappearance of second twitch tension of the train-of-four (T2). 4 mg/kg sugammadex is recommended if recovery has reached at least 1- 2 post-tetanic counts (PTC). For immediate reversal following administration of rocuronium a dose of 16 mg/kg sugammadex is recommended","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"257.90","prescriberCat":"A*"},{"id":"drug-1264","genericName":"Desflurane Liquid","brandName":"Supane","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["Liquid"],"indications":"i) Induction and maintenance of anaesthesia in adult \\nii) Maintenance of anaesthesia in infants & children","dosing":"ADULT: Induction , initially 3% in oxygen or nitrous oxide/oxygen and increased by 0.5%-1% every 2-3 breaths or as tolerated (up to 11%), until loss of consciousness. Maintenance: 2.5%-8.5% with or without concomitant nitrous oxide \\nCHILD: maintenance, inhaled in concentrations of 5.2%-10% with or without concomitant nitrous oxide","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"510.00","prescriberCat":"A"},{"id":"drug-1265","genericName":"Etomidate 20 mg Injection","brandName":"Etomidate-Lipuro","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["Injection"],"indications":"Induction of general anaesthesia for haemodynamically unstable patients","dosing":"Adult: 300 mcg/kg given slowly over 30-60 seconds into a large vein in the arm. Child: Up to 30% more than the standard adult dose. Elderly: 150-200 mcg/kg, subsequently adjusted according to effects.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit required for purchase\\n(UKK)","price":"26.12","prescriberCat":"A*"},{"id":"drug-1266","genericName":"Isoflurane Liquid","brandName":"Forane","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["Liquid"],"indications":"i) Induction \\nii) Maintenance of anaesthesia","dosing":"i) Induction- Initiate at a concentration of 0.5 % \\nii) Maintenance- 1 - 2.5 % in oxygen or nitrous oxide mixture. 0.5 - 0.75 % with oxygen and nitrous oxide for Caesarian section","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"177.90","prescriberCat":"B"},{"id":"drug-1267","genericName":"Ketamine 50 mg/ml Injection","brandName":"Kanox","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["Injection"],"indications":"Sole anaesthetic for short procedures or induction of anaesthesia in certain types of patients (e.g in shock states)","dosing":"IV Initially, 1-4.5 mg/kg IV, a dose of 2 mg/kg produces anesthesia for 5-10 mins. IM Initially, 6.5-13 mg/kg IM, a dose of 10 mg/kg produces anesthesia for 12-25 mins.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"25.88","prescriberCat":"B"},{"id":"drug-1268","genericName":"Propofol 1 % Injection (200mg/20ml)","brandName":"Troypofol","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["(200mg/20ml)"],"indications":"i) Induction & maintenance of general anaesthesia\\n\\nii) Sedation of ventilated patients in intensive care","dosing":"Adult: \\nInduction: 20- 40 mg by injection or infusion every 10 sec. Usual dose: 1.5-2.5 mg/kg. \\nMaintenance: 4-12 mg/kg/hr or intermittent bolus inj of 20-50 mg. \\nChild: >8 yr: \\nInduction dose: of 2.5 mg/kg. Maintenance dose: 9-15 mg/kg/hr by IV infusion or intermittent bolus inj. \\nElderly: Including neurosurgical and debilitated patients: Infuse at a rate of 20 mg every 10 sec. Maintenance: 3-6 mg/kg/hr. Usual dose needed: 1-1.5 mg/kg. \\nDuration of use : Can be administered for a maximum period of 7 days. Sedation: 0.3 - 4 mg/kg/hour up to 3 days","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.58","prescriberCat":"A*"},{"id":"drug-1269","genericName":"Sevoflurane Liquid 250ml","brandName":"Sevoflurane inhalation anesthetic liquid","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["250ml"],"indications":"To be used only for i) induction and ii) maintenance of anaesthesia","dosing":"i) Adult: Given via a calibrated vaporiser: Up to 5% v/v with oxygen or a mixture of oxygen and nitrous oxide. Child: Given via a calibrated vaporiser: Up to 7% v/v. \\nii) Adult: 0.5-3% v/v with or without nitrous oxide. Child: 0.5-3% v/v with or without nitrous oxide.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"242.44","prescriberCat":"A*"},{"id":"drug-1270","genericName":"Thiopental Sodium 500 mg Injection","brandName":"Pentotex","category":"18.0 ANAESTHETICS\\n18.1 GENERAL ANAESTHETICS","forms":["Injection"],"indications":"i) General anaesthesia, induction \\nii) Anticonvulsant for cases resistant to conventional anticonvulsants in the ICU","dosing":"i) ADULT : For induction 200 - 400 mg. For repeat injection 3 - 5 mg/kg over 10 - 15 seconds until desired depth of anaesthesia is obtained. Not FDA approved for use in pediatric patients \\nii) 75 - 125 mg IV single dose; \\nfor local-anaesthetic induced convulsion: 125 - 250 mg IV over 10 minutes","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"13.78","prescriberCat":"B"},{"id":"drug-1273","genericName":"Bupivacaine 0.5 % Injection","brandName":"Pivakan","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Injection"],"indications":"For peripheral sympathetic nerve and epidural (excluding caudal) anaesthesia and obstetrics anaesthesia","dosing":"Regional nerve block or epidural block: 15 - 30 ml. Nerve block of finger or toe: 2 - 6 ml. Maximum: 2 mg/kg body weight in any 4 hours period, equivalent to 25 - 30 ml in adults of average weight","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"5.75","prescriberCat":"B"},{"id":"drug-1274","genericName":"Bupivacaine 0.5 % with Adrenaline 1:200,000 Injection","brandName":"Marcain 0.5% with Adrenaline","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Injection"],"indications":"Regional nerve block or epidural block.","dosing":"10 - 40 ml (0.25 %) or maximum : 2 mg/kg body weight in any 4 hours period, equivalent to 25 - 30 ml of 0.5% solution","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"23.73","prescriberCat":"B"},{"id":"drug-1275","genericName":"Bupivacaine 0.5 % Heavy Injection","brandName":"Marcaine Spinal 0.5% Heavy","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Injection"],"indications":"Used for spinal anaesthesia","dosing":"ADULT: 2 - 4 ml. Not to exceed 2 mg/kg in a single dose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.79","prescriberCat":"A"},{"id":"drug-1276","genericName":"Ethyl Chloride Spray","brandName":"Wari Ethyl Chloride Spray","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Spray"],"indications":"For minor surgical procedures including lancing boils, incision and drainage of small abscesses, pain due to athletic injuries and pain due to injection administration","dosing":"Spray to affected area at a distance of about 30cm until a fine white film is produced","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"23.20","prescriberCat":"C"},{"id":"drug-1277","genericName":"Levobupivacaine 5mg/ml Injection","brandName":"Chirocaine","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Injection"],"indications":"Production of local or regional anesthesia for surgery and obstetrics, and for postoperative pain management","dosing":"Surgical anesthesia : Lumber epidural : 10 - 20 ml (50 - 150 mg) , caesarean section : 15 - 30 ml (75 - 150 mg), intrathecal: 3 ml (15 mg), peripheral nerve block : 1 - 40 ml, ilioinguinal/iliohypogastric block. CHILD : 0.25 - 0.5 ml/kg (1.25-2.5 mg/kg)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota","price":"15.26","prescriberCat":"A"},{"id":"drug-1278","genericName":"Lidocaine 25mg and Prilocaine 25mg Cream","brandName":"RACSER","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Cream"],"indications":"Used for painless venepunctures, radial artery cannulations before extradural/spinal and other regional blocks in children above 1 year old and adults. Also used in chronic renal failure patients for insertion of A-V fistulas and shunts for haemodialysis.","dosing":"Apply a thick layer under occlusive dressing at least 1 hour before the procedure","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan, Pediatrik)","price":"8.13","prescriberCat":"A"},{"id":"drug-1279","genericName":"Lignocaine HCl (Lidocaine) 2% Injection","brandName":"Pharmaniaga Lidocaine","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Injection"],"indications":"For local or regional anaesthesia and nerve block. Not for IV use.","dosing":"Local anesthesia: ADULT Maximum: 100 mg; CHILD Maximum: 3 mg/kg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"7/25: To remove from formulary after finish stock","price":"1.38","prescriberCat":"B"},{"id":"drug-1280","genericName":"Lignocaine 2% Jelly","brandName":"Axcel \\nLignocaine","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Jelly"],"indications":"Use for endotracheal tubes and instruments, painful procedures in the ear, nose and throat, burns, wounds, abrasions, lacerations; catheterisation of the male and female urethra and for symptomatic treatment of cystitis and urethritis","dosing":"Apply to affected area 10 mins before catheterization, etc","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"7.54","prescriberCat":"B"},{"id":"drug-1281","genericName":"Lignocaine 2% Viscous Solution (100ml)","brandName":"Vignocaine","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["(100ml)"],"indications":"i) To relief pain associated with irritated or inflamed mucous membranes of the:\\na) mouth;\\nb) pharynx (post-tonsillectomy)\\nc) upper gastrointestinal tract (e.g esophagitis).\\n\\nii) Use for instrumentation of the respiratory and digestive tracts (e.g. bronchoscopy, oesophagoscopy).","dosing":"i) a) For anaesthesia of the mouth: Rinse the mouth with 5-15 ml (100- 300 mg lignocaine), then the solution is spat out. In dental practice, 10 ml solution (200 mg lidocaine) are used. The solution should be spat out when adequate anaesthesia has been achieved (after approx. 1 minute).\\nb) For anaesthesia of the pharynx: Gargle with 5-10 ml (100-200 mg lignocaine), after which the solution is slowly swallowed.\\nc) Painful conditions in the upper GI tract: 5-15 ml (100-300 mg lignocaine) are rapidly swallowed all at once.\\n*Daily dose should not exceed 1200 mg (Total of 60 ml)\\n\\nii) Instrumentations into the stomach: 10-15 ml (200-300 mg lignocaine) are swallowed.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"58.88","prescriberCat":"A"},{"id":"drug-1283","genericName":"Lignocaine 10 % w/w Spray","brandName":"Lox 10%","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Spray"],"indications":"For surface anaesthesia in dental practice, in otorhinolaryngology and \\nparacentesis","dosing":"Spray to affected part","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"92.70","prescriberCat":"B"},{"id":"drug-1284","genericName":"Lignocaine (Lidocaine) 5% and Phenylephrine HCl 0.5% Nasal Spray","brandName":"Co-Phenylcine Forte","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Spray"],"indications":"Preparation of nasal mucosa for surgery (eg. Cautery to Little's area), aid the treatment of acute nose bleeds and removal of foreign bodies from the nose, topical anaesthesia of the pharynx prior to direct or indirect laryngoscopy, topical anaesthesia and local vasoconstriction prior to endoscopy of the upper airways","dosing":"Adults and children over 12 years : 5 squirts per nostril. Children: 8 to 12 years 3 squirts per nostril, \\n4 to 8 years 2 squirts per nostril, \\n2 to 4 years 1 squirt per nostril. \\n\\nDoses are to be administered once only.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: ENT)","price":"314.75","prescriberCat":"A*"},{"id":"drug-1285","genericName":"Ropivacaine HCl 7.5 mg/ml (=0.75%) Injection","brandName":"Naropin","category":"18.0 ANAESTHETICS\\n18.2 REGIONAL ANAESTHETICS","forms":["Injection"],"indications":"i) Surgical anaesthaesia including obstetrics \\nii) Acute pain management","dosing":"Dose adjusted according to patient physical status and nature of procedure. \\ni) Lumbar epidural: 15-25 ml of 7.5 mg/ml solution; Caesarean section, 15-20 ml of 7.5 mg/ml solution in incremental doses ( max . total dose 150 mg). \\nii) lumbar epidural: 10-20 ml of 2mg/ml solution followed by 10-15 ml of 2 mg/ml solution at interval at of least 30 minutes. Labour pain 6-10 ml/hour of 2mg/ml solution","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"32.80","prescriberCat":"A*"},{"id":"drug-1288","genericName":"Haemophillus Influenza Type B (HiB) Conjugate Vaccine Injection","brandName":"Hiberix","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Injection"],"indications":"Immunisation of infants against Haemophilus Influenzae Type B","dosing":"0.5ml by IM. In patients with thrombocytopenia or bleeding disorders, vaccine can be administered by SC.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"57.42","prescriberCat":"C+"},{"id":"drug-1289","genericName":"Hepatitis B Vaccine Injection","brandName":"Euvax-B","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Injection"],"indications":"Immunisation against infections caused by Hepatitis B virus","dosing":"Dose depends on the products used. Please refer to package insert. \\nExample: 1. Euvax-B Adult (from 16 years old) - 20mcg/dose \\nNeonates, infants & children up to and including 15 years - 10mcg/dose \\n2. Engerix-B Adult (from 20 years old) - 20mcg/dose \\nNeonates, infants & children up to and including 19 years - 10mcg/dose \\nSecond dose to be given after 1 month and booster dose after 6 months","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"6.84  (adult), 4.29 (paed)","prescriberCat":"C+"},{"id":"drug-1290","genericName":"Influenza Vaccine","brandName":"Vaxigrip","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Vaccine"],"indications":"i) Prophylaxis of influenza for frontliners (KKM staff and essential services personnel). \\nii) Prophylaxis of influenza in high risk groups, particularly individuals who have chronic cardiovascular, pulmonary, metabolic or renal disease, or who are immunocompromised and elderly patients. Refer to current recommendation by WHO for selection of product of inactivated influenza vaccines.","dosing":"CHILD 6-35 months: Single dose of 0.5 ml IM or deep SC; 3-8 years: 1-2 doses of 0.5 ml IM \\nADULT & CHILD more than 9 years: Single dose of 0.5 ml IM","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"24.83","prescriberCat":"B"},{"id":"drug-1291","genericName":"Meningococcal A, C, Y, W 135 Vaccine Injection","brandName":"Menactra","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Injection"],"indications":"Immunisation against meningococcal diseases caused by Neisseria meningitis Group A, Group C, Group Y or Group W-135","dosing":"Prophylaxis: 0.5 ml intramuscular injection.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"97.21","prescriberCat":"B"},{"id":"drug-1292","genericName":"Palivizumab 100 mg Injection","brandName":"Synagis","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Injection"],"indications":"For the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in paediatric patients at high risk of RSV disease","dosing":"15 mg/kg IM once a month during season of RSV risk","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Kuota","price":"3488.00","prescriberCat":"A*"},{"id":"drug-1293","genericName":"Pneumococcal Vaccine (Polyvalent)","brandName":"PneumoVax","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["(Polyvalent)"],"indications":"Prevention of pneumococcal infections in high risk subjects from the age of 2 years including patient with a history of splenectomy or scheduled splenectomy","dosing":"Primary injection: 1 single injection (0.5 ml) only. Booster: Must not be given within 5 years except in very high risk patient who received the vaccine while under immunosuppressive treatment","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"101.90","prescriberCat":"A"},{"id":"drug-1294","genericName":"Rabies Human Diploid Cell Vaccine (Lyophilised) Injection","brandName":"Verorab","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Injection"],"indications":"Pre-exposure and post-exposure vaccination against rabies","dosing":"Pre-exposure (prophylaxis): 3 doses scheduled on D0, D7 and D28. Booster dose after every 6 months to 5 years (refer to manufacturer's recommendations). Post-exposure prophylaxis: use after attack of a potential rabid animal: 1 dose on D0, D3, D7, D14 and D28. In previously vaccinated individuals 2 doses on D0 and D3.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"78.00","prescriberCat":"B"},{"id":"drug-1295","genericName":"Tetanus Toxoid Vaccine  Injection","brandName":"Vaksin TT","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.1 VACCINES","forms":["Injection"],"indications":"Immunization against tetanus infection","dosing":"2 doses of 0.5 mL IM at an interval of 4-8 wk, followed by the 3rd dose 6-12 mth later. Booster: 0.5 mL IM every 10 yr.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"10.15","prescriberCat":"C+"},{"id":"drug-1298","genericName":"Anti RhD Gamma Globulin 300 mcg/2 ml Injection","brandName":"Rhophylac (150mcg = 750IU)","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Injection"],"indications":"Prevention of Rh(D) sensitisation to Rh(D)-negative woman: \\ni) Pregnancy/delivery of Rh(D)-positive infant \\nii) Abortion/threatened abortion, ectopic pregnancy or hydatidiform mole iii) Transplacental haemorrhage resulting from antepartum haemorrhage, amniocentesis, chorionic biopsy or obstetric manipulative procedures e.g. external version or abdominal trauma","dosing":"i) Antenatal prophylaxis: According to general recommendations, currently administered doses range from 50  330 micrograms or 250 - 1650 IU. For specific details, please refer to product's package insert. \\nii) Postnatal prophylaxis: According to general recommendations, currently administered doses range from 100  300 micrograms or 500  1500 IU. For specific details, please refer to product's package insert.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"464.00","prescriberCat":"B"},{"id":"drug-1299","genericName":"Antivenene Green Pit Viper Injection","brandName":"Green Pit Viper Snake Antivenin","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Injection"],"indications":"Green pit viper snake bite","dosing":"initial dose 3 vials, subsequent doses can be given every 6 hours according to clinical symptoms. \\nTotal dose for adults to be further diluted in 250ml-500ml NS% or D5%. \\nTotal dose for children to be further diluted in 5-10ml/kg of NS or D5%\\n\\nto run at initial rate of 1ml/min for 10 minutes, then 2ml/min for 10 minutes, if no anapylactic reaction, increase to 5-10ml/min to complete the infusion within 1 hour\\nAs product may differ from batches and manufacturer, it is strongly recommended to refer to the product insert on dosing recommendation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase (UKK)","price":"351.90","prescriberCat":"-"},{"id":"drug-1300","genericName":"Antivenene Malayan Pit Viper Injection","brandName":"Malayan Pit Viper Antivenin","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Injection"],"indications":"Treatment of patients who exhibit manifestations of systemic envenoming following a bite by Malayan Pit Viper (Calloselasma rhodostoma).","dosing":"Initial dose of 30ml of reconstituted antivenene given by slow intravenous infusion (2ml/min). Subsequent dose can be given every 6 hours according to the clinical symptoms. As product may differ from batches and manufacturer, it is strongly recommended to refer to the product insert on dosing recommendation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"452.40","prescriberCat":"B"},{"id":"drug-1301","genericName":"Antivenene Serum (Cobra) Injection","brandName":"Cobra Antivenin","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Injection"],"indications":"Treatment of patients who exhibit manifestations of systemic envenoming following a bite by Cobra (Naja kaouthia).","dosing":"Initial dose of 100ml of reconstituted antivenene given by slow intravenous infusion (2ml/min). Subsequent dose can be given every 12 hours according to the clinical symptoms. As product may differ from batches and manufacturer, it is strongly recommended to refer to the product insert on dosing recommendation.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"754.00","prescriberCat":"B"},{"id":"drug-1302","genericName":"Antivenom Serum Snake Polyvalent Injection (Hemato Polyvalent)","brandName":"Hemato Polyvalent Snake Antivenin","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Polyvalent)"],"indications":"Passive immunisation against poisonous of a range of haematotoxic snakebites or neurotoxic snakebites, based on the type of snake identified.","dosing":"For initial does, at least 20mL of reconstituted serum should be given by slow intravenous infusion (not more than 1mL/minute). If symptoms still persist, the second dose should be repeated 2 hours or even earlier after the initial dose. The further dose should be repeated every 6 hours according to the clinical symptoms. Administration: Draw 10mL of the sterile water for injection to the freeze-dried antivenin, shake well to dissolve the contents until the serum became clear colourless or pale yellow liquid, ready for administration.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"507.96","prescriberCat":"-"},{"id":"drug-1303","genericName":"Antivenom Serum Snake Polyvalent Injection (Neuro Polyvalent)","brandName":"Neuro Polyvalent Snake Antivenin","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Polyvalent)"],"indications":"Passive immunisation against poisonous of a range of haematotoxic snakebites neurotoxic snakebites, based on the type of snake identified.","dosing":"For initial dose, at least 20mL of reconstituted serum should be given by slow intravenous infusion (not more than 1mL/minute). If symptoms still persist, the second dose should be repeated 2 hours or even earlier after the initial dose. The further dose should be repeated every 6 hours according to the clinical symptoms. Administration: Draw 10mL of the sterile water for injection to the freeze-dried antivenin, shake well to dissolve the contents until the serum became clear colourless or pale yellow liquid, ready for administration.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"507.96","prescriberCat":"-"},{"id":"drug-1304","genericName":"Antivenene Serum (Sea snake) 1000 IU","brandName":"CSL Sea Snake Antivenom","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["IU"],"indications":"Treatment of patients who exhibit manifestations of systemic envenoming following a bite by sea snake.","dosing":"1000 units by IV infusion over 1/2 to 1 hour. In severe cases 3000 -10000 units may be required","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"20752.40","prescriberCat":"B"},{"id":"drug-1305","genericName":"Hepatitis B Immunoglobulin (Human) Injection 100U/0.5ml","brandName":"Hepabig","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["100U/0.5ml"],"indications":"i) For post-exposure prophylaxis of hepatitis B \\nii) Prophylaxis against recurrence of hepatitis B infection in chronic hepatitis B post liver transplantation","dosing":"i) Adults: Recommended Dose: 1000-2000 IU IM and if necessary, the dose should be increased or repeated. \\nChildren: Inject 32-48 IU/kg of body weight, should be administered within 7 days after exposure to HBsAg (preferably within 48 hrs). \\nNeonates: Recommended Initial Dose: 100-200 IU. The 1st dose should be administered within 5 days after birth (preferably within 48 hrs) and booster dose should be 32-48 IU/kg body weight. The booster dose should be administered between 2 and 3 months after the 1st administration. \\nii) Different regimens depending on hepatitis B virus (HBV) DNA positivity","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"211.30","prescriberCat":"A"},{"id":"drug-1306","genericName":"Hyperimmune Gamma Globulin IM/IV Inj.","brandName":"Gamma-16","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Inj."],"indications":"","dosing":"","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"556.80","prescriberCat":"-"},{"id":"drug-1307","genericName":"Human Normal Immunoglobulin Injection 3g/50ml (6%)","brandName":"Flebogamma 5% DIF","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["(6%)"],"indications":"i. Replacement therapy such as:\\na) Primary immunodeficiency syndromes\\nb) Severe secondary hypogammabulinaemia and\\nrecurrent infections\\nc) Congenital or acquired immune deficiency syndrome\\nwith recurrent infections\\nd) Allogeneic haematopoietic stem cell transplantation\\n(HSCT)","dosing":"0.2-2g/kg as required\\n\\nDosing and frequency of administration are according to product insert and protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"517.36","prescriberCat":"A"},{"id":"drug-1309","genericName":"Immunoglobulin Tetanus Human 250 Units/Vial Injection","brandName":"Sero-Tet","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Injection"],"indications":"Passive immunization against tetanus","dosing":"Prophylaxis of tetanus: IM 250 units. \\nTreatment of tetanus: IM 30 - 300 units/kg","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"120.00","prescriberCat":"B"},{"id":"drug-1310","genericName":"Interferon Beta-1a 44mcg /0.5mlInjection","brandName":"Rebif","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["/0.5mlInjection"],"indications":"Multiple sclerosis of the relapsing remitting type with 2 or more relapses within the last 2 years","dosing":"44 mcg 3 times weekly","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"297.00","prescriberCat":"A*"},{"id":"drug-1311","genericName":"Palivizumab 100mg injection","brandName":"Synagis","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["injection"],"indications":"For the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in paediatric patients at high risk of RSV disease","dosing":"15 mg/kg IM once a month during season of RSV risk","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"3676.00","prescriberCat":"A*"},{"id":"drug-1312","genericName":"Varicella-Zoster Immunoglobulin","brandName":"Varitect CP","category":"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS\\n19.2 ANTISERA AND IMMUNOLOGICALS","forms":["Immunoglobulin"],"indications":"To provide passive immunity to babies born to mothers with active varicella infection within 5 days before or 48 hours after delivery","dosing":"IM 125 unit ( for baby weighing 0-10 kg)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Import Permit Required for purchase (UKK) (Dept: Pediatrik)","price":"1015.00","prescriberCat":"Not in FUKKM"},{"id":"drug-1315","genericName":"Human Albumin 20% Injection 50ml","brandName":"Albapure","category":"20.0 PLASMA SUBSTITUTE","forms":["50ml"],"indications":"i) Acute hypovolemic shock \\nii) Hypoproteinaemia \\niii) Neonatal hyperbilirubinaemia","dosing":"i) ADULT 25 g. CHILD 0.6 g/kg body weight \\nii) Maximum daily dose is 2g \\nii) 1 g/kg before exchange transfusion. Dose is given at rate of 1 ml of 25% solution per minute","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"123.70","prescriberCat":"B"},{"id":"drug-1316","genericName":"Hydroxyethyl Starch 6% Injection (6% hydroxyethyl starch 130/0.4 in an isotonic electrolyte injection)","brandName":"Voluven","category":"20.0 PLASMA SUBSTITUTE","forms":["injection)"],"indications":"Therapy and prophylaxis of hypovolaemia and shock in connection with surgery trauma, infections and burns","dosing":"ADULT daily dose up to 20 ml/kg/day. Normally 500-1500 ml. The rate of infusion may approach 20 ml/kg/hour in acute haemorrhagic shock, slower rates in burns and septic shock. CHILD under 10 years do not exceed 15 ml /kg/hour.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"45.63","prescriberCat":"B"},{"id":"drug-1317","genericName":"Modified Fluid Gelatin 4% Injection","brandName":"Infusol SG","category":"20.0 PLASMA SUBSTITUTE","forms":["Injection"],"indications":"For primary volume replacement in hypovolaemia, peri-operative stabilization of the circulation, haemodilution, extracorporeal circulation (haemodialysis and heart-lung machine)","dosing":"ADULT 500 - 1500 ml given as IV infusion","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"13.57","prescriberCat":"B"},{"id":"drug-1320","genericName":"Balanced Salt Solution","brandName":"BSS","category":"21.0 MISCELLANEOUS","forms":["Solution"],"indications":"For irrigation during ocular surgery","dosing":"Irrigate as directed","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"18.27","prescriberCat":"A"},{"id":"drug-1321","genericName":"Beractant Intratracheal Suspension (200 mg phospholipids in 8 ml vial)","brandName":"Survanta","category":"21.0 MISCELLANEOUS","forms":["vial)"],"indications":"Treatment of newborn baby with birth weight of 700 g or greater undergoing mechanical ventilation for respiratory distress syndrome, whose heart rate and arterial oxygenation are continuously monitored","dosing":"100 mg/kg (4 ml/kg) body weight intratracheally up to 4 doses in 1st 48 hr. Doses should not be given more frequently than 6 hrly. To be administered as soon as possible.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"1,503","prescriberCat":"A*"},{"id":"drug-1322","genericName":"Calfactant 35mg/ml intratracheal suspension","brandName":"Intrasurf","category":"21.0 MISCELLANEOUS","forms":["suspension"],"indications":"For the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS and for the treatment (rescue) of premature infants who develop RDS. Prophylaxis: Indicated for premature infants <29 weeks of gestational age at significant risk for RDS. Should be administered as soon as possible, preferably within 30 minutes after birth. Treatment: Indicated for infants 72 hours of age with RDS (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.","dosing":"3mL/kg body weight at birth to be administered every 12 hours for total up to 3 doses.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Pediatrik)","price":"1,400","prescriberCat":"A*"},{"id":"drug-1323","genericName":"Ether Solvent 1 L","brandName":"Ether","category":"21.0 MISCELLANEOUS","forms":["L"],"indications":"To remove adhesive plaster from the skin","dosing":"Dose depending on the route and procedure","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"210.00","prescriberCat":"C"},{"id":"drug-1324","genericName":"Haemodialysis Concentrate with Acetate","brandName":"Renacid","category":"21.0 MISCELLANEOUS","forms":["Acetate"],"indications":"For acute renal failure, chronic renal failure, overhydration, intoxication, adjustment of acid-base and electrolyte balance","dosing":"Dose depending on clinical cases","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"16.40","prescriberCat":"A"},{"id":"drug-1325","genericName":"Haemodialysis Concentrate with Bicarbonate","brandName":"Renacarb K2","category":"21.0 MISCELLANEOUS","forms":["Bicarbonate"],"indications":"For acute renal failure, chronic renal failure, overhydration, intoxication, adjustment of acid-base and electrolyte balance","dosing":"Dose depending on clinical cases","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"33.92","prescriberCat":"A"},{"id":"drug-1326","genericName":"Haemodialysis Concentrate Acidic Component","brandName":"Renacid K5","category":"21.0 MISCELLANEOUS","forms":["Component"],"indications":"For acute renal failure, chronic renal failure, overhydration, intoxication, adjustment of acid-base and electrolyte balance","dosing":"Dose depending on clinical cases","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"33.92","prescriberCat":"A"},{"id":"drug-1327","genericName":"Hydroxyethyl Cellulose Jelly","brandName":"QC Lubricating Jelly","category":"21.0 MISCELLANEOUS","forms":["Jelly"],"indications":"For lubricating purpose","dosing":"Apply sufficiently for lubricating purpose","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"8.00","prescriberCat":"B"},{"id":"drug-1328","genericName":"Methadone 5 mg/ml Syrup 1L","brandName":"Sunward \\nMethadone","category":"21.0 MISCELLANEOUS","forms":["1L"],"indications":"Detoxification treatment or maintenance treatment of narcotic addiction. \\nOff-label use: Pain control in cancer","dosing":"Initial 10-20mg per day, increasing by 10-20mg per day until there are no signs of withdrawal or intoxication. Usual dose 40-60mg/day\\ncancer pain: refer pain specialist. Doses of 2.5mg OD to 5mg BD have been used in HSM. WHO: titrated up to 20mg BD","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Special\\n drugs\\n approval (UKK) \\n(by bulk) required for off label use (Dept: Psikiatrik\\nPerubatan\\nPembedahan)","price":"22.51","prescriberCat":"A/KK"},{"id":"drug-1329","genericName":"Methylene Blue 0.5%, 1% Injection","brandName":"Proveblue","category":"21.0 MISCELLANEOUS","forms":["Injection"],"indications":"i) For treatment of idiopathic and drug-induced methaemoglobinemia \\nii) As dye in diagnostic procedures\\nHSM: Surgical markings in OT","dosing":"i) Adult and children: 1 to 2 mg/kg IV over 5 minutes.\\nThis dosage can be repeated if necessary after one hour.\\n\\nii) A dose of 5 mg/kg diluted in 500 mL of glucose 5% infused over 1 hour has been used successfully to stain and identify the parathyroid glands.\\n\\nDosing is individualised and according to product insert/protocol.","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"Currently using 0.5%\\n\\n1% no longer a registered product in M'sia (Dept: Pembedahan)","price":"63.01","prescriberCat":"B"},{"id":"drug-1330","genericName":"Nicotine 2 mg, 4mg Gum","brandName":"Nicorette 2mg\\n\\nNicorette 4 mg","category":"21.0 MISCELLANEOUS","forms":["Gum"],"indications":"For the treatment of tobacco dependence by relieving nicotine withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit.","dosing":"Smokes  20 sticks/day, chew 2mg gum. Smokes  20 sticks/day,chew 4 mg gum. (MAX 24 pieces /day for up to 12 week.)","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"0.79   1.18","prescriberCat":"A/KK"},{"id":"drug-1331","genericName":"Peritoneal Dialysis with 1.5% Glucose Solution 2 L","brandName":"Peritonil H1","category":"21.0 MISCELLANEOUS","forms":["L"],"indications":"For chronic renal disease requiring dialysis and for acute renal failure","dosing":"Dose depending on clinical cases","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.23","prescriberCat":"B"},{"id":"drug-1332","genericName":"Peritoneal Dialysis with 4.25% Glucose Solution 2 L","brandName":"Peritonil H2","category":"21.0 MISCELLANEOUS","forms":["L"],"indications":"For chronic renal disease requiring dialysis and for acute renal failure","dosing":"Dose depending on clinical cases","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"","price":"12.55","prescriberCat":"B"},{"id":"drug-1333","genericName":"Protein Free Haemodialysate 10% Jelly","brandName":"Solcoseryl","category":"21.0 MISCELLANEOUS","forms":["Jelly"],"indications":"Trophic lesions in patients with arterial occlusive disease and with chronic venous insufficiency, burn injuries, impaired wound healing, decubitus ulcers and skin ulcer caused by irradiation","dosing":"Apply 3 - 5 times daily","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"product discont","price":"25.00","prescriberCat":"A"},{"id":"drug-1334","genericName":"Varenicline Tartrate 0.5 mg + 1 mg Tablet Starter Pack","brandName":"Champix","category":"21.0 MISCELLANEOUS","forms":["Pack"],"indications":"Smoking cessation treatment","dosing":"0.5 mg once daily for Day 1-3, then 0.5 mg twice daily for Day 4-7, then 1 mg twice daily; duration of treatment is 12 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"103.22","prescriberCat":"A/KK"},{"id":"drug-1335","genericName":"Varenicline Tartrate 1 mg Tablet","brandName":"Champix","category":"21.0 MISCELLANEOUS","forms":["Tablet"],"indications":"Smoking cessation treatment","dosing":"0.5 mg once daily for Day 1-3, then 0.5 mg twice daily for Day 4-7, then 1 mg twice daily; duration of treatment is 12 weeks","renalDose":"Check guidelines","pregnancy":"Not specified","highAlert":false,"notes":"(Dept: Perubatan)","price":"103.22","prescriberCat":"A/KK"}]`),xd=[{id:"dilution-001",genericName:"Acyclovir",brandName:"Vaxcel Acyclovir IV For Infusion",strength:"250mg",reconstitution:"Reconstitute 1 vial (250mg) with 10ml WFI or NS to provide a solution containing 25mg/ml",furtherDilution:"Dilute the required volume of reconstituted solution to give a concentration not greater than 5mg/ml (0.5% w/v). For children and neonates, dilute 4ml reconstituted solution (100mg) added to 20ml of infusion fluid. For adults, use 100ml infusion bags.",diluents:["NS"],administration:"IV infusion: Administer by slow IV infusion over 1 hour",storage:"After reconstitution: 48 hours | After dilution: 48 hours | Protect from light | DO NOT REFRIGERATE",remarks:"Do not give by IV bolus, IM or subcutaneous route. Beware that too-rapid infusion may damage renal tubules.",category:"Antiviral"},{id:"dilution-002",genericName:"Amikacin",brandName:"Apalin",strength:"500mg/2ml",reconstitution:"Not required",furtherDilution:"Add 500mg amikacin solution to 100-200ml diluent",diluents:["NS","D5"],administration:"IM or IV infusion. Adult: infuse slowly over 30-60 minutes | Infants: infuse slowly over 1-2 hours",storage:"After dilution: RT (25C) 24 hours | Fridge (4C) 60 days",remarks:"Slow IV infusion may help to avoid neuromuscular blockade. Do not physically premix with other drugs.",category:"Aminoglycoside"},{id:"dilution-003",genericName:"Amoxicillin & Clavulanate",brandName:"Clavam For Injection BP",strength:"1.2g",reconstitution:"Reconstitute 1 vial (1.2g) with 20ml WFI (Final volume 20.9ml)",furtherDilution:"IV infusion: Dilute the reconstituted solution to 100ml diluent",diluents:["NS","WFI"],administration:"Slow IV bolus: Administer slowly over 3-4 minutes within 20 minutes of reconstitution | IV infusion: Administer over 30-40 minutes",storage:"After reconstitution: 20 minutes | After dilution: RT 4 hours | Fridge 8 hours",remarks:"Color may range from cream to pale yellow. Not suitable for IM administration. Less stable in glucose/dextrose infusions. Should not be mixed with blood products or protein fluids.",category:"Penicillin + Beta-lactamase Inhibitor"},{id:"dilution-004",genericName:"Amphotericin B",brandName:"Photericin B For Injection USP",strength:"50mg",reconstitution:"Reconstitute 1 vial (50mg) with 10ml WFI. Shake immediately until clear colloidal solution.",furtherDilution:"Further dilute to 0.1mg/ml concentration (0.25mg/ml for central line). Final concentration should not exceed these limits.",diluents:["D5"],administration:"IV infusion: Administer by slow IV infusion over 2-6 hours depending on dose. Single IV test dose (1mg in 20ml D5) over 20-30 minutes may be preferred.",storage:"After reconstitution: RT 24 hours | Fridge 7 days | After dilution: RT 24 hours | Fridge 2 days | Protected from light",remarks:"Monitor temperature, pulse, respiration, BP every 30 minutes for 2-4 hours. Rapid IV infusion (< 1 hour) associated with hyperkalemia and arrhythmias. Do not reconstitute with saline. In-line filter (1 micron) may be used.",category:"Antifungal"},{id:"dilution-005",genericName:"Ampicillin",brandName:"Kampibiotic Injection",strength:"500mg",reconstitution:"IV: Dissolve 1 vial (500mg) in 10ml WFI | IM: Dilute 1 vial (500mg) with 1.5ml WFI",furtherDilution:"IV infusion: Dilute with 50-100ml NS (maximum concentration: 30mg/ml)",diluents:["NS"],administration:"Slow IV bolus: Administer slowly over 3-4 minutes. Do not exceed 100mg/minute | Intermittent IV infusion: Administer over 15-30 minutes | IM",storage:"Use immediately",remarks:"Too-rapid infusion may cause seizures. Do not mix beta-lactam antibiotics with aminoglycosides. If prescribed concurrently, administer at separate sites at least 1 hour apart.",category:"Penicillin"},{id:"dilution-006",genericName:"Ampicillin & Sulbactam",brandName:"Amsubac Injection",strength:"1.5g (Ampicillin 1g + Sulbactam 500mg)",reconstitution:"IV: Reconstitute 1 vial (1.5g) with 3.2ml WFI. Allow foaming to dissipate | IM: Reconstitute with 3.2ml WFI or 0.5% lignocaine HCl",furtherDilution:"IV infusion: Further dilute to 50-100ml diluent",diluents:["NS"],administration:"Slow IV bolus: Administer slowly over minimum 3 minutes | IV infusion: Administer over 15-30 minutes | IM: Deep IM injection",storage:"Not specified",remarks:"Do not mix or give through same IV line with aminoglycosides. Rapid infusion may cause seizures.",category:"Penicillin + Beta-lactamase Inhibitor"},{id:"dilution-007",genericName:"Anidulafungin",brandName:"Eraxis",strength:"100mg",reconstitution:"Reconstitute 1 vial (100mg) with 30ml WFI to provide 3.33mg/ml. Reconstitution time can be up to 5 minutes.",furtherDilution:"100mg dose: Add 30ml reconstituted to 100ml diluent (130ml total, 0.77mg/ml final) | 200mg dose: Add 60ml reconstituted to 200ml diluent (260ml total, 0.77mg/ml final)",diluents:["NS","D5"],administration:"IV infusion ONLY. Rate should not exceed 1.1mg/minute (1.4ml/min or 84ml/hour). Duration: 100mg over 90 minutes | 200mg over 180 minutes",storage:"After reconstitution: RT 24 hours | After dilution: RT 48 hours | Frozen 72 hours | For single use only",remarks:"Anaphylactic reactions and infusion-related adverse events reported. Infusion-related events infrequent when rate does not exceed 1.1mg/minute. Do not give as IV bolus.",category:"Antifungal"},{id:"dilution-008",genericName:"Artesunate",brandName:"Artesun Powder For Injection",strength:"60mg",reconstitution:"Reconstitute 1 vial (60mg) with provided diluent (5% sodium bicarbonate). Shake for 2-3 minutes until clear solution.",furtherDilution:"IV: Dilute 1ml reconstituted with 5ml diluent = 6ml total (10mg/ml) | IM: Dilute 1ml reconstituted with 2ml diluent = 3ml total (20mg/ml)",diluents:["NS","D5"],administration:"Slow IV bolus: Administer required dose slowly at 3-4ml/minute | IM",storage:"Use immediately",remarks:"Do not use in intravenous drip. Discard if solution not clear.",category:"Antimalarial"},{id:"dilution-009",genericName:"Azithromycin",brandName:"Vaxcel Azithromycin IV For Infusion",strength:"500mg",reconstitution:"Reconstitute 1 vial (500mg) with 4.8ml WFI to obtain 100mg/ml",furtherDilution:"Add 5ml reconstituted to 500ml diluent (1mg/ml, infuse over 3 hours) OR add 5ml reconstituted to 250ml diluent (2mg/ml, infuse over 1 hour)",diluents:["NS","D5"],administration:"IV infusion: 500mg dose over minimum 1 hour. Do not administer as IV bolus or IM injection.",storage:"After reconstitution: RT (252C) 24 hours | After dilution: RT (<25C) 24 hours | Fridge (2-8C) 7 days",remarks:"Do not add other substances or medications to azithromycin or infuse simultaneously through same IV line.",category:"Macrolide"},{id:"dilution-010",genericName:"Benzathine Penicillin",brandName:"Benzapen Sterile Penicillin G Benzathine USP",strength:"2.4 Mega Units",reconstitution:"Reconstitute with 8ml WFI",furtherDilution:"Not required",diluents:[],administration:"IM only. Avoid sciatic nerve damage in infants/small children - do not inject upper outer quadrant of buttock except in special cases.",storage:"Use immediately",remarks:"Alert patient to potential allergic reactions. Observe patient for 30 minutes after administration. Must NOT be injected subcutaneously, intravenously, intrathecally or into body cavities.",category:"Penicillin"},{id:"dilution-011",genericName:"Benzylpenicillin",brandName:"Bepen Injection",strength:"1MU (600mg), 5MU (3g)",reconstitution:"1MU vial with 2ml or more WFI | 5MU vial with 10ml or more WFI",furtherDilution:"Intermittent IV infusion: Dilute in 50-100ml NS | Continuous IV infusion: Dilute in 1000-2000ml NS",diluents:["NS"],administration:"IM: Alternate sites for repeated injections | Intermittent IV infusion: Over 1-2 hours (adults) | 15-30 minutes (children/infants) | Continuous IV infusion: Over 24 hours (preferred for large doses)",storage:"After reconstitution: RT 2 days | Fridge 6 days | Reconstituted solutions intended for immediate administration",remarks:"Should be administered separately from solutions containing metal ions. Too-rapid infusion may cause electrolyte imbalance or seizures.",category:"Penicillin"},{id:"dilution-012",genericName:"Caspofungin Acetate",brandName:"Cancidas For Injection",strength:"50mg, 70mg",reconstitution:"Bring refrigerated vial to RT. 50mg vial: Add 10.5ml NS or WFI (5.2mg/ml) | 70mg vial: Add 10.5ml NS or WFI (7.2mg/ml)",furtherDilution:"70mg dose: Transfer 5ml to each of two 100ml IV bags (0.33mg/ml each) | 50mg dose: Transfer 10ml to 100ml IV bag (0.45mg/ml) | Pediatric: Dilute to 250ml or reduced volume, max 0.5mg/ml",diluents:["NS","0.45% Sodium Chloride (Pediatric)"],administration:"IV infusion ONLY. Administer slowly over approximately 1 hour. For 70mg dose, administer each bag sequentially over 30 minutes.",storage:"After reconstitution: RT (<25C) 24 hours | After dilution: RT 24 hours | Fridge 48 hours | Lyophilized powder: Store at 2-8C",remarks:"Do not use diluents containing dextrose. Do not mix or co-infuse with other medications. Visually inspect for particulate matter or discoloration.",category:"Antifungal"},{id:"dilution-013",genericName:"Cefazolin",brandName:"Cefazolin Sandoz",strength:"1g",reconstitution:"IV: Reconstitute 1 vial (1g) with 4ml NS or WFI | IM: Reconstitute with 4ml 0.5% lidocaine solution",furtherDilution:"IV infusion: Dilute in 50-100ml NS",diluents:["NS"],administration:"Slow IV bolus: Administer slowly over 3-5 minutes (up to 1g) | IV infusion: doses >1g over 20-30 minutes | IM: Inject into major muscle mass",storage:"Use immediately",remarks:"Do not mix in same infusion with aminoglycoside as both drugs may be inactivated.",category:"Cephalosporin (1st Gen)"},{id:"dilution-014",genericName:"Cefepime",brandName:"Cefmex Powder For Injection",strength:"1g",reconstitution:"IV: Reconstitute 1 vial (1g) with 10ml diluent (approx 90mg/ml) | IM: Reconstitute with 3ml diluent (approx 230mg/ml)",diluents:["WFI","D5","NS"],furtherDilution:"IV infusion: Dilute to 50-100ml diluent",administration:"Slow IV bolus: Administer slowly over 3-5 minutes | IV infusion: Administer over 30 minutes | IM: Deep IM injection into large muscle mass",storage:"After reconstitution & dilution: Fridge (2-8C) 48 hours | Compatible at 1-40mg/ml",remarks:"Inspect visually for particulate matter before administration. Do not use if particulate matter present.",category:"Cephalosporin (4th Gen)"},{id:"dilution-015",genericName:"Cefoperazone",brandName:"Bicafar",strength:"1g",reconstitution:"IV: Reconstitute 1g with 5ml D5, NSD5, NS or WFI. For continuous IV, dissolve each gram in 5ml WFI | IM: Use 2-step process with WFI then lidocaine for concentrations 250mg/ml",furtherDilution:"IV (max 2g/day): Dilute to 100mg/ml | Intermittent IV infusion: Dilute with 20-100ml diluent",diluents:["D5","NSD5","NS"],administration:"Slow IV bolus: Over 3-5 minutes | Intermittent IV infusion: Over 15 minutes to 1 hour | IM: Deep IM into gluteus maximus or anterior thigh",storage:"After reconstitution (300mg/ml): RT (15-25C) 24 hours | Fridge (2-8C) 5 days",remarks:"Cefoperazone and aminoglycoside solutions should not be directly mixed - physical incompatibility.",category:"Cephalosporin (3rd Gen)"},{id:"dilution-016",genericName:"Cefoperazone & Sulbactam",brandName:"Vaxcel Cefobactam Injection",strength:"1g (Cefoperazone 500mg + Sulbactam 500mg)",reconstitution:"IV: Reconstitute 1 vial (1g) with 3.4ml WFI, D5 or NS | IM: Reconstitute with 3.4ml WFI then dilute with 2% lidocaine to 125mg/125mg per ml in 0.5% lidocaine",furtherDilution:"Intermittent IV infusion: Dilute reconstituted solution to 20ml with same solution",diluents:["WFI","NS","D5"],administration:"Slow IV bolus: Over minimum 3 minutes | Intermittent IV infusion: Over 15-60 minutes | IM",storage:"After reconstitution: RT (<25C) 24 hours",remarks:"Sulbactam/cefoperazone and aminoglycosides should not be directly mixed - physical incompatibility.",category:"Cephalosporin + Beta-lactamase Inhibitor"},{id:"dilution-017",genericName:"Cefotaxime",brandName:"Rekaxime Injection",strength:"500mg, 1g",reconstitution:"500mg vial with 2ml WFI | 1000mg vial with 4ml WFI",furtherDilution:"Short infusion: Dilute in 40ml WFI or 10% glucose | Continuous drip: Dilute in 100ml isotonic saline or glucose",diluents:["NS","D5","D10"],administration:"Slow IV bolus: Over 3-5 minutes | Short infusion: Infuse in approximately 20 minutes | Continuous drip: Infuse over 50-60 minutes | IM: Deep into gluteus, max 4ml per side. If daily dose >2g, IV preferred",storage:"Cefotaxime solutions: RT (<25C) 24 hours | Should be administered as soon as prepared",remarks:"Incompatible with alkaline solutions (sodium bicarbonate) and hetastarch. Do not mix with aminoglycosides or metronidazole. Pale yellow color does not mean impaired efficacy. IV bolus <1 minute can cause life-threatening arrhythmias.",category:"Cephalosporin (3rd Gen)"},{id:"dilution-018",genericName:"Ceftazidime",brandName:"Cefatum Injection",strength:"1g, 2g",reconstitution:"1g IM: 3ml 0.5% lignocaine (260mg/ml) | 1g IV: 10ml WFI (90mg/ml) | 2g IV: 10ml WFI (170mg/ml)",diluents:["WFI","0.5% lignocaine"],furtherDilution:"Intermittent IV infusion: Dilute in 100ml diluent",administration:"Slow IV bolus: Over 3-5 minutes | Intermittent IV infusion: Over 30 minutes | IM: Deep IM into large muscle mass",storage:"After reconstitution with WFI: RT 12 hours | Fridge 7 days | With lignocaine: RT 6 hours | Fridge 4 days | After dilution (1-40mg/ml): RT 12 hours | Fridge 7 days",remarks:"Sodium bicarbonate not recommended as diluent. Color ranges from light yellow to amber depending on concentration/storage. Individual doses >1g should be given IV. Do not mix beta-lactams with aminoglycosides.",category:"Cephalosporin (3rd Gen)"},{id:"dilution-019",genericName:"Ceftriaxone",brandName:"Unocef Injection",strength:"500mg, 1g",reconstitution:"IM: 500mg vial with 1.8ml WFI (250mg/ml) or 1ml WFI (350mg/ml) | 1g vial with 3.6ml WFI (250mg/ml) or 2.1ml WFI (350mg/ml) | IV: 500mg with 4.8ml WFI | 1g with 9.6ml WFI",furtherDilution:"IV infusion: Dilute reconstituted solution to 50 or 100ml diluent",diluents:["WFI","NS","D5","1% Lidocaine (IM only)"],administration:"IV infusion: Administer over 30 minutes (concentration 10-40mg/ml recommended) | IM: Deep IM into large muscle mass. Doses >1g distributed between two sites",storage:"Varies with diluent. WFI/NS/D5 at 100mg/ml: RT 3 days | Fridge 10 days | At 250-350mg/ml: RT 24 hours | Fridge 3 days",remarks:"DO NOT use diluents containing calcium (Ringer's or Hartmann's solution). Must not be administered with calcium-containing IV solutions. After reconstitution, protection from normal light is not necessary.",category:"Cephalosporin (3rd Gen)"},{id:"dilution-020",genericName:"Cefuroxime",brandName:"Pharmaniaga Cefuroxime Injection",strength:"750mg, 1.5g",reconstitution:"IM: 750mg vial with 3ml WFI | IV: 750mg vial with 6ml WFI or 1.5g vial with 12ml WFI",furtherDilution:"IV infusion: Further dilute to 50-100ml diluent",diluents:["NS","D5"],administration:"Slow IV injection: Over 3-5 minutes | IV infusion: Over 30 minutes | IM: Deep IM injection",storage:"Varies with diluent and concentration (RT 5-24 hours, Fridge 24-48 hours depending on formulation)",remarks:"Do not add to solutions of aminoglycosides or sodium bicarbonate.",category:"Cephalosporin (2nd Gen)"},{id:"dilution-021",genericName:"Clindamycin",brandName:"Generic",strength:"300mg/2ml, 600mg/4ml",reconstitution:"Not required",furtherDilution:"300mg to 50ml | 600mg to 50ml | 900mg to 50-100ml | 1200mg to 100ml",diluents:["NS","D5"],administration:"300mg over 10 minutes | 600mg over 20 minutes | 900mg over 30 minutes | 1200mg over 40 minutes | Max rate: 30mg/minute",storage:"After dilution: RT 16-24 hours (varies by diluent) | Fridge up to 32 days",remarks:"Do not inject undiluted as bolus. Do not use if precipitate forms. Reduce rate if adverse reactions occur.",category:"Lincosamide"},{id:"dilution-022",genericName:"Cloxacillin",brandName:"Generic",strength:"500mg, 1g",reconstitution:"IV: 500mg with 5ml WFI (100mg/ml) | 1g with 10ml WFI (100mg/ml) | IM: 500mg with 2ml WFI (250mg/ml)",furtherDilution:"IV infusion: Dilute to 50-100ml diluent",diluents:["NS","D5","WFI"],administration:"Slow IV injection: Over 3-4 minutes | IV infusion: Over 30-60 minutes | IM: Deep IM",storage:"After reconstitution: Use within 1-2 hours | After dilution: Use promptly",remarks:"Incompatible with aminoglycosides - administer separately. Do not mix in same syringe/infusion.",category:"Penicillin"},{id:"dilution-023",genericName:"Ertapenem",brandName:"Invanz Injection",strength:"1g",reconstitution:"IV infusion: Reconstitute with 10ml sterile WFI, NS or bacteriostatic WFI | IM: Reconstitute with 3.2ml 1% lidocaine HCl injection (without epinephrine)",furtherDilution:"IV infusion: Transfer reconstituted to 50ml NS",diluents:["NS"],administration:"IV infusion: Administer over 30 minutes | IM: Deep IM injection into large muscle mass (gluteal or lateral thigh)",storage:"After reconstitution: Use immediately (within 6 hours) | After dilution for infusion: RT 6 hours | Fridge 24 hours",remarks:"Must NOT be mixed or co-infused with other medications. Do not use diluents containing dextrose.",category:"Carbapenem"},{id:"dilution-024",genericName:"Erythromycin Lactobionate",brandName:"Eritrotex Injection",strength:"500mg",reconstitution:"Reconstitute 1 vial (500mg) with 10ml WFI to obtain 50mg/ml",furtherDilution:"IV infusion: Dilute with not less than 100ml diluent to final concentration 1-5mg/ml",diluents:["NS","D5"],administration:"Intermittent IV infusion: Administer over 60 minutes every 6 hours | Continuous IV infusion: Administer over 24 hours",storage:"Should be freshly prepared and unused portion discarded",remarks:"Erythromycin IV may cause phlebitis. Dilute appropriately and infuse slowly to minimize risk.",category:"Macrolide"},{id:"dilution-025",genericName:"Ganciclovir",brandName:"Cymevene",strength:"500mg",reconstitution:"Reconstitute with 10ml WFI (50mg/ml). Do not use bacteriostatic water.",furtherDilution:"Dilute in 100ml diluent (concentration should not exceed 10mg/ml)",diluents:["NS","D5"],administration:"IV infusion: Administer over 1 hour. Do not give by rapid or bolus IV injection.",storage:"After reconstitution: Use within 12 hours | Do not refrigerate | After dilution: Use within 24 hours if refrigerated",remarks:"Do not administer IM or SC. Hydration recommended before infusion. Handle as cytotoxic agent.",category:"Antiviral"},{id:"dilution-026",genericName:"Gentamicin",brandName:"Garasent",strength:"80mg/2ml",reconstitution:"Not required",furtherDilution:"IV infusion: Dilute in 50-200ml diluent",diluents:["NS","D5"],administration:"IM or IV infusion over 30-60 minutes",storage:"Not specified",remarks:"Should not be physically premixed with other drugs.",category:"Aminoglycoside"},{id:"dilution-027",genericName:"Imipenem & Cilastatin",brandName:"Imipenem/Cilastatin Kabi Powder For Solution",strength:"500mg",reconstitution:"Reconstitute with 100ml compatible diluent",furtherDilution:"May be added to compatible IV solutions",diluents:["NS","D5"],administration:"IV infusion: 500mg over 20-30 minutes | 1g over 40-60 minutes",storage:"After reconstitution: RT 4 hours | After dilution: Varies by diluent (4-24 hours)",remarks:"Should not be mixed with or physically added to other antibiotics. May be administered through same tubing if flushed between medications.",category:"Carbapenem"},{id:"dilution-028",genericName:"Meropenem",brandName:"Nuronem Injection",strength:"500mg, 1g",reconstitution:"Reconstitute 1 vial (500mg) with 10ml WFI (5ml WFI per 250mg) to obtain 50mg/ml",furtherDilution:"IV infusion: Dilute reconstituted solution with 50-200ml diluent",diluents:["NS","D5"],administration:"Slow IV bolus: Administer slowly over 5 minutes | IV infusion: Administer over 15-30 minutes",storage:"After dilution in NS: RT 8 hours | Fridge 48 hours | After dilution in D5: RT 3 hours | Fridge 14 hours | Do not freeze",remarks:"Should not be mixed in solution with other antibiotics.",category:"Carbapenem"},{id:"dilution-029",genericName:"Micafungin",brandName:"Mycamine Powder For Solution",strength:"50mg, 100mg",reconstitution:"Add 5ml NS or D5 to vial. Gently swirl (do not shake vigorously)",furtherDilution:"Add reconstituted solution to 100ml NS or D5 infusion bag",diluents:["NS","D5"],administration:"IV infusion ONLY. Flush existing IV line with NS prior to infusion. Administer over approximately 1 hour.",storage:"After reconstitution: RT 24 hours | After dilution: 6 hours without light protection | 24 hours with light protection",remarks:"Concentrate should be used immediately for dilution. Single use only - discard residue. Place in opaque bag for light protection.",category:"Antifungal"},{id:"dilution-030",genericName:"Netilmicin",brandName:"Lotifar Injection",strength:"150mg/2ml, 100mg/2ml",reconstitution:"Not required",furtherDilution:"IV infusion: Dilute single dose in 50-200ml diluent",diluents:["NS","D5"],administration:"Slow IV bolus: Administer over 3-5 minutes | IV infusion: Administer over 1.5-2 hours",storage:"After dilution: RT (<25C) 7 days at 3mg/ml concentration",remarks:"Should not be physically premixed with other drugs. Administer separately.",category:"Aminoglycoside"},{id:"dilution-031",genericName:"Pentamidine Isethionate",brandName:"DBL Pentamidine Isethionate For Injection",strength:"300mg",reconstitution:"Reconstitute 1 vial (300mg) with 3-5ml WFI",furtherDilution:"Dilute required dose in 50-250ml diluent",diluents:["NS","D5"],administration:"IV infusion: Administer over at least 60 minutes",storage:"After reconstitution: RT (212C) 48 hours | Fridge (2-8C) 48 hours | After dilution: 24 hours (both RT and fridge) at 1-2.5mg/ml",remarks:"Direct bolus IV or rapid administration must NOT be used. Keep patient supine during administration to minimize hypotension.",category:"Antiprotozoal"},{id:"dilution-032",genericName:"Piperacillin & Tazobactam",brandName:"Tapicin Powder For Injection",strength:"4.5g (Piperacillin 4g + Tazobactam 0.5g)",reconstitution:"Reconstitute 1 vial (4.5g) with 20ml diluent",diluents:["WFI","NS","D5"],furtherDilution:"IV infusion: Dilute reconstituted solution with 50-150ml diluent",administration:"Slow IV bolus: Administer over 3-5 minutes | IV infusion: Administer over 20-30 minutes",storage:"After reconstitution: RT (25C) 24 hours | Fridge (2-8C) 7 days",remarks:"Contains no preservative - use aseptic technique. When used with another antibiotic, administer separately. Do not use with sodium bicarbonate or add to blood products/albumin.",category:"Penicillin + Beta-lactamase Inhibitor"},{id:"dilution-033",genericName:"Sulphamethoxazole-Trimethoprim",brandName:"DBL Sulfamethoxazole & Trimethoprim Concentrate",strength:"5ml per ampoule (SMX 400mg + TMP 80mg)",reconstitution:"Not required",furtherDilution:"1 ampoule (5ml) to 125ml diluent | 2 ampoules (10ml) to 250ml | 3 ampoules (15ml) to 500ml",diluents:["D5","NS","D10"],administration:"IV infusion: Administer slowly over 60-90 minutes. Duration should not exceed 1.5 hours.",storage:"After dilution: RT 24 hours | Do NOT refrigerate prepared solution",remarks:"Must be diluted prior to administration. Administer IV only as infusion - not undiluted or directly into tube. Shake well to ensure mixing. Discard if turbidity or crystallization appears.",category:"Sulfonamide + Folate Antagonist"},{id:"dilution-034",genericName:"Vancomycin",brandName:"Celovan Powder For Solution",strength:"500mg",reconstitution:"Dissolve 500mg in 10ml WFI to obtain 50mg/ml",furtherDilution:"Intermittent IV infusion: Dilute with at least 100ml diluent (max 5mg/ml, or up to 10mg/ml for fluid-restricted patients)",diluents:["NS","D5"],administration:"Intermittent IV infusion: Administer over at least 60 minutes (max rate 10mg/minute). 1g dose usually given over 2 hours.",storage:"After dilution: RT (<25C) 48 hours | Fridge (2-8C) 48 hours",remarks:"Not for IM administration. Watch for 'red-man syndrome' - nonallergic histamine reaction from rapid IV. Symptoms: hypotension, pruritus, maculopapular rash on face/neck/trunk/limbs.",category:"Glycopeptide"},{id:"dilution-035",genericName:"Voriconazole",brandName:"Vfend",strength:"200mg",reconstitution:"Reconstitute 1 vial (200mg) with 19ml WFI (10mg/ml, extractable volume 20ml)",furtherDilution:"Further dilute required volume to final concentration 0.5-5mg/ml according to patient body weight",diluents:["NS","HSD5","D5"],administration:"IV infusion ONLY. Administer over 1-2 hours. Maximum rate: 3mg/kg/hour",storage:"After reconstitution: Fridge (2-8C) 24 hours | Product must be used immediately",remarks:"Must NOT be infused with blood products or concentrated electrolytes. Not for IV bolus. Must NOT be diluted with 4.2% sodium bicarbonate.",category:"Antifungal"},{id:"dilution-036",genericName:"Zidovudine",brandName:"Retrovir",strength:"200mg/20ml",reconstitution:"Not required",furtherDilution:"Mix required dose with diluent to obtain 2mg/ml or 4mg/ml concentration. Use full aseptic technique.",diluents:["D5"],administration:"IV infusion: Administer slowly over 1 hour. Avoid rapid infusion or bolus injection.",storage:"After dilution: RT (25C) 48 hours | Fridge (5C) 48 hours | Discard unused portion",remarks:"Do not administer as IM injection. Must be DILUTED prior to administration. Discard if visible turbidity appears before/after dilution or during infusion.",category:"Antiviral"}],gf={author:"Medication Safety Section, Pharmacy Practice and Development Division, Pharmaceutical Services Programme, Ministry of Health Malaysia"},Xg={disclaimer:"These are quick reference dosing guidelines. Always refer to the full Paediatric Protocols PDF for complete clinical context, contraindications, and special circumstances. Dosing must be individualized based on patient condition.",totalMedications:75},$o=[{id:"med-001",name:"Adrenaline (Epinephrine)",category:"Emergency & Resuscitation",indications:["Anaphylaxis","Cardiac arrest","Severe bradycardia","Croup"],dosing:{anaphylaxis:{route:"IM",dose:"0.01 mL/kg of 1:1000 (0.01 mg/kg)",maxDose:"0.5 mL (0.5 mg)",notes:"Repeat every 5-15 minutes as needed"},cardiacArrest:{route:"IV/IO",dose:"0.01 mg/kg of 1:10,000",maxDose:"1 mg",notes:"Repeat every 3-5 minutes"},croup:{route:"Nebulized",dose:"0.5 mL/kg of 1:1000 (max 5 mL)",notes:"Dilute in NS to total 5 mL"}},contraindications:["Hypovolemic shock without fluid resuscitation"],monitoring:["Heart rate","Blood pressure","ECG"],pdfChapters:[11]},{id:"med-002",name:"Ampicillin",category:"Antibiotics - Neonatal",indications:["Neonatal sepsis","Meningitis","Group B Strep prophylaxis"],dosing:{neonate_0_7days:{sepsis:"50 mg/kg IV q12h",meningitis:"100 mg/kg IV q12h"},neonate_8_28days:{sepsis:"75 mg/kg IV q8h",meningitis:"100 mg/kg IV q6-8h"}},route:["IV"],contraindications:["Penicillin allergy"],monitoring:["Renal function"],pdfChapters:[19]},{id:"med-003",name:"Gentamicin",category:"Antibiotics - Neonatal",indications:["Neonatal sepsis","Gram-negative infections"],dosing:{neonate:{dose:"4-5 mg/kg IV q24-48h",notes:"Extended interval dosing preferred. Adjust based on gestational age and postnatal age"}},route:["IV"],contraindications:["Aminoglycoside allergy"],monitoring:["Renal function","Peak and trough levels","Hearing"],sideEffects:["Nephrotoxicity","Ototoxicity"],pdfChapters:[19]},{id:"med-004",name:"Ceftriaxone",category:"Antibiotics",indications:["Meningitis","Sepsis","Pneumonia","UTI"],dosing:{infant_child:{standard:"50-75 mg/kg/day IV/IM once daily",meningitis:"100 mg/kg/day IV once daily (max 4g/day)",maxDose:"4 g/day"}},route:["IV","IM"],contraindications:["Hyperbilirubinemia in neonates","Concurrent calcium administration"],monitoring:["Renal function","LFTs"],pdfChapters:[11,49,50]},{id:"med-005",name:"Cefotaxime",category:"Antibiotics",indications:["Neonatal sepsis","Meningitis","Sepsis"],dosing:{neonate:{standard:"50 mg/kg IV q8-12h",meningitis:"50 mg/kg IV q6-8h"},infant_child:{standard:"50 mg/kg/dose IV q6-8h",meningitis:"75-100 mg/kg/dose IV q6h"}},route:["IV","IM"],notes:"Preferred over ceftriaxone in neonates with hyperbilirubinemia",pdfChapters:[19,50]},{id:"med-006",name:"Salbutamol (Albuterol)",category:"Bronchodilators",indications:["Asthma","Bronchiolitis","Hyperkalemia"],dosing:{nebulized:{dose:"2.5-5 mg nebulized",frequency:"q20min x 3 doses, then q1-4h as needed",notes:"Continuous nebulization for severe exacerbations"},iv_hyperkalemia:{dose:"4-5 mcg/kg IV over 20 minutes",notes:"For hyperkalemia management"}},route:["Nebulized","IV","MDI"],contraindications:["Hypersensitivity"],sideEffects:["Tachycardia","Tremor","Hypokalemia"],pdfChapters:[31,32]},{id:"med-007",name:"Ipratropium Bromide",category:"Bronchodilators",indications:["Moderate-severe asthma exacerbation"],dosing:{nebulized:{dose:"250-500 mcg nebulized with salbutamol",frequency:"q20min x 3 doses for acute exacerbation"}},route:["Nebulized","MDI"],notes:"Add to salbutamol in moderate-severe exacerbations",pdfChapters:[31]},{id:"med-008",name:"Dexamethasone",category:"Corticosteroids",indications:["Croup","Asthma","Meningitis","BPD"],dosing:{croup:{dose:"0.15-0.6 mg/kg PO/IV/IM (max 16 mg)",notes:"Single dose usually sufficient"},meningitis:{dose:"0.15 mg/kg IV q6h for 2-4 days",notes:"Give before or with first antibiotic dose"},bpd_dart:{day1_3:"75 mcg/kg/dose q12h",day4_6:"50 mcg/kg/dose q12h",day7_8:"25 mcg/kg/dose q12h",day9_10:"10 mcg/kg/dose q12h",notes:"Low-dose DART regimen for BPD"}},route:["PO","IV","IM"],contraindications:["Systemic fungal infection"],sideEffects:["Hyperglycemia","Hypertension","Immunosuppression"],pdfChapters:[29,33,50]},{id:"med-009",name:"Prednisolone",category:"Corticosteroids",indications:["Asthma exacerbation","Croup","Nephrotic syndrome"],dosing:{asthma:{dose:"1-2 mg/kg/day PO (max 40-60 mg)",duration:"3-5 days",notes:"No need to taper for short courses"},croup:{dose:"1 mg/kg PO (max 50 mg)",notes:"Alternative to dexamethasone"}},route:["PO"],pdfChapters:[31,33,64]},{id:"med-010",name:"Hydrocortisone",category:"Corticosteroids",indications:["Adrenal insufficiency","Septic shock","Anaphylaxis"],dosing:{stress_dose:{dose:"50-100 mg/m/day IV divided q6-8h",notes:"For adrenal crisis or stress dosing"},septic_shock:{dose:"50 mg/m IV q6h or 1-2 mg/kg/dose IV q6h",notes:"Consider in refractory septic shock"}},route:["IV","IM","PO"],pdfChapters:[11,63]},{id:"med-011",name:"Midazolam",category:"Anti-Seizure / Sedative",indications:["Status epilepticus","Seizures","Sedation"],dosing:{buccal_im:{dose:"0.2-0.5 mg/kg (max 10 mg)",route:"Buccal or IM",notes:"First-line for seizures outside hospital"},iv:{dose:"0.1-0.2 mg/kg IV (max 10 mg)",notes:"For status epilepticus"},infusion:{dose:"0.05-0.4 mg/kg/hr IV",notes:"For refractory status epilepticus"}},route:["IV","IM","Buccal","IN"],contraindications:["Acute narrow-angle glaucoma"],sideEffects:["Respiratory depression","Hypotension"],pdfChapters:[47]},{id:"med-012",name:"Levetiracetam (Keppra)",category:"Anti-Seizure",indications:["Status epilepticus","Seizure prophylaxis"],dosing:{loading:{dose:"40-60 mg/kg IV over 15 minutes (max 3000 mg)",notes:"For status epilepticus"},maintenance:{dose:"10-30 mg/kg/dose PO/IV q12h"}},route:["IV","PO"],advantages:["Minimal side effects","No significant drug interactions"],pdfChapters:[46,47]},{id:"med-013",name:"Phenytoin",category:"Anti-Seizure",indications:["Status epilepticus","Seizures"],dosing:{loading:{dose:"20 mg/kg IV at max rate 1 mg/kg/min or 50 mg/min",notes:"Requires cardiac monitoring, use NS only"},maintenance:{dose:"5-8 mg/kg/day divided q8-12h PO/IV"}},route:["IV","PO"],contraindications:["Heart block","Sinus bradycardia"],monitoring:["ECG during loading","Drug levels"],sideEffects:["Hypotension","Arrhythmias","Purple glove syndrome"],pdfChapters:[46,47]},{id:"med-014",name:"Dopamine",category:"Inotropes & Vasopressors",indications:["Septic shock","Cardiogenic shock","Hypotension"],dosing:{infusion:{lowDose:"2-5 mcg/kg/min (renal dose)",moderateDose:"5-10 mcg/kg/min (inotropic)",highDose:"10-20 mcg/kg/min (vasopressor)",notes:"High doses may worsen pulmonary hypertension"}},route:["IV continuous infusion"],contraindications:["Pheochromocytoma","Uncorrected tachyarrhythmias"],monitoring:["Heart rate","Blood pressure","Urine output"],pdfChapters:[11,25]},{id:"med-015",name:"Noradrenaline (Norepinephrine)",category:"Inotropes & Vasopressors",indications:["Septic shock","Hypotension","PPHN"],dosing:{infusion:{dose:"0.05-2 mcg/kg/min IV",notes:"May selectively reduce PVR and increase SVR in PPHN"}},route:["IV continuous infusion - central line preferred"],monitoring:["Blood pressure","Peripheral perfusion"],sideEffects:["Tissue necrosis if extravasation"],pdfChapters:[11,25]},{id:"med-016",name:"Calcium Gluconate 10%",category:"Electrolytes",indications:["Hypocalcemia","Hyperkalemia","Magnesium toxicity"],dosing:{hypocalcemia:{dose:"0.5-1 mL/kg IV slow push (50-100 mg/kg elemental Ca)",rate:"Over 15-20 minutes if stable, 2-5 minutes if unstable"},hyperkalemia:{dose:"0.5 mL/kg IV (max 20 mL)",rate:"Over 2-5 minutes with cardiac monitoring",notes:"Cardioprotective, does not lower K+"}},route:["IV"],contraindications:["Hypercalcemia","Digoxin toxicity"],monitoring:["ECG","Serum calcium"],notes:"0.5 mL/kg = 0.1 mmol/kg elemental calcium",pdfChapters:[9]},{id:"med-017",name:"Potassium Chloride",category:"Electrolytes",indications:["Hypokalemia"],dosing:{oral:{dose:"Up to 2 mmol/kg/day in divided doses",notes:"For mild-moderate hypokalemia"},iv:{dose:"0.2 mmol/kg/hr IV infusion",maxConcentration:"40 mmol/L (peripheral), 60 mmol/L (central)",notes:"NEVER give IV bolus"},severe:{dose:"0.4 mmol/kg/hr into central vein",notes:"For K+ <2.5 mmol/L, requires ICU setting"}},route:["IV infusion","PO"],contraindications:["Hyperkalemia","Renal failure"],monitoring:["Serum potassium","ECG","Urine output"],pdfChapters:[9]},{id:"med-018",name:"Furosemide (Lasix)",category:"Diuretics",indications:["Heart failure","Pulmonary edema","Hyperkalemia","Fluid overload"],dosing:{infant_child:{iv:"0.5-2 mg/kg/dose IV q6-12h",oral:"1-4 mg/kg/day PO divided 1-2 times daily",infusion:"0.05-0.4 mg/kg/hr continuous IV"}},route:["IV","PO"],sideEffects:["Hypokalemia","Hyponatremia","Dehydration","Ototoxicity"],monitoring:["Electrolytes","Renal function","Fluid balance"],pdfChapters:[41]},{id:"med-019",name:"Paracetamol (Acetaminophen)",category:"Analgesics & Antipyretics",indications:["Fever","Pain"],dosing:{neonate:{oral:"10-15 mg/kg/dose q6-8h",iv:"7.5-10 mg/kg/dose q6h"},infant_child:{oral:"10-15 mg/kg/dose q4-6h (max 75 mg/kg/day or 4g/day)",iv:"<10kg: 7.5 mg/kg q6h, 10-50kg: 15 mg/kg q6h (max 60 mg/kg/day)",rectal:"15-20 mg/kg/dose q6-8h"}},route:["PO","IV","PR"],contraindications:["Severe hepatic impairment"],toxicity:"Hepatotoxicity with overdose",antidote:"N-acetylcysteine",pdfChapters:[109]},{id:"med-020",name:"Morphine",category:"Analgesics - Opioid",indications:["Moderate-severe pain","Sedation","PPHN"],dosing:{neonate:{iv:"0.05-0.1 mg/kg/dose q3-4h",infusion:"10-20 mcg/kg/hr"},infant_child:{iv:"0.05-0.2 mg/kg/dose q2-4h",infusion:"10-40 mcg/kg/hr",oral:"0.2-0.5 mg/kg/dose q4-6h"}},route:["IV","PO","SC"],contraindications:["Respiratory depression","Paralytic ileus"],sideEffects:["Respiratory depression","Hypotension","Constipation"],monitoring:["Respiratory rate","Sedation level","Blood pressure"],reversal:"Naloxone",pdfChapters:[25,112]},{id:"med-021",name:"Insulin (Regular/Actrapid)",category:"Endocrine - Insulin",indications:["Diabetic ketoacidosis","Hyperglycemia","Hyperkalemia"],dosing:{dka:{infusion:"0.05-0.1 units/kg/hr IV",notes:"Start after initial fluid bolus, adjust to drop glucose 4-5 mmol/L/hr"},hyperkalemia:{dose:"0.05 units/kg/hr with glucose 10% at 5 mL/kg/hr",notes:"Monitor blood glucose closely"}},route:["IV infusion"],contraindications:["Hypoglycemia"],monitoring:["Blood glucose q1h","Electrolytes","Ketones"],sideEffects:["Hypoglycemia","Hypokalemia"],pdfChapters:[9,61]},{id:"med-022",name:"Glucose (Dextrose)",category:"Fluids & Nutrition",indications:["Hypoglycemia","With insulin therapy"],dosing:{hypoglycemia_neonate:{bolus:"200-250 mg/kg IV (2-2.5 mL/kg of D10%)",maintenance:"6-8 mg/kg/min IV infusion"},hypoglycemia_child:{bolus:"0.5-1 g/kg IV (5-10 mL/kg of D10% or 2-5 mL/kg of D25%)",maintenance:"Variable based on response"}},route:["IV"],monitoring:["Blood glucose"],notes:"Use D10% in neonates, D25% or D50% in children",pdfChapters:[9,18,61]},{id:"med-023",name:"Phenobarbital",category:"Anti-Seizure",indications:["Neonatal seizures","Status epilepticus"],dosing:{loading:{dose:"20 mg/kg IV over 20-30 minutes",additionalDoses:"10 mg/kg q15-20min (max total 40 mg/kg)",notes:"For neonatal seizures or status epilepticus"},maintenance:{dose:"3-5 mg/kg/day divided q12h PO/IV",notes:"Start 12-24 hours after loading"}},route:["IV","PO"],sideEffects:["Sedation","Respiratory depression"],monitoring:["Drug levels","Respiratory status"],pdfChapters:[46,47]},{id:"med-024",name:"Acyclovir",category:"Antivirals",indications:["HSV infection","Varicella","Neonatal herpes"],dosing:{hsv_encephalitis:{dose:"20 mg/kg/dose IV q8h for 14-21 days",notes:"For CNS HSV infection"},neonatal_hsv:{dose:"20 mg/kg/dose IV q8h for 14-21 days",notes:"Disseminated or CNS disease"},varicella:{dose:"10-15 mg/kg/dose IV q8h or 20 mg/kg PO qid",notes:"For severe or immunocompromised patients"}},route:["IV","PO"],contraindications:["Hypersensitivity"],sideEffects:["Nephrotoxicity","Neurotoxicity"],monitoring:["Renal function","Adequate hydration"],pdfChapters:[26,27]},{id:"med-025",name:"Ondansetron",category:"Antiemetics",indications:["Nausea","Vomiting","Gastroenteritis"],dosing:{infant_child:{dose:"0.15 mg/kg/dose IV/PO q8h (max 16 mg/day)",weight_based:{"8-15kg":"2 mg","15-30kg":"4 mg",">30kg":"8 mg"}}},route:["IV","PO"],contraindications:["Congenital long QT syndrome"],sideEffects:["QT prolongation","Constipation"],pdfChapters:[10]},{id:"med-026",name:"Oral Rehydration Solution (ORS)",category:"Fluids & Rehydration",indications:["Mild-moderate dehydration","Gastroenteritis"],dosing:{mild_dehydration:{volume:"50 mL/kg over 4 hours",replacement:"10 mL/kg for each loose stool"},moderate_dehydration:{volume:"100 mL/kg over 4 hours",replacement:"Plus ongoing losses"}},route:["PO"],composition:"WHO-ORS: 75 mmol/L Na+, 75 mmol/L glucose",pdfChapters:[10]},{id:"med-027",name:"Sodium Bicarbonate",category:"Electrolytes & Buffers",indications:["Metabolic acidosis","Hyperkalemia","TCA overdose"],dosing:{metabolic_acidosis:{dose:"1-2 mmol/kg IV over 30-60 minutes",calculation:"Dose (mEq) = 0.3  weight (kg)  base deficit",notes:"Give half the calculated dose initially"},hyperkalemia:{dose:"1-2 mmol/kg IV over 5-30 minutes",notes:"For severe hyperkalemia with acidosis"}},route:["IV"],contraindications:["Metabolic/respiratory alkalosis","Hypocalcemia"],monitoring:["pH","Electrolytes","Ionized calcium"],pdfChapters:[9]},{id:"med-028",name:"Magnesium Sulfate",category:"Electrolytes",indications:["Hypomagnesemia","Torsades de pointes","PPHN"],dosing:{hypomagnesemia:{dose:"25-50 mg/kg/dose IV over 15-30 minutes",maxDose:"2 g/dose"},pphn:{loading:"200 mg/kg IV over 20 minutes",maintenance:"20-50 mg/kg/hr to maintain level 3-5.5 mmol/L"}},route:["IV"],sideEffects:["Hypotension","Bradycardia","Respiratory depression"],monitoring:["Magnesium levels","Deep tendon reflexes","Blood pressure"],antidote:"Calcium gluconate",pdfChapters:[9,25]}],Ed=[{id:"counsel-001",name:"Abacavir",pharmacologicalGroup:"Nucleoside reverse transcriptase inhibitor",indication:"Antiretroviral combination therapy for the treatment of HIV infection in adults, adolescents and children weighing at least 25 kg. a) Adult",dosage:"300mg BD or 600mg OD",methodOfAdministration:"1. May be administered with or without food. Missed dose management : 1. To take medication consistently at the same time everyday . Any missed dose to be taken as soon as possible. 2. For twice daily dosing of abacavir , if the gap is more than 6 hours, to skip and continue with a regular dosing schedule. Do not double the dose on the next administration time. 3. For once daily dosing of abacavir , if the gap is more than 12 hours, to skip and continue with a regular dosing schedule. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Patients who become pregnant while taking abacavir may continue if viral suppression is effective and the regimen is well tolerated.",breastfeeding:"Abacavir is present in breast milk. 2. It is recommended that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.",elderly:"No pharmacokinetic data are currently available in patients over 65 years of age. Special care is advised in this age group due to age associated changes such as decrease in hepatic, renal and cardiac function, and concomitant disease or other drug therapy .",paediatric:"Children weighing 14 to < 20 kg: one-half of a scored abacavir tablet twice daily. Children weighing  20 kg to < 25 kg: one-half of a scored abacavir tablet taken in the morning and one whole tablet taken in the evening. For adolescents and children who weigh less than 25kg, commercial oral solution is available. Alternatively , the tablets 5 may be crushed. 1,2",fasting:"To be discussed with infectious disease consultant",hepaticImpairment:", the use of abacavir is not recommended unless judged necessary .",renalImpairment:"No dosage adjustment necessary for any degree of kidney dysfunction."},sideEffects:["Abacavir is associated with a risk for hypersensitivity reactions. Patients who test positive for HLA-B*5701 are at the highest risk of experiencing HSRs. HLA screening should be done before initiating ABC.","Symptoms usually appeared within the first six weeks of initiation of treatment with abacavir , although these reactions may occur at any time during therapy . These reactions usually include signs or symptoms from two or more of the following: fever , skin rash, constitutional symptoms (malaise, fatigue, aches), respiratory symptoms (eg, pharyngitis, dyspnea, cough), and GI symptoms (eg, abdominal pain, diarrhea, nausea, vomiting).","Abacavir/Lamivudine must be stopped without delay , even in the absence of the HLA-B*5701 allele, if an HSR is suspected. Delay in stopping treatment with abacavir/lamivudine after the onset of hypersensitivity may result in a life-threatening reaction.","Do not restart abacavir/lamivudine as it can result in a prompt return of symptoms within hours. This recurrence is usually more severe than on initial presentation, and may include life-threatening hypotension and death"],others:{storage:"Store in a dry place below 30 C. Store in the original container .",other_points:"Precautions 1. Abacavir should not be used in patients known to carry the HLA-B*5701 allele or in patients with a prior hypersensitivity reaction to abacavir . 6"}},{id:"counsel-002",name:"Abacavir/Lamivudine",pharmacologicalGroup:"Nucleoside reverse transcriptase inhibitor",indication:"1. Indications: Antiretroviral combination therapy for the treatment of HIV infection in adults, adolescents and children weighing at least 25 kg",dosage:"1 tablet once daily",methodOfAdministration:"1. May be administered with or without food. Missed dose management 1. To take medication consistently at the same time everyday . Any missed dose to be taken as soon as possible. 2. However if the gap is more than 12 hours, to skip and continue with a regular dosing schedule. Do not double the dose on the next administration time. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Patients who become pregnant while taking abacavir/lamivudine may continue if viral suppression is effective and the regimen is well tolerated.",breastfeeding:"Abacavir and lamivudine are present in breast milk. 2. It is recommended that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.",elderly:"No pharmacokinetic data are currently available in patients over 65 years of age. Special care is advised in this age group due to age associated changes such as the decrease in renal function and alteration of haematological parameters.",paediatric:"Abacavir/Lamivudine should not be administered to children who weigh less than 25 kg because it is a fixed-dose tablet that cannot be dose reduced.",fasting:"To be discussed with infectious disease consultant",hepaticImpairment:", the use of abacavir/lamivudine is not recommended unless judged necessary .",renalImpairment:"It is not recommended for use in patients with a creatinine clearance < 30 ml/min. ( use dose-adjusted individual components)"},sideEffects:["Abacavir is associated with a risk for hypersensitivity reactions. Patients who test positive for HLA-B*5701 are at the highest risk of experiencing HSRs. HLA screening should be done before initiating ABC.","Symptoms usually appeared within the first six weeks of initiation of treatment with abacavir , although these reactions may occur at any time during therapy . These reactions usually include signs or symptoms from two or more of the following: fever , skin rash, constitutional symptoms (malaise, fatigue, aches), respiratory symptoms (eg, pharyngitis, dyspnea, cough), and GI symptoms (eg, abdominal pain, diarrhea, nausea, vomiting).","Abacavir/Lamivudine must be stopped without delay , even in the absence of the HLA-B*5701 allele, if an HSR is suspected. Delay in stopping treatment with abacavir/lamivudine after the onset of hypersensitivity may result in a life-threatening reaction.","Do not restart abacavir/lamivudine as it can result in a prompt return of symptoms within hours. This recurrence is usually more severe than on initial presentation, and may include life-threatening hypotension and death."],others:{storage:"1. Store in a dry place below 30 C. Store in the original container .",other_points:"Precautions 1. Abacavir should not be used in patients known to carry the HLA-B*5701 allele or in patients with a prior hypersensitivity reaction to abacavir ."}},{id:"counsel-003",name:"Acetylsalicyclic Acid (Aspirin",pharmacologicalGroup:"Antiplatelet agent Non-steroidal anti-inflammatory drug (NSAID)",indication:"1. i) Prevention of myocardial infarct, stroke, vascular occlusion and deep vein thrombosis. ii) Transient ischaemic attacks a. Acetylsalicylic Acid 100 mg & Glycine 45 mg Tablet 2. Initial treatment of cardiovascular disorders such as angina pectoris and myocardial infarction and for the prevention of cardiovascular events in patients at risk. Other such uses include the treatment and prevention of cerebrovascular disorders such as stroke a. Acetylsalicylic Acid 300 mg Soluble Tablet b. Acetylsalicylic Acid 150mg Dispersible Tablet c. Acetylsalicylic Acid 75mg Dispersible Tablet Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Aspirin may be taken after food to reduce stomach discomfort. 2. Acetylsalicylic Acid 100 mg & Glycine 45 mg Tablet may be swallowed whole or place on the tongue to dissolve for rapid absorption 3. Dispersible tablet formulations can be dispersed in water immediately before use or swallowed whole. Missed dose management: Take aspirin as soon as you remember if you forget to take it. However , if it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to. Do not take a double dose to make up for the dose that you missed. Inform all treating doctors, dentists, and pharmacists that you are taking aspirin Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Do not use aspirin if you are pregnant or trying for a baby unless directed by your doctor . Aspirin can prolong labour and affect blood clotting in the mother or baby . 2. Aspirin should be avoided 1 week prior to and during labor and delivery because it can result in excessive blood loss at delivery . Prolonged gestation and prolonged labor due to prostaglandin inhibition have been reported. 10",breastfeeding:"Nursing mothers should avoid using aspirin because salicylate is excreted in breast milk. Use of high doses may lead to rashes, platelet abnormalities, and bleeding in nursing infants.",elderly:"Beers Criteria: a. Avoid initiating aspirin for primary prevention of cardiovascular disease. Consider deprescribing aspirin in older adults already taking it for primary prevention . Risk of major bleeding from aspirin increases markedly in older age. Studies suggest lack of net benefit and potential for net harm when initiated for primary prevention in older adults. There is less evidence about stopping aspirin among long-term users, although similar principles as for initiation may apply . Note: Aspirin is generally indicated for secondary prevention in older adults with established cardiovascular disease . b. Avoid in patients with a history of gastric or duodenal ulcers unless other alternatives are not effective and patients can take gastroprotective agents (i.e., proton-pump inhibitor or misoprostol). May exacerbate existing ulcers or cause new/ additional ulcers",paediatric:"There is a possible association between aspirin and Reye's syndrome when given to children. Reye s syndrome typically occurs after a viral infection such as chickenpox or influenza.",fasting:"Not applicable To refer to the latest advisory by religious authority"},sideEffects:["Aspirin may cause allergic reactions involving severe urticaria, angioedema, or bronchospasm (asthma).","Aspirin may cause dizziness or light-headedness in some people. Make sure patients know how they react to aspirin before they drive a car, operate machinery , or do anything else that could be dangerous if they are dizzy or lightheaded.","These possible side-ef fects may go away during treatment as your body adjusts to the medicine. If they continue, are severe or bother you, tell your doctor or pharmacist. a. stomach pain or discomfort, indigestion or heartburn. b. nausea or vomiting. 11","Although the following side effects are less common, if they do occur , they need medical attention. Contact your doctor as soon as possible if you notice: a. unusual bleeding or bruising b. black stools c. vomiting blood d. chest tightness and difficulty in breathing, and may provoke asthma attack in susceptible individuals'"],others:{storage:"1. Store below 30 o C. 2. Protect from light and moisture. 3. Keep out of the reach and sight of children 4. Keep aspirin in the original bottle or blister package to keep it dry (protect the tablets from moisture).",other_points:"1. Do not use aspirin continuously for more than 10 days for pain or more than 3 days for fever without consulting a doctor ."}},{id:"counsel-004",name:"Acyclovir, Topical",pharmacologicalGroup:"Antiviral Agent, Topical",indication:"Herpes simplex infections of the skin, including initial and recurrent labial and genital herpes simplex infections",dosage:"Apply 6 times daily (every  3 hours), omitted night sleep time, for 5-10 days To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Apply as early as possible following the onset of prodromal symptoms or when lesions appear 2. Wash your hands with soap and water prior to application and after application 3. Ensure application sites are clean and dry 4. A finger cot or rubber glove should be used while applying the cream to prevent autoinoculation of other body sites or transmission of infection to another person 5. Apply sufficient amount to cover all lesions, including the outer margin 6. Avoid unnecessary rubbing of the affected area 7. Do not apply to mucous membranes e.g. in the mouth, eyes or vagina as it may be irritant 8. To help clear up the herpes infection, continue using the medicine for the full course of treatment, even if the symptoms or lesions begin to clear up after a few days Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Compatible",breastfeeding:"to prevent direct viral transmission to the infant.",elderly:"patients."},sideEffects:["May be irritating and cause contact sensitization.","Do not apply to mucous membranes e.g.","in the mouth, eyes or vagina.."],others:{storage:"Store under room temperature, below 30C.",other_points:"1. Women with herpes genitalis may have an increased risk of cervical cancer , an annual Pap test may be recommended. 2. Kindly seek medical attention if no improvement after a few days of treatment. 3. Use of acyclovir has not been shown to prevent transmission of herpes simplex virus to sexual partners."}},{id:"counsel-005",name:"Adapalene",pharmacologicalGroup:"Topical retinoid",indication:"Treatment for acne vulgaris where comedones, papules and pustules predominate. Apply a thin layer once daily, at bedtime. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Wash face with a gentle, non-medicated cleanser and allow the face to dry thoroughly . 2. Dispense a small amount of the medication onto fingertips and spread a thin layer to the entire face and any other affected areas of the skin once daily at bedtime. 3. Avoid application to eyelids, lips and mucous membranes. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"only if the potential benefits justifies the potential risk to the fetus.",breastfeeding:"Caution should be exercised to nursing women. Risk to the nursing infant is considered low, as only a negligible amount is absorbed after topical application. Do not apply at the nipple area and ensure the infant's skin does not come into direct contact with treated skin areas.",elderly:"Not applicable. Refer to the usual adult dose.",paediatric:"patients below 12 years old have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Skin dryness, erythema, scaling, stinging/burning May use gentle moisturizers not containing alpha hydroxy or glycolic acids to relieve dry skin.","Caution should be exercised when using products containing sulfur , resorcinol, salicylic acid, preparations that may dry/irritate the skin such as those with astringents, spices and with high concentration of alcohol.."],others:{storage:"Store at room temperature below 30 o C",other_points:"15 NA"}},{id:"counsel-006",name:"Amiodarone",pharmacologicalGroup:"Antiarrhythmic agent, Class III C01BD01",indication:"1. Arrhythmias Loading",dosage:"400mg every 8 to 24 hours for a total loading dose of 6 to 10g (total of intravenous and oral doses), then change to a maintenance dose. Maintenance dose: 100 to 200mg once daily",methodOfAdministration:"1. May be taken with or without food. 2. Take with meals if high dose or to reduce GI discomfort. 3. Swallow whole with sufficient amount of water Missed dose management : Take a missed dose as soon as remembered. If it is close to the time for the next dose,skip and go back to normal time. Do not take 2 doses at the same time Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"when other treatments are contraindicated.",breastfeeding:"Breast feeding could expose nursing infants to significant doses of the drug; risk of exposing infants to amiodarone must be weighed against potential benefit of arrhythmia suppression in mother . There are cases of hypothyroidism and bradycardia in breastfed infants",elderly:"patients with low body mass. 17",paediatric:"Given its extensive side effect profile, amiodarone is typically used in refractory cases.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Endocrine disorders: Hypothyroidism or hyperthyroidism","Nervous system disorders: Extrapyramidal tremors, nightmare, dyssomia, sensory , motor and mixed peripheral neuropathy","Eye disorders: Cornea verticillate","Cardiac disorders: Bradycardia","Respiratory: Hypersensitivity pneumonitis (result of pulmonary toxicity of amiodarone)","Gastrointestinal disorders: Nausea, vomiting, taste disturbance at the beginning of treatment","Hepatobiliary disorders: Isolated elevation of serum transaminases at the beginning of therapy (1.5 to 3 fold the normal value). Value normalizes spontaneously or with dose reduction.","Skin and subcutaneous tissue disorders: Photosensitisation with increased tendency to sunburn, Eczema."],others:{storage:"Do not store above 30 0 C",other_points:"1. Renal impairment: No dosage adjustment necessary 2. Hepatic impairment If hepatic enzymes exceed three times normal or double in a patient with an elevated baseline, consider decreasing the dose or discontinuing amiodarone"}},{id:"counsel-007",name:"Amitriptyline",pharmacologicalGroup:"Tricyclic antidepressant (TCA)",indication:"Depression: Adult: 25-150 mg/day in divided doses (max: 300mg/day) Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"May be taken with or without food Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"May be used if other agents are ineffective or contraindicated, considering the risks and benefits of use.",breastfeeding:"Very small amounts of amitriptyline can be detected in the plasma of infants. 2. I nfants exposed to amitriptyline via breast milk for adverse effects (eg, over sedation, poor feeding)",elderly:"whose syncope may be due to OH. 2. TCAs are highly anticholinergic and sedating, which may increase the risk of cognitive impairment, delirium, falls, fractures in older adults. 3. Use with caution, may exacerbate or cause SIADH or hyponatremia; monitor sodium levels closely when starting or changing dosages in older adults. 4. Avoid concomitant use of 3 or more CNS active agents in any combination due to increased risk of falls and fracture. STOPP/Start Criteria: 1. Avoid initiation of TCA as first-line treatment for major depression (higher risk of adverse drug reactions with TCA than with SSRIs or SNRIs). 2. Avoid TCA in patients with dementia, narrow angle glaucoma, cardiac conduction abnormalities, prostatism, chronic constipation, recent falls, prior history of urinary retention or orthostatic hypotension (risk of worsening these conditions).",paediatric:"Safety and efficacy of Amitriptyline in pediatrics patients below 12 years of age have not been 20 established.",fasting:"Administer during Sahur or after Iftar. Kindly refer to the latest advisory by religious authority",hepaticImpairment:"Liver impairment may lead to increased drug exposure and may cause increased propensity to cause side effects such as sedation and constipation. Inform your prescriber if you have increased or intolerable side effects.",renalImpairment:"Dose adjustments may be required in pre-existing or newly developed renal or"},sideEffects:["Anticholinergic: a. Blurred vision, constipation, urinary retention and dry mouth b. Constipation can be managed by physical activity , fluid and fibre intake or laxatives.","Gastrointestinal: a. Nausea & vomiting: consider taking doses with food b. Heartburn, anorexia, diarrhea, abdominal discomfort such as gastric or bloatedness c. Weight Gain: advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise.","Neurologic: a. Anxiety: Contact your prescriber if intolerable b. Headache, dizziness, fatigue, weakness, insomnia, agitation, nervousness, restlessness. May require dosage adjustment. Inform prescriber at next appointment c. Sedation: Avoid activity requiring mental alertness or coordination. Do not drink alcohol during treatment with this medicine as it might increase the sedative effect. Do not drive or work with tools or machinery if affected","Sexual dysfunction: impotence, change in libido a. Inform your prescriber at next appointment","Cardiac: a. Increase heart rate, prolong QT interval, slows cardiac conduction b. Postural hypotension: Rise slowly when getting up or from lying down.  Most side effects are immediate but often go away with time.  It may take a few weeks before the patient feels any improvement. Therefore, advise patients not to change the dose of the medicine or stop taking the medicine without consulting the doctor first.  Instruct patient to immediately report worsening depression, suicidal ideation, especially at initiation of 21 therapy (children and adolescents are at higher risk for these effects during the first few months of therapy)."],others:{storage:"Store at temperatures below 30C",other_points:"1. Significant Pharmacodynamic Interactions a. Risk of life-threatening Serotonin syndrome when SSRIs co-prescribed with serotonergic drugs. (e.g. tramadol, ondansetron, sumatriptan, MAOI) Signs and Symptoms i. Mild: Insomnia, anxiety , nausea, diarrhea, hypertension, tachycardia, hyper-reflexia ii. Moderate:Agitation, myoclonus, tremor , mydriasis, flushing, diaphoresis, low fever (<38.5C) iii. Severe: Severe hyperthermia, confusion,rigidity , respiratory failure, coma, death Management: Seek immediate medical attention if you experience any of the symptoms mentioned above. b. Increase risk of upper GI bleeding if SSRIs are used together with Aspirin and NSAID due to inhibition of platelet aggregation. Watch out for black or tarry stools, easily bleeding gums or spontaneous bruises c. Risk of hyponatremia especially if SSRIs are used with drugs such as diuretics. 2. Discontinuation Syndrome a. TCA should not be stopped abruptly as this may cause discontinuation/ withdrawal symptoms. The symptoms are usually mild and selflimiting, but can occasionally be severe and prolonged. b. The patients must inform prescribers if they wish to change or stop medications"}},{id:"counsel-008",name:"Amlodipine",pharmacologicalGroup:"Dihydropyridine Calcium Antagonist - Antihypertensive",indication:"Hypertension Initial 5mg OD, may titrate to maximum dose 10mg OD",dosage:"See indication for dosage details",methodOfAdministration:"Amlodipine can be taken with or without food and at any time of the day, try to make sure it's around the same time every day. Swallow amlodipine tablets whole. In general, amlodipine tablets may be cut or crushed. Missed dose management: If a dose of amlodipine is not taken at the scheduled time, the dose should be taken as soon as possible on the same day. If the dose was missed for the whole day, skip the missed dose and take the usual dose the next day at the usual time. Never take 2 doses at once to make up for a forgotten one. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"only if the potential benefit justifies the potential risk to the fetus",breastfeeding:"No data available. It is recommended nursing be discontinued while on amlodipine",elderly:"MALPIP Increased risk of ankle oedema, to consider dosage adjustment, switching CCB or switching to other classes if necessary .",paediatric:"Limited data available for children <6 years old.",fasting:"Not applicable"},sideEffects:["Most common side effects include: a. Flushing b. Fatigue c. Edema d. Dizziness,headache e. Abdominal pain,nausea f. Palpitation g. Somnolence","If pedal edema occurs, may consider to elevate feet using a stool or pillow , and avoid prolonged sitting or standing"],others:{storage:"Store below 30 0 C",other_points:"1. Amlodipine may be used in patients with renal impairment at normal doses. Amlodipine is not dialyzable. 2. Amlodipine half-life is prolonged in patients with 23 impaired liver function and dosage recommendations have not been established, thus amlodipine should be administered with caution in these patients"}},{id:"counsel-009",name:"Amorolfine",pharmacologicalGroup:"Topical Antifungal",indication:"Fungal nail infections (onychomycosis): Use 1 or 2 applications weekly . Treat fingernails for 6 months, toenails for 9-12 months (review at interval of 3 months). To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"i. Before the first application, file down the infected areas of the nail, including the nail surface, as much as possible using the nail file provided. CAUTION: Do not use nail files used for infected nails on healthy nails, otherwise you may spread the infection. ii. Use one of the swabs provided to clean the nail surface. Repeat steps 1 and 2 for each affected nail. iii. Dip the applicator into the bottle of nail lacquer . The lacquer must not be wiped off on the edge of the bottle before it is applied. iv. Apply the nail lacquer evenly over the entire surface of the nail. Repeat steps 3 and 4 for each affected nail. v. Let the treated nail(s) dry for approximately 3 minutes. Wait at least 10 minutes before applying cosmetic nail varnish. vi. The applicator provided is re-usable. However , it is important to clean it thoroughly after completing each treatment procedure, using the same swab you used for nail cleansing. Avoid touching newly treated nails with the swab. Close the nail lacquer bottle tightly . Dispose of the swab carefully as it is inflammable. REMINDER: a) Before using this again, first remove the old lacquer and any nail varnish from your nails using a swab, then file down the nails again if necessary . b) Re-apply the lacquer as described above. c) When dried, the nail lacquer is unaffected by soap and water , so you may wash your hands and feet as normal. When working with organic solvents (thinners or white spirit), wear impermeable (waterproof) gloves to protect the lacquer on your fingernails. d) It is important to continue the treatment without interruption until the nail is regenerated and the affected areas are cured. In general, this usually takes 6 months for finger nails and 9 to 12 months for toe nails. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:", its use should be avoided. 25",breastfeeding:"No clinical experience exists with nursing, its use should be avoided.",elderly:"None specifically to those products.",paediatric:"patients below age 18 have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Burning sensation and contact dermatitis may occur","Nail disorders (eg. nail discolouration, brittle or broken nails) have been reported in rare cases. However , these reactions can also be linked to the onychomycosis itself."],others:{storage:"1. Store in a cool dry place below 30 degrees Celsius. 2. Protect from light and heat. 3. Keep out of reach of children.",other_points:"NA"}},{id:"counsel-010",name:"N-methyl-D-aspartate ( NMDA) Receptor Antagonist",pharmacologicalGroup:"Anticholinesterases Donepezil Rivastigmine NMDA receptor antagonist Memantine",indication:"1. Donepezil a. Dementia in Alzheimer's disease: Tablet & Orodispersible tablet: 5-10mg/day (as single daily dose) 2. Rivastigmine Oral & patch: a. Dementia in Alzheimer's disease & Dementia associated with Parkinson's disease: b. Oral: Initial dose 1.5 mg BD, increased every two weeks to 6-12mg/day (in 2 divided doses) c. Transdermal patch: Initial: 4.6mg/24 hours daily, then increased after 4 weeks to 9.6mg/24hours -13.3mg/24hours (applied once daily) 1. Memantine d. Moderate to severe Alzheimer's disease. Oral:Initial 5mg/day , then increased at weekly intervals to maximum of 20mg/day (in 1 or 2 divided doses) *Used to slow down the progression of the disease & manage symptoms but NOT cure or reverse the condition Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Donepezil: 1. Tablet: May be taken with or without food 2. Orodispersible Tablet: a. Tablet should be taken orally immediately after removal b. Placed the tablet on the tongue and allowed it to disintegrate before swallowing with or without water Rivastigmine: 1. Capsule/ Oral Solution: May be taken with or without food 2. Transdermal Patch: Steps to apply patch a. Open the pouch only when you are ready to apply the patch b. Cut the pouch carefully along the dotted line. Not to cut the patch inside. Then, remove the patch from the pouch c. Bend the patch slightly to raise the edge of one half of the release liner covering the 27 patch. Then, peel off that side of the liner and avoid touching the sticky part of the patch d. Patch should be applied once a day to clean, dry, hairless skin with no cuts or sores. e. Put the sticky side of the patch on the skin (on the upper or lower back, upper arm or chest) in a place which not be rubbed by tight clothing f. Peel off the second side of the release liner and firmly press down on the patch g. The previous days patch must be removed before applying a new one h. The patch should be replaced by a new one after 24 hours. Only ONE patch should be worn at a time i. The patch should not be applied to skin that is red, irritated or cut. It is recommended to change the application site daily ( not using the same spot for at least 14 days) to avoid potential irritation j. If the patch falls off, a new patch should be applied to the same site for the rest of the 24 hours, and it should be replaced at the same time as usual the next day k. The patch can be used in everyday situations, including bathing and during hot weather l. The patch should not be exposed to any external heat sources (e.g. Excessive sunlight, saunas) for long periods of time m. The patch should not be cut into pieces Steps to remove patch e. Gently pull at one edge of the patch to remove it slowly from the skin. Fold the used patch in half (with the sticky sides together). In case the adhesive residue is left over on your skin, gently soak the area with warm water and mild soap or use baby oil to remove it. Alcohol or other dissolving liquids (nail polish remover or other solvents) should not be used f. Wash your hands with soap and water after removing the patch. In case of contact with eyes or if the eyes become red after handling the patch, rinse immediately with plenty of water and seek medical advice if symptoms do not resolve Memantine: 1. Tablet: May be taken with or without food. Missed dose management: 1. Take the missed dose as soon as you remember . If its nearly time for your next dose, skip the missed one and take only the next dose. Do not take two doses at once. 2. Rivastigmine patch a. If you miss more than 3 doses of applying rivastigmine patch, contact the prescriber before putting on a new patch. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"Should not be used during",breastfeeding:"Women taking these medications should not breast-feed.",elderly:"Beers Criteria: For anticholinesterase (Donepezil, Rivastigmine): 1) Avoid use in older adults with syncope as it may increase the risk of bradycardia. 2) ECG must be performed at baseline and post initiation of the drug. To suggest regular monitoring of BP/HR at home. STOPP/ST ART Criteria: 1) Acetylcholinesterase inhibitors with a known history of persistent bradycardia (< 60 beats/min.), heart block or recurrent unexplained syncope (risk of cardiac conduction failure, syncope and injury). 2) Acetylcholinesterase inhibitors with concurrent treatment with drugs that induce persistent bradycardia (< 60 beats/min.) such as beta-blockers, digoxin, diltiazem, verapamil (risk of cardiac conduction failure, syncope and injury). 3) Memantine with known current or previous seizure disorder (increased risk of seizures).",paediatric:"The safety and efficacy of Rivastigmine in pediatric patients have not been established. 2. The safety and efficacy of Memantine and Donepezil in pediatric patients younger than 6 years of age have not been established. 3. The safety and efficacy of extended-release Memantine and Donepezil in pediatric patients have not been established.",fasting:"Administer during Sahur or after Iftar. Kindly refer to the latest advisory by religious authority",hepaticImpairment:"Anticholinesterase (Donepezil & Rivastigmine) 1. Mild to moderate: Dose adjustment not necessary 2. Severe: Caution should be exercised. NMDA receptor antagonist (Memantine) 1. Does not require dose adjustment Cardiac Impairment 29 Anticholinesterase (Donepezil & Rivastigmine) 1. Should be used with caution 2. Syncopal episodes have been reported NMDA receptor antagonist (Memantine) 1. Not likely to require dosage adjustment",renalImpairment:"Anticholinesterase (Donepezil & Rivastigmine) 1. Dose adjustment not necessary; titrate to point of tolerability NMDA receptor antagonist (Memantine) 1. No dose adjustment required in mild or moderate impairment 2. If CrClr <30ml/min, dose should not exceed 10mg/day"},sideEffects:["Anticholinesterase (Donepezil & Rivastigmine)","Nausea, diarrhea, vomiting, appetite loss, increased gastric acid secretion, weight loss (take with meals to reduce GI effects), insomnia, headache, dizziness, fatigue, abnormal dreams","Rivastigmine patch: application site reactions with transdermal patch.(other s/e may differ from capsule formulation) NMDA receptor antagonist (Memantine)","Dizziness, headache (take before sleep to lower the side effects)","Constipation (ensure adequate hydration and increase fibre intake)"],others:{storage:"Store at a temperature below 30C. Keep rivastigmine patch and orodispersible donepezil sealed until ready to use.",other_points:""}},{id:"counsel-011",name:"Antipsychotics, First Generation",pharmacologicalGroup:"First Generation Antipsychotics Chlorpromazine Haloperidol Perphenazine Trifluoperazine Sulpiride",indication:"I ndication: Treatment of psychotic disorders",dosage:"1. Chlorpromazine: 25  50 mg BD/TDS, up to 100 mg BD/TDS 2. Haloperidol tablet: 0.5  2 mg BD/TDS up to 5 mg TDS ( doses >30 mg/day are not recommended) 3. Perphenazine: 4 mg TDS (max 24 mg/day) 4. Trifluoperazine: 5mg BD (max 40mg/day) 5. Sulpiride: 200  1000 mg/day (max 2.4g/day) Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. May be taken with or without food 2. Trifluoperazine: do not take within 2 hours of any antacids 3. Chlorpromazine: brown precipitate may occur when chlorpromazine is mixed with caffeine-containing liquids. Do not stop taking your medication abruptly unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"or become pregnant while taking antipsychotics.",breastfeeding:"Lactating mother are advised not to breastfeed while on treatment.For those who do not wish to continue lactating, formula milk supplementation should be offered to the infants",elderly:"Beers Criteria: 1) Use in caution for approved FDA indications such as schizophrenia, bipolar disorder , Parkinson disease psychosis. Avoid use as adjunctive treatment of major depressive disorder , or for short-term use as antiemetic. 2) Increased risk of stroke and greater rate of cognitive decline and mortality in persons with dementia. Additional evidence suggests association of increased risk between antipsychotic medication and mortality independent of dementia. Avoid antipsychotics for behavioral problems of dementia or delirium unless documented nonpharmacologic options (e.g., behavioral interventions) have failed and/or the patient is threatening substantial harm to self or others. In these circumstances, periodic deprescribing attempts should be considered to assess ongoing need and/or lowest effective dose. STOPP/Start Criteria: 1) Antipsychotics (i.e., other than clozapine or quetiapine) in those with parkinsonism or Dementia with Lewy Bodies (risk of severe extra-pyramidal symptoms). 2) Antipsychotics prescribed for behavioural and psychological symptoms of dementia (BPSD) an unchanged dose for > 3 months without medication review (increased risk of extrapyramidal side-ef fects and chronic worsening of cognition, increased risk of major cardiovascular morbidity and mortality). 3) Antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) for longer than 12 weeks unless BPSD symptoms are severe and other nonpharmacological treatments have failed (increased risk of stroke, myocardial infarction). 4) Antipsychotics with moderate-marked antimuscarinic/anticholinergic effects (acepromazine, chlorpromazine, clozapine, flupenthixol, fluphenzine, levomepromazine, olanzapine, pipothiazine, promazine, thioridazine) with a history of lower urinary tract symptoms associated with benign prostatic hyperplasia or previous urinary retention (high risk of urinary retention). 5) Antipsychotics as hypnotics, unless sleep disorder is due to psychosis or BPSD effects of dementia (not recommended in summary of product characteristics; increased risk of confusion, hypotension, extra-pyramidal side effects, falls). 6) Antipsychotics with dysphagia (increased risk of aspiration pneumonia) 7) Antipsychotic drugs in patients with recurrent falls (may cause Parkinsonism). Paediatrics 1) Chlorpromazine: The safety and efficacy in pediatric patients younger than 6 months of age have not been established 2) Haloperidol: The safety and efficacy in pediatric patients younger than 3 years of age have not been established 3) Perphenazine: The safety and efficacy in pediatric patients younger than 12 years of age have not been established 32 4) Trifluoperazine: The safety and efficacy in pediatric patients younger than 6 years of age have not been established 5) Sulpiride: Clinical experience in children under 14 years of age is insuf ficient to permit specific recommendations.",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"Watch out for signs of liver problems such as yellowing of your skin or eyes, dark urine, severe tiredness, nausea, or pain on the right side of your abdomen. If you notice any of these symptoms, contact your prescriber immediately 2. In general: Sulpiride: no dosage reduction required if renal function is normal Paliperidone: if depot required",renalImpairment:"Watch for signs of kidney problems, like reduced urination, swelling in your hands or feet, feeling very tired, shortness of breath, or changes in your blood pressure. If you notice these symptoms, contact your prescriber immediately 2. No agent clearly preferred to another; however , in general a. avoid sulpiride and amisulpride b. avoid highly anticholinergic agents because they can contribute to urinary retention c. May consider haloperidol 2-6 mg a day"},sideEffects:["Common adverse drugs reactions are as below:  Extrapyramidal side effects Inform your prescriber if you have symptoms like tremor , rigidity , reduced arm swing, drooling of saliva, slurred speech, uprolling eyeball (oculogyric crisis)  Tachycardia (palpitation)  Contact your prescriber if intolerable."," Weight gain and metabolic syndrome  advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise."," Postural hypotension (dizziness)  change of position should be done slowly and gradually and any sudden change of position should be avoided."," Anticholinergic effects such as constipation, dry mouth, blurred vision or urinary retention Staying well-hydrated, taking a high-fiber diet and being physically active may help with constipation.","Immediately contact prescriber if unable to pass flatus or if there is abdominal pain  Drowsiness and lethargy : usually occur only during the initial stage of medication therapy.","Avoid activity requiring mental alertness or coordination.","Do not drink alcohol during treatment with this medicine as it might increase the sedative effect.","Do not drive or 33 work with tools or machinery if affected.","Inform prescriber at next appointment  Sexual dysfunction : inform physicians/pharmacists if you experience problems with libido and arousal  Hyperprolactinemia : female patients may experience menstrual disturbance or excessive production of breast milk despite not breastfeeding, whereas male patients may experience growth of breast tissue.","Inform physicians/pharmacists if it occurs."," Sun-sensitivity : advise patients to use sunscreen and avoid excessive exposure to sunlight."],others:{storage:"Store at a temperature below 30C.",other_points:""}},{id:"counsel-012",name:"Antipsychotics, Injectables",pharmacologicalGroup:"First Generation Antipsychotics Flupentixol Fluphenazine Zuclopenthixol Second Generation Antipsychotics Aripiprazole Paliperidone",indication:"Maintenance treatment of schizophrenia",dosage:"First Generation Antipsychotics Drug Dose Dosing Interval Flupentixol Decanoate 50mg - 400mg 2-4 weeks Fluphenazine Decanoate 12.5mg - 100mg 2-5 weeks Zuclopenthixol Decanoate 200 - 600mg 1-4 weeks Second Generation Antipsychotics Drug Dose Dosing Interval Aripiprazole LAI 300 - 400mg Every month Paliperidone Palmitate LAI 1-month 50-150mg Every month Paliperidone Palmitate LAI 3-month 175  525mg Every 3 months Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"Test dose and Injection Site First Generation Antipsychotics Drug Test Dose Injection Site Fluphenazine Decanoate 12.5mg* Gluteal region Flupenthixol 20mg* Gluteal region 35 Decanoate Zuclopenthixol Decanoate 100mg* Gluteal region, Lateral thigh *balance of the doses should be given 7 days after the initial dose (may be between 4 - 7 days for certain products) Second Generation Antipsychotics Do not require a test dose but tolerability and response to oral preparation should be established before administering the injections. Drug Test Dose Injection Site Aripiprazole LAI Tolerability to the oral preparation should be established first. Deltoid or gluteal Paliperidone Palmitate LAI 1-month First and second initiation doses are administered in the deltoid muscle. Following monthly maintenance doses can be administered in either the deltoid or gluteal muscle. Paliperidone Palmitate LAI 3-month After 4 months treatment with Paliperidone Palmitate LAI 1-month. The last 2 doses of Paliperidone Palmitate LAI 1-month must be the same dosage strength before starting Paliperidone Palmitate LAI 3-month in order to establish a consistent maintenance dose. Missed dose management: If a dose is missed, ask the patient to contact the healthcare provider right away to discuss what should be done next. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"should be avoided in order to limit the duration of any possible toxic effect to the foetus.",breastfeeding:"on exposure to antipsychotics in infants and associated benefits and harms should be discussed with all women. For those who do not wish to continue lactating, formula milk supplementation should be offered to the infants. 36",elderly:"with dementia. Use is associated with fall risk. To advise on fall precautions.",paediatric:"SAIs are only used in an acute state for a short term. All LAIs are not indicated for children and adolescents. If use is required, to monitor side effects.",fasting:"Not applicable"},sideEffects:["Side effects for LAIs are the same or less when compared with oral medications (e.g.","EPS, anticholinergic effects), except injection site reactions such as pain, oedema, pruritus and sometimes a palpable mass.","The physical discomfort of regular injections can also be reduced by alternating the injection site each time.."],others:{storage:"Not applicable. Not intended to be kept by patient",other_points:"1. Advantages and Disadvantages These drugs are administered via deep intramuscular injection and are gradually released from the injection site, resulting in relatively stable plasma drug levels over extended periods, allowing the injections to be given every few weeks. Advantages of LAI: 1. Given once a week to once a month, compared to oral medication, which must be taken every day. 2. Reduced likelihood of forgetting to take the medication, which consequently decreases the risk of becoming ill Disadvantages of LAI 1. Some people feel uncomfortable about having injections, such as anxiety about needles. 2. Some people experience pain from the injection which can last for a few days but this is usually mild. 2. Dosing window Advise patients not to miss doses. If necessary , patients may receive injection: 1. Aripiprazole: No sooner than 26 days after the previous injection. The injection should be administered as soon as possible within 7 days of the monthly time point. 2. Paliperidone Palmitate LAI 1-month: 37 The second initiation dose can be administered up to 4 days before or after the 1-week time point. Monthly maintenance dose can be administered up to 7 days before or after the monthly time point. 3. Paliperidone Palmitate LAI 3-month: Up to 2 weeks before or after the 3-month time point."}},{id:"counsel-013",name:"Antipsychotics, Second Generation",pharmacologicalGroup:"Second Generation Antipsychotics Amisulpride Aripiprazole Asenapine Olanzapine Paliperidone Quetiapine Risperidone",indication:"Treatment of psychotic disorder .",dosage:"1. Amisulpride: 300-600 mg /day in 2 divided doses (max 1200 mg/day) 2. Aripiprazole: 10-15mg /day as single daily dose (max 30 mg/day) 3. Asenapine: 5-10mg /day in 2 divided doses (max 20 mg/day) 4. Clozapine: max 900 mg/day (refer to clozapine section) 5. Olanzapine: 5-20mg / day as single daily dose (max 20 mg/day) 6. Paliperidone: 3-6 mg /day as single daily dose (max 12 mg/day) 7. Quetiapine: 300-600 mg /day (IR in divided does; XR as single daily dose) (max 800 mg/day) 8. Risperidone: 2mg- 8mg /day in single or divided doses (max 16 mg/day) Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"Drugs/ Formulation Special Counselling Amisulpride Tablet 1. It must be swallowed whole tablets with the aid of liquids before meals. Aripiprazole Tablet 1. To be taken in the morning before or after as sedation is unusual, and to prevent sleeping difficulty as it can cause akathisia and activation. Asenapine Sublingual Tablet 1. Place the whole tablet under the tongue and allow it to dissolve completely; do not split, crush, chew , or swallow the tablet. 2. Do not eat or drink for 10 minutes after administration as it can reduce the absorption of drugs. 3. Do not remove the tablet from the original package until ready to administer . 39 Clozapine Tablet Refer Clozapine section Olanzapine Tablet / Orodispersible Tablet 1. It must be swallowed whole with the aid of liquids before or after a meal. 2. Orosdispersible tablet should be placed in the mouth, where it will rapidly disperse in saliva, so it can be easily swallowed with or without liquid. Alternatively , it may be dispersed in a full glass of water or other suitable beverage (orange juice, apple juice, milk or coffee) immediately before administration. Do not remove the tablet from the original package until ready to administer . Paliperidone Extended Release Tablet 1. To be taken in the morning before or after a meal. It must be swallowed whole with the aid of liquids, and must not be chewed, divided or crushed. 2. The medication is contained within a nonabsorbable shell designed to release the drug at a controlled rate. The tablet shell is eliminated from the body and the patient should not be concerned if it appears in the stool. Quetiapine Immediate Release Tablet 1. It must be swallowed whole with the aid of liquids before a meal or with a light meal (300 calories). Quetiapine Extended Release Tablet 1. It must be swallowed whole and not split, chewed or crushed before a meal or with a light meal (300 calories). 2. Preferably administered once daily, in the evening 3. Taking high fat or calorie meals with this medication should be avoided. Risperidone Tablet/Syrup 1. It must be swallowed whole with the aid of liquids before or after meal. 2. It can be mixed with water or orange juice and consumed immediately . 3. Syrup is Incompatible with most types of cola and tea including black tea. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"All APs that have been studied to date cross the placenta, are present in amniotic fluid and excreted in breast milk. Hence APs withdrawal can occur in newborns when they are used in the third trimester . The symptoms are crying, agitation, increased suckling, abnormal increase in tone, tremors, sleepiness, difficulty in feeding and breathing which alleviate within hours or days and do not require 40 specific treatment. However the benefit of treatment for mothers and newborns superseded the harm of discontinuing APs and generally favours continuation of APs.",breastfeeding:"is not recommended while on treatment with Clozapine. For those who do not wish to continue lactating, formula milk supplementation should be offered to the infants",elderly:"patients with dementia-related psychosis. Start with a low dose and increase slowly . 2) Avoid use as adjunctive treatment of major depressive disorder , or for short-term use as antiemetic. 3) Use in caution for approved FDA indications such as schizophrenia, bipolar disorder , Parkinson disease psychosis. 4) Avoid in PD patients (except Clozapine and Quetiapine). Antipsychotics may precipitate the worsening of Parkinson disease. 5) Use is associated with fall risk. To advise on fall precautions. Strong anticholinergic properties which may be detrimental in older adults (e.g., ataxia, impaired psychomotor function, syncope, or additional falls). STOPP/Start Criteria: 1) Antipsychotics (i.e., other than clozapine or quetiapine) in those with parkinsonism or Dementia with Lewy 41 Bodies (risk of severe extra-pyramidal symptoms). 2) Antipsychotics prescribed for behavioural and psychological symptoms of dementia (BPSD) an unchanged dose for > 3 months without medication review (increased risk of extrapyramidal side-ef fects and chronic worsening of cognition, increased risk of major cardiovascular morbidity and mortality). 3) Antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) for longer than 12 weeks unless BPSD symptoms are severe and other nonpharmacological treatments have failed (increased risk of stroke, myocardial infarction). 4) Antipsychotics with moderate-marked antimuscarinic/anticholinergic effects (acepromazine, chlorpromazine, clozapine, flupenthixol, fluphenzine, levomepromazine, olanzapine, pipothiazine, promazine, thioridazine) with a history of lower urinary tract symptoms associated with benign prostatic hyperplasia or previous urinary retention (high risk of urinary retention). 5) Antipsychotics as hypnotics, unless sleep disorder is due to psychosis or BPSD effects of dementia (not recommended in summary of product characteristics; increased risk of confusion, hypotension, extra-pyramidal side effects, falls). 6) Antipsychotics with dysphagia (increased risk of aspiration pneumonia) 7) Antipsychotic drugs in patients with recurrent falls (may cause Parkinsonism).",paediatric:") The safety and efficacy of Aripiprazole (Oral / Depot) in pediatric patients younger than 6 years of age have not been established. 2) The safety and efficacy of Asenapine (Oral) in pediatric patients have not been established. 3) The safety and efficacy of Clozapine (Oral) in pediatric patients have not been established. 4) The safety and efficacy of Olanzapine (Oral) in pediatric patients younger than 13 years of age have not been established. 5) The safety and efficacy of Paliperidone (Oral / Depot) in pediatric patients have not been established. 6) The safety and efficacy of Quetiapine(Oral) in pediatric patients younger than 10 years of age have not been established. 7) The safety and efficacy of Risperidone (Oral) in pediatric patients younger than 5 years of age have not been established.",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"Watch out for signs of liver problems such as yellowing of your skin or eyes, dark urine, severe tiredness, nausea, or pain on the right side of your abdomen. If you notice any of these symptoms, contact your prescriber immediately 2. In general: Sulpiride/Amisulpride: no dosage reduction required if renal function is normal Paliperidone: if depot required",renalImpairment:"Watch for signs of kidney problems, like reduced urination, swelling in your hands or feet, feeling very tired, shortness of breath, or changes in your blood pressure. If you notice these symptoms, contact your prescriber immediately 2. No agent clearly preferred to another; however , in general 42 a. avoid sulpiride and amisulpride b. avoid highly anticholinergic agents because they can contribute to urinary retention c. May consider olanzapine 5mg a day"},sideEffects:["Drugs High Incidence Moderate Incidence Low incidence Amisulpride Prolactin elevation QT prolongation, constipation Weight gain, akathisia, parkinsonism, tardive dyskinesia Aripiprazole - - Constipation, akathisia, tardive dyskinesia, QT prolongation Asenapine - - Constipation, sedation, weight gain, akathisia, tardive dyskinesia, QT prolongation, prolactin elevation Clozapine Refer clozapine section Olanzapine Weight gain Constipation, sedation, Tardive dyskinesia, anticholinergic, hypotension, QT prolongation, prolactin elevation Paliperidone Prolactin elevation Constipation, weight gain, hypotension Sedation, akathisia, parkinsonism, tardive dyskinesia, anticholinergic, QT prolongation 43 Quetiapine - Constipation, sedation, weight gain, hypotension, QT prolongation, Tardive dyskinesia, anticholinergic Risperidone Prolactin elevation Constipation, weight gain, akathisia, hypotension, Sedation, parkinsonism, tardive dyskinesia, anticholinergic, QT prolongation Side Effects and Management Strategies Side Effects Onset Management Strategies Constipation First four months of AP administration","Ensure adequate fiber, fluid and exercise","May require additional medication, consult your prescriber","Immediately Contact prescriber if unable to pass flatus or if there is abdominal pain EPS: Dystonia Within hours to days of AP administration or dose increase","May require a change in dose of medication. Inform prescriber at next visit","Contact immediately if if you are having repeated uncontrolled movements, pain or severe muscle stiffness EPS: Pseudoparkinso nism Day to weeks after AP administration or dose increase","May require a change in dose of medication. Inform prescriber at next visit if you are having symptoms of tremor , rigidity , bradykinesia Akathisia Within hours to weeks of AP","May require a change in dose 44 administration or dose increase of medication. Inform your prescriber if you feel like you can't sit still or constantly need to move, such as pacing, tapping your feet, or shifting in your seat. Tardive dyskinesia After months to years of AP administration","May require a change in dose of medication. Inform prescriber at next visit if you are having repetitive movements, often around the face, mouth, or tongue, like lip smacking, blinking, or chewing motions. Sedation Within hours to days of AP administration","Avoid activity requiring mental alertness or coordination.","Do not drink alcohol during treatment with this medicine as it might increase the sedative effect. Do not drive or work with tools or machinery if affected.","Inform prescriber at next appointment. You may require a change in dose or medication. Weight Gain Within three months of AP administration","Advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise Hyperprolactina emia Within hours to months of AP administration","May require a change in dose or medication. Inform doctor / pharmacist if any signs of irregular or no menses and galactorrhoea (milky nipple 45 discharge) in women Orthostatic hypotension Within hours to days of AP administration or dose increase","Advice to patients, eg. sitting on the edge of the bed for several minutes before attempting to stand in the morning and slowly rising from a seated position ECG changes - QT prolongation After 2-4 weeks of AP administration","May be asymptomatic. However , immediately visit the prescriber if you have chest pain or discomfort.","You may have more frequent monitoring of heart (ECT) and salt levels in your blood"],others:{storage:"Store at a temperature below 30C.",other_points:"Monitoring Parameters Parameter / Test Suggested Frequency Drugs with precautions Drugs which do not require monitoring Blood Pressure Baseline, during dose titration and dose changes Clozapine and Quetiapine Amisulpride, Aripiprazole Weight (include waist size and BMI) Baseline, frequently for three months then yearly Clozapine, Olanzapine Aripiprazole Full blood count Baseline and yearly Clozapine None Plasma glucose Baseline, at 4-6 month, then yearly Clozapine, Olanzapine All patients should be monitored. Urea and electrolyte s including creatinine Baseline, at 4-6 month, then yearly Amisulpride None 46 Blood lipids Baseline, three months, then yearly Clozapine, Olanzapine All patients should be monitored. Liver Function Test (LFT) Baseline and yearly to detect chronic AP induced changes (rare) Clozapine Amisulpride Prolactin Baseline, then at 6 months, then yearly Amisulpride, Risperidone, Paliperidone Asenapine, Aripiprazole, Clozapine, Quetiapine, Olanzapine (<20mg). Measure if symptoms arise. Creatinine phosphoki nase Baseline, then if NMS is suspected NMS is more likely with FGAs None ECG Baseline None Risk of sudden cardiac death increased with most APs. All patients should be offered an ECG at least yearly ."}},{id:"counsel-014",name:"European geriatric medicine, 14(4), 625-632. Apixaban",pharmacologicalGroup:"Factor Xa inhibitors",indication:"1. Prophylaxis of venous thromboembolic events following hip and knee replacement surgery",dosage:"2.5 mg twice daily, starting 12-24 hours after surgery . Duration of treatment: 10-14 days (knee replacement); 32-38 days (hip replacement) 2. Prophylaxis of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as prior stroke or TIA, age 75 years, hypertension, diabetes mellitus, symptomatic heart failure (NYHA Class II) 3. Dosage: 5 mg twice daily. Dose reduction in patients with at least 2 of the following criteria: 80 years old, body weight 60 kg, serum creatinine 1.5 mg/dL (133 micromole/L): 2.5 mg twice daily 4. Deep vein thrombosis, Pulmonary embolism 5. Dosage: Treatment :10 mg bid for 7 days followed by 5 mg bid. Prophylaxis of recurrent cases: 2.5 mg bid following completion of 6 months of anticoagulant treatment",methodOfAdministration:"1. May be taken with or without food. 2. May be crushed & suspended in water/D5W/apple juice or mixed with apple puree. Take the mixture immediately or within 4 hours. Missed dose management: Take the missed dose as soon as remembered. If it is close to the time for the next dose, skip and go back to normal time. Do not take 2 doses at the same time",specialConsiderations:{pregnancy:"Preferable to avoid the use of apixaban during",breastfeeding:"It is unknown whether apixaban or its metabolites are excreted in human milk. Available data in animals have shown excretion of apixaban in milk. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from apixaban therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.",elderly:"MALPIP: Increased risk of gastrointestinal bleeding. Increased serum concentrations may occur with",paediatric:"Not recommended in children and adolescents under 18 years of age.",renalImpairment:"and dose adjustment may be indicated. Assess renal profile before initiation."},sideEffects:["Blood and lymphatic system disorders: Anaemia, thrombocytopenia.","Haemorrhagic risk. Apixaban should be discontinued if severe haemorrhage occurs."],others:{storage:"Store between 15-30C.",other_points:"49 1. Hepatic Impairment: Severe (Child-Pugh class C): Not recommended. 2. Renal impairment: Patients undergoing dialysis: Not recommended."}},{id:"counsel-015",name:"Atazanavir",pharmacologicalGroup:"Protease inhibitors (PIs)",indication:"Treatment of HIV-1 infected, antiretroviral treatment experienced adults, in combination with other antiretroviral medicinal products a. The recommended dose is 300 mg once daily taken with ritonavir 100 mg once daily and with food. Ritonavir is used as a booster of atazanavir pharmacokinetics. Atazanavir is not approved for use in neonates and infants aged <3 months. Atazanavir should not be administered to neonates because of risks associated with hyperbilirubinemia. Because Ritonavir oral solution is no longer commercially available, use of Atazanavir/Ritonavir is limited to children weighing 15 kg who can use the Ritonavir 100 mg powder packet or 100 mg tablet. a. 15 kg to <35 kg - ATV/r 200 mg/100 mg, both with food b. 35 kg - ATV/r 300 mg/100 mg, both with food",dosage:"See indication for dosage details",methodOfAdministration:"Atazanavir should be taken with food, the capsule should be swallowed whole with a drink such as a glass of water or fruit juice. It is recommended that you take your medicine at about the same time each day. Taking it at the same time each day will have the best effect. It will also help you remember when to take it. Missed dose management: If you forget to take it, and if it is almost time for your next dose, skip the dose you missed and take the next dose when you are meant to take it. Otherwise, take it as soon as you remember , and then go back to take your medicine as you would normally . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". Ritonavir-boosted Atazanavir (ATV/r) is an alternative protease inhibitor for pregnant patients with HIV who are antiretroviral-naive (initial therapy), who have had ART therapy in the past but are restarting, or who require a new ART regimen (due to poor tolerance or poor virologic response of current regimen). Patients who become pregnant while taking Atazanavir boosted with Ritonavir may continue if viral suppression is effective and the regimen is well tolerated.",breastfeeding:"if they are taking Atazanavir . 2. It is recommended that HIV infected women do not breastfeed their infants under any circumstances to 51 avoid transmission to the infant .",elderly:"A dose adjustment for age is not recommended.",paediatric:"Do not use it in children below three months of age due to potential for kernicterus.",fasting:"To refer to the latest advisory by religious authority",hepaticImpairment:"No dose adjustment in patients with mild impairment (Child-Pugh Class A). Otherwise; Moderate (Child-Pugh Class B): 300mg once daily (unboosted) for ARV-naive patients only. Severe (Child-Pugh Class C): Not recommended",renalImpairment:"No dosage adjustment is needed. However , Atazanavir with Ritonavir is not recommended in treatment-experienced patients undergoing hemodialysis."},sideEffects:["Rashes: usually mild to moderate skin eruptions that occur within 3 weeks of starting Atazanavir . Patients should be advised of signs and symptoms and monitored closely for skin reactions. Atazanavir should be discontinued if severe rashes develop.","Hyperbilirubinemia: Most patients experience asymptomatic increases in indirect bilirubin, which is reversible upon discontinuation; do not reduce; if concomitant transaminase increase occurs, evaluate for alternative etiologies.","Fat redistribution: Central obesity , buffalo hump, peripheral wasting, facial wasting, breast enlargement, and cushingoid appearance. Clinical examination should include evaluation for physical signs of fat redistribution.","Metabolic disorders: Dyslipidemia, new onset diabetes mellitus, hyperglycemia, and exacerbation of existing diabetes mellitus. Standard guidelines for management of dyslipidemia and diabetes mellitus."],others:{storage:"1. Store below 25C.",other_points:"Beware of Atazanavir/ritonavir-drug interactions. Kindly refer to Liverpool HIV Interactions website for further information. 1. Atazanavir/Ritonavir is an inhibitor of the P450 isoform CYP3A. Co-administration of Atazanavir/Ritonavir and drugs primarily metabolised by CYP3A may result in increased plasma concentrations of the other drugs (e.g. HMG CoA reductase, dihydropyridine calcium channel blockers, immunosuppressant etc). 2. Overdoses with Atazanavir/Ritonavir have been reported in association with jaundice due to indirect (unconjugated) hyperbilirubinemia or PR interval prolongations. Treatment of overdose should consist of general supportive measures including monitoring of 52 vital signs and ECG, and observations of the clinical status of patients."}},{id:"counsel-016",name:"Azelaic Acid, Topical",pharmacologicalGroup:"1. Anti microbial Inhibits the growth of susceptible organisms (Propionibacterium acnes) on the skin surface and inhibits follicular keratinisation. This restricts the development of comedone.",indication:"1. Treatment of Acne Vulgaris Apply twice daily (for sensitive skin, once daily during the 1st week) . Treatment should not exceed 6 months. (12 months based on product insert)",dosage:"See indication for dosage details",methodOfAdministration:"1. Wash face with a gentle, non-medicated cleanser and allow the face to dry thoroughly . 2. Put a thin layer to the affected skin and rub in gently , twice daily (morning and evening). 3. Avoid application to eyelids, lips and mucous membranes. 4. A daily dose of approximately 2.5cm/1 inch of cream is sufficient for the entire facial area. Excessive amounts must be avoided. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"unless the benefit outweighs the risk.",breastfeeding:"unless the benefit outweighs the risk.",elderly:"-specific problems have been documented to date. Refer to the usual adult dosage guide.",paediatric:"patients below 12 years old have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Local skin irritation (erythema, scaling, burning, itching)","Photosensitivity If excessive skin irritation occurs, consider the following until the 54 irritation ceases: i) reduce the frequency of application to once daily or ii) reduce the amount of cream, or iii) temporarily withhold the treatment for a few days. Use a gentle moisturizer to reduce dryness."],others:{storage:"1. Keep the container tightly closed. 2. Store at room temperature. 3. Protect from light, heat and moisture. 4. Keep medicine out of reach of children.",other_points:"1. Prolonged and repeated administration may lead to hypersensitivity . Excessive use should be avoided. 2. If severe irritation or allergic reactions occur , discontinue use and consult a healthcare provider . 3. Avoid contact with eyes, mouth and other mucous surfaces. 4. Avoid occlusive dressings/wrappings. 5. For external use only. 6. Dispose of any remaining product in the tube after completing your course of treatment or once the product has expired."}},{id:"counsel-017",name:"Benzodiazepines",pharmacologicalGroup:"Benzodiazepines Diazepam Lorazepam Bromazepam Alprazolam Clonazepam Midazolam",indication:"1. Diazepam: Anxiety disorder: Oral: 2 mg 3 times daily, increased in severe anxiety to 15 - 30 mg daily in divided doses 2. Lorazepam: Severe anxiety: 1-10mg daily in divided doses Insomnia: 1-2mg on night 3. Bromazepam: Anxiety disorder: 6-18mg daily initially in divided doses. (max",dosage:"60mg) 4. Alprazolam: Anxiety disorder: 0.25mg-0.5mg 3 times daily. (max: 3mg/day) 5. Clonazepam: Anxiety: 0.5 mg/day to 4 mg/day in 2 to 4 divided doses (max of 8 mg/day) 6. Midazolam: Insomnia: Oral: 7.5mg - 15mg/day Benzodiazepines are usually used as an adjunct therapy in psychiatric disorders such as mood disorder (e.g. anxiety disorder & major depressive disorder), schizophrenia and sleep disorders. Benzodiazepines are usually used as short term therapy of no more than 2 to 4 weeks together with first line medications. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Tablets should be swallowed whole or crushed. 2. Benzodiazepines provide symptomatic relief but do not treat the underlying psychological problem, duration of the therapy is usually short term or take it only when necessary . 3. Tolerance and dependence may occur after prolonged use.Use ONLY as instructed, DO NOT take more than prescribed. Inform your prescriber if your usage increases. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:". Seizures, even mild ones, may cause harm to the embryo/foetus.",breastfeeding:"Not recommended",elderly:"Beers Criteria: 1. Avoid use of benzodiazepines; expose users to risks of abuse, misuse, and addiction. Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death. Older adults have increased sensitivity to benzodiazepines and decreased metabolism of long-acting agents; the continued use of benzodiazepines may lead to clinically significant physical dependence. 2. In general, all benzodiazepines increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle crashes in older adults. May be appropriate for seizure disorders, rapid eye movement sleep behavior disorder , benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder , and periprocedural anesthesia. STOPP/Start Criteria: 1) Use as short a term as possible (not exceeding 4 weeks). 2) Use for agitated behaviour or psychotic symptoms of dementia (no evidence of efficacy). 3) Use for insomnia for  2 weeks (high risk of dependency , increased risk of falls, fractures and road traffic accidents).",paediatric:"Safety and efficacy of Benzodiazepines remain unapproved for pediatric use outside of epilepsy and seizures . Use with caution.",fasting:"Administer during Sahur or after Iftar. Kindly refer to the latest advisory by religious authority",hepaticImpairment:"1. Prolonged duration of effect particularly for drugs with active metabolites (diazepam, midazolam, clonazepam). Lorazepam does not have active metabolites and are preferred. Use low doses with caution, as sedative drugs used in severe disease can precipitate hepatic encephalopathy .",renalImpairment:". Advise patients to monitor for signs & symptoms of toxicity ."},sideEffects:["Management Common Being very unsteady on your feet.","Inform your prescriber at next visit Feeling light headed, faint or as if head is spinning.","Stand up slower.","Try to sit or lie down when symptoms occur ..","Do not drive.","Feeling sleepy or sluggish.","Possible to lead to falls.","Hangover the next morning.","Do not drive or operate heavy machinery.","Ask your prescriber if adjustments in medication, dose or timing is required Rare You may feel like fainting when standing up.","A low blood pressure.","Rise slowly when getting up or from lying down.","Do not drive if you feel dizzy.","Loss of memory or difficulty in remembering.","Inform your prescriber at next visit Headaches May take analgesics.","Inform your prescriber if too frequent.","Rare - significant concern You may be too talkative, excited or unfriendly.","Immediately contact your prescriber.","Change in mediation will likely be required Confusion, disorientated Inform your prescriber at next visit Rashes, skin redness, trouble breathing Stop taking and immediately see your prescriber."],others:{storage:"Store at a temperature below 30C.",other_points:"1. Do not combine with alcohol or other CNS depressants because it can intensify side effects. 2. Educate patients with sleep problems on sleep hygiene. 3. You may experience these effects upon stopping the medication: Common symptoms: anxiety , insomnia, restlessness,muscle tension, irritability . Immediately contact your prescriber if intolerable. 58"}},{id:"counsel-018",name:"Benzoyl Peroxide, Topical",pharmacologicalGroup:"Antibacterial and anti-inflammatory agent",indication:"Treatment for acne vulgaris. To be applied on acne spots once or twice daily. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Wash the affected area with a mild skin cleanser and water and pat skin dry. Apply a thin film of medication to the affected area once daily. Start at night for a week, if there is no skin irritation/redness/peeling, can apply twice daily if needed. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"only if clearly needed.",breastfeeding:"woman to avoid accidental transfer to the infant.",elderly:"Not applicable.",paediatric:"patients below 12 years old have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Skin dryness, skin redness, peeling of the skin, burning sensation of the skin, itching of the skin.","Avoid products that may dry or irritate skin such as products containing alcohol, harsh skin cleaners and medicated soap.."],others:{storage:"Store at room temperature below 25 o C 60",other_points:"Not applicable."}},{id:"counsel-019",name:"Beta-Blockers",pharmacologicalGroup:"Beta-blockers",indication:"Hypertension Drug Initial Dose Maximum Dose Atenolol 50mg OD 100mg OD Bisoprolol 5mg OD 20mg/day Labetalol 100mg BD 2400mg/day Metoprolol 50mg BD 200mg BD Propranolol 40mg BD 320mg BD Heart Failure Drug Initial Dose Target Dose Bisoprolol 1.25mg OD 10mg OD Carvedilol 3.125mg BD 25mg BD Arrythmias Drug Initial Dose Maximum Dose Sotalol 80mg BD 480 - 640mg in divided doses To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Can take without regards to meal: a. Atenolol b. Bisoprolol 2. Recommended to administer on empty stomach: a. Propranolol 3. Recommended to administer with food: a. Carvedilol: to minimise orthostatic hypotension b. Metoprolol Missed dose management: 1. Single daily dosing regime: missed dose taken up to until 12 h after the scheduled dosing 2. Twice daily dosing regime: missed dose taken up until 62 6 h after the scheduled intake Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"; monitor the newborn for 48 hours after delivery for bradycardia, hypoglycemia, and respiratory depression.",breastfeeding:"infants and neonates may also be at risk for hypoglycemia. Adverse events may be more likely in premature infants or infants with impaired renal function.",elderly:"Refer to adult dosing. Consider lower initial doses and titrate to response.",paediatric:"Dose should be individualized based on patient response.",fasting:"Not applicable"},sideEffects:["Worsening symptoms or signs (e.g. increasing dyspnoea, fatigue, oedema, weight gain):  If increasing congestion, increase a dose of diuretic or halve a dose of beta-blocker (if increasing diuretic dose does not work).  If serious deterioration, halve the dose of beta-blocker or stop this treatment (rarely 63 necessary); seek specialist advice.","Low heart rate:  If <50 b.p.m. and worsening symptoms, halve the dose of beta-blocker , or, if severe deterioration, stop beta-blocker (rarely necessary).  Review need for other heart rate-slowing drugs (e.g. digoxin, ivabradine, amiodarone, diltiazem, or verapamil).  Arrange ECG to exclude heart block.","Asymptomatic low blood pressure:  Does not usually require any change in therapy .","Symptomatic hypotension:  If dizziness, light-headedness, or confusion and a low blood pressure, reconsider the need for nitrates, calcium-channel blockers and other vasodilators and reduce/stop, if possible.  If there are no signs or symptoms of congestion, consider reducing diuretic dose."],others:{storage:"Store it at room temperature and away from excess heat and moisture.",other_points:"Monitoring parameters: Heart rate, blood pressure, serum glucose (in diabetic patients), ECG."}},{id:"counsel-020",name:"Benzyl Benzoate, Emulsion (EBB",pharmacologicalGroup:"Scabicide",indication:"1. For the treatment of scabies a. 12.5%: 2 years old to 12 years old b. 25%: More than 12 years old To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Individuals to be treated should have a shower or bath with soap, and dry their body thoroughly prior to treatment. 2. The emulsion should be shaken well before use. 3. Apply from neck to soles, paying particular attention to all skin folds such as between fingers and toes, underarms and groin. Avoid head, face and private areas. 4. Allow the emulsion to dry (usually takes about 10min) and then put on clean clothes. Do not wash your hands. 5. Leave the emulsion on the body . Do not bath, shower or change clothes before the second application. 6. Apply on the skin surface continuously for 24 hours for 2-3 days. 7. Rinse off after 24 hours and then reapply , with a bath taken in between each application. 8. A third application may be required in some cases i.e. HIV/ immunocompromised patients. 9. Wash off thoroughly after the recommended time period. 10. Alternatively , may do 3 applications within a 12 hour interval. Missed dose management : If a dose is missed, use it as soon as possible. If it is almost time for the next dose, use only that dose. Do not use double or extra doses. Do not stop your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Use of EBB is contraindicated in breast feeding women.",elderly:"should 65 be used.",paediatric:"Use of EBB is contraindicated in infants of <2 years old.",fasting:"N/A"},sideEffects:["Burning sensation, rashes, skin irritation.","Irritation of the skin, eyes and mucous membranes.","If incorrectly used for long periods of time it will induce both irritant and allergic dermatitis reactions."],others:{storage:"1. Store at room temperature below 25C. 2. Discard any unused medicine after the expired date.",other_points:"1. Should NOT be used on the face due to its irritant effect on the skin, and should NOT be used on broken, irritated or inflamed skin."}},{id:"counsel-021",name:"Bisphosphonates",pharmacologicalGroup:"Bisphosphonate",indication:"1. Alendronate sodium 70mg tablet i) Treatment of osteoporosis in high-risk postmenopausal women: 70 mg once weekly . ii) Male Osteoporosis: 70 mg once weekly . 2. Alendronate sodium 70mg + Cholecalciferol 5600 IU tablet i) Osteoporosis in postmenopausal women with a history of vertebral fracture and whom oestrogen replacement therapy is contraindicated: 1 tablet once weekly [70mg/5600 IU] ii) Male Osteoporosis",dosage:"1 tablet once weekly [70mg/5600 IU] 3. Ibandronic 150mg i) Treatment of postmenopausal osteoporosis to reduce the risk of fracture: 150mg once monthly",methodOfAdministration:"1. Alendronate sodium 70mg tablet 2. Alendronate sodium 70mg + Cholecalciferol 5600 IU tablet ADMINISTRA TION 1. Take 1 dose every week on the chosen day after getting up for the day and before taking first food, drink, or other medicine while sitting or standing up. 2. Swallow one tablet with a full glass of plain water (not mineral water , coffee, tea or juice). Do not chew or suck. 3. After taking, wait at least 30 minutes : a. Before lying down. May sit, stand or walk, and do normal activities like reading. b. Before taking the first food or drink except for plain water . c. Before taking other medicines, including antacids, calcium, and other supplements and vitamins. MISSED DOSE 1. If you miss a dose, take only 1 dose in the morning after remembering. 2. Do not take 2 doses on the same day. 3. Continue the usual schedule of 1 dose once a week on the chosen day. OVERDOSE 1. If taken more than the prescribed dose, drink a full glass of milk and visit the doctor right away . 2. Do not try to vomit. 3. Do not lie down. 3. Ibrandronic Acid 150mg Tablet 1. One tablet once a month. Choose the day of the month that best fits your schedule. Can choose either the same date (such as the 1st of each month) or the same day (such as the first Sunday of each month) to take the tablet. 2. Take the tablet at least 6 hours after having eaten or drank anything except water . 67 3. Swallow one tablet with a full glass of plain water (not mineral water , coffee, tea or juice). Do not chew or suck. 4. After taking, wait at least 60 minutes : a. Before lying down. May sit, stand or walk, and do normal activities like reading. b. Before taking the first food or drink except for plain water . c. Before taking other medicines, including antacids, calcium, and other supplements and vitamins. M ISSED DOSE 1. If forgotten to take the tablet on the morning of the chosen day, do not take a tablet later in the day. Instead, consult the calendar and find out when the next scheduled dose is: 2. If the next scheduled dose is only 1 to 7 days away a. Should wait until the next scheduled dose is due and take it as normal; then, continue taking one tablet once a month on the scheduled days marked on the calendar . 3. If the next scheduled dose is more than 7 days away . a. Should take one tablet the next morning after the day the patient remembers; then, continue taking one tablet once a month on the scheduled days marked on the calendar . 4. Never take two doses within the same week. OVERDOSE If taken more than the prescribed dose, drink a full glass of milk and visit the doctor right away . Do not try to vomit. Do not lie down Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"May cause fetal harm. Limited human data- animal data suggest risk.",breastfeeding:"Infant risk cannot be ruled out. No human data- probably compatible.",elderly:"and must be corrected before starting alendronate. STOPP/ST ART Criteria: 68 1. Avoid use of oral bisphosphonate in patient with current or recent history of upper gastrointestinal disease ( eg esophagitis, gastritis, duodenitis, or peptic ulcer disease )",paediatric:"patients below age 18 have not been established .",fasting:"Refer to the latest advisory by religious authority ."},sideEffects:["May cause problems in the oesophagus including irritation, inflammation or ulcers which may sometimes bleed.  This may occur especially if patients do not drink a full glass of water with the medication or if lying down in less than 30 minutes (alendronate and alendronate/cholecalciferol) and less than 60 minutes (ibandronate) or before the first food of the day.","Mouth sores (ulcers) may occur if the medication is chewed or dissolved in the mouth.","May get flu-like symptoms, typically at the start of treatment.","May get allergic reactions, such as hives or, in rare cases, swelling of the face, lips, tongue, or throat.","May cause jaw-bone problems in some people. Jaw-bone problems may include infection, and delayed healing after teeth are pulled.","Stop taking the medication and call the doctor right away if there are any of these signs of possible serious problems of the oesophagus:  Chest pain  New or worsening heartburn  Trouble or pain when swallowing.","The most common side effect is stomach area (abdominal) pain. Less common side effects are nausea, vomiting, a full or bloated feeling in the stomach, constipation, diarrhoea, black or bloody stools (bowel movements), gas, eye pain, rash that 69 may be made worse by sunlight, hair loss, headache, dizziness, a changed sense of taste, joint swelling or swelling in the hands or legs, and bone, muscle, or joint pain."],others:{storage:"1. Store your tablets in the original blister pack at or below 30C. 2. Protect from moisture and light",other_points:"1. Contraindicated in patient with: a. esophageal abnormalities b. hypocalcemia c. inability to stand or sit upright for 30 minutes (alendronate and alendronate/cholecalciferol) and for 60 minutes (ibandronate). 2. Renal impairment :use not recommended in patient with: a. CrCl < 35ml/min (alendronate and alendronate/cholecalciferol) b. CrCl < 30ml/min (ibandronate) 3. Hepatic impairment : No adjustments necessary 4. Musculoskeletal pain (severe) : Discontinue use 5. Upper gastrointestinal adverse effects : Discontinue use and evaluate 6. Special populations : Use cautiously in patient with: a. restricted sodium intake b. effervescent tablet contains sodium"}},{id:"counsel-022",name:"Buprenorphine, Transdermal Patch",pharmacologicalGroup:"Opioid Analgesic",indication:"Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Not suitable for the treatment of acute pain. For elderly patients or patients with comorbidities/ difficulties to swallow . Once weekly transdermal patch/for hospital use only. Patients aged 18 years and over. Initial",dosage:"5 mcg/hr . Renal impairment: No special dose adjustments necessary in patients with renal impairment. Hepatic impairment: Patients with hepatic insuf ficiency should be carefully monitored during the treatment with buprenorphine patch. Alternate therapy should be considered. Patch should be used with cautions in severe hepatic impairment patients. To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"Step 1: Preparing the skin a. Make sure the skin is completely dry, clean and cool before putting the patch on. b. Sites of application are chest, back and upper arms Step 2: Open the sachet a. Each patch is sealed in its own sachet b. Tear or cut open the sachet at the notch, shown by the arrow Step 3: Peel and press a. Carefully peel one half of the shiny plastic backing away from the centre of the patch. Try not to touch the sticky side of the patch b. Press the sticky part of the patch onto the skin c. Remove the other part of the backing and press the whole patch onto the skin with the palm of your hand. d. Hold for at least 30 seconds. Make sure it sticks well, especially the edges e. The date and time of application and/or renewal should be written on the patch. Step 4: Disposing of the patch a. As soon as take a patch off, fold it firmly in half so that the sticky side sticks to itself b. Put it back in its original sachet and dispose of the sachet as instructed Step 5: Wash a. Always wash the hands after handling the patch using clean water only Step 6: Change of patch a. Change patch every 7 days at the same time b. If the patch falls off before the scheduled change date (7 days), discard it and apply a new patch to a different skin site. 71 c. Rotate the site after each patch removal and wait for at least 3-4 weeks before reapplying to the same site Missed dose management: 1. Apply a new patch as soon as you remember 2. Do not apply twice the number of patches to make up for the patch that you missed. 3. This will increase the chance of you getting unwanted side-ef fects Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"May need dose adjustment; depends on withdrawal signs and symptoms need to be monitored. 2. Use of an extended period of time may expose in the neonatal opioids withdrawal syndrome 3. Advice of the risk of neonatal opioids withdrawal syndrome and ensure that management by neonatology experts will be available at delivery",breastfeeding:"Infant risk cannot be ruled out.",elderly:"patients carry risks of constipation that lead to delirium and increased risk of falls. 4. Avoid in patients with a history of fractures or falls, it may contribute to additional fall.",paediatric:"The safety and efficacy in pediatric patients have not been established."},sideEffects:["Opioid-induced constipation a. A common side effect b. Tolerance does not develop, hence laxatives 72 must be taken regularly c. Use combination of stimulant (e.g. bisacodyl) + softener (e.g. lactulose) d. Increase fluid and dietary fibre intake, maintain good physical activity , and try to establish a toilet routine","Opioid-induced sedation / impaired alertness a. May occur upon initiation of opioids b. Avoid driving and other activities that require mental alertness until it is clear how morphine/ Oxycodone affects the patient c. Tolerance develops after 5 - 10 days","Opioid-induced neurotoxicity (delirium, confusion) a. May occur , but usually transient b. May consider use of haloperidol for delirium","Opioid-induced nausea and vomiting a. May occur upon initiation of opioids b. Tolerance develops 5 - 10 days after starting c. May use antiemetics (e.g. metoclopramide, haloperidol or prochlorperazine) d. Be consistent when taking morphine with or without meals","Opioid-induced dry mouth a. Sip water often, let small ice chips melt in your mouth b. Minimise intake of caffeinated drinks, such as coffee, tea, and some sodas as well as use of tobacco and alcohol c. Chew sugarless gum or suck on sugarless hard candy to stimulate saliva flow","Dermatologic: a. Severe application site reactions may occur . Onset ranged from days to months after initiation."],others:{storage:"1. Store your medication in a cool, dry place away from heat, moisture and direct sunlight 2. Disposal: FOLD used patches so that the adhesive side adheres to itself.",other_points:"1. Addiction: abuse, misuse, or opioid addiction may occur . Use cautiously in patients with a history of substance abuse or mental illness. 2. Fever with increased core body temperature might increase adverse effects; adjust dose if necessary 3. Heat exposure: Avoid heat exposure to application site or surrounding areas (e.g: heating pads, electric blankets, heating lamps, sauna, hot water or direct sunlight) 4. Concomitant use with others: Benzodiazepines or Central Nervous System(CNS) depressants including alcohol may result in profound sedation, respiratory depression, coma, and death."}},{id:"counsel-023",name:"Calcium Carbonate",pharmacologicalGroup:"Calcium Calcium Carbonate",indication:"1. Hyperphosphatemia (phosphate binder) in chronic kidney disease patients a. Total dose of elemental calcium from calcium-based phosphate binder not to exceed 1,500 mg/day .Dosing is individualised based on serum phosphate level and according to product insert/protocol 2. Calcium supplementation a. 500 mg to 4g per day as calcium carbonate in 1-3 divided doses (500mg capsule contains 200mg elemental calcium).Dosing is individualised based on serum calcium level and according to product insert/protocol To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Hyperphosphatemia Tablet 1. To chew / crush and take WITH meals / snacks 2. Can be crushed and served through Ryle s tube Capsule 1. To swallow WITH meals / snacks OR to open the capsule and sprinkle the powder on the meal 2. Calcium Supplements 1. To swallow the whole tablet / capsule with food. 2. Post parathyroidectomy , to swallow the whole tablet / capsule on empty stomach to minimise the phosphate binding effects. Missed dose management: In case of a missed dose, take it during the meal or immediately after the meal. Omit the dose if totally forgotten and remember to take as per instructed during the next meal. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Calcium is found in breast milk 2. Calcium carbonate is unlikely to be harmful to a nursing baby if used as directed.",elderly:"who are more prone to decreased renal function. 75",paediatric:"Can be used for children with CKD for phosphate binding / calcium supplements. 2. Monitor serum calcium level regularly .",fasting:") and Iftar (breaking fast). 2. If more than two doses have been prescribed, consult with the healthcare provider to adjust your phosphate binder administration."},sideEffects:["Generally , well tolerated.","Gastrointestinal: Abdominal pain, anorexia, constipation, flatulence, nausea, vomiting","Endocrine/metabolic: Hypercalcemia"],others:{storage:"1. Store at room temperature. 2. Store in a dry place and protect from moisture. 3. Keep out of reach of children.",other_points:"No dosage adjustment was provided in the manufacturer s labelling."}},{id:"counsel-024",name:"Carbamazepine",pharmacologicalGroup:"Antiepileptic drugs/ Anticonvulsants drugs",indication:"1. Epilepsy a. 100-200 mg 1-3 times daily increased gradually to the usual dose of 0.8-1.2 g daily in divided doses. 2. Trigeminal neuralgia a. Initial dose 200- 400 mg should be slowly raised daily until freedom from pain is achieved. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Should be taken with food. 2. Try to take it at the same time each day. 3. Avoid grapefruit juice. Missed dose management: 1. If you forget to take a dose, take it as soon as you remember . Do not take two doses at once. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Associated with increased risk of major congenital malformations. Use only when benefits outweigh risks.",breastfeeding:"Excreted in human milk with concentration ranging from 1%  10% of maternal serum levels.",elderly:"Initiate at lower dose and increase slowly . Initial dose of 100mg twice daily is recommended. 2. Precaution with falls as associated with ataxia, dizziness, hypotension, 3. May exacerbate or cause SIADH or hyponatremia; monitor sodium levels closely when starting or changing dosages in older adults.",paediatric:"HLA-B*15:02 allele screening in patients with risk of genetic variant prior to initiation.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Sedation, Nausea, dizziness, tremor , Hypotension or hypertension.","This drug may cause drowsiness or blurred vision, do not drive or operate machinery .","Women of childbearing potential must use highly effective birth control methods without interruption during therapy ."],others:{storage:"Store between 15  30 c. Protect from light and moisture.",other_points:"Hepatic Impairment: Special precaution"}},{id:"counsel-025",name:"Cetrimide, Lotion",pharmacologicalGroup:"1. Antiseptic 2. Bactericidal activity against gram-positive bacteria",indication:"1. Treatment of Acne Vulgaris 2. General antiseptic and skin disinfectant for wounds, cuts and insect bites. Apply to the affected area as required or as directed by the physician.",dosage:"See indication for dosage details",methodOfAdministration:"1. Apply solution onto the face twice daily . 2. Cetrimide mix with water on palms, rub hand together until froth 3. Apply froth on face 4. Then rinse off with water 5. Dap dry Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"only if the potential benefits justify the potential risks to the fetus.",breastfeeding:"when applied topically . 2. Avoid applying it to the breast area to prevent accidental ingestion by the infant.",elderly:"Not applicable. Refer to the usual adult dose.",paediatric:"patients for antiseptic and disinfectant use. 2. Safety depends on different concentrations and skin conditions.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Burning sensation Prolonged and repeated administration may lead to hypersensitivity.","If this occurs, stop using the lotion and consult your physician.."],others:{storage:"1. Keep the container tightly closed. 79 2. Store at room temperature. 3. Protect from light, heat and moisture. 4. Keep medicine out of reach of children. 5. Dispose of any remaining product in the tube after completing your course of treatment or once the product has expired.",other_points:"1. Do not use it if the skin is weeping or badly inflamed. 2. Avoid contact with eyes and middle ear. 3. It should not be used in body cavities (eg:mouth & ears) 4. For external use only."}},{id:"counsel-026",name:"Clarithromycin",pharmacologicalGroup:"Macrolide",indication:"1. Second-line treatment for leprosy 2. Drug-resistant leprosy Adult : 500mg once daily (in combination with other anti-leprosy drugs)",dosage:"See indication for dosage details",methodOfAdministration:"Food: Administered with or without food RT administration: No specific data on enteral tube administration are available for this formulation. Alternative route available: parenteral route. Missed dose: Take the missed dose as soon as possible Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Avoid unless benefits outweigh risks",breastfeeding:"Avoid",elderly:"Adverse effects may be increased in older patients",paediatric:"NA",fasting:"NA"},sideEffects:["Gastrointestinal Disturbance: Dysgeusia, diarrhea, vomiting, nausea Taste Alteration: metallic taste, loss of taste sensation Central nervous System: Headache, dizziness, insomnia Cardiovascular : QT prolongation Ototoxicity: Hearing loss and tinnitus reported in association 81 with long-term use.."],others:{storage:"Store at room temperature (do not refrigerate) and protect from light",other_points:": 1. Renal impairment (CrCl < 30 mL/min): No dose adjustment required at doses used in leprosy 2. Liver Impairment: No dose adjustment required at doses used for leprosy"}},{id:"counsel-027",name:"Clofazimine",pharmacologicalGroup:"Iminophenazine",indication:"1. First-line treatment for leprosy (Paucibacillary & Multibacillary) (to be used in combination with other anti-leprosy agents) a. Adult: 300mg once a month & 50mg once daily b. Children: i) 10-14 years old : 150mg once a month & 50mg on alternate day ii) <10 years old or <40kg: 6mg/kg once a month & 1mg/kg once daily C. Duration: Paucibacillary: 6 month Multibacillary: 12 mont h 2. Drug-resistant leprosy Adult : 50mg once daily (in combination with other anti-leprosy drugs)",dosage:"See indication for dosage details",methodOfAdministration:"Oral; not available parenterally Food 1. To be taken with food to avoid stomach upset and improve absorption (including enteral feeding). RT administration 1. Capsules containing powdered therapeutic substances can be administered enterally Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Not recommended due to limited data (some reports of normal outcomes, some reports of neonatal deaths)",breastfeeding:"due to pigmentation of the infant",elderly:"NA",paediatric:"The 100 mg soft gel capsule is difficult to swallow for young children and therefore countries are strongly encouraged to make the 50 mg tablet formulation available. [WHO WEIGHT BAND]",fasting:"To refer to the latest advisory by religious authority 83"},sideEffects:["Orange-pink, red, or brownish-black discoloration of skin, conjunctiva, cornea, and body fluids.","Gastrointestinal intolerance","Photosensitivity","QT prolongation (risk for torsades de pointes) Advise patients to inform their healthcare providers if they experience any side effects. Inform pt discoloration effect goes away after stopping the medicine but may take a long time to do so (months to years). Patients should avoid the sun and use strong sunscreens."],others:{storage:"Room temperature",other_points:"Use in renal disease: No dosage adjustment required Use in hepatic disease: Avoid in patients with liver impairment (Child-Pugh classes A, B, and C) unless benefit outweighs risk."}},{id:"counsel-028",name:"Clopidogrel",pharmacologicalGroup:"Antiplatelet-Thienopyridine P2Y12 Antagonist",indication:"1. Indication 1 :Non-ST segment elevation acute coronary syndrome(unstable angina or non-Q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention a. Dosage for indication 1: 75mg od 2. Indication 2: ST segment elevation acute myocardial infarction,in combination with acetylsalicylic acid (ASA) in medically treated patients eligible for thrombolytic therapy a. Dosage for indication 2: 75mg od 3. Indication 3: Ischaemic stroke a. Dosage for indication 3: 75mg od",dosage:"See indication for dosage details",methodOfAdministration:"Take with or without food. Can be crushed to administer through an NG tube Missed dose management: Take a missed dose as soon as remembered.If it is close to the time for the next dose, skip and go back to normal time. Do not take 2 doses at the same time. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"are available",breastfeeding:"Limited data",elderly:"Safe in",paediatric:"Should not be used in children",fasting:"Not applicable"},sideEffects:["Haematoma,Epistaxis,Gastro-intestinal haemorrhage,diarrhoea,abdominal pain,dyspepsia,bruising"],others:{storage:"1. Store below 30C. Protected from light",other_points:"1. Experience is limited in patients with moderate hepatic 85 disease who may have bleeding diathesis. 2. Experience is limited in patients with severe and moderate renal impairment."}},{id:"counsel-029",name:"Clotrimazole, Topical",pharmacologicalGroup:"Antifungal agent: Imidazole Derivatives",indication:"Adult Candidal balanitis 1. Apply 2 or 3 times onto male sexual partner s genital organ, for up to 2 weeks. Skin fungal infections 1. Apply thinly to the affected area(s) 2 or 3 times per day. Continue treatment for at least 4 weeks (dermatophyte infections) or at least 2 weeks (candida infections) Paediatric Tinea Cruris 1. Apply twice daily (morning & night) up to 2 weeks. Tinea Corporis and Tinea Pedis 1. Apply twice daily (morning & night) up to 4 weeks To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Adult 1. For external use only 2. Avoid contact with eyes and application to severely cracked or irritated areas of the skin. Apply a thin layer to the affected area. 3. Athlete s foot; pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once a day. Paediatric 1. For external use only 2. Apply sparingly and rub gently into the cleansed, affected area. 3. Do not apply to the eye. 4. Tinea pedis: apply to spaces between toes Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"category (USFDA): C",breastfeeding:"Presence in breast milk is unknown",elderly:"Refer to adult dosing 2. Patients who use topical oils, creams, and ointments have potential fall risk .Patients may be advised to 87 wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces.",paediatric:"Children under 12 years old should be supervised during use."},sideEffects:["General disorders and administration site conditions: Application site reactions may include. peeling/exfoliation, stinging sensation, pain, discomfort","Skin and subcutaneous tissue disorders: Rash, urticaria, pruritus.","Local irritation:If irritation or sensitivity develops, discontinue therapy immediately . Consult a healthcare provider for appropriate alternative therapy ."],others:{storage:"1. Protect from light. 2. Store below 25C / 30C",other_points:"No dosage adjustments in kidney impairment and liver impairment as well as paediatric populations"}},{id:"counsel-030",name:"Clozapine",pharmacologicalGroup:"Atypical Antipsychotic s",indication:"Treatment-resistant schizophrenia 1. Suggested starting",dosage:"12.5mg once or twice on the first day, followed by 25 or 50mg on the second day. If well tolerated, the dose may then be increased in increments of 25-50mg/day in order to achieve a daily dose of 300mg within 2-3 weeks. Thereafter , may be further increased in 50-100mg increments at half or weekly intervals. 2. Speed & dose titration depends if pt is naive and care setting e.g. inpatient vs outpatient) 3. Therapeutic dose range (usually given in two divided doses): i. Female 250mg/day [smokers, 450mg/day] ii. Male 350mg/day [smokers, 550mg/day] 4. Maximum dose : 900mg/day . Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Take Clozapine at the same time every day with water or a cool drink 2. This medication can be taken with or without food. Missed dose management: 1. Take as soon as you remember , omit If it is almost time for next dose 2. Take the next dose as usual. Do not double the dose. 3. If you miss 2 or more days of Clozapine doses, talk to your doctor before you start taking it again. You might have to restart the medicine at a lower dose. 4. Treatment interruption may lead to changes to the blood monitoring schedule Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"or become pregnant while taking clozapine.",breastfeeding:"Lactating mothers on clozapine are advised not to breastfeed while on treatment. For those who do not wish to continue lactating, formula milk supplementation should be offered to the infants 89",elderly:"In older patients (  60 years) initiation of treatment at a particularly low dose is recommended (12.5mg given once on the first day), with subsequent dose increment restricted to 25mg/day . Beers Criteria: 1) Avoid in adjunctive treatment of MDD or for short term use as antiemetic, except in FDA approved indications (e.g Schizophrenia, bipolar disorder , Parkinson disease psychosis). Increase risk of death, metabolic effects, orthostatic hypotension and cardiac arrhythmias. 2) Use is associated with fall risk. To advise on fall precautions. Micromedex: Black Box Warning :Avoid for behavioral problems related psychosis of dementia or delirium",paediatric:"Safety and effectiveness in pediatric patients have not been established",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority . Pre-Operative 1. If clozapine was withheld before surgery and discontinued for more than 48 hours, treatment should be re-initiated. Changes to blood monitoring schedule may be required. Contact your prescriber .",hepaticImpairment:"Contraindicated in active liver disease associated with nausea, anorexia or jaundice; progressive liver disease, hepatic failure. 2. If you develop symptoms of possible liver dysfunction such as yellowing of the skin, abdominal pain, nausea, vomiting and/or anorexia during clozapine treatment, Immediately contact your prescriber Dietary and lifestyle considerations  Adopt healthy lifestyle which includes well balanced diet, adequate hydration and exercise  Cleaning teeth morning and night (this also helps keep white cell counts up)  Reduce or quit smoking. Plan this with the doctor .",renalImpairment:"."},sideEffects:["Common side effects:","Sedation: may improve with time. Avoid activity requiring mental alertness or coordination. Do not drink 90 alcohol during treatment with this medicine as it might increase the sedative effect. Do not drive or work with tools or machinery if affected. Inform prescriber at next appointment (to consider night-time dosing only)","Constipation: bowel habit monitoring, increase your physical activity , fluid and fibre intake. May require medications. Contact prescriber if unable to pass flatus or if there is abdominal pain/discomfort (warning sign)","Tachycardia: contact your prescriber if you experience persistent palpitation","Weight gain: Advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise.","Hypersalivation: often improves over time. If persistent, inform your prescriber at the next appointment. Use a towel on the pillow while sleeping and make sure to bring towel/tissue along.","Blood pressure changes: clozapine can cause both hypotension and hypertension","Hyperglycaemia: watch out for symptoms of increased sugar levels such as frequent urination, increased thirst and delay in wound healing Rare but serious side effects :","Severe infection (due to drop in white cells - a condition called Neutropenia): advise to seek urgent medical assessment it patient develop flu-like symptoms","Clozapine lowers the seizure threshold. Higher risk with higher doses. Immediately contact your prescriber in an event of seizure.","Cardiac complications including myocarditis and cardiomyopathy . In cases where tachycardia persists at rest and is associated with fever , hypotension or chest pain, it may indicate myocarditis. Immediately contact your prescriber ."],others:{storage:"Store at a temperature below 30C.",other_points:"Drug-lifestyle interactions  Cigarette smoking can decrease clozapine levels. May require a decrease clozapine dose during periods of smoking cessation, please inform your prescriber Blood regular monitoring  During the first 18 weeks of administration, patients are required to have their full blood count checked weekly . This changes to fortnightly after 18 weeks and then monthly after one year."}},{id:"counsel-031",name:"Corticosteroids, Topical",pharmacologicalGroup:"TOPICAL CORTICOSTEROIDS 1. Very Potent (Class I) Clobetasol propionate 0.05% cream/ointment 2. Potent (Class II) Betamethasone dipropionate 0.05% cream/ointment Betamethasone valerate 0.1% cream/ointment Mometasone furoate 0.1% cream/ointment 3. Moderate Potent (Class III) Betamethasone valerate 0.05% cream/ointment (1:2) Betamethasone valerate 0.025% cream/ointment (1:4) Clobetasone butyrate 0.05% cream/ointment 4. Mild Potent (Class IV) Betamethasone valerate 0.0125% cream/ointment (1:8) Hydrocortisone acetate 0.5-1% cream/ointment *Based on UK classification: Creams are generally less potent than ointments of the same medication.",indication:"For the relief of inflammatory and pruritic manifestations associated with steroid responsive dermatoses. For disease:  eczema  such as atopic eczema  contact dermatitis  which causes symptoms such as dandruf f and scaly patches on the skin  psoriasis Apply as directed by the prescribing doctor .",dosage:"See indication for dosage details",methodOfAdministration:"1. The medicine should only be applied to affected areas of skin. Gently smooth a thin layer onto your skin in the direction the hair grows. Wash your hands before and after you've applied the medicine, unless you are treating an area on your hands. 2. If you're using both topical corticosteroids and emollients, topical corticosteroids should be applied 20- 30 minutes after the application of emollient 3. Sometimes, the amount of medicine you're advised to use will be given in fingertip units (FTUs). 4. A FTU (about 500mg of cream/ointment or 2% Body Surface Area) is the amount needed to squeeze a line from the tip of an adult finger to the first crease of the finger . It should be enough to treat an area of skin double the size of your palm with your fingers together . 5. Duration of usage: a) short-term therapy with potent and very potent topical corticosteroids may be used to gain rapid clearance in psoriasis patients with limited 93 plaques. These preparations should be avoided on the face, genitalia and body folds. b) Limit use of super potent corticosteroids to less than 30g/week. c) Limit use of potent corticosteroids to less than 60g/week. d) Continuous use of potent corticosteroids should not exceed four weeks. e) Continuous use of super potent corticosteroids should not exceed two weeks. f) Mild potency corticosteroids may be used for face, genitalia and body folds. g) Do not abruptly discontinue using topical steroids as it can cause the disease to flare up. Apply the principle of Step down and Step up and not PRN basis. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". High-potency topical corticosteroids should be avoided if possible and when they must be used they should be used only for a short time, the amount used should be kept to a minimum and fetal growth should be monitored.",breastfeeding:"There are no studies assessing the safety of topical corticosteroid use during lactation. It is recommended that the topical treatment in the nipple region be applied after nursing the child, to allow the drug to be absorbed before the next feeding, and that the nipple area be gently cleaned of the remaining drug before nursing.",elderly:"NA",paediatric:"Safety and efficacy of topical steroids are established in pediatric patients. Follow the specific instructed duration, use different potencies on different areas, avoid sensitive areas and occlusion unless directed, and monitor for side effects such as skin atrophy or systemic absorption.",fasting:"NA"},sideEffects:["When used correctly , topical corticosteroids rarely cause serious side effects. The most common side effect is a burning or stinging sensation, which typically improves with continued use.","Less common side effects can include:","Skin issues: Thinning, striae formation, contact 94 dermatitis, acne, rosacea, changes in skin color (more noticeable in dark skin), and excessive hair growth.","Infections: Worsening or spreading of existing infections and inflamed hair follicles (folliculitis).","Risks are higher with more potent steroids, prolonged use, large application areas, and in vulnerable groups like the elderly and young children. Prolonged use of high-potency steroids can lead to systemic effects like Cushing's syndrome or growth suppression in children.","For detailed side effect information, consult the medicine leaflet."],others:{storage:"Keep the jar tightly closed. Store below 30C and protect from heat, moisture, and light. Do not freeze. Keep out of reach of children.",other_points:"NA"}},{id:"counsel-032",name:"Crotamiton, Topical",pharmacologicalGroup:"Scabicide Antipruritic agent",indication:"1. Scabies for infant <2yo 2. Pruritus 3. Insect bite reaction Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Scabies a. Bath and dab dry before applying the cream. b. Apply the cream by massaging into the skin from the chin to the toes including skin folds and creases. Special attention should be paid to sites that are particularly susceptible to infestation by the mites (interdigital space, wrist, axillae and genitalia). c. Cut fingernails short and make sure to apply under fingernails too. d. DO NOT apply the cream in the eyes or mouth. e. DO NOT apply to raw, weeping, or inflamed skin. f. Areas where there is pus formation should be covered with a dressing impregnated with crotamiton. g. The application should be repeated once daily, preferably in the evening, for a total of 3-5 days depending on the response. h. For nodular scabies, apply to the nodules 3 times a day for 7-14 days. i. Finish the full course prescribed by your doctor even if you think your condition is better . 2. Pruritus and Insect bite reaction a. Massage the cream into itchy patches until the medication is absorbed into the skin 2-3 times a day until itching has subsided. b. DO NOT apply the cream in the eyes or mouth. c. DO NOT apply to raw, weeping, or inflamed skin. Miss dose management : If a dose is missed, use it as soon as possible. If it is almost time for the next dose, use only that dose. Do not use double or extra doses. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:", particularly during the first trimester is NOT ADVISED. 96",breastfeeding:"women. Nursing mothers should, in all events, avoid applying crotamiton in the area of the nipples.",elderly:"None specifically to the product",paediatric:"Dosing and treatment recommendations may vary among individual products or between countries.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Burning, itching, rash, redness, stinging, swelling, numbness","Discontinue use if severe irritation or sensitization occurs."],others:{storage:"1. Store at room temperature below 25C. 2. Protect from light 3. Discard any unused medicine after the expired date",other_points:"N/A"}},{id:"counsel-033",name:"Dabigatran",pharmacologicalGroup:"Direct Oral Anticoagulant - Direct Thrombin Inhibitor",indication:"1. Prevention of venous thromboembolic events in patients who have undergone total knee replacement or total hip replacement surgery . a. Following total knee replacement: Initially ADUL T 110mg (ELDERL Y, 75 mg) within 1- 4 hours after surgery , then 220 mg (ELDERL Y, 150 mg) once daily thereafter for 6-10 days Following total hip replacement: Initially ADUL T 110 mg (ELDERL Y, 75 mg) within 1- 4 hours after surgery , then 220 mg (ELDERL Y, 150 mg) once daily thereafter for 28-35 days 2. Reduction of the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF) a. Recommended daily dose is 300mg taken orally as 150mg hard capsule twice daily. Therapy should be continued lifelong. b. For the following groups, the recommended daily dose is 220 mg taken as one 110mg capsule twice daily: - Patients aged 80 years or above -Patients who receive concomitant verapamil Special patient population for renal impairment: Renal function should be assessed by calculating the creatinine clearance (CrCl) prior to initiation of treatment with Dabigatran to exclude patients for treatment with severe renal impairment (i.e. CrCl < 30 ml/min). 3. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults. a. Recommended daily dose is 300mg taken as one 150mg capsule BD following treatment with a parenteral anticoagulant for at least 5 days. The duration of therapy should be individualized after careful assessment of the treatment benefit against the risk for bleeding. b. Same as 2b",dosage:"See indication for dosage details",methodOfAdministration:"1. The capsules should be swallowed whole. 2. Breaking, chewing, or emptying the contents of the capsule can result in increased exposure.The oral bioavailability of dabigatran etexilate increases by 75% when the pellets are taken without the capsule shell compared to the intact capsule formulation. 3. Dabigatran can be taken with or without food. Missed dose management : 1. If a dose of dabigatran is not taken at the scheduled time, the dose should be taken as soon as possible on the same day; the missed dose should be skipped if it cannot be taken at least 6 hours before the next 99 scheduled dose. The dose of dabigatran should not be doubled to make up for a missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"There are no adequate and well-controlled studies in pregnant women. 2. Safety and effectiveness of dabigatran during labor and delivery have not been studied in clinical trials.",breastfeeding:"It is not known whether dabigatran is excreted in human milk.",elderly:"Dose reductions may be required as per "},sideEffects:[],others:{storage:"1. Store dabigatran at room temperature between 15C to 30C. 2. Keep dabigatran in the original blister package to keep it dry (protect the capsules from moisture). 3. Do not put dabigatran in pill boxes or pill organizers.",other_points:"1. No dose adjustment of dabigatran is recommended in patients with mild or moderate renal impairment 2. Reduce the dose of dabigatran in patients with severe renal impairment (CrCl 15-30 mL/min). The recommended dose is 75 mg twice daily 3. Dosing recommendations for patients with a CrCl <15mls/min or on dialysis cannot be provided. 4. For patients with liver disease that is associated with changes in the blood tests, the use of dabigatran is not recommended. Side Effects and their 1. In some people, dabigatran can cause symptoms of an allergic reaction, including hives, rash, and itching. 100 Management* 2. To seek medical assistance right away if you have any of the following symptoms of a serious allergic reaction with dabigatran: a. chest pain or chest tightness b. swelling of your face or tongue c. trouble breathing or wheezing d. feeling dizzy or faint 3. To seek emergency care right away if there are signs or symptoms of unusual or serious bleeding from any parts of the body . 4. Common side effects of dabigatran include: a. indigestion, upset stomach, or burning b. stomach pain"}},{id:"counsel-034",name:"Dapsone",pharmacologicalGroup:"Sulfone antibiotic",indication:"First-line treatment for leprosy (Paucibacillary & Multibacillary) (to be used in combination with other anti-leprosy agents) a. Adult: 100mg daily b. Children: i) 10-14 years old : 50mg daily ii) <10 years old or <40kg: 2mg/kg daily",dosage:"See indication for dosage details",methodOfAdministration:"Food To be taken with meals if GI upset occurs RT administration Tablet can be crushed, mixed with water and administered through Ryles Tube Missed dose Take as soon as remembered, skip if near next dose; do not double dose Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Safe in",breastfeeding:", but avoid for infants with G6PD deficiency .",elderly:"NA",paediatric:"Dapsone syrup 2mg/ml can be prepared",fasting:"NA"},sideEffects:["GI disorders: nausea and vomiting","Headache","Haematologic: haemolytic anaemia, haemolysis, 102 methaemoglobinaemia","Hypersensitivity reaction, including SJS, TEN","Hepatitis, transaminitis Advise patients to inform their healthcare providers if they experience any side effects."],others:{storage:"1. Tablet should be kept at room temperature 2. Suspension should be refrigerated and protected from light; stable for 91 days (Extemp formulation 2015)",other_points:"Use in renal disease: Can be used without dose adjustment Use in hepatic disease: No recommended dose adjustment, use with caution"}},{id:"counsel-035",name:"Darbepoetin Alfa",pharmacologicalGroup:"Other antianemic preparations Darbepoetin Alfa",indication:"1. Treatment of anaemia associated with chronic kidney failure, including patients on dialysis and patients not on dialysis a. CKD ON dialysis: IV/SC: 0.45 mcg/kg once weekly or 0.75 mcg/kg once every 2 weeks b. CKD NOT on dialysis: SC: 0.45 mcg/kg once every 2 to 4 weeks Dose may be increased or decreased by 25% once every 4 weeks, according to Hb level. The dose should not exceed 180mcg per single injection. 2. Anemia with myelodysplastic syndrome a. 240 mcg as a single subcutaneous injection once weekly . The dose should be decreased in view of the degree of anemic symptoms and the patient s age. Dosing is according to product insert . To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Route of Administration: Intravenous (IV) or Subcutaneous (SC): Site of administration for SC: Lower part of abdomen, thigh or arm Injection technique for SC (for self-administered) 1. Take one syringe out of the package and check that the solution is clear , colourless and free from visible particles . 2. Allow the syringe to reach room temperature. 3. Wash your hands.. 4. Unscrew the cap from the syringe. 5. Remove the needle from the pack, fix it on the syringe and remove the protective cap from the needle. 6. Clean the skin at the site of injection using an alcohol swab. 7. Form a skin fold by pinching the skin between thumb and forefinger . 8. Fully insert the needle 45 0 or 90 0 angle into the skin fold with a quick, short motion. Once the needle is inserted, release the pinch. 9. Slowly inject the darbepoetin solution. 10. Withdraw the needle and apply pressure over the injection site with a dry and sterile pad. 11. Dispose the empty syringe in a special waste container 12. Tear off the medication label on the syringe and stick into the booklet/diary (e.g., CAPD book) after the injection for the administration record, if available. 104 Consideration: 1. Blood pressure (BP) cutof f for administering Erythropoietin Stimulating Agent (ESA) is individualised. Generally , ESA is not given if BP exceeds 160/100 mmHg. Patients need to be informed about their specific BP cutof f whether to continue or hold ESA at home. 2. The site of SC injection should be rotated. Missed dose management: The missed dose should be administered as soon as possible and administration of Darbepoetin Alfa is to be restarted at the prescribed dosing frequency . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Not recommended. 2. When use is necessary , should be limited to cases where expected therapeutic benefits outweigh possible risks",breastfeeding:"Not recommended. 2. When necessary ,patients should avoid lactation during the treatment.Safety has not been established.",elderly:"generally have reduced physiological function and are likely to have cardiovascular complications such as hypertension",paediatric:"Safe to be used in children. The recommended dosing schedule should be individualized.",fasting:"Administer as usual"},sideEffects:["Common side effects, generally not serious: headache, increased blood pressure, irritation or pain at the injection site. Note:  To advise on the importance of compliance with antihypertensive medications and dietary restrictions for BP control.  If side effects persist, please consult a healthcare professional","Uncommon/rare: Pure red cell aplasia (PRCA)"],others:{storage:"1. Transport of ESA is only allowed in a cool box with ice 105 packs. 2. Preferably to return home immediately after getting ESA from the pharmacy to facilitate fast storage. 3. ESA is very sensitive to light and temperature. 4. Protect ESA from light 5. Store ESA in the refrigerator , do not freeze. Keep at 2-8C. 6. Avoid fridge doors, and vegetable compartments. Ensure there is proper air circulation around your ESA. 7. If you're travelling, try to keep your medication in a cooler with ice packs, and avoid storing it in any place where it might get too hot, like in a car. 8. According to the stability data for NESP Injection, the syringe remains stable for up to 3 months when stored in its box or a dark place at 25C. Handling of disposal: 1. Needles and syringes should never be reused. 2. Place all used needles and syringes into a sharps container (puncture-proof disposable container). 3. Keep the sharp container out of the reach of children. 4. Avoid disposing of used sharps containers in household waste. 5. Dispose of full sharps containers according to local regulations or at designated facilities.",other_points:"No dosage adjustment was provided in the manufacturer s labelling."}},{id:"counsel-036",name:"Darunavir",pharmacologicalGroup:"Protease Inhibitors",indication:"HIV Infection in combination with other antiretroviral agents. Adult: Darunavir 600mg twice daily to be taken together with 100mg Ritonavir twice daily Children  12 years old or adolescents weighing  40kg: Darunavir 600mg together with 100mg Ritonavir twice daily",dosage:"See indication for dosage details",methodOfAdministration:"Take Darunavir always together with Ritonavir Should take Darunavir with food (increase bioavailability) To take medication consistently at the same time everyday Enteral feeding/enteral tube: No data. Oral suspension formulation is available. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"and postpartum .",breastfeeding:"It is not known whether darunavir is excreted in human milk. Studies in rats have demonstrated that Darunavir is excreted in milk. Because of both the potential for HIV transmission and the potential for serious adverse events in nursing infants, mothers should be instructed not to breastfeed if they are receiving Darunavir .",elderly:"N/A",paediatric:"Darunavir is not recommended in children below 3 years old and less than 10kg.",fasting:". 107"},sideEffects:["Very common side effects (may affect more than 1 in 10 people) - diarrhoea","Common side effects (may affect up to 1 in 10 people) - vomiting, nausea, abdominal pain or distension, dyspepsia, flatulence headache, tiredness, dizziness, drowsiness, numbness, tingling or pain in hands or feet, loss of strength, difficulty falling asleep."],others:{storage:"Do not store above 30C.",other_points:"Adult: 1. Renal impairment : No dosage adjustment needed 2. Hepatic impairment : Mild to moderate impairment - No dosage adjustment needed Severe impairment - Use is not recommended"}},{id:"counsel-037",name:"Deferiprone",pharmacologicalGroup:"ORAL IRON CHELA TORS DEFERIPRONE (DFP) Tab Deferiprone (DFP) 500mg Immediate Release (IR) Tab Deferiprone (DFP) 1000mg Delayed Release (DR) Syrup Deferiprone 100mg/ml DEFERASIROX (DFX) Tab Deferasirox (DFX) Film-Coated 90mg, 180mg, 360mg Can be used as monotherapy or in combination with other oral iron chelating agents.",indication:"To remove excessive iron in the body due to regular blood transfusion in thalassemia patients. The goal is to maintain a safe level of body iron at all times, to prevent iron overload from transfusion therapy . DFP 50-100mg/kg/day Tablet: Not recommended for children below 6 years of age. Syrup: Not recommended for children below 3 years of age. DFX 14-28mg/kg/day Not recommended for children below 2 years of age. Tablets may be halved for necessary dose rounding. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"DFP DFP is available as: i) Syrup 100mg/ml form, ii) Tablet 500mg immediate-release (three-times-a-day) iii) Tablet 1000mg delayed release (twice-a-day) Always verify formulation prior to dispensing. Administration: To be taken orally . Oral solution 100mg/ml: Administer in three divided dosing (in the morning, at midday , and in the evening). Measure dose accurately . After dose administration, add 10mL to 15mL of water to the cup, swirl around to mix any remaining medication and consume. 500mg IR tablet: Administer in three divided dosing (in the morning, at midday , and in the evening). 1000mg DR tablet ONLY: Administer in two divided doses , approximately every 12 hourly . May be taken before or after a meal, but taking it after a meal may reduce nausea. 109 The tablets are scored and breakable in half. Missed dose management : If a dose is missed, take it as soon as possible. If it is almost time for the next dose, skip the missed dose; do not catch-up or double doses to make up for the missed dose. DFX DFX is available as a film-coated 90mg, 180mg, 360mg tablet. Administration: To be taken orally . Swallow it whole with a full glass of water . Take it on an empty stomach (30 minutes before eating) or with a light meal (low in fat), if necessary for better tolerability . Take it in the evening before dinner , and to be administered consistently at the same time. Can also be crushed and sprinkled on to soft food e.g. yoghurt or apple puree immediately prior to administration. (Does not require to be dissolved in water , compared to previous effervescent tablet form) Missed dose management : If a dose is missed, take it as soon as possible. If it is almost time for the next dose, skip the missed dose; do not catch-up or double doses to make up for the missed dose. These oral iron chelators can be taken in combinations of the following regimens including parenteral deferoxamine (DFO) & DFX, DFO & DFP or DFP & DFX). Combination use of DFP with DFO has synergistic effect and has been shown to improve outcome in patients with severe iron load in the heart. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"is confirmed in thalassaemic patients. Pregnant patients should be immediately referred to haematologists for further management.",breastfeeding:"patients. Resume oral iron chelators after cessation of",elderly:"and younger patients. DFX Use with caution due to the higher incidence of adverse drug reaction or toxicity (eg: hepatotoxicity) and fatal reactions during use; monitor closely . May require dose adjustment.",paediatric:"DFP 1. Syrup : For 3 years old and above 2. Tablet: For 6 years old and above (European Licensing); for 8 years old and above (USA Licensing) 3. Due to risk of agranulocytosis, monitoring of absolute neutrophil count (ANC) is needed as below:  Baseline  First 6 months : every week  Subsequent 6 months: every 2 weeks  After 1 year: every 2-4weeks DFX 1. For 2 years old and above",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["DFP Common adverse drug reactions : Dry skin (if associated with zinc deficiency), gastrointestinal disturbances which include abdominal pain, nausea &vomiting, dyspepsia; increased liver enzyme, joint pain & stiffness (10%), red coloring of urine (desirable side effect as it shows iron is being excreted through the urine). Serious adverse drug reactions: very low white blood cell count i.e agranulocytosis (2%), neutropenia (6%) Deferiprone can cause serious side effects, including a very low white blood cell count. One type of white blood cell that is important for fighting infection is called a neutrophil. If the neutrophil count is low (neutropenia) or severely low (agranulocytosis), patients can be at risk of developing a serious infection that may be life-threatening. 111 The healthcare provider will do a blood test before starting deferiprone and regularly during treatment to check the neutrophil count. DFX: Common adverse drug reactions: rash, protein in the urine (frothy urine), renal impairment, neurotoxicity (visual and auditory) Refer to dosage adjustment/cessation for management of these adverse effects. The doctor will monitor these side effects closely . Remind patients to attend clinic appointments as scheduled and inform their healthcare providers if they experience any of the above undesirable side effects. Diet & Lifestyle Advice Diet","Restrict iron rich food intake (i.e beef, oyster , liver, spinach, pucuk paku , chickpeas, chocolate, egg yolk, iron -fortified cereals)","Take a high calcium diet i.e milk, cheese, oily fish, with calcium and vit D supplementation.","High calorie, nutrient dense diet to promote growth in children. Lifestyle","Weight-bearing exercise to strengthen bone (i.e walking, jogging, light weights lifting)","Avoidance of smoking and excessive alcohol consumption. Refer to the smoking cessation clinic, if applicable. Supplementations","Doctors may also prescribe zinc supplement (if deficient), vitamin D and calcium supplement for healthy bone.","Ascorbic acid (less than or equal to 100mg) may also be prescribed for those with vitamin C deficiency . The dosage may not exceed 100mg/day ."],others:{storage:"1. DFP : Store below 30C. Protect from moisture and light. 2. Syrup DFP : stable for 35 days once opened. 3. DFX: Store your tablets in the original blister pack at or below 30C. Protect from moisture and light.",other_points:"Dosing adjustment/treatment cessation DFP The dosing of DFP remains unchanged for patients with renal or liver impairment (refer to standard dose adjustment guide). Treatment may be interrupted/ceased if a patient shows toxicity (persistent increase in liver enzyme serum transaminase level, neutropenia, agranulocytosis). DFX The dosing of DFX may be adjusted in patients with renal or liver impairment (refer to standard dose adjustment guide). Treatment may be interrupted /ceased if a patient showing toxicity (auditory , vision, bone marrow suppression, severe rashes, gastrointestinal ulceration)"}},{id:"counsel-038",name:"Desferrioxamine B Methanesulphonate",pharmacologicalGroup:"Iron Chelating Agent",indication:"Subcutaneous: Usually slowly infused over 8 - 12 hours (or in some patients, over 24 hr) using a small portable pump for 5 to 7 days per week. The longer the infusion time, the more iron can be removed due to desferal s short half lives. Chronic iron overload or toxicity Adult: Monotherapy Usual average daily dose of 40-60 mg/kg daily. Administer 5 -7 times a week, depending on the extent of iron overload. Combination therapy (added with oral iron chelator) Usual average daily dose of 40-50 mg/kg daily. Administer 2 - 5 times a week Guys and St Thomas (NHS) Guidelines for iron chelation in adults with a haemoglobinopathy or other inherited anaemia diagnosis. (2016) : Ferritin Desferrioxamine Dose (7 nights) Desferrioxamine Dose (5 nights) <2000 25mg/kg/day 35mg/kg/day 2000-3000 35mg/kg/day 49mg/kg/day >3000 Up to 50mg/kg/day 70mg/kg/day Note : ensure dose within therapeutic index Pediatrics: Usual average daily dose of 20-40 mg/kg daily. Administer 5 -7 times a week depending on the extent of iron overload. Aim for therapeutic index <0.025 at all times Therapeutic index = Mean daily dose (mg/kg) / ferritin (ng/mL). Combination or sequential dosing of desferrioxamine with oral chelators is indicated when monotherapy fails. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Choose a clean and well-lit area. 2. Gather all necessary items for the Desferrioxamine infusion: Desferrioxamine vials, syringe, sterile needle, extension tube, butterfly needle set/Thalaset, and a sharps bin. 114 3. Wash your hands thoroughly and dry them with a clean towel. 4. Unwrap a sterile syringe and attach a new sterile needle. 5. Break the top off an ampoule of sterile Water for Injections (WFI). 6. Draw the required amount of WFI into the syringe:  For each 500 mg vial, use 5 mL of WFI to dissolve the powder .  For a 2 g vial, use 20 mL of WFI. 7. Clean the rubber stopper of the Desferal vial with an alcohol wipe. 8. Inject the WFI from the syringe into the vial through the rubber stopper . 9. Shake the vial well to dissolve the powder . The solution should become clear , colorless, or slightly yellowish. Do not use if the solution is cloudy or if you cannot see through it. 10. Clean the stopper of the vial again with an alcohol wipe, then draw the diluted Desferal solution back into the syringe. Preparing the Portable Pump 1. Attach the extension tube to the syringe. 2. Connect the extension tube to the butterfly needle (or Thalaset). 3. Fill the extension tube with the solution from the syringe. 4. Place the syringe in the infusion pump and secure it with the strap. 5. Follow the instructions provided by your healthcare provider or the pump manufacturer for setting up the pump. Infusion Sites & Administration 1. Clean the injection site with an alcohol swab. 2. Insert the needle at a 45-degree angle underneath the skin. 3. Secure the needle with a plaster . 4. Place the pump in a pouch. 5. The pump can be worn on a belt or in a shoulder holster , allowing you to move about while the infusion is ongoing (e.g., over 8-12 hours). 6. Rotate the infusion sites regularly to ensure proper absorption of the medication and to reduce the risk of skin breakdown or scar tissue formation. Needle Disposal 1. Remove the needle from the syringe and immediately place it in a proper sharps disposal container . 2. If a designated container is unavailable, a sturdy , empty hard plastic detergent bottle or a similar container can be used as a temporary solution. 3. Ensure that the container is tightly sealed and cannot be accessed by others. 4. Always refer to your local disposal regulations for proper disposal guidelines. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Consider the benefits and risks of Desferrioxamine for the mother and possible risks to the fetus when 115 prescribing Desferrioxamine to a pregnant woman.",breastfeeding:"can be recommenced after delivery as its concentration is very low in breastmilk and not orally absorbed.",elderly:"patients are at increased risk for hearing loss.",paediatric:"patients receiving Desferrioxamine every 3 months.",fasting:"Not applicable. To refer to the latest advisory by religious authority"},sideEffects:["Adverse events associated with desferrioxamine:  injection site reactions  neurotoxicity (visual, auditory)  retinopathy  hypersensitive reactions  growth disturbance  Yersinia and Mucor infections Management of adverse effects:","Hypersensitivity reactions, including anaphylaxis, have occurred in patients treated with desferrioxamine . These reactions have included skin flushing, urticaria, hypotension, and shock. They typically occur if desferrioxamine is administered via rapid intravenous injection; administered by slow IV infusion.","If the patient shows signs or symptoms of Yersinia infections (such as fever , diarrhea, or abdominal pain), advise them to temporarily discontinue desferrioxamine and seek immediate medical attention.","Local Skin Reactions 116 i) Ensure proper dilution (10%), appropriate infusion rate, and check for potential dressing allergies. ii) Rotate injection sites to prevent persistent local skin reactions. iii) For doses greater than 2g, consider dividing the infusion into two parts to reduce the risk of local skin reactions(e.g., divide 3g/24hr dose into 1.5g/12hrs x2) iv) In severe cases, your doctor may recommend adding mild steroids i.e. 510 mg of hydrocortisone to the infusion mixture. Alternatively , applying a topical low-potency corticosteroid cream after injection may help reduce local reactions. v) If skin ulceration occurs, ensure proper needle depth to avoid excessive skin trauma. Other considerations:","Desferrioxamine may cause dizziness, which can impair the ability to drive or operate machinery .","Careful monitoring of the eyes, ears, bones, and growth (in children) is necessary to detect any drug-related toxicity .","Urine discoloration: urine may have a pink, reddish or orange discoloration (vin rose discoloration)."],others:{storage:"1. Before reconstitution, store below 25C (77F). 2. After reconstitution, may store at room temperature up to 7 days. 3. Protect from light. 4. Do not refrigerate the reconstituted solution.",other_points:"1. The dosing of desferrioxamine may be adjusted in patients with renal impairment (refer to standard dose adjustment guide). 2. Advise patients to temporarily discontinue desferrioxamine and seek immediate medical attention if showing signs and symptoms of infections."}},{id:"counsel-039",name:"Digoxin",pharmacologicalGroup:"Cardiac glycoside C01AA05",indication:"1. Heart failure (reserve for use in patients with persistent NYHA class III or IV symptoms despite optimal guideline-directed medical therapy) a) Loading dose not recommended b) Maintenance",dosage:"0.125mg to 0.25mg od 2.Supraventricular arrhythmias (particularly atrial fibrillation) a) May initiate with a loading dose followed by maintenance dosing if rapid titration if desired or initiate with maintenance dosing without a loading dose. 0.25mg to 0.5mg once, repeat doses of 0.25mg every 6 hours to a maximum of 1.5mg over 24 hours b) Maintenance dose: 0.0625 mg to 0.25mg od",methodOfAdministration:"May be taken with or without food Missed dose management: If missed dose, to take as soon as possible, however , if near to next dose, skip the missed dose and go back to your regular dosing schedule Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"is not contraindicated. Use should be considered only when the expected clinical benefit treatment to mother outweighs any possible risk to developing fetus",breastfeeding:"is not contraindicated",elderly:"Beers Criteria: Avoid this rate control agent as first-line therapy for atrial fibrillation. Avoid first-line therapy for heart failure. See rationale for caution about withdrawal in long-term users with HFrEF . If used for atrial fibrillation or heart failure, avoid dosages >0.125 mg/day . Use in atrial fibrillation: should not be used as a first-line agent because there are safer and more effective alternatives for rate control. Use in heart failure: evidence for benefits and harms of digoxin is conflicting and of lower quality; most (but not all) evidence concerns use in HFrEF . There is strong evidence for other agents as first-line therapy to reduce hospitalizations and mortality in adults with HFrEF . In heart failure, higher dosages are not associated with additional benefit and may increase risk of toxicity . Use caution in discontinuing digoxin among current users with HFrEF , given limited evidence suggesting worse clinical outcomes after discontinuation. Decreased renal clearance of digoxin may lead to increased risk of toxic effects; further dose reduction may be necessary in those with Stage 4 or 5 chronic kidney disease.",paediatric:"Dose calculated based on body weight.",fasting:"Not applicable To refer to the latest advisory by religious authority"},sideEffects:["Digoxin toxicity is typically associated with level > 2ng/ml, however , due to its narrow therapeutic window , digoxin toxicity is possible at therapeutic levels.","Symptoms of digoxin toxicity: nausea, vomiting, visual disturbances (halos, yellow or blurred vision), lethargy , life threatening arrhythmias (paroxysmal atrial tachycardia, atrioventricular block, ventricular premature contractions, ventricular tachycardia, ventricular fibrillation)","Management: digoxin immune fab"],others:{storage:"Store below 30 ",other_points:"1. Renal impairment: dosing recommendations should be considered as renal clearance of digoxin is reduced 2. Liver impairment: no dosage adjustment necessary"}},{id:"counsel-040",name:"Diltiazem",pharmacologicalGroup:"Non dihydropyridine calcium-channel blocker",indication:"1. Treatment for angina a. Immediate release: Initial",dosage:"30mg four times daily, may be increased gradually at one to two day intervals until optimum response is achieved. Usual dose range: 180 to 360mg daily. b. Sustained release: Initial dose: 60mg twice daily, may be increased to 360mg daily if necessary . Max dose: 480mg daily 2. Hypertension a. Immediate release: Initial dose: 30 to 60mg thrice daily (90 to 180mg daily). b. Sustained release: Initial dose: 60 to 120mg twice daily, increase dose as needed after 7 to 14 days; usual dose: 120 to 360mg once daily To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"May be taken with or without food. Swallow tablet,do not chew Missed dose management: Take the missed dose as soon as remembered. If it is close to the time for the next dose, skip and go back to normal time. Do not take 2 doses at the same time Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Should not be administered to pregnant women or women who may possibly be pregnant.",breastfeeding:"Use not recommended in women who are breast feeding",elderly:"Consider lower initial doses (eg 120mg once daily using extended-release capsule) MALPIP: May increase the risk of bradycardia and interact with digoxin, beta-blockers Beers Criteria: Potential to promote fluid retention and/ or exacerbate heart failure (NSAIDs and COX-2 inhibitors, non-dihydropyridine CCBs, thiazolidinediones) 122",paediatric:"Hypertension a. Infants and children Immediate release: Initial dose 1.5 to 2 mg/kg/day in 3 to 4 divided doses, increase gradually at 1 to 2 day intervals until optimum response is obtained; Max: 3.5mg/kg/day Sustained release: Total daily dose of immediate release dose converted to extended release dose with appropriate interval (once or twice daily) in children able to swallow capsules whole b. Adolescents: Immediate release: Initial dose: 30 to 120mg /dose administered 3 to 4 times daily; usual daily dosage range:180 to 360mg/day . Sustained release: 120mg to 300mg once daily",fasting:"(morning) and after breaking fast. May omit afternoon dose."},sideEffects:["Bradyarrhythmia. May cause first-degree atrioventricular (AV) block, second-degree AV block, complete AV block. Reversal of symptoms is possible after discontinuation","Bradycardia","Peripheral edema"],others:{storage:"Store between 15 to 30 0 C. Protect from light. Avoid storing in excessive heat and humidity",other_points:"1. Renal impairment: No dosage adjustment. 2. Liver impairment: No dosage adjustment. Use with caution as Diltiazem is extensively metabolized by liver, half-life is increased in patients with cirrhosis"}},{id:"counsel-041",name:"Direct-Acting Antiviral (DAA",pharmacologicalGroup:"NS5B polymerase inhibitor 1. Tab Sofosbuvir 400mg NS5A inhibitors 1. Tab Daclatasvir 30mg/ 60mg 2. Tab Ravidasvir 200mg NS5B polymerase inhibitor/NS5A inhibitors 1. Tab Sofosbuvir 400mg & Velpatasvir 100mg",indication:"For the treatment of chronic hepatitis C virus (HCV) infection in adults  DAAs must be used in combination as per relevant guidelines.  The choice of DAA regimen, dosage and treatment duration is individualized and depends on the stage of liver disease. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:" Must be taken orally at the same time everyday , with or without food, according to prescribed treatment regimen as instructed.  Tablets should be swallowed whole and should not be chewed or crushed (to avoid bitter aftertaste).  Patients must complete the prescribed treatment regimen. This is to ensur e treatment effectiv eness and prevent resistance.  DO NOT RUN OUT OF MEDICA TION . Rell the prescription befor e it nishes. Missed dose management:  If you miss a dose and it is less than 18 hours past your usual time, take the missed dose as soon as possible.  If more than 18 hours have passed since your usual dose, skip the missed dose and take your next dose at the usual time.  DO NOT take two doses at the same time to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:".  Use is not currently recommended for the purpose of reducing mother to child transmission of HCV due to lack of safety and efficacy data.  The decision to continue treatment in a patient who becomes pregnant while taking DAAs should be individualized after considering potential risks and benefits of therapy . 125",breastfeeding:"It is unknown whether sofosbuvir and its metabolites are excreted in human milk. A risk to new-borns/infants cannot be excluded.",elderly:".",paediatric:" Adolescents aged  12 years can be treated with regimens approved for adults, with caution pending on more safety data in this population.  In children younger than 12 years, treatment should be deferred until DAAs are approved for this age group.",fasting:"To take once daily during Sahur or Iftar .",renalImpairment:"(eGFR <30 ml/min/1.73 m2) or those with end stage renal disease on dialysis: Sofosbuvir-free regime is preferred. If there is no alternative, a sofosbuvir-based regime may be used with close monitoring and treatment should be interrupted if renal function deteriorates.  Hemodialysis: When a scheduled dose falls on hemodialysis day, DAAs should be taken after hemodialysis."},sideEffects:[" Side effects may include fatigue, headache, nausea and diarrhoea."," If patients experience any allergic reaction (e.g.","rashes, breathlessness, swollen eyes), they should stop the medication immediately and seek immediate medical assistance.."],others:{storage:" Store below 30  C.  Keep medication in its original container , tightly sealed to protect from moisture and light.  Keep out of reach and sight of children.",other_points:"Drug-drug/ Drug-food Interactions:  Patients should report all prescribed medications, over-the-counter medications, traditional medicines or drinks, and health supplements, both before starting therapy and during treatment.  They must stop taking any traditional or herbal medications, health supplements, or health drinks during treatment and should consult prescribers before starting any new medications. Vomiting Management:  If vomiting occurs within 2 hours of dosing, an additional tablet should be taken.  If vomiting occurs more than 2 hours after dosing, no additional dose is needed. 126"}},{id:"counsel-042",name:"Dolutegravir",pharmacologicalGroup:"Integrase Inhibitor",indication:"Dolutegravir 50mg tablets are used in treatment of HIV-1 infected, antiretroviral treatment naive or experienced adults, in combination with other antiretroviral medicinal products. a. 50 mg OD for patients without documented or clinically suspected resistance to the integrase class b. 50 mg BD for patients with resistance to the integrase class Dolutegravir tablets for oral suspension are used in pediatric patients (treatment-nave or -experienced but INSTI nave) aged at least 4 weeks and weighing at least 3 kg. a. 3 kg to < 6 kg - 5 mg once daily (one-half tablet) b. 6 kg to < 10 kg - 15 mg once daily (1 and one-half tablets) c. 10 kg to <14 kg - 20 mg once daily (2 tablets) d. 14 kg to <20 kg - 25 mg once daily (2 and one-half tablets) e. 20 kg and greater - 30 mg once daily (3 tablets) Dolutegravir tablets and dolutegravir tablets for oral suspension are not bioequivalent and are not interchangeable on a milligram-per-milligram basis",dosage:"See indication for dosage details",methodOfAdministration:"Can be taken with or without food. Dolutegravir 50 mg tablet is ideally to be swallowed whole. The tablet may also be split into halves followed by immediate ingestion OR it may be crushed and added to a small amount of semi-solid food or liquid and to be consumed immediately . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"when the expected benefits justify the potential risk to the fetus.",breastfeeding:"Dolutegravir is excreted in human milk in small amounts. There is insuf ficient information on its effects in neonates/infants. However , it is recommended HIV infected women do not 128 breast-feed their infants in order to avoid HIV transmission.",elderly:"require different doses compared to younger adult patients.",paediatric:"Dolutegravir dispersible tablet for oral suspension is available for treatment-naive or treatment-experienced INSTI-naive patients aged at least 4 weeks and weighing at least 3 kg. Film coated 50 mg tablets are not bioequivalent to dispersible tablets.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Common side effects are nausea, headache and insomnia.","Changing the administration time of dolutegravir to morning time may help to reduce the incidence of insomnia."],others:{storage:"Store below 30 degree celsius",other_points:"No data are available in patients with severe hepatic impairment (Child-Pugh Grade C). Use with caution in these patients."}},{id:"counsel-043",name:"Dolutegravir /Lamivudine/Tenofovir Disoproxil Fumarate",pharmacologicalGroup:"Antiretroviral: Combination of two Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Lamivudine and Tenofovir disoproxil fumarate) with Integrase Inhibitor (INSTI): Dolutegravir",indication:"A complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age and weighing 40 kg or greater .",dosage:"One tablet once daily.",methodOfAdministration:"May be administered orally with or without food. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Studies found that all Dolutegravir , Lamivudine, and Tenofovir disoproxil fumarate are excreted in breast milk. It is recommended that HIV-1 infected mothers not to breastfeed their infants to avoid risking postnatal transmission of HIV-1 infection and potential of serious adverse reactions in nursing infants.",elderly:"patients, however monitoring on renal function is required as this preparation contains Tenofovir disoproxil fumarate that may induce renal toxicity .",paediatric:"Dolutegravir , Lamivudine, Tenofovir disoproxil fumarate should not be administered to children less than 12 years of age and those who weigh less than 35 kg.",fasting:"."},sideEffects:["Hypersensitivity reaction: Discontinue Dolutegravir , Lamivudine, Tenofovir disoproxil immediately . Delay in action may result in life-threatening reactions.","Renal toxicity , including cases of acute renal failure and Fanconi syndrome: Assess renal function prior to initiation of this medication. Avoid concomitant use with nephrotoxic agents such as high dose NSAIDs.","Hepatotoxicity: Avoid use in severe liver disease.","Bone effects of Tenofovir disoproxil fumarate: Supplementation with calcium and Vitamin D may be beneficial. Assessment on bone health should be monitored accordingly .","Insomnia effects of Dolutegravir: Adjust administration time accordingly to ensure good quality of sleep thus not affecting daily activities.","Others: TELDY may cause dizziness and reduce alertness. It is advisable for patients not to drive or operate machinery ."],others:{storage:"1. Store below 30C. 2. Protect from light and moisture.",other_points:"1. Hepatic impairment No dosage adjustment is necessary for patients with mild to moderate hepatic impairment (Child-Pugh Score A or B). The effect of severe hepatic impairment (Child-Pugh Score C) on the pharmacokinetics of dolutegravir has not 130 been studied. Therefore, dolutegravir is not recommended for use in patients with severe hepatic impairment. 2. Renal impairment Dolutegravir , Lamivudine, Tenofovir disoproxil fumarate is a fixed-dose tablet, thus it is not recommended to be used among patients requiring renal-dose adjustment."}},{id:"counsel-044",name:"Edoxaban",pharmacologicalGroup:"Direct Oral Anticoagulant - Factor Xa inhibitor",indication:"1. Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, and age  75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA). a. The recommended dose is 60 mg edoxaban once daily for life-long. b. The recommended dose is 30 mg once daily in patients with one or more of the following clinical factors: - Moderate or severe renal impairment (creatinine clearance (CrCL) 15 - 50 mL/min) - Low body weight  60 kg - Concomitant use of the following P-glycoprotein (P-gp) inhibitors: ciclosporin, dronedarone, erythromycin, or ketoconazole.",dosage:"See indication for dosage details",methodOfAdministration:"1. Swallow the tablet, preferably with water . 2. Edoxaban may be taken with or without food. 3. The tablet may be crushed and mixed with water or apple puree immediately before administration. Missed dose management: If a dose of edoxaban is missed, the dose should be taken immediately and then be continued the following day with the once-daily intake as recommended. The prescribed dose should not take doubled on the same day to make up for a missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Contraindicated during",breastfeeding:"Contraindicated during",elderly:"patients should be used cautiously because of a potentially higher bleeding risk 133 MALPIP 1. Use with caution and monitor bleeding risk 2. Increased serum concentration may occur with",fasting:": Not applicable",renalImpairment:"and dose adjustment may be indicated. Assess renal profile before initiation. START/ST OPP criteria 1. No added benefit for anti-platelet combination therapy with factor Xa inhibitor in patients with chronic atrial fibrillation unless there is concurrent coronary artery stent or presence of high grade (>50%) coronary artery stenosis. 2. No added benefit for anti-platelet combination therapy with factor Xa inhibitor in patients with stable coronary , cerebrovascular/peripheral arterial disease. 3. Concomitant use with P-glycoprotein (P-gp) inhibitors increased risk of bleeding. 4. Concomitant use with NSAID or SSRI leads to risk of major gastrointestinal bleeding and increased bleeding risk respectively . 5. Avoid factor Xa inhibitor use in patients with concurrent significant bleeding risk. Pediatric The safety and efficacy of edoxaban in children and adolescents less than 18 years of age have not been established. No data available."},sideEffects:["To seek emergency care right away if there are signs or symptoms of unusual or serious bleeding from any parts of the body .","Common side effects of edoxaban include: a. Stomach pain b. Dizziness & tiredness 134"],others:{storage:"1. Store between 20-25 C 2. Do not use this medicine after the expiry date which is stated on the carton and on each blister (after EXP). The expiry date refers to the last day of that month.",other_points:"1. The recommended dose in patients with renal impairment a. Mild (CrCl > 50  80 mL/min): 60 mg once daily. b. moderate or severe (CrCl 15  50 mL/min): 30 mg once daily c. end stage renal disease (ESRD) (CrCl < 15 mL/min) or on dialysis: Not recommended 2. The recommended dose in patients with liver impairment a. Mild to moderate: 60 mg once daily b. Elevated liver enzymes (alanine aminotransferase (ALT) or aspartate transaminase (AST) 6 > 2 x upper limit of normal (ULN) or total bilirubin  1.5 x ULN: Use with caution because these patients were excluded from studies c. Severe: Not recommended d. Hepatic disease associated with coagulopathy and clinically relevant bleeding risk: Contraindicated"}},{id:"counsel-045",name:"Efavirenz",pharmacologicalGroup:"Non-Nucleoside Reverse Transcriptase Inhibitors (NNR TIs)",indication:"1. Treatment for HIV-1 infections in combination with other antiretroviral agents indicated a) Adults : 600 mg or 400mg PO once daily on an empty stomach, preferably at or before bedtime b) Children aged >3 years weighing >10 kg : 13-15kg 200mg once daily 15-20kg 250mg once daily 20-25kg 300mg once daily 25-32kg 350mg once daily 33-40kg 400mg once daily >40kg 600mg once daily",dosage:"See indication for dosage details",methodOfAdministration:"1. Efavirenz may be taken with or without food. It is recommended that efavirenz be taken on an empty stomach. The increased efavirenz concentrations observed following administration of efavirenz with food may lead to an increase in frequency of adverse reactions. 2. In order to improve the tolerability of central nervous system side effects, bedtime dosing is recommended and in patients who continue to experience these symptoms. 3. Efavirenz 200mg/600mg tablet is ideally to be swallowed whole. Missed dose management 1. To take medication consistently at the same time everyday . Any missed dose to be taken as soon as possible. 2. However if the gap is more than 12 hours, to skip and continue with a regular dosing schedule. Do not double the dose on the next administration time. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"Registry , an increased risk of overall teratogenic effects has not been observed following first trimester exposure to efavirenz. Neural tube and other CNS defects have been reported; however , data collected by the registry has shown that the risk for neural tube defects after efavirenz exposure in the first trimester 136 are not greater than those in the general population. 3. Patients who become pregnant while taking efavirenz may continue if viral suppression is effective and the regimen is well tolerated. 4. Although not recommended by the manufacturer , available guidelines do not restrict the use of efavirenz in the first trimester .",breastfeeding:"Efavirenz is present in breast milk. 2. It is recommended that HIV infected women do not breastfeed their infants under any circumstances to avoid transmission to the infant.",elderly:"patients with cardiovascular risk factors.",paediatric:"Use of efavirenz tablets in patients younger than 3 months of age OR less than 3.5 kg body weight is not recommended because the safety , pharmacokinetics, and antiviral activity of efavirenz tablets have not been evaluated in this age group and there is a risk of developing HIV resistance if efavirenz tablets are underdosed.",fasting:"To be discussed with the infectious disease consultant."},sideEffects:["Nervous system symptoms: a) The frequently reported undesirable effects are dizziness, insomnia, somnolence, impaired concentration and abnormal dreams. b) Nervous system symptoms usually begin during the first one or two days of therapy and generally resolve after the first 2-4 weeks. c) These symptoms may occur more frequently when efavirenz is taken concomitantly with meals possibly due to increased plasma levels. d) Dosing at bedtime seems to improve tolerability and can be recommended.","Psychiatric disorder such as anxiety and depression","Hepatic disorder:Increased liver enzymes (incidence higher with hepatitis B and/or C coinfection)","Gastrointestinal disorder:Abdominal pain, diarrhea, nausea, vomiting","Metabolic disorder:Increased serum cholesterol, increased HDL, increased triglycerides","Hypersensitivity reactions:Rash"],others:{storage:"1. Do not store above 30  .",other_points:"1. Efavirenz tablets are not recommended for patients with moderate or severe hepatic impairment because there is insuf ficient data to determine whether dose adjustment is necessary . Patients with mild hepatic impairment may be treated with efavirenz without any adjustment in dose. Because of the extensive cytochrome P450-mediated metabolism of efavirenz and limited clinical experience in patients with hepatic impairment, caution should be exercised in administering efavirenz tablets to these patients. 2. EFV 400mg daily was found to be better tolerated than standard dose of EFV 600mg daily and is comparable to EFV 600mg in terms of viral suppression and mortality . 3. EFV 400mg can be co-administered with rifampicin- containing anti-TB treatment 4. The impact of renal impairment on efavirenz 137 elimination should be minimal."}},{id:"counsel-046",name:"Enoxaparin",pharmacologicalGroup:"Antithrombotic Agent - Low Molecular Weight Heparin (LMWH)",indication:"1. Prophylaxis of venous thromboembolism (VTE) in surgical patients a. moderate risk - 20mg or 40mg once daily b. high risk - 40mg once daily 2. Prophylaxis of venous thromboembolism (VTE) in medical patients a. 40mg once daily 3. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) a. 1mg/kg twice daily (recommended), or b. 1.5mg/kg once daily 4. Prevention of extra corporeal thrombus during hemodialysis a. 1mg/kg b. high risk of hemorrhage - 0.5 mg/kg for double vascular access or 0.75 mg/kg for single vascular access 5. Treatment of unstable angina and non-Q-wave myocardial infarction (NSTEMI) a. 1mg/kg twice daily 6. Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI) a. single IV bolus of 30 mg plus a 1 mg/kg SC dose, followed by 1 mg/kg twice daily 7. Prevention of DVT in antenatal and/or postnatal women with VTE risk scoring of 3 or more. a. <50 kg: 20mg OD b. 50-90 kg: 40mg OD c. 91-130 kg: 60mg OD d. 131-170 kg: 80mg OD e. >170 kg: 0.6mg/kg/day To counsel based on specific medication s indication and dosage as prescribed as doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Subcutaneous (SC) injection : prevention of VTE, treatment of DVT and PE, treatment of unstable angina NSTEMI and acute STEMI. 2. IV bolus injection : single IV bolus injection immediately followed by a subcutaneous injection, for treatment of acute STEMI. 3. Arterial line injection : administered through the arterial line of a dialysis circuit for the prevention of thrombus formation in the extra-corporeal circulation during haemodialysis 139 4. Should NOT be administered by intramuscular route. Subcutaneous Injection Technique Preparation 1. Prior to injection, wash your hands thoroughly with soap and water . Towel dry. 2. Adjust the dose to be injected (if necessary): Hold the syringe pointing down (to keep the air bubble in the syringe) and expel the excess medicine into an appropriate container . 3. When there is no need to adjust the dose, the prefilled syringe is ready to use. Do not expel any air from the syringe before administering the injection. You may lose some of the medicine if you do. 4. Sit in a comfortable position so you can easily see the area of their stomach where you will be injecting. A lounge chair , recliner ,or bed (propped up with pillows) is ideal. Inspection 5. Check the expiry date on the syringe. Do not use if the date has passed. 6. Check the syringe is not damaged and the medicine in it is a clear solution without particles. If the syringe is damaged or the medicine is not clear , use another syringe. Injection site 7. Choose an area on the right or left side of your stomach. This should be at least 5 centimetres away from your belly button and out towards your sides. 8. Change the place where you inject between the left and right sides of your stomach, depending on the area you were last injected. This is to prevent scarring which will make it harder to inject the area and also affect how the medication is released into your body . Avoid injecting on scars and bruises. Injection technique 9. Cleanse (do not rub) the selected site for injection with an alcohol swab. 10. Remove the protective cap off the needle, do not allow the needle to touch anything to make sure it stays clean. 11. Hold the syringe in the hand you write with (like a pencil) and with your other hand, gently pinch the cleaned area of your abdomen between your forefinger and thumb to make a fold in the skin. Make sure you hold the skin fold throughout the injection. 12. Hold the syringe with the needle pointing downwards (vertically at 90 degree angle) and inject a full length needle into the skin fold. Inject at 45 angle for needle length 8 mm or if the patient is thin. 13. Press down plunger with your finger (thumb). Complete the injection using all of the medicine in the syringe. Hold for 10 seconds. 14. Remove the needle by pulling it straight out. Let go of the skin fold. 15. To avoid bruising, do not rub the injection site. 16. Drop the used syringe into a hard, puncture-proof container . Close the container lid tightly and place the container out of reach of children. 17. When the container is full, dispose of it safely . Missed dose management If you miss a dose of Enoxaparin, inject it as soon as you remember . If it is too near the next dose, skip the missed dose and go back to your usual dosing times. Do not double dose. 140 Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Safe to use",breastfeeding:"Safe to use",elderly:"< 45kg.",paediatric:"Dosing based on age and body weight"},sideEffects:["May develop hematoma at the injection site (a localised swelling that is filled with blood).","Symptoms of bleeding such as bruises with unknown cause, blood in urine/dark coloured urine, black stools, gum bleeding or heavy menstrual bleeding","Seek medical attention if any sign or symptom of bleeding occurs"],others:{storage:"Do not store above 30C, do not freeze.",other_points:"1. Renal impairment a. Not recommended for patients with end stage renal disease (creatinine clearance < 15ml/min) due to limited clinical data b. Severe renal impairment (creatinine clearance 15-30 ml/min) prophylactic dose - 20mg once daily c. Severe renal impairment (creatinine clearance 15-30 ml/min) treatment dose - 1mg/kg once daily 2. Hepatic impairment - Use with caution"}},{id:"counsel-047",name:"Entecavir",pharmacologicalGroup:"Nucleoside reverse transcriptase inhibitors",indication:"First line treatment of Chronic Hepatitis B in patients who satisfy the criteria for treatment and require long-term therapy or have a very high baseline viral load",dosage:"0.5-1mg once daily. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:" Should be taken orally on an EMPTY STOMACH (2 hours before or after a meal)  Must be taken at the same time every day as instructed for it to be effective.  Continue taking this medicine as prescribed, even if you feel better . This medication does not cure hepatitis B; it helps to suppress the virus and prevent relapse.  DO NOT RUN OUT OF MEDICA TION . Rell the prescription befor e it nishes. Missed dose management  Take the missed dose as soon as you remember , on an empty stomach  If the missed dose is close to your next dose, skip the missed dose and take the next dose at the usual time.  DO NOT take two doses at the same time to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:" Agents other than entecavir are recommended when hepatitis B treatment is needed in pregnant patients.  Patients who become pregnant while taking entecavir should be switched to the preferred agent.",breastfeeding:" It is not known if entecavir is present in breast milk. The effect of this exposure on a nursing infant is unknown.  Patients requiring antivirals for hepatitis B may breastfeed if the infant received immunoprophylaxis (hepatitis B immune globulin at birth & hepatitis B vaccine series soon after birth)",elderly:".",paediatric:"For children  2 years with weighing 10kg",fasting:"To refer to the latest advisory by religious authority",renalImpairment:"CrCl > 50 mL/min: No dosage adjustment required 2. CrCl 30 - 49 mL/min: administer the usual indication-specific dose every 48 hours 3. CrCl 10 - 29 mL/min: administer the usual indication-specific dose every 72 hours 4. CrCl <10 mL/min, hemodialysis, or CAPD: administer the usual indication-specific dose every 7 days. 5. When a scheduled dose falls on hemodialysis day, entecavir should be taken after hemodialysis."},sideEffects:["Side effects may include nausea, dizziness, headache and fatigue.","Advise patients to report symptoms of lactic acidosis (nausea, vomiting, abdominal pain, tachypnea) and liver problems (dark urine, light-coloured stools, or yellow skin or eyes)"],others:{storage:"1. Store below 30  C. 2. Keep medication in its original container , tightly sealed to protect from moisture and light. 3. Keep out of reach and sight of children.",other_points:"1. Advise patients against sudden discontinuation of the drug due to potential exacerbation of hepatitis B. 2. Advise patients to practise safe sex and ensure to take proper precautions to avoid transmission. This drug does not prevent disease transmission."}},{id:"counsel-048",name:"Erythropoietin Human Recombinant (Alfa/Beta",pharmacologicalGroup:"Other antianemic preparations Erythropoietin Product available: Erythropoietin alfa - Erysaa , Eprex , Binocrit  Erythropoietin beta - Recormon ",indication:"1. Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases. a. Initiation : 50 IU/kg three times per week, with dose adjustments should be made in increments of 25 IU/kg three times per week at intervals of at least 4 weeks. b. Maintenance : Total weekly dose is between 75 to 300 IU/kg. 2. Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy a. EPO Alfa: Initiation: 150 IU/kg three times weekly or 40,000 IU once weekly . May increase to 60,000 IU once weekly units after 4 weeks if necessary . b. EPO Beta: Initiation:: 450 IU/kg once weekly or 30,000 IU once weekly . Max: 60,000 IU/week. Dosing is according to product insert . To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Route of Administration: Intravenous (IV) or Subcutaneous (SC): Erythropoietin alfa (Eprex, Binocrit ) and Erythropoietin beta (Recormon ) Intravenous (IV) ONLY for Erythropoietin alfa (Erysaa ) Site of administration for SC: Lower part of abdomen, thigh or arm Injection technique for SC (for self-administered): 1. Take one syringe out of the package and check that the solution is clear , colourless and free from visible particles . 2. Allow the syringe to reach room temperature. 3. Wash your hands. 4. Remove the rubber cap from the syringe. 5. Remove the needle from the pack, fix it on the syringe and remove the protective cap from the needle. 6. Expel air from the syringe and needle by holding the syringe vertically and gently pressing the plunger upwards. 7. Clean the skin at the site of injection using an alcohol swab. 8. Form a skin fold by pinching the skin between thumb and forefinger . 145 9. Fully insert the needle 45 0 or 90 0 angle into the skin fold with a quick, firm action. 10. Inject erythropoietin solution. 11. Withdraw the needle quickly and apply pressure over the injection site with a dry, sterile pad . 12. Dispose the empty syringe in a special waste container 13. Tear off the medication label on the syringe and stick into the booklet/diary (e.g., CAPD book) after the injection for the administration record, if available. Consideration: 1. Blood pressure (BP) cutof f for administering Erythropoetin Stimulating Agent (ESA) is individualised. Generally , ESA is not given if BP exceeds 160/100 mmHg. Patients need to be informed about their specific BP cutof f whether to continue or hold ESA at home. 2. Site of SC injection should be rotated Missed dose management: The missed dose should be administered as soon as possible and administration of Erythropoietin is to be restarted at the prescribed dosing frequency . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Safety information is based on post-marketing experience. Consult the prescriber if pregnant.",breastfeeding:"Unknown risk to the infant. The decision to continue should be based on the benefits outweigh the risks.",elderly:"No dosage adjustment provided in the manufacturer s labelling.",paediatric:"Safe to be used in children. The younger the patients, the higher erythropoietin doses required. However , the recommended dosing schedule should be individualized.",fasting:"Administer as usual"},sideEffects:["Common side effects, generally not serious: headache, increased blood pressure, irritation or pain at the injection site. Note:  To advise on the importance of compliance with antihypertensive medications and dietary restrictions for BP control.  If side effects persist, please consult a healthcare professional","Uncommon/rare: Pure red cell aplasia (PRCA). 146"],others:{storage:"1. Transport of ESA is only allowed in cool box with ice packs. 2. Preferably to return home immediately after getting ESA from the pharmacy to facilitate fast storage. 3. ESA is very sensitive to light and temperature. 4. Protect ESA from light 5. Store ESA in the refrigerator , do not freeze. Keep at 2-8C. 6. Avoid fridge doors, and vegetable compartments. Ensure there is proper air circulation around your ESA. 7. If you're travelling, try to keep your medication in a cooler with ice packs, and avoid storing it in any place where it might get too hot, like in a car. Do not take out the ESA from the fridge unless it is time for use. If the ESA is accidentally left outside the fridge, it should be used as soon as possible to prevent damage. Below is the expiry period following a break in the cold chain: Product Expiry period after break of cold chain Recormon 3 Days Erysaa 7 days Eprex 7 days Binocrit 3 Days Handling of disposal:  Needles and syringes should never be reused.  Place all used needles and syringes into a sharps container (puncture-proof disposable container).  Keep the sharp container out of the reach of children.  Avoid disposing of used sharps containers in household waste.  Dispose of full sharps containers according to local regulations or at designated facilities.",other_points:"No dosage adjustment was provided in the manufacturer s labelling."}},{id:"counsel-049",name:"Everolimus",pharmacologicalGroup:"Mammalian target of rapamycin (mTOR) kinase inhibitors Everolimus",indication:"1. Prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant in combination with ciclosporin for microemulsion and corticosteroids. Product available - Certican : Tablet dosage form available in two strength: 0.25mg and 0.75mg : Dose is adjusted based on therapeutic drug monitoring. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"To be swallowed whole twice daily, 12 hours apart. Do not chew or crush the tablets. Must be taken at the same time every day either with or without food, but advisable to be taken on empty stomach. To ensure the accuracy of everolimus levels, it is important to take the everolimus after the blood is drawn for therapeutic drug monitoring. Missed dose management: 1. If the everolimus dose is missed, patients should take it as soon as possible within six hours after regular dose. 2. If it is more than 6 hours, skip the missed dose and return to normal dosing schedule. 3. Do not double a dose under any circumstances. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"The potential risk to humans is unknown. There is no adequate data from the use of Certican in pregnant women. 2. Everolimus should not be given to pregnant women unless the potential benefit outweighs the potential risk to the fetus 3. To inform specialist if you want to get pregnant / pregnant",breastfeeding:"is not recommended",elderly:"patient should be cautious, usually starting at the low end of the dosing range.",paediatric:"There are limited data on the use of Everolimus in children and adolescents however , Everolimus can be used in renal transplant pediatric patients",fasting:"is permissible,tacrolimus can be taken on an empty stomach during Sahur and Iftar. It's important to stay hydrated throughout the night. If you miss a dose during Sahur , you must break your fast that day to take the missed dose."},sideEffects:["Metabolic abnormalities: Diabetes mellitus, Hyperlipidaemia, hypokalemia","Delayed wound healing","Increased risk of infection. Seek healthcare advice if have any symptoms of infections such as fever , chills, or flu-like symptoms.","GI disorder: Nausea, diarrhea, vomiting, dry mouth, mouth ulcer , mucositis","Hypertension","Nephrotoxicity"],others:{storage:"1. Store at room temperature. 2. Store in the original package in order to protect from light and moisture. 3. The tablet should remain in the blister when kept in the pillbox.",other_points:"1. Mild hepatic impairment (Child-Pugh Class A), reduce the dose to 2/3 of the normal dose. 2. Moderate hepatic impairment (Child-Pugh B) reduce the dose to  of the normal dose. 3. Severe hepatic impairment (Child-Pugh C) reduce the dose to 1/3 of the normal dose Further dose titration should be based on therapeutic drug monitoring"}},{id:"counsel-050",name:"Evolocumab",pharmacologicalGroup:"Lipid modifying agent - PCSK9 inhibitors",indication:"1. Prevention of cardiovascular events a. 140mg every 2 weeks b. 420mg monthly 2. Primary hyperlipidemia (including heterozygous familial hypercholesterolemia HeFH) a. 140mg every 2 weeks b. 420mg monthly 3. Homozygous familial hypercholesterolemia HoFH a. 420mg monthly When switching dosing regimen, administer the first dose of the new regimen on the next scheduled date of the prior regimen.",dosage:"See indication for dosage details",methodOfAdministration:"1. Evolocumab is administered under the skin (subcutaneously), every 2 weeks or 1 time each month. 2. 420mg dose can be administered by giving 3 injections consecutively within 30 minutes at different injection sites. Preparation 1. Remove the pre-filled pen from the original package carefully . Return the original package with unused pre-filled pen to the refrigerator . 2. Wait for at least 30 minutes for the pre-filled pen to reach room temperature before injecting. This will minimise pain at the injection site. Do not warm or expose to direct sunlight to warm the pre-filled pen. 3. Do not shake the pre-filled pen. Inspection 4. Check the solution in the window . It should be clear and colourless to slightly yellow . 5. Do not use if  The solution is cloudy or discoloured or contains large lumps.  Any part of the pre-filled pen appears cracked or broken.  If the pre-filled pen has been dropped.  The orange cap is missing or not securely attached.  The expiration date has passed. Injection Site 6. Only inject at these injection sites:  Thigh  Abdomen, except 2 inches (5 cm) area around belly button.  Outer area of upper arm (not for self-injection). 7. Rotate injection site. If you need to use the same injection site, make sure it is not the same spot on the site you used in the previous injection. 8. Do not inject into areas where the skin is tender , 152 bruised, red or hard. Avoid injecting into areas with scars or stretch marks. 9. Do not co-administer with other injectable drugs at the same administration site. Injection Technique 10. Clean the injection site with alcohol wipe. Let the skin dry before injection. Do not touch this area again before injecting. 11. Pull the orange cap straight off.  Do not twist, bend or wiggle the orange cap.  Do not put the orange cap back onto the pre-filled pen.  Do not leave the orange cap off for more than 5 minutes as this can dry out the medicine. 12. It is normal to see a drop of liquid at the end of the needle or yellow safety guard. Do not put fingers into the yellow safety guard. 13. Create a firm surface at the selected injection site by using either stretch method or pinch method.  Stretch method: stretch the skin firmly by moving your thumb and fingers in the opposite direction, creating an area about 2 inches (5 cm) wide.  Pinch method: pinch the skin firmly between your thumb and fingers, creating an area about 2 inches (5 cm) wide. It is important to keep skin stretched or pinched while injecting. 14. Keep holding the stretched or pinched skin. With the orange cap off, put the yellow safety guard on your skin at 90 degrees. The needle is inside the yellow safety guard. Do not touch the grey button yet. 15. Firmly push down the pre-filled pen onto the skin until it stops moving. 16. When you are ready to inject, press the grey start button. You will hear a click. 17. Keep pushing down on the skin. Window on the pre-filled pen turns from clear to yellow when the injection is done. You may hear a second click. Your injection could take about 15 seconds. 18. Lift your thumb while still holding the pre-filled pen on your skin. 19. Remove the pre-filled pen from your skin. The needle will be automatically covered. Do not recap the pre-filled pen or put fingers into yellow safety guard. 20. Discard the used pre-filled pen and orange cap in a hard, puncture-proof disposal container . 21. If there is blood at injection site, press a cotton ball or gauze pad on your injection site. Do not rub the injection site. Apply a plaster if needed. Missed dose management 1. If a dose is missed and administer within 7 days from the missed dose, you can resume the original schedule. 2. If a 2-weekly dose is not administered within 7 days, wait until the next dose of the original schedule and inject. 3. If a monthly dose is not administered within 7 days, administer the dose and start a new schedule based on the new injection date. Do not stop taking your medication unless advised to do so by your prescriber 153",specialConsiderations:{pregnancy:"No data on use of evolocumab to inform a drug-associated risk.",breastfeeding:"No data on the presence of evolocumab in human milk.",elderly:"( 65 or  75 years old) and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Pediatric 1. Safety and effectiveness have not been established in pediatric patients with primary hyperlipidemia or HeFH; and HoFH who are younger than 10 years old"},sideEffects:["Hypersensitivity reaction (e.g.","rash, urticaria).","evolocumab is contraindicated in patients with a history of serious hypersensitivity reaction.."],others:{storage:"1. Store in a refrigerator (2 - 8 o C). Do not freeze or use the pre-filled pen if it has been frozen. 2. May be stored at room temperature (25 o C) and used within 1 month. 3. Protected from light.",other_points:"1. Renal Impairment - No dose adjustment is needed. 2. Hepatic impairment a. No dose adjustment for mild to moderate hepatic impairment (Child-Pugh A or B). b. No data for severe hepatic impairment. (Child-Pugh C). Use with caution"}},{id:"counsel-051",name:"Felodipine",pharmacologicalGroup:"Dihydropyridine Calcium Antagonist - Antihypertensive",indication:"1. Hypertension a. Initial 5mg OD, may titrate to maximum dose 20mg/day",dosage:"See indication for dosage details",methodOfAdministration:"1. Felodipine should preferably be taken in the morning on an empty stomach or following a light, low fat or carbohydrate meal. 2. Felodipine tablets must be swallowed with water and not be divided, crushed or chewed Missed medication management If you forgot to take a dose of felodipine, take it as soon as you remember it. However , if it is almost time for your next dose, skip the missed dose. Do not take a double dose (two doses at the same time) to make up for a forgotten dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Avoid use in pregnant women as there is a risk of harm to the foetus.",breastfeeding:"Although detected in breast milk. when taken in therapeutic dose felodipine is unlikely to affect the infant",elderly:"with dysphagia or requiring enteral tube feeding. MALPIP 1. Increased risk of ankle oedema, to consider dosage adjustment, switching CCB or switching to other classes if necessary",paediatric:"Limited data",fasting:"Not applicable 155"},sideEffects:["Most of reactions are dose dependent & appear at the start of treatment or after dose increment such as flushing,headache,palpitations, dizziness and fatigue","Dose-dependant ankle swelling,results from precapillary vasodilation and not related to fluid retention If pedal edema occurs, may consider to elevate feet using a stool or pillow , and avoid prolonged sitting or standing","Mild gingival enlargement with pronounced gingivitis/peridontitis"],others:{storage:"Do not store above 30 0 C",other_points:"1. No dose adjustment is required. However , Plendil should be used with caution in patients with severely impaired renal function 2. Patients with impaired hepatic function may have elevated plasma concentrations of felodipine and may respond to treatment at lower doses"}},{id:"counsel-052",name:"Fentanyl, Transdermal Patch",pharmacologicalGroup:"Opioid analgesic",indication:"1. As a second line drug in the management of opioid responsive, moderate to severe chronic cancer pain. 2. It should only be considered in patients with stable opioid requirements who have difficulties in swallowing and intractable nausea and vomiting. a. Dose requirement is established using short-acting preparations before switching to transdermal formulation. b. Dose is individualised based on patient-specific factors and severity of pain, and is given every 72 hours. c. Subsequently , dose is adjusted according to patient response, taking into account the amount of rescue medication used, pain score, functional assessment and side effects. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Step 1: Preparing the Skin a. Make sure the skin is completely dry, clean and cool before putting the patch on. b. Sites of application are chest, back and upper arms Step 2: Open the sachet a. Each patch is sealed in its own sachet b. Tear or cut open the sachet at the notch, shown by the arrow Step 3: Peel and press a. Carefully peel one half of the shiny plastic backing away from the centre of the patch. Try not to touch the sticky side of the patch b. Press the sticky part of the patch onto the skin c. Remove the other part of the backing and press the whole patch onto the skin with the palm of your hand. d. Hold for at least 30 seconds. Make sure it sticks well, especially the edges e. The date and time of application and/or renewal should be written on the patch. Step 4: Disposing of the patch a. As soon as take a patch off, fold it firmly in half so that the sticky side sticks to itself b. Put it back in its original sachet and dispose of the sachet as instructed Step 5: Wash a. Always wash the hands after handling the patch using clean water only Step 6: Change of patch a. Change patch every 3 days at the same time of day b. If the patch falls off before the scheduled change date (3 days), discard it and apply a new patch to a different skin site. 157 c. Rotate the site after each patch removal and wait for at least 3 days before reapplying to the same site. Missed dose management: 1. Apply a new patch as soon as you remember 2. Do not apply twice the number of patches to make up for the patch that you missed. 3. This will increase the chance of you getting unwanted side-ef fects Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"may cause neonatal opioid withdrawal syndrome",breastfeeding:"Fentanyl is excreted in human milk; therefore, it is not recommended for use in nursing women because of the possibility of effects in their infants.",elderly:"patients. Starts at lower dosage in this population. 6. Avoid in patients with very low BMI (< 18.5kg/m2) due to concern about absorption variability . 7. Caution in patient with thin, fragile skin : a. it may reduce the patch adhesion to the skin b. reduce absorption due to inadequate subcutaneous fat",paediatric:"patients. Starts at lower dosage in this population."},sideEffects:["Opioid-induced constipation a. A common side effect b. Tolerance does not develop, hence laxatives must be taken regularly c. Use combination of stimulant (e.g. bisacodyl) + softener (e.g. lactulose) d. Increase fluid and dietary fibre intake, maintain good physical activity , and try to establish a toilet routine","Opioid-induced sedation / impaired alertness a. May occur upon initiation of opioids b. Avoid driving and other activities that require mental alertness until it is clear how morphine/ Oxycodone affects the patient c. Tolerance develops after 5 - 10 days","Opioid-induced neurotoxicity (delirium, confusion) a. May occur , but usually transient b. May consider use of haloperidol for delirium","Opioid-induced nausea and vomiting a. May occur upon initiation of opioids b. Tolerance develops 5 - 10 days after starting c. May use antiemetics (e.g. metoclopramide, haloperidol or prochlorperazine) d. Be consistent when taking morphine with or without meals","Opioid-induced dry mouth a. Sip water often, let small ice chips melt in your mouth b. Minimise intake of caffeinated drinks, such as coffee, tea, and some sodas as well as use of tobacco and alcohol c. Chew sugarless gum or suck on sugarless hard candy to stimulate saliva flow","Dermatologic: a. Severe application site reactions may occur . Onset ranged from days to months after initiation."],others:{storage:"1. Store your medication in a cool, dry place away from heat, moisture and direct sunlight. 2. Disposal: FOLD used patches so that the adhesive side adheres to itself.",other_points:"1. Addiction: abuse, misuse, or opioid addiction may occur . Use cautiously in patients with a history of substance abuse or mental illness. 2. Heat exposure: Avoid heat exposure to application site or surrounding areas (e.g: heating pads, electric blankets, heating lamps, sauna, hot water or direct sunlight) 3. Concomitant use with others: Benzodiazepines or Central Nervous System(CNS) depressants including alcohol may result in profound sedation, respiratory depression, coma, and death 158"}},{id:"counsel-053",name:"Flecainide Acetate",pharmacologicalGroup:"Antiarrhythmic, Class 1C",indication:"1. Sustained monomorphic ventricular tachycardias a. Initial",dosage:"50 to 100mg twice daily for 3 to 5 days. Reduced to the lowest dose that controls the arrhythmias. Max: 400mg daily 2. Pre excited atrial fibrillation or Syndrome Reciprocating Atrio-V entricular tachycardias (AVT) associated with Wolff Parkinson White Syndrome a. Initial dose: 50mg every 12 hours; increase by 50mg twice daily at 4-day intervals. Max: 300mg/day 3. Supraventricular tachycardias due to Intra-Atrio Ventricular Nodal Reentry a. Initial dose: 50mg twice daily. Max: 300mg daily",methodOfAdministration:"May be taken with or without food Take flecainide at about the same time each day. Missed dose management If you miss a dose, take it as soon as you remember . If it is near to the next dosing time, do not take a double dose to replace it. Just take the dose as usual. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Flecainide is excreted in human milk and appears in concentrations which reflect those in maternal blood. Relative infant dose (RID) of flecainide is 8% when calculated using the highest average breast milk concentration located and compared to a weight -adjusted maternal dose of 200mg/day . Breast feeding is considered acceptable when the RID of a medication is < 10%. 2. The risk of adverse effects to the nursing infant is very 161 small. The benefit of Tambocor Tablet 100mg during lactation should therefore be weighed against the possible effects on the child.",elderly:"patients should not exceed 300 mg per day (or 150 mg twice daily). MALPIP 1. May increase risk of bradycardia, orthostatic hypotension, urinary retention, and falls. 2. Examine drug-drug interactions, tailor regime according to patient s physiology and medication profile. 3. Routine blood test and ECG warranted.",paediatric:"Tambocor Tablet 100mg is not recommended for children under 12 years of age, as there is insuf ficient evidence of its use in this age group 2. Children are particularly susceptible to flecainide toxicity given its narrow therapeutic window and the frequent need among younger patients for extemporaneous compounding of a liquid formulation,increasing the risk for medication dosing errors.",fasting:"Not applicable"},sideEffects:["Common side effects:","Heartbeat changes, it starts to pound, or it gets faster or slower","Skin problems associated with exposure to sunlight","Nausea and vomiting","Increased in liver enzyme or jaundice","Giddiness, dizziness, and light-headedness.","Numb and tingling hand or feet","Unsteady walking or uncontrolled movement","Small cloudy spot on the eyeball","Double vision and blurring of vision","Certain lungs disease (pulmonary fibrosis) or inflammation of the lungs (pneumonitis)"],others:{storage:"Store between 20 to 25 0 C",other_points:"1. Renal impairment CrCl  35 ml/min: Max initial dose: 100mg daily. Dose may be adjusted after 6-7 days as tolerated. 2. Hepatic impairment Max dose: 100mg daily 3. Patients with permanent pacemaker; Patients receiving cimetidine or amiodarone Max dose: 100mg daily"}},{id:"counsel-054",name:"Follitropin Alpha (Recombinant Human FSH",pharmacologicalGroup:"Recombinant Human Follicle-Stimulating Hormone (FSH)",indication:"Indication Anovulation, including polycystic ovarian syndrome (PCOS), in women who have been unresponsive to treatment with clomiphene citrate.",dosage:"75 - 150 IU daily, should commence within the first 7 days of the menstrual cycle and increase by 37.5 IU or 75 IU at 7- or 14-days intervals. Max daily dose 225 IU Indication Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART). Dosage : 150 - 225 IU daily commencing on days 2 or 3 of the cycle. Max daily dose 450 IU. Dosing is individualised and according to product insert/protocol. Site &",methodOfAdministration:"Site of administration or injection:  Abdomen (preferably)  Buttock <HEADER_METHOD>: a) Wash your hands with soap and water . b) Check that the - The expiry had not passed - The solution is clear and colourless and does not contain particle - The pre-filled pen is not damaged c) Sit in a comfortable position so you can easily see the area of their stomach where you will be injecting. d) Select an area on the right or left side of your stomach, at least 2 inches from your navel. Alternate left and right side of the lower abdominal area at each injection. Do not inject yourself within about 2 inches of your navel, near scars, bruises or stretch marks. e) Clean the area you have selected for your injection with an alcohol swab and allow the area to dry. f) Remove the protective cap. g) Screw a new needle to the pen. Remove the inner and outer cap. h) Prime the Gonal-F pen with the needle pointing upwards for 164 when you use a new cartridge. (Observe at least a drop of medication at the needle tip before injecting.) i) Dial the dose knob to the desired dose by turning the dose knob. j) If by mistake you dial past the correct number , turn the dose setting knob backward to correct the dose. k) Once you have set the correct dose, swab the site of injection with an alcohol swab and pinch the area with two fingers. l) Insert the pen needle into the skin at an angle of 90 and push the end of the dose knob until the figure in the dose window returns to 0. m) Count to 10 slowly before withdrawing the needle from the skin. Counting past 10 may be necessary for higher doses. This is to ensure full dose delivery and prevent leakage. n) Recap the used pen needle using the outer needle cap on and unscrew the needle. o) Replace the pen cap. p) Immediately discard the used needle into a designated disposal bin. q) Do not rub the injection site after administration Do not stop taking your medication unless advised to do so by your prescriber Missed dose : Administer as soon as you remember . If it is close to the next dose, omit the current dose and administer the current dose. DO NOT DOUBLE THE DOSE Administer as soon as you remember . If it is close to the next dose, omit the current dose and administer the current dose. DO NOT DOUBLE THE DOSE",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:"Contraindicated",elderly:"NA",paediatric:"patients below age 18 have not been established .",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Bloating","Nausea & vomiting","Breast tenderness","Injection site reaction (bruising, pain, redness) *Note for IVF : Ovarian Hyperstimulation Syndrome (OHSS) warning signs and symptoms: Severe abdominal pain, severe nausea and vomiting, difficulty in breathing Seek help from doctor if symptoms worsen"],others:{storage:" Store at 2-8 C (in a refrigerator).  DO NOT FREEZE.  Avoid storage at the door of the fridge and vegetable compartment, ensure there is proper air circulation around medication.  TRANSPOR T of medication is only allowed in a COOL BOX WITH ICE/ICE PACKS  Preferable return home immediately after getting medication from pharmacy to facilitate proper storage",other_points:"NA"}},{id:"counsel-055",name:"Follitropin Beta (Recombinant Human FSH",pharmacologicalGroup:"Recombinant Human Follicle-Stimulating Hormone (FSH)",indication:"Indication Anovulation, including polycystic ovarian syndrome (PCOS), in women who have been unresponsive to treatment with clomiphene citrate.",dosage:"50 IU daily, maintaining the starting dose for at least 7 days. Indication Controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (ART). Dosage : 100-225 IU daily, maintaining the starting dose for at least the first 4 days. Dosing is individualised and according to product insert/protocol. Site &",methodOfAdministration:"Site of administration or injection:  Abdomen (preferably)  Buttock <HEADER_METHOD>: a) Wash your hands with soap and water . b) Check that - The expiry had not passed - The cartridge solution is clear and colourless and does not contain particle - The puregon pen is not damaged c) Sit in a comfortable position so you can easily see the area of their stomach where you will be injecting. d) Select an area on the right or left side of your stomach, at least 2 inches from your navel. Alternate left and right side of the lower abdominal area at each injection. Do not inject yourself within about 2 inches of your navel, near scars, bruises or stretch marks. e) Clean the area you have selected for your injection with alcohol swab and allow the area to dry. f) Remove the protective cap and unscrew the cartridge holder . g) Insert the cartridge into the cartridge holder . Screw the cartridge holder to the pen body tightly . h) Screw a new needle to the pen. Remove the inner and outer cap. i) Prime the Puregon pen with the needle pointing upwards for when you use a new cartridge. (Observe at least a drop of medication at the needle tip before injecting.) 167 j) Dial the dose knob to the desired dose by turning the dose knob. k) If by mistake you dial past the correct number , DO NOT try to turn the knob backward to fix the mistake. Continue to turn the dosage knob in the same direction past the 450iu mark, as far as it will turn. The dosage scale must move freely . Push the injection button all the way. Start to dial again starting from 0 upwards. l) Once you have set the correct dose, swab the site of injection with an alcohol swab and pinch the area with two fingers. m) Insert pen needle into the skin at an angle of 90 and push the end of the dose knob until the figure in the dose window returns to 0. n) Count to 10 slowly before withdrawing the needle from the skin. Counting past 10 may be necessary for higher doses. This is to ensure full dose delivery and prevent leakage. o) Recap the used pen needle using the outer needle cap on and unscrew the needle. p) Replace the pen cap. q) Immediately discard the used needle into a designated disposal bin. r) Do not rub the injection site after administration Do not stop taking your medication unless advised to do so by your prescriber Missed Dose : Administer as soon as you remember . If it is close to the next dose, omit the current dose and administer the current dose. DO NOT DOUBLE THE DOSE",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:"No information available from clinical or animal studies.",elderly:"NA",paediatric:"patients below age 18 have not been established .",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Bloating","Nausea & vomiting","Breast tenderness","Injection site reaction (bruising, pain, redness) *Note for IVF : Ovarian Hyperstimulation Syndrome (OHSS) warning signs and symptoms : Severe abdominal pain, severe nausea and vomiting, difficulty in breathing Seek help from doctor if symptoms worsen"],others:{storage:" Store at 2-8 C (in a refrigerator). DO NOT FREEZE. Avoid storage at the door of the fridge and vegetable compartment, ensure there is proper air circulation around medication.  TRANSPOR T of medication is only allowed in a COOL BOX WITH ICE/ICE PACKS  Preferable return home immediately after getting medication from pharmacy to facilitate proper storage",other_points:"168 NA"}},{id:"counsel-056",name:"Fondaparinux",pharmacologicalGroup:"Antithrombotic Agent - Synthetic and Selective Inhibitor of activated Factor X (Xa)",indication:"1. Prophylaxis of venous thromboembolism (VTE) in surgical patients a. 2.5mg once daily 2. Prophylaxis of venous thromboembolism (VTE) in medical patients a. 2.5mg once daily 3. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), dose depends on body weight a. <50kg: 5mg once daily b. 50-100kg: 7.5mg once daily c. >100kg: 10mg once daily 4. Treatment of unstable angina and non-Q-wave myocardial infarction (NSTEMI) a. 2.5mg once daily 5. Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) a. 2.5mg once daily, first dose administered intravenously and subsequent doses administered by subcutaneous injection",dosage:"See indication for dosage details",methodOfAdministration:"1. Subcutaneous (SC) injection : prevention of VTE, treatment of DVT and PE, treatment of unstable angina NSTEMI and acute STEMI. 2. IV bolus injection : first dose in treatment of acute STEMI. 3. Should NOT be administered by intramuscular route. Subcutaneous Injection Technique : Preparation 1. Prior to injection, wash your hands thoroughly with soap and water . Towel dry. 2. Sit in a comfortable position so you can easily see the area of their stomach where you will be injecting. A lounge chair , recliner , or bed (propped up with pillows) is ideal. Inspection 1. Check the expiry date on the syringe. Do not use it if the date has passed. 2. Check the syringe is not damaged and the medicine in it is a clear solution without particles. If the syringe is damaged or the medicine is not clear , use another syringe. 3. Do not expel any air from the syringe before administering the injection. You may lose some of the medicine if you do. 170 Injection Site 1. Only inject at these injection sites:  Thigh  Abdomen, except 2 inches (5 cm) area around belly button.  Outer area of upper arm (not for self-injection). 2. Choose an area on the right or left side of your stomach. This should be at least 5 centimetres away from your belly button and out towards your sides. 3. Rotate injection site. Change the place where you inject between the left and right sides of your stomach, depending on the area you were last injected. This is to prevent scarring which will make it harder to inject the area and also affect how the medication is released into your body . Avoid injecting on scars and bruises. 4. Do not co-administer with other injectable drugs at the same administration site. Injection Technique 1. Clean (do not rub) the injection site with alcohol wipe. Let the skin dry before injection. Do not touch this area again before injecting. 2. Hold the syringe in the hand you write with (like a pencil) and with your other hand, gently pinch the cleaned area of your abdomen between your forefinger and thumb to make a fold in the skin. Make sure you hold the skin fold throughout the injection 3. Hold the syringe with the needle pointing downwards (vertically at 90 degree angle) and inject a full length needle into the skin fold. Inject at 45 angle for needle length 8 mm or if the patient is thin. 4. Press down plunger with your finger (thumb). Complete the injection using all of the medicine in the syringe. Hold for 10 seconds. 5. Release the plunger and the needle will withdraw automatically from the skin and retract into the security sleeve where it will be locked permanently . Let go of the skin fold. 6. To avoid bruising, do not rub the injection site. 7. Drop the used syringe into a hard, puncture-proof container . Close the container lid tightly and place the container out of reach of children. 8. When the container is full, dispose of it safely . 9. If there is blood at the injection site, press a cotton ball or gauze pad on your injection site. Do not rub the injection site. Apply a plaster if needed. 10. Do not stop taking your medication unless advised to do so by your prescriber . Missed dose management If you forget to take a dose, inject it as soon as you remember . Do not inject a double dose to make up for a forgotten dose Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Not recommended unless potential benefit outweighs risk",breastfeeding:"Not recommended 171",elderly:"Used with caution in older adults (from 75 years age and above) due to the risk of hemorrhage. MALPIP 1. Use caution and monitor bleeding risk.",paediatric:"The safety and efficacy of fondaparinux in patients under the age of 17 has not been established"},sideEffects:["May develop hematoma at the injection site (a localised swelling that is filled with blood).","Educate patient on symptoms of bleeding such as bruises with unknown cause, blood in urine/dark coloured urine, black stools, gum bleeding or heavy menstrual bleeding","Seek immediate medical attention if any sign or symptom of bleeding occurs"],others:{storage:"1. Store below 25C, do not freeze.",other_points:"1. Renal impairment - Not recommended in severe renal impairment (creatinine clearance <30 ml/min) 2. Liver impairment - no dose adjustment 3. Body weight below 50 kg are at increased risk of bleeding"}},{id:"counsel-057",name:"Fusidic Acid, Topical",pharmacologicalGroup:"Fusidic acid cream is a topical antibiotic (Group: Fusidanes) used to treat bacterial skin infections.",indication:"Fusidic acid is indicated for the treatment of mild to moderately severe skin and soft-tissue infections which include impetigo, folliculitis, erythrasma, furunculosis, abscesses and infected traumatic wounds and infected eczema Fusidic acid is particularly effective against Gram-positive organisms , with Staphylococcus aureus , including methicillin-resistant Staphylococcus aureus (MRSA) , being one of its most notable targets. Dosage Apply to the affected area 2 - 3 times daily for a duration of 7 days. Do not use it for more than 2 weeks. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Apply a thin layer of fusidic acid cream to the affected area 2 to 3 times a day, or as directed by a healthcare provider . 2. Clean the affected area gently before application to remove any dirt or debris. 3. Treatment duration generally lasts 7 to 14 days, depending on the severity of the infection, or as prescribed by a healthcare provider . Do not discontinue treatment prematurely , even if symptoms improve, unless advised by your healthcare provider . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". However , if administration is necessary , its potential benefits should be weighed against possible hazards to the fetus.",breastfeeding:"No effects on the breast-fed new-born/infant are anticipated since systemic exposure of topically applied fusidic acid/sodium fusidate to the breast-feeding woman is negligible. 2. Topical fusidic cream can be used during breast-feeding but it is recommended to avoid applying on the breast.",elderly:"1. Patients who use topical oils, creams, and ointments have potential fall risk .Patients may be advised to wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces.",paediatric:"The frequency , type and severity of adverse reactions in children are expected to be the same as in adults."},sideEffects:["Various skin reactions such as pruritus and rash","Application site reactions such as pain and irritation.","Hypersensitivity and angioedema."],others:{storage:"1. Keep out of reach of children. 2. Keep the container tightly closed. 3. Store in a dry place below 30C. 4. Protect from light.",other_points:"1. Overdose is unlikely to occur . 2. Unless hypersensitivity to fusidic acid or any of the excipients exists, accidental ingestion of fusidic acid and the concentration of the excipients is too low to constitute a safety risk. 3. Avoid prolonged use as it may lead to antibiotic resistance. 4. Do not apply to the eyes, mouth, or mucous membrane. 5. Avoid using under occlusive dressings unless directed by a physician."}},{id:"counsel-058",name:"Gamma Benzene Hexachloride, Topical",pharmacologicalGroup:"Topical insecticide",indication:"1. For topical treatment of head lice (Second-line treatment) Risk of neurologic toxicity . Should only be used in patients who cannot tolerate or have failed first-line treatment with safer medications for the treatment of scabies. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Before applying, wash hair with shampoo for at least 1 hour and dry it thoroughly . Do not use any creams, oils, or conditioners. 2. Shake the lotion well. Apply just enough lotion to make hair, scalp, and the small hairs on the back of neck wet. 3. Leave the shampoo on your hair for exactly 4 minutes. Keep hair uncovered during this time. 4. At the end of 4 minutes, use a small amount of warm water to lather the shampoo. Do not use hot water . 5. Wash all of the shampoo off of hair and skin with warm water . 6. Dry hair with a clean towel. 7. Comb hair with a fine tooth comb (nit comb) or use tweezers to remove nits (empty egg shells ). 8. Missed dose management : If a dose is missed, use it as soon as possible. If it is almost time for the next dose, use only that dose. Do not use double or extra doses. Do not stop your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"There are no adequate and well-controlled studies of gamma benzene hexachloride in pregnant women. A nother safer agent should be used.",breastfeeding:"Topical application may increase drug milk levels for at least several days. Because it is potentially toxic in infants, is a persistent environmental contaminant, and possibly has estrogenic effects that could decrease lactation as well as affect the nursing infant, another agent should be used .",elderly:"Use with caution due to increased systemic absorption and neurotoxicity . 175",paediatric:"Use with caution due to increased systemic absorption and neurotoxicity . 2. Contraindicated for premature infants because their skin may be more permeable than that of full term infants and their liver enzymes may not be sufficiently developed to metabolize gamma benzene hexachloride .",fasting:"N/A"},sideEffects:["If irritation, sensitization, drowsiness, headache, dizziness, seizure occurs, the patient should be advised to consult a physician.."],others:{storage:"1. Store below 30 degrees. 2. Keep out of reach of children. 3. For external use only.",other_points:"1. Cotraindicated in individuals with known uncontrolled seizure disorders. 2. Increased systemic absorption and neurotoxicity for people weighing less than 50 kg and d individuals with other skin conditions (eg, atopic dermatitis, psoriasis)."}},{id:"counsel-059",name:"Ganirelix",pharmacologicalGroup:"Gonadotropin-releasing hormone (GnRH) antagonist",indication:"Indication Prevention of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for assisted reproduction technique Dose Given by SC 0.25 mg once daily, starting on day 6 of ovarian stimulation and continued until ovulation induction",dosage:"See indication for dosage details",methodOfAdministration:"Site of administration or injection:  Upper leg (preferably)  Abdomen  Buttock <HEADER_METHOD>: a) Wash hands with soap and water . Dry your hands b) Check that the - The expiry had not passed - The solution is clear and colourless and does not contain particle - The syringe had not been opened or damaged c) Sit in a comfortable position so you can easily see the area of site of injection d) Do not inject within 2 inches of your navel area, near scars, bruises or stretch marks. Use alternate site for the next dose e) Clean the area you have selected for your injection with alcohol swab and allow the area to dry for at least 1 minute f) Remove the cap to expose the needle. To prevent infection, do not touch the needle or let it come in contact with any surface before injection. g) Do not press on the plunger to get rid of air bubbles. This can lead to a loss of the medicine. h) Hold the syringe with the dominant hand and with the other hand, gently pinch the cleaned area of the injection site between the forefinger and thumb to make a fold in the skin. Make sure to hold the skin folded throughout the injection. i) Insert the full length of the needle into the skin fold at an angle of 45-90 degree and press down the plunger fully. j) Hold for 10 seconds before removing the needle by pulling it straight out, then let go of the skin fold. k) Immediately discard the used needle into a designated disposal bin l) Do not rub the injection site after administration Do not stop taking your medication unless advised to do so by your prescriber Missed dose management: I f you realize that you forgot a dose, administer it as soon as possible. Do not inject a double dose to make up for a missed dose. If you are more than 6 hours late (so the time between two injections is longer than 30 hours) administer the dose as 177 soon as possible, and contact your doctor for further advice.",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:"Contraindicated",elderly:"NA",paediatric:"patients below age 18 have not been established .",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Redness, swelling of skin at the injection site.","Headache, Nausea, Dizziness.","Tiredness and malaise (general feeling of being unwell) Abdominal pain, Hot flushes, Vaginal bleeding.","Seek help from doctor if symptoms worsen."],others:{storage:" Keep out of reach and sight of children.  Store at room temperature between 15C and 30C.  Store in the original package in order to protect from light",other_points:"NA"}},{id:"counsel-060",name:"Gentamicin, Topical",pharmacologicalGroup:"Antibiotic, Topical",indication:"For the treatment of primary and secondary skin infections caused by susceptible bacteria.",dosage:"Apply 2 - 4 times daily to affected area To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Clean the affected area and remove any crusts (e.g., in cases of impetigo contagiosa) if necessary 2. Apply a small amount of cream/ointment gently to the affected area. 3. The treated area may be covered with a sterile gauze dressing, if needed, to protect the application site. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"should be considered only if the potential benefits outweigh the risks, and under the guidance of a healthcare provider .",breastfeeding:"infant. 2. Avoid applying gentamicin to the breast area to prevent accidental ingestion by the infant.",elderly:"patients may also have an increased risk of nephrotoxicity and ototoxicity if systemic absorption occurs, especially in those with pre-existing",paediatric:"Apply a small amount gently to the cleansed affected area. May cover with gauze dressing.",renalImpairment:". - Close monitoring is recommended for prolonged use or extensive application. - Patients who use topical oils, creams, and ointments 179 have potential fall risk .Patients may be advised to wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces."},sideEffects:["Hypersensitivity reactions: Topical use has been associated with itching, redness, swelling and other signs of irritation that are not present before therapy . Discontinuation of therapy normally brings relief to the symptoms.","Superinfection: Prolonged use may result in fungal or bacterial superinfection; discontinue if superinfection is noted."],others:{storage:"1. Store under room temperature, below 30 o C",other_points:"1. Hepatic and renal impairment: There are no dosage adjustments provided in the manufacturer's labelling for kidney and liver impairment. However , dosage adjustment is unlikely due to low systemic absorption. 2. Contraindication: Hypersensitivity to g   tami  i  or any component of the formulation"}},{id:"counsel-061",name:"like peptide-1 Receptor Agonist (GLP-1 RA",pharmacologicalGroup:"GLP-1 receptor agonist (GLP-1 RA) 1. Currently available in Malaysia: a. Liraglutide (daily injection) b. Dulaglutide (weekly injection) c. Semaglutide (weekly injection and oral tablet) d. combination of insulin Glargine with Lixisenatide (daily injection)",indication:"1. Treatment for T2DM.",dosage:"titration and maintenance dose depending on agent a. Liraglutide: i. Initiate at 0.6 mg injected subcutaneously once daily for one week then increase to 1.2 mg daily. ii. If additional glycemic control is required, increase the dose to 1.8 mg daily after one week of treatment with the 1.2 mg daily dose. b. Dulaglutide: i. Recommended starting dosage is 0.75 mg injected subcutaneously once weekly . ii. After 4 weeks, the dosage may be increased to 1.5 mg once weekly for additional glycemic control. iii. If additional glycemic control is needed, increase the dosage in 1.5 mg increments after at least 4 weeks on the current dosage. iv. The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly c. Semaglutide (injection): i. Start at 0.25 mg once weekly . ii. After 4 weeks, increase the dosage to 0.5 mg once weekly . iii. If additional glycemic control is needed, increase the dosage to 1 mg once weekly after at least 4 weeks on the 0.5 mg dose. iv. If additional glycemic control is needed, increase the dosage to 2 mg once weekly after at least 4 weeks on the 1 mg dosage d. Semaglutide (oral tablet): i. Day 1 to 30: The recommended starting dosage is 3 mg orally once daily for 30 days (this dosage is not effective for glycemic control) ii. Days 31 to 60: Increase the dosage to 7 mg orally once daily. iii. On Day 61 or thereafter , if: No additional glycemic control is needed, maintain the dosage at 7 mg orally once daily. Additional 181 glycemic control is needed, increasing the dosage to 14 mg orally once daily. e. Lixisenatide (in combination with insulin Glargine): i. Discontinue therapy with basal insulin or a GLP-1 RA prior to initiation of insulin glargine + lixisenatide. ii. In patients inadequately controlled on less than 30 units of basal insulin or on lixisenatide, the starting dosage is 15 units (15 units insulin glargine/5 mcg lixisenatide) given subcutaneously once daily. iii. In patients inadequately controlled on 30 to 60 units of basal insulin, the starting dosage is 30 units (30 units insulin glargine/10 mcg lixisenatide) given subcutaneously once daily. iv. Titrate the dosage upwards or downwards by two to four units every week based on the patient s metabolic needs, blood glucose monitoring results, and glycemic control goal until the desired fasting plasma glucose is achieved. v. Maximum daily dosage is 60 units (60 units of insulin glargine and 20 mcg of lixisenatide). 2. Treatment for obesity a. Liraglutide: Doses up to 3 mg daily are approved for obesity management. b. Semaglutide: Higher doses (e.g., 2.4 mg weekly SC) have been approved for weight management in obesity .",methodOfAdministration:"Injection Administration and missed dose management A. Liraglutide (Victoza  ) 1. Administer subcutaneously (SC) in the abdomen, thigh, or upper arm once daily at any time of the day, with or without meals. 2. Rotate injection sites to reduce irritation. 3. When using injection of Liraglutide with insulin, administer as separate injections. It is acceptable to inject Liraglutide and insulin in the same body region but the injections should not be adjacent to each other . 4. If a dose is missed less than 12 hours, administer the dose as soon as possible. If more than 12 hours have passed, skip the dose and resume the once-daily dosage regimen as prescribed with the next scheduled dose. Do not administer an extra dose or increase the dose to make up for the missed dose. 5. If more than 3 days elapsed since the last dose, initiate therapy at 0.6 mg/day to avoid GI symptoms. B. Dulaglutide (Trulicity  ) 182 1. Administer subcutaneously (SC) in the abdomen, thigh, or upper arm once weekly on the same day each week at any time of the day, with or without food. 2. Rotate injection sites to reduce irritation. 3. When using injection Dulaglutide with insulin, administer as separate injections. It is acceptable to inject Dulaglutide and insulin in the same body region but the injections should not be adjacent to each other . 4. If a dose is missed, administer as soon as possible within 4 days after the missed dose. If less than 3 days remain before the next scheduled dose, skip the missed dose and administer the next dose on the regularly scheduled day. 5. The day of weekly administration can be changed, if necessary , as long as the last dose was administered 3 or more days before the new day of administration. C. Semaglutide (Ozempic  ) 1. Administer subcutaneously (SC) in the abdomen, thigh, or upper arm once weekly at any time of day, with or without meals. 2. Rotate injection sites to reduce irritation. 3. When using injection Semaglutide with insulin, administer as separate injections. It is acceptable to inject Semaglutide and insulin in the same body region but the injections should not be adjacent to each other . 4. If a dose is missed, administer it as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once-weekly dosing schedule. 5. The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours). D. Lixisenatide/ insulin Glargine ( Soliqua  ) 1. Administer subcutaneously (SC) in the abdomen, thigh, or upper arm once daily, 60 minutes before the first meal of the day. 2. Rotate injection sites to reduce irritation. 3. If a dose is missed, resume the once-daily regimen as prescribed with the next scheduled dose. Injection technique Dulaglutide (Trulicity  ) 1. Before removing the cap, make sure the pen is locked. Pull off the grey base cap. Do not put the base cap back on because this could damage the needle. 2. Place the clear base flat and firmly against the skin at the injection site. Unlock by turning the lock ring. 3. Press and hold the green injection button. Listen for the first click to indicate injection start. 4. Hold in place until the second click (510 seconds), which signals needle retraction. 183 5. Remove the pen from the skin. The injection is complete when the grey part is visible. 6. Remove the needle from the skin, recap it with the outer cap, and unscrew it carefully . Replace the pen cap. Semaglutide (Ozempic  ) and Liraglutide (Victoza  ) 1. Remove the protective tab from the outer needle cap. 2. Remove the paper tab, screw the needle to the pen and remove the inner and outer cap (do not keep the inner cap). 3. Prime only before the first use of a new pen. To prime, turn the dose knob until the flow check symbol. Hold the pen with the needle pointing up, and tap the cartridge gently with your finger a few times to bring any air bubbles to the top of the cartridge. 4. Keep the needle pointing up and press the dose button until 0 mg aligns with the pointer and until a drop can be seen at the needle tip. 5. Turn the dose knob until the needed dose aligns with the pointer . 6. If mistakenly select a wrong dose, change it by turning the dose knob backwards or forwards until the correct dose aligns with the pointer . Be careful not to press the dose button when turning the dose knob. 7. Inject by pressing the dose button until 0 mg aligns with the pointer . Hold in place for at least 6 seconds. 8. Remove the needle from the skin, recap it with the outer cap, and unscrew it carefully . Replace the pen cap. Lixisenatide/ insulin Glargine ( Soliqua  ) 1. Remove the protective tab from the outer needle cap. 2. Remove the paper tab, screw the needle to the pen and remove the inner and outer cap (do not keep the inner cap). 3. Prime before each injection. To prime, select 2 units by turning the dose selector until the dose pointer is at the 2 mark. 4. Keep the needle pointing up and press the injection button all the way in. 5. Turn the dose knob until the needed dose aligns with the pointer . 6. If mistakenly select a wrong dose, change it by turning the dose knob backwards or forwards until the correct dose aligns with the pointer . Be careful not to press the dose button when turning the dose knob. 7. Inject by placing the thumb on the injection button. Then press all the way in and hold for 10 seconds. 8. Remove the needle from the skin, recap it with the outer cap, and unscrew it carefully . Replace the pen cap. Oral Semaglutide tablet ( Rybelsus  ) 1. Should be taken on an empty stomach upon waking up. 2. The tablet should not be split, crushed or chewed. 3. It should be swallowed whole with a sip of plain water (up to half a glass of plain water equivalent to 120 ml). Taking the tablet with more than 120ml of water may result in adverse absorption of the drug. 184 4. Wait at least 30 minutes to 2 hours before eating or drinking. Taking semaglutide with food or less than 30 minutes before food, beverages or other oral drugs may decrease the absorption of the drug. 5. If a dose is missed, skip the dose for that day and take the next dose on the following day. 6. Do not place tablets in pill boxes, keep in original blister packs until use. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". Discontinue agents at least 2 months before trying to conceive.",breastfeeding:".",elderly:"patients which can cause undernutrition and lead to osteopenia and osteoporosis.",paediatric:"Lixisenatide, Semaglutide: Safety and efficacy not established in individuals under 18 years. 2. Liraglutide and Dulaglutide: Safety and efficacy not established in children under 10 years.",fasting:"(e.g., Ramadan) if dose titration is completed 24 weeks prior. No further modifications are needed."},sideEffects:[],others:{storage:"A. Liraglutide (Victoza  ) - Store new, unused pens in the refrigerator at 2C to 8C. Do not freeze. - After first use, the pen can be stored for 30 days at controlled room temperature (15C to 30C) or in a refrigerator (2C to 8C). - Keep the pen cap on when not in use. Protect the pen from excessive heat and sunlight. - Always remove the needle after each injection and store the pen without the needle attached. This reduces the risk of contamination, infection, leakage and inaccurate dosing. B. Dulaglutide (Trulicity) - Store new, unused pens in the refrigerator at 2C to 8C. Do not freeze - If needed, each single-dose pen can be kept at room temperature, not to exceed 30C for a total of 14 days. - Keep the pen cap on when not in use. Protect the pen from excessive heat and sunlight. - <HEADER_STORAGE> in the original carton is recommended until the time of administration. C. Semaglutide (Ozempic  ) - Store new, unused pens in the refrigerator at 2C to 8C. Do not freeze - After the first use, pens can be stored at room temperature (15C to 30C) or refrigerated (2C to 8C) and used within 56 days. - Keep the pen cap on when not in use. Protect the pen from excessive heat and sunlight. - Always remove and safely discard the needle after each injection and store the pen without an injection needle attached. D. Lixisenatide/ insulin Glargine ( Soliqua  ) - Store new, unused pens in the refrigerator at 2C to 8C. Protect the pen from light. Do not freeze the pen and do not use it if it has been frozen. - After first use, store the pen at room temperature no higher than 25C. Use the pen for up to 28 days. - Replace the pen cap after each use to protect it from light. - Remove the needle after each injection and store the pen without a needle attached.",other_points:"1. GLP-1 RA is not a substitute for insulin. 2. GLP-1 RA cannot be used for patients with T1DM. 3. GLP-1 RA can be used as an adjunct to oral glucose-lowering drugs and with insulin therapy . 4. GLP-1 RA should not be used in patients with a history of pancreatitis. 5. GLP-1 RA should not be used in patients with a history of or a family history of MEN 2A or 2B or medullary thyroid cancer . 6. Lixisenatide should not be used in patients with gastroparesis. 7. For Semaglutide, patients with a history of diabetic retinopathy should be monitored for progression of retinopathy and slower dose titration may be warranted. 8. Use with caution in patients at risk of kidney injury due to dehydration or volume contraction (e.g., polyuria, polydipsia, or those on renin-angiotensin system inhibitors). Side Effects and their 1. Gastrointestinal symptoms - The most common side effects are usually mild to 185 Management* moderate but some patients may experience severe symptoms that can increase the risk of acute kidney injury due to volume contraction. - Usually started with a low dose of GLP-1 RA and increased slowly to reduce the likelihood of GI side effects. - General advice to reduce the likelihood of GI side effects: 1. Improve eating habits: - Eat slowly - Eat when hungry and stop at the first sign of fullness - Eat smaller , more frequent meals. - Choose easy-to-digest food (ie. bland options) - Drink in small sips throughout the day - Avoid lying down after having a meal - Try not to be too active after eating - Avoid eating too close to bedtime 2. Get some fresh air and do some light exercise 3. Keeping a food diary may be useful in identifying foods and meal timing that worsen GI side effects - Additional advice for managing GI side effects: a. Nausea - avoid strong smells - eat crackers, mint, or ginger-based food or drinks about half an hour after taking a GLP-1 RA. b. Vomiting - stay well hydrated - have more frequent meals in smaller amounts. c. Diarrhea - drink plenty of water - avoid dairy products and high-fiber foods until symptoms resolve - Eat chicken broth, rice, carrots, very ripe fruit without skin d. Constipation - Drink generous amounts of water or other sugar-free liquids - Ensure adequate intake of fibre in diet - Increase physical activity - In case of persistence of nausea and/or vomiting, avoid drinks during meals, rather have them between 30 and 60 min before and/or after meals 2. Skin side effects - Injection site reactions (rash, erythema or itching) - Usually mild, often transient in nature - Management: rotate injection sites and use proper injection techniques. Cold compresses can help reduce pain. 3. Small increase in heart rate, clinically not significant 4. Infections (Upper respiratory tract infections and nasopharyngitis) 5. Headache 186 - Monitor and manage symptomatically ."}},{id:"counsel-062",name:"Glyceryl Trinitrate (GTN) Sublingual Spray",pharmacologicalGroup:"Nitrate; Antianginal agent",indication:"1. Angina pectoris 2. Variant angina",dosage:"1-2 metered sprays sublingual every 5 minutes as required or 5-10minutes prior to activities that might precipitate an acute attack. Dosing is according to product insert or protocol.",methodOfAdministration:"1. Priming: Before using GTN spray for the first time, check that the spray is working by pressing the spray button a few times until it produces a fine mist of liquid. 2. During application the patient should rest, ideally in the sitting position. Advise patients to hold breath prior to spray . 3. The canister should be held vertically with the valve head uppermost and the spray orifice as close to the mouth as possible. Press down the button firmly . 4. The spray should not be inhaled. 5. A spray may be repeated approximately every 5 minutes as needed. 6. If chest pain persists after a total of 3 sprays, prompt medical attention is recommended. 7. Patients should be instructed to familiarise themselves with the position of the spray orifice, which can be identified by the finger rest on top of the valve, in order to facilitate orientation, for administration at night. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"unless considered essential.  To inform the prescriber if you are pregnant.",breastfeeding:".",elderly:"patients with careful dose management, monitoring for side effects, and patient education to mitigate risks like 189 hypotension, falls, and tolerance.",paediatric:"No data",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["may include severe headache, blurred vision, dry mouth, dizziness or flushing.","If affected, do not drive or operate machinery .."],others:{storage:"1. Store below 30C. 2. Do not refrigerate or freeze. 3. Do not use GTN Spray if you are near a naked flame, e.g. a cigarette.",other_points:"NA"}},{id:"counsel-063",name:"Glyceryl Trinitrate (GTN) Sublingual Tablet",pharmacologicalGroup:"Nitrate; Antianginal agent",indication:"Prophylaxis and treatment of angina and left ventricular failure",dosage:"0.5-1 mg sublingually may be repeated every 5 minutes until relief is obtained.",methodOfAdministration:"Treatment of angina 1. During an acute angina attack, the patient should rest, preferably in a sitting position. 2. Place one tablet under the tongue, allowing it to dissolve. Do not swallow or chew the tablet. 3. If pain remains, remove the undissolved tablet and place a new tablet under the tongue. The dose may be repeated every 5 minutes for a maximum of 3 times. 4. If pain persists or becomes more intense after a total dose of 3 times in 15 minutes, patient should call the ambulance or go to the hospital. Prophylaxis of angina 1. Take 1 tablet 5 to 10 minutes before exercise or exertion to prevent an attack. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"unless considered essential. 3. To inform the prescriber if you are pregnant.",breastfeeding:".",elderly:"patients with careful dose management, monitoring for side effects, and patient education to mitigate risks like hypotension, falls, and tolerance.",paediatric:"No data",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["may include severe headache, blurred vision, dry mouth, dizziness or flushing.","If affected, do not drive or operate machinery .."],others:{storage:"1. Store the tablets below 25C in a cool, dry place, protected from direct sunlight. 2. Discard the tablets 2 months after first opening of the bottle (mark the date on the bottle). 3. Do not put cotton wool, other medicines, or anything else in the bottle with the tablets. 4. Do not expose the opened bottle or keep the bottle in a humid condition/area. 5. Keep out of reach and sight of children",other_points:"NA"}},{id:"counsel-064",name:"Gonadotropin-Releasing Hormone Antagonists / Gonadotropins",pharmacologicalGroup:"Gonadotropin-Releasing Hormone (GnRH) Antagonists : 1. Cetrorelix (Asporelix) 0.25 mg Injection 2. Cetrorelix (Cetrotide) 0.25mg Injection Gonadotropins : 1. Human Chorionic Gonadotrophin (Hucog) 5000IU Injection 2. Menotrophin, Highly Purified (Humog) 75iu Injection 3. Urofollitropin (Folliculin) 75iu, 150iu Injection",indication:"To counsel based on specific medication s indication and dosage as prescribed by the doctor Preparation and Reconstitution of Medicine [For preparation of Cetrorelix - see Preparation and Administration of Cetrorelix Injection ] Preparation and Administration : Preparation of medication and disposables required for administration of medication  Medication (powder in vial) and diluent (ampoule)  Syringe 3cc  Needle (23G x 25mm)  Needle (26G x 12mm)  Alcohol swab Reconstitution of medication: a) Wash hands with soap and water . Dry your hands b) Check that the - The expiry had not passed - The correct drug and strength - The vial and ampoule is not damaged c) Attach needle to syringe for mixing (23G x 25mm), twist to tighten. Set aside. d) Hold the glass ampoule base upright. Tap the ampoule gently to ensure all solution is at the base. Look for a scoring/line at the neck of the ampoule. Hold the top and base firmly . e) For safety , use a piece of paper/cloth to hold the top. Apply pressure at 90, turn and snap the top off. The ampoule should break at the neck only. f) Insert needles that were set aside in (a) and draw out all the solution from the ampoule. g) Remove the cap from the vial and wipe the top of the vial with an alcohol swab. h) Insert the needle at an angle through the grey rubber circle. Point the needle tip to the wall of the vial and gently empty the solution into it. i) Swirl the bottle to solubilise the powder inside the vial while keeping the needle inside until the solution becomes a clear solution. j) Invert the vial upside down. Inject air into the vial to put more pressure into the vial. k) Gently pull back the tip of the needle to the same level as the rubber stopper of the vial. l) Release the plunger of the syringe and the solution will enter 193 the syringe automatically . m) Repeat step (b) to (j) until you have reached the prescribed dose. n) Remove the needle from the syringe while it is still in the vial for safety . o) Attached the smaller needle (26G x 12mm). p) Turn the syringe upside down, slowly tap the syringe to remove air bubbles. Depress plunger to expel air out of the syringe through the needle slowly until a tiny drop of solution appears at the tip of the needle. The solution is now ready to be injected. Preparation and Administration of Cetrorelix Injection : Preparation of medication and disposables required for administration of medication  Medication (powder in vial) and prefilled syringe with diluent  Needle (20G x 40mm)  Needle (27G x 19mm)  Alcohol swab Reconstitution of medication: a) Wash hands with soap and water . Dry your hands b) Check that the - The expiry had not passed - The solution in the syringe is clear and colourless and does not contain particle - The vial is not opened or damaged c) Attach the pre-filled syringe to the marked yellow needle, twist to tighten. d) Remove the cap from the vial and wipe the top of the vial with an alcohol swab. e) Insert the needle at an angle through the grey rubber circle. Point the needle tip to the wall of the vial and gently empty the solution into it. f) Swirl the bottle to solubilise the powder inside the vial while keeping the needle inside until the solution becomes a clear solution. g) Invert the vial upside down. Inject air into the vial to put more pressure into the vial. h) Gently pull back the tip of the needle to the same level as the rubber stopper of the vial. i) Release the plunger of the syringe and the solution will enter the syringe automatically . Repeat until all dissolved solution is transferred into the syringe. j) Remove the needle from the syringe while it is still in the vial for safety . k) Attached the marked grey needle to the syringe with the dissolved medicine inside, twist to tighten. l) Turn the syringe upside down, slowly tap the syringe to remove air bubbles. Depress plunger to expel air out of the syringe through the needle slowly until a tiny drop of solution appears at the tip of the needle. The solution is now ready to be injected.",dosage:"See indication for dosage details",methodOfAdministration:"Site of administration or injection:  Abdomen (preferably)  Buttock <HEADER_METHOD>: a) Sit in a comfortable position so you can easily see the area of their stomach where you will be injecting. b) Select an area on the right or left side of your stomach, at least 2 inches from your navel. Alternate left and right side of 194 the lower abdominal area at each injection. Do not inject yourself within about 2 inches of your navel, near scars, bruises or stretch marks. c) Clean the area you have selected for your injection with alcohol swab and allow the area to dry d) Remove the protective needle cap. e) Insert needle into the skin at an angle of 90 and push the entire length of the needle into the subcutaneous tissue. Push all the solution into the tissue. f) Count to 10 slowly before withdrawing the needle from the skin at the same angle it was inserted. This is to ensure full dose delivery and prevent leakage. g) Immediately discard the used needle into a designated disposal bin. h) Do not rub the injection site after administration Missed Dose Administer as soon as you remember . If it is close to the next dose, omit the current dose and administer the current dose. DO NOT DOUBLE THE DOSE Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:"Contraindicated",elderly:"NA",paediatric:"NA",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Injection site reaction (bruising, pain, redness)","Headache Seek help from doctor if symptoms worsen"],others:{storage:"1. Store at 2-8 C (in a refrigerator). DO NOT FREEZE. Avoid storage at the door of the fridge and vegetable compartment, ensure there is proper air circulation around medication. 2. TRANSPOR T of medication is only allowed in a COOL BOX WITH ICE/ICE PACKS 3. Preferable return home immediately after getting medication from pharmacy to facilitate proper storage",other_points:"NA"}},{id:"counsel-065",name:"Heparin Sodium",pharmacologicalGroup:"Antithrombotic agent",indication:"1. Prophylaxis and treatment of venous thrombosis and pulmonary embolism. a. By intravenous injection, loading dose of 5000 units (10,000 units in severe pulmonary embolism) followed by continuous infusion of 15-25 units/kg/hr . By subcutaneous injection (for DVT) of 15,000 units every 12 hours (laboratory monitoring on daily basis essential to adjust dose). 2. Treatment of myocardial infarction and arterial embolism. a. Same as 1 a. 3. Prevention of clotting in arterial and heart surgery and for prevention of cerebral thrombosis a. Prophylaxis in general surgery ,by subcutaneous injection 5000 units 2 hr before surgery , then every 8-12 hrs for 7 days or until patient is ambulant.During pregnancy (with monitoring), 5000-10000 units every 12 hours.An adjusted dose regimen may be used for major orthopaedic surgery or low molecular weight heparin may be selected. To counsel based on specific medication s indication and dosage as prescribed as doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Administer only by intermittent IV injection, IV infusion, or deep subQ injection; avoid IM administration Preparation 1. Prior to injection, wash your hands thoroughly with soap and water . Towel dry. 2. Sit in a comfortable position so you can easily see the area of their stomach where you will be injecting. A lounge chair , recliner ,or bed (propped up with pillows) is ideal. Inspection 1. Check the expiry date on the syringe. Do not use it if the date has passed. 2. Check the syringe is not damaged and the medicine in it is a clear solution without particles. If the syringe is damaged or the medicine is not clear , use another syringe. Injection site 1. Choose an area on the right or left side of your stomach. This should be at least 5 centimetres away from your belly button and out towards your sides. 2. Change the place where you inject between the left and right sides of your stomach, depending on the area you were last injected. This is to prevent scarring which will make it harder to inject the area and also affect how the medication is released into your body .Avoid injecting on scars and bruises. Dose preparation 1. Wipe the top of the heparin vial with an alcohol swab. 197 2. Remove the cap from the plunger . 3. Attach a long needle (21G) and remove the shield from the needle to withdraw heparin. 4. Pull the plunger back to draw air into the syringe equal to the dose of heparin to be injected. 5. Insert the needle into the rubber stopper of the heparin vial at a 45 angle. 6. Press down the plunger to inject air into the vial. 7. Turn the vial upside down. 8. Pull the plunger back to draw the desired dose into the syringe. 9. To remove air bubbles (if present) in the syringe, draw up several more units of heparin, tap the barrel to move them to the top then expel them by pushing the plunger 10. Remove the needle straight out of the vial and change to a shorter needle (26G) for injection purposes Injection technique 1. Cleanse (do not rub) the selected site for injection with an alcohol swab. 2. Remove the protective cap off the needle, do not allow the needle to touch anything to make sure it stays clean. 3. Hold the syringe in the hand you write with (like a pencil) and with your other hand, gently pinch the cleaned area of your abdomen between your forefinger and thumb to make a fold in the skin. Make sure you hold the skin fold throughout the injection 4. Hold the syringe with the needle pointing downwards (vertically at 90 degree angle) and inject a full length needle into the skin fold. Inject at 45 angle for needle length 8 mm or if the patient is thin. 5. Press down plunger with your finger (thumb). Complete the injection using all of the medicine in the syringe. Hold for 10 seconds 6. Remove the needle by pulling it straight out. Let go of the skin fold 7. To avoid bruising, do not rub the injection site. 8. Drop the used syringe into a hard, puncture-proof container . Close the container lid tightly and place the container out of reach of children. 9. When the container is full, dispose of it safely . Missed dose management If you miss a dose of heparin, inject it as soon as you remember . If it is too near the next dose, skip the missed dose and go back to your usual dosing times. Do not double dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Available evidence is inconclusive or inadequate for determining fetal risk when used in pregnant women.",breastfeeding:"Heparin is not distributed in milk",elderly:"Older adults >60 years of age, especially women may have higher serum levels and clinical response (longer aPTT s) as compared to younger patients receiving 198 similar dosages. 2. Dosage reduction and monitoring of APTT may be advisable.",paediatric:"As some heparin preparations may contain benzyl alcohol, its use should be avoided in children under two years of age. Not to be used in neonates.",fasting:"Not applicable"},sideEffects:["May develop hematoma at the injection site (a localised swelling that is filled with blood).","Symptoms of bleeding such as bruises with unknown cause, blood in urine/dark coloured urine, black stools, gum bleeding or heavy menstrual bleeding","Seek medical attention if any sign or symptom of bleeding occurs"],others:{storage:"1. Do not store above 30C.Do not refrigerate. 2. Stable for 28 days if aseptic technique is used.",other_points:"No dosage adjustment required in both hepatic and renal impairment"}},{id:"counsel-066",name:"Imiquimod",pharmacologicalGroup:"Immune response modifier",indication:"External Genital/Perianal Warts To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Apply Imiquimod exactly as directed by your doctor or according to the instructions on the label. Do not use it more often or over a larger area than instructed by the doctor . 1. Wash your hands. 2. Clean and thoroughly dry the affected area before application, usually before bedtime. 3. Open the sachet and squeeze some cream onto your fingertip. 4. Apply a thin layer on the affected area and rub the cream gently on the skin until it disappears. Do not cover , wrap or bandage the area unless instructed by the doctor . 5. Leave the cream on the affected area for a certain time as prescribed by the doctor . Do not bathe, shower or swim after applying the cream. 6. After the prescribed treatment time, wash the affected area with mild soap and water . 7. Wash your hands carefully after application. 8. Cream sachets should not be reused once opened. Open a new sachet each time you use the cream. Throw away the opened sachet according to your doctor or pharmacist's instructions even if all the cream was not completely used. MISSED DOSE : Apply cream as soon as you remember and then continue in your regular schedule. Do not apply the cream more than once per day. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Drugs should be given only if the potential benefit justifies the potential risk to the fetus.",breastfeeding:"Not known",elderly:"and younger patients. 200",paediatric:"patients below age 12 have not been established.",fasting:"N/A"},sideEffects:["Wart Site  very common: erythema, erosion, excoriation/flaking, oedema, itching, burning","Remote Site  common: bleeding, burning, itching, pain, tenderness, tinea cruris"],others:{storage:"1. Store at below 25C. 2. Store in a place that is not exposed to heat and moisture. 3. Do not freeze. 4. Keep this medication in the original container , tightly closed and out of reach of children.",other_points:"N/A"}},{id:"counsel-067",name:"Insulin",pharmacologicalGroup:"A. BOLUS 1. Short-acting regular human insulin: E.g:  Actrapid   Insugen  R 2. Rapid-acting analogue insulin: a. Aspart (Novorapid  ) b. Lispro (Humalog  ) c. Glulisine (Apidra  ) B. BASAL 1. Intermediate-acting or NPH insulin. E.g:  Insulatard   Insugen  N 2. Long-acting analogue insulin: a. Glargine U100 (Basalog  , Lantus  Solostar) b. Detemir (Levemir  ) c. Glargine U300 (Toujeo  Solostar) d. Degludec (Tresiba  ) C. PREMIXED 1. Premixed human insulin: a. (30% regular insulin + 70% NPH):  Mixtard  30  Insugen  30/70 2. Premixed analogue insulin: a. 30% insulin aspart + 70% insulin aspart protamine (Novomix  30) b. 25% insulin lispro + 75% insulin lispro protamine (HumalogMix  25 TM ) c. 50% insulin lispro + 50% insulin lispro protamine (HumalogMix  50 TM ) D. CO-FORMULA TION 1. 70% insulin degludec + 30% insulin aspart; iDegAsp (Ryzodeg 70/30) 2. Insulin glargine + lixisenatide (Soliqua TM )",indication:"A. Bolus insulin  administered pre-meal due to its short or rapid onset of action. It is used to control the post-meal glucose excursion and can be used with an insulin pump B. Basal insulin  administered once or twice daily due to its intermediate or long-acting profile. It covers the basal insulin requirements between meals and overnight secondary to endogenous hepatic glucose production C. Premixed insulin  biphasic insulin incorporating a combination of short or rapid-acting insulin with its intermediate-acting counterpart into a single formulation. It covers both post-prandial glucose excursions as well as basal insulin requirements simultaneously D. Co-formulations  a combination of two types of insulin or insulin with a glucagon like peptide-1 receptor analogue (GLP1-RA) such as: 203 1. Insulin Degludec-Aspart (iDegAsp)  a combination of a rapid-acting (insulin aspart) and an ultra-long-acting (insulin degludec) insulin in a single formulation, which can be injected once a day to provide both bolus and basal insulin coverage 2. Insulin glargine/lixisenatide  a combination of long-acting insulin and a GLP1RA in a single formulation. Insulin glargine provides basal insulin while lixisenatide stimulates endogenous insulin secretion to cover for bolus insulin requirement. Insulin dosage is individualised and dose adjustments are typically made weekly based on the patient s metabolic needs, blood glucose monitoring results, and glycemic control goal until the desired glycaemic control is achieved. Counsel based on specific medication indications and dosages as prescribed by the doctor . Administration time 1. Short-acting regular human insulin:  30 minutes before meals 2. Rapid-acting analogue insulin:  Inject immediately before meals or when necessary , 0-15 minutes before or after meals 3. Intermediate-acting regular human insulin:  For daily dosing, usually inject before sleep (1 hour before bed)  For twice daily dosing, inject pre-breakfast and pre-bed 4. Long-acting analogue insulin:  Inject once daily at any time of the day, preferably at the same time every day  Insulin Detemir: Administer once-daily doses with the evening meal or at bedtime. For twice-daily dosing, administer the evening dose with the evening meal, at bedtime, or 12 hours after the morning dose. 5. Premixed human insulin:  Once daily doses: 30 minutes before dinner  Twice daily doses: 30 minutes before breakfast and dinner 6. Premixed analogue insulin:  Inject immediately before meals or when necessary , 0-15 minutes before or after meals 7. Co-formulation:  Ryzodeg - Can be administered once or twice daily with the main meal(s). When needed, the time of administration can be changed, as long as it is dosed with the main meal when taken once daily  Soliqua TM - Once a day within the hour before the first meal of the day",dosage:"See indication for dosage details",methodOfAdministration:"1. Gently roll refrigerated insulin between the palms 10 times to warm the insulin. 2. Pull off the pen cap. 3. Inserting a new cartridge (Only for non-prefilled insulin pen): i. Detach the cartridge holder by twisting & pulling gently away from the pen with a click. ii. Reset the plunger rod by pushing the plunger rod gently back into the pen body . 204 iii. Insert the insulin cartridge into the cartridge holder of the insulin pen and screw the cartridge holder to the pen body tightly . 4. Mixing / Resuspending the insulin pen (only for cloudy insulin eg NPH, and premixed insulin). i. Gently tip cloudy insulin up and down for 10 cycles or until uniformly cloudy . Vigorous shaking should be avoided since this produces bubbles which reduce dose accuracy ii. Visually check for milky white appearance.  Inadequate resuspension of cloudy insulin before injection may lead to varying concentrations of medication dosage that can cause unpredictable clinical responses 5. Fix the needle to the insulin pen. i. Remove the paper tab of a new needle, screw the needle to the pen and remove the inner and outer cap (do not keep the inner cap).  Shorter needles (4, 5, 6 mm) provide equal efficacy and safety when compared with the longer needle (8 mm) and are suitable for all patients regardless of BMI.  8 mm needles should be discouraged to prevent the risk of intramuscular injection ii. Using a new needle each time may reduce the risk of needle breakage in the skin, clogging of the needle, inaccurate dosing and complications associated with using blunt needles (e.g. lipohypertrophy , abscess) 6. Priming the insulin pen i. Priming should be done when changing to new insulin cartridge/ prefilled pen and before each injection. ii. To prime, turn the dose selector to select 2 units and hold the insulin pen with the needle pointing up. iii. Tap the top of the pen gently a few times to let any air bubbles rise to the top. iv. Press and hold in the dose button until the dose counter shows 0. The 0 must line up with the dose pointer . A drop of insulin should be seen at the needle tip v. If you do not see a drop of insulin, repeat steps ii - iv. 7. Dial the correct dose  Check the dose indicator to ensure the correct dose is selected. 8. Identify proper injection site/rotation.  For ease of self-injection, the abdomen and thighs are the two main recommended injection sites for adults. a. Abdomen  inject at any place between the bottom of the ribs and the pubic area, 3 fingers width away from the navel. b. Thighs  inject in the top and outer part of the thigh, between 5 fingers width away from the knee and 5 fingers width away from the groin. Avoid the inner thigh. c. Buttocks and flanks  Inject into the upper , outer area of the buttocks. This site can be very difficult to use for self-injection and may require another person for administration. d. Arm  inject at the back of the arm, between 4 fingers width away from the 205 shoulder and 4 fingers width away from the elbow .  Injection site rotation within any quadrant or half should be done systematically with spacing of at least 1 cm apart from each injection to prevent repeat tissue trauma.  Advise to rotate injection sites within the same part of the body , not to change the injection part of the body too frequently due to different absorption of insulin at different parts of the body .  Do not inject where the skin has pits, is thickened, or has lumps. Do not inject where the skin is tender , bruised, scaly or hard, or into scars or damaged skin. 9. Inject the insulin on clean skin. i. Insert the needle into the skin at 90.  For extremely thin adults with diabetes (BMI <19), the proper injection technique is to use the 4 mm needle accompanied by the lifting of the skin fold when injecting to avoid the intramuscular injection  Individuals who have to continue using 8 mm needles should always lift a skin fold and/or inject at 45  to avoid intramuscular injections ii. Press the injection button until the figure in the dose window returns to 0. iii. Count to 10 slowly before withdrawing the needle from the skin iv. Counting past 10 may be necessary for higher insulin doses. This is to ensure full dose delivery and prevent insulin leakage 10. Disposal of used needle i. Recap the used insulin needle using the outer cap. ii. Always remove and safely discard the needle after each injection and store the pen without an injection needle attached. This reduces the risk of contamination, infection, leakage and inaccurate dosing. 11. Keep the insulin pen in its case at room temperature, away from heat and light",specialConsiderations:{pregnancy:", many case reports and observational studies did not find any association with adverse maternal or neonatal outcome.",breastfeeding:"Exogenous insulin has been detected in human milk, including 206 biosynthetic insulin. Insulin is not absorbed by the infant but may have beneficial local activity in the gastrointestinal tract.",elderly:"significantly increases the risk of falls.",paediatric:"patients below 2 years old have not been established 4. Treatment recommendations may vary among individual products and countries, refer to local treatment guidelines",fasting:"."},sideEffects:["Hypoglycaemia (Plasma glucose level below 3.9 mmol/L)  It may happen if the patient a. did not take a meal after the injection b. if he/she has a sudden change in diet c. alcohol consumption with no carbohydrate intake d. excessive physical activity e. excessive dose f. sick day or poor appetite g. inject the wrong type of insulin  Recognition of hypoglycaemia symptoms a. Shivering b. Palpitation c. Sweating d. Dizziness e. Hunger pangs f. Tingling or numbness  Treatment of hypoglycaemia (Rule of 15) i. Check plasma glucose level to confirm that the plasma glucose level is below 4.0 mmol/L (or 70 mg/dL) if possible ii. In adult patients, consume 15 grams of simple 207 carbohydrate e.g:  1 tablespoon of honey ,  150-200 ml of fruit juice such as orange juice or regular soft drink; or  3 teaspoons of table sugar dissolved in water iii. In children , give 0.3g/kg of simple carbohydrates. iv. After consuming the CHO, wait for 15 minutes to allow the glucose to be absorbed and the plasma glucose to rise v. Recheck plasma glucose. If plasma glucose remains below 4.0 mmol/L, repeat step ii. vi. Once hypoglycaemia has been reversed (BG > 4.0 mmol/L), the patient should have the usual meal that is due at that time of the day or 15g of complex carbohydrate to prevent recurrent hypoglycaemia. E.g:  3 pieces of crackers  1 piece of bread","Weight gain  Insulin-related weight gain may be a consequence of several factors: a. Improving metabolic control reduces glycosuria resulting in fewer calories lost in this manner b. The fear of hypoglycaemia might induce increased snacking between meals, increasing calorie intake. c. The anabolic nature of insulin can increase lean body mass. d. Using insulin can also cause salt and water retention  Educate patient on steps to counter weight gain: a. Advise restricting calories and using portion control, particularly for carbohydrates and fats. b. Advise patients to keep physically active and practice regular exercise. c. Avoiding high doses of insulin by reducing carbohydrate intake and being physically active (reduces insulin requirement). d. Preventing hypoglycaemia as it can lead to defensive eating/snacking"],others:{storage:"A. New insulin cartridges and prefilled pen  Unopened insulin should be kept at a refrigerated temperature between 2C8C.  Do not keep the insulin at the side of the fridge door and do not put it inside the freezer .  Do not use insulin that has been frozen.  Check the manufacturer s storage instructions as there may be possible differences from one manufacturer to the other B. In-use insulin cartridges and prefilled pen  In-use insulin pens can be stored at room temperature (15 -30C).  Do not remove cartridges from non-prefilled insulin pen between use and never refrigerate non-prefilled insulin pen.  Write the date of opening on insulin cartridges or prefilled insulin pens. Most insulins can be used within 28 - 42 days once opened.  Please refer to the individual product information for further details. 208",other_points:"NA"}},{id:"counsel-068",name:"Iron Supplements, Oral",pharmacologicalGroup:"Iron bivalent, oral preparations ferrous fumarate ferrous sulfate Iron trivalent, oral preparations ferric oxide polymaltose complexes",indication:"1. Prevention and treatment of iron deficiency anaemia Tablet formulations: a. Ferrous fumarate 200 mg tablet (66 mg elemental iron per tablet) b. Zincofer  capsule (Ferrous fumarate salt providing 115 mg elemental iron per capsule) c. Iberet  Folic 500 tablet (Ferrous sulfate salt providing 105 mg elemental iron per tablet) d. New Obimin  tablet (Ferrous fumarate salt providing 30 mg elemental iron per tablet) e. Maltofer  (Iron (III) hydroxide polymaltose complex providing 100 mg elemental iron per tablet) Syrup formulations: a. Ferric ammonium citrate solution (providing 17.2 mg/ml elemental iron) b. Maltofer  syrup (Iron (III) hydroxide polymaltose complex providing 10 mg/ml elemental iron) To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Ferrous fumarate tablets should be taken on an empty stomach (1 hour before or 2 hours after meals) for better absorption. However , may take with meals to minimise gastrointestinal (GI) irritation. It can be crushed and administered via Ryle s tube. 2. Zincofer  capsule should be taken with meal. 3. Iberet  Folic to be swallowed whole with or without meals. Do not chew or crush as Iberet is formulated with a controlled-release vehicle. 4. Maltofer  may be chewed or swallowed whole during or immediately after meals. 5. New Obimin  tablet to be taken with/ without meal. May be taken with meals for better absorption or if GI discomfort occurs. Missed dose management: In case of a missed dose, take it immediately . Omit the dose if totally forgotten and remember to take as per instructed during the next dose. Do not stop taking your medication unless advised to do so by your prescriber 211",specialConsiderations:{pregnancy:".",breastfeeding:".",elderly:"Lower doses of iron may have similar clinical efficacy but with less gastrointestinal side effects compared to higher doses.",paediatric:"Dosage range: 3 - 6 mg elemental iron/kg/day . Milk and/or dairy products should be avoided for approximately one hour before and two hours after each dose because such products limit iron absorption.",fasting:") or Iftar (breakfast)."},sideEffects:["Gastrointestinal side effects e.g. metallic taste, nausea, vomiting, darkening of stools, constipation, stomach cramps.","Increase fluid and fibre intake to ease constipation. If constipation persists, the use of stool softeners or laxatives may be considered."],others:{storage:"1. Store in room temperature and dry place. 2. Keep out of reach of children. 3. Keep Maltofer tablets in original packaging in order to protect from light.",other_points:"No dosage adjustment necessary"}},{id:"counsel-069",name:"Isosorbide Dinitrate/ Isosorbide Mononitrate",pharmacologicalGroup:"Nitrate; Antianginal agent  Isosorbide dinitrate (ISDN)  Isosorbide mononitrate (ISMN)",indication:"1. Prophylaxis and treatment of angina pectoris a. Isosorbide dinitrate 5-20mg 2-3 times daily (up to 120mg per day). b. Isosorbide mononitrate 30 to 120mg daily (up to 240mg per day) 2. Heart failure a. Isosorbide dinitrate 20-40mg tds; trials were done in combination with hydralazine. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. ISDN & ISMN should be taken without food, preferably first thing in the morning, and same time everyday , as advised 2. Swallow controlled release tablets whole because if they are crushed or chewed they won't work properly . 3. In general, immediate release tablets may be cut or crushed. 4. Allow nitrate-free intervals of 10-12 hours to prevent development of tolerance. 5. Isosorbide dinitrate a. For twice daily dosing, consider administering at 8am and 1pm b. For 3-times-daily dosing, consider 8am, 1pm, and 6pm. 6. Isosorbide mononitrate, a. consider once daily dosing at the same time everyday . b. For twice daily dosing, consider administering at 8am and 1pm Missed dose management If you miss a dose of this medicine, take it as soon as possible. However , if it is almost time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not double doses. Do not stop taking your medi cation unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Use with caution if benefits outweigh risks.",breastfeeding:".",elderly:"with dysphagia or requiring enteral tube feeding. MALPIP 1. Increased risk of orthostatic hypotension. START/ST OPP criteria 1. Avoid use in patients with recurrent falls with persistent postural hypotension, due to increased risk of syncope and falls. 2. Aim to carefully reduce and discontinue these drugs in patients who have had no reported anginal symptoms in previous 12 months AND who have no proven or objective evidence of coronary artery disease.",paediatric:"The safety and effectiveness of isosorbide dinitrate in children has not been established.",fasting:"Not applicable"},sideEffects:["Report these symptoms to the physician: Severe headache, blurred vision, dizziness or flushing.","If affected, do not drive or operate machinery ."],others:{storage:"1. Store under room temperature. Protect from moisture.",other_points:"Drug-drug interactions: Avoid use with Phosphodiesterase-5 (PDE-5) inhibitors (e.g. avanafil, sildenafil, tadalafil, vardenafil) as it may cause severe hypotension."}},{id:"counsel-070",name:"Ivabradine",pharmacologicalGroup:"I f current inhibitors Other cardiac preparations Ivabradine",indication:"1. Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate  70 bpm a. Dosage adjustment based on resting heart rate: Initial: 5mg twice daily or 2.5mg twice daily (patients with history of conduction defects/hemodynamic compromise due to bradycardia) If heart rate > 60bpm: Increase dose by 2.5mg twice daily; maximum",dosage:"7.5mg twice daily. If heart rate 50 to 60 bpm: Maintain dose. If heart rate <50bpm or signs and symptoms of bradycardia: Decrease dose by 2.5mg twice daily; if current dose is 2.5mg twice daily, discontinue therapy . 2. Treatment of chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is  70 bpm a. Initial: 2.5mg to 5mg twice daily; titrate up in increments of 2.5mg after 3 to 4 weeks if symptoms persists and heart rate is >60 bpm; maximum dose: 7.5mg twice daily",methodOfAdministration:"Taken twice daily orally i.e. once in the morning and once in the evening with food Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". Animal studies data have shown embryotoxic and teratogenic effects.",breastfeeding:"Contraindicated during breast feeding. Animal studies indicate that Ivabradine is excreted in milk",elderly:"patients or those with concomitant conditions that lower heart rate.",paediatric:"Data available for use in 6 months old and older . 216",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Common side effects include:","Nervous system disorders: Headache (generally during first month of treatment), dizziness (related to bradycardia)","Eye disorders: Blurred vision","Cardiac disorders: Bradycardia, AV 1st degree block, Atrial fibrillation","Vascular disorders: Uncontrolled blood pressure"],others:{storage:"Store below 30 0 C",other_points:"1. Renal impairment  No dose adjustment is required in patients with renal insuf ficiency and creatinine clearance (CrCl) above 15 ml/min. No data are available in patients with CrCl less than 15 ml/min. Ivabradine should be therefore be used with precaution 2. Hepatic impairment  No dose adjustment is required in patients with mild hepatic impairment. Caution should be exercised when using Ivabradine in patients with moderate hepatic impairment. Ivabradine is contraindicated for use in patients with severe hepatic insuf ficiency , since it has not been studied in this population."}},{id:"counsel-071",name:"Ketoconazole / Selenium Sulfide Lotion/Shampoo",pharmacologicalGroup:"Imidazole Antimycotic and Topical Antifungal",indication:"A) Ketoconazole 2% Shampoo 1. Seborrhoeic dermatitis & dandruf f a) Apply twice weekly for 2 to 4 weeks. 2. Pityriasis versicolor a) Apply once daily for up to 5 days. 3. Prophylaxis a) Once every 1 or 2 weeks. B) Selenium Sulfide 2.5% Lotion/Shampoo 1. Dandruf f & seborrheic dermatitis of scalp a) Use twice weekly at first, then as necessary as directed by the physician. 2. Pityriasis versicolor a) Apply daily for 1 week, then apply 2-3 times per week.. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"A) Ketoconazole 2% Shampoo: Apply onto skin/hair and leave it for 3-5 minutes before rinsing. B) Selenium Sulfide 2.5% Lotion/Shampoo: i) Dandruf f & seborrheic dermatitis of scalp: Apply onto wet hair, lather and leave on scalp for 3 minutes. Rinse and repeat application, then rinse thoroughly . ii) Pityriasis versicolor: Apply to affected areas and lather with small amounts of water for 10-15 minutes, then rinse thoroughly . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". B) Selenium Sulfide 2.5% Lotion/Shampoo: Should only use it on the scalp, and not on the body to treat skin infections. Risks and benefits should be discussed with the doctor before use.",breastfeeding:"A) Ketoconazole 2% Shampoo: There are no adequate and well-controlled studies in lactating women. There are no known risks associated with its use in lactation. B) Selenium Sulfide 2.5% Lotion/Shampoo: It is not known whether or not this drug is secreted in human milk. Caution should be exercised when this product is administered to a nursing woman.",elderly:"None specifically to those products.",paediatric:"patients below age 5 have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Burning sensation and contact dermatitis may occur with all the above preparations."],others:{storage:"1. Store in a cool dry place below 30 degrees Celsius. 2. Protect from light and heat. 3. Keep out of reach of children.",other_points:"NA"}},{id:"counsel-072",name:"Lamivudine",pharmacologicalGroup:"Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)",indication:"HIV Infection in combination with other antiretroviral agents. a. Dosage for indication : ADUL T 150 mg BD or 300 mg OD. b. Dosage for indication Neonates and Children : > 32 weeks Gestation at Birth, Birth to age 4 weeks : 2 mg/kg BD. Age > 4 weeks and Child 3 months or over : 4mg/kg BD. (Maximum 300 mg daily)",dosage:"See indication for dosage details",methodOfAdministration:"1. May be administered without regard to meals. 2. Crushability: Not to be cut. For patients who are unable to swallow tablets, the tablet is crushed and added to a small amount of semi-solid or liquid and immediately consumed. Missed dose management 1. To take medication consistently at the same time everyday . Any missed dose to be taken as soon as possible. 2. For lamivudine prescribed twice daily dosing, if the gap is more than 6 hours, to skip and continue with a regular dosing schedule. Do not double the dose on the next administration time. 3. For lamivudine prescribed once daily dosing, if the gap is more than 12 hours, to skip and continue with the regular dosing schedule. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"has not been associated with adverse maternal, obstetric, or infant outcomes.",breastfeeding:"Lamivudine is detected in breastmilk. The lack of long-term safety data with long-term, low-level infant exposure should be discussed with the mother . 2. It is recommended that HIV infected women do not breastfeed their infants under any circumstances in order to avoid transmission of HIV.",elderly:"None specifically to Lamivudine.",paediatric:"Use extra caution during calculations to ensure accurate mg of 221 lamivudine administered.",fasting:"To be discussed with infectious disease consultant",hepaticImpairment:"Adult : No dosage adjustment necessary . However , it has not been studied in the setting of decompensated liver disease 2. Paediatrics : No dose adjustment is req uired. Safety and efficacy have not been established in patients with decompensated liver disease.",renalImpairment:"Dose adjustment required for CrCl (ml/min) : a) 30-49 : 150mg OD b) 15-29 : 1 x 150mg, then 100mg OD, or 150mg OD c) 15 : 1 x 150mg, then 50mg OD, or 75mg OD d) Haemodialysis : 1 x 50mg, then 25-50mg OD, or 75mg OD *Note - Intermittent HD or PD : No additional doses are required, negligible amounts are removed by 4 hour HD or PD."},sideEffects:["Minimal toxicity","Severe acute hepatitis flare may occur in HBV co-infected patients who discontinue lamivudine."],others:{storage:"1. Suggest to refer to product leaflet (in respect to brand purchased) 2. General recommendation is to store below 30C and protect from light & moisture.",other_points:""}},{id:"counsel-073",name:"Lamotrigine",pharmacologicalGroup:"Antiepileptic drugs/ Anticonvulsants drugs",indication:"1. Adjunct or monotherapy for partial seizure and generalised tonic clonic seizures a. up to 200 mg daily in single or divided dose 2. Prevention of mood episodes a. 25-200 mg daily Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. May be taken with or without food 2. Try to take lamotrigine at the same time each day Missed dose management (if applicable): 1. If you forget to take a dose, take it as soon as you remember . 2. Do not take two doses at once. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Possible risk but likely to be low",breastfeeding:"Passes in uncertain levels into breast milk, not known to cause harm to infant",elderly:"with history of falls or fractures ( unless used for seizure or mood disorders) and unless safer alternatives are not available, syncope , impaired psychomotor function, or ataxia may occur 2. Avoid concomitant use of 3 or more CNS active agents in any combination due to increased risk of falls.",paediatric:"To adhere strictly to recommended initial dose, titration schedules and adjustments to reduce the risk of severe reaction. 2. With valproic acid: The safety and efficacy of Lamotrigine in patients below age 2 have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Sleepiness, nausea and vomiting, general aches  including joint point and back ache, headache, tremor , dizziness, aggression or irritability , rash","It is recommended that people taking lamotrigine should avoid alcohol. This is because both can cause drowsiness and if the two are taken together , severe drowsiness can result."],others:{storage:"1. Store lamotrigine as directed by the manufacturers information, it does not usually require any special storage conditions.",other_points:"1. Hepatic: Doses should generally be reduced by 50% in moderate impairment and by 75% in severe hepatic impairment 2. Renal: In end-stage renal failure, initial doses of lamotrigine should be based on patients' concomitant medicinal products; reduced maintenance doses may be effective in significant renal impairment"}},{id:"counsel-074",name:"Lanthanum Carbonate",pharmacologicalGroup:"Drugs for treatment of hyperkalemia and hyperphosphatemia Lanthanum carbonate",indication:"1. Phosphate binding agent for the treatment of hyperphosphataemia in dialysis patients with sustained hypercalcaemia of more than three months and secondary hyperparathyroidism a. Initial: 750 to 1500 mg/day in divided doses with meals, then titrate in increments of 750 mg/day at intervals of 2 to 3 weeks. b. Maintenance: 1500-3000 mg/day in divided doses. Max: 3750 g/day To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. To chew / crush and take WITH meals / snacks or IMMEDIA TELY after meals. 2. Do not swallow intact tablets. 3. Consider crushing tablets completely for patients with poor dentition. Missed dose management: In case of a missed dose, take it during the meal or immediately after the meal. Omit the dose if totally forgotten and remember to take as per instructed during the next meal. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Not recommended (Lanthanum may cross the placenta)",breastfeeding:"There is no data on the presence of lanthanum carbonate in human milk, the effects on the breastfed infant, or the effects on milk production.",elderly:"NA",paediatric:"Not recommended",fasting:") and Iftar (breaking fast). 2. If more than two doses have been prescribed, consult with the healthcare provider to adjust your phosphate binder administration."},sideEffects:["Significant: a. Gastrointestinal: nausea, vomiting, abdominal pain, constipation, dyspepsia. ,metallic taste","Others: a. Endocrine: hyperparathyroidism, hyperglycemia b. Dermatologic: alopecia, sweating c. Musculoskeletal: bone deposition, myalgia, arthralgia, osteoporosis Advise patients to chew or crush the tablet completely to reduce the risk of serious adverse gastrointestinal events."],others:{storage:"1. Store at room temperature. 2. Store in a dry place and protect from moisture. 3. Keep out of reach of children.",other_points:"225 NA"}},{id:"counsel-075",name:"Levofloxacin",pharmacologicalGroup:"Fluoroquinolone",indication:"Secondary-line leprosy treatment",dosage:"500mg daily f or 6-18 months (in combination with other anti-leprosy agents)",methodOfAdministration:"Food: Can be administered with or without food. Should not be administered by mouth within 2 hours of ingestion of milk-based products, antacids, or other medications containing divalent cations (iron, magnesium, calcium, zinc, vitamins, didanosine, sucralfate). RT administration: 1. Tablets do not disperse readily in water . 2. The tablet can be crushed, but the flaky coating makes crushing difficult. It takes a few minutes for the coating to dissolve when mixed with water . 3. Use an 8Fr NG tube to ease administration/minimize blockage. Suggestion: 1. As the tablets do not disperse readily in water , consider changing to an alternative antibiotic available in a liquid or dispersible tablet formulation. 2. When continued therapy with oral levofloxacin is essential use the extemporaneous preparation; consider using the higher end of the dose range. 3. Stop feed 1 hour before dose and restart feed 2 hours after dose Missed dose: Administer as soon as possible if 8 hours until next scheduled dose; otherwise, wait until next scheduled dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". 227",breastfeeding:"Based on data on other fluoroquinolones and very limited data on levofloxacin it can be presumed that levofloxacin will be excreted in human milk. Because of the potential for serious adverse reactions from levofloxacin in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother",elderly:"Geriatric patients are at increased risk for developing severe tendon disorders including tendon rupture when being treated with a fluoroquinolone. This risk is further increased in patients receiving concomitant corticosteroid therapy",paediatric:"Quinolones, including levofloxacin, cause arthropathy and osteochondrosis in juvenile animals of several species.",fasting:"N/A To refer to the latest advisory by religious authority"},sideEffects:["Tendon Effects","Hypersensitivity reactions","Hepatotoxicity","Central nervous system effects","Clostridium difficile-associated diarrhea","Peripheral neuropathy","Prolongation of the QT interval","Blood glucose dDisturbances","Photosensitivity / Phototoxicity"],others:{storage:"Store at room temperature (do not refrigerate) and protect from light. 228",other_points:": 1. Renal impairment (If usual recommended dose is 500mg daily) - CrCl 50ml/min: no dosage adjustment - CrCl 20 - <50ml/min: 500mg initial dose, then 250mg daily - CrCl <20ml/min: 500mg initial dose, then 250mg every 48H - HD, intermittent (3x/week) / PD: 500mg initial dose, then 250mg every 48H or 125mg daily - Administer dose after HD after on dialysis days - CRR T: 500mg initial dose, then 250mg daily or 500mg 48H - PIRR T: 500mg initial dose, then 250mg daily (after PIRR T treatment when possible) - Moxifloxacin may be preferred in renal failure 2. Liver impairment The pharmacokinetics of levofloxacin are not expected to be affected by hepatic impairment. 3. Obesity Patients with BMI 40kg/m2 and CrCl >110ml/min; consider use TDM (if available) or alternative treatment options"}},{id:"counsel-076",name:"Lignocaine (Lidocaine), Medicated Plaster",pharmacologicalGroup:"Local Anaesthetic, Topical",indication:"Symptomatic relief of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN) a. 1 plaster once daily. Cover the painful area for up to 12 hours within a 24-hour period. Not more than 3 plasters should be applied at the same time. b. Renal impairment: No special dose adjustments necessary in patients with renal impairment. c. Hepatic impairment: No special dose adjustments necessary in patients with hepatic impairment. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Step 1: Preparing the skin a. The plaster must be applied to the most painful area. The area must be intact, dry, non-irritated skin. Step 2: Cut the plaster a. The plaster may be cut into smaller sizes with scissors prior to removal of the release liner. Step 3: Apply the plaster a. The plaster must be applied to the skin immediately after removal from the sachet and following removal of the release liner from the gel surface. b. Leave the plaster on for 12 hours only. c. If your pain is worse during the day, apply the plaster in the morning and remove it after 12 hours in the evening. Step 4: Disposing of the plaster a. To remove previous plaster , use your finger to peel off slowly . Fold the plaster into half and press firmly to seal it shut. Discard properly . b. Remove immediately if a burning sensation occurs. Missed dose management: a. Apply a new plaster as soon as you remember b. Do not apply twice the number of plasters to make up for the plaster that you missed. c. This will increase the chance of you getting unwanted side-ef fects Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"unless clearly necessary .",breastfeeding:"Lignocaine is excreted in breast milk. However , there 230 are no studies of the plaster in breast-feeding women. The metabolism of lidocaine occurs relatively fast and almost in the liver, only very low levels of lidocaine to be excreted into human milk.",paediatric:"patients below 18 years old have not been established."},sideEffects:["Rash, skin irritation, burning, dermatitis erythema, pruritus."],others:{storage:"1. Store your medication in a cool, dry place (below 30C) away from heat, moisture and direct sunlight 2. After first opening, keep the sachet tightly closed. The plaster contains water and will dry out if the sachet is not closed properly .",other_points:"1. The plaster should be used caution in patients with severe cardiac impairment, severe renal impairment or severe hepatic impairment"}},{id:"counsel-077",name:"Lithium",pharmacologicalGroup:"Mood stabiliser",indication:"a. Prophylaxis and treatment of acute mania b. Prophylaxis and treatment of acute hypomania c. Prophylaxis of manic depression in bipolar illness or bipolar depression and recurrent depression 2.",dosage:"a. Acute Mania: 600 - 1800 mg/day in divided dose. (Therapeutic range: 0.8 to 1.2 mEq/L (SI: 0.8 to 1.2 mmol/L) b. Usual Maintenance dose: 300 - 1800 mg/day . May be given as a single dose at night. (Therapeutic range 0.8 to 1 mEq/L (SI: 0.6 to 1 mmol/L) 3. Blood levels can be drawn to make sure you are in the right range to get the most benefit with the least side effects.Encourage patients to learn their own blood levels. a. Blood sampling should be done 5 - 7 days after initiation or after a dose/formulation change or after introduction of interacting medication, & weekly until levels are stable. b. A 12-hour trough level is preferred, but in some circumstances it may be drawn 8 to12 hours post dose (I,e, TDS dose). Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Administration instruction a. Take each dose at the same time every day with water or a cool drink b. This medication can be taken with or without food. 2. Missed dose management: a. Take the missed dose as soon as you remember . If its nearly time for your next dose, skip the missed one and take only the next dose. Do not take two doses at once. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Inform your doctors if you are planning to become pregnant 2. Seek immediate medical advice if you become pregnant while taking Lithium",breastfeeding:"should be avoided during maternal use of lithium",elderly:"patients secondary to age-related decreases in renal function. Monitor closely for emergence of adverse reactions or toxicity  Beers Criteria: Avoid using with ACEi, ARB, ARNI, Loop diuretics. Interaction with the listed class of drug increased risk of toxicity . Monitor lithium concentration.  STOPP/Start Criteria: Monitor ECG in view of predictably for prolonged QTc interval  MALPIP: May affect cognitive function, cause hypothyroidism, impair renal functions.",paediatric:"The safety and efficacy of Lithium for the treatment of acute manic and mixed episodes in bipolar disorder have not been established in patients younger than 7 years of age. 2. The safety and efficacy of sustained -release (SR) Lithium for the treatment of acute manic and mixed episodes in bipolar disorder have not been established in patients younger than 12 years of age.",fasting:"Administer during Sahur or after Iftar. Kindly refer to the latest advisory by religious authority Pre-Operative Inform your prescriber if you're planned for surgery Lithium should be withheld 24 hours before minor surgery and up to 72 hours prior to major surgery .",hepaticImpairment:"No dose adjustment",renalImpairment:"Mild to moderate (30  89 ml/min) : Initiate lower doses and titrate more slowly . 2. Use is not recommended when CrCl is less than 30 ml/min."},sideEffects:["Possible side effects a. Dry mouth and / or metallic taste, sedation, mild diarrhoea, mild shaking or tremor of your hands, thirst, Gastrointestinal discomforts (e.g. nausea), weight gain, low thyroid activity (tiredness, easily feel cold), excessive thirst and frequent urination","Signs and symptoms of toxicity (when there is too much lithium in your body) a. Severe hand shakes (tremor), blurred vision, being unsteady on your feet, clumsiness, confusion, feeling unusually sleepy , difficulty 233 in speaking or slurring of words, muscle twitches or weakness, stomach-ache along with feeling sick and having diarrhoea","Dietary and lifestyle considerations to ensure stable blood medication levels a. Adequate hydration (2 - 3 L of water everyday) b. Keep salt intake about the same (avoid drastic changes in salt intake) c. Avoid alcohol if possible OR avoid alcohol in the first month or two, then drink in moderation i.e. up to 1 - 2 drinks 3 times a week d. Avoid excessive use and keep caffeine intake (e.g. coffee, tea, cola, other soft drinks) about the same e. Seek doctor s review if you fall sick (e.g. fever , sore throat, flu-like symptoms) or have diarrhoea more than a day"],others:{storage:"Store at a temperature below 30C.",other_points:"Drug-drug interactions 1. Always inform your other doctor , pharmacist or healthcare professional that you are taking lithium 2. Should not be taken with NSAIDs, diuretics, ACE-Inhibitors, SLGT2 inhibitors, sodium-containing antacids (seek medical advice first)"}},{id:"counsel-078",name:"Loop Diuretics",pharmacologicalGroup:"Loop Diuretics : Furosemide Bumetanide",indication:"Indications: Signs and symptoms of congestion 1. Furosemide: Initial daily",dosage:"20-40mg od/bd Usual daily dose: 20-40mg od/bd 2. Bumetanide Initial daily dose: 0.5-1mg od/bd Usual daily dose: 0.5-1mg od/bd To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. May administer with or without food. 2. Preferably to take in day time to avoid frequent urination at sleep time. Do not stop taking your medication unless advised to do so by your prescriber Self Dosage Adjustment (in selected patient) 1. If there is a consistent increase in weight of > 2kg in 3 days, selected patients can be taught to self-adjust the dose of furosemide. (eg. additional dose of furosemide 20-40mg/day / bumetanide 0.5-1mg/day) 2. Once dry weight is achieved, change furosemide dose to baseline. 3. If there is no response to the increased furosemide dose after 3 days (or earlier if condition deteriorates), seek medical attention immediately . 4. Dose may need to be decreased if there is fluid loss (e.g. due to diarrhoea/vomiting, excessive sweating).",specialConsiderations:{pregnancy:"is associated with adverse maternal and fetal outcomes. Furosemide may be used for symptoms management in pregnant patients with HF 2. Closely monitor volume status and adjust dose to minimize risk of placenta hypoperfusion",breastfeeding:"Furosemide is present in breast milk. 2. Large doses of loop diuretics have the potential to decrease milk volume and suppress lactation; When used for the treatment of heart failure, furosemide may be considered with close neonatal monitoring (AHA/ACC/HFSA [Heidenreich 2022]).",elderly:"Refer to adult dosing. Consider lower initial doses and titrate to response. 2. STOPP/ST ART Criteria: Increase risk of falls, urinary incontinence, acute 235 kidney injury , electrolyte imbalances. Should not be used as first-line agent",paediatric:"Consider lower initial doses and titrate to response.",renalImpairment:"eGFR 30 mL/minute/1.73 m2: No dosage adjustment necessary . 2. eGFR <30 mL/minute/1.73 m2: Higher doses may be required to achieve desired diuretic response due to decreased secretion into the tubular fluid. 3. ESRF- Anuric patients: There is no expected clinical benefit; use not recommended. Liver impairment Diminished natriuretic effect with increased sensitivity to hypokalemia and volume depletion in cirrhosis. Monitor effects, particularly with high doses."},sideEffects:["Asymptomatic low blood pressure a. Dose may be reduced if there are no symptoms or signs of congestion.","Symptomatic hypotension a. Dizziness/light-headedness; reduce dose if no signs/symptoms of congestion. b. Review medications and reconsider the need for nitrates, CCBs and other vasodilators.","Hypokalaemia/hypomagnesaemia a. Increase an ACE-I/ARB dose b. Add an MRA, K+ supplements; magnesium supplements","Hyponatraemia (<135 mmol/L) a. If volume depleted:  Stop thiazide  Reduce dose/stop loop diuretics if possible b. If volume overloaded: (seek specialist advice- patient might need IV diuretic)  Fluid restriction  Consider increasing dose of loop diuretic  Consider AVP antagonist (e.g. tolvaptan if available)","Hypovolaemia / dehydration a. Assess volume status; consider a diuretic dosage reduction","Hyperuricaemia / gout a. For gouty flares use colchicine for pain relief. b. Avoid NSAIDs. c. Consider allopurinol prophylaxis (not initiated during acute exacerbation)","Insuf ficient diuretic response/diuretic resistance a. Check adherence and fluid/salt intake. b. Increase dose of diuretic / consider switching from furosemide to bumetanide c. Add an MRA/increase dose of an MRA. d. Combine loop diuretic and thiazide/metolazone. e. Administer loop diuretic twice (or more times) daily or on empty stomach","Worsening of renal function a. Check for hypovolaemia/dehydration. b. If using concomitant loop and thiazide 236 diuretic, stop thiazide diuretic. c. Avoid nephrotoxic agents, e.g. NSAIDs, trimethoprim. d. Withhold an MRA. e. Consider reducing a dose of ACE-I/ARB."],others:{storage:"1. Store at room temperature protected from light. Store in a dry place. 2. Keep all drugs in a safe place. Keep all drugs out of the reach of children. 3. Throw away unused or expired drugs.",other_points:"Monitoring Parameters a. Renal function b. Fluid status - Fluid input and output ] c. Serum electrolyte - Sodium, potassium, magnesium d. Blood pressure e. Body weight Drug-drug Interactions Nonsteroidal Anti-Inflammatory Agents: May diminish the therapeutic effect of Loop Diuretics. Loop Diuretics may enhance the nephrotoxic effect of Nonsteroidal Anti-Inflammatory Agents."}},{id:"counsel-079",name:"Lopinavir/Ritonavir",pharmacologicalGroup:"Antiretroviral: Protease Inhibitor (PI)",indication:"Second line treatment of HIV-1 infected patients, in combination with other antiretroviral medicinal products. a. Adults: Therapy-naive patients: 400/100mg BD or 800/200mg once daily (with no prior PI used) Therapy-experience patients: 400/100mg BD. b. Children (> 6 months): Oral tablet: 15-25kg or > 0.6 -<0.9m2: 200mg/50mg BD 25-35kg or > 0.9 -<1.4m2: 300mg/50mg BD >35kg or > 1.4m2: 400mg/100mg BD Oral solution (based on LPV component): 7-14kg: 12mg/kg BD 15-40kg: 10mg/kg BD > 40kg: 400mg BD c. Infants (14 days - 6 months) 300mg/75mg LPV/r per m2 BD or 16mg/4mg LPV/r per kg BD",dosage:"See indication for dosage details",methodOfAdministration:"Lopinavir/Ritonavir solution: To be taken with food. Lopinavir/Ritonavir tablets: May be taken with or without food. The tablets should be swallowed whole and not chewed, crushed or broken. Use of Oral solution with feeding tube: Lopinavir/Ritonavir oral solution can be administered via feeding tube. Missed dose management 1. Patients should take Lopinavir/Ritonavir as soon as they remember it. However , if it is almost time for the next dose, the patient should skip the missed dose and simply resume the normal dosing schedule. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"if clinically indicated.",breastfeeding:"Lopinavir/Ritonavir are present in breast milk. Because of both the potential for HIV transmission and the potential for serious adverse reactions in nursing infants, mothers should be instructed not to breastfeed if they are receiving Lopinavir/Ritonavir . 238",elderly:"which may include hepatic, renal and cardiac function.",paediatric:"The safety and efficacy of Lopinavir/Ritonavir in premature neonates below the age of 14 days have not been established. 2. Reserve when benefits outweigh risks and no alternatives are available.",fasting:"To discuss with ID Consultant as it would be based on the patient's latest viral load status."},sideEffects:["Commonly reported adverse reactions to Lopinavir/Ritonavir included diarrhea, nausea, vomiting, hypertriglyceridemia and hypercholesterolemia.","Diarrhea, nausea and vomiting may occur at the beginning of the treatment."],others:{storage:"1. Lopinavir/Ritonavir solution: (2-8  ) until dispensed. Avoid exposure to excessive heat. Refrigeration is not required if used within 2 months and stored below 25  . 2. Lopinavir/Ritonavir tablets: store tablets at or below 30  .",other_points:"1. Hepatic impairment: No data are available in patients with severe hepatic impairment (Child-Pugh Grade C). Use with caution in these patients. 2. Renal Impairment: Lopinavir pharmacokinetics have not been studied in patients with renal insuf ficiency . However , since renal clearance of lopinavir is negligible, a decrease in total body clearance is not expected in patients with renal insuf ficiency"}},{id:"counsel-080",name:"Methadone",pharmacologicalGroup:"Full opioid agonist 1. Synthetic opioid that acts as a full agonist at the - opioid receptor and other opioid receptors. 2. These - opioid receptors are located in different parts of the central nervous system (CNS), such as the brainstem, locus coeruleus, periaqueductal gray matter , and various parts of the gastrointestinal tract. 3. These receptors are crucial in modulating various neurochemical activities linked to analgesia, euphoria, and sedation. 4. It induces receptor internalization and recycling, contributing to reduced opioid tolerance in patients. 5. It occupies and activates these opioid receptors, it does so more slowly than other opioids in an opioid-dependent person. 6. Treatment doses do not produce euphoria. Brief pharmacokinetic of Methadone 1. Onset: 30 minutes 2. Peak effects: ~ 3 hours 3. Half-life: 24-36 hours 4. Time to reach steady state: 3-10 days 5. Absorption (PO): 30 minutes 6. Metabolized in the liver by the cytochrome P450 system through N-demethylation and cyclization. Susceptible to interactions with other drugs by speeding up or slowing down its breakdown",indication:"Detoxification treatment or maintenance treatment of narcotic addiction. Dosage Initial 10-20mg per day, increasing by 10 - 20mg per day until there are no signs of withdrawal or intoxication. Usual therapeutic dose 40 - 60mg per day Therapeutic dose in opioid dependence is determined by methadone ability to prevent cravings, prevent withdrawal symptoms, and prevent relapse without inducing euphoria or sedation. Induction Dosage Initial: 10 - 20mg per day Maximum induction",dosage:"40mg per day Reevaluation is advised within 2 to 4 hours, once peak levels have been attained. The timing of reassessment should not impede the initiation of methadone Supplementary dose of 5mg can be given on the same day after induction dose (not counted as total therapeutic dose) Titration Dosage: Increase 5 - 10mg every 3 days Maximum increment: 20mg per week Maintenance Dosage Usual maintenance dose: 40 - 60mg per day But some patient may require higher doses (80 - 100mg per day) 241 In certain cases, dosages exceeding 120mg per day may be cautiously considered, especially for patients misusing highly potent opioids such as fentanyl and other synthetic opioids Due to methadone's extended half-life, caution is essential to prevent rapid dose escalation within the initial 1 to 3 weeks of therapy . Patients should be informed that experiencing discomfort is expected during the initial days of methadone titration. Detoxification: In general, methadone treatment is a long-term treatment, similar to other chronic conditions. However , for patients who wish to discontinue treatment, they should be referred to a doctor for appropriate assessment and intervention. i. The reduction of the methadone dose should be discussed with the patient. It is advisable for the patient to gradually reduce the dose over a long period until they feel comfortable with the tapering regimen to ensure that the withdrawal process can be safely managed. ii. It is recommended to reduce the methadone dose by 10 mg per week until reaching 40 mg per day, and then by 5 mg per week thereafter , and should only be done once a week. Contraindication Methadone is contraindicated in individuals with:  Severe respiratory depression or asthma. Methadone can further depress breathing, increasing the risk of respiratory arrest or death  Recent use of MAO inhibitors (e.g., Selegiline) within the last 14 days. Combining methadone with MAOIs can cause serious, potentially fatal interactions, such as serotonin syndrome  Paralytic ileus due to the risk of intestinal obstruction and gastrointestinal (GI) complications or severe liver disease (e.g., cirrhosis or liver failure) due to the risk of increased methadone levels and toxicity .  Severe CNS depression, including head injuries or coma.  Significant hypersensitivity to methadone. It is essential that methadone use be carefully monitored especially for individuals with any of the above conditions, to avoid serious side effects, including overdose, respiratory depression, and death.",methodOfAdministration:"Once daily (OD) dispensing in low-concentration liquid form via Direct-Observation Therapy (DOT) and Take Away (TA) doses per orally (PO) Direct-Observation Therapy (DOT) 1. Methadone has to be diluted until 30ml or more and must be swallowed completely . 2. Appropriate measures must be in place to ensure methadone is swallowed completely and reduce any risk of diversion such as by a. Directly observe the patient while they take their dose of methadone b. Drink the remaining methadone dose by rinsing the container c. Encourage patient to speak after swallowing methadone 242 Takeaway (TA) dose 1. Methadone dose should be diluted as follows or as according to latest guideline: a. For a methadone dose  25 mg, dilute to 30 ml. b. For a methadone dose > 25 mg, dilute to 50 ml or more. 2. Hand over TA doses to the patient. In situations where the patient is accompanied by a guardian, it is recommended that TA doses be handed over to the guardian. Ideally to be taken in the morning and after meal In specific cases, total daily dose can be divided into BD dose. Dosing interval for BD dose is not restricted to 12 hours interval Takeaway and divided doses should be supplied in Unit of Dose (UoD) in a separate labelled container Missed dose management Take full dose immediately as soon as patient remember within the same day  1-2 days missed dose: Maintain same dose  3 days missed dose: Half of total dose and discuss with prescriber  4 days missed dose: Discuss with prescriber before dispensing  5 days and more missed dose: Reinitiation with induction dose Do not inject methadone dose Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"FDA Category: C",breastfeeding:"Methadone can be excreted through human milk 2. Therefore, patient is advised to breastfeed their infant to prevent Neonatal Abstinence Syndrome (NAS) 3. Abrupt weaning of breastfed infants of women on methadone might result in precipitation of or an increase in infant withdrawal symptoms, and gradual weaning is advised 4. Methadone patient with HIV is not advised to breastfeed and infant to be monitored for Neonatal Abstinence Syndrome (NAS)",elderly:"If methadone is deemed necessary for opioid dependence management, it should be done under strict medical supervision, with dose adjustments based on the individual s age, renal function, hepatic function, and concomitant medications (Refer Beers Criteria) Beers Criteria: 243 a. Avoid in patients with or at high risk for delirium, as may induce or worsen delirium. b. Avoid in patients with a history of fractures or falls (excludes pain management for severe acute pain) as ataxia, syncope, impaired psycho-motor function or additional falls may occur . c. Avoid concomitant use of 3 or more CNS active agents in any combination due to increased risk of falls",paediatric:"patients under 18 years old have not been established in d etoxification or maintenance treatment of narcotic addiction.",fasting:"Patient is advised to drink during pre-dawn meal (sahur)"},sideEffects:["Drowsiness","Cause: overdose, concomitant substance use (benzodiazepine, alcohol, CNS depressants)","Plan: a. Inform your doctor or pharmacist. b. Avoid driving a vehicle or operating machinery for at least the first two weeks Nausea, vomiting and loss of appetite","Cause: methadone syrup","Plan: Avoid taking on an empty stomach Craving towards heroin","Cause: insuf ficient dose","Plan: Inform your doctor or pharmacist Increase in body weight","Cause: water retention in body","Plan:  Inform your doctor or pharmacist for dose review  Healthy lifestyle & diet adjustment Constipation","Cause: methadone syrup, unhealthy diet & lifestyle","Plan:  Inform your doctor or pharmacist for dose 244 review  Healthy lifestyle & diet adjustment  Medication for constipation Insomnia","Cause: underdose or overdose, time of methadone consumption, concomitant substance use (stimulants)","Plan:  Adjust methadone dose and time of methadone consumption  Sleep hygiene  Identify & advise on concomitant substance use Dental issues","Cause: methadone syrup reduces saliva production, inappropriate dental care","Plan: increase awareness of oral hygiene Decrease in libido & sexual function","Cause: high methadone dose, psychological & personal issues","Plan:  Discuss with doctor or pharmacist for dose review  Seek advice from counselor Lethargy","Cause: environmental factor , overdose","Plan:  Discuss with doctor or pharmacist  Enough rest Excess perspiration","Cause: overdose","Plan:  Wear clothing that is not too thick  Discuss with doctor or pharmacist Bruised and itchy skin","Cause: methadone syrup","Plan: Inform your doctor or pharmacist Tachycardia / Bradycardia","Cause: overdose","Plan: Seek medical treatment Breathing difficulties","Cause: overdose","Plan: Seek medical treatment"],others:{storage:"Methadone syrup that is taken home must be stored: 1. In a safe place (in a high, locked cabinet or drawer) and out of reach of children. 2. At room temperature (in a dry place and not hot), and not in the refrigerator . 3. Do not store with other food or medications 4. Avoid exposure to sunlight 5. Use a sling bag or pouch to store the newly obtained takeaway doses temporarily 6. Do not transfer takeaway doses into unlabelled containers as it could cause confusion 245",other_points:"Hepatic Impairment Close dose monitoring required for patient with hepatic impairment Vomited dose 1. If a patient vomits the given dose:  Less than 15 minutes after taking the dose: replace the full dose  Between 15 minutes to 30 minutes after taking the dose: replace 50% of the dose  If vomiting occurs more than 30 minutes after taking the dose: no replacement dose"}},{id:"counsel-081",name:"Methoxy Polyethylene-glycol Epoetin Beta",pharmacologicalGroup:"Other antianemic preparations methoxy polyethylene glycol-epoetin beta",indication:"1. Treatment of anaemia associated with chronic kidney failure.Patients who require higher doses of erythropoietin if it is more cost saving to use a long-acting agent instead of short-acting agents. a.CKD ON dialysis: IV/SC: 0.6 mcg/kg once every 2 weeks b.CKD NOT on dialysis: SC: 0.6 mcg/kg once every 2 weeks or 1.2 mcg/kg once monthly Dosing is according to product insert To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Route of Administration: Intravenous (IV) or Subcutaneous (SC) Site of administration for SC: Lower part of abdomen, thigh or arm Injection technique for SC (for self-administered): 1. Take one syringe out of the package and check that the solution is clear , colourless and free from visible particles . 2. Allow the syringe to reach room temperature. 3. Wash your hands. 4. Holding the syringe by the middle of the body without touching the release clip to avoid premature release of the safety device. 5. Remove the rubber tip cap from the syringe (bend and pull). 6. Break the seal of the needle, using a twisting motion, and remove the needle cap. Do not remove the needle shield that protects the needle. 7. Attach the needle to the syringe by pushing it firmly on the syringe by twisting it. Pull off the needle shield and throw it away . 8. Hold the syringe with the needle pointing up and tap the syringe gently to bring any bubble to the top. Push the plunger up slowly to remove the air. 9. Clean the skin at the site of injection using an alcohol swab. 10. Pinch a fold of loose skin at the clean injection site. 11. Fully insert the needle 90 0 angle into the skin in a quick, dart-like  motion. Once the neddle is inserted, release the pinch. 12. Slowly push the plunger until all the medicine is injected. The plunger rod should be fully pushed down until hear a click indicating the activation of the needle guard. Do not release the plunger before the end of injection. 13. Take the needle out of the skin without releasing the plunger . 250 14. Once the needle is fully out, release the plunger to activate the needle guard. 15. Dispose the empty syringe in a special waste container . 16. Tear off the medication label on the syringe and stick into the booklet/diary (e.g., CAPD book) after the injection for the administration record, if available. Consideration: 1. Blood pressure (BP) cutof f for administering Erythropoietin Stimulating Agent (ESA) is individualised. Generally , ESA is not given if BP exceeds 160/100 mmHg. Patients need to be informed about their specific BP cutof f whether to continue or hold ESA at home. 2. The site of SC injection should be rotated if necessary . Missed dose management: The missed dose should be administered as soon as possible and administration of MIRCERA is to be restarted at the prescribed dosing frequency .. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"No adequate data on the use of MIRCERA in pregnant women",breastfeeding:"Unknown",elderly:"patient should be cautious, usually starting at the low end of the dosing range",paediatric:"MIRCERA can be used in children from 3 months to 17 years old if the patient's hemoglobin is already stabilized on either epoetin or darbepoetin.",fasting:"Administer MIRCERA as usual"},sideEffects:["Common side effects, generally not serious: Headache, increased blood pressure, irritation or pain at the injection site.","Note:  To advise patients on the importance of compliance with antihypertensive medications and dietary restrictions for BP control."," If side effects persist, please consult a healthcare professional Uncommon/rare: 251 Pure red cell aplasia (PRCA).."],others:{storage:"1. Transport of ESA is only allowed in cool box with ice packs. 2. Preferably to return home immediately after getting ESA from the pharmacy to facilitate fast storage. 3. ESA is very sensitive to light and temperature. 4. Protect ESA from light 5. Store ESA in the refrigerator , do not freeze. Keep at 2-8C. 6. Avoid fridge doors, and vegetable compartments. Ensure there is proper air circulation around your ESA. 7. If you're travelling, try to keep your medication in a cooler with ice packs, and avoid storing it in any place where it might get too hot, like in a car. Do not take out the ESA from the fridge unless it is time for use. If the ESA is accidentally left outside the fridge, it should be used as soon as possible to prevent damage. Below is the expiry period following a break in the cold chain: Product Expiry period after break of cold chain Mircera 30 Days Handling of disposal:  Needles and syringes should never be reused.  Place all used needles and syringes into a sharps container (puncture-proof disposable container).  Keep the sharp container out of the reach of children.  Avoid disposing of used sharps containers in household waste.  Dispose of full sharps containers according to local regulations or at designated facilities.",other_points:"No dosage adjustment was provided in the manufacturer s labelling."}},{id:"counsel-082",name:"Miconazole, Topical",pharmacologicalGroup:"Antifungals for dermatological use.",indication:"Miconazole cream used for the treatment of fungal skin infections, including: 1. Cutaneous candidiasis: 2. Tinea infections a. Tinea pedis (athlete's foot) b. Tinea capitis (scalp ringworm) c. Tinea corporis (ringworm of the body) d. Other dermatophyte infections caused by Trichophyton and Epidermophyton species. Apply a thin layer of cream to the affected area twice daily. Treatment usually lasts 2 to 6 weeks, depending on the localization and severity of the infection.",dosage:"See indication for dosage details",methodOfAdministration:"1. Clean and dry the affected area before applying the cream. 2. Apply a thin layer to the affected skin and surrounding area. 3. Gently rub the cream into the skin until absorbed. Do not stop using your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". Most studies have shown that miconazole at low doses (<400 mg/day) does not increase the chance of birth defects.",breastfeeding:"It is not known if miconazole is present in breast milk. Use with caution.",elderly:"Patients who use topical oils, creams, and ointments have potential fall risk .Patients may be advised to wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces.",paediatric:"patients age below 2 have not been established. 257",fasting:". To refer to the latest advisory by religious authority ."},sideEffects:["Allergic contact dermatitis, burning sensation of skin and maceration of skin.","Discontinue if sensitivity or irritation occurs."],others:{storage:"Store between 20 - 25  . Protect from light.",other_points:"N/A"}},{id:"counsel-083",name:"Minocycline",pharmacologicalGroup:"Tetracycline",indication:"Second-line leprosy treatment/drug-resistant leprosy",dosage:"100mg daily for 6-18 months (in combination with other anti-leprosy agents)",methodOfAdministration:"Oral : 1. Take at the same time each day. 2. To be taken with or without food. 3. Pellet-filled capsule should be taken on an empty stomach 4. May be taken with food to reduce GI discomfort. 5. Swallow whole. Take with a full glass of water or a small amount of food. This is to avoid oesophageal irritation and ulceration. 6. Food and/or milk products may decrease the rate and extent of oral absorption. 7. Avoid products containing iron, aluminium, calcium or magnesium at least 2 hours before/after administration. 8. Avoid alcohol Missed dose : 1. Take a missed dose as soon as remembered, however , if near to the next dose, skip the dose and continue with the usual dosing time. Do not double the dose or take extra doses. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". 3. Causes permanent tooth staining in the fetus and is more likely to occur following long-term exposure or repeated exposure.",breastfeeding:"patients. 5. Use alternatives if possible.",elderly:", however need to be done cautiously , taking into consideration the declining in hepatic and renal function as well as the use of other medications.",paediatric:"Contraindicated for patients under 12 years old. 2. Safety and effectiveness for those below 12 years old have not been established 3. Contraindicated in neonates and those below 8 years old due to teeth staining and potentially suppresses bone growth",fasting:"N/A To refer to the latest advisory by religious authority"},sideEffects:["Headache","Nausea and vomiting","Stomach pain","Indigestion","Difficulty swallowing","Joint pain and stiffness","Swollen tongue","Nail discolouration Minocycline can cause abnormal blood test results."],others:{storage:"1. Keep in original packaging 2. Store below 30C",other_points:"Renal impairment 1. No dosage adjustment Hepatic impairment 1. Hepatotoxicity has been reported. Use with caution."}},{id:"counsel-084",name:"Mirtazapine",pharmacologicalGroup:"Noradrenaline and Specific Serotonergic Agent (NaSSA)",indication:"1. Major Depressive Disorder a. Initial 15 mg daily at bedtime, increase based on response and tolerability to max 45mg daily as single dose at bedtime or in 2 divided dose Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Orodispersible Tablet: a. In order to prevent crushing the tablet, do not push against the tablet pocket. b. Each strip contains six tablet pockets, which are separated by perforations. Tear off one tablet pocket along the dotted lines. c. Carefully peel off the lidding foil, starting in the corner indicated by the arrow . d. The tablet should be taken out of the strip with dry hands and should be placed on the tongue. The tablet will rapidly disintegrate and can be swallowed without water . 2. Tablet: Swallow the tablets with some fluid Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"or become pregnant while taking this medication.",breastfeeding:"or drugs may need to be discontinued.",elderly:"Use with caution and dose conservatively by starting at the low end of range To be aware of hypersomnolence (sleepiness) adverse effects especially during the initiation period. To advise on fall precautions. Mirtazapine is also associated with increased appetite & weight gain. Suggest for routine monitoring. Beers Criteria: 1) May exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults. 262 Pediatrics Safety and efficacy in pediatrics patients have not been established. Should not be used in children under the age of 18 years. If based on clinical need, a decision to treat is nevertheless taken, should carefully monitor suicidal symptoms.",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"Moderate to severe: A decrease in dosage may be necessary .",renalImpairment:"egfr > 30ml/min : No dosage adjustment necessary egfr < 30ml/min : Initial 7.5mg to 15mg OD, titrate dosage carefully"},sideEffects:["Endocrine metabolic: weight gain, increased appetite. a. advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise.","Anticholinergic: a. Constipation can be managed by physical activity , fluid and fibre intake or laxatives b. Dry mouth","Neurologic a. Headache, dizziness, fatigue. May require dosage adjustment. Inform prescriber at next appointment b. Sedation: Avoid activity requiring mental alertness or coordination. Do not drink alcohol during treatment with this medicine as it might increase the sedative effect. Do not drive or work with tools or machinery if affected. Inform prescriber at next appointment. Most side effects are immediate but often go away with time. It may take a few weeks before you feel any improvement. Therefore, do not change the dose of the medicine or stop taking the medicine without consulting your doctor first. Instruct patient to immediately report worsening depression, suicidal ideation, especially at initiation of therapy (children and adolescents are at higher risk for these effects during the first few months of therapy)."],others:{storage:"Store below 30C. Avoid light & moisture. Other 1. Significant Pharmacodynamic Interactions a. Risk of life-threatening Serotonin syndrome when SSRIs co-prescribed with serotonergic drugs. (e.g. tramadol, ondansetron, sumatriptan, MAOI) Signs and Symptoms: i. Mild: Insomnia, anxiety , nausea, diarrhea, hypertension, tachycardia, hyper-reflexia 263 ii. Moderate:Agitation, myoclonus, tremor , mydriasis, flushing, diaphoresis, low fever (<38.5C) iii. Severe: Severe hyperthermia, confusion,rigidity , respiratory failure, coma, death Management: Seek immediate medical attention if you experience any of the symptoms mentioned above. b. Increase risk of upper GI bleeding if SSRIs are used together with Aspirin and NSAID due to inhibition of platelet aggregation. Watch out for black or tarry stools, easily bleeding gums or spontaneous bruises c. Risk of hyponatremia especially if SSRIs are used with drugs such as diuretics. 2. Discontinuation Syndrome a. SSRIs should not be stopped abruptly as this may cause discontinuation/ withdrawal symptoms. The symptoms are usually mild and selflimiting (e.g. include flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances and hyperarousal), but can occasionally be severe and prolonged. b. The patients must inform prescribers if they wish to change or stop medications",other_points:""}},{id:"counsel-085",name:"Moxifloxacin",pharmacologicalGroup:"Fluoroquinolone",indication:"1. Second-line treatment for leprosy (Moxifloxacin may replace Ofloxacin) 2. Drug-resistant leprosy Adult : 400mg once daily (in combination with other anti-leprosy drugs)",dosage:"See indication for dosage details",methodOfAdministration:"Food: Administered with or without food RT administration: Absorption was not significantly affected by concurrent enteral nutrition; however , it may be advisable to hold enteral nutrition for up to 2 hours before and after administration to ensure optimal absorption Missed dose: Take as soon as remembered if more than 8 hours before the next scheduled dose. Skip the missed dose if less than 8 hours remain before the next dose Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Avoid unless benefits outweigh risks",breastfeeding:"Limited data available-- use with caution",elderly:"Increased risk of adverse effectsuse with caution",paediatric:"Limited data",fasting:": NA"},sideEffects:["Common Side Effects Gastrointestinal: Abdominal cramps, abdominal pain, nausea, vomiting, diarrhoea 265 Neurological: Headache, dizziness, insomnia Serious but Rare Side Effects Tendinopathy and tendon rupture Peripheral neuropathy QTc prolongation."],others:{storage:"Store in a cool, dry place, away from sunlight",other_points:": 1. Renal impairment: No dose adjustment needed 2. Liver Impairment: No dose adjustment needed"}},{id:"counsel-086",name:"Mupirocin, Topical",pharmacologicalGroup:"Antibiotics for dermatological use",indication:"Bacterial skin infection,e.g. impetigo, folliculitis and furunculosis: Apply 2-3 times daily for 5 days. The duration may be extended up to 10 days, depending on the clinical response.",dosage:"See indication for dosage details",methodOfAdministration:"Topical Application: Apply a small amount of mupirocin ointment to the affected area, ensuring it is fully covered. If desired, the treated area may be covered with a dressing, though this is optional unless specifically advised by a healthcare provider . Completion of Treatment: Continue using the medication for the full prescribed duration, even if symptoms improve before completing the treatment. Do not discontinue the ointment unless instructed by a healthcare provider . This ensures the infection is fully treated and helps prevent resistance.",specialConsiderations:{pregnancy:"only if the potential benefits outweigh the possible risks.",breastfeeding:"to prevent any contact with the infant.",elderly:"No restriction of use. 2. Patients who use topical oils, creams, and ointments have potential fall risk .Patients may be advised to wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces.",paediatric:"Application as per adult patients."},sideEffects:["Burning localized to the area of application is usually transient and resolves with continued use.","However , if the burning persists, discontinue use.","The patient should be treated supportively , with appropriate monitoring as needed.."],others:{storage:"1. Store in a dry place at a temperature below 30C. 2. Protect from light. 3. Do not freeze.",other_points:"1. Do not use polyethylene glycol-based ointments in conditions where absorption of large quantities of polyethylene glycol is possible (e.g. extensive burn or 267 open wounds), especially in the presence of moderate to severe renal impairment."}},{id:"counsel-087",name:"Mycophenolate Mofetil/Mycophenolate Sodium",pharmacologicalGroup:"Selective immunosuppressants mycophenolic acid",indication:"1. Prophylaxis of acute organ rejection in patients receiving allogeneic kidney , cardiac and hepatic transplant 2. Used with steroids for induction and maintenance of severe lupus nephritis Available in two formulations: i) Mycophenolate mofetil (MMF) - Cellcept , Mycofit  - Available in 250 mg capsule and 500 mg tablet ii) Mycophenolate sodium (MPS) - Myfortic  - Available in 180 mg tablet and 360 mg tablet Equimolar dose in terms of mycophenolic acid: i) MMF 250 mg = MPS 180 mg ii) MMF 500 mg = MPS 360 mg  Both are NOT interchangeable. : (WARNING: These two formulations are at risk of medication errors) *Dose will be adjusted based on indication, kidney function & immune response. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. To be swallowed whole twice daily, 12 hours apart. 2. It may be taken before a meal to improve absorption. If a patient experiences gastrointestinal adverse effects, may take it after a meal to reduce the incidence of adverse effects. Be consistent on either taking it before or after a meal. 3. Do not cut/ crush/ open/ chew the capsule or tablet. Missed dose management: 1. If dose is missed, patients should take it as soon as possible within six hours after regular dose. 2. If it is more than 6 hours, skip the missed dose and return to normal dosing schedule. 3. Do not double a dose under any circumstances. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"and",breastfeeding:"is not recommended while the patient is taking mycophenolate.",elderly:"patients may be at an increased risk of adverse events such as infections, possibly gastrointestinal haemorrhage and pulmonary oedema.",paediatric:"patients have the same adverse effect profile as adult patients. Apply the same counselling points as adult patients.",fasting:"is permissible, take mycophenolate during Sahur (the meal before dawn) and Iftar (the meal after sunset). 2. Its important to stay hydrated throughout the night. If you miss a dose during Sahur , you must break your fast that day to take the missed dose."},sideEffects:["Gastrointestinal - heartburn, nausea, vomiting, diarrhoea - May take the dose after a meal - May discuss with the prescriber to split the dosing into TDS or QID to minimise the adverse effect. For example, Mycophenolate mofetil 500 mg TDS instead of 750 mg BD - May discuss with the prescriber to switch to a different strength or different formulation. For example, switch from MMF to MPS, or replace every 500 mg MMF tablet with two 250 mg MMF capsule - Notify the prescriber if symptoms persist","Cytopenias, including anaemia, leukopaenia and thrombocytopaenia - Monitor blood counts - Take note of signs and symptoms of infections (such as fever , cough, sore throat, pain or difficulty in passing urine) - Take note of signs and symptoms of bleeding (such as bruising, tarry stools, blood in vomitus or blood in urine) - Seek treatment immediately when signs and symptoms occur","Increase risk of infections - Practise frequent hand-washing - Avoid close contact with sick people who have 270 active infections - Seek treatment immediately when signs and symptoms occur","Increase risk of malignancies, especially lymphoma and skin cancer - Use sunscreen with a high protection factor and wear protective clothing that covers the head, neck, arms and legs when being outdoors."],others:{storage:"1. Store at room temperature. Protect from moisture. Store in the original package. 2. Mycophenolate capsules or tablets should remain in the blister when kept in the pillbox. 3. Mycophenolate capsules or tablets should be taken immediately after being removed from the blister pack.",other_points:"1. Teratogenic effect. Capsules should not be opened, and tablets should not be crushed. 2. Avoid inhalation or contact of the skin or mucous membranes with the powder in the capsules. Wash thoroughly with soap and water , rinse eyes with plain water if such contact occurs."}},{id:"counsel-088",name:"Neomycin, Topical",pharmacologicalGroup:"Antibiotic, Topical",indication:"Neomycin is indicated for the treatment of skin infection caused by susceptible organisms: Apply sparingly to the affected area up to 3 times daily (for short term use, 1-2 weeks).",dosage:"See indication for dosage details",methodOfAdministration:"1. Clean the affected area thoroughly with soap and water before applying the cream. Dry the area completely with a clean towel or cloth. 2. Apply a thin layer of the cream to the affected area, gently massaging it in to ensure even coverage. 3. If desired, you can cover the treated area with a sterile gauze dressing after application, but this is not required unless a healthcare provider recommends it. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Category: C)",breastfeeding:"has not been established.",elderly:"Patients who use topical oils, creams, and ointments have potential fall risk .Patients may be advised to wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces.",paediatric:"There is limited data specifically regarding the use of topical neomycin in pediatric populations. Therefore, there is no specific information available comparing the safety and efficacy of neomycin cream in children.",fasting:"Not applicable"},sideEffects:["Hypersensitivity Reactions: - Common reactions (often delayed) include burning, redness, or irritation at the application site.","These are 272 typically mild and resolve after discontinuing use.","Serious Side Effects (Rarely Reported): - Balance or hearing problems (especially with prolonged or widespread use, as neomycin can be systemically absorbed in certain cases).","- Folliculitis: Small red bumps or pustules may appear on the skin.."],others:{storage:"Store at or below 30 o C. Protect from freezing.",other_points:"N/A"}},{id:"counsel-089",name:"Nevirapine",pharmacologicalGroup:"Non-Nucleoside Reverse Transcriptase Inhibitors (NNR TIs)",indication:"Treatment for HIV-1 infections in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) 1. Adults: a. 200mg OD for the first 14 days upon initiation, followed by 200mg BD if no rash or hepatitis. b. If a patient experiences non-severe rash (without constitutional symptoms) during the 14-day lead-in period with 200mg/day , do not increase to 200mg BD until rash has resolved. If rash continues beyond 28 days on the 200mg/day dose, use an alternative regimen. b. Re-introduce with lead-in dose for 14 days if treatment is interrupted for >7 days. 2. Paediatrics: a. Infants and children <8 years: 200mg/m 2 /dose OD (max: 200mg/dose) the first 14 days upon initiation, followed by 200mg/m 2 /dose BD (max: 200mg/dose) if no rash. b. Children  8 years: 120-150mg/m 2 /dose OD (max: 200mg/dose) the first 14 days upon initiation, followed by 120-150mg/m 2 /dose BD (max: 200mg/dose) if no rash. c. Adolescents: 200mg OD for the first 14 days upon initiation, followed by 200mg BD if no rash. c. If a patient experiences non-severe rash (without constitutional symptoms) during the 14-day lead-in period, do not increase the dose until the rash has resolved. If rash continues beyond 28 days, use an alternative regimen. d. If nevirapine is interrupted  14 days (infants/children) or  7 days (adolescents), restart at the full dose. Re-introduce with lead-in dose for 14 days if treatment is interrupted for >7 days.",dosage:"See indication for dosage details",methodOfAdministration:"1. May be taken with or without food. 2. For oral suspensions, shake the suspension gently prior to administration, the use of oral dosing syringe is recommended. Missed dose management 1. To take medication consistently at the same time everyday . Any missed dose to be taken as soon as possible. 2. However if the gap is more than 6 hours, to skip and continue with a regular dosing schedule. Do not double the dose on the next administration time. Do not stop taking your medication unless advised to do so by your prescriber . Special Pregnancy 274 Considerations 1. Nevirapine is not recommended in female patients who are trying to conceive. 2. Nevirapine has a high level of transfer across the human placenta. 3. Nevirapine is not recommended as an initial NNR TI for use in treatment of nave pregnant patients because of the potential adverse events. 4. Patients who become pregnant while on nevirapine may continue if viral load suppressive is achieved and the regimen is well tolerated. Breastfeeding 1. Nevirapine is present in breast milk. 2. Mothers living with HIV are not recommended to breastfeed their infants to avoid risk of transmission to the baby . Because of the potential for HIV transmission in breastfed infants, advise women not to breastfeed. Elderly None specifically to Nevirapine Paediatric 1. May use the oral suspension or tablet formulation. 2. CD4 >15%: 3-fold increased risk of rash and hepatotoxicity during initiation. Fasting 1. To be discussed with infectious disease consultant",specialConsiderations:{},sideEffects:["Rash, including Stevens-Johnson syndrome - Patients must be monitored intensively during the 18 weeks of therapy to detect any potentially life-threatening event.","Hepatotoxicity - Patients must be monitored intensively during the 18 weeks of therapy to detect any potentially life-threatening hepatotoxicity . - Do not restart nevirapine following clinical hepatitis, transaminitis combined with rash or other systemic symptoms","Abdominal pain, diarrhoea"],others:{storage:"Store at room temperature.",other_points:"1. Contraindicated in moderate or severe hepatic impairment (Child-Pugh B or C). 2. No renal dose adjustment needed for any degree of impairment. An additional dose of nevirapine should be given following dialysis."}},{id:"counsel-090",name:"Nifedipine",pharmacologicalGroup:"Nifedipine",indication:"1. Hypertension a. 10mg TDS. Maximum 60mg/day 2. Antianginal a. 10mg TDS. Maximum 60mg/day To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Should be taken swallowed with water ,before or after meal 2. Avoid taking with grapefruit juice. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Human Data Suggest Low Risk in",breastfeeding:"Nifedipine is excreted into breast milk . Classified as compatible with",elderly:"Initial treatment with lower daily dose should be considered. 2. Beers Criteria: Avoid use, potential for hypotension; risk of precipitating myocardial ischemia.",paediatric:"Limited data.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Significant: Peripheral oedema, deterioration of heart failure; symptomatic hypotension with or without syncope (conventional form). Rarely , exacerbation of 277 angina and/or acute MI (during treatment initiation or dose increase","Cardiac disorders: Palpitations","Gastrointestinal disorders: Constipation, abdominal pain, dyspepsia, diarrhoea, flatulence, dry mouth, nausea, heartburn.","Musculoskeletal and connective tissue disorders: Muscle cramps","Nervous system disorders: Headache, dizziness, tremor .","Psychiatric disorders: Nervousness, mood changes.","Respiratory , thoracic and mediastinal disorders: Nasal congestion, cough, wheezing, sore throat, dyspnoea.","Skin and subcutaneous tissue disorders: Dermatitis, rash, pruritus, urticaria, diaphoresis.","Vascular disorders: V asodilation, flushing."],others:{storage:"1. Room temperature. Do not store above 30 0 C",other_points:"1. Renal impairment: No dosage adjustment. Not removed by hemo- or peritoneal dialysis; supplemental dose is not necessary 2. Liver impairment: No dosage adjustment. Use with caution as clearance of Nifedipine is reduced in cirrhotic patients. A dose reduction may be necessary ."}},{id:"counsel-091",name:"Anti-inflammatory Drugs (NSAIDs) / COX-2 Inhibitors",pharmacologicalGroup:"Antiinflammatory and antirheumatic products, non-steroids",indication:"Indication 1. Pain and inflammation in rheumatic disease Dosage 1. Celecoxib: 200 - 400 mg daily in 1-2 divided doses 2. Diclofenac: Initial dose of 150 mg daily. Mild or long term: 75 - 150 mg daily in 2 to 3 divided doses after food. 3. Etoricoxib: 60 - 120 mg once daily 4. Ibuprofen: 200 - 400 mg 3 times daily after food, maximum 3.2 g daily 5. Mefenamic acid: 250 - 500 mg 3 times daily after meals. 6. Meloxicam: initially 7.5 mg daily. May be increased to 15 mg daily 7. Naproxen: 500 mg initially then 250 mg every 6 - 8 hour as required To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Immediate release: 1. Administer IR formulations with food or milk to avoid gastric distress. 2. RT administration: IR formulations can be crushed (e.g.: Ibuprofen) or capsules (e.g.: Celecoxib) can be opened and mixed with water for RT administration. Extended release: 1. Do not break, crush or chew delayed-release or ER tablets. Should swallow the tablet whole with food or milk to avoid gastric distress. 2. In the event RT administration is required: Place the tablet in 10 mL of water , where it quickly breaks into fine granules that can be easily mixed and flushed through a RT. 3. E.g.: Etoricoxib and Meloxicam Please refer to the specific brand guidelines for feasibility and instructions for RT administration. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"unless absolutely necessary . They should not be used in the third 279 trimester .",breastfeeding:"is generally considered safe as they typically pass into breast milk in very small amounts.",elderly:"Beers criteria: a. Avoid combining NSAIDs with steroids, blood thinners, or medications that prevent clots unless absolutely necessary . If needed, a stomach-protecting medicine should also be used. b. Potential to promote fluid retention and lead to heart failure exacerbation 2. Always start with the lowest possible dose.",paediatric:"population, therapy should be initiated with the lowest age-appropriate or weight-based dose. Duration of treatment and drug doses used should be regularly evaluated and maximum dose limits and other recommendations by the manufacturer or expert committees should be followed."},sideEffects:["1) Gastrointestinal (Stomach) Effects: Management: Take NSAIDs with food or antacids to reduce stomach irritation.","If you're at higher risk (e.g., elderly or history of ulcers), a stomach-protecting medicine like a proton pump inhibitor may help.","2) Cardiovascular Effects: Management: Before starting NSAIDs, your doctor will check for heart-related risks.","If you have heart disease or high blood pressure, other pain relievers like acetaminophen might be safer.","3) Kidney Effects: Management: Avoid NSAIDs if you have severe kidney problems (e.g., CrCl  30 ml/min).","Stay well-hydrated, use the lowest dose for the shortest time, and your doctor may monitor kidney function if you're using NSAIDs long-term.","4) NSAID-Exacerbated Respiratory Disease: Management: Use with caution in patient with pre-existing asthma."],others:{storage:"1. Store the medication at room temperature in a safe location, away from direct sunlight and humidity . 2. Keep the medication out of children s reach.",other_points:"1. Chronic non-cancer pain: Do not use NSAIDs / COX-2 inhibitors longer than 1-2 weeks. You may use them for a few days to get control of a flare up of chronic pain, but they should never be given for long term as the patient will have a risk of developing renal failure and higher risk of cardiovascular events. 280"}},{id:"counsel-092",name:"Nystatin, Topical",pharmacologicalGroup:"Antifungal for dermatological use.",indication:"1. Adult Fungal infections (cutaneous and mucocutaneous) caused by Candida albicans : Apply to the affected areas twice daily or as indicated until healing is complete. 2. Paediatric Diaper dermatitis, Mucocutaneous candida infection: Apply 2 to 4 times daily to the affected area.",dosage:"See indication for dosage details",methodOfAdministration:"1. Wash and dry your hands: Before application, cleanse your hands thoroughly with soap and water and dry them completely . 2. Prepare the affected area: Gently clean and dry the skin where the cream will be applied. Ensure the area is free of dirt or residue. 3. Check the cream label: Verify the cream's label to confirm you are using nystatin cream as prescribed. 4. Apply the cream: - Remove the cap and squeeze a small amount of cream onto your fingertip. - Apply a thin layer of the cream to the affected area, ensuring complete coverage. - For areas with hair, apply the cream gently in the direction of hair growth to reduce irritation and ensure even application. 5. Avoid contamination: Do not touch the tube's tip to the skin or any other surface to prevent contamination. 6. Post-application hygiene: Wash your hands again with soap and water to remove any residual cream unless the treated area is on your hands. 7. Follow prescribed duration: - Continue using the cream for the full duration prescribed by your healthcare provider , even if symptoms improve early . - Do not skip doses or stop the treatment prematurely to ensure the infection is fully treated. Additional Notes:  Avoid contact with eyes, mouth or other mucous membranes unless directed by a healthcare provider .  Inform your healthcare provider if irritation or worsening of symptoms occurs during use.",specialConsiderations:{pregnancy:": 1. Animal reproduction studies have not been conducted. 2. Nystatin topical preparations should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus. 282",breastfeeding:"It is not known if nystatin is excreted in breast milk;. The manufacturer recommends that caution be exercised when administering nystatin to nursing women.",elderly:"Patients who use topical oils, creams, and ointments have potential fall risk .Patients may be advised to wear nonslip socks if applying topical medications to feet. Patients should be advised to apply cream while seated or standing on non-slip surfaces.",paediatric:"Dosage recommendations may vary among individual products. To refer to individual products.",fasting:". To refer to the latest advisory by religious authority"},sideEffects:["If irritation or sensitisation develops, treatment should be discontinued and appropriate measures taken as indicated.."],others:{storage:"1. Keep the container tightly closed in a dry place. 2. Store below 30  C. or at 20- 25  C. 3. Protect from light and avoid freezing.",other_points:"1. For topical external use only; not for systemic, oral, intravaginal or ophthalmic use. 2. Since nystatin is not absorbed systemically when applied to intact skin or mucous membranes, the likelihood of drug interactions or incompatibilities is minimal."}},{id:"counsel-093",name:"Nystatin Oral Suspension",pharmacologicalGroup:"Polyenes Antifungal",indication:"Nystatin 100,000units/ml Suspension Prevention and treatment of candidiasis of the skin and mucous membranes, protection against candidas overgrowth during antimicrobial /corticosteroid therapy and as selective decontamination regimens (Dosage as per prescribed)",dosage:"See indication for dosage details",methodOfAdministration:"1. Shake the bottle well before use, then draw up the correct amount into the measuring dropper provided. 2. The suspension should be swished throughout or be retained in the mouth for as long as possible(several minutes) before swallowing. 3. Individuals should avoid taking food or drink earlier than one hour after a dose. In infants and young children, apply one half of a dose in each side of the mouth. 4. The dosage should be continued for 48 hours after lesions have resolved. Missed dose management Take the missed dose as soon as you remember . If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take a double dose to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"N/A",breastfeeding:"Nystatin is poorly absorbed after oral administration, if at all, serum and milk levels would not occur .",elderly:"None specifically to Nystatin",paediatric:"Some dosage forms may contain propylene glycol. In neonate receiving propylene glycol > 3000mg/day via orally , intravenously or topically have been associated with toxicities e.g. seizures,renal failure and central nervous system depression",fasting:"To refer to the latest advisory by religious authority 284"},sideEffects:["Nausea","Vomiting","Diarrhoea","Mouth irritation or sensitivity Management:","Drink plenty of water to avoid dehydration","Stop using medication if you experience any irritation or sensitivity and seek medical assistance."],others:{storage:"1. Store below 30C in a well-closed container . 2. Do not freeze and protect from light. 3. Refer product insert",other_points:"NA"}},{id:"counsel-094",name:"Ofloxacin",pharmacologicalGroup:"Fluoroquinolone",indication:"1. Second-line treatment for leprosy 2. Drug-resistant leprosy Adult : 400mg once daily (in combination with other anti-leprosy drugs)",dosage:"See indication for dosage details",methodOfAdministration:"Food: Administered with or without food RT administration: Significant interaction when mixed directly with the enteral formula. Should not be given within 2 hours before or 4 hours after enteral formulas Missed dose: Take the missed dose as soon as possible Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Avoid unless benefits outweigh risks",breastfeeding:"Avoid",elderly:"Adverse effects may be increased in older patients",paediatric:": Use with caution  risk of arthropathy",fasting:"NA"},sideEffects:["Common Side Effects Gastrointestinal: Abdominal cramps, abdominal pain, nausea, vomiting, diarrhoea 286 Neurological: Headache, dizziness, insomnia Serious but Rare Side Effects Tendinopathy and tendon rupture Peripheral neuropathy QTc prolongation."],others:{storage:"Store in a cool, dry place, away from sunlight",other_points:": 1. Renal impairment CrCl 20 mL/min: No dose adjustment required at doses used in leprosy 2. Liver Impairment: No dose adjustment required at doses used for leprosy"}},{id:"counsel-095",name:"Opioids, Short Acting Strong",pharmacologicalGroup:"Opioid Analgesic Available preparations: 1. Aqueous Morphine 10mg/5ml 2. Oxycodone HCL 1mg/ml Oral Solution 3. Oxycodone HCL 5mg and 10mg Immediate Release Capsules",indication:"1. Aqueous morphine: For use in management of moderate to severe pain especially that associated with neoplastic disease",dosage:"5-20mg or more regularly every 4 hours in terminal pain. 2. Oxycodone HCl 1mg/ml Oral Solution: As a second-line drug in the management of responsive, moderate to severe pain in patients who; a. Have difficulty swallowing b. Require low dose oxycodone (<5mg) Dose: Initial dose for opioid nave patients or patients presenting with severe pain uncontrolled by weak opioids is 5mg, 4-6 hourly . The dose should be carefully titrated, as frequently as once a day, to achieve pain relief. 3. Oxycodone HCl 5mg and 10 mg Immediate Release Capsules a. As a second line drug in the management of opioid responsive, moderate to severe chronic cancer pain b. As a step-down analgesic drug in post-operative procedures Dose: Initially 5 mg every 4 to 6 hours, increased if necessary , according to severity of pain To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"How to take immediate release solution 1. Take exactly as instructed 2. Aqueous morphine solution/ Syrup Oxycodone Immediate Release is usually taken every 4 - 6 hours. 3. Take the solution by mouth. Use a plastic syringe to measure your dose. 4. Your doctor may instruct you to take additional doses for breakthrough pain  as often as every hour. 5. Record the number of additional doses you have taken and inform your doctor at the next visit. 6. DO NOT exceed the dose prescribed by your doctor . 7. If you find that you are still in pain whilst taking this drug, discuss this with your doctor . How to take Oxycodone Immediate Release Capsules 1. Take exactly as instructed 2. DO NOT break, crush or chew them. 3. Swallow your capsule whole with a glass of water . 288 4. OxyNORM capsules are usually taken every 4 - 6 hours. 5. OxyNORM capsules may also be prescribed as when needed medication for breakthrough pain. (Breakthrough pain occurs despite regular painkillers)  Always take the capsules exactly as instructed. 6. Record the number of additional doses you have taken and inform your doctor at the next visit. 7. DO NOT exceed the dose prescribed by your doctor . 8. If you find that you are still in pain whilst taking this drug, discuss this with your doctor . Missed dose management 1. If you forget a dose, take it as soon as you remember it and take your next dose at the usual time. 2. DO NOT take a double dose to make up for a forgotten dose Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"and",breastfeeding:"needs to be carefully considered and there is a need to balance pain management and the risk of neonatal opioid withdrawal symptoms.",elderly:"patients carry risks of constipation that lead to delirium and increased risk of falls. 4. Avoid in patients with a history of fractures or falls, it may contribute to additional fall.",paediatric:"Although opioids are highly effective in treating pain, their use frequently results in various side effects including nausea and vomiting, pruritus, constipation, sedation as well as potentially fatal respiratory depression in children. Abuse / Misuse / Diversion 1. Use with caution in patients with a history of substance use disorder , as the potential for drug dependency exists."},sideEffects:["Opioid-induced constipation a. A common side effect b. Tolerance does not develop, hence laxatives must be taken regularly c. Use combination of stimulant (e.g. bisacodyl) + softener (e.g. lactulose) d. Increase fluid and dietary fibre intake, 289 maintain good physical activity , and try to establish a toilet routine","Opioid-induced sedation / impaired alertness a. May occur upon initiation of opioids b. Avoid driving and other activities that require mental alertness until it is clear how morphine/ Oxycodone affects the patient c. Tolerance develops after 5 - 10 days","Opioid-induced neurotoxicity (delirium, confusion) a. May occur , but usually transient b. May consider use of haloperidol for delirium","Opioid-induced nausea and vomiting a. May occur upon initiation of opioids b. Tolerance develops 5 - 10 days after starting c. May use antiemetics (e.g. metoclopramide, haloperidol or prochlorperazine) d. Be consistent when taking morphine with or without meals","Opioid-induced dry mouth a. Sip water often, let small ice chips melt in your mouth b. Minimise intake of caffeinated drinks, such as coffee, tea, and some sodas as well as use of tobacco and alcohol c. Chew sugarless gum or suck on sugarless hard candy to stimulate saliva flow"],others:{storage:"1. Medication may be kept at room temperature, in a safe place and out of direct sunlight, and humidity . 2. Ensure medication is out of the reach of children and pets.",other_points:"1. Respiratory depression is rare but may occur if morphine is used incorrectly and can be fatal. 2. Do not take more than what has been prescribed. 3. Concurrent use of other central nervous system (CNS) depressants, such as benzodiazepines, barbiturates, sedatives, hypnotics, or alcohol, can potentiate the sedative and respiratory depressant effects of morphine, increasing the risk of profound sedation, respiratory depression, coma, or death. 4. Medication should be tapered gradually when discontinuing therapy to minimize withdrawal effects.."}},{id:"counsel-096",name:"Opioids, Sustained-Release Strong",pharmacologicalGroup:"Opioid Analgesic Preparations available: 1. Morphine Sulphate Prolonged Release Tablets 2. Oxycodone Hydrochloride Controlled Release Tablets",indication:"1. Moderate to severe cancer pain 2. Non-cancer chronic pain refractory to adjuvant analgesics and non-pharmacological approaches a. Dose requirement is established using short-acting preparations before switching to long-acting formulations. b. Dose is individualised based on patient-specific factors and severity of pain, and usually given in 12 hourly intervals (twice a day). c. Subsequently , dose is adjusted according to patient response, taking into account the amount of rescue medication used, pain score, functional assessment and side effects. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Tablets must be swallowed whole, with enough water to ensure complete swallowing. 2. Do not crush, chew or dissolve the tablets as it may result in uncontrolled delivery of drugs. 3. Cannot be administered through a feeding tube. 4. May be administered with food. Missed dose management 1. In the event of a missed dose, take it as soon as possible. Omit the dose if more than 6 hours has passed. Never double a dose to make up for a missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"and",breastfeeding:"needs to be carefully considered and there is a need to balance pain management and the risk of neonatal opioid withdrawal symptoms.",elderly:"patients carry risks of constipation that lead to delirium and increased risk of falls. 4. Avoid in patients with a history of fractures or falls, it may contribute to additional fall. 5. Avoid use in patients with dysphagia.",paediatric:"Although opioids are highly effective in treating pain, their use frequently results in various side effects including nausea and vomiting, pruritus, constipation, sedation as well as potentially fatal respiratory depression in children. Abuse / Misuse / Diversion 1. Use with caution in patients with a history of substance use disorder , as the potential for drug dependency exists."},sideEffects:["Opioid-induced constipation a. A common side effect b. Tolerance does not develop, hence laxatives must be taken regularly c. Use combination of stimulant (e.g. bisacodyl) + softener (e.g. lactulose) d. Increase fluid and dietary fibre intake, maintain good physical activity , and try to establish a toilet routine","Opioid-induced sedation / impaired alertness a. May occur upon initiation of opioids b. Avoid driving and other activities that require mental alertness until it is clear how morphine/ Oxycodone affects the patient c. Tolerance develops after 5 - 10 days","Opioid-induced neurotoxicity (delirium, confusion) a. May occur , but usually transient b. May consider use of haloperidol for delirium","Opioid-induced nausea and vomiting a. May occur upon initiation of opioids b. Tolerance develops 5 - 10 days after starting c. May use antiemetics (e.g. metoclopramide, haloperidol or prochlorperazine) d. Be consistent when taking morphine with or without meals e.","Opioid-induced dry mouth a. Sip water often, let small ice chips melt in your mouth b. Minimise intake of caffeinated drinks, such as 293 coffee, tea, and some sodas as well as use of tobacco and alcohol c. Chew sugarless gum or suck on sugarless hard candy to stimulate saliva flow."],others:{storage:"1. Medication may be kept at room temperature, in a safe place and out of direct sunlight, and humidity . 2. Ensure medication is out of the reach of children and pets.",other_points:"( eg. hepatic impairment, renal impairment which will be relevant to the patient) 1. The use of long-acting formulations is not advisable if a patient develops renal impairment or hepatic impairment. 2. Speak to your doctor about using a more appropriate analgesic to manage your pain."}},{id:"counsel-097",name:"Opioids, Weak",pharmacologicalGroup:"Weak opioid Analgesic Preparations available: 1. Tramadol HCl 50mg Tablet 2. Dihydrocodeine Tartrate 30mg Tablet(DF1 18)",indication:"1. Tramadol: Moderate to severe acute or chronic pain a.",dosage:"50  100 mg 6  8-hourly (Maximum dose: 400 mg/day) b. Paediatric: Over 12 years: Maximum dose 1 mg/kg 6-8h, max 400 mg/day c. Renal adjustment: CrCl <30 ml/min : 200 mg/day , BD dosing d. Severe hepatic impairment: 50 mg BD 2. Dihydrocodeine: For the control of moderate to severe pain a. 30  60 mg, 4-6 hourly (Maximum dose: 240 mg/day) b. Paediatric: Over 4 years: 0.5-1mg/kg (adult 15-60mg) 4-6h c. Renal/hepatic adjustment: To avoid or reduce dose To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Tramadol a. May be taken with or without food. b. Capsules can be opened easily and the contents mix easily with water to form a fine suspension that flushes easily via a Ryle s Tube (RT). 2. Dihydrocodeine a. Should be taken with food. b. Tablets can be crushed. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"may cause neonatal opioid withdrawal syndrome. 2. Dihydrocodeine Human data suggest risk in third trimester",breastfeeding:"Tramadol Limited human data. Unlikely to cause harm in healthy 295 term infants 2. Dihydrocodeine No human data. Probably compatible",elderly:"patients carry risks of constipation that lead to delirium and increased risk of falls.",paediatric:"Although opioids are highly effective in treating pain, their use frequently results in various side effects including nausea and vomiting, pruritus, constipation, sedation as well as potentially fatal respiratory depression in children."},sideEffects:["Opioid-induced constipation a. A common side effect b. Tolerance does not develop, hence laxatives must be taken regularly c. Use combination of stimulant (e.g. bisacodyl) + softener (e.g. lactulose) d. Increase fluid and dietary fibre intake, maintain good physical activity , and try to establish a toilet routine","Opioid-induced sedation / impaired alertness a. May occur upon initiation of opioids b. Avoid driving and other activities that require mental alertness until it is clear how morphine/ Oxycodone affects the patient c. Tolerance develops after 5 - 10 days","Opioid-induced neurotoxicity (delirium, confusion) a. May occur , but usually transient b. May consider use of haloperidol for delirium 296","Opioid-induced nausea and vomiting a. May occur upon initiation of opioids b. Tolerance develops 5 - 10 days after starting c. May use antiemetics (e.g. metoclopramide, haloperidol or prochlorperazine) d. Be consistent when taking morphine with or without meals","Opioid-induced dry mouth a. Sip water often, let small ice chips melt in your mouth b. Minimise intake of caffeinated drinks, such as coffee, tea, and some sodas as well as use of tobacco and alcohol c. Chew sugarless gum or suck on sugarless hard candy to stimulate saliva flow."],others:{storage:"1. Medication may be kept at room temperature, in a safe place and out of direct sunlight, and humidity . 2. Ensure medication is out of the reach of children and pets.",other_points:"1. Tramadol a. Risk of seizures in patients with a history of seizures and with high doses. b. Use with caution in patients taking drugs which decrease seizure threshold eg: tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRI) & serotonin noradrenalin reuptake inhibitors (SNRI). c. Avoid concomitant use with or within 14 days following MAO inhibitor therapy . 2. Dihydrocodeine Cautions and contraindications: a. May cause the release of histamine thus should not be administered during an asthmatic attack. b. Respiratory depression, acute alcoholism, paralytic ileus, raised intracranial pressure"}},{id:"counsel-098",name:"Paracetamol",pharmacologicalGroup:"Non-opioid analgesic",indication:"Indication 1. Relief of fever 2. Relief of pain Dosage 1. Adults and children above 12 years: 500mg - 1g every 4 - 6 hours. Maximum 4g daily. 2. Children: a. 0 - 3 months: 15mg/kg 6  8H (Max: 60mg/kg/day; if preterm 28-32 CGA, max 30mg/kg/day) b. > 3months -12 years: 15mg/kg 4-6H (Max: 75mg/kg/day or 4 grams/day) To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. May be taken with or without food. 2. Missed dose management: Take the missed dose as soon as you remember . If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take a double dose to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"and no adverse fetal effects have been recorded.",breastfeeding:"Compatible with breast feeding.",elderly:"; deranged liver enzyme.",paediatric:"1. There are different types of paracetamol, including two strengths of oral syrup. Care must be taken to avoid accidental overdose."},sideEffects:["Cutaneous hypersensitivity reaction including skin rashes, angioedema, Stevens Johnson Syndrome","Risk of hepatotoxicity"],others:{storage:"1. Store in a dry place, below 30 ",other_points:"1. Should be given with care to patients with impaired kidney or liver function 2. Contraindicated in patients with severe hepatic impairment or active liver disease"}},{id:"counsel-099",name:"Permethrin, Lotion",pharmacologicalGroup:"Scabicides; Topical insecticide",indication:"1. Permethrin 1% Lotion For topical treatment of head lice 2. Permethrin 5% Lotion Treatment of scabies To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Permethrin 1% Lotion ( Treatment of head lice) 1. Before application, wash hair with a mild regular shampoo and towel dry. 2. Apply sufficient amounts to completely saturate the hair and scalp (especially behind the ear and nape of the neck). 3. Leave on the hair for 10 minutes then rise thoroughly with water . 4. Remove nits with fine-toothed comb as necessary . 5. May repeat treatment 7 - 1 days after initial application if live lice or nits are found. Permethrin 5% Lotion ( Treatment of scabies) 1. Applied from the jawline downwards, and left overnight for 814 hours. Reapplication is needed if hands are washed during the treatment period. Infants, the elderly , and the immunosuppressed should also treat the face and scalp. 2. Application should include under the nails and between the toes. 3. Treatment should be repeated after 710 days. Missed dose management : If a dose is missed, use it as soon as possible. If it is almost time for the next dose, use only that dose. Do not use double or extra doses. Do not stop your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Safe for pregnant women.",breastfeeding:"women.",elderly:"None specifically to the product 300",paediatric:"Not recommended for infants less than 2 months of age.",fasting:"N/A"},sideEffects:["Itching & burning/stinging sensation on application."],others:{storage:"1. Store at room temperature below 25C. 2. Protect from light. 3. Discard any unused medicine after the expired date.",other_points:"N/A"}},{id:"counsel-100",name:"Podophyllum Paint",pharmacologicalGroup:"Keratolytic Agent",indication:"External genital warts",dosage:"Apply 2-3 drops carefully to lesion after protecting the surrounding area with white soft paraf fin. Wash off after 6 hours or if you feel a burning sensation. Repeat 2-3 times weekly or once weekly .",methodOfAdministration:"1. Use a toothpick or a cotton-tipped or given applicator to apply this medicine. Apply 1 drop at a time, allowing time for drying between drops, until the affected area is covered. 2. After podophyllum is applied, allow it to remain in the affected area for 1 to 6 hours as directed by your doctor . Then, remove the medicine by thoroughly washing the affected area with soap and water . If this medicine contains tincture of benzoin, it may be removed more easily by swabbing the affected area with rubbing alcohol. However , this may be more irritating than washing with soap and water . 3. Immediately after applying this medicine, wash your hands to remove any medicine that may be on them. Missed dose management: If you miss a dose of this medicine, take it as soon as possible. However , if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:".",elderly:"None specifically to Podophyllum",paediatric:"patients have not been established. 302",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Local skin irritation Special care must be taken to ensure application is restricted to the wart itself.."],others:{storage:"Room Temperature",other_points:"Not applicable"}},{id:"counsel-101",name:"Ranolazine",pharmacologicalGroup:"Antianginal drug  as adjunct therapy MOA: inhibition of the late sodium current in heart cells.",indication:"1. Add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists) a. Initial 375mg bd, titrate to 500mg bd after 2-4 weeks; may further titrate to maximum 750mg bd according to patient s response b. Down-titration to 375mg or 500mg bd or even discontinued may be required if patient experiences treatment-related adverse events.",dosage:"See indication for dosage details",methodOfAdministration:"Should be swallowed whole and not crushed, broken, or chewed. They may be taken with or without food. If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) to take your next dose. Do not take a double dose to make up for a forgotten dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"unless clearly necessary .",breastfeeding:"Should not be used during breast-feeding.",elderly:"Use with caution in patients 75 years of age, they may experience more adverse events and drug discontinuation due to adverse events",paediatric:"No data available.",fasting:"Not applicable."},sideEffects:["usually develop within the first 2 weeks of treatment.","Nervous system disorders: dizziness, headache.","Gastrointestinal disorders: constipation, vomiting, nausea.","General fatigue and weakness (asthenia)"],others:{storage:"This medicinal product does not require any special storage conditions. Store below 30C.",other_points:"Contraindicated in concomitant administration of potent CYP3A4 inhibitors; crcl <30 ml/min; moderate or severe hepatic 304 impairment; concomitant administration of Class Ia (e.g. quinidine) or Class III (e.g. dofetilide, sotalol) antiarrhythmics other than amiodarone."}},{id:"counsel-102",name:"Renin-angiotensin aldosterone system inhibitor (RAASi",pharmacologicalGroup:"Angiotensin-Converting Enzyme Inhibitors (ACE-I) Angiotension Receptor Blocker (ARB) Anigiotensin Receptor Blocker Neprisylin Inhinitor (ARNI)",indication:"Hypertension Drug Initial dose Maksimum dose ACE-I Captopril 25mg bd 50g tds Enalapril 2.5mg od 20g bd Lisinopril 5mg od 80mg od Perindopril erbumine 2mg od 8mg od Ramipril 2.5mg od 8mg od ARB Candesartan 8mg od 16mg od Losartan 50mg od 100mg od Valsartan 80mg od 160mg od Heart Failure Drug Initial dose Maksimum dose ACE-I Captopril 6.25mg bd 50mg tds Enalapril 2.5mg od 10-20mg bd Lisinopril 2.5-5.mg od 20-40mg od Perindopril erbumine 2mg od 8-16mg od Ramipril 2.5mg od 10mg od ARB Candesartan 4-8mg od 32mg od Losartan 25-50mg od 50-150mg od Valsartan 40mg od 160mg bd ARNI Sacubutril/ Valsartan 100mg bd 200mg bd Stable Coronary Artery Disease Drug Initial dose Maximum dose ACE-I Captopril 6.25mg bd/tds 25-50mg tds Enalapril 2.5-5mg od 20g bd Lisinopril Perindopril erbumine 2mg 8mg od Ramipril 2.5mg od 10mg od ARB Candesartan 4mg od 32mg od Losartan 25-50mg od 100mg od Valsartan 40mg od 160mg bd To counsel based on specific medication s indication and dosage as prescribed by the doctor 306",dosage:"See indication for dosage details",methodOfAdministration:"Drug Before Food After Food Compatible with RT administration Consideration on fluid restriction ACE-I  \0  \0 ARB    \0 ARNI    \0 Missed dose management: Single daily dosing regime: missed dose taken upto until 12 h after the scheduled dosing Twice daily dosing regime: missed dose taken up until 6 h after the scheduled intake Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:"Contraindicated",elderly:". Beers Criteria: Avoid routinely using 2 or more RAS inhibitors, or a RAS inhibitor and potassium sparing diuretic, concurrently in those with chronic kidney disease Stage 3a or higher due to an increased risk of hyperkalemia.",paediatric:"Dose calculated based on body weight",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Dizziness,symptomatic hypotension, hyperkalaemia (To seek medical attention immediately)","For ACE-I induced cough: consider replacement with ARB","Angioedema: switching among RAASi is not recommended"],others:{storage:"To store at room temperature",other_points:"Renal impairment: consider starting at low dose, monitor renal function and potassium level closely"}},{id:"counsel-103",name:"Ribavirin",pharmacologicalGroup:"Purine nucleoside analogue",indication:"For the treatment of chronic hepatitis C - Use as part of an appropriate combination regimen.  <75 kg: 1 g/day in 2 divided doses  75 kg: 1.2 g/day in 2 divided doses  Dosage is individualized and titrated in accordance with the baseline characteristics of the disease and patient s liver status Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. To be taken orally with food to improve absorption 2. Must be taken at the same time everyday . 3. Capsules should not be opened, crushed, or broken. 4. Patients must complete the prescribed treatment regimen. This is to ensure treatment effectiveness and prevent resistance. 5. DO NOT RUN OUT OF MEDICA TION . Refill the prescription before it finishes. Missed dose management: 1. If you miss a dose and it is less than 6 hours past your usual time, take the missed dose as soon as possible. 2. If more than 6 hours have passed since your usual dose, skip the missed dose and take the next dose at the usual time. 3. DO NOT take double doses to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Contraindicated in male patients whose partners are pregnant",breastfeeding:"It is not known whether ribavirin is excreted in human milk. Because of the potential for adverse reactions in nursing infants, a decision should be made either to discontinue nursing or not to initiate therapy .",elderly:"; may be more susceptible to adverse effects such as anemia. Monitor renal function closely .",paediatric:"patients less than 3 years old",fasting:"To take twice daily during Sahur and Iftar .",hepaticImpairment:"Low initial dosage (600 mg/day) with titration as tolerated is recommended in patients with Child-Pugh Class C. 2. During treatment of Hepatitis C:  Asymptomatic increases in ALT <10-fold: Closely monitor with repeat testing every 2 weeks. If persistent elevation, consider stopping therapy  Symptomatic (weakness, nausea, vomiting, jaundice) increases in ALT <10-fold from baseline OR significantly increased bilirubin, alkaline phosphatase, or INR: Discontinue DAA  10-fold increase in ALT from baseline: Discontinue DAA",renalImpairment:"The dosage of ribavirin may be adjusted based on the patient's kidney function. 1. CrCl  50mL/min: No dosage adjustments necessary 2. CrCl 30-50mL/min: Alternate 200mg and 400mg every other day 3. CrCl < 30mL/min: 200mg once daily 4. Hemodialysis: 200mg once daily"},sideEffects:["Hemolytic anemia: Usually occurs within 1 to 2 weeks after starting therapy . a. Hematologic tests should be performed prior to starting therapy and at treatment weeks 2 and","Birth defects - advise on contraception","Insomnia - to take higher doses in morning","Fatigue, nausea, rash, dry skin and itch","If patients experience any aller gic reaction ( e.g. rashes, breathlessness, swollen eyes), they should stop the medication immediately and seek immediate medical assistance."],others:{storage:"1. Store below 30  C. 2. Keep medication in its original container , tightly sealed to protect from moisture and light. 3. Keep out of reach and sight of children.",other_points:"Drug-drug/ Drug-food Interactions: 1. Patients should report all prescribed medications, over-the-counter medications, traditional medicines or drinks, and health supplements, both before starting therapy and during treatment. 2. They must stop taking any traditional or herbal medications, health supplements, or health drinks during treatment and should consult prescribers before starting any new medications. Precautions: 1. Advise female patients to use effective form of contraception during treatment and for 9 months 310 post-therapy 2. As for male patients with female partners, effective forms of contraception should be used during treatment and for 6 months post-therapy ."}},{id:"counsel-104",name:"Rifampicin",pharmacologicalGroup:"Rifamycin antibiotic",indication:"1. First-line treatment for leprosy (Paucibacillary & Multibacillary) (to be used in combination with other anti-leprosy agents) a. Adult: 600mg once a month b. Children: i) 10-14 years old : 450mg once a month ii) <10 years old or <40kg: 10mg/kg once a month 2. Contact chemoprophylaxis (to be administered as single dose only) a. Adult (age 15 years and above): 600mg b. Children: i) 10-14 years old: 450mg ii) 6-9 years old (body weight 20kg): 300mg iii) 2 years old (body weight <20kg)): 10-15mg/kg",dosage:"See indication for dosage details",methodOfAdministration:"Food To be taken preferably before food. However , this can be disregarded if Direct Observation Therapy (DOT) is being performed. RT administration Capsule can be opened, its content mixed with water and administered through Ryles Tube Missed dose Take as soon as remembered, skip if near next dose; do not double dose Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Safe in",breastfeeding:"Safe to be used in",elderly:"NA",paediatric:"Extemporaneous preparations with different concentrations can be compounded:  Rifampicin syrup 10mg/ml  Rifampicin suspension 25mg/ml  Rifampicin suspension 50mg/ml 312",fasting:"NA"},sideEffects:["Orange discolouration of body fluids (e.g. urine, saliva, tears, sweat)","Rash and pruritus","GI upset (nausea, vomiting)","Flu-like symptoms","Hepatotoxicity (jaundice and hepatitis) A dvise patients to inform their healthcare providers if they experience any side effects."],others:{storage:"1. Capsules should be kept at room temperature 2. 10mg/ml syrup should be refrigerated and protected from light; stable for 28 days (Extemp formulation 2015) 3. 25mg/ml and 50mg/ml oral suspensions can be stored at room temperature and protected from light; stable for 90 days (X-Temp Oral Suspension Master Formulation Sheets)",other_points:"1. Use in renal disease: Can be used without dose adjustment 2. Use in hepatic disease: Use with caution. Consider discontinuation if hepatic function worsens."}},{id:"counsel-105",name:"Rilpivirine",pharmacologicalGroup:"Non-nucleoside reverse transcriptase inhibitors (NNR TIs)",indication:"Children and adolescent (aged >12 years and weighing >35 kg) and adult",dosage:"1. Indicated with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (H1V -1) infection in antiretroviral treatment-naive adult patients with a viral load is less than 100,000 copies/mL. a. The recommended dose is 25 mg once daily taken with meals. 2. Indicated in combination with cabotegravir as a complete regimen for short-term treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral therapy (ART) regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine. a. The recommended dose is 25 mg once daily taken with meals.",methodOfAdministration:"Must administer a meal of at least 500 calories on a regular schedule (a protein drink alone does not constitute a meal) once a day. Antacids should be administered either at least 2 hours before or at least 4 hours after Rilpivirine. Enteral feeding/enteral tube: Swallow tablet whole with water , cannot crush. Tablets for oral suspension are available for dispersing in water for administration. If the patient missed a dose, the patient should take the missed dose as soon as possible with a meal. Howe ver,if it has been more than 12 hours since the last dose, skip the missed dose and continue the regular dosing schedule. Do not take a double dose to mak e up for a missed one. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Registry (APR) show no difference in the overall risk of birth defects for rilpivirine compared with the background rate for major birth defects of 2.7% in the Metropolitan Atlanta Congenital Defects Program (MACDP) reference population. 2. In animal reproduction studies, no adverse developmental outcomes were observed when drug was administered orally at exposure up to 15 (rats) and 314 70 (rabbits) times exposure in humans at recommended dose of 25 mg once daily.",breastfeeding:"It is not known whether Rilpivirine is secreted in human milk. Because of both the potential for HIV transmission and the potential for adverse effect events in nursing infants, mothers should be obstructed not to breastfeed if they are receiving Rilpivirine.",elderly:"None specifically to Rilpivirine.",paediatric:"Rilpivirine should not be administered to children less than 12 years of age and those who weigh less than 25 kg.",fasting:"Advice for nighttime dose taking."},sideEffects:["Common side effects are rash along with fever , swelling of the face, lips, mouth, tongue or throat, blisters, trouble breathing or swallowing, mouth sores, redness or swelling of the eyes (conjunctivitis), pain on the right side of the stomach (abdominal) area, or dark colored urine.","Severe skin and hypersensitivity reactions reported with rilpivirine-containing regimens, immediately discontinue treatment if hypersensitivity or rash develop and closely monitor clinical status, including hepatic serum biochemistries.","May increase risk for depressive disorders if coadministration with other NNR TIs. Avoid use with other NNR TIs."],others:{storage:"Store it at room temperature and away from light, excess heat and moisture.",other_points:"1. Mild to moderate renal impairment: No dose adjustment required. 2. Severe renal impairment or ESRD: Used with caution and with increased monitoring for adverse effects, plasma concentrations may be increased because of altered drug absorption, distribution and metabolism secondary to renal impairment. 3. Severe hepatic impairment (Child-Pugh Class C): Has not been studied."}},{id:"counsel-106",name:"Rivaroxaban",pharmacologicalGroup:"Factor Xa inhibitors",indication:"1. Prophylaxis of postoperative venous thromboembolism",dosage:"10 mg once daily. Dose starts 6-10 hours after surgery . Treatment duration: 2 weeks (major knee surgery); 5 weeks (major hip surgery). 2. Prophylaxis of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors, such as congestive heart failure, hypertension, age75 yrs, diabetes mellitus, prior stroke or transient ischaemic attack. Dosage: 20 mg OD (CrCl50 mL/min) or 15 mg OD (CrCl 15-49 mL/min) 3. Deep vein thrombosis, Pulmonary embolism Dosage: Treatment: Initially , 15 mg twice daily for 3 weeks. Maintenance: 20 mg once daily. Prevention of recurrence: 10 mg once daily, following completion of at least 6 months of anticoagulant therapy . May consider 20 mg daily in patients at high risk of recurrence. 4. Prevention of atherothrombotic events Dosage: In cases following an acute coronary syndrome: 2.5 mg twice daily in combination with aspirin alone, or aspirin plus clopidogrel or ticlopidine.",methodOfAdministration:"1. Must be taken at the dose prescribed 2. Swallow the tablet whole with water 3. MUST be taken with food to maximise absorption 4. Aim to take at the same time each day 5. Do not stop taking your medication unless advised to do so by your prescriber 6. If a dose is missed, take it as soon as possible (do not double the dose) Once daily dosing: take within 12 hours of missed dose, if more than 12 hours, omit the dose and then continue at the usual time. Twice daily dosing: take within 6 hours of missed dose, if more than 6 hours, omit the dose and then continue at the usual time.",specialConsiderations:{pregnancy:"Use Rivaroxaban with caution in pregnant women due to the potential for obstetric haemorrhage and/or emergent delivery . Promptly evaluate signs and symptoms of blood loss. 317",breastfeeding:"Discontinue drug or discontinue nursing",elderly:"Beers Citeria: 1. At doses used for long-term treatment of VTE or nonvalvular atrial fibrillation, rivaroxaban appears to have higher risk of major bleeding and GI bleeding in older adults than other DOACs, particularly apixaban 2. Rivaroxaban may be reasonable in special situations, for example when once-daily dosing is necessary to facilitate medication adherence. ** alternative patient on enteral tube feeding",paediatric:"Rivaroxaban was not studied and therefore dosing cannot be reliably determined or recommended in children less than 6 months who were less than 37 weeks of gestation at birth, had less than 10 days of oral feeding, or had a body weight of less than 2.6 kg."},sideEffects:["The most concerning side effect is the bleeding, which is the result of the blood being too thin.  Bruising  Nosebleeds  Bleeding gums (careful when brushing teeth  use soft toothbrush)  Pink or brown urine  Red or black stools  Vomiting blood or material that looks like coffee grounds","Allergic reactions  Itching or hives  Swelling in face, hands, mouth, or throat  Difficulty breathing or chest tightness  Skin rash"],others:{storage:"1. Store at room temperature between 15C to 30C",other_points:"1. Renal impairment: To avoid usage when CrCl 50 mL/min 2. Moderate to severe hepatic impairment (Child-Pugh class B and C): Contraindicated."}},{id:"counsel-107",name:"Salicylic Acid, Topical",pharmacologicalGroup:"Keratolytic Agent",indication:"Salicylic Acid 2-10% Cream/Ointment 1. Indication: Seborrhoeic dermatitis, scalp, psoriasis & hyerkeratotic skin disorders.",dosage:"Apply sparingly to the affected area 2-3 times daily Salicylic Acid 20% Ointment 2. Indication: Plantar warts. Dosage: Apply daily.May need to continue up to 3 months",methodOfAdministration:"Salicylic Acid 2-10% Cream/Ointment NA Salicylic Acid 20% Ointment: a) Before using Salicylic Acid 20% ointment, moisten or soak the wart in warm water for but 5 minutes to help soften the treatment area. b) Dry thoroughly . c) Use the emery board to remove the top dead skin layer of the skin. d) Protect surrounding healthy skin (eg white soft paraf fin or specifically designated plaster). e) Apply the ointment onto the affected area.",specialConsiderations:{pregnancy:"Should be only used only if potential benefit outweighs the potential risk to the fetus. 2. It should not be used extensively in large amounts or prolonged periods in pregnant women.",breastfeeding:"Should be used cautiously in nursing mothers. If used by nursing mothers, should not be used on the chest area to avoid accidental contamination of the child.",elderly:".",paediatric:"Avoid prolonged use over large areas; may result in salicylism. 2. Limit application area in children <12 years of age. 3. Use caution in children with varicella or influenza.",fasting:"To refer to the latest advisory by religious authority 320"},sideEffects:["Contact dermatitis or skin irritation; flushing, unusually warm skin, burning sensation, pruritus and stinging of skin.","Skin ulceration","Excessive drying and peeling of skin Management:","Do not use large amounts or longer than directed.","If irritation or sensitisation develops, seek medical advice."],others:{storage:"1. Keep the tube tightly closed. 2. Store below 30C. 3. Protect from heat, moisture and light.",other_points:"NA"}},{id:"counsel-108",name:"Selective Norepinephrine Reuptake Inhibitor (SNRI",pharmacologicalGroup:"Serotonin Norepinephrine Reuptake Inhibitor (SNRI) Duloxetine Venlafaxine Desvenlafaxine",indication:"1. Duloxetine: a. Major Depressive Disorder , Diabetic peripheral neuropathic pain : Initial: 60 mg once daily up to a maximum dose of 120mg/day (in divided doses) b. Generalised Anxiety Disorder Initial: 30 mg once daily up to a usual recommended dose of 60 mg/day 2. Venlafaxine: a. Major Depressive Disorder , Generalised Anxiety Disorder , Social Anxiety Disorder: Initial:75mg OD, may g radually increase based on response and tolerability to a maximum 225 mg/day (severe depression, max: 375mg/day) b. Panic Disorder: Initial: 37.5mg/day , may g radually increase based on response and tolerability to a maximum 225mg/day 3. Desvenlafaxine: a. Major Depressive Disorder Recommended: 50mg once daily. The maximum dose should not exceed 200 mg/day . Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Duloxetine Delayed Release Capsule: Must be swallowed whole with fluid and not divided, crushed, chewed. Can be taken with or without food 2. Venlafaxine Extended-Release Capsule: It is recommended that venlafaxine extended-release capsules can be taken with food. Capsule must be swallowed whole with fluid and not divided, crushed, chewed or dissolved or it may be administered by carefully opening the capsule and sprinkling the entire contents on a spoonful of applesauce. This drug/food mixture should be swallowed immediately without chewing and followed with a glass of water to ensure complete swallowing of the pellets. 3. Desvenlafaxine Extended-Release Capsule: Must be swallowed whole with fluid and not divided, crushed, chewed. Can be taken with or without food Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"or become pregnant while taking antidepressants.",breastfeeding:"women if the expected benefits outweigh any possible risk",elderly:"with CrCl less than 30ml/min due to increased GI adverse effect. STOPP/Start Criteria: 1) Avoid Serotonin/noradrenaline reuptake inhibitors (SNRI s e.g., venlafaxine, duloxetine) and severe hypertension i.e., systolic blood pressure > 180 mmHg +/- diastolic blood pressure > 105 mmHg (likely to make hypertension worse). Pediatrics Safety and efficacy in pediatrics patients have not been established.",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"Duloxetine : Avoid use Venlafaxine : Decrease total daily dose by 50% Desvenlafaxine : No adjustment",renalImpairment:"Duloxetine: eGFR > 30ml/min : there is no dosage adjustment eGFR 30mL/min or less: avoid use Venlafaxine : eGFR 30  89 mL/min: decrease total daily dose by 25% t0 50% eGFR 30mL/min or less: reduce total daily dose by 50% or more Desvenlafaxine: eGFR 30mL/min or less: 25mg daily 323"},sideEffects:["Hypertension: Check blood pressure before initiating the treatment and regularly monitor during treatment. (more common with venlafaxine & desvenlafaxine)","Anticholinergic: a. Blurred vision(more common with desvenlafaxine & venlafaxine), constipation, urinary retention and dry mouth b. Constipation can be managed by physical activity , fluid and fibre intake or laxatives.","Neurologic a. Anxiety: Contact your prescriber if intolerable b. Headache, dizziness, fatigue, weakness, insomnia, agitation, nervousness, restlessness. May require dosage adjustment. Inform prescriber at next appointment c. Sedation: Avoid activity requiring mental alertness or coordination. Do not drink alcohol during treatment with this medicine as it might increase the sedative effect. Do not drive or work with tools or machinery if affected. Inform prescriber at next appointment.","Gastrointestinal: a. Nausea & vomiting: consider taking doses with food b. Heartburn, anorexia(more common with desvenlafaxine & venlafaxine), diarrhea, abdominal discomfort such as gastric or bloatedness c. Weight Gain: advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise.","Sexual Dysfunction: Decrease libido, delayed ejaculation, anorganism and erectile dysfunction a. Inform prescriber at next appointment","Hyponatremia and SIADH: Rare but potentially fatal side effects a. Signs and Symptoms: headache, difficulty concentrating, memory changes, confusion, weakness and unsteadiness on your feet. In severe or more sudden cases, symptoms can include: hallucinations (seeing or hearing things that are not real), fainting, seizures and coma b. Contact your prescriber and restrict water intake","Sweating (more common with desvenlafaxine & venlafaxine)","Liver failure with or without jaundice Most side effects are immediate but often go away with time. 324 It may take a few weeks before you feel any improvement. Therefore, do not change the dose of the medicine or stop taking the medicine without consulting your doctor first. Instruct patient to immediately report worsening depression, suicidal ideation, especially at initiation of therapy (children and adolescents are at higher risk for these effects during the first few months of therapy)."],others:{storage:"Store below 30c. Protect from light and moisture.",other_points:"1. Significant Pharmacodynamic Interactions a. Risk of life-threatening Serotonin syndrome when SSRIs co-prescribed with serotonergic drugs. (e.g. tramadol, ondansetron, sumatriptan, MAOI) Signs and Symptoms i. Mild: Insomnia, anxiety , nausea, diarrhea, hypertension, tachycardia, hyper-reflexia ii. Moderate:Agitation, myoclonus, tremor , mydriasis, flushing, diaphoresis, low fever (<38.5C) iii. Severe: Severe hyperthermia, confusion,rigidity , respiratory failure, coma, death Management: Seek immediate medical attention if you experience any of the symptoms mentioned above. b. Increase risk of upper GI bleeding if SSRIs are used together with Aspirin and NSAID due to inhibition of platelet aggregation. Watch out for black or tarry stools, easily bleeding gums or spontaneous bruises c. Risk of hyponatremia especially if SSRIs are used with drugs such as diuretics. 2. Discontinuation Syndrome a. SSRIs should not be stopped abruptly as this may cause discontinuation/ withdrawal symptoms. The symptoms are usually mild and selflimiting (e.g. include flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances and hyperarousal), but can occasionally be severe and prolonged. b. The patients must inform prescribers if they wish to change or stop medications"}},{id:"counsel-109",name:"Inhibitors (SSRIs) / Multimodal Serotonin Modulator",pharmacologicalGroup:"Selective Serotonin Reuptake Inhibitors (SSRIs) Fluoxetine Sertraline Fluvoxamine Escitalopram Multimodal serotonin modulator Vortioxetine",indication:"1. Escitalopram : a. Major depression, Social anxiety disorder (social phobia), Obsessive-compulsive disorder (OCD), Generalised Anxiety Disorder (GAD): Adult Initial 10mg/day , may gradually increase based on response and tolerability to a maximum dose of 20mg/day b. Treatment of panic disorder with or without Agoraphobia: Adult Initial: 5mg/day , may gradually increase based on response and tolerability to a maximum dose of 20mg/day 2. Fluvoxamine a. Depression: Adult Initial: 50 - 100 mg daily in the evening, increased if necessary to 300 mg daily b. Obsessive Compulsive Disorder: Adult: 50mg per day for 3  4 days, increase gradually up to a maximum of 300 mg/day c. Doses over 150 mg should be given in 2 -3 divided doses 3. Fluoxetine a. Depression, Obsessive-compulsive disorder: Adult Initial 20mg/day may gradually increase based on response and tolerability to a maximum dose of 80 mg/day 4. Sertraline a. Major depression, obsessive-compulsive disorder (OCD) Initial 50mg/day may gradually increase based on response and tolerability to a maximum dose of 200mg/day b. Panic disorder , Social anxiety disorder (social phobia), Post-traumatic stress disorder Initial 25mg/day then after one week, the dose should be increased to 50 mg/day . Thereafter , may gradually increase based on response and tolerability to a maximum dose of 200mg/day 5. Vortioxetine a. Major depression 327 Adult Initial:10mg/day may gradually increase based on response and tolerability to a maximum dose of 20mg/day Or To counsel based on specific medication s indication and dosage as prescribed by the doctor .",dosage:"See indication for dosage details",methodOfAdministration:"General Instructions : 1. Must be swallowed whole with water , and must not be chewed or crushed. Specific Instructions : 1. Fluoxetine should be taken in the morning due to its activating properties. 2. Fluvoxamine is preferably taken in the evening as it tends to be sedative. Doses > 150 mg to be taken at divided dose with higher dose taken at evening. 3. Sertraline and Escitalopram, generally not sedating, can be taken once daily either morning or night. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"or become pregnant while taking antidepressants.",breastfeeding:"In general, a relative infant dose (RID) below 10% of the average maternal level of an antidepressant is considered safe. Reported RID 1. Escitalopram: 4.50 - 6.40% 2. Fluoxetine: 2.40 - 6.80% 3. Fluvoxamine: 0.20 - 0.62% 4. Sertraline: 0.50 - 3.70%",elderly:": 1. Escitalopram: Starting dose 5 mg/day . Maximum 10 mg/day . Risk of dose related increase in QTc prolongation. 2. Fluoxetine: Lower initial dose and/or longer dosing interval recommended. 3. Sertraline: No dose adjustment required. Beers Criteria: 1) SSRI may exacerbate or cause SIADH or hyponatremia; monitor sodium level closely when starting or changing dosages in older adults. 2) Avoid SSRI in patients with a history of fall or fracture; unless safer alternatives are not available. Avoid concomitant use of 3 or more CNS-active agents as may increase risk of fall. 1 328 3) Avoid SSRI if used together with warfarin. SSRI may increase the risk of bleeding. Caution if used together with other class of drugs that may induce bleeding (e.g. NSAIDS, antiplatelet) STOPP/Start Criteria: 1) Selective serotonin reuptake inhibitors (SSRIs) in combination with Vitamin K antagonist, direct thrombin inhibitor or factor Xa inhibitor with a previous history of major haemorrhage (increased risk of bleeding due to antiplatelet effects of SSRIs). 2) Selective serotonin re-uptake inhibitors (SSRI s) with current or recent significant hyponatraemia i.e., serum Na+ < 130 mmol/l (risk of exacerbating or precipitating hyponatraemia). 3) Selective serotonin re-uptake inhibitors (SSRI s) with current or recent significant bleeding (risk of exacerbation or recurrence of bleeding due to antiplatelet effects of SSRI s).",paediatric:") The safety and efficacy of Fluoxetine younger than 6 years of age have not been established. 2) The safety and efficacy of Fluvoxamine in pediatric patients younger than 8 years of age have not been established except for the treatment of OCD. 3) The safety and efficacy of Sertraline in pediatric patients younger than 6 years of age have not been established except for the treatment of OCD. 4) The safety and efficacy of Vortioxetine in pediatric patients have not been established.",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"(Child-Pugh score 10-15) is not recommended. 6. Vortioxetine: No dosing adjustment required.",renalImpairment:"Dose adjustments may be required in pre-existing or newly developed renal or"},sideEffects:["Neurologic a. Anxiety: Contact your prescriber if intolerable b. Headache, dizziness, fatigue, weakness, insomnia (more common with fluoxetine), agitation, nervousness, restlessness. May require dosage adjustment. Inform prescriber at next appointment c. Sedation: Avoid activity requiring mental alertness or coordination. Do not drink alcohol during treatment with this medicine as it might increase the sedative effect. Do not drive or work with tools or machinery if affected. Inform prescriber at next appointment.","Gastrointestinal: a. Nausea & vomiting: consider taking doses with food (more common with Sertaline) b. Heartburn, anorexia, diarrhea, abdominal discomfort such as gastric or bloatedness c. Weight Gain: advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise.","Sexual Dysfunction: Decrease libido, delayed ejaculation, anorgasmia and erectile dysfunction a. Inform prescriber at next appointment","Anticholinergic: a. Constipation can be managed by physical activity , fluid and fibre intake or laxatives.","Hyponatremia and SIADH: Rare but potentially fatal side effects a. Signs and Symptoms: headache, difficulty concentrating, memory changes, confusion, weakness and unsteadiness on your feet. In severe or more sudden cases, symptoms can include: hallucinations (seeing or hearing things that are not real), fainting, seizures and coma b. Contact your prescriber and restrict water intake","QTc Prolongation a. Escitalopram associated with higher risk of QTc prolongation (dose related)","Hyperhidrosis: abnormally excessive sweating thats not necessarily related to heat or exercise (common in Vortioxetine) a. Inform your prescriber at next appointment Most side effects are immediate but often go away with time. It may take a few weeks before you feel any improvement. Therefore, do not change the dose of the medicine or stop taking the medicine without consulting your doctor first. Instruct patient to immediately report worsening depression, suicidal ideation, especially at initiation of therapy (children and 330 adolescents are at higher risk for these effects during the first few months of therapy)."],others:{storage:"Store at a temperature below 30C.",other_points:"1. Possible Drug Interactions a. Cytochrome P450 Interaction with SSRIs Isoform Drugs Degree of Inhibition Clinical Relevance 1A2 Fluvoxamine Potent Avoid or use caution with Clozapine, Warfarin and Methylxanthines. 2C19 Fluoxetine Fluvoxamine Moderate Caution with concomitant warfarin due to increased risk of bleeding. Use with caution with medication metabolised by CYP2C19 (e.g Diazepam, Phenytoin). 2D6 Fluoxetine Escitalopram Sertraline Potent Weak-Moderate Weak-Moderate (> 150 mg/day) Avoid or use with caution with medications solely metabolised by CYP2D6 (e.g Metoprolol). Avoid coadministration of potent CYP2D6 inhibitors with Tamoxifen or use cautiously as the efficacy of Tamoxifen may be reduced. 3A4 Fluvoxamine Weak-Moderate Avoid or use with caution with medication metabolised by CYP3A4 (e.g Simvastatin, other HMG-CoA reductase inhibitors). 2. Significant Pharmacodynamic Interactions a. Risk of life-threatening Serotonin syndrome when SSRIs co-prescribed with serotonergic drugs. (e.g. tramadol, ondansetron, sumatriptan, MAOI) Signs and Symptoms i. Mild: Insomnia, anxiety , nausea, diarrhea, hypertension, tachycardia, hyper-reflexia ii. Moderate:Agitation, myoclonus, tremor , mydriasis, flushing, diaphoresis, low fever (<38.5C) iii. Severe: Severe hyperthermia, confusion,rigidity , respiratory failure, coma, death Management: Seek immediate medical attention if you experience any of the symptoms mentioned above. b. Increase risk of upper GI bleeding if SSRIs are used together with Aspirin and NSAID due to inhibition of platelet aggregation. Watch out for black or tarry stools, easily bleeding gums or spontaneous bruises c. Risk of hyponatremia especially if SSRIs are used with drugs such as diuretics. 3. Discontinuation Syndrome a. SSRIs should not be stopped abruptly as this may cause discontinuation/ withdrawal symptoms. The symptoms are usually mild and selflimiting (e.g. include flu-like 331 symptoms, insomnia, nausea, imbalance, sensory disturbances and hyperarousal), but can occasionally be severe and prolonged. b. The patients must inform prescribers if they wish to change or stop medications"}},{id:"counsel-110",name:"Sevelamer",pharmacologicalGroup:"Drugs for treatment of hyperkalemia and hyperphosphatemia Sevelamer",indication:"Control of hyperphosphataemia in adult patients receiving haemodialysis and peritoneal dialysis. a. Starting dose is one or two 800mg tablets three times per day with meals.Adjust by one tablet per meal in two weeks interval as needed to obtain serum phosphorus target (1.13 to 1.78mmol/L). To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"To swallow whole WITH meals. DO NOT crush, chew or break. Missed dose management: If a dose is missed, it should be skipped. Do not double the dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Sevelamer is not absorbed systemically , therefore fetal risk is minimal. But may reduce maternal absorption of folic acid and fat soluble vitamins.",breastfeeding:"infant.",elderly:"patients should be cautious, usually starting at the lower end of the dosing range. 2. Swallowing difficulties (dysphagia): May benefit from alternative formulations.",paediatric:"Not recommended to be used in children that are below 6 years of age, have a BSA below 0.75 m2 , or that have mild hyperphosphatemia.",fasting:"schedule during Ramadhan; to take during Sahur and Iftar. 2. If more than two doses have been prescribed, consult with your healthcare provider to adjust your phosphate binder administration."},sideEffects:["Serious adverse events: Cases of dysphagia and esophageal tablet retention have been reported in association with use of the tablet formulation of Sevelamer , some requiring hospitalization and intervention.","Cases of bowel obstruction and perforation have also been reported with Sevelamer use.","Constipation may be a preceding symptom.","Others: Endocrine & metabolic: Metabolic acidosis Gastrointestinal: Abdominal pain, constipation, flatulence, peritonitis Dermatologic: Pruritus, skin rash."],others:{storage:"1. Store at room temperature. 2. Store in a dry place and protect from moisture. 3. Keep out of reach of children.",other_points:"333 No dosage adjustment provided in the manufacturer s labelling"}},{id:"counsel-111",name:"SGLT2) Inhibitor (SGLT2-i",pharmacologicalGroup:"Antidiabetic agent, Sodium-Glucose Cotransporter 2 (SGL T2) Inhibitor",indication:"1. Add-on combination therapy in combination with other glucose-lowering medicinal products including insulin, to improve glycaemic control in adult patients with type 2 diabetes mellitus when these, together with diet and exercise, do not provide adequate glycaemic control. Dapagliflozin: 10mg once daily Empagliflozin: 10mg once daily (starting dose), 25mg once daily (maximum dose) 2. To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD). Dapagliflozin: 10mg once daily Empagliflozin: 10mg once daily (starting dose), 25mg once daily (maximum dose) 3. To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class ll - lV) with reduced ejection fraction. Dapagliflozin: 10mg once daily Empagliflozin: 10mg once daily 4. For cardiorenal protection in adult patients with chronic kidney disease, with or without Type 2 Diabetes Mellitus, with eGFR25mL/min/1.73m2 and urine albumin creatinine ratio (UACR) 200-5,000mg/m2 (or the equivalent in uPRC/u-dipstick) receiving stable treatment with ACEi or ARB (unless they are contraindicated or not tolerated). Dapagliflozin: 10mg once daily",dosage:"See indication for dosage details",methodOfAdministration:"Administration 1. Swallow the tablet whole with water . 2. Do not chew , crush or split the tablet (no data available on enteral feeding). 3. Take the tablet with or without food. 4. Take it once a day, in the morning. Missed dose management: 1. Take a missed dose as soon as you remember it. 2. If it is close to the time for your next dose (<12 hours until the next dose), skip the missed dose and take the next dose at the usual time. 3. Do not take a double dose to make up for a forgotten dose. Do not stop taking your medication unless advised to do so by your prescriber Special Pregnancy 335 Consideration 1. Pregnancy Category: C (should be avoided especially during 2 nd or 3 rd trimester of pregnancy) 2. To discontinue medications once pregnancy is detected as a precautionary measure. Animal studies have shown adverse effects on postnatal development. Breastfeeding Should not be used while breastfeeding due to insuf ficient data on the excretion of SGLT2-i into human breast milk. Elderly MALPIP 1. Higher incidence of volume depletion-related adverse reactions (hypotension., acute kidney injury). To assess volume status and blood pressure before initiating treatment. Beers Criteria 1. Use with caution. Monitor patient for urogenital infection and ketoacidosis (increased risk of urogenital infections and euglycaemic diabetic ketoacidosis in elderly). Paediatric 1. Empagliflozin can be used in children aged 10 years and older for the treatment of type 2 diabetes. No data are available in children below 10 years of age. Not recommended for children and adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, because it has not been studied in these patients. 2. Dapagliflozin is not to be used in children and adolescents under 18 years of age. Fasting 1. No dosage adjustment is needed during fasting 2. Advisable to be taken after iftar. 3. Ensure good hydration is maintained To refer to the latest advisory by religious authority",specialConsiderations:{},sideEffects:["Polyuria, dehydration and hypotension - The degree of polyuria is typically higher in people with more marked hyperglycaemia. - Management: a. Maintain adequate hydration (mindful of any fluid restrictions required for renal disease or heart failure) b. For elderly patients or those on other antihypertensives, blood pressure should be reassessed one to two weeks after SGLT2 inhibitor commencement","Urinary tract infections - Mostly mild to moderate - Occurs more frequently in female patients - Symptoms : a. Burning or pain during urination b. Frequent urination c. Strong-smelling urine d. Fever , nausea & vomiting - General advice to reduce the likelihood of urinary tract infections: a. Maintain good genital hygiene. b. Wash genital area from front to back and wipe genital organs with clean clothes c. Do not hold urine.","Genital mycotic infections - Mostly mild to moderate - Symptoms: a. Swelling in the genital area b. Pain/ itchiness in the genital area c. Foul-smelling vaginal or penile discharge - General advice to reduce the likelihood of genital infections: a. Clean the private part thoroughly following urination, defecation or sexual intercourse. b. Wash the genital area from front to back and wipe genital organs with clean clothes. c. Change sanitary pads or adult diapers frequently . d. Seek medical attention if there are symptoms of urogenital infection","Diabetic ketoacidosis (DKA) / Euglycemic ketoacidosis - This can occur due to dehydration - Signs and symptoms: a. Unusual fatigue b. Nausea, vomit c. Frequent urination d. Fruity smelling breath e. Shortness of breath - General advice: a. Temporarily stop taking SGLT2-i when unwell (vomit/diarrhoea/fever) or when unable to eat/drink as usual. Resume taking SGLT2-i once able to eat/drink as usual. b. Interruption of treatment should be considered in patients who are hospitalized for major surgical procedures, serious infections or acute serious medical illness. c. Drink plenty of fluid to avoid dehydration."],others:{storage:"Store at room temperature (<30C) in a dry place.",other_points:"1. Liver impairment a. No dosage adjustment is required. b. Severe: no data (Dapagliflozin) 2. Renal impairment a. More likely to experience hypotension. b. Higher risk for acute kidney injury . c. Increased risk of urinary tract infection. d. Contraindicated use in ESRF and dialysis patients. 3. SGLT2 -inhibitor should not be used in Type 1 Diabetes Mellitus. 4. Use with caution in patients who may be at higher risk of DKA (i.e very low carbohydrate diet, patients with conditions that restricted food intake, severe dehydration, or conditions that increased insulin requirements due to acute medical illness, surgery or alcohol abuse). If DKA is suspected, discontinue use of SGLT2 -inhibitor 336"}},{id:"counsel-112",name:"Sodium Valproate",pharmacologicalGroup:"Mood Stabiliser",indication:"1. Treatment and prevention of mania associated with bipolar disorders a. Initial",dosage:"Fixed dose method: 500 - 1000mg/day in divided doses. Loading dose method 20mg-30mg/kg in divided doses (Therapeutic range in mania 50 -125 mg/L) b. Usual maintenance dose range: 1g/day - 2.5g/day (suggested max; 3g/day; Therapeutic range 50 -100 mg/L) 2. Epilepsy a. Initially 15mg/kg then increased by 5-10 mg/kg at weekly intervals until seizures are controlled. Max 60 mg/kg daily administered in divided doses if total daily dose exceeds 250 mg",methodOfAdministration:"1. Sodium valproate enteric coated 200mg and and Epilim Chrono Controlled Release 500mg a. Tablets should be swallowed whole.Do not crush or chew the tablets. b. Tablets are hygroscopic. The tablet should not be removed from the foil or container until immediately before they are taken. c. Epilim EC tablet should be taken in divided doses. d. Epilim Chrono can be taken once or twice daily 2. Missed dose management: If you forget to take a dose, take it as soon as you remember . Do not take two doses at once. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". 2. Men and women taking Valproate should practise effective contraception methods. 3. Talk to your doctor immediately if you plan to have a baby or become pregnant while taking this medication. 4. Patient card for sodium valproate may be issued to patient as educational material",breastfeeding:"should be weighed against the potential risk of adverse effects occurring in the 339 infant. 2. If medication is continued, infants exposed to valproate via breast milk should be monitored for sign of liver damage, including jaundice and unusual bruising or bleeding",elderly:"with history of falls or fractures ( unless used for seizure or mood disorders) and unless safer alternatives are not available, syncope , impaired psychomotor function, or ataxia may occur 2. Avoid concomitant use of 3 or more CNS active agents in any combination due to increased risk of falls.",paediatric:"The safety and efficacy of Sodium Valproate for the treatment of manic episodes in bipolar disorder has not been established in patients aged less than 18 years (product leaflet).",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"Child-T urcotte-Pugh class A: Lowest dose possible, gradually adjust dose to reach desired clinical effect. 2. Child-T urcotte-Pugh class B & C: Contraindicated",renalImpairment:"CrCl >10ml/min: No dosage adjustment 2. CrCl <10ml/min: No specific dosage adjustment necessary . Free valproate clearance reduces to ~ 30%. Closely monitor clinical response and tolerability in addition to TDM level when appropriate"},sideEffects:["Weight gain: Advise on nutritional counselling (avoid low-volume, high-calorie foods) and emphasize need for physical exercise.","Gastrointestinal a. Nausea, vomiting, gingival hyperplasia, stomatitis, upper abdominal pain upper , diarrhoea frequently occur in some patients at the start of treatment, but they usually disappear after a few days without discontinuing the treatment b. Taking with or after food may minimise the GI upset 340","Hepato-biliary disorders a. Liver injury , severe liver damage, including hepatic failure sometimes resulting in death, has been reported. b. Symptoms may include but are not limited to jaundice, abdominal pain, lethargy . Immediately contact your prescriber .","Nervous system disorders a. Tremor , somnolence, sedation and dizziness b. Occurs early in treatment and is usually transient, wears off over time c. May require dosage adjustment. Inform your prescriber at next appointment","Blood and lymphatic disorders a. Anaemia and thrombocytopenia: Spontaneous bruising or bleeding, blood in stools or black tarry stools. Immediately contact your prescriber ."],others:{storage:"Store at a temperature below 30C, protect from light and moisture.",other_points:"1. Contraception a. Concomitants of oestrogen-containing products, including oestrogen-containing hormonal contraceptives, may potentially result in decreased valproate efficacy . 2. Drug-drug interaction Advise patients always let healthcare providers know about all the medications they are taking, including over-the-counter drugs and supplements a. Valproate may potentiate the effect of other psychotropics such as neuroleptics, MAO inhibitors, antidepressants and benzodiazepines; therefore, clinical monitoring is advised and dosage should be adjusted when appropriate b. Clinical toxicity has been reported when valproate was co-administered with carbamazepine as valproate may potentiate toxic effect of carbamazepine c. Epilim reduces the metabolism of lamotrigine and increases the lamotrigine mean half-life by nearly two-fold. This interaction may lead to increased lamotrigine toxicity , in particular serious skin rashes d. Valproic acid may decrease the olanzapine plasma concentration e. Carbapenem antibiotics such as imipenem, panipenem and meropenem: Decreases in blood levels of valproic acid f. Rifampicin may decrease the valproic acid blood levels resulting in a lack of therapeutic effect 3. Blood levels can be drawn to make sure that the drug levels are in the right range to get the most benefit with the least side effects. Encourage patients to learn their own blood levels. 4. Monitoring parameters: a. Serum level of valproate b. Liver function test c. Blood count with platelets 341"}},{id:"counsel-113",name:"Spironolactone",pharmacologicalGroup:"Antagonists of Mineralocorticoid Receptors: Potassium-sparing Diuretic; Aldosterone antagonist",indication:"Key Monitoring Before Starting Therapy 1. Serum Potassium : <5 mmol/L 2. eGFR : >30 mL/min/1.73 m If Issues Arise: Hyperkalemia or Kidney Function Decline :  Reduce dose or switch to every-other-day dosing.  Discontinue if serum potassium >5.5 mmol/L despite adjustments.  Investigate other causes before stopping permanently Hypertension  25-100mg/day (once daily or split into two doses)  Doses greater than 100mg/day do not provide additional reduction in blood pressure Heart Failure with Preserved Ejection Fraction (HFpEF) Dosing:  Initial: 12.5 mg once daily  Adjustments: Double dose every 24 weeks if stable, up to 50 mg/day Conservative Approach:  Start or increase dose only if potassium 4.7 mmol/L Heart Failure with Reduced Ejection Fraction (HFrEF) Dosing:  Tablet: 12.525 mg once daily. Max: 50 mg/day (can divide into 12 doses) Titration:  Increase dose every 4 weeks if stable Post-Myocardial Infarction (MI) with Reduced Ejection Fraction (Off-label) Dosing:  Tablet: 12.525 mg once daily. Max: 50 mg/day Note: Regularly monitor serum potassium and kidney function during treatment.",dosage:"See indication for dosage details",methodOfAdministration:"Tablet: Take with or without food, but stay consistent with how you take it.",specialConsiderations:{pregnancy:". Patients with primary aldosteronism (PA) should stop spironolactone before conception or during the first trimester . Alternative treatments are recommended if PA remains uncontrolled. Potassium-sparing diuretics like spironolactone have been used in rare cases to treat conditions like Gitelman syndrome during",breastfeeding:"against potential infant exposure and the mother s need for treatment.",elderly:"STOPP/ST ART Criteria: 1. Avoid spironolactone if eGFR < 30 ml/min/1.73m2 (risk of dangerous hyperkalaemia). 2. Avoid spironolactone with concurrent potassium conserving drugs (e.g., ACEI s, ARB s, amiloride, triamterene) without monitoring of serum potassium (risk of dangerous hyperkalaemia i.e., > 6.0 mmol/l  serum K should be monitored regularly , i.e., at least every 6 months)",paediatric:"dosing is based on experience with tablets and extemporaneously compounded suspension.",fasting:"NA"},sideEffects:["Adverse Reactions to Spironolactone: Key Considerations","Gynecomastia (Breast Enlargement) a. Description: May affect one or both breasts, usually reversible upon stopping the medication. b. Mechanism: Related to decreased androgen activity and increased estrogen effects. c. Onset: Delayed; occurs after 112+ months of therapy . d. Risk Factors: e. Higher doses (150 mg/day) f. Longer treatment duration g. Alternative: Consider switching to eplerenone (lower risk of gynecomastia).","Hyperkalemia (High Potassium Levels) a. Description: Can lead to serious complications, including hospitalization or death. b. Mechanism: Inhibits aldosterone, reducing potassium excretion. c. Onset: Intermediate; typically within 4 weeks of starting or adjusting the dose. d. Risk Factors: e. Kidney impairment f. Older age g. Excessive potassium intake (supplements, salt substitutes) h. Concurrent use of medications that increase potassium (e.g., ACE inhibitors, ARBs, NSAIDs) i. Heart failure, especially with diabetes or higher baseline potassium levels"],others:{storage:"1. Store below 30 o c. Keep away from children. 2. Protect from moisture and light",other_points:"Kidney Impairment (Adults) General Guidance:  Use with caution and monitor potassium closely .  Consider low-potassium diets or other interventions (e.g., loop diuretics, sodium bicarbonate) to manage risks. Heart Failure:  eGFR >50 mL/min: No dosage adjustment needed.  eGFR 3050 mL/min: Start with 12.5 mg daily or every other day. Increase gradually up to 25 mg/day if potassium remains <5 mEq/L.  eGFR <30 mL/min: Not recommended. Liver Impairment (Adults) General Guidance:  No dosage adjustment needed for liver cirrhosis (Child-T urcotte-Pugh Class A to C), but monitor closely due to slower drug elimination in liver impairment.  Careful dose titration is necessary , especially in patients with ascites and cirrhosis, as aldosterone levels may be elevated. 344"}},{id:"counsel-114",name:"Statin",pharmacologicalGroup:"Antihyperlipidemic (HMG  COA reductase inhibitor )",indication:" Simvastatin Indication: 1. Hypercholesterolaemia 2. Prevention of cardiovascular disease",dosage:"10 - 40 mg once daily. Maximum: 80 mg daily  Atorvastatin Indication: 1. Hypercholesterolaemia 2. Prevention of cardiovascular disease Dosage: 10 mg once daily. Maximum: 80 mg daily  Pravastatin Indication: Hypercholesterolaemia and coronary heart disease intolerant or not responsive to other forms of therapy . In health clinics, Pravastatin is restricted to HIV patients on HAAR T. Dosage: 10 - 20 mg once daily. Maximum: 40 mg daily.  Rosuvastatin: Indication: Dyslipidaemia not responsive to atorvastatin 40mg or equivalent doses of other statins Dosage: Initially 5-10 mg once daily (5mg in patients with pre-disposing factors to myopathy), increased if necessary at intervals of at least 4 weeks to 20 mg once daily, increased after further 4 weeks to 40 mg daily ONLY in severe hypercholesterolemia with high cardiovascular risk. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Simvastatin: Take in the evening. 2. Atorvastatin: Any time of the day with or without food. 3. Pravastatin: a. Any time of the day with or without food b. To take at least 1 hour before or 4 hours after bile acid sequestrant. 4. Rosuvastatin: a. Any time of the day with or without food b. Administer at least 2 hours before antacid containing both aluminium and magnesium Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"Avoid, can cause fetal harm 347",breastfeeding:".",elderly:"STOPP/ST ART Criteria: Avoid using statins for primary cardiovascular prevention in persons aged  85 and established frailty with expected life expectancy likely less than 3 years (lack of evidence of efficacy).",paediatric:"Safety and effectiveness in children below 10 years old have not been established except for Rosuvastatin can be used in children 7 years and above as well as Pravastatin in children 8 years and above.",fasting:"To refer to the latest advisory by religious authority",hepaticImpairment:"differs according to statin type.",renalImpairment:"Simvastatin a. Mild to moderate : No dose adjustment b. Severe (CrCl < 30ml/min), dosage above 10mg/day should be carefully considered c. 2. Atorvastatin: No dosage adjustment a. 3. Pravastatin: No dosage adjustment 4. Rosuvastatin - Mild to moderate: No dosage adjustment - Severe (CrCl < 30ml/min) 5-10mg OD"},sideEffects:["Elevated serum transaminases and hepatoxicity a. Patients who developed elevated transaminase levels should be monitored until abnormality resolves. b. Withdrawal of treatment is recommended if there is persistent increase in serum transaminases more than 3 times upper limit of normal.","Muscle- related effect (myalgia, myopathy , rhabdomyolysis) a. Patient should be advised of myopathy risk, and rhabdomyolysis and to report any unexplained muscle pain, tenderness, or weakness b. Discontinued immediately in patients with rhabdomyolysis","Gastrointestinal (constipation, nausea, dyspepsia, diarrhea)"],others:{storage:"Store at room temperature 348",other_points:"1. Avoid grapefruit juice. 2. Use of gemfibrozil should be avoided in combination with pravastatin or simvastatin. 3. Patients on higher doses of atorvastatin may be at increased risk of digoxin toxicity; close monitoring of digoxin toxicity is recommended. 4. Strong CYP3A4 inhibitors are contraindicated with use of simvastatin."}},{id:"counsel-115",name:"calamine/ petrolatum",pharmacologicalGroup:"Parasiticidal",indication:"1. 1st line treatment of scabies for infants <2months old 2. 2nd line treatment of scabies for infants <2yo and pregnant woman To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Rinse off after 24 hours and then reapply every day for the next 3 days (with a bath taken in between each application). 2. Treat the whole body including the face (avoid eyes and mouth). Missed dose management : If a dose is missed, use it as soon as possible. If it is almost time for the next dose, use only that dose. Do not use double or extra doses. Do not stop your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Safe for pregnant women.",breastfeeding:"women.",elderly:"None specifically to the product.",paediatric:"Safe for infants.",fasting:"N/A"},sideEffects:["Skin Irritation."],others:{storage:"1. Store at room temperature below 25C. 2. Discard any unused medicine after the expired date. *Mandatory for validation / peer review",other_points:"N/A"}},{id:"counsel-116",name:"by: Name & Signature Date: Tacrolimus",pharmacologicalGroup:"Calcineurin inhibitors",indication:"1. Primary immunosuppression in liver and kidney allograft recipients 2. Liver and kidney allograft rejection resistant to conventional immunosuppressive agents. Available in two formulations: i) Tacrolimus immediate release (IR) - Prograf  ii) Tacrolimus prolonged release (PR) - Advagraf   Both are in capsule form available in three strength: 0.5mg, 1mg and 5mg  Both are NOT interchangeable. : (WARNING: These two formulations are at risk of medication errors) Dose is adjusted based on therapeutic drug monitoring. To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Tacrolimus IR: To be swallowed whole twice daily, 12 hours apart. 2. Tacrolimus PR: To be swallowed whole once daily in the morning. 3. Both must be taken at the same time every day on an empty stomach (1 hour before or 2 hours after a meal) for the best absorption. 4. Do not chew , crush or open the capsule. 5. Capsules should be taken immediately following removal from the blister . 6. To ensure the accuracy of tacrolimus levels, it is important to take the tacrolimus after the blood is drawn for therapeutic drug monitoring. Missed dose management: 1. If an immediate release tacrolimus dose is missed, patients should take it as soon as possible, ideally within four hours. 2. If a prolonged-release tacrolimus dose is missed, the patient should take it as soon as possible within 14-15 hours. 3. Do not double a dose under any circumstances Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Tacrolimus can cross the placenta, causing risks to infants, including prematurity , birth defects, low birth weight, and fetal distress.It may still be used in pregnant women if there are no safer options available and if the benefits outweigh the potential risks to the fetus. 2. To inform specialist if you want to get pregnant / 352 pregnant",breastfeeding:"is not recommended.",elderly:"patient should be cautious, usually starting at the low end of the dosing range.",paediatric:"Younger children generally require higher maintenance doses on a mg/kg basis than older children, adolescents, or adults.",fasting:"is permissible,tacrolimus can be taken on an empty stomach during Sahur and Iftar. It's important to stay hydrated throughout the night. If you miss a dose during Sahur , you must break your fast that day to take the missed dose."},sideEffects:["Mild tremor is common.","Increased risk of infection. Seek healthcare advice if have any symptoms of infections such as fever , chills, or flu-like symptoms.","Metabolic abnormalities: diabetes mellitus, hyperlipidaemia, hyperkalaemia, hypomagnesemia","Hypertension","Nephrotoxicity","Increased risk of squamous cell skin cancer , therefore exposure to sunlight and UV light should be limited by wearing clothing and using a broad-spectrum with a sun protection factor (SPF) of 30 or higher are recommended when performing outdoor activities."],others:{storage:"1. Store at room temperature. 2. Prograf  : After opening the outer aluminium wrapper containing the blisters inside the box, the capsules remain stable for 3 months. 3. Advagraf  :After opening the outer aluminium wrapper containing the blisters inside the box, the capsules remain stable for 1 year. 4. The capsules should remain in the blister when kept in the pillbox.",other_points:"Severe liver impairment (Child-Pugh class C): Lower initial doses may be required (due to reduced clearance and increased half-life)."}},{id:"counsel-117",name:"Tar, Topical",pharmacologicalGroup:"Antipsoriatics for topical use",indication:"1. Eczema and Psoriasis 2. Seborrheic Dermatitis",dosage:"Apply sparingly to the affected area as required or as directed by your pharmacist or doctor .",methodOfAdministration:"1. Coal tar and salicylic acid shampoo (Sebitar shampoo) a. Use it 2-3 times a week. b. Wet hair, apply to the affected area & massage well. c. Apply for 5 minutes then wash off. d. Do not scratch the scalp as it will worsen the psoriasis. 2. Liquor Picis Carbonis 3% or 6% in Ung Emulsificans a. Start with coal tar in vaseline 1% and slowly titrate to higher strength if needed. b. Test dose: To apply onto the affected area (small amount). If a patient experienced irritation with LPC, please ask the patient to see a doctor immediately . c. Usually apply at night due to the unpleasant smell. 3. Coal tar solution 20% a. 1 cap (15 ml) added to 10L of water in a pail. b. Soak diluted solution for 20 minutes. c. Do not rinse again with tap water . 4. Ung Cocois Co a. Separate hair-Part your hair to expose the scalp for easy application. b. Apply directly to scalp areas where raised plaques are noticeable. c. Preferably to be applied at night. d. Use a towel or shower cap to wrap the scalp. e. Cover the pillow with a towel to prevent stains. f. Shampoo off the next morning. g. Apply on the scalp, wash off after 1 hour (for Cera scalp only) Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Do not apply to the breast and areas of skin that the infant may come in contact with or suck on. Extreme care should be taken to avoid contact with the mother's skin during treatment or a safer alternative should be chosen. 355",elderly:"NA",paediatric:"Safety and efficacy of tar preparations are established in pediatric patients. Follow the specific instructed duration and need for different potencies. 2. Safety and efficacy of topical salicylic acid preparations in pediatric patients below the age of 2 years have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["May cause staining, skin irritation, photosensitivity or folliculitis.","Avoid applying to open wounds."],others:{storage:"1. Keep the jar tightly closed. 2. Store below 30C 3. Protect from heat, moisture, and light. 4. Do not freeze. 5. Keep out of reach of children.",other_points:"NA"}},{id:"counsel-118",name:"Tenofovir Alafenamide",pharmacologicalGroup:"Antiretroviral: Reverse Transcriptase Inhibitor , Nucleotide (NRTI)",indication:"1. Indicated for the treatment of Chronic Hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35kg). a. One tablet once daily To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. May be administered orally with food. 2. If a patient vomits within 1 hour of taking Tenofovir Alafenamide, the patient should take another tablet. Missed dose management 1. Patients should take Tenofovir Alafenamide as soon as possible, provided that less than 18 hours have passed from the time it is usually taken. 2. If more than 18 hours have passed, the patient should not take the missed dose and simply resumes the normal dosing schedule. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:", if necessary .",breastfeeding:".",elderly:"No dose adjustment is required.",paediatric:"No safety and efficacy data available in children younger than 12 years of age or weighing < 35 kg.",fasting:"To be discussed with infectious disease consultant"},sideEffects:["The most frequently reported adverse reactions were headache, nausea and fatigue."],others:{storage:"Store in a dry place below 30 C. Store in the original container .",other_points:"357 1. Renal adjustment: No dose adjustment of Tenofovir Alafenamide is required in adults or adolescents with estimated creatinine clearance (CrCl) > 15mL/min or in patients with CrCl < 15mL/min who are receiving hemodialysis (Tenofovir Alafenamide should be administered after completion of hemodialysis treatment). The use of Tenofovir Alafenamide is not recommended in patients with CrCl < 15mL/min who are not receiving hemodialysis. 2. Hepatic impairment: Mild impairment (Child-Pugh A): No dose adjustment of Tenofovir Alafenamide is required. Decompensated cirrhosis (Child-Pugh B or C): Use is not recommended."}},{id:"counsel-119",name:"Tenofovir Disoproxil Fumarate (TDF",pharmacologicalGroup:"Nucleotide reverse transcriptase inhibitors",indication:"1. Use as first line monotherapy for chronic hepatitis B or as a rescue therapy for patients with drug resistance hepatitis B virus (according to resistant profile or treatment guidelines).",dosage:"300mg once daily 2. Treatment of HIV-1 infected adults in combination with other antiretroviral agents. Dosage: 300mg once daily plus other antiretrovirals 3. For antenatal patients only with chronic Hepatitis B with HBeAg reactive or HBV DNA more than 200,000 or deranged LFT. Dosage: 300mg once daily from 28 weeks of gestation and continue till 4 weeks postpartum Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"1. Can be taken orally with or without food. 2. Must be taken at the same time every day as instructed for it to be effective. 3. Continue taking this medicine as prescribed, even if you feel better . This medication does not cure hepatitis B; it helps to suppress the virus and prevent relapse. 4. For patients with swallowing difficulties, the tablet can be crushed and dispersed in water . 5. DO NOT RUN OUT OF MEDICA TION . Rell the prescription befor e it nishes. Missed dose management 1. If you miss a dose and it is less than 12 hours past your usual time, take the missed dose as soon as possible, then take the next dose at the usual time. 2. If more than 12 hours have passed since your missed dose, skip the missed dose and take your next dose at the usual time. 3. DO NOT take double doses to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"related outcomes during third trimester . 3. Preferred antiviral for hepatitis B e antigen-positive mothers or viral load >200,000 IU/ml (antiviral prophylaxis) 359",breastfeeding:"is not contraindicated. 2. It is unknown if TDF affects lactation or has effects on breastfed children.",elderly:"Decreased bone mineral density , effects on long-term bone health and future fracture risk. Consider monitoring bone density in patients with history of pathologic fractures or with other risk factors for bone loss or osteoporosis.",paediatric:"For children  2 years weighing 10kg",fasting:"To take once daily during Sahur or Iftar .",renalImpairment:"CrCl > 50 mL/min: No dosage adjustment required 2. CrCl 30 - 49 mL/min: 300mg every 48 hours 3. CrCL 10 - 29 mL/min: 300mg every 72 - 96 hours 4. CrCl <10 mL/min: Has not been studied. If alternative therapy is not available, may consider 300mg every 7 days. 5. Hemodialysis: 300mg every 7 days. When a scheduled dose falls on hemodialysis day, TDF should be taken after hemodialysis."},sideEffects:["Side effects may include rash, diarrhea, nausea, dizziness, headache, fatigue and fever .","Advise patients to report symptoms of lactic acidosis (nausea, vomiting, abdominal pain, tachypnea) and liver problems (dark urine, light-coloured stools, or yellow skin or eyes).","Advise patients to report any bone problems such as bone pain. Take calcium and vitamin D as instructed by prescribers."],others:{storage:"1. Store below 30  C. 2. Keep medication in its original container , tightly sealed to protect from moisture and light. 3. Keep out of reach and sight of children.",other_points:"1. Advise patients against sudden discontinuation of TDF due to potential exacerbation of hepatitis B. 2. Advise patients to practise safe sex and ensure to take proper precautions to avoid transmission. This drug does not prevent disease transmission. Vomiting management 1. If vomiting occurs within 1 hour of dosing, an additional tablet should be taken. 2. If vomiting occurs more than 1 hour after dosing, no additional dose is needed. 360"}},{id:"counsel-120",name:"Tenofovir Disoproxil Fumarate / Emtricitabine",pharmacologicalGroup:"Antiretroviral - Nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs)",indication:"1. HIV-1 Treatment (in combination with other antiretroviral agents) a. One tablet orally once daily 2. In combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection in adults at increased risk. a. Daily PrEP: One tablet orally once daily b. Event driven PrEP (only for cisgender men, trans and gender diverse people assigned male at birth who are not taking exogenous estradiol-based hormones) : 2 loading tablets 2-24 hours before sex, followed by 1 tablet 24 hours later and 1 tablet 48 hours later.",dosage:"See indication for dosage details",methodOfAdministration:"1. It can be taken with or without food. Missed dose management 1. For HIV-1 treatment and daily PrEP , to take as soon as remember , however if gap is more than 12 hours, to skip and continue with regular dosing schedule 2. Event driven PrEP: to contact prescriber as post exposure prophylaxis (PEP) may be needed Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Excreted in breast milk, insuf ficient information in newborn/infants. 2. It is recommended that HIV infected women do not breastfeed their infants under any circumstances to avoid transmission to the infant.",elderly:"as they are more likely to have decreased renal function.",paediatric:"population below 35kg.",renalImpairment:"1. Monitoring of renal function required. 2. Dosage adjustment required for CrCl below 50ml/min: a. 30-49 ml/min: 1 tab EOD b. <30 ml/min : not recommended"},sideEffects:["Renal toxicity: Monitor kidney function; dose adjustments may be needed. Prevention: drink at least 1.52 litres of non-caf feinated fluid per day (preferably water & no requirement of fluid restriction).","Bone Density Loss : Consider calcium and vitamin D supplementation and regular bone health monitoring. 3."],others:{storage:"1. Do not store above 30C. 2. Protect from light.",other_points:"(headache, nausea, diarrhoea, or abdominal pain) : may require symptomatic treatment."}},{id:"counsel-121",name:"Ticagrelor",pharmacologicalGroup:"Antiplatelet-Non thienopyridine P2Y12 Antagonist",indication:"Co-administration with aspirin (ASA), for the prevention of atherothrombotic events: 1. Second line treatment for patients readmitted to hospital with recurrent atherothrombotic event failing treatment with clopidogrel. 2. STEMI patients going for invasive PCI 3. NSTEMI/UA patients with intermediate to high risk TIMI score. 4. Other complicated ACS cases treated either medically or invasively via PCI or CABG(risk of Stent thrombosis,3VD etc.)",dosage:"Initially , 180mg as a single dose followed by 90mg bd with maintenance dose of ASA 75-150mg daily.",methodOfAdministration:"1. Take with or without food. 2. Tablet can be crushed and mixed with half a glass of water and drank immediately . 3. Can be administered via a nasogastric tube.It is important to flush the nasogastric tube through with water after administration of the mixture. Missed dose management : If you forget or miss a dose, skip the missed dose and take your next dose at the usual time. Do not take two doses at once to make up for the missed dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Available pharmacodynamic/toxicological data in animals have shown excretion of ticagrelor and its active metabolites in milk.A risk to newborns/infants cannot be excluded. Drugs should be given only if the potential benefit justifies the potential risk to the newborn/infants.",elderly:"Beers Criteria: 1. Use with caution, particularly in adults 75 years old and older . Increase the risk of major bleeding in older adults compared with Clopidogrel, especially among those 75 years old and older . However , this risk may be offset by cardiovascular benefits in select patients. 364",paediatric:"The safety and efficacy of ticagrelor in children below the age of 18 in the approved adult indication has not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Most common: bleeding and dyspnoea.","Dizziness and confusion have been reported.Therefore, patients who experience these symptoms should be cautious while driving or using machines.","Hyperuricemia."],others:{storage:"Do not store above 30C",other_points:"1. No dosage adjustment is necessary for patients with renal impairment. 2. Contraindicated in patients with severe renal impairments.There is limited experience with ticagrelor in patients with moderate hepatic impairment therefore caution is advised."}},{id:"counsel-122",name:"Ticlopidine",pharmacologicalGroup:"Antiplatelet.",indication:"1. Prevention of thrombotic stroke for patients who are sensitive /intolerant to Acetylsalicylic Acid 2. Maintenance of coronary bypass surgery or angioplasty 3. Maintenance of patency of access in patients on chronic",dosage:"Ticlopidine 250mg twice daily",methodOfAdministration:"To be taken with food. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:". Animal reproduction studies have not shown teratogenic effects.",breastfeeding:"It is not known if ticlopidine is excreted in breast milk. Due to the potential for serious adverse reactions in the nursing infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of treatment to the mother .",elderly:"STOPP/ST ART Criteria: 1. Avoid ticlopidine in any circumstances (clopidogrel and prasugrel have similar efficacy , stronger evidence and fewer side-ef fects).",paediatric:"use.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Seek medical attention if you have signs/symptoms as below after initiation :","Fever , chills, sore throat or other sign of infection","Bruising, purpura","Prolonged/ abnormal bleeding, dark stool","Yellow eyes/skin, dark urine, light coloured stool","Fatigue, shortness of breath"],others:{storage:"Keep out of reach of children, Store in dry places below 30 o C. Protect from light.",other_points:"1. Renal impairment - Dose adjustment not necessary 2. Liver impairment - Use with caution. Contraindicated in severe liver impairment 366"}},{id:"counsel-123",name:"Tretinoin, Topical",pharmacologicalGroup:"Acne product; Vitamin A derivative",indication:"1. Treatment of Acne Vulgaris and recalcitrant cases of acne in which comedones,papules and pustules predominate. Apply once daily to the affected area at bedtime.",dosage:"See indication for dosage details",methodOfAdministration:"1. Wash face with a gentle, non-medicated cleanser and allow the face to dry thoroughly . 2. Apply a thin layer to the entire face or other affected area at night. 3. Wash well in the morning. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"should be avoided during treatment and for at least 4 weeks after discontinuing the use of tretinoin .",breastfeeding:".",elderly:"-specific problems have been documented to date.",paediatric:"patients below 9 years old have not been established. Precautions do apply .",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Erythema","Scaling","Dryness","Pruritus","Burning sensation","Photosensitivity","Skin peeling 368"],others:{storage:"1. Keep the container tightly closed. 2. Store at room temperature. 3. Protect from light, heat and moisture. 4. Keep medicine out of reach of children.",other_points:"1. After applying the medication, a mild sensation of warmth, slight redness, and a burning feeling may occur . 2. Some redness and skin peeling may occur in the days following application but should subside with time. 3. Protect the face from direct sunlight. Wear sunscreen. 4. Excessive sun exposure, including sunlamps, should be avoided while using the preparation. 5. Particular caution is needed when using products containing sulfur , resorcinol, or salicylic acid, as they may cause peeling or irritation when combined with tretinoin . 6. Prolonged or repeated use may lead to hypersensitivity . Excessive application should be avoided. If hypersensitivity symptoms occur , discontinue use and consult your physician. 7. Do not use the cream if the skin is weeping or severely inflamed. 8. Avoid contact with the eyes, mouth, and other mucous membranes. 9. For external use only. 10. Dispose of any remaining product in the tube after completing your course of treatment or once the product has expired."}},{id:"counsel-124",name:"Trihexyphenidyl (benzhexol",pharmacologicalGroup:"Antimuscarinic agents",indication:"1. Symptomatic treatment of paralysis agitans and of parkinsonism, arteriosclerotic, idiopathic, or post-encephalitic origin, spasmodic torticollis, facial spasms and other dyskinesia: Initially 1-2 mg daily. May gradually increase to 6-10mg daily according to response. 2. Alleviate extrapyramidal syndrome induced by phenothiazine derivatives or reserpine: From 5-15 mg daily in 3-4 divided doses Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. May be taken with or without food. 2. Take before meals if dry mouth occurs, after meals if drooling/ nausea occurs. 3. Take at the same time each day. 4. Missed dose: take as soon as you remember . If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not take 2 doses at the same time or extra doses. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"or become pregnant while taking this medication.",breastfeeding:".",elderly:"Beer Criteria : Avoid. Strong anticholinergic activity . Not recommended for prevention or treatment of extrapyramidal symptoms due to antipsychotics; more effective agents available for treatment of Parkinson disease.",paediatric:"patients have not been established.",fasting:"Administer during Sahur or after Iftar. To refer to the latest advisory by religious authority",hepaticImpairment:"Use with caution",renalImpairment:"Use with caution"},sideEffects:["Anticholinergic a. Blurred vision, constipation, urinary retention and dry mouth b. Constipation can be managed by physical activity , fluid and fibre intake or laxatives. c. Increased ocular pressure: Change in eyesight, eye pain, or severe eye irritation. Immediately contact your prescriber","Cardiovascular a. May cause rapid, slow or irregular heart beats","Neurologic a. Memory problems or loss, confusion, hallucination (seeing or hearing things that is not there), agitation, change in behavior , dizziness, nervousness","Other potentially concerning side effects a. GI s/e such as nausea & vomiting b. Unexplained fever or not sweating during activities or in warm temperatures c. Sensitivity to light"],others:{storage:"Store at a temperature below 30C. Other Used with caution in patients with arteriosclerosis, history of drug idiosyncrasy , CV disease, glaucoma, GI obstruction, prostatic hyperplasia and /or urinary stricture. Not intended for treatment of tardive dyskinesia",other_points:""}},{id:"counsel-125",name:"Trimetazidine/Trimetazidine Modified Release (MR",pharmacologicalGroup:"Antianginal drug, MOA: 3-Ketoacyl CoA thiolase [KAT] inhibitor",indication:"Prophylactic treatment of episodes of angina pectoris 1. Trimetazidine 20mg tds 20mg 3 times daily 2. Trimetazidine MR 35mg bd 35mg twice daily in the morning and evening with meals",dosage:"See indication for dosage details",methodOfAdministration:"1. To be taken with food. 2. For MR preparation, swallow whole. Do not split, crush. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:".",breastfeeding:"Not recommended.",elderly:"patients should be exercised with caution.",paediatric:"No data available.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:[],others:{storage:"1. Store below 30 o C. Keep out reach of children.",other_points:"( eg. hepatic impairment, renal impairment which will be relevant to the patient) Renal impairment 1. CrCl< 30ml/min: contraindicated 2. CrCl 30-60 ml/min: Require dose adjustment to Trimetazidine 20mg bd OR Trimetazidine MR 35mg om Side Effects and 1. New-onset or worsening of parkinsonian symptoms 372 their Management* (e.g. akinesia, hypertonia, tremor). Close monitoring in elderly and patients with renal impairment. 2. Drowsiness and dizziness. If affected, do not drive or operate machinery . 3. May cause headache; gastrointestinal disorders ie abdominal pain, diarrhea, dyspepsia, nausea, vomiting; rash, pruritus, urticarial; asthenia."}},{id:"counsel-126",name:"Verapamil",pharmacologicalGroup:"Antianginal; Calcium Channel Blocker , Nondihydropyridine Antihypertensive; antiarrhythmic agent",indication:"1. Supraventricular arrhythmias (SVT) prophylaxis : 120mg -480mg in 2-3 divided dose 2. Angina: 80mg-120mg 3 times daily 3. Hypertension: Initially 240mg daily in 2-3 divided dose Maximum : 480mg daily 4. Supraventricular tachycardia: Initially 5-10 mg via slow iv over at least 2 minutes.The dose can be repeated 10mg 30 minutes after the first dose if the initial response is not adequate.",dosage:"See indication for dosage details",methodOfAdministration:"1. Should be taken with food 2. Should not be taken with grapefruit juice Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Limited data. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.",breastfeeding:"Limited Human DataProbably Compatible",elderly:"STOPP/ST ART Criteria: 1. Avoid Verapamil with NYHA Class III or IV heart failure (may worsen heart failure with reduced ejection fraction i.e., HFREF). 2. Avoid beta-blocker in combination with verapamil (risk of heart block). 3. Avoid verapamil with bradycardia (< 50/min), type II heart block or complete heart block (risk of complete heart block, asystole) 4. Avoid apixaban, dabigatran, edoxaban, rivaroxaban and P-glycoprotein (P-gp) drug efflux pump inhibitors and verapamil (increased risk of bleeding) 5. Avoid acetylcholinesterase inhibitors with concurrent treatment with verapamil (risk of cardiac conduction failure, syncope and injury). 6. Avoid verapamil with chronic constipation where non-constipating alternatives are available (risk of exacerbation of constipation).",paediatric:"1. Antihypertensive 2 yr 20 mg 2-3 times daily; >2 yr 40-120 mg 2-3 times daily, depending on age and response. 2. Supraventricular arrhythmias : a. ORAL: 2 yr 20 mg 2-3 times daily >2 yr 40-120 mg 2-3 times daily, depending on age and response. b. IV: 1 years 0.1-0.2 mg/kg 1-15 years 0.1-0.3 mg/kg (Max: 5 mg). All doses to be given over at least 2 minutes, repeat after 30 min if needed.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["- Common side effect : AV block, bradycardia, worsening heart failure, transient asystole, hypotension, dizziness, flushing, fatigue, headache, dyspnoea, peripheral oedema, constipation, nausea, abnormal liver function, skin reactions, gingival hyperplasia, extrapyramidal symptoms.","- Rarely , gynaecomastia.","- Potentially Fatal: H epatotoxicity .."],others:{storage:"1. Store below 30 0 C, protect from light.",other_points:"( eg. hepatic impairment, renal impairment which will be relevant to the patient) 1. Renal impairment: No dosage adjustment. Not removed by hemo- or peritoneal dialysis; supplemental dose is not necessary 2. Liver impairment: Oral: In cirrhosis, reduce dose to 20% of normal and monitor ECG. IV: In cirrhosis, reduce dose to 50% of normal and monitor ECG."}},{id:"counsel-127",name:"Vitamin D Analogues",pharmacologicalGroup:"Antipsoriatics for topical use; Vitamin D Analogues",indication:"1. Psoriasis vulgaris 2. Resistant plaque psoriasis Calcipotriol 50mcg/g Ointment: ADUL T: Apply to the affected skin lesions twice daily. Maintenance therapy may be achieved with less frequent application. The weekly dose should not exceed 100g. CHILD over 6 years: apply twice daily. 6-12 years maximum 50gm weekly , over 12 years maximum 75gm weekly The dosing is individualized according to product insert / protocol. Calcipotriol Hydrate 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Ointment: Apply once daily up to 4 weeks with maximum weekly dose of 100g and maximum treatment area 30% of body surface. Calcipotriol Monohydrate 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Gel: Should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for non-scalp areas. The body surface area treated with calcipotriol containing products should not exceed 30% and maximum dose should not exceed 15g or 100g/ week. Calcipotriol Monohydrate 50mcg/g & Betamethasone Dipropionate 0.5mg/g Cutaneous Foam: Apply once daily up to 4 weeks with maximum daily dose of 15g and maximum treatment area 30% of body surface. Or To counsel based on specific medication s indication and dosage as prescribed by the doctor",dosage:"See indication for dosage details",methodOfAdministration:"Calcipotriol ointment:  Should be applied to the affected area.  Use as directed by your doctor or pharmacist Calcipotriol + Betamethasone Ointment:  Should be applied to the affected area. In order to achieve optimal effect, it is not recommended to take a shower or bath immediately after application. Once daily application (usually at night) Calcipotriol + Betamethasone Gel: 1. Use only for scalp psoriasis and do not use it on skin which does not have psoriasis. 2. Washing your hair before application of Xamiol is not necessary . 377 3. Shake the bottle before use and remove the cap. 4. Before applying Xamiol to the scalp, comb the hair to remove any loose scales. Apply Xamiol to the affected area with your fingertips, and rub it in gently . 5. Do not bandage, tightly cover or wrap the treated skin area. 6. Wash your hands well after using Xamiol. This will avoid accidentally spreading the gel to other parts of your body (especially the face, mouth and eyes). 7. In order to achieve optimal effect, it is recommended that the hair is not washed immediately after application of Xamiol. Let Xamiol remain on the scalp during the night or during the day. 8. Apply a mild shampoo to the dry hair, especially to those areas where the gel was applied. 9. Leave the shampoo on the scalp for a couple of minutes before washing. 10. Then wash your hair as usual. Calcipotriol + Betamethasone cutaneous foam:  Should be applied to dry skin on the affected areas of the body . For body psoriasis: 1. The can should be shaken for a few seconds before use. 2. Apply the foam by holding the can at least 3 cm from the skin and spray directly onto each affected area. 3. The foam can be sprayed holding the can in any orientation except horizontally . 4. It should be sprayed directly onto each affected skin area and rubbed in gently . 5. After applying the foam, put the cap back on the can to prevent accidental spraying when not in use. 6. Wash your hands well after using (unless you are using the foam to treat your hands). This will avoid accidentally spreading the foam to other parts of your body (especially the face, mouth and eyes). 7. In order to achieve optimal effect, it is recommended that the body is not washed immediately after application. Let the foam remain on the skin during the night or during the day. 8. The treated area does not need to be covered. You may wear your usual clothes however avoid contact with fabric that is easily stained by grease (e.g.silk). For scalp psoriasis: 1. Comb the hair to remove any loose scales. 2. Shake the can for a few seconds before use. 3. Hold the can at least 3 cm away . Spray directly into the palm of your hand. The foam can be sprayed holding the can in any orientation except horizontally . 4. Scoop the foam onto your finger and apply it directly to the affected areas. Minimize applying into the hair to make it easier to wash it out. Gently rub the foam into the scalp. After applying the foam, put the cap on the can to prevent accidental spraying when not in use. 5. Wash your hands well after using Enstilar (unless you are using the foam to treat your hands). This will avoid accidentally spreading the foam to other parts of your body (especially the face, mouth and eyes). 6. In order to achieve optimal effect, it is recommended that the hair is not washed immediately after 378 application. Let the foam remain on the scalp during the night or during the day. 7. Apply a mild, non-medicated shampoo to the dry hair, focusing on the areas where the foam was applied. It is easier to remove Enstilar when shampoo is applied to dry hair as water dilutes the cleansing effect of the shampoo. 8. Massage the shampoo into the dry hair/scalp. Leave the shampoo on the scalp for a couple of minutes before washing. 9. Rinse thoroughly with water . 10. Repeat normal shampooing if necessary . Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Limited data on humans. 2. Studies with animals show higher incidence of skeletal abnormalities. 3. Systemic absorption may occur with topical vitamin D analogues. Although the recommended topical dosage is considered safe, caution is required .",breastfeeding:".",elderly:"patients. Severity of skin-related adverse reactions may be increased compared to younger adults.",paediatric:") Safety and efficacy of topical Vitamin D analogues preparations in pediatric patients below the age of 6 years have not been established. 2) Safety and efficacy with a combination of topical steroids are established in pediatric patients. Follow the specific instructed duration, use different potencies on different areas, avoid sensitive areas and occlusion unless directed, and monitor for side effects such as skin atrophy or systemic absorption",fasting:"NA"},sideEffects:["Itching, rash, thinning of the skin, skin burning 379"],others:{storage:"Keep the jar tightly closed. Store below 30C and protect from heat, moisture, and light. Do not freeze. Keep out of reach of children. Calcipotriol + Betamethasone cutaneous foam: 1. Do not store above 25C. 2. Extremely flammable aerosol. 3. Pressurised container: May burst if heated. Protect from sunlight. Do not expose to temperatures exceeding 50C. 4. Do not pierce or burn, even after use. 5. Do not spray on an open flame or other ignition source. Keep away from sparks, open flames and other ignition sources. No smoking near the can.",other_points:"( eg. hepatic impairment, renal impairment which will be relevant to the patient) 1."}},{id:"counsel-128",name:"Warfarin",pharmacologicalGroup:"Anticoagulant, Vitamin K antagonist",indication:"Treatment and prophylaxis of thromboembolic disorders 1. Initially 2-5mg per day. 2. Maintenance dose 2-10mg daily according to the INR. 3. Dosing is individualised based on the patient's INR and according to product insert/ protocol/ guideline.",dosage:"See indication for dosage details",methodOfAdministration:"1. To be taken with or without food, at the same time each day. Missed dose management : 2. If you miss a dose (within 8 hours of usual time), take it as soon as you remember . 3. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. 4. Do not take a double dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"/ have become pregnant while taking warfarin.",breastfeeding:".",elderly:"Beers Criteria: Avoid starting warfarin as initial therapy for the treatment of nonvalvular atrial fibrillation or VTE unless alternative options (i.e., DOACs) are contraindicated or there are substantial barriers to their use. Rationale: Compared with DOACs, warfarin has higher risks of major bleeding (particularly intracranial bleeding) and similar or lower effectiveness for the treatment of nonvalvular atrial fibrillation and VTE. Patients more than 60 years of age tend to require lower dosage to produce a therapeutic level of anticoagulation. ( Due to changes in warfarin metabolism)",paediatric:"Initiation and follow up is carried out by pediatricians. Monitor to ensure INR is in therapeutic range. 381",fasting:"To be taken after breaking fast. To refer to the latest advisory by religious authority"},sideEffects:["Educate patients on symptoms of bleeding such as bruises of unknown cause, blood in urine/dark-coloured urine, black stools, gum bleeding or heavy menstrual bleeding.","Seek urgent medical attention if you experience symptoms as above."],others:{storage:"1. Store below 30 o c. Keep away from children. 2. Protect from moisture and light",other_points:"Renal impairment/ Hepatic impairment  Patients may have a higher risk of bleeding and enhanced response to warfarin. Monitor to avoid over-anticoagulation. 2, 3"}},{id:"counsel-129",name:"Zidovudine / Lamivudine",pharmacologicalGroup:"",indication:"",dosage:"See indication for dosage details",methodOfAdministration:"",specialConsiderations:{},sideEffects:[],others:{storage:"",other_points:""}},{id:"counsel-130",name:"Accuhaler",pharmacologicalGroup:"",indication:"The indication and dosage depend on the drug content.",dosage:"See indication for dosage details",methodOfAdministration:"DEVICE PREP ARA TION Before Every Use Make sure: The Accuhaler has not expired. The Accuhaler is not empty . Check inside the mouthpiece of the Accuhaler and ensure it is free from foreign objects. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Hold the outer case in one hand and place the thumb of the other hand on the thumb grip of Accuhaler to slide open the cover until a click sound is heard.  Hold the Accuhaler horizontally; slide the lever away as far as it will go until another click sound is heard. The dose is loaded. Note: Do not tip the Accuhaler upside down or shake the device after dose loading. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully, away from the Accuhaler . Chin & mouth Step 3  Slightly tilt the chin up.  Place the inhaler mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes: Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece. Inhale Step 4 Breathe in forcefully and deeply through the mouth. Hold breath Step 5 Remove the Accuhaler from the mouth, and with the lips closed, hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 1 Breathe out (exhale) gently , away from the Accuhaler . Close & Rinse Step 7  Close the device by sliding the thumb grip back to the original position until a click sound is heard.  Rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider patient-related factors such as inspiratory effort , manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Some DPIs may be appropriate for older children. Refer guidelines, for example Global Initiative for Asthma",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Keep it safely out of the reach of children.",other_points:"NA"}},{id:"counsel-131",name:"Breezhaler",pharmacologicalGroup:"",indication:"The indication and dosage depend on the drug content.",dosage:"See indication for dosage details",methodOfAdministration:"DEVICE PREP ARA TION Before Every Use Make sure: The Breezhaler capsule is not expired. The patient has the capsules. Check inside the mouthpiece of the Breezhaler and ensure it is free from foreign objects. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Pull off the cap and tilt the mouthpiece to open the inhaler .  Ensure the hands are dry and clean. Remove one capsule from the blister pack.  Insert the capsule into the chamber in the middle of the Breezhaler and close the mouthpiece until a click sound is heard.  Hold the inhaler upright and pierce the capsule by firmly pressing both side buttons at the same time. Pierce the capsule only ONCE.  Release the side buttons of the Breezhaler . Notes: Do not tip the Breezhaler upside down or shake the device after dose loading. Do not block the air vents. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully, away from the Breezhaler . Chin & mouth Step 3  Slightly tilt the chin up.  Place the inhaler mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes: Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece. Inhale Step 4 4 Breathe in forcefully and deeply through the mouth. A whirring sound is heard during inhalation. Notes : If the whirring sound is not heard, the capsule may be stuck in the capsule chamber . Loosen the capsule by gently tapping the base of the inhaler and start from step 2 again. Hold breath Step 5 Remove the Breezhaler from the mouth, and with the lips closed, hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 Breathe out (exhale) gently , away from the Breezhaler . Repeat Step 7 Open the mouthpiece and inspect for any remaining powder left in the capsule. If there is so, close the mouthpiece and repeat steps 2 to 6 ( do not pierce the capsule again). Note : A good practice based on expert opinion is to perform two separate inhalations from a single capsule. Close & Rinse Step 8  Remove the empty capsule and dispose appropriately .  Replace the mouthpiece with the cap after use.  Rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider patient-related factors such as inspiratory effort , manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Some DPIs may be appropriate for older children. Refer guidelines, for example Global Initiative for Asthma 5",fasting:"To refer to the latest advisory by religious authority ."},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Breezhaler capsules must always be stored in the blister card and only removed immediately before use.  Keep it safely out of the reach of children.",other_points:"NA"}},{id:"counsel-132",name:"Bowel Cleansing",pharmacologicalGroup:"Laxatives and bowel preparation agents: 1. Polyethylene Glycol/Macrogol 4000 Powder 2. Sodium picosulfate, magnesium oxide & citric acid powder 3. Monobasic Sodium Phosphate 48%, Dibasic Sodium Phosphate 18% 4. Sodium Biphosphate 16%, Sodium Phosphate 6% Rectal Solution",indication:"This medicine is used as part of a bowel cleansing procedure before x-ray examination, endoscopy , colonoscopy , radiological examination or colonic surgery . It works by producing bowel motions. It usually works within 30 minutes, however , it may take as long as 6 hours to produce the effect. Expect frequent liquid stools. The patient needs to stay close to a toilet until the cleansing effect is complete. Refer",dosage:"See indication for dosage details",methodOfAdministration:"for dosage of each agent. To counsel based on specific medication s indication and dosage as prescribed by the doctor <HEADER_METHOD> Polyethylene Glycol/Macrogol 4000 Powder 1. Dilute 1 sachet (3 in total) with 1 L of water (3 L in total) at the recommended timing by the physician. Volume adjustment is not needed for fluid restriction patients. 2. To improve the flavour , the solution may be chilled or lemon juice added. 3. Dosing time: a. Early morning procedure: First dose taken at 4 pm, second dose at 6 pm, and third dose at 8 pm, one day before the procedure. b. Afternoon (or later) procedure: First dose taken at 6 pm, second dose at 8 pm, one day before procedure and third dose at 6 am on the day of procedure. Sodium picosulfate, magnesium oxide & citric acid powder 1. Fill a mug with 150ml of cold water . Empty contents of 1 sachet in the mug. Stir until completely dissolved. 2. Following each dose, advise the patient to drink 1.5L to 2L of a variety of clear fluids over 4 hours. 3. No fluid should be taken at least 2 hours before the procedure. 4. Dosing time: a. Early morning procedure: First dose taken at 5pm and second dose at 9pm, one day before the procedure. b. Afternoon (or later) procedure: First dose taken at 7 pm, one day before procedure and second dose at 6 am on the day of procedure. Monobasic Sodium Phosphate 48%, Dibasic Sodium Phosphate 18% 1. Adult: 45 mL solution diluted in half glass cold water (~120 mL of cold water) for 2 doses. This should be drunk over  hour followed by at least 4  6 glasses of 7 plain water thereafter . Drink a glass of clear liquid before taking this preparation to prevent vomiting. 2. Dosing time: a. For morning appointment: First dose is given at 7 am then 2nd dose at 7 pm on the day before the procedure. b. For afternoon appointment: First dose is given at 7 pm on the day before the procedure then 2nd dose at 7 am on the day of the procedure. Timing recommendations may vary. Sodium Biphosphate 16%, Sodium Phosphate 6% Rectal Solution (Enema) 1. Lie on your left side with both knees bent and your arm are rest in front of you. 2. Remove protective shield from the enema tip while holding the bottle upright. 3. Gently insert enema tip into rectum with the tip pointing towards the navel. 4. Do not force enema into the rectum as this may cause injury . 5. Squeeze the bottle until nearly all liquid is expelled. It is not necessary to empty the bottle completely as it has more than the amount needed. 6. Remove enema from rectum. Maintain position until the urge to evacuate is strong (Usually 2-5 minutes). 7. Dosing regimen: Using more than 1 enema within 24 hours can be harmful. 8. The enema should be inserted 2 hours before the procedure. 9. Patients with stoma bag: 50ml to be inserted into stoma bag, another 50ml to be inserted through anal. 7 days before procedure: 1. Stop taking iron preparation. 2. Persons taking antiplatelet agents, e.g. aspirin, ticlopidine, should discontinue them upon a prior consultation with the prescribing physician. 3. Persons taking anticoagulants, e.g. Warfarin, should consult their attending physician. It should be withheld 3  5 days prior to the procedure and restarted within 24 hours. 4. Continuation or re-initiation of anticoagulation should be adjusted according to the stability of the patient and estimated risks surrounding the specific intervention/ procedure performed. Dietary and medication consideration:  2 days before procedure: 1. Eat a low residue and low fiber diet. Avoid fruits and vegetables, particularly those with fine seeds, red meat, high fibre breads or high fibre cereals.  1 day before procedure 1. Milk or milk products, red/purple-coloured drink or meal, alcohol and carbonated drink should not be taken. a. No solid food after lunch. b. Drink plenty of clear water before midnight.  On the day of procedure 1. Continue taking other medications as advised by the doctor a. Check on the patient's medication list that to be continued, stopped or day for reinitiating. 8  Clear fluid list 1. Water, tea or coffee (no milk or non dairy creamer), sweeteners are acceptable. 2. Carbonated or non-carbonated soft drinks (not red- or purple-coloured). 3. Fruit flavoured cordial (not red- or purple-coloured). 4. Strained fruit juices without pulp. 5. Do not drink any alcoholic beverages. 6. Clear soups. 7. Strained low-sodium chicken or beef soup without solid material. Do not stop taking your medications unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"category C",breastfeeding:"Monobasic Sodium Phosphate 48%, Dibasic Sodium Phosphate 18% : It is not known whether it enters nursing milk. Do not breastf eed from the rst dose to 24 hours after the last dose. 2. Polyethylene Glycol/Macrogol 4000 Powder : Limited data is available. Should only be used when necessar y.",elderly:"patients with heart or kidney disease. Option : split-dose regimen (half the dose the evening before, and half on the morning of the procedure)",paediatric:"Polyethylene Glycol/Macrogol 4000 Powder: contra-indicated (subjected to brand) 2. Sodium Biphosphate 16%, Sodium Phosphate 6% Rectal Solution: caution in children aged 2-11 3. Monobasic Sodium Phosphate 48%, Dibasic Sodium Phosphate 18%: no approved indication for",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Frequent bowel movement within 1  2 hours, stay within easy reach to the toilet.","Some people may encounter nausea, vomiting and bloating.","It is advisable to bring a responsible adult to accompany the patient before and after the procedure."],others:{storage:"Store in a cool dry place.",other_points:"1. Sodium Biphosphate 16%, Sodium Phosphate 6% 9 Rectal Solution: Use in caution in patients with severe renal impairment (creatinine clearance <30mL/min) 2. May cause fluid and electrolyte disturbances due to dehydration 3. Use cautiously in people with cardiac insuciency and those treated with diuretics, who may be at higher risk of uid and electr olyte imbalances. 4. Polyethylene Glycol/Macrogol 4000 Powder can be used in people with uid restriction (eg. renal failur e, hear t failur e) with the same method of dilution."}},{id:"counsel-133",name:"Combined Oral Contraceptive Pills (COCP",pharmacologicalGroup:"Hormonal Contraception : 1. Ethinyl Estradiol 30 mcg and Levonorgestrel 150 mcg (Rigevidon) 2. Ethinyl Estradiol 30 mcg and Desogestrel 150 mcg (Marvelon) 3. Ethinyl Estradiol 20 mcg and Desogestrel 150 mcg (Mercilon) 4. Ethinyl Estradiol 20 mcg and Levonorgestrel 100 mcg (Loette) 5. Ethinyl Estradiol 20 mcg and Drospirenone 3mg (Yaz) 6. Ethinyl Estradiol 35 mcg and Cyproterone 2mg (Dianne 35)",indication:"Indication (1-3) Oral Contraception, Abnormal Uterine Bleeding (PCOS, Fibroid, Endometriosis)",dosage:"1 tablet daily as prescribed by the doctor . Duration to be taken will depend on desire of withdrawal bleed. Cyclical (21/7 or 24/4) vs Extended (84/7) vs Continuous. Subsequent courses of COCP can be repeated as per doctor s instructions. Indication (4-6) Oral Contraception, Abnormal Uterine Bleeding (PCOS, Fibroid, Endometriosis). Used especially in patients with PCOS androgen features Dosage : 1 tablet daily as prescribed by the doctor . Duration to be taken will depend on desire of withdrawal bleed. Cyclical (21/7 or 24/4) vs Extended (84/7) vs Continuous. Subsequent courses of COCP can be repeated as per doctor s instructions. To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"For Contraception: Need to be taken immediately or at least within (including) D5 of menstrual cycle. If it exceeds D5 of the menstrual cycle, an additional contraception method is needed for 7 days. For Other Indication: Can be taken anytime once prescribed by the doctor . Must be taken at the same time every day before or after a meal. If prone to nausea, can be taken after meal It is important to take the pills as directed because missing pills or taking them not on time make them less effective. Do not stop taking your medication unless advised to do so by your prescriber 11 Missed Pills Cyclical COCP (21/7) Management 1 tablet daily for 21 consecutive days, followed by a 7-days tablet (hormone) free interval Hormone-Free Interval (HFI) is considered to start 24 hours after the last pill is taken. INCORRECT USE OF COCP RECOMMENDA TION LATE REST ARTING AFTER HFI  9 days since last active pill was taken  Take the most recent missed pill as soon as possible  Continue the remaining pills at the usual time  Condoms should be used or sex avoided until pills have been taken for 7 consecutive days  Consider follow up pregnancy test  Consider EC if UPSI has taken place during or after the HFI 1 MISSED PILL (48 TO <72 HOURS SINCE LAST PILL IN CURRENT PACK WAS TAKEN) Week 1 1 pill missed after HFI (The first pill after the HFI must have been taken correctly; if not, follow recommendation for late restarting)  Take the missed pill as soon as possible  Continue the remaining pills at the usual time  No additional contraceptive precaution required*  EC not required* * If the pack is used correctly earlier in week 1 and the 7 days prior to the HFI. If in doubt, consider additional contraceptive precaution/ EC Week 2 or Week 3 (or subsequent consecutive weeks of continuous pill-taking) 1 pill missed after HFI  Take the missed pill as soon as possible  Continue the remaining pills at the usual time  No additional contraceptive precaution required**  EC not required** ** If the pack is used correctly in the previous 7 days. If in doubt, consider additional contraceptive precaution/ EC 2 OR MORE MISSED PILLS (72 HOURS SINCE LAST PILL IN CURRENT PACK WAS TAKEN) Week 1 2-7 pills missed after HFI (The first pill after the HFI must have been taken correctly; if not, follow recommendation for  Take the most recent missed pill as soon as possible  Continue the remaining pills at the usual time  Condoms should be used or sex avoided until pills have been taken for 7 consecutive days  Consider follow up pregnancy test  Consider EC if UPSI has taken 12 late restarting) place during the HFI or week 1 Week 2 or Week 3 (or subsequent consecutive weeks of continuous pill-taking) 2-7 pills missed after HFI  Take the most recent missed pill as soon as possible  Continue the remaining pills at the usual time  If 2 or more pills missed in the 7 days prior to a scheduled HFI, omit the HFI  Condoms should be used or sex avoided until pills have been taken for 7 consecutive days  EC not required** ** If the pack is used correctly in the previous 7 days. If in doubt, consider additional contraceptive precaution/ EC >7 consecutive pills missed in any week of pill taking  Manage as new start contraception  Consider immediate pregnancy test  Quick start new COCP packet (or consider other effective contraception)  Condoms should be used or sex avoided until pills have been taken for 7 consecutive days  Consider follow up pregnancy test  Consider EC Abbreviations: COCP , combined oral contraception; EC, emergency contraception; HFI, hormone-free interval; UPSI, unprotected sexual intercourse Note: Always read the product information leaflet before counsel the patient. Information may differ depending on the product Missed Pills Cyclical COCP (24/4) Management 1 tablet daily for 24 consecutive days, followed by a 4-days inactive tablet (hormone- free interval) Missed pill management refers to hormone-containing tablets INCORRECT USE OF COCP RECOMMENDA TION < 12 Hours Late  Take the most recent missed pill as soon as possible  Continue the remaining pills at the usual time  12 Hours Late  Take the most recent missed pill as soon as possible  Continue the remaining pills at the usual time  Do not miss taking the tablets for longer than 4 days (or up to 7 days for optimum contraception) Day 1 to Day 7  Take the most recent missed pill as soon as possible (this may mean take 2 tablets at the same time) 13  Continue the remaining pills at the usual time  Condoms should be used or sex avoided until pills have been taken for 7 consecutive days  Consider follow up pregnancy test if UPSI has taken place in the preceding 7 days Day 8 to Day 14  Take the most recent missed pill as soon as possible (this may mean take 2 tablets at the same time)  Continue the remaining pills at the usual time  If have taken the tablets correctly in the 7 days before the 1 st missed tablet, no extra contraception is needed  If the tablets are not taken correctly or more than 1 tablet is missed, extra contraception is advised for 7 days Day 15 to Day 24  Take the most recent missed pill as soon as possible (this may mean take 2 tablets at the same time)  Continue the remaining pills at the usual time  Discard the 4 inactive tablet and start the next pack right away  If the tablets are not taken correctly or more than 1 tablet is missed, extra contraception is advised for 7 days Abbreviations: COCP , combined oral contraception; EC, emergency contraception; HFI, hormone-free interval; UPSI, unprotected sexual intercourse Note: Always read the product information leaflet before counsel the patient. Information may differ depending on the product",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:": Start after Day 21 postpartum. If started beyond this, additional contraception is needed for 7 days.",elderly:"Caution in women who are above 60 years old due to stroke, cardiovascular and VTE risk",paediatric:"The safety and efficacy of COCP in children who have not achieved menarche have not been established.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Nausea, headaches, breast tenderness, diarrhoea, bloating and breakthrough bleeding.","Continue taking the pills as most of these symptoms will improve with time.","If any of the following symptoms occur , the drug should be stopped and urgent medical advice should be sought after:  Severe and sudden pain in the chest  Breathlessness  Severe headache  Abdominal pain  Sudden blurred vision or loss of sight  Unexplained tenderness or pain and swelling in one leg  Weakness, numbness or difficulty speaking  Change in mood or depression."],others:{storage:"Store in dry, cool places at room temperature. Direct sunlight and extreme temperatures may cause them to break down and become less effective",other_points:"Hepatic Impairment : Contraindicated 14"}},{id:"counsel-134",name:"Ear Drops",pharmacologicalGroup:"1. Antiinfective 2. Antiinflammatory 3. Cerumenolytics",indication:"To counsel based on specific medication s indication and dosage as prescribed by doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Read the medication label. 2. Wash hands with soap and water . Dry them with a clean towel or tissue. 3. If the ear drops are a cloudy suspension, shake the bottle well for 10 seconds. If necessary , roll the bottle between the palms of your hands to help warm the drops to near body temperature. 4. Remove the dropper cap and look closely at the tip to make sure it is not cracked or chipped. Do not touch the tip. 5. Position the head with the affected ear facing upward. Either lie on your side or tilt the affected ear up. Pull the upper ear back and upward. Look for the ear canal to open. 6. Place the correct number of drops in the ear. 7. Keep the ear tilted up for 5-10 minutes or insert a soft cotton plug in the ear to keep the solution in the ear. 8. Use a clean tissue to absorb and wipe away any drops that spill out of the ear. 9. Repeat steps 4 till 7 on the other ear, if using ear drops on both ears,. 10. Replace cap on the bottle and screw it on securely . 11. Use the drops as directed for the length of time prescribed. Missed dose management: 1. Take as soon as you remember and do not double the dose.",specialConsiderations:{pregnancy:"a. Polymyxin B Sulphate 10,000U, Neomycin Sulphate 5mg and Hydrocortisone 10mg Ear Drops 2. Used only if the benefit outweighs the risk a. Ofloxacin b. Gentamicin",breastfeeding:"a. Polymyxin B Sulphate 10,000U, Neomycin Sulphate 5mg and Hydrocortisone 10mg Ear Drops b. Ofloxacin",paediatric:"Infant: try swaddling them to keep them still. 2. Toddlers: may need to be cradled with their arms and 17 legs fully restrained. 3. For children <3 year old, you will need to pull the edge of the ear downward and backward. Look for the ear canal to open.",fasting:"Refer to the latest advisory by the religious authority"},sideEffects:["Irritation.","Swelling.","Skin rash.","Unpleasant taste in your mouth. This is because the ear canal is connected to the throat and some of the liquid may drain into your mouth. Contact your healthcare provider if you think you are having a side effect of a medicine."],others:{storage:"1. Keep away from the reach of children. 2. Store in a cool, dry place, away from direct heat and light. 3. For ear drops requiring storage inside the fridge, do not store at the door side and inside the freezer . 4. Discard if there is any preparation left in the container after you have finished your course of treatment. 5. Ear drops should not be used if the bottle has been open for longer than prescribed duration.",other_points:"1. Do not allow the dropper tip to touch your ears, fingers or any other surface. 2. Do not poke inside your ear with a cotton bud as this can cause a perforated eardrum. 3. Do not share ear drops with anyone else. 4. If you have a ruptured eardrum, do not use drops unless your healthcare provider says to. It can allow potentially damaging chemicals into the middle ear. 5. After you have completed the course of treatment, throw away any leftover drops. 6. If unopened drops have expired, discard them at once."}},{id:"counsel-135",name:"Ellipta",pharmacologicalGroup:"",indication:"The indication and dosage depend on the drug content.",dosage:"See indication for dosage details",methodOfAdministration:"DEVICE PREP ARA TION Before Every Use Make sure: The Ellipta has not expired. The Ellipta is not empty . Check inside the mouthpiece of the Ellipta and ensure it is free from foreign objects. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Hold the inhaler upright with the cover on the top.  Slide the cover down until a click sound is heard. The dose is loaded. The dose counter counts down by 1 to confirm. Note: Do not tip the Ellipta upside down or shake the device after dose loading. Do not block the air vents. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully, away from the Ellipta. Chin & mouth Step 3  Slightly tilt the chin up.  Place the inhaler mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes: Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece. Inhale Step 4 Breathe in forcefully and deeply through the mouth. Hold breath Step 5 Remove the Ellipta from the mouth, and with the lips closed, hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 Breathe out (exhale) gently , away from the Ellipta. 19 Close & Rinse Step 7  Slide the cover upwards as far as it will go to cover the mouthpiece.  Rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider patient-related factors such as inspiratory effort , manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Some DPIs may be appropriate for older children. Refer guidelines, for example Global Initiative for Asthma",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Ellipta is packed in a tray (with a desiccant sachet). Dont open the tray until ready to start using the new inhaler .  Keep it safely out of the reach of children.",other_points:"NA"}},{id:"counsel-136",name:"Emergency Contraception",pharmacologicalGroup:"Progestogens / Progestogens and estrogens in combination 1. Levonorgestrel 1.5mg (Escapelle) Yuzpe Method 2. Ethinyl Estradiol 30 mcg and Levonorgestrel 150 mcg (Rigevidon) 3. Ethinyl Estradiol 20 mcg and Levonorgestrel 100 mcg (Loette)",indication:"Indication Prevent pregnancy following sexual intercourse",dosage:"Single dose immediately (Escapelle) Dosage for Yuzpe Method* : Rigevidon 4 tablets immediately . Repeat 12 hours later Loette 5 tablets immediately . Repeat 12 hours later *Refer",methodOfAdministration:"Need to be taken as soon as possible within 72 hours of unprotected sex. Note: Always read the product information leaflet before counsel the patient. Information may differ depending on the product Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"NA",breastfeeding:"Safe to be taken",elderly:"Contraindicated in post-menopausal women",paediatric:"The safety and efficacy of these medications in children who have not achieved menarche.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Nausea, abdominal pain, headache, dizziness, breast tenderness, vomiting, diarrhoea, irregular bleeding and spotting. These symptoms will usually pass within 24 hours","Pills can be taken with water or milk to curb nausea","If the pills are vomited within 2 hours of taking the dose, repeat the dose again"],others:{storage:"1. Store below 30 o C. 2. Protect from light and moisture.",other_points:"Section"}},{id:"counsel-137",name:"Emollient/ Moisturisers",pharmacologicalGroup:"Emollients & Protectives Emollient: Fill in cracks and lines by repairing the skin barrier , helps smooth and soften skin Humectant: Attract and hold water in the top layer of skin. It increases water holding capacity of stratum corneum 1. Urea cream 10% 2. Glycerin 25% - 50% in Aqueous cream Occlusive: Repels water , also form a protective barrier to trap the moisture in the skin 1. Aqueous cream 2. Emulsifying ointment 3. White soft paraf fin + liquid paraf fin 4. White/ Yellow soft paraf fin",indication:"1. As an emollient for the symptomatic relief of dry skin conditions and as soap-substitute for skin-bathing 2.",dosage:"Apply sparingly to the affected area as required or as directed by your pharmacist or doctor . 3. Moisturisers come in a range of formulations such as lotion, cream, ointment and usage depends on their own preference. Generally , moderately dry to very dry skin responds best to an ointment and mildly dry skin responds best to creams or lotions.",methodOfAdministration:"As an emollient:  Best apply after taking a bath or showering when the skin is moist, while water is still trapped in the skin for extra hydration.  To apply emollients liberally (at least 2-4 times a day).  To apply by smoothing into the skin gently in the same direction of hair grows to avoid folliculitis As a soap substitute:  To use when washing, put a half to one teaspoonful in the palm of your hand and mix with a small amount of warm water . This can then be applied to wet skin and rinse off with water .  If having a bath or shower , emollients can be rubbed neat directly into the skin and then rinsed off with water .  Please be careful, as it may cause the floor to be slippery and increase risk of patient fall. Using emollients with other skin treatments:  If youre using a steroid cream or another treatment for your skin condition, wait 20 to 30 minutes between using an emollient and using the other treatment. To counsel based on specific medication s indication and dosage as prescribed by the doctor Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"has not been 24 established but is not considered to constitute a hazard during these periods.",breastfeeding:"The safety of emollients during lactation has not been established but is not considered to constitute a hazard during these periods.",elderly:"NA",paediatric:"Safety and efficacy of emollients for pediatric patients are established as per the indications stated.",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Emollients can sometimes cause a skin reaction, such as:","An overheating, burning sensation or stinging that does not settle after a few days of treatment  usually caused by a reaction to a certain ingredient in the emollient","Blocked or inflamed hair follicles (folliculitis) that may cause boils","Rashes on the face that can aggravate acne"],others:{storage:"Keep the jar tightly closed. Store below 30C and protect from heat, moisture, and light. Do not freeze. Keep out of reach of children.",other_points:"NA"}},{id:"counsel-138",name:"Eye Drops",pharmacologicalGroup:"1. Anticholinergic (e.g. Atropine Sulphate 1% Eye Drops, Homatropine 2% Eye Drops) 2. Antiglaucoma (e.g. Bimatoprost 0.01% ophthalmic solution, Brimonidine Tartrate 0.15% Ophthalmic solution, Dorzolamide HCl 2% Ophthalmic Solution) 3. Antihistamine (e.g. Sodium Cromoglycate 2% Eye Drops) 4. Antiinfective (e.g. Chloramphenicol 0.5% Eye Drops, Ciprofloxacin HCl 0.3% Ophthalmic Solution, Gentamicin 0.3% Eye Drops) 5. Antiinflammatory (e.g. Dexamethasone Sodium Phosphate 0.1% Eye Drops, Prednisolone Acetate 1% ophthalmic suspension, Fluorometholone 0.1% Ophthalmic Suspension) 6. Antimuscarinic (e.g. Cyclopentolate 1% Eye Drops, Pilocarpine 1% & 2% Eye Drops) 7. Lubricating/ Moisturizing agent (e.g. Sodium Chloride 0.9% Eye Drops, Artificial tears/eye lubricant ophthalmic solution) 8. Mydriatic agent (e.g. Phenylephrine HCI 2.5% Eye Drops)",indication:"Counsel patients based on indication and dosage as prescribed.",dosage:"See indication for dosage details",methodOfAdministration:"1. Read the medication label. 2. Wash hands with soap and water . Dry them with a clean towel or tissue. 3. Remove contact lenses if wearing them. 4. Wash hands with soap and water again. Dry them with a clean towel or tissue. 5. Warm the bottle by rolling between palms if the eye drop is stored in the refrigerator . 6. Gently agitate the bottle before use to make sure the drug is properly mixed. 7. Unscrew the cap of the bottle. Look closely at the tip to make sure its not cracked or damaged. DO NOT TOUCH THE TIP . 8. Lie down or tilt the head back and look up at the ceiling, keeping the eyes wide open. 9. Place one or two fingers on the face and gently pull the lower eyelid down with the finger to form a pocket. 10. Hold the eye drop bottle at least 1 2 cm above the eye with the other hand. Be careful not to let the dropper touch any surface to avoid contamination. 11. Squeeze/ drop the correct number of drops inside the lower eyelid. 12. Close the eyes slowly for approximately 1 minute to allow the medication to be absorbed. 13. To keep as much of the drop on the eye as possible, gently press a finger against the inside corner of each eye next to the nose. 14. Straighten the head and use a clean tissue to wipe away any drops that spilled out. 15. Repeat steps 8 till 14 on the other eye if need to instill eye drop in both eyes. 16. Replace cap on the bottle and screw it on securely . 26 17. If more than one eye drop at a time is prescribed, wait about 5 minutes before using the next eye drop. Repeat steps 5 till 14. 18. Order of using different types of eye drops is as below: I. aqueous based eye drops e.g. artificial tears II. suspension based eye drop e.g. antibiotic eye drops III. ointment based eye preparation 19. If using both eye drops and eye ointment, put the eye drop in at least 10 minutes before the ointment.",specialConsiderations:{pregnancy:"Use only if the benefit outweighs the risk :  Atropine /  Cyclopentolate /  Fluorometholone /  Gentamicin /  Homatropine /  Latanoprost /  Phenylephrine  Pilocarpine /  Tafluprost & Timolol /  Travoprost & Timolol  Tropicamide /",breastfeeding:"Long-term use might reduce milk production or milk letdown. Observe the infant for signs of decreased lactation (e.g., insatiety , poor weight gain) : atropine, cyclopentolate, tropicamide 2. Monitor the infant for signs of cholinergic excess (diarrhea, lacrimation, and excessive salivation or urination) : pilocarpine 3. Potential for serious adverse effects in nursing infants. Decision should be made whether to discontinue nursing or to discontinue drug, taking into account the importance of the drug to the mother : fluorometholone eye drop",elderly:"and younger patients.",paediatric:"Precaution: safety and efficacy of most eye drops have not been demonstrated in children of the age group 2 years and below . 2. Sodium Cromoglycate eye drop use recommended for children above 4 years old onwards.",fasting:"Refer to the latest advisory by the religious authority"},sideEffects:["Eye burning, irritation, stinging or itching It should go after a few minutes as your eyes get used to the medicines. If symptoms continue, stop using the eye drop and inform the doctor .","Eye redness","Blurry/ changes in vision If vision does not go back to normal after a few minutes or slowly gets worse, stop using the eye drop and inform the doctor .","Unpleasant taste in the mouth Rinse your mouth with water or have a drink of water . Contact your healthcare provider if you think you are having a side effect of a medicine."],others:{storage:"1. Keep away from reach of children 2. Store in a cool, dry place, away from direct heat and light. 3. Some eye drops, such as chloramphenicol, must be stored in a refrigerator before and after opening while others are stored in the refrigerator after opening only - it is important to read the instructions carefully . 4. For eye drops requiring storage inside the fridge, do not store at the door side and inside the freezer 5. Eye drops should not be used if the bottle has been open for longer than prescribed duration or after 4 weeks. 6. Discard if there is any preparation left in the container after you have finished your course of treatment.",other_points:"27 1. Contact lenses should not be worn for the first 20 minutes following the instillation of the drops. In certain cases, you may need to stop using your contact lenses 2. To minimise the absorption of any drug into the blood stream you can apply naso-lachrymal occlusion (pressing over the tear duct to close it off) as you use the drops. 3. To avoid in G6PD Deficiency (definite risk of haemolysis)  Chloramphenicol  Brinzolamide  Dorzolamide  Ciprofloxacin  Levofloxacin  Ofloxacin"}},{id:"counsel-139",name:"Eye Ointment",pharmacologicalGroup:"1. Antiinfectives 2. Antiinflammatory",indication:"To counsel based on specific medication s indication and dosage as prescribed by doctor",dosage:"See indication for dosage details",methodOfAdministration:"1. Read the medication label. 2. Wash hands with soap and water . Dry them with a clean towel or tissue. 3. Remove contact lenses if wearing them. 4. Wash hands with soap and water again. Dry them with a clean towel or tissue. 5. Unscrew the cap from tube and hold the tube as if holding a pen 6. Tilt the head slightly backwards and look up, keeping the eyes wide open. 7. Using the one/two fingers of the free hand, gently pull down the lower eyelid to form a pocket . 8. Squeeze the tube to apply about 0.5  1 cm of ointment inside the pocket of the lower eyelid. Avoid touching the eye with the tube. 9. Remove the fingers from the face then close the eyes gently for 1 to 2 minutes to allow medication to absorb. The vision can become blurry for a few minutes as the medication is quite viscous. You should remain comfortably seated until vision is cleared. 10. Use a clean tissue to wipe away any excess ointment. Do not dab at the eye directly . 11. Repeat steps 6 till 10 on the other eye if using both eyes . 12. Replace the cap of the tube and screw it on securely . 13. If more than one eye ointment is prescribed at a time, wait about 5 minutes before using the next eye ointment. Repeat steps 5 till 12. 14. If using both eye drops and eye ointment, put the eye drop in at least 10 minutes before the ointment. Missed dose management: 1. Take as soon as you remember and do not double the dose.",specialConsiderations:{pregnancy:"a. Dexamathasone and Neomycin Sulphate and Polymyxin B Eye Ointment 3. Used only if the benefit outweighs the risk a. Gentamicin 0.3% Eye Ointment b. Oxytetracycline with Polymyxin B Sulphate Eye Ointment",breastfeeding:"Maternal use of most eye ointment presents little or no 30 risk for the nursing infant. 2. Used only if the benefit outweighs the risk for Dexamathasone and Neomycin Sulphate and Polymyxin B Eye Ointment",elderly:"-specific problems have been documented to date with most eye ointments.",paediatric:"No pediatrics-specific problems have been documented to date with most eye ointments.",fasting:"Refer to the latest advisory by the religious authority"},sideEffects:["Eye burning, irritation, stinging or itching: It should go after a few minutes as your eyes gets used to the medicines. If symptoms continue, stop using the eye drop and inform the doctor .","Eye redness","Blurry/ changes in vision: If vision does not go back to normal after a few minutes or slowly gets worse, stop using the eye drop and inform the doctor . Contact your healthcare provider if you think you are having a side effect of a medicine."],others:{storage:"1. Keep out of the reach of children. 2. Store in a cool, dry place, away from direct heat and light. 3. For eye ointment requiring storage inside the fridge, do not store at the door side and inside the freezer 4. Discard if there is any preparation left in the container after you have finished your course of treatment. Eye ointment should not be used if the tube has been open for longer than prescribed duration or after 4 weeks.",other_points:"1. Chloramphenicol: to avoid in G6PD Deficiency (definite risk of haemolysis)"}},{id:"counsel-140",name:"Menopausal Hormone Therapy",pharmacologicalGroup:"Estrogen; Progestin; Progestogen; Selective estrogen receptor modulator (SERM) : 1. Estradiol 1mg & Estradiol 1mg with Dydrogesterone 10mg 2. Estradiol 1mg 3. Estradiol Valerate 2mg and Norgestrel 500mcg with Estradiol Valerate 2mg 4. Lactobacillus Acidophilus 100million viable cells & Estriol 0.03mg vaginal tablet 5. Tibolone 2.5mg 6. Conjugated estogens 0.3mg 7. Conjugated estrogens 0.625mg 8. Conjugated estrogens 0.625mg/g Cream",indication:"a. Hormone Replacement Therapy (HRT) for for women with disorders due to natural or surgically induced menopause with intact uterus",dosage:"1 tablet daily without pill-free days, starting with Estradiol 1mg for first 14 days, followed by Estradiol 1mg with Dydrogesterone 10mg 2. Indication : a. Hormone Replacement Therapy (HRT) for treatment of signs and symptoms of estrogen deficiency due to natural menopause or total hysterectomy (TAHBSO) b. Prevention of postmenopausal osteoporosis Dosage : 1 tablet daily continuously . Titrate dose to minimum effective dose necessary to control symptoms 3. Indication : a. Hormone Replacement Therapy (HRT) for treatment of signs and symptoms of estrogen deficiency due to natural menopause or hypogonadism, TAHBSO or primary ovarian failure in women with intact uterus b. Prevention of postmenopausal osteoporosis c. Control of irregular menstrual cycle d. Treatment of primary or secondary amenorrhea Dosage : 1 white tablet daily for 11 days followed by 1 light brown tablet for 10 days then stop for 7 days (tablet free interval before starting new pack). 4. Indication : a. Atrophic vaginitis due to estrogen deficiency during menopause and post-menopause, or as co-medication to systemic hormone replacement therapy b. Restoration of the Lactobacillus flora after local and/or systemic treatment with anti-infective agents or chemotherapeutic agents 33 Dosage : a. Atropic vaginitis daily for 6-12 days followed by a maintenance dose of 1 vaginal tablet for 1-2 days per week b. Restoration therapy: 1-2 vagital tableets daily for 6-12 days 5. Indication : a. Treatments of complaints resulting from the natural or surgical menopause & in cases at high risk for breast carcinomas where general hormone replacement therapy is contraindicated b. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis Dosage : 2.5mg daily 6. Indication: a. Prevention of management of osteoporosis associated with estrogen deficiency b. Female hypoestrogenism c. Moderate to severe vasomotor symptoms associated with estrogen deficiency d. Atrophic vaginiti and atrophic urethritis Dosage: a. 0.3 - 0.625mg daily b. 0.3 - 1.25mg daily for 3 weeks, then off for 1 week c. 0.3 - 1.25mg daily d. 0.3 - 1.25mg daily 7. Indication: a. Prevention of management of osteoporosis associated with estrogen deficiency b. Female hypoestrogenism c. Moderate to severe vasomotor symptoms associated with estrogen deficiency d. Atrophic vaginiti and atrophic urethritis Dosage: a. 0.3 - 0.625mg daily b. 0.3 - 1.25mg daily for 3 weeks, then off for 1 week c. 0.3 - 1.25mg daily d. 0.3 - 1.25mg daily 8. Indication: Treatment of atrophic vaginitis, dyspareunia and kraurosis vulvae Dosage: a. Atrophic vaginitis and Kraurosis Vulvae: Cyclical regimen: Intravaginal 0.5g daily for 21 days then off for 7 days . Dose range between 0.5g - 2g daily between individual response b. Dyspareunia: Intravaginal i. 0.5g twice weekly continuously or cyclically for 21 days and 7 days off treatment.",methodOfAdministration:"1. To be taken daily at the same time with or without food. 2. Preferably to take with oily food for better absorption 3. Take will full glass of water 34 4. Hormone medications should not be crushed and not suitable for Ryle s Tube administration 5. For pessary preparations, kindly refer to the pessary administration method. Do not stop taking your medication unless advised to do so by your prescriber Special Consideration 1. Contraindicated in patients with a. liver diseases b. history of estrogen hormone receptor sensitive malignancies including breast cancer , ovarian cancer , and endometrial cancers. c. coronary arterial disease. d. history of thromboembolism or thrombophlebitis Elderly Beers Criteria: Estrogens with or without progestins (includes natural and synthetic estrogen preparations). Do not initiate systemic estrogen (e.g., oral tablets or transdermal patch). Consider deprescribing among older women already using this medication. Vaginal cream or vaginal tablets: acceptable to use low-dose intravaginal estrogen for management of dyspareunia, recurrent lower urinary tract infections, and other vaginal symptoms. Evidence of carcinogenic potential (breast and endometrium); lack of cardioprotective effect and cognitive protection in older women. For women who start HRT at age 60 and older , the risks of HRT are greater than the benefits, as HRT is linked to a higher risk of heart disease, stroke, blood clots, and dementia . Evidence indicates that vaginal estrogens for the treatment of vaginal dryness are safe and effective; women with a history of breast cancer who do not respond to nonhormonal therapies are advised to discuss the risks and benefits of low-dose vaginal estrogen (e.g., dosages of estradiol <25 mcg twice weekly) with their healthcare provider . Adverse Effects and their Management* 1. Headache or abdominal pain a. mild NSAIDS or Paracetamol may help to reduce symptoms. b. Take regular rest c. If symptoms worsen, kindly go to the clinic for treatment. 2. Unexpected vaginal bleeding a. Spotting is common especially within the first few months of starting HRT however if frequent to stop medications and seek prescriber s opinion. 3. Vaginal or urinary tract discomfort itchiness or infection a. Common while using pessaries, advice for proper toilet hygiene b. If prolonged discomfort to seek doctor s opinion 4. Shortness of breath a. Seek medical assistance 5. Swelling/ water retention a. Seek medical assistance",specialConsiderations:{},sideEffects:[],others:{storage:"1. To store at room temperature in a cool dry place and avoid direct heat or light.",other_points:"VTE risk increases with high ethinyl estradiol dose, special 35 precaution should be taken when prescribing patient to reduce risk"}},{id:"counsel-141",name:"Nasal Douche/Irrigation",pharmacologicalGroup:"Alkaline nasal douche",indication:"1. To remove nasal plug (Dosage as per prescribed)",dosage:"See indication for dosage details",methodOfAdministration:"1. Douche solution is prepared by adding warm water if undiluted product or pre-mixed preparation is given. 2. Wash hands thoroughly with soap and water . 3. Lean over a sink at a 45-degree angle, tilting your head so one nostril is pointed toward the sink. 4. Place the tip of the device at your nostril opening and gently squeeze or pour the solution into your nose. (Remember to breathe through your mouth or hold your breath while performing the irrigation.) The solution should come out of your other nostril. 5. Blow your nose to clear out any remaining solution. 6. Repeat the procedure with the other nostril. Missed dose management If you forget to take a dose, take it as soon as you remember . However , if it is almost time to take the next dose, wait until then. Do not take a double dose to make up for a forgotten dose.",specialConsiderations:{pregnancy:"N/A",breastfeeding:"N/A",elderly:"None specifically to alkaline nasal douche",paediatric:"Nasal douching can be performed by parents/caregivers for their children.",fasting:"Refer to latest advisory by religious authority"},sideEffects:["Stinging of the nasal passage wall may be experienced.","However , this may be improved by further diluting down the douche solution with water."],others:{storage:"1. Store the medicine in a dry place at room temperature, away from heat and direct light.",other_points:"Epistaxis, not to be used in cranial surgery or trans nasal neurosurgical procedure."}},{id:"counsel-142",name:"Nasal Drops",pharmacologicalGroup:"Decongestant 1. Oxymetazoline HCL 0.01% Nasal Drops 2. Oxymetazoline HCL 0.025% (Paediatric) Nasal Drops 3. Oxymetazoline HCL 0.05% (Adult) Nasal Drops",indication:"Counsel patients based on the medication and indications as prescribed.",dosage:"See indication for dosage details",methodOfAdministration:"PRIMING 1. Prime the nasal drops before using it for the first time. Check the dropper tip to make sure that it is not chipped or cracked. 2. Squeeze the bottle until a few drops appear from the dropper tip. ADMINISTRA TION 1. Blow your nose gently . 2. Wash hands thoroughly with soap and water . 3. Shake well before use. Remove cap of the bottle (for bottles with integrated dropper , draw some liquid into the dropper) 4. Tilt your head as far as possible or lie down on your back on a flat surface and hang your head over the edge. 5. Hold the bottle or dropper above your nostrils and gently squeeze the correct number of drops into the nostrils. Breath normally through your mouth while putting the drops into your nostril.(Do not touch the nose with the tip of the bottle or dropper) 6. Keep your head tilted back for two minutes to allow the drops to drain into the back of the nose. 7. Repeat steps 5 till 6 for the other nostril 8. Wipe dropper tip with dry cloth 9. Replace cap on bottle right away ADMINISTRA TION (PAEDIA TRIC) 1. Wipe your child s nose and ask them to blow it if needed. 2. Wash your hands thoroughly with soap and water . 3. Shake well before use. Remove cap of the bottle (for bottles with integrated dropper , draw some liquid into the dropper) 4. Get your child into any of these positions to give the nasal drops: : a. Tilt your child s head back b. Lay your child flat on their back c. Ask someone to hold your child in a safe position as above d. Wrap your baby or young child in a light blanket or sheet to keep their arms still. 5. Keep your child in the position for two minutes to allow the drops to drain into the back of the nose. 6. Repeat step 3 till 5 for the other nostril 7. Wipe dropper tip with dry cloth 8. Replace cap on bottle right away 40 MISSED DOSE If you forget to take a dose, take it as soon as you remember . However , if it is almost time to take the next dose, wait until then. Do not take a double dose to make up for a forgotten dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Fetal risk cannot be ruled out (oxymetazoline)",breastfeeding:"Infant risk cannot be ruled out (oxymetazoline) 2. Nasal Oxymetazoline has minimal systemic absorption.",elderly:"Caution in patients with hypertension, cardiac disease,metabolic disorder . 2. Caution in patients with narrow-angle glaucoma. 3. Has anticholinergic effects. To use short term.",paediatric:") Nasal Drops 1. Effect set in within few minutes 2. Effect last around 12 hours 3. Should not be used for children under 1 year old 4. Should not be used for more than consecutive 10 days without medical supervision. A treatment-free period should precede any repeated use",fasting:"Refer to the latest advisory by religious authority ."},sideEffects:["Dryness or irritation of nose/throat","Nose bleeds Management:","Rinse your mouth with water or drink water .","Refer to the doctor ."],others:{storage:"1. Store in a cool, dry and dark place. 2. Keep away from the reach of children.",other_points:"NA"}},{id:"counsel-144",name:"Oral Ovulation Induction Drugs",pharmacologicalGroup:"1. Letrozole 2.5mg Tablet (Aromatase Inhibitors) 2. Clomiphene Citrate 50mg Tablet (Selective Oestrogen Receptor Modulator (SERM))",indication:"1. Used to induce ovulation and increase the chances of pregnancy in women who do not ovulate regularly or at all, particularly those with PCOS.",dosage:"Lestrozole: 2.5mg from D2- D7 of menstrual cycle continuously Clomiphene: 50mg on D5-D25 of menstruation 2. Letrozole: H ormonal therapy in breast cancer in postmenopausal women if failed /contraindicated to tamoxifen",methodOfAdministration:"1. Medication should be taken whole with a full glass of water and with meals 2. Medication should be taken at the same time daily for five consecutive days. 3. Medication should not be crushed and should not be administered via Ryle s Tube 4. If missed dose, a. within 12H of expecting dosing time: : take medication as remembered and to continue same schedule the next day b. after 12H of expected dosing time: to omit the dose and continue taking the next following dose. Do not double the dose. 5. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Contraindicated in",breastfeeding:"Contraindicated in",elderly:"No dose adjustment 1",paediatric:"No dose adjustments required",fasting:"period, kindly ensure to take medication at the same time"},sideEffects:["GI disturbance (gastritis, nausea vomiting, heartburn loss of appetite ) - to take medication with meals","Hot flushes, headache, insomnia - suggest to take medication early morning with full glass of water and to wear thin clothes,","Muscle pain, mild headache - mild NSAIDS like paracetamol and ibuprofen may help to reduce pain and muscle aches - avoid driving while taking on medication."],others:{storage:"1. Store in a cool dry place away from direct heat, moisture and sunlight. (below 30  )",other_points:"1. Renal and mild liver impairment: No dose adjustment is necessary 45 2. Patients with cirrhosis or severe hepatic dysfunction: Lestrozole : 2.5mg EOD for 5 days (not to complete whole cycle) Clomiphene : contraindicated"}},{id:"counsel-145",name:"Pressurised Metered-dose Inhaler (pMDI",pharmacologicalGroup:"",indication:"The indication and dosage depend on the drug content",dosage:"See indication for dosage details",methodOfAdministration:"DEVICE PREP ARA TION Before Every Use Make sure: The pMDI has not expired The pMDI is not empty Check inside the mouthpiece of the pMDI and ensure it is free from foreign objects. Priming Conditions in which priming is required:  Before using pMDI for the first time.  If pMDI has not been used for a specific period. Priming steps:  Remove the cap and hold the inhaler in an upright position.  Shake the pMDI well.  Press down the canister to release 1 spray into the air.  Repeat the above steps if needed. Notes: The number of puffs, non-use period, and the need for shaking differ from product to product. Refer to product inserts for specific instructions . DEVICE INHALA TION TECHNIQUES Prepare Step 1 Remove the cap and hold the pMDI in an upright position. Shake the pMDI well (suspensions). Notes: Shaking is not required for solution-based pMDIs. Refer to product inserts. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully, away from the pMDI. Chin & mouth Step 3  Slightly tilt the chin up.  Place the inhaler mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes: Do not block the opening of the mouthpiece with the tongue or teeth. The 47 tongue should be lowered under the mouthpiece. Inhale Step 4 Inhale slowly and deeply through the mouth , pressing the canister down ONCE at the start of inhalation. Continue breathing in slowly and deeply for 4-5 seconds. Note: Do not actuate the canister before starting the inhalation Hold breath Step 5 Remove the pMDI from the mouth and with the lips closed, hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 Breathe out (exhale) gently , away from the pMDI. Repeat Step 7 Wait about 30 seconds to 1 minute. Repeat steps 1 to 6 if another dose is needed. Close & Rinse Step 8  Replace the cap.  Rinse and gargle the mouth with water and spit it out (for steroid-containing inhalers). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider spacers or valved holding chambers 2. Consider patient-related factors such as manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Choose age-appropriate spacers/ valved holding chambers",fasting:"To refer to the latest advisory by religious authority 48"},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Keep it safely out of the reach of children.",other_points:"NA"}},{id:"counsel-146",name:"Progestogen-Only Pills (POP",pharmacologicalGroup:"Progestogen : 1. Norethisterone 0.35mg Tablet (Noriday) 2. Desogestrel 0.075mg Tablet (Cerazette) 3. Medroxyprogesterone 5mg Tablet (Provera)",indication:"I ndication (1-2) Oral Contraception",dosage:"1 tablet daily as prescribed by the doctor . Duration to be taken will depend on desire of withdrawal bleed (Cyclical vs Continuous). Subsequent courses of POP can be repeated as per doctor s instructions. Indication (3) Abnormal Uterine Bleeding Secondary Amenorrhea Dosage : 5 to 10 mg daily for 5-10 days started anytime during cycle or on day 16-21 of menstrual cycle as prescribed by the doctor . Duration to be taken will depend on desire of withdrawal bleed (Cyclical vs Continuous). Subsequent courses of POP can be repeated as per doctor s instructions. To counsel based on specific medication s indication and dosage as prescribed by the doctor",methodOfAdministration:"Must be taken at the same time every day after meal For Contraception: Need to be taken immediately or at least within D5 of the menstrual cycle. If it exceeds D5 of the menstrual cycle, an additional contraception method is needed for 7 days. It is important to take the pills as directed because missing pills or taking them not on time make them less effective. Do not stop taking your medication unless advised to do so by your prescriber Missed dose management Norethisterone 0.35mg Tablet consider missed dose if > 3 hours later than the usual dose timing Desogestrel 0.075mg Tablet consider missed dose if > 12 hours later than the usual dose timing If you missed the dose, take one pill as soon as you remember . Take the next pill at the usual time. This may mean taking 2 pills in one day. This is not harmful 51 Additional method of contraception (condoms or abstinence) is advised for the next 2 days (48 hours after the POP has been taken). Medroxyprogesterone 5mg Tablet Take it as soon as remembered within 12 hours of the missed dose. If it is more than 12 hours since your missed dose, skip the missed dose and go back to the usual dosing times. Note: Always read the product information leaflet before counsel the patient. Information may differ depending on the product",specialConsiderations:{pregnancy:"Contraindicated",breastfeeding:": Start within Day 21 postpartum. If exceeded, additional contraception methods are needed.",elderly:"Caution in women who are above 60 years old due to stroke, cardiovascular and VTE risk",paediatric:"patients below age 18 have not been established .",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Nausea, headaches, breast tenderness, diarrhoea, bloating and breakthrough bleeding.","Continue taking the pills as most of these symptoms will improve with time.","If any of the following symptoms occur , the drug should be stopped and urgent medical advice should be sought after:  Severe and sudden pain in the chest  Breathlessness  Severe headache  Abdominal pain  Sudden blurred vision or loss of sight  Unexplained tenderness or pain and swelling in one leg  Weakness, numbness or difficulty speaking  Change in mood or depression a 52."],others:{storage:"Store in dry, cool places at room temperature. Direct sunlight and extreme temperatures may cause them to break down and become less effective",other_points:"Hepatic Impairment: Contraindicated"}},{id:"counsel-147",name:"Respimat (Re-usable",pharmacologicalGroup:"",indication:"The indication and dosage depend on the drug content.",dosage:"See indication for dosage details",methodOfAdministration:"DEVICE PREP ARA TION  Respimat Re-usable is available in two different packaging: a) Device Pack consist of one device and a cartridge b) Refill Pack consists of a cartridge only.  The Respimat device is designed for use with up to 6 cartridges. Before Every Use Make sure: The Respimat has not expired The Respimat is not empty Check inside the mouthpiece of the Respimat and ensure it is free from foreign objects. Assemble With the cap closed, press the safety catch and pull off the clear base. Take the cartridge out of the box. Push the narrow end of the cartridge into the Respimat until it clicks into place. Note: The cartridge should be pushed gently against a firm surface. Mark the checkbox on the inhaler s label to track the number of cartridges. Replace the clear base into place until it clicks. 54 Priming Conditions in which priming is required:  Before using Respimat for the first time.  If Respimat has not been used for a specific period. 1) Hold the Respimat upright with the cap closed. 2) Turn the clear base in the direction of the black arrows on the label until it  clicks  (half a turn). 3) Open the cap until it snaps fully open. 4) Point the Respimat towards the ground. Press the dose release button. Close the cap. 5) Perform steps 1-4 until a cloud is visible. After a cloud is visible, repeat steps 1-4, three (3) more times to ensure the inhaler is prepared for use. 6) Hold the Respimat upright with the cap closed. Notes: If Respimat has not been used for more than 7 days , release ONE (1) puff towards the ground. If Respimat has not been used for more than 21 days , repeat step 5. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Hold the Respimat upright with the cap closed.  Turn the clear base in the direction of the black arrows on the label until it  clicks  (half a turn). The dose is loaded.  Open the cap until it snaps fully open. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully, away from the Respimat. Chin & mouth Step 3  Slightly tilt the chin up.  Place the inhaler mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes: Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece . Do not block the air vents. Inhale Step 4  Inhale slowly and deeply through the mouth, pressing the dose release button at the start of inhalation.  Continue breathing in slowly and deeply for 4-5 seconds. 55 Hold breath Step 5 Remove the Respimat from the mouth, and with the lips closed hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 Breathe out (exhale) gently , away from the Respimat. Repeat Step 7 Repeat steps 1 to 6 for the second dose. Close Step 8 Close the cap of the Respimat. Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider patient-related factors such as manual dexterity , hand strength , tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Can be used with VHC (Aerochamber Plus Flow-V u)",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["Depend on the drug contents"],others:{storage:"",other_points:"NA"}},{id:"counsel-148",name:"Suppositories / Enema",pharmacologicalGroup:"1. Laxative a. Bisacodyl suppository (5mg, 10mg) b. Glycerin 25% and Sodium Chloride 15% Enema 2. NSAIDS a. Diclofenac suppository (12.5mg, 25mg, 50mg) 3. Antipyretic a. Paracetamol suppository (125mg, 250mg) 4. Opioid a. Morphine sulphate suppository (10mg, 20mg, 30mg) 5. Antiinflammatory a. Lignocaine (Lidocaine), Aluminium Acetate, Zinc Oxide and Hydrocortisone Suppository b. Mesalazine 1g suppository c. Mesalazine 1g/100ml enema d. Mesalazine 6.67% w/w Enema e. Zinc oxide, benzyl benzoate and balsam peru suppository",indication:"Counsel patients based on indication and dosage as prescribed.",dosage:"See indication for dosage details",methodOfAdministration:"A. SUPPOSIT ORY 1. A visit to the toilet is recommended before inserting a suppository . 2. Wash hands with soap and water and dry it. 3. Take out the suppositories from its storage place. (Refer to product insert for specific storage condition) 4. Remove the wrapper . 5. Do not cut the suppositories unless instructed otherwise. If you need to cut it in half, cut it length wise with a clean single edge razor blade. 6. Lubricate the tip of the suppositories with water . 7. Lie down on the side with the upper leg bent forward toward the stomach while your lower leg straightens out. 8. Insert the suppository , pointed end first with the finger about 1 inch (adult) and 1/2 inch (infant) depth. 9. Straighten both legs together and hold buttocks together for about a few seconds. 10. Remain lying down for about 15 to 20 minutes to ensure the suppository is fully absorbed. 11. Discard the wrapper and wash your hands thoroughly . B. ENEMA 1. The best results are achieved if the bowel is emptied before administration of enemas. 2. Preparation: i. Shake the bottle for 30 seconds. ii. Remove the protective cap of the applicator . iii. The bottle should be held at the top and the bottom. 3. The patient should lie down on his/her left side with his/her left leg stretched out and right leg bent. This makes it easier for the rectal suspension to be administered and for the enema to be effective 4. Administration of the rectal suspension: 58 i. The tip of the applicator should be inserted deep into the rectum. ii. The bottle should be tipped downwards slightly and then squeezed slowly . Maintain sufficient steady hand pressure while dispersing the bottle content iii. Once the bottle is empty , the applicator tip should be slowly withdrawn from the rectum. iv. The patient should remain lying down in this position for at least 30 minutes to allow the contents of the enema to spread throughout the rectum. v. If possible, the rectal suspension should be allowed to exert its effects all night. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"Refer to individual product information.",breastfeeding:"Refer to individual product information.",elderly:"Refer to individual product information.",paediatric:"Refer to individual product information.",fasting:"."},sideEffects:["In general, administration of a suppository or enema may lead to painful sensations and local irritation, especially in patients with anal fissures, stomach or bowel disorders including ulcerative proctitis or Crohn s disease.","Suppositories or enemas should be used under medical advice or as directed by a physician.","Refer to individual product information for specific side effects for each medication."],others:{storage:"Store suppositories and enemas in a cool, dry place and away from direct heat and light. Generally , there is no need to store in the refrigerator unless stated on drug labels. Store the medications out of reach of children to avoid accidental ingestion.",other_points:"For rectal use only."}},{id:"counsel-149",name:"Throat Spray",pharmacologicalGroup:"Non-steroidal anti-inflammatory drug (NSAID) : Benzydamine HCl",indication:"Temporary relief of painful conditions of the mouth and throat including tonsillitis, sore throat, radiation mucositis, aphthous ulcers, pharyngitis, swelling, redness, inflammatory conditions, post-orosurgical and periodontal procedures. (For paediatric and otorhinolaringology use. Restrict to patients who are not able to gargle) Adults and children over 12 years 2-4 sprays (1-2 mg) directly onto the sore/inflamed area and swallow gently . Repeat every 1 to 3 hours as necessary . Children (6-12 years) 2 sprays (1 mg) directly onto the sore/inflamed area and swallow gently . Repeat every 1 to 3 hours as necessary . Children under 6 years Not recommended. Uninterrupted treatment should not exceed 7 days, unless under medical supervision.",dosage:"See indication for dosage details",methodOfAdministration:"1. Hold the bottle in an upright position. 2. You need to prime the spray the first time you use it (max. 5 sprays). Point the spray-tube away from your face. Press down firmly until a fine spray appears from the end of the spray-tube. 3. Point the spray-tube at the affected area and press down. One press releases one actuation. 4. After spraying the desired number of actuations, wipe the end of the spray-tube with a tissue. This prevents the spray-tube becoming blocked. Precaution : 1. Do not push anything into the end of the spray-tube if it becomes blocked. Return the spray to the pharmacist. 2. If any spray gets in your eyes, wash them immediately with cold water . MISSED DOSE If you forget to use the medication, take the next dose as soon as you remember . Do not take a double dose to make up for a dose you have missed. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"The safety of benzydamine hydrochloride has not been established in pregnant patients. 61",breastfeeding:"It is unknown if benzydamine via throat spray is excreted in breast milk.",elderly:"None specifically to Benzydamine",paediatric:"Not recommended for children below 6 years old.",fasting:"To refer to the latest advisory by religious authority ."},sideEffects:["Oral numbness, burning or stinging, dryness or thirst, tingling, warm feeling in mouth, altered sense of taste. Seek immediate medical assistance if:","Severe allergic reaction (anaphylaxis) seen as swelling of throat and mouth, difficulty in swallowing or speaking, alterations in heart rate, severe asthma, collapse, and unconsciousness."],others:{storage:"1. Do not store above 30C. Do not refrigerate. Protect from light. After opening, refer to the respective product leaflet for shelf life.",other_points:"NA"}},{id:"counsel-150",name:"Turbuhaler",pharmacologicalGroup:"",indication:"The indication and dosage depend on the drug content.",dosage:"See indication for dosage details",methodOfAdministration:'DEVICE PREP ARA TION Before Every Use Make sure: The Turbuhaler has not expired The Turbuhaler is not empty . Check inside the mouthpiece of the Turbuhaler and ensure it is free from foreign objects. Priming Conditions in which priming is required: Before using the Turbuhaler for the first time. Priming steps (single occasion only with the newly opened device):  Unscrew the cover of the Turbuhaler and lift it off.  Hold the Turbuhaler upright with the base grip at the bottom.  Turn the base grip as far as it will go in one direction and then turn it back as far as it will go in the other direction. A "click" sound will be heard (it does not matter which way it is turned first)  Repeat this step one more time to complete priming. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Unscrew the cover of the Turbuhaler and lift it off.  Hold the Turbuhaler upright with the base grip at the bottom.  To load the Turbuhaler with a dose, turn the base grip as far as it will go in one direction. Then turn it back again as far as it will go in the opposite direction until a click sound is heard (it does not matter which way it is turned first) Notes: Do not tip the Turbuhaler upside down or shake the device after dose loading. Do not hold the mouthpiece when turning the grip. Do not block the air vents. Exhale Step 2  Sit upright or stand in an erect position. 63  Breathe out (exhale) slowly and fully, away from the Turbuhaler . Chin & mouth Step 3  Slightly tilt the chin up.  Place the inhaler mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes: Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece. Inhale Step 4 Breathe in forcefully and deeply through the mouth. Hold breath Step 5 Remove the Turbuhaler from the mouth, and with the lips closed, hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 Breathe out (exhale) gently , away from the Turbuhaler . Repeat Step 7 Repeat steps 1 to 6 if another dose is needed. Close & Rinse Step 8  Replace the cover tightly after use.  Rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .',specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider patient-related factors such as inspiratory effort , manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Some DPIs may be appropriate for older children. Refer guidelines, for example Global Initiative for Asthma 64",fasting:"To refer to the latest advisory by religious authority ."},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Keep it safely out of the reach of children.",other_points:"( eg. hepatic impairment, renal impairment which will be relevant to the patient) NA"}},{id:"counsel-151",name:"Vaginal Preparation/Pessary",pharmacologicalGroup:"Antifungal a. Clotrimazole 500mg vaginal tablet Progestin a. Progesterone 100mg capsule b. Progesterone 8% Vaginal Gel Estrogens a. Conjugated Estrogen 0.625mg/g cream",indication:"Counsel based on indication and dosage as prescribed by the doctor .",dosage:"See indication for dosage details",methodOfAdministration:"1. Read the product insert before counselling. Each product will have specific instructions for use. 2. The recommended time of administration is just before your bedtime. 3. Wash hands with soap and water , rinse and dry it. 4. Prepare pessary for application: a. Tablet: i. Remove the foil or plastic wrapping from the pessary . ii. Place the blunt end of the pessary into the open end of the applicator (if you have been supplied with one) iii. During pregnancy the applicator should NOT normally be used. b. Vaginal Cream: i. Firmly attach the applicator to the opening of the tube. ii. Squeeze the cream into the applicator until it reaches the level of the indicator of your dose. iii. Twist and remove the applicator . 5. Lie on your back with your knees bent and legs apart. 6. Using the applicator gently put the pessary into the vagina as far as it will comfortably go. If there is no applicator available, see point 13. 7. Holding the outer part of the applicator push the plunger in to release the pessary from the applicator . 8. Remove the applicator from the vagina. 9. Remain lying down for about 15 - 30 minutes to ensure the medication is fully absorbed. 10. Wash your hands thoroughly . 11. If the applicator is to be used again, clean it in warm soapy water , then dry and keep it in a clean place. 12. If you encounter any remaining medication that is not absorbed on the next coming morning, do not reinsert the remaining medication and wash your vagina area. You may use a sanitary pad / panty liner to prevent staining. 13. To insert without using the plastic applicator: Holding the pessary between your thumb and first two fingers, gently put the pessary , narrow end first, as high into the vagina as is comfortable. Then wash your hands. Missed dose management: 1. Use or insert the missed dose once remembered. 2. If it is almost time for the next dose, skip the missed dose and continue the regular dosing schedule. Do not 67 use a double dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"occurs during treatment, treatment should be withdrawn immediately .",breastfeeding:"Clotrimazole Vaginal Tablet: use with precautions. 2. Progesterone Vaginal Capsule: can pass into breast milk and may harm a nursing baby 3. Conjugated Estrogens Cream and Progesterone Gel ; not to be used in lactation.",elderly:"more than 65 years old. 4. Beers Criteria: Vaginal cream: acceptable to use low-dose intravaginal estrogen for the management of dyspareunia, recurrent lower urinary tract infections, and other vaginal symptoms.",paediatric:"Clotrimazole Vaginal Tablet: use with precautions in children < 16 years old (refer to individual product leaflet) 2. Conjugated Estrogens Cream and Progesterone Gel ; not to be used in children who have not achieved menarche",fasting:"."},sideEffects:["Vaginal skin irritation or burning, Itching or discomfort","Drowsiness or dizziness","Breast tenderness or swelling","Headache and nausea Other specific side effects refer to individual active ingredients."],others:{storage:"1. Store at below 25C. 2. Store in a place that is not exposed to light.",other_points:"1. Clotrimazole Vaginal Tablet: Use with cautions in patients with hepatic impairment, patients who have had >2 infections of candidal vaginitis for the past 6 months, history of STD or exposure to partner with STD, irregular or abnormal bleeding, vaginal ulcers, diarrhoea, dysuria or lower abdominal pain, fever or chills. 2. Progesterone Vaginal Capsule: Contraindicated in history of stroke or blood clot, circulation problems, 68 liver disease , breast or uterine cancer , abnormal vaginal bleeding, or recently had a tubal pregnancy or an incomplete abortion. 3. Conjugated Estrogens Cream : contraindicated in active or chronic liver dysfunction or disease"}},{id:"counsel-152",name:"Tidal Breathing Method",pharmacologicalGroup:"",indication:"A medical device used with a pMDI",dosage:"See indication for dosage details",methodOfAdministration:"Before Every Use Make sure: The pMDI has not expired The pMDI is not empty The VHC structure is intact (e.g., there is no crack), and the valve is working properly (e.g., it is not stuck or brittle). Check inside the pMDI mouthpiece and VHC, ensure it is free from foreign objects. Priming Conditions in which priming is required:  Before using pMDI for the first time.  If pMDI has not been used for a specific period. Priming steps:  Remove the cap and hold the inhaler in an upright position.  Shake the pMDI well.  Press down the canister to release 1 spray into the air.  Repeat the above steps if needed. Notes : The number of puffs, non-use period, and the need for shaking differ from product to product. Refer to product inserts for specific instructions. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Remove the cap and hold the pMDI in an upright position.  Shake the pMDI well (suspensions).  Insert pMDI upright into the back of the VHC. Notes : Shaking is not required for solution-based pMDIs. Refer to product inserts. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully Chin & mouth Step 3 71  Slightly tilt the chin up.  Apply VHC facemask to face and ensure an effective seal over mouth and nose . Inhale Step 4  Inhale slowly and deeply through the mouth, pressing the canister down ONCE at the start of inhalation .  Inhale and exhale slowly 5 times through the mouth. Remove the VHC from the mouth. Note : Some HCPs may recommend the Single Breath Method, however , this is not common Repeat Step 5 Wait about 30 seconds to 1 minute, repeat steps 1 to 4 if another dose is needed. Close & Rinse Step 6  Remove the pMDI from the VHC.  Recap the mouthpiece of pMDI.  Wash the face area in contact with the facemask; rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider VHCs among pMDI users 2. Consider patient-related factors such as manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Choose age-appropriate valved holding chambers",fasting:"To refer to the latest advisory by religious authority"},sideEffects:["For corticosteroid-containing inhalers, gargle mouth with water and spit it out; wash the face area in contact with the facemask."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Keep it safely out of the reach of children.",other_points:"NA 72"}},{id:"counsel-153",name:"Mouthpiece Single Breath Method",pharmacologicalGroup:"",indication:"A medical device used with a pMDI",dosage:"See indication for dosage details",methodOfAdministration:"Before Every Use Make sure: The pMDI has not expired The pMDI is not empty The VHC structure is intact (e.g., there is no crack), and the valve is working properly (e.g., it is not stuck or brittle). Check inside the pMDI mouthpiece and VHC, and ensure it is free from foreign objects. Priming Conditions in which priming is required:  Before using pMDI for the first time.  If pMDI has not been used for a specific period. Priming steps:  Remove the cap and hold the inhaler in an upright position.  Shake the pMDI well.  Press down the canister to release 1 spray into the air.  Repeat the above steps if needed. Notes : The number of puffs, non-use period, and the need for shaking differ from product to product. Refer to product inserts for specific instructions. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Remove the cap and hold the pMDI in an upright position.  Shake the pMDI well (suspensions).  Insert pMDI upright into the back of the VHC. If the VHC has a mouthpiece cap, remove it. Notes : Shaking is not required for solution-based pMDIs. Refer to product inserts. Exhale Step 2  Sit upright or stand in an erect position.  Breathe out (exhale) slowly and fully, 74 away from the VHC. Chin & mouth Step 3  Slightly tilt the chin up.  Place the VHC mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes : Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece. Inhale Step 4  Inhale slowly and deeply through the mouth, pressing the canister down ONCE at the start of inhalation.  Continue breathing in slowly and deeply for 4-5 seconds. Hold Breath Step 5 Remove the VHC from the mouth and with the lips closed, hold the breath for 5-10 seconds or as long as comfortable. Exhale Step 6 Breathe out (exhale) gently away from the VHC. Repeat Step 7 Wait about 30 seconds to 1 minute, repeat steps 1 to 6 if another dose is needed. Close & Rinse Step 8  Remove the pMDI from the VHC.  Recap the mouthpiece of pMDI and VHC (if the VHC has a cap)  Rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber .",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider VHCs among pMDI users 2. Consider patient-related factors such as manual 75 dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Choose age-appropriate valved holding chambers",fasting:"To refer to the latest advisory by religious authority ."},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Keep it safely out of the reach of children.",other_points:"NA"}},{id:"counsel-154",name:"Tidal Breathing Method",pharmacologicalGroup:"",indication:"A medical device used with a pMDI",dosage:"See indication for dosage details",methodOfAdministration:"Before Every Use Make sure: The pMDI has not expired The pMDI is not empty The VHC structure is intact (e.g., there is no crack), and the valve is working properly (e.g., it is not stuck or brittle). Check inside the pMDI mouthpiece and VHC, ensure it is free from foreign objects. Priming Conditions in which priming is required:  Before using pMDI for the first time.  If pMDI has not been used for a specific period. Priming steps:  Remove the cap and hold the inhaler in an upright position.  Shake the pMDI well.  Press down the canister to release 1 spray into the air.  Repeat the above steps if needed. Notes : The number of puffs, non-use period, and the need for shaking differ from product to product. Refer to product inserts for specific instructions. DEVICE INHALA TION TECHNIQUES Prepare Step 1  Remove the cap and hold the pMDI in an upright position.  Shake the pMDI well (suspensions).  Insert pMDI upright into the back of the VHC. If the VHC has a mouthpiece cap, remove it. Notes : Shaking is not required for solution-based pMDIs. Refer to product inserts. Exhale Step 2  Sit upright or stand in an erect position  Breathe out (exhale) slowly and fully 78 Chin & mouth Step 3  Slightly tilt the chin up.  Place the VHC mouthpiece gently between the teeth. Ensure a tight seal of the lips around the mouthpiece. Do not bite the mouthpiece. Notes : Do not block the opening of the mouthpiece with the tongue or teeth. The tongue should be lowered under the mouthpiece . Inhale Step 4  Inhale slowly and deeply through the mouth, pressing the canister down ONCE at the start of inhalation .  Inhale and exhale slowly 5 times through the mouth. Remove the VHC from the mouth. Repeat Step 5 Wait about 30 seconds to 1 minute, repeat steps 1 to 4 if another dose is needed. Close & Rinse Step 6  Remove the pMDI from the VHC.  Recap the mouthpiece of pMDI and VHC (if the VHC has a cap)  Rinse and gargle the mouth with water and spit it out (for a steroid-containing inhaler). Missed dose management : If a maintenance dose is missed, take it as soon as possible and then resume the regular schedule. However , if it is almost time for the next dose, skip the missed dose. Never take a double dose to make up for a missed maintenance dose. Do not stop taking your medication unless advised to do so by your prescriber",specialConsiderations:{pregnancy:"NA",breastfeeding:"NA",elderly:"Consider VHCs among pMDI users 2. Consider patient-related factors such as manual dexterity , hand strength, tremors, vision, comorbidities, respiratory muscle strength, cognition and others.",paediatric:"Choose age-appropriate valved holding chambers",fasting:"To refer to the latest advisory by religious authority Others: 79 NA"},sideEffects:["For corticosteroid-containing inhalers, gargle the mouth with water and spit it out."],others:{storage:"Refer to product inserts for complete information. In general:  Store the device in a clean, cool, and dry place at appropriate temperatures.  Avoid extreme temperatures and humidity (e.g., do not store it in cars or bathrooms).  Keep it safely out of the reach of children.",other_points:"Cleaning* Clean VHC and pMDI at least once a week. Cleaning instructions vary between products. Refer to the product insert for specific instructions. Dose checking Check pMDI for remaining doses:  Check the dose counter (if the pMDI has one).  For pMDI without a dose counter , mark the date of opening on the new pMDI and keep track of the doses used. Record the doses used on a daily log. Additional notes Some VHCs are equipped with alert whistles intended to indicate fast inhalation. Instruct the patient to slow the breathing if a whistling sound is heard."}}],Zg={title:"Borang Penilaian Kaunseling",lastUpdated:"2025-11-26"},uf=[{id:"amikacin-md",name:"Amikacin (Multiple Daily Doses)",route:"IV",usualDose:"7.5 mg/kg BD",renalDosing:[{crcl:">50-90",adjustment:"7.5mg/kg q12h"},{crcl:"30-50",adjustment:"7.5mg/kg q24h"},{crcl:"10-30",adjustment:"7.5mg/kg q48h"},{crcl:"<10",adjustment:"7.5mg/kg q72h"}],notes:"Administer post HD on HD day",category:"Aminoglycoside",matchKeywords:["amikacin"]},{id:"amikacin-od",name:"Amikacin (Once Daily)",route:"IV",usualDose:"15mg/kg OD",renalDosing:[{crcl:">80",adjustment:"15mg/kg q24h"},{crcl:"60-80",adjustment:"12mg/kg q24h"},{crcl:"40-60",adjustment:"7.5mg/kg q24h"},{crcl:"30-40",adjustment:"4mg/kg q24h"},{crcl:"20-30",adjustment:"7.5mg/kg q48h"},{crcl:"10-20",adjustment:"4mg/kg q48h"},{crcl:"<10",adjustment:"3mg/kg q72h"}],notes:"Administer post HD on HD day",category:"Aminoglycoside",matchKeywords:["amikacin"]},{id:"ampicillin",name:"Ampicillin",route:"IV",usualDose:"500mg-2g q6h",renalDosing:[{crcl:">50",adjustment:"q6h"},{crcl:"10-50",adjustment:"q6-12h"},{crcl:"<10",adjustment:"q12-24h"}],notes:"Administer post HD on HD day",category:"Penicillin",matchKeywords:["ampicillin"]},{id:"augmentin",name:"Augmentin (Amoxycillin 1g/Clavulanate 200mg)",route:"IV",usualDose:"1.2g TDS",renalDosing:[{crcl:"10-50",adjustment:"1.2g BD"},{crcl:"<10",adjustment:"1.2g OD"}],notes:"",category:"Penicillin + Beta-lactamase Inhibitor",matchKeywords:["augmentin","amoxycillin","clavulanate"]},{id:"azithromycin",name:"Azithromycin",route:"IV",usualDose:"500mg OD",renalDosing:[{crcl:"All",adjustment:"No adjustment recommended"}],notes:"Use with caution if GFR <10 ml/min",category:"Macrolide",matchKeywords:["azithromycin"]},{id:"bactrim",name:"Bactrim (Sulfamethoxazole/Trimethoprim)",route:"IV",usualDose:"8-20mg/kg/day (Trimethoprim) in divided doses",renalDosing:[{crcl:">30",adjustment:"No adjustment"},{crcl:"15-30",adjustment:" of recommended dose (BD for PCP)"},{crcl:"<15",adjustment:"Not recommended. If used: 5-10mg/kg OD post HD"}],notes:"Administer after HD",category:"Sulfonamide",matchKeywords:["bactrim","sulfamethoxazole","trimethoprim","cotrimoxazole","co-trimoxazole"]},{id:"cefazolin",name:"Cefazolin",route:"IV",usualDose:"1-2g TDS",renalDosing:[{crcl:"35-54",adjustment:"Full dose TDS"},{crcl:"11-34",adjustment:" usual dose BD"},{crcl:"<10",adjustment:" usual dose OD"}],notes:"Administer post HD on HD day",category:"Cephalosporin (1st gen)",matchKeywords:["cefazolin"]},{id:"cefepime",name:"Cefepime",route:"IV",usualDose:"1-2g BD/TDS",renalDosing:[{crcl:">60",adjustment:"500mg BD to 2g TDS (based on severity)"},{crcl:"30-60",adjustment:"500mg OD to 2g BD"},{crcl:"11-29",adjustment:"250mg-500mg OD to 2g OD"},{crcl:"<11",adjustment:"250mg OD to 1g OD"}],notes:"Administer post HD on HD day",category:"Cephalosporin (4th gen)",matchKeywords:["cefepime"]},{id:"ceftazidime",name:"Ceftazidime",route:"IV",usualDose:"1-2g BD/TDS",renalDosing:[{crcl:"31-50",adjustment:"1g q12h"},{crcl:"16-30",adjustment:"1g q24h"},{crcl:"6-15",adjustment:"0.5g q24h"},{crcl:"5",adjustment:"0.5g q48h"}],notes:"Administer post HD on HD day. May increase by 50% in severe infection",category:"Cephalosporin (3rd gen)",matchKeywords:["ceftazidime"]},{id:"ceftriaxone",name:"Ceftriaxone",route:"IV",usualDose:"1-2g OD",renalDosing:[{crcl:"All",adjustment:"No adjustment necessary"}],notes:"Max 2g/day if concurrent renal and hepatic dysfunction",category:"Cephalosporin (3rd gen)",matchKeywords:["ceftriaxone"]},{id:"cefuroxime",name:"Cefuroxime",route:"IV",usualDose:"750mg-1.5g TDS",renalDosing:[{crcl:">50",adjustment:"TDS"},{crcl:"10-50",adjustment:"BD-TDS"},{crcl:"<10",adjustment:"OD"}],notes:"Administer post HD on HD day",category:"Cephalosporin (2nd gen)",matchKeywords:["cefuroxime"]},{id:"ciprofloxacin-iv",name:"Ciprofloxacin",route:"IV",usualDose:"200-400mg BD",renalDosing:[{crcl:"50",adjustment:"No adjustment"},{crcl:"10-50",adjustment:"200mg BD"},{crcl:"<10",adjustment:"200mg BD"}],notes:"Administer post HD on HD day",category:"Fluoroquinolone",matchKeywords:["ciprofloxacin"]},{id:"ciprofloxacin-oral",name:"Ciprofloxacin",route:"Oral",usualDose:"250-750mg BD",renalDosing:[{crcl:"30-50",adjustment:"250-500mg BD"},{crcl:"5-29",adjustment:"250-500mg OD"},{crcl:"HD",adjustment:"250-500mg OD post HD"}],notes:"",category:"Fluoroquinolone",matchKeywords:["ciprofloxacin"]},{id:"meropenem",name:"Meropenem",route:"IV",usualDose:"500mg-2g TDS",renalDosing:[{crcl:"26-50",adjustment:"Recommended dose BD"},{crcl:"10-25",adjustment:" recommended dose BD"},{crcl:"<10",adjustment:" recommended dose OD"}],notes:"Administer after HD on HD day (500mg OD post HD)",category:"Carbapenem",matchKeywords:["meropenem"]},{id:"vancomycin",name:"Vancomycin",route:"IV",usualDose:"2-3g/day in 2-4 divided doses (Max: 4g/day)",renalDosing:[{crcl:">50",adjustment:"15-20mg/kg BD/TDS"},{crcl:"20-49",adjustment:"15-20mg/kg OD"},{crcl:"<20",adjustment:"TDM-guided after 1g stat"}],notes:"Dose based on therapeutic drug monitoring",category:"Glycopeptide",matchKeywords:["vancomycin"]},{id:"gentamicin-md",name:"Gentamicin (Multiple Daily)",route:"IV",usualDose:"1.7mg/kg TDS",renalDosing:[{crcl:">50-90",adjustment:"1.7mg/kg TDS"},{crcl:"10-50",adjustment:"1.7mg/kg q12-48h"},{crcl:"<10",adjustment:"1.7mg/kg q48-72h"}],notes:"Administer post HD on HD day. Further adjust based on TDM",category:"Aminoglycoside",matchKeywords:["gentamicin"]},{id:"gentamicin-od",name:"Gentamicin (Once Daily)",route:"IV",usualDose:"3-5mg/kg OD",renalDosing:[{crcl:">80",adjustment:"5mg/kg q24h"},{crcl:"60-80",adjustment:"4mg/kg q24h"},{crcl:"40-60",adjustment:"3.5mg/kg q24h"},{crcl:"30-40",adjustment:"2.5mg/kg q24h"},{crcl:"20-30",adjustment:"4mg/kg q48h"},{crcl:"10-20",adjustment:"3mg/kg q48h"},{crcl:"<10",adjustment:"2mg/kg q72h"}],notes:"Administer post HD on HD day. Further adjust based on TDM",category:"Aminoglycoside",matchKeywords:["gentamicin"]},{id:"metronidazole",name:"Metronidazole (Flagyl)",route:"IV",usualDose:"500mg TDS",renalDosing:[{crcl:"All",adjustment:"No adjustment necessary"}],notes:"",category:"Nitroimidazole",matchKeywords:["metronidazole","flagyl"]},{id:"tazocin",name:"Tazocin (Piperacillin 4g/Tazobactam 0.5g)",route:"IV",usualDose:"4.5g TDS-QID (Max: 18g/day)",renalDosing:[{crcl:"20-40",adjustment:"2.25g QID"},{crcl:"<20",adjustment:"2.25g TDS or QID for nosocomial pneumonia"}],notes:"Administer post HD on HD day",category:"Penicillin + Beta-lactamase Inhibitor",matchKeywords:["tazocin","piperacillin","tazobactam"]}],hf={antibiotics:uf},Qg=JSON.parse(`[{"id":"fs-0001","name":"Abacavir (ABC)","dosage":"8mg/kg (adult 300mg) 12H oral. Abacavir 600mg + dolulegravir 50mg + lamivudine 300mg. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-0002","name":"Abacavir 600mg + lamivudine 300mg","dosage":">16yr: 1 tab daily. Abaca vir 300mg + lamivudine 150mg + zidovudine 300mg. >40kg: 1 tab 12H oral."},{"id":"fs-0003","name":"Abarelix","dosage":"Adult, NOT/kg: 1 vial (delivers 100mg) IM on days 1. 15 and 29, and then every 28 days."},{"id":"fs-0004","name":"Abatacept","dosage":"NOT/kg: 500mg (40-60kg) 750mg (60-'100 kg) 1g (>100kg) IV over 30min day 1, 2wk, 4wk, then every 4wk."},{"id":"fs-0005","name":"Abciximab","dosage":"0.25mg/kg IV stat 1 0min before angioplasty, then 0.2mcg/kg/min (max 10mcg/min) IV for 12H. 1\\\\biraterone. Adult, NOT/kg: 1g daily+ prednisolone 5mg 12H oral. Monitor hepatic enzymes."},{"id":"fs-0006","name":"Acamprosate","dosage":"Adult, NOT/kg. <601<[): 666mg mane, 333mg noon and nocte oral. >60kg: 666mg 8H."},{"id":"fs-0007","name":"Acarbose","dosage":"1-4mg/kg (adult 50-200mg) 8H oral."},{"id":"fs-0008","name":"Acebutolol","dosage":"4-8mg/kg (adult 200-400mg) 8-24H oral."},{"id":"fs-0009","name":"Aceclofonac","dosage":"2mg/kg (adult 100mg) 12H oral."},{"id":"fs-0010","name":"Acemetacin","dosage":"1.2mg/kg (adult 60mg) g. 12H oral.Acenocournarol. See nicournalone."},{"id":"fs-0011","name":"Acetaminophen","dosage":"See paracetamol."},{"id":"fs-0012","name":"Acetazolamide","dosage":"5-10mg/kg (adult 100-250mg) G. eH (daily for oral. TB hydrocephalus: 25. 50mg/kg 6-8H plus 0.25mg/kg 6H."},{"id":"fs-0013","name":"Acetic acid","dosage":"1% 3 drops/ear 8H. Box jellyfish: apply vinegar."},{"id":"fs-0014","name":"Acetohydroxamic acid","dosage":"5mg/kg (adult 250mg) 6~8H oral."},{"id":"fs-0015","name":"Acetyl sulfisoxazole","dosage":"1 1.0g sulphafurazole (qv)."},{"id":"fs-0016","name":"Acetylcholine chloride","dosage":"NOT/kg: -1% instil 0.5-2ml into anterior chamber of the eye."},{"id":"fs-0017","name":"Acetylcysteine","dosage":"Liver failure, paracetamol. nnl poisoning (regard loss of delay): 150mg/kg in IV over 1 hr; then 10mg/kg /hr for 20hr (delay <10hr), 32hr (delay -10-16hr), 72hr (deby >\\"16hr) and longer if still encephalopathic; oral140mg/kg stat, then 70mg/kg 4H for l2hr. Monitor serum I<'. Give if paracetamol >10OOumol/L (150mg/L) at 4hr, >500umol/L. 8hr, >250umol/L 12H. Lung disease: 20% solution 0.1 ml/kg (adult 5ml) 6-12H nebulised or intratracheal. Meconium ileus equivalent: 5ml (NOT/kg) of 20% solution 8H oral; 60-100ml of 50mg/ml for 45 min PR CF: 4-Smg/kg 8H oral."},{"id":"fs-0018","name":"Acetylcysteine 5% + hypromellose 0.35%","dosage":"1 drop/eye 6-SH."},{"id":"fs-0019","name":"Acetylsalicylic acid","dosage":"See aspirin."},{"id":"fs-0020","name":"Aciclovir","dosage":"IV, enceph or cella IV ovor 111r: 12H >36wk. 12yr >12yr herpes IV over 'lhr: 250mg/m2 (birth--12yr) 5mg/kg (>12yr) 8H. Genital herpes (>12yr NOT/kg): 200mg oral x5/day for 10 days, then 200mg x2-3/day for 6mo if required. Zoster (>12yr NOT/kg): 400 mg (<2yr) or 800mg (>=2yr) oral x5/day for 7 days. Cold sores: 5% cream xb/day. Eye: 3% oint x5/day."},{"id":"fs-0021","name":"Acipimox","dosage":"bmg/kg (adult 2.50mg) 8-12H oral"},{"id":"fs-0022","name":"Acitrelin","dosage":"0. 5-1. Omg/kg (adult 25-50mg) daily oral; occasion- ally up to 1 mg/kg (adult 75mg) daily oral"},{"id":"fs-0023","name":"Acitretin","dosage":"0. 5-1 mg/kg (adult 25. 50mg) daily oral."},{"id":"fs-0024","name":"Aclidinium","dosage":"NOT/kg: 322 or 400mcg inhalation 12H."},{"id":"fs-0025","name":"Acriflavine hydrochloride","dosage":"0.1% solution: apply 12-24H."},{"id":"fs-0026","name":"Acrivastine","dosage":"0. 15mg/kg (adult Smg) 8H oral."},{"id":"fs-0027","name":"Actinomycin D","dosage":"See dactinomycin."},{"id":"fs-0028","name":"Activated charcoal","dosage":"See charcoal, activated."},{"id":"fs-0029","name":"Acyclovir","dosage":"See aciclovir."},{"id":"fs-0030","name":"Adalimumab","dosage":"NOTIkg: 40mg (15. 30kg) 80mg (>30kg) SC stat, then 20mg (15-30kg) 40mg (>30kg) every 2wk."},{"id":"fs-0031","name":"Adapalene","dosage":"0. 1% cream, gel, lotion; 0. 3% gel: apply daily."},{"id":"fs-0032","name":"Adapalene 0","dosage":"1% + benzoyl peroxide 2. 5% geL Apply daily."},{"id":"fs-0033","name":"Adefovir","dosage":"Adult, NOT/kg: 10mg daily oral."},{"id":"fs-0034","name":"Adenosine","dosage":"Arrhythmia: 0. 1 mg/kg (adult 3mg) stat by rapid IV push, increase by 0. 1 mg/kg (adult 3mg) every 2min to max O. ii mg/kg (adult i 8mg). Pul hypertension: 50mcg/kg/min (3 mg/ml at 1 mltkg/hr) into central vein."},{"id":"fs-0035","name":"Ado-trastuzumab","dosage":"3.6mg/kg IV every 3wk."},{"id":"fs-0036","name":"Adrenaline","dosage":"Asthma, bronchiolitis, croup inhaltn (<2yr 101./min gas flow): 1% 0. 02ml/kg diltd to 6ml, or 1/1000 0.2 mlkg (max 6ml) diltd to 6ml; ventr circuit 1% 0. 02ml/kg diltd to 6ml, or 1/1000 (max 6ml) diltd to 6ml. Cardiac arrest (repeat if required): 0. 1mlkg of 1/10,000 IV or intracardiac; via ETT 0. 1 mlkg of 1/1000. Anaphylaxis: IV 0.05-0.1ml/kg of 1/10,000, repeat if required; IM into thigh 0. 01mg/kg (0. 01mlkg of 1/1000) up to 0.1mg/kg, x3 doses 20min apart if required. IV infusion 0.15 mg/kg in 50ml at 1-10ml/llr (0. 05-0. 5mcg/kg/min). TY, 2min."},{"id":"fs-0037","name":"Adrenaline 0","dosage":"1% + fluorouracil3. 33%. Gel: inject into each wart weekly for up to 6wk."},{"id":"fs-0038","name":"Adrenocorticotrophic hormone (ACTH)","dosage":"See corticotrophin."},{"id":"fs-0039","name":"Afatinib","dosage":"Adult, NOT/kg: 40mg daily oral, if tolerated increase to 50mg daily after 3wk."},{"id":"fs-0040","name":"Afliborcept","dosage":"2mg (0.05ml) intravitreal 4wkly x3, then 8wkly."},{"id":"fs-0041","name":"Agalsidase alpha","dosage":"0. 2mg/kg IV over 40min every 2wk."},{"id":"fs-0042","name":"Agalsidase beta","dosage":"0. 2-1 mg/kn IV over 40 min every 2wk."},{"id":"fs-0043","name":"Agar+ paraffin 65%","dosage":"NOT/kg: 6rno-2yr 5ml, 3--5yr 5-10ml, >5yr 10ml 8-24H oral."},{"id":"fs-0044","name":"Agar+ paraffin+ phenolphthalein (Agarol)","dosage":"NOT/kg: 6mo- 2yr 2.5ml, 3-t:iyr 2.5-Sml, >5yr 5ml 8--24H oral"},{"id":"fs-0045","name":"Agomelatine","dosage":"Adult, NOT/kg: 25mg (max 50mg) daily oral"},{"id":"fs-0046","name":"Albendazole","dosage":"l'inworrn, threadworm, roundworm, hool<wonn, whipworm: 200mg (<10kg) 400mg (>10kg) oral once (may repeat after 2wk). Strongyloides, cutaneous larva migrans, $9. % + postage frorn orders@drugdoses.com l'age 2 courses 14 NOT/ktJ"},{"id":"fs-0047","name":"Albumin","dosage":"20%: ?-5mlkg IV. 4%: plasma: dose (ml/ko) ,_, 5 x (incn'><Jso gil.) AlbuteroL See salbutarnol."},{"id":"fs-0048","name":"Al<:aftadine","dosage":"0.25% ;;oltn 1 drop in each eye daily."},{"id":"fs-0049","name":"Alclornetasone","dosage":"O.Oli% cream or oinlrnent: apply 8-12H."},{"id":"fs-0050","name":"Alcohol","dosage":"See chlorhoxidine, ethanol."},{"id":"fs-0051","name":"Alcohol","dosage":"See ethanol."},{"id":"fs-0052","name":"Aldesleukin (synthetic IL-2)","dosage":"Maliqnancy: constant IV intsn loss toxic than bolus injln: 3,000,000-5,000,000u/rn'iday tor li de1ys, if tolerated x1-2 with 5 day interval. 1\\\\lcfacepl. Adult, IV, 1timg IM wkly J::>wk. 1\\\\lemtuzumab. Adult, over 2H. CLL: 3mg daily for 2<l 10mg daily ?-3 x3/wk for up to daily for 5 for 3d anually. daily oral. Postmenn 1 o\\"mg daily, or IOmq clnw.n\\"'\\"\\"OA Wkly."},{"id":"fs-0053","name":"Alendronate 70rn(l +vitamin IJ3 2800u","dosage":"'I taiJ oac:h wk oral. 1\\\\lfacalcidol. O.Wimcq/kg (max 1mcq) daily oral or IV, ncJ. ju;;tcd accordinq to  Alfcnlanil. 10men/kg or IM stat, Ilion fimcg/1<[1 prn. lhcmtru (vontilntecl): ~J(). 50rncq/kg IV over timin, then 1 timgJ/kg prn or O.:S--1 mcg/l<n/min. ICU (ventilated): t)(). J OOrncn/kg IV ovor 1 0min, then 0.5-imcg/kg/min. 1\\\\lfuzosin. 1\\\\dtJit, NOT/kg: ?.timg G--Sfl oral; slow-rol10mq e>oo liqllld 2.ml meals."},{"id":"fs-0054","name":"Alirocumab","dosage":"1\\\\dtJII, 150mg) ovcry 2.wk SC."},{"id":"fs-0055","name":"Alisl<iren","dosage":"Adult, NOT/1\\\\q: 300tTllJ) daily oral. /\\\\lisl<iron + amlodipine. -1 ti0/5, 300/5 or 300/\\"10rnn tab. Adult, NOI/kg: 1:00ruq/5mq dHily mal, inc:r ovor 2.-4wk lo max Aliskiren + llv.rllt>d'rlnrrntilic; or 300/2.C>mo tab. Adult NDT/kn:"},{"id":"fs-0056","name":"Alisl<iren + valnarten","dosage":"1 b0/'1 60 or NOT/I<q: 1 tab cluily oral."},{"id":"fs-0057","name":"Alitretinoin","dosage":"0_ 1% ti-1 /H. 1\\\\llerwm exlract mite, 1\\\\llopurinol. -10--/0mg/kg (max 1ti0/2S, 300/12.ti oral. tab. Adult, t1ll{tl\\"[jOrlS. daily oral. Provnnt $D.9b J po;;lnqc from oniom(f})dn.Judusos.com Page 3 turnourlysis: J 00--'1tiOrnu/m2 12H IV, oral"},{"id":"fs-0058","name":"Almotriptan","dosage":"Aclott, NOT/kg: 6.25-12.fimg oral, repeat in 21lr if required (max 2 dosus in 241lr)."},{"id":"fs-0059","name":"Alogliptin","dosage":"Adult, NcJ T/kg: 12.ti-2timg daily oral"},{"id":"fs-0060","name":"Alogliptin 12.5mg + metlormin 50tlmg","dosage":"1 tab 12H oral"},{"id":"fs-0061","name":"Alogliplin 25mg + pioglitazorw 30mg","dosage":"1 tab daily oral"},{"id":"fs-0062","name":"Alosetron","dosage":"Adult, NOT/kg: 1 mg daily oral, increase if required after 4wk to 1mg 12H (stop if no response aftcor 4wk)."},{"id":"fs-0063","name":"Alpha tocopheryl acetate","dosage":"One alpha-tocopheryl (at) equivalent \\"' 1 mg d-al 1. -1 mg d-at acetate 1.t)mg dl-at acetate 1.5u vit F. 1\\\\betalipoproteinaernia: 100mg/kg (max 4[J) daily oral. Cystic fibrosis: 45-200mg (NOT/kg) daily oral."},{"id":"fs-0064","name":"Newborn (high dose","dosage":"toxicity r<oported): 10-25mg/kg daily IM or IV, 10 100mg/kg daily oral."},{"id":"fs-0065","name":"Alpha1 antitrypsin","dosage":"60mg/kg once Wl(ly IV over 30min."},{"id":"fs-0066","name":"Alpha, proteinase inhihitor","dosage":"See alpha, antitrypsin."},{"id":"fs-0067","name":"Alprazolam","dosage":"(adult 0.2S-1mg) 8H oral. Slow rei: 0.5-1rn(J daily, increase to (max 10mg) daily oral. 1\\\\lpronolol. 1-4mg/kg (max 6-12H oral. Alprostadil (prostaglandin E1, Maintain PDA: 60 in 50ml 0.9% saline OS3ml/llr (10-60ng/kg/min); TY, dysftn (adult NOT/kg): 2.5mcg intracavmnous if to max OOmcg (max 3 doses/wk). lasmi1rocmn activator). 0. 1-0.6mg/l(g/hr (longer if 110 rosponsEl); keep fibrinooen >100mg/dl (uive cryoprecipitate 1 bag/5kg), give heparin -10u/l<q/llr IV, give frm;h froLen plasma (ICFf') 10ml/kg IV daily in i11fants. Local 1/\\\\ rnfsn: O.Obmg/k[]ihr, give FTP 10ml/kg IV daily. Blocl<ccl cannula: O.t)mg/2ml (<10kg) 2mg/2ml (>10kg) pm lumen left for 2-4hr, witl1dmw drug, flush with saline; once in 2~hr if rcqcl. l=rnpyoma: 4mg in 40ml saline 1 hr dwell, daily for total 3 doses. oral. compresses, or daily to molluscum"},{"id":"fs-0068","name":"Aluminium chloride hexahydrat<l","dosage":"20% x1--2/wk."},{"id":"fs-0069","name":"Aluminium hydroxide","dosage":"?5mn/kg (adult 0.5-1g) 4--6H oral. Gel (64mg/ml) 0.1 ml/kg 6H oral. Aluminium hydroxide 40mg/ml, IM(l hydroxide 40mg/ml, simethicone 4mg/ml (IMylanta, Gelusil). 0.5--1 ml/kg (adult 10--20ml) ll--8H om I. ICU: 0.5ml/kg 3H oral if pll <ti. Aluminium 20% solution: to stinD. then 12H"},{"id":"fs-0070","name":"Ambrisentan rladalafil","dosage":"Adult (NOT/kg): S/20mg daily oral increase 4wkly to 10/~0mg daily."},{"id":"fs-0071","name":"Amcinonide","dosage":"0.1% lotion, croam, ointment: Apply tJ. 12H."},{"id":"fs-0072","name":"Amethocaine","dosage":"Gel 4'% in mettlylcolluloso (RCH AnGel): to skin, apply occlusive dressing, wait 30-60min, remove 0.5%, 1%: 1 drop/eye."},{"id":"fs-0073","name":"Amifampridine","dosage":"Adult, NOT/kg: 15 mg daily oral, increase avery ti days if mqd to max 20mg 8H."},{"id":"fs-0074","name":"Amifostine","dosage":"910mg/rn' IV over 15m in daily 30min before chemotherapy; reduce to 7 40mq/m2 if severo side eft'octs."},{"id":"fs-0075","name":"Arnikacin","dosage":"Single daily dose IV or IM. Neonate: 15rnoikg stat, then 7.5mg/ko (<lOwk) 10mg/kg (30-35wk) 15mg/kg (term <1wk) daily. 1wk 10yr: 25mg/l<o day 1, then 18mnlkg daily. >10yr: 20mglkg day 1, then 15mglkg (max 1.tio) daily. t'rough level <5.0mg/L."},{"id":"fs-0076","name":"Amiloride","dosage":"0.2mg/kg (adult 12-24H-1 oral."},{"id":"fs-0077","name":"Aminacrino hydrochloride","dosage":"1 drop/eye 2-AII."},{"id":"fs-0078","name":"Aminoacridino hydrochloride","dosage":"See aminacrine."},{"id":"fs-0079","name":"Aminobenzoic acid","dosage":"60mglkg (max :Jg) 6H oral"},{"id":"fs-0080","name":"Aminocaproic acid","dosage":"3g/m2 (adult over 1 hr IV, then per 11r (max 1-1.2~n/hr). l\\"rophylax: (JIIIV,"},{"id":"fs-0081","name":"Aminonlutethimide","dosage":"Adult, NOT/1\\\\g: 250mg oral, I ncr over 4wk to 2ti0mg 6H."},{"id":"fs-0082","name":"Aminohippuric acid (PAHA)","dosage":"6-10mglkg stat, them O.Z. 0.5 mglkg/min IV gives 2mg/10Oml in plasma."},{"id":"fs-0083","name":"Aminolevulinic acid","dosage":"20% solution: apply to lesions, expose to 400-450nrn blue lioht for 10OOsec (10 J/cm') next day; repeat after 8wk if required."},{"id":"fs-0084","name":"Aminophylline","dosage":"-100m9 80mg tlwophylline. Load: 10mrJ/ko 500mg) IV ovor 1 hr. Maintenance: 1st wk lifo 2.Smg/kg over 1H 12H; 2nd wk life 12H; 3wk-12 mo ((0.12 x ago in wk) + 3) mg/kg 8H; and 2t)mg/kg at 0.044mlkg/hr (1.1mq/kolhr) or 6111q/kg IV over 6H; >35kg and <17yr, or >1/yr and srnol<er, 25mg/ml at 0.02fl mlkg/hr (O.lmg/kg/hr) or 4mglkg IV over 1 hr 6H; >17yr non. srnol<er 2.5mg/ml at 0.02mlkglhr (0.5rn[Jikglhr) or 3mg/kg IV over 1H 61l; 25mglml at 0.014 ml/kglhr (0.3fi"},{"id":"fs-0085","name":"IV over 111r 6H","dosage":"Level 60-SOumol/L (x0.1 flcmcg/ml). See rm~salo.zine. lno-salll<O\\\\rlic acid (4-Aminosalicylic 50-\\"100mglkg (adult in 50ml 5%1.1 $9.9f5 + po~;tngc~) tron1 ordors@tlrugdusos.com Page 5 f'nuresis: 1-1.Grno/kn (max"},{"id":"fs-0086","name":"Amlexanox","dosage":"G% oral Amlodipine. Amlodipine + olmesartan."},{"id":"fs-0088","name":"Amlodipine + perindopril","dosage":"3.5/2.5rno, \\"7/5, 14/10 tab. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-0089","name":"Amlodipinc + telmisartan","dosage":"5/40mg, 5/80, 10/40 or 10/80 lab. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-0090","name":"Amlodipine + valsarlan","dosage":"5/160mg, 5/320, 10/1GO. 10/320 tab."},{"id":"fs-0092","name":"Amobarbital","dosage":"Seo arnylobarbitono."},{"id":"fs-0093","name":"Amodiaquin<>","dosage":"Treatment: 10mg/kg daily for 3 days oral. l\\"'rophylaxis: 5mg/kg once a wk."},{"id":"fs-0094","name":"Amorolfinc","dosage":"Nail lacquer ti%: apply x1-2/wk."},{"id":"fs-0095","name":"Amoxapine","dosage":"0.5-2mg/kg 25-100mg) 8H oral."},{"id":"fs-0096","name":"Amoxicillin","dosage":"See"},{"id":"fs-0097","name":"Amoxycillin","dosage":"25mg/kg 0.25-1g) 8H IV, IM, oral; or 25 40mgll<q 12H. Slow :e12yr T75mg tab daily oral. Sevore inftn: tiOmg/kg (adult 2g) IV 12fl (1st wk life), GH (2- 3wk), 4. 6H or constant infusion (?4wk). H.pylori: omepraLolo. + clavulanic acid. Dose as arnoxicillin, oral. 4:1 111ay cause tiln:ornhorJh mg GH prophylaxis. oint 3%: apply 6-12H. ti00/12timg) 8H; 7:1 12H; or 10:1 (XI'<) 30- Amphotericin, colloidal dispersion (Amphocil, Ampholec). Usually :lAmg/kfJ (up to Gmg/kg for aspergillus) daily IV over ?.-3hr. 6H or Ampidllin + fluclctJ<aciltlin. 2t50 (cl1ild), ?tJ0/2t50 or b00/500 Ampicillin 'l,g + sulbactmn ?h'illrno/l<n ampicillin GIIIM or IV over $9,Df) J postH~JCt t\\"rorn ordors(ciy)rugdosos.com Pane 6"},{"id":"fs-0098","name":"Amprenavir","dosage":"~4yr. Soltn (max 17mg/kg 8H oral. Caps (max 15mg/kg 8H oral. ?2.5 mg/I<[J12H, or 2.0mg/kg 12H, or"},{"id":"fs-0099","name":"Amrinone","dosage":"<4wlc 4mg/kg IV over 1H, then 3-5mcg/kg/min. >4wk: 1-3mg/kg IV over 1 hr, then 5-15mcg/kg/min."},{"id":"fs-0100","name":"Amsacrine","dosage":"450-600mg/m2 IV over 2H daily for 3-5 days."},{"id":"fs-0101","name":"Amylase","dosage":"See pancreatic enzymes."},{"id":"fs-0102","name":"Arnylmotacresol","dosage":"0.6mq lozenge as required (max 8/day)."},{"id":"fs-0103","name":"Arnylobarbitone","dosage":"0.3-1mg/kg (adult 15-50mg) 8-12H, or 2- 4mg/kg (adult 200-400mg) at night, oral."},{"id":"fs-0104","name":"Anagrelide","dosage":"Adult, NOT/kg: 0.5mg 12H, increase slowly if roqd to max 2.5mg 6H oral."},{"id":"fs-0105","name":"Anakinra","dosage":"Adult, NOT/kg: 100mg daily SC."},{"id":"fs-0106","name":"Anastrozolo","dosage":"Adult, NOT/kg: 1 mg daily oral."},{"id":"fs-0107","name":"Ancestim (human stem coil factor)","dosage":"20mcg/kg/day SC."},{"id":"fs-0108","name":"Aneurine","dosage":"See thiamine."},{"id":"fs-0109","name":"Angel cream (RCH)","dosage":"See amethocaine."},{"id":"fs-0110","name":"Anidulafungin","dosage":"2-Amg/kg (adull100-~00mg) IV day 1, then 1- 2mglkg (8dult 50-100mg) daily."},{"id":"fs-0111","name":"Anisindione","dosage":"6mglkg (adult 300mg) oral 1, (adult ?OOmg) 2mtJ/kg (adult 100mg) then mg/kg/day 25-250mg) according prothrombin timo."},{"id":"fs-0112","name":"Anistreplase","dosage":"Adult, NOT/ko: 30u IV over 5min."},{"id":"fs-0113","name":"Anthraquinone","dosage":"Soe sennosicle. Anthrax vaccil\\"' (BioThrax). Inanimate. O.timiiM stat, 4wk, 6mo, 12mo, 18mo (5dosos), then yearly. 1ost-exposuro 0.5 miiM stat, 2wk, 4wk (3 doses) with antibiotic."},{"id":"fs-0114","name":"Antihaemophilic factor","dosage":"Seo factor 8."},{"id":"fs-0115","name":"AntHnhibitor coagulant complex","dosage":"Soe factor 8 inhibitor bypassing fmction."},{"id":"fs-0116","name":"Antilymphocyte globulin","dosage":"See immunoglobulin, antilym'te. Antithrombin, antithrombin alfa, antithrombin Ill, recom. binant human antithrombin (rhAT). Adult: units (100% actual%) x Wt I 2.2 load, then 23% of this hrly; double dose nrr>~m.Rnr'v Child: either 10OOu in 20ml water diluted Ia 2.5 mltkg/hr (50u/kg/hr) for 3hr, than 0.3 ml/kg/hr (Gu/kg/hr) or 1750u in 10ml water diluted to 50ml with saline: 1 Amlkg/ilr (49u/kg/ilr) for 3hr, then 0.17mltkg/hr (6u/kg/hr). Monitor antithrombin activity after 6hr, then 8- 12H: if <80% increase dose 30%; if >120% reduce dose 30%."},{"id":"fs-0117","name":"Antithymo<:yte (Jiobulin","dosage":"Soe antilyrnpl1'te. Antivonom to Australian snakes (black, brown, death adder, tiger), (funnel- web) and tid<s. Dose on amount venom injec- ted, not size of patient. doses needed for multiple bites, 8evero administration. Give adrenaline of -1 in 1 000) SC. Initial dose solution IV over 30m in. Do extra doses for Anlivenom to black widow spider spider (Australia). NUJ\\"/I1g: 1arnp IM, may repeat in 2H. Severe: 2 amp diluted 1/10 in Hartmann solution IV over 30min. No clear benefit from redbacl1 spider anitvenom (Aust Prescr 35:152)."},{"id":"fs-0118","name":"Anlivenom to coral snalw (USA)","dosage":"NOT/kg: 3--6 vials IV over 1-2H, 1epeat if signs progress. Premed with diphenhydra mine 5mg/kg (adult 300mg) IV, have adrenaline available. Antivenom to Crotalidae (pit vipers, rattlesnal1es- USA). NOT/kg: ~-6 vials, with higher dose for more severo enveno mation, diluted 1/10 in saline IV over 1H, repeated 1H later if required; tl\\"len ?. vials 6H for 3 doses."},{"id":"fs-0119","name":"Antivenom, bark scorpion","dosage":"NOT/kg: 3 vials IV over 10min; further 1-2 vials at 30-60min intervals if required."},{"id":"fs-0120","name":"Antivenom, stonefish","dosage":"10OOu (2ml) per puncture IM. Severe: 1000u/puncture dilutd 1/10 in Hartmann solution IV over 30min."},{"id":"fs-0121","name":"Apixaban","dosage":"Adult, NOT/kg: surgery 2.5mg 12H oral, atr fib 5mg 1?11."},{"id":"fs-0122","name":"Apomorphine","dosage":"Adult, NOT/kg: usually 2.4-3.6mg/dose (max 6mg) prn to max 50mg/day SC. lnfsn: 0.02--0.0Smg/kg/ill\\" (max 200mg/day) SC."},{"id":"fs-0123","name":"Apraclonidine","dosage":"1 drop/eye 8H (0.5%), 12H (1%)."},{"id":"fs-0124","name":"Aprernilast","dosage":"Adult, NOT/kg: 10mg 12H om I, increase over 6 days to 30mg 12H."},{"id":"fs-0125","name":"Aprepilant","dosage":"Adult, NOT/kg: 12.(img oral1hr before cherno, then 80mg on days 2 and 3."},{"id":"fs-0126","name":"Aprostadil","dosage":"See alprostadil. Aprotinin (1kiu ~ 140ng \\"0.00056epu, Hng ~ 7143kiu). 1,200,000 kiu/m2 IV over 1 hr (plus 1,200,000 kiu/m2 in prime), then 300,000 kiu/m2/hr; half for \\"low dose\\". Adult, NOT/kg: 2,000,000 kiu IV over 1 hr (plus 2,000,000 kiu in prime), then 500,000 kiu/hr; half for \\"low dose\\". l\\"rophylaxis: 4000 kiu/kg, then 2000 kiu/kg 6H IV."},{"id":"fs-0127","name":"Arachis oil","dosage":"130mt enema as mquired. Arachis oil 57% + chlorbutol 5% + dichlorobenzene 16% (Cerumol). i drops to eilr 15-30min before syringing."},{"id":"fs-0128","name":"Arformoterol","dosage":"NOT/kg: 15mcg in 2mi12H by nebulisation."},{"id":"fs-0129","name":"Argatroban","dosage":"2mcg/kg/min IV; adjust to maintain APTT x1.5-3."},{"id":"fs-0130","name":"Arginine hydrochloride","dosage":"Dose (mg) = BE x Wt(kg) x 70; give half this IV over 1 hr, then repeat if mqd."},{"id":"fs-0131","name":"Arginine vasopressin, argipressin","dosage":"See vasopressin."},{"id":"fs-0132","name":"Aripipraz.ole","dosage":"0.1 mg/kg (adult 5mg) increase if required by 0.1mg/l1g (adult 5mg) each wl\\\\ to max 0.6mg/l\\\\g (adult 30mg) daily. Extended rolease: fl-Smg/kg (adult 300--400mg) IM monthly."},{"id":"fs-0133","name":"Aripiprazolo lauroxil","dosage":"Adult, NOT/kg: 441 mg (''10mg/clayoral) or 662mg (=15mg/day) monthly, or 882mg every 4--6wl\\\\ IM."},{"id":"fs-0134","name":"Armodafinil","dosage":"Adult, NOT/kg: 150mg (max 2f50mg) daily oral."},{"id":"fs-0135","name":"Arsenic trioxide","dosage":"0.15mg/kg daily IV until remission (max 60 closes), wait 6wk, then 0:15mg/l\\\\g for 25"},{"id":"fs-0136","name":"Artemethor, oily solution","dosage":"3.2mg/kg IM then t daily until oral therapy possible (See artesunate)."},{"id":"fs-0137","name":"Artmnether 20mg + lumefantrine 120mg","dosage":"NOT/kg: 1 tab (5- Pago 8 14kg), 2 tab (15-24kg), 3 tab (25-341<9), 4 tab (<:35kg) with fatty food (e.g. milk) at Ohr, Bhr, 24H, 36hr, 48hr and 60hr. Repeat dose if vomit within 1 hr of ingestion."},{"id":"fs-0138","name":"Artesunate","dosage":"Treatment of choice for severe malaria. 2.4mg/kg IV or IM at Ohr, 12H, 24H, then daily x7 days; after at least 3 doses and when oral therapy possible change to full course of artemether + lumefantrine."},{"id":"fs-0139","name":"Articane 40mg/ml +adrenaline 1:100,000","dosage":"Adult, NOT/kg avge dose 1.7ml (max 7mg/kg = 0.175ml/kg) by injection."},{"id":"fs-0140","name":"Ascorbic acid","dosage":"Burn (NOT/kg): 200-500mg daily IV, IM, SC, oral. Metabolic dis (NOT/kg): 250mg (<7yr) 500mg (>7yr) daily oral. Scurvy (NOT/kg): 100mg 8H oral for 10 days. Urine acidification: 10-30mg/kg 6H."},{"id":"fs-0141","name":"Asenapine","dosage":"Adult, NOT/kg: 10-20mg daily sublingual."},{"id":"fs-0142","name":"Asfotase","dosage":"2mg/kg (infants 3mg/kg) three times a week SC."},{"id":"fs-0143","name":"Asparaginase","dosage":"See colaspase."},{"id":"fs-0144","name":"Aspirin","dosage":"10-15mgikg (adult 300-600mg) 4-6H oral. Antiplate let, preeclampsia (enteric-coat poor absorbtn): 5mg/kg (adult 81-100mg) daily; ER adult(NOT/kg) 162.5mg daily. Kawasaki: 10mg/kg 6H (low dose) 25mg/kg 6H (high dose) for 2wk, then 3-5 mg/kg daily. Arthritis: 25mg/kg (max 2g) 6H for 3 days, then 15-20mg/kg 6H. Salicylate level (arthritis) mid dose 0.7 -2.0mmoi/L (x13.81 =mg/10Oml)."},{"id":"fs-0145","name":"Aspirin 25mg + dipyridamole 200mg","dosage":"Adult, NOT/kg 1 sustained rei cap 12H oral."},{"id":"fs-0146","name":"Aspirin lysine 1.62g + metoclopramide 10mg","dosage":"Adult, NOT/kg: 1 sachet oral, rnay repeat in 2H; max 3/day."},{"id":"fs-0147","name":"Asunaprevir","dosage":"Adult, NOT/kg: 100mg 12H + daclatasvir 60mg daily ribavirin oral."},{"id":"fs-0148","name":"Atazanavir (ATV)","dosage":">16yr: 400mg/daily with food. Trough ?.150ng/ml."},{"id":"fs-0149","name":"Atazanivir + cobicistat","dosage":"Adult, NOT/kg: 300/150mg daily."},{"id":"fs-0150","name":"Atazinavir + ritonavir","dosage":"15-24kg: 150/80mg daily with food oral; 25-31kg: 200/100mg daily; 32-38kg: 250/100mg daily; <:39i<g: 300/100mg daily with food. ATV trough <:150ng/ml. Atazinavir 400mg + efavirenz 600mg + ritonavir 100mg. >16yr: all daily oral, at different times (EFV not with food)."},{"id":"fs-0151","name":"Atenolol","dosage":"Oral: 0.5-1mg/kg (max 25-50mg) 12-24H. IV: 0.05 mg/kg (max 2.5mg) every 5min if required (max 4 doses), then 0.1-0.2mg/kg (max 5-10mg) over.10min 12-24H."},{"id":"fs-0152","name":"Atenolol 50mg + nifedipine 20mg","dosage":"Adult, NOT/kg: 1 cap 12H oral. Slow-rei: 1 cap daily oral."},{"id":"fs-0153","name":"Atomoxetine","dosage":"0.5mg/kg (max 40mg) daily oral, increase after at least 3 days to max 1.2-1.4mg/kg (max 100mg) as single daily dose or divided 12H."},{"id":"fs-0154","name":"Atorvaslatin","dosage":"0.2mg/kg (adult 10mg) daily, increase if required every 4wk to max '1.6mg/kg (adult 80mg) daily."},{"id":"fs-0155","name":"Atorvastatin + ezetimibe","dosage":"10/10mg, 20/10, 40/10, 80/10. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-0156","name":"Atosiban","dosage":"Adult, NOT/kg: 6.75mg IV over 1min, then 300 Page 9 meg/min for 3hr, then 10Omcg/min for max 45hr."},{"id":"fs-0157","name":"Atovaquone, micronised","dosage":"Pneumocystis: 3-24mo 45mg/kg, >24mo 30mg/kg (max 1500mg) daily oral. Atovaquone 62.5mg + proguanil 25mg (Malarone paed iatric). Treat: 2 tab (5-8kg) 3 tab (9-10kg) 8H for 3 days. Prophylaxis: 5mg/kg (adult 250mg) daily oral."},{"id":"fs-0158","name":"Atovaquone 250mg + proguanil 100mg (Malarone)","dosage":"Malaria treat: 20mg/kg of atovaquone (max 1 g) daily for 3 days oral; proph: 5mg/kg of atovaquone (adult 250mg) daily."},{"id":"fs-0159","name":"Atracurium","dosage":"0.3-0.6mg/kg stat, then 0.1-0.2mg/kg when required or 5-10mcg/kg/min IV."},{"id":"fs-0160","name":"Atropine","dosage":"0.02mg/kg (max 0.6mg) IV or IM, then 0.01mg/kg 4- 6H. Organophosphate poisoning: 0.05-1mg/kg (adult 2mg) IV, then 0.02-0.05mg/kg (adult 2mg) every 15-60min until atropinised, then 0.02-0.0Smg/kg/hr for several days. Auto injector (adult, NOT/kg): 2mg + obidoxime 110mg IM. Atropine 25mcg + diphenoxylate 2.5mg tab (Lomotil). Adult, NOT/kg: 1-2 tab 6-8H oral."},{"id":"fs-0161","name":"Attapulgite","dosage":"Adult, NOT/kg: 0.6-1.2g 3-6H oral."},{"id":"fs-0162","name":"Auranofin","dosage":"0.1 mg/kg (adult 6mg) daily oral, increase if required to max 0.05mg/kg (adult 3mg) 8H."},{"id":"fs-0163","name":"Aurothioglucose, aurothiomalate","dosage":"0.25mg/kg wkly IM, increase to 1 mg/kg (max 50mg) wkiy for 20wk, then every 1-4wk."},{"id":"fs-0164","name":"Avanafil","dosage":"Adult, NOT/kg: 100mg (50-200mg) 30min before sexual activity, max once/day."},{"id":"fs-0165","name":"Avibactam","dosage":"See ceftazidime."},{"id":"fs-0166","name":"Axitinib","dosage":"Adult, NOT/kg: 5mg (2-10mg) 12H oral."},{"id":"fs-0167","name":"Azacitidine","dosage":"75mg/m2 SC daily for 7 days, repeated every 4wk; increase if required after 2 cycles to 1 00mg/m2 daily."},{"id":"fs-0168","name":"Azapropazone","dosage":"10mg/kg (max 600mg) 12H oral. Acute gout: 6H (day 1), 8H (day 2), then 12H."},{"id":"fs-0169","name":"Azatadine","dosage":"NOT/kg: 0.5-1 mg (>6y), 1-2mg (>12y) 12-24H po."},{"id":"fs-0170","name":"Azathioprine","dosage":"25-75mg/m2 (approx 1-3mg/kg) daily oral, IV."},{"id":"fs-0171","name":"Azelaic acid","dosage":"20% cream, 15% gel: apply 12H."},{"id":"fs-0172","name":"Azelastine","dosage":"0.1% spray, >5yr: 0.15ml to each nostril 12H."},{"id":"fs-0173","name":"Azelastlne + flutlcasone","dosage":"1 spray (137/50mcg) I nostril 12H."},{"id":"fs-0174","name":"Azidothymidine (AZT)","dosage":"See zidovudine."},{"id":"fs-0175","name":"Azilsartan","dosage":"1-2mg/kg (adult 40-80mg) daily oral."},{"id":"fs-0176","name":"Azilsartan + chlorthalidone","dosage":"40/12.5, 40/25mg. Adult, NOT/kg: 40/12.5 tab daily, increase to 40/25 daily if required."},{"id":"fs-0177","name":"Azithromycin","dosage":"Oral (only 40% bioavailable): 15mg/kg (adult 500mg) on day 1 then 7.5mg/kg (adult 250mg) days 2-5, or 15mg/kg (adult 500mg) daily for 3 days; trachoma 20 mg/kg (adult 1g) wkly x3; MAC prophylaxis (adult) 1.2g wkly; Gp A strep 20mg/kg daily x3. IV: 15mgikg (adult 500mg) day 1, then 5mg/kg (adult 200mg) daily. 1% eye drops: 1 drop 12H for 2 days, then daily for 5 days."},{"id":"fs-0178","name":"Aztreonam","dosage":"30mg/kg (adult 1 g) 8H IV. Severe inftn: 50mg/kg (adult 2g) 12H (1st wk life), 8H (2-4 wi<), 6H or infusion (4+ wk). Nobulised (adult, NOT/kg): 75mg 8H. Page 10"},{"id":"fs-0179","name":"Bacampicillin","dosage":"15-25mg/kg (adult 400-BOOmg) 12H oral."},{"id":"fs-0180","name":"Bacillus Calmette-Guerin (BCG) vaccine (CSL)","dosage":"Live. Intra dermal (1 mg/ml): 0.075ml (<3mo) or 0.1 ml (>3mo) once. Percutaneous (60mg/ml suspension): 1 drop on skin, inoculated with Heal apparatus, once. Bacillus Calmette-Guerin (BCG) vaccine suspension, about 5 x 1QA8 cfu/vial. Adult: 1 vial (OncoTICE) or 3 vials (lmmuCyst) left in bladder for 2H each wk for 6wks, then at 3, 6, 12, 18 and 24mo."},{"id":"fs-0181","name":"Bacitracin 500u/g + polymyxin B 10,OOOu/g","dosage":"Eye ointment: apply x2-5/day. Bacitracin 400u/g + polymyxin B 5000u/g + neomycin 5mg/g (Neosporin). Ointment or eye ointment: apply x2- 5/day. Powder: apply 6-12H (skin inftn), every few days (burns). Eye drops: See gramicidin."},{"id":"fs-0182","name":"Baclofen","dosage":"0.2mg/kg (adult 5mg) 8H oral, increase every 3 days to 1 mg/kg (adult 25mg, max 50mg) 8H. Intrathecal infusion: 2-20 meg/kg (max 1000mcg) per 24H. , Balsalazide. Adult, NOT/kg: 2. 25g 8H oral (= 2.34g mes- alazine daily)."},{"id":"fs-0183","name":"Bambuterol","dosage":"0.2-0.4mg/kg (adult 10-20mg) nocte oral."},{"id":"fs-0184","name":"Basiliximab","dosage":"12mg/m2 (max 20mg) IV 2H preop and day 4. Bazedoxifene 20mg + conjugated oestrogens 0.45mg. Adult, NOT/kg: 1 tab daily."},{"id":"fs-0185","name":"BCG vaccine","dosage":"See Bacillus Calmette-Guerin vaccine."},{"id":"fs-0186","name":"Becaplermin","dosage":"Length 0.01% gel in ern: ulcer length x width /4 (15g tabe), or L x WI 2 (2g tabe) daily; wash off after 12H."},{"id":"fs-0187","name":"Beclomethasone dipropionate","dosage":"Rotacap or aerosol (NOT /kg): 100-200mcg (<Syr), 1t50-400mcg (>Byr) x2/day (rarely x4/day). Nasal (NOT/kg): aerosol (80mg/spray) or pump (42- 50mcg/spray): 1spray 12H (<12yr), 2spray 12H (>12yr). Beclomethasone extrafine 10Omcg + formoterol 6mcg. 2:12yr (NOT/kg): 1-2 puffs 12H inhaled."},{"id":"fs-0188","name":"Bedaquiline","dosage":"Adult, NOT/kg: 400mg daily oral for 2wk, then 200mg x3/wk for wks 3-24."},{"id":"fs-0189","name":"Belatacept","dosage":"10mg/kg IV over 30m in day 1, day 5, 2wk, 4wk, 8wk and 12wk; then 5mg/kg every 4wk.  Belimumab. 10mg/kg IV over 1 hr every 2wk x3, then 4wkly."},{"id":"fs-0190","name":"Belinostat","dosage":"1g/m2 IV over 30min day1-5 of 21 day cycle."},{"id":"fs-0191","name":"Bemiparin","dosage":"Surgery (adult, NOT/kg): 2500u (orthopaedics 3500u) SC 2H pre-op or 6hr post-op, then daily for 7-10 days. DVT: 115u/kg daily 5-9 days (or until oral anticoag)."},{"id":"fs-0192","name":"Benazepril","dosage":"0.2-0.4mg/kg (adult 10-20mg) 12-24H oral."},{"id":"fs-0193","name":"Bendamustine","dosage":"CLL: 1 00mg/m2 IV on days 1 and 2 of 28--day cycle for up to 6 cycles; 70mg/m2 with rituxirnab. NHL: 120 mg/m2 on days 1 and 2 of 21-day cycle for up to 8 cycles; 90mg/m2 with rituximab."},{"id":"fs-0194","name":"Bendrofluazide","dosage":"0.1-0.2mg/kg (adult 5-10mg) daily oral."},{"id":"fs-0195","name":"Bendroflumethiazide","dosage":"See bendrofluazide."},{"id":"fs-0196","name":"Benflumetol (lurnefantrine)","dosage":"See artemether. Page 11"},{"id":"fs-0197","name":"Benorylate","dosage":"30mglkg (adult 1.5g) 8H oral."},{"id":"fs-0198","name":"Benperidol","dosage":"5-15mcglkg (adult 0.25-1.5mg) 12-24H oral."},{"id":"fs-0199","name":"Benserazide","dosage":"See levodopa + benserazide."},{"id":"fs-0200","name":"Benzathine penicillin","dosage":"See penicillin, benzathine."},{"id":"fs-0201","name":"Benzatropine","dosage":"See benzlropine."},{"id":"fs-0202","name":"Benzbromarone","dosage":"Adult, NOT/kg: 50--300mg daily oral, or 20- 25mg with allopurinol."},{"id":"fs-0203","name":"Benzhexol","dosage":">3yr: 0.02mglkg (adult 1 mg) 8H, increase to 0.1-0.3 mglkg (adult 1.5-5mg) 8H oral."},{"id":"fs-0204","name":"Benzocaine","dosage":"1%-20% topical: usually applied 4-6H."},{"id":"fs-0205","name":"Benzocaine+ cetylpyridinium","dosage":"Mouth wash (Cepacaine): apply 3H prn, do not swallow."},{"id":"fs-0206","name":"Benzocaine + phenazone 5.4% (Auralgin)","dosage":"3 drops per ear x3/day for 2-3 days."},{"id":"fs-0207","name":"Benzoic acid 6% + salicylic acid 3%","dosage":"Whitfield's ointment: apply 12H."},{"id":"fs-0208","name":"Benzonatate","dosage":"Adult, NOT/kg: 1-2 100mg cap 8H oral; must be swallowed whole, toxic if capsule not intact."},{"id":"fs-0209","name":"Benzoyl peroxide","dosage":"Liquid, gel2.5%-10%: apply x1-31day. See also adapalene + benzoyl peroxide."},{"id":"fs-0210","name":"Benzoyl peroxide+ clindamycin gel","dosage":"1%/5%, 1.2%12.5%, 1.2%13.75%, 1.2%15%. Apply pea-sized amount to face daily."},{"id":"fs-0211","name":"Benzphetamine","dosage":"25-50mg daily oral, increase if required to 8H."},{"id":"fs-0212","name":"Benzquinamide","dosage":"IM: 0.5-1 mglkg (adult 50mg) stat and repeat in 1H if needed, then 3-4H prn. IV over 1-5min: 0.2-0.4mglkg (adult 25mg) once."},{"id":"fs-0213","name":"Benzthiazide 25mg + triamterene 50mg","dosage":"Adult, NOT/kg: 1-2 tab on alternate days, oral."},{"id":"fs-0214","name":"Benztropine","dosage":">3yr: 0.02mg/kg (adult 1 mg) statIM or IV, rnay repeat in 15min. 0.02.-0.06mglkg (adult 1-3mg) 12-24H oral."},{"id":"fs-0215","name":"Benzydamine","dosage":"3% cream: apply 8H."},{"id":"fs-0216","name":"Benzyl benzoate","dosage":"25% lotion. Scabies: apply neck down after hot bath, wash off after 24H; repeat in 5 days. Lice: apply to infected region, wash off after 24H; repeat in 7 days."},{"id":"fs-0217","name":"Benzylpenicillin","dosage":"See penicillin G."},{"id":"fs-0218","name":"Bepotastine","dosage":"1.5% ophthalmic solution: 1 drop 12H."},{"id":"fs-0219","name":"Bepridil","dosage":"4-8mglkg (adult 200-400mg) daily oral."},{"id":"fs-0220","name":"Beractant (bovine surfactant, Survanta)","dosage":"25mglml solution. 4mlkg intratracheal 2-4 doses in 48hr, each dose in 4 parts: body inclined down with head to right, body down head left, body up head right, body up head left"},{"id":"fs-0221","name":"Besifloxacin","dosage":"0.6% eye ointment: apply 8H."},{"id":"fs-0222","name":"Beta carotene","dosage":"Porphyria: 1-5mglkg (adult 30-300mg) daily."},{"id":"fs-0223","name":"Betahistine","dosage":"0. 15-0.3mglkg (adult 8-16mg) 8H oral."},{"id":"fs-0224","name":"Betaine hydrochloride","dosage":"Usually 60mglkg (adult 3g) 12H oral, max 100mglkg (adult 5g) 12H."},{"id":"fs-0225","name":"Betamethasone","dosage":"0.01-0.2mglkg daily oral. Betamethasone has no mineralocorticoid action, 1 mg = 25mg hydrocortisone in glucocorticoid action. Gel 0.05%; cream, lotion or oint- ment, 0.02%, 0.05%, 0.1%: apply sparingly 8-24H. Eye Page 12 0.1%: initially 1 drop/eye 1-2H, then 6H; or 0.6cm oint 8-12H."},{"id":"fs-0226","name":"Betamethasone 0.1% +neomycin 0.5%","dosage":"1drop/eye 4-SH. Betamethasone acetate 3mg/ml + betamethasone sodium phosphate 3.9mg/ml (Celestone Chronodose). Adult: 0.25-2ml (NOT/kg) intramuscular, intra-articular, or intra. lesional injection. Betamethasone dipropionate 0.064% + calcipotriol 0.005% (Dovonex). Foam, ointment: apply daily to no more than 30% of body for up to 4wk (max 10Og/wk in adult)."},{"id":"fs-0227","name":"Betaxolol","dosage":"0.4-0.Smg/kg (adult 20-40mg) daily oral. Eye drops 0.25%-0.5%: 1 drop/eye 12H."},{"id":"fs-0228","name":"Bethanecol","dosage":"Oral: 0.2-1mg/kg (adult 10-50mg) 6-8H. SC: 0.05-0.1 mg/kg (adult 2.5-5mg) 6-8H."},{"id":"fs-0229","name":"Bevacizumab","dosage":"10mg/kg IV over 90min every 2wk or 15mg/kg every 3wk. lntravitreal (NOT/kg): 1.25mg every month."},{"id":"fs-0230","name":"Bexarotene","dosage":"300mg/m2 (rangG 1 00-400mg/m2) daily oral."},{"id":"fs-0231","name":"Bezafibrate","dosage":"4mg/kg (adult 200mg) 8H oral with food."},{"id":"fs-0232","name":"Bicalutamide","dosage":"Adult, NOT/kg: 50-150mg daily oral."},{"id":"fs-0233","name":"Bicalutamide + goserelin","dosage":"Adult, NOT/kg: 50mcg daily oral, + goserelin 10.Bmg implant 4wkly or 10.8mg SC every 3mo."},{"id":"fs-0234","name":"Bicarbonate","dosage":"Slow IV: dose (mmol) =BE x Wt/4 (<5kg), BE x"},{"id":"fs-0235","name":"Wt/6 (child), BE x Wt/1 0 (adult)","dosage":"These doses correct half the base deficit. Alkalinise urine: 0.25mmol/kg 6-12H oral."},{"id":"fs-0236","name":"Bifonazole","dosage":"1% cream: apply daily for 2-4wk."},{"id":"fs-0237","name":"Bilastine","dosage":"Adult, NOT/kg: 20mg daily oral."},{"id":"fs-0238","name":"Bimatoprost","dosage":"0.03% drops: 1 drop/eye each evening."},{"id":"fs-0239","name":"Bimatoprost 0.3mg/ml + timolol 5mg/ml","dosage":"1drop/eye daily."},{"id":"fs-0240","name":"Biotin (coenzyme R, vitamin H)","dosage":"NOT/kg: 5-20mg daily IV, IM, SC or oral."},{"id":"fs-0241","name":"Biperiden","dosage":"0.02-0.04mg/kg (adult 1-2mg) 8-12H oral. IM or slow IV: 0.05-0.1mg/kg (adult 2.5-5mg), max x4/day."},{"id":"fs-0242","name":"Bisacodyl","dosage":"NOT/kg: <12mo 2.5mg PR, 1-5yr 5mg PR or 5- 10mg oral, >5yr 10mg PR or 10-20mg oral. Enema: half daily (6mo-3yr), 1 enema daily (>3yr)."},{"id":"fs-0243","name":"Bisacodyl 10mg + docusate sodium 10Omg","dosage":"<2yr 10 suppos, 1-11yr Y,-1 suppos, >11yr 1 suppos daily."},{"id":"fs-0244","name":"Bismuth subgallate","dosage":"See bismuth subcitrate."},{"id":"fs-0245","name":"Bismuth subsalicylte","dosage":"5mg/kg (adult 240mg) 12H oral 30min before meal. H. pylori, See omeprazole."},{"id":"fs-0246","name":"Bisoprolol","dosage":"0.2-0.4mg/kg (adult 10-20mg) daily oral."},{"id":"fs-0247","name":"Bitolterol","dosage":"Resp solution (0.2%): 1 ml diluted to 4ml 3-6H (mild), 2m I diltd to 4ml1-2H (moderate), undiltd constant (severe, in"},{"id":"fs-0248","name":"ICU)","dosage":"Aerosol 370mcg/puff: 1-2 puff 4-6H."},{"id":"fs-0249","name":"Bivalirudin","dosage":"IV: percutaneous coronary intervtn 0.75mg/kg stat, then 1.75mg/kg/hr for up to 72hr; HIT 0.15-0.Zmg/kg/hr."},{"id":"fs-0250","name":"Bleomycin sulfate","dosage":"10-20u/m21M, SC or IV over 15min x1- 2/wk. Max total dose 250u/m2"},{"id":"fs-0251","name":"Blinatumornab","dosage":"NOT/kg. <:45kg: 9mcg/day continuous IV infusion day1-'7, 28mcg/day day8-28, 2wk rest; then 4 cycles of 28mcg/day day1-28 then 2wk rest. Page 13"},{"id":"fs-0253","name":"Boceprevir","dosage":"15mg/kg ~adult 800mg) 8H oral."},{"id":"fs-0254","name":"Bortezomib","dosage":"1.3mg/m on days 1, 4, 8, 11; then 10 day rest (21 day cycle, average 6 cycles). Stop if toxicity, then use 1 mg/m2/dose; stop if toxicity recurs, then use 0.7mg/m2/dose."},{"id":"fs-0255","name":"Bosentan","dosage":"1mg/kg (adult62.5mg) 12H oral for 1-4wk, then 2mg/kg (adult 125mg) 12H. IV: half oral dose."},{"id":"fs-0256","name":"Bosutinib","dosage":"Adult, NOT/kg: 500mg (300-600mg) daily oral."},{"id":"fs-0257","name":"Botulinum toxin type A","dosage":"NOT/kg: SOu IM per site, every 12wk if required. Blepharospasm: 1.25-2.5u into 3 sites/eye (max 5u/site) IM, max total200u/30days. Oesoph achalasia: 10Ou per session divided between 4-6 sites. Hyperhidrosis: 50u/2ml intradermal per axilla (given in 10-15 sites)."},{"id":"fs-0258","name":"Botulinum toxin type B","dosage":"NOT/kg: usual total dose 2,500- 10,OOOu, repeated every 12wk if required."},{"id":"fs-0260","name":"Brentuxim;;~b","dosage":"1.8mg/kg IV over 3D min every 3wk."},{"id":"fs-0261","name":"Bretylium tosylate","dosage":"5mg/kg IV in 1 hr, then 5-30 meg/kg/min."},{"id":"fs-0262","name":"Brexpipra:zole","dosage":"0.5--1 mg daily oral, lncr if required to 2mg on day 5, and 4mg day 8."},{"id":"fs-0263","name":"Brimonidine","dosage":"Gel 3.3mg/g: pea--sized amount to face daily."},{"id":"fs-0264","name":"Brimonidine","dosage":"0.2% 1 drop/eye 12H. 0.33% gel applied daily."},{"id":"fs-0265","name":"Brimonidine 0.2% + brinzolamide 1%","dosage":"1 drop/eye 8H."},{"id":"fs-0266","name":"Brimonidine 0.2% + timolol 0.5%","dosage":"1 drop/eye 12H."},{"id":"fs-0267","name":"Brinzolamide","dosage":"1%: 1 drop/eye 8-12H. See also brimonidine."},{"id":"fs-0268","name":"Brivaracetam","dosage":"0.5-2mg/kg (adult 25-100mg) 12H oral."},{"id":"fs-0269","name":"Bromazepam","dosage":"0.02-0.1mg/kg (adult 1--3mg) 8H oral. Bromhexine 0.3mgikg (adult 16mg) 8H oral for 7 days, then 0.15mg/kg (adult 8mg) 8H."},{"id":"fs-0270","name":"Bromocriptine","dosage":"0.025mg/kg (adult 1.25mg) 8-12H, increase wkly to 0.05-0.2mg/kg (adult 2.5-10mg) 6-12H oral. Diabetes (adult, NOT/kg): 0.8mg tab daily oral, increase wkly to max 1.6- 4.8mg daily. Inhibit lactation, NOT/kg: 2.5mg 12H for 2wk."},{"id":"fs-0271","name":"Brompheniramine","dosage":"0.1-0.2mg/kg (adult 5--10mg) 6-8H oral, SC, IM or slow IV."},{"id":"fs-0272","name":"Buclizine","dosage":"0.25-1mg/kg (adult 12.5-50mg) 8--24H oral."},{"id":"fs-0273","name":"Budesonide","dosage":"Metered dose inhaler (NOT/kg): <12yr 50--200 meg 6-12H, reducing to 100-200mcg 12H; >12yr 100-600 meg 6-12H, reducing to 100-400mcg 12H. Nebuliser (NOT/kg): <12yr 0.5-1 mg 12H, reducing to 0.25-0.5mg 12H; >12yr 1-2mg 12H, reducing to 0.5-1mg 12H. Croup: 2mg (NOT/kg) 12H nebulised. Nasal spray, aerosol (NOT/kg): 64- 128 mcg/nostrii12-24H. Crohns dis, Adult, NOT/kg: 9mg slow-release tab daily for 8wk, then reduce over 4wk; rectal foam 2mg 12H for 2wk, then daily 4wk."},{"id":"fs-0274","name":"Budesonide + eformoterol","dosage":"Inhalations. Chronic :512yr 100/6mcg 1-2 12H, or 200/6 1 daily; >12yr 100/6 1-2 12H or 200/6 1-2 12H or 400/12 1 12H. Acute >12yr: 100/6 or 200/6 (not 400/12) up to 6 inhaltn ifrequired, max 12/day."},{"id":"fs-0275","name":"Bumetanide","dosage":"25mcg/kg (adult 1 mg) daily oral, may increase to Page 14 max 50mcglkg (adult 3mg) 8-12H."},{"id":"fs-0276","name":"Bupivacaine","dosage":"Max dose: 2-3mg/kg (0.4-0.6ml/kg of 0.5%)."},{"id":"fs-0277","name":"Intrathecal: 1 mgkg (0.2ml/kg of 0.5%)","dosage":"Epidural: 2mg/kg (0.4ml/kg of 0.5%) stat intraop, then 0.25mg/kg/hr (0.2 ml/kg/hr of 0.125%) postop. Intrapleural: 0.5% 0.5ml/kg (max 20ml) 8-12H, or 0.5ml/kg (max 10ml) stat then 0.1--0.25 mlkg/hr (max 10ml/hr). Epidural in ICU: 25ml 0.5% + 1mg (20m I) fentanyl + saline to 10Oml at 2-Sml/hr in adult"},{"id":"fs-0278","name":"Bupivacaine +fentanyl","dosage":"1 mg+2mcg/ml. Adult, NOT/kg. Epidural: 10-20ml, then 5--10ml/hr or 3-20ml as required."},{"id":"fs-0279","name":"Buprenorphine","dosage":"Adult, NOT/kg: 200-800mcg 6-8H sublingual, IM or slow IV; transdermal patch 5, 10 or 20mcg/hr wkly; buccal film 75mcg 12-14H, increase if required to max 900mcg 12H. Implant 74.2mg, adult NOT/kg: x4 subdermal replace 6 mnthly."},{"id":"fs-0280","name":"Buprenorphine +naloxone","dosage":"NOT/kg: oral 2/0.5mg (1.4/0.36 mg SL) 8/2mg (5.7/1.4mg SL) daily adjusted to response."},{"id":"fs-0281","name":"Bupropion","dosage":"2-3mg/kg (adult 75-150mg) 8-12H oral. NOT/kg: sustained 1 00-200mg 12H; extended: 150--300mg daily."},{"id":"fs-0282","name":"Bupropion 90mg + naltrexone Smg","dosage":"Adult, NOT/kg 1 tab in am daily oral wk1, 1 tab 12H wk2, 2 tab in am+ 1 tab pm wk3, 2 tab 12H from wk4 on."},{"id":"fs-0283","name":"Burrow's solution","dosage":"See aluminium acetate solution."},{"id":"fs-0284","name":"Buserelin","dosage":"Adult, NOT/kg. Intranasal: 100mcg 4H, or 150 meg each nostril SH. Prostate carcinoma: 0.5mg SH SC for 7 days, then 10Omcg dose of spray to each nostril x6/day."},{"id":"fs-0285","name":"Buspirone","dosage":"0.1mg/kg (adult 5mg) 8-12H oral, increase to max 0.3mglkg (adult 15mg) 8-12H."},{"id":"fs-0286","name":"Busulfan","dosage":"Induction: 0.06mg/kg (max 4mg) daily oral if leu cocytes >20,000/rnm3 and platelets >100,000/mm3. Main tcmance: 0.01-0.03mg/kg (max 2mg) daily."},{"id":"fs-0287","name":"Butabarbital","dosage":"See secbutobarbitone."},{"id":"fs-0288","name":"Butalbital","dosage":"1-2mg/kg (adult 50-100mg) 8-24H oral."},{"id":"fs-0289","name":"Butenafine","dosage":"1% cream: apply 12-24H-1 for 1-4wk."},{"id":"fs-0290","name":"Butobarbitone","dosage":"2-Amg/kg (adult 1 00-200mg) nocte oral."},{"id":"fs-0291","name":"Butoconazole","dosage":"2% vaginal cream: 5g (NOT/kg) nocte."},{"id":"fs-0292","name":"Butorphanol","dosage":"IM: 0.02-0.1mg/kg (adult 1-4mg) 3-4H. IV: 0.01- 0.05mg/kg (adult 0.5-2mg) 3-4H."},{"id":"fs-0293","name":"C1 esterase inhibitor","dosage":"1u =activity 1ml plasrna. Prophylaxis (Cinryze): 10-50u/kg (adult 10OOu) IV over 1H every 3-4 days. Treatment: 20u/kg IV (Berinert), 50u/kg (max 4200u) (Ruconest)."},{"id":"fs-0294","name":"Cabazitaxel","dosage":"25mg/m2 IV over 1 hr every 3wk."},{"id":"fs-0295","name":"Cabergoline","dosage":"10mcglkg/wk (adult 0.5mg) in 1-2 doses, increase if required monthly by 10mcg/kg/wk to usually 20mcglkg/wk (adult 1 mg) in 1-4 doses, max 90mcg/kg/wk (adult 4.5mg). Inhibit lactation: 1mg oral stat."},{"id":"fs-0296","name":"Cabozantinib","dosage":"Adult, NOT/kg: 60mg daily oral."},{"id":"fs-0297","name":"Caffeine citrate","dosage":"2mg citrate = 1 mg base. Neonate 20mg/kg citrate stat, then 5-10mg/kg daily oral, IV. Adult 50--250mg citrate 4-8H oral, IV. Level 5-30mg/L midway between doses. Page 1fi"},{"id":"fs-0298","name":"Caffeine 10Omg + ergotamine tartrate 1 mg tabs","dosage":"Adult, NOT/kg: 2 stat, then 1 Y,hrly if required (max 6/attack,10/wk)."},{"id":"fs-0299","name":"Cake, diablo","dosage":"Fan oven 180e. Melt 180g dark cooking choc olate + 170g unsalted butter in double boiler. Off heat, mix in 4 well-whisked egg yolks, 170g sugar, 40g almond meal; sift in 80g self-raising flour, mix. Fold in Y, of egg whites (beaten stiff with pinch of salt); fold back into rest of beaten whites. Put in buttered + floured 20cm tin, tap out air, bake 30min."},{"id":"fs-0300","name":"Calcifediol (25-0H 03)","dosage":"Deficiency: 1-2mcg/kg daily oral."},{"id":"fs-0301","name":"Calciferol (Vitamin 02)","dosage":"See ergocalciferol."},{"id":"fs-0302","name":"Calcipotriene","dosage":"See calcipotriol."},{"id":"fs-0303","name":"Calcipotriol","dosage":"50mcg/g (0.005%) ointment: apply 12-24H. See also betamethasone + calcipotriol ointment."},{"id":"fs-0304","name":"Calcitonin","dosage":"Hypercalcaemia: 4u/kg 12-24H IM or se, may increase up to Su/kg 6-12H. Paget's: 1.5-3u/kg (max 160u) x3/wk IM or SC. Nasal spray: 200u daily."},{"id":"fs-0305","name":"Calcitriol (1,25-0H vitamin 03)","dosage":"Oral, IV. Renal failure, vit D resistant rickets: 0.02mcg/kg (max 0.25mcg/kg) daily; adjust every 2-4wk by Ca, phos, PTH alk pt10s. Post-dialysis (NOT /kg): usually 0.25-2mcg x3/wk (monitor ea, phos, PTH)."},{"id":"fs-0306","name":"Calcium (as carbonate, lactate or phosphate)","dosage":"NOT/kg. Neonate: 50mg x4-6/day; 1 mo-3yr: 100mg x2-5/day oral; 4- 12yr: 300mg x2-3/day; >12yr: 1000mg x1-2/day."},{"id":"fs-0307","name":"Calcium actelae","dosage":"667mg (169mg ea). x3 cap or tab SH oral titrated to serum phosphate 1.1-1.Smmoi/L."},{"id":"fs-0308","name":"Calcium carbimide","dosage":"1-2mg/kg (adult 50-100mg) 12H oral."},{"id":"fs-0309","name":"Calcium carbonate","dosage":"Adult NOT/kg: 1250-1500mg (500-600 mg calcium) SH oral with meals for hyperphosphataemia."},{"id":"fs-0310","name":"Calcium chloride","dosage":"10% solution (0.7mmol/ml Ca): 0.2ml/kg (max 10ml) slow IV stat. Requirement <16yr 2ml/kg/day IV. lnotrope: 0.03-0.12ml/kg/hr (0.5-2mmol/kg/day) via eve."},{"id":"fs-0311","name":"Calcium edetate (EDTA)","dosage":"See sodium calciurnedetate."},{"id":"fs-0312","name":"Calcium folinate","dosage":"NOT/kg: 5-15mg oral, or 1mg IM or IV daily. Rescue starting up to 24H after methotrexate: 10-15 mg/m2 6H for 36-48hr IV. Methotrexate toxicity: 100-1 000mg/m2 6H"},{"id":"fs-0314","name":"Calciumgluconate","dosage":"10% solution (0.22mmol/ml ea): 0.5ml/kg (max 20m I) slow IV stat. Requirement <16yr 5ml/kg/day IV. lnotrope: 0.5-2mmol/kg/day (0. 1-0.4ml/kg/hr) via eve."},{"id":"fs-0315","name":"Calcium heparin","dosage":"See heparin."},{"id":"fs-0316","name":"Calcium leucovorin","dosage":"See calcium folinate."},{"id":"fs-0317","name":"Calcium levofolinate","dosage":"Half the dose of calcium folinate."},{"id":"fs-0318","name":"Calcium polystyrene sulfonate (Calcium Resonium)","dosage":"0.3- 0.6g/kg (adult 15-30g) GH NG (+ lactulose), f'R."},{"id":"fs-0319","name":"Calfactant","dosage":"35mg/ml phosphlipids, 0.65mg/ml proteins: 1.5 ml/kg intratracheal gradually over 20-30 breaths during inspiration with infant lying on one side, then another 1.5 ml/kg with infant lying on other side."},{"id":"fs-0320","name":"Canagliflozin","dosage":"Adult, NOT/kg: 1 00-300mg daily oral. Page 16"},{"id":"fs-0321","name":"Canagliflozin + metformin","dosage":"50/500mg, 50/1000, 150/500, 150/1000. 1 tab 12H oral."},{"id":"fs-0322","name":"Canakinumab","dosage":";,7.5kg: 4mg/kg (max 300mg) SC every 4wk."},{"id":"fs-0323","name":"Candesartan","dosage":"0.1-0. 3mg/kg (adult 4-16mg) daily oral."},{"id":"fs-0324","name":"Cangrelor","dosage":"30mcg/kg bolus then 4mcg/kg/min IV for duration of procedure (minimum 2H). Cannabidiol 25mg + delta-9-tetrahydrocannabinol 27mg per 10011L spray. Titrate over 2wk to max 12 sprays/day. to different parts of oral mucosa; review response after 4wk."},{"id":"fs-0325","name":"Cannabis","dosage":"See cannabidiol,dronabinol, nabilone, nabiximols~"},{"id":"fs-0326","name":"Canrenoate","dosage":"3-Bmg/kg (adult 150-400mg) daily IV."},{"id":"fs-0327","name":"Capecitabine","dosage":"1250mgim' 12H oral for 2wk then 1wk off, in 3wk cycles."},{"id":"fs-0328","name":"Capreomycin","dosage":"20mg/kg (adult 1 g) IM daily, deer alter 2-4mo to 2-3 times per wk."},{"id":"fs-0329","name":"Capsaicin","dosage":"Cream 0.025%, 0.075% apply 6-8H. Postherpetic neuralgia: 8% patch applied for 60min every 3mo."},{"id":"fs-0330","name":"Captopril","dosage":"Beware hypotension. 0.1 mg/kg (adult 2.5-5mg) 8H oral, increase if required to max 2mg/kg (adult 50mg) 8H. Less hypo tension if mixed with NG feeds given continuously (or 1-2H)."},{"id":"fs-0331","name":"Carbachol","dosage":"0.01%: max 0.5ml in anterior chamber of eye."},{"id":"fs-0332","name":"Carbamazepine","dosage":"Zmg/kg (adult 100mg) 8H oral, may increase over 2-4wk to 5-10mg/kg (adult 250-500mg) 8H. Bipolar dis order (adult, NOT/kg): 200mg as slow-rei cap 12H oral, increase if required to max 800mg 12H. Level 20-40umol/L (x0.24=mg/L)."},{"id":"fs-0333","name":"Carbaryl","dosage":"0.5% lotion: rub into hair, leave 12H, shampoo."},{"id":"fs-0334","name":"Carbenicillin","dosage":"382mg tab, Adult, NOT/kg: 1-2 tab 4H oral."},{"id":"fs-0335","name":"Carbenoxolone","dosage":"Adult, NOT/kg: 20-50mg 6H oral. Mouth gel 2%, or 2g granules in 40ml water, apply 6H."},{"id":"fs-0336","name":"Carbetocin","dosage":"Adult, NOT/kg: 100mcg IV over 1min, or IM."},{"id":"fs-0337","name":"Carbidopa","dosage":"See levodopa + carbidopa."},{"id":"fs-0338","name":"Carbimazole","dosage":"0.4mg/kg (adult 20mg) 8-12H oral for 2wk, then 0.1mg/kg (adult 5-10mg) 8-24H."},{"id":"fs-0339","name":"Carbinoxamine","dosage":"NOT/kg: 2mg (1-3yr), 2-4mg (3-6yr), 4-8mg (>6yr) 6-8H oral. Carbocisteine.10-15mg/kg (adult 500-750mg) 8H oral."},{"id":"fs-0340","name":"Carbomer","dosage":"0.2% gel: 1 drop per eye x3-4/day."},{"id":"fs-0341","name":"Carboplatin","dosage":"300-400mg/m2 IV over 60min every 4wk."},{"id":"fs-0342","name":"Carboprost (15-Me-PGF2-alpha)","dosage":"Termination (NOT/kg): 250-500mcg 1-4H (max total 12mg) IM. Postpartum hge (NOT/kg): 250mcg every 15-120min IM (max total 12mg)."},{"id":"fs-0343","name":"Carfilzomib","dosage":"20mg/m2 IV over 10m in on days 1 ,2,8,9, 15,16 then 12 day rest; increase to 27mg/m2 (max 60mg) if tolerated."},{"id":"fs-0344","name":"Carglumic acid","dosage":"50mg/kg 12H oral, increase to 6H if required; titrate dose to plasma ammonia concentration."},{"id":"fs-0345","name":"Cariprazine","dosage":"Adult, NOT/kg: 1.5mg increase to max 6mg daily oral."},{"id":"fs-0346","name":"Carisoprodol","dosage":"7mg/kg (adult 350mg) 6H oral."},{"id":"fs-0347","name":"Carmustine (BCNU)","dosage":"200mg/m2 IV over 2H every 6wk (reduce if leucocytes <3000/mm' or platelets <75,000). Wafers: implant 8 x 7.7mg wafers (total 61.6mg) at surgery. Page 17"},{"id":"fs-0348","name":"Carnitine, L form","dosage":"IV: 5-15mg/kg (max 1g) 6H. Oral: 25mg/kg 6-12H (max 400mg/kg/day)."},{"id":"fs-0349","name":"Carob bean gum (Carobellnstant)","dosage":"NOT/kg: 1 scoop (1.8g) in 10Oml water, give 10-20ml by spoon; or add half a scoop to every 1 00-200ml of milk."},{"id":"fs-0350","name":"Carteolol","dosage":"0.05-0.2mg/kg (adult 2.5-10mg) daily oral. 1%,2%: 1drop/eye 12H."},{"id":"fs-0351","name":"Carvedilol","dosage":"0.1mg/kg (adult 3.125mg) 12H oral; if tolerated increase by 0.1 mg/kg (adult 3.125mg) every 1-2wk to max 0.5- 0.8mg/kg (adult 25mg) 12H."},{"id":"fs-0352","name":"Casanthranol + docusate sodium","dosage":"Cap 30/100mg (NOT/kg): adult 1-2cap 12-24H oral. Syrup 2/4mg per ml (NOT/kg): child 5-15ml bedtime, adult 15-30mi12-24H."},{"id":"fs-0353","name":"Caspofungin","dosage":"70mg/m2 (max 70mg) day 1, then <3mo 25 mg/m2, <:3mo 50mg/m2 (max 50mg) daily IV over 1H. Severe inftn <:3mo: 70mg/m2 (max 70mg) daily IV over 1 hr."},{"id":"fs-0354","name":"Catumaxomab","dosage":"Adult, NOT/kg. Intraperitoneal infusion over 6hr: 10mcg day 1, 20mcg day 3, 50 meg day 7, 150mcg day1 0."},{"id":"fs-0355","name":"Cefaclor","dosage":"10-15mg/kg (adult 250-500mg) 8H oral; 12H used in some mild infectns. Slow release tab 375mg (adult, NOT/kg): 1-2 tab 12H oral."},{"id":"fs-0356","name":"Cefadroxil","dosage":"15-25mg/kg (adult 0.5-1 g) 12H oral. Cefalexin, See cephalexin."},{"id":"fs-0357","name":"Cefalotin","dosage":"25mg/kg (max 1g) 6H IV, IM. Serious inftn: 25 mg/kg (max 1g) 3-4H IV."},{"id":"fs-0358","name":"Cefamandole","dosage":"See cepharnandole."},{"id":"fs-0359","name":"Cefazolin","dosage":"See cephazolin."},{"id":"fs-0360","name":"Cefdinir","dosage":"14mg/kg (adult 600mg) daily (or 2 div doses) oral."},{"id":"fs-0361","name":"Cefditoren","dosage":"4-8mg/kg (adult 200-400mg) 12H oral."},{"id":"fs-0362","name":"Cefepime","dosage":"25mg/kg (adult 1 g) 12H IV, IM. Severe inftn: 50 mg/kg (adult 2g) IV 8H or constant infusion."},{"id":"fs-0363","name":"Cefixime","dosage":"5mg/kg (adult 200mg) 12-24H oral."},{"id":"fs-0364","name":"Cefodizime","dosage":"25mg/kg (max 1g) 12H IV or IM."},{"id":"fs-0365","name":"Cefonicid","dosage":"15-50mg/kg (adult 0.5-2g) IV or IM daily."},{"id":"fs-0366","name":"Cefoperazone","dosage":"25-60mg/kg (max 1-3g) 6-12H IV in 1H or IM."},{"id":"fs-0367","name":"Cefotaxime","dosage":"25mg/kg (adult 1g) 12H (<4wk), 8H (4+wk) IV. Severe inftn: 50mg/kg (adult 2-3g) IV 12H (preterm), 8H (1st wk life). 6H (2-4 wk), 4-6H or constant infusion (4+ wk)."},{"id":"fs-0368","name":"Cefotetan","dosage":"25mg/kg (adult 1g) 12H IM, IV. Severe inftn: 50mg/kg (max 2-3g) 12H or constant infusion."},{"id":"fs-0369","name":"Cefoxitin","dosage":"20-40mglkg (max 2g) 12H (1st wk life), 8H (1-4wk), 6-SH (>4wk) IV. Severe inftn: 50mglkg (max 3g) 6H IV. Surgery: 40mg/kg (max 2g) at induction anaesthesia."},{"id":"fs-0370","name":"Cefpirome","dosage":"25-50mg/kg (adult 1-2g) 12H IV."},{"id":"fs-0371","name":"Cefpodoxime","dosage":"5mg/kg (adult 100-200mg) 12H oral."},{"id":"fs-0372","name":"Cefprozil","dosage":"15mg/kg (adult 500mg) 12-24H oral."},{"id":"fs-0373","name":"Cefradine","dosage":"See cephradine."},{"id":"fs-0374","name":"Ceftaroline","dosage":"15mg/kg (adult 600mg) 12H IV over 1 hr."},{"id":"fs-0375","name":"Ceftazidirne","dosage":"25mglkg (adult 0.5-1g) 12H (1\\" wk life), 8H IV,"},{"id":"fs-0377","name":"Ceftazidime 2g + avibactam 0.5g","dosage":"50mg/kg ceftazidime 8H"},{"id":"fs-0378","name":"IV over 2hr","dosage":"Add metronidazole for abdominal inftn."},{"id":"fs-0379","name":"Ceftibuten","dosage":"10mg/kg (adult 400mg) daily oral."},{"id":"fs-0380","name":"Ceftizoxime","dosage":"25-60mg/kg (adult 1-3g) 6-8H IV."},{"id":"fs-0381","name":"Ceftolozane 1g + tazobactam 0.5g","dosage":"IV over 1H: <3mo 12/6 mg/kg 6-8H, 3mo-11yr 18/9 mg/kg 6-8H, ;;o12yr 1g/0.5g 8H."},{"id":"fs-0382","name":"Ceftriaxone","dosage":"<:4wk: 5Q. 75mg/kg (adult 1-2g) daily IV, IM (in 1% lignoc). Severe inftn: 50mg/kg (max 2g) 12H. Epiglottitis: 100mg/kg (max 2g) stat, then 50mg/kg (max 2g) after 24H. Meningococ proph (NOT/kg): child 125mg, >12yr 250mg IM in 1% lig once. H.infproph: 50mg/kg (max 1g) IM in 1% lig once. Ganoe conj: 50mg/kg (max 1 g) IM in 1% lig daily x2."},{"id":"fs-0383","name":"Cefuroxime","dosage":"Oral: 10-15mg/kg (adult 250-500mg) 12H. IV: 25mg/kg (adult 1g) SH. Severe inftn: 50mg/kg (max 2g) IV 12H (1st wk life), SH (2nd wk), 6H or constant infusion (>2wk)."},{"id":"fs-0384","name":"Celecoxib","dosage":"Usually 2mg/kg (adult 100mg) 12H, or 4mg/kg (adult 200mg) daily oral. Familial adenornatous polyposis (adult, NOT/kg): 400mg 12H oral."},{"id":"fs-0385","name":"Celiprolol","dosage":"5-10mg/kg (adult 200-400mg) daily oral."},{"id":"fs-0386","name":"Cephalexin","dosage":"Skin or UTI: 12.5mg/1<9 (max 500mg) 6H, or 25mg/kg (max 1 g) 12H oral. Systemic inftn; 25mg/kg (max 1g) 6H. Prophylaxis: 12.5 mg/kg (max 250mg) at night."},{"id":"fs-0387","name":"Cephalothin","dosage":"15-25mg/kg (adult 0.5-1g) 6H IV or IM. Severe inftn: 50mg/kg (max 2g) IV 4H or constant infusion. Irrigation fluid: 2g/L (2mg/ml)."},{"id":"fs-0388","name":"Cephamandole","dosage":"15-25mg/kg (adult 0.5. 1g) 6-8H IV over 10min or IM. Severe inftn: 40mg/kg (adult 2g) IV over 20min 4-6H or constant infusion."},{"id":"fs-0389","name":"Cephazolin","dosage":"10-15mg/kg (max 1g) 8H IV or IM. Severe inftn: 50mg/kg (max 2g) IV 6H or constant infusion. Surgical proph: 50mg/kg (max 2g) IV at induction."},{"id":"fs-0390","name":"Cephradine","dosage":"Oral: 10-25mg/kg (adult 0.25-1g) 6H. IM or IV: 25-50mglkg (adult 1-2g) 6H."},{"id":"fs-0391","name":"Ceritinib","dosage":"Adult, NOT/kg: 750mg oral daily."},{"id":"fs-0392","name":"Certolizumab","dosage":"Adult, NOT/kg: 400mg SC every 2wk for 3 doses, then every 4wk if response."},{"id":"fs-0393","name":"Certoparin","dosage":"Prophylaxis: 60u/kg (adult 3000u) 1-2H preop, then daily SC."},{"id":"fs-0394","name":"Cerumol","dosage":"See arachis oil +chlorbutol + dichlorobenzene otic."},{"id":"fs-0395","name":"Cetirizine","dosage":"NOT/kg: 2.5mg (6mo-2yr), 2.5-5mg (2-5yr), 5-10 mg (>5yr) daily oral."},{"id":"fs-0396","name":"Cetrimide","dosage":"See chlorhexidine."},{"id":"fs-0397","name":"Cetrorelix (GnRH antagonist)","dosage":"Adult, NOT/kg: 0.25mg SC on stimulation day 5, then daily until hCG given."},{"id":"fs-0398","name":"Cetuxirnab","dosage":"400mg/m2 IV over 2H, then 250mg/m2 wkly."},{"id":"fs-0399","name":"Cetylpyridinium","dosage":"See benzocaine + cetylpyridinium."},{"id":"fs-0400","name":"Cevimeline","dosage":"0.6mg/kg (adult 30mg) 8H oral."},{"id":"fs-0401","name":"Charcoal, activated","dosage":"1-2g/kg (adult 50-100(J) NG; then 0.25g/k>J hrly if required. Laxative: sorbitol 1 g/kg (1.4ml/kg of 70%) once NCo, rnay repeat x 1. Page 19"},{"id":"fs-0402","name":"Chenodeoxycholic acid","dosage":"5-10mg/kg 12H oral."},{"id":"fs-0403","name":"Chickenpox vaccine","dosage":"See varicella vaccine."},{"id":"fs-0404","name":"Chlomethiazole","dosage":"See clomethiazole."},{"id":"fs-0405","name":"Chloral betaine","dosage":"1.7mg = 1 mg chloral hydrate."},{"id":"fs-0406","name":"Chloral hydrate","dosage":"Hypnotic: 50mg/kg (max 2g) stat (ICU up to 100mg/kg, max 5g). Sedative: 10mg/kg 6-SH oral or PR."},{"id":"fs-0407","name":"Chlorambucil","dosage":"Typically 0.1-0.2mg/kg daily oral."},{"id":"fs-0408","name":"Chloramphenicol","dosage":"Severe inftn: 40mg/kg (max 2g) stat IV, IM or oral; then 25mg/kg (max 1 g) daily (1st wk life) 12H (2-4 wk) 8H (>4wk) x5 days, then GH. Eye drop, oint: apply 2-6H."},{"id":"fs-0409","name":"Ear: 4drop 6H","dosage":"Serum level20-30mg/L 2H, <15mg/L trough."},{"id":"fs-0410","name":"Chlorbutol","dosage":"See arachis oil + chlorbutol + dichlorobenzene."},{"id":"fs-0411","name":"Chlordiazepoxide","dosage":"0.1mg/kg (adult 5mg) 12H oral, may increase to max 0.5mg/kg (adult 30mg) 6-8H."},{"id":"fs-0412","name":"Chlorhexidine","dosage":"0. 'I%: catheterisation prep, impetigo. 0.2%: mouthwash. 1%: skin disinfection. 2-4%: hand wash."},{"id":"fs-0413","name":"Chlorhexidine 0.5% + alcohol 70%","dosage":"Skin disinfection."},{"id":"fs-0414","name":"Chlorhexidine + cetrimide","dosage":"0.05%/0.5%, 0.1%/1%, 0.15%/0.15% solution: wound cleaning."},{"id":"fs-0415","name":"Chlorhexidine 1.5% + cetrimide 15%","dosage":"1/30 in water: cleaning tissues, wounds or equipment. 140mt in 1 L water: dis infecting skin, equipment (soak 2m in, rinse in sterile water)."},{"id":"fs-0416","name":"Chlorhexidine 1% + hexamidine 0.15%","dosage":"Powder: wounds."},{"id":"fs-0417","name":"Chlormethiazole","dosage":"See clornethiazole."},{"id":"fs-0418","name":"Chlormezanone","dosage":"5mg/kg (adult 200mg) 6-SH, or 10mg/kg (adult 400mg) at night oral."},{"id":"fs-0419","name":"Chlorophyllin copper complex","dosage":"2mg/kg 8-24H oral."},{"id":"fs-0420","name":"Chloroprocaine","dosage":"Max 11 mg/kg (max 800mg). With adrenaline (1/200,000) max 14mg/kg (max 1000mg)."},{"id":"fs-0421","name":"Chloroquine, base","dosage":"Oral: 10mg/kg (max 600mg) daily x3 days. IM: 4mg/kg (max 300mg) 12H for 3 days. Prophylaxis: 5mg/kg (adult 300mg) oral x1/wk. Lupus, rheu arth: 12mg/kg (max 600mg) daily, reduce to 4-Smg/kg (max 400mg) daily."},{"id":"fs-0422","name":"Chloroquine+ pyrimethamine + sulphadoxine","dosage":"Chloroquine base 10mg/kg (max 600mg) daily for 3 days oral, plus pyrimethamine 1.25mg/kg (max 75mg) and sulphadoxine 25 mg/kg (max 1.5g) on first day."},{"id":"fs-0423","name":"Chlorothiazide","dosage":"5-20mg/kg (adult 0.25-1g) 12-24H oral, IV."},{"id":"fs-0424","name":"Chlorphenamine","dosage":"See chlorpheniramine."},{"id":"fs-0425","name":"Chlorphenasin","dosage":"1% ointment: apply 12H."},{"id":"fs-0426","name":"Chlorpheniramine","dosage":"0.1 mg/kg (adult 4mg) 6-SH oral."},{"id":"fs-0427","name":"Chlorpheniramine 10mg +ephedrine 15mg","dosage":"NOT/kg slow- release: 1 tab 12-24H."},{"id":"fs-0428","name":"Chlorpheniramine 4mg + hydrocodone 5mg","dosage":"NOT/kg: 1 tab 6H oral. Chlorpheniramine 1.25mg +phenylephrine 2.5mg in 5ml. Syrup (NOT/kg): 1.25-2.5ml (0-1yr), 2.5-5ml (2-5yr), 5-10mi (6-12yr), 10-15ml (>12yr) 6-SH oral."},{"id":"fs-0429","name":"Chlorpheniramine + pseudoephedrine","dosage":"2/30mg in 5ml. NOT/kg: 2.5ml (2-6yr) iml (6-12yr) 10ml (>12yr) 8H. Page 20"},{"id":"fs-0430","name":"Chlorpromazine","dosage":"Oral or PR: 0.5-2mg/kg (max 100mg) 6-8H; up to 20mg/kg 8H for psychosis. IM (painful) or slow IV (beware hypotension): 0.25-1 mg/kg (usual max 50mg) 6-8H."},{"id":"fs-0431","name":"Chlorpropamide","dosage":"Adult. NOT/kg: initially 125-250mg oral, max 500mg daily."},{"id":"fs-0432","name":"Chlorquinaldol","dosage":"5% paste: apply 12H."},{"id":"fs-0433","name":"Chlortalidone","dosage":"See chlorthalidone."},{"id":"fs-0434","name":"Chlortetracycline","dosage":"3% cream or ointment: apply 8-24H. Chlortetracycline 115.4mg + demeclocycline 69.2mg + tetracycline 115.4mg. NOT/kg. >12yr: 1 tab 12H oral."},{"id":"fs-0435","name":"Chlorthalidone","dosage":"2mg/kg (max 100mg) 3 times a wk oral."},{"id":"fs-0436","name":"Chlor:zoxazone","dosage":"5-15mg/kg (adult 250-750mg) 6-8H oral."},{"id":"fs-0437","name":"Cholecalciferol (Vitamin D3)","dosage":"1 meg = 40u = 1 meg ergo- calciferol (qv). Osteodystrophy: 0.2mcg/kg (hepatic) 15- 40mcg/kg (renal) daily oral."},{"id":"fs-0438","name":"Cholera (Vaxchora)","dosage":"Live. 1 B-64yr: single oral dose protects for at least 6mo. Cholera, whole cell plus toxin b subunit recombinant vaccine (Dukoral). Inanimate. Dissolve granules in 150mt water. 2-6yr: give 75ml x3 doses 1wk apart oral, boost after 6rno. >6yr: give 150mt x2 doses 1 wk apart, boost after 2yr."},{"id":"fs-0439","name":"Cholestyramine","dosage":"NOT/kg. 1g (<6yr) 2-4g (6-12yr) 4g (>12yr) daily oral, increase over 4wk to max 1-2x initial dose 8H."},{"id":"fs-0440","name":"Cholic acid","dosage":"10-15mg/kg in 1-2 divided doses oral."},{"id":"fs-0441","name":"Choline magnesium trisalicylate","dosage":"See aspirin."},{"id":"fs-0442","name":"Choline salicylate, mouth gel (Bonjela)","dosage":"Apply 3H prn."},{"id":"fs-0443","name":"Choline theophyllinate (200mg =theophylline 127mg)","dosage":"See theophylline."},{"id":"fs-0444","name":"Choriogonadotropin alta","dosage":"Adult, NOT/kg: 250mcg SC."},{"id":"fs-0445","name":"Chorionic gonadotrophin","dosage":"NOT/kg. Cryptorchidism all ages: 500-1000u x1-2/wk for 5wk. After FSH: 10,000iu IM once. Men: 7000iu IM x2/wk, with 75iu FSH and 75iu LH IM x3/wk."},{"id":"fs-0446","name":"Chymopapain","dosage":"Adult, NOT/kg: 2000-4000 picokatal units per disc, max 10,000 picokatal units per patient. Ciclesonide.lnhaltn 80-160mcg (6-12yr) 80-320mcg (>12yr) 12-24H-1. Nasal >5yr: pump 2 spray (100mcg) or aerosol1 spray (37mcg) per nostril once daily."},{"id":"fs-0447","name":"Ciclopirox","dosage":"1% cream, lotion: 12H; 8% lacquer daily for 48wk."},{"id":"fs-0448","name":"Ciclosporin","dosage":"See cyclosporin."},{"id":"fs-0449","name":"Cidofovir","dosage":"5mg/kg IV over 1 hr, in 1wk, then every 2wk; 20 ml/kg fluid IV before and after infusion, probenecid 1-1.25mg/m2 3hr before infusion and 1 hr and 8hr after. Papilloma: inj 6.25 mg/ml solution (max total 0.6mg/kg) ;;:2wkly."},{"id":"fs-0450","name":"Cilazapril","dosage":"Usually 0.02-0.1mg/kg (adult 1-5mg) daily oral. Renal hypertension: 0.005-0.01mg/kg daily oral."},{"id":"fs-0451","name":"Cilostazol","dosage":"Adult, NOT/kg: 100mg 12H oral."},{"id":"fs-0452","name":"Cimetidine","dosage":"Oral: 5-10mg/kg (adult 300-AOOmg) 6H, or 20 mg/kg (adult 800mg) nocte. IV: 10-15mg/kg (adult200mg) 12H (newborn), 6H (>4wk)."},{"id":"fs-0453","name":"Cinacalcet","dosage":"Adult, NOT/kg 30mg daily oral, increase every 2-4wk Page 21 (to max 180mg) to control parathyroid hormone level. Para thyroid carcinoma: 30mg 12H, increase every 2-4wk if required to control serum Ca to max 90mg 6H oral."},{"id":"fs-0454","name":"Cinchocaine","dosage":"Max dose 2mg/kg (0.4ml/kg of 0.5%) by injec tion. Oint 0.5% with hydrocortisone 0.5%: apply 8-24H."},{"id":"fs-0455","name":"Cinnarizine","dosage":"0.3-0.6mg/kg (adult 15-30mg) 8H oral. Periph vase dis: 1.5mg/kg (adult 75mg) 8H oral."},{"id":"fs-0456","name":"Cinnarizine 20mg + dimenhydrinate 40mg","dosage":"Adult 1 tab 8H."},{"id":"fs-0457","name":"Cinoxacin","dosage":"10mg/kg (adult 500mg) 12H oral."},{"id":"fs-0458","name":"Ciprofibrate","dosage":"2-4mg/kg (adult 1 00-200mg) daily oral."},{"id":"fs-0459","name":"Ciprofloxacin","dosage":"10-15mg/kg (max 500mg) 12H oral, 10mg/kg (adult 200-300mg) 12H IV. Severe inftn, or cystic fibrosis: 20mg/kg (max 750mg) 12H oral, 10mg/kg (max 400mg) 8H"},{"id":"fs-0460","name":"IV; higher doses used occasionally","dosage":"Meningococcus proph: 15mg/kg (max 500mg) once oral."},{"id":"fs-0461","name":"Ciprofloxacin, eye drops","dosage":"0.3%. Corneal ulcer: 1drop /15min for 6hr then 1drop/30min for 18hr (day 1 ), 1drop 1 H (day 2), 1drop 4H (day 3-14). Conjunctivitis: 1 drop 4H; if severe 1 drop 2H when awake for 2 days, then 6H."},{"id":"fs-0462","name":"Ciprofloxacin, eye ointment","dosage":"0.3%. Apply 1.25cm 8H for 3 days, then 12H for 3 or more days."},{"id":"fs-0463","name":"Ciprofloxacin, otic","dosage":"6%. Suction effusion, then inject 0.1 ml (6mg) into middle ear before inserting tympanostomy tabe."},{"id":"fs-0464","name":"Cisapride","dosage":"0.2mg/kg (max 10mg) 6-8H oral."},{"id":"fs-0465","name":"Cisatracurium","dosage":"0.1mgikg (child) or 0.15mg/kg (adult) IV stat, then 0.03mg/kg if required or 1-3mcg/kg/min. ICU: 0.15 mg/kg stat, then (1-10mcg/kg/min) IV."},{"id":"fs-0466","name":"Cisplatin","dosage":"60-100mg/m21V over 6hr every 3-4wk x6 cycles."},{"id":"fs-0467","name":"Citalopram","dosage":"0.4mg/kg (adult 20mg) daily, increase if required over 4wk to max 0.4mg/kg (adult 60mg) daily oral."},{"id":"fs-0468","name":"Citric acid 0.25g + potassium citrate 1.5g","dosage":"Urine alkalinis ation >6yr (NOT/kg): 2 tab 8-12H oral."},{"id":"fs-0469","name":"Cladribine","dosage":"Hairy cellleuk: usually 0.09mg/kg/day for 7 days by continuous IV infusion. Ch lymph leuk: 0.12mg/kg/day over 2H IV on days 1-5 of 28 day cycle, max 6 cycles."},{"id":"fs-0470","name":"Clarithromycin","dosage":"7.5-15mg/kg (adult 250-500mg) 12H oral."},{"id":"fs-0471","name":"Slow release tab, Adult, NOT/kg: 0.5g or 1g daily","dosage":"H.pylori, See omeprazole."},{"id":"fs-0472","name":"Clavulanic acid","dosage":"See amoxycillin, ticarcillin."},{"id":"fs-0473","name":"Clemastine","dosage":"0.02-0.06mg/kg (adult 1-3mg) 12H oral."},{"id":"fs-0474","name":"Clenbuterol","dosage":"Adult, NOT/kg: 20mcg (up to 40mcg) 12H oral."},{"id":"fs-0475","name":"Clevidipine","dosage":"Adult, NOT/kg: 1mg/hr increase every 5min to 4- 6mg/hr (max 16mg/hr) IV."},{"id":"fs-0476","name":"Clidinium","dosage":"0.05-0.1 mg/kg (adult 2.5-5mg) 6-8H oral."},{"id":"fs-0477","name":"Clindamycin","dosage":"6mg/kg (adult 150-450mg) 6H oral. IV, IM: 5 mg/kg 12H (preterm <1wk old), 5mg/kg 8H (preterm >1wk, term <1wk), 7.5mg/kg 8H (term >1wk), >28 days 10mg/kg (adult 600mg) 8H. Severe inftn (>28 days): 15-20 mg/kg (adult 900mg) 8H IV over 1 hr. Malaria: 10mg/kg stat then 5 mg/kg 8H IV or 7mg/kg 8H oral x7days. Acne solution 1%: 12H. Page 22"},{"id":"fs-0478","name":"Clindamycin 1.2% + tretinoin 0.025%","dosage":"Acne gel: apply daily."},{"id":"fs-0479","name":"Clioquinol","dosage":"10mg/g cream, 100% powder: apply 6--12H."},{"id":"fs-0480","name":"Clioquinol1% + flumetasone 0.02%","dosage":"2-3 drops/ear 8-12H."},{"id":"fs-0481","name":"Clioquinol 1% + hydrocortisone 1% cream","dosage":"Apply 8-2.4H."},{"id":"fs-0482","name":"Clobazam","dosage":"0.1mg/kg (adult 10mg) daily oral, increase if required to max 0.4mg/kg (max 30mg) 12H oral."},{"id":"fs-0483","name":"Clobetasol","dosage":"0.05% spray, cream, ointment, gel, solution, foam, lotion, shampoo: apply 12H."},{"id":"fs-0484","name":"Clobetasone","dosage":"0.1% solution: 1 drop/eye 1-6H."},{"id":"fs-0485","name":"Clocortolone","dosage":"Cream 0.1%: apply 8H."},{"id":"fs-0486","name":"Clodronate","dosage":"10-30mg/kg (adult 0.6-1.8g) IV over 2H every 2mo; or 6mg/kg (adult 300mg) IV over 2H daily x'T days, then 15-30/mg/kg (adult 0.8-1.6g) 12H oral."},{"id":"fs-0487","name":"Clofarabine","dosage":"52mg/m2 IV over 2H for 5 days every 2-6wk."},{"id":"fs-0488","name":"Clofazimine","dosage":"2mg/kg (adult 100mg) daily oral. Lepra reaction: up to 6mg/kg (max 300mg) daily for max 3mo."},{"id":"fs-0489","name":"Clofibrate","dosage":"10mg/kg 8-12H oral."},{"id":"fs-0490","name":"Clomethiazole","dosage":"Cap (192mg base) equivalent action to 5ml syrup (250mg edisilate). Adult, NOT/kg: 1-2 cap, or 5-10ml syrup, at bedtime oral. Alcohol withdrawal: IV (edisylate 0.8%): 1-2ml/kg (8-16 mg/kg) over 15min, then 0.5-1ml/kg/hr (4-Bmglkglhr); capsule 192 mg base, Adult, NOT/kg: 2-4cap stat (may repeat in 1-2H), then 1-2cap SH, oral."},{"id":"fs-0491","name":"Clomiphene","dosage":"Adult, NOT/kg: 50mg daily for 5 days oral, increase to 100mg daily for 5 days if no ovulation."},{"id":"fs-0492","name":"Clomipramine","dosage":"0.5-1mg/kg (adult 25-50mg) 12H oral, increase if required to max 2mglkg (adult 100mg) 8H."},{"id":"fs-0493","name":"Clonazeparn","dosage":"1 drop= 0.1mg. 0.01mg/kg (max 0.5mg) 12H oral, slowly increase to 0.1 mglkg (max 5mg) 6-12H oral. Status (may be repeated if ventilated), NOT/kg: neonate 0.25mg, child 0.5mg, adult 1 mg IV; reapeat after 15min if required."},{"id":"fs-0494","name":"Clonidine","dosage":"Hypertension: 1-5mcg/kg slow IV, 1-6mcglkg (adult 50-300mcg) 8-12H oral. Migraine: start with 0.5mcglkg (adult 50-75mcg) 12H oral. AOHD (NOT/kg): 0.1mg daily"},{"id":"fs-0495","name":"ER-tab oral, increase to max 0.2mg 12H","dosage":"Analgesia: 2.5mcg/kg premed oral, 0.3mcg/kg/hr IV, 1-2mcg/kg local block; ventld 0.5-2mcg/kg/hr <12kg put 50mcg/kg in 50ml saline at 0.5- 2ml/hr, >12kg put 25mcg/kg in 50ml saline at 1-4ml/hr."},{"id":"fs-0496","name":"Clopamide 5mg + pindolol10mg","dosage":"Adult: 1-2 tab (max 3 tab) daily oral."},{"id":"fs-0497","name":"Clopidogrel","dosage":"Child 0.2mg/kg daily, adult 75mg daily oral (note higher dose in adults). Poor converters to active form (15- 30% CYP2C19 variant) need higher doses, or pasugrel."},{"id":"fs-0498","name":"Clorazepate","dosage":"0.3-2mg/kg (adult 15-90mg) daily at night oral, or 0.1-0.Smg/kg (adult 5-30mg) SH."},{"id":"fs-0499","name":"Clostridia antitoxin","dosage":"See gas gangrene antitoxin."},{"id":"fs-0500","name":"Ciotrirnazole","dosage":"Topical: 1% cream or solution 8--12H. Vaginal (NOT/kg): 1% crearn or 100mg tab daily for 6 days, or 2% cream or 500mg tab daily for 3 days. Oral candida (NOT/kg): 10mg lozenge dissolved in rnouth x5/day for 14 days. Page 23"},{"id":"fs-0501","name":"Cloxacillin","dosage":"15mg/kg (adult 500mg) 6H oral, IM or IV. Severe inftn: 25-50mg/kg (adult 1-2g) IV 12H (1st wk life), 8H (2- 4wk), 4-6 H (>4wk) or constant infusion (>4wk)."},{"id":"fs-0502","name":"Clozapine","dosage":"0.5mg/kg (max 25mg) daily oral, increase over2--3wk to 5mg/kg (max 200mg) daily; max 5mg/kg (adult 300mg) 12H."},{"id":"fs-0503","name":"Coal tar, topical","dosage":"0.5% increase to max 10%, applied 6-SH."},{"id":"fs-0504","name":"Cobicistat","dosage":"Adult, NOT/kg: 150mg daily oral. See atazanavir, darunavir. Cobicistat 150mg + elvitegravir 150mg + emtricitabine 200 mg + (tenofoviralafenamide 10mg or tenofovir disoproxil fumarate 300mg). Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-0505","name":"Cobimetinib","dosage":"Adult, NOT/kg: 60mg daily for 21 of every 28 day cycle oral with vemurafenib."},{"id":"fs-0506","name":"Cocaine","dosage":"Topical: 1-3mg/kg."},{"id":"fs-0507","name":"Co-cyprindiol","dosage":"See cyproterone acetate + ethinyloestradiol."},{"id":"fs-0508","name":"Co-da nth ramer, co-danthrusate","dosage":"See dantron."},{"id":"fs-0509","name":"Codeine","dosage":"Inactive in ~10% of adults, poor activity in children <5yrs. Analgesic: 0.5-1mg/kg (adult 15-60mg) 4-6H oral, IM,"},{"id":"fs-0511","name":"Codeine+ guaiacol","dosage":"7mg/75mg per 5ml. Adult, NOT/kg: 10m I 8H oral."},{"id":"fs-0512","name":"Co-dergocrine mesylate","dosage":"Adult, NOT/kg: 3-4.5mg doily before meal oral or subling; 300mcg daily IM, SC or IV infusion."},{"id":"fs-0513","name":"Coenzyme Q1 0","dosage":"See ubidecarenone."},{"id":"fs-0514","name":"Colaspase","dosage":"Test 2-50u intradermal. Typical dose 6000u/m2 every 3rd day x9 doses IV over 411r, IM or SC."},{"id":"fs-0515","name":"Colchicine","dosage":"Acute gout: 0.02mg/kg (adult 1 mg) 2H oral (max 3 doses/day). Chronic use (gout, FMF): 0.01-0.04mg/kg (adult 0.5-2mg) daily oral."},{"id":"fs-0516","name":"Colecalciferol","dosage":"1mcg = 40iu. NOT/kg. 25mcg (<12mo) 75-100 mcg (>12mo) daily oral. Prophylaxis: 10mcg daily oral."},{"id":"fs-0517","name":"Colesevelam","dosage":"625mg tab. Adult, NOT/kg: 3 tab 12H oral, or 6 tab daily. With stalin: 4-6 tab/day (in 1-2 doses)."},{"id":"fs-0518","name":"Colestipol hydrochloride","dosage":"0.1-0.Zg/kg (adult 5-10g) 8H oral."},{"id":"fs-0519","name":"Colestyramine","dosage":"See cholestyramine."},{"id":"fs-0520","name":"Colfosceril palmitate (Exosurf Neonatal)","dosage":"Soltn 13.5 mg/ml. Prophylaxis: 5ml/kg intratracheal over 5min straight after birth, and at 12H and 24H if still ventilated. Rescue: 5ml/kg intratracheal over 5min, repeat in 12H if still ventilated."},{"id":"fs-0521","name":"Colistimethate","dosage":"See colistin sulfomethate sodium."},{"id":"fs-0522","name":"Colistin sulphomethate sodium","dosage":"2.6mg = 1 mg colistin base = 30,000u. IM, or IV over 5min: 40,000u/kg (adult 2 million u) 8H, or 1.25-2.5mg/kg of colistin base 12H. Oral or inhaled: 30,000-60,000 u/kg (adult 1.5-3 million u) 8H."},{"id":"fs-0523","name":"Colistin 3mg/ml +neomycin 3.3mg/ml","dosage":"Otic: 4 drops 8H."},{"id":"fs-0524","name":"Collagenase","dosage":"Ointment 250u/g: apply daily. Colonic lavage, macrogol-3350 and macrogol-4000 (polyethylene glyol) 105g/L. Poisoning, severe constipat ion: if bowel sounds present, 25ml/kg/hr (adult 1.5Uhr) oral or NG for 2--4hr (until metal effluent clear). 13efore colo nos-- copy: clear fluids only to noon, 1 whole 5mg bisacodyl tab per 10kg (adult 4 tab) at noon, wait for bowel motion (max 6hr), then macrogol 4g/kg (adult 200g) in 40ml/kg fluid (adult 2L) over 2H oral or NG. See Macrogol 3350 in Gatorade."},{"id":"fs-0525","name":"Colony stimulating factors","dosage":"See ancestrim, epoetin, fil- grastim, lenograstim, molgramostim, sargramostim."},{"id":"fs-0526","name":"Coloxyl","dosage":"See docusate sodium."},{"id":"fs-0527","name":"Conestat alfa","dosage":"SOu/kg (max 4200u) IV, may repeat in 24H."},{"id":"fs-0528","name":"Conivaptan","dosage":"Adult, NOT/kg: 20mg over 30min IV, then 20mg (max 40mg) over 24H by IV infusion. Conjugated oestrogens (CO) + medroxyprogesterone (MP). NOT/kg. CO (NOT/kg): 0.625mg (Q.3. 1.25mg) daily continuously, with MP 10mg (up to 20mg) daily oral for last 10--14 days of 28 day cycle."},{"id":"fs-0529","name":"Corifollitropin alta","dosage":"Adult, NOT/kg: 10Omcg (:S60kg) 150mcg (>60kg) SC, GnRH day 5-6, FSH for 6-18 days from day 8."},{"id":"fs-0530","name":"Corticorelin","dosage":"1-2mcg/kg (max 100mcg) IV."},{"id":"fs-0531","name":"Corticotrophin releasing factor, hormone","dosage":"See corticorelin."},{"id":"fs-0532","name":"Cortisone acetate","dosage":"1-2.5mg/kg 6-8H oral. Physiological: 7.5 mg/m2 8H. Cortisone acetate 1 mg =hydrocortisone 1.25mg in mineralo- and gluco-corticoid action."},{"id":"fs-0533","name":"Cosyntropin (ACTH subunit)","dosage":"NOT/kg: <2yr 0.125mg, >2yr 0.25-0.75mg IM, IV, or infused over 4-8hr."},{"id":"fs-0533-b","name":"Cotrimoxazole (trimethoprim 1mg: sulphamethoxazole 5mg)","dosage":"TMP 4mg/kg (adult 80-160mg) 12H IV over 1H or oral. Renal proph: TMP 2mg/kg (max 80mg) daily oral. P jirovecii: proph TMP 5mg/kg daily on 3 days/wk; treatment (Siber, Rev Infect Dis 1982;4:566-78) TMP 250mg/m2 stat, then 150mg/m2 8H (<11yr) or 12H (> 10yr) IV in 5%D over 1 hr; in renal failure dose interval (hr) = serum creatinine (mmol/L) x 135 (max 48hr); 1H post-infusion serum TMP 5-10 mcg/ml, SMX 100-200mcg/ml. IV infusion: TMP max 1.6 mg/ml in 5%D via central line."},{"id":"fs-0534","name":"Coumarin","dosage":"Oral: 1-8mg/kg (adult 50-400mg) daily. Cream 100mg/g: apply 8-12H."},{"id":"fs-0535","name":"Coxiella burnetti vaccine","dosage":"Inanimate. 0.5ml SConce."},{"id":"fs-0536","name":"Crisantaspase","dosage":"See colaspase."},{"id":"fs-0537","name":"Crizotinib","dosage":"Adult, NOT/kg 250mg 12H oral."},{"id":"fs-0538","name":"Crofelemer","dosage":"Adult, NOT/kg: 125mg slow-rei tab 12H oral."},{"id":"fs-0539","name":"Cromoglycate","dosage":"Inhalation (increase to 3-4H if severe): 1 cap (20mg) 6-8H, 2ml solution (20mg) 6-8H, aerosoi10-20mg 6-8H."},{"id":"fs-0541","name":"Cromolyn, sodium","dosage":"See sodium cromoglycate."},{"id":"fs-0542","name":"Crotamiton","dosage":"10% cream or lotion: apply x2-3/day."},{"id":"fs-0543","name":"Cryoprecipitate","dosage":"Low factor 8: 1 u/kg increase activity 2% (half life 12H); usual dose 5ml/kg or 1 bag/4kg 12H IV for 1-2 infusion (muscle, joint), 3-6 infusion (hip, forearm, retroperitoneal, oro pharynx), 7-14 infusion (intracranial). Low fibrinogen: usually 5mlkg or 1 bag/4kg IV. Bag usually 20-30ml: factor 8 about Page 25 5u/ml (100u/bag), fibrinogen about 10mg/ml (200mg/bag)."},{"id":"fs-0544","name":"Cyanocobalamin (Vit 812)","dosage":"20mcg/kg (adult 1000mcg) IM daily for 7 days then wkly (treatment), monthly (prophylaxis)."},{"id":"fs-0545","name":"IV dangerous in megaloblastic anaemia","dosage":"Maintenance treat ment (adult NOT/kg): 50-150mcg daily oral; 50mcg (increase if required to 10Omcg) daily nasal, or 500mcg wkly nasal. Trans cobalamin II deficiency: 10OOmcg x3/wk for 1 yr, then wkly."},{"id":"fs-0546","name":"Cyclizine","dosage":"1 mg/kg (adult 50mg) SH orai,IM,IV. See morphine."},{"id":"fs-0547","name":"Cyclizine 30mg + dipipanone 10mg","dosage":"Adult, NOT/kg: 1 tab 6H oral, increase by Y, tab if required to max 3 tab 6H."},{"id":"fs-0548","name":"Cyclizine 50mg +ergotamine 2mg","dosage":"Adult, NOT/kg: 1 tab stat, then %-1 every 30min; max 4/attack, 6/wk."},{"id":"fs-0549","name":"Cyclobenzaprine","dosage":"0.2-0.4mg/kg (adult 5-15mg) SH oral. Extended-release (adult, NOT/kg): 15mg or 30mg daily oral."},{"id":"fs-0550","name":"Cyclopenthiazide","dosage":"5-10mcg/kg (adult 250-500mcg) 12-24H."},{"id":"fs-0551","name":"Cyclopentojate","dosage":"0.5%, 1%: 1 drop/eye, repeat after 5min. Pilocarpine 1% speeds recovery."},{"id":"fs-0552","name":"Cyclophosphamide","dosage":"A typical regimen is 600mg/m2 IV over 30min daily for 3 days, then 600mg/m2 IV wkly or 10mg/kg twice wkly (if leucocytes >3000/mm3)."},{"id":"fs-0553","name":"Cycloserine","dosage":"5-10mg/kg (adult 250--500mg) 12H oral. Keep plasma cone <30mcg/ml."},{"id":"fs-0554","name":"Cyclosporin","dosage":"1-3mcg/kg/min IV for 24-48hr, then 5-Smg/kg 12H reducing by 1 mg/kg/dose each mo to 3-4 mg/kg/dose 12H oral. Eczema, juvenile arthritis, nephritic synd, psoriasis: 1.25-2.5mg/kg 12H oral. Usual target trough levels by Abbott TDx monoclonal specific assay (x 2.5 = non-specific assay level) on whole blood: 100-250 ng/ml (marrow), 300-400 ng/ml first 3mo then 100-300 ng/ml (kidney), 200-250 first 3mo then 100-125 (liver), 1 00-400ng/ml (heart, lung)."},{"id":"fs-0555","name":"Cyclosporin ophthalmic","dosage":"0.05% 1 drop in each eye 12H."},{"id":"fs-0556","name":"Cyclosporine","dosage":"See cyclosporin."},{"id":"fs-0557","name":"Cyproheptadine","dosage":"0.1 mg/kg (adult 4mg) 6-8H oral. Migraine 0.1 mg/kg (adult 4mg), repeated in 30m in if required."},{"id":"fs-0558","name":"Cyproterone","dosage":"1mg/kg (adult 50mg) 8-12H oral. Prec puberty: 25-50mg/m2 8-12H oral. Hyperandrogenism: 50-100mg daily days 5-14, with oestradiol valerate 1mg daily days 5-25."},{"id":"fs-0559","name":"Prostate carcinoma (NOT/kg): 100mg 8-12H oral","dosage":"See also oestradiol + cyproterone. Cyproterone 2mg + ethinyloestradiol 35mcg x 21 tab, + 7 inert tab. In females for acne, contraception, or hirsutism: 1 tab daily, starting 1st day of mensturation."},{"id":"fs-0560","name":"Cysteamine","dosage":"0.05mg/m2 6H oral, increase over 6wk to 0.33 mg/m2/dose (<50kg) or 0.5m~/kg/dose (>50kg) 6H."},{"id":"fs-0561","name":"Cytarabine","dosage":"Usually 100mg/m daily for 10 days by IV injn or constant infusion. Intrathecal: 30mg/m2 every 4 days until CSF normal (dissolve in saline not diluent)."},{"id":"fs-0562","name":"Cytomegalovirus immunoglobn","dosage":"See immunoglobn, CMV."},{"id":"fs-0563","name":"Dabigatran","dosage":"Adult, NOT/kg: 150mg 12H or 220mg daily oral."},{"id":"fs-0564","name":"Dabrafenib","dosage":"Adult, NOT/kg 150mg 12H oral with trametinib. Page 26"},{"id":"fs-0565","name":"Dacarbazine","dosage":"250mg/m2 IV daily for 5 days every 3wk, or 1000mg/m2 IV every 3wk."},{"id":"fs-0566","name":"Daclatasvir","dosage":"Adult, NOT/kg: 60mg + sofosbuvir 400mg  ribavirin daily oral12wk (24wk if cirrhosis). See asunaprevir."},{"id":"fs-0567","name":"Daclizumab","dosage":"Adult, NOT/kg: 150mg every month SC."},{"id":"fs-0568","name":"Dactinomycin","dosage":"Usually 400-600mcg/m2 IV daily for 5 days, repeat after 3-4wk."},{"id":"fs-0569","name":"Dalbavancin","dosage":"15mg/kg (adult 1g) IV over 30min, then 7.5 mg/kg (adult 0.5g) 1 wk later."},{"id":"fs-0570","name":"Dalfampridine","dosage":"Slow release (adult, NOT/kg): 10mg 12H oral. Dalfopristin 350mg + quinupristin 150mg (Synercid IV). 7.5mg/kg (combined) 8H IV over 1 hr."},{"id":"fs-0571","name":"Dalteparin sodium","dosage":"Proph (adult): 2500-5000u SC 1-2H preop, then daily. Venous thrombosis: 10Ou/kg 12H SC, or infuse 200u/kg/day IV (anti-Xa 0.5-1u/ml4hr post dose). Haernodialysis: 5-10u/kg stat, then 4-5u/kg/hr IV (acute renal failure, anti-Xa 0.2-0.4u/ml); 30-40u/kg stat, then 10-15 u/kg/hr (chronic renal failure, anti-Xa 0.5-1 u/ml)."},{"id":"fs-0572","name":"Danaparoid","dosage":"Prevention: 15u/kg (adult 750u) 12H SC. Heparin induced thrombocytopenia: 30u/kg stat IV, then 1.2 2u/kg/rlr to maintain anti-Xa 0.4-0.Bu/ml."},{"id":"fs-0573","name":"Danazol","dosage":"2-4mg/kg (adult 100-200mg) 6-121\\"1 oral."},{"id":"fs-0574","name":"Dantro len e","dosage":"Hyperpyrexia: 1 mg/kg/min until improves (max 10mg/kg), then 1-2mg/kg 6H for 1 \\"3day IV or oral. Spasticity: 0.5m(J/kg (adult 25mg) 6H, increase over 2wk if roqd to 3mg/kg (adult 50-100mg) 6H oral."},{"id":"fs-0575","name":"Dantron + docusate (co-danthrusate)","dosage":"NOT/kg. 50/60mg cap: 7 -12yr 1 cap, adult 1-3cap at nigl1t 50/60mg in 5ml: 1- 6yr 2.5ml, 7-12yr 5ml, adult 5-15ml at night."},{"id":"fs-0576","name":"Dantron + poloxamer 188 (co-danthramer)","dosage":"NOT/kg. 25/ 200mg cap: 7-12yr 1cap, adult 1-3cap at night. 25/200mg in 5ml: 1-6yr 2.5ml, 7-12yr 5ml, adult 5-15ml at night."},{"id":"fs-0577","name":"Dapagliflozin","dosage":"Adult, NOT/kg: 5-10mg daily oral."},{"id":"fs-0578","name":"Dapagliflozin + metformin","dosage":"5/500, 5/1000, 10/500, 10/10OOmg ER tabs\\" 1 ER tab 12H daily oral."},{"id":"fs-0579","name":"Dapoxetine","dosage":"NOT/kg: 30mg 1-3hr before sex, max x1/day."},{"id":"fs-0580","name":"Dapsone","dosage":"2mg/kg (<10yr) 50mg (10-15yr) 100mg (>15yr) daily oral. P jirovecii: 2mg/kg (max 100mg) daily oral with trimethoprirn 5mg/kg 6H. Derrn herpet: 1-6mg/kg (adult 50- 300mg) daily oral."},{"id":"fs-0581","name":"Dapsone 100mg +pyrimethamine 12.5mg (Maloprirn)","dosage":"1 4yr quarter tab wkly, 5-10yr %tab, >10yr 1tab."},{"id":"fs-0582","name":"Daptomycin","dosage":"4mg/kg IV over 30min daily. SfJVere inftn: 8-10 mg/kg IV daily."},{"id":"fs-0583","name":"Daraturnumab","dosage":"16mg/kg IV wkly for 8wk, then every 2wk wks 9-24, then every 4wk."},{"id":"fs-0584","name":"Darbepoetin alia","dosage":"I ncr or reduce dose if required by 25% every 4wk. Renal failure: 0.45mcg/kg wkly or 0.75mcg/kg 2wkly (O.l5mcg/kg wkly if not on dialysis) SC or IV. Cancer: 6.75 meg/kg every 3wk, or 2.25mcg/kg every wk, SC or IV. $9\\"95 +postage from orders@drugdoses.com F'age 2f"},{"id":"fs-0585","name":"Darifenacin","dosage":"Adult, NOT/kg: 7.5-15mg daily oral."},{"id":"fs-0586","name":"Darunavir (DRV)","dosage":"Adult, NOT/kg: 600mg 12H with food oral."},{"id":"fs-0587","name":"Darunavir + cobicistat","dosage":"Adult, NOT/kg: 800/150mg daily oral."},{"id":"fs-0588","name":"Darunavir + ritonavir","dosage":"20-29kg: 375/50mg 12H with food; 30- 39kg: 450/60mg 12H; 2:40kg: 600/100mg 12H. 2:18yr: 800/ 100mg (naNe) 600/100mg (past Rx) daily with food."},{"id":"fs-0589","name":"Dasabuvir","dosage":"Adult, NOT/kg: 250mg tab 12H + ornbitasvir paritaprevir--ritonavir 12.5/l5/50mg 2 tab daily ribavirin 500mg (>75kg 600mg) 12H oral for 12-14wk. Dasabuvir + ornbitasvir + paritaprevir + ritonavir ER. 200/8.33/50/33.3mg. Adult, NOT/kg: 3 tab daily oral for 12wk."},{"id":"fs-0590","name":"Dasatinib","dosage":"Adult, NOT/kg: 70mg (up to 100mg) 12H oral."},{"id":"fs-0591","name":"D;mnorubicin","dosage":"30mg/m2 wkly slow IV, or 60-90mg/m2 every 3wk. Max total dose 500mgtrn'-"},{"id":"fs-0592","name":"DDAVP","dosage":"See desrnopressin."},{"id":"fs-0593","name":"Decitabine","dosage":"15mg/m2 IV over 3hr 8H for 3 days, repeated every 6wk (minirnurn of 4 cycles)."},{"id":"fs-0594","name":"Deferasirox","dosage":"20-40mg/kg (Exjade) or 14-28mg/kg (Jadenu) daily oral; monitor ferritin."},{"id":"fs-0595","name":"Deferiprone","dosage":"25mg/kg 8H (max 100mg/kg/day) oral."},{"id":"fs-0596","name":"Deferoxamine","dosage":"See desferrioxamine."},{"id":"fs-0597","name":"Defibrotide","dosage":"6.25mg/kg 6H IV over 2H for minirnurn21 days."},{"id":"fs-0598","name":"Deflazacort","dosage":"Usually 0.1-1.5mg/kg (adult 5-90mg) 24-48H oral. 1.2 mg = 1 mg prednisolone in glucocorticoid activity."},{"id":"fs-0599","name":"Degarelix","dosage":"Adult, NOT/kg: 240mg in two SC injections, then 80mg SC every 4wk."},{"id":"fs-0600","name":"Delavirdine","dosage":"Adult, NOT/kg: 400mg 8H, or 600mg 12H oral."},{"id":"fs-0601","name":"Delta-9-tetrahydrocannabinol","dosage":"See cannabidiol."},{"id":"fs-0602","name":"Demecarium bromide","dosage":"0.125%,0.25% ophthalmic solution."},{"id":"fs-0603","name":"Glaucoma: 1 drop x2/day to x2/wk","dosage":"Strabismus: 1 drop daily for 2wk, then 1 drop alternate days for 2-3wk."},{"id":"fs-0604","name":"Demeclocycline","dosage":">8yr: 3mg/kg (adult 150mg) 6H, or 6mg/kg (adult 300mg) 12H oral. See also chlortetracycline."},{"id":"fs-0605","name":"Denileukin diftitox","dosage":"9-18mcg/kg daily IV over 15min for 5 consecutive days every 21 days."},{"id":"fs-0606","name":"Denosumab","dosage":"Adult, NOT/kg. Ostoporosis: 60mg every 6mo SC, with calcium 10OOmg daily and at least 400iu vitamin D daily. Prostate cancer: 120mg SC every 4wlc"},{"id":"fs-0607","name":"Deoxycholic acid","dosage":"10mg/ml. NOT/kg: 2mg/crn2 SC 1cm apart."},{"id":"fs-0608","name":"Dequalinium","dosage":"NOT/kg: one 0.25mg pastile 4H oral."},{"id":"fs-0609","name":"Deserpidine","dosage":"0.005-0.02mg/kg (adult 0.25-img) daily oral."},{"id":"fs-0610","name":"Desferrioxamine","dosage":"Antidote: 10-15mg/kg/hr IV for 12-24H (max 6g/24H) if Fe >60-90umol/L at 4hr or 8hr; some also give 5-10g (NOT/kg) once oral. Thalassaemia (NOT/kg): 30 60mg/kg daily over 8-12H 5-7 days a wlc"},{"id":"fs-0611","name":"Desflurane","dosage":"Usually child 5-10%, adult 3-8% by inhalation."},{"id":"fs-0612","name":"Desipramine","dosage":"2-4mg/kg (adult 1 00-200), occasionally increase up to 6mg/kg (adult 300mg), daily oral."},{"id":"fs-0613","name":"Desirudin","dosage":"0.3mg/kg (adult 15mg) 12H SC."},{"id":"fs-0614","name":"Desloratadine","dosage":"0.1 mg/kg (adult 5mg) daily oral. Page 28"},{"id":"fs-0615","name":"Desmopr~ssin (DDAVP)","dosage":"1u = 1mcg. NOT/kg. Enuresis, at night, >6yr: 200-400mcg oral, 120-240mcg subllng, 10-40 meg nasal. Dl: 1-5mcg (1mo-2yr) 5mcg (2-12yr) 5-10mcg (>12yr) 12H nasal (more at night); 10mcg (<2yr) 50mcg (2- 12yr) 50-100mcg (>12yr) x2-3/day oral; 2-18yr 60mcg 8H subling; 0.025mcg/kg (max 4mcg) in 1-2 doses/day SC, IM,"},{"id":"fs-0617","name":"Desogestrel","dosage":"Contraception: 75mcg daily oral, starting 1'1 day of menstruation."},{"id":"fs-0618","name":"Desogestrel + ethinyloestradiol","dosage":"150/30, 150/20mcg x21 tab, + 7 inert tab. Contraception: 1 tab daily, starting 1st day of mer>struation."},{"id":"fs-0619","name":"Desonide","dosage":"0.05% cream, ointment, lotion: apply 8-12H."},{"id":"fs-0620","name":"Desoximetasone","dosage":"See desoxymethasone."},{"id":"fs-0621","name":"Desoxymethasone","dosage":"0.05%,0.25% cream, oint, gel: apply 12H."},{"id":"fs-0622","name":"Desoxyribonuclease","dosage":"See fibrinolysin."},{"id":"fs-0623","name":"Desvenlafaxine","dosage":"Adult, NOT/kg: 50-100mg daily oral."},{"id":"fs-0624","name":"Dexamethasone","dosage":"Biological half life 2-3 days. Mild croup: 0.15mg/kg oral once. Severe croup, extabtn stridor, bronch iolitis: 0.6mg/kg (max 20mg) IV or IM stat, then prednisolone 1 mg/kg 8H oral. Cer oedema: 1 mg/kg (max 12mg) stat, then 0.25mg/kg 6H IM or IV. Meningitis: 0.15mg/kg (max 12mg) 6H IV for 4 days. Antiemetic: 0.5 mg/kg (adult 16mg) daily"},{"id":"fs-0625","name":"IM, IV, oral","dosage":"BPD: 0.4mg/kg daily for 3 days, then 0.3mg/kg 3 days, 0.2mg/kg 3 days, 0.1 mg/kg 3 days, 0.05mg/kg 7 days."},{"id":"fs-0626","name":"Gong adr hypopl: 0.27 mg/m2 daily oral","dosage":"Eye drops 0.1%: 1 drop/eye 3-8H. Dexamethasone has no mineralocorticoid action; 1 mg = 25mg hydrocortisone in glucocorticoid action. Dexamethasone 0.5mg/ml {0.05%) + framycetin 5mg/ml (0.5%) +gramicidin 0.05mg/ml (0.005%) (Sofradex). Eye 1 drop 1-3H, ear 2-3 drops 6-8H, ointment 8-12H. Dexamethasone 0.1% +neomycin 0.35% +polymyxin 6000u/g. 1 drop/eye 6-8H."},{"id":"fs-0627","name":"Dexamethasone 0.1% + tobramycin 0.3%","dosage":"Usually 1 drop/ eye 4-6H; up to 2H for 2 days after surgery if required. Dexamethasone 20mcg + tramazoline 120mcg per dose. Aerosol: 1 puff in each nostril 4-8H."},{"id":"fs-0628","name":"Dexamphetamine","dosage":"0.2mg/kg (max 10mg) daily oral, increase if required to max 0. 5mg/kg (max 20mg) 12H. See amphetamine."},{"id":"fs-0629","name":"Dexchlorpheniramine maleate","dosage":"0.05mg/kg (adult 2mg) 6-8H oral. Repetab (adult NOT/kg): 6mg 12H oral."},{"id":"fs-0630","name":"Dexibuprofen","dosage":"Adult, NOT/kg: 400mg 12H (max SH) oral."},{"id":"fs-0631","name":"Dexketoprofen","dosage":"Adult, NOT/kg: 12.5mg 4-6H, or 25mg 8H (max 75mg/day) oral."},{"id":"fs-0632","name":"Dexlansoprazole","dosage":"1-2mg/kg (adult 30-60tng) daily oral."},{"id":"fs-0633","name":"Dexmedetomidine","dosage":"ICU: 0.4 (0.2-1.0) mcg/kg/hr IV (some times after 1 meg/kg load over 20 min). Procedure: 0.5. 1 meg/kg IV over 10-20min, then 0.6 (0.2-1) meg/kg/hr. TY, 2H. Page 29"},{"id":"fs-0634","name":"Dexmethylphenidate","dosage":"NOT/kg, given as two doses/day 4hr apart: 2.5mg/dose oral, increase if required to 10mg/dose. Long acting (NOT/kg): child 5-10mg (adult 5-20mg) daily oral."},{"id":"fs-0635","name":"Dexpanthenol","dosage":"5-10mg/kg (adult 250-500mg) IM. 5% cream: apply 12-24H "},{"id":"fs-0636","name":"Dexrazoxane","dosage":"10mg for each 1 mg doxorubicin IV. Extravasa tion of anthracyclines: within 6hr give 1 g/m2 (max 2g) IV over 2H, repeated after 24H; then 0.5g/m2 48hr after first dose."},{"id":"fs-0637","name":"Dextran 1 (Prom it)","dosage":"15% solution. 0.3ml/kg IV 1-2min before giving dextran 40 or dextran 70."},{"id":"fs-0638","name":"Dextran 40","dosage":"10% solution: 10ml/kg x1-2 on day 1, then 10 ml/kg/day IV. Half life about 3hr. Dextran 70.6% solution: 10ml/kg x1-2 on day 1, then 10 ml/kg/day IV. Half life about 12H."},{"id":"fs-0639","name":"Dextroamphetamine","dosage":"See dexamphetamine."},{"id":"fs-0640","name":"Dextromethorphan","dosage":"0.2-0.4mg/kg (adult 10-20mg) 6-SH oral."},{"id":"fs-0641","name":"Dextromethorphan 20mg +quinidine 10mg","dosage":"Adult; NOT/kg: 1 cap daily for 7 days, then 1 cap 12H oral."},{"id":"fs-0642","name":"Dextromoramide","dosage":"0.1 mg/kg (adult 5mg) 8H, may increase to 0.5mg/kg (adult 20mg) 8H oral or PR."},{"id":"fs-0643","name":"Dextrose","dosage":"Infant sedation (NOT/kg): 1 ml 50%D oral. Hypo glycaemia: 0.5ml/kg 50%D or 2.5ml/kg 10%D slow IV, then tncr maintenance mg/kg/min. Hyperkalaemia: 0.1 u/kg insulin + 2ml/kg 50%D IV. Neonates: 6g/kg/day (about 4mg/kg/min) day 1, increase to 12g/kg/day (up to 18g/kg/day with hypoglyc aemia). lnfsn rate (ml/hr) = (4.17 x Wt x g/kg/day) I %D = (6 x Wt x mg/kg/min) I %D. Dose (g/kg/day) = (ml/hr x %D) I (4.17 x Wt). Dose (mg/kg/min) = (ml/hr x %D) I (6 x Wt). mg/kg/min = g/kg/day /1.44. 0.5ml/kg/hr of 50%= 6g/kg/day."},{"id":"fs-0644","name":"Dextrose-heparin (dex-hep)","dosage":"Dextrose solution (usually 5%) with heparin 1 u/ml."},{"id":"fs-0645","name":"Dezocine","dosage":"IM: 0.1-0.4mg/kg (adult 5-20mg) 3-6H.IV: 0.05- 0.2mg/kg (adult 2.5-10mg) 2-4H. 3,4-Diaminopyridine. Adult, NOT/kg: 10mg 6-SH oral, increase if required to max 20mg x5/day."},{"id":"fs-0646","name":"Diamorphine","dosage":"Adult, NOT/kg: 5-10mg 4H IV, IM, SC, oral."},{"id":"fs-0647","name":"Diazepam","dosage":"0.04-0.Zmg/kg (adult 2-10mg) 8-12H oral. Seizure (repeat after 15min if required): 0.1-0.4mg/kg (max 10mg) IV; 0.3-0.5mg/kg (max 20mg) PR. Do not give by IV infusion (binds to PVC); emulsion can be infused. Premed: 0.2-0.4mg/kg oral, PR. 2-3mg = 1 mg midazolarn."},{"id":"fs-0648","name":"Diazoxide","dosage":"Hypertension: 1-3mg/kg (max 150mg) stat by rapid IV injection (severe hypotension may occur) repeat once if required, then 2-5mg/kg IV 6H. Hyperinsulinism: <12mo 5mg/kg 8-12H oral; >12mo 30-100mg/m2 per dose 8H oral."},{"id":"fs-0649","name":"Dibotermin alfa","dosage":"8ml of 1.5mg/ml spread evenly on matrix."},{"id":"fs-0650","name":"Dibromopropamidine","dosage":"0.15% cream on dressing prn."},{"id":"fs-0651","name":"Dibucaine","dosage":"See cinchocaine. Dichloralphenazone 100mg + isometheptene mucate 65mg + paracetamol 325mg. Adult, NOT/kg: 2 capsules Page 30 stat, then 1/hr if required (max 5cap in 12H),"},{"id":"fs-0652","name":"Dichlorobenzene","dosage":"See arachis oil + chlorbutoL ~-"},{"id":"fs-0653","name":"Dichlorphenamide","dosage":"2-4mg/kg (adult 100-200mg) stat, then  2mg/kg (adult 100mg) 12H until response, then 0.5-1mg/kg ;: (adult 50mg) 8-24H oral _"},{"id":"fs-0654","name":"Diclofenac","dosage":"0.5-1mg/kg (adult 50mg) 8-12H oral, I0R JIA: 1- 1.5mg/kg (max 75mg) 12H oral Adult, NOT/kg: IV 37.5mg 6H (max 150mg/d); subrnicron 18mg or 35mg 8H oral; patch 1.3% (180mg) 10x14crn apply 12H. Eye drops 0.1%: preop 1-5 drops over 3hr, postop 1 drop stat, then 1 drop 4-8H. Topical gel1% (arthritis) 3% (keratoses): apply 2-4g 6-8H."},{"id":"fs-0655","name":"Diclofenac + misoprostal","dosage":"Adult, NOT/1<9-50mg/200mcg tab 8-12H oral; 75mg/200mcg tab 12H oral"},{"id":"fs-0656","name":"Dicloxacillin","dosage":"15-25mg/kg (adult 250-500mg) 6H oral, IM or"},{"id":"fs-0658","name":"Dicobalt edetate","dosage":"10mg/kg (adult 300mg) IV over 1-5min, repeat x2 if no response."},{"id":"fs-0659","name":"Dicyclomine","dosage":"0.5mg/kg (adult 10-20mg) 6-8H oral"},{"id":"fs-0660","name":"Dicycloverine","dosage":"See dicyclomine."},{"id":"fs-0661","name":"Didanosine (ddl)","dosage":"<3mo 50mg/m212H oral; 3-Brno 100 mg/m2 (max 200mg) 12H; 9rno-12yr 120mg/m2 (90-150 mg/m2) 12H; >12yr 250mg (<60kg) 400mg (<:60kg) daily oral. Adult with tenofovir: 200mg (<60kg) 250mg (260kg), CNS disease; 150mg/m2 12H."},{"id":"fs-0662","name":"Dideoxycytidine (ddC)","dosage":"See zalcitabine."},{"id":"fs-0663","name":"Dienestrol","dosage":"See dienoestroL"},{"id":"fs-0664","name":"Dienoestrol","dosage":"0.01% vaginal cream: 1 applicatorful (5g) 12- 24H for 1-2wk, reducing gradually to x1-3/wk."},{"id":"fs-0665","name":"Dienogest","dosage":"Adult, NOT/kg: 2mg daily oral"},{"id":"fs-0666","name":"Dienogest (Di) +oestradiol valerate OV)","dosage":"Contraception, daily: day 1-20V 3mg; day 3-7 Di 2mg + OV 2mg; day 8-24 Di 3mg + OV 2mg; day 27-28 OV 1mg; (day 25-2.6) placebo."},{"id":"fs-0667","name":"Diethylcarbamazine","dosage":"6mg/kg daily for 12 days oral, or a single dose of 6mg/kg repeated every 6-12 months."},{"id":"fs-0668","name":"Diethylpropion","dosage":"6-12yr 25mg (NOT/kg) 12H oral. >12yr 25mg (NOT/kg) 6-8H oral."},{"id":"fs-0669","name":"Diethylstilboestrol","dosage":"See stilboestroL"},{"id":"fs-0670","name":"Difenoxin","dosage":"See atropine+ diphenoxylate."},{"id":"fs-0671","name":"Diflorasone","dosage":"0.05% cream, ointment apply 6-24H."},{"id":"fs-0672","name":"Diflunisal","dosage":"5-10mg/kg (adult 250-SOOmg) 12H oral."},{"id":"fs-0673","name":"Digitoxin","dosage":"4mcg/kfl (max 0.2mg) 12H oral for 4 days, then 1- 6mcg/kg (adult usually 0. 15mg, max 0.3mg) daily."},{"id":"fs-0674","name":"Digoxin","dosage":"15mcg/kg stat and 5mcg/kg after 6H, then 3-5 meg/kg (usual max 200mcg IV, 250mcg oral) 12H slow IV or oral. Level 6hr or more after dose: 1.0-2.5 nrnoi/L (xO. 78c'ng/ml)."},{"id":"fs-0675","name":"Digoxin immmune FAB (antibodies)","dosage":"IV over 30min. Dose (to nearest 40mg) ~serum digoxin (nmoi/L) x Wt (kg) x 0,3, or mg ingested x 55. Give if >0.3mg/kg ingested, or level Page 31 >6.4 nmoi/L (5.0ng/ml)."},{"id":"fs-0676","name":"Dihydrazaline","dosage":"IV infusion: 0.1 mg/kg/hr titrated to effect (max 3.5mg/kg/day). Oral: 0.25-1 mg/kg 12H."},{"id":"fs-0677","name":"Dihydroartemisinin 40mg + piperaquine 320mg","dosage":"Oral daily for 3 days: dihydroartemisinin 2.5mg/kg (adult 1.6mg/kg) + piperaquine 20mg/kg (adult 12.8mg/kg)."},{"id":"fs-0678","name":"Dihydrocodeine","dosage":"0.5-1 mg/kg 4-6H oral."},{"id":"fs-0679","name":"Dihydroergotamine mesylate","dosage":"Adult, NOT/kg: 1 mg IM, SC or"},{"id":"fs-0680","name":"IV, repeat hrly x2 if needed","dosage":"Max 6mg/wk."},{"id":"fs-0681","name":"Dihydromorphinone","dosage":"See hydromorphone."},{"id":"fs-0682","name":"Dihydrotachysterol (1-0H vitamin D2)","dosage":"Renal failure, vit D resistant rickets: 20mcg/kg daily oral, increase by 20mcg/kg every 4-Swk according to serum calcium."},{"id":"fs-0683","name":"Dihydrotestosterone","dosage":"See stanolone."},{"id":"fs-0684","name":"Dihydroxyacelone","dosage":"5% solution: apply 1-3 coats 1 hr apart, every 1-3 days."},{"id":"fs-0685","name":"Diiodohydroxyquin","dosage":"See di-iodohydroxyquinoline."},{"id":"fs-0686","name":"Di-iodohydroxyquinoline","dosage":"10-13.3mg/kg (adult 650mg) SH oral for 20 days."},{"id":"fs-0687","name":"Diloxanide","dosage":"10mg/kg (adult 500mg) SH oral."},{"id":"fs-0688","name":"Diltiazem","dosage":"1 mg/kg (adult 60mg) 8H, increase if required to max 3mg/kg (adult 180mg) 8H oral. Slow release (adult, NOT/kg): 120-240mg daily, or 90-180mg 8-12H oral."},{"id":"fs-0689","name":"Dimenhydrinate","dosage":"1-1.5mg/kg (max 50-75mg) 4-6H orai,IM,IV."},{"id":"fs-0690","name":"Dimercaprol (BAL)","dosage":"3mg/kg (max 150mg) IM 4H for 2 days, then 6H for 1 day, then 12H for 10 days."},{"id":"fs-0691","name":"Dimethindene","dosage":"0.02-0.04mg/kg (adult 1-2mg) SH oral."},{"id":"fs-0692","name":"Dimethyl fumarate","dosage":"Adult, NOT/kg: 120mg 12H oral for 1 wk, then 240mg 12H."},{"id":"fs-0693","name":"Dimethyl sulfoxide (DMSO)","dosage":"50% solution: 50ml in bladder for 15 min every 2wk."},{"id":"fs-0694","name":"Dimeticone","dosage":"Infant colic (NOT/kg): 42mg/5ml, 2.5ml with feeds (max x6/day). 10%, 15% barrier cream: apply prn."},{"id":"fs-0695","name":"Dinutuximab","dosage":"17.5mg/m21Vover 10-20hr for4 consecutive days in 24,32,24,32,24-day cycles."},{"id":"fs-0696","name":"Dinoprost (Prostaglandin F2 alpha)","dosage":"Extra-amniotic: 1 ml of 250mcg/ml stat, then 3ml 2H. Intra-amniotic: 40mg stat, then 10-40mg after 24H if required."},{"id":"fs-0697","name":"Dinoprostone (Prostaglandin E2)","dosage":"Labour induction: 1 mg into posterior vagina, may repeat dose 1-2mg after 6l1r (max 60mcg/kg over 6hr). Maintain PDA: 25mcg/kg 1 H (less often after 1 wk) oral; or 0.003-0.01 meg/kg/min IV."},{"id":"fs-0698","name":"Dioctyl sodium sulphosuccinate","dosage":"See docusate sodium."},{"id":"fs-0699","name":"Diphemanil methylsulphate","dosage":"20mg/g powder: apply 8-12H."},{"id":"fs-0700","name":"Diphenhydramine hydrochloride","dosage":"1-2mg/kg (adult 50-100 mg) 6-8H oral."},{"id":"fs-0701","name":"Diphenoxylate","dosage":"See atropine + diphenoxylate (L.omotil)."},{"id":"fs-0702","name":"Diphtheria antitoxin (horse)","dosage":"IM or IV (NOT/kg): 2500u (nasal), 10,OOOu (unilateral tonsillar), 20,000u (bilateral tonsillar), 30,000u (laryngeal), 50,000u (beyond tonsillar Page 32 fossa), 150,000u (bullneck). Repeat dose may be needed. See also immunoglobulin, diphtheria."},{"id":"fs-0703","name":"Diphtheria vaccine, adult (CSL)","dosage":"Inanimate. 0.5miiM stat, 6wk later, and 6mo later {3 doses). Boost every 10yr."},{"id":"fs-0704","name":"Diphtheria vaccine, child <Byr (CSL)","dosage":"Inanimate. 0.5miiM stat, in 6wk, then 6mo (3 doses). Boost with adult vaccine. Diphtheria + hepatitis B + Hib + pertussis (acellular) + tetanus vaccine [DaPT-hepB-Hib] (lnfanrix Hexa)."},{"id":"fs-0705","name":"Inanimate","dosage":"0.5miiM at 2mo, 4mo, 6mo (3 doses). Diphtheria + hepatitis B + pertussis (acellular) + polio + tetanus [DaPT-HepB-IPV] (Pediarix). Inanimate. 0.5mi'IM at 2mo, 4mo, 6mo (3 doses), and (DaPT) 18mo. Diphtheria + hepatitis B + pertussis (acellular) +tetanus vaccine [DaPT -hepB] (lnfanrix Hep B). Inanimate. 0.5ml IM at 2mo, 4mo, 6mo (3 doses), and (without hep B) 18mo. Diphtheria + Hib + pertussis (acellular) + polio +tetanus [DaPT -Hib-IPV] (lnfanrix Penta, Pediacel). Inanimate. 0.5miiM at 2mo, 4mo, 6mo (3 doses), and (DaPT) 18rno. Diphtheria + pertussis (acellular)+ polio +tetanus vaccine [DaPT -IPV] (Quadracel). Inanimate. 0.5miiM at 2, 4 and 6rno (3 doses). Diphtheria + pertussis (acellular) + polio +tetanus vaccine [DaPT-IPV] (lnfanrix-IPV).Inanimate. 16mo-13yr: 0.5ml IM once as booster. Diphtheria + pertussis (acellular) + polio +tetanus vaccine [daPT-IPV] (Repevax). Inanimate. >3yr: 0.5mi1M once RS booster. Diphtheria + pertussis (acellular) + polio +tetanus vaccine, adult [daPt-IPV] (Adacel Polio, Boostrix-IPV)."},{"id":"fs-0706","name":"Inanimate","dosage":"<o10yr: 0.5ml IM once as booster. Diphtheria+ pertussis (acellular)+ tetanus vaccine [DaPT] (Tripacel). Inanimate. 0.5rniiM at 2rno, 4mo, 6mo, 18rno and 4-5yr of age ( 5 doses). Diphtheria+ pertussis (acellular)+ tetanus vaccine, adult [daPt] (Adacel, Boostrix). Inanimate. <o10yr: 0.5miiM. Diphtheria + pertussis (whole cell)+ tetanus vaccine [OPT] (Triple Antigen). Inanimate. 0.5rn11M at 2mo, 4mo, 6mo, 18rno and 4-5yr of age (5 doses). Diphtheria+ polio+ tetanus vaccine [dT-IPV] (Revaxis)."},{"id":"fs-0707","name":"Inanimate","dosage":">6yr: 0.5ml IM once as booster. Diphtheria +tetanus vaccine, adult [dt] (ADT Booster)."},{"id":"fs-0708","name":"Inanimate","dosage":"0.5ml IM for revaccination after primary course."},{"id":"fs-0709","name":"Diphtheria +tetanus vaccine, child <8yr [DT] (COT)","dosage":"Inani- mate. 0.5ml IM, in 6wk, 6mo laler (3 dose). Boost with ADT."},{"id":"fs-0710","name":"Dipipanone","dosage":"See cyclizine."},{"id":"fs-0711","name":"Dipivefrin","dosage":"0.1% solution: 1 drop per eye 12H."},{"id":"fs-0712","name":"Diprophylline","dosage":"Usually 15mg/kg 6H oral or IM."},{"id":"fs-0713","name":"Dipyridamole","dosage":"1-2mg/kg (adult 50-100mg) 6-8H oral. See also aspirin + dipyridamole."},{"id":"fs-0714","name":"Dirithromycin","dosage":"10mglkg (adult 500mg) daily oral. Page 33"},{"id":"fs-0715","name":"Disodium clodronate","dosage":"See sodium clodronate."},{"id":"fs-0716","name":"Disodium edetate","dosage":"See trisodium edetate."},{"id":"fs-0717","name":"Disodium etidronate","dosage":"See etidonrate."},{"id":"fs-0718","name":"Disodium levofolinate","dosage":"Half the dose of calcium folinate."},{"id":"fs-0719","name":"Disodium pamidronate","dosage":"See pamidronate."},{"id":"fs-0720","name":"Disodium tiludronate","dosage":"See tiludronate."},{"id":"fs-0721","name":"Disopyramide","dosage":"Oral: 1.5-4mg/kg (adult 75-200mg) 6H. IV: 2mg/kg (max 150mg) over 5min, then 0.4mg/kg/hr (max 800mg/day). Level 9-15umol/L (x0.3395 = mcg/ml)."},{"id":"fs-0722","name":"Distigmine","dosage":"Neurogenic bladder, megacolon: 0.01 mg/kg (adult 0.5mg) IM daily, 0.1 mg/kg (adult 5mg) oral daily. Myasth gravis: 0.1-0.Zmg/kg 12-24H (max 20mg/day) oral."},{"id":"fs-0723","name":"Disulfiram","dosage":"Adult, NOT/kg: 500mg oral daily for 1-2wk, then 125-500mg daily."},{"id":"fs-0724","name":"Dithranol","dosage":"0.1%-2% cream, ointment: start with lowest strength, apply daily, wash off after 10m in increase to 30min."},{"id":"fs-0725","name":"Divalproex","dosage":"Dose as for sodium valproate."},{"id":"fs-0726","name":"Dl-alpha-tocopheryl acetate","dosage":"See vitamin E."},{"id":"fs-0727","name":"DMSA","dosage":"See suocimer."},{"id":"fs-0728","name":"Dobutamine","dosage":"<30kg: 15mg/kg in 50ml saline at 1-3ml/hr (5- 15mcg/kg/min) via CVC or periph IV; >30kg: 6mg/kg in 100 ml saline at 5-15ml/hr (5-15mcg/kg/min). TY, 2min."},{"id":"fs-0729","name":"Docetaxel","dosage":"Initially 75-100mg/m2 over 1H IV every 3wk."},{"id":"fs-0730","name":"Docosahexaenoic acid","dosage":"See omega-3. acid esters."},{"id":"fs-0731","name":"Docosanol","dosage":"10% cream: apply 5 times a day."},{"id":"fs-0732","name":"Docusate","dosage":"NOT/kg: 100mg (3-10yr), 120-240mg (>10yr) daily oral. Enema (5ml 18% + 155ml water): 30ml (newborn), 60ml (1-12mo), 60-120ml (>12mo) PR."},{"id":"fs-0733","name":"Docusate 50mg + sennoside 8mg, tab","dosage":">12yr: 1-4 tab at night oral. See also bisacodyl; casanthranol; dantron."},{"id":"fs-0734","name":"Dofetilide","dosage":"10mcg/kg (adult 500mcg) 12H oral, less if renal impairment or increaseeased QTc interval."},{"id":"fs-0735","name":"Dolasetron","dosage":"Cancer: 1.8mg/kg (adult 100mg) IV 30m in before chemo, or 4mg/kg (adult 200mg) oral 1 hr before chemo. Surgery: 1 mg/kg (adult 50mg) oral at induction, or 0.25mg/kg (adult 12.5mg) IV postop."},{"id":"fs-0736","name":"Dolutegravir","dosage":":e40kg: 50mg daily oral. See abacavir."},{"id":"fs-0737","name":"Domperidone","dosage":"Oral: 0.2-0.Smg/kg (adult 10-20mg) 4-Bf-1. Rectal suppos: Adult, NOT/kg 30-60mg 4-SH."},{"id":"fs-0738","name":"Donepezil","dosage":"Adult, NOT/kg: 5mg at night oral, increase to 10mg after 1 mo if required."},{"id":"fs-0739","name":"Donepezil + memantine","dosage":"14/10, 28/10mg. 1 tab daily oral."},{"id":"fs-0740","name":"Dopamine","dosage":"Via CVC <30kg: 15mg/kg in 50ml at 1-3ml/hr (5- 15 meg/kg/min); >30kg: 6mg/kg made up to 100ml at 5-15 ml/hr (5-15mcg/kg/min). TY, 2min."},{"id":"fs-0741","name":"Dopexamine","dosage":"IV infusion 0.5--6mcg/kg/min."},{"id":"fs-0742","name":"Doripenem","dosage":"10mg/kg (adult 500mg) 8H IV."},{"id":"fs-0743","name":"Dornase alpha (deoxyribonuclease 1)","dosage":"NOT/kg: usually 2.5mg (max 10mg) inhaled daily (5-21yr), 12-24H (>21yr)."},{"id":"fs-0744","name":"Dorzolamide","dosage":"2% drops: 1 drop/eye 8-12H. Page 34"},{"id":"fs-0745","name":"Dorzolamide 2% + timolol 0.5%","dosage":"1 drop/eye 12H."},{"id":"fs-0746","name":"Dosulepin","dosage":"See dothiepin."},{"id":"fs-0747","name":"Dothiepin","dosage":"0.5-1mg/kg (adult 25-50mg) 8-12H oral."},{"id":"fs-0748","name":"Doxacurium","dosage":"50-80mcg/kg stat, then 5-10mcg/kg/dose IV."},{"id":"fs-0749","name":"Doxapram","dosage":"5mg/kg IV over 1 hr, then 0.5-1 mg/kg/hr for 1 hr (max total dose 400mg)."},{"id":"fs-0750","name":"Doxazosin","dosage":"Usually 0.02-0.1 mg/kg (adult 1-4mg) daily oral."},{"id":"fs-0751","name":"Doxepin","dosage":"0.2-2mg/kg (adult 10-100mg) 8H oral. Insomnia (adult, NOT/kg): 6mg nocte oral. 5% cream: apply x3-4/day."},{"id":"fs-0752","name":"Doxercalciferol (1,25-0H D2 analogue)","dosage":"Initially 0.2mcg/kg (adult 10mcg) oral, or 0.08mcg/kg (adult 4mcg) IV, x3/wk at end of dialysis. Aim for blood iPTH 150-300pg/ml."},{"id":"fs-0753","name":"Doxorubicin","dosage":"30mg/m2 IV over 15min wkly, or 30mg/m2 daily for 2-3days every 3-4wk. Max total dose 480mg/m2 (300 mg/m2 if mediastinal irradiation)."},{"id":"fs-0754","name":"Doxorubicin, liposomal","dosage":"Carcinoma: 50mg/m2 IV every 3wk. Kaposi: 20mg/m2 IV every 2wk."},{"id":"fs-0755","name":"Doxycycline","dosage":">Byr, oral or IV. 2mg/kg (adult 100mg) 12H for 2 doses, then daily. Severe: 2mg/kg 12H. Malaria 2.2mg/kg (max 100mg) 12H 7 days; proph 2mg/kg (max 100mg) daily. Acne (NOT/kg): 50mg daily for 6wk, 100mg daily if required."},{"id":"fs-0756","name":"Doxycycline 30mg + 10mg slow release","dosage":"Rosacea in adults (NOT/kg): 1 tab daily oral."},{"id":"fs-0757","name":"Doxylamine","dosage":"0.25-0. 5mg/kg (adult 12. 5-25mg) 8H oral. Hypnotic: 0.5-1 mg/kg (adult 25-50mg)."},{"id":"fs-0758","name":"Doxylamine 10mg +pyridoxine 10mg","dosage":"Adult, NOT/kg: 2 tab at night; add 1 tab moming and afternoon if required."},{"id":"fs-0759","name":"D-penicillamine","dosage":"See penicillamine."},{"id":"fs-0760","name":"Dronabinol","dosage":"Initially 5mg/m2 2-4H (max 4-6 doses per day) oral, slow increase by 2.5mg/m2/dose to max 15mg/m2 4H."},{"id":"fs-0761","name":"Dronedarone","dosage":"8mg/kg (adult 400mg) 12H oral."},{"id":"fs-0762","name":"Droperidol","dosage":"Antiemetic: postop 0.02-0.05mg/kg (adult 1.25 mg) 4-6H IM or slow IV, chemother 0.02-0.1 (adult 1-5mg) 1 6H. Psychiatry, neuroleptanalg, IM or slow IV: 0.1 mg/kg (adult 5mg) stat, increase to max 0.3mg/kg (adult 15 mg) 4-8H."},{"id":"fs-0763","name":"Drospirenone + oestradiol","dosage":"0.5mg/1 mg, 2mg/1 mg tab. Post menopause (NOT/kg): 1 tab daily oral. Drospirenone 3mg + ethinyloestradiol 20mcg + levome folate 451 meg x 24 tab, + 4 tab levomefolate 451 meg. Contraception: 1 daily starting 1\\" day of menstruation. Drospirenone 3mg + ethinyloestradiol 20mcg x 24 tab, + 4 inert tab. Contraceptn: 1 daily starting 1\\" day of rnenstruatn. Drospirenone 3mg + ethinyloestradiol 30mcg x 21 tab + 7 inert tab. Contraceptn: 1 daily starting 1\\" day menstruatn."},{"id":"fs-0764","name":"Droxidopa","dosage":"Adult, NOT/kg: 100mg increase every 1-2 days if required to max 600mg oral moming, noon, and late afternoon."},{"id":"fs-0765","name":"Duaglucide","dosage":"Adult, NOT/kg 0.75-i.Smg SConce a week."},{"id":"fs-0766","name":"Duloxetine","dosage":"Adult, NOT/kg: 20-30mg 12H. or 60mg daily oral."},{"id":"fs-0767","name":"Dust mite allergen extract","dosage":"?.5yr, NOT/kg: 100 IR day1, 200 IR day2, then 300 IR daily sublingual. Page 35"},{"id":"fs-0768","name":"Dutasteride","dosage":"Adult, NOT/kg: 0.5mg daily oral."},{"id":"fs-0769","name":"Dutasteride O.Smg + tamsulosin 0.4mg","dosage":"Adult, NOT/kg: 1 cap daily oral."},{"id":"fs-0770","name":"Dyclonine hydrochloride","dosage":"See dyclocaine hydrochloride."},{"id":"fs-0771","name":"Dydrogesterone","dosage":"0.2mg/kg (adult 10mg) 12-24H oral."},{"id":"fs-0772","name":"Dydrogesterone + oestradiol","dosage":"5/1 mg, 10/1, 10/2 tab. Adult,"},{"id":"fs-0773","name":"NOT/kg","dosage":"Postmenopausal: 1 tab daily oral. Dydrogesterone 10mg tab+ oestradiol patch (40 or 80 mcg/24H). Adult, NOT/kg. Postmenopausal: apply new patch every 3-4 days, 1 tab daily oral for last 14days of cycle."},{"id":"fs-0774","name":"Dyphylline","dosage":"See diprophylline."},{"id":"fs-0775","name":"Ecallantide","dosage":"0.6mg/kg (adult 30mg) SC, repeat if required."},{"id":"fs-0776","name":"Econazole","dosage":"Topical: 1% cream, powder or lotion 8-12H. Vaginal: 75mg cream or 150mg ovule twice daily."},{"id":"fs-0777","name":"Ecothiopate iodide","dosage":"0.03%, 0.06%, 0.125%, 0.25% solution: usually 0.125% 1 drop/eye every 1-2 days at bedtime."},{"id":"fs-0778","name":"Eculizumab","dosage":"600mg IV over 35min wkly for 4wk, 900mg the next wk, then 900mg every 2wk."},{"id":"fs-0779","name":"Edrophonium","dosage":"Test dose 20mcg/kg (adult 2mg), then 1 min later 80mcg/kg (adult Smg) IV. SVT: 0.15mg/kg (max 2mg) increase to max 0.75mg/kg (max 10mg) IV, with atropine if required."},{"id":"fs-0780","name":"EDT A","dosage":"See sodium calciumedetate."},{"id":"fs-0781","name":"Efalizumab","dosage":"0. 7mg/kg stat, then 1 mg/kg wkly SC."},{"id":"fs-0782","name":"Efavirenz (EFV)","dosage":"Daily oral10-14kg 200mg, 15-19mg 250mg, 20-24 kg 300mg, 25-32kg 350mg, 33-39kg 400mg, <:40kg GOOmg (minimum trough 1000 ng/ml)."},{"id":"fs-0783","name":"Efavirenz + fosamprenavir + ritonavir","dosage":">18yr: EFV 600mg daily+ FPV 700mg 12H + RTV 100mg 12H oral. If Rx na'ive, can use EFV 600mg + FPV 1400mg + RTV 300mg daily. Efavirenz 600mg + emtricitabine 200mg + tenofovir diso- proxil fumarate 300mg. ;;,40kg: 1 tab daily."},{"id":"fs-0784","name":"Efinaconazole","dosage":"10% 1 drop (2 for big toe) daily for 48wk."},{"id":"fs-0785","name":"Eflornithine","dosage":"13.9% cream: apply 12H."},{"id":"fs-0786","name":"Eformoterol + fluticasone","dosage":"5/50mcg, 5/125, 10/250. NOT/kg. 2:12yr: 2 inhalations 12H."},{"id":"fs-0787","name":"Eformoterol","dosage":"6mcg or 12mcg cap (max 24mcg) inhaled 12H."},{"id":"fs-0788","name":"Eicosapentaenoic acid","dosage":"See omega-3-acid esters."},{"id":"fs-0789","name":"Elbasvir 50mg + grazoprevir 10Omg","dosage":"Adult, NOT/kg: 1 tab daily oral. ribavirin for 12-16wk."},{"id":"fs-0790","name":"Electrolyte solution","dosage":"See glucose electrolyte solution."},{"id":"fs-0791","name":"Eletriptan","dosage":"Adult, NOT/kg: 20-40mg, repeat after 2H if required (max 80mg/day)."},{"id":"fs-0792","name":"Eliglustat","dosage":"NOT/kg: 84mg orai12H (daily if poor metaboliser)."},{"id":"fs-0793","name":"Eloctate","dosage":"<6yr 40-SOu/kg, 2:6yr 25-65u/kg, IV every 4 days."},{"id":"fs-0794","name":"Elosulfase alfa","dosage":"2mg/kg/wk IV over 4hr."},{"id":"fs-0795","name":"Elotuzumab","dosage":"10mg/kg on days 1 ,8, 15,22 for two 28-day cycles, then on days 1 and 15."},{"id":"fs-0796","name":"Eitrombopag","dosage":"Adult, NOT/kg: 25-75mg daily oral."},{"id":"fs-0797","name":"Eiuxadoline","dosage":"Adult, NOT/kg: 100mg 12H oral."},{"id":"fs-0798","name":"Elvitegravir","dosage":"See cobicistat. Page 36"},{"id":"fs-0799","name":"Emedastine","dosage":"0.5mg/ml solution: 1 drop/eye 12H."},{"id":"fs-0800","name":"EMLA cream","dosage":"See lignocaine + prilocaine."},{"id":"fs-0801","name":"Empagliflozin","dosage":"Adult, NOT/kg: 10mg (up to 25mg) daily oral."},{"id":"fs-0802","name":"Empagliflozin + linagliptin","dosage":"10/5mg, 25/5 tab. Adult, NOT/kg: 10/5 daily oral, increase to 25/5 if required."},{"id":"fs-0803","name":"Empagliflozin + metformin","dosage":"5/500mg, 5/1000, 12.5/500, 12.5/1000 tab. 1 tab 12H oral with meals."},{"id":"fs-0804","name":"Emtricitabine (FTC)","dosage":"0-3rno: solution 3mg/kg daily oral; >3mo: solution 6mg/kg (adult 240mg), cap (>33kg) 200mg daily oral. Emtricitabine 200mg + rilpivirine 25mg + tenofovir alafen amide 25mg. NOT/kg. 2:35kg 1 tab daily oral with food. Emtricitabine 200mg + rilpivirine 25mg + tenofovir diso proxil fumarate 300mg. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-0805","name":"Emtricitabine 200mg + tenofovir alafenarnide 25mg","dosage":"2:12yr, NOT/kg: 1 tab daily oral. Emtricitabine 200mg + tenofovir disoproxil fumarate 300mg. 2:18yr: 1tab daily oral. See also efavirenz, cobicistat."},{"id":"fs-0806","name":"Enalapril","dosage":"0.1 mg/kg (adult 2.5mg) daily oral, increase over 2wk if required to max 0.5mg/kg (adult 5-20mg) 12H."},{"id":"fs-0807","name":"Enalaprilat","dosage":"Usually 0.025mg/kg (max 1.25mg) 6H IV, max 0.1 mg/kg (max 5mg) 6H."},{"id":"fs-0808","name":"Endoxaban","dosage":"Adult, NOT/kg: :560kg 30mg, >60kg 60mg daily oral. Lower dose if taking P-glycoprotein inhibitors."},{"id":"fs-0809","name":"Enflurane","dosage":"2-4.5% induction, then 0.5-3% by inhalation."},{"id":"fs-0810","name":"Enfuvirtide (ENF)","dosage":"?.6yr: 2mg/kg (max 90mg) 12H SC."},{"id":"fs-0811","name":"Enoxacin","dosage":"4-Bmg/kg (adult 200-400mg) 12H oral."},{"id":"fs-0812","name":"Enoxaparin (1mg=100u)","dosage":"<3rno 1.8mg/kg, 3-12mo 1.5mg/kg, 1-5yr 1.25mg/kg, >5yr 1 mg/kg (max 40mg) 12H SC; anti-Xa 0.5-1 u/ml 4hr post dose. Prophylaxis SC: <2mo 0.75mg/kg 12H, 2mo-18yr 0.5mg/kg 12H, >18yr 20mg (low risk) 40mg (high risk) 2-12H preop, then daily SC. Haemodialysis: 1 mg/kg into arterial line at start 4hr session."},{"id":"fs-0813","name":"Enoximone","dosage":"IV: 5-20mcg/kg/min. Oral: 1-3mg/kg (adult 50- 150mg) 8H."},{"id":"fs-0814","name":"Entacapone","dosage":"Adult, NOT/kg: 200mg with each 1-dopa/DDC inhibitor dose (av 800-1400mg/day, max 2000mg) oral. See also levodopa."},{"id":"fs-0815","name":"Entecavir","dosage":"Hepatitis B (adult, NOT/kg): 0.5mg daily oral; 1 mg daily if refractory to lamivudine."},{"id":"fs-0816","name":"Entravirine","dosage":"See etravirine."},{"id":"fs-0817","name":"Enzalutamide","dosage":"Adult, NOT/kg: 160mg daily oral."},{"id":"fs-0818","name":"Enzymes, pancreatic","dosage":"See pancreatic enzymes."},{"id":"fs-0819","name":"Ephedrine","dosage":"0.25-1mg/kg (adult 12. 5-60mg) 4-8H oral, IM, SC,"},{"id":"fs-0821","name":"Epinastine","dosage":"0.05% ophthalmic: 1 drop/eye 12H."},{"id":"fs-0822","name":"Epinephrine","dosage":"See adrenaline."},{"id":"fs-0823","name":"Epirubicin","dosage":"Adult: 75. 90mg/m2 IV over 10m in every 3wk."},{"id":"fs-0824","name":"Eplerenone","dosage":"0.5-1 mg/kg (adult 25-50mg) 12-24H oral."},{"id":"fs-0825","name":"Epoetin alia, beta, delta, theta, zeta","dosage":"50u/kg x3/wk, increase to 75-300u/kg/wk divided into 1-3 doses/wk SC, IV; once Hb Page 3'1 >100g/L give 25-10Ou/kg x3/wk (or give single wkly dose). Epoetin as methoxy polyethylene glycol-epoetin beta. 1.2mcg/kg SC monthly, or 0.6mcg/kg SC or IV every 2wk adjusted to Hb 1 00-120g/L."},{"id":"fs-0826","name":"Epoprostenol (prostacyclin, PGI2)","dosage":"Dilute to 2-10mcg/ml, new syringe every 8hr. <8kg: 12mcg/kg in 10m I diluent at 0.25-0.75ml/hr (5-15ng/kg/min); >8kg: 500mcg in 50ml diluent at 0.03-0.09ml/kg/hr (5-15ng/kg/ min). ECMO: 5.ng/kg/min IV. Chronic pul ht: 2ng/kg/min IV, increase to 20-40 ng/kg/min. ns imin."},{"id":"fs-0827","name":"Eprosartan","dosage":"12mg/kg (adult 600mg) daily, increase if required to 6- Bmg/kg (adult 300-400mg) 12H oral."},{"id":"fs-0828","name":"Epsilon aminocaproic acid","dosage":"See aminocaproic acid."},{"id":"fs-0829","name":"Eptacog alta (recombinant factor 7a)","dosage":"See factor 7a."},{"id":"fs-0830","name":"Eptifibatide","dosage":"Adult, NOT/kg: 1 80mcg/kg stat IV, then 2 meg/kg/min for up to 72hr."},{"id":"fs-0831","name":"Erdosteine","dosage":"Adult, NOT/kg: 300mg 12H oral."},{"id":"fs-0832","name":"Ergocalciferol (Vitamin 02)","dosage":"40u = 1 meg = 1 meg cholecal ciferol (D3). Cystic fibrosis, cholestasis: 10-20mcg daily oral."},{"id":"fs-0833","name":"Cirrhosis: adult 40-120mcg daily oral","dosage":"Deficiency: 50-10Omcg daily for 2wk oral, then 10-625mcg daily (more if severe malabs); or 2.5-5mg (100,000-200,000u) every 6-Swk. Monitor serum calcium; measure alk phos and parathyroid hormone after 6-Swk. See also doxercalciferol."},{"id":"fs-0834","name":"Ergoloid mesylates","dosage":"See co-dergocrine mesylate."},{"id":"fs-0835","name":"Ergometrine maleate","dosage":"Adult, NOT/kg: 250. 500mcg IM or IV; 500mcg 8H oral, sublingual or PR."},{"id":"fs-0836","name":"Ergometrine maleate 0.5mg +oxytocin 5u in 1ml","dosage":"1miiM; may repeat after 2H, max 3 doses in 24H."},{"id":"fs-0837","name":"Ergonovine maleate","dosage":"See ergometrine maleate."},{"id":"fs-0838","name":"Ergotamine tartrate","dosage":">10yr (NOT/kg): 2mg sublingual stat, then 1mg/hr (max 6mg/episode, 10mg/wk). Suppos (1-2mg): 1 stat, may repeat once after 1 hr. See caffeine, cyclizine."},{"id":"fs-0839","name":"Eribulin","dosage":"1.4mg/m2 IV over 5min day 1 and 8 of 21-day cycle."},{"id":"fs-0840","name":"Erlotinib","dosage":"Adult, NOT/kg: 150 mg daily oral; reduce to 100mg then 50mg daily if required."},{"id":"fs-0841","name":"Ertapenem","dosage":"<12yr 15mg/kg (max 500mg) 12H, >12yr 1g daily IM, IV over 30min."},{"id":"fs-0842","name":"Erythromycin","dosage":"<2mo may cause pyloric stenosis. Oral, slow IV (max 5mg/kg/hr): usually 10mg/kg (adult 250-500mg) 6H; severe inftn 15-25mg/kg (adult 0.75-1g) 6H. Rheu fever proph (NOT /kg): 250mg 12H oral. Gut prokinetic: 2mg/kg 8H. 2% gel: apply 12H. Same dose for base, salts and esters, except ethylsuccinate x1.6 higher dose (max 4g/day)."},{"id":"fs-0843","name":"Erythropoietin","dosage":"See epoetin."},{"id":"fs-0844","name":"Escitalopram","dosage":"NOT/kg. >12yr: 5mg daily oral, increase if required to max 10mg (rarely 20mg) daily."},{"id":"fs-0845","name":"Esketamine","dosage":"Soe ketamine."},{"id":"fs-0846","name":"Eslicarbazepine","dosage":"8mg/kg (adult 400mg) daily oral, increase to 15 mg/kg (adult 800mg) after 2wk; max 30mg/kg (adult 1800 Page 38 mg) daily."},{"id":"fs-0847","name":"Esmolol","dosage":"0.5mg/kg (500mcg/kg) IV over 1min, repeat if required. lnfsn (undiluted 10mg/ml solution; or 2.5g diluted to 250ml): 0.15-1.8ml/kg/hr (25-300mcg/kg/min); rarely given for >48hr. Esomeprazole, Base: 0.4-0.Smg/kg (adult 20-40mg) daily oral, IV. H.pylori, See omeprazole. May lower Mg."},{"id":"fs-0848","name":"Esomeprazole + naproxen","dosage":"375mg/20mg, 500/20 tab. Adult, NOT/kg: 1 tab 12H before meal oral."},{"id":"fs-0849","name":"Estazolam","dosage":"0.02-0.1 mg/kg (adult 1-4mg) at night oral."},{"id":"fs-0850","name":"Estradiol","dosage":"See oestradiol."},{"id":"fs-0851","name":"Estramustine","dosage":"200mg/m2 8H oral (avoid milk)."},{"id":"fs-0852","name":"Estriol","dosage":"See oestriol, and oestradiol + oestriol."},{"id":"fs-0853","name":"Estrogens","dosage":"See oestrogens."},{"id":"fs-0854","name":"Estrone","dosage":"See oestrone."},{"id":"fs-0855","name":"Estropipate","dosage":"1 mg \\"' 0.83mg piperazine oestrone sulphate. Not/kg: induction puberty 0.19mg daily oral, increase over 2-3yr to 1.5mg (add progestogen for 12 days per cycle); vasomotor symptoms or vaginal atrophy 0.75-6mg daily; hypogonadism 1.5-9mg daily for 21 days of 31-day cycle; osteoporosis 0.75mg daily for 25 days of 31-day cycle."},{"id":"fs-0856","name":"Eszopiclone","dosage":"Adult, NOT/kg: 1mg (1-3mg) at night oral. Etamsylate, 12.5mg/kg (adult 500mg) 6H oral."},{"id":"fs-0857","name":"Etanercept","dosage":"0.4mg/kg (max 25mg) x2/wk, or 0.8mgikg (max 50mg) wkly SC."},{"id":"fs-0858","name":"Eteplirsen","dosage":"30mg/kg every week IV over 35-60min; trial of 30mg/kg daily in progress."},{"id":"fs-0859","name":"Ethacrynic acid","dosage":"IV: 0.5-1mg/kg (adult 25-50mg) 12-24H. Oral: 1-4mg/kg (adult 50-200mg) 12-24H."},{"id":"fs-0860","name":"Ethambutol hydrochloride","dosage":"25mg/kg daily for Swk oral, then 15 mg/kg daily or 35mg/kg x3/wk. IV: 80% oral dose."},{"id":"fs-0861","name":"Ethamsylate","dosage":"12.5mg/kg (max 500mg) 6H oral, 1M, IV."},{"id":"fs-0862","name":"Ethanol","dosage":"10% ethanol 8ml/kg IV over 1 hr, then O.Sml/kg/hr (child) 1.4ml/kg/hr (adult) 2ml/l\\\\g/hr (drinker) so blood ethanol 1-1.5mg/ml (22-33rnmoi/L) until ethylene glycol <0.2g/L (3.2mmoi/L) or methanol <0.2g/L (6.2mmoi/L)."},{"id":"fs-0863","name":"Ethanol, dehydrated (1 00%)","dosage":"Vessel sclerosis: inject max of 1 ml/kg."},{"id":"fs-0864","name":"Ethanolamine oleate","dosage":"5% solution, Adult, NOT/kg: 1.5-Sml per varix (max 20m I per treatment)."},{"id":"fs-0865","name":"Ethchlorvynol","dosage":"10-20mg/kg (adult 0.5-1g) at night oral."},{"id":"fs-0866","name":"Eihinyloestradiol","dosage":"10-50mcg daily for 21 days per month. See also cyproterone; desogestrel."},{"id":"fs-0867","name":"Ethinyloestradiol + ethynodiol diacetate","dosage":"(50mcg/0.5mg or 50/1) x 21 tab, + 7 inert tab. Contraception: 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0868","name":"Ethinyloestradiol + gestodene","dosage":"(30/75mcg, 20/75) x 21 tab+ 7 inert tab. 1 daily, starting 1st day of menstruation."},{"id":"fs-0869","name":"Ethinyloestradiol + gestodene","dosage":"30/50mcg x6 + 40/70 x5 + 30/100 x1 0 +inert x7 tab. 1 tab daily, starting 1st day of menstruation. Page 39"},{"id":"fs-0870","name":"Ethinyloestradiol + levonorgestrel","dosage":"(30/150mcg, 50/125) x 21 tab,+ 7 inert tab. Contraception: 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0871","name":"Ethinyloestradiol + levonorgestrel","dosage":"20mcg/0.15mg x42, 25/0.15 x21, 30/0.15 x21, 10/0 x7 tab. Contraception: 1 tab daily starting 1 '1 day of menstruation."},{"id":"fs-0872","name":"Ethinyloestradiot + levonorgestrel","dosage":"30/150mcg x 84 tab, then either 7 inert or 7 ethinyloestradol 10 meg tab. Contra ception: 1 daily, starting 1st day menstruation."},{"id":"fs-0873","name":"Ethinyloestradiol + levonorgestrel","dosage":"30/50mcg x6 + 40/75 x5 + 30/125 x10 +inert x7 tab. 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0874","name":"Ethinyloestradiol + norelgestromin","dosage":"20/150mcg or 33.9mcg/203mcg or 0. 75mg/6mg patches. Contraception: apply 1 patch wkly x3, wk 4 patch-free."},{"id":"fs-0875","name":"Ethinyloestradiol + norethisterone","dosage":"(35mcg/0.25mg, 30/0.5, 35/0.5, 35/0.75, 20/1, 35/1 or 30/1.5) x 21 tab, + 7 inert tab. Contraception: 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0876","name":"Ethinyloestradiol + norethisterone","dosage":"2.5mcg/0.5mg, 5mcg/ 1 mg tab. Post-menopausal (NOT/kg): 1 tab daily oral."},{"id":"fs-0877","name":"Ethinyloestradiol + norethisterone","dosage":"20mcg/1 mg x 24 tab, + 4 inert tab. Contraception: 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0878","name":"Ethinyloestradiol + norethisterone","dosage":"35mcg/0.5mg x7 + 35/0.75 x7 + 35/1 x7+ inert x7 tab. Contraception: 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0879","name":"Ethinyloestradiol + norethisterone","dosage":"35mcg/0.5mg x7 + 35/1 x14 +inert x7 tab. Contraception: 1 daily, starting 1'1 day of menstruation."},{"id":"fs-0880","name":"Ethinyloestradiol + norethisterone","dosage":"35mcg/0.5mg x7 + 35/1 x9 + 35/0.5 x5 +inert x? tab. Contraception: 1 tab daily, starting 1st day of menstruation."},{"id":"fs-0881","name":"Ethinyloestradiol 10Omcg + levonorgestrel 0.5mg","dosage":"Post coital: first dose within 72hr, repeated after 12H."},{"id":"fs-0882","name":"Ethinyloestradiol 20mcg + levonorgestrel 90mcg","dosage":"Contra ception: 1 tab daily (with no hormone-free interval)."},{"id":"fs-0883","name":"Ethionamide","dosage":"TB: 15-20mg/kg (max 1g) at night oral. Lep rosy: 5-Bmg/kg (max 375mg) daily."},{"id":"fs-0884","name":"Ethoheptazine","dosage":"3mg/kg (adult 150mg) 6-SH oral."},{"id":"fs-0885","name":"Ethosuximide","dosage":"5mg/kg (max 250mg) daily oral, increase by 50% each wk to max 40mg/kg (max 2g) daily. Trough level 0.3- 0.7mmoi/L."},{"id":"fs-0886","name":"Ethotoin","dosage":"5mg/kg (adult 250mg) 6H oral, increase to max 15mg/kg (adult 750mg) 6H."},{"id":"fs-0887","name":"Ethyl chloride","dosage":"Spray on affected area from a distance of 10- 20cm for 3-7sec (bottle) or 4-10sec (aerosol can)."},{"id":"fs-0888","name":"Ethynodiol","dosage":"See ethinyloestradiol + etl1ynodiol diacetate."},{"id":"fs-0889","name":"Etidocaine","dosage":"0.5%-1.5% solution: max 6mg/kg (0.6ml/kg of 1%) parenteral, or 8mg/kg (O.Sml/kg of 1%) with adrenaline."},{"id":"fs-0890","name":"Etidronate","dosage":"5-20mg/kg daily oral (no food for 2H before and"},{"id":"fs-0891","name":"I after dose) for max 6mo","dosage":"IV: 7.5mg/kg daily for 3-7 days."},{"id":"fs-0892","name":"Elidonale + calcium citrate","dosage":"Etidronate 400mg tab daily 14 days, then calcium citrate 500mg daily for 76 days oral."},{"id":"fs-0893","name":"Etodolac","dosage":"4-8mg/kg (adult 200-400mg) 6-SH oral."},{"id":"fs-0894","name":"Etomidate","dosage":"0.3mg/kg slow IV."},{"id":"fs-0895","name":"Etonogestrel","dosage":"68mg sub-dermal implant lasts 3yr."},{"id":"fs-0896","name":"Etoposide","dosage":"50-60mg/m2 IV over 1 hr daily for 5 days, repeat after 2-4wk. Oral dose 2-3 times IV dose."},{"id":"fs-0897","name":"Etoricoxib","dosage":"Adult, NOT/kg. 60-90mg daily oral. Gout: 120 mg daily, max 8 days."},{"id":"fs-0898","name":"Etravirine (ETR)","dosage":"4mg/kg (adLrlt 200mg) 12H oral after meal."},{"id":"fs-0899","name":"Etretinate","dosage":"0.25mg/kg 8-12H oral for 2-4wk, then 6H (max 75mg daily) if required for 6-Swk, then 12. 24H."},{"id":"fs-0900","name":"Etynodiol diacetate","dosage":"Contraception: 500mcg daily oral, starting 1 '1 day of menstruation."},{"id":"fs-0901","name":"Everolimus","dosage":"Adult, NOT/kg:10mg (5mg if toxicity) daily oral."},{"id":"fs-0902","name":"Evolocumab","dosage":"2:12yr, NOT/kg: 140mg every 2wk, or 420mg monthly SC."},{"id":"fs-0903","name":"Exemestane","dosage":"Adult, NOT/kg: 25mg daily oral."},{"id":"fs-0904","name":"Exenatide","dosage":"Adult, NOT/kg: 5mcg SC before moming and evening meals, increase if required to 10mcg/dose after 1 mo; extended release 2mg SC wkly."},{"id":"fs-0905","name":"Ezetimibe","dosage":"Adult, NOT/kg: 10mg daily oral. See atorvastatin."},{"id":"fs-0906","name":"Ezetimibe + rosuvastatin","dosage":"10/5mg, 10/10, 10/20, 10/40. 10/5 mg tab daily oral, adjust 4wkly to 10/20mg (max 10/40) daily."},{"id":"fs-0907","name":"Ezetimibe + simvastatin","dosage":"10/20mg, 10/40 or 10/80 tab. Adult, NOT/kg: 10/20mg tab daily oral, increase strength 4wkly if required. See simvastatin for drug interactions."},{"id":"fs-0908","name":"Factor 2","dosage":"See factor 9 complex."},{"id":"fs-0909","name":"Factor 7a, recombinant (rFVIIa)","dosage":"Usually 90mcg/kg IV 2H until haemostasis, then 3-6H. See also factor 9 complex. Factor 8 concentrate (vial 200-250u), recombinant anti haemophilic factor (rAHF). Joint 20u/kg, psoas 30u/kg, cerebral 50u/kg. 2 x dose(u/kg) %normal activity, eg 35u/kg gives peak level of 70% normal. See also Von Willebrand factor I Factor VII concentrate."},{"id":"fs-0910","name":"Factor 8 inhibitor bypassing fraction","dosage":"Factors 2,7,8,9,10, IV max 2u/kglmin: joint 50u/kg 12H, mucous mem 50u/kg 6H, soft tissue 100u/kg 12H, cerebral100u/kg 6-12H."},{"id":"fs-0911","name":"Factor 9","dosage":"IV infusion (max 2u/kg/min): minor hge 25u/kg daily, joint 40u/kg 12-24H, surgery 50u/kg stat then 30u/kg 12- 24H, major surgery 85u/kg stat then 50u/kg 12-24H. Pro ph: 25-40u/kg x2/wk (trough >1u/dl). See also factor 9 complex."},{"id":"fs-0912","name":"Factor 9 complex (Beriplex, Ocatplex)","dosage":"Factors 2, 7, 9, 10, protein C, protein S: approx 25u/ml. 1 mlkg (INR 2. 3.9) 1.4mltkg (INR 4-6) 2 ml/kg (INR >6) + phytomenadione (if reversing warfarin)."},{"id":"fs-0913","name":"Factor 9 complex (Prothrombinex-VF)","dosage":"Factors 2, 9, 10 500u per 20ml vial, antithrombin Ill 25u/vial, low levels factor 5 and 7. 1ml/kg slow IV daily. Risk of thrombosis in acute liver failure. Reverse warfarin: 1-2ml/kg + phytomenadione (Vit K1) + FFP 5ml/kg."},{"id":"fs-0914","name":"Factor 10","dosage":"See factor 9 complex."},{"id":"fs-0915","name":"Factor 13","dosage":"Vial250u. Prophylaxis: 10uikg IV every 4wk. Pre op: up to 3u/kg just before surgery, then 10u/kg daily x5. Severe ~lge: 10-20u/kg daily."},{"id":"fs-0916","name":"Famciclovir","dosage":"Severe infection: 320mg/m2 (adult 500mg) 8H oral. Zoster, varicella: 160mg/m2 (adult 250mg) 8H oral for 7 days; immunocompromised 320mg/m2 (adult 500mg) 8H for 10 days. Genital herpes (adult, NOT/kg): 125mg 12H oral for 5 days (treat), 250mg daily (suppress) 12H; immunocompro mised 500mg 12H for 7 days (treat), 500mg daily (suppress)."},{"id":"fs-0917","name":"Famotidine","dosage":"0.5-1 mg/kg (adult 20-40mg) 12-24H oral. 0.5 mg/kg (max 20mg) 12H slow IV."},{"id":"fs-0918","name":"Famotidine 26.6mg + ibuprofen 800mg","dosage":"Adult 1 tab SH oral."},{"id":"fs-0919","name":"Fampridine","dosage":"Adult, NOT/kg: 10mg 12H oral."},{"id":"fs-0920","name":"Fat emulsion 20%","dosage":"See lipid emulsion."},{"id":"fs-0921","name":"Febuxostat","dosage":"Adult, NOT/kg: 80mg (max 120mg) daily oral."},{"id":"fs-0922","name":"Felbamate","dosage":"5mg/kg 6-8H (max 1200mg/day) oral, increase over 2- 3wk to 15mg/kg 6-8H (max 3600mg/day)."},{"id":"fs-0923","name":"Felbinac","dosage":"3% gel, foam: apply x2-4/day."},{"id":"fs-0924","name":"Felodipine","dosage":"0.1 mg/kg (adult 2.5mg) daily, increase if required to 0.5 mg/kg (adult 10mg) daily oral."},{"id":"fs-0925","name":"Fenbufen","dosage":"10mg/kg (adult 450mg) 12H oral."},{"id":"fs-0926","name":"Fenofibrate, fenofibric acid","dosage":"Adult, NOT/kg: 135-200mg daily oral (better absorption with micronised caps)."},{"id":"fs-0927","name":"Fenoglide","dosage":"Adult, NOT/kg: 40-120mg daily oral."},{"id":"fs-0928","name":"Fenoldopam","dosage":"0.1 meg/kg/min IV infusion increase gradually if required every 15-30min to max 1.6mcg/kg/min."},{"id":"fs-0929","name":"Fenoprofen","dosage":"4mg/kg (adult 200mg) 6-8H oral, may increase gradually to 12mg/kg/dose (max 800mg)."},{"id":"fs-0930","name":"Fenoterol","dosage":"Oral: 0.1 mg/kg 6H. Resp solution 1mg/ml: 0.5ml diluted to 2m I 3-6H (mild), -1 ml diluted to 2m I 1-2H (moder ate), undiluted continuous (severe, in ICU). Aerosol (200mcg/puff): 1-2 puffs 4-8H."},{"id":"fs-0931","name":"Fentanyl","dosage":"Not ventltd: 1-2 meg/kg (adult 50-100mcg) IM or IV; infusion 2-4mcg/kg/hr (<10kg 100mcg/kg in 50ml at 1-2ml/hr; >10kg amp 50mcg/ml at 0.04. 0.08ml/kg/hr). Ventilated: 5-10 meg/kg stat or 50mcg/kg IV over 1 hr; infusion 5-10mcg/kg/hr (amp 50mcg/ml at 0.1-0.2ml/kg/hr). Adult, NOT/kg: patch (lasts 72hr) 25mcg/hr, increase if required by 25mcg/hr every 3 days; lonsys 40mcg max x6/hr. Transmucosal tabs (adult, NOT/kg): 100mcg between cheek and upper gum until disolved (15-30 min) 4-8H, increase if required to max 800mcg 4H. Buccal film: 200mcg increase to max 1200mcg x4/day. Nasal spray (adult, NOT/kg): 50, 100 or 200mcg doses titrated to response. Epidural: 0.5 meg/kg stat, or 0.4mcg/kg/hr."},{"id":"fs-0932","name":"Fenticonazole vaginal pessaries","dosage":"600mg nocte once, or 200mg nocte for 3 nights."},{"id":"fs-0933","name":"Ferric carboxymaltose","dosage":"15mg/kg (max 750mg) IV over 15 Page 42 min, repeated after >J days."},{"id":"fs-0934","name":"Ferric citrate","dosage":"Adult, NOT/kg: 2g (420mg ferric iron) 8H oral, titrated to serum phosphate 1.1-1.8mmoi/L (max 12g/day)."},{"id":"fs-0935","name":"Ferrous salts","dosage":"Prophylaxis 2mg/kg/day elemental iron oral, treatment 6mg/kg/day elemental iron oral. Fumarate 1 mg = 0.33mg iron. Gluconate 1mg = 0.12mg iron; so Fergon (60 mg/ml gluconate) prophylaxis 0.3mltkg daily, treatment 1ml/kg daily oral. Sulphate (dry) 1mg = 0.3mg iron; so Ferro Gradumet (350mg dry sulphate) prophylaxis 7mg/kg (adult 350mg) daily, treatment 20mg/kg (adult 1050mg) daily oral."},{"id":"fs-0936","name":"Ferumoxides","dosage":"Fe 11.2mg/ml. 0.05ml/kg (Fe 0.56mg/kg) in 2ml/kg (adult 100ml) 5% dextrose IV over 30min."},{"id":"fs-0937","name":"Ferumoxytol","dosage":"510mg in 17ml, total dose (ml) = 0.08 x Wt in kg x (15 --Hb in g/dl) IV over 1 min; adult 510mg IV stat and in 3-8 days. Fesoterodine, Adult, NOT/kg: 4-Bmg daily oral."},{"id":"fs-0938","name":"Fexofenadine","dosage":"NOT/kg: 30mg 12H (6-11yr), 60mg 12H or 180mg daily (>11 yr) oral."},{"id":"fs-0939","name":"Fibrin glue","dosage":"See thrombin glue."},{"id":"fs-0940","name":"Fibrinogen concentrate","dosage":"70mg/kg IV; or mg/kg = (target measured g/L) I 0.017 = (target- measured mg/dL) I 1.7; usual target 1g/L (100mg/dL), severe hge 1.5g/L. (150mg/dl). Fibrinolysin 8-10u/ml + desoxyribonuclease 500-667 u/ml. Ointment or solution: apply topically 6--24H."},{"id":"fs-0941","name":"Fidaxomicin","dosage":"Gl activity only: 5mg/kg (adult 200mg) 12H oral."},{"id":"fs-0942","name":"Filgrastim (granulocyte CSF)","dosage":"Idiopathic or cyclic neutro paenia: 5mcg/kg daily SC or IV over 30m in. Gong neutro paenia: 12mcg/kg daily SC or IV over 1 hr. Marrow trans: 20- 30mcg/kg daily 1Vover4-24H, reduce if neutrophil >1x109/L."},{"id":"fs-0943","name":"Finasteride","dosage":"Adult, NOT/kg. Prostatic hyperplasia: 5mg daily oral. Alopecia: 1 mg daily oral."},{"id":"fs-0944","name":"Fingolimod","dosage":"Adult, NOT/kg: 0.5mg daily oral."},{"id":"fs-0945","name":"Flavocoxid","dosage":"Adult, NOT/kg: 250-500mg 12H oral."},{"id":"fs-0946","name":"Flavoxate","dosage":"2-4mg/kg (adult 100-200mg) 6-8H, or single dose at bedtime oral."},{"id":"fs-0947","name":"Flecainide","dosage":"2-3mg/kg (max 100mg) 12H oral, may increase over 2wk to 7mg/kg (max 200mg) 8-12H. IV in 5%0 over 30min: 0.5-2mg/kg (max 150mg) 12H."},{"id":"fs-0948","name":"Flibanserin","dosage":"Adult, NOT/kg: 100mg daily oral."},{"id":"fs-0949","name":"Floxuridine (FUDR)","dosage":"100-300mcg/kg/day by constant intra arterial infusion (400-600mcg/kg/day in hepatic artery). Stop if wee <3500/mm3 or platelets <1 00,000/mm'-"},{"id":"fs-0950","name":"Fiucloxacillin","dosage":"Oral: 12.5-25mg/kg (adult 250-500mg) 6H. IM or IV: 25mg/kg (adult 1g) 6H. Severe inftn: 50mg/kg (adult 2g) IV 12H (1st wk life), 8H (2-4 wk), 6H or constant infusion (>4 wk). Surgery: 50mg/kg at inductn. See also ampicillin + flucl."},{"id":"fs-0951","name":"Fluconazole","dosage":"12mg/kg (adult 200-400mg) daily IV, higher doses if very severe infection; if haemofiltered 12mg/kg (adult 600mg) 12H; neonate 12mg/kg 72H (<14 days) 48H (15-28 days). Superficial inftn: Gmg/kg (adult 200mg) stat, Page 43 then 3mg/kg (adult 100mg) daily oral or IV."},{"id":"fs-0952","name":"Flucytosine (5-fluorocytosine)","dosage":"400-1200mg/m2 (max 2g) 6H"},{"id":"fs-0953","name":"IV over 30 min, or oral","dosage":"Peak level 50-10Omcg/ml, trough 25- 50mcg/ml (x7.75=umoltL)."},{"id":"fs-0954","name":"Fludarabine","dosage":"25mg/m2 daily x5 IV over 30m in, every 28 days."},{"id":"fs-0955","name":"Fludrocortisone acetate","dosage":"150mcg/m2 daily oral. Fludrocor tisone 1 mg = hydrocortisone 125mg in mineralocorticoid activity, 10mg in glucocorticoid."},{"id":"fs-0956","name":"Flumazenil","dosage":"5mcg/kg every 60sec IV until awake (max total 50 meg/kg, adult 2mg); then 2. 10mcg/kg/hr if overdose."},{"id":"fs-0957","name":"Flumetasone","dosage":"See clioquinol + flumetasone."},{"id":"fs-0958","name":"Flunarizine","dosage":"Adult, NOT/kg: 10mg daily oral, reducing to 5 days/wk with two successive days off."},{"id":"fs-0959","name":"Flunisolide","dosage":"Asthma (250mcg/puff): 1-2 puffs 12H. Nasal (25mcg/puff): 1-2 puffs/nostrii8. 24H."},{"id":"fs-0960","name":"Flunitrazepam","dosage":"Adult, NOT/kg: 0.5-2mg at night, oral."},{"id":"fs-0961","name":"Fluocinolone","dosage":"See fluocinonide."},{"id":"fs-0962","name":"Fluocinonide","dosage":"0.025%, 0.05% cream or oint: apply 5. 12H."},{"id":"fs-0963","name":"Fluocortolone","dosage":"0.25% cream, ointment: apply 8-12H."},{"id":"fs-0964","name":"Fluorescein","dosage":"1%, 2% drops: 1 drop/eye. 10% (1 00 mg/ml), 25% (250mg/ml): 8mg/kg (max 500mg) IV."},{"id":"fs-0965","name":"Fluorescein 0.25% + oxybuprocaine 0.4%","dosage":"1 drop/eye."},{"id":"fs-0966","name":"Fluoride","dosage":"0.25mg (<3yr) 0.5mg (3-6yr) 1 mg (>6yr) daily oral. See also sodium fluoride. 5-Fluorocytosine. See flucytosine. 9-alpha-fluorohydrocortisone. See fludrocortisone."},{"id":"fs-0967","name":"Fluorometholone","dosage":"0.1% solution: 1 drop/eye 6-12H."},{"id":"fs-0968","name":"Fluorouracil","dosage":"15mg/kg (max 1 g) IV over 41lr daily until side effects, then 5-10mg/kg wkly. See also adrenaline + fluoro uracil; and folinic acid."},{"id":"fs-0969","name":"Fluothane","dosage":"Induction 0.5-4%, then 0.5-1.5% inhalation."},{"id":"fs-0970","name":"Fluoxetine","dosage":"0.5mg/kg (max 20mg) daily, increase to max 1mg/kg (max 40mg) 12H oral. Weekly 90mg cap: 1 per wk."},{"id":"fs-0971","name":"Fluoxetine + olanzapine","dosage":"25mg/6mg, 25/12, 50/6 or 50/12 tab. Adult, NOT/kg: 1 cap daily oral."},{"id":"fs-0972","name":"Fluoxymesterone","dosage":"0.1-0.2mg/kg (adult 5-10mg) daily oral."},{"id":"fs-0973","name":"Flupenthixol","dosage":"Oral: 0.05-0.2mg/kg (adult 3-9mg) 12H. Depot IM: usually 0.4-0.Smg/kg (up to 5mg/kg, max 300 mg) every 2-4wk (1 mg flupenthixol deconate = 0.625mg fluphenazine decanoate = 1.25mg haloperidol)."},{"id":"fs-0974","name":"Flupentixol","dosage":"See flupenthixol."},{"id":"fs-0975","name":"Fluphenazine","dosage":"0.02-0.2mg/kg (adult 1-10mg) 8-12H oral."},{"id":"fs-0976","name":"Flurandrenolide","dosage":"See flurandrenolone."},{"id":"fs-0977","name":"Flurandrenolone","dosage":"0.025%, 0.05% cream, ointment or lotion: apply 6-24H. 4mcg/m2 tape: apply 12H."},{"id":"fs-0978","name":"Flurazepam","dosage":"Adult, NOT/kg: 15-30mg at night, oral."},{"id":"fs-0979","name":"Flurbiprofen","dosage":"1-2mgikg (adult 50-100mg) 8H oral or PR. 0.03% drops: 1 drop/eye every 30min x4 doses."},{"id":"fs-0980","name":"Flutamide","dosage":"Adult, NOT/kg: 250mg 8H oral."},{"id":"fs-0981","name":"Fluticasonefuroate","dosage":"NOT/kg: inhale 100mcg daily, increase to Page 44 200mg daily after 2wk if required."},{"id":"fs-0982","name":"Fluticasone furoate + vilanterol","dosage":"NOT/kg 1 00/25mcg inhaled daily."},{"id":"fs-0983","name":"Fluticasone propionate","dosage":"NOT/kg. 50-100mcg (child), 100- 500 meg (adult) 12H inhaled. 0.05% solution: 1-4 sprays/nostril daily. 0.05% cream: daily. See also azelastine, eformoterol."},{"id":"fs-0984","name":"Fluticasone propionate+ formoterol","dosage":"50/5mcg, 125/5, 250/10 MDI. e:12yr (NOT/kg): 1-2 puffs 12H inhaled."},{"id":"fs-0985","name":"Fluticasone propionate+ salmeterol","dosage":"NOT/kg. Accuhaler: 100/50mcg (child), 250/50 or 500/50 (adult) x1-2 inhltn 12H. MDI: 50/25 (child), 125/25or250/25(adult) 1-2inhltn 12H."},{"id":"fs-0986","name":"Fluvastatin","dosage":"0.4mg/kg (adult 20mg) nocte oral, increase to 0.8 mg/kg (adult40mg) 12H if required. Slow relse: 80mg nocte."},{"id":"fs-0987","name":"Fluvoxamine","dosage":"0.5mg/kg (max 25mg) daily oral, increase slowly if required to max 2mg/kg (adult 100mg) 8-24H. Slow-release (adult, NOT/kg): 100-300mg at night oral."},{"id":"fs-0988","name":"Folic acid","dosage":"NOT/kg. Deficiency: 50mcg (neonate), 0.1-0.25mg (<4yr), 0.5-1mg (>4yr) daily IV, IM, SC or oral. Metabolic dis: 5mg/day. Pregnancy: 0.5mg (high risk 4mg) daily oral. With methotrexate (NOT/kg): 5mg wkly on different day to MTX."},{"id":"fs-0989","name":"Folinate or folinic acid","dosage":"See calciurn folinate."},{"id":"fs-0990","name":"Follicle stimulating hormone (FSH)","dosage":"Adult, NOT/kg, monitor urinary oestrogen. Anovulation: usually 50-150iu SC daily for 9-12 days. Superovulation (2wk after starting GnRH agonist): 1 00-225iu/kg daily starting day 3 of cycle."},{"id":"fs-0991","name":"Follitropin alpha, beta","dosage":"See follicle stimulating hormone."},{"id":"fs-0992","name":"Follitropin alta 150iu + lutropin alfa 75iu","dosage":"1 vial daily SC."},{"id":"fs-0993","name":"Fomepizole","dosage":"15mg/kg load, then 10mg/kg 12H for 48hr, then 15mg/kg 12H IV until ethylene glycol <0.2g/L (3.2mmoi/L) or methanol <0.2g/L (6.2mmoi/L)."},{"id":"fs-0994","name":"Fomivirsen","dosage":"lntravitreal injection, Adult, NOT/kg. New disease: 165mcg/eye wkly x3, then every 2wk. Previously treated: 330mcg/eye stat, in 2wk, then every 4wk."},{"id":"fs-0995","name":"Fondaparin","dosage":"Adult, NOT/kg: 2.5mg SC 6hr postop, t11en daily for 5-9 days; HIT 7.5mg daily SC."},{"id":"fs-0996","name":"Fondaparinux","dosage":"See fondaparin."},{"id":"fs-0997","name":"Formestane","dosage":"Adult, NOT/kg: 250mg 2wkly deep IM."},{"id":"fs-0998","name":"Formoterol","dosage":">4yr (NOT/kg). Powder: 12mcg inhalation 12H."},{"id":"fs-0999","name":"Solutn: 20mcg in 2ml nebulised 12H","dosage":"See also budesonide."},{"id":"fs-1000","name":"Formoterol + glycopyrrolate","dosage":"4.8/9mcg MDI. 2 puffs 12H."},{"id":"fs-1001","name":"Formoterol + mometasone","dosage":"5/10Omcg, 5/200. MDI2 puffs 12H."},{"id":"fs-1002","name":"Fosamprenavir (FPV)","dosage":"?.2yr: 30mg/kg (max 1400mg) 12H oral. Amprenavir trough ?.400ng/ml. See also efavirenz."},{"id":"fs-1003","name":"Fosamprenavir + ritonavir","dosage":"<o6yr: FPV 18mg/kg (max ?00 mg) + RTV 3mg/kg (max 100mg) 12H oral. If >18yr can use FPV 1400mg + RTV 200mg (na\\"lve) 100mg (past Rx) daily."},{"id":"fs-1004","name":"Fosaprepitant","dosage":"Adult, NOT/kg: 125mg oral or IV over 15min on day 1, then 80mg on day 2 and day 3."},{"id":"fs-1005","name":"Foscarnet","dosage":"20mg/kg IV over 30min, then 200mg/kg/day by constant IV infusion (less if creatinine >0.1 i mmoitL) or 60 Page 45 mg/kg 8H IV over 2H. Chronic use: 90-120mg/kg IV over 2H daily."},{"id":"fs-1006","name":"Fosfestrol","dosage":"Adult, NOT/kg. Initial: 0.5g IV over 1H day 1, then 1g x5 days. Maintenance: 120-240mg 8H oral, later reducing to 120-240mg daily."},{"id":"fs-1007","name":"Fosfomycin","dosage":"5.63g (3g base) sachet mixed with water oral."},{"id":"fs-1008","name":"Fosinopril","dosage":"0.2-0.8mg/kg (adult 10-40mg) daily oral."},{"id":"fs-1009","name":"Fosphenytoin","dosage":"75mg = 50mg pheny1oin (qv). Prescribed and dispensed as phenytoin equivalents."},{"id":"fs-1010","name":"Fospropofol","dosage":"Usually 6.5mg/kg IV, then 1.6mg/kg no more frequently than every 4min (0.3-0.4mg/kg/min)."},{"id":"fs-1011","name":"Fotemustine","dosage":"IV over 1 hr, or lA over 4hr: 100mg/m2 weekly x3, rest 4-5wk, then every 3wk."},{"id":"fs-1012","name":"Framycetin sulfate (Soframycin)","dosage":"Subconjunctival: 500mg in 1 ml water daily x3 days. Bladder: 500mg in 50ml saline 8H x10 days. 0.5%: eye 1drop 8H, ear 3drops 8H, ointment 8H."},{"id":"fs-1013","name":"Framycetin sulfate 15mgig + gramicidin 0.05mg/g","dosage":"Cream, oint (Soframycin topical): apply 8-12H. See dexamethasone."},{"id":"fs-1014","name":"Frangula 8% +sterculia 62%","dosage":"NOT/kg: 1-2 sachets (or 1-2 5ml spoonfuls) 12-24H oral."},{"id":"fs-1015","name":"Fresh frozen plasma","dosage":"Contains all clotting factors. 10-20 mlikg IV. A bag is about 230ml."},{"id":"fs-1016","name":"Frovatriptan","dosage":"Adult, NOT/kg: 2.5mg oral (max 7.5tng/day)."},{"id":"fs-1017","name":"Frusemide","dosage":"Usually 0.5-1 mg/kg (adult 20-40mg) 6-24H (daily if preterm) oral, IM, or IV over 20min (max 0.05mglkglmin"},{"id":"fs-1018","name":"IV)","dosage":"IV infusion: 0.1. 1mg/kg/hr (<20kg 25 mg/kg in 50ml 0.9% saline wiU1 heparin 1 u/ml at 0.2-2 ml/hr; >20kg amp 10mg/ml at 0.01-0.1 mlkg/hr); protect from light."},{"id":"fs-1019","name":"Fuller's earth","dosage":"2g/kg (adult 150g) 15% in water."},{"id":"fs-1020","name":"Fulvestrant","dosage":"Adult, NOT/kg: 250mg IM once a month."},{"id":"fs-1021","name":"Furazolidone","dosage":"2mg/kg (adult 100mg) 6H oral7-10day."},{"id":"fs-1022","name":"Furosemide","dosage":"See frusemide."},{"id":"fs-1023","name":"Fusafungine","dosage":"125mcg spray: oral1spray/10kg (adult 5 sprays) x5/day, nasal1spray/20kg (adult 3sprays) x5/day."},{"id":"fs-1024","name":"Fusidate, sodium","dosage":"See sodium fusidate."},{"id":"fs-1025","name":"Fusidic acid","dosage":"Fusidic acid (susp) absorption only 70% that of sodium fusidate (tabs). Suspension: 15-20mg/kg (adult 750mg) 8H oral. Eye %: 1 drop/eye 12H. For tablets and IV, See sodium fusidate."},{"id":"fs-1026","name":"Gabapentin","dosage":"Anticonvulsant: 10mg/kg (adult 300mg) once day 1 oral, 12H day 2, 8H day 3; then adjusted to 10-20 mg/kg 8H (max 2.4g/day). Premed: 25mg/kg (adult 1200mg) 1 hr preop. Analgesia: 2mg/kg (adult 100mg) 8H, increase if required to 15mg/kg (adult 800mg) or higher 8H if tolerated. Adult, NOT/kg with evening meal oral: restless legs 600mg daily, postherp neur 300mg increase over 4wk to 1800mg daily."},{"id":"fs-1027","name":"Gadobutrol","dosage":"0.1 mmoltkg IV."},{"id":"fs-1028","name":"Gadopentetic acid","dosage":"Adult, NOT/kg. 2mmoi/L inj: finger 1-2ml, wrist 4ml, ankle-elbow-hip-shoulder 10-20ml, knee 25-50ml."},{"id":"fs-1029","name":"Gadoteridol","dosage":"0.1 (max 0.3) mmol/kg IV. Page 46"},{"id":"fs-1030","name":"Gadoxetic acid","dosage":"0.25mmol (181.43mg) per ml: 0.1ml/kg IV."},{"id":"fs-1031","name":"Galantamine","dosage":"Adult, NOT/kg: 4mg 12H for 4wk, then 8mg 12H, increase after 4wk if required to 12mg 12H oral."},{"id":"fs-1032","name":"Gallamine","dosage":"1-2mg/kg (adult 50-100mg) IV."},{"id":"fs-1033","name":"Gallium nitrate","dosage":"1 00-200mg/m2/day x5days constant IV infusion."},{"id":"fs-1034","name":"Galsulfase","dosage":"1 mg/kg (to nearest 5mg) weekly IV over 4-20hr."},{"id":"fs-1035","name":"Gamma benzene hexachloride","dosage":"See lindane."},{"id":"fs-1036","name":"Gamma globulin","dosage":"See immunoglobulin. Gamma hydroxybutyrate See sodium oxybate. Gamolenic acid, 2-5mg/kg (adult 120-240mg) 12H oral."},{"id":"fs-1037","name":"Ganciclovir","dosage":"5mg/kg 12H IV over 1 hr for 2-3wk; then 5mg/kg IV daily, or 6mg/kg IV on 6 days/wk, or 20 mg/kg (adult 1 g) 8H oral. Congenital CMV: 7.5mg/kg 12H IV over 2H."},{"id":"fs-1038","name":"Ganirelix","dosage":"Adult, NOT/kg: 0.25mg daily SC from day 6 of FSH to day of ovulation induction."},{"id":"fs-1039","name":"Gas gangrene (Clostridia) antitoxin","dosage":"Prophylaxis: 25,000u"},{"id":"fs-1040","name":"IM or IV","dosage":"Treatment: 75,000-150,000u IV over 1 hr, repeat x1- 2 after 8-12H; if severe also give 100,OOOu IM."},{"id":"fs-1041","name":"Gatifloxacin","dosage":"8mg/kg (adult 400mg) daily IV over 1 hr."},{"id":"fs-1042","name":"Gonorrh: 8mg/kg (adult 400mg) once","dosage":"0.3% ophthalmic: 1 drop/eye 2H when awake days 1-2, then x4/day days 3-7."},{"id":"fs-1043","name":"Gaviscon","dosage":"See alginic acid."},{"id":"fs-1044","name":"Gefitinib","dosage":"Adult, NOT/kg: 250mg daily oral."},{"id":"fs-1046","name":"Gemcitabine","dosage":"1g/m2 IV over 30m in wkly for 3wk, rest for 1wk, then repeat 4wk cycle."},{"id":"fs-1047","name":"Gemeprost (PGE1 analogue)","dosage":"Cervical dilatation: 1 pessary (1 mg) into posterior vagina 3hr before surgery. Termination: 1 pessary (1 mg) into posterior vagina 3H (max 5 pessaries)."},{"id":"fs-1048","name":"Gemfibrozil","dosage":"10mgikg (max 600mg) 12H oral."},{"id":"fs-1049","name":"Gemifloxacin","dosage":"Adult, NOT/kg: 320mg daily oral."},{"id":"fs-1050","name":"Gemtuzumab ozogamicin","dosage":"9mg/m2 IV over 2H, repeated after 14 days."},{"id":"fs-1051","name":"Gentamicin","dosage":"IV or IM. 1wk-10yr: 8mg/kg day 1, then 6 mg/kg daily. >10yr: 7mg/kg day 1, then 5mg/kg (max 240-360mg) daily. Neonate, 5mg/kg dose: <1200g 48H (0-7 days of life), 36H (8-30 days), 24H (>30 days); 1200-2500g 36H (0-7 days of life), 24H (>7 days); term 24H (0-7 days of life), then as for 1wk-10yr. Trough level <1.0mg/L."},{"id":"fs-1052","name":"Gentamicin, eye drops","dosage":"0.3% 1 drop/eye every 15m in if severe, reducing to 1drop 4-6H."},{"id":"fs-1053","name":"Gestodene","dosage":"See ethinyloestradiol + gestodene."},{"id":"fs-1054","name":"Geslrinone","dosage":"Adult, NOT/kg: 2.5mg x2/wk un day 1 and 4 of menstrual cycle, then on same days each wk."},{"id":"fs-1055","name":"Gestronol","dosage":"Adult, NOT/kg: 200-400mg every 5-7 days IM."},{"id":"fs-1056","name":"Getfitinib","dosage":"Adult, NOT/kg: 250mg daily oral."},{"id":"fs-1057","name":"Gimeracil","dosage":"See tegafur."},{"id":"fs-1058","name":"Ginkgo biloba","dosage":"Adult, NOT/kg: 1200mg 12H oral. Gtatiramer, Adult, NOT/kg: 20mg daily SC."},{"id":"fs-1059","name":"Glibenclarnide","dosage":"Adult, NOT/kg: initially 2.5mg daily oral, max Page 47 20mg daily."},{"id":"fs-1060","name":"Glibenclamide + metformin","dosage":"Adult, NOT/kg: 1.25/250mg 12- 24H oral, increase if required to 2.5/500 or 5/500 (max 10/1000) 12H."},{"id":"fs-1061","name":"Gliclazide","dosage":"Adult, NOT/kg: initially 40mg daily oral, max 160mg 12H."},{"id":"fs-1062","name":"Glimepiride","dosage":"Adult, NOT/kg: 2-4mg (max 6mg) daily oral."},{"id":"fs-1063","name":"Glimepiride + pioglitazone","dosage":"2/30mg or 4/30 tab. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-1064","name":"Glimepiride + rosiglitazone","dosage":"1/4mg, 2/4 or 4/4 tab. Adult, NOT/kg: 1-2 tab daily (max 4mg/8mg) oral."},{"id":"fs-1065","name":"Glipizide","dosage":"Adult, NOT/kg: 5mg daily oral, max 20mg 12H."},{"id":"fs-1066","name":"Gliquidone","dosage":"0.25-1mg/kg (adult 15-60mg) 8-12H oral."},{"id":"fs-1067","name":"Globulin","dosage":"See immunoglobulin."},{"id":"fs-1068","name":"Glucagon","dosage":"1u=1mg. 0.04mg/kg (adult 1-2mg) IV or IM stat, then 10-50mcg/kg/hr (0.5mg/kg in 50ml at 1-5mlthr) IV. Beta blocker overdose: 0.1 mg/kg IV stat, then 0.3-2mcg/kg/min."},{"id":"fs-1069","name":"Glucarpidase","dosage":"50u/kg IV over 5min."},{"id":"fs-1070","name":"Glucosamine","dosage":"Adult, NOTIkg: 1500mg daily oral."},{"id":"fs-1071","name":"Glucose","dosage":"See dextrose."},{"id":"fs-1072","name":"Glucose electrolyte solution","dosage":"Not dehydrated: 1 heaped teaspoon sucrose in large cup of water (4% sucrose= 2% glucose); do NOT add salt. Dehydrated: 1 sachet of Gastro lyte in 200ml water; give frequent sips, or infuse by NG tabe."},{"id":"fs-1073","name":"Glutamic acid","dosage":"10-20mg/kg (adult 0.5-1g) oral with meals."},{"id":"fs-1074","name":"Glutaraldehyde","dosage":"10% solution: apply to wart 12H."},{"id":"fs-1075","name":"Glyburide","dosage":"See glibenclamide."},{"id":"fs-1076","name":"Glycerin","dosage":"See sorbolene + glycerin cream."},{"id":"fs-1077","name":"Glycerol","dosage":"Suppos: 0.7-1g infant, 1.4-2g child, 2.8-4g adult."},{"id":"fs-1078","name":"Glycerol phenyl butyrate","dosage":"1.7-4.1g/m2 (1.5-3.7ml/m2 of 1.1g/ml) 8H with meal, oral. 1g=1.28g sod phenylbutyrate."},{"id":"fs-1079","name":"Glyceryl trinitrate","dosage":"Adult, NOT/kg: sublingual tab 0.3-0.9 mg/dose (lasts 30-G0min); sublingual aerosol 0.4-1.2 mg/ dose; slow-release buccal tab 1-10mg 8-12H; transdermal 0.5-5cm of 2% ointment, or 5-15mg patch 8-12H; anal fissure 2.5crn 0.4% oint 12H. IV infusion 0.5-5mcg/kg/min ( <30kg 3mg/kg in 50ml at 0.5-5ml/hr; >30kg 3mg/kg in 10Oml at 1-10ml/hr); use special non-PVC tabing. TY, 1-4min."},{"id":"fs-1080","name":"Glycopyrrolate","dosage":"Reduce secretions, treat bradycardia: 5-10 meg/kg (adult 0.2-0.4mg) 6-8H IV, IM. With 0.05mg/kg neo stigmine: 10-15rnc~;/kg IV. Anticholinergic: 0.02-0.04mg/kg (max 2mg) 8H oral. Inhaled (adult, NOT/kg): 50mcg or 15.6mcg cap daily. See fonnoterol."},{"id":"fs-1081","name":"Glycopyo alate + indacaterol","dosage":"15.6/27.5 mco inhale 1 cap 12H. 50/110mcg inhale 1 cap daily."},{"id":"fs-1082","name":"Glycopyrronium","dosage":"See glycopyrrolate."},{"id":"fs-1083","name":"GM-CSF","dosage":"See sargramostim."},{"id":"fs-1084","name":"Gold","dosage":"See auranofin, aurothioglucose, aurothiornalate."},{"id":"fs-1085","name":"Golimumab","dosage":"Adult, NOT/kg: 200mg SC, 100mg after 2wk, then 100mg every 4wk."},{"id":"fs-1086","name":"Gonadorelin (GnRH or LHRH)","dosage":"Pituitary function test, child or Page 48 adult: 10Omcg IV. See also leuprorelin."},{"id":"fs-1087","name":"Gonadotrophin","dosage":"See chorionic gonadtrn, and menotrophin."},{"id":"fs-1088","name":"Goserelin","dosage":"Adult, NOT/kg: 3.6mg SC every 28 days; implant 10.Smg SC every 12wk. See also bicalutamide. Gramicidin 0.025% + neomycin 0.25% + nystatin 100,000 u/g + triamcinolone 0.1%. Kenacomb ointment: apply 8- 12H. Kenacomb otic oint, drops: apply 8-12H (2-3 drops). Gramicidin 25mcg/ml +neomycin 2.5mg/ml +polymyxin B 5000u/ml (Neosporin). Eye drops: 1 drop/eye every 15-30 min, reducing to 6-12H. See also dexamethasone."},{"id":"fs-1089","name":"Granisetron","dosage":"0.02-0.04mg/kg (adult 1 mg) daily oral, IV over 5min. Chemotherapy: 0.04mg/kg (adult max 1-3mg) IV over 5min; up to 3 doses/day, at least 10min apart; adult 1 patch daily for up to 7 days starting 1-2 days before chemo. Granulocyte-macrophage colony stimulating factor (GM"},{"id":"fs-1090","name":"CSF)","dosage":"See lenograstim, sargramostim."},{"id":"fs-1091","name":"Grass allergen extract","dosage":"Sublingual, NOT/kg. Ora lair <:5yr: 100 IR day1, 200 IR day2, then 300 IR daily sublingual."},{"id":"fs-1092","name":"Timothy grass: 2800 BAU daily","dosage":"Ragweed: I tab daily."},{"id":"fs-1093","name":"Grazoprevir","dosage":"See elbasvir."},{"id":"fs-1094","name":"Grepafloxacin","dosage":"8-12mg/kg (adult 400-600mg) daily oral."},{"id":"fs-1095","name":"Griseofulvin (Grisovin, Fulcin)","dosage":"10-20mg/kg (adult 0.5-1g) daily oral."},{"id":"fs-1096","name":"Griseofulvin, ultramicrosize (Griseostatin)","dosage":"5.5-7mg/kg (adult 330-660mg) daily oral."},{"id":"fs-1097","name":"Growth hormone","dosage":"See somatropin."},{"id":"fs-1098","name":"Guaiacol","dosage":"See codeine+ guaiacol."},{"id":"fs-1099","name":"Guaifenesin","dosage":"See guaiphenesin."},{"id":"fs-1100","name":"Guaiphenesin","dosage":"4-8mg/kg (adult 200-400mg) 4H oral."},{"id":"fs-1101","name":"Guanabenz","dosage":"0.1mg/kg (max 4mg) 12H oral, increase to max 0.6 mg/kg (max 32mg) 12H."},{"id":"fs-1102","name":"Guanadrel","dosage":"0.1mg/kg (max 5mg) 12H oral, increase to max 0.5 mg/kg (max 25mg) 8-12H."},{"id":"fs-1103","name":"Guanethidine","dosage":"0.2mg/kg (max 10mg) daily oral, increase to 0.5-6 mg/kg (max 300mg) daily. Regnl symp block (adult): cuff 55 mmHg >syst BP, 10-20mg in 10-25ml saline (arm) or 15-30 mg in 15-50ml (leg) IV, wait 10-Z0min, release cuff over 5 min; >=7 days between injctns (max 12/yr)."},{"id":"fs-1104","name":"Guanfacine","dosage":"0.02mg/kg (max 1mg) daily oral, increase over sev eral wks to 0.05-0.0Bmg/kg (max 4mg) daily, sometimes up to 0.12mg/kg (max 4mg) daily."},{"id":"fs-1105","name":"Guar gum","dosage":"1g/10kg (adult 5g) 8H oral in fluid 40ml/g gum."},{"id":"fs-1106","name":"Haem arginate","dosage":"3-4mg/kg daily IV over 30-60min."},{"id":"fs-1107","name":"Haemaccel","dosage":"See polygeline."},{"id":"fs-1108","name":"Haemophilus influenzae type b, vaccines","dosage":"Inanimate. <12mo: give diphtheria protein conjugate (HibTITER, ProHIBiT), or tetanus conjugate (Act-1-IIB, Hiberix) 0.5miiM at 2mo, 4mo, 6mo and 15mo; or meningococcal conjugate (Pedvax HIB) 0.5rniiM at 2mo, 4mo and 15mo. If 1st dose >18mo: give 1 dose of HibTITER or Pedvax HIB. Haemophilus influenzae type b + hepatitis B vaccine (Comvax).lnanimate.0.5mi1M 2mo, 4mo, 12-15mo x3 dose. Haemophilus influenzae type b + meningococcus type c vaccine (Menitorix). Inanimate. 0.5ml IM 2mo, 3mo, 4mo (3 doses); boost from 12mo."},{"id":"fs-1109","name":"Halcinonide","dosage":"0.1% cream: apply sparingly 8-12H."},{"id":"fs-1110","name":"Halobetasol","dosage":"0.05% cream, ointment: apply 12-24H."},{"id":"fs-1111","name":"Halofantrine","dosage":"10mg/kg (max 500mg) 6H for 3 doses oral, repeat after 1 wk if non immune."},{"id":"fs-1112","name":"Haloperidol","dosage":"0.02mg/kg (max 1 mg) daily, increase up to 0.1 mg/kg (max 5mg) 12H IV or oral; up to 0.2mg/kg (max 10mg) 121'1 used rarely. Acutely disturbed: 0.1-0.2mg/kg (adult 5-10mg)"},{"id":"fs-1114","name":"Halothane","dosage":"0.5-4% induction, then 0.5. 2% inhalation."},{"id":"fs-1115","name":"Hemin","dosage":"1-3mg/kg 12-24H IV over 30min."},{"id":"fs-1116","name":"Heparin","dosage":"1mg=100u. Low dose: 75u/kg'IV stat, then 500u/kg in 50ml 0.9% saline at 1-1.5ml/hr (10-15u/kg/hr) IV. Full dose: 75u/kg (adult 5000u) IV stat, then 500u/kg in 50ml saline at 2-4ml/hr (20. 40u/kg/hr) <12mo, 2-3ml/hr (20-30 u/kg/hr) child, 1.5-2ml/hr (15-20u/kg/hr) adult; adjust to give"},{"id":"fs-1117","name":"APTT 60-85 sec, or anti-Xa 0.3-0","dosage":"7u/ml. Hep lock: 10Ou/ml."},{"id":"fs-1118","name":"Heparin calcium","dosage":"Low dose: 75u/kg SC 12H."},{"id":"fs-1119","name":"Heparin, low molecular weight","dosage":"See certoparin, dalteparin, danaparoid, enoxaparin, nadroparin."},{"id":"fs-1120","name":"Heparinoid 0.2% + lauromacrogol 5%","dosage":"Oint: apply x1-4/day."},{"id":"fs-1121","name":"Hepatitis A vaccine (Havrix)","dosage":"Inanimate. 0.5ml (child) or 1 ml (adult) IM stat, and in 6-12mo (2doses). Boost every 5yr."},{"id":"fs-1122","name":"Hepatitis A vaccine (VAQTA)","dosage":"Inanimate. 0.5ml (child) or 1ml (>17yr) IM stat, and after6-18mo (2 doses)."},{"id":"fs-1123","name":"Hepatitis A+ hepatitis B vaccine (Twinrix)","dosage":"Inanimate. 1- 15yr 0.5ml, >15yr 1miiM stat, after 1mo, and after5mo (3 doses). Boost every 5yr."},{"id":"fs-1124","name":"Hepatitis B immune globulin","dosage":"See immunoglobulin, hep B."},{"id":"fs-1125","name":"Hepatitis B vaccine (Engerix-B, HB Vax II)","dosage":"Inanimate. Engerix-B 10mcg/dose (<10yr), 20mcg (>9yr); HB Vax II 2.5mcg/dose (<10yr), 5mcg (10-19yr), 10mcg (>19yr), 40mcg (dialysis) IM stat, after 1 rno, and after 6rno (3 doses)."},{"id":"fs-1126","name":"Boost every 5yr","dosage":"See diphtheria and haemophilus vaccines."},{"id":"fs-1127","name":"Herpes zoster vaccine (Zostavax)","dosage":"Live. Age 50yr or more: 0.65ml SC once. See also Immunoglobulin, zoster."},{"id":"fs-1128","name":"Hetastarch","dosage":"6% 1 o. 20ml/kg IV."},{"id":"fs-1129","name":"Hexachlorophane","dosage":"3% emlsn. >12rno: apply 5ml, scrub 3min."},{"id":"fs-1130","name":"Hexarnethylmelamine","dosage":"150-260mg/m2 daily oral for 14-21 consecutive days of a 28 day cycle."},{"id":"fs-1131","name":"Hexamidine","dosage":"See chlorhexidine."},{"id":"fs-1132","name":"Hexamine hippurate","dosage":"20mg/kg (adult 1 g) 6H oral."},{"id":"fs-1133","name":"Hexaminolevulinate","dosage":"Adult, NOT/kg: instill100mg in 50ml."},{"id":"fs-1134","name":"Hexetidine","dosage":"0.1% soln: rinse/gargle 15ml (NOT/kg) 8-12H."},{"id":"fs-1135","name":"Histamine phosphate","dosage":"1 mg/ml base: prick, puncture or scratch testing. 0.1 mg/ml base: intradermal testing. Page 50"},{"id":"fs-1136","name":"Histrelin","dosage":"Usually 10mcg/kg daily SC."},{"id":"fs-1137","name":"Homatropine","dosage":"2%, 5% solution: 1 drop/eye 4H."},{"id":"fs-1138","name":"Hormone replacement therapy","dosage":"With uterus: sequential combined oestrogen (eg.oestradiol) and progestogen (eg. norethisterone) if perimenopausal; continuous combined therapy if postmenopausal. Without uterus: oestrogen."},{"id":"fs-1139","name":"Human chorionic gonadotrophin","dosage":"Chorionic gonadotrophin."},{"id":"fs-1140","name":"Human menopausal gonadotrophin","dosage":"See menotrophin. Human papillomavirus vaccine (Cervarix 2-valent,"},{"id":"fs-1141","name":"Gardasil 4 and 9-valent)","dosage":"Inanimate. Females 9-26yr, males 9-15yr: 0.5mtIM Omo, 1-2mo, 6mo (3 doses)."},{"id":"fs-1142","name":"Hyaluronic acid","dosage":"Gel 20mg/ml: 0.7-1.4ml injctd in wrinkles."},{"id":"fs-1143","name":"Hyaluronidase","dosage":"Hypodermoclysis: add 1-1.5u/ml fluid. Local anaesthesia: add 50u/ml solution."},{"id":"fs-1144","name":"Hydralazine","dosage":"0.1. 0.2mg/kg (adult 5-10mg) stat IV or IM, then 4-6mcg/kg/min (adult 200-300mcg/min) IV. Oral: 0.4 mg/kg (adult 20mg) 12H, slow increase to 1.5mg/kg (max 50mg) 6-8H."},{"id":"fs-1145","name":"Hydrochloric acid","dosage":"Use solution of i OOmmoi/L (0. 1M = 0.1 N = 10OmEq/L); give IV by central line only. Alkalosis: dose (ml) =BE x Wt x 3 (give half this); max rate 2ml/kg/hr. Blocked central line: 1.5mllumen over 2-4hr."},{"id":"fs-1146","name":"Hydrochlorothiazide","dosage":"i -1.5mg/kg (adult 25-50mg) 12-24H-1."},{"id":"fs-1147","name":"Hydrochlorothiazide+ quinapril","dosage":"10mg/12.5mg or 20/12.5 tab. Adult, NOT/kg: 10/12.5 tab daily oral, increase if required to 20/12.5 tab, max two 10/12.5 tab daily."},{"id":"fs-1148","name":"Hydrochlorothiazide + telmisarlan","dosage":"12.5/40mg, 12.5/80 or 25/80 tab. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-1149","name":"Hydrochlorothiazide + valsartan","dosage":"12.5/SOmg, 12.5/160 or 25/160 tab. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-1150","name":"Hydrocodone","dosage":"0.1-0.2mg/kg (max 10--15mg) 4-6H oral. Adult, NOT/kg: slow-rel10mg 12H oral, increase every 3-l days, extended-rei 20mg daily oral, increase every 3-7 days."},{"id":"fs-1151","name":"Hydrocortisone","dosage":"Inflammation, immunosupp, acute adr insuff: 2-4mg/kg (max IOOmg) 6H IV, reducing as tolerated. Physio logical, stress: 1 mg/kg 6H IV, IM. Chronic replacement, oral: adrenal insuff 3-4mg/m2 (max 10mg) 8H; congen adr hypo pi 6-8mg/rn28H (infant), >12mo 3-6mg/m2 (max 10mg) 8H. 0.5%,1% cream, ointment: apply6-12H. 10% rectal foarn: 125mg/dose. 2.5% eye ointment: apply 6H. See clioquinol."},{"id":"fs-1152","name":"Hydrocortisone 1% + pramocaine 1%","dosage":"Cream, foam: apply 8-12H after defaecation."},{"id":"fs-1153","name":"Hydroflumethiazide","dosage":"0.5-2mg/kg (adult 25-100mg) 12-48H."},{"id":"fs-1154","name":"Hydrogen peroxide","dosage":"10 volume (3%). Mouthwash 1:2 parts water. Skin or ear disinfectant 1:1 part water."},{"id":"fs-1155","name":"Hydromorphone","dosage":"Oral: 0.05-0.1mg/kg (adult 2-4mg) 4H. IM,"},{"id":"fs-1156","name":"SC: 0.02-0.05mg/kg (adult 1","dosage":"2mg) 4-6H. Slow IV: 0.01-0.02 mg/kg (adult 0.5-1 mg) 4-6H. l\\"alliative: increase to 40-50mg/day (up to 500mg/day) oral divided doses. 1 mg 4mg oxycodone."},{"id":"fs-1157","name":"Hydroquinone","dosage":"3-4% cream: apply 12H."},{"id":"fs-1158","name":"Hydrotatcite","dosage":"20mg/kg (adult 1g) 6H oral. Page 51"},{"id":"fs-1159","name":"Hydroxocobalamin (Vit 1312)","dosage":"20mcg/kg (adult 10OOmcg) IM daily for 7 days then wkly (treatment), then every 2-3mo (prophyl); IV dangerous in megaloblastic anaemia. Homo cystinuria, methylmalonic acidur: 1 mg daily IM; after re sponse, some patients maintained on 1-10mg daily oral."},{"id":"fs-1160","name":"Hydroxyapatite","dosage":"20-40mg/kg (adult 1-2g) 8H oral."},{"id":"fs-1161","name":"Hydroxycarbamide","dosage":"See hydroxyurea."},{"id":"fs-1162","name":"Hydroxychloroquine sulphate","dosage":"Doses as sulphate (200mg = 155mg base). Malaria: 10mg/kg (max 600mg) daily for 3 days; prophylaxis 5mg/kg (max 300mg) once a wk oral. Arthritis, SLE: 3-6.5mg/kg (adult 200-600mg) daily oral."},{"id":"fs-1163","name":"Hydroxyethylcellulose","dosage":"0.44% 1 drop per eye 6-8H."},{"id":"fs-1164","name":"Hydroxyethylrutosides","dosage":"5mg/kg (adult 250mg) 6-8H for 3- 4wk, then 12-24H; or 10mg/kg (adult 500mg) 12H for 3-4wk, then daily oral."},{"id":"fs-1165","name":"Hydroxyprogesterone","dosage":"Adult, NOT/kg: 250-500mg/wk IM."},{"id":"fs-1166","name":"Hydroxypropyl (methyl)cellulose","dosage":"See hypromellose."},{"id":"fs-1167","name":"Hydroxyquinone","dosage":"4% cream: apply 12H."},{"id":"fs-1168","name":"Hydroxyurea","dosage":"80mg/kg oral every 3rd day, or 20-30mg/kg daily. CNS tumors: 1.5-3g/m2 oral stat, in 2wk, then every 4- 6wk. Sickle cell: 15mg/kg daily, increase by 5mg/kg every 12wk to max 35mg/kg daily."},{"id":"fs-1169","name":"Hydroxyzine","dosage":"0.5-2mg/kg (adult 25-100mg) 6-8H oral. 0.5-1 mg/kg (adult 25. 100mg) 4-6H if required IM."},{"id":"fs-1170","name":"Hylan","dosage":"8mg inj into knee wkly x3; max 6 doses in 6rno."},{"id":"fs-1171","name":"Hyoscine (scopolamine) butylbromide","dosage":"0.5 mg/kg (adult 20- 40mg) 6-8H IV, IM or oral."},{"id":"fs-1172","name":"Hyoscine (scopolamine) hydrobromide","dosage":"6-8mcg/kg (adult 400-600mcg) 6-8H IV, IM, SC. Motion sickness 300mcg tab (NOT/kg): y,; tab (2-7yr), Y, tab (7-12yr), 1-2 tab (>12yr) 6- 24H oral 30 min before, may repeat in 4hr. Transdermal (1.5mg patch): >10yr 1 every 72hr. Hyoscine hydrobromide 0.4mg/ml + papaveretum 20mg /mi. 0.008 mg/kg (H)+ 0.4 mg/kg (P) = 0.02ml/kg/dose IM."},{"id":"fs-1173","name":"Hyoscine methobromide (methscopolamine)","dosage":"0.2mglkg (adult 2.5-5mg) 6H oral."},{"id":"fs-1174","name":"Hyoscyamine (Lalropine)","dosage":"2-5mcg/kg (adult 100-300 meg) 4-6H oral, sublingual, IM or IV."},{"id":"fs-1175","name":"Hypromellose","dosage":"0.5% solution: 1 drop/eye prn."},{"id":"fs-1176","name":"Hypromellose 0.3% + dextran 70 0.1%","dosage":"1 drop/eye prn. lbandronate (ibandronic acid). Adult, NOT/kg. Hypercal- caemia: 2-4mg IV over 2H once. Osteoporosis: 2.5mg daily, or 150mg each month oral; or 3mg IV bolus evey 3mo. lbopamine. 1.5-3mg/kg 8H oral. lbritumomab. Adult, NOT/kg. Dosimetric dose (after ritux imab): 5.5 rnCi of ln-1-11 labelled ibritumomab IV over 1 0min. Therapeutic dose of Y-90 ibritumornab based on response to dosimetric dose and platelet count. lbrutinib. Adult, NOT/kg, oral. 420mg (CLL) 560mg (MCL) daily."},{"id":"fs-1177","name":"Ibuprofen","dosage":"10mg/kg (adult 200-400mg) 4-8H oral, IV; max Page 52. 40mg/kg (adult 3.2g) per day. Arthritis: 10mg/kg (adult 400-"},{"id":"fs-1178","name":"BOOmg) 6-8H (max 2.4g/day)","dosage":"Cystic fibrosis: 20-30mg/kg 12H. PDA: 10mg/kg stat, then 5mg/kg after 24 and 48 hr IV over 15min. See also famotidine + ibuprofen. lbutilide. 0.017mg/kg (max 1 mg) IV over 1 0min, then wait 10m in and repeat once if required. lcatibant. 15u/kg (to nearest 500u) SC, repeat 6H x2 if required. lcatibant. Adult, NOT/kg: 30mg SC. lchthammol. 1-10% crearn, ointment. Apply 6-8H. lcodextrin 7.5% in electrolyte solution. Adults: 1.5-2.5 litres as once daily replacemnt for a 6-12H glucose dialysis. lcosapent ethyl. Adult, NOT/kg: 1-2g 12H oral with food. ldarubicin. 12mg/m2 IV over 15min daily for 3 days. ldarucizumab. Adult, NOT/kg: 5g IV. ldebenone. Adult, NOT/kg: 30mg 8H oral. ldelalisib. Adult, NOT/kg: 150mg tab 12H oral. ldinavir. 500mg/m2 (adult800mg)8H oral, min trough 10Ong/ml. ldoxuridine. 0.1% eye drops: 1 drop every 15min for 2H, then hourly by day and 2H at night. 0.1% solution or 0.5% ointment: apply hourly first 24H, then 4H. ldursulfase. 0.5mg/kg weekly IV over 1-3hr."},{"id":"fs-1179","name":"Ifosfamide","dosage":"Usually 1.2-2.0g/m2 IV over 4hr daily x5, or 5-6 g/m2 (max 10g) IV over 24H once. Repeat every 2-4wk. lloperidone. Adult, NOT/kg: 1 mg 12H, increase to 6-12mg 12Horal. lloprost. IV: 0.2ng/kg/min increase every 4-6hr to 2ng/kg/min (up to 10ng/kg/min rarely). lnhaltn (NOT/kg): 2.5-5mcg x6-9/day. lmatinib. Adult, NOT/kg: 400mg daily (chronic CML), 600mg daily (blast crisis) or 400mg 12H (unresponsive blast) oral. lmidapril. 0.1 mg/kg (adult 5mg) daily oral, increase if required to 0.2- 0.3mg/kg (adult 10-20mg) daily. lmiglucerase. Usual initial dose 60u/kg every 2wk IV over 2H, adjusted according to response; reduce every 3-6rno. lmipenem (+ cilastatin). 15mg/kg (adult 500mg) 6H IV over 30min. Severe inftn: 25mg/kg IV over 1H (adult 1g) 12H (1st wk life), 8H (2-4 wk), 6-8H or constant infusion (4+ wk)."},{"id":"fs-1180","name":"Imipramine","dosage":"0.5-1.5mg/kg (adult 25-75mg) SH oral. Enuresis: 5-6yr 25mg, 7-10yr 50mg, >10yr 50-75mg nocte. lmiquimod. 5% crearn: apply x2-3/wk (max 16wk) before bed; wash off after 6-10hr. Molluscum: 0.2% cream x3/wk."},{"id":"fs-1181","name":"Immunoglobulin","dosage":"See also antivenorns."},{"id":"fs-1182","name":"Immunoglobulin, anthrax","dosage":"60u/50ml vials: <10kg x1, 10-17 kg x2, 18-24kg x3, 25-34kg x4, 35-49kg x5, 50-59kg x6, \\"60kg x7 IV at 0.01 mlkg/min (max 0.5 mlmin) for 30min, 0.02mlkg/min (max 1 ml/min) 30 min, then 0.04mlkg/min (max 2mlmin). Severe: double dose if >5kg."},{"id":"fs-1183","name":"Immunoglobulin, antilymphocyte (thymocyte)","dosage":"Horse (Atgarn): 10-15mg/kg daily for 3--5 days IV over 4hr; occa sionally up to 30mg/kg daily. Rabbit (ATG-r\\"resenius): 2.5- 5mg/kg daily over 4-6hr IV."},{"id":"fs-1184","name":"Immunoglobulin, CMV","dosage":"100-200mg/kg IV over 2H. Trans- Page 5:1 plant: daily for first 3 days, wkly x6, monthly x6."},{"id":"fs-1185","name":"Immunoglobulin, diphtheria","dosage":"250u IM once."},{"id":"fs-1186","name":"Immunoglobulin, hepatitis B","dosage":"400u IM within 5 days of needle stick, repeat in 30 days; 10Ou IM within 24H birth to baby of Hep B carrier."},{"id":"fs-1187","name":"Immunoglobulin, human","dosage":"Hypogammaglobulinaemia: 10-15 ml/kg of 6% solution (600-900mg/kg) IV over 5-8hr, then 5-7.5 ml/kg (300-450mg/kg) over 3-4hr monthly; or 0.6ml/kg of 16% solution (100mg/kg) every 2-4wk IM. Sepsis: 0.5g/kg IV over 4hr. Kawasaki, Guillain-Barre, ITP, myasth gravis, Still's dis: 35mlikg of 6% solution (2g/kg) IV over 16hr stat, then if required 15 ml/kg (900mg/kg) IV over 8hr each month. Pre vention hep A: 0.1ml/kg (16mg/kg) IM. Prevent measles: 0.2 ml/kg (32mg/kg) IM (repeat next day if immunocompromisd)."},{"id":"fs-1188","name":"Immunoglobulin, human subcutanoeus (SCIG)","dosage":"Multiply previous IV lgG dose by 1.37, and divide this into weekly doses. Usually 1 00-200mg/kg by SC infusion weekly. lgG/ hyaluronidase (100mg/160u): hyaluronidase 480-960u/kg SC 10m in before 300-600mg/kg lgG every 3-4wk SC."},{"id":"fs-1189","name":"Immunoglobulin, rabies (Hyperab, lmogam)","dosage":"20iu (0.133 ml)/kg IM once (half SC around wound), with rabies vaccine."},{"id":"fs-1190","name":"Immunoglobulin, respiratory syncytial virus","dosage":"750mg/kg every month IV (50mg/ml: 1.5ml/kg/hr for 15min; 3ml/kg/hr for 15min, then 6ml/kg/hr)."},{"id":"fs-1191","name":"Immunoglobulin, Rh (anti-D)","dosage":"1ml (625iu, 125mcg) IM within 72hr of exposure. Large transfusion: 0.16ml (100iu, 20mcg) per ml RH positive red cells (maternal serum should be anti- 0 positive 24-48hr after injection)."},{"id":"fs-1192","name":"Immunoglobulin, tetanus (TIG)","dosage":"IM preparation, prophylaxis: 250-500iu (1-2amp). IV preparation, treatment: 4000iu  (100mt) at 0.04ml/kg/min for 30min, then 0.075 ml/kg/min IV; intrathecal usually 250iu."},{"id":"fs-1193","name":"Immunoglobulin, zoster","dosage":"1 iu ~ 1.5mg. Within 96hr of expo sure: 0-10kg 300mg, 11-30kg 600mg, >30kg 900mg IM. lncobotulinumtoxin A. NOT/kg: 120u divided between affected muscles IM, every 12wk if required. Blepharospasm: 1.25-2.5u in 3 sites/eye IM max total200u/30days. lndacaterol. Adult, NOT/kg: 75-120mcg (max 300mcg) cap daily using special inhaler. See glycopyrrolate. lndapamide. 0.03-0.05mg/kg (adult 1.5-2.5mg) daily oral. lndapamide 1.25mg + perindopril 5mg. Adult, NOT/kg: 1 tab daily oral. lndinavir (IDV). >28 days: 500mg/m2 (adult 800mg) 8H oral. lndinavir + ritonavir (LPVr). >18yr: IDV 800mg + RTV 100- 200mg 12H oral. lndocyanine green. IV. Dye dilutn: 0.1 mg/kg (adult 5mg)."},{"id":"fs-1194","name":"Pulsion monitor: 0.25-0.Smg/kg","dosage":"Liver functn: 0.5mg/kg."},{"id":"fs-1195","name":"Indomethacin","dosage":"0.5-1mg/kg (adult 25-50mg) 8H (max 6H) oral or PR; max 4mg/kg (adult 200mg) per day. Submicron (adult,"},{"id":"fs-1196","name":"NOT/kg): 20mg or40mg 8H oral","dosage":"PDA: 0.1mg/kg (<1kg) or Page 54 0.2mg/kg (>~1 kg) day 1, then 0.1 mglkg daily days 2-.Y oral or IV over 1H. lndoramin. 0.5-1.5mglkg (adult 25-75mg) 8-12H oral. lnfliximab. 3mg/kg (arthritis, with methotrexate) 5mglkg (Crohn's, Ulc Colitis) IV over 2H, then (if response) after 2wk, 6wk, and then 5-10mglkg every 8wk."},{"id":"fs-1197","name":"Influenza A and B live nasal vaccine {Fiumist)","dosage":">5yr: 0.25 mlnostril; repeat after 6wk if aged 5-8yr and previously unimmunised. Boost annually (1 dose)."},{"id":"fs-1198","name":"Influenza A and 8 vaccine","dosage":"Inanimate. 0. 125ml (3rno-2yr), 0.25ml (2-6yr), 0.5ml (>6yr) SC stat and 4wk later (2 doses). Boost annually (1 dose)."},{"id":"fs-1199","name":"Influenza A and 8 vaccine (Fiuad, Fluzone HD)","dosage":"~65yr (inanimate): 0.5ml SC annually. lngenol mebutate. 0.015% gel to head lesions daily x3; 0.05% gel to trunk or limbs daily x2."},{"id":"fs-1200","name":"Inosine acedoben dimepranol","dosage":"Herpes, genital warts: 20 mglkg (adult 1g) 6-8H oral. SSPE: 10-15mg/kg 4H oral."},{"id":"fs-1201","name":"Inositol nicotinate","dosage":"20mglkg (adult 1g) 6-8H oral."},{"id":"fs-1202","name":"Insulin","dosage":"Regular insulin IV: 0.025-0.1 ulkg prn, or 0.025-0.1 u/kglhr (2.5u/kg in 50ml at 0.5-2mlhr); later 1 u/10g dextrose. For hyperkalaemia: 0.1ulkg insulin and 2mlkg 50% dextrose"},{"id":"fs-1204","name":"Insulin (Exubera)","dosage":"Initially 30-39kg 1 mg, 40-59kg 2mg, 60- 79kg 3mg, 80-99kg 4mg, inl1aled 10min before meal."},{"id":"fs-1205","name":"Interferon alfa-2a, recombinant","dosage":"Haemangiorna: 1 million u/m2 daily SC or IM increase over 4wk to 2-3 million u/m2 daily for 16-24wk, then x3/wk. Hep B, C: 3-6 million u/m2 x3/wk SC or IM for 4-6mo; higher doses may be required in hep B."},{"id":"fs-1206","name":"Interferon alfa-2a I alfa-2b, pegylated","dosage":"See peginterferon."},{"id":"fs-1207","name":"Interferon alfa-2b, recombinant","dosage":"Condylomata: 1 million unit into each lesion (max 5) x3/wk for 5wk. Haemangiorna: as for interferon alfa-2a. Hep B: monotherapy as for interferon alfa-2a. Hep C (adult, NOT/kg) 3 million unit x3/wk SC, plus ribavirin 1 g (1.2g if> 75kg) daily oral, for 24-48wk."},{"id":"fs-1208","name":"Interferon alfacon-1","dosage":"Hepatitis C (adult, NOT/kg): lJ(lUally 9 meg (7.5mcg if not tolerated) x3/wk SC for 24wk; if relapse 15mcg x3/wk SC tor 6mo."},{"id":"fs-1209","name":"Interferon alfa-n3","dosage":"Warts (NOT/kg): 250,000u injected into base of wart (max 10 doses/session) x2/wk for max 8wk. $9.tl5 +postage from orders@drugdoses.com Page 55"},{"id":"fs-1210","name":"Interferon beta1a","dosage":"Mult scler (adult, NOT/kg): Avonex 30mcg (6 million IU) once a wk IM, Rebif 44mcg x3/wk SC."},{"id":"fs-1211","name":"Interferon beta1b","dosage":"Mull scler (adult, NOT/kg): 250mcg (8 million IU) SC alternate days."},{"id":"fs-1212","name":"Interferon gamma-1 b","dosage":"Chronic granulom dis: 1.5mcg/kg (body area <=0.5m2) or 50mcg/m2 (area >0.5rn2) x3/wk SC. lnterleukin-2. See aldesleukin. lobenguane (iodine 123). 5.8 rnCi per rn21V over 2min."},{"id":"fs-1213","name":"Iodine 5% + Kl10%","dosage":"Oral, NOT/kg. Crisis: 0.1-1mi8H. Thyroidectomy (Graves): 0.1-0.3ml 8H for l-10 days preop. lodoquinol. See di-iodohydroxyquinoline."},{"id":"fs-1214","name":"Ipecacuanha syrup (total alkaloids 1.4mg/ml)","dosage":"1-2ml/kg (adult 30ml) stat oral, NG. May repeat once in 30min. lpilimumab. 3mg/kg IV plus nivolumab 1 mg/kg IV every 3wk for 4 doses, then nivolurnab 3mg/kg every 2wk. lpratropium bromide. Resp solution (250mcg/ml): 0.25-1 ml diluted to 4ml 4-SH; severe attack every 20min for 3 doses, then 4-6H. Aerosol 20mcg/puff: 2-4 puffs 6-8H. Nasal: 84 mcg/nostrii6-12H. lrbesartan. 3mg/kg (adult 150mg) daily oral, increase to 6mg/kg (adult 300mg) daily if required. lrinotecan. 350mg/m2 IV over 90min every 3wk; reduce to 250-300mg/m2 every 3wk if toxicity. lrinotecan, liposomal. 70mg/m2 (50-70mgim2 if UGT1 A 1 *28 l10mozygous) IV over 90min every 2wk."},{"id":"fs-1215","name":"Iron","dosage":"See ferric salts, ferrous salts."},{"id":"fs-1216","name":"Iron dextran, iron polymaltose, iron sucrose","dosage":"Fe 50mgiml: dose (ml) ~ 0.05 x Wt in kg x (15-Hb in g%) IM (often in divided doses). IV infusion possible (but dangerous). lsavuconazonium sulphate. Adult. NOT/kg: 372mg 8H oral or IV over 1 hr for 6 doses, then daily. lsocarboxazid. Adult, NOT/kg: 10mg 12H oral, increase over 1wk to 20mg 12H; then increase if required over 2wk to max 30mg 12H. lsoconazole. 1% cream 12H. Vaginal: 600mg (2 tab) once. lsoetharine. lnhaltn solution (1%): 0.5ml diltd to 4rni3-6H (rnild), 1 ml diltd to 4m11-2H (moderate), undiltd constant (severe, in"},{"id":"fs-1217","name":"ICU)","dosage":"Aerosol 340mcg/puff: 1-2 puffs 4-6H. lsoflurane. 1.5-3% for induction, then 1-2.5% inhalation. lsometheptene. 2.5mg/kg (max 130mg) stat, then 1.5mg/kg (max 65mg) 1H to max 7mg/kg (max 325mg) in 12H oral. See also dichloralphenazone."},{"id":"fs-1218","name":"Isoniazid (INAH)","dosage":"10mg/kg (max 300mg) daily oral, IM or IV."},{"id":"fs-1219","name":"Intermittent: 15mg/kg 3 times a week","dosage":"TB meningitis: 15-20 mg/kg (max 500mg) daily."},{"id":"fs-1220","name":"Isoniazid + rifampicin","dosage":"30-49kg 150mg/100mg tabs x3 daily, ''50kg 300mg/150mg tabs x2 daily oral. Isoniazid 50mg +pyrazinamide 300mg +rifampicin 120mg tab. 30-39kg x3, 40-49kg x4, 50-64kg x5, <:65kg x6tab daily. isoprenaline. IV infusion (start with low dose and increaseease gradually): <33kg 0.3mg/kg in 50ml at 0.5-10ml/hr (0.05- Page 56 1mcg/kg/min); >33kg give 1/5000 (0.2 mg/ml) solution at 0.015 0.15ml/kg/hr (0.05-0.5mcg/kg/min). TY, 2min."},{"id":"fs-1221","name":"Isoproterenol","dosage":"See isoprenaline. lsosorbide dinitrate. Sublingual: 0.1-0.2mg/kg (max 10mg) 2H or as needed. Oral: 0.5-1 mg/kg (max 40mg) 6H or as needed. Slow release tab, Adult, NOT/kg: 20-80mg 12H. IV infusion 0.6-2mcg/kg/min. lsosorbide mononitrate. Slow release tab, Adult, NOT/kg: 60-120mg daily oral. lsotretinoin. 0.5-1mg/kg daily oral for 2-4wk, reducing if possible to 0.1-0.2mg/kg daily for 15.ZOwk; total dose 120- 150mg/kg to reduce relapse. Infant: often 10mg cap alternate days. 0.05% gel: apply sparingly at night. lsoxsuprine. 0.2-0.5mg/kg (adult 10-20mg) 6-12H oral. lspaghula husk. Adult, NOT/kg: 1-2 x5ml teaspoonfuls 6-12H oral. Half this dose 6-12yr. lsradipine. 0.05mg/kg 12H oral, may increase after 2-4wk gradually to 0.1-0.2mg/kg (max 10mg) 12H. ltraconazole. Oral. Daily: liquid 3-5mg/kg cap 5-7.5 mglkg (adult 200mg). 12H: Liquid 1.5-2.5mg/kg cap 2.5-4mg/kg (adult 100mg). Severe inftn: liquid 5mg/kg (adult 200mg) 12H. Trough level >0.5 mcg/ml at 10-14 days. lvabradine. 0.1mg/kg (adult 5mg) 12H oral, range 0.05-0.15 mg/kg (adult 2.5-7.5mg) 12H. lvacaftor. NOT/kg: 150mg 12H with fatty meal oral. lvacaftor 125mg + lumacaftor 200mg. NOT/kg: 2 tab 12H oral. lvermectin. 0.2-0.4mg/kg (adult 12-24mg) oral; repeat after 7- 10 days. Onchocerciasis: 0.2mg/kg every 3-12mo (not curative). Head lice: 0.5% lotion to hair for 10min then rinse; repeat after 7-10 days. Rosacea: 1% cream to face daily. lxabepilone. 40mg/m2 IV over 3hr every 21 days for median of 4 cycles. Vary dose with CYP3A4 inhibitors or inducers. lxazomib. Adult NOT/kg: 4mg oral day 1 ,8, 15 of 28-day cycle. lxekizumab. Adult, NOT/kg: 160mg SC wk 0, then 80mg wk 2, 4, 6, 8, 10, 12, then every 4wk."},{"id":"fs-1222","name":"Japanese encephalitis vaccine, inanimate","dosage":"lxiaro: adult 0.5miiM stat and 28 days later. JE-Vax: 0.5ml (1-3yr), 1ml (>3yr) SC stat, 7-14 days later, and (optionally) 1mo later. Boost after 1 yr."},{"id":"fs-1223","name":"Japanese encephalitis vaccine, live","dosage":"lmojev: <:12mo 0.5ml SC, boost after 1-2yr (age 1-17yr) or 5yr (adult)."},{"id":"fs-1224","name":"Kanamycin","dosage":"Single daily dose IV or IM. Neonate: 15mg/kg stat, then 7.5mg/kg (<30wk) 10mg/kg (30-35wk) 15mg/kg (term <1wk) daily. 1wk-10yr: 25mglkg day 1, then 18mg/kg daily. >10yr: 20mglkg day 1, then 15mg/kg (max 1.5g) daily. Trough level <5.0mgll."},{"id":"fs-1225","name":"Kcentra","dosage":"Factor IX 25u/kg (INR 2-4), 35u/kg (INR 4-6), 50/ukg (INR >6) at 3u/kg/min (max 210u/min) IV."},{"id":"fs-1226","name":"Keppra","dosage":"See levetiracetam."},{"id":"fs-1227","name":"Ketamine","dosage":"Sedation, analgesia: 1-1.5mg/kg IV, 3-4mg/kg IM Page 57 (may repeat after 10min); infusion 2-6 meg /kg/min IV (6mg/kg in 50ml at 1-3ml/hr). Anaesthesia: 5-10mg/kg IM, 1-2mg/kg IV, infusion 15mg/kg in 50ml at 2-8ml/hr (10-40mcg/kg/min)."},{"id":"fs-1228","name":"Premed: 5mg/kg oral","dosage":"Incompatible with aminophylline, mag nesium and salbutamoiiV."},{"id":"fs-1229","name":"Ketanserin","dosage":"IV: 0.5-5mcg/kg/min (max 150mg/day). Oral 0.5 mg/kg (max 20mg), increase to max 1 mg/kg (max 40mg) 12H."},{"id":"fs-1230","name":"Ketoconazole","dosage":"Oral: 5mg/kg (adult 200mg) 12-24H-1. 2% cream: apply 12-24H-1. 2% shampoo: wash hair, apply liquid for 5min, wash off."},{"id":"fs-1231","name":"Ketoprofen","dosage":"1-2mg/kg (adult 50-100mg) 6-12H (max 4mg/kg or 200mg in 24H) oral, IM. PR. Slow-rei, adults (NOT/kg): 200mg daily."},{"id":"fs-1232","name":"Ketoprofen + omeprazole","dosage":"1 00mg/20mg or 200/20 slow-rei cap. Adult, NOT/kg 1 cap daily oral."},{"id":"fs-1233","name":"Ketorolac","dosage":"Oral: 0.2mg/kg (adult 10mg) 4-6H (max 0.8 mg/kg/day or 40mg/day). IV or IM: usually 0.2mg/kg (adult 10mg) 6H; but may use 0.6mg/kg (adult 30mg) 6H (max 120mg/d) for 5 days, then 0.2mg/kg (adult 10mg) 6H. Single dose 1mg/kg (adult 60mg) IM. Nasal15.75mg/spray: adult 1 each nostril (<:65yr 1 nostril). Eye drop 0.5%: 1 drop 8H."},{"id":"fs-1234","name":"Ketotifen","dosage":"Child >2yr (NOT/kg): 1mg 12H oral with food. Adult, NOT/kg: 1-2mg 12H oral with food."},{"id":"fs-1235","name":"Labetalol","dosage":"Oral: 1. 2mg/kg (adult 50-100mg) 12H, may increase wkly to max 10mg/kg (max 600mg) 6H. IV: 0.25-0.5mg/kg (adult 20mg) over 2min repeated every 10min if required, then 0.25-3mg/kg/hr."},{"id":"fs-1236","name":"Lacidipine","dosage":"0.04-0.12mg/kg (adult 2-6mg) daily oral."},{"id":"fs-1237","name":"Lacosamide","dosage":"1mg/kg (adult 50mg) 12H, increase weekly if required to 2-4mg/kg (adult 1 00-200mg) 12H IV over 1 hr or oral."},{"id":"fs-1238","name":"Lactase","dosage":"See tilactase."},{"id":"fs-1239","name":"Lactitol","dosage":"0.1-0.3g/kg (adult 10-20g) 1-3 times a day oral."},{"id":"fs-1240","name":"Lactulose","dosage":"3.3g/5ml solution. Laxative: 0.5ml/kg 12H oral. Hepatic coma: 1 ml/kg hrly until diarrhoea, then 6-8H."},{"id":"fs-1241","name":"Lamivudine (3TC)","dosage":"Neonate <30 days: 2mg/kg 12H oral."},{"id":"fs-1243","name":"B: 3-4 mg/kg (max 10Omg) daily oral","dosage":"See also abacavir."},{"id":"fs-1244","name":"Lamivudine 150mg + zidovudine 300mg (Combivir)","dosage":"<:30kg 1 tab 12H oral."},{"id":"fs-1245","name":"Lamotrigine","dosage":"0.2mg/kg (adult 25mg) oral daily, double dose every 2wk if required to max 1-2.5mg/kg (adult 50-200mg) 12H. Beware drug interactions. Lanreotide, 0.5-1.0mg/kg (adult 30mg) IM every 2wk (adjust dose and frequency according to response)."},{"id":"fs-1246","name":"Lansoprazole","dosage":"NOT/kg. 15mg (1yr-30kg) 30mg (>30kg) daily."},{"id":"fs-1247","name":"Lanthanum carbonate","dosage":"Adult, NOT/kg: 0.5-1g 8H with meal."},{"id":"fs-1248","name":"Lapatinib","dosage":"Adult, NOT/kg: 1.25g every day oral (plus capecit- abine 2g/m2/day on days 1-14 of a repeating 21 day cycle)."},{"id":"fs-1249","name":"Laronidase","dosage":"0.58mg/kg IV once a week. Page 58"},{"id":"fs-1250","name":"Laropiprant +nicotinic acid","dosage":"Adult. NOT/kg. 20mg/1g tabs:1 tab daily oral. increase to 2 tab daily after 4wk."},{"id":"fs-1251","name":"L-asparaginase","dosage":"See colaspase."},{"id":"fs-1252","name":"Latanoprost","dosage":"50mcg/ml: 1 drop/eye daily."},{"id":"fs-1253","name":"Latanoprost 0.005% + timolol 0.5%","dosage":"1drop per eye daily."},{"id":"fs-1254","name":"Laureth-9","dosage":"Spider veins: inject 0.1-0.2ml of 0.5% (10mg /2m I)."},{"id":"fs-1255","name":"Small varices: 0.1-0.3ml of 1% (20mg/2ml)","dosage":"Medium varices: 0.5-1 ml of 3% (60mg/2ml). Max 2mg/kg/day."},{"id":"fs-1256","name":"Lauromacrogol","dosage":"See heparinoid + lauromacrogol ointment."},{"id":"fs-1257","name":"L-carnitine","dosage":"See carnitine, L form."},{"id":"fs-1258","name":"Ledipasvir 90mg + sofosbuvir 400mg","dosage":"Adult, NOT/kg 1 tab daily oral: no cirrhosis 8wk (RNA <6m IU/ml), 12wk (RNA 26m IU/ml); cirrhosis 24wk (12wk with ribavirin)."},{"id":"fs-1259","name":"Leflunomide","dosage":"Adult, NOT/kg: 100mg daily x3, then 20mg daily oral."},{"id":"fs-1260","name":"Lenalidomide","dosage":"Adult, NOT/kg: 10mg daily oral; or 25mg daily on days 1-21 of28 day cycles."},{"id":"fs-1261","name":"Lenograstim (rHuG-CSF, Granocyte)","dosage":"150mcg/m2 daily se or IV over 30min. Keep wee 5,000-10,000/mm3."},{"id":"fs-1262","name":"Lenvatinib","dosage":"Adult, NOT/kg: 24mg daily oral."},{"id":"fs-1263","name":"Lepirudin","dosage":"0.4mg/kg IV stat, then 0.15mg/kg/hr (adjusted by Af\\"TT) for 2-10 days."},{"id":"fs-1264","name":"Lercanidipine","dosage":"0.2mg/kg (adult 10mg) daily oral, increase to 0.4 mg/kg (adult 20mg) daily if required."},{"id":"fs-1265","name":"Letrozole","dosage":"Adult, NOT/kg: 2.5mg daily oral."},{"id":"fs-1266","name":"Leucovorin","dosage":"See folinic acid."},{"id":"fs-1267","name":"Leuprolide","dosage":"See leuprorelin."},{"id":"fs-1268","name":"Leuprorelin (GnRH or LHRH)","dosage":"Adult, NOT/kg: 7.5mg depot injtn monthly IM; or microspheres 11.25mg se every 3mo. Precocious puberiy: depot 30mg IM every 3mo."},{"id":"fs-1269","name":"Levalbuterol (levosalbutamol)","dosage":"See salbutamol. l.evamisole. Antihelmintic: 3mg/kg (adult 150mg) oral once (ascaris), repeat in 1wk (hookworm). Adenocarcinoma colon (with 5-fluorouracil 450mg/m2 IV wkly): 1 mg/kg (adult 50mg) 8H oral for 3 days every 2wk."},{"id":"fs-1270","name":"Levetiracetam","dosage":"7mg/kg (adult 500mg) 12H oral, IV, IM, increase every 2-4wk to max 30mg/kg (max 1.5g) 12H if required; higher doses used in resistant cases. Status: 50mg/kg (max 2.5g) IV over 10min, then 30-40mg/kg (max 2g) 8H (up to 4H if required) while fitting."},{"id":"fs-1271","name":"Levobetaxolol","dosage":"0.5% solution: 1drop/eye 12H."},{"id":"fs-1272","name":"Levobunolol","dosage":"0.25%-0.5% solution: 1drop/eye 12-24H."},{"id":"fs-1273","name":"Levobupivacaine","dosage":"See bupivacaine."},{"id":"fs-1274","name":"Levocabasline","dosage":"0.5mg/ml: 1drop/eye 6-12H max Bwk, 2 sprays/nostril 6-12H max 8wk."},{"id":"fs-1275","name":"Levocarnitine","dosage":"See carnitine. l.evocetirizine. NOT/kg: 2.5mg (6-11 yr) 5mg (adult) daily."},{"id":"fs-1276","name":"Levodopa + benserazide (4: 1 )","dosage":"Adult, NOT/kg: initially levodopa 100mg 8H oral; if not controlled, increase wkly by 100mg/day to max 250mg 6H. Page 59 Levodpa + carbidopa n;, immediate < sustained < extended."},{"id":"fs-1277","name":"Levodopa + carbidopa","dosage":"Immediate 250/25mg, 100/25 100/10 tab. Adult, NOT/kg: initially one 100/10 tab 8H oral; if not controlled, substitute one 250/25 tab for one 100/25 tab every 2nd day; if not controlled on 250/25 8H, increase by one 250/25 tab every 2nd day to max 6-8 tab/day. Sustained 25/100, 50/200 tab: 400-1600mg levodopa daily, divided."},{"id":"fs-1278","name":"Levodpa + carbidopa","dosage":"Extended 23.75/95mg, 36.25/145, 48.75/195, 61.25/245 cap. Adult, NOT/kg: 8H oral23.75/95 day1, day4 36.25/145, if required 97.5/390 day? (increase up to x5/day if required). Transfer: 1.7 x daily dose of immediate levodopa divided 8H, then adjust."},{"id":"fs-1279","name":"Levodopa + carbidopa + entacapone","dosage":"50/12.5/200mg, 75/18.75/200, 100/25/200, 125/31.25/200, 150/37.5/200, 175/43.75/200,200/50/200. 1 tab 8H, titrate dose to response (max entacapone 2g/day, levodopa 1g/day)."},{"id":"fs-1280","name":"Levofloxacin","dosage":"5-10mg/kg {adult 250-500mg) 12-24H-1 oral or"},{"id":"fs-1281","name":"IV over 1 hr","dosage":"Eye 5mg/ml: 1 drop x8/day for 2 days, then 6H."},{"id":"fs-1282","name":"Levofolinate, levofolinic acid, levoleucovorin","dosage":"Half the dose of calcium folinate."},{"id":"fs-1283","name":"Levornepromazine","dosage":"See rnethotrimeprazine."},{"id":"fs-1284","name":"Levomethadyl acetate","dosage":"Adult, NOT/kg: usual starting dose 20-40mg every 2-3 days oral."},{"id":"fs-1285","name":"Levomilnacipran","dosage":"Adult, NOT/kg: 20mg daily oral, increase by 20mg every 2 days to max 120mg daily."},{"id":"fs-1286","name":"Levonorgestrel","dosage":"Contraception: 30mcg daily oral, starting 1st day menstruation. Intrauterine T-systern 52mg or 13.5mg: insert within 7 days of start of menstruation, replace after 3yr. Post-coital: 0.75mg stat and in 12H, or 1.5mg stat oral preferably within 12H and no later than 7211r; or 0.5mg + ethinyloestradiol 10Omcg oral witllin 72hr, repeat in 12H. See ethinyloestradiol, oestradiol."},{"id":"fs-1287","name":"Levonorgestrel +oestradiol","dosage":"7/50mcg or 15/45 per day patch. Post-menopausal (NOT/kg): 1 patch/wk."},{"id":"fs-1288","name":"Levorphanol","dosage":"0.03-0.1 mg/kg 12-24H-1 oral or SC."},{"id":"fs-1289","name":"Levosimendan","dosage":"0.3mg/kg {adult 0.15-0.3mg/kg) in 6ml/kg 5%1J (no heparin) and give 1.5ml/kg/hrfor 10min (12.5 meg/kg), then 0.24ml/kg/hr (0.2mcg/kg/min; adult 0.1-0.2 meg/kg/min) for 24H IV. Via CVC or peripheral IV."},{"id":"fs-1290","name":"Levothyroxine sodium","dosage":"See thyroxine."},{"id":"fs-1291","name":"Lidocaine","dosage":"See lignocaine."},{"id":"fs-1292","name":"Lifitegrast","dosage":"5% 1 drop per eye 12H."},{"id":"fs-1293","name":"Lignocaine","dosage":"IV: 1% solution 0.1ml/kg (1mg/kg) over 2min, then 0.09-0.3ml/kg/hr (15-50mcg/kg/min); or 30mg/kg in 50ml at 50ml/hr for 2min, then 1.5-15ml/hr (15-50mcg/kg/min). Nerve block: without adrenaline max 4mg/kg (0.4ml/kg of 1%), with adrenaline 7mg/kg (O.lml/kg of 1%). Topical spray: max 3-4 mg/kg (Xylocaine 10% spray pack: about 10mg/puff). Topical 2% gel, 2.5% compound mouth paint/gel (SM-33), 2% and 4% solution. 5% ointment, 10% dental ointment: apply 3H prn. l0age 60 Calculation of drug infusions (50ml syringe pump)"},{"id":"fs-1295","name":"Lignocaine 2.5% + prilocaine 2.5%","dosage":"Cream (EMLA): 0.5g /10cm2(0-3mo) 1g/10cm2(3mo-12yr) 1-2g/10cm' (>12yr) under occlusive dressing for 1-3hr. Patch (EMLA): max 1 for 1 hr (0-3mo), 2 for 4hr (3-12mo), 5 for 4hr (>12mo)."},{"id":"fs-1296","name":"Lignocaine+ tetracaine","dosage":"Cream 70mg+70mg/g. >18yr: apply 1.3g/10cm2 for 30-60min, max 400cm2."},{"id":"fs-1297","name":"Linaclotide","dosage":"Adult, NOT/kg: 145-290mcg daily oral. ~"},{"id":"fs-1298","name":"Linagliptln","dosage":"Adult NOT/kg 5mg tab daily. See empagliflozin."},{"id":"fs-1299","name":"Linagliptin + metformin","dosage":"Adult, NOT/kg oral. 2.5/1000mg, 2.5/850,5/1500: 1 tab 12H. ER2.5/1000mg, 5/1000: 1 tab daily. ,"},{"id":"fs-1300","name":"Lincomycin","dosage":"15mg/kg (adult 600mg) 8H oral, IM or IV over 1 hr. Severe inftn: 15-20mg/kg (adult 1.2g) IV over 2H 6H."},{"id":"fs-1301","name":"Lindane","dosage":"1% cream, lotion. Scabies: apply from neck down, wash off after 8-12H. Lice: rub into hair for 4min, then wash off; repeat after 24H (max x2/wk)."},{"id":"fs-1302","name":"Linezolid","dosage":"10mg/kg SH (child, max 600mg) or 600mg 12H (adult), IV over 1-2H or oral."},{"id":"fs-1303","name":"Linoleic acid","dosage":"See fatty acids."},{"id":"fs-1304","name":"Liothyronine sodium (L T3)","dosage":"Oral: 0.2mcg/kg (adult 10mcg)"},{"id":"fs-1305","name":"SH, titrated to 0.4mcg/kg (adult 20mcg) 8H","dosage":"IV: 0.1-0.4 meg/kg (adult 5-20mcg) 8-12H. Septic sl10ck: 0.1-0.2 mcg/kg/hr (adult 1D0-200mcg/day) IV. l.T4, See thyroxine."},{"id":"fs-1306","name":"Liotrix (L T3/LT4)","dosage":"Adult, NOT/kg: 12.5/50mcg to 25/100 daily oral."},{"id":"fs-1307","name":"Lipase, lipolytic enzymes","dosage":"See pancreatic enzymes."},{"id":"fs-1308","name":"Lipegfilgrastim","dosage":"Adult, NOT/kg: 6mg SC day 2 of chemo cycle."},{"id":"fs-1309","name":"Lipid","dosage":"20%: 1-3g/kg/day IV (ml/hr = g/kg/day x Wt x 0.21)."},{"id":"fs-1310","name":"Liraglutide","dosage":"Adult, NOT/kg SC: diabetes 0.6mg for 1wk, then 1.2-1.8mg daily; obesity 0.6mg increase over 5wk to 3mg daily."},{"id":"fs-1311","name":"Lisdexamphetamine","dosage":"NOT/kg. 6-12yr: 30mg daily oral, increase over 2-3wk to max 70mg daily. l.isinopril. 0.1 mg/kg (adult 5mg) daily oral, may increase over 4- 6wk to 0.2-1 mg/kg (adult 10-20mg) daily."},{"id":"fs-1312","name":"Lithium","dosage":"5-20mg/kg 8-24H oral. Slow release tab 450mg (adult, NOT/kg): 1-2. tab 12H. Maintain trough level 0.8. 1.6mrnoi/L (>2mmoi/L toxic)."},{"id":"fs-1313","name":"Lixisenatide","dosage":"Adult, NOT/kg: 10mcg daily SC for 2wk, then 20mcg daily."},{"id":"fs-1314","name":"L-methylfotate","dosage":"Adult, NOT/kg: 7.5-15mg daily oral."},{"id":"fs-1315","name":"Lodoxamide","dosage":"0.1% solution: 1 drop/eye 6H."},{"id":"fs-1316","name":"Lofepramide","dosage":"Adult, NOT/kg: 70mg am, 70-'140mg night oral."},{"id":"fs-1317","name":"Lofexidine","dosage":"2-8mcg/kg (adult 10Q. 400mcg) 6-12H oral."},{"id":"fs-1318","name":"Lomefloxacin","dosage":"Smg/kg (adult 400mg) daily oral."},{"id":"fs-1319","name":"Lomita pi de","dosage":"Adult, NOT/kg: 5mg daily oral, increase every 4wk to max 60mg daily if tolerated."},{"id":"fs-1320","name":"Lomustine (CCNU)","dosage":"100-130mg/m2 oral every 6 wk."},{"id":"fs-1321","name":"Loperamide","dosage":"0.05-0.1 mg/kg (adult 2-4mg) 8-12H oral, increase if required to max 0.4mg/kg (max 4mg) 8H."},{"id":"fs-1322","name":"Lopinavir + ritonavir (LPV/r)","dosage":"~2wk: 230/57.5 mg/m2 (max 400/100 mg) 1211 oral. With efavirenz, fosamprerwvir, nelfin- Pane 63 avir or nevirapine (if ;e6mo): 300/75 mg/m2 (max 600/150mg) 12H. Trough lopinavir ~10OOng/ml."},{"id":"fs-1323","name":"Lopinavir + ritonavir + saquinavir","dosage":"7 -15yr: l.PV 400mg/m2 + RTV 100mg/m2 + SQV 750mg/m2 12H oral."},{"id":"fs-1324","name":"Loprazolam","dosage":"Adult, NOT/kg: 1mg (max 2mg) bedtime oral."},{"id":"fs-1325","name":"Loracarbef","dosage":"4-8mg/kg (adult 200-400mg) 12H oral."},{"id":"fs-1326","name":"Loratadine","dosage":"NOT/kg: 2.5mg (1yr-12kg) 5mg (12-30kg), 10mg (>30kg) daily oral."},{"id":"fs-1327","name":"Lorazepam","dosage":"0.02-0.06mg/kg (adult 1-3mg) 8-24H oral. IV: 0.05-0.2mg/kg IV over 2min, then 0.01-0.1 mg/kg/hr."},{"id":"fs-1328","name":"Lorcaserin","dosage":"Adult, NOT/kg: 10mg 12H oral."},{"id":"fs-1329","name":"Lormetazepam","dosage":"Adult, NOT/kg: 0.5mg (max 1.5mg) at bed- time oral."},{"id":"fs-1330","name":"Losartan","dosage":"0.5-2mg/kg (adult 25-100mg) daily oral."},{"id":"fs-1331","name":"Loteprednol","dosage":"NOT/kg. 0.5% 1-2 drops/eye 6H."},{"id":"fs-1332","name":"Lovastatin","dosage":"0.4-0.8mg/kg (adult 20-40mg) 12-24H oral. Slow release (adult, NOT/kg): 10-60mg at bedtime."},{"id":"fs-1333","name":"Lovastatin +niacin","dosage":"20/500mg, 20/750, 20/1000 or 40/1000 slow-rei tab. 20mg/500mg at bedtime oral, increase if required every 4wk by 500mg niacin to max 40mg/2000mg."},{"id":"fs-1334","name":"Loxapine","dosage":"0.2-1mg/kg (adult 10-60mg) 6-12H oral, IM. Inhaled (adult, NOT/kg): 10mg daily."},{"id":"fs-1335","name":"Lopinavir + ritonavir (LPV/r)","dosage":"2:2wk: 230/57.5 mg/m2 (max 400/100mg) 12H oral. With efavirenz, fosamprenavir, nelfina vir or nevirapine (if 2:6mo): 300/75 mg/m2 (max 600/150mg) 12H. Trough lopinavir 2:10OOng/ml."},{"id":"fs-1336","name":"Lopinavir + ritonavir + saquinavir","dosage":"7-15yr: LPV 400mg/m2 + RTV 100mg/m2 + SQV 750mg/m212H oral."},{"id":"fs-1337","name":"Loprazolam","dosage":"Adult, NOT/kg: 1 mg (max 2mg) bedtime oral."},{"id":"fs-1338","name":"Loracarbef","dosage":"4-8mg/kg (adult 200-400mg) 12H oral."},{"id":"fs-1339","name":"Loratadine","dosage":"NOT/kg: 2.5mg (1yr-12kg) 5mg (12-30kg), 10mg (>30kg) daily oral."},{"id":"fs-1340","name":"Lorazepam","dosage":"0.02-0.06mg/kg (adult 1-3mg) 8-24H oral. IV: 0.05-0.2mg/kg IV over 2min, then 0.01-0.1mg/kg/hr."},{"id":"fs-1341","name":"Lorcaserin","dosage":"Adult, NOT/kg: 10mg 12H oral."},{"id":"fs-1342","name":"Lormetazepam","dosage":"Adult, NOT/kg: 0.5mg (max 1.5mg) at bed- time oral."},{"id":"fs-1343","name":"Losartan","dosage":"0.5-2mg/kg (adult 25-100mg) daily oral."},{"id":"fs-1344","name":"Loteprednol","dosage":"NOT/kg. 0.5% 1-2 drops/eye 6H."},{"id":"fs-1345","name":"Lovastatin","dosage":"0.4-0.Bmg/kg (adult 20-40mg) 12-24H-1 oral. Slow release (adult, NOT/kg): 10-60mg at bedtime."},{"id":"fs-1346","name":"Lovastatin + niacin","dosage":"20/500mg, 20/750, 20/1000, 40/1000 slow-rei tab. Adult, NOT/kg: 20/500 at bedtime oral, increase if required every 4wk by 500mg niacin to max 40/2000mg."},{"id":"fs-1347","name":"Loxapine","dosage":"0.2-1mg/kg (adult 10-60mg) 6-12H oral, IM. Inhaled (adult, NOT/kg): 10mg daily."},{"id":"fs-1348","name":"L-tryptophan","dosage":"Adult, NOT/kg: 1-2g 8H oral."},{"id":"fs-1349","name":"Lubiprostone","dosage":"Adult, NOT/kg: 8-24mcg 12H oral with food."},{"id":"fs-1350","name":"Luliconazole","dosage":"1% cream. Apply daily."},{"id":"fs-1351","name":"Lumacaftor","dosage":"See ivacaftor. Page 64"},{"id":"fs-1352","name":"Lumefantrine (benflumetol)","dosage":"See artemether."},{"id":"fs-1353","name":"Lurasidone","dosage":"Adult, NOT/kg: 40mg daily oral with food, increase to max 80mg daily if required."},{"id":"fs-1354","name":"Lutropin alfa (luteinising hormone)","dosage":"Adult, NOT/kg: 75iu daily SC, with 75-150iu follicle stimulating hormone."},{"id":"fs-1355","name":"Lymecycline","dosage":"408mg = 300mg tetracycline base. Adult, NOT/kg: 408mg 121-l oral."},{"id":"fs-1356","name":"Lymphocyte immune glob","dosage":"See immunoglobulin, lymphocyte."},{"id":"fs-1357","name":"Lynestrenol","dosage":"Mentrual disorders (NOT/kg): 5mg (max 15mg) daily oral. Contraception: 0.5-2.5mg daily."},{"id":"fs-1358","name":"Lypressin (lysine-8-vasopressin)","dosage":"1 spray (2.5iu) in 1 nostril 4-81-l, may increase to 1 spray both nostrils 4-81-l. T:/, 15min."},{"id":"fs-1359","name":"Lysuride","dosage":"Migraine: 0.5mcg/kg (adult 25mcg) 8H oral. Parkinson's, adults (NOT/kg): 0.2mg daily, increase by 0.2mg daily each wk to max 1.6mg 81-l oral."},{"id":"fs-1360","name":"Macitentan","dosage":"NOT/kg: 10mg daily oral; gradual introdtn in child."},{"id":"fs-1361","name":"Macrogol3350, 105g/L","dosage":"2-11yr 6.563g in 60ml water, >11yr 13. 125g in 125m I water: 1 sachet daily oral, increase to 2-3/day if required. Faecal impactn >2yr: one 13. 125g sachet in 125ml water per 5kg body wt (adult 8 sachet) consumed in <6hr (max 3 days therapy). See also colonic lavage."},{"id":"fs-1362","name":"Macrogol 3350 powder 255g in 2L Gatorade","dosage":"Adult 1 L oral over 1 hr night before, 1 L next moming 5hr pre-colonoscopy. llilacrogol 400 (polyethylene glycol) 1% + tetrahydrozoline 0.05%. 1 drop/eye 8-12H."},{"id":"fs-1363","name":"Macrogol 4000","dosage":";eayr (NOT/kg): 10-20g daily oral."},{"id":"fs-1364","name":"Mafenide acetate","dosage":"8.5% cream: apply 2mm layer 12-24H. 5% solution: apply 4-8H to keep dressings wet."},{"id":"fs-1365","name":"Maggots of Lucilia sericata, sterile","dosage":"Packs: standard (for standard wound), boot (toe, amputation stump), boot (foot), sleeve (limb wound). Change after 3 days; sooner if required."},{"id":"fs-1366","name":"Magnesium alginate","dosage":"See alginic acid."},{"id":"fs-1367","name":"Magnesium aspartate (Magmin)","dosage":"500mg tab= 1.5mmol Mg. Low Mg: 5 tabs per m2 per day in divided doses."},{"id":"fs-1368","name":"Magnesium chloride 10%","dosage":"0.48g/5ml = Mg 1mmollml. Low"},{"id":"fs-1369","name":"Mg: 0.4ml/kg slow IV, then 0.3ml/m2/hr","dosage":"My infarct (NOT/kg): 5mlhr IV for 6hr, then 1 ml/hr for 24-48hr. VF: 0.06ml/kg IV."},{"id":"fs-1370","name":"Magnesium hydroxide","dosage":"58mg = Mg 1mmol. Low Mg: 7.5 mrnol/m2/day oral (1.4 ml/m2 6H of 78mg/ml solution). Antacid: 10-40mg/kg (max 2g) 61-l oral. Laxative: 50-100mg/kg (max 5g). See also AI hydroxide+ Mg hydroxide+ simethicone."},{"id":"fs-1371","name":"Magnesium oxide","dosage":"40mg = Mg 1 rnmol. Low Mg: 7.5 mmol/m2/day oral (1.4 ml/m2 61-l of 55mg/ml solution)."},{"id":"fs-1372","name":"Magnesium sulphate 50% (2mmol/ml)","dosage":"Low Mg: 0.2mlkg IM or slow IV, then 0. 16ml/m2/hr. Asthma, digoxin tachycardia, eclampsia, prem labour, pul ht: 0.1 mlkg (50 mg/kg) IV over 20min, then 0.06 mlkg/hr (30mg/kg/hr); keep serum Mg 1.5- 2.5mmoi/L (pul ht 3-4mmoi/L). Myoc infarct (NOT/kg): 2.5 ml/hr (5mmol/hr) IV for 6hr, then 0.5 mlhr (1 mmol/hr) for 24- 48hr. VF: 0.05-0.1 ml/kg (0.1-0.2 mmol/kg) IV. Incompatible Page 65 with aminophylline, ketamine, salbutamol. Laxative: 1 mlkg = 0.5g/kg (max 15g) as 10% solution 8H for 2 days oral."},{"id":"fs-1373","name":"Malathion","dosage":"See maldison."},{"id":"fs-1374","name":"Maldison","dosage":"0.5% liquid: 20ml to hair, wash off after 12H."},{"id":"fs-1375","name":"Mannitol","dosage":"0.25-0.5g/kg IV (2-4ml/kg of 12.5%, 1.25-2.5ml/kg of 20%, 1-2mlkg of 25%) 2H prn, if ser osmolal <330mmoi/L."},{"id":"fs-1376","name":"Maprotiline","dosage":"0.15-1mg/kg (adult 10-50mg) 8-24H oral."},{"id":"fs-1377","name":"Maraviroc (MVC)","dosage":"?: 16yr: 150mg (with strong CYP3A inhibit ors, incl protease inhibitors), 300mg (with tipranavir or riton avir), 600mg (with CYP3A inducers, incl efavirenz) 12H oral. Resistant HIV-1 trough >50 ng/ml."},{"id":"fs-1378","name":"Marimastat","dosage":"Adult, NOT/kg: 5-25mg (usual 10mg) 12H oral."},{"id":"fs-1379","name":"Mazindol","dosage":"Adult, NOT/kg: 0.5mg daily oral, up to 3mg daily."},{"id":"fs-1380","name":"Measles vaccine (Attenuvax)","dosage":"Live. ?:12mo: 0.5ml SConce."},{"id":"fs-1381","name":"Measles+ mumps vaccine (Rimparix)","dosage":"Live. ?:12mo: 0.5ml SConce."},{"id":"fs-1382","name":"Measles+ mumps+ rubella vaccine (MMRII, Priorix)","dosage":"Live. ?:12mo: 0.5ml SC. Measles + mumps + rubella +varicella vaccine (Priorix"},{"id":"fs-1383","name":"Tetra)","dosage":"?:9mo: 0.5ml SC, if 9mo-12yr boost after 6-12wk."},{"id":"fs-1384","name":"Mebendazole","dosage":"Oral, NOT/kg: 50mg (6mo-10kg) 100mg (>10kg) 12H x3 days (hook, round, whip) or single dose repeated after 2wk (thread)."},{"id":"fs-1385","name":"Mebeverine","dosage":"135mg tab: Adult, NOT/kg 1-3 tab daily oral."},{"id":"fs-1386","name":"Mebhydrolin","dosage":"1-2mg/kg (adult 50-100mg) 8-12H oral."},{"id":"fs-1387","name":"Mecamylamine","dosage":"0.05mg/kg (adult 2.5mg) 12H oral; may increase to max 0.5mg/kg (adult 25mg) 6H oral."},{"id":"fs-1388","name":"Mecasermin","dosage":"40-SOmcg/kg (max 120mcg/kg) 12H SC."},{"id":"fs-1389","name":"Mechlorethamine","dosage":"See mustine HCI."},{"id":"fs-1390","name":"Meclizine","dosage":"See meclozine."},{"id":"fs-1391","name":"Meclofenamate","dosage":"1-2mg/kg (adult 50-100mg) 6-8H oral."},{"id":"fs-1392","name":"Meclozine","dosage":"0.5-1mg/kg (adult 25-50mg) 12-24H oral."},{"id":"fs-1393","name":"Mecysteine","dosage":"Adult, NOT/kg: 200mg 8-12H oral."},{"id":"fs-1394","name":"Medroxyprogesterone","dosage":"Adult, NOT/kg: 5mg daily for 5-10 days per month oral; precocious puberty 5-10mg daily; to achieve amenorrhoea 10-20mg daily; uterine hge 60mg daily reducing over 10 days to 10mg; malignancy 0.5g daily IM or oral for 4wk, then 1 g wkly. Depot contraceptive: 150 mg deep IM during 1\\" 5 days of cycle, then repeat every 12wk. See also conjugated oestrogens."},{"id":"fs-1395","name":"Medroxyprogesterone +oestradiol","dosage":"2.5/1mg, 5/0.625, 5/1, 5/2 tabs. Post-menopausal: 1 tab daily oral. Medroxyprogesterone 10mg tab+ oestradiol 4mg patch. NOT/kg: 10mg tab daily oral for first 10-14 days of each 28 day cycle, and 4mg patch x2/wk continuously."},{"id":"fs-1396","name":"Medrysone","dosage":"1% solution: 1 drop/eye 6-12H."},{"id":"fs-1397","name":"Mefenamic acid","dosage":"10mg/kg (adult 500mg) 8H oral."},{"id":"fs-1398","name":"Mefloquine hydrochloride","dosage":"15mg/kg (max 750mg) stat, then 10mg/kg (max 500mg) after 6-12H. Prophylaxis: 5mg/kg (adult 250mg) wkly. 15mg hydrochloride= 13.7mg base. Page 66"},{"id":"fs-1399","name":"Mefruside","dosage":"0.5-1mg/kg (up to 2mg/kg for 3 days) daily 10-14 days. then 0.5-1mg/kg (adult 25-50mg) every 2-3 days."},{"id":"fs-1400","name":"Megestrol acetate","dosage":"NOT/kg: 80mg per dose 12H oral."},{"id":"fs-1401","name":"Meglumine antimonate","dosage":"Soltn 85mg/ml of pentavalent antimony. Same dose as sodium stibogluconate, deep IM."},{"id":"fs-1402","name":"Melatonin","dosage":"Usually 0.1 mg/kg (adult 5mg) at night oral. Slow- rei (NOT/kg): 2mg tab at night. Sack NEJM 2010;362:440."},{"id":"fs-1403","name":"Meloxicam","dosage":"0.1-0.3mg/kg (adult 5-15mg) daily oral, PR."},{"id":"fs-1404","name":"Melphalan","dosage":"Usually 6mg/m2 daily x5, repeat every 6wk."},{"id":"fs-1405","name":"Memantine","dosage":"Adult, NOT/kg: 5mg daily oral, increase by 5mg wkly to max 10mg 12H. See donepezil."},{"id":"fs-1406","name":"Menadiol, menadione","dosage":"See menaphthone sod bisulphate."},{"id":"fs-1407","name":"Menapthone sodium bisulphite (vitamin K3)","dosage":"NOT/kg: 5- 10mg x1-2/wk (infant) 10mg daily (child) 10mg 8H (adult) oral. Mitochondrial dis (all ages, noUkg): 10mg 6H oral. Meningococcus gp A, C, W135, Y conjugate vaccines."},{"id":"fs-1408","name":"Inanimate","dosage":"Menactra 2-55yr 0.5miiM. Menveo 11-55yr 0.5ml"},{"id":"fs-1410","name":"ACWY)","dosage":"Inanimate. >2yr: 0.5ml SC. Boost 1-3yrly. Meningococcus gp B, conjugate vaccine (Bexsero)."},{"id":"fs-1411","name":"Inanimate","dosage":"0.5mi1M: 2mo, 3mo, 4mo, boost 12-23mo; 6-11 rno x2 doses <:2mo apart, boost 12-23mo; 1-10yr x2 doses ;,2mo apart; 11-50yr x2 doses 2:1 mo apart. Meningococcus gp B, conjugate vaccine (Trumenba)."},{"id":"fs-1412","name":"Inanimate","dosage":"10-25yr 0.5ml x3 doses: stat, 2mo, 6mo IM. Meningococcus gp C, conjugate vaccine (Meningitec,"},{"id":"fs-1413","name":"Menjugate, NeisVac-C)","dosage":"Inanimate. 0.5miiM: 3 doses 1- 2mo apart (6wk-6mo), 2 doses (6-12mo), 1 dose (>12mo)."},{"id":"fs-1414","name":"Menopausal gonadotrophin","dosage":"See rnenotrophin."},{"id":"fs-1415","name":"Menotrophin (FSH + LH activity)","dosage":"Females (NOT/kg): 75+ 75iu or 150+150'1u IM daily for 9-12 days until oestrogen levels rise, then give HCG. Males (NOT/kg): 75+75iu IM x2- 3/wk with HCG 7000iu IM x2/wk."},{"id":"fs-1416","name":"Mepenzolate","dosage":"Adult, NOT/kg: 25-50mg 6H oral."},{"id":"fs-1417","name":"Meperidine","dosage":"See pethidine."},{"id":"fs-1418","name":"Mephenytoin","dosage":"See methoin."},{"id":"fs-1419","name":"Mephobarbital","dosage":"See rnethylphenobarbitone."},{"id":"fs-1420","name":"Mepivacaine","dosage":"Max dose 5-7mg/kg."},{"id":"fs-1421","name":"Mepolizumab","dosage":"Adult, NOT/kg: 100mg every 4wk SC."},{"id":"fs-1422","name":"Meprobamate","dosage":"5-10mg/kg (max 800mg) 8-12H oral."},{"id":"fs-1423","name":"Meptazinol","dosage":"4mg/kg (adult 200mg) 3-6H oral."},{"id":"fs-1424","name":"Mepyramine","dosage":"2-4mg/kg (adult 100-200mg) 8H oral."},{"id":"fs-1425","name":"Mequitazine","dosage":"0.1 mg/kg (adult 5mg) 12H oral."},{"id":"fs-1426","name":"Mercaptamine","dosage":"See cysteamine."},{"id":"fs-1427","name":"Mercaptopurine (6MP)","dosage":"75-1 00mg/m2 daily oral."},{"id":"fs-1428","name":"Meropenem","dosage":"10-20mg/kg (adult 0.5-1 g) 8H IV over 5. 30min. Severe inftn: 20-40mg/kg (adult 1-2g) 12H (1st wk life) 8H (>1wk) or constant infusion."},{"id":"fs-1429","name":"Mesalazine (mesalamine)","dosage":"Usually high initial dose, lower Page 67 maintenance. Mesasal, Salofalk: 15-20mg/kg (adult 500mg) 8H, deer to 10mg/kg (adult 250mg) 8H oral. Adult, NOT/kg: 0.4-1.6g 8H (Asacol, Coltec); 0.5-1g 6H (Pentasa); slow release 1.5g (Apriso) 2.4-4.8g (Lialda) daily oral. Suppes: 0.5-1g 8H. Enema: 1-4g nocte."},{"id":"fs-1430","name":"Mesna","dosage":"IV over 30min: 20% of cyclophosphamide or ifos famide dose at 0, 4 and 6 hr. Oral: 40% of dose of cytotoxic at -2, 2 and 6hr. Nebulisr: 0.6-1.2g (NOT/kg) 4-6H."},{"id":"fs-1431","name":"Mesoridazine","dosage":"Oral: 0.25-3mg/kg (adult 25-150mg) 8H. IM: 0.5mg/kg (adult 25mg, max 200mg/day)."},{"id":"fs-1432","name":"Mesterolone","dosage":"0.5mg/kg (adult 25mg) 6-12H oral."},{"id":"fs-1433","name":"Mestranol 50mcg + norethisterone 1mg","dosage":"Contraception: tab daily from 5th to 25th day of menstrual cycle."},{"id":"fs-1434","name":"Metaproterenol","dosage":"See orciprenaline."},{"id":"fs-1435","name":"Metaraminol","dosage":"IV: 0.01 mg/kg stat (repeat prn), then 0.15 mg/kg in 50ml 5% dextrose (no heparin) at 1-10ml/hr (0.05- 0.5mcg/kg/min) and titrate dose against BP. SC: 0.1mg/kg."},{"id":"fs-1436","name":"Metaxalone","dosage":"15mg/kg (max 800mg) 6-8H oral."},{"id":"fs-1437","name":"Metformin","dosage":"NOT/kg: 250mg (8-10yr) 500mg (>10yr) daily oral; increase slowly 1-2wkly to max 1 g 8H. See also alogliptin, cana gliflozin, dapagliflozin, empagliflozin, glibenclamide."},{"id":"fs-1438","name":"Metformin + rosiglitazone","dosage":"500/2, 1000/2 or 1 000/4mg tab. Adult: 1000/2 (1000/4 after 8wk if required) 1 tab 12H oral."},{"id":"fs-1439","name":"Metformin + saxagliptin","dosage":"500/5, 1000/5 or 1 000/2.5mg extended-release tab. Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-1440","name":"Metformin + sitagliptin","dosage":"500/50 or 1 000/50mg cap. 1-2 cap 12H (max 2000mg/100mg per day) oral."},{"id":"fs-1441","name":"Metformin + vildagliptin","dosage":"50/850mg or (if tolerated) 50/1000 12H oral."},{"id":"fs-1442","name":"Methacycline","dosage":"NOT/kg: 150mg (>By) 300mg (>12y) 12H oral."},{"id":"fs-1443","name":"Methadone","dosage":"0.1-0.Zmg/kg (adult 5-10mg) 6-12H oral, SC, IM."},{"id":"fs-1444","name":"Methamphetamine","dosage":"See methylamphetamine."},{"id":"fs-1445","name":"Methazotamide","dosage":"1-2mg/kg (adult 50-100mg) 8-12H oral."},{"id":"fs-1446","name":"Methdilazine","dosage":"0.1-0.3mg/kg (adult 4-16mg) 12-24H-1 oral."},{"id":"fs-1447","name":"Methenamine hippurate or mandelate","dosage":"See hexamine."},{"id":"fs-1448","name":"Methenolone","dosage":"Adult, NOT/kg. Oral: 5-10mg 12H. IM: 100mg every 1-2wk or 200mg every 2-3wk (carcinoma); 50-100mg every 2wk, then every 3-4wk (osteopor)."},{"id":"fs-1449","name":"Methimazole","dosage":"0.3-1mg/kg (adult 20-60mg) daily oral, reducing to 0.1-0.5mg/kg (adult 5-30mg) daily."},{"id":"fs-1450","name":"Methionine","dosage":"50mg/kg (max 2.5g) oral 4H for 4 doses. Prophylaxis: 1 mg to paracetamol 5mg."},{"id":"fs-1451","name":"Methocarbamol","dosage":"Oral: 30mg/kg (adult 1.5g) 6H for 3 days, then 15-20mg/kg (adult 0.75-1g) 6-8H. IV over 5-10 min or IM: 15mg/kg (adult 750mg) 6H."},{"id":"fs-1452","name":"Methohexital","dosage":"See methohexitone."},{"id":"fs-1453","name":"Methohexitone","dosage":"1-2mg/kg (adult 50-120mg) slow IV."},{"id":"fs-1454","name":"Methoin","dosage":"1 mg/kg (adult 50mg) daily oral, may increase by 1 mg/kg each wk to max 10mg/kg (adult 600mg) dailt"},{"id":"fs-1455","name":"Methotrexate","dosage":"Leukaemia: typically 3.3mg/m IV daily for 4- Page 68 6wk; then 2.5mg/kg IV every 2wk, or 30mg/m2 oral or IM x2/wk; higher doses with folinic acid rescue. Intrathecal: 12 mg/m2 wkly for 2wk, then monthly. Arthritis, psoriasis, Crohn: 15mg/m2 (max 25mg) wkly oral, IV, IM or SC until response, then reduce."},{"id":"fs-1456","name":"Methotrimeprazine","dosage":"0.25-1mg/kg (adult 12.5-50mg) 6-8H oral, IM or IV. Up to 1g/day in severe psychosis."},{"id":"fs-1457","name":"Methoxamine","dosage":"0.1-0.4mg/kg (adult 5-20mg) IM, or 0.1-0.2 mg/kg (adult 5-10mg) IV over 5-10min (at least 15min between doses). Nose drop 0.25%: 1-3drop/nostrii6-12H."},{"id":"fs-1458","name":"Methoxsalen","dosage":"Adult, NOT/kg: 20mg 2H before UV exposure. 1% lotion: wkly before 1 min of UV light."},{"id":"fs-1459","name":"Methoxyflurane","dosage":"Adult: 0.2-0.7% max 6ml/day or 15ml/wk."},{"id":"fs-1460","name":"Methoxy polyethylene glycol-epoetin beta","dosage":"See epoetin."},{"id":"fs-1461","name":"Methoxypsoralen","dosage":"See methoxsalen."},{"id":"fs-1462","name":"Methscopolamine","dosage":"See hyoscine methobromide."},{"id":"fs-1463","name":"Methsuximide","dosage":"5mg/kg (adult 300mg) daily, may increase to max 10mg/kg (adult 400mg) s. 12H oral."},{"id":"fs-1464","name":"Methyclothiazide","dosage":"0.05-0.2mg/kg (adult 2.5-10mg) daily oral."},{"id":"fs-1465","name":"Methyl aminolevulinate","dosage":"See aminolevulinic acid."},{"id":"fs-1466","name":"Methylcellulose","dosage":"Constipation: 30-60mg/kg (adult 1.5-3g) with at least 10ml/kg (adult 300ml) fluid 12H oral. Obesity: 30mg/kg (adult 1.5g) with 5ml/kg water %hr before a meal."},{"id":"fs-1467","name":"Methylcysteine","dosage":"4mg/kg (adult 200mg) 5. 12H oral."},{"id":"fs-1468","name":"Methyldopa","dosage":"3mg/kg (adult 150mg) 8H oral, may increase to max 15mg/kg/dose (adult 750mg)."},{"id":"fs-1469","name":"Methyldopate","dosage":"5-20mg/kg (adult 0.25-1g) 6H IV over 1H."},{"id":"fs-1470","name":"Methylene blue","dosage":"1-2mg/kg (G6PD deficiency 0.4mg/kg) IV prn. Septic shock: 2mg/kg stat IV, then 0.25-2mglkg/hr."},{"id":"fs-1471","name":"Methylergometrine","dosage":"Adult, NOT/kg: 200mcg IM, IV over 5min, or oral; rnay repeat in 2H, then 4-6H."},{"id":"fs-1472","name":"Methylergonovine","dosage":"See methylergometrine."},{"id":"fs-1473","name":"Methylnatrexone","dosage":"0.15mglkg (max 12mg) 48H SC."},{"id":"fs-1474","name":"Methylphenidate","dosage":"5mg (<12yr) 10mg (>12yr) oral Sam, noon and (occasionally) 4pm; increase wkly if required to max 0.4mg/kg per dose (adult 20mg). Long acting (NOT/kg): child 10-60mg (adult 10-80mg) in moming. Transdermal patch: apply for up to 9hr; start with 12.5crn2, and increase to 18. 75cm2, 25cm2, and 3\\"1.5cm2 if rqd."},{"id":"fs-1475","name":"Methylphenobarbitone","dosage":"4-12mglkg (adult 200-600mg) daily."},{"id":"fs-1476","name":"Methylprednisolone","dosage":"Asthma: 0.5-1 mg/kg 6H oral, IV or IM day 1, 12H day 2, then 1 mglkg daily, reducing to minimum effective dose. Severe croup: 4mg/kg IV stat, then 1 mglkg"},{"id":"fs-1478","name":"Methylprednisolone aceponate","dosage":"0.1% cream, ointment: apply 12. 24H."},{"id":"fs-1479","name":"Methyltestosterone","dosage":"NOT/kg: 2.5-12.5mg/day buccal. Page 69"},{"id":"fs-1480","name":"Methylthioninium chloride","dosage":"0.5-0.5mg/kg (<3mo) 1-2mg/kg (>3mo) IV over 5min, repeat after 1H if required."},{"id":"fs-1481","name":"Methysergide","dosage":"0.02mg/kg (adult 1 mg) 12H oral, increase if required to max 0.04mg/kg (adult 2mg) 8H for 3-6mo."},{"id":"fs-1482","name":"Metipranolol","dosage":"0.1%, 0.3%, adult: 1 drop/eye 12H."},{"id":"fs-1483","name":"Metirosine","dosage":"5-20mg/kg (adult 0.25-1g) 6H oral."},{"id":"fs-1484","name":"Metoclopramide","dosage":"0.1-0.3mg/kg (adult 10-15mg) 8H IV, IM, oral; 0.2-0.4mg/kg (adult 10-20mg) 8H PR. Periop: 0.5 mg/kg (adult 15-20mg) IV stat, then 0.2mg/kg (adult 10mg) 4-6H if required. With chemotherapy: up to 1--2mg/kg 4H IV."},{"id":"fs-1485","name":"Metocurine iodide","dosage":"ICU: 0.4mg/kg IV prn. Theatre: 0.1-0.4 mg/kg stat, then 0.01-0.02mg/kg/dose."},{"id":"fs-1486","name":"Metolazone","dosage":"0.1-0.2mg/kg (adult 5-10mg) daily oral. Up to 0.5mg/kg (adult 30mg) daily short term."},{"id":"fs-1487","name":"Metoprolol","dosage":"IV: 0.1 mg/kg (adult 5mg) over 5 min, repeat every 5 min to max 3 doses, then 1-5mcgikgimin. Oral: 1-2mg/kg (adult 50-100mg) 6-12H."},{"id":"fs-1488","name":"Metreleptin","dosage":"0.06mg/kg (max 5mg) SC daily, increase if required to 0.13mg/kg (max 10mg) daily."},{"id":"fs-1489","name":"Metronidazole","dosage":"Avoid alcohol. 15mg/kg (max 1 g) stat, t11en 7.5mg/kg (max 1g) 12H in neonate (1st maintenance dose 48hr after load if <2kg, 24H in term baby), 8H (4+ wk) IV, PR or oral. Giardiasis: 30mg/kg (adult 2g) daily x3 oral. Amoe biasis: 15mg/kg (adult 750-800mg) 8H oral x10 days, follow with paromycin. 10mg/kg (adult 500mg) 8H oral x10 days."},{"id":"fs-1490","name":"C.difficile: 10 mg/kg (adult 500mg) 8H oral","dosage":"Topical gel 0.5%: apply daily. Level 60-300umol/ml (x0.17mcg/ml)."},{"id":"fs-1491","name":"Metyrapone","dosage":"Diagnosis: 15mg/kg (minimum 250mg) 4H x6 dose oral. Cushing: 1-20mg/kg (max 1 g) 4H."},{"id":"fs-1492","name":"Metyrosine","dosage":"See metirosine."},{"id":"fs-1493","name":"Mexiletine","dosage":"IV infusion: 2-5mg/kg (max 250mg) over 15 min, then 5-20mcg/kg/min (max 250mg/hr). Oral: 8mg/kg (max 400mg) stat, then 4-8mg/kg (max 400mg) 8H starting 2H after load."},{"id":"fs-1494","name":"Mezlocillin","dosage":"50mg/kg 6-8H (1st wk life), 4-6H (2+ wk) IM or IV. Serious inftn: 60mg/kg (max 3g) 4H."},{"id":"fs-1495","name":"Mianserin","dosage":"0.2-0.5mg/kg (adult 10-40mg) 8H oral."},{"id":"fs-1496","name":"Micafungin","dosage":"IV over 1H. Infant 10mg/kg, child 8mg/kg, adult 50-150mg daily. Proph: 1 mg/kg (adult 50mg) daily."},{"id":"fs-1497","name":"Miconazole","dosage":"Topical: 2% cream, powder, lotion, tincture or gel 12-24H. Vaginal: 2% cream or 100mg ovule daily x?. Oral candida (NOT/kg): buccal tab 50mg apply to gum above upper incisor on alternate sides daily x14."},{"id":"fs-1498","name":"Micro lax, Micolette enema","dosage":"See saline laxatives."},{"id":"fs-1499","name":"Midazolam","dosage":"Sedation: usually 0.1-0.2mg/kg (adult 5mg) IV or IM, up to 0.5mg/kg used in children; 0.2mg/kg (repeated in 1 0min if required) nasal; 0.5 mg/kg (max 20mg) oral. Infusion (ventltd): 3mg/kg in 50ml at 1-4ml/hr (1-4mcg/kg /min); fitting usually 2-4 ml/hr (range 1-24ml/hr). 1 mg = 2-3mg diazepam."},{"id":"fs-1500","name":"Midodrine","dosage":"0.06mg/kg (adult 3mg) moming and 4-6pm oral, increase slowly if required to max 0.2-0.4mg/kg (adult 10-20mg) Page 70 moming, noon and 4-6pm. Beware supine hypertension."},{"id":"fs-1501","name":"Mifamurtide","dosage":"2mg/m2 IV x2/wk for 12wk, then wkly lor 24wk."},{"id":"fs-1502","name":"Mifepristone","dosage":"Adult, NOT/kg. Termination: 200mg oral once, then in 24-48hr misoprostol 800mcg buccal or 400mcg oral. Cushing's syndrome: 300mg daily oral with meal, increase every 2wk if required to max 1200mg daily."},{"id":"fs-1503","name":"Miglitol","dosage":"Adult, NOT/kg: 25mg 8-24H increase over 3-6rno to usual maintenance dose of 50mg (max 100mg) 8H oral."},{"id":"fs-1504","name":"Miglustat","dosage":"Y, dose wk1, Y, dose wk2, then 110mg/m2 (adult 200mg) 8H oral if tolerated."},{"id":"fs-1505","name":"Milnacipran","dosage":"0.25mg/kg (adult 12.5mg) daily oral increase over 7 days to 1 mg/kg (adult 50mg) 12H."},{"id":"fs-1506","name":"Milrinone","dosage":"<30kg: 1.5mg/kg in 50ml, 2.5ml over 1 hr (75 meg/kg), then 1-1.5 ml/hr (0.5-0.75mcg/kg/min). >30kg: 1.5 mg/kg made up to 100m I, 5ml over 1 hr (75mcg/kg), then 2-3 mlhr (0,5-0.75mcg/kg/min). TY, 2-3hr."},{"id":"fs-1507","name":"Miltefosine","dosage":"Male 80mg/m2 (max 50mg), female 70mg/m2 (max 50mg) divided into 3 doses per day oral."},{"id":"fs-1508","name":"Mineral mixture (Aminogram)","dosage":"<5.5kg: 1.5g/kg daily oral, mixed with feed. >5.5kg: 8g daily (NOT/kg)."},{"id":"fs-1509","name":"Mineral oil","dosage":"See paraffin liquid."},{"id":"fs-1510","name":"Minocycline","dosage":"Over 8yr: 4mg/kg (max 200mg) stat, then 2mg/kg (max 100mg) 12H oral or IV over 1H. Sustained release tabs (NOT/kg): 45mg (45-59kg), 90mg (60-89kg), 135mg (90kg or more) daily oral. Acne (NOT/kg): 50mg 12H or 100mg daily oral."},{"id":"fs-1511","name":"Minoxidil","dosage":"0.1 mg/kg (max 5mg) daily, increase to max 0.5mg/kg (max 25mg) 12-24H-1 oral. Baldness: 2% solution (male and female) 5% solution (males only) 1mi12H to dry scalp."},{"id":"fs-1512","name":"Mipornersen","dosage":"4mg/kg (adult 200mg) SC weekly."},{"id":"fs-1513","name":"Mirabegron","dosage":"Adult, NOT/kg: 25-100mg daily oral."},{"id":"fs-1514","name":"Mirtazapine","dosage":"0.3-1mg/kg (adult 15-60mg) daily oral."},{"id":"fs-1515","name":"Misoprostol (PGE1 analogue)","dosage":"5mcg/kg (max 200mcg) 4-6H oral. 1\\" trimester spont abortion: 800mcg vaginal, repeat in 24-72hr if tissue passage incomplete. See also mifepristone."},{"id":"fs-1516","name":"Mitomycin-C","dosage":"2mim2 IV daily x1 0 days, repeat only if leuco- cytes >3000/mm + platelets >75,000."},{"id":"fs-1517","name":"Mitotane","dosage":"10-BOmg/kg (adult 0.5-4g) 6H oral."},{"id":"fs-1518","name":"Mitoxantrone","dosage":"See mitozantrone."},{"id":"fs-1519","name":"Mitozantrone","dosage":"Breast cancer or lymphoma: 10-14mg/rrr2 IV over 10min every 3wk. Leukaemia: 10-12mg/m21V over 1 0min daily for 3-5 days. MS: 12mg/m2 IV every 3mo."},{"id":"fs-1520","name":"Mivacurium","dosage":"0.15mg/kg stat, then 0.1mg/kg/dose IV. lnfsn: 5- 15mcg/kg/min."},{"id":"fs-1521","name":"Mizolastine","dosage":"Adult, NOT/kg: slow rei tab, 10mg daily oral."},{"id":"fs-1522","name":"Moclobemide","dosage":"2-3mg/kg (adult 50-150mg) 6-12H oral."},{"id":"fs-1523","name":"Modafinil","dosage":"2-4mg/kg (adult 1 00-200mg) 12H oral. Adult, NOT/kg: 200mg moming (obs sleep apnoea), 1H before shift (night worl( sleep disorder) oral."},{"id":"fs-1524","name":"Moexipril","dosage":"0.15-0.2mg/kg (adult r.5-10mg) 8-24H oral. Page 71"},{"id":"fs-1525","name":"Molgramostim","dosage":"5-10mcg/kg daily SC or IV over 6hr."},{"id":"fs-1526","name":"Molindone","dosage":"0. H.5mg/kg (adult 50--75mg) 8H oral."},{"id":"fs-1527","name":"Mometasone","dosage":"50mcg spray: 1spray/nostril (2-12yr) 2spray/ nostril (>12yr) daily. 0.1% cream or oint: apply daily."},{"id":"fs-1528","name":"Montelukast","dosage":"NOT/kg: 4mg (1-5yr) 5mg (6-14yr) 10mg (>14yr) daily at bedtime, oral. 2H before exercise: 5mg (6- 15yr) 10mg (>15yr) oral, max 1 dose daily."},{"id":"fs-1529","name":"Moracizine","dosage":"4-6mg/kg (adult 200-300mg) 8H oral."},{"id":"fs-1530","name":"Moricizine","dosage":"See moracizine."},{"id":"fs-1531","name":"Moroctogog alfa","dosage":"Recombinant human factor 8; See factor 8."},{"id":"fs-1532","name":"Morphine","dosage":"Half life 2-4 hr. IM: neonate 0.1 mg/kg, child 0.1-0.2 mg/kg, adult 10-20mg; half this IV over 10 min. IV (ventltd): 0.1-0.Zmg/kg/dose (adult 5-10mg). lnfsn of 1mg/kg in 50ml: ventltd neonate 0.5-1.5 ml/hr (10-30mcg/kg/hr), child or adult 1-4ml/hr (20-80mcg/kg/hr). Patient controlled: 20mcg/kg boluses (1 ml of 1 mg/kg in 50ml) with 5min lockout time + (in child) 5mcg/kg/hr. Oral double IM dose; slow release: start with 0.6mg/kg 12H and increase every 48hr if required."},{"id":"fs-1533","name":"Morphine+ cyclizine","dosage":"10mg/50mg or 15/50. Adult, NOT/kg: 10-20mg morphine SC,IM,IV max 4hrly; max 3 doses/day."},{"id":"fs-1534","name":"Morphine + naltrexone","dosage":"20mg/0.8mg, 30/1.2, 50/2, 60/2.4, 80/3.2 or 100/4 cap. 1 cap 12-24H oral."},{"id":"fs-1535","name":"Morrhuate sodium","dosage":"Adult, NOT/kg: 50-250mg per injtn."},{"id":"fs-1536","name":"Moxifloxacin","dosage":"20mg/kg (max 400mg) daily oral or IV. 0.5% ophthalmic: 1 drop/eye SH for 7 days."},{"id":"fs-1537","name":"Moxisylyte","dosage":"Adult, NOT/kg: 40-SOmg 6H oral."},{"id":"fs-1538","name":"Moxonidine","dosage":"4mcg/kg (adult 200mcg) 8-24H oral."},{"id":"fs-1539","name":"Mumps vaccine (Mumpsvax)","dosage":"Live. >12mo: 0.5ml SConce. See also measles + mumps + rubella vaccine."},{"id":"fs-1540","name":"Mupirocin","dosage":"2% ointment: apply 8-12H."},{"id":"fs-1541","name":"MuromonabCD3 (Orthoclone OKT3)","dosage":"0.1 mg/kg (adult 5mg) daily for 10-14 days IV over 1min."},{"id":"fs-1542","name":"Mustine HCI (nitrogen mustard)","dosage":"0.1 mg/kg IV daily for 3-4 days. Hodgl<ins: 6mg/m2 IV day 1,8 of 14 day cycle with 14 days rest. Gel 0.016%: apply daily."},{"id":"fs-1543","name":"Mycophenolic acid","dosage":"400mg/m2 (max 720mg) 12H oral."},{"id":"fs-1544","name":"Mycophenolate mofetil","dosage":"12H oral or IV over 2H: 400mg/m2 (max 1g) + tachrolimus, 600mg/m2 (max 1g) + cyclosporin."},{"id":"fs-1545","name":"Mycophenolate sodium","dosage":"720mg = 1g mofetil. With cyclo sporin: 400-450mg/m2 (max 720mg) 12H oral."},{"id":"fs-1546","name":"Nabilone","dosage":"Adult, NOT/kg: 1mg 12H, up to 2mg 8H oral."},{"id":"fs-1547","name":"Nabixirnols","dosage":"THC/CBD 27/25mg/ml. Adult, NOT/kg: 1 oral spray daily, increase over 2wk to max x5 moming + x7 evening."},{"id":"fs-1548","name":"Nabumetone","dosage":"10-20mg/kg (adult 0.5-1g) 12-24H oral."},{"id":"fs-1549","name":"Nadolol","dosage":"1-5mg/kg (adult 40-240mg) daily oral."},{"id":"fs-1550","name":"Nadroparin","dosage":"Venous thrombosis: 90anti-XaU/kg 12H SC. Prophylaxis: genrl surgery 2850anti-XaU (adult, NOT/kg) daily SC; orthopaedics 40anti-XaU/kg 24H (start' 12H pre. surgery) SC, then 55anti-XaU/kg daily. Haemodialysis: 65anti-XaU/kg into arterial line at start 4hr session. Page 72 'Nafarelin. Adult, NOT/kg: 200mcg spray to 1 nostril 12H."},{"id":"fs-1551","name":"Nafcillin","dosage":"Oral: 15-30mg/kg 6H. Severe inftn (slow IV, IM): 40mg/kg (max 2g) 12H (1st wk life), 8H (2nd wk), 6H or constant infusion (>2wk)."},{"id":"fs-1552","name":"Naftidrofuryl","dosage":"2-4mg/kg (adult 100-200mg) 8H (oral) or 12H (IM, or IV or lA infusion over 2H)."},{"id":"fs-1553","name":"Naftifine","dosage":"1% cream, gel: apply daily."},{"id":"fs-1554","name":"Nalbuphine","dosage":"0.2-0.5mg/kg (adult 20-30mg) 3-6H SC, IM or IV. Anaesthesia: 0.3-1 mg/kg IV over 15min, then 0.2-0.5mg/kg every 30min."},{"id":"fs-1555","name":"Nalidixic acid","dosage":"15mg/kg (adult 1 g) 6H oral, reducing to 7.5mg/kg (adult 500mg) 6H after 2wk."},{"id":"fs-1556","name":"Nalmefene","dosage":"Opiate intoxication: 0.007mg/kg IV, and 0.0014 mg/kg after 2-5min (15min if IM, SC) if required. Postop sedtn: 0.25mcg/kg every 2-5min (max 4 doses). Half life 10hr."},{"id":"fs-1557","name":"Naloxegol","dosage":"Adult, NOT/kg: 12.5-25mg daily oral."},{"id":"fs-1558","name":"Naloxone","dosage":"Postop sedatn: 0.002mg/kg/dose (0.4mg diluted to 20ml, give 0.1 mltkg/dose) repeat every 2min x4 if required, then 0.3mg/kg in 30m I at 1 ml/l1r (0.01 mg/kg/hr) IV. Opiate over dose (including newborn): 0.01 mg/kg (adult 0.4mg) (0.4mg diluted to 10ml, give 0.25ml/kg/dose), repeated every 2min IV (15min if IM or SC) x4 if required, then 0.3mg/kg in 30ml at 1 ml/hr (0.01mg/kg/hr) IV; intranasal (NOT/kg) 1mg mist per nostril, or 4mg in one nostril, repeated if required after 3-5 min."},{"id":"fs-1559","name":"Naltrexone","dosage":"0.5mg/kg (adult 25mg), then 1mg/kg (adult 50mg) daily oral. Adult, NOT/kg slow-rei: 380mg every 4wk IM."},{"id":"fs-1560","name":"Nandrolone decanoate","dosage":"Anaemia: 1-4mg/kg (adult 50-- 200mg) wkly deep IM. Osteoporsis: Adult, NOT/kg 50mg deep IM every 3wk."},{"id":"fs-1561","name":"Naphazoline","dosage":"0.012-0.1%: 1-2drop/nostril, 1drop/eye 3-4H."},{"id":"fs-1562","name":"Naproxen.1mg = 1.1mg naproxen sodium","dosage":">1mo: 5-10mg/kg (adult 250-500mg) 8-12H oral. Adult: 500mg 12H PR."},{"id":"fs-1563","name":"Naproxen + esomeprazole","dosage":"See esomeprazole + naproxen."},{"id":"fs-1564","name":"Naproxen 500mg + sumatriptan 85mg","dosage":"Adult, NOT/kg:1 tab oral, may repeat after 2 hours (max 2 tab per day)."},{"id":"fs-1565","name":"Naratriptan","dosage":"0.05mg/kg (adult 2.5mg), repeat after 4hr if required."},{"id":"fs-1566","name":"Natalizumab","dosage":"Adult, NOT/kg: 300mg IV over 1 hr every 4wk."},{"id":"fs-1567","name":"Natamycin","dosage":"5%: 1 drop in eye x6-8/day for 14-21 days."},{"id":"fs-1568","name":"Nateglinide","dosage":"Adult, NOT/kg: 60-120mg 8H oral."},{"id":"fs-1569","name":"Nebivolol","dosage":"0.1 mg/kg (adult 5mg) daily oral, increase to max 1 mg/kg (adult 40mg) daily."},{"id":"fs-1570","name":"Nebivol 5mg + valsartan 80mg","dosage":"Adult, NOT/kg: 1 tab daily."},{"id":"fs-1571","name":"Nedocromil","dosage":"lnhltn: 4mg (2 puffs) 6H, reducing to 12H when imporoved. 2% eye drops: 1 drop/eye 6-24H."},{"id":"fs-1572","name":"Nefazodone","dosage":"1 mg/kg (adult 50 mg) 12H oral, increase by 1 mg/kg per dose (adult 50mg) each wk to 4-6mg/kg (adult 200-300 mg) 12H. Slow release: daily dose."},{"id":"fs-1573","name":"Nefopam","dosage":"Oral: 0.5-2mg/kg (adult 30-90mg) 8H. IM: 0.4mg/kg (adult 20mg), may repeat in 6hr."},{"id":"fs-1574","name":"Neisseria meningitidis vaccine","dosage":"See meningococcal vacc. Page ?3"},{"id":"fs-1575","name":"Nelarabine","dosage":"Child: 650mg/m2 IV over 1 hr daily for 5 days; repeated every 21 days. Adult: 1500mg/m2 IV over 2H on days 1, 3 and 5; repeated every 21 days."},{"id":"fs-1576","name":"Nelfinavir (NFV)","dosage":"45-55mg/kg (adult 1250mg) 12H oral, or 25- 35mg/kg (adult 750mg) 81-\\\\. MS metabolite trough <:SOOng/ml."},{"id":"fs-1577","name":"Neomycin","dosage":"1 g/m2 4-6H oral (max 12g/day). Bladder washout: 40-2000mg/L. See also colistin; dexamethasone; gramicidin. Neomycin 0.5% +prednisolone sodium phosphate 0.5%. 1 drop/eye 4-6H."},{"id":"fs-1578","name":"Neostigmine","dosage":"Reverse relaxants: 0.05-0.07mg/kg (adult 0.5- 2.5mg) IV; suggested dilution: neostigmine (2.5mg/ml) 0.5ml +atropine (0.6mg/ml) 0.5ml +saline 0.5ml, give 0.1 mlikg IV. Myasth gravis (NOT/kg): neonate 0.05-0.25mg, child 0.2-0.5 mg, adult 1-2.5mg 2-4H IM, SC."},{"id":"fs-1579","name":"Nepafenac","dosage":"1 mg/ml (NOT/kg): 1 drop/eye 8H."},{"id":"fs-1580","name":"Nesirilide","dosage":"2mcg/kg IV, then 0.01mcg/kg/min (range 0.005- 0.03mcg/kg/min)."},{"id":"fs-1581","name":"Netilmicin","dosage":"IV or IM. 1wk-10yr: 8mg/kg day 1, then 6mg/kg daily. >10yr: 7mg/kg day 1, then 5mg/kg (max 240-360mg) daily. Neonate, 5mg/kg dose: <1200g 48H (0-7 days of life), 36H (8. 30 days), 24H (>30 days); 1200-2500g 36H (0-7 days of life), 24H (>7 days); term 24H (0-7 days of life), then as for 1wk-10yr. Trough level <1.0mg/L."},{"id":"fs-1582","name":"Netupitant 300mg + palonosetron 0.5mg","dosage":"1 cap 1 hr pre chemo; + dexamethasone 12mg day1  8mg days 2-4 oral."},{"id":"fs-1583","name":"Nevi rapine (NVP)","dosage":"<Syr: 200mg/m2 (max 200mg) daily oral for 2wk, then 12H if no rash; 28yr: 120-150mg/m2 (max 200mg) daily for 2wk, then 12H if no rash. Min trough 3000 ng/ml."},{"id":"fs-1584","name":"Niacin","dosage":"Adult, NOT/kg: 1.5-Z.Og daily oral."},{"id":"fs-1585","name":"Niacin + lovastatin","dosage":"See lovastatin + niacin."},{"id":"fs-1586","name":"Niacin + simvastatin","dosage":"500mg/20mg, 750/20 or 1000/20 slow rei tab. Adult, NOT/kg: 500mg/20mg at bedtime oral, increase by 500mg every 4wk to max 2000/40mg."},{"id":"fs-1587","name":"Niacinamide","dosage":"Gel, cream: apply 12H."},{"id":"fs-1588","name":"Nicardipine","dosage":"0.4-0.Smg/kg (adult 20-40mg) 8H oral. 1- 3mcg/kg/min (max 20mg/hr) IV."},{"id":"fs-1589","name":"Niclosamide","dosage":"50mg/kg (adult 2g) oral."},{"id":"fs-1590","name":"Nicorandil","dosage":"0.1-0.6mg/kg (adult 5-30mg) 12H oral."},{"id":"fs-1591","name":"Nicotinamide","dosage":"4% gel: apply sparingly 12-24H"},{"id":"fs-1592","name":"Nicotine","dosage":"<:12yr (NOT/kg). Gum 2-4mg: chewed over 30min if inclined to smoke; usually 16-24mgiday, max 60mg/day."},{"id":"fs-1593","name":"Lozenge 2mg, 4mg: 8-12/day oral, max 15/day","dosage":"Subling tab 2mg: 1-2/hr, max 40/day. Oral spray 1 mg: max 64/day, reduce over 3mo. Inhaler 10-15mg cartridges: 10mg max 12/day, 15mg max 6/day for 3mo, then reduce over 6-Swk. Nasal 500mcg/spray: 1/nostril prn max 64/day for 8wk, reducing over max 3mo. Transdermal patch 7mg, 10, 14, 15. 21: if smol<ed >20cig/day apply strongest patch daily 3-4WI<, medium patch daily 3-4wk (initial dose if' smoked :520cig /day), weakest patch daily 3-4wk. Page 74"},{"id":"fs-1594","name":"Nicotinic acid","dosage":"Hypercholesterolaemia and hypertriglycerid aemia: 5mg/kg (adult 200mg) 8H. gradually increase to 20-30 mg/kg (adult 1-2g) 8H oral. See also laropiprant."},{"id":"fs-1595","name":"Nicotinyl alcohol tartrate","dosage":"Adult, NOT/kg: 25-50mg 6H, slow release tab 150-300mg 12H oral."},{"id":"fs-1596","name":"Nicoumalone","dosage":"0.2mg/kg (adult 10mg) day 1, 0.12m/kg (adult 6mg) day 2, then 0.02-0.25mg/kg (adult 1-12mg) daily oral. INR 2-2.5 for prophylaxis, 2-3 for treatment."},{"id":"fs-1597","name":"Nifedipine","dosage":"Caps 0.25-0.Smg/kg (adult 10mg) 12H, tabs 0.5 mg/kg (adult 20mg) 12H oral or sublingual; increase gradually if required to max 1 mg/kg (max 40mg) 8H oral."},{"id":"fs-1598","name":"Nilotinib","dosage":"Adult, NOT/kg: 400mg 12H oral."},{"id":"fs-1599","name":"Nilutamide","dosage":"Adult, NOT/kg: 300mg daily oral for 4wk, then 150mg daily."},{"id":"fs-1600","name":"Nimodipine","dosage":"10-15mcg/kg/hr (adult 1 mg/hr) IV for 2H, then 10-45mcg/kg/hr (adult 2 mg/hr). Adult: 60mg 4H oral."},{"id":"fs-1601","name":"Nintedanib","dosage":"Adult, NOT/kg: 150mg 12H with food oral."},{"id":"fs-1602","name":"Nisoldipine","dosage":"Slow release: 0.2 mg/kg (adult 10mg) daily oral, increase to 0.4-0.Bmg/kg (adult 20-40mg) daily."},{"id":"fs-1603","name":"Nitazoxanide","dosage":"100mg (12-4lmo) 200mg (4-11yr) 500mg (>11 yr) 12H for 3 days oral."},{"id":"fs-1604","name":"Nitisinone","dosage":"0.5mg/kg increase after 1rno to 0.75mg/kg (max 1 mg/kg) 12H oral."},{"id":"fs-1605","name":"Nitrazeparn","dosage":"Child epilepsy: 0.125-0.Smg/kg 12H oral. Hyp notic (NOT/kg): 2.5-5mg (child) 5-10mg (adult) nocte."},{"id":"fs-1606","name":"Nitric oxide","dosage":"1-40pprn (up to 80pprn used occasionally). 0.1 1/min of 10OOppm added to 10 1/min gas gives 10pprn. [NO] ="},{"id":"fs-1607","name":"Cylinder [NO] x (1 -(Patient Fi02/ Supply Fi02))","dosage":"[NO]= Cylinder [NO] x NO flow I Total flow."},{"id":"fs-1608","name":"Nitrofurantoin","dosage":"1.5mg/kg (adult 50-100mg) 6H oral. Prophyl- axis: 1-2mg/kg (adult 50-100mg) at night."},{"id":"fs-1609","name":"Nitrofurazone","dosage":"0.2% cream, solution: 'apply every 1. 3 days."},{"id":"fs-1610","name":"Nitrogen mustard","dosage":"See rnustine HCI."},{"id":"fs-1611","name":"Nitroglycerine","dosage":"See glyceryl trinitrate."},{"id":"fs-1612","name":"Nitroprusside","dosage":"See sodium nitroprusside."},{"id":"fs-1613","name":"Nivolurnab","dosage":"3mg/kg IV every 2wk. See ipilimumab."},{"id":"fs-1614","name":"Nizatidine","dosage":"3-5mg/kg (adult 150mg) 12H oral for max 8wk, then daily. H pylori (adult): 300mg 12-24H."},{"id":"fs-1615","name":"Nomegestrol + oestradiol","dosage":"2.5mg/1.5mg x24 + inert x4-7 tab. Contraception: 1 tab daily, starting 1st day menstruation."},{"id":"fs-1616","name":"Nonacog alfa, gamma","dosage":"Recomb human factor 9, See factor 9."},{"id":"fs-1617","name":"Nonoxynol-9","dosage":"2% (Ortho), 5% (Delfen) cream: 1 applicatorful just before intercourse. 12.5% (Delfen) foam: 1 applicatorful <60min before intercourse."},{"id":"fs-1618","name":"Noradrenaline","dosage":"Flows <2ml/hr may cause swings in blood pressure. eve: for 0.02-0.2mcg/kg/min put 0.06mg/kg in 50 mi5%D at 1-10ml/hr; for 0.1-0.5mcg/kg/min put 0.15mg/kg in 50mi5%D at 2-10ml/hr. Periph IV (short-term): 0.15mg/kg in 500ml at 10-20ml/hr (0.05-0.1mcg/kg/min). H\\\\ 1-2min."},{"id":"fs-1619","name":"Norelgestromin","dosage":"See ethinyloestradiol + norelgestromin. Page 75"},{"id":"fs-1620","name":"Norepinephrine","dosage":"See noradrenaline."},{"id":"fs-1621","name":"Norethindrone","dosage":"See norethisterone."},{"id":"fs-1622","name":"Norethisterone","dosage":"Contraception: 350mcg daily. starting 1\\" day of menstruation: or 200mg oily solution IM in 1'1 5 days of cycle. repeated once after 8wk. Menorrhagia: 10mg 3H until hge stops, then 5mg 6H for 1 wk, then 5mg 8H for 2wk; or 5mg 8- 12H on days 19-26 of cycle. See also ethinyloestradiol, mestranol, and oestradiol with norethisterone."},{"id":"fs-1623","name":"Norethisterone +oestradiol patches","dosage":"Post-menop, NOT/kg: none/4mg (50mcg/24H) patch x2/wk for 2wk, then 30mg/ 10mg (170/50 or 250/50mcg per 24H) patch x2/wk for 2wk; 0.14mg/0.05mg or 0.1410-25 per day patch: 1 patch x2/wk."},{"id":"fs-1624","name":"Norelhisterone +oestradiol","dosage":"0.1/0.5mg, 0.5/1, 0.7/2, 112 tab. Post-menopause (NOT/kg): 1 tab daily."},{"id":"fs-1625","name":"Norfloxacin","dosage":"10mglkg (adult 400mg) 12H oral."},{"id":"fs-1626","name":"Norgestimate","dosage":"See ethinyloestradiol + norgestimate."},{"id":"fs-1627","name":"Norgestrel","dosage":"See levonorgestrel."},{"id":"fs-1628","name":"Normacol granules","dosage":"6mo-5yr halfteasp 12H, 6-10yr 1 teasp 12H, >10yr 1 teasp 8H."},{"id":"fs-1629","name":"Nortriptyline","dosage":"0.5-1.5mglkg (adult 25-75mg) 8H oral."},{"id":"fs-1630","name":"Noscapine","dosage":"NOT/kg: 7.5mg (1-6yr) 15mg (6-12yr) 15-30mg (adult) 6-8H oral."},{"id":"fs-1631","name":"Noxythiolin","dosage":"1-2.5% solution into body cavity 12-24H; left at least 30min. Max daily dose 200mglkg (max 10g). NTBC (nitro-trifluoromethylbenzoyl cyclohexanedione). 0.5mglkg 12H oral."},{"id":"fs-1632","name":"Nystatin","dosage":"<12mo 100,000u, >12mo 500,000u (1 tab) 6H NG or oral. Prophylaxis <12mo 50,000u, >12mo, 250,000u 8H."},{"id":"fs-1633","name":"Topical: 10O,OOOu/g gel, cream or ointment 12H","dosage":"Vaginal: 100,OOOu 12-24H. See also gramicidin + neomycin + nystatin + triamcinolone cream and ointment."},{"id":"fs-1634","name":"Obidoxime","dosage":"4mglkg (adult 250mg) slow IV, then 0.6mg/kg/hr (adult 30mglhr). See also atropine."},{"id":"fs-1635","name":"Obinutuzumab","dosage":"Adult, NOT/kg. Cycle 1: 100mg IV day 1, 900mg day 2, 1g day 8,15. Cycle 2-6: 1g IV day 1."},{"id":"fs-1636","name":"Ocriplasmin","dosage":"NOT/kg: 0.125mg intravitreous into one eye: wait at least 1 wk if other eye requires treatment."},{"id":"fs-1637","name":"Octocog alfa (recombinant factor 8)","dosage":"See factor 8."},{"id":"fs-1638","name":"Octoxinol (octoxynol)","dosage":"1% jelly (Ortho-Gynol): 1 teaspoonful on diaphragm before intercourse."},{"id":"fs-1639","name":"Octreotide","dosage":"Diarrhoea: 1mcglkg (adult 50mcg) 12-24H SC, may increase to 10mcg/kg (adult 250mcg) 8H. IV: 1 meg/kg stat, then 1-5mcglkg/hr. Chyle: 5mcg/kglhr IV. Acromegaly (NOT /kg): 0.05-0.1mg 8-12H SC increase if required to max 0.5mg 8H for 4wk, then slow release 20mg (10-30mg) every 4wk deep IM. 17-beta-Oestradiol. 2mg vaginal ring, replace every 3mo."},{"id":"fs-1640","name":"Oestradiol","dosage":"NOT/kg. Post-menopausal (add a progestogen for 14 days/mo if uterus intact): tab 1-2mglday oral; patch 0.1% (release 25, 37.5, 40, 50, 75, 80, 100mcg/day) to H1igh x1- 2/wk: metereddose pump (0.52mgldose of 0.06%; 1.53 Page 76 mg/dose of 1.7%) 1-3 doses/day to arm; vaginal tab 25mcg: 1 tab daily for 2wk, then 1 tab x2/wk. Oesteoporosis: every wk apply a patch releasing 12.5mcg/day. Induction puberty: O.Smg alternate days oral, increase over 2-3yr to 2mg/day (add progestogen for 14 days/mo when dose 1.5mg/day or when bleeding occurs). Tall stature: 12mg/day oral until bone age >16yr (add progestogen for 14 days/ cycle). Gonadal failure: 2mg/day oral (add progestogen for 14 days/cycle). See also bazedoxifene, dienogest, dydrogesterone, levonorgestrel, medroxyprogesterone, and norethisterone with oestradiol. Oestradiol patch, and oestradiol + norethisterone patch. Post-menopausal (NOT/kg): oestradiol patch (50mcg/24H) x2/wk for 2wk, then oestradiol + norethisterone patch (50/170 or 50/250 mcg/24H) x2/wk for 2wk. Oestradiol patch, and oestradiol+ levonorgestrel patch. Post-menopausal (NOT/kg): oestradiol patch (50mcg/24H) x1/wk for 2wk, then oestradiol+ levonorgestrel patch (50/10 mcg/24H) x1/wk for 2wk. Oestradiol 0.6mg +oestriol 0.27mg +oestrone 1.4mg."},{"id":"fs-1641","name":"Post-menopausal (NOT/kg): 1-2 tab daily oral","dosage":"Add a pro gestogen for 14 days/mo if uterus intact. Oestradiol1mg (x11 tab), oestradiol+ levonorgestrel 1mg/0.25mg or 2mg/0.5mg (x10 tabs). Post-menopausal (NOT/kg): 1 tab daily oral for 21 days, then no tab 7 days. Oestradiol1mg (x16 tab), oestradiol1mg + norethisterone 1 mg (x12 tab). Post-menopausal (NOT/kg): 1 tab daily oral. Oestradiol 2mg (x11 tab), oestradiol2mg +cyproterone 1mg (x10 tab). Post-menopausal (NOT/kg): 1 tab daily for 21 days (start 5th day of menstruation), then 7 days no tab. Oestradiol2mg (x16 tab), oestradiol 2mg + levonorgestrel 0.75mg (x12 tabs). Postmenopausal (NOT/kg): 1 tab daily. Oestradiol2mg (x16 tab), oestradiol2mg + norethisterone 1-2mg (x12 tab). Post-menopausal (NOT/kg): 1 tab daily. Oestradiol 2mg (x70 tab), oestradiol 2mg + medroxypro gesterone 20mg (x14 tab), placebo (x7 tab). Postmeno pausal (NOT/kg): 1 tab daily oral. Oestradiol2mg or 4mg (x12 tab), oestradiol1mg (x6 tab), oestradiol + norethisterone 2mg/1 mg or 4mg/1 mg (x1 0 tab), Post-menopausal (NOT/kg): 1 tab daily oral."},{"id":"fs-1642","name":"Oestriol","dosage":"lnductn puberty: 0.25 mg/day increase to 2mg/day (+ progestogen12days/cycle) oral. Epiphyseal maturation: 10 mg/day (+progestogen 12days/cycle). Vaginal: 0.5mg daily, reducing to x2/wk. Patch (Menorest) 37.5 (3.28mg), 50 (4.33mg), 75 (6.57mg), 100 (8.66mg): apply 1 patch x2/wk (adjust dose monthly), with medroxyprogesterone acetate (if uterus intact) 10mg x10 days/mo."},{"id":"fs-1643","name":"Oestrogen","dosage":"See ethinyloestradiol."},{"id":"fs-1644","name":"Oestrone","dosage":"Adult, NOT/kg. Menopause: oral 0.625-5mg daily; vaginal 0.1-1 mg daily, deer to 1mg x2-3/wlc Hypogonadism: 1.25-7.5mg daily oral. f'age77"},{"id":"fs-1645","name":"Oestropipate","dosage":"Adult, NOT/kg: 0.625-7.5mg daily starting 1st day menstruation, for 3 of every 4wk oral. Menopause: 1.5- 3mg daily oral. Intravaginal: 2-4g cream daily."},{"id":"fs-1646","name":"Ofatumumab","dosage":"Adult, NOT/kg: 300mg IV, then 2g wkly for 7wk, then 2g every 4wk."},{"id":"fs-1647","name":"Ofloxacin","dosage":"5mg/kg (adult 200mg) 8-12H, or 10mg/kg (adult 400mg) 12H oral or IV over 1 hr. 0.3%: 1 drop/eye hrly for 2 days (4H overnight), reducing to 3-6H."},{"id":"fs-1648","name":"OKT3","dosage":"See muromonab-CD3."},{"id":"fs-1649","name":"Olanzapine","dosage":"0.1-0.2mg/kg (adult 5-10mg) daily oral; slow increase to 0.4mg/kg (adult 20mg) daily if required. See also fluoxetine."},{"id":"fs-1650","name":"Olmesartan","dosage":"0.3mg/kg (max 10mg) daily oral; if required increase 2wkly to max 0.8mg/kg (max 40mg) daily oral. See also amlodipine + olmesartan."},{"id":"fs-1651","name":"Olodaterol","dosage":"NOT/kg: 2.5mcg inhaled once daily."},{"id":"fs-1652","name":"Olodaterol + tiolropium","dosage":"NOT/kg: 2.5/2.5mcg inhaled daily."},{"id":"fs-1653","name":"Olopatadine","dosage":"0.1-0.2% solution: 1 drop/eye twice a day. 0.6% solution: 1-2 sprays/nostrii12H."},{"id":"fs-1654","name":"Olpadronate","dosage":"O.Smg/kg daily oral."},{"id":"fs-1655","name":"Olaparib","dosage":"Adult, NOT/kg: 400mg 12H oral."},{"id":"fs-1656","name":"Olsalazine","dosage":"NOT/kg: 250mg 12H, increase to max 500mg 6H oral. Maintenance: 500mg 12H."},{"id":"fs-1657","name":"Omacetaxine","dosage":"1.25mg/m2 12H SC day1-14 of 28 day cycle until remission, then day1-7 of 28 day cycle."},{"id":"fs-1658","name":"Omalizumab","dosage":"2:6yr (NOT/kg) 150-375mg SC every 2-4wk de pehding on body weight and serum lgE level. Ombltasvir 12.5mg + paritaprevir 75mg + ritonavir 50 mg. Adult, NOT/kg: 2 tab daily dasabuvir 250mg 12H  ribavirih 500mg (>75kg 600mg) 12H oral for 12-14wk. See dasabuvir."},{"id":"fs-1659","name":"Omega-3-acid ethyl esters (1g cap)","dosage":"Adult, NOT/kg. Post-MI: 1' cap daily oral. Hypertriglyceridaemia: 2 cap 12H oral."},{"id":"fs-1660","name":"Omeprazole","dosage":"Usually 0.4-0.8mg/kg (adult 20-40mg) 12-24H oral. ZE synd: 1 mg/kg (adult 60mg) 12-24H oral, increase up to 3mg/kg (adult 120mg) 8H ifrequired. IV: 2mg/kg (adult 80mg) stat, then 1 mg/kg (adult 40mg) 8-12H. H.pylori quadruple therapy (adult NOT/kg): 20mg 12H +bismuth subcitrate potassium 420mg 6H + metronidazole 375mg 6H + tetra cycline hydrochloride 3l5mg 6H oral for 10-14 days. 1-i.pylori triple therapy (adult, NOT/kg): 20mg + amoxycillin 500mg + clarithromycin 500mg 12H oral for 7 days. May lower Mg. See also ketoprofen + omeprazole."},{"id":"fs-1661","name":"Ondansetron","dosage":"IV: proph 0.15mg/kg (adult 4mg); treatment 0.2mg/kg (adult 8mg) over 5 min, or 0.2-0.Smcg/kg/min. Chemotherapy: 0.15mg/kg (max 16mg) 4H x3 doses IV. Oral: 0.1-0.2mg/kg (usual max 8mg) 6-12H."},{"id":"fs-1662","name":"Oprelvekin (IL-11)","dosage":"2mg/m2 (adult 50mcg/kg) SC daily."},{"id":"fs-1664","name":"Orciprenaline","dosage":"Oral: 0.25-0.Smg/kg (adult 20mg) 6H. Resp solution (2%): 0.5ml diltd to 4ml 3-6H (mild), 1ml diltd to 4ml (moderate), undiluted continuously (severe, in ICU). Aerosol Page 78 750mcg/dose: 2 puffs 4-6H."},{"id":"fs-1665","name":"Oritavancin","dosage":"Adult, NOT/kg 1.2g IV over 3hr once."},{"id":"fs-1666","name":"Orlistat","dosage":"1.5-3mg/kg (adult 60-120mg) with each main meal containing fat (max 3 doses/day)."},{"id":"fs-1667","name":"Ornipressin (POR 8)","dosage":"IV: 0.1 u/kg/hr (max 6u/hr) for max 4hr, then 0.03u/kg/hr (max 1.5u/hr). SC: 5u in 30ml saline, max total dose 0.1 u/kg."},{"id":"fs-1668","name":"Orphenadrine","dosage":"1-2mg/kg (adult 50-100mg) 8H oral."},{"id":"fs-1669","name":"Osalazine","dosage":"Adult, NOT/kg: 500mg 6H oral."},{"id":"fs-1670","name":"Oseltamivir","dosage":"Prem <38wk 1 mg/kg, >38wk-8mo 3mg/kg, <:9mo 3.5mg/kg (max 75mg) 12H for 5 days oral. Prophylaxis: same dose, daily."},{"id":"fs-1671","name":"Osimertinib","dosage":"Adult, NOT/kg: 80mg daily oral. Ospemifene, Adult, NOT/kg: 60mg daily oral."},{"id":"fs-1672","name":"Oteracil","dosage":"See tegafur."},{"id":"fs-1673","name":"Oxacillin","dosage":"15-30mg/kg 6H oral, IV, IM. Severe inftn: 40 mg/kg (max 2g) 12H (1st wk life), 8H (2nd wk), 6H or infusion (>2wk)."},{"id":"fs-1674","name":"Oxaliplatin","dosage":"85mg/m2 every 2wk over 2-6hr IV before 5-FU."},{"id":"fs-1675","name":"Oxandrolone","dosage":"0.1-0.2mg/kg (adult 2.5-20mg) daily oral. Turner's synd: 0.05-0.img/kg daily."},{"id":"fs-1676","name":"Oxaprozin","dosage":"Usually 20mg/kg (max 1200mg), range 10- 26mg/kg (max 1800mg), daily oral."},{"id":"fs-1677","name":"Oxazepam","dosage":"0.2-0.5mg/kg (adult 10-30mg) 6-8H oral."},{"id":"fs-1678","name":"Oxcarbazepine","dosage":"4-5mg/kg (max 150mg) 12H oral; increase wkly by max 5mg/kg/dose (max 300mg) to usually 15mg/kg/dose (adult 750mg), max 25mg/kg/dose (adult 1200mg)."},{"id":"fs-1679","name":"Oxerutin","dosage":"10mg/kg (adult 500mg) 12H oral."},{"id":"fs-1680","name":"Oxethazaine","dosage":"10mg/5ml (with AI hydrox + Mg hydrox): Adult, NOT/kg 5-10ml 6-8H oral."},{"id":"fs-1681","name":"Oxiconazole","dosage":"1% cream, lotion: apply 12-24H."},{"id":"fs-1682","name":"Oxitropium","dosage":"lnhaltn: 200mcg (NOT/kg) 8-12H."},{"id":"fs-1683","name":"Oxpentifylline","dosage":"Adult, NOT/kg: slow release tab 400mg 8-12H oral."},{"id":"fs-1684","name":"Oxprenolol","dosage":"0.5-2mg/kg (adult 30-120mg) 8-12H oral."},{"id":"fs-1685","name":"Oxtriphylline","dosage":"See choline theophyllinate."},{"id":"fs-1686","name":"Oxybuprocaine","dosage":"4mg/ml (0.4%): 1 drop/eye 8-12H. Deep anaes: 1 drop/eye every 90sec x3 doses. See also fluores cein + oxybuprocaine."},{"id":"fs-1687","name":"Oxybutynin","dosage":"<5yr: 0.2mg/kg 8-12H oral. >5yr (NOT/ kg): 2.5- 5mg 8-12H oral. Slow rei: adult 5-30mg daily oral. Adult, NOT/kg: apply 39cm2 patch (3.9mg/day) x2/wk; apply 100 mg gel sachet daily."},{"id":"fs-1688","name":"Oxycodone","dosage":"0.1-0.2mg/kg (adult 5-iOmg) 4-6H oral, SC or IV (beware hypoventilation); increase if required. IV infusion: 0.05mg/kg/hr (adult 2mg/hr) adjusted. Slow release: 0.6-0.9mg/kg (adult 10mg) 12H oral, increase if required. Suppos: adult 30mg 6-8H PR."},{"id":"fs-1689","name":"Oxycodone + naloxone","dosage":"5mg/2.5mg, 10/5, 20/10, 40/20 tabs. If >80mg oxycodone/day, supplement with oxycodone."},{"id":"fs-1690","name":"Oxymetazoline","dosage":"0.25mg/ml = 0.025% (<6yr), 0.5mg/ml = 0.05% (>6yr): 2-3 drops or sprays in each nostril 8-12H. Page 79. I"},{"id":"fs-1691","name":"I Oxymetholone","dosage":"1-2mglkg (up to Smg/kg) daily oral."},{"id":"fs-1692","name":"Oxymorphone","dosage":"Usually 0.02-0.03mg/kg (adult 1-1.5mg) 4-6H"},{"id":"fs-1693","name":"IM or SC","dosage":"Slow IV: 0.01mglkg (adult 0.5mg) 4-6H. Oral: 0.1- 0.4mglkg (adult 5-20mg) 4-6H; slow-release adult 5mg 12H. PR: 0.1mg/kg (adult 5mg) 4-6H."},{"id":"fs-1694","name":"Oxytetracycline","dosage":">8yr (NOT/kg): 250-500mg 6H oral, or 250- 500mg 6-12H slow IV."},{"id":"fs-1695","name":"Oxytocin","dosage":"Labour, NOT/kg: 1-4mUimin IV, may increase to 20 mU/min max. Lactation: 1 spray (4iu) into each nostril 5min before infant feeds."},{"id":"fs-1696","name":"Packed cells","dosage":"4ml/kg raises Hb 1 g%. A bag is about 300m I."},{"id":"fs-1697","name":"Paclitaxel","dosage":"175mg/m2 IV every 3wk, x3-6 doses. Albumin bound: 260mglm2 IV every 3wk."},{"id":"fs-1698","name":"Palbociculib","dosage":"Adult, NOT/kg: 125mg daily oral for 21 days of 28 day cycle, with letrozole 2.5mg daily on all 28 days."},{"id":"fs-1699","name":"Palifermin","dosage":"60mcg/kg IV daily for 3 days before chemo, and for 3 days after."},{"id":"fs-1700","name":"Paliperidone","dosage":"3mg, 6mg or 9mg slow-rei tab. Adult (NOT/ kg): 6mg daily oral; may increase by 3mg every 5-7 days; Injection slow-rel234mg IM, 156mg after 1wk, then 117mg monthly."},{"id":"fs-1701","name":"Paliperidone palmitate","dosage":"78mg (=273mglmo), 117mg (=410mg /mo), 156mg (=546mglmo), 234mg (=89mglmo) every3mo IM."},{"id":"fs-1702","name":"Palivizumab","dosage":"15mg/kg IM once a month."},{"id":"fs-1703","name":"Palonosetron","dosage":"Adult: 0.25mg IV 30min before chemo."},{"id":"fs-1704","name":"Pamidronate","dosage":"Osteoporosis, 01: 3-7mg/kg daily oral, 1 mg/kg (adult 15-90mg) IV over 4hr daily x3 every 4mo, or once every 3-4wk. Hypercalcaemia 20-50mglm2 (depending on Ca level) IV over 4hr every 4wk."},{"id":"fs-1705","name":"Pancreatic enzymes","dosage":"Cotazyme, Creon, Nutrizym, Pancre ase, Pancrex, Ultrase, Viokase. NOT/kg: usually 1-5 caps with meals. Max lipase 10,OOOu/kg/day."},{"id":"fs-1706","name":"Pancuronium","dosage":"ICU: 0.1-0.15mg/kg IV prn. Theatre: 0.1 mg /kg"},{"id":"fs-1707","name":"IV, then 0.02mglkg prn","dosage":"lnfsn: 0.25-0.75mcglkg/min."},{"id":"fs-1708","name":"Panitumumab","dosage":"6mglkg IV over 1-2H every 14 days."},{"id":"fs-1709","name":"Panobinostat","dosage":"Adult, NOT/kg: 20mg oral day 1,3,5,8,10,12 of 21 day cycle for 8-16 cycles."},{"id":"fs-1710","name":"Pantoprazole","dosage":"1mg/kg (adult 40mg) 12-24H oral, IV. Gl hge, adult: 80mg stat, then 8mglhr. ZE: 80mg 8-12H adjusted to achieve acid <10mmoi/L. May lower Mg."},{"id":"fs-1711","name":"Papaveretum (Omnopon)","dosage":"0.2mg/kg IV, 0.4mg/kg IM (half life 2-4hr). ICU: 0.3mglkg IV, 0.6mg/kg IM. See also hyo scine + papaveretum."},{"id":"fs-1712","name":"Papaverine","dosage":"Adult, NOT/kg: 150-300mg 12H oral, 12-40 mg x1-2/wk intracavernosal. lA lines: 0.12mg/ml."},{"id":"fs-1713","name":"Para-aminobenzoic acid","dosage":"See aminobenzoate."},{"id":"fs-1714","name":"Para-aminohippuric acid","dosage":"See aminohippuric acid."},{"id":"fs-1715","name":"Paracetamol","dosage":"Oral, IV: 20mg/kg stat, then 15mglkg 4-6H (max 4glday); child usual daily max 60mg/kg (up to 90mglkg for 48hr). Neonate: 7.5mg/kg (<10 days) 15mg/kg (>10 day) 6H. Rectal: 40mg/kg stat, then 30mg/kg 6H (max 5g/day). Page 80"},{"id":"fs-1716","name":"Paraffin","dosage":"Liquid: 1ml/kg (adult 30-45ml) daily oral. Liquid 50% + white soft 50%, ointmnt: apply 6-12H. See also agar."},{"id":"fs-1717","name":"Paraldehyde","dosage":"IM: 0.2ml/kg (adult 10m I) stat, then 0.1 ml/kg 4- 6H. IV: 0.2ml/kg (adult 10m I) over 15 min, then 0.02ml/kg/hr (max 1.5ml/hr). Rectai,NG: 0.3ml/kg (adult 10ml) dilute 1:10."},{"id":"fs-1718","name":"Parathyroid hormone","dosage":"1 meg/kg (adult 50 meg) increase if required to max 2mcg/kg (adult 100mcg) daily SC. See also teriparatide."},{"id":"fs-1719","name":"Parecoxib","dosage":"Adult, NOT/kg: 40mg statIM or IV, then 20-40mg 6-12H; max 80mg/day."},{"id":"fs-1720","name":"Paricalcitol","dosage":"0.04-0.1 meg/kg x2-3/wk IV during dialysis, increase every 2-4wk if required to max 0.24mcg/kg. Or dose in meg= [iPTH picomoi/L]/ 7."},{"id":"fs-1721","name":"Paritaprevir","dosage":"See ombitasvir."},{"id":"fs-1722","name":"Paromomycin","dosage":"Amoebiasis: 10mg/kg 8H oral for 5-10 days. Hepatic coma: 20mg/kg (adult 1 g) 6H oral."},{"id":"fs-1723","name":"Paroxetine","dosage":"0.4mg/kg (adult 10mg) daily oral, increase if rqd over 4wk to 1 mg/kg (adult 20-60mg) daily. Hot flushes (NOT/kg) 7.5mg at night oral."},{"id":"fs-1724","name":"Pasireotide","dosage":"Adult, NOT/kg: 0.6-0.9mg 12H SC."},{"id":"fs-1725","name":"Pasugrel","dosage":"Adult, NOT/kg: 60mg stat, then 5mg (<60kg) 10mg (\\"60kg) daily oral."},{"id":"fs-1726","name":"Paliromer","dosage":"Adult, NOT/kg: 8.4g daily oral, increase to max 25.2g/d."},{"id":"fs-1727","name":"Pazopanib","dosage":"Adult, NOT/kg 800mg (400mg if toxicity) daily oral."},{"id":"fs-1728","name":"Pegademase","dosage":"10u/kg IM wkly, increase to 20u/kg wkly."},{"id":"fs-1729","name":"Pegaptanib sodium","dosage":"Adult: 1.65mg (0.3mg of free acid form) by intravitreous inj every 6wk."},{"id":"fs-1730","name":"Pegaspargase","dosage":"82.5iu/kg (<0.6m2) or 2500iu/m2 (>0.6m2) IM, or IV over 2H, every 14 days."},{"id":"fs-1731","name":"Pegfilgrastim","dosage":">44kg: 6mg SC 24H after chemo."},{"id":"fs-1732","name":"Peginesatide","dosage":"0.04mg/kg monthly IV or SC."},{"id":"fs-1733","name":"Peginterferon alfa-2a","dosage":"Hep C, Adult, NOT/kg: 180mcg wkly SC, plus ribavirin 1 g (1.2g if >l5kg) daily oral, for 48wk."},{"id":"fs-1734","name":"Peginterferon alfa-2b","dosage":"Hep C: 1.5mcg/kg wkly SC, plus ribavirin 15mg/kg (adult 800mg) daily oral, for 48wk. Melanoma: 6mcg/kg/wk SC for Swk, then 3mcg/kg/wk."},{"id":"fs-1735","name":"Peg interferon beta-1a","dosage":"Adult, NOT/kg: 63mcg SC day1, 94mcg day15, 125mcg day29 and every 14 days."},{"id":"fs-1736","name":"Pegloticase","dosage":"Adult, NOT/kg: Smg every 2wk IV over 2H."},{"id":"fs-1737","name":"Pegvisomant","dosage":"40mg SC stat, then 10mg daily adjusted up or down by 5mg (max 30mg/day) every 4-6wk based on serum IGF-1 concentration."},{"id":"fs-1738","name":"Pembrolizumab","dosage":"2mg/kg IV over 30m in every 3wk."},{"id":"fs-1739","name":"Pemetrexed","dosage":"500mg/m2 IV over 10m in every 3wk."},{"id":"fs-1740","name":"Pemoline","dosage":">6yr (NOT/kg): 20-120mg daily oral."},{"id":"fs-1741","name":"Penbutolol","dosage":"0.4-1.5mg/kg (adult 20-80mg) daily oral."},{"id":"fs-1742","name":"Penciclovir","dosage":"1% cream (10mg/g): apply x6/day for 4 days."},{"id":"fs-1743","name":"Penicillamine (d-penicillamine)","dosage":"Arthritis: 1.5mg/kg (adult 125mg) 12H oral, increase over 3mo to max 3mg/kg (adult 375 mg) 6-8H. Wilson's dis, lead poisoning: 5-7.5 mg/kg (adult 250-500mg) 6H oral. Cystinuria: l.5mg/kg (adult 250-1000 Page 81 mg) 6H oral, titrated to urine cystine <100-200mg/day."},{"id":"fs-1744","name":"Penicillin V","dosage":"See phenoxymethylpenicillin."},{"id":"fs-1745","name":"Penicillin, benzathine +procaine","dosage":"900mg/300mg in 2ml: 0- 2yr half vial, 3yr or more 1 via liM once."},{"id":"fs-1746","name":"Penicillin, benzathine","dosage":"1mg = 1250u. Usually 25mg/kg (max 900mg) IM once. Venereal disease: 40mg/kg (max 1.8g) IM once. Strep proph: 25mgikg (max 900mg) IM 3-4wkly, or 10 mg/kg IM 2wkly."},{"id":"fs-1747","name":"Penicillin, benzyl (penicillin G, crystalline)","dosage":"1 mg = 1667u. 30mg/kg 6H. Severe inftn: 50mg/kg (max 2g) IV 12H (1st wk life), 6H (2-4 wk), 4H or constnt infusion (>4 wk)."},{"id":"fs-1748","name":"Penicillin, procaine","dosage":"1mg = 1000u. 25-50mg/kg (max 1.2- 2.4g ) 12-24H IM. Single dose: 100mg/kg (max 4.8g)."},{"id":"fs-1749","name":"Penicilloyl polylysine (Prepen)","dosage":"0.00006 molar. Scratch: 1 drop. Intradermal: 0.01-0.02ml (NOT/kg)."},{"id":"fs-1750","name":"Pentaerythritol tetranitrate","dosage":"0.2-1mg/kg (adult 10-60mg) 6- SH oral."},{"id":"fs-1751","name":"Pentagastrin","dosage":"6mcg/kg SC, or 0.6mcg/kg/hr IV."},{"id":"fs-1752","name":"Pentamidine isethionate","dosage":"3-4mg/kg (1.7-2.3mg/kg base) IV over 2H or IM daily for 10-14 days (1 mg base= 1.5mg mesylate = 1.74mg isethionate). Neb: 600mg/6ml daily for 3wk (treatment), 300mg/3ml every 4wk (prophylaxis)."},{"id":"fs-1753","name":"Pentastarch","dosage":"10% solution: 10-40mg/kg IV."},{"id":"fs-1754","name":"Pentazocine","dosage":"Oral: 0.5-2.0mg/kg (adult 25-100mg) 3-4H. SC,"},{"id":"fs-1755","name":"IM or slow IV: 0.5-1mg/kg (adult 30-60mg) 3-4H","dosage":"PR: 1mg/kg (adult 50mg) 6-12H."},{"id":"fs-1756","name":"Pentetate calcium trisodium","dosage":"14mg/kg (adult 1g) IV."},{"id":"fs-1757","name":"Pentetate zinc disodium","dosage":"14mg/kg (adult 1g) IV."},{"id":"fs-1758","name":"Pentobarbital","dosage":"See pentobarbitone."},{"id":"fs-1759","name":"Pentobarbitone","dosage":"0.5-1 mg/kg (adult 30-60mg) 6-8H oral, IM, slow IV. Hypnotic: 2-4mg/kg (adult 100-200mg)."},{"id":"fs-1760","name":"Pentosan","dosage":"2mg/kg (adult 100mg) 8H oral."},{"id":"fs-1761","name":"Pentostatin","dosage":"4mg/m2 IV wkly."},{"id":"fs-1762","name":"Pentoxifylline","dosage":"See oxpentifylline."},{"id":"fs-1763","name":"Pentoxyverine","dosage":"0.3mg/kg (adult 15mg) 3-6H oral."},{"id":"fs-1764","name":"Peppermint oil","dosage":"Adult, NOT/kg. 0.2ml cap: 1-2 8H oral."},{"id":"fs-1765","name":"Peramivir","dosage":"10mg/kg (max 600mg) IV over 30min once."},{"id":"fs-1766","name":"Perampanel","dosage":";,12yr (NOT/kg): 2mg at night oral, increase by 2mg wkly to max 12mg daily."},{"id":"fs-1767","name":"Pergolide","dosage":"Parkinson's: 1 meg/kg (max 50mcg) daily, increase to max 25mcg/kg (max 2mg) 8H oral. Hyperprolactinaemia: 0.5-3mcg/kg daily."},{"id":"fs-1768","name":"Perhexiline","dosage":"2mg/kg (adult 100mg) daily oral; adjust every 2- 4wk to max 6-Bmg/kg (adult 300-400mg) daily. Maintain plasma level 150-600mcg/L."},{"id":"fs-1769","name":"Periciazine","dosage":"0.5mg/yr of age (1-10yr) 10mg (>10yr) daily oral, increase if required to max 1mg/yr (1-10yr) 25mg (>10yr) 8H."},{"id":"fs-1770","name":"Pericyazine","dosage":"See periciazine."},{"id":"fs-1771","name":"Perindopril","dosage":"0.05-0.15mg/kg (adult 2-8mg) daily oral. See also amlodipine, indanapamide. Page 82"},{"id":"fs-1772","name":"Permethrin","dosage":"1% creme rinse (head lice): wash hair, apply creme for 1 0min, wash off; repeat in 7 days. 5% cream (scabies): wash body, apply to whole body except face, wash off after 12-24H; repeat in 7 days."},{"id":"fs-1773","name":"Perphenazine","dosage":"0.1-0.3mg/kg (adult 5-20mg) 8-12H oral."},{"id":"fs-1774","name":"Pertussis","dosage":"See diphtheria +tetanus + pertussis vaccine."},{"id":"fs-1775","name":"Pertuzumab","dosage":"Adult, NOT/kg: 840mg IV over 1 hr stat, then 420mg over 30m in every 3wk."},{"id":"fs-1776","name":"Pethidine","dosage":"0.5-1mg/kg (adult 25-50mg) IV, 0.5-2mg/kg (adult 25-100mg) IM (half life 2-4hr). lnfsn: 5mg/kg in 50ml at 1- 4ml/hr (0.1-0.4mg/kg/hr). PCA 5mg/kg in 50ml: usually bolus 2ml with lockout 5min, optional background 0.5ml/hr."},{"id":"fs-1777","name":"Phenacemide","dosage":"10-20mg/kg (adult 0.5-1g) 8H oral."},{"id":"fs-1778","name":"Phenazocine","dosage":"0.1-0.4mg/kg (adult 5-20mg) 4-6H oral or sublingual."},{"id":"fs-1779","name":"Phenazone","dosage":"See benzocaine + phenazone."},{"id":"fs-1780","name":"Phenazopyridine","dosage":"4mg/kg (adult 200mg) 6H oral for 2 days."},{"id":"fs-1781","name":"Phendimetra:zine","dosage":"0.4-1.4mg/kg (adult 20-70mg) SH oral."},{"id":"fs-1782","name":"Phenelzine","dosage":"0.3-2mg/kg (adult 15-90mg) 8H oral."},{"id":"fs-1783","name":"Phenindamine","dosage":"0.5-1mg/kg (adult 25-50mg) 8-12H oral."},{"id":"fs-1784","name":"Phenindione","dosage":"2mg/kg (adult 100mg) 12H day 1, 1 mg/kg (adult 50mg) 12H day 2, then 0.25-1 mg/kg (adult 12.5-50mg) 12H oral. INR for prophylaxis 2-2.5, treatment 2-3."},{"id":"fs-1785","name":"Pheniramine","dosage":"0.5-1 mg/kg (adult 25-50mg) 6-8H oral. Slow release tab 75mg at night."},{"id":"fs-1786","name":"Phenobarbital","dosage":"See phenobarbitone."},{"id":"fs-1787","name":"Phenobarbitone","dosage":"Loading dose in emergency: 20mg/kg IM or"},{"id":"fs-1788","name":"IV over 30min stat","dosage":"Ventilated: repeat doses of 10-15mg/kg up to 120mg/kg or more in 24H (beware hypotension). Usual maintenance: 2mg/kg (adult 100mg) daily IV, IM or oral, increase to 3-Bmg/kg daily. Level 60-172 umol/L (x0.23 = mcg/ml)."},{"id":"fs-1789","name":"Phenolphthalein","dosage":"0.5-5mg/kg (adult 30-270mg) at night oral. See also agar+ paraffin + phenolphthalein."},{"id":"fs-1790","name":"Phenoperidine","dosage":"0.03-0.05mg/kg (adult 1 mg) every 40-60min. Ventilated: 0.1-0.15mg/kg (adult 2-5mg) every 40-60min."},{"id":"fs-1791","name":"Phenothrin","dosage":"Apply; shampoo after 30m in (0.5% mousse) 2H (0.2% lotion), 12H (0.5% emulsion); comb hair when wet."},{"id":"fs-1792","name":"Phenoxybenzamine","dosage":"0.2-0.5mg/kg (adult 10-40mg) 8-12H oral. Cardiac surgery: 1 mg/kg IV over 1-4hr stat, then 0.5 mg/kg 8-12H IV over 1H or oral."},{"id":"fs-1793","name":"Phenoxymethylpenicillin (penicillin V)","dosage":"10-15mg/kg (adult 250-500mg) 6H oral. Proph: 250mg (1mo-12yr) 250mg (>12yr) 12H."},{"id":"fs-1794","name":"Phentermine","dosage":"Adult, NOT/kg: 30-40mg daily oral, reducing to 15-40mg daily."},{"id":"fs-1795","name":"Phentermine resin","dosage":"Adult, NOT/kg: 15-30mg daily oral."},{"id":"fs-1796","name":"Phentermine + topiramate","dosage":"3. 75mg/23mg, 7.5/46, 11.25/69, 15/92 cap. Adult, NOT/kg: increaseto 7.5/46 or 15/92 cap daily."},{"id":"fs-1797","name":"Phentolamine","dosage":"15mg/kg in 50ml saline at 1-10ml/hr (5-50 meg/kg/min) IV. TV, 19min, longer if renal impairment. Page 8ct"},{"id":"fs-1798","name":"Phenylbutazone","dosage":"Initially 2mg/kg (adult 100mg) 4H, reducing to 1-2mg/kg (adult 50-100mg) 6-SH oral."},{"id":"fs-1799","name":"Phenylephrine","dosage":"IV: 2-10mcg/kg stat (adult 500mcg), then 1- 5mcg/kg/min. SC or IM: 0.1-0.2mg/kg (max 10mg). Oral: 0.2 mg/kg (max 10mg) 6-SH. 0.15%, 10% eye drops: 1 drop/eye 6-8H. 0.25%, 0.5% nose drops: 1-3 drops/sprays per nostril 6-8H. See also chlorpheniramine."},{"id":"fs-1800","name":"Phenylephrine 0.12% +prednisolone acetate 1%","dosage":"1 drop per eye 6-12H."},{"id":"fs-1801","name":"Phenyltoloxamine","dosage":"1mg/kg (adult 50mg) 8H oral."},{"id":"fs-1802","name":"Phenytoin","dosage":"Loading dose in emergency: 15-20mg/kg (max 1.5g) in saline IV over 1 hr. Initial maintenance, oral or IV: 2mg/kg 12H (preterm); 3mg/kg 12H (1st wk life), 8H (2wk- 4yr), 12H (5-12yr); 2mg/kg (usual max 100mg) 8H >12 yr. Level 40-80 umol/L (x0.25 = mcg/ml)."},{"id":"fs-1803","name":"Pholcodine","dosage":"NOT/kg: 2.5-5mg (6-12yr) 10-15mg (>12yr) 6-8H oral. Phosphate, as potassium dihydrogenphosphate (1mmol/ ml). Usually 0.06mmol/kg/hr for 6hr IV, max 0.2mmol/kg/hr (max 70mmol/day)."},{"id":"fs-1804","name":"Phosphate, sodium","dosage":"Laxative, diluted, NOT/kg: 250mg (2- 4yr) 250-500mg (>4yr) 6H oral."},{"id":"fs-1805","name":"Phosphate, sodium (Fleet enema)","dosage":"Na 1.61 mEq/L + P04 4.15 mEq/L + P 1.38mEq/L: 33ml (2-5yr), 66ml (5-11yr), 133ml (adult) rectal."},{"id":"fs-1806","name":"Phosphatidylcholine","dosage":"Usually 60mg/kg (max 3g) daily oral."},{"id":"fs-1807","name":"Phosphocol P32","dosage":"Adult, NOT/kg. Peritoneum: 370-740 MBq (10-20 mCi). Peritoneal: 222-444 MBq (6-12 mCi). Interstitial: 3.7-18.5 MBq (0.1-0.5 mCi) per gram of tumor."},{"id":"fs-1808","name":"Phosphocysteamine","dosage":"10mg/kg 6H oral, increase by 2.5mg/kg per dose every 2wk to 10-20mg/kg 61-l so leukocyte half-cysteine <2nmol per mg protein 6hr after dose."},{"id":"fs-1809","name":"Physostigmine","dosage":"0.02mg/kg (max 1 mg) IV every 5 min until response (max 0.1mg/kg), then 0.5-Z.Omcg/kg/min."},{"id":"fs-1810","name":"Phytomenadione (vitamin K1 )","dosage":"Deficiency with hge: FFP 10ml/kg, then 0.3mg/kg (max 10mg), IM or IV over 1H. Prophylaxis in neonates (NOT/kg): 1mg (0.1ml) IM at birth. Warfarin reversal: 0.02mg/kg (max 1 mg) IV, SC, oral (repeat if required); if severe hge 0.3mg/kg (max 10mg) with FFP 10 ml/kg. Mitochondrial disease (NOT/kg): 10mg 61-l oral. Cystic fib: 2.5mg (<2yr) 5mg (2-5yr) 10mg (>5yr) x2/wk."},{"id":"fs-1811","name":"Phytonadione","dosage":"See phytomenadione."},{"id":"fs-1812","name":"Picibanil (OK-432)","dosage":"1 Klinishe Einheit = 0.1 mg. 1 mg into tumour 1-2wk preop, then 0.5mg/2wk ID for 1yr postop."},{"id":"fs-1813","name":"Pilocarpine","dosage":"0.1mg/kg (adult 5mg) 4-81-l oral. 0.5%, 1%, 2%, 3%,4% eye drops: 1 drop/eye 6-12H."},{"id":"fs-1814","name":"Pimavanserin","dosage":"Adult, NOT/kg: 34mg daily oral."},{"id":"fs-1815","name":"Pimecrolimus","dosage":"1% cream: apply 12H."},{"id":"fs-1816","name":"Pimozide","dosage":"0.04mg/kg (adult 20mg) daily oral, increase if required to max 0.4mg/kg (adult 20mg) daily. $9.95 +postage from orders@drugdoses.uom"},{"id":"fs-1817","name":"Pindolol","dosage":"0.3mg/kg (adult 15mg) 8-24H oral."},{"id":"fs-1818","name":"Pine tar","dosage":"Gel, solution: 5ml to baby bath, 15-30ml to adult bath; soak for 10m in."},{"id":"fs-1819","name":"Pioglitazone","dosage":"Adult, NOT/kg: 15-45mg daily oral. See also alogliptin, glimepiride."},{"id":"fs-1820","name":"Pipamperone","dosage":"Adult, NOT/kg: 40mg (max 120mg) 8H oral."},{"id":"fs-1821","name":"Pipecuronium","dosage":"20-85mcg/kg IV stat, then 5-25mcg/kg prn."},{"id":"fs-1822","name":"Piperacillin","dosage":"100mg/kg (adult 2-4g) 8H (<6mo) 6-8H (e:6rno); consider constant infusion for severe inftn."},{"id":"fs-1823","name":"Piperacillin 4g + tazobactam 0.5g","dosage":"As for piperacillin."},{"id":"fs-1824","name":"Piperaquine","dosage":"See dihydroartemisinin + piperaquine."},{"id":"fs-1825","name":"Piperazine","dosage":"75mg/kg (max 4g) oral daily for 2 days (ascaris), 7 days (pinworm)."},{"id":"fs-1826","name":"Piperazine oestrone sulphate","dosage":"See estropipate."},{"id":"fs-1827","name":"Piperonyl butoxide bioallethrin","dosage":"Apply enough to wet scalp or body, leave 30min, wash off."},{"id":"fs-1828","name":"Pipotiazine","dosage":"Oily injtn: initially 0.5mg/kg (adult 25mg), then gradual increase to 1-4mg/kg (adult 50-200mg) every 4wk IM."},{"id":"fs-1829","name":"Piracetam","dosage":"15mg/kg (max 800mg) 8H oral, IM or IV."},{"id":"fs-1830","name":"Pirbuterol","dosage":"Oral: 0.2-0.3mg/kg (adult 10-15mg) 6-8H. lnhaltn (NOT/kg): 0.2-0.4mg 4-6H."},{"id":"fs-1831","name":"Pirfenidone","dosage":"267mg. Adult, NOT/kg: 1cap 8H oral for 1wk, 2cap 8H 1 wk, then 3cap 8H."},{"id":"fs-1832","name":"Piroxicam","dosage":"0.2-0.4mg/kg (adult 10-20mg) daily oral. Gel 5mg/g: apply 1g (3cm) 6-8H for up to 2wk."},{"id":"fs-1833","name":"Pitavastatin","dosage":"Adult, NOT/kg: 2mg (max 4mg) daily orai."},{"id":"fs-1834","name":"Pivampicillin","dosage":"15mg/kg (adult 500mg) 8-12H oral."},{"id":"fs-1835","name":"Pivampicillin 1.25mg + pivmecillinam 1mg","dosage":"10mg/kg per dose (adult 250mg) of pivampicillin 12H oral."},{"id":"fs-1836","name":"Pivmecillinam","dosage":"5-10mg/kg (adult 200-400mg) 6-8H oral."},{"id":"fs-1837","name":"Pixantrone","dosage":"50mg/m2 IV over 60min on days 1, 8 and 15 of each 28 day cycle."},{"id":"fs-1838","name":"Pizotifen","dosage":"NOT/kg: 0.5mg daily oral, increase if required to max 0.5mg moming and 1 mg at night."},{"id":"fs-1839","name":"Plague vaccine (CSL)","dosage":"Inanimate. Adult (>11 yr): 0.5ml SC stat, and 1-4wk later (2 doses); boost every 6mo. Child: 0.1ml (6rno-2yr), 0.2ml (3-6yr), 0.3ml (7-11yr) SC stat, 1-4wk later, and 1-4wk later (3 doses); boost every 6mo."},{"id":"fs-1840","name":"Platelets","dosage":"<10kg 10ml/kg (max 1 paed pack); 10-20kg 10 ml/kg (or 2 paed pack); 20-30kg 10ml/kg (or 3 paed pack); >30kg 1 adult pack (max 10ml/kg). Packs: paed 40-60ml, apheresis ~200m I (1 00-400ml), pooled 160-300ml."},{"id":"fs-1841","name":"Plerixafor","dosage":"0.24mg/kg (max 40mg) daily SC for up to 4 days."},{"id":"fs-1842","name":"Plicamycin","dosage":"Testicular tumours: 25-30mcg/kg daily for 8-10 days IV over 6hr, repeat monthly if response. Hypercal caemia: 25mcg/kg daily for 3-4 days, then x1-3/wk. Pneumococcal vaccine, CRM conjugate (Prevenar) or"},{"id":"fs-1843","name":"H.influenzae conjugate (Synflorix)","dosage":"Inanimate. 0.5miiM. :56mo: 2rno, 3mo, 4mo, 12-15rno (4 doses). 7-11 mo: 6rno, 'Trno, 12-15mo (3 doses). 12-23rno: 2 doses 2mo apart. Page 85 >23mo: 1 dose. Pneumococcal vaccine, polysaccharide (Pneumovax 23)."},{"id":"fs-1844","name":"Inanimate","dosage":">2yr: 0.5ml SC or IM once. Boost every 5yr."},{"id":"fs-1845","name":"Podofilox","dosage":"See podophyllotoxin."},{"id":"fs-1846","name":"Podophyllotoxin","dosage":"0.5% paint: apply 12H for 3 days, then none for 4 days; 4wk course."},{"id":"fs-1847","name":"Podophyllum","dosage":"15%-25% solution, oint: apply to wart x2/day."},{"id":"fs-1848","name":"Polidocanol","dosage":"0.5%, 1%: 0.1-0.3ml/dose IV, max 10mlday."},{"id":"fs-1849","name":"Polifeprosan","dosage":"See carmustine wafers."},{"id":"fs-1850","name":"Poliomyelitis vaccine, oral (Sabin)","dosage":"Live. 2 drops oral at 2mo, 4mo and 6rno (3 doses). Boost at 5yr, and if going to epidemic area."},{"id":"fs-1851","name":"Poliomyelitis vaccine, SC (I POL)","dosage":"Inanimate. 0.5ml SC stat, 8wk later, and 8wk later (3 doses). Boost 12mo later, and at school entry. See also diphtheria combination vaccines."},{"id":"fs-1852","name":"Poloxalkol","dosage":"See poloxarner."},{"id":"fs-1853","name":"Poloxamer","dosage":"10% solution: <6mo 0.3ml, 6-18mo 0.5ml, 18mo-3yr 0.8ml 8H oral. >3mo use docusate."},{"id":"fs-1854","name":"Polyethylene glycol","dosage":"See colonic lavage, macrogol."},{"id":"fs-1855","name":"Polygeline","dosage":"10-20ml/kg (may be repeated). Half life 2H."},{"id":"fs-1856","name":"Polymyxin B","dosage":"See bacitracin; dexamethasone."},{"id":"fs-1857","name":"Polynoxylin","dosage":"10% gel: apply 12H."},{"id":"fs-1858","name":"Polystyrene sulphonate","dosage":"See sodium polystyrene sui ph."},{"id":"fs-1859","name":"Polythiazide","dosage":"0.02-0.1mg/kg (adult 1-4mg) daily oral."},{"id":"fs-1860","name":"Polyvinyl alcohol","dosage":"1.4%, 3% solution: 1 drop/eye prn."},{"id":"fs-1861","name":"Pomalidomide","dosage":"Adult, NOT/kg: 4mg daily on days 1-21 of 28 day cycle; use 1-3mg dose if toxicity."},{"id":"fs-1862","name":"Ponatinib","dosage":"Adult, NOT/kg: 45mg (30mg if neutropaenia, thrombocy1opaenia or liver toxicity) oral daily."},{"id":"fs-1863","name":"POR 8","dosage":"See ornipressin."},{"id":"fs-1864","name":"Poractant alfa (porcine surfactant, Curosurf)","dosage":"80mg/ml. Intratracheal: 1.25-2.5ml/kg stat, then up to 2 extra doses of 1.25ml/kg 12H if required."},{"id":"fs-1865","name":"Porfimer","dosage":"2mg/kg IV, then 630nm laser light after 40-50hr and 96-120hr; max 3 courses at least 30 days apart."},{"id":"fs-1866","name":"Posaconazole","dosage":"Invasive inftn: oral with fatty meal 150mg/m2 (max 200mg) 6H, or 300mg/m2 (max 400mg) 12H; IV over 90min 230mg/m2 (max 300mg) 12H day1, then daily. Oral candida (adult NOT/kg): 200mg stat, then 100mg daily. Pro phylaxis: 230mg/m2 (max 300mg) 12H oral with fatty meal."},{"id":"fs-1867","name":"Potassium citrate","dosage":"See citric acid + potassium citrate."},{"id":"fs-1868","name":"Potassiumguaiacolsulfonate","dosage":"1-3mg/kg (adult 50-160 mg) 4-6H oral."},{"id":"fs-1869","name":"Potassium","dosage":"Deficiency: usually 0.3mmol/kg/hr (max 0.4 mmol/kg/hr) for 4-6 hr IV, then 4mmol/kg/day. Max oral dose 1 mmol/kg (<5yr), 0.5mmol/kg (>5yr). Maintenance 2-4 mmollkg/day. If peripheral IV, max 0.05 mmol/ml. 1g KCI = 13.3mmol K, 7.5% KCI = 1mmol/ml."},{"id":"fs-1870","name":"Potassium iodide","dosage":"Nuclear accident (NOT/kg): 16.25mg (<1mo), 32.5mg (1mo-3yr), 65mg (4yr-18yr and <70kg), Page 86 130mg (adult) daily oral."},{"id":"fs-1871","name":"Potatoes, roast","dosage":"Oven 230C (210C fan-forced), pan with 5mm peanut oil in oven; peel potatoes, boil 20-30min until friable on outside, drain, put in hot oil, cook on top shelf of oven for 60-100min until crisp (baste every 20min)."},{"id":"fs-1872","name":"Povidone-iodine","dosage":"Cream, oint, paint, solution: apply 6-12H."},{"id":"fs-1873","name":"Pralatrexate","dosage":"30mg/m2 IV wkly for 6wk in 7wk cycle."},{"id":"fs-1874","name":"Pralidoxime","dosage":"50mg/kg (adult 2g) over 30min, then 20 mg/kg/hr (adult 1g/hr) for 48hr, then 20mg/kg (adult 1g) 4H."},{"id":"fs-1875","name":"Pramipexole","dosage":"Adult, NOT/kg: 0.125mg 8H increase by 0.125-0.25 mg every 5-7 days to 0.5-1.5mg 8H oral. Restless legs: 0.125mg (max 0.5mg) 2-3 hours before bedtime. Sustained release: 0.26mg daily oral, increase if required to max 3.15mg daily."},{"id":"fs-1876","name":"Pramlintide","dosage":"Reduce insulin dose by 50% initially. Adult,"},{"id":"fs-1877","name":"NOT/kg","dosage":"Type 1 diabetes: 15mcg SC before meals (x4/day), increase if tolerated to 30-60mcg/dose. Type 2: 60mcg SC before meals (x4/day), increase if tolerated to 90-120mcg/dose."},{"id":"fs-1878","name":"Pramocaine","dosage":"See hydrocortisone+ pramocaine cream."},{"id":"fs-1879","name":"Pramoxine","dosage":"1% cream, lotion: apply 6-8H."},{"id":"fs-1880","name":"Prasugrel","dosage":"Adult, NOT/kg: 60mg load, then 5mg ( <60kg) 10mg (<:60kg) daily oral."},{"id":"fs-1881","name":"Pravastatin","dosage":"Adult, NOT/kg: 20-80mg at bedtime oral."},{"id":"fs-1882","name":"Praziquantel","dosage":"25mg/kg oral once (dwarf tapeworm), 4H x3 doses (schistosomiasis), 8H x6 doses (other flukes), 8H 14 days (cysticercosis). Adult tapeworm 10mg/kg once."},{"id":"fs-1883","name":"Prazosin","dosage":"5mcg/kg (max 0.25mg) test dose, then 0.025-0.1 mg/kg (adult 1-5mg) 6-12H oral."},{"id":"fs-1884","name":"Prednisolone","dosage":"Oral. Alopecia, autoimm liver, Crohn, epilepsy, JIA, Kawasaki, MS, SLE, ulc col: 1-2mglkg (max 60mg) daily, gradually reducing. Asthma: 0.5-1mg/kg GH for 24H, 12H x2, then 1mg/kg daily. Croup: 1mg/kg stat and in 12H; severe 4 mg/kg stat, then 1mg/kg 8H. ITP: 4mg/kg daily. Transpl reject, nephrotic synd: 60mg/m2 (max 80mg) daily, reducing over several mont11s. Physiological: 4-5mg/m2 daily."},{"id":"fs-1886","name":"Prednisolone sodium phosphate","dosage":"0.5%: ear 2-3 drops/ear, eye 1 drop/eye 2-6H."},{"id":"fs-1887","name":"Prednisone","dosage":"Action equivalent to prednisolone."},{"id":"fs-1888","name":"Pregabalin","dosage":"Adult, NOT/kg: 50mg 8H oral, increase gradually if required to max 200mg 8H."},{"id":"fs-1889","name":"Pridopidine","dosage":"Adult, NOT/kg: 45mg 12.H oral."},{"id":"fs-1890","name":"Prilocaine","dosage":"Max dose 6mg/kg (0.6mlkg of 1%). With adre naline max dose 9mg/kg (0.9ml/kg of 1%)."},{"id":"fs-1891","name":"Primaquine base","dosage":"7.5mg base= 13.2mg phosphate. Oral. 0.5 mg/kg (adult 30mg) daily for 14 days (>70kg 30mg daily until 6mg/kg given); if nausea 0.25mg/kg (max 15mg) 12H 14-21 days. Proph: 0.5mg/kg (max 30mg) daily. Gameteocyte: 0. 7 Page 8'7 mg/kg (adult 45mg) once."},{"id":"fs-1892","name":"Primidone","dosage":"Initially 2.5mg/kg (adult 125mg) at night, increase if required to max 15mg/kg (adult750mg) 12H oral. Trough level (phenobarbitone) 60-120umol/L."},{"id":"fs-1893","name":"Pristinamycin","dosage":"Adult, NOT/kg: 0.5-1g 8-12H oral."},{"id":"fs-1894","name":"Probenicid","dosage":"25mg/kg (adult 1g) stat, then 10mg/kg (adult 500mg) 6H oral."},{"id":"fs-1895","name":"Probucol","dosage":"10mg/kg (adult 500mg) 12H oral."},{"id":"fs-1896","name":"Procainamide","dosage":"IV: 0.4mg/kg/min (adult 20mg/min) for max 25min, then 20-80mcg/kg/min (max 2g/day). Oral: 5-8mg/kg 4H. Level3-10mcg/ml."},{"id":"fs-1897","name":"Procaine","dosage":"Max dose 20mg/kg (1 ml/kg of 2%)."},{"id":"fs-1898","name":"Procarbazine","dosage":"1 mg/kg (adult 50mg) daily oral, increase over 4-6 days to 4-6mg/kg (adult 200-300mg) daily until remission, then 1-2mlt{kg (adult 50-100mg) dail~ Suspend if leucocytes <3000/mm or platelets <80,000/mm."},{"id":"fs-1899","name":"Prochlorperazine","dosage":"1 mg base = approx 1.5mg edisylate, mal eate or mesylate. Only use if >10kg. Oral (salt): 0.2mg/kg (adult 5-10mg) 6-8H, slow increase if required to max 0.6mg/kg (max 35mg) 6H in psychosis. IM, slow IV (salt): 0.2mg/kg (adult 12.5mg) 8-12H. Buccal (salt): 0.05-0.1mg/kg (max 6mg) 12- 24H. PR (base): 0.2mg/kg (adult 25mg) 8-12H."},{"id":"fs-1900","name":"Procyclidine","dosage":"0.05-0.Zmg/kg (adult 2.5-10mg) 6-8H oral."},{"id":"fs-1901","name":"Progesterone","dosage":"Adult, NOT/kg. Post-menopausal: 100mg daily on days 1-25 of cycle, or 200mg daily on days 15-26. Premenst syn: 200-400mg PV or PR 12-24H (last half of cycle). Dysf ut hge: 5-10mgiday IM for 5-10 days before menses. Prevent abrtn: 25-100mg IM every 2-4 days."},{"id":"fs-1902","name":"Proguanil","dosage":"3.5mg/kg (adult 200mg) daily oral after food. See also atovaquone + proguanil."},{"id":"fs-1903","name":"Promazine","dosage":"Oral: 2-4mg/kg (adult 1 00-200mg) 6H. IM 0.7mg/kg (max 50mg) 6-SH."},{"id":"fs-1904","name":"Promethazine","dosage":"Antihist, antiemetic: 0.2-0.5mg/kg (adult 10- 25mg) 8H IV, IM or oral. Sedative, i1ypnotic: 0.5-1.5mg/kg (adult 25-100mg). Propacetamol IV preparation: 1 g = 0.5g paracetamol."},{"id":"fs-1905","name":"Propafenone","dosage":"Oral: 70mg/m2 (adult 150mg) SH, increase if required to max 165mg/m2 (adult 300mg) 8H. IV: 2mg/kg over 2H, then 4mcg/kg/min increase if required to max 8mcg/kg/min."},{"id":"fs-1906","name":"Propamidine","dosage":"0.1%: 1 drop/eye 6H for up to 2 days."},{"id":"fs-1907","name":"Propantheline","dosage":"0.3-0.6mg/kg (adult 15-30mg) 6H oral."},{"id":"fs-1908","name":"Propiverine","dosage":"0.3mg/kg (adult 15mg) 5. 12H oral."},{"id":"fs-1909","name":"Propofol","dosage":"Sedation in ICU: 1-3mg/kg/hr (max 4mg/kg/hr) IV, for no longer than 48 hr. Short-term anaesthesia: child 2.5- 3.5mg/kg stat, then 7.5-15mg/kg/hr IV; adult 1-2.5mg/kg stat, then 3-12 mg/kg/hr IV."},{"id":"fs-1910","name":"Propranolol","dosage":"Oral: 0.2-0.5mg/kg (adult 10-25mg) 6-8H, increase to max 1.5mg/kg (max 80mg) 6-8H if required. Haemangioma 5wk- 5mo old: 0.6mg/kg wk1, 1.1mg/kg wk2, then 1.7mg/kg 12H oral with feed. IV: 0.1 mg/kg (adult 5mg) over 10min (repeat x1-3 prn), then 0.1-0.3 mg/kg (adult 5-15mg) 3H."},{"id":"fs-1911","name":"Propylthiouracil","dosage":"50mg/m2 8H oral, reduce with response."},{"id":"fs-1912","name":"Proscillaridin","dosage":"10-15mcg/kg (adult 500-750mcg) 8-12H oral."},{"id":"fs-1913","name":"Prostacyclin","dosage":"See epoprostenol."},{"id":"fs-1914","name":"Prostaglandin","dosage":"See alprostadil (PGE1), carboprost (15-Me PGF2-alpha), dinoprost (PGF2-alpha), dinoprostone (PGE2), epoprostenol (PGI2, prostacyclin), gemeprost (PGE1 analogue), and misoprostol (PGE1 analogue)."},{"id":"fs-1915","name":"Protamine","dosage":"IV 1 mg/10Ou heparin (0.5mg/10Ou if >1 hr since heparin dose) slow IV stat; subsequent doses 0.25-0.5mg/kg (max 50mg). 1 mg per 10Ou of heparin infused in last 2H. 1 mg per 25m I pump blood. Monitor APTT 30min after prot."},{"id":"fs-1916","name":"Protein C","dosage":"60-BOu/kg to achieve 100% protein C activity, maintain >25%, measure 6hrly until stable, then 12hrly."},{"id":"fs-1917","name":"Protein C and S","dosage":"See factor 9 complex (Beriplex, Octaplex)."},{"id":"fs-1918","name":"Prothionamide","dosage":"TB: 15-20mg/kg (adult 0.75-1g) at night oral. Leprosy: 5-Smg/kg (adult 250-375mg) daily."},{"id":"fs-1919","name":"Prothrombin complex","dosage":"See factor 9 complex."},{"id":"fs-1920","name":"Protionamide","dosage":"See prothionamide."},{"id":"fs-1921","name":"Protirelin","dosage":"NOT/kg: 200mcg IV stat."},{"id":"fs-1922","name":"Protriptyline","dosage":"0.1-0.4mg/kg (adult 5-20mg) 6-SH oral."},{"id":"fs-1923","name":"Proxymetacaine","dosage":"0.5% solution: 1 drop/eye stat, t11en 1 drop every 10m in for 5-7 doses."},{"id":"fs-1924","name":"Prucalopride","dosage":"Adult, NOT/kg: 1-2mg daily oral."},{"id":"fs-1925","name":"Pseudoephedrine","dosage":"1mg/kg (adult 60mg) 6-SH oral. Slow release (adult, NOT/kg): 120mg 12H. Pseudoephedrine 60mg + triprolidine 2.5mg (Actifed). 10mt elixir=1tab. NOT/kg: 2.5ml (<2yr), 2.5-5ml (2-5yr), 0.5tab (6-12yr), 1tab (>12yr) 6-SH oral."},{"id":"fs-1926","name":"Psyllium","dosage":"Usually 0.1-0.2g/kg (adult 5-10g) 8-24H oral."},{"id":"fs-1927","name":"Pumactant (ALEC)","dosage":"Preterm babies (NOT/kg): disconnect ETT, rapidly inject 100mg in 1 ml saline via catheter at lower end ETT, flush with 2ml air; repeat after 1 hr and 24H. Prophylaxis if unintabated: 100mg into pharynx."},{"id":"fs-1928","name":"Pyrantel","dosage":"Threadwm, roundwm: 10mg/kg (max 1g) once oral, may repeat wkly x2-3. Hookwm: 10mg/kg (max 1 g) daily x3."},{"id":"fs-1929","name":"Pyrazinamide","dosage":"35mg/kg (max 2g) daily oral, or 75 mg/kg (max 3g) x2/wk."},{"id":"fs-1930","name":"Pyrethrins + piperonyl butoxide","dosage":"Lice: apply enough shampoo to wet hair, wash off in 15min: repeat in 10 days."},{"id":"fs-1931","name":"Pyridostigmine","dosage":"Myas gravis: 1mg/kg (adult 60mg) 4-6H oral, increase to max 2-3mg/kg (adult 120-180mg) 4-6H if required. 180mg slow rei tab (Timespan), Adult, NOT/kg: 1-3 tab 12-24H oral. 1 mg IV, IM or SC = 30mg oral."},{"id":"fs-1932","name":"Pyridoxine","dosage":"With isoniazid or penicillamine (NOT/kg): 5-10mg daily IV, oral. Fits: 10-15mg/kg daily IV or oral. Siderobl an: 2- 8mg/kg (max 400mg) daily IV or oral. Premenstrual synd: 50- 100mg daily oral. See also doxylamine."},{"id":"fs-1933","name":"Pyrilamine","dosage":"See mepyramine."},{"id":"fs-1934","name":"Pyrimethamine","dosage":"Adult, NOT/kg: 25mg tab weekly oral. Page 89 Pyrimethamine 25mg + sulphadoxine 500mg (Fansidar). <4yr Y, tab once, 4-8yr 1 tab, 9-14yr 2 tab, >14yr 3 tab. Prophylaxis: <4yr% tab wkly, 4-8yr Y, tab, 9-14yr% tab, >14yr 1 tab. See also artesunate, chloroquine, dapsone."},{"id":"fs-1935","name":"Q fever vaccine (Q-Vax)","dosage":"See Coxiella burnetti vaccine."},{"id":"fs-1936","name":"Quazepam","dosage":"0.15-0.6mg/kg (adult 15-30mg) at night oral."},{"id":"fs-1937","name":"Quetiapine","dosage":">12yr (NOT/kg) 12H oral per dose: 25mg day 1, 50mg day 2, 100mg day 3, 150mg day 4, then 150-250mg (range 75-400mg) 12H. Beware long QTc interval."},{"id":"fs-1938","name":"Quinagolide","dosage":"0.5mcg/kg (adult 25mcg) nocte, increase to 1.5-3 meg/kg (adult 75-150mcg) nocte oral."},{"id":"fs-1939","name":"Quinalbarbitone","dosage":"Sedative 5mg/kg. Premed 10mg/kg."},{"id":"fs-1940","name":"Quinapril","dosage":"0.2-0.8mg/kg (adult 10-40mg) daily oral. See also hydrochlorothiazide."},{"id":"fs-1941","name":"Quinidine, base","dosage":"10mg/kg stat, then 5mg/kg (max 333mg) 4- 6H oral. IV: 6.3mg/kg (10mg/kg of gluconate) over 2H, then 0.0125mg/kg/min (0.2mg/kg/min of gluconate). IM: 15mg/kg stat, then 7.5mg/kg (max 400mg) 8H. NOTE: 1 mg base= 1.2mg sulphate = 1.3mg bisulphate = 1.6mg gluconate."},{"id":"fs-1942","name":"Quinine, base","dosage":"Oral: 8.3mg/kg (max 542mg) 8H for 3-7 days."},{"id":"fs-1943","name":"Parenteral: 16","dosage":"7mg/kg IV over 4hr or IM, then 8.3mg/kg (max 542mg) 8H IV over 2H or IM. NOTE: 1mg base= 1.7 mg bi sulphate = 1.2mg dihydrochloride = 1.2mg ethyl carbonate = 1.3mg hydrobromide = 1.2mg hydrochloride = 1.2mg sulph."},{"id":"fs-1944","name":"Quinine dihydrochloride or sulphate","dosage":"Malaria. Oral: 10 mg/kg (max 650mg) 8H for 3-7 days. Parenteral: 20mg/kg IV over 4hr or IM, then 10mg/kg (max 650mg) IV over 2H or IM."},{"id":"fs-1945","name":"Quinupristin","dosage":"See dalfopristin + quinupristin."},{"id":"fs-1946","name":"Rabeprazole","dosage":"Adult, NOT/kg: 20mg daily oral4-8wk (DU), 6- 12wk (GU), 4wk then 10-20mg daily (reflux). ZE: 60mg daily, increase if required to 12H. H.pylori, See omeprazole. May lower Mg."},{"id":"fs-1947","name":"Rabies vaccine","dosage":"Inanimate. 1 miiM days 0, 7 and 21 or 28 (3 doses). Boost every 2yr, or if antibody low. Postexposure: immune 1mi1M days 0, 3 (2 doses); non-immune 1mi1M days 0, 3, 7, 14, 30, 90 (6 doses), with immunoglobln."},{"id":"fs-1948","name":"Racecadotril","dosage":"NOT/kg: 10mg (3mo-8kg) 20mg (9-12kg) 30mg (13-27kg) 60mg (27-40kg) 100mg (adult) 8H oral."},{"id":"fs-1949","name":"Radium-223","dosage":"50 kBq/kg IV every 4wk for 6 injections."},{"id":"fs-1950","name":"Raloxifene","dosage":"1 mg/kg (adult 60mg) daily oral."},{"id":"fs-1951","name":"Raltegravir","dosage":"8mg/kg (adult 400mg, max 600mg) 12H oral."},{"id":"fs-1952","name":"Raltitrexed","dosage":"Initially 3mg/m2 IV over 15min every 3wk."},{"id":"fs-1953","name":"Ramelteon","dosage":"Adult, NOT/kg: 8mg at bedtime oral."},{"id":"fs-1954","name":"Ramipril","dosage":"0.05mg/kg (adult 2.5mg) oral daily, may increase over 4- 6wk to 0.1-0.2mg/kg (adult 5-10mg) daily."},{"id":"fs-1955","name":"Ramucirumab","dosage":"8mg/kg IV over 1H every 2wk."},{"id":"fs-1956","name":"Ranibizumab","dosage":"0.5mg (diabetic 0.3mg) by intravitreous injection every month."},{"id":"fs-1957","name":"Ranitidine","dosage":"IV: 1 mg/kg (max 50mg) 6-8H, or 2mcg/kg/min. Oral: 2-5mg/kg (max 150mg) 8-12H, or 300mg (adult) nocte."},{"id":"fs-1958","name":"Ranitidine bismuth citrate","dosage":"Bmg/kg (adult 400mg) 12H oral. Page 90 H.pylori, See omeprazole."},{"id":"fs-1959","name":"Ranolazine","dosage":"10mg/kg (adult 500mg) 12H increase if required to 20mg/kg (adult 1g) 12H oral."},{"id":"fs-1960","name":"Rapacuronium","dosage":"Initially 2mg/kg (child), 1.5mg/kg (adult), 2.5mg/kg Caesar); maintenance 33-50% initial."},{"id":"fs-1961","name":"Rasagiline","dosage":"Adult, NOT/kg: 0.5-1mg daily oral."},{"id":"fs-1962","name":"Rasburicase","dosage":"0.15-0.2mg/kg IV daily for 5-7 days."},{"id":"fs-1963","name":"Raxibacumab","dosage":"IV over 135min once: 80mg/kg (<15kg), 60mg/kg (15-SOkg). 40mg/kg (>50kg)."},{"id":"fs-1964","name":"Razoxane","dosage":"2mg/kg (max 125mg) 8-24H oral; or 7.5-15mg/l(g (max 750mg) daily for 2-3 days every 1-4wk. Kaposi sarc, leukaemia: max 0.33g/m2 8H oral."},{"id":"fs-1965","name":"Reboxetine","dosage":"Adult, NOT/kg: 2-4mg 12H oral, increase gradually if required to max 10mg 12H."},{"id":"fs-1966","name":"Recombinant antihaemophilic factor","dosage":"See factor 8."},{"id":"fs-1967","name":"Recombinant human antithrombin","dosage":"See antithrombin."},{"id":"fs-1968","name":"Regorafenib","dosage":"Adult, NOT/kg: 160mg daily oral for 21 of every 28 day cycle."},{"id":"fs-1969","name":"Remifentanil","dosage":"0.05-0.2mcg/kg/min. Ventilated: usually 0.5-1 meg/kg/min; occasionally' up to 8mcg/kg/min if required."},{"id":"fs-1970","name":"Repaglinide","dosage":"Adult, NOT/kg before main meals, oral: initially 0.5mg, increase every 1-2wk to 4mg (max 16mg/day)."},{"id":"fs-1971","name":"Reproterol","dosage":"Aerosol 0.5mg/puff: 1-2 puffs 3-8H."},{"id":"fs-1972","name":"Reserpine","dosage":"0. 005-0.01 mg/kg (adult 0.25-0.Smg) 12-24H--1 oral."},{"id":"fs-1973","name":"Residonrate","dosage":"Adult, NOT/kg: 5mg daily oral; slow release 35mg once a week."},{"id":"fs-1974","name":"Reslizumab","dosage":"3mg/kg IV over 20-50min every 4wk."},{"id":"fs-1975","name":"Resonium","dosage":"See sodium polystyrene sulphonate."},{"id":"fs-1976","name":"Retapamulin","dosage":"1% ointment: apply 12H for 5 days."},{"id":"fs-1977","name":"Reteplase","dosage":"Adult, NOT/kg for myocard infarct: give heparin 5000u IV + aspirin 250-350mg oral; then reteplase 10u IV over 2m in + 2nd dose 30min later; then heparin 10OOu/hr for 24-72hr and aspirin 75-150mg/day until discharge."},{"id":"fs-1978","name":"Retigabine","dosage":"Adult, NOT/kg: 200-AOOmg 8H oral."},{"id":"fs-1979","name":"Retinol A","dosage":"See vitamin A."},{"id":"fs-1980","name":"Reviparin","dosage":"Child >2mo: 100u/kg 12H SC. Adult, NOT/kg: 1432u 211r before surgery, then daily SC."},{"id":"fs-1981","name":"Ribavirin","dosage":"lnhltn (Viratek nebulizer): 20mg/ml at 25ml/hr (190mcg/L of gas) for 12-18hr/day for 3-7 days. Oral: 7.5 mg/kg 12H. Hepatitis C, oral: 23-33kg 200mg 12H, 34-46 kg 200mg am+ 400mg pm, 47-59kg 400mg 12H, 60. 74kg 400mg am  600mg pm, 2:75kg 600mg 12H; See daclatasvir, elbasvir, interferon alfa-2b, ledipasvir, ornbitasvir, simeprevir."},{"id":"fs-1982","name":"Riboflavine","dosage":"NOT/kg: 5-10mg daily oral. Organic acidosis (NOT/kg): 50-200mg daily oral, IM or IV."},{"id":"fs-1983","name":"Rifabutin","dosage":"Pulmonary TB: 3-5 mg/kg (adult 150-300mg) daily oral. Resistant pul TB: 5-7.5 mg/kg (adult 300-450mg) daily. Mycobact avium complex: 7.5-12mg/kg (adult 450-600mg) daily; prophylaxis 5mg/kg (adult 300mg) daily."},{"id":"fs-1984","name":"Rifampicin","dosage":"15mg/kg (max 600mg) daily oral fasting, or IV Page 91 over 3hr (monitor AST): staph 10mg/kg (max 600mg) 12H"},{"id":"fs-1986","name":"Rifampin","dosage":"See rifampicin."},{"id":"fs-1987","name":"Rifapentine","dosage":"Usually 10-15 mg/kg (adult 600mg) x2/wk for 2mo, then wkly for 4 months."},{"id":"fs-1988","name":"Rifaximin","dosage":"Gl activity only. 7.5-10mg/kg (adult 200-400mg) 8H oral. Adult, NOT/kg: hepatic enceph 550mg 12H oral, irrit able bowel diarrhoea: 550mg 8H oral14 days."},{"id":"fs-1989","name":"Rilonacept","dosage":"Adult, NOT/kg: 320mg, then 160mg wkly SC."},{"id":"fs-1990","name":"Rilpivirine","dosage":"Adult, NOT/kg: 25mg daily oral. See also emtricitabine."},{"id":"fs-1991","name":"Riluzole","dosage":"1mg/kg (adult 50mg) 12H oral."},{"id":"fs-1992","name":"Rimantadine","dosage":"2.qmg/kg (adult 100mg) 12H oral."},{"id":"fs-1993","name":"Rimexolone","dosage":"1%. 1drop/eye 6H. Uveitis: 1drop 1H in daytime for 1wk, 2H for 1wk, 6H for 1wk, daily 1wk."},{"id":"fs-1994","name":"Riociguat","dosage":"Adult, NOT/kg: 1mg 8H oral, increase by 0.5mg every 2wk to max 2.5mg 8H."},{"id":"fs-1995","name":"Risedronate","dosage":"Osteoporosis: 0.1mg/kg (adult 5mg) daily oral; slow release (adult): 35mg weekly, 75mg twice a month, 150mg monthly. Paget's: 0.5mg/kg (adult 30mg) daily oral."},{"id":"fs-1996","name":"Risperidone","dosage":"0.01mg/kg (adult 0.5mg) daily, increase if required to max 0.15mg/kg (adult 2-4mg, max 8mg) 12H oral."},{"id":"fs-1997","name":"Ritodrine","dosage":"Prem labour (NOT/kg): 50mcg/min, increase to 150- 350mcg/min IV: then oral 10mg 2H for 24H, 10-20mg 4-6H."},{"id":"fs-1998","name":"Ritonavir (RTV)","dosage":"See atazinavir, darunavir, efavirenz, fosamprenavir, indinavir, lopinavir, maraviroc, ombitasvir."},{"id":"fs-1999","name":"Ritonavir + saquinavir","dosage":"5-14kg: RTV 3mg/kg + SQV 50 mg/kg 12H oral with food: 15-39kg: RTV 2.5mg/kg + SOV 50mg/kg 12H; ;;,4Qkg: RTV 100mg + SQV 50mg/kg (adult 10OOmg) 12H."},{"id":"fs-2000","name":"Ritonavir + tipranavir","dosage":";;,zyr: RTV 150mg/m2 (max 200mg) + TPV 375 mg/m2 (max 500mg) 12H oral with food."},{"id":"fs-2001","name":"Rituximab","dosage":"Leukaemia: 370mg/m2 by IV infusion day1, then 500mg/m2 wi<IY x5. Rheumatoid arthritis (adult, NOT/kg): 1 g IV twice, 2wk apart."},{"id":"fs-2002","name":"Rivaroxaban","dosage":"Adult, NOT/kg: 10mg daily oral."},{"id":"fs-2003","name":"Rivastigmine","dosage":"Adult, NOT/kg: initially 1.5mg 12H, increase every 2wk to max 6mg 12H oral. Patch: apply 4.6mg (5crn2) daily for 4wk, then 9.5mg (10cm2 ) daily."},{"id":"fs-2004","name":"Rizatriptan","dosage":"Adult, NOT/kg: 10mg oral, may repeat x1 in 2H."},{"id":"fs-2005","name":"Rocuronium","dosage":"0.6-1.2mg/kg IV stat, then 0.1-0.Zmg/kg bolus- es or 5-15mcg/kg/min."},{"id":"fs-2006","name":"Roflumilast","dosage":"Adult, NOT/kg: 500mcg daily oral."},{"id":"fs-2007","name":"Rolapitant","dosage":"Adult, NOT/kg: 180mg oral 1-2H before cherno."},{"id":"fs-2008","name":"Romidepsin","dosage":"14mg/m2 IV over 4hr on days 1, 8 and 15 of a 28-day cycle. Pnge 92 'Romiplostim. 1-10mcg/kg weekly SC."},{"id":"fs-2009","name":"Ropinirole","dosage":"Adult, NOT/kg: 0.25mg daily for 2 days, 0.5mg for 5 days, then 1 mg daily; increase wkly to max 4mg daily oral. Restless legs: 0.25mg (max 4mg) 2H before bedtime."},{"id":"fs-2010","name":"Ropivacaine","dosage":"2-3mg/kg (adult max 200-250mg). Intrathecal: 1mg/kg (0.1ml/kg of 1%). Postop infusion 0.2-0.4mg/kg/hr (0.1-0.2ml/kg/hr of 0.2%)."},{"id":"fs-2011","name":"Rosiglitazone","dosage":"Adult, NOT/kg: 4mg daily oral, increase after 6-8 wk to 4mg 12H if required. See also glimepiride, metformin."},{"id":"fs-2012","name":"Rosuvastatin","dosage":"10mg daily oral, increase if required to 20mg then 40 mg at 4wk intervals."},{"id":"fs-2013","name":"Rotavirus vaccine (Rotarix)","dosage":"Live, monovalent. 1.5ml oral at 6-14wk, and at least 4wk later at 14-24wk (total 2 doses)."},{"id":"fs-2014","name":"Rotavirus vaccine (Rotateq)","dosage":"Live, pentavalent. 2m I oral at 6-12wk, then at 4-10wk intervals (total 3 doses)."},{"id":"fs-2015","name":"Rotavirus vaccine, human-bovine (RotaTeq)","dosage":"Live, penta valent. 2ml oral at age 2mo, 4mo, 6mo (3 doses)."},{"id":"fs-2016","name":"Rotigotine","dosage":"Adult, NOT/kg. Parkinson's 2mg patch daily for 1wk, then 4mg daily; increase if required to 6-Smg daily. Restless legs 1-3mg daily."},{"id":"fs-2017","name":"Roxithromycin","dosage":"<40kg: 4mg/kg (max 150mg) 12H oral. 2:40kg (NOT/kg): 150mg 12H or 300mg daily oral."},{"id":"fs-2018","name":"Rubella vaccine (Ervevax, Meruvax II) Live","dosage":">12mo: 0.5ml"},{"id":"fs-2019","name":"SC once","dosage":"See also measles + mumps + rubella vaccine."},{"id":"fs-2020","name":"Rufinamide","dosage":"10mg/kg (adult 400mg) daily oral, increase over 1-2 wk to 45mg/kg (adult 3200mg). Lower dose if on valproate."},{"id":"fs-2021","name":"Rupatadine","dosage":"Adult, NOT/kg: 10mg daily oral."},{"id":"fs-2022","name":"Ruxolilinib","dosage":"Adult, NOT/kg: 15mg (up to 25mg) 12H oral."},{"id":"fs-2023","name":"Sacrosidase","dosage":"s15kg 1 ml or 1 full scoop (8500-u), >15kg 2m I or 2 full scoops (17000u) oral with each meal or snack."},{"id":"fs-2024","name":"Sacubitril + valsartan","dosage":"24/26mg, 49/51, 97/103. 1 tab 12H oral."},{"id":"fs-2025","name":"Salbutamol (and levalbuterol)","dosage":"0.1-0.15mg/kg (adult 2-4mg) 6H oral. lnhaltn: mild resp solution (5mg/ml, 0.5%) 0.5ml diluted to 4ml, or nebule 2.5mg/2.5ml (0.1%) 3-6H; moderate 0.5% solution 1ml diluted to 4ml, or nebule 5mg/2.5ml (0.2%) 1-2H; severe (in ICU) 0.5% solution undiluted continuous. Aerosol 100mcg/puff: 1-2 puff 4-6H; acute 4-8puff (<6yr) 8-12puff (>6yr). Powder 90mcg/inh: 1-2 inh 4-6H. Rotahaler: 200-400 mcg 6-8H. IM or SC: 10-20mcg/kg (adult 500mcg) 3-6H. IV in child: amp 1 mg/ml at 0.3-0.6 ml/kg/hr (5-10mcg/kg/min) for 1H, then 0.06-0.12ml/kg/hr (1-2mcg/kg/min). Preterm labour: (adult, NOT/kg): 200mcg/ml in 5%D at 3ml/hr (10 meg/min), increase until contractions cease (usually at 3-15ml/hr), then halve dose every 6hr; max duration usually 48hr. IV infusion incompatible with aminophylline, ketamine and magnesium."},{"id":"fs-2026","name":"Salcatonin","dosage":"Hypercalcaemia: 5u/kg 12-24H IM, SC or IV over 6-12H. Paget's: adult 50-100u daily. Cancer bone pain: 4 u/kg (adult 200u) up to x4/day."},{"id":"fs-2027","name":"Salicylic acid","dosage":"Cradle cap: 6% solution (Egocappol) 12H 3-5 days. Plantar warts: 15% solution x1-2/day, 40% medicated Page 93 disc 24-48H. See also benzoic acid+ salicylic acid."},{"id":"fs-2028","name":"Sallcylsalicylic acid","dosage":"See salsalate."},{"id":"fs-2029","name":"Saline laxatives (Microlax, Micolette)","dosage":"<12mo 1.25ml, 1-2yr 2.5ml, >2yr 5ml."},{"id":"fs-2030","name":"Salmeterol","dosage":"Aerosol, diskhaler (NOT/kg): 50-100mcg 12H. See also fluticasone + salmeterol."},{"id":"fs-2031","name":"Salmonella typhi vaccine","dosage":"See typhoid vaccine."},{"id":"fs-2032","name":"Salsalate","dosage":"10-20mg/kg (adult 0.5-1g) 6H oral."},{"id":"fs-2033","name":"Samarium-153","dosage":"Adult: 1.0mCi/kg IV over 1 min."},{"id":"fs-2034","name":"Sapropterin","dosage":"10mg/kg (max 20mg/kg) daily oral."},{"id":"fs-2035","name":"Saquinavir (SQV)","dosage":"See lopinavlr, ritonavir. Trough <t1 00-250 ng/ml."},{"id":"fs-2036","name":"Saracenia purpurea (Sarapin)","dosage":"Adult, NOT/kg: 2-10ml nerve block, 5-10mlocal infiltration."},{"id":"fs-2037","name":"Sargramostim (GM-CSF, Leucomax)","dosage":"3-5mcg/kg daily SC, or IV over 6hr. Keep wee 5,000-10,000/mm3."},{"id":"fs-2038","name":"Saxagliptin","dosage":"Adult, NOT/kg: 2.5-5mg daily oral. See also met formin + saxagliptin."},{"id":"fs-2039","name":"Scopolamine","dosage":"See hyoscine hydrobromide."},{"id":"fs-2040","name":"Sebelipase alta","dosage":"<6mo: 1 mg/kg (max 3mg/kg) IV over 2H weekly. >6mo: 1 mg/kg IV over 2H every other wk."},{"id":"fs-2045","name":"Selegiline","dosage":"Adult, NOT/kg: 10mg daily, oral. Transdermal patch: 6mg daily; increase to max 9-12mg daily if required."},{"id":"fs-2046","name":"Selenium sulphide","dosage":"2.5% shampoo x2/wk for 2wk. Selexipag.Adult, NOT/kg: 200mcg 2H oral, increase if required to max 1600mcg 12H."},{"id":"fs-2047","name":"Senna, Sennoside","dosage":"Tab 7.5mg, granules 15mg/5ml. Daily (NOT/kg): 6mo-2yr7.5mg, 3-10yr7.5-15mg, >10yr 1-30mg."},{"id":"fs-2048","name":"Sermorelin (GHRH)","dosage":"1 meg/kg fasting in moming IV."},{"id":"fs-2049","name":"Sertaconazole","dosage":"2% cream: apply 12H for 4wk."},{"id":"fs-2050","name":"Sertindole","dosage":"Adult, NOT/kg 4mg daily, increase to 12-24mg daily oral."},{"id":"fs-2051","name":"Sertraline","dosage":"0.5mg/kg (adult 25mg) daily oral, increase if required to 1- 2mg/kg (adult 50-100mg) daily; may give 3-4mg/kg (adult 150-200mg) daily for up to 8wk."},{"id":"fs-2052","name":"Sevelamer carbonate","dosage":"20-40mg/kg (adult 800-1600mg) 8H oral, titrated to serum phosphate 1.1-1.8rnmoi/L."},{"id":"fs-2053","name":"Sevoflurane","dosage":"7% (child) 5% (adult) induction, then 0.5-3%."},{"id":"fs-2054","name":"Sildenafil","dosage":"Adult sexual dysfntn: 25-100mg (NOT/kg) oral1hr before sexual activity (max once/day). Pul hypertensn: oral 0.3mg/kg 3-6H increase until effective or systemic hypotension (usual max 2-3 mg/kg/dose): adult, NOT/kg usually 20mg 8H; at 2ppm NO (1 hr before stopping) 0.4mg/kg oral once. IV infusion: 0.4 mg/kg over 3hr, then 1.6mg/kg/day. Page 94 'silodosin. Adult, NOT/kg: 8mg daily oral."},{"id":"fs-2055","name":"Siltuximab","dosage":"11 mg/kg IV over 1 hr every 3wk."},{"id":"fs-2056","name":"Silver nitrate, stick","dosage":"Apply daily to affected area only."},{"id":"fs-2057","name":"Silver sulfadiazine 1% + chlorhexidine 0.2%","dosage":"Cream: apply in 3-5mm layer."},{"id":"fs-2058","name":"Simeprevir","dosage":"Adult, NOT/kg: 150mg daily+ sofosbuvir400mg daily( ribavirin 500-600mg 12H) oral for 12wk."},{"id":"fs-2059","name":"Simethicone","dosage":"See aluminium hydroxide compound. 1"},{"id":"fs-2060","name":"Simvastatin","dosage":"Adult, NOT/kg: 10mg daily oral, increase 4wkly if I required to max 80mg daily; max 10mg/day with amiodarone, ~ diltiazem or verapamil; 20mg/day with amlodipine or ranol- azine. See also ezetimibe + simvastatin."},{"id":"fs-2061","name":"Simvastatin + sitagliptin","dosage":"10/50mg, 20/50,40/50, 10/100, ' 20/100, 40/100 tab. See simvastatin doses."},{"id":"fs-2062","name":"Sincalide","dosage":"Contract gallbladder: 0.02mcg/kg IV over 1 min, then 0.04mcg/kg after 15min if required; or 0.1 meg/kg IM; or 0.12mcg/kg in 100mt saline at 2ml/min. Pancreas test: 0.25 u/kg secretin IV over 60min, plus sincalide 0.02mcg/kg IV infusion during 2\\"' 30min of secretin infusion."},{"id":"fs-2063","name":"Sinecatechins","dosage":"15% ointment: apply 8H for up to 16wk."},{"id":"fs-2064","name":"Sipuleucei-T","dosage":"Adult, NOT/kg: ;,so million treated autologous CD54+ cells IV over 60min on 3 occasions 2wk apart."},{"id":"fs-2065","name":"Sirolimus","dosage":"3mg/m2 (adult 6mg) stat, then 1 mg/m2 (adult 2mg) daily oral."},{"id":"fs-2066","name":"Sitagliptin","dosage":"2mg/kg (adult 100mg) daily oral. See also met formin + sitagliptin, and sirnvastatin + sitagliptin."},{"id":"fs-2067","name":"Sitaxentan","dosage":"2mg/kg (adult 100mg) daily oral."},{"id":"fs-2068","name":"Sodium","dosage":"Deficit (ml saline)= Wt(kg) x 4 x (140 [Na]) I% saline. To increase serum Na by 0.5mmoi/L/hr (max safe rate), infusn rate (ml/hr) = 2 x Wt(kg) I(% saline infused); hours of infusion= 2 x (140-serum Na). 4ml/kg of X% saline raises serum Na by Xmmoi/L. Need 2-6 mmol/kg/day. NaCI MW = 58.45, 1g NaCI = 17.1mmol Na, NaCI20% = 3.4mmollml."},{"id":"fs-2069","name":"Sodium alginate","dosage":"See alginic acid."},{"id":"fs-2070","name":"Sodium aurothiomalate","dosage":"See aurothiomalate."},{"id":"fs-2071","name":"Sodium benzoate","dosage":"Neonate: 250mg/kg over 2H stat, then 1 o. 20mg/kg/hr IV."},{"id":"fs-2072","name":"Sodium bicarbonate","dosage":"See bicarbonate."},{"id":"fs-2073","name":"Sodium calcium edetate (EDTA)","dosage":"25-40mg/kg 12H IM or IV over 1 hr for 5 days; repeat after 3 days if required. With dimer caprol: 12.5mg/kg 4H for 3-7 days."},{"id":"fs-2074","name":"Sodium cellulose phosphate (Calcisorb)","dosage":"Adult, NOT/kg 5mg 8H oral."},{"id":"fs-2075","name":"Sodium chloride","dosage":"See sodium."},{"id":"fs-2076","name":"Sodium citrate","dosage":"Constipation (adult, NOT/kg): usually 450mg in 5ml as enema, often with sodium Iauryt sulphoacetate, glycerol, sorbitol or sorbic acid."},{"id":"fs-2077","name":"Sodium citrotartrate","dosage":"40-80mg/kg (adult 2-4g) in 50ml water 8--12H oral."},{"id":"fs-2078","name":"Sodium clodronate","dosage":"See clodronate. Page 95"},{"id":"fs-2079","name":"Sodium cromoglycate","dosage":"See cromoglycate."},{"id":"fs-2080","name":"Sodium feredetate","dosage":"See ferrous salts."},{"id":"fs-2081","name":"Sodium ferric gluconate","dosage":"Fe 12.5mg/ml. 0.05ml/kg (adult 2m I) test dose IV over 1 hr, then 0.25ml/kg (adult 10m I) IV over 1H with each dialysis (usually for 8 doses)."},{"id":"fs-2082","name":"Sodium fluoride","dosage":"NOT/kg: <2yr 0.55mg oral daily, 2-4yr 1.1 mg, >4yr 2.2mg. Osteoporosis, Paget's, bone secondaries in Adult, NOT/kg: 20-40mg 8-12H."},{"id":"fs-2083","name":"Sodium fusidate","dosage":"175mg = 250mg fusidic acid. Tablets: 10- 15mg/kg (adult 250-500mg) 8H oral. IV over 2-8hr: 10mg/kg (adult 500mg) 8H; severe inftn 15mg/kg (adult 750mg). Peak level 30-200umol/L (x0.52 = mcg/ml). Suspensn: fusidic acid."},{"id":"fs-2084","name":"Sodium hyaluronate","dosage":"Adult, NOT/kg. Cystitis 800mcg/ml: 50ml into bladder wkly x4, then 4wkly. Ophthalmic: 10-15 mg/ml (1-1.5%) 0.2-0.6ml into anterior chamber; 0.18% drops 1/eye as required. Osteoarthritis 10-15mg/ml: 2-2.5ml intra-articular wkly x3\\"5."},{"id":"fs-2085","name":"Sodium nitrite","dosage":"3%: 0.2ml/kg (max 10ml) IV over 5 min."},{"id":"fs-2086","name":"Sodium nitroprusside","dosage":"IV. <30kg: 3mg/kg in 50ml 5%0 at 0.5-4 ml/hr (0.5-4mcg/kg/min). >30kg: 3mg/kg made to 100ml in 5%0 at 1-Sml/hr (0.5-4mcg/kg/min). If used for >24H, max rate 4mcg/kg/min. Max total 70mg/kg with normal renal function (or sodium thiocyanate <1725 umol/L, x0.058 = mg/l.). TYz 2min.Protect from light."},{"id":"fs-2087","name":"Sodium oxybate","dosage":"Narcolepsy (NOT/kg): 2.25g at bedtime, repeated 2-4hr later; increase if required by 0.75g every 2wk to max 4.5g + 4.5g (9g per night)."},{"id":"fs-2088","name":"Sodium phenylbutyrate","dosage":"10-13g/m2/day divided into equal amounts with each feed or meal, oral."},{"id":"fs-2089","name":"Sodium phosphate","dosage":"See phosphate, sodium."},{"id":"fs-2090","name":"Sodium picosulphate","dosage":"2.5mg (1-4yr), 2.5-5mg (4-10yr), 5-10 mg (>10yr) at night oral."},{"id":"fs-2091","name":"Sodium polystyrene sulphonate (Resonium)","dosage":"0.3-1 g/kg (adult 15-30g) 6H NG (give lactulose) or PR."},{"id":"fs-2092","name":"Sodium pyrrolidone carboxylate","dosage":"2.5% cream: apply prn."},{"id":"fs-2093","name":"Sodium salicylate","dosage":"1 g = 1.1 g aspirin."},{"id":"fs-2094","name":"Sodium stibogluconate","dosage":"Soltn 100mg/ml of pentavalent anti mony. 20mg/kg (usual max 850mg) daily IV over 10min for 20 days (visceral) or at least 4wk (mucocutaneous); 10-15 mg/kg 12H if toxicity. Early cutaneous: infiltrate lesions with 1-3ml, repeat x1-2 if required after 1-2 days. Severe cutaneous: 20mg/kg daily IV over 10m in until 3 days after cure (usually), 4wk after (l_.braziliensis), or 3mo after (L.amazonensis)."},{"id":"fs-2095","name":"Sodium tetradecyl sulphate","dosage":"NOT/kg: 0.25-1ml per vein as 1% (max 10 small veins) or 3% (max 41arge veins)."},{"id":"fs-2096","name":"Sodium thiosulphate","dosage":"1 ml/kg (adult 50ml) 25% solution IV over 10min."},{"id":"fs-2097","name":"Sodium valproate","dosage":"5mg/kg (adult 200mg) 12H oral or IV, increase if reqcl to max 20mg/kg (adult 1g) 8-12H. Status: 20-40mg/kg"},{"id":"fs-2098","name":"IV over 5min, then 1-5mg/kglhr","dosage":"Slow-release 15-60mg/kg Page 96 (adult 1 000-3000mg) daily. Level 2H after dose 350. 900 umol/L (x0.14=mg/L)."},{"id":"fs-2099","name":"Sofosbuvir 400mg + velpatasvir 10Omg","dosage":"Adult, NOT/kg: 1 tab daily oral for 12wk  ribavirin. See daclatasvir, ledipasvir, ombitasvir, simeprevir."},{"id":"fs-2100","name":"Solifenacin","dosage":"Adult, NOT/kg: 5-10mg daily oral."},{"id":"fs-2101","name":"Solifenacin 6mg + tamsulosin 400mcg","dosage":"Adult, NOT/kg: 1 tab daily oral."},{"id":"fs-2102","name":"Somatorelin","dosage":"Diagnostic: 1 meg/kg IV. Therapy: 30mcg/kg daily at bedtime SC."},{"id":"fs-2103","name":"Somatostatin","dosage":"See octreotide."},{"id":"fs-2104","name":"Somatrem","dosage":"4u/m2 3 days a wk IM."},{"id":"fs-2105","name":"Somatropin.1mg = 3iu","dosage":"Usually 0.5-1mg/m2 on 5-7 days a wk"},{"id":"fs-2106","name":"SC, or 1-2mg/m2 on 3 days a wk IM","dosage":"Short bowel: 0.1mg/kg (max Bmg) daily SC."},{"id":"fs-2107","name":"Sonidegib","dosage":"Adult, NOT/kg: 200mg daily oral."},{"id":"fs-2108","name":"Sorafenib","dosage":"Adult, NOT/kg: 400mg 12H (or 24-48H) oral."},{"id":"fs-2109","name":"Sorbitol 70%","dosage":"0.2-0.Sml/kg (adult 2Q. 30ml) 8-24H oral. With activated charcoal: 1g/kg (1.4ml/kg) NG, x1-2. Sorbolene cream; pure, with 10% glycerin, or with 5% or 10% olive oil or peanut oil. Skin moisturiser: apply prn."},{"id":"fs-2110","name":"Sotalol","dosage":"IV: 0.5-2mg/kg (adult 25-120mg) over 10min 6H. Oral: 1-4mg/kg (adult 50-160mg) 8-12H."},{"id":"fs-2111","name":"Sparfloxacin","dosage":"10mg/kg (adult 400mg) stat, then 5mg/kg (adult 200mg) daily oral."},{"id":"fs-2112","name":"Spectinomycin","dosage":"40-BOmg/kg (adult 2-4g) IM once."},{"id":"fs-2113","name":"Spinosad","dosage":"0.9% to dry hair 10min then rinse, repeat in 1wk."},{"id":"fs-2114","name":"Spironolactone","dosage":"Oral (NOT/kg): 0-10kg 6.25mg 12H, 11-20kg 12.5mg 12H, 21-40kg 25mg 12H, over 40kg 25mg 8H."},{"id":"fs-2115","name":"Female hirsutism 50mg BH","dosage":"IV: See potassium canrenoate."},{"id":"fs-2116","name":"Stanolone","dosage":"2.5% gel. Male: apply 5-10g daily to a large area of skin and allow 5 min to dry. Female (lichen sclerosus): apply 2.5g to vulva on alternate days."},{"id":"fs-2117","name":"Stanozolol","dosage":"0.05-0.2mg/kg oral (adult 2.5-10mg) daily at first, then every 2-3 days."},{"id":"fs-2118","name":"Stavudine (d4T)","dosage":"0.5mg/kg (<14days) 1mg/kg (<30kg), 30mg (30-59kg), 40mg (\\"60kg) 12H oral. Slow rei (adult, NOT/kg): 75mg (<60kg), 100mg (\\"60kg) daily oral."},{"id":"fs-2119","name":"Sterculia","dosage":"NOT/kg: 3.5-?g 12-24H oral. See also frangula."},{"id":"fs-2120","name":"Stibogluconate","dosage":"See sodium stibogluconate."},{"id":"fs-2121","name":"Stilboestrol","dosage":"Ca breast (NOT/kg): 10-20mg daily oral. Ca prostate: 1-3mg daily oral or IV."},{"id":"fs-2122","name":"Stiripentol","dosage":"I ncr over 3 days to 15mg/kg 8H oral, max 35 mg/kg 8H (max 4g/day) oral."},{"id":"fs-2123","name":"Streptokinase (SK)","dosage":"Short term (myoc infarct): 30,000u/kg (max 1 ,500,000u) IV over 1 hr, repeat if occlusion recurs <5 days. Long terrn (DVT, pul emb, art thrombosis): 2,000 u/kg (max 100,OOOu) IV over 1 0min, then 10OOu/kg/hr (max 100,000u/hr); stop heparin and aspirin, if PTT <x2 normal at 4hr give extra 10,000u/kg (max 500,000u) IV over 30min, Page 97 stop SK if PTT >x5 normal then give 10OOu/kg/hr. Local infusion: 50 u/kg/hr (continue heparin 10-15u/kg/hr). Blocked IV cannula: 5000u/kg in 2ml in cannula for 2H then remove, may repeat x2. Alteplase usually preferable."},{"id":"fs-2124","name":"Streptomycin","dosage":"20-30mg/kg (max 1 g) IM daily."},{"id":"fs-2125","name":"Streptozocin","dosage":"1-1.5g/m2 wkly IV."},{"id":"fs-2126","name":"Strontium ranelate","dosage":"Adult, NOT/kg: 2g daily at bedtime."},{"id":"fs-2127","name":"Strontium-89","dosage":"1.5-2.2 MBq/kg (40-60~Ci/kg) IV over 2m in."},{"id":"fs-2128","name":"Succimer","dosage":"350mg/m2 8H for 5 days, then 12H x14 days oral."},{"id":"fs-2129","name":"Succinylcholine","dosage":"See suxamethonium."},{"id":"fs-2130","name":"Sucralfate","dosage":"1g tab (NOT/kg): 0-2yr quarter tab 6H, 3-12 yr half tab 6H, >12yr 1 tab 6H oral."},{"id":"fs-2131","name":"Sucroferric oxyhydroxide","dosage":"Adult, NOT/kg: 500mg 8H oral adjusted wkly to serum phosphate 1.1-1.Bmmoi/L."},{"id":"fs-2132","name":"Sucrose","dosage":"Analgesia in infants: 0.17g/kg (0.5mlikg of 33% solution) 2m in before procedure."},{"id":"fs-2133","name":"Sufentanil","dosage":"2-50mcg/kg slow IV; may then infuse so that total dose is 1 mcg/kg/hr of expected surgical time."},{"id":"fs-2134","name":"Sugammadex","dosage":"2mg/kg (after spontaneous recovery), 4mg/kg (if 1-2 post-tetanic counts), 16mg/kg for immediate reversal of rocouronium (but not vecuronium)."},{"id":"fs-2135","name":"Sulbactam","dosage":"See ampicillin c sulbactarn."},{"id":"fs-2136","name":"Sulconazole","dosage":"1% cream: apply 12H for 3wk after cure."},{"id":"fs-2137","name":"Sulfacetamide","dosage":"See sulphacetamide."},{"id":"fs-2138","name":"Sulfadiazine","dosage":"50mg/kg (max 2g) 6H slow IV."},{"id":"fs-2139","name":"Sulfadoxine","dosage":"See pyrimethamine+ sulphadoxine."},{"id":"fs-2140","name":"Sulfamethizole","dosage":"See sulphamethizole."},{"id":"fs-2141","name":"Sulfamethoxazole + trimethoprim","dosage":"See cotrimoxazole."},{"id":"fs-2142","name":"Sulfametopyrazine","dosage":"40mgikg (adult 2g) wkly oral."},{"id":"fs-2143","name":"Sulfasalazine","dosage":"See sulphasalazine."},{"id":"fs-2144","name":"Sulfinpyrazone","dosage":"See sulphinpyrazone."},{"id":"fs-2145","name":"Sulfisoxazole","dosage":"See sulphafurazole."},{"id":"fs-2146","name":"Sulindac","dosage":"4mg/kg (adult 200mg) 12H oral."},{"id":"fs-2147","name":"Sulphacetamide","dosage":"100mg/ml 1 drop/eyo 2-3H during the day."},{"id":"fs-2148","name":"Sulphadoxine","dosage":"See pyrimethamine + sulphadoxine."},{"id":"fs-2149","name":"Sulphafurazole","dosage":"75mg/kg (adult 4g) stat, then 35mg/kg (adult 1.5g) 4-6H oral."},{"id":"fs-2150","name":"Sulphamethizole","dosage":"10mg/1\\\\g (adult 0.5-1g) 6H oral."},{"id":"fs-2151","name":"Sulphamethoxazole + trimethoprim","dosage":"See cotrimoxazole."},{"id":"fs-2152","name":"Sulphasalazine","dosage":"Active colitis: 20mg/kg 6-12H (max 4g/day) oral; remission 7.5mg/kg (max 0.5g) 6-SH, suppos (NOT/kg) adult 0.5-1g 12H. Arthritis: 5mg/kg 12H, increase if required to 10mg/kg 8-12H (max 2g/day)."},{"id":"fs-2153","name":"Sulphinpyrazone","dosage":"2-3mg/kg (max 200mg) 6-12H oral."},{"id":"fs-2154","name":"Sulpiride","dosage":"4mg/kg (adult 200mg) 12H, slow increase if required to 4. 24mg/kg (adult 0.2-1.2g) 12H oral."},{"id":"fs-2155","name":"Sulthiame","dosage":"1 mg/kg (adult 50mg) 8-12H oral, may increase to 5 mg/kg (adult 200mg) 8H."},{"id":"fs-2156","name":"Sumatriptan","dosage":"Oral: 1-2mg/kg (adult 50-100mg) stat, may repeat x2. SC or needle-free: 0.12mg/kg (max 6mg) stat, Page 98 ' may repeat x1 after 1 hr. Nasal: 10-11mg/nostril, may repeat x1 after 2H. Patch 6.5mg: 1--2/day 2H apart. See naproxen."},{"id":"fs-2157","name":"Sunitinib","dosage":"Adult, NOT/kg: 50mg (37.5-87.5mg) daily oral for 4wk, then 2wk off."},{"id":"fs-2158","name":"Surfactant","dosage":"See beractant (Survanta), calfactant (lnfasurf), colfosceril palmitate (Exosurf), poractant alfa (Curosurf), pumactant (ALEC)."},{"id":"fs-2159","name":"Suvorexant","dosage":"Adult, NOT/kg: 10-20mg at night oral."},{"id":"fs-2160","name":"Suxamethonium","dosage":"IV: neonate 3mg/kg, child 2mg/kg, adult 1 mg/kg. IM: double IV dose."},{"id":"fs-2161","name":"Tacalcitol","dosage":"4mcg/g oint, lotion: apply sparingly at bedtime (max 10g oint or lotion per day)."},{"id":"fs-2162","name":"Tacrine","dosage":"Adult, NOT/kg: 10mg 6H oral for 6wk, then increase if required by 10mg every 6wk to max 40mg 6H."},{"id":"fs-2163","name":"Tacrolimus ointment","dosage":"2-16yr: apply 0.03% sparingly 12H for max 3wk, then daily. >16yr: apply 0.1% sparingly 12H for max 3wk, then 0.03% -12H."},{"id":"fs-2164","name":"Tacrolimus","dosage":"IV infusion: 2mg/m2/day. Oral: 3mg/m2 12H. Trough level: whole blood 10-15ng/ml (sent to Austin daily at 1000 from RCH)."},{"id":"fs-2165","name":"Tadalafil","dosage":"Adult, NOT/kg: 10mg (range 5-20mg) oral 30min before sex (max x1/day), or 2.5mg (max 5mg) daily. Benign prostatic hypertrophy: 5mg daily. Pul hyp; See arnbrisentan."},{"id":"fs-2166","name":"Tafamidis","dosage":"Adult, NOT/kg: 20mg daily oral."},{"id":"fs-2167","name":"Tafluprost","dosage":"15mcg/ml: 1 drop/eye at bedtirno."},{"id":"fs-2168","name":"Taliglucerase","dosage":"60u/kg IV over 1-2H every 2wk."},{"id":"fs-2169","name":"Talimogene","dosage":"Adult, NOT/kg: up to 4ml injected into lesions using 106 PF'U/ml wkO, 108 PFU/ml wk3 and then every 2wk"},{"id":"fs-2170","name":"Tamoxifen","dosage":"Adult, NOT/kg: 20mg daily, increase to ~Omg daily if no response after 1 rna."},{"id":"fs-2171","name":"Tamsulosin","dosage":"Adult 400mcg daily after breakfast oral. See also dutasteride + tamsulosin. See solifenacin."},{"id":"fs-2172","name":"Tapentadol","dosage":"1-2mg/kg (adult 50-100mg) 4-6H oral. Slow-rei (adult, NOT/kg): 100-250mg 12H oral."},{"id":"fs-2173","name":"Tar","dosage":"See coal tar."},{"id":"fs-2174","name":"Tasimelteon","dosage":"Adult, NOT/kg: 20mg at bedtime. oral"},{"id":"fs-2175","name":"Tasonermin","dosage":"Isolated limb perfusion: arm 3mg, leg 4mg."},{"id":"fs-2176","name":"Tavaborole","dosage":"5% solution to affected nails daily for 48wk."},{"id":"fs-2177","name":"Tazarotene","dosage":"0.05%, 0.1% gel, cream: apply a thin layer to affected area daily (or on alternate days) in the evening."},{"id":"fs-2178","name":"Tazobactam","dosage":"See piperacillin + tazobactarn."},{"id":"fs-2179","name":"Tedizolid","dosage":"Adult, NOT/kg: 200mg daily oral or IV."},{"id":"fs-2180","name":"Teduglutide","dosage":"0.05mg/kg daily SC."},{"id":"fs-2181","name":"Tegafur + gimeracil + oteracil","dosage":"15/4.35/11.8mg, 20/5.8/15.8 cap. >18yr: 25mg/m2 of tegafur (20mg/m2 or 15mg/m2 if toxicity) oral on days 1-21 of each 28 day cycle."},{"id":"fs-2182","name":"Tegafur 10Omg + uracil 224mg","dosage":"1 00mg/m2 tegafur + 224 mg/m2 uracil (with 30mg calcium folinate) SH oral for 28 days, 7 days off, then repeat cycle. See also girneracil."},{"id":"fs-2183","name":"Tegaserod","dosage":"Adult, NOT/kg: 6mg 12H oral before a meal. Page 99"},{"id":"fs-2184","name":"Teicoplanin","dosage":"250mg/m2 (adult 800mg) IV over 30min stat, then 125mg/m2 (adult 400mg) IV or IM daily. Severe inftn: 250mg/m2 12H x3 doses, then 250mg/m2 IV or IM daily."},{"id":"fs-2185","name":"Telaprevir","dosage":"15mg/kg (adult 750mg) 8H oral."},{"id":"fs-2186","name":"Telavancin","dosage":"10mg/kg IV over 1 hr daily."},{"id":"fs-2187","name":"Telbivudine","dosage":"Adult, NOT/kg: 600mg daily oal."},{"id":"fs-2188","name":"Telithromycin","dosage":"Adult, NOT/kg: 800mg oral daily."},{"id":"fs-2189","name":"Telmisartan","dosage":"1 mg/kg (adult 40mg) daily, increase if required to 2mg/kg (adult 80mg) daily oral. See also hydrochlorothiazide."},{"id":"fs-2190","name":"Temazepam","dosage":"0.3mg/kg (adult 20-40mg) oral."},{"id":"fs-2191","name":"Temocillin","dosage":"25-50mg/kg (adult 1-2g) 12H IV or IM."},{"id":"fs-2192","name":"Temoporfin","dosage":"150mcg/kg IV over 1 0min; 96hr later give 652 nm laser for about 200 sec to give 20J/cm2; repeat once after 4wk if required."},{"id":"fs-2193","name":"Temozolomide","dosage":"200mg/m2 daily oral for 5 days per 28 day cycle (150mg/m2 for first cycle if previous chemotherapy)."},{"id":"fs-2194","name":"Temsirolimus","dosage":"Adult, NOT/kg: 25mg IV over 1 hr wkly."},{"id":"fs-2195","name":"Tenecteplase","dosage":"img = 200u. Myocar infarct (adult): 100u/kg (max 10,000u) IV over 10sec once; also give aspirin 150- 325mg/day, and heparin to maintain APTT 50-75sec."},{"id":"fs-2196","name":"Teniposide","dosage":"1 00-150mg/m2 IV over 1 hr wkly."},{"id":"fs-2197","name":"Tenofovir (TDF)","dosage":"300mg of tenofovir DF = 245mg tenofovir D. <35kg: 8-10mg/kg daily oral; \\"35kg: 300mg daily oral. See also efavirenz, emtricitabine and cobicistat."},{"id":"fs-2198","name":"Tenoxicam","dosage":"0.2-0.4mg/kg (adult 10-20mg) daily oral."},{"id":"fs-2199","name":"Terazosin","dosage":"0.02mg/kg test, then 0.04-0.4mg/kg (adult 2-20 mg) daily oral."},{"id":"fs-2200","name":"Terbinafine","dosage":"Tinnea corp, ped, ung: 62.omg (10-20kg), 125 mg (20-40kg), 250mg (adult) daily oral. Tinnea capitis: 125 mg (10-25kg), 187.5mg (25-35kg), 250mg (>35kg) daily. 1% cream, gel: apply 12-24H to dry skin."},{"id":"fs-2201","name":"Terbutaline","dosage":"Oral: 0.05-0.1 mg/kg (adult 2.5-5mg) 6H. SC: 5- 10mcg/kg (adult 0.25-0.5mg). IV: child 3-6mcg/kg/min for ihr, then 0.4-imcg/kg/min; adult 0.25mg stat over 10min, then 1-iOmcg/kg/hr. lnhaltn: mild resp solution (1%, 10mg/ml) 0.25ml diluted to 4ml 3-6H; moderate 0.5ml of 1% diluted to 4ml, or respule 5mg/2ml 1-2H; severe (in ICU) undiluted continuous. Aerosol 250mcg /puff: 1-2 puffs 4-6H."},{"id":"fs-2202","name":"Terfenadine","dosage":"30mg (6-12yr), 60mg (adult) 12H oral."},{"id":"fs-2203","name":"Teriflunomide","dosage":"Adult, NOT/kg: 7-14mg daily oral."},{"id":"fs-2204","name":"Teriparatide","dosage":"Adult, NOT/kg: 20mcg SC daily."},{"id":"fs-2205","name":"Terlipressin","dosage":"0.04mg/kg (adult 2mg) IV, then 0.02-0.04mg/kg (adult 1-2mg) 4-6H for max 72hr. Slow onset, long effect (TY, 6hr): continuous infusion may cause necrosis."},{"id":"fs-2206","name":"Tesamorelin","dosage":"Adult, NOT/kg: 2mg SC daily."},{"id":"fs-2207","name":"Testolactone","dosage":"5. 10mg/kg (max 250mg) 6H oral."},{"id":"fs-2208","name":"Testosterone","dosage":"NOT/kg. Esters: 100-500mg IM every 2-4wk."},{"id":"fs-2209","name":"Implant: 8mg/kg (to nearest 10Omg) every 16","dosage":"24wk. Undec anoate: 40mg daily oral, increase to 80-120mg daily; depot 750 mg IM, after4wk, then every 10wk. 1% gel: 5g tabe (50mg Page 100 testosterone) to skin daily. Transdermal patch: 2.5-5mg daily; gel 40-50mg. Metered dose pump: 40-60mg daily. 30mg buccal tab: applied just above incisor 12H. Intranasal gel 5.5mg in each nostril 8H. Postmenopausal breast cancer: 100mg x2-3/wk IV or IM. Testosterone level: <16y 5-10 nmoi/L, >16y 10-30nmoi/L."},{"id":"fs-2210","name":"Tetanus toxoid","dosage":"0.5ml IM stat, 6wk later, and 6mo later."},{"id":"fs-2211","name":"Boost every 10yr, or if contaminated wound","dosage":"See also diphtheria compound vaccines. "},{"id":"fs-2212","name":"Tetrabenazine","dosage":"Adult, NOT/kg: 12.5 daily oral; slow increaseease if required to max 37.5mg 8H oral."},{"id":"fs-2213","name":"Tetracaine","dosage":"See amethocaine."},{"id":"fs-2214","name":"Tetracosactrin zinc injection (Synacthen Depot)","dosage":"600 mcglm' (max 1mg) IM every 1-7 days."},{"id":"fs-2215","name":"Tetracycline","dosage":">8yr (NOT/kg): 250-500mg 6H oral. Acne (NOT/kg): 500mg 12H, reducing to 250mg 12H. Eye: apply 2-SH. See also rolitetracycline."},{"id":"fs-2216","name":"Tetrahydrobiopterin","dosage":"Defective synthesis: 20mg/kg daily oral."},{"id":"fs-2217","name":"Defective regeneration: 5mg/kg 6H oral","dosage":"Loading test: 20 mg/kg oral, 2mg/kg IV."},{"id":"fs-2218","name":"Tetrahydrozoline","dosage":"0.05%: 1 drop/eye 8-12H. See also macro gal + tetrahydrozoline."},{"id":"fs-2219","name":"Thalidomide","dosage":"4mg/kg (adult 200mg) 12H oral, reducing over 2-4wk to 0.5-1 mg/kg (adult 25-50mg) 12H."},{"id":"fs-2220","name":"THAM","dosage":"See trornethamine."},{"id":"fs-2221","name":"Theophylline","dosage":"80mg theophylline= 100mg aminophylline)."},{"id":"fs-2222","name":"Load: 8mg/kg (max 500mg) oral","dosage":"Maintenance: 1st wk life 2mg/kg 12H; 2nd wk 3mg/kg 12H; 3wk-12mo ((0.1 x age in wk) + 2.7) mg/kg 8H; 1-9yr 4mg/kg 4-6H, or 10mg/kg slow rei 12H; 10-16yr or adult smoker 3mg/kg 4-6H, or 7mg/kg 12H slow rei; adult non-smoker 3mg/kg 6-8H; elderly 2mg/kg 6- 8H. Serum level: neonate 60-SOumol/L, asthma 60-110 (x0.18 = mcg/ml)."},{"id":"fs-2223","name":"Thiabendazole","dosage":"25mg/kg (max 1.5g) 12H oral 3 days."},{"id":"fs-2224","name":"Thiamazole","dosage":"See methimazole."},{"id":"fs-2225","name":"Thiamine","dosage":"Beriberi: 1-2mg/kg IV, IM or oral daily. Metabolic disease (NOT/kg): 100mg 8H IV, IM, SC, oral."},{"id":"fs-2226","name":"Thiethylperazine","dosage":">10kg: 0.2mg/kg (adult 10mg) 8-24H oral, IM, or PR."},{"id":"fs-2227","name":"Thioguanine","dosage":"100mg/m2 daily oral; or 100mg/m2 12H for 5-7 days."},{"id":"fs-2228","name":"Thiopental","dosage":"See thiopentone."},{"id":"fs-2229","name":"Thiopentone","dosage":"2-5mg/kg slowly stat (beware hypotension). IV infusion: amp 25mg/ml at 0.04-0.2ml/kgihr (1-5mg/kg/hr). Level 150-200umol/L (x0.24 = mcg/ml)."},{"id":"fs-2230","name":"Thioridazine","dosage":"0.5-3mg/kg (adult 25-150mg) 6-SH oral or IM."},{"id":"fs-2231","name":"Thiosulphate","dosage":"See sodium thiosulphate."},{"id":"fs-2232","name":"Thiotepa","dosage":"10-14mg/m2 IV every 1-4wk."},{"id":"fs-2233","name":"Thiotepa","dosage":"1 in 2000: 1 drop/eye 4-6H for 6wk."},{"id":"fs-2234","name":"Thiothixene","dosage":">12yr (NOTikg): initially 2mg 8H oral, slow increase Page 101 to 2-20mg per dose. Threonine.15-30mg/kg (adult 0.75-1.5g) 8H oral."},{"id":"fs-2235","name":"Thrombin glue","dosage":"10,000u thrombin in 9ml mixed with 1ml10% calcium chloride in syringe 1, 10ml cryoprecipitate in syringe 2: apply to bleeding sites together. Do not inject."},{"id":"fs-2236","name":"Thrombin, topical","dosage":"1 00-2000u/ml onto bleeding surface."},{"id":"fs-2237","name":"Thymidine","dosage":"75g/m2 every 4-6wk IV over 24H."},{"id":"fs-2238","name":"Thymoxamine","dosage":"Adult, NOT/kg: 40-80mg 6H oral."},{"id":"fs-2239","name":"Thyrotropin alfa","dosage":"Adult, NOT/kg: 0.9mg IM 24H x2 doses, or 72H x3 doses."},{"id":"fs-2240","name":"Thyroxine, levothyroxine (LT4)","dosage":"1.6mcg/kg (adult 100-200 meg) daily oral, titrated. IV: 1.2mcg/kg daily. See also liothyronine (LT3), liotrix (LT3/LT4)."},{"id":"fs-2241","name":"Tiagabine","dosage":"0.1 mg/kg (adult 5mg) 12H oral, increase wkly to 0.1-0.2 mg/kg (adult 5-10mg) 8H; 0.2-0.3mg/kg (adult 10-15mg) 8H if on carbamazepine, phenobarb, phenytoin, primidone."},{"id":"fs-2242","name":"Tiaprofenic acid","dosage":"2-4mg/kg (adult 1 00-200mg) 8H oral."},{"id":"fs-2243","name":"Tibolone","dosage":"Adult, NOT/kg: 2.5mg daily oral."},{"id":"fs-2244","name":"Ticagrelor","dosage":"Adult, NOT/kg: 180mg stat, then 90mg 12H oral."},{"id":"fs-2245","name":"Ticarcillin","dosage":"50mgikg (adult 3g) 8H (1st wk life) 6H (>1wk) IV. Severe inftn: 50mg/kg 6H (1\\" wk life) 4H (>1wk) or constant infusion. Cystic fib: 100mgikg (max 6g) 8H IV."},{"id":"fs-2246","name":"Ticarcillin + clavulanic acid","dosage":"Dose as for ticarcillin."},{"id":"fs-2247","name":"Tick-borne encephalitis vaccine","dosage":"Inanimate. 0.5m11M stat, after 4-12wk, and after 9-12mo. Boost every 3-6yr."},{"id":"fs-2248","name":"Ticlopidine","dosage":"5mg/kg (adult 250mg) 12H oral."},{"id":"fs-2249","name":"Tigecycline","dosage":"2mgikg (adult 100mg) IV over 1 hr stat, then 1 mg/kg (adult 50mg) IV over 30min 12H."},{"id":"fs-2250","name":"Tilactase","dosage":"200u/drop: 5-15 drops/L added to milk 24H before use. 3300u/tab: 1-3tabs with meals oral."},{"id":"fs-2251","name":"Tiludronate","dosage":"Adu It 400mg daily for 12 wk oral."},{"id":"fs-2252","name":"Tiludronic acid","dosage":"See tiludronate disodium."},{"id":"fs-2253","name":"Timolol","dosage":"0.1mg/kg (adult 5mg) 8-12H, increase to max 0.3mgikg (adult 15mg) 8H. Eye drops (0.25%, 0.5%): 1 drop/eye 12- 24H; See also bimatoprost + timolol, latanoprost + tirnolol."},{"id":"fs-2254","name":"Timolol 5mg/ml + travoprost 40mcg/ml","dosage":"1 drop/eye daily."},{"id":"fs-2255","name":"Tinidazole","dosage":"Giardia, trichomonas: 50mg/kg (adult 2g) daily for 2 days oral, or 25mg/kg (adult 1g) daily x5 days. Amoebiasis: 50mg/kg (adult 2g) daily for 3-5 days, usually followed by diloxanide furoate 10mg/kg (adult 500mg) 8H x10 days."},{"id":"fs-2256","name":"Tinzaparin","dosage":"1mg = 75 anti-Xa IU. Prophylaxis: 50u/kg SC 2H before surgery, then daily for 7-10 days. Treatment: 175u/kg SC daily for at least 6 days."},{"id":"fs-2257","name":"Tioconazole","dosage":"280mgiml: apply to nails 12H for 6-12mo."},{"id":"fs-2258","name":"Tioguanine","dosage":"Usually 200mg/m2 daily oral for 5-20 days."},{"id":"fs-2259","name":"Tiopronin","dosage":"3-10mg/kg (adult 150-500mg) 6-8H oral."},{"id":"fs-2260","name":"Tiotropium","dosage":"Inhaled daily NOT/kg: cap 18mcg; MDI 5mcg. See olodaterol."},{"id":"fs-2261","name":"Tipiracil","dosage":"See triflu1idine."},{"id":"fs-2262","name":"Tipranavir (TPV)","dosage":"See ritonavir. Resistant HIV-1 trough Page 102 <o20,500 ng/ml."},{"id":"fs-2263","name":"Tirilazad","dosage":"1.5mg/kg 6H IV over 30min."},{"id":"fs-2264","name":"Tirofiban","dosage":"0.4mcg/kg/min for 30min, then 0.1 meg/kg/min for 2- 5 days; also give heparin to APTT x2 normal."},{"id":"fs-2265","name":"Tissue plasminogen activator","dosage":"See alteplase."},{"id":"fs-2266","name":"Tizanidine","dosage":"0.01 mg/kg (adult 0.5mg) 8H, increase gradually to 0.1- 0.25mg/kg (adult 6-12mg) 8H oral."},{"id":"fs-2267","name":"Tobramycin","dosage":"IV or IM. 1wk-10yr: 8mg/kg day 1, then 6 mg/kg daily. >1 oyr: 7mg/kg day 1' then 5mgikg (max 240-360mg) daily. Neonate, 5mg/kg dose: <1.2kg 48H (0-7 days of life), 36H (8-30 days), 24H (>30 days); 1.2-2.5kg 36H (0-7 days of life), 24H (>7 days): term 24H (0-7 days of life), then as for 1wk-10yr. Trough level <1.0mg/L. lnhaltn alternate months: 80mg in 4mi12H; DPI112mg 12H; PARI, TOBI 300mg 12H."},{"id":"fs-2269","name":"Tocainide","dosage":"5-10mg/kg (max 400-800mg) 8-1211 IV over 30min or oral."},{"id":"fs-2270","name":"Tocilizumab","dosage":"12mg/kg (<30kg) 8mg/kg (>30kg) IV over 1H every 2wk."},{"id":"fs-2271","name":"Tocopherol","dosage":"See alpha-tocopheryl acetate, and vitamin E."},{"id":"fs-2272","name":"Tofacitinib","dosage":"Adult, NOT/kg: 5mg 12H oral."},{"id":"fs-2273","name":"Tolazamide","dosage":"2-5mg/kg (adult 1 00-250mg) 6-24H oral."},{"id":"fs-2274","name":"Tolazoline","dosage":"Newborn: 1-2mg/kg slowly stat (beware hypoten- sion), then 2-6mcg/kg/min (0.12-0.36mg/kg/hr) IV. Note: 1-2 mgikgihr too much (Ward, Pediatrics 1986;77:307-15)."},{"id":"fs-2275","name":"Tolbutamide","dosage":"Adult, NOT/kg: initially 1g 12H oral, often reducing to 0.5-1g daily."},{"id":"fs-2276","name":"Tolcapone","dosage":"Adult, NOTikg: 100mg 8H oral; if no response, try maximum dose of 200mg 8H. Monitor AL T and AST."},{"id":"fs-2277","name":"Tolfenamic acid","dosage":"4mg/kg (adult 200mg) oral, may repeat once after 2H."},{"id":"fs-2278","name":"Tolmetin","dosage":"5-10mg/kg (adult 400-600mg) 8H oral."},{"id":"fs-2279","name":"Tolnaftate","dosage":"1% cream, ointmnt, powdr, solution: apply 8-12H."},{"id":"fs-2280","name":"Tolterodine","dosage":"0.05mg/kg (adult 2mg) 1211 oral. Slow rei: adult 2-4mg daily oral."},{"id":"fs-2281","name":"Tolvaptan","dosage":"Adult, NOT/kg: 15mg (max 60mg) daily oral."},{"id":"fs-2282","name":"Topiramate","dosage":"0.5mg/kg (adult 25mg) daily oral, increase wkly if required to 3-5mg/kg (adult 1 00-200mg) 12H; max 15mg/kg (max 1 g) 12H. Slow-rei: same toll dose given daily. See phentermine."},{"id":"fs-2283","name":"Topotecan","dosage":"1.5mg/m2 daily x5 IV over 30min, repeat every 3wk for at least 4 courses."},{"id":"fs-2284","name":"Torasernide","dosage":"0.1-1mg/kg (adult 5-50mg) daily oral or IV. Rarely up to 4mg/kg (adult 200mg) daily in renal failure."},{"id":"fs-2285","name":"Toremifene","dosage":"Adult, NOT/kg: 60mg daily oral."},{"id":"fs-2286","name":"Torsemide","dosage":"See torasernide."},{"id":"fs-2287","name":"Tositumomab","dosage":"Dosimetric dose (adult, NOT/kg): 450mg in 50ml saline IV over 60min, then 1131 (5mCi) tositumornab (35mg) in 30ml saline IV over 20min. Therapeutic dose based on response to dosimetric dose and platelet count"},{"id":"fs-2288","name":"Trabectedin","dosage":"Premed with dexamethasone 0.4mg/kg (max Page 103 20mg) IV. Sarcoma 1.5mg/m2 IV over 24H every 3wk; ovarian cancer 1.1 mg/m2 IV over 3hr every 3wk (given after pegylated liposomal doxorubicin 30mg/m2 IV over 15min)."},{"id":"fs-2289","name":"Tramadol","dosage":"2-3mg/kg {adult 50-100mg) stat, then 1-Zmg/kg (adult 50-100mg) 4-6H (usual max 400mg/day, up to 600 mg/day) oral or IV over 3min.Siow-release (adult, NOT/kg): up to 8mg/kg (max 400mg) daily. IV infusion 2-Bmcg/kg/min."},{"id":"fs-2290","name":"Tramazoline","dosage":"Nasal: 82mcg each nostril x3-6/day. See also dexamethasone + tramazoline."},{"id":"fs-2291","name":"Trametinib","dosage":"Adult, NOT/kg: 2mg daily oral with dabrafenib."},{"id":"fs-2292","name":"Trandolapril","dosage":"0.01-0.1mg/kg (adult 0.5-4mg) daily oral. Tranexamic acid, Oral: 15-25mg/kg (adult 1-1.5g) 8H for :>5 days. IV: 10-15mg/kg (adult 0.5-1g) 8H; surgery for cyanotic congenital heart disease 100mg/kg load, then 10mg/kg/hr."},{"id":"fs-2293","name":"Tranylcypromine","dosage":"0.2mg/kg (adult 10mg) 8-12H oral."},{"id":"fs-2294","name":"Trastuzumab","dosage":"4mg/kg IV over 90min load, then 2mg/kg IV over 30min wkly. Early cancer after chemo: 8 mg/kg IV over 90min, then 6mg/kg IV over 90min every 3wk."},{"id":"fs-2295","name":"Travoprost","dosage":"40mcg/ml (0.004%): 1 drop/eye in evening. See also timolol + travoprost."},{"id":"fs-2296","name":"Trazodone","dosage":"1-4mg/kg (adult 50-200mg) 8H oral. Slow rei (adult, NOT/kg): 75-150mg each evening oral, increase by 75mg every 3 days to 375-600mg daily."},{"id":"fs-2297","name":"Treosulfan","dosage":"Adjust dose according to response. 3-8g/m2 IV over 30m in every 1-3wk. Adult, NOT/kg: 4wk cycles of 250mg 611 oral for 2.wk, then 2wk off."},{"id":"fs-2298","name":"Treprostinil","dosage":"1.25ng/kg/min SC or IV infusion, increase each wk by 1.25-2. 5ng/kg/min to max 40-160ng/kg/min. Adu It (NOT/kg): ER tabs 0.25-21mg 12H oral; inhaltn (1.74mg/2.9ml) 3 breat11s 6H increase wkly to 9 breaths (54mcg) 6H."},{"id":"fs-2299","name":"Tretinoin","dosage":"22.5mg/m2 12H oral. Cream or lotion 0.05%, gel 0.01%: apply daily for 3-4 months, then x1-3/wk."},{"id":"fs-2300","name":"Triamcinolone","dosage":"Joint, tendon (NOT/kg): 0.5-20mg (up to 40 mg) stat. IM: 0.05-0.2mg/kg every 1-7 days. Cream or oint ment 0.02%, 0.05%: apply sparingly 6-8H. Nasal: 55rnog spray 1-2/nostril daily. Triamcinolone has no mineralcorticoid action, 1 mg = 5mg hydrocortisone in glucocorticoid action. See also gramicidin combination cream and ointment."},{"id":"fs-2301","name":"Triamterene","dosage":"2mg/kg (adult 100mg) 8-24H oral. See also benzthiazide + triamterene."},{"id":"fs-2302","name":"Triazolam","dosage":"0.005-0.01mg/kg (adult 0.125-0.5mg) at night oral. 30 min preop: 0.01-0.03 mg/kg {adult 0.5mg) oral."},{"id":"fs-2303","name":"Tribavirin","dosage":"See ribavirin."},{"id":"fs-2304","name":"Triclofos","dosage":"25-30mg/kg (adult 0.5-1g) at bedtime oral."},{"id":"fs-2305","name":"Triclosan","dosage":"0.5%-5% lotion: 2ml to wet skin for 30sec, rinse and repeat. Bath oil: 20ml in 20crn bath, soak 15min."},{"id":"fs-2306","name":"Trientine","dosage":"10mg/kg (adult 500mg) 6-12H oral."},{"id":"fs-2307","name":"Triethylenethiophosphoramide","dosage":"See thiotepa."},{"id":"fs-2308","name":"Trifluoperazine","dosage":"0.02-0.4mg/kg (adult 1-10mg, occasionally 20mg) 12H oral. Capsule: adult 15mg daily. Page 104"},{"id":"fs-2309","name":"Trifluridine","dosage":"1% solution: 1 drop/eye 2H (max 9 drops/day) until epithelialised, then 4H (max 5 drops/day) for 7 days."},{"id":"fs-2310","name":"Trifluridine + tipiracil","dosage":"15/6.14mg, 20/8.19 tab. 35mg/m2 (of trifluridine) 12H oral day 1-5 and 8-12 of 28 day cycle."},{"id":"fs-2311","name":"Trihexyphenidyl","dosage":"See benzhexol."},{"id":"fs-2312","name":"Triiodothyronine (T3)","dosage":"See liothyronine."},{"id":"fs-2313","name":"Trilostane","dosage":"0.5-4mg/kg (adult 30-240mg) 6H oral."},{"id":"fs-2314","name":"Trimeprazine","dosage":"Antihist: 0.1-0.Smg/kg (adult 2.5-25mg) 6H oral. Sedatn: 0.5-1 mg/kg IM, 2-4mg/kg oral."},{"id":"fs-2315","name":"Trimethobenzamide","dosage":"5mg/kg (adult 250mg) 6-SH orai,IM,PR."},{"id":"fs-2316","name":"Trimethoprim","dosage":"4mglkg (adult 75-150mg) 12H, or 6-8mg/kg (usual max 300mg) daily oral or IV. Urine prophylaxis: 2 mg/kg (adult 150mg) at night oral. P jirovecii: See dapsone."},{"id":"fs-2317","name":"Trimethoprim + sulphamethoxazole","dosage":"See cotrimoxazole."},{"id":"fs-2318","name":"Trimethylglycine","dosage":"See betaine hydrochloride."},{"id":"fs-2319","name":"Trimetrexate","dosage":"45mgim' IV over 90min daily for 21 days, with folinic acid 20mg/m2 IV over 10m in 6H for 24 days (ie for 3 days longer than the trimetrexate)."},{"id":"fs-2320","name":"Trimipramine","dosage":"1-2mglkg (adult 50-100mg) 8-24H oral."},{"id":"fs-2321","name":"Trioxsalen","dosage":"See trioxysalen."},{"id":"fs-2322","name":"Trioxysalen","dosage":"Adult: 5-10mg daily 2H before UV exposure."},{"id":"fs-2323","name":"Tripelennamine","dosage":"1.25mglkg (adult 75mg) 6H oral."},{"id":"fs-2324","name":"Tripotassiurn dicitratobismuthate","dosage":"See bismuth subcitrate."},{"id":"fs-2325","name":"Triprolidine","dosage":"See pseudoephedrine+ triprolidene."},{"id":"fs-2326","name":"Triptorelin","dosage":"Adult, NOT/kg. Depot: 3.75-4.2mg IM every 28 days. Long acting: 11.25mg IM every 12wk."},{"id":"fs-2327","name":"Tris","dosage":"See tromethamine."},{"id":"fs-2328","name":"Trisodium edetate","dosage":"40-70mg/kg (max 3g) IV over 6hr daily for 5 days; max 3 courses each 2 days apart."},{"id":"fs-2329","name":"Trometamol (THAM, Tris)","dosage":"See tromethamine."},{"id":"fs-2330","name":"Tromethamine (THAM)","dosage":"ml of 0.3 molar (18g/500ml) solution = (Wt in kg) x BE; give half IV over 30min, then repeat if required."},{"id":"fs-2331","name":"Tropicamide","dosage":"0.5%, 1%: 1 drop/eye, repeat after 5min."},{"id":"fs-2332","name":"Tropisetron","dosage":"Perioperative: 0.1 mg/kg (adult 2mg) IV or oral, then 12-24H. Chemotherapy: 0.2mg/kg (adult 5mg) IV or oral just before chemo, then 12-24H-1."},{"id":"fs-2333","name":"Trospium","dosage":"0.4mglkg (adult 20mg) 12H oral."},{"id":"fs-2334","name":"Trovafloxacin","dosage":"4mg/kg (adult 200mg) daily oral. Severe inftn: 6mg/kg (adult 300mg) daily oral."},{"id":"fs-2335","name":"Tryptophan, L isomer","dosage":"Adult, NOT/kg 1-2g 8H oral."},{"id":"fs-2336","name":"Tulobuterol","dosage":"0.04mg/kg (adult 2mg) 8-12H oral."},{"id":"fs-2337","name":"Tyloxapol","dosage":"See colfosceril palmitate."},{"id":"fs-2338","name":"Typhoid vaccine, oral (Vivotif)","dosage":"Live. 1 cap oral days 1, 3, 5 and (for better immunity) 7. Boost yearly. Typhoid vaccine, parenteral, polysaccharide (Typherix,"},{"id":"fs-2339","name":"Typhim Vi)","dosage":"Inanimate. >5yr: 0.5ml IM once. Boost 3yrly."},{"id":"fs-2340","name":"Ubidecarenone","dosage":"1-3mg/kg (adult 50-150mg) 12H oral."},{"id":"fs-2341","name":"Ulipristal","dosage":"NOT/kg. 30mg oral within 120hr of intercourse. Fibroids: 5mg daily for max 3mo; repeat after 1 mo if required."},{"id":"fs-2342","name":"Umeclidinium","dosage":"Adult, NOT/kg: 62.5mcg inhaled daily. Page 105"},{"id":"fs-2343","name":"Umeclidinium 62.5mcg + vilanterol 25mcg","dosage":"Adult, NOT/kg: 1 inhalation daily."},{"id":"fs-2344","name":"Undecenoic acid, undecylenic acid","dosage":"2-5% cream, oint, powder: apply 12H."},{"id":"fs-2345","name":"Uracil","dosage":"See tegafur + uracil."},{"id":"fs-2346","name":"Urea","dosage":"10% cream: apply 8-12H."},{"id":"fs-2347","name":"Uridine triacetate","dosage":"6.2g/m2 (max 10g) daily oral."},{"id":"fs-2348","name":"Urofollitrophin","dosage":"See follicle stimulating hormone."},{"id":"fs-2349","name":"Urokinase","dosage":"4000u/kg IV over 10m in, then 4000u/kg/hr for 12 hr (start heparin 3-4hr later). Blocked cannula: instill 5000- 25000u in 2-3ml saline for 2-4hr. Empyema: 2ml/kg of 1500 u/ml in saline, position head up/down and right side up/down 30min each, then drain. Pericard elf: 10,000 u/ml, 1ml/kg (max 20ml), clamp 1 hr, drain. Alteplase usually preferable."},{"id":"fs-2350","name":"Ursodeoxycholic acid","dosage":"5-10mg/kg (adult 200-400mg) 12H oral."},{"id":"fs-2351","name":"Ursodiol","dosage":"See ursodeoxycholic acid."},{"id":"fs-2352","name":"Ustekinumab","dosage":"Adult, NOT/kg 45mg (90mg if >10Okg) stat, 4wk later, then every 12wk SC."},{"id":"fs-2353","name":"Valaciclovir","dosage":"Varicella: 20mg/kg (adult 1g) 8H oral. Genital herpes (NOT/kg): treatment 500mg 12H, prevention 500mg daily ( <10 episodes/yr) 1 g daily (>9 episodes/yr). Orolabial herpes: 40mg/kg (adult 2g) 12H for 2 doses. Proph CMV: 40mg/kg (max 2g) 6H."},{"id":"fs-2354","name":"Valcyte","dosage":"Adult, NOT/kg: 900mg 12H oral for 3wk, then 900mg daily."},{"id":"fs-2355","name":"Valdecoxib","dosage":"Adult(NOT/kg): 10mg daily (arthritis), 20mg 12H (dysmenorrhoea) oral."},{"id":"fs-2356","name":"Valganciclovir","dosage":"Treatment: neonate 15mg/kg 12H, >4wk 520 mg/m2 (max 900mg) 12H oral with food for 21 days, then daily. Prophylaxis: 520mg/m2 (max 900mg) daily oral with food. Lower doses with renal impairment."},{"id":"fs-2357","name":"Valproic acid, valproate","dosage":"See sodium valproate,"},{"id":"fs-2358","name":"Valrubicin","dosage":"Adult, NOT/kg: 800mg wkly x6 intravesical."},{"id":"fs-2359","name":"Valsartan","dosage":"0.8-3mg/kg (adult 40-160mg) daily oral. See also amlodipine, hydrochlorothiazide, nebivolol."},{"id":"fs-2360","name":"Vancomycin","dosage":"Max 0.3mg/kg/min. Usually 25mg/kg IV, then 15-20mg/kg 8-12H; trough 10-15mg/L. Severe inftn: 30 mg/kg IV, then 15-20 mg/kg 8-12H; trough 15-20mg/L, MIC <1 mg/L, AUC/MIC 400. Surgical proph: 25mg/kg IV over 90min ending just before procedure. C. difficile: 10mg/kg (adult 500mg) 6H oral. lntraventric (NOT/kg): 10mg 48H."},{"id":"fs-2361","name":"Vandetanib","dosage":"Adult, NOT/kg: 300mg daily oral. Check QTc. ~ardenafil. Erectile dysfunction (NOT/kg): 10mg (range 5-20 mg) oral 1 hr before sexual activity (max once/day)."},{"id":"fs-2362","name":"Varenicline","dosage":"Adult, NOT/kg: 0.5mg oral daily for 3 days, 12H days 4-7; then 1 mg 12H for 11 wk (23wk if stopped smoking)."},{"id":"fs-2363","name":"Varicella vaccine (Varilix, Varivax)","dosage":"Live. 0.5ml SCat 18mo and 12yr (Year 7). >12yr: 0.5ml SC stat, and 4-Swk later. See herpes zoster, measles, immunolobulin- zoster. Page 106"},{"id":"fs-2364","name":"Vasopressin, aqueous","dosage":"1M, SC: 2.5-10u 6-12H. IV: put 2-5u in 1 L fluid. and replace urine output+ 10% each hour. Hypo. tension (brain death, sepsis, post-bypass): 1 u/kg in 50ml at 1-3ml/hr (0.02-0.06u/kg/hr) + adrenaline 0.1-0.Zmcg/kg/min."},{"id":"fs-2365","name":"Gl hge: 6u/kg in 50ml at 1-5ml/hr IV, 1 ml/hr local lA","dosage":"TY, 10- 35min. See desmopressin, lypressin."},{"id":"fs-2366","name":"Vasopressin, oily","dosage":"2.5-5u (NOT/kg) IM every 2-4 days."},{"id":"fs-2367","name":"Vecuronium","dosage":"ICU: 0.1 mg/kg prn IV. Theatre: 0.1 mg/kg stat, then 0.5-2mcg/kg/min; up to 10mcg/kg/min occasionally."},{"id":"fs-2368","name":"Vedolizumab","dosage":"NOT/kg>12yr 300mg at 0,2,6wk, then 8wkly IV."},{"id":"fs-2369","name":"Velaglucerase alpha","dosage":"60u/kg infused IV every 2wk."},{"id":"fs-2370","name":"Velpatasvir","dosage":"See sofosbuvir."},{"id":"fs-2371","name":"Vemurafenib","dosage":"Adult, NOT/kg: 960mg (480-720mg if toxicity) 12H oral with cobimetinib."},{"id":"fs-2372","name":"Venetoclax","dosage":"Adult, NOT/kg: 20mg daily oral, increase wkly to 50mg, 100mg, 200mg. then 400mg daily."},{"id":"fs-2373","name":"Venlafaxine","dosage":"Adult, NOT/kg: 37.5mg 12H oral, increase if required to max 150mg 12H. Slow rei: '15mg daily oral, increase if required to max 225mg daily. Not recommended in cl1ildren."},{"id":"fs-2374","name":"Verapamil","dosage":"IV: 0.1-0.Zmg/kg (adult 5-10mg) over 10min, then 5mcg/kg/min. Oral: 1-3 mg/kg (adult 80-120mg) 8-12H."},{"id":"fs-2375","name":"Veregen","dosage":"15% ointment: apply 8H for up to 16wk."},{"id":"fs-2376","name":"Versenate","dosage":"See sodium calciumedetate."},{"id":"fs-2377","name":"Verteporfin","dosage":"6mg/m2 over 10m in IV; 15m in after start of infusion give diode laser of 689nm at 600mW/cm2 for 83sec."},{"id":"fs-2378","name":"Vidarabine","dosage":"Eye ointment: x5/day until epithelialised, then 12H 7 days. IV infusion: 10mg/kg/day 5-10 days (varicella zoster), 15mg/kg/day 10 days (herpes encephalitis)."},{"id":"fs-2379","name":"Vigabatrin","dosage":"25mg/kg (adult 500mg) 12H oral, increase if required to max 75mg/kg (adult 1.5g) 12H."},{"id":"fs-2380","name":"Vilanterol","dosage":"See fluticasone, umeclidinium."},{"id":"fs-2381","name":"Vilazodone","dosage":"Adult, NOT/kg daily oral: 10mg wk1, 20mg wk2, 40mg wk3."},{"id":"fs-2382","name":"Vildagliptin","dosage":"Adult, NOT/kg. With sulfonylurea (eg glimepiride) 50mg moming oral. With thiazolidinedione (eg pioglitazone) 50mg moming or 12H. See also metformin."},{"id":"fs-2383","name":"Viloxazine","dosage":"2-5mg/kg (adult 100-250mg) moming, and 2-3 mg/kg (adult 100-150mg) noon oral. Elderly: 100mg daily."},{"id":"fs-2384","name":"Vinblastine","dosage":"6.5mg/m2 IV over 1 min every 1-4wk."},{"id":"fs-2385","name":"Vincreaseistine","dosage":"1.5mg/m2 wkly IV over 1 min."},{"id":"fs-2386","name":"Vindesine","dosage":"3-4mg/m2 IV every 7-10day if WCC>2500/mm3."},{"id":"fs-2387","name":"Vinflunine","dosage":"320mg/m2 IV over 20min every 3wk; 200-280 mg/m2 if neutropenia, renal impairment or liver toxicity."},{"id":"fs-2388","name":"Vinorelbine","dosage":"30mg/m2 IV over 1 0min weekly."},{"id":"fs-2389","name":"Vismodegib","dosage":"Adult, NOT/kg: 150mg daily oral."},{"id":"fs-2390","name":"Vitamin A","dosage":"NOT/kg. High risk: 100,000iu (<8kg), 200,000iu (>8kg) oral or IM every 4-Gmo. Severe measles: 400,000iu once. Cystic fib: 1500u daily (<3yr) 5000u daily (3-10yr) 10000u daily (>10yr) oral. Dose >10,000iu daily or >25000u per wk may be teratogenic. Page 107"},{"id":"fs-2391","name":"Vitamin A, 8, C, 0 compound (Pentavite, child)","dosage":"NOT/kg. <3yr 2.5ml daily, >3yr 5ml daily."},{"id":"fs-2392","name":"Vitamin A, B, C, 0 compound (Pentavite, infant)","dosage":"NOT/kg. <3yr 0.15ml daily, increase with age by 0.15ml/day to 0.45ml/day."},{"id":"fs-2393","name":"Vitamin B group","dosage":"Amp: IV over 30 min. Tab: 1-2/day."},{"id":"fs-2394","name":"Vitamin 81","dosage":"See thiamine."},{"id":"fs-2395","name":"Vitamin 82","dosage":"Metabolic disease: 50-150mg 12-24H oral."},{"id":"fs-2396","name":"Vitamin B6","dosage":"See pyridoxine."},{"id":"fs-2397","name":"Vitamin 812","dosage":"See hydroxocobalamin."},{"id":"fs-2398","name":"Vitamin C","dosage":"See ascorbic acid."},{"id":"fs-2399","name":"Vitamin 02","dosage":"See ergocalciferol."},{"id":"fs-2400","name":"Vitamin 03","dosage":"See cholecalciferol."},{"id":"fs-2401","name":"Vitamin E","dosage":"1u = 1mg. Preterm babies, Coperol E (NOT/kg): 40u (2 drops) daily oral. CF, malabs: 50-100u (<3yr) 200- 400u (>3yr) daily oral. Cholestasis: 50u/kg daily oral, increase if required in 50u/kg increaseements. A-beta-lipoproteinaemia: 35-70 u/kg 8H oral. HUS: 0.25g/m2 6H oral. See alpha-tocopheryl."},{"id":"fs-2402","name":"Vitamin K1","dosage":"See phytomenadione."},{"id":"fs-2403","name":"Vitamin K3","dosage":"See menapthone sodium bisulphite."},{"id":"fs-2404","name":"Vitamins, parenteral","dosage":"MVI-12 (for adult): 5ml in 1 litre IV fluid. MVI Paediatric, added to IV fluid: 65% of a vial (<3kg), 1 vial (3kg to -11 yr)."},{"id":"fs-2405","name":"Vitaprem (RCH: Pentavite, folate, 812, C)","dosage":"1 ml daily oral. Von Willebrand factor I Factor VII concentrate (Wilate)."},{"id":"fs-2406","name":"Minor hge: 20-40 IU/kg then 20-30 IU/kg 12-14H","dosage":"Surgery: 35-50 IU/kg, then 30-40 IU/kg 12. 24H."},{"id":"fs-2407","name":"Vorapaxar","dosage":"Adult, NOT/kg: 2.08mg daily oral."},{"id":"fs-2408","name":"Voriconazole","dosage":"Oral: <40kg liquid 9mg/kg 12H; <:40kg load 400mg 12H x2 doses, then 200-300mg 12H. IV (max 3 mg/kg/hr): load 9mg/kg (<40kg) 6mg/kg (<:40kg) 12H x2 doses, then Bmg/kg (<40kg) 3-4mg/kg (<:40kg) 12H. Beware interactions. Trough level1-5mg/L (3-16umol/L)."},{"id":"fs-2409","name":"Vorinostat","dosage":"Adult, NOT/kg: 400mg daily oral; may need to decrease to 300mg daily, or 300mg on 5 days a week."},{"id":"fs-2410","name":"Votiioxetine","dosage":"Adult, NOT/kg: 10mg increase to 20mg daily oral."},{"id":"fs-2411","name":"Warfarin","dosage":"Usually 0.2mg/kg (max 5mg) stat, 0.2mg/kg (adult 5mg) next day if INR <1.3, t11en 0.05-0.2mg/kg (adult 2-5mg) daily oral. UsuaiiNR 2-2.5 for prophylaxis, 2-3 for treatment, 3-4 mechanical valve. Beware drug interactions. Severe hge: reverse with either coagulation factor (Prothrombinex) 25 u/kg (adult 500u) or factor 7a (rFVIIa) 20mcg/kg, and phyto menadione 0.3mg/kg (adult 10mg), and fresh frozen plasma 10ml/kg; repeat according to INR."},{"id":"fs-2412","name":"Whole blood","dosage":"6mlkg raises Hb 1 g%. 1 bag ~ 400ml approx."},{"id":"fs-2413","name":"Xamoterol","dosage":"4mg/kg (adult 200mg) 12-24H oral."},{"id":"fs-2414","name":"Xipamide","dosage":"0.5\\"1.5mg/kg (adult 20-BOmg) daily oral."},{"id":"fs-2415","name":"Xylometazoline","dosage":"<6yr: 0.05% 1 drop or spray 8-12H. 6-12yr: 0.05%2-3 drops or sprays 8-12H. >12yr: 0.1%2-3 drops or sprays 6-12H."},{"id":"fs-2416","name":"Yellow fever vaccine (Stamaril)","dosage":"Live. >12mo: 0.5ml SC Page 108 once. Boost every 10yr."},{"id":"fs-2417","name":"Yohimbine","dosage":"0.05-0.1mg/kg (adult 2.7-5.4mg) 8H oral."},{"id":"fs-2418","name":"Zafirlukast","dosage":"NOT/kg: 10mg (>7yr) 20-40mg (adult) 12H oral."},{"id":"fs-2419","name":"Zalcitabine","dosage":"Usually 0.015mg/kg (adult 1mg) 12H oral."},{"id":"fs-2420","name":"Zaleplon","dosage":"Adult, NOT/kg: 10mg (5-20mg) at night oral."},{"id":"fs-2421","name":"Zanamivir","dosage":"Adult, NOT/kg: 10mg 12H for 5 days inhaled. Prophylaxis: 10mg daily inhaled."},{"id":"fs-2422","name":"Ziconotide","dosage":"Adult, NOT/kg: 2.4mcg/day by intrathecal infusion, increase every 24-48hr to max 21.6mcg/day."},{"id":"fs-2423","name":"Zidovudine (AZT, ZDV)","dosage":"Preterm: 1.5mg/kg 12H IV, or 2 mg/kg 12H oral to 2wk (<:30wk gest) or 4wk (<30wk gest), then 8H. Term newborn: 1.5mg/kg 6H IV, 2mg/kg 6H oral. Child: usually 180mg/m2 (up to 240mg/m2) 12H oral; 120 mg/m2 6H IV, or 20mg/m2/hr IV (range 90-180 mg/m2 6-8H"},{"id":"fs-2424","name":"IV)","dosage":"<:18yr: usually 200mg 8H oral, or 300mg 12H oral, or 150mg SH IV. See also abacavir and lamivudine."},{"id":"fs-2425","name":"Zileuton","dosage":"Adult, NOT/kg: 600mg 6H oral."},{"id":"fs-2426","name":"Zinc chloride","dosage":"5.3mg/ml = 2.5mg/ml Zn = 38umol/ml Zn. 2- 4umol/kg/day (<1yr), 1umol/kg/day (child), 40-60umol/day (adult). Serum zinc 11-22 umol/L."},{"id":"fs-2427","name":"Zinc sulphate","dosage":"(220mg cap = 50mg Zn = 765umol Zn). Defic iency, acroderm enteropath: initially 3mg/kg (adult 220mg) 8 12H oral, adjusted to achieve serum zinc 11-22umol/L (0.7- 1.4mg/L). Diarrhoea child (NOT/kg): 10-20mg daily oral."},{"id":"fs-2428","name":"Ziprasidone","dosage":"Adult, NOT/kg: 20mg 12H, increase if required to max 80mg 12H oral."},{"id":"fs-2429","name":"Ziv-aflibercept","dosage":"4mg/kg IV over 1 hr every 2wk."},{"id":"fs-2430","name":"Zoledronate","dosage":"0.02mg/kg IV over 15min, then 0.04-0.05 mg/kg (max 4mg) every 3-6 months. Postmenopausal osteoporosis (adult, NOT/kg): 5mg IV every 1-2 years."},{"id":"fs-2431","name":"Zoledronic acid","dosage":"See zoledronate."},{"id":"fs-2432","name":"Zolrnitriptan","dosage":"Adult, NOT/kg: 2.5-5mg oral, repeat in 2.hr if required; max 15mg in 24H. Nasal: 5mg spray in each nostril, repeat in 2H if required; max twice in 24H."},{"id":"fs-2433","name":"Zolpidern","dosage":"0.1-0.4mg/kg (adult 5-20mg) nocte oral; lower dose for women. Sublingual: 5-10mg nocte; Intermezzo 1.75mg (women) 3.5mg (men). Oral spray 5mg: 1-2 sprays nocte."},{"id":"fs-2434","name":"Zonisamide","dosage":"2mg/kg (adult 100mg) daily oral, increase if required after 2wk to 12H, then 3mg/kg (adult 150mg) 12h, then 4mg/kg (adult 200mg) 12H; rarely up to 6mg/kg (adult 300mg) 12H. Level 10-20mg/L."},{"id":"fs-2435","name":"Zopiclone","dosage":"0.1-0.3mg/kg (adult 5-15mg) at bedtime oral."},{"id":"fs-2436","name":"Zotepine","dosage":"0.5mg/kg (adult 25mg) 8H oral, adjusted every 4 days to 0.5-2mg/kg 8H."},{"id":"fs-2437","name":"Zuclopenthixol","dosage":"Usually slow increaseease: 0.2-3.0mg/kg (adult 10-150mg) daily oral. IM Adult, NOT/kg: acetate (50mg = 45mg base) 50-150mg every 2-3 days (max total 400mg); decanoate (200mg = 144mg base) depot 200-400mg (oral daily dose x8) every 2-4wk. Page 109 HAEMOFILTRATION (VENO-VENOUS) Cannula: 6.5 Fr double lumen in newborn (blood flow 10-40 ml/min), 8 Fr in child (flow 30-60 ml/min), 11.5 Fr in teen ager (flow 50-150ml/min), 14Fr adult (flow 100-300 ml/min)."},{"id":"fs-2438","name":"Filter: Removes particles up to approx 20,000 Dalton","dosage":"Filtrate: 10-50ml/kg/hr (monitor serum creatinine). Keep blood flow at least five times filtration rate. Heparin: 10Ou/kg in 50ml saline at 1-10ml/hr prefilter, 10 u/kg in 50ml saline at 1-10ml/hr postfilter; keep ACT 1.5 x nor mal (Actalyke 140-160). Citrate (no heparin): prefilter ACD 1.8ml/hr per 1 ml/min of blood flow (so prefilter ionised Ca <0.3 mmoi/L); postfilter 10% CaCI2 1 ml/hr (adjust so patient ionised Ca >1 mmoi/L). Replacement fluid: dextrose 0.18%, Na 135mmoi/L, K 3.5, Ca 1.7, Mg 0.7, Bic 25, Phos 1.0, Cl110, acetate balance. Nutrition: x2 normal amino acids, trace elements, vit B&C. PLASMAFILTRATION (VENOVENOUS) Cannula, blood flow and heparin: as for haemofiltration. Filter: Removes particles of MW up to 3,000,000 Dalton. Filtrate: 20-50ml/kg/hr (a 2-volume plasma exchange is 20ml/kg/hr for 4hr). Blood flow <:5x filtrate flow. Acid citrate dextrose solution, formula A (ACDA): 1 ml/hr prefilter for every 1 ml/min of blood flow. Replacement fluid: albumin 30g/L, dextrose 0.3%, Na 135 mmoi/L, K 3.5, Ca 2.0, Mg 0. 7, bic 25, phos 1.5, Cl 100, acetate to balance. Give 1 bag FFP (about 230mt) per 800ml replacement, cryoprecipitate 5ml/kg (1 bag/4kg) if fibrinogen <2g/L, and immunoglob 0.5g/kg prn. ECMO Indications (preductal gas): Newborn 01 >0.4 or VI >90. Flow: VA: <10kg 100-150ml/kg/min, >10kg: 2.4Lim2/min; higher flows needed in sepsis. W: about 70% of VA flows. Ventilation of neonates: typically 10 x 20/10 (PIP minimum needed to move chest) in air. Heparin: 10Ou/kg cannulatn; then 20u/kg/hr, adjust to ACT."},{"id":"fs-2439","name":"Maintain: Plasma Hb <0.1g/L","dosage":"ACT x2 normal (Actalyke 150- 160), pi >80,000. Hge: Actalyke 140-150, pi >150,000."},{"id":"fs-2440","name":"Preparation: clear prime in emergency","dosage":"Cross match 1 u whole blood, up to 4u packed cells, 2u FFP, 1 u cryo, 2-5u platelets. Ensure good CVC and arterial line, correct ETT. Page 110 'CYTOCHROME P450 INTERACTIONS For more information, See Medical Letter 2016;58:e46-e47 and http://medicine.iupui.edu/CLJNPHARMtddis/clinlcal-table. Increase the dose of a substrate drug if it is given with a drug that induces the metabolism of that group, and reduce it when given with an Inhibitor. For example, phenytoin is metabolised by CYP2C9 (group 2C9), and this enzyme group is inhibited by fluconazole -so the dose of phen'Y1oin should be reduced if fluconazole is given to a patient who is already on phenytoin."},{"id":"fs-2441","name":"Substrate dr.tt9.Jl","dosage":"Alfentanil 3A, alprazolam 3A, amiodarone 3A, amitriptyline 2C 19 & 206, amlodipine 3A, amodiaquine 2C8, amprenavir 3A, aniline 2E1, aripiprazole 206 & 3A, artemisin 286, astemizole 3A, atazanavir 3A, atomoxetine 206, atorvastatin 3A, benzene 2E1, boceprevir 3A, budesonide 3A, bupropion 286, buspirone 3A, carbamazepine 3A, carisoproaoi2C19, carvedilol 206, celecoxib 2C9, cerivastatin 2C8 & 3A, chlorpheniramine 3A, chlorzoxazone 2E1, cisapride 3A, citalopram 2C19, clarithromycin 3A, clomipramine 2C19 & 206, clopidogrei2C19, clozapine 1A2, codeine 206, cortisol 3A, cyclobenzaprine 1 A2, cyclophosphamide 286 & 2C19 & 3A, cyclosporin 3A, darifenacin 3A, delaviridine 3A, desipramine 206, dextromethorphan 206, diazepam 2C19 & 3A, diclofenac 2C9, diltiazem 3A, doxepine 206, duloxetine 1A2 & 206, efavirenz 286, enfiurane 2E1, erlotinib 3A, erythromycin 3A, esomeprazole 2C19, ethanoi2E1, everoiimus 3A, felodipine 3A, fentanil 3A, flecainide 206, fluoxetine 206, fluvastatin 2C9, fluvoxamine 1A2, formamide 2E1, gleevec 3A, glipizide 2C9, glyburide 2C9, haloperidoi1A2 & 206 & 3A, halothane 2E1, ibuprofen 2C9, ifosfamide 286, imipramine 1A2 & 2C19 & 206, indinavir 3A, lrbesartan 2C9, isoflurane 2E1, ketamine 286, labetaiol 2C19, lansoprazole 2C19, losartan 2C9, lovastatin 3A, meperidine 286, methadone 286 & 3A, methoxy11urane 2E1, metoproio1206, mexiletine 1A2 & 206, midazolam 3A, nifedipine 3A, nimodipine 3A, omeprazole 2C19, ondansetron 206, nabumetone 1A2, naproxen 1A2 & 2C9, nelfinavir 3A, nevirapine 286 & 3A, nifedipine 3A, nisoldipine 3A, nitrendipine 3A, oestradiol 3A, oianzapine 1A2, omeprazole 2C19, ondansetron 206, oxybut ynin 3A, oxycodone 206, paclitaxel 2C8, pantoprazole 2C19, para. cetamol 2E1, paroxetine 206, pazopanib 3A, phenobarbitone 2C19, phenytoin 2C9 & 2C19, pirnozide 3A, piroxicam 2C9, progesterone 2C19 & 3A, proguanii2C19, propafenone 206, propofol 286, quinidine 3A, quinine 3A, rabeprazoie 2C19, repa. glinide 2C8 & 3A, riluzole 1A2, risperidone 206, ritonavir 3A, rosig litazone 2C9, saquinavir 3A, selegiline 286, sevoflurane 2E1, sildenafil 3A, simvastatin 3A, sirolimas 3A, solifenacin 3A, sulfa methoxazoie 2C9, sufentanii3A, tacrine 1A2, tacrolimus 3A, tadalafil 3A, tamoxifen 2C9 & 206 & 3A, telaprevir 3A, telithro mycin 3A, theophylline 1A2 & 2E1, thioridazine 206, timoiol206, tizanidine 1A2, tolbutamide 2C9, tolterodine 3A. torsemide 2C8 & 2C9, tramadol206 & 3A, trazodone 3A, triamterene 1A2, triazoiarn 3A, troleandomycin 3A, valproate 2C9, vardenafil 3A, venlafaxine 206, verapamil 3A, vinblastine 3A, vincreaseistine, 3A, voriconazole 2C19, warfarin 2C9, zafirlukast 2C9, zileuton 1A2, zolmitriptan 1A2. Page 111 I Inhibitor and inducer drugs: strong inhibitors in italics Group 1A21nhibitor: amiodarine, cimetidine, ciprol/oxacin, desferasirox, efavirenz, enoxacin, f/uvoxamfne, levofloxacin, lomeftoxacin, mexiletine, noriloxacin, oestrogens, ofloxacin, spar~ floxacin, thiabendazole, ticlopidine, trovafloxacin, vemurafenib, zileuton. Inducer: barbiturates, carbamazepine, primidone, rifampicin, tobacco. Group 2B6 Inhibitor: clopidrogel, mifepristone, thiotepa, ticlopidine, voriconazote. Inducer; artemisin, carbamazine, efavirens, isavuconazonium, nevirapine, phenobarbitone, phenytoin, rifampicin, ritonavir. Group 2C8 Inhibitor: abiraterone, deferasirox, gemfibrosi/, lapatinib, montelukast, nilotinib, sorafenib, teriflunomide, trimethoprim. Inducer: rifampicin. Groul1_2C9 Inhibitor: amiodarone, capecitabine, ceritinib, clopidrogel, delavirdine, disulfiram, efavirenz, etavirine, fenofibrate, fluconazole, floxuridine, fluorouracil, fluvastatin, imatinib, isoniazid, metronidazole, miconazote, nilotinib, paroxetine, sorafenib, sulfisoxazole, sulphadiazine, sulphmethoxazole, valproate, voriconazole, zafirlukast. Inducer: aprepitant, barbiturates, bosentan, carbamazepine, dabrafenib, enzalutamide, phenytoin, prirnidone, rifampicin, secobarbitone. glroup 2C19_ Inhibitor: armodafinil, bortezomib, cimetidine, delavirdine, efavirenz, esomeprazole, etravirine, felbamate, fluoxetine, fluconazole, fluoxetine, fluvoxamine, isoniazid, ketoconazole, lansoprazole, modafinil, omeprazole, oral contraceptives, oxycarbazepine, tlc/opidine, voriconazole. Inducer: barbiturates, carbamezepine, efavirenz, enzalutamide, phenytoin, rifampicin, ritonavir, StJohn wort. Group 206 Inhibitor: amiodarone, buproprion, chlorpheniramine, cimetidlne, cinaca/el, clomipramine, duloxetine, fluoxetine, haloperidol, methadone, paroxetine, quinidine, quinine, ritonavir, terbinafine, tipranavlr."},{"id":"fs-2442","name":"Group 2E1 Inhibitor: disulfiram","dosage":"Inducer: ethanol, isoniazid. Group 3A4,5, 7 Inhibitor: amiodarone, amprenavir, aprepitant, atazanavir, ceritinib, ciprofloxacin, clarithromycin, clotrimazole, cobicistat, conivaptan, crizotinib, cyclosporine, dalfopristin, darun avir, delavirdine, diltiazem, dronedarone, erythromycin, flucon azole, fluvoxamine, fosamprenavir, grapefruit juice, idelalislb, imatinib, indinavir, isavuconazoniurn, isoniazid, itraconazole, ivacaftor, ketoconazole, lomitapide, topinavfr, mibefradit, micon azote, nefazodone, ne/finavir, netupitant, norfloxacin, posacon- azo/e, quinupristin, ritonavir, saquinavir, tefithromycin, tipranavir, troleandomycin, verapamil, voriconazole1 zafirlukast. Inducer: armodafinil, arternether, barbiturates, bexarotene, bosentan, carbamazepine, dabrafenib, deferasirox, dexamethasone, efavir enz, enzalutamide, etravlrine, lumacaftm, mitotane, modafinil, nafcillin, nevirapine, oxcarbazepine, phenobarbitone, phenytoin, pioglitazone, primadone, rifabutin, rifampicin, rifapentine, StJohn wort, troglitazone. Page 112 ALVEOLAR- ART 02, MEAN AIRWAY PRESSURE, 01, VI A-aD0 2 = PA02 -Pa02 = ((Pbar-Pwater) x Fi02)-(PaC02 I 0.8)-Pa02 Usually= (716xFi0 2)-(PaC0,t0.8)- Pa02 Child <10mmHg, adult <15mmHg, elderly <40 mmHg. MAP= ((PIPxiT) +(PEEP x ((60/RR)-IT))) I (60/RR). Oxygenation index (01) = MAP x Fi02 I Pa02. Ventilation index (VI)= pCO, x RR x PIP /1000. MUSCLE RELAXANTS"},{"id":"fs-2443","name":"Normally use pancuronium","dosage":"If tachycardia a problem, use vecuronium. If severe renal or liver failure, use atracurium. Approximate relative cost per day: pancuronium 1.0, vecur onium 10, atracurium 35. PACING (p=paced, s=sensed, A=atrial, V=ventricular) Code: chamber pI chambers I response to s WI = Vp I Vs I inhibition with Vs AAI = Ap I As I inhibition with As DVI = Ap Vp I Vs only/ inhibition and reset by Vs DOD= A&V p + s + response; eg As Vp, Ap Vs, or Ap Vp If the atrial pacing wires are connected to the Rand L arm leads from ECG machine, lead I is an atrial electrogram. INTRAVASCULAR CATHETERS Right internal jugular central line (inserted midway between mastoid and sternal notch): depth= (Height in em) /10 UA line (tip above diaphragm, below left subcl art): depth = 2cm more than distance from of the shoulder to umbilicus. UV line: catheter depth = distance from end of umbilical stump to junction of lower and middle third of sternum. HAEMATOLOGY Extrinsic pathway (PT): 7, 10, 5, 2 (proth), 1 (fibrinogen). Intrinsic pathway (APTT): 12, 11, 9, 8, 10, 5, 2(proth), 1(fib). See albumin, cryoprecipitate, factor 8 concentrate, fresh frozen plasma, packed cells, platelets, prothrombinex, thrombin glue and whole blood in drug dOSElS section. Compatible blood groups are: Whole Packed Cryo- Patient blood red cells FFP precip 0 0 0 Any 0 A A orO' A orO AorAB A B B or 0' BorO B arAB A AB Any' Any AB A ' Low titre group 0 blood. Do not use whole blood. Platelets: donor preferably has same ABO and Rh groups as recipient, otherwise usually as for FFP. Page 113 INTRAVENOUS FLUID REQUIREMENTS (ml/hr) Wt kg: 3 5 10 15 20 25 30 40 50 60 70 Active 12 20 30 40 50 60 65 70 80 90 95 100 Sick 6 10 14 20 25 30 35 40 45 55 60 70 Intabatd 5 10 14 17 21 25 28 32 40 45 50 Post-cardiac surgery: volume for \\"Intabated\\" in the table. Active neonates: 2ml/kg/hr (day 1 of life), 3ml/kg/hr (day 2 of life), 4ml/kg/hr (day 3 to 12mo). <4wk: 10% Dex in 0.45% NaCI with 20mmoi/L KCI e:4wk and <10kg: 10% Dex in 0.9% NaCI with 20mmoi/L KCI e:10Kg: 5% Dex in 0.9% NaCI with KCI20 mmoi/L FLUID AND ELECTROLYTE FORMULAE"},{"id":"fs-2444","name":"Anion gap = Na -(bicarb + Cl)","dosage":"Normal <12. Anuria (noncatabolic): urea rises 3-5mmoi/Liday, creatinine rises 50-10Oumol/L/day (0.05-0.1 mmoi/Liday)."},{"id":"fs-2445","name":"Bicarbonate","dosage":"See drug doses section. Blood volume = 85ml/kg in neonate, 65ml/kg in adult. Chloride deficit: ml20% NaCI = Wtx 0.2 x (104-serum Cl). Corrected Na =measured Na + 0.3 (glucose- 5.5) mmoi/L."},{"id":"fs-2446","name":"Effective osmolality = 2Na +glucose (mmoi/L)","dosage":"N 265-290. Extracellular fluid: birth 400ml/kg, >1yr 250ml/kg. Number ml/hr IV = microdrop/min = 4 x drop/min."},{"id":"fs-2448","name":"Osmolality serum = 2Na + glue+ urea (mmoi/L)","dosage":"N 270-295. Plasma volume = 45ml/kg in neonate, 35 ml/kg in adult. Sodium deficit: ml saline= Wt x 4 x (140-[Na]) I(% saline). Sodium in hyperglycaemia = Na + 0.3(glucose- 5.5). Urine: minimum acceptable is 0.5-1.0ml/kg/hour. Water deficit ml = 600 x Wt(kg) x (1 -140/sodium). DIALYSIS If required: gentamicin 8-10mg/L, or cephazolin 250mg/L."},{"id":"fs-2449","name":"Cycles","dosage":"Ventilated: 10-20mlkg/cycle (in/dwell 20min, out 10 min). Normal: 40ml/kg/cycle (in/dwell 40min, out 20min)."},{"id":"fs-2450","name":"Potassium","dosage":"0-4rnmoi/L."},{"id":"fs-2451","name":"Solution","dosage":"1.5% isotonic, 4.25% hypertonic. VENTILATION Minimum flow rate 2-3 Llkg/min. Head box oxygen: minimumgas flow 2-3 L/kg/min. Nasopharyngeal oxygen: insert catheter to a depth equal to distance from side of nose (ala nasi) to front of ear (tragus). 150ml/kg/min delivers approx 50% oxygen. Volume control: tidal volume usually 6-10 ml/kg. Ventilator rate/min: neonate 30, 6mo 25, 1-5yr 20, >5yr 16. Page 114 'VICTORIA (AUSTRALIA) IMMUNISATION"},{"id":"fs-2452","name":"Birth","dosage":"Hepatitis B (HB Vax II Paediatric) 0.5miiM. 2 months. Diphtheria + tetanus + acellular pertussis + polio + Hib (DTPa-hepB-IPV-Hib) (lnfanrix-Hexa) 0.5 miiM; pneu mococ (Prevenar13)0.5mi1M; rotavirus (RotaTeq) 2ml oral. 4 months. DTPa-hepB-IPV-Hib (lnfanrix-Hexa) 0.5m11M; 0.5 miiM; pneumococcus (Prevenar13) 0.5mi1M; rotavirus (RotaTeq) 2m I oral. 6 months. DTPa-hepB-IPV-Hib (lnfanrix-Hexa) 0.5miiM; 0.5 miiM; pneumococcus (Prevenar 13) 0.5miiM; rotavirus (RotaTeq) 2m I oral. 12 months. Measles+ mumps+ rubella (MMR-11/ Priorix) 0.5 ml SC; Hib + men C (Menitorix) 0.5mi1M. 18 months. MMR-chickenpox (Priorix-Tetra) 0.5 ml SC; DTPa (lnfanrix or Tripacel) 0.5miiM. 4 yr. DTPa-IPV (lnfanrix-IPV) 0.5ml IM; MMR (MMR-11/ Priorix) 0.5ml SC."},{"id":"fs-2453","name":"School Year 7 (age 12-13yr)","dosage":"Chickenpox (Varivax I Varilrix) 0.5ml SC; human papillomavirus (Gardasil) 0.5ml IM at 0, 2 and 6 mo (3 doses); DTP (Boostrix) 0.5miiM. 50-59 years. Diptheria +tetanus (ADT) 0.5miiM."},{"id":"fs-2454","name":"From 65 years","dosage":"Pneumococcus (Pneumovax 23) 0.5ml IM;"},{"id":"fs-2455","name":"Influenza (Fiuarix","dosage":"Fluvax, Vaxigrip) 0.5ml SC every year. 70 years. Shingles (Zostavax) 0.65ml SC. ANTIBIOTIC GUIDELINES CNS,EYE"},{"id":"fs-2456","name":"Herpes el]cephalitis","dosage":"Aciclovir 500mg/m2 (:>12yr) 10mg/kg (>12yr) 8H IV."},{"id":"fs-2457","name":"Meningitis","dosage":";,2mo ceftriaxone 50mg/kg (max 2g) 12H IV; <2mo cefotaxime 50mg/kg 6H IV and benzylpenicillin 60 mg/kg 12H (wk1) 8H (wk2) 6H (wk3-4) 4H (>wk4) IV."},{"id":"fs-2458","name":"Meningococcal prophylaxis","dosage":"Rifampicin 10mg/kg (max 600 mg) 12H for 2 days. Orbital cellulitis (proptosis, chemosis, eye movement painful). Ceftriaxone 50mg/kg (max 2g) 12H IV and flu cloxacillin 50mg/kg (max 2g) 6H IV."},{"id":"fs-2459","name":"Periorbital cellulitis","dosage":"See soft tissue cellulitis. cvs"},{"id":"fs-2460","name":"Prophylaxis","dosage":"Before cardiac surgery: cefazolin 50mg/kg IV. Dental and upper respiratory procedures: amoxycillin 50 mg/kg (max 2g) oral 1 hr before or IV at induction. Page 115 GITRACT"},{"id":"fs-2461","name":"Acute peritonitis or ascending cholangitis","dosage":"Benzylpenicillin 50mg/kg (max 2g) 4-6H IV and gentamicin daily IV and metronidazole 15mg/kg (max 1.6g) stat then 7.5mg/kg (max 800 mg) 8H IV."},{"id":"fs-2462","name":"Acute giardiasis","dosage":"Metronidazole 30mg/kg (max 2g) daily for 3 days. URINARY TRACT INFECTION"},{"id":"fs-2463","name":"Sick, or <6mo, or acute pyelonephritis","dosage":"Benzylpenicillin 50 mg/kg (max 2g) 6H IV and gentamicin daily IV."},{"id":"fs-2464","name":"Not sick and >6mo","dosage":"Trimethoprim tab 4mg/kg 12H oral or cotrimox syrup 8/40mg/ml 0.5ml/kg (max 20ml) 12H oral."},{"id":"fs-2465","name":"Prophylaxis","dosage":"Trimethoprim or cotrimoxazole, half the above doses daily. RESPIRATORY"},{"id":"fs-2466","name":"Acute tonsillitis","dosage":"Consider no antibiotic (particularly if <4yr) or penicillin V 30 mg/kg (max 1g) 12H oral for 10 days."},{"id":"fs-2467","name":"Acute otitis media","dosage":"Consider none for 48hr (particularly if >2yr) or amoxycillin 15mg/kg (max 500mg) 8H oral."},{"id":"fs-2468","name":"Pertussis","dosage":"Clarithromycin 7.5mg/kg (max 500mg) 12H oral? days or azithromycin 10mgikg (max 500mg) daily 5 days."},{"id":"fs-2469","name":"Community acquired pneumonia","dosage":"Mild: amoxycillin 15 mg/kg (max 500mg) 8H oral or roxithromycin 4mg/kg (max 150mg) 12H oral. Moderate: benzylpenicillin 50mg/kg (max 3g) 6H IV or roxithromycin. Severe pneumonia, or large effusion: benzylpenicillin 50mg/kg (max 3g) 4H IV (or flucloxacillin only if staph likely) and gentamicin daily IV and azithromycin IV if considering mycoplasma. SEPTICAEMIA, SKIN, SOFT TISSUE, BONE"},{"id":"fs-2470","name":"Septicaemia, no meningitis, no obvious source","dosage":"Fluclox acillin 50mg/kg (max 2g) 4H (or vancomycin if central line or suspect MRSA) IV and gentamicin daily IV."},{"id":"fs-2471","name":"Septicaemia, unknown CSF","dosage":"Fluclox or vane and cefotaxime."},{"id":"fs-2472","name":"Adenitis","dosage":"Flucloxacillin 50mg/kg (max 2g) 6H IV."},{"id":"fs-2473","name":"Cellulitis","dosage":"Mild: cephalexin 25mg/kg (max 500mg) 6H oral. Moderate, not responding, or facial: flucloxacillin 50mg/kg (max 2g) 6H IV and gentamicin IV."},{"id":"fs-2474","name":"Bites, animal or human","dosage":"Amoxycillin/clavulanate 15 mg/kg (of amoxycillin) (max 500/125mg) 8H oral. Severe: Ticarcillinclavulanate 50mg/kg (max 3g) 6H IV"},{"id":"fs-2475","name":"Osteomyelitis, septic arthritis","dosage":"Flucloxacillin 50mg/kg (max 2g) 4-6H IV (andcefotaxime if <5yr and not Hib immunised)."},{"id":"fs-2476","name":"Impetigo","dosage":"Mupirocin 2% ointment 8H if localised or cepha lexin 25mg/kg (max 500mg) 12H oral."},{"id":"fs-2477","name":"Lice, scabies","dosage":"Permethrin 1% (head lice), 5% (scabies). Page 116 NORMAL VALUES: BLOOD AND SWEAT Acid phosphatase (prostatic): 0-0.8 IU/L ACTH (0800hr): <20 pmoi/L Activated partial t11romboplastin time (APTT): 22-39 sec Alanine aminotransferase (ALT, SGPT): 0-35 IU/L. Albumin: (>1y): 33-47 giL (x0.1 g/100ml) Alkaline phos (0-2y): 100-3501U (x0.041=KA/100ml) Ammonia: <50 umol/L (x1.703 = ug/10Oml) Amylase: 8-85 IU {x0.546 = SU/10Oml) Aspartate transaminase (AST) (1-3y): 15-60 IU (was SGOT) Base excess: -4 to +3 mmoi/L (x1 = mEq/L) Bicarbonate: 18-25 mmoi/L (x1 = mEq/L) Bilirubin (>1m): <10 umol/L (x0.0585 = mg/100ml) Caeruloplasmin: 200-430 mg/L (x0.001143 = ODU) Calcium ionized: 1.2-1.3 mmoi/L (x4.008 = mg/100ml)"},{"id":"fs-2478","name":"Calcium total: 2.0-2","dosage":"7 mmoi/L (x4.008 = mg/10Oml) Carboxyhaemoglobin: <5% total Chloride: 98-110 mmoi/L (x1 = mEq/L) Chloride, sweat (<12y): <50 mmoi/L (x1 = mEq/L) Cholesterol {>1 y): 3.1-5.4 mmoi/L (x38.66 = mg/10Oml) Cholinesterase: 600-1500 IU Copper (1-9y): 14-28 umol/L (x6.354 ug/100ml) Coproporphyrin: <0.3 umol/L (x654 = ug/L) Cortisol: 150-600 nmoitL Creatine kinase (CK, CPK): 40-240 IU Creatinine (1-9y): 10-60 umol/L (x0.0113 = mg/100ml) Cross-linked degradation products: <0.25 mg/L Cyanide: <8umol/ml, >40 fatal (x0.026 = mcg/ml) Ferritin: 18-300 mcg/L (x1 = ng/ml) Fibrinogen: 1.9-5.0 gil (split products <10 mg/L) Free fatty acids: 0.1-0.6 mmoi/L Free thyroxine index (>4m): 60-155%"},{"id":"fs-2479","name":"Globulins (>3y): 17-38 gil","dosage":"(x0.1 = g/10Oml) Glucose (>1m): 3.6-5.4 mmoi/L (x18.02 = mg/100ml) Gamma-glutamyltransferase (GGT) {>3m): <40 IU Immature/total neutrophil ratio: <0.15 (neonate <0.2) Insulin, fasting: 3-26 mlJ/L Iron: 9-27 umol/L {x5.585 = ug/10Oml) Iron binding capacity: 45-72 umol/L (x5.585 = ug/100ml) Lactate (venous): 1.0-1.8 rnrnoi/L (x8.904 = mg/100ml) Lactate dehydrogenase (LD): 210-420 IU Lead: 0.2-1.2 umol/L (x20.72 = ug/100ml)"},{"id":"fs-2480","name":"Lipase: 0-2.66 ukat/l","dosage":"(x60 = IU/L) Magnesium: 0.7-1.0 mmoi/L {x2.432 = mg/100ml) Methaemoglobin: <2% total Osmolality: 270-295 rnrnol/kg (x1 = mOsm/kg H20) PC02: 32-45 (x0.1317 = kPa) pH (>1m): 7.34-7.43"},{"id":"fs-2481","name":"Phosphate (>2y): 1.1-1.8 mmoltl","dosage":"(x3.098 = mg/100ml) Page 117 PO, (>2w): 80-100 mmHg (x0.1317 = kPa) Potassium (>1y): 3.5-5.0 mmoi/L (x1 = mEq/L) Protein (>3y): 57-80 g/L (x0.1 = g/100ml) Prothrombin time (PT): 9-14 sec, INR 0.8-1.3 Protoporphyrin: 0.3-1.0 umol/L (x56.2 = ug/100ml)"},{"id":"fs-2482","name":"Pyruvate: <0.1 mmoi/L (xB","dosage":"702 = mg/10Oml) Renin activity: 1-4 ng/ml/h Sodium: 135-145 mmoi/L (x1 = mEq/L) Thyroid bind glob (adult): 12-28mg/L (x0.078=ugT4/100ml) Thyroid stimulating hormone (TSH) (>14d): <5 nmoi/L Thyroxine free (adult): 9-26 pmoi/L Thyroxine total (>1y): 70-155 nmoi/L (x0.078 = ug/100ml) Triglycerides: 0.9-2.0 mmoi/L; TPN <2.8 mmoi/L (<4wk) <4.5 mmoi/L (;;,4wk). (x88 = mg/100ml)"},{"id":"fs-2483","name":"Triiodothyronine (T3) (adult): 1.0-2","dosage":"7 nmoi/L Triiodothyronine (T3) uptake (0-adult): 70-115% Troponin I (cardiac troponin): 0-0.29 mcg/L Urea (>4y); 2.1-6.5 mmoi/L (x6.006 = mg/100ml) Uric acid (<12y): 0.13-0.4 mmoi/L (x16.81 = mg/100ml) Vitamin D (25-0H-D3): 28-165 nmoitL Zinc: 11-22 umol/L (x6.538 = ug/10Oml) NORMAL VALUES: URINE Adrenaline (1-6y): <0.05 umol/d Delta ALA: <40 umol/L (x0.13 = mg/L) Calcium: <0.12 mmol/kg/d (x40.08 = mg/kg/d) Calcium/creatine ratio: <0.7 mmol/mmol Copper: <0.3 umolld (x63.5 = ug/d) Coproporphyrin: <0.3 umol/L (x654=ug/Ll Creatinine clearance: 1.4-2.4 ml/s/1.73m Dopamine (1-6y): 0.1H.16 umol/d Dopamine (1-6y): <1.1 umol/mmol creal 5HIAA: <0.05 mmolld (x0.19=mg/d) Homovanillic acid (HVA) (1-6y): 3-16 umol/mmol creal MHMA, VMA or HMMA (1-6y): <12 umol/d Osmolality: 50-1400 mmol/kg (x1 = mOsm/kg H20) Oxalate: <0.6 mmol/d (x90 = mg/d) Phosphate index (<12y): -0.2 to +0.04 Porphobilinogen: <9 umol/L (x0.23 = mg/L) Protein: <4 mg/h/m2 Uroporphyrin: <0.05 umol/L (x830 = ug/L) NORMAL VALUES: CEREBROSPINAL FLUID Glucose: >2.5 mrnoi/L (>=60% blood level) Protein: 0.5--4 (prem), 0.4-1.7 (<1wk), 0.05-0.4 g/L (>2mo) Lymphocytes (x 106/L): <20 (<1wk), <6 (>1wk) Neutrophils (x 106): <10 (<1wk), 0 (>1wk) Page 118 -~ \\"' m ~ : ~ 0 ~ -< Q_ g < Atprostadil PGE1 y.E -< An::no?hytline I y P.rr;todarone Yd P.:;-:photerir::ir B I ? Yd DobutaGine c y Dopamine y y y Esmolol y ? y Fentanyl y ? y FrL:se;-r-ide y y y Giyceryl trinit;-ate y y y tnsutin in albumin lsoprenaHne y Ketamine evcsemendan ? ? ? Ligrocaine y y DRUG INFUSION COMPATIBILITY TABLE Incompatible \\"' ro ? Unknown C Standard concentrations compatible (See bottom row oftable)  -~ ~ i.~ E.c E <J::O.roo Y Standard concentrations compatible mixed at Y connection near patient E -~., <t: E E y I 0 \\"' Yj1:5-20 9: >-YttC ~~~ YIIYYw~~ <D \\"' : ~ ;:: :::1 -.0 Yd I Yd y y y IlL ~ 1\\\\ I I I I y ~ ~ ro '.~ ~ d Both solutions in 5% dextrose s Both solutions in 0.9% saline Epoprostenot is incompatible with all other drugs c ro \\"0 y I Yd c c y i y y i I I YjYY - 1~.-9 y y g :Ji ~ <D g r y y '\\" \\"' Y C Y Y C Y Cl Y C ~ ~ ? ::J \\".c E CL ~ ~ a; ~ 2 Magnesium sulph Y ? Metilmminol C ? Y Mldazo1am Y Y Milr:no:~e C ? Y -?5 y y y ~ Na~cxone Y ? Y - y ? t ~ PhentolaminB Y Y Y ~ ? ? t :g Sodlum 11itroprus Y Yd Y (f) I ? y V;tsopres~in Y ? Y Y :g 0 c.~ \\" \\"' c. \\"'.Q ~ _c \\"-}- ;3:: y y Heparin C y Y Y I I Y c Y I I Yd Cs C yly c y y y c c Yj y Y) C cl c cl c c 'r y 1 Y? Y[Y Y C yl'? C Y Y i Y Y1 Y Y Y Y? C., Y Dextrose 5% C Potassium chlor Y Nutrient Lipid 20kg child mglml 0.1 c c c c y c II y ? I y y I 7 i I Y I 22 6 0.6 6 c c c c c c c c y y y y y y I ? y y 0.20-1 10 1.2 Yll y y y y Y) y 0.1 c c c c 12 0.1 c y c c c ct c c c c c c 1 c cccccccccccc Y Y C Y I Y? Y YYIYYYCY'> Y YY?Y?IYY ? ? y ? ? y 500 0.1 1.20-4 0.20-1 6 1 1.2 25 RESUSCITATION Coma, apnoea, pulselessness: CPR, intabate, ventilate with 100% oxygen, insert IV or 10 or sagittal sinus, display EGG and: -asystole: adrenaline every 3min, bicarbonate or volume or atropine 20 meg/kg (0.03 ml/kg of 0.6 mg/ml), defib 2-4 joule/kg, pace -VF or VT: defibrillate-2-4 joule/kg x1-4, adrenaline every 3min, defibrillate, lignocaine 1% 0.1 ml/kg, defibrillate (then try amiodarone 5mg/kg, magnesium sulphate 50% 0.06 ml/kg, bicarbonate, volume) -electromechanical dissociation: treat hypovolaemia or pneumothorax or tamponade, adrenaline every 3min, bicarbonate. AGE (years} WEIGHT (kilograms) ADRENALINE IV/IO 1,10,000 0.1ml/kg via ETT 1,1000 O.lml/kg SODIUM BICARBONATE 8.4% l-2ml/kg stat SODIUM BICARBONATE 8.4% lml/kg/10 min arrest time BIRTH 1 2 3 4 5 6 7 8 9 10 11 12 13 yr I I I I I I I I I I I I I 10 15 20 25 30 35 40 kg I I I 1 1 1.5 2 2.5 3 3.5 4 ml I I I i i I I I I I 6 10 25 30 40 50 60 70 80 ml ' I 5 10 15 20 25 30 35 40 ml I I I I I I I I LIGKOCAIN3 1% O.lml/kg (1mg/kg), then 20-40ug/kg/min"},{"id":"fs-2484","name":"VOLUME EXPANSION","dosage":"Initially lOml/kg, repeat x2-3 if required ENDOTRP.CHEAL TUBE Internal diameter (mm) ENDOTRACHEAL TUBE (ORAL) ~ength at lip {em) ENDOT~~CHEAL TUBE (NASAL) Length at nose (em)"},{"id":"fs-2485","name":"CARDIOVERSION","dosage":"Atrial arrhythmia 1 joule/kg"},{"id":"fs-2486","name":"CARDIOVERSION","dosage":"Ventricular arrhythmias 2-4 joule/kg 0.5 1.5 2 2.5 3 3.5 4 ml I I I l I I so 100 I 125 150 200 250 300 350 400 m1 t I I t I I _l I _I i I 3.o 3.s 4.o s.o s.5 6.o 6.s 1.o 1 mm 8.5 11 12 14 15 16 17 18 em I t I I I I I I 10.5 14 15 16 17 19 20 21 22 em t I I I I I I 3 5 10 15 20 25 30 35 40 jl I I t I 9 30 45 60 75 90 115 120 jl PHARMACOKINETICS IV BOLUS, 1 COMPARTMENT, 1ST ORDER Loading Vd x Cp MDxtY. dose (mg/kg) ------------- --------------- F Dl X 0.693 Maintenance LD x Dl Css x Vd x Dl dose (mg/kg) --------------- -------------------- t)l, X 1.44 t% xFx1.44 Steady state F x MD tY., x F x MD cone. (ug/ml) --------------------- Cl x Dl 0.693 X Vd X Dl"},{"id":"fs-2487","name":"Vol","dosage":"distri- D D xtY. bution (Likg) ------------------- Co 0.693 x AUC Clearance Vd D D X 0.693 (Likg/hr) 1.44 X t)l, AUC t)l, X Co Elimination constant (Kel) 0.693 I tY. Concentration at timeT hr Co I eA(T x Kel) Kel [ln(high)- ln(low)] I interval in hr AUG= Cl area under curve (hr.ug/ml) Co = Cp = Css = Kel tY. Vd clearance (Likg/hr) (x 16.67 = ml/kg/min) concentration at time zero (ug/ml, mg/L) plasma/serum concentration (ug/ml, mg/L) steady state concentration (ug/ml, mg/L) dose (mg/kg) dose interval (hours) 2.71828 fraction of drug absorbed elimination constant loading dose (mg/kg) maintenance dose (mg/kg) half life (hours) volume of distribution (L/kg)"}]`),le="https://sites.google.com/moh.gov.my/nag/contents",Wg="https://sites.google.com/moh.gov.my/nag/appendices",Od={adult:[{id:"A1",title:"Cardiovascular Infections",url:`${le}/section-a-adult/a1-cardiovascular-infections`},{id:"A2",title:"Central Nervous Infections",url:`${le}/section-a-adult/a2-central-nervous-infections`},{id:"A3",title:"Chemoprophylaxis",url:`${le}/section-a-adult/a3-chemoprophylaxis`},{id:"A4",title:"Gastrointestinal Infections",url:`${le}/section-a-adult/a4-gastrointestinal-infections`},{id:"A5",title:"Immunocompromised Patients",url:`${le}/section-a-adult/a5-infections-in-immunocompromised-patients`},{id:"A6",title:"Obs & Gynae Infections",url:`${le}/section-a-adult/a6-obstetrics-gyneacological-infections`},{id:"A7",title:"Ocular Infections",url:`${le}/section-a-adult/a7-ocular-infections`},{id:"A8",title:"Oral / Dental Infections",url:`${le}/section-a-adult/a8-oral-dental-infections`},{id:"A9",title:"Orthopaedic Infections",url:`${le}/section-a-adult/a9-orthopaedic-infections`},{id:"A10",title:"ORL Infections",url:`${le}/section-a-adult/a10-otorhinolaryngology-infections`},{id:"A11",title:"Respiratory Infections",url:`${le}/section-a-adult/a11-respiratory-infections`},{id:"A12",title:"Sepsis",url:`${le}/section-a-adult/a12-sepsis`},{id:"A13",title:"STIs",url:`${le}/section-a-adult/a13-sexually-transmitted-infections`},{id:"A14",title:"Skin & Soft Tissue",url:`${le}/section-a-adult/a14-skin-soft-tissue-infections`},{id:"A15",title:"Trauma Related",url:`${le}/section-a-adult/a15-trauma-related-infections`},{id:"A16",title:"Tropical Infections",url:`${le}/section-a-adult/a16-tropical-infections`},{id:"A17",title:"Urinary Tract Infections",url:`${le}/section-a-adult/a17-urinary-tract-infections`}],paeds:[{id:"B1",title:"Cardiovascular",url:`${le}/section-b-paediatrics/b1-cardiovascular-infections`},{id:"B2",title:"CNS Infections",url:`${le}/section-b-paediatrics/b2-central-nervous-infections`},{id:"B6",title:"Neonatal Infections",url:`${le}/section-b-paediatrics/b6-neonatal-infections`},{id:"B10",title:"Respiratory Infections",url:`${le}/section-b-paediatrics/b10-respiratory-infections`},{id:"B13",title:"Urinary Tract Infections",url:`${le}/section-b-paediatrics/b13-urinary-tract-infections`},{id:"B14",title:"Vascular Infections",url:`${le}/section-b-paediatrics/b14-vascular-infections`}],primary:[{id:"C1",title:"Acute Bronchitis/Pneumonia",url:`${le}/section-c-clinical-pathways-in-primary-care/c1-acute-bronchitis-and-pneumonia`},{id:"C2",title:"Acute Otitis Media",url:`${le}/section-c-clinical-pathways-in-primary-care/c2-acute-otitis-media`},{id:"C3",title:"Acute Pharyngitis",url:`${le}/section-c-clinical-pathways-in-primary-care/c3-acute-pharyngitis`},{id:"C4",title:"Acute Rhinosinusitis",url:`${le}/section-c-clinical-pathways-in-primary-care/c4-acute-rhinosinusitis`},{id:"C5",title:"Acute Gastroenteritis",url:`${le}/section-c-clinical-pathways-in-primary-care/c5-acute-gastroenteritis`},{id:"C7",title:"UTI (Non-Pregnancy)",url:`${le}/section-c-clinical-pathways-in-primary-care/c7-urinary-tract-infection-in-non-pregnancy`}]},Mn=({isOpen:v,onClose:w,children:b})=>v?r.jsx("div",{className:"fixed inset-0 bg-slate-900/70 z-50 flex items-center justify-center p-4 backdrop-blur-md animate-in fade-in duration-200",children:r.jsx("div",{className:"bg-white dark:bg-slate-800 rounded-2xl shadow-2xl w-full max-w-2xl max-h-[90vh] overflow-y-auto transform transition-all scale-100 border border-slate-200 dark:border-slate-700",children:r.jsxs("div",{className:"relative",children:[r.jsx("button",{onClick:w,className:"absolute right-4 top-4 p-2 bg-slate-100 dark:bg-slate-700 rounded-full hover:bg-slate-200 dark:hover:bg-slate-600 transition-colors z-10 text-slate-500 dark:text-slate-400",children:r.jsx(au,{size:20})}),b]})})}):null,xi=({children:v,type:w="default"})=>{const b={default:"bg-slate-100 dark:bg-slate-700 text-slate-800 dark:text-slate-200",highAlert:"bg-rose-100 dark:bg-rose-900/30 text-rose-700 dark:text-rose-400 border border-rose-200 dark:border-rose-800",category:"bg-teal-50 dark:bg-teal-900/30 text-teal-700 dark:text-teal-400 border border-teal-100 dark:border-teal-800",form:"bg-blue-50 dark:bg-blue-900/30 text-blue-700 dark:text-blue-400 border border-blue-100 dark:border-blue-800",prescriber:"bg-violet-50 dark:bg-violet-900/30 text-violet-700 dark:text-violet-400 border border-violet-100 dark:border-violet-800"};return r.jsx("span",{className:`px-2.5 py-1 rounded-md text-xs font-bold tracking-wide ${b[w]}`,children:v})},Ii=({icon:v,label:w,value:b,warning:u=!1})=>r.jsxs("div",{className:"flex items-start space-x-4 py-4 border-b border-slate-100 dark:border-slate-700 last:border-0 group hover:bg-slate-50 dark:hover:bg-slate-800/50 px-2 rounded-lg transition-colors",children:[r.jsx("div",{className:`p-2.5 rounded-xl shadow-sm ${u?"bg-amber-50 dark:bg-amber-900/30 text-amber-600 dark:text-amber-400":"bg-teal-50 dark:bg-teal-900/30 text-teal-600 dark:text-teal-400"}`,children:r.jsx(v,{size:20,strokeWidth:1.5})}),r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsx("h4",{className:"text-xs font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-1.5",children:w}),r.jsx("p",{className:"text-slate-800 dark:text-slate-200 text-sm leading-relaxed whitespace-pre-line break-words font-medium",children:b||"N/A"})]})]}),pf=()=>{const v=w=>{window.open(w,"_blank")};return r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6 space-y-6 md:space-y-8",children:[r.jsxs("div",{className:"bg-gradient-to-r from-slate-800 to-slate-900 dark:from-slate-800 dark:to-slate-900 rounded-2xl p-6 md:p-8 text-white shadow-xl relative overflow-hidden",children:[r.jsx("div",{className:"absolute top-0 right-0 w-64 h-64 bg-white/5 rounded-full -mr-16 -mt-16 blur-3xl"}),r.jsx("div",{className:"absolute bottom-0 left-0 w-48 h-48 bg-teal-500/10 rounded-full -ml-10 -mb-10 blur-2xl"}),r.jsxs("div",{className:"relative flex flex-col md:flex-row items-start md:items-center justify-between gap-6",children:[r.jsxs("div",{children:[r.jsxs("h2",{className:"text-2xl md:text-3xl font-bold mb-3 flex items-center gap-3",children:[r.jsx(eu,{size:32,className:"text-teal-400"}),r.jsx("span",{children:"National Antimicrobial Guideline"})]}),r.jsx("p",{className:"text-slate-300 text-sm md:text-base max-w-2xl leading-relaxed",children:"Official Ministry of Health Malaysia guidelines for antibiotic prescribing. Access the latest protocols for Adult, Paediatric, and Primary Care, tailored for Hospital Seri Manjung."})]}),r.jsxs("button",{onClick:()=>v("https://sites.google.com/moh.gov.my/nag/home"),className:"w-full md:w-auto bg-teal-600 hover:bg-teal-500 text-white px-6 py-3 rounded-xl font-bold shadow-lg shadow-teal-900/20 transition-all transform hover:-translate-y-0.5 flex items-center justify-center gap-2 whitespace-nowrap",children:["Open Official Site ",r.jsx(wd,{size:18})]})]})]}),r.jsxs("div",{className:"grid md:grid-cols-3 gap-4 md:gap-6",children:[r.jsxs("div",{className:"bg-white dark:bg-slate-800 rounded-xl border border-slate-200 dark:border-slate-700 shadow-sm overflow-hidden group hover:shadow-md transition-all",children:[r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 p-4 border-b border-slate-100 dark:border-slate-700 flex items-center gap-3",children:[r.jsx("div",{className:"p-2 bg-teal-100 dark:bg-teal-900/30 rounded-lg text-teal-600 dark:text-teal-400",children:r.jsx(iu,{size:20})}),r.jsx("h3",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Section A: Adult"})]}),r.jsx("div",{className:"p-2 max-h-[300px] overflow-y-auto scrollbar-thin scrollbar-thumb-slate-200 dark:scrollbar-thumb-slate-600",children:Od.adult.map(w=>r.jsxs("button",{onClick:()=>v(w.url),className:"w-full text-left px-4 py-3 hover:bg-slate-50 dark:hover:bg-slate-700 rounded-lg flex items-center justify-between group/item transition-colors min-h-[44px]",children:[r.jsx("span",{className:"text-sm text-slate-600 dark:text-slate-300 group-hover/item:text-teal-700 dark:group-hover/item:text-teal-400 font-medium",children:w.title}),r.jsx("span",{className:"text-[10px] font-bold text-slate-400 dark:text-slate-500 bg-slate-100 dark:bg-slate-700 px-1.5 py-0.5 rounded border border-slate-200 dark:border-slate-600",children:w.id})]},w.id))})]}),r.jsxs("div",{className:"bg-white dark:bg-slate-800 rounded-xl border border-slate-200 dark:border-slate-700 shadow-sm overflow-hidden group hover:shadow-md transition-all",children:[r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 p-4 border-b border-slate-100 dark:border-slate-700 flex items-center gap-3",children:[r.jsx("div",{className:"p-2 bg-blue-100 dark:bg-blue-900/30 rounded-lg text-blue-600 dark:text-blue-400",children:r.jsx(Pt,{size:20})}),r.jsx("h3",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Section B: Paediatrics"})]}),r.jsx("div",{className:"p-2",children:Od.paeds.map(w=>r.jsxs("button",{onClick:()=>v(w.url),className:"w-full text-left px-4 py-3 hover:bg-slate-50 dark:hover:bg-slate-700 rounded-lg flex items-center justify-between group/item transition-colors min-h-[44px]",children:[r.jsx("span",{className:"text-sm text-slate-600 dark:text-slate-300 group-hover/item:text-blue-700 dark:group-hover/item:text-blue-400 font-medium",children:w.title}),r.jsx("span",{className:"text-[10px] font-bold text-slate-400 dark:text-slate-500 bg-slate-100 dark:bg-slate-700 px-1.5 py-0.5 rounded border border-slate-200 dark:border-slate-600",children:w.id})]},w.id))})]}),r.jsxs("div",{className:"bg-white dark:bg-slate-800 rounded-xl border border-slate-200 dark:border-slate-700 shadow-sm overflow-hidden group hover:shadow-md transition-all",children:[r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 p-4 border-b border-slate-100 dark:border-slate-700 flex items-center gap-3",children:[r.jsx("div",{className:"p-2 bg-violet-100 dark:bg-violet-900/30 rounded-lg text-violet-600 dark:text-violet-400",children:r.jsx(ir,{size:20})}),r.jsx("h3",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Section C: Primary Care"})]}),r.jsx("div",{className:"p-2",children:Od.primary.map(w=>r.jsxs("button",{onClick:()=>v(w.url),className:"w-full text-left px-4 py-3 hover:bg-slate-50 dark:hover:bg-slate-700 rounded-lg flex items-center justify-between group/item transition-colors min-h-[44px]",children:[r.jsx("span",{className:"text-sm text-slate-600 dark:text-slate-300 group-hover/item:text-violet-700 dark:group-hover/item:text-violet-400 font-medium",children:w.title}),r.jsx("span",{className:"text-[10px] font-bold text-slate-400 dark:text-slate-500 bg-slate-100 dark:bg-slate-700 px-1.5 py-0.5 rounded border border-slate-200 dark:border-slate-600",children:w.id})]},w.id))})]})]}),r.jsxs("div",{className:"grid md:grid-cols-2 gap-4 md:gap-6",children:[r.jsxs("div",{onClick:()=>v(`${Wg}/appendix-2-antibiotic-dosages-in-patients-with-impaired-renal-function`),className:"bg-amber-50 dark:bg-amber-900/20 rounded-xl p-5 border border-amber-100 dark:border-amber-800 cursor-pointer hover:shadow-md transition-all group",children:[r.jsxs("h4",{className:"font-bold text-amber-800 dark:text-amber-400 mb-2 flex items-center gap-2",children:[r.jsx(Ca,{size:18})," Renal Dosage Adjustment",r.jsx(wd,{size:14,className:"opacity-0 group-hover:opacity-100 transition-opacity"})]}),r.jsx("p",{className:"text-sm text-amber-700 dark:text-amber-300",children:"Guidance on adjusting antibiotic doses for patients with impaired renal function (CrCl based)."})]}),r.jsxs("div",{onClick:()=>v(`${Wg}/appendix-4-antibiotic-in-pregnancy-lactation`),className:"bg-rose-50 dark:bg-rose-900/20 rounded-xl p-5 border border-rose-100 dark:border-rose-800 cursor-pointer hover:shadow-md transition-all group",children:[r.jsxs("h4",{className:"font-bold text-rose-800 dark:text-rose-400 mb-2 flex items-center gap-2",children:[r.jsx(Pt,{size:18})," Pregnancy & Lactation",r.jsx(wd,{size:14,className:"opacity-0 group-hover:opacity-100 transition-opacity"})]}),r.jsx("p",{className:"text-sm text-rose-700 dark:text-rose-300",children:"Safety profiles and category references for antimicrobial use during pregnancy."})]})]})]})},ff=()=>{const[v,w]=_.useState(""),[b,u]=_.useState(null),H=hf.antibiotics,C=_.useMemo(()=>{if(!v)return H;const L=v.toLowerCase();return H.filter(x=>x.name.toLowerCase().includes(L)||x.category.toLowerCase().includes(L)||x.route.toLowerCase().includes(L))},[v,H]);return r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6 space-y-6",children:[r.jsxs("div",{className:"sticky top-0 z-20 bg-white/95 dark:bg-slate-900/95 backdrop-blur-md -mx-4 px-4 pb-4 mb-6",children:[r.jsx("div",{className:"flex items-center justify-between py-3 border-b border-slate-200 dark:border-slate-700 mb-4",children:r.jsxs("div",{className:"flex items-center gap-3",children:[r.jsx(Ca,{size:24,className:"text-emerald-600 dark:text-emerald-400"}),r.jsxs("div",{children:[r.jsx("h2",{className:"font-bold text-slate-800 dark:text-slate-100",children:"ABX Regime HSM 2017"}),r.jsx("p",{className:"text-xs text-slate-500 dark:text-slate-400",children:"Antibiotic Renal Dosing Adjustments"})]})]})}),r.jsxs("div",{className:"relative",children:[r.jsx(gi,{className:"absolute left-4 top-1/2 transform -translate-y-1/2 text-slate-400 dark:text-slate-500",size:20}),r.jsx("input",{type:"text",placeholder:"Search antibiotic name, category, or route...",className:"w-full pl-12 pr-4 py-3.5 bg-slate-100 dark:bg-slate-800 border-transparent focus:bg-white dark:focus:bg-slate-700 focus:border-emerald-500 dark:focus:border-emerald-400 focus:ring-4 focus:ring-emerald-500/10 dark:focus:ring-emerald-900/50 rounded-2xl text-slate-800 dark:text-slate-200 placeholder-slate-400 dark:placeholder-slate-500 transition-all outline-none text-base font-medium shadow-sm",value:v,onChange:L=>w(L.target.value)})]}),r.jsx("div",{className:"flex items-center justify-between px-2 mt-3",children:r.jsxs("span",{className:"text-xs font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider",children:["Showing ",C.length," of ",H.length," antibiotics"]})})]}),r.jsxs("div",{className:"space-y-3",children:[C.map(L=>r.jsx("div",{onClick:()=>u(L),className:"bg-white dark:bg-slate-800 rounded-xl p-4 border border-slate-200 dark:border-slate-700 hover:border-emerald-300 dark:hover:border-emerald-600 hover:shadow-md transition-all cursor-pointer",children:r.jsxs("div",{className:"flex items-start justify-between gap-3",children:[r.jsxs("div",{className:"flex-1",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-1",children:[r.jsx("h3",{className:"font-bold text-slate-800 dark:text-slate-100",children:L.name}),r.jsx("span",{className:"text-xs px-2 py-0.5 rounded-full bg-emerald-100 dark:bg-emerald-900/30 text-emerald-700 dark:text-emerald-400 font-medium",children:L.route})]}),r.jsxs("p",{className:"text-sm text-slate-600 dark:text-slate-400 mb-1",children:[r.jsx("strong",{children:"Usual Dose:"})," ",L.usualDose]}),r.jsx("p",{className:"text-xs text-slate-500 dark:text-slate-500",children:L.category})]}),r.jsx(Lt,{size:20,className:"text-slate-400 flex-shrink-0"})]})},L.id)),C.length===0&&r.jsxs("div",{className:"text-center py-12",children:[r.jsx(gi,{className:"mx-auto text-slate-300 dark:text-slate-600 mb-3",size:48}),r.jsx("p",{className:"text-slate-500 dark:text-slate-400",children:"No antibiotics found"})]})]}),b&&r.jsx("div",{className:"fixed inset-0 bg-black/50 flex items-center justify-center z-50 p-4",onClick:()=>u(null),children:r.jsxs("div",{className:"bg-white dark:bg-slate-800 rounded-2xl max-w-2xl w-full max-h-[90vh] overflow-y-auto",onClick:L=>L.stopPropagation(),children:[r.jsx("div",{className:"sticky top-0 bg-gradient-to-r from-emerald-600 to-teal-600 p-6 rounded-t-2xl",children:r.jsxs("div",{className:"flex items-start justify-between",children:[r.jsxs("div",{className:"flex-1",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-2",children:[r.jsx("h3",{className:"text-xl font-bold text-white",children:b.name}),r.jsx("span",{className:"px-2 py-1 rounded-lg bg-white/20 text-white text-xs font-bold",children:b.route})]}),r.jsx("p",{className:"text-emerald-100 text-sm",children:b.category})]}),r.jsx("button",{onClick:()=>u(null),className:"p-2 hover:bg-white/20 rounded-lg transition-colors",children:r.jsx(au,{size:20,className:"text-white"})})]})}),r.jsxs("div",{className:"p-6 space-y-6",children:[r.jsxs("div",{children:[r.jsxs("h4",{className:"font-bold text-slate-800 dark:text-slate-100 mb-2 flex items-center gap-2",children:[r.jsx($g,{size:18,className:"text-emerald-600"}),"Usual Dose"]}),r.jsx("p",{className:"text-slate-700 dark:text-slate-300 bg-slate-50 dark:bg-slate-700/50 p-3 rounded-lg",children:b.usualDose})]}),r.jsxs("div",{children:[r.jsxs("h4",{className:"font-bold text-slate-800 dark:text-slate-100 mb-3 flex items-center gap-2",children:[r.jsx(Ca,{size:18,className:"text-emerald-600"}),"Renal Dosing Adjustments"]}),r.jsx("div",{className:"overflow-x-auto",children:r.jsxs("table",{className:"w-full text-sm",children:[r.jsx("thead",{className:"bg-slate-100 dark:bg-slate-700/50",children:r.jsxs("tr",{children:[r.jsx("th",{className:"px-4 py-2 text-left font-bold text-slate-700 dark:text-slate-300",children:"CrCl (ml/min)"}),r.jsx("th",{className:"px-4 py-2 text-left font-bold text-slate-700 dark:text-slate-300",children:"Dosage Adjustment"})]})}),r.jsx("tbody",{className:"divide-y divide-slate-200 dark:divide-slate-700",children:b.renalDosing.map((L,x)=>r.jsxs("tr",{className:"hover:bg-slate-50 dark:hover:bg-slate-700/30",children:[r.jsx("td",{className:"px-4 py-3 font-medium text-slate-700 dark:text-slate-300",children:L.crcl}),r.jsx("td",{className:"px-4 py-3 text-slate-600 dark:text-slate-400",children:L.adjustment})]},x))})]})})]}),b.notes&&r.jsx("div",{className:"bg-amber-50 dark:bg-amber-900/20 border border-amber-200 dark:border-amber-800 rounded-lg p-4",children:r.jsxs("div",{className:"flex items-start gap-2",children:[r.jsx(wa,{size:18,className:"text-amber-600 dark:text-amber-400 flex-shrink-0 mt-0.5"}),r.jsxs("div",{children:[r.jsx("h5",{className:"font-bold text-amber-800 dark:text-amber-400 text-sm mb-1",children:"Important Notes"}),r.jsx("p",{className:"text-xs text-amber-700 dark:text-amber-300",children:b.notes})]})]})})]})]})})]})},yf=()=>{const[v,w]=_.useState(""),[b,u]=_.useState(null),H=_.useMemo(()=>{if(!v)return xd;const C=v.toLowerCase();return xd.filter(L=>L.genericName.toLowerCase().includes(C)||L.brandName.toLowerCase().includes(C)||L.category.toLowerCase().includes(C))},[v]);return r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6",children:[r.jsxs("div",{className:"sticky top-0 z-20 bg-white/95 dark:bg-slate-900/95 backdrop-blur-md -mx-4 px-4 pb-4 mb-6",children:[r.jsx("div",{className:"flex items-center justify-between py-3 border-b border-slate-200 dark:border-slate-700 mb-4",children:r.jsxs("div",{className:"flex items-center gap-3",children:[r.jsx(Rd,{size:24,className:"text-amber-600 dark:text-amber-400"}),r.jsxs("div",{children:[r.jsx("h2",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Dilution Protocol"}),r.jsxs("p",{className:"text-xs text-slate-500 dark:text-slate-400",children:[xd.length," Injectable Drugs"]})]})]})}),r.jsxs("div",{className:"relative",children:[r.jsx(gi,{className:"absolute left-4 top-1/2 transform -translate-y-1/2 text-slate-400 dark:text-slate-500",size:20}),r.jsx("input",{type:"text",placeholder:"Search by drug name or category...",className:"w-full pl-12 pr-4 py-3.5 bg-slate-100 dark:bg-slate-800 border-transparent focus:bg-white dark:focus:bg-slate-700 focus:border-amber-500 dark:focus:border-amber-400 focus:ring-4 focus:ring-amber-500/10 dark:focus:ring-amber-900/50 rounded-2xl text-slate-800 dark:text-slate-200 placeholder-slate-400 dark:placeholder-slate-500 transition-all outline-none text-base font-medium shadow-sm",value:v,onChange:C=>w(C.target.value)})]})]}),H.length===0?r.jsxs("div",{className:"text-center py-12 md:py-20",children:[r.jsx("div",{className:"bg-slate-100 dark:bg-slate-800 rounded-full w-16 h-16 md:w-20 md:h-20 flex items-center justify-center mx-auto mb-4",children:r.jsx(gi,{className:"text-slate-400 dark:text-slate-500",size:32})}),r.jsx("h3",{className:"text-base md:text-lg font-medium text-slate-600 dark:text-slate-300",children:"No drugs found"}),r.jsx("p",{className:"text-slate-400 dark:text-slate-500",children:"Try adjusting your search"})]}):r.jsx("div",{className:"grid gap-4 sm:grid-cols-2 lg:grid-cols-2",children:H.map(C=>r.jsxs("div",{onClick:()=>u(C),className:"bg-white dark:bg-slate-800 rounded-xl p-4 md:p-5 shadow-sm border border-slate-200 dark:border-slate-700 hover:shadow-lg hover:border-amber-200 dark:hover:border-amber-700 transition-all cursor-pointer group relative",children:[r.jsx("div",{className:"flex items-start justify-between mb-3",children:r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-1",children:[r.jsx(Ht,{size:16,className:"text-amber-600 dark:text-amber-400 flex-shrink-0"}),r.jsx("h3",{className:"text-base md:text-lg font-bold text-slate-800 dark:text-slate-100 group-hover:text-amber-600 dark:group-hover:text-amber-400 transition-colors leading-tight",children:C.genericName})]}),r.jsx("p",{className:"text-sm font-medium text-slate-500 dark:text-slate-400",children:C.brandName}),C.strength&&r.jsxs("p",{className:"text-xs text-slate-400 dark:text-slate-500 mt-1",children:["Strength: ",C.strength]})]})}),r.jsx("div",{className:"flex flex-wrap gap-2 mb-3",children:r.jsx(xi,{type:"default",children:C.category})}),r.jsxs("div",{className:"flex items-center justify-between pt-3 border-t border-slate-100 dark:border-slate-700",children:[r.jsxs("div",{className:"flex items-center gap-1 text-xs text-slate-500 dark:text-slate-400",children:[r.jsx(Cd,{size:14}),r.jsxs("span",{children:[C.diluents.length," diluent(s)"]})]}),r.jsxs("div",{className:"flex items-center text-amber-600 dark:text-amber-400 text-sm font-bold group-hover:translate-x-1 transition-transform",children:["View Protocol ",r.jsx(Lt,{size:16})]})]})]},C.id))}),r.jsx(Mn,{isOpen:!!b,onClose:()=>u(null),children:b&&r.jsxs("div",{className:"bg-white dark:bg-slate-800 w-full",children:[r.jsxs("div",{className:"px-5 md:px-6 py-4 md:py-5 border-b border-slate-100 dark:border-slate-700 bg-amber-50 dark:bg-amber-900/20",children:[r.jsxs("div",{className:"flex items-start gap-3 mb-2",children:[r.jsx(Ht,{size:24,className:"text-amber-600 dark:text-amber-400 flex-shrink-0 mt-1"}),r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsx("h2",{className:"text-xl md:text-2xl font-bold text-slate-900 dark:text-slate-100 leading-tight",children:b.genericName}),r.jsx("p",{className:"text-base md:text-lg text-slate-600 dark:text-slate-400",children:b.brandName}),b.strength&&r.jsxs("p",{className:"text-sm text-slate-500 dark:text-slate-400 mt-1",children:["Strength: ",b.strength]})]})]}),r.jsx(xi,{type:"default",children:b.category})]}),r.jsxs("div",{className:"p-5 md:p-6 space-y-1",children:[b.reconstitution&&r.jsx(Ii,{icon:Rd,label:"Reconstitution",value:b.reconstitution}),b.furtherDilution&&r.jsx(Ii,{icon:Cd,label:"Further Dilution",value:b.furtherDilution}),b.diluents&&b.diluents.length>0&&r.jsxs("div",{className:"flex items-start space-x-4 py-4 border-b border-slate-100 dark:border-slate-700 last:border-0 group hover:bg-slate-50 dark:hover:bg-slate-800/50 px-2 rounded-lg transition-colors",children:[r.jsx("div",{className:"p-2.5 rounded-xl shadow-sm bg-teal-50 dark:bg-teal-900/30 text-teal-600 dark:text-teal-400",children:r.jsx(Cd,{size:20,strokeWidth:1.5})}),r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsx("h4",{className:"text-xs font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2",children:"Diluents"}),r.jsx("div",{className:"flex flex-wrap gap-2",children:b.diluents.map((C,L)=>r.jsx("span",{className:"px-3 py-1 bg-blue-50 dark:bg-blue-900/30 text-blue-700 dark:text-blue-400 border border-blue-100 dark:border-blue-800 rounded-md text-xs font-bold",children:C},L))})]})]}),b.administration&&r.jsx(Ii,{icon:Ht,label:"Administration",value:b.administration}),b.storage&&r.jsx(Ii,{icon:Hd,label:"Storage & Stability",value:b.storage,warning:!0}),b.remarks&&r.jsx(Ii,{icon:wa,label:"Important Remarks",value:b.remarks,warning:!0})]}),r.jsx("div",{className:"px-5 md:px-6 py-4 bg-slate-50 dark:bg-slate-800/50 border-t border-slate-100 dark:border-slate-700",children:r.jsxs("div",{className:"flex items-start gap-2",children:[r.jsx(Mt,{size:16,className:"text-slate-400 dark:text-slate-500 flex-shrink-0 mt-0.5"}),r.jsxs("p",{className:"text-xs text-slate-500 dark:text-slate-400 leading-relaxed",children:[r.jsx("strong",{children:"Source:"})," ",gf.author," | Always refer to current product insert for your specific brand."]})]})})]})})]})},bf=()=>{const[v,w]=_.useState(""),[b,u]=_.useState(null),[H,C]=_.useState("All"),L=_.useMemo(()=>{let y=$o;if(H!=="All"&&(y=y.filter(O=>O.category===H)),v){const O=v.toLowerCase();y=y.filter(E=>E.name.toLowerCase().includes(O)||E.category.toLowerCase().includes(O)||E.indications.some(J=>J.toLowerCase().includes(O)))}return y},[v,H]),x=_.useMemo(()=>["All",...[...new Set($o.map(O=>O.category))].sort()],[]),D=()=>{window.open("/Paediatric Protocols 5th Edition PDF_compressed.pdf","_blank")};return r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6",children:[r.jsxs("div",{className:"sticky top-0 z-20 bg-white/95 dark:bg-slate-900/95 backdrop-blur-md -mx-4 px-4 pb-4 mb-6",children:[r.jsxs("div",{className:"flex items-center justify-between py-3 border-b border-slate-200 dark:border-slate-700 mb-4",children:[r.jsxs("div",{className:"flex items-center gap-3",children:[r.jsx(Pt,{size:24,className:"text-purple-600 dark:text-purple-400"}),r.jsxs("div",{children:[r.jsx("h2",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Paediatric Medications"}),r.jsxs("p",{className:"text-xs text-slate-500 dark:text-slate-400",children:[$o.length," Medications"]})]})]}),r.jsxs("button",{onClick:D,className:"text-xs font-bold text-purple-600 dark:text-purple-400 hover:underline flex items-center gap-1",children:[r.jsx(Mt,{size:14})," View PDF"]})]}),r.jsxs("div",{className:"relative mb-4",children:[r.jsx(gi,{className:"absolute left-4 top-1/2 transform -translate-y-1/2 text-slate-400 dark:text-slate-500",size:20}),r.jsx("input",{type:"text",placeholder:"Search medications by name or indication...",className:"w-full pl-12 pr-4 py-3.5 bg-slate-100 dark:bg-slate-800 border-transparent focus:bg-white dark:focus:bg-slate-700 focus:border-purple-500 dark:focus:border-purple-400 focus:ring-4 focus:ring-purple-500/10 dark:focus:ring-purple-900/50 rounded-2xl text-slate-800 dark:text-slate-200 placeholder-slate-400 dark:placeholder-slate-500 transition-all outline-none text-base font-medium shadow-sm",value:v,onChange:y=>w(y.target.value)})]}),r.jsx("div",{className:"flex gap-2 overflow-x-auto pb-2",children:x.map(y=>r.jsx("button",{onClick:()=>C(y),className:`px-4 py-2 rounded-lg text-xs font-bold whitespace-nowrap transition-all ${H===y?"bg-purple-600 text-white shadow-sm":"bg-slate-100 dark:bg-slate-800 text-slate-600 dark:text-slate-400 hover:bg-slate-200 dark:hover:bg-slate-700"}`,children:y},y))})]}),r.jsxs("div",{className:"grid grid-cols-2 md:grid-cols-3 gap-4",children:[r.jsxs("div",{className:"bg-purple-50 dark:bg-purple-900/20 rounded-xl p-4 border border-purple-100 dark:border-purple-800",children:[r.jsx("p",{className:"text-2xl font-bold text-purple-600 dark:text-purple-400",children:Xg.totalMedications}),r.jsx("p",{className:"text-xs text-purple-700 dark:text-purple-300 font-medium",children:"Medications"})]}),r.jsxs("div",{className:"bg-pink-50 dark:bg-pink-900/20 rounded-xl p-4 border border-pink-100 dark:border-pink-800",children:[r.jsx("p",{className:"text-2xl font-bold text-pink-600 dark:text-pink-400",children:x.length-1}),r.jsx("p",{className:"text-xs text-pink-700 dark:text-pink-300 font-medium",children:"Categories"})]}),r.jsxs("div",{className:"bg-violet-50 dark:bg-violet-900/20 rounded-xl p-4 border border-violet-100 dark:border-violet-800 col-span-2 md:col-span-1",children:[r.jsx("p",{className:"text-2xl font-bold text-violet-600 dark:text-violet-400",children:"2024"}),r.jsx("p",{className:"text-xs text-violet-700 dark:text-violet-300 font-medium",children:"5th Edition"})]})]}),r.jsx("div",{className:"bg-purple-50 dark:bg-purple-900/20 border border-purple-200 dark:border-purple-800 rounded-xl p-4",children:r.jsxs("div",{className:"flex items-start gap-3",children:[r.jsx(wa,{size:20,className:"text-purple-600 dark:text-purple-400 flex-shrink-0 mt-0.5"}),r.jsxs("div",{children:[r.jsx("h4",{className:"font-bold text-purple-800 dark:text-purple-400 mb-1 text-sm",children:"Important Notice"}),r.jsx("p",{className:"text-xs text-purple-700 dark:text-purple-300 leading-relaxed",children:Xg.disclaimer})]})]})}),r.jsx("div",{className:"flex items-center justify-between px-2",children:r.jsxs("span",{className:"text-xs font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider",children:["Showing ",L.length," of ",$o.length," medications"]})}),L.length===0?r.jsxs("div",{className:"text-center py-12 md:py-20",children:[r.jsx("div",{className:"bg-slate-100 dark:bg-slate-800 rounded-full w-16 h-16 md:w-20 md:h-20 flex items-center justify-center mx-auto mb-4",children:r.jsx(gi,{className:"text-slate-400 dark:text-slate-500",size:32})}),r.jsx("h3",{className:"text-base md:text-lg font-medium text-slate-600 dark:text-slate-300",children:"No medications found"}),r.jsx("p",{className:"text-slate-400 dark:text-slate-500",children:"Try adjusting your search or category filter"})]}):r.jsx("div",{className:"grid gap-4 sm:grid-cols-2 lg:grid-cols-2",children:L.map(y=>r.jsxs("div",{onClick:()=>u(y),className:"bg-white dark:bg-slate-800 rounded-xl p-4 md:p-5 shadow-sm border border-slate-200 dark:border-slate-700 hover:shadow-lg hover:border-purple-200 dark:hover:border-purple-700 transition-all cursor-pointer group relative",children:[r.jsx("div",{className:"flex items-start justify-between mb-3",children:r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-1",children:[r.jsx(Ht,{size:18,className:"text-purple-600 dark:text-purple-400 flex-shrink-0"}),r.jsx("h3",{className:"text-base md:text-lg font-bold text-slate-800 dark:text-slate-100 group-hover:text-purple-600 dark:group-hover:text-purple-400 transition-colors leading-tight",children:y.name})]}),r.jsx("p",{className:"text-xs text-slate-500 dark:text-slate-400 mb-2",children:y.category}),r.jsxs("div",{className:"flex flex-wrap gap-1",children:[y.indications.slice(0,3).map((O,E)=>r.jsx("span",{className:"text-xs bg-purple-50 dark:bg-purple-900/30 text-purple-700 dark:text-purple-300 px-2 py-0.5 rounded-full",children:O},E)),y.indications.length>3&&r.jsxs("span",{className:"text-xs text-slate-400 dark:text-slate-500",children:["+",y.indications.length-3," more"]})]})]})}),r.jsxs("div",{className:"flex items-center justify-between pt-3 border-t border-slate-100 dark:border-slate-700",children:[r.jsxs("div",{className:"flex items-center gap-1 text-xs text-slate-500 dark:text-slate-400",children:[r.jsx(Mt,{size:14}),r.jsx("span",{children:"View Dosing"})]}),r.jsxs("div",{className:"flex items-center text-purple-600 dark:text-purple-400 text-sm font-bold group-hover:translate-x-1 transition-transform",children:["Details ",r.jsx(Lt,{size:16})]})]})]},y.id))}),r.jsx(Mn,{isOpen:!!b,onClose:()=>u(null),children:b&&r.jsxs("div",{className:"bg-white dark:bg-slate-800 w-full",children:[r.jsxs("div",{className:"px-5 md:px-6 py-4 md:py-5 border-b border-slate-100 dark:border-slate-700 bg-purple-50 dark:bg-purple-900/20",children:[r.jsxs("div",{className:"flex items-start gap-3 mb-2",children:[r.jsx(Ht,{size:24,className:"text-purple-600 dark:text-purple-400 flex-shrink-0 mt-1"}),r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsx("h2",{className:"text-xl md:text-2xl font-bold text-slate-900 dark:text-slate-100 leading-tight",children:b.name}),r.jsx("p",{className:"text-sm text-slate-600 dark:text-slate-400 mt-1",children:b.category})]})]}),r.jsx("div",{className:"flex flex-wrap gap-2",children:b.indications.map((y,O)=>r.jsx(xi,{type:"default",children:y},O))})]}),r.jsxs("div",{className:"p-5 md:p-6 space-y-4 max-h-[60vh] overflow-y-auto",children:[r.jsxs("div",{children:[r.jsx("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-3",children:"Dosing Information"}),r.jsx("div",{className:"space-y-3 bg-slate-50 dark:bg-slate-700/50 rounded-lg p-4",children:Object.entries(b.dosing).map(([y,O])=>r.jsxs("div",{className:"border-b border-slate-200 dark:border-slate-600 last:border-0 pb-3 last:pb-0",children:[r.jsx("h4",{className:"text-sm font-bold text-purple-700 dark:text-purple-300 mb-2 capitalize",children:y.replace(/_/g," ")}),typeof O=="object"?r.jsx("div",{className:"space-y-1 text-xs text-slate-700 dark:text-slate-300",children:Object.entries(O).map(([E,J])=>r.jsxs("p",{className:"leading-relaxed",children:[r.jsxs("strong",{className:"text-slate-900 dark:text-slate-100",children:[E.replace(/_/g," "),":"]})," ",J]},E))}):r.jsx("p",{className:"text-sm text-slate-700 dark:text-slate-300",children:O})]},y))})]}),b.route&&r.jsxs("div",{children:[r.jsx("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2",children:"Routes of Administration"}),r.jsx("div",{className:"flex flex-wrap gap-2",children:b.route.map((y,O)=>r.jsx("span",{className:"text-xs bg-blue-50 dark:bg-blue-900/30 text-blue-700 dark:text-blue-300 px-3 py-1 rounded-full font-medium",children:y},O))})]}),b.contraindications&&r.jsxs("div",{children:[r.jsx("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2",children:"Contraindications"}),r.jsx("div",{className:"bg-red-50 dark:bg-red-900/20 border border-red-200 dark:border-red-800 rounded-lg p-3",children:r.jsx("ul",{className:"text-xs text-red-800 dark:text-red-300 space-y-1",children:b.contraindications.map((y,O)=>r.jsxs("li",{children:[" ",y]},O))})})]}),b.monitoring&&r.jsxs("div",{children:[r.jsx("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2",children:"Monitoring"}),r.jsx("div",{className:"flex flex-wrap gap-2",children:b.monitoring.map((y,O)=>r.jsx("span",{className:"text-xs bg-amber-50 dark:bg-amber-900/30 text-amber-700 dark:text-amber-300 px-3 py-1 rounded-full",children:y},O))})]}),b.sideEffects&&r.jsxs("div",{children:[r.jsx("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2",children:"Common Side Effects"}),r.jsx("div",{className:"bg-yellow-50 dark:bg-yellow-900/20 border border-yellow-200 dark:border-yellow-800 rounded-lg p-3",children:r.jsx("ul",{className:"text-xs text-yellow-800 dark:text-yellow-300 space-y-1",children:b.sideEffects.map((y,O)=>r.jsxs("li",{children:[" ",y]},O))})})]}),b.notes&&r.jsxs("div",{children:[r.jsx("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2",children:"Additional Notes"}),r.jsx("p",{className:"text-xs text-slate-700 dark:text-slate-300 bg-slate-50 dark:bg-slate-700/50 p-3 rounded-lg",children:b.notes})]})]}),r.jsx("div",{className:"px-5 md:px-6 py-4 bg-slate-50 dark:bg-slate-800/50 border-t border-slate-100 dark:border-slate-700 flex gap-3",children:r.jsxs("button",{onClick:D,className:"flex-1 bg-purple-600 hover:bg-purple-500 text-white px-4 py-2.5 rounded-lg font-bold transition-all flex items-center justify-center gap-2",children:[r.jsx(Mt,{size:16}),"View Full Protocol"]})})]})})]})},Af=()=>{const[v,w]=_.useState(""),[b,u]=_.useState(null),H=_.useMemo(()=>{if(!v)return Qg;const C=v.toLowerCase(),L=Qg.filter(O=>O.name.toLowerCase().includes(C)||O.dosage.toLowerCase().includes(C)),x=L.filter(O=>O.name.toLowerCase()===C),D=L.filter(O=>O.name.toLowerCase()!==C&&O.name.toLowerCase().startsWith(C)),y=L.filter(O=>O.name.toLowerCase()!==C&&!O.name.toLowerCase().startsWith(C));return x.sort((O,E)=>O.name.localeCompare(E.name)),D.sort((O,E)=>O.name.localeCompare(E.name)),y.sort((O,E)=>O.name.localeCompare(E.name)),[...x,...D,...y]},[v]);return r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6",children:[r.jsxs("div",{className:"sticky top-0 z-20 bg-white/95 dark:bg-slate-900/95 backdrop-blur-md -mx-4 px-4 pb-4 mb-6",children:[r.jsx("div",{className:"flex items-center justify-between py-3 border-b border-slate-200 dark:border-slate-700 mb-4",children:r.jsxs("div",{className:"flex items-center gap-3",children:[r.jsx(ir,{size:24,className:"text-pink-600 dark:text-pink-400"}),r.jsxs("div",{children:[r.jsx("h2",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Frank Shann Drug Doses"}),r.jsx("p",{className:"text-xs text-slate-500 dark:text-slate-400",children:"17th Edition (2017)"})]})]})}),r.jsxs("div",{className:"relative",children:[r.jsx(gi,{className:"absolute left-4 top-1/2 transform -translate-y-1/2 text-slate-400 dark:text-slate-500",size:20}),r.jsx("input",{type:"text",placeholder:"Search Frank Shann formulary...",className:"w-full pl-12 pr-4 py-3.5 bg-slate-100 dark:bg-slate-800 border-transparent focus:bg-white dark:focus:bg-slate-700 focus:border-pink-500 dark:focus:border-pink-400 focus:ring-4 focus:ring-pink-500/10 dark:focus:ring-pink-900/50 rounded-2xl text-slate-800 dark:text-slate-200 placeholder-slate-400 dark:placeholder-slate-500 transition-all outline-none text-base font-medium shadow-sm",value:v,onChange:C=>w(C.target.value)})]}),r.jsx("div",{className:"flex items-center justify-between px-2 mt-3",children:r.jsxs("span",{className:"text-xs font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider",children:["Showing ",H.length," entries"]})})]}),H.length===0?r.jsxs("div",{className:"text-center py-12",children:[r.jsx("div",{className:"bg-slate-100 dark:bg-slate-800 rounded-full w-16 h-16 flex items-center justify-center mx-auto mb-4",children:r.jsx(gi,{className:"text-slate-400 dark:text-slate-500",size:32})}),r.jsx("p",{className:"text-slate-400 dark:text-slate-500",children:"No results found"})]}):r.jsxs("div",{className:"grid gap-4 sm:grid-cols-1",children:[H.slice(0,100).map(C=>r.jsxs("div",{onClick:()=>u(C),className:"bg-white dark:bg-slate-800 rounded-xl p-4 shadow-sm border border-slate-200 dark:border-slate-700 hover:shadow-md hover:border-pink-300 dark:hover:border-pink-700 transition-all cursor-pointer group",children:[r.jsxs("div",{className:"flex items-center justify-between",children:[r.jsx("h3",{className:"font-bold text-slate-800 dark:text-slate-100 group-hover:text-pink-600 dark:group-hover:text-pink-400 transition-colors",children:C.name}),r.jsx(Lt,{size:16,className:"text-slate-300 dark:text-slate-600 group-hover:text-pink-500 dark:group-hover:text-pink-400 transition-colors"})]}),r.jsx("p",{className:"text-sm text-slate-500 dark:text-slate-400 line-clamp-2 mt-1 font-mono bg-slate-50 dark:bg-slate-900/50 p-2 rounded-lg",children:C.dosage})]},C.id)),H.length>100&&r.jsx("div",{className:"text-center py-4 text-slate-400 dark:text-slate-500 text-sm italic",children:"Showing first 100 results. Refine search to see more."})]}),r.jsx(Mn,{isOpen:!!b,onClose:()=>u(null),children:b&&r.jsxs("div",{className:"bg-white dark:bg-slate-800 w-full",children:[r.jsxs("div",{className:"px-5 md:px-6 py-4 border-b border-slate-100 dark:border-slate-700 bg-pink-50 dark:bg-pink-900/20",children:[r.jsx("h2",{className:"text-xl font-bold text-slate-900 dark:text-slate-100",children:b.name}),r.jsx("p",{className:"text-xs text-pink-600 dark:text-pink-400 font-mono mt-1",children:b.id})]}),r.jsx("div",{className:"p-6 max-h-[70vh] overflow-y-auto",children:r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 rounded-lg p-4 border border-slate-100 dark:border-slate-600",children:[r.jsxs("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-3 flex items-center gap-2",children:[r.jsx(Mt,{size:16})," Dosage & Information"]}),r.jsx("p",{className:"text-base text-slate-800 dark:text-slate-200 whitespace-pre-wrap leading-relaxed font-medium",children:b.dosage})]})}),r.jsx("div",{className:"px-5 md:px-6 py-4 bg-slate-50 dark:bg-slate-800/50 border-t border-slate-100 dark:border-slate-700",children:r.jsxs("p",{className:"text-xs text-slate-500 dark:text-slate-400 text-center",children:[r.jsx("strong",{children:"Source:"})," Frank Shann 17th Edition. Always verify with clinical judgment."]})})]})})]})},kf=()=>{const[v,w]=_.useState("frankshann");return r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6 space-y-6 md:space-y-8",children:[r.jsxs("div",{className:"flex p-1 bg-slate-100 dark:bg-slate-800 rounded-xl mb-6",children:[r.jsxs("button",{onClick:()=>w("frankshann"),className:`flex-1 py-2.5 text-sm font-bold rounded-lg transition-all flex items-center justify-center gap-2 ${v==="frankshann"?"bg-white dark:bg-slate-700 shadow-sm text-pink-600 dark:text-pink-400":"text-slate-500 dark:text-slate-400 hover:text-slate-700 dark:hover:text-slate-300"}`,children:[r.jsx(ir,{size:16})," Frank Shann"]}),r.jsxs("button",{onClick:()=>w("protocol"),className:`flex-1 py-2.5 text-sm font-bold rounded-lg transition-all flex items-center justify-center gap-2 ${v==="protocol"?"bg-white dark:bg-slate-700 shadow-sm text-purple-600 dark:text-purple-400":"text-slate-500 dark:text-slate-400 hover:text-slate-700 dark:hover:text-slate-300"}`,children:[r.jsx(Pt,{size:16})," Paediatric Protocol"]})]}),r.jsx("div",{className:"animate-in fade-in slide-in-from-bottom-4 duration-300",children:v==="frankshann"?r.jsx(Af,{}):r.jsx(bf,{})})]})},vf=()=>{const[v,w]=_.useState(""),[b,u]=_.useState(null),[H,C]=_.useState("All"),L=_.useMemo(()=>{let x=Ed;if(H!=="All"&&(x=x.filter(D=>D.pharmacologicalGroup===H)),v){const D=v.toLowerCase();x=x.filter(y=>y.name.toLowerCase().includes(D)||y.pharmacologicalGroup.toLowerCase().includes(D)||y.indication.toLowerCase().includes(D))}return x},[v,H]);return _.useMemo(()=>["All",...[...new Set(Ed.map(D=>D.pharmacologicalGroup))].sort()],[]),r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-6",children:[r.jsxs("div",{className:"sticky top-0 z-20 bg-white/95 dark:bg-slate-900/95 backdrop-blur-md -mx-4 px-4 pb-4 mb-6",children:[r.jsx("div",{className:"flex items-center justify-between py-3 border-b border-slate-200 dark:border-slate-700 mb-4",children:r.jsxs("div",{className:"flex items-center gap-3",children:[r.jsx(er,{size:24,className:"text-emerald-600 dark:text-emerald-400"}),r.jsxs("div",{children:[r.jsx("h2",{className:"font-bold text-slate-800 dark:text-slate-100",children:"Counseling Points"}),r.jsxs("p",{className:"text-xs text-slate-500 dark:text-slate-400",children:[Ed.length," Medications"]})]})]})}),r.jsxs("div",{className:"relative",children:[r.jsx(gi,{className:"absolute left-4 top-1/2 transform -translate-y-1/2 text-slate-400 dark:text-slate-500",size:20}),r.jsx("input",{type:"text",placeholder:"Search medications...",className:"w-full pl-12 pr-4 py-3.5 bg-slate-100 dark:bg-slate-800 border-transparent focus:bg-white dark:focus:bg-slate-700 focus:border-emerald-500 dark:focus:border-emerald-400 focus:ring-4 focus:ring-emerald-500/10 dark:focus:ring-emerald-900/50 rounded-2xl text-slate-800 dark:text-slate-200 placeholder-slate-400 dark:placeholder-slate-500 transition-all outline-none text-base font-medium shadow-sm",value:v,onChange:x=>w(x.target.value)})]})]}),L.length===0?r.jsxs("div",{className:"text-center py-12 md:py-20",children:[r.jsx("div",{className:"bg-slate-100 dark:bg-slate-800 rounded-full w-16 h-16 md:w-20 md:h-20 flex items-center justify-center mx-auto mb-4",children:r.jsx(gi,{className:"text-slate-400 dark:text-slate-500",size:32})}),r.jsx("h3",{className:"text-base md:text-lg font-medium text-slate-600 dark:text-slate-300",children:"No medications found"}),r.jsx("p",{className:"text-slate-400 dark:text-slate-500",children:"Try adjusting your search or filter"})]}):r.jsx("div",{className:"grid gap-4 sm:grid-cols-2 lg:grid-cols-2",children:L.map(x=>r.jsxs("div",{onClick:()=>u(x),className:"bg-white dark:bg-slate-800 rounded-xl p-4 md:p-5 shadow-sm border border-slate-200 dark:border-slate-700 hover:shadow-lg hover:border-emerald-200 dark:hover:border-emerald-700 transition-all cursor-pointer group relative",children:[r.jsx("div",{className:"flex items-start justify-between mb-3",children:r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-1",children:[r.jsx(_g,{size:18,className:"text-emerald-600 dark:text-emerald-400 flex-shrink-0"}),r.jsx("h3",{className:"text-base md:text-lg font-bold text-slate-800 dark:text-slate-100 group-hover:text-emerald-600 dark:group-hover:text-emerald-400 transition-colors leading-tight",children:x.name})]}),r.jsx("p",{className:"text-xs text-slate-500 dark:text-slate-400 mb-2",children:x.pharmacologicalGroup}),r.jsx("p",{className:"text-xs text-slate-600 dark:text-slate-300 line-clamp-2",children:x.indication})]})}),r.jsxs("div",{className:"flex items-center justify-between pt-3 border-t border-slate-100 dark:border-slate-700",children:[r.jsxs("div",{className:"flex items-center gap-1 text-xs text-slate-500 dark:text-slate-400",children:[r.jsx(er,{size:14}),r.jsx("span",{children:"Counseling Info"})]}),r.jsxs("div",{className:"flex items-center text-emerald-600 dark:text-emerald-400 text-sm font-bold group-hover:translate-x-1 transition-transform",children:["Details ",r.jsx(Lt,{size:16})]})]})]},x.id))}),r.jsx(Mn,{isOpen:!!b,onClose:()=>u(null),children:b&&r.jsxs("div",{className:"bg-white dark:bg-slate-800 w-full",children:[r.jsx("div",{className:"px-5 md:px-6 py-4 md:py-5 border-b border-slate-100 dark:border-slate-700 bg-emerald-50 dark:bg-emerald-900/20",children:r.jsxs("div",{className:"flex items-start gap-3 mb-2",children:[r.jsx(_g,{size:24,className:"text-emerald-600 dark:text-emerald-400 flex-shrink-0 mt-1"}),r.jsxs("div",{className:"flex-1 min-w-0",children:[r.jsx("h2",{className:"text-xl md:text-2xl font-bold text-slate-900 dark:text-slate-100 leading-tight",children:b.name}),r.jsx("p",{className:"text-sm text-slate-600 dark:text-slate-400 mt-1",children:b.pharmacologicalGroup})]})]})}),r.jsxs("div",{className:"p-5 md:p-6 space-y-4 max-h-[70vh] overflow-y-auto",children:[r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 rounded-lg p-4",children:[r.jsxs("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2 flex items-center gap-2",children:[r.jsx(Ca,{size:16})," Indication"]}),r.jsx("p",{className:"text-sm text-slate-700 dark:text-slate-300",children:b.indication})]}),r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 rounded-lg p-4",children:[r.jsxs("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2 flex items-center gap-2",children:[r.jsx(Hd,{size:16})," Dosage"]}),r.jsx("p",{className:"text-sm text-slate-700 dark:text-slate-300",children:b.dosage})]}),r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-700/50 rounded-lg p-4",children:[r.jsxs("h3",{className:"text-sm font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider mb-2 flex items-center gap-2",children:[r.jsx(Ht,{size:16})," Method of Administration"]}),r.jsx("div",{className:"space-y-2",children:b.methodOfAdministration.split(/(?=\d+\.\s)/).filter(x=>x.trim()).map((x,D)=>r.jsx("p",{className:"text-sm text-slate-700 dark:text-slate-300",children:x.trim()},D))})]}),b.specialConsiderations&&r.jsxs("div",{className:"space-y-2",children:[r.jsxs("h3",{className:"font-semibold text-gray-900 dark:text-white flex items-center gap-2",children:[r.jsx(wa,{size:18,className:"text-amber-500"}),"Special Considerations"]}),r.jsxs("div",{className:"space-y-3",children:[b.specialConsiderations.pregnancy&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Pregnancy"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.pregnancy})]}),b.specialConsiderations.breastfeeding&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Breastfeeding"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.breastfeeding})]}),b.specialConsiderations.elderly&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Elderly"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.elderly})]}),b.specialConsiderations.paediatric&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Paediatric"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.paediatric})]}),b.specialConsiderations.fasting&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Fasting"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.fasting})]}),b.specialConsiderations.hepaticImpairment&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Hepatic Impairment"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.hepaticImpairment})]}),b.specialConsiderations.renalImpairment&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Renal Impairment"}),r.jsx("p",{className:"text-sm text-gray-600 dark:text-gray-400 pl-4",children:b.specialConsiderations.renalImpairment})]}),b.specialConsiderations.other&&b.specialConsiderations.other.length>0&&r.jsxs("div",{className:"space-y-1",children:[r.jsx("h4",{className:"font-medium text-sm text-gray-700 dark:text-gray-300",children:"Other"}),r.jsx("ul",{className:"list-disc list-inside text-sm text-gray-600 dark:text-gray-400 pl-4 space-y-1",children:b.specialConsiderations.other.map((x,D)=>r.jsx("li",{children:x},D))})]})]})]}),b.sideEffects&&b.sideEffects.length>0&&r.jsxs("div",{className:"bg-amber-50 dark:bg-amber-900/20 border border-amber-200 dark:border-amber-800 rounded-lg p-4",children:[r.jsxs("h3",{className:"text-sm font-bold text-amber-800 dark:text-amber-400 mb-3 flex items-center gap-2",children:[r.jsx(wa,{size:16})," Side Effects & Management"]}),r.jsx("ul",{className:"space-y-2",children:b.sideEffects.map((x,D)=>r.jsxs("li",{className:"flex items-start gap-2",children:[r.jsx(wa,{size:14,className:"flex-shrink-0 mt-0.5 text-amber-600 dark:text-amber-400"}),r.jsx("span",{className:"text-sm text-amber-900 dark:text-amber-300",children:x})]},D))})]}),b.others&&r.jsxs("div",{className:"space-y-3",children:[b.others.contraindications&&r.jsxs("div",{className:"bg-red-50 dark:bg-red-900/20 border border-red-200 dark:border-red-800 rounded-lg p-3",children:[r.jsx("h4",{className:"text-xs font-bold text-red-800 dark:text-red-400 mb-1",children:"Contraindications"}),r.jsx("p",{className:"text-xs text-red-700 dark:text-red-300",children:b.others.contraindications})]}),b.others.drugInteractions&&r.jsxs("div",{className:"bg-orange-50 dark:bg-orange-900/20 border border-orange-200 dark:border-orange-800 rounded-lg p-3",children:[r.jsx("h4",{className:"text-xs font-bold text-orange-800 dark:text-orange-400 mb-1",children:"Drug Interactions"}),r.jsx("p",{className:"text-xs text-orange-700 dark:text-orange-300",children:b.others.drugInteractions})]}),b.others.monitoring&&r.jsxs("div",{className:"bg-purple-50 dark:bg-purple-900/20 border border-purple-200 dark:border-purple-800 rounded-lg p-3",children:[r.jsx("h4",{className:"text-xs font-bold text-purple-800 dark:text-purple-400 mb-1",children:"Monitoring Parameters"}),r.jsx("p",{className:"text-xs text-purple-700 dark:text-purple-300",children:b.others.monitoring})]}),b.others.counselingPoints&&r.jsxs("div",{className:"bg-emerald-50 dark:bg-emerald-900/20 border border-emerald-200 dark:border-emerald-800 rounded-lg p-4",children:[r.jsxs("h4",{className:"text-sm font-bold text-emerald-800 dark:text-emerald-400 mb-2 flex items-center gap-2",children:[r.jsx(er,{size:16})," Patient Counseling Points"]}),r.jsx("ul",{className:"text-xs text-emerald-700 dark:text-emerald-300 space-y-1.5",children:b.others.counselingPoints.map((x,D)=>r.jsxs("li",{className:"flex items-start gap-2",children:[r.jsx("span",{className:"text-emerald-500 dark:text-emerald-400 font-bold",children:""}),r.jsx("span",{children:x})]},D))})]})]})]}),r.jsx("div",{className:"px-5 md:px-6 py-4 bg-slate-50 dark:bg-slate-800/50 border-t border-slate-100 dark:border-slate-700",children:r.jsxs("div",{className:"flex items-start gap-2",children:[r.jsx(Mt,{size:16,className:"text-slate-400 dark:text-slate-500 flex-shrink-0 mt-0.5"}),r.jsxs("p",{className:"text-xs text-slate-500 dark:text-slate-400 leading-relaxed",children:[r.jsx("strong",{children:"Source:"})," ",Zg.title," | Updated: ",Zg.lastUpdated]})]})})]})})]})};function Nf(v,w){const[b,u]=_.useState(v);return _.useEffect(()=>{const H=setTimeout(()=>{u(v)},w);return()=>{clearTimeout(H)}},[v,w]),b}function If(){const[v,w]=_.useState(""),b=Nf(v,300),[u,H]=_.useState(20),[C,L]=_.useState([]),[x,D]=_.useState(null),[y,O]=_.useState("list"),[E,J]=_.useState("formulary"),[ze,Be]=_.useState(!1),Ce=mf;_.useEffect(()=>{const j=window.matchMedia("(prefers-color-scheme: dark)"),ae=we=>Be(we.matches);return j.addEventListener("change",ae),()=>j.removeEventListener("change",ae)},[]),_.useEffect(()=>{ze?document.documentElement.classList.add("dark"):document.documentElement.classList.remove("dark")},[ze]),_.useEffect(()=>{const j=localStorage.getItem("formulary_favorites");if(j)try{L(JSON.parse(j))}catch{console.error("Failed to parse favorites")}},[]),_.useEffect(()=>{localStorage.setItem("formulary_favorites",JSON.stringify(C))},[C]),_.useEffect(()=>{H(20),window.scrollTo({top:0,behavior:"smooth"})},[b,y,E]);const Ti=()=>{H(j=>j+20)},Ge=(j,ae)=>{j.stopPropagation(),C.includes(ae)?L(we=>we.filter(Ae=>Ae!==ae)):L(we=>[...we,ae])},Ke=_.useMemo(()=>{let j=Ce;return y==="favorites"&&(j=j.filter(ae=>C.includes(ae.id))),j.filter(ae=>{const we=b.toLowerCase();return ae.genericName&&ae.genericName.toLowerCase().includes(we)||ae.brandName&&ae.brandName.toLowerCase().includes(we)})},[b,C,y,Ce]);return r.jsxs("div",{className:"min-h-screen bg-gray-50 dark:bg-slate-900 font-sans text-gray-900 dark:text-gray-100 transition-colors",children:[r.jsx("div",{className:"sticky top-0 z-30 bg-white/95 dark:bg-slate-800/95 backdrop-blur-sm border-b border-slate-200 dark:border-slate-700 shadow-sm transition-all",children:r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-2",children:[r.jsxs("div",{className:"flex items-center justify-between mb-2 gap-3",children:[r.jsxs("div",{className:"flex items-center gap-2 md:gap-3",children:[r.jsx("div",{className:"bg-white p-0.5 rounded-full shadow-sm border border-slate-100 dark:border-slate-700 w-10 h-10 md:w-12 md:h-12 flex items-center justify-center overflow-hidden shrink-0",children:r.jsx("img",{src:"/hsm-logo.jpg",alt:"HSM Logo",className:"w-full h-full object-cover"})}),r.jsxs("div",{children:[r.jsx("h1",{className:"text-lg md:text-xl font-extrabold text-slate-800 dark:text-slate-100 leading-none tracking-tight",children:"HOSPITAL SERI MANJUNG"}),r.jsx("p",{className:"text-[10px] md:text-xs text-slate-500 dark:text-slate-400 font-semibold mt-0.5 tracking-wide uppercase",children:"Official Formulary & Guidelines"}),E==="formulary"&&r.jsx("p",{className:"text-[10px] text-teal-600 dark:text-teal-400 font-bold mt-0.5",children:"Updated: 2 October 2025"})]})]}),r.jsx("div",{className:"flex items-center gap-2",children:r.jsx("div",{className:"hidden md:flex items-center px-3 py-1 bg-slate-100 dark:bg-slate-800 border border-slate-200 dark:border-slate-700 rounded-full",children:r.jsx("span",{className:"text-[10px] font-bold text-slate-500 dark:text-slate-400 uppercase tracking-wider",children:"Authorized Personnel Only"})})})]}),E==="formulary"&&r.jsxs("div",{className:"relative mb-1",children:[r.jsxs("div",{className:"relative group",children:[r.jsx(gi,{className:"absolute left-3 top-1/2 transform -translate-y-1/2 text-slate-400 dark:text-slate-500 transition-colors group-focus-within:text-teal-500",size:18}),r.jsx("input",{type:"text",placeholder:"Search by generic or brand name...",className:"w-full pl-10 pr-12 py-2.5 bg-slate-100 dark:bg-slate-800/50 border border-transparent focus:bg-white dark:focus:bg-slate-800 focus:border-teal-500 dark:focus:border-teal-400 focus:ring-4 focus:ring-teal-500/10 dark:focus:ring-teal-900/50 rounded-xl text-slate-800 dark:text-slate-200 placeholder-slate-400 dark:placeholder-slate-500 transition-all outline-none text-sm md:text-base font-medium shadow-sm",value:v,onChange:j=>w(j.target.value)}),r.jsx("button",{onClick:()=>O(y==="list"?"favorites":"list"),className:`absolute right-2 top-1/2 transform -translate-y-1/2 p-1.5 rounded-lg transition-all ${y==="favorites"?"bg-rose-50 dark:bg-rose-900/30 text-rose-500 dark:text-rose-400":"text-slate-400 dark:text-slate-500 hover:text-slate-600 dark:hover:text-slate-300 hover:bg-slate-200 dark:hover:bg-slate-700"}`,title:"Toggle Favorites",children:r.jsx(Dd,{size:18,fill:y==="favorites"?"currentColor":"none"})})]}),r.jsx("div",{className:"md:hidden mt-3 flex gap-2 overflow-x-auto pb-1 no-scrollbar",children:r.jsxs("button",{onClick:()=>J("abx"),className:"flex items-center gap-1.5 px-3 py-1.5 bg-amber-50 dark:bg-amber-900/20 border border-amber-200 dark:border-amber-800 rounded-full flex-shrink-0",children:[r.jsx(Ca,{size:13,className:"text-amber-600 dark:text-amber-400"}),r.jsx("span",{className:"text-xs font-bold text-amber-700 dark:text-amber-300",children:"Renal Dosing"})]})})]})]})}),r.jsx("div",{className:"pb-20",children:E==="nag"?r.jsx(pf,{}):E==="abx"?r.jsx(ff,{}):E==="dilution"?r.jsx(yf,{}):E==="paediatric"?r.jsx(kf,{}):E==="counseling"?r.jsx(vf,{}):r.jsxs("div",{className:"max-w-4xl mx-auto px-4 py-4 md:py-6",children:[Ce.length>0&&r.jsx("div",{className:"flex items-center justify-between mb-4 px-2",children:r.jsxs("span",{className:"text-xs font-bold text-slate-400 dark:text-slate-500 uppercase tracking-wider",children:["Showing ",Ke.length," of ",Ce.length," medications"]})}),Ke.length===0?r.jsxs("div",{className:"text-center py-12 md:py-20",children:[r.jsx("div",{className:"bg-slate-100 dark:bg-slate-800 rounded-full w-16 h-16 md:w-20 md:h-20 flex items-center justify-center mx-auto mb-4",children:r.jsx(gi,{className:"text-slate-400 dark:text-slate-500",size:32})}),r.jsx("h3",{className:"text-base md:text-lg font-medium text-slate-600 dark:text-slate-300",children:"No medications found"}),r.jsx("p",{className:"text-slate-400 dark:text-slate-500",children:"Try adjusting your search or filters"})]}):r.jsx("div",{className:"grid gap-4 sm:grid-cols-2 lg:grid-cols-2",children:Ke.slice(0,u).map(j=>r.jsxs("div",{onClick:()=>D(j),className:"bg-white dark:bg-slate-800 rounded-xl p-4 md:p-5 shadow-sm border border-slate-200 dark:border-slate-700 hover:shadow-lg hover:border-teal-200 dark:hover:border-teal-700 transition-all cursor-pointer group relative",children:[r.jsxs("div",{className:"flex justify-between items-start mb-3",children:[r.jsxs("div",{className:"flex-1 pr-2 min-w-0",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-1 flex-wrap",children:[r.jsx("h3",{className:"text-base md:text-lg font-bold text-slate-800 dark:text-slate-100 group-hover:text-teal-600 dark:group-hover:text-teal-400 transition-colors leading-tight break-words",children:j.genericName}),j.highAlert&&r.jsx(wa,{size:16,className:"text-rose-500 dark:text-rose-400 flex-shrink-0"})]}),r.jsx("p",{className:"text-sm font-medium text-slate-400 dark:text-slate-500 uppercase tracking-wide",children:j.brandName})]}),r.jsx("button",{onClick:ae=>Ge(ae,j.id),className:`p-2 rounded-full transition-all flex-shrink-0 min-h-[40px] min-w-[40px] flex items-center justify-center ${C.includes(j.id)?"text-rose-500 dark:text-rose-400 bg-rose-50 dark:bg-rose-900/30":"text-slate-300 dark:text-slate-600 hover:text-slate-500 dark:hover:text-slate-400 hover:bg-slate-50 dark:hover:bg-slate-700"}`,children:r.jsx(Dd,{size:20,fill:C.includes(j.id)?"currentColor":"none"})})]}),r.jsxs("div",{className:"flex flex-wrap gap-2 mb-4",children:[r.jsx(xi,{type:"category",children:j.category}),j.notes&&j.notes.toLowerCase().includes("kuota")&&r.jsx(xi,{type:"highAlert",children:"KUOTA"}),j.notes&&(()=>{const ae=j.notes.match(/Dept:\s*([^\)\n]+)/i);return ae?ae[1].split(/[,;]/).map(Ae=>Ae.trim()).filter(Ae=>Ae.length>0).map((Ae,X)=>r.jsx(xi,{type:"prescriber",children:Ae},X)):null})(),j.prescriberCat&&j.prescriberCat!=="N/A"&&r.jsxs(xi,{type:"prescriber",children:["Cat: ",j.prescriberCat]}),j.highAlert&&r.jsx(xi,{type:"highAlert",children:"High Alert"})]}),r.jsx("div",{className:"space-y-2 text-sm text-slate-600 dark:text-slate-300 mb-4",children:r.jsxs("p",{className:"flex items-start gap-2",children:[r.jsx(Ca,{size:14,className:"text-slate-400 dark:text-slate-500 mt-1 flex-shrink-0"}),r.jsx("span",{className:"line-clamp-2 font-medium",children:j.indications})]})}),r.jsxs("div",{className:"flex items-center justify-between pt-4 border-t border-slate-100 dark:border-slate-700",children:[r.jsx("span",{className:"text-xs font-bold text-slate-400 dark:text-slate-500",children:j.price&&j.price!=="N/A"?`RM ${j.price}`:"Price N/A"}),r.jsxs("div",{className:"flex items-center text-teal-600 dark:text-teal-400 text-sm font-bold group-hover:translate-x-1 transition-transform",children:["Details ",r.jsx(Lt,{size:16})]})]})]},j.id))}),Ke.length>u&&r.jsx("div",{className:"mt-8 text-center",children:r.jsxs("button",{onClick:Ti,className:"bg-white dark:bg-slate-800 hover:bg-slate-50 dark:hover:bg-slate-700 text-slate-600 dark:text-slate-300 font-bold py-3 px-8 rounded-xl shadow-sm border border-slate-200 dark:border-slate-700 transition-all transform hover:-translate-y-0.5",children:["Load More Results (",Ke.length-u," remaining)"]})})]})}),r.jsx(Mn,{isOpen:!!x,onClose:()=>D(null),children:x&&r.jsxs("div",{className:"bg-white dark:bg-slate-800 w-full",children:[r.jsxs("div",{className:"px-5 md:px-6 py-4 md:py-5 border-b border-slate-100 dark:border-slate-700 flex items-start justify-between bg-slate-50 dark:bg-slate-800/50",children:[r.jsxs("div",{className:"flex-1 pr-4 min-w-0",children:[r.jsxs("div",{className:"flex items-center gap-2 mb-1 flex-wrap",children:[r.jsx("h2",{className:"text-xl md:text-2xl font-bold text-slate-900 dark:text-slate-100 leading-tight break-words",children:x.genericName}),x.highAlert&&r.jsxs("span",{className:"flex items-center gap-1 text-xs font-bold text-rose-600 dark:text-rose-400 bg-rose-100 dark:bg-rose-900/30 px-2 py-0.5 rounded-full border border-rose-200 dark:border-rose-800",children:[r.jsx(wa,{size:12})," HIGH ALERT"]})]}),r.jsx("p",{className:"text-base md:text-lg text-slate-500 dark:text-slate-400 font-medium",children:x.brandName})]}),r.jsx("button",{onClick:j=>Ge(j,x.id),className:`p-2 rounded-full min-h-[44px] min-w-[44px] flex items-center justify-center ${C.includes(x.id)?"text-rose-500 dark:text-rose-400 bg-rose-50 dark:bg-rose-900/30":"text-slate-300 dark:text-slate-600 hover:text-slate-500 dark:hover:text-slate-400 hover:bg-slate-50 dark:hover:bg-slate-700"}`,children:r.jsx(Dd,{size:24,fill:C.includes(x.id)?"currentColor":"none"})})]}),r.jsxs("div",{className:"p-5 md:p-6",children:[r.jsxs("div",{className:"flex flex-wrap gap-2 mb-6",children:[r.jsx(xi,{type:"category",children:x.category}),x.prescriberCat&&x.prescriberCat!=="N/A"&&r.jsxs(xi,{type:"prescriber",children:["Prescriber: ",x.prescriberCat]}),x.forms.map((j,ae)=>r.jsx(xi,{type:"form",children:j},ae))]}),r.jsxs("div",{className:"space-y-1",children:[r.jsx(Ii,{icon:Ca,label:"Indications",value:x.indications}),r.jsx(Ii,{icon:Hd,label:"Dosing Regimen",value:x.dosing}),r.jsx(Ii,{icon:nf,label:"Renal Adjustments",value:x.renalDose,warning:!0}),r.jsx(Ii,{icon:Pt,label:"Pregnancy Category",value:x.pregnancy}),r.jsx(Ii,{icon:$g,label:"Notes & Remarks",value:x.notes}),r.jsx(Ii,{icon:_p,label:"Price / Unit",value:x.price?`RM ${x.price}`:"N/A"}),r.jsx(Ii,{icon:iu,label:"Prescriber Category",value:x.prescriberCat})]})]}),r.jsxs("div",{className:"bg-slate-50 dark:bg-slate-800/50 px-5 md:px-6 py-4 border-t border-slate-100 dark:border-slate-700 text-xs text-center text-slate-400 dark:text-slate-500",children:["Reference ID: ",x.id,"  Source: HSM Formulary 2025"]})]})}),r.jsx("div",{className:"fixed bottom-0 left-0 right-0 bg-white dark:bg-slate-800 border-t border-slate-200 dark:border-slate-700 z-40 pb-safe",children:r.jsxs("div",{className:"max-w-4xl mx-auto flex justify-between md:justify-around items-center h-16 overflow-x-auto no-scrollbar px-2",children:[r.jsxs("button",{onClick:()=>J("formulary"),className:`flex flex-col items-center justify-center min-w-[64px] h-full space-y-1 ${E==="formulary"?"text-teal-600 dark:text-teal-400":"text-slate-400 dark:text-slate-500"}`,children:[r.jsx(gi,{size:20}),r.jsx("span",{className:"text-[10px] font-medium",children:"Formulary"})]}),r.jsxs("button",{onClick:()=>J("nag"),className:`flex flex-col items-center justify-center min-w-[64px] h-full space-y-1 ${E==="nag"?"text-blue-600 dark:text-blue-400":"text-slate-400 dark:text-slate-500"}`,children:[r.jsx(eu,{size:20}),r.jsx("span",{className:"text-[10px] font-medium",children:"NAG"})]}),r.jsxs("button",{onClick:()=>J("abx"),className:`flex flex-col items-center justify-center min-w-[64px] h-full space-y-1 ${E==="abx"?"text-emerald-600 dark:text-emerald-400":"text-slate-400 dark:text-slate-500"}`,children:[r.jsx(Ca,{size:20}),r.jsx("span",{className:"text-[10px] font-medium",children:"Renal"})]}),r.jsxs("button",{onClick:()=>J("dilution"),className:`flex flex-col items-center justify-center min-w-[64px] h-full space-y-1 ${E==="dilution"?"text-amber-600 dark:text-amber-400":"text-slate-400 dark:text-slate-500"}`,children:[r.jsx(Rd,{size:20}),r.jsx("span",{className:"text-[10px] font-medium",children:"Dilution"})]}),r.jsxs("button",{onClick:()=>J("paediatric"),className:`flex flex-col items-center justify-center min-w-[64px] h-full space-y-1 ${E==="paediatric"?"text-purple-600 dark:text-purple-400":"text-slate-400 dark:text-slate-500"}`,children:[r.jsx(Pt,{size:20}),r.jsx("span",{className:"text-[10px] font-medium",children:"Paeds"})]}),r.jsxs("button",{onClick:()=>J("counseling"),className:`flex flex-col items-center justify-center min-w-[64px] h-full space-y-1 ${E==="counseling"?"text-emerald-600 dark:text-emerald-400":"text-slate-400 dark:text-slate-500"}`,children:[r.jsx(er,{size:20}),r.jsx("span",{className:"text-[10px] font-medium",children:"Counsel"})]})]})}),r.jsx("footer",{className:"bg-white dark:bg-slate-800 border-t border-slate-200 dark:border-slate-700 py-8 mt-auto mb-16",children:r.jsxs("div",{className:"max-w-4xl mx-auto px-4 text-center",children:[r.jsxs("div",{className:"flex items-center justify-center gap-2 mb-4 text-teal-600 dark:text-teal-400",children:[r.jsx(ir,{size:24}),r.jsx("span",{className:"font-bold text-lg tracking-tight",children:"Hospital Seri Manjung"})]}),r.jsx("p",{className:"text-slate-500 dark:text-slate-400 text-sm mb-2",children:" 2025 Hospital Seri Manjung. All Rights Reserved."}),r.jsxs("p",{className:"text-xs text-slate-400 dark:text-slate-500 mb-3",children:["For additions or to report issues, please contact ",r.jsx("span",{className:"font-semibold text-slate-600 dark:text-slate-300",children:"Syahidah"})]}),r.jsx("p",{className:"text-xs text-slate-400 dark:text-slate-500 uppercase tracking-widest font-semibold",children:"AUTHORIZED PERSONNEL ONLY. FOR THE USE OF HOSPITAL SERI MANJUNG STAFF ONLY"})]})})]})}Pp.createRoot(document.getElementById("root")).render(r.jsx(_.StrictMode,{children:r.jsx(If,{})}));
